PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Foley, CJ; Fanjul-Fernandez, M; Bohm, A; Nguyen, N; Agarwal, A; Austin, K; Koukos, G; Covic, L; Lopez-Otin, C; Kuliopulos, A				Foley, C. J.; Fanjul-Fernandez, M.; Bohm, A.; Nguyen, N.; Agarwal, A.; Austin, K.; Koukos, G.; Covic, L.; Lopez-Otin, C.; Kuliopulos, A.			Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis	ONCOGENE			English	Article						angiogenesis; lung cancer; Mmp1a; MMP1; PAR1	CELL-PENETRATING PEPDUCINS; BREAST-CANCER CELLS; ACTIVATED RECEPTOR-1; 13-DEFICIENT MICE; ENDOTHELIAL-CELLS; SIGNALING SYSTEM; POOR-PROGNOSIS; OVARIAN-CANCER; EXPRESSION; GENE	Matrix metalloprotease-1 (MMP1) is an important mediator of tumorigenesis, inflammation and tissue remodeling through its ability to degrade critical matrix components. Recent studies indicate that stromal-derived MMP1 may exert direct oncogenic activity by signaling through protease-activated receptor-1 (PAR1) in carcinoma cells; however, this has not been established in vivo. We generated an Mmp1a knockout mouse to ascertain whether stromal-derived Mmp1a affects tumor growth. Mmp1a-deficient mice are grossly normal and born in Mendelian ratios; however, deficiency of Mmp1a results in significantly decreased growth and angiogenesis of lung tumors. Coimplantation of lung cancer cells with wild-type Mmp1a(+/+) fibroblasts completely restored tumor growth in Mmp1a-deficient animals, highlighting the critical role of stromal-derived Mmp1a. Silencing of PAR1 expression in the lung carcinoma cells phenocopied stromal Mmp1a-deficiency, thus validating tumor-derived PAR1 as an Mmp1a target. Mmp1a secretion is controlled by the ability of its prodomain to facilitate autocleavage, whereas human MMP1 is efficiently secreted because of stable pro-and catalytic domain interactions. Taken together, these data demonstrate that stromal Mmp1a drives in vivo tumorigenesis and provide proof of concept that targeting the MMP1-PAR1 axis may afford effective treatments of lung cancer.	[Foley, C. J.; Nguyen, N.; Agarwal, A.; Austin, K.; Koukos, G.; Covic, L.; Kuliopulos, A.] Tufts Univ, Sch Med, Tufts Med Ctr, Div Hematol Oncol,Mol Oncol Res Inst, Boston, MA 02111 USA; [Foley, C. J.; Bohm, A.; Austin, K.; Koukos, G.; Covic, L.; Kuliopulos, A.] Tufts Univ, Sch Med, Dept Biochem, Sackler Sch Grad Biomed Sci,Program Genet, Boston, MA 02111 USA; [Foley, C. J.; Bohm, A.; Austin, K.; Koukos, G.; Covic, L.; Kuliopulos, A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Fanjul-Fernandez, M.; Lopez-Otin, C.] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain	Tufts Medical Center; Tufts University; Tufts University; Tufts University; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, Div Hematol Oncol,Mol Oncol Res Inst, 75 Kneeland St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	López-Otín, Carlos/AAB-2106-2020; Koukos, Georgios/B-1544-2009	López-Otín, Carlos/0000-0001-6964-1904; Koukos, Georgios/0000-0002-9470-0651; Miriam, Fanjul Fernandez/0000-0002-0074-2325	NIH [F30-HL104835, CA122992, HL64701, CA104406]; NATIONAL CANCER INSTITUTE [R01CA122992, R01CA104406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL104835, R01HL064701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Sheida Sharifi for her expertise in quantifying tumor angiogenesis, and Rutika V Pradhan and Namrata Nammi for the analysis of endothelial tube formation. This work was supported, in part, by NIH grants F30-HL104835 (to CJF), CA122992, HL64701 (to AK) and CA104406 (to LC).	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; BOLON I, 1995, AM J PATHOL, V147, P1298; Bostrom P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-348; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eck SM, 2009, J AUTOIMMUN, V33, P214, DOI 10.1016/j.jaut.2009.09.011; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; FOWLKES JL, 1994, J BIOL CHEM, V269, P25742; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Heppner KJ, 1996, AM J PATHOL, V149, P273; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Ito A, 1996, J BIOL CHEM, V271, P14657, DOI 10.1074/jbc.271.25.14657; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kanamori Y, 1999, CANCER RES, V59, P4225; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Nikkola J, 2002, INT J CANCER, V97, P432, DOI 10.1002/ijc.1636; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; ODAKE S, 1994, BIOCHEM BIOPH RES CO, V199, P1442, DOI 10.1006/bbrc.1994.1392; Pfaffen S, 2010, EXP CELL RES, V316, P836, DOI 10.1016/j.yexcr.2009.11.004; Saarinen J, 1999, EUR J BIOCHEM, V259, P829, DOI 10.1046/j.1432-1327.1999.00105.x; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Smith Victoria, 2008, Cancer Genomics & Proteomics, V5, P263; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Vanlaere I, 2009, CLIN MICROBIOL REV, V22, P224, DOI 10.1128/CMR.00047-08; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666	43	30	30	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2264	2272		10.1038/onc.2013.157	http://dx.doi.org/10.1038/onc.2013.157			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23708660	Green Accepted			2022-12-25	WOS:000334996000012
J	Du, J; Cao, XQ; Zou, L; Chen, Y; Guo, J; Chen, ZJ; Hu, SS; Zheng, Z				Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe			MicroRNA-21 and Risk of Severe Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CIRCULATING MICRORNAS; BIOMARKERS; SERUM; IDENTIFICATION; PROGRESSION; EXPRESSION; MORTALITY; DISEASE; CANCER	Background: Severe acute kidney injury (AKI) after cardiac surgery is associated with poor clinical outcomes. This study evaluated the potential use of miR-21 as a risk marker for postoperative AKI progression and other poor outcomes. Methodology/Principal Findings: The study included 120 adult patients undergoing cardiac surgery: 40 non-AKI controls, 39 patients with progressive AKI, and 41 with non-progressive AKI. Urine and plasma levels of miR-21 were assessed by quantitative real-time PCR (RT-qPCR). Associations between miR-21 levels and AKI progression were determined by estimating areas under receiver operating characteristic curves (AUC). We demonstrated that up-regulated urine and plasma levels of miR-21 in patients with AKI were both associated with AKI progression. The AUCs for urine and plasma levels of miR-21 associated with established AKI were 0.68 (95% CI: 0.59-0.78) and 0.80 (95% CI: 0.73-0.88), respectively. Multiple logistic regression analysis, adjusting for clinical variables, indicated that the prognostic predictive power of urine and plasma miR-21 levels for AKI progression were represented by AUCs of 0.81 (95% CI: 0.72-0.91) and 0.83 (95% CI: 0.74-0.92), respectively. Urinary and plasma miR-21 levels also predicted the need for postoperative renal replacement therapy (RRT), development of Acute Kidney Injury Network (AKIN) stage 3 AKI, 30-day in-hospital mortality and prolonged stay in hospital or ICU. Urine miR-21 was a better outcome predictor than plasma miR-21, being associated with higher (1.4- to 2.6-fold) unadjusted odds ratio for progression of AKI and other poor outcomes. Conclusions: Urinary and plasma miR-21 are associated with severe AKI and other poor postoperative outcomes of cardiac surgery, indicating their potential use as prognostic markers.	[Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp,State Key Lab Cardiovasc Med, Beijing 100730, Peoples R China; [Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Peking Union Med Coll, Fuwai Hosp, Dept Surg, Beijing 100730, Peoples R China; [Du, Juan; Cao, Xiaoqing; Zou, Liang; Chen, Yi; Guo, Jin; Chen, Zujun; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Peking Union Med Coll, Cardiovasc Inst, Beijing 100730, Peoples R China; [Du, Juan; Cao, Xiaoqing; Hu, Shengshou; Zheng, Zhe] Natl Ctr Cardiovasc Dis, Minist Hlth, Key Lab Cardiac Regenerat Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Hu, SS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp,State Key Lab Cardiovasc Med, Beijing 100730, Peoples R China.	shengshouhu@yahoo.com; zhengzhe@fuwai.com			National High Technology Reseach and Development Program of China (863 Program) [2011AA020101]	National High Technology Reseach and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National High Technology Reseach and Development Program of China (863 Program) (Grant No. 2011AA020101). The URL of the funders website is: http://most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JR, 2007, CIRCULATION, V116, pI139, DOI 10.1161/CIRCULATIONAHA.106.677070; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang KP, 2012, ANN PLAS SURG, V69, P668, DOI 10.1097/SAP.0b013e3182742c45; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Demirjian S, 2012, AM J KIDNEY DIS, V59, P382, DOI 10.1053/j.ajkd.2011.10.046; Denby L, 2011, AM J PATHOL, V179, P661, DOI 10.1016/j.ajpath.2011.04.021; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Englberger L, 2010, AM J KIDNEY DIS, V56, P623, DOI 10.1053/j.ajkd.2010.04.017; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Hall IE, 2011, CLIN J AM SOC NEPHRO, V6, P2740, DOI 10.2215/CJN.04960511; Hoste EAJ, 2010, CONTRIB NEPHROL, V165, P1, DOI 10.1159/000313737; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; James MT, 2010, KIDNEY INT, V78, P803, DOI 10.1038/ki.2010.258; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Koyner JL, 2012, J AM SOC NEPHROL, V23, P905, DOI 10.1681/ASN.2011090907; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Parolari A, 2012, ANN THORAC SURG, V93, P584, DOI 10.1016/j.athoracsur.2011.09.073; Pepe MS, 2004, STAT EVALUATION MED; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Shaw A, 2012, J THORAC CARDIOV SUR, V143, P676, DOI 10.1016/j.jtcvs.2011.08.054; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056	39	59	71	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63390	10.1371/journal.pone.0063390	http://dx.doi.org/10.1371/journal.pone.0063390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717419	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600014
J	Thedrez, A; Lavoue, V; Dessarthe, B; Daniel, P; Henno, S; Jaffre, I; Leveque, J; Catros, V; Cabillic, F				Thedrez, Aurelie; Lavoue, Vincent; Dessarthe, Benoit; Daniel, Pascale; Henno, Sebastien; Jaffre, Isabelle; Leveque, Jean; Catros, Veronique; Cabillic, Florian			A Quantitative Deficiency in Peripheral Blood V gamma 9V delta 2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients	PLOS ONE			English	Article							DELTA-T-CELLS; MULTIPLE-MYELOMA; ADOPTIVE IMMUNOTHERAPY; MEDIATED RECOGNITION; ZOLEDRONIC ACID; THERAPY PRODUCT; SOLID TUMORS; PHASE-I; CARCINOMA; LYMPHOCYTES	V gamma 9V delta 2 cells are cytotoxic T cells that are able to recognize epithelial ovarian carcinoma (EOC) cells. Therefore, V gamma 9V delta 2 cell-based adoptive transfer is an attractive therapy for EOC. However, the inefficient ex vivo expansion after specific stimulation of V gamma 9V delta 2 cells from some patients and the relationships between V gamma 9V delta 2 cells and clinical course of EOC are issues that remain to be clarified. Herein, peripheral blood mononuclear cells (PBMCs) from 60 EOC patients were stimulated with bromohydrin pyrophosphate (BrHPP) or zoledronate, which are specific agonists of V gamma 9V delta 2 cells. The compounds differed in their efficacies to induce ex vivo V gamma 9V delta 2 PBMC expansion, but 16/60 samples remained inefficiently expanded with both stimuli. Interestingly, the V gamma 9V delta 2 cells in these low-responding PBMCs displayed before expansion (ex vivo PBMCs) an altered production of the pro-inflammatory cytokines IFN-gamma and TNF-alpha, a decreased naive fraction and a reduced frequency. No evidence of an involvement of CD4(+)CD25(+)Foxp(3+) regulatory cells was observed. Importantly, our data also demonstrate that a V gamma 9V delta 2 cell frequency of 0.35% or less in EOC PBMCs could be used to predict low responses to both BrHPP and zoledronate. Moreover, our data highlight that such a deficiency is not correlated with advanced EOC stages but is associated with more refractory states to platinum-based chemotherapy and is an independent predictor of shorter disease-free survival after treatment. These results are the first to suggest a potential contribution of V gamma 9V delta 2 cells to the anti-tumor effects of chemotherapeutic agents and they strengthen interest in strategies that might increase V gamma 9V delta 2 cells in cancer patients.	[Thedrez, Aurelie; Lavoue, Vincent; Dessarthe, Benoit; Catros, Veronique; Cabillic, Florian] Univ Rennes 1, UMR 991, Inst Natl Sante & Rech Med, Rennes, France; [Thedrez, Aurelie; Lavoue, Vincent; Dessarthe, Benoit; Leveque, Jean; Catros, Veronique; Cabillic, Florian] Univ Rennes 1, Fac Med, Rennes, France; [Lavoue, Vincent; Leveque, Jean] Ctr Hosp Univ Rennes, Dept Gynecol & Obstet, Rennes, France; [Daniel, Pascale; Catros, Veronique; Cabillic, Florian] Ctr Hospitalier Univ Rennes, Serv Cytogenet & Biol Cellulaire, Rennes, France; [Henno, Sebastien] Ctr Hosp Univ Rennes, Dept Anat & Cytol Pathol, Rennes, France; Inst Cancerol Ouest Rene Gauducheau, Dept Oncol Chirurg, St Herblain, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; CHU Rennes; Universite de Rennes; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Thedrez, A (corresponding author), Univ Rennes 1, UMR 991, Inst Natl Sante & Rech Med, Rennes, France.	aurelie.thedrez@univ-rennes1.fr	Cabillic, Florian/AAM-4296-2020; LAVOUE, Vincent/L-5644-2017	Cabillic, Florian/0000-0001-7204-5652; LAVOUE, Vincent/0000-0002-4682-2806; THEDREZ, Aurelie/0000-0003-1736-5244	Institut National du Cancer (INCA) [PL2008-034]; Canceropole Grand-Ouest; Medicine Faculty of Rennes University	Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Canceropole Grand-Ouest; Medicine Faculty of Rennes University	This work was supported by grants from Institut National du Cancer (INCA) PL2008-034, Canceropole Grand-Ouest and financial support from the Medicine Faculty of Rennes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, EXP HEMATOL, V37, P956, DOI 10.1016/j.exphem.2009.04.008; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Battistini L, 2005, MICROBES INFECT, V7, P510, DOI 10.1016/j.micinf.2004.12.008; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Bennouna J, 2010, CANCER IMMUNOL IMMUN, V59, P1521, DOI 10.1007/s00262-010-0879-0; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Bonneville M, 2005, MICROBES INFECT, V7, P503, DOI 10.1016/j.micinf.2005.03.004; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bouet-Toussaint F, 2008, CANCER IMMUNOL IMMUN, V57, P531, DOI 10.1007/s00262-007-0391-3; Burjanadze M, 2007, BRIT J HAEMATOL, V139, P206, DOI 10.1111/j.1365-2141.2007.06754.x; Cabillic F, 2010, CANCER IMMUNOL IMMUN, V59, P1611, DOI 10.1007/s00262-010-0887-0; Caccamo N, 2006, J LEUKOCYTE BIOL, V79, P663, DOI 10.1189/jlb.1105640; Cairo C, 2010, HUM IMMUNOL, V71, P968, DOI 10.1016/j.humimm.2010.06.014; Capietto AH, 2011, CELL MOL LIFE SCI, V68, P2433, DOI 10.1007/s00018-011-0705-7; Dessarthe B, 2013, J IMMUNOL IN PRESS; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kobayashi H, 2010, ANTICANCER RES, V30, P575; Kunzmann V, 2009, IMMUNOLOGY, V126, P256, DOI 10.1111/j.1365-2567.2008.02894.x; Lang JM, 2011, CANCER IMMUNOL IMMUN, V60, P1447, DOI 10.1007/s00262-011-1049-8; Lavoue V, 2011, INT J CANC; Mariani S, 2005, LEUKEMIA, V19, P664, DOI 10.1038/sj.leu.2403693; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Nicol AJ, 2011, BRIT J CANCER, V105, P778, DOI 10.1038/bjc.2011.293; Pecorelli S, 1999, INT J GYNECOL OBSTET, V65, P243, DOI 10.1016/S0020-7292(99)00070-3; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Sakamoto M, 2011, J IMMUNOTHER, V34, P202, DOI 10.1097/CJI.0b013e318207ecfb; Salot S, 2007, J IMMUNOL METHODS, V326, P63, DOI 10.1016/j.jim.2007.07.010; Scotet E, 2008, FRONT BIOSCI-LANDMRK, V13, P6872, DOI 10.2741/3195; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Viey E, 2008, J IMMUNOTHER, V31, P313, DOI 10.1097/CJI.0b013e3181609988; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	37	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63322	10.1371/journal.pone.0063322	http://dx.doi.org/10.1371/journal.pone.0063322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717410	Green Published, gold			2022-12-25	WOS:000319435600009
J	Han, MH; Park, C; Jin, CY; Kim, GY; Chang, YC; Moon, SK; Kim, WJ; Choi, YH				Han, Min Ho; Park, Cheol; Jin, Cheng-Yun; Kim, Gi-Young; Chang, Young-Chae; Moon, Sung-Kwon; Kim, Wun-Jae; Choi, Yung Hyun			Apoptosis Induction of Human Bladder Cancer Cells by Sanguinarine through Reactive Oxygen Species-Mediated Up-Regulation of Early Growth Response Gene-1	PLOS ONE			English	Article							EGR-1 TRANSCRIPTION; CARCINOMA-CELLS; KAPPA-B; ACTIVATION; EXPRESSION; PTEN; ROS; DEATH	Although the effects of sanguinarine, a benzophenanthridine alkaloid, on the inhibition of some kinds of cancer cell growth have been established, the underlying mechanisms are not completely understood. This study investigated possible mechanisms by which sanguinarine exerts its anticancer action in cultured human bladder cancer cell lines (T24, EJ, and 5637). Sanguinarine treatment resulted in concentration-response growth inhibition of the bladder cancer cells by inducing apoptosis. Sanguinarine-induced apoptosis was correlated with the up-regulation of Bax, the down-regulation of Bid and XIAP, the activation of caspases (-3, -8, and -9), and the generation of increased reactive oxygen species (ROS). The ROS scavenger N-acetyl cysteine (NAC) completely reversed the sanguinarine-triggered apoptotic events. In addition, sanguinarine effectively increased the activation of the c-Jun N-terminal kinase (JNK) and the expression of the early growth response gene-1 (Egr-1), which was recovered by pretreatment with NAC. Furthermore, knockdown of Egr-1 expression by small interfering RNA attenuated sanguinarine-induced apoptosis, but not the JNK inhibitor, indicating that the interception of ROS generation blocked the sanguinarine-induced apoptotic effects via deregulation of the expression of Egr-1 proteins. Taken together, the data provide evidence that sanguinarine is a potent anticancer agent, which inhibits the growth of bladder cancer cells and induces their apoptosis through the generation of free radicals.	[Han, Min Ho; Choi, Yung Hyun] Dong Eui Univ, Antiaging Res Ctr & Blue Bio Ind RIC, Busan, South Korea; [Han, Min Ho; Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Busan, South Korea; [Park, Cheol] Dong Eui Univ, Coll Nat Sci, Dept Mol Biol, Busan, South Korea; [Jin, Cheng-Yun] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou, Henan, Peoples R China; [Kim, Gi-Young] Jeju Natl Univ, Dept Marine Life Sci, Immunobiol Lab, Jeju, South Korea; [Chang, Young-Chae] Catholic Univ, Daegu Sch Med, Res Inst Biomed Engn, Daegu, South Korea; [Chang, Young-Chae] Catholic Univ, Daegu Sch Med, Dept Med, Daegu, South Korea; [Moon, Sung-Kwon] Chung Ang Univ, Sch Food Sci & Technol, Ansung, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea	Dong-Eui University; Dong-Eui University; Dong-Eui University; Zhengzhou University; Jeju National University; Catholic University of Daegu; Catholic University of Daegu; Chung Ang University; Chungbuk National University	Choi, YH (corresponding author), Dong Eui Univ, Antiaging Res Ctr & Blue Bio Ind RIC, Busan, South Korea.	choiyh@deu.ac.kr			National Research Foundation of Korea (NRF); Korea government [2012-0000476, 2012046358]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2012-0000476 and 2012046358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2004, MOL CANCER THER, V3, P933; Aggeli IKS, 2010, PHYSIOL RES, V59, P443, DOI 10.33549/physiolres.931806; Ahmad N, 2000, CLIN CANCER RES, V6, P1524; Ahmed MM, 2004, CURR CANCER DRUG TAR, V4, P43, DOI 10.2174/1568009043481704; Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Chang MC, 2007, TOXICOL APPL PHARM, V218, P143, DOI 10.1016/j.taap.2006.10.025; Choi WY, 2008, CHEMOTHERAPY, V54, P279, DOI 10.1159/000149719; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; DATTA R, 1993, P NATL ACAD SCI USA, V90, P2419, DOI 10.1073/pnas.90.6.2419; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Depre C, 2001, P NATL ACAD SCI USA, V98, P9336, DOI 10.1073/pnas.171297498; Downes CP, 2004, BIOCHEM SOC T, V32, P338, DOI 10.1042/BST0320338; Fantini D, 2008, FREE RADICAL RES, V42, P20, DOI 10.1080/10715760701765616; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Jones N, 2003, J CELL PHYSIOL, V196, P326, DOI 10.1002/jcp.10308; Kang JM, 2010, AM J PHYSIOL-GASTR L, V299, pG1147, DOI 10.1152/ajpgi.00218.2010; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kim JH, 2011, BMB REP, V44, P452, DOI 10.5483/BMBRep.2011.44.7.452; Kim S, 2008, J CELL BIOCHEM, V104, P895, DOI 10.1002/jcb.21672; Kim SO, 2007, BIOSCI BIOTECH BIOCH, V71, P2169, DOI 10.1271/bbb.70103; LASTER LL, 1990, J CAN DENT ASSOC, V56, pS19; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee JS, 2012, INT J TOXICOL, V31, P70, DOI 10.1177/1091581811423845; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; MAHADY GB, 1994, PLANTA MED, V60, P553, DOI 10.1055/s-2006-959570; Matkar SS, 2008, CHEM-BIOL INTERACT, V172, P63, DOI 10.1016/j.cbi.2007.12.006; Mishra S, 2006, P NATL ACAD SCI USA, V103, P5191, DOI 10.1073/pnas.0600241103; MITSCHER LA, 1978, LLOYDIA, V41, P145; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Park H, 2010, BIOCHEM BIOPH RES CO, V399, P446, DOI 10.1016/j.bbrc.2010.07.114; RAUSCHER FJ, 1993, ADV EXP MED BIOL, V348, P23; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Shin DY, 2009, BIOMED PHARMACOTHER, V63, P86, DOI 10.1016/j.biopha.2008.08.001; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Tak JK, 2012, BMB REP, V45, P242, DOI 10.5483/BMBRep.2012.45.4.242; TANDON RK, 1975, AM J CLIN NUTR, V28, P883, DOI 10.1093/ajcn/28.8.883; Tsukamoto H, 2011, ANTICANCER RES, V31, P2841; Vavreckova Ctirada, 1994, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V138, P7; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; WALTEROVA D, 1981, J MED CHEM, V24, P1100, DOI 10.1021/jm00141a019; Wang MF, 2011, EXP MOL MED, V43, P189, DOI 10.3858/emm.2011.43.4.023; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027441	49	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63425	10.1371/journal.pone.0063425	http://dx.doi.org/10.1371/journal.pone.0063425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717422	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700020
J	Blair, JMA; Richmond, GE; Bailey, AM; Ivens, A; Piddock, LJV				Blair, Jessica M. A.; Richmond, Grace E.; Bailey, Andrew M.; Ivens, Al; Piddock, Laura J. V.			Choice of Bacterial Growth Medium Alters the Transcriptome and Phenotype of Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; EPITHELIAL-CELLS; SSRA-SSRB; EXPRESSION; INFECTION; GENES; INVASION; PROLIFERATION; VIRULENCE	The type of bacterial culture medium is an important consideration during design of any experimental protocol. The aim of this study was to understand the impact of medium choice on bacterial gene expression and physiology by comparing the transcriptome of Salmonella enterica SL1344 after growth in the widely used LB broth or the rationally designed MOPS minimal medium. Transcriptomics showed that after growth in MOPS minimal media, compared to LB, there was increased expression of 42 genes involved in amino acid synthesis and 23 genes coding for ABC transporters. Seven flagellar genes had decreased expression after growth in MOPS minimal medium and this correlated with a decreased motility. In both MOPS minimal medium and MEM expression of genes from SPI-2 was increased and the adhesion of S. Typhimurium to intestinal epithelial cells was higher compared to the levels after growth in LB. However, SL1344 invasion was not significantly altered by growth in either MOPs minimal media or MEM. Expression of SPI-2 was also measured using chromosomal GFP reporter fusions followed by flow cytometry which showed, for the first time, that the reduction in SPI-2 transcript after growth in different media related to a reduction in the proportion of the bacterial population expressing SPI-2. These data highlight the profound differences in the global transcriptome after in vitro growth in different media and show that choice of medium should be considered carefully during experimental design, particularly when virulence related phenotypes are being measured.	[Blair, Jessica M. A.; Richmond, Grace E.; Bailey, Andrew M.; Piddock, Laura J. V.] Univ Birmingham, Sch Immun & Infect, Antimicrobials Res Grp, Birmingham, W Midlands, England; [Blair, Jessica M. A.; Richmond, Grace E.; Bailey, Andrew M.; Piddock, Laura J. V.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Ivens, Al] Univ Edinburgh, Ctr Immun Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Birmingham; University of Birmingham; University of Edinburgh	Piddock, LJV (corresponding author), Univ Birmingham, Sch Immun & Infect, Antimicrobials Res Grp, Birmingham, W Midlands, England.	l.j.v.piddock@bham.ac.uk		Blair, Jessica/0000-0001-6904-4253; Ivens, Al/0000-0002-0112-3876; Piddock, Laura/0000-0003-1460-473X	Medical Research Council (MRC) DTG at the University of Birmingham; Wellcome Trust; MRC [G0501415]; Medical Research Council [G9818340, G0501415] Funding Source: researchfish; MRC [G9818340] Funding Source: UKRI	Medical Research Council (MRC) DTG at the University of Birmingham(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JB was funded by a Medical Research Council (MRC) DTG at the University of Birmingham, a Wellcome Trust VIP award and then by an MRC Programme grant (G0501415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey AM, 2006, ANTIMICROB AGENTS CH, V50, P1071, DOI 10.1128/AAC.50.3.1071-1074.2006; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Blair JMA, 2009, J ANTIMICROB CHEMOTH, V64, P965, DOI 10.1093/jac/dkp311; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christensen KA, 2002, J CELL SCI, V115, P599; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Clark L, 2011, MICROBIOL-SGM, V157, P2072, DOI 10.1099/mic.0.048496-0; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Dibb-Fuller MP, 1999, MICROBIOL-SGM, V145, P1023, DOI 10.1099/13500872-145-5-1023; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	28	25	25	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63912	10.1371/journal.pone.0063912	http://dx.doi.org/10.1371/journal.pone.0063912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704954	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200085
J	Brew, N; Hooper, SB; Zahra, V; Wallace, M; Harding, R				Brew, Nadine; Hooper, Stuart B.; Zahra, Valerie; Wallace, Megan; Harding, Richard			Mechanical Ventilation Injury and Repair in Extremely and Very Preterm Lungs	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BRONCHOPULMONARY DYSPLASIA; PREMATURE-INFANTS; METALLOTHIONEIN; EXPRESSION; CYTOKINES; EXPOSURE; ELASTIN; INFLAMMATION; MATURATION	Background: Extremely preterm infants often receive mechanical ventilation (MV), which can contribute to bronchopulmonary dysplasia (BPD). However, the effects of MV alone on the extremely preterm lung and the lung's capacity for repair are poorly understood. Aim: To characterise lung injury induced by MV alone, and mechanisms of injury and repair, in extremely preterm lungs and to compare them with very preterm lungs. Methods: Extremely preterm lambs (0.75 of term) were transiently exposed by hysterotomy and underwent 2 h of injurious MV. Lungs were collected 24 h and at 15 d after MV. Immunohistochemistry and morphometry were used to characterise injury and repair processes. qRT-PCR was performed on extremely and very preterm (0.85 of term) lungs 24 h after MV to assess molecular injury and repair responses. Results: 24 h after MV at 0.75 of term, lung parenchyma and bronchioles were severely injured; tissue space and myofibroblast density were increased, collagen and elastin fibres were deformed and secondary crest density was reduced. Bronchioles contained debris and their epithelium was injured and thickened. 24 h after MV at 0.75 and 0.85 of term, mRNA expression of potential mediators of lung repair were significantly increased. By 15 days after MV, most lung injury had resolved without treatment. Conclusions: Extremely immature lungs, particularly bronchioles, are severely injured by 2 h of MV. In the absence of continued ventilation these injured lungs are capable of repair. At 24 h after MV, genes associated with injurious MV are unaltered, while potential repair genes are activated in both extremely and very preterm lungs.	[Brew, Nadine; Harding, Richard] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Hooper, Stuart B.; Zahra, Valerie; Wallace, Megan] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Hooper, Stuart B.; Wallace, Megan] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University	Brew, N (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	Nadine.brew@monash.edu		Hooper, Stuart/0000-0003-1676-4825; Wallace, Megan/0000-0001-5785-5120	National Health and Medical research Council of Australia; Victorian Government's Operational Infrastructure Support Program	National Health and Medical research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work is supported by the National Health and Medical research Council of Australia and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; Allison BJ, 2008, PEDIATR RES, V64, P387, DOI 10.1203/PDR.0b013e318181e05e; Allison BJ, 2010, PEDIATR RES, V67, P238, DOI 10.1203/PDR.0b013e3181cde9b3; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Bach KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047044; BHUTANI VK, 1981, RESP PHYSIOL, V43, P221, DOI 10.1016/0034-5687(81)90104-3; Bland RD, 2008, AM J PHYSIOL-LUNG C, V294, pL3, DOI 10.1152/ajplung.00362.2007; Bose C, 2011, PEDIATR RES, V69, P347, DOI 10.1203/PDR.0b013e31820a58f3; Brass DM, 2008, IMMUNOGENETICS, V60, P353, DOI 10.1007/s00251-008-0293-3; Brew N, 2011, AM J PHYSIOL-LUNG C, V301, pL917, DOI 10.1152/ajplung.00207.2011; Capoluongo E, 2005, EUR CYTOKINE NETW, V16, P199; Chen ZM, 2007, FREE RADICAL BIO MED, V43, P628, DOI 10.1016/j.freeradbiomed.2007.05.024; Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004; COALSON JJ, 1992, AM REV RESPIR DIS, V145, P872, DOI 10.1164/ajrccm/145.4_Pt_1.872; Courtade M, 1998, CHEST, V113, P371, DOI 10.1378/chest.113.2.371; Cullen AB, 2006, BIOL NEONATE, V90, P17, DOI 10.1159/000091742; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Fakhoury KF, 2010, PEDIATRICS, V125, pE1441, DOI 10.1542/peds.2009-0668; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; Hennessy EM, 2008, ARCH DIS CHILD, V93, P1037, DOI 10.1136/adc.2008.140830; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Inoue K, 2008, FREE RADICAL BIO MED, V45, P1714, DOI 10.1016/j.freeradbiomed.2008.09.008; Inoue KI, 2005, EXP BIOL MED, V230, P75; Kaarteenaho-Wiik R, 2002, J HISTOCHEM CYTOCHEM, V50, P423, DOI 10.1177/002215540205000313; KAGI JHR, 1960, J BIOL CHEM, V235, P3460; Kallapur SG, 2011, AM J PHYSL LUNG CELL; Kroon AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016910; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; LEE RMKW, 1988, AM REV RESPIR DIS, V137, P450, DOI 10.1164/ajrccm/137.2.450; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; MOTOYAMA EK, 1987, AM REV RESPIR DIS, V136, P50, DOI 10.1164/ajrccm/136.1.50; Nie J, 2011, J SURG RES, V168, P281, DOI 10.1016/j.jss.2009.10.020; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; O'Reilly M, 2009, AM J PHYSIOL-LUNG C, V297, pL992, DOI 10.1152/ajplung.00099.2009; Oh JH, 2009, INHAL TOXICOL, V21, P347, DOI [10.1080/08958370802464281 , 10.1080/08958370802464281]; PIEDBOEUF B, 1994, AM J RESP CELL MOL, V10, P123, DOI 10.1165/ajrcmb.10.2.8110467; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; Pierce RA, 2007, PEDIATR RES, V61, P703, DOI 10.1203/pdr.0b013e318053661d; PITT BR, 1992, PEDIATR RES, V32, P424, DOI 10.1203/00006450-199210000-00011; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; Sarafidis K, 2011, J PERINATOL, V31, P104, DOI 10.1038/jp.2010.78; Singhal KK, 1996, PEDIATR RES, V39, P229, DOI 10.1203/00006450-199602000-00007; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Takano H, 2004, THORAX, V59, P1057, DOI 10.1136/thx.2004.024232; Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766; Thibeault DW, 2000, PEDIATRICS, V106, P1452, DOI 10.1542/peds.106.6.1452; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Tiddens HAWM, 2008, PEDIATR PULM, V43, P1206, DOI 10.1002/ppul.20928; Toti P, 1997, PEDIATR PULM, V24, P22, DOI 10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Wilson A, 2000, PEDIATRICS, V105, P822, DOI 10.1542/peds.105.4.822	56	14	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63905	10.1371/journal.pone.0063905	http://dx.doi.org/10.1371/journal.pone.0063905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704953	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200084
J	Diersch, N; Mueller, K; Cross, ES; Stadler, W; Rieger, M; Schutz-Bosbach, S				Diersch, Nadine; Mueller, Karsten; Cross, Emily S.; Stadler, Waltraud; Rieger, Martina; Schuetz-Bosbach, Simone			Action Prediction in Younger versus Older Adults: Neural Correlates of Motor Familiarity	PLOS ONE			English	Article							SPORT-RELATED ANTICIPATION; EXPERT-NOVICE DIFFERENCES; POINT-LIGHT ACTIONS; MIRROR-NEURON; FUNCTIONAL CONNECTIVITY; HEMISPHERIC-ASYMMETRY; ORBITOFRONTAL CORTEX; BASKETBALL PLAYERS; UNDERSTAND OTHERS; BRAIN ACTIVATION	Generating predictions during action observation is essential for efficient navigation through our social environment. With age, the sensitivity in action prediction declines. In younger adults, the action observation network (AON), consisting of premotor, parietal and occipitotemporal cortices, has been implicated in transforming executed and observed actions into a common code. Much less is known about age-related changes in the neural representation of observed actions. Using fMRI, the present study measured brain activity in younger and older adults during the prediction of temporarily occluded actions (figure skating elements and simple movement exercises). All participants were highly familiar with the movement exercises whereas only some participants were experienced figure skaters. With respect to the AON, the results confirm that this network was preferentially engaged for the more familiar movement exercises. Compared to younger adults, older adults recruited visual regions to perform the task and, additionally, the hippocampus and caudate when the observed actions were familiar to them. Thus, instead of effectively exploiting the sensorimotor matching properties of the AON, older adults seemed to rely predominantly on the visual dynamics of the observed actions to perform the task. Our data further suggest that the caudate played an important role during the prediction of the less familiar figure skating elements in better-performing groups. Together, these findings show that action prediction engages a distributed network in the brain, which is modulated by the content of the observed actions and the age and experience of the observer.	[Diersch, Nadine; Mueller, Karsten; Cross, Emily S.; Stadler, Waltraud; Rieger, Martina; Schuetz-Bosbach, Simone] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Diersch, Nadine] Max Planck Inst Demog Res, MaxNetAging Res Sch, Rostock, Germany; [Cross, Emily S.] Bangor Univ, Sch Psychol, Wales Inst Cognit Neurosci, Bangor, Gwynedd, Wales; [Cross, Emily S.] Radboud Univ Nijmegen, Inst Behav Sci, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Stadler, Waltraud] Tech Univ Munich, Fac Sports & Hlth Sci, Movement Sci Unit, D-80290 Munich, Germany; [Rieger, Martina] Hlth & Life Sci Univ, UMIT, Med Sci & Management Dept, Inst Psychol, Hall Tyrol, Austria	Max Planck Society; Max Planck Society; Bangor University; Radboud University Nijmegen; Technical University of Munich	Diersch, N (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	diersch@cbs.mpg.de	Cross, Emily S./B-4565-2009	Cross, Emily S./0000-0002-1671-5698; Schutz-Bosbach, Simone/0000-0002-0937-9454; Rieger, Martina/0000-0002-2421-296X	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Addis DR, 2011, NEUROPSYCHOLOGIA, V49, P3656, DOI 10.1016/j.neuropsychologia.2011.09.021; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bischoff M, 2012, NEUROPSYCHOLOGIA, V50, P2085, DOI 10.1016/j.neuropsychologia.2012.05.009; Brown EC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00147; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Carp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029411; Carp J, 2011, NEUROIMAGE, V56, P736, DOI 10.1016/j.neuroimage.2010.04.267; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Catmur C, 2009, PHILOS T R SOC B, V364, P2369, DOI 10.1098/rstb.2009.0048; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cooper JC, 2012, J COGNITIVE NEUROSCI, V24, P106, DOI 10.1162/jocn_a_00114; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2013, HUM BRAIN MAPP, V34, P467, DOI 10.1002/hbm.21450; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; den Ouden HEM, 2010, J NEUROSCI, V30, P3210, DOI 10.1523/JNEUROSCI.4458-09.2010; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Dennis NA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.004; Diersch N, 2012, PSYCHOL RES-PSYCH FO, V76, P525, DOI 10.1007/s00426-011-0404-x; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Erickson KI, 2007, NEUROBIOL AGING, V28, P272, DOI 10.1016/j.neurobiolaging.2005.12.012; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002327; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gabbard C, 2011, ARCH GERONTOL GERIAT, V53, P206, DOI 10.1016/j.archger.2010.10.006; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Graf M, 2007, NEUROIMAGE, V36, pT22, DOI 10.1016/j.neuroimage.2007.03.017; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2010, NEUROBIOL AGING, V31, P301, DOI 10.1016/j.neurobiolaging.2008.03.021; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jin H, 2011, NEUROSCI LETT, V492, P139, DOI 10.1016/j.neulet.2011.01.074; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; Kokal I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013507; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Li SC, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P103; Liew SL, 2011, HUM BRAIN MAPP, V32, P1986, DOI 10.1002/hbm.21164; Lustig C., 2003, METH NE FRO NEUROSCI, P261; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; O'Doherty JP, 2007, ANN NY ACAD SCI, V1121, P254, DOI 10.1196/annals.1401.036; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson C-J, 2008, Open Neuroimag J, V2, P5, DOI 10.2174/1874440000802010005; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Parkinson J, 2012, PSYCHOL RES-PSYCH FO, V76, P421, DOI 10.1007/s00426-012-0422-3; Perrett DI, 2009, Q J EXP PSYCHOL, V62, P2081, DOI 10.1080/17470210902959279; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Press C, 2011, BIOL LETTERS, V7, P457, DOI 10.1098/rsbl.2010.0850; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Saygin AP, 2012, PSYCHOL RES-PSYCH FO, V76, P388, DOI 10.1007/s00426-012-0426-z; Schacter DL, 2012, GERONTOLOGY; Schiffer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036445; Schiffer AM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00038; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schutz-Bosbach Simone, 2007, Cogn Process, V8, P93, DOI 10.1007/s10339-007-0167-x; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Sparenberg P, 2012, PSYCHOL RES-PSYCH FO, V76, P41, DOI 10.1007/s00426-011-0321-z; Stadler W, 2012, PSYCHOL RES-PSYCH FO, V76, P395, DOI 10.1007/s00426-012-0431-2; Stadler W, 2011, HUM BRAIN MAPP, V32, P677, DOI 10.1002/hbm.20949; Urgesi C, 2012, PSYCHOL RES-PSYCH FO, V76, P542, DOI 10.1007/s00426-011-0383-y; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiler JA, 2010, BEHAV BRAIN RES, V212, P196, DOI 10.1016/j.bbr.2010.04.013; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Wright MJ, 2010, NEUROREPORT, V21, P94, DOI 10.1097/WNR.0b013e328333dff2; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	112	31	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64195	10.1371/journal.pone.0064195	http://dx.doi.org/10.1371/journal.pone.0064195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704980	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200122
J	Kaida, A; Matthews, LT; Kanters, S; Kabakyenga, J; Muzoora, C; Mocello, AR; Martin, JN; Hunt, P; Haberer, J; Hogg, RS; Bangsberg, DR				Kaida, Angela; Matthews, Lynn T.; Kanters, Steve; Kabakyenga, Jerome; Muzoora, Conrad; Mocello, A. Rain; Martin, Jeffrey N.; Hunt, Peter; Haberer, Jessica; Hogg, Robert S.; Bangsberg, David R.			Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REPRODUCTIVE HEALTH-CARE; INFECTED WOMEN; FERTILITY INTENTIONS; MALE CIRCUMCISION; PREEXPOSURE PROPHYLAXIS; MISSED OPPORTUNITIES; DISCORDANT COUPLES; EXPANDING ACCESS; RISK BEHAVIOR	Objective: Many people living with HIV in sub-Saharan Africa desire biological children. Implementation of HIV prevention strategies that support the reproductive goals of people living with HIV while minimizing HIV transmission risk to sexual partners and future children requires a comprehensive understanding of pregnancy in this population. We analyzed prospective cohort data to determine pregnancy incidence and predictors among HIV-positive women initiating antiretroviral therapy (ART) in a setting with high HIV prevalence and fertility. Methods: Participants were enrolled in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort of HIV-positive individuals initiating ART in Mbarara. Bloodwork (including CD4 cells/mm(3), HIV viral load) and questionnaires (including socio-demographics, health status, sexual behavior, partner dynamics, HIV history, and self-reported pregnancy) were completed at baseline and quarterly. Our analysis includes 351 HIV-positive women (18-49 years) who enrolled between 2005-2011. We measured pregnancy incidence by proximal and distal time relative to ART initiation and used multivariable Cox proportional hazards regression analysis (with repeated events) to identify baseline and time-dependent predictors of pregnancy post-ART initiation. Results: At baseline (pre-ART initiation), median age was 33 years [IQR: 27-37] and median prior livebirths was four [IQR: 2-6]. 38% were married with 61% reporting HIV-positive spouses. 73% of women had disclosed HIV status to a primary sexual partner. Median baseline CD4 was 137 cells/mm(3) [IQR: 81-207]. At enrolment, 9.1% (31/342) reported current pregnancy. After ART initiation, 84 women experienced 105 pregnancies over 3.8 median years of follow-up, yielding a pregnancy incidence of 9.40 per 100 WYs. Three years post-ART initiation, cumulative probability of at least one pregnancy was 28% and independently associated with younger age (Adjusted Hazard Ratio (AHR): 0.89/year increase; 95% CI: 0.86-0.92) and HIV serostatus disclosure to primary sexual partner (AHR: 2.45; 95% CI: 1.29-4.63). Conclusions: Nearly one-third of women became pregnant within three years of initiating ART, highlighting the need for integrated services to prevent unintended pregnancies and reduce periconception-related risks for HIV-infected women choosing to conceive. Association with younger age and disclosure suggests a role for early and couples-based safer conception counselling.	[Kaida, Angela; Hogg, Robert S.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Matthews, Lynn T.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Matthews, Lynn T.; Haberer, Jessica; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Matthews, Lynn T.; Haberer, Jessica; Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kanters, Steve] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kabakyenga, Jerome; Muzoora, Conrad; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Mocello, A. Rain; Martin, Jeffrey N.; Hunt, Peter] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hogg, Robert S.] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada	Simon Fraser University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of British Columbia; Mbarara University of Science & Technology; University of California System; University of California San Francisco; B.C. Centre for Excellence in HIV/AIDS	Kaida, A (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	kangela@sfu.ca	Haberer, Jessica/AAH-7976-2019; Hunt, Peter W./P-2976-2017; Muzoora, Conrad/AAV-7023-2021	Haberer, Jessica/0000-0001-5845-3190; Hunt, Peter W./0000-0002-4571-4870; Muzoora, Conrad/0000-0002-7866-5198; Hogg, Robert/0000-0003-3463-5488	National Institute of Child Health and Human Development [NICHD R21-HD069194]; National Institute of Mental Health [NIMH R01-MH54907]; Sullivan Family Foundation;  [K-23 MH095655];  [K-24 MH87227]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD069194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907, K23MH095655] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sullivan Family Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by grants from the National Institute of Child Health and Human Development (NICHD R21-HD069194), the National Institute of Mental Health (NIMH R01-MH54907), and the Sullivan Family Foundation. LTM received support from K-23 MH095655 and DRB received support from K-24 MH87227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andia I, 2009, AM J PUBLIC HEALTH, V99, P340, DOI 10.2105/AJPH.2007.129528; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bekker L. G., 2011, Southern African Journal of HIV Medicine, V12, P31; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Blair JM, 2004, OBSTET GYNECOL, V103, P663, DOI 10.1097/01.AOG.0000117083.33239.b5; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Bussmann H, 2007, JAIDS-J ACQ IMM DEF, V45, P269; Chadwick Rachelle J, 2011, Top Antivir Med, V19, P148; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; DECHERNEY AH, 1982, NEW ENGL J MED, V306, P424, DOI 10.1056/NEJM198202183060712; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Farrell B, 2007, FAMILY PLANNING INTE; Frodsham LCG, 2006, FERTIL STERIL, V85, P285, DOI 10.1016/j.fertnstert.2005.07.1326; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Giaquinto C, 2005, BJOG-INT J OBSTET GY, V112, P881, DOI 10.1111/j.1471-0528.2005.00569.x; Gibb DM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001217; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gruskin S, 2007, REPROD HEALTH MATTER, V15, P4, DOI 10.1016/S0968-8080(07)29028-7; Guthrie BL, 2010, AIDS BEHAV, V14, P1066, DOI 10.1007/s10461-010-9716-x; Heard I, 2007, AIDS, V21, pS77, DOI 10.1097/01.aids.0000255089.44297.6f; Heffron R, 2010, SEX TRANSM DIS, V37, P621, DOI 10.1097/OLQ.0b013e3181e1a162; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kabami J, 2011, 6 INT AIDS SOC IAS C; Kaida A, 2012, INFECT DIS OBSTET GY, V2012, P9; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Kaida A, 2009, AIDS BEHAV, V13, pS1, DOI 10.1007/s10461-009-9568-4; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kastner J, 2013, AFR FOR ENT UG JAN 1; Kharsany ABM, 2010, HIV MED, V11, P661, DOI 10.1111/j.1468-1293.2010.00838.x; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Kisakye P, 2010, CULT HEALTH SEX, V12, P445, DOI 10.1080/13691051003628922; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Linas BS, 2011, AIDS, V25, P707, DOI 10.1097/QAD.0b013e3283445811; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Mantell JE, 2009, J PUBLIC HEALTH POL, V30, P367, DOI 10.1057/jphp.2009.35; Martinez P, 2008, AIDS BEHAV, V12, P605, DOI 10.1007/s10461-007-9312-x; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Matthews LT, 2012, CURR OPIN HIV AIDS, V7, P569, DOI 10.1097/COH.0b013e328358bac9; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; [Ministry of Health Uganda ORC Macro], 2006, UG HIV AIDS SER SURV; Mmeje Okeoma, 2012, Infect Dis Obstet Gynecol, V2012, P587651, DOI 10.1155/2012/587651; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Muyindike W, 2012, INFECT DIS OBSTET GY, V2012; Myer L, 2007, TROP MED INT HEALTH, V12, P1484, DOI 10.1111/j.1365-3156.2007.01955.x; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Myer L, 2009, JAIDS-J ACQ IMM DEF, V52, pS52, DOI 10.1097/QAI.0b013e3181bbc818; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Ogilvie GS, 2007, AIDS, V21, pS83, DOI 10.1097/01.aids.0000255090.51921.60; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Polis CB, 2011, CONTRACEPTION, V83, P549, DOI 10.1016/j.contraception.2010.10.002; Revicki DA, 1998, MED CARE, V36, P126, DOI 10.1097/00005650-199802000-00003; SAS, 2011, SAS VERS 9 3; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Sharma A, 2007, AM J OBSTET GYNECOL, V196, P541, DOI 10.1016/j.ajog.2007.01.005; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Snow RC, 2013, AM J PUBLIC HEALTH, V103, P278, DOI 10.2105/AJPH.2012.300892; Taulo F, 2009, AIDS BEHAV, V13, pS20, DOI 10.1007/s10461-009-9547-9; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tweya H, 2012, AIDS BEHAV; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200; Uganda Ministry of Health, 2008, NAT ANT TREATM CAR G; Uganda Ministry of Health, 2003, NAT ANT TREATM CAR G; Ugandan Ministry of Health, 2009, NAT ANT TREATM GUID; Ujiji OA, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-13; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Population Division, 2009, WORLD FERT DAT 2008; US Census Bureau International Programs, 2008, GLOB POP PROF 2008 I; van Benthem BHB, 2000, AIDS, V14, P2171, DOI 10.1097/00002030-200009290-00014; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vitorino RL, 2011, FERTIL STERIL, V95, P1684, DOI 10.1016/j.fertnstert.2011.01.127; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wilcher R, 2009, AIDS, V23, pS1, DOI 10.1097/01.aids.0000363772.45635.35; World Health Organization,, 2020, UNDERSTANDING SEXUAL; World Vision, 2017, INT LIV ASS TARG REF; Wu AW., 1999, MOS HIV HLTH SURVEY; Zaba B, 1998, AIDS, V12, pS41	90	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63411	10.1371/journal.pone.0063411	http://dx.doi.org/10.1371/journal.pone.0063411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704906	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200036
J	Ayoub, MA; See, HB; Seeber, RM; Armstrong, SP; Pfleger, KDG				Ayoub, Mohammed Akli; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Pfleger, Kevin D. G.			Profiling Epidermal Growth Factor Receptor and Heregulin Receptor 3 Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technology	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PHOSPHATIDYLINOSITOL 3-KINASE; BREAST-CANCER; DEPENDENT ACTIVATION; SIGNALING NETWORK; HER3; DIMERIZATION; ERBB3; EGFR; HETERODIMERIZATION	Heteromerization can play an important role in regulating the activation and/or signal transduction of most forms of receptors, including receptor tyrosine kinases (RTKs). The study of receptor heteromerization has evolved extensively with the emergence of resonance energy transfer based approaches such as bioluminescence resonance energy transfer (BRET). Here, we report an adaptation of our Receptor-Heteromer Investigation Technology (Receptor-HIT) that has recently been published as the G protein-coupled receptor (GPCR) Heteromer Identification Technology (GPCR-HIT). We now demonstrate the utility of this approach for investigating RTK heteromerization by examining the functional interaction between the epidermal growth factor (EGF) receptor (EGFR; also known as erbB1/HER1) and heregulin (HRG) receptor 3 (HER3; also known as erbB3) in live HEK293FT cells using recruitment of growth factor receptor-bound protein 2 (Grb2) to the activated receptors. We found that EGFR and HER3 heteromerize specifically as demonstrated by HRG inducing a BRET signal between EGFR/Rluc8 and Grb2/Venus only when HER3 was co-expressed. Similarly, EGF stimulation promoted a specific BRET signal between HER3/Rluc8 and Grb2/Venus only when EGFR was co-expressed. Both EGF and HRG effects on Grb2 interaction are dose-dependent, and specifically blocked by EGFR inhibitor AG-1478. Furthermore, truncation of HER3 to remove the putative Grb2 binding sites appears to abolish EGF-induced Grb2 recruitment to the EGFR-HER3 heteromer. Our results support the concept that EGFR interacts with Grb2 in both constitutive and EGF-dependent manners and this interaction is independent of HER3 co-expression. In contrast, HER3-Grb2 interaction requires the heteromerization between EGFR and HER3. These findings clearly indicate the importance of EGFR-HER3 heteromerization in HER3-mediated Grb2-dependent signaling pathways and supports the central role of HER3 in the diversity and regulation of HER family functioning.	[Ayoub, Mohammed Akli; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol GPCRs, Nedlands, WA 6009, Australia; [Ayoub, Mohammed Akli; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Pfleger, Kevin D. G.] Dimerix Biosci Pty Ltd, Nedlands, WA, Australia; [Ayoub, Mohammed Akli] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia	University of Western Australia; University of Western Australia; King Saud University	Pfleger, KDG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol GPCRs, Nedlands, WA 6009, Australia.	kevin.pfleger@waimr.uwa.edu.au	Seeber, Ruth/AAS-9411-2021; Pfleger, Kevin/H-5629-2014	Seeber, Ruth/0000-0003-3265-7931; AYOUB, Mohammed Akli/0000-0003-0022-578X; Pfleger, Kevin/0000-0001-8261-9189	Australian Research Council [FT100100271]; Dimerix Bioscience Pty Ltd	Australian Research Council(Australian Research Council); Dimerix Bioscience Pty Ltd	This research was funded by the Australian Research Council (www.arc.gov.au) Future Fellowship (FT100100271) awarded to KDGP, as well as Dimerix Bioscience Pty Ltd (www.dimerix.com). Other than KDGP, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Balz LM, 2012, J PATHOL, V227, P234, DOI 10.1002/path.3991; Banappagari S, 2012, J BIOMOL STRUCT DYN, V30, P594, DOI 10.1080/07391102.2012.687525; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Britten CD, 2004, MOL CANCER THER, V3, P1335; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; Choi BK, 2012, PROTEIN CELL, V3, P781, DOI 10.1007/s13238-012-2065-y; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Freeman MR, 2004, CANCER CELL, V6, P427, DOI 10.1016/j.ccr.2004.10.018; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Johnstone Elizabeth K M, 2012, Front Endocrinol (Lausanne), V3, P101, DOI 10.3389/fendo.2012.00101; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kamath AV, 2012, CANCER CHEMOTH PHARM, V69, P1063, DOI 10.1007/s00280-011-1806-6; Kamath S, 2006, MED RES REV, V26, P569, DOI 10.1002/med.20070; KIM HH, 1994, J BIOL CHEM, V269, P24747; Klapper LN, 2000, ADV CANCER RES, V77, P25; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Mustafa S, 2011, JALA-J LAB AUTOM, V16, P285, DOI 10.1016/j.jala.2011.03.002; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Sakai K, 2007, CANCER SCI, V98, P1498, DOI 10.1111/j.1349-7006.2007.00553.x; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Suenaga A, 2005, J BIOL CHEM, V280, P1321, DOI 10.1074/jbc.M410436200; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; Vijapurkar U, 1998, J BIOL CHEM, V273, P20996, DOI 10.1074/jbc.273.33.20996; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Way Tzong-Der, 2005, Future Oncol, V1, P841, DOI 10.2217/14796694.1.6.841; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang K, 1996, J BIOL CHEM, V271, P3884; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-78	53	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64672	10.1371/journal.pone.0064672	http://dx.doi.org/10.1371/journal.pone.0064672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700486	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400062
J	Trushina, E; Dutta, T; Persson, XMT; Mielke, MM; Petersen, RC				Trushina, Eugenia; Dutta, Tumpa; Persson, Xuan-Mai T.; Mielke, Michelle M.; Petersen, Ronald C.			Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer's Disease Using Metabolomics	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID; AMYLOID-BETA; BIOMARKERS; BRAIN; NEURODEGENERATION; PROGRESSION; TRYPTOPHAN; DIAGNOSIS; STEROLS	Alzheimer's Disease (AD) currently affects more than 5 million Americans, with numbers expected to grow dramatically as the population ages. The pathophysiological changes in AD patients begin decades before the onset of dementia, highlighting the urgent need for the development of early diagnostic methods. Compelling data demonstrate that increased levels of amyloid-beta compromise multiple cellular pathways; thus, the investigation of changes in various cellular networks is essential to advance our understanding of early disease mechanisms and to identify novel therapeutic targets. We applied a liquid chromatography/mass spectrometry-based non-targeted metabolomics approach to determine global metabolic changes in plasma and cerebrospinal fluid (CSF) from the same individuals with different AD severity. Metabolic profiling detected a total of significantly altered 342 plasma and 351 CSF metabolites, of which 22% were identified. Based on the changes of <150 metabolites, we found 23 altered canonical pathways in plasma and 20 in CSF in mild cognitive impairment (MCI) vs. cognitively normal (CN) individuals with a false discovery rate <0.05. The number of affected pathways increased with disease severity in both fluids. Lysine metabolism in plasma and the Krebs cycle in CSF were significantly affected in MCI vs. CN. Cholesterol and sphingolipids transport was altered in both CSF and plasma of AD vs. CN. Other 30 canonical pathways significantly disturbed in MCI and AD patients included energy metabolism, Krebs cycle, mitochondrial function, neurotransmitter and amino acid metabolism, and lipid biosynthesis. Pathways in plasma that discriminated between all groups included polyamine, lysine, tryptophan metabolism, and aminoacyl-tRNA biosynthesis; and in CSF involved cortisone and prostaglandin 2 biosynthesis and metabolism. Our data suggest metabolomics could advance our understanding of the early disease mechanisms shared in progression from CN to MCI and to AD.	[Trushina, Eugenia; Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Trushina, Eugenia] Mayo Clin, Dept Pharmacol & Expt Therapeut, Rochester, MN USA; [Dutta, Tumpa; Persson, Xuan-Mai T.] Mayo Clin, Ctr Translat Sci Act Metabol Core Facil, Rochester, MN USA; [Dutta, Tumpa] Mayo Clin, Div Endocrinol, Rochester, MN USA; [Dutta, Tumpa] Mayo Clin, Endocrine Res Unit Rochester, Rochester, MN USA; [Mielke, Michelle M.; Petersen, Ronald C.] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Trushina, E (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	Trushina.Eugenia@mayo.edu		Mielke, Michelle/0000-0001-7177-1185; Dutta, Tumpa/0000-0003-0400-209X	National Institute of Environmental Health Sciences (NIEHS) [R01ES020715]; National Institute on Aging to the Mayo Clinic Study of Aging (MCSA) [AG006786]; National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center [AG016574]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016574, U01AG006786] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging to the Mayo Clinic Study of Aging (MCSA); National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National Institute of Environmental Health Sciences (NIEHS), grant number R01ES020715; the National Institute on Aging to the Mayo Clinic Study of Aging (MCSA), grant number AG006786; and the National Institute on Aging award to the Mayo Clinic Alzheimer's Disease Research Center, grant number AG016574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI N, 2012, MOL MECH ASPECT ER S; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Bassett C N, 2003, J Nutr Health Aging, V7, P24; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bazan NG, 2002, PROSTAG OTH LIPID M, V68-9, P197, DOI 10.1016/S0090-6980(02)00031-X; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Cedazo-Minguez A, 2010, EXP GERONTOL, V45, P5, DOI 10.1016/j.exger.2009.09.008; Chen J, 2008, ANAL CHEM, V80, P1280, DOI 10.1021/ac702089h; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Combrinck M, 2006, J NEUROL NEUROSUR PS, V77, P85, DOI 10.1136/jnnp.2005.063131; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; Dragicevic N, 2011, J PINEAL RES, V51, P75, DOI 10.1111/j.1600-079X.2011.00864.x; Dutta T, 2012, DIABETES, V61, P1004, DOI 10.2337/db11-0874; Eriksson L., 2001, MULTI MEGAVARIATE DA; Farooqui AA, 1997, NEUROCHEM RES, V22, P523, DOI 10.1023/A:1027380331807; FLEISHER AS, 2012, LANCET NEUROLOGY; Fonteh AN, 2007, AMINO ACIDS, V32, P213, DOI 10.1007/s00726-006-0409-8; Friedman JI, 1999, BIOL PSYCHIAT, V46, P1243, DOI 10.1016/S0006-3223(99)00232-2; Funk K. E., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/752894; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gomez-Villafuertes R, 2004, J PHARMACOL EXP THER, V308, P1148, DOI 10.1124/jpet.103.061564; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Hendricksen M, 2004, AM J PSYCHIAT, V161, P1096, DOI 10.1176/appi.ajp.161.6.1096; HOLTZMAN DM, 2011, SCI TRANSLATIONAL ME, V3; Ibach B, 2006, NEUROBIOL AGING, V27, P1202, DOI 10.1016/j.neurobiolaging.2005.06.005; IBANEZ C, 2012, ANAL CHEM; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Jovanovic A, 1998, FEBS LETT, V423, P314, DOI 10.1016/S0014-5793(98)00114-8; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Lembcke J, 2005, J LIPID RES, V46, P21, DOI 10.1194/jlr.C400004-JLR200; McDonald JG, 2007, METHOD ENZYMOL, V432, P145, DOI 10.1016/S0076-6879(07)32006-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Miras-Portugal MT, 1998, FEBS LETT, V430, P78, DOI 10.1016/S0014-5793(98)00560-2; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberts RO, 2008, NEUROEPIDEMIOLOGY, V30, P58, DOI 10.1159/000115751; Rosales-Corral S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/843649; Rosales-Corral Sergio A, 2012, Int J Alzheimers Dis, V2012, P459806, DOI 10.1155/2012/459806; Ruan BF, 2001, J LIPID RES, V42, P799; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; SCHAECHTER JD, 1990, BRAIN RES, V532, P203, DOI 10.1016/0006-8993(90)91761-5; Schmitt K, 2012, ANTIOXID REDOX SIGN, V16, P1456, DOI 10.1089/ars.2011.4400; Schuierer S, 2010, BIOINFORMATICS, V26, P1922, DOI 10.1093/bioinformatics/btq307; SELFRIDGE JE, 2012, NEUROBIOLOGY DIS; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Song F, 2009, BRAIN RES REV, V61, P69, DOI 10.1016/j.brainresrev.2009.05.003; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019477; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Wurtman R. J., 1969, Recent Progress in Hormone Research, V25, P493; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	71	280	290	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63644	10.1371/journal.pone.0063644	http://dx.doi.org/10.1371/journal.pone.0063644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700429	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400026
J	Evseenko, D; Latour, B; Richardson, W; Corselli, M; Sahaghian, A; Cardinal, S; Zhu, YH; Chan, R; Dunn, B; Crooks, GM				Evseenko, Denis; Latour, Brooke; Richardson, Wade; Corselli, Mirko; Sahaghian, Arineh; Cardinal, Sofie; Zhu, Yuhua; Chan, Rebecca; Dunn, Bruce; Crooks, Gay M.			Lysophosphatidic Acid Mediates Myeloid Differentiation within the Human Bone Marrow Microenvironment	PLOS ONE			English	Article							STEM-CELLS; B-CELLS; PROGENITOR; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; TRAFFICKING; GENERATION; RECEPTORS; HISTOLOGY; MICE	Lysophosphatidic acid (LPA) is a pleiotropic phospholipid present in the blood and certain tissues at high concentrations; its diverse effects are mediated through differential, tissue specific expression of LPA receptors. Our goal was to determine if LPA exerts lineage-specific effects during normal human hematopoiesis. In vitro stimulation of CD34+ human hematopoietic progenitors by LPA induced myeloid differentiation but had no effect on lymphoid differentiation. LPA receptors were expressed at significantly higher levels on Common Myeloid Progenitors (CMP) than either multipotent Hematopoietic Stem/Progenitor Cells (HSPC) or Common Lymphoid Progenitors (CLP) suggesting that LPA acts on committed myeloid progenitors. Functional studies demonstrated that LPA enhanced migration, induced cell proliferation and reduced apoptosis of isolated CMP, but had no effect on either HSPC or CLP. Analysis of adult and fetal human bone marrow sections showed that PPAP2A, (the enzyme which degrades LPA) was highly expressed in the osteoblastic niche but not in the perivascular regions, whereas Autotaxin (the enzyme that synthesizes LPA) was expressed in perivascular regions of the marrow. We propose that a gradient of LPA with the highest levels in peri-sinusoidal regions and lowest near the endosteal zone, regulates the localization, proliferation and differentiation of myeloid progenitors within the bone marrow marrow.	[Evseenko, Denis; Corselli, Mirko; Sahaghian, Arineh; Zhu, Yuhua; Chan, Rebecca] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Evseenko, Denis; Dunn, Bruce; Crooks, Gay M.] Eli & Edythe Broad Inst Regenerat Med & Stem Cell, Los Angeles, CA USA; [Latour, Brooke; Crooks, Gay M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Richardson, Wade; Dunn, Bruce] Univ Calif Los Angeles, Dept Engn, Los Angeles, CA USA; [Cardinal, Sofie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Evseenko, D (corresponding author), Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	devseenko@mednet.ucla.edu	Latour, Brooke/AAW-9199-2021		National Institutes of Health (NIH) [K01AR061415]; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI [UL1TR000124]; California Institute of Regenerative Medicine [RB3-05217]; Broad Stem Cell Research Center (BSCRC) at UCLA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR061415] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Broad Stem Cell Research Center (BSCRC) at UCLA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health (NIH) K01AR061415 and by NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124 (DE), the California Institute of Regenerative Medicine RB3-05217 (GMC), and from the Broad Stem Cell Research Center (BSCRC) at UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Blackburn J, 2012, BONE, V50, P756, DOI 10.1016/j.bone.2011.12.002; Chiang CL, 2011, STEM CELLS, V29, P1763, DOI 10.1002/stem.733; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Hao QL, 1998, BLOOD, V91, P4145, DOI 10.1182/blood.V91.11.4145.411a10_4145_4151; ITOH K, 1989, EXP HEMATOL, V17, P145; Juarez JG, 2012, BLOOD, V119, P707, DOI 10.1182/blood-2011-04-348904; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; OSMOND DG, 1992, BLOOD, V79, P1695; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Seitz G, 2005, ANN NY ACAD SCI, V1044, P84, DOI 10.1196/annals.1349.011; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; WILKINS BS, 1992, J CLIN PATHOL, V45, P645, DOI 10.1136/jcp.45.8.645; Yanai N, 2000, BLOOD, V96, P139, DOI 10.1182/blood.V96.1.139.013k15_139_144	20	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63718	10.1371/journal.pone.0063718	http://dx.doi.org/10.1371/journal.pone.0063718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696850	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900056
J	Ji, GJ; Zhang, ZQ; Zhang, H; Wang, J; Liu, DQ; Zang, YF; Liao, W; Lu, GM				Ji, Gong-Jun; Zhang, Zhiqiang; Zhang, Han; Wang, Jue; Liu, Dong-Qiang; Zang, Yu-Feng; Liao, Wei; Lu, Guangming			Disrupted Causal Connectivity in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							ALTERED FUNCTIONAL CONNECTIVITY; LOW-FREQUENCY FLUCTUATION; BASAL GANGLIA; NEURAL NETWORKS; FMRI; MRI; AMPLITUDE; PATTERNS; CHILDREN; SEIZURES	Although mesial temporal lobe epilepsy (mTLE) is characterized by the pathological changes in mesial temporal lobe, function alteration was also found in extratemporal regions. Our aim is to investigate the information flow between the epileptogenic zone (EZ) and other brain regions. Resting-state functional magnetic resonance imaging (RS-fMRI) data were recorded from 23 patients with left mTLE and matched controls. We first identified the potential EZ using the amplitude of low-frequency fluctuation (ALFF) of RS-fMRI signal, then performed voxel-wise Granger causality analysis between EZ and the whole brain. Relative to controls, patients demonstrated decreased driving effect from EZ to thalamus and basal ganglia, and increased feedback. Additionally, we found an altered causal relation between EZ and cortical networks (default mode network, limbic system, visual network and executive control network). The influence from EZ to right precuneus and brainstem negatively correlated with disease duration, whereas that from the right hippocampus, fusiform cortex, and lentiform nucleus to EZ showed positive correlation. These findings demonstrate widespread brain regions showing abnormal functional interaction with EZ. In addition, increased ALFF in EZ was positively correlated with the increased driving effect on EZ in patients, but not in controls. This finding suggests that the initiation of epileptic activity depends not only on EZ itself, but also on the activity emerging in large-scale macroscopic brain networks. Overall, this study suggests that the causal topological organization is disrupted in mTLE, providing valuable information to understand the pathophysiology of this disorder.	[Ji, Gong-Jun; Zang, Yu-Feng] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Sch Brian & Cognit Sci, Beijing 100875, Peoples R China; [Zhang, Zhiqiang; Lu, Guangming] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Han; Wang, Jue; Liu, Dong-Qiang; Zang, Yu-Feng; Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zhang, Han; Wang, Jue; Liu, Dong-Qiang; Zang, Yu-Feng; Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Zhang, Han; Wang, Jue; Liu, Dong-Qiang; Zang, Yu-Feng; Liao, Wei] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Nanjing University; Hangzhou Normal University; Hangzhou Normal University	Liao, W (corresponding author), Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	weiliao.wl@gmail.com; cjr.luguangming@vip.163.com	ZANG, Yu-Feng/J-1558-2012	ZANG, Yu-Feng/0000-0003-1833-8010; JI, Gong-Jun/0000-0002-7073-5534; Zhang, Han/0000-0002-6645-8810	Natural Science Foundation of China [81020109022/H1802, 81201155, 81271553]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the Natural Science Foundation of China (81020109022/H1802 to Yu-Feng Zang; 81201155 to Wei Liao; 81271553 to Zhiqiang Zhang) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio A, 2013, HUM BRAIN MAPP, V34, P186, DOI 10.1002/hbm.21432; Angelini L, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.037201; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Bertram EH, 2001, EPILEPSIA, V42, P967, DOI 10.1046/j.1528-1157.2001.042008967.x; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020071; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Chaudhary UJ, 2013, HUM BRAIN MAPP, V34, P447, DOI 10.1002/hbm.21448; Chen G, 2009, P INT SOC MAGN RES M, V17; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Drane DL, 2002, EPILEPSY BEHAV, V3, pS49; Dupont P, 2009, EUR J NUCL MED MOL I, V36, P823, DOI 10.1007/s00259-008-1040-6; Ebersole JS, 1997, J CLIN NEUROPHYSIOL, V14, P470, DOI 10.1097/00004691-199711000-00003; Eckert U, 2012, HUM BRAIN MAPP, V33, P2627, DOI 10.1002/hbm.21389; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Hamandi K, 2008, J NEUROL NEUROSUR PS, V79, P594, DOI 10.1136/jnnp.2007.125401; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Kobayashi E, 2006, EPILEPSIA, V47, P343, DOI 10.1111/j.1528-1167.2006.00427.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mankinen K, 2012, EPILEPSY RES, V100, P168, DOI 10.1016/j.eplepsyres.2012.02.010; Morgan VL, 2007, EPILEPSY RES, V76, P22, DOI 10.1016/j.eplepsyres.2007.06.008; Morgan VL, 2011, EPILEPSIA, V52, P1741, DOI 10.1111/j.1528-1167.2011.03196.x; Morgan VL, 2010, EPILEPSY RES, V88, P168, DOI 10.1016/j.eplepsyres.2009.10.018; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Rektor I, 2012, EPILEPSY BEHAV, V25, P56, DOI 10.1016/j.yebeh.2012.04.125; Rektor I, 2011, EPILEPSY BEHAV, V20, P512, DOI 10.1016/j.yebeh.2011.01.003; Riley JD, 2011, EPILEPSY BEHAV, V21, P80, DOI 10.1016/j.yebeh.2011.03.013; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Szaflarski JP, 2010, EPILEPSY BEHAV, V18, P404, DOI 10.1016/j.yebeh.2010.05.009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wendling F, 2001, CLIN NEUROPHYSIOL, V112, P1201, DOI 10.1016/S1388-2457(01)00547-8; WU JW, 1998, CHIN J RADIOL, V32, P220; Wurina, 2012, NEUROSCI BULL, V28, P449, DOI 10.1007/s12264-012-1255-1; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	69	43	46	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63183	10.1371/journal.pone.0063183	http://dx.doi.org/10.1371/journal.pone.0063183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696798	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900014
J	Tasdelen, I; Berger, R; Kalkhoven, E				Tasdelen, Ismayil; Berger, Ruud; Kalkhoven, Eric			PPAR gamma Regulates Expression of Carbohydrate Sulfotransferase 11 (CHST11/C4ST1), a Regulator of LPL Cell Surface Binding	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HEPARAN-SULFATE PROTEOGLYCANS; LIPOPROTEIN-LIPASE; IDENTIFICATION; DIFFERENTIATION; ADIPOCYTES; TARGETS; GENE; CHONDROITIN-4-SULFOTRANSFERASE-1; ADIPOGENESIS	The transcription factor PPAR gamma is the key regulator of adipocyte differentiation, function and maintenance, and the cellular target of the insulin-sensitizing thiazolidinediones. Identification and functional characterization of genes regulated by PPAR gamma will therefore lead to a better understanding of adipocyte biology and may also contribute to the development of new anti-diabetic drugs. Here, we report carbohydrate sulfotransferase 11 (Chst11/C4st1) as a novel PPAR gamma target gene. Chst11 can sulphate chondroitin, a major glycosaminoglycan involved in development and disease. The Chst11 gene contains two functional intronic PPAR gamma binding sites, and is up-regulated at the mRNA and protein level during 3T3-L1 adipogenesis. Chst11 knockdown reduced intracellular lipid accumulation in mature adipocytes, which is due to a lowered activity of lipoprotein lipase, which may associate with the adipocyte cell surface through Chst11-mediated sulfation of chondroitin, rather than impaired adipogenesis. Besides directly inducing Lpl expression, PPAR gamma may therefore control lipid accumulation by elevating the levels of Chst11-mediated proteoglycan sulfation and thereby increasing the binding capacity for Lpl on the adipocyte cell surface.	[Kalkhoven, Eric] Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kalkhoven, E (corresponding author), Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands.	e.kalkhoven@umcutrecht.nl			Wilhelmina Children's Hospital Research Fund; The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/The Netherlands Organization for Scientific Research (NWO)	Wilhelmina Children's Hospital Research Fund; The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Wilhelmina Children's Hospital Research Fund and by the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/The Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; CALVO JC, 1991, J BIOL CHEM, V266, P11237; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gonzales AM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-22; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hegele RA, 2005, INT J OBESITY, V29, pS31, DOI 10.1038/sj.ijo.0802911; HENNIG B, 1984, ARTERIOSCLEROSIS, V4, P489, DOI 10.1161/01.ATV.4.5.489; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Jeninga EH, 2009, J BIOL CHEM, V284, P26385, DOI 10.1074/jbc.M109.040741; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Koppen A, 2009, MOL CELL PROTEOMICS, V8, P2212, DOI 10.1074/mcp.M900209-MCP200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; MISRA KB, 1994, J BIOL CHEM, V269, P23838; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rutledge JC, 1997, CIRC RES, V80, P819; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1991, P NATL ACAD SCI USA, V88, P2254, DOI 10.1073/pnas.88.6.2254; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673; Wilsie Larissa C, 2005, Lipids Health Dis, V4, P2, DOI 10.1186/1476-511X-4-2; Yamauchi S, 1999, J BIOL CHEM, V274, P2456, DOI 10.1074/jbc.274.4.2456; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64284	10.1371/journal.pone.0064284	http://dx.doi.org/10.1371/journal.pone.0064284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696875	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900078
J	Ost, M; Jaatinen, K				Ost, Markus; Jaatinen, Kim			Relative Importance of Social Status and Physiological Need in Determining Leadership in a Social Forager	PLOS ONE			English	Article							EIDERS SOMATERIA-MOLLISSIMA; BROOD-REARING COALITIONS; COMMON-EIDERS; DECISION-MAKING; BODY CONDITION; CLUTCH SIZE; EVOLUTION; PAIRS; CARE; INCUBATION	Group decisions on the timing of mutually exclusive activities pose a dilemma: monopolized decision-making by a single leader compromises the optimal timing of activities by the others, while independent decision-making by all group members undermines group coherence. Theory suggests that initiation of foraging should be determined by physiological demand in social foragers, thereby resolving the dilemma of group coordination. However, empirical support is scant, perhaps because intrinsic qualities predisposing individuals to leadership (social status, experience or personality), or their interactions with satiation level, have seldom been simultaneously considered. Here, we examine which females initiated foraging in eider (Somateria mollissima) brood-rearing coalitions, characterized by female dominance hierarchies and potentially large individual differences in energy requirements due to strenuous breeding effort. Several physiological and social factors, except for female breeding experience and boldness towards predators, explained foraging initiation. Initiators spent a larger proportion of time submerged during foraging bouts, had poorer body condition and smaller structural size, but they were also aggressive and occupied central positions. Initiation probability also declined with female group size as expected given random assignment of initiators. However, the relative importance of physiological predictors of leadership propensity (active foraging time, body condition, structural size) exceeded those of social predictors (aggressiveness, spatial position) by an order of magnitude. These results confirm recent theoretical work suggesting that 'leading according to need' is an evolutionary viable strategy regardless of group heterogeneity or underlying dominance structure.	[Ost, Markus] Abo Akad Univ, Aronia Coastal Zone Res Team, Ekenas, Finland; [Ost, Markus] Novia Univ Appl Sci, Ekenas, Finland; [Jaatinen, Kim] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Abo Akademi University; Novia University of Applied Sciences; Australian National University	Ost, M (corresponding author), Abo Akad Univ, Aronia Coastal Zone Res Team, Ekenas, Finland.	Markus.Ost@novia.fi	Öst, Markus/C-7376-2008; Jaatinen, Kim/A-3221-2011	Öst, Markus/0000-0002-2205-1437; Jaatinen, Kim/0000-0002-5568-5647	Academy of Finland [128039]; Maj and Tor Nessling Foundation	Academy of Finland(Academy of Finland); Maj and Tor Nessling Foundation	The study was funded by the Academy of Finland (grant number 128039; http://www.aka.fi/eng) and Maj and Tor Nessling Foundation (http://www.nessling.fi/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Bedard J, 1976, BEHAVIOUR, V60, P221; Bolduc F, 2003, BIOL CONSERV, V110, P77, DOI 10.1016/S0006-3207(02)00178-7; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carter AJ, 2012, ANIM BEHAV, V84, P603, DOI 10.1016/j.anbehav.2012.06.015; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Cox DR., 1970, ANAL BINARY DATA; Ekroos J, 2012, OECOLOGIA, V170, P979, DOI 10.1007/s00442-012-2378-9; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; GUILLEMETTE M, 1994, AUK, V111, P900, DOI 10.2307/4088822; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Jaatinen K, 2013, AM NAT, V181, P171, DOI 10.1086/668824; Jaatinen K, 2012, MOL ECOL, V21, P3341, DOI 10.1111/j.1365-294X.2012.05603.x; Jaatinen K, 2011, ANIM BEHAV, V81, P1289, DOI 10.1016/j.anbehav.2011.03.020; Jaatinen K, 2011, J ANIM ECOL, V80, P49, DOI 10.1111/j.1365-2656.2010.01757.x; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Kilpi M, 1997, OECOLOGIA, V111, P297, DOI 10.1007/s004420050238; Kilpi M, 2001, ANIM BEHAV, V62, P527, DOI 10.1006/anbe.2001.1784; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King Andrew J., 2009, Communicative & Integrative Biology, V2, P147; Kurvers RHJM, 2011, P ROY SOC B-BIOL SCI, V278, P2018, DOI 10.1098/rspb.2010.2266; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Lusseau D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1067, DOI 10.1007/s00265-009-0740-7; McClure M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1573, DOI 10.1007/s00265-011-1167-5; McComb K, 2011, P ROY SOC B-BIOL SCI, V278, P3270, DOI 10.1098/rspb.2011.0168; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043747; Ost M, 2003, ANIM BEHAV, V66, P1069, DOI 10.1006/anbe.2003.2300; Ost M, 2003, BEHAV ECOL SOCIOBIOL, V54, P451, DOI 10.1007/s00265-003-0641-0; Ost M, 2003, BEHAV ECOL, V14, P311, DOI 10.1093/beheco/14.3.311; Ost M, 2008, OECOLOGIA, V158, P205, DOI 10.1007/s00442-008-1139-2; Ost M, 2008, J ANIM ECOL, V77, P315, DOI 10.1111/j.1365-2656.2007.01348.x; Ost M, 2007, ANIM BEHAV, V73, P239, DOI 10.1016/j.anbehav.2006.04.010; Ost M, 2011, BEHAV ECOL, V22, P378, DOI 10.1093/beheco/arq223; Ost M, 2011, OECOLOGIA, V166, P327, DOI 10.1007/s00442-010-1855-2; Ost M, 2010, OECOLOGIA, V162, P59, DOI 10.1007/s00442-009-1444-4; PARKER H, 1990, AUK, V107, P660, DOI 10.2307/4087996; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002252; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Seltmann MW, 2012, ANIM BEHAV, V84, P889, DOI 10.1016/j.anbehav.2012.07.012; Sueur C, 2012, J THEOR BIOL, V306, P93, DOI 10.1016/j.jtbi.2012.04.020; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Trillmich J, 2004, BEHAVIOUR, V141, P1103, DOI 10.1163/1568539042664579; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6; WITHERS PC, 1992, COMP ANIMAL PHYSL	52	3	3	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64778	10.1371/journal.pone.0064778	http://dx.doi.org/10.1371/journal.pone.0064778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691258	gold, Green Submitted, Green Published			2022-12-25	WOS:000319052700115
J	Vanderslice, P; Biediger, RJ; Woodside, DG; Brown, WS; Khounlo, S; Warier, ND; Gundlach, CW; Caivano, AR; Bornmann, WG; Maxwell, DS; McIntyre, BW; Willerson, JT; Dixon, RAF				Vanderslice, Peter; Biediger, Ronald J.; Woodside, Darren G.; Brown, Wells S.; Khounlo, Sayadeth; Warier, Navin D.; Gundlach, C. William; Caivano, Amy R.; Bornmann, William G.; Maxwell, David S.; McIntyre, Bradley W.; Willerson, James T.; Dixon, Richard A. F.			Small Molecule Agonist of Very Late Antigen-4 (VLA-4) Integrin Induces Progenitor Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; LIGAND-BINDING; STEM-CELLS; ALPHA-4-BETA-1; RECRUITMENT; ENGRAFTMENT; CD11B/CD18; SUBUNIT	Activation of the integrin family of cell adhesion receptors on progenitor cells may be a viable approach to enhance the effects of stem cell-based therapies by improving cell retention and engraftment. Here, we describe the synthesis and characterization of the first small molecule agonist identified for the integrin alpha 4 beta 1 (also known as very late antigen-4 or VLA-4). The agonist, THI0019, was generated via two structural modifications to a previously identified alpha 4 beta 1 antagonist. THI0019 greatly enhanced the adhesion of cultured cell lines and primary progenitor cells to alpha 4 beta 1 ligands VCAM-1 and CS1 under both static and flow conditions. Furthermore, THI0019 facilitated the rolling and spreading of cells on VCAM-1 and the migration of cells toward SDF-1 alpha. Molecular modeling predicted that the compound binds at the alpha/beta subunit interface overlapping the ligand-binding site thus indicating that the compound must be displaced upon ligand binding. In support of this model, an analog of THI0019 modified to contain a photoreactive group was used to demonstrate that when cross-linked to the integrin, the compound behaves as an antagonist instead of an agonist. In addition, THI0019 showed cross-reactivity with the related integrin alpha 4 beta 7 as well as alpha 5 beta 1 and alpha L beta 2. When cross-linked to alpha L beta 2, the photoreactive analog of THI0019 remained an agonist, consistent with it binding at the alpha/beta subunit interface and not at the ligand-binding site in the inserted ("I") domain of the L subunit. Co-administering progenitor cells with a compound such as THI0019 may provide a mechanism for enhancing stem cell therapy.	[Vanderslice, Peter; Biediger, Ronald J.; Woodside, Darren G.; Khounlo, Sayadeth; Warier, Navin D.; Gundlach, C. William; Caivano, Amy R.; Willerson, James T.; Dixon, Richard A. F.] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77030 USA; [Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Bornmann, William G.; Maxwell, David S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Vanderslice, P (corresponding author), St Lukes Episcopal Hosp, Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77030 USA.	pvanderslice@texasheart.org			National Institutes of Health Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [T32CA009598, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Rebecca Bartow, Ph.D., and Nicole Stancel, Ph.D., of the Texas Heart Institute for editorial assistance and Deenadayalan Bakthavatsalam, Ph.D., for confocal microscopy advice. The Translational Chemistry Core Facility at the University of Texas M. D. Anderson Cancer Center was the recipient of National Institutes of Health Cancer Center Support Grant CA016672.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; ARROYO AG, 1993, J BIOL CHEM, V268, P9863; Asaumi N, 2001, ANN HEMATOL, V80, P387, DOI 10.1007/s002770100309; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biediger R. J., 2001, U.S. Patent, Patent No. [6,194,448, 6194448]; Biediger R. J., 2012, International Patent, Patent No. [PCT/US2011/060996, 2011060996]; Bjorklund M, 2006, BIOCHEMISTRY-US, V45, P2862, DOI 10.1021/bi052238b; Bougie DW, 2002, BLOOD, V100, P2071, DOI 10.1182/blood.V100.6.2071.h81802002071_2071_2076; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Coller BS, 1997, J CLIN INVEST, V100, pS57; Dobaczewski M, 2006, CELL TISSUE RES, V324, P475, DOI 10.1007/s00441-005-0144-6; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Duan HX, 2006, THROMB HAEMOSTASIS, V96, P807, DOI 10.1160/TH06-04-0199; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Kassir J. M., 2000, 219 ACS NAT M SAN FR; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Leone DR, 2003, J PHARMACOL EXP THER, V305, P1150, DOI 10.1124/jpet.102.047332; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; Liu JW, 2012, CIRC-CARDIOVASC IMAG, V5, P481, DOI 10.1161/CIRCIMAGING.111.969329; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; NOWLIN DM, 1993, J BIOL CHEM, V268, P20352; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Park JY, 2007, J BIOMOL SCREEN, V12, P406, DOI 10.1177/1087057106299162; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pepinsky RB, 2002, BIOCHEMISTRY-US, V41, P7125, DOI 10.1021/bi020024d; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; Ruiz-Velasco N, 2000, J BIOL CHEM, V275, P7052, DOI 10.1074/jbc.275.10.7052; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Scott D., 2003, U.S. Patent, Patent No. [6,630,503, 6630503]; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467; SZABO MC, 1995, J IMMUNOL, V154, P2112; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Vanderslice P, 1997, J IMMUNOL, V158, P1710; Vanderslice P, 2010, BIOCHEM BIOPH RES CO, V400, P619, DOI 10.1016/j.bbrc.2010.08.114; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Woodside DG, 2006, J IMMUNOL, V176, P5041, DOI 10.4049/jimmunol.176.8.5041; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2006, J BIOL CHEM, V281, P37904, DOI 10.1074/jbc.M606888200; You TJ, 2002, BIOPHYS J, V82, P447, DOI 10.1016/S0006-3495(02)75409-X; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang S, 2007, CIRC RES, V100, P693, DOI 10.1161/01.RES.0000260803.98329.1c; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	54	20	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19414	19428		10.1074/jbc.M113.479634	http://dx.doi.org/10.1074/jbc.M113.479634			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703610	hybrid, Green Published			2022-12-25	WOS:000321515800010
J	Rocca, S; Schiavoni, G; Sali, M; Anfossi, AG; Abalsamo, L; Palucci, I; Mattei, F; Sanchez, M; Giagu, A; Antuofermo, E; Fadda, G; Belardelli, F; Delogu, G; Gabriele, L				Rocca, Stefano; Schiavoni, Giovanna; Sali, Michela; Anfossi, Antonio Giovanni; Abalsamo, Laura; Palucci, Ivana; Mattei, Fabrizio; Sanchez, Massimo; Giagu, Anna; Antuofermo, Elisabetta; Fadda, Giovanni; Belardelli, Filippo; Delogu, Giovanni; Gabriele, Lucia			Interferon Regulatory Factor 8-Deficiency Determines Massive Neutrophil Recruitment but T Cell Defect in Fast Growing Granulomas during Tuberculosis	PLOS ONE			English	Article							LEUKEMIA-LIKE SYNDROME; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; DENDRITIC CELLS; MICE; PATHOLOGY; LUNGS; GENE; IMMUNODEFICIENCY; ACTIVATION	Following Mycobacterium tuberculosis (Mtb) infection, immune cell recruitment in lungs is pivotal in establishing protective immunity through granuloma formation and neogenesis of lymphoid structures (LS). Interferon regulatory factor-8 (IRF-8) plays an important role in host defense against Mtb, although the mechanisms driving anti-mycobacterial immunity remain unclear. In this study, IRF-8 deficient mice (IRF-8(-/-)) were aerogenously infected with a low-dose Mtb Erdman virulent strain and the course of infection was compared with that induced in wild-type (WT-B6) counterparts. Tuberculosis (TB) progression was examined in both groups using pathological, microbiological and immunological parameters. Following Mtb exposure, the bacterial load in lungs and spleens progressed comparably in the two groups for two weeks, after which IRF-8(-/-) mice developed a fatal acute TB whereas in WT-B6 the disease reached a chronic stage. In lungs of IRF-8(-/-), uncontrolled growth of pulmonary granulomas and impaired development of LS were observed, associated with unbalanced homeostatic chemokines, progressive loss of infiltrating T lymphocytes and massive prevalence of neutrophils at late infection stages. Our data define IRF-8 as an essential factor for the maintenance of proper immune cell recruitment in granulomas and LS required to restrain Mtb infection. Moreover, IRF-8(-/-) mice, relying on a common human and mouse genetic mutation linked to susceptibility/severity of mycobacterial diseases, represent a valuable model of acute TB for comparative studies with chronically-infected congenic WT-B6 for dissecting protective and pathological immune reactions.	[Rocca, Stefano; Anfossi, Antonio Giovanni; Giagu, Anna; Antuofermo, Elisabetta] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Schiavoni, Giovanna; Abalsamo, Laura; Mattei, Fabrizio; Sanchez, Massimo; Belardelli, Filippo; Gabriele, Lucia] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Sali, Michela; Palucci, Ivana; Fadda, Giovanni; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy	University of Sassari; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gabriele, L (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lucia.gabriele@iss.it	Sanchez, Massimo/AAD-1746-2021; Schiavoni, Giovanna/T-4418-2017; Mattei, Fabrizio/J-6585-2016; Schiavoni, Giovanna/K-2448-2019; Gabriele, Lucia/J-8335-2016; palucci, ivana/J-8542-2018	Sanchez, Massimo/0000-0003-3696-7582; Schiavoni, Giovanna/0000-0001-9135-0556; Mattei, Fabrizio/0000-0002-5357-7773; Schiavoni, Giovanna/0000-0001-9135-0556; Gabriele, Lucia/0000-0002-1483-866X; palucci, ivana/0000-0003-2106-1761; Delogu, Giovanni/0000-0003-0182-8267; Belardelli, Filippo/0000-0002-3082-3169; SALI, Michela/0000-0003-3609-2990; GIAGU, ANNA/0000-0002-1424-073X; ANTUOFERMO, Elisabetta/0000-0002-1193-7777; ROCCA, Stefano/0000-0001-8897-5707	European Community Seventh Framework Programme (HOMITB) [200732]	European Community Seventh Framework Programme (HOMITB)	This work was funded by the European Community Seventh Framework Programme (Project acronym: HOMITB, Title: "Host and microbial molecular dissection of pathogenesis and immunity in tuberculosis''; Grant agreement no.: 200732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker AM, 2012, BLOOD, V119, P2003, DOI 10.1182/blood-2011-06-364976; Behr M, 2010, CELL, V140, P615, DOI 10.1016/j.cell.2010.02.030; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Chen CY, 2012, J IMMUNOL, V188, P4278, DOI 10.4049/jimmunol.1101291; Corsiero E, 2012, IMMUNOL LETT, V145, P62, DOI 10.1016/j.imlet.2012.04.013; Day TA, 2010, EUR J IMMUNOL, V40, P1663, DOI 10.1002/eji.201040299; Delogu G, 2006, INFECT IMMUN, V74, P3006, DOI 10.1128/IAI.74.5.3006-3011.2006; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; El Shikh MEM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00292; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gabriele L, 2007, CYTOKINE GROWTH F R, V18, P503, DOI 10.1016/j.cytogfr.2007.06.008; Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Guglani L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050052; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hunter RL, 2011, TUBERCULOSIS, V91, P497, DOI 10.1016/j.tube.2011.03.007; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Kashino SS, 2010, AM J PATHOL, V176, P198, DOI 10.2353/ajpath.2010.090446; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Mattei F, 2006, BLOOD, V108, P609, DOI 10.1182/blood-2005-11-4490; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]; Sali M, 2008, MICROBES INFECT, V10, P605, DOI 10.1016/j.micinf.2008.02.012; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Slight SR, 2012, CYTOKINE GROWTH 1115, DOI [10.1016/j.cytogfr.2012.10.002, DOI 10.1016/J.CYT0GFR.2012.10.002.[]; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Turcotte K, 2005, J EXP MED, V201, P881, DOI 10.1084/jem.20042170; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Yoshikai Y, 2006, CRIT REV IMMUNOL, V26, P515, DOI 10.1615/CritRevImmunol.v26.i6.40; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	46	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e62751	10.1371/journal.pone.0062751	http://dx.doi.org/10.1371/journal.pone.0062751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717393	Green Submitted, gold, Green Published			2022-12-25	WOS:000319385300041
J	Johnson, L; Supuk, E; Buckley, JG; Elliott, DB				Johnson, Louise; Supuk, Elvira; Buckley, John G.; Elliott, David B.			Effects of Induced Astigmatism on Foot Placement Strategies when Stepping onto a Raised Surface	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADAPTIVE GAIT CHANGES; EYE CATARACT-SURGERY; OLDER-PEOPLE; VISUAL IMPAIRMENT; HEALTH-STATUS; HIP FRACTURE; FALLS; VISION; MAGNIFICATION	Purpose: Large changes in spectacle prescription can increase falls risk in older people. We investigated the effect of induced astigmatism (a common cause of distorted or blurred vision in older people) on locomotor stepping patterns to determine whether the orientation of astigmatic changes could have differential effects on gait safety when negotiating steps and stairs. Methods: 10 older adults (mean age 76.0 +/- 6.4 years) walked up to and stepped onto a raised block whilst wearing their spectacle prescription and when blurred with +/- 3.00D cylinders at axes 45 degrees, 90 degrees, 135 degrees and 180 degrees. Gait measurements included foot placement before the block, toe clearance over the block edge and foot placement on the block. Results: Induced astigmatism with axes at 90 degrees, providing magnification in the horizontal meridian only, caused no change in stepping pattern. Induced astigmatism with axes at 180 degrees caused foot placement changes in the anterior or posterior direction according to whether magnification was positive or negative in the vertical meridian (block perceived higher or lower respectively). Induced astigmatism with axes oblique at 45 degrees and 135 degrees (causing the block to be perceived as a parallelogram sloping downwards either to the right or left) caused gait changes in the anterior and posterior, vertical and lateral directions. Changes in lateral foot placement appeared to be an attempt to maintain constant foot clearance levels over the block edge by stepping over the perceived 'lower' side of the 'sloping' block. Conclusions: Astigmatic changes with oblique axes had the greatest effect on gait. Clinicians, including optometrists, physiotherapists, occupational therapists and nurses should counsel older patients about the effects of astigmatism on gait safety. Furthermore, partial prescribing of astigmatic corrections should be considered to reduce the risk of falling.	[Johnson, Louise] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England; [Supuk, Elvira; Elliott, David B.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Buckley, John G.] Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford; University of Bradford	Elliott, DB (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	d.elliott1@bradford.ac.uk	Elliott, David/B-1806-2009	Elliott, David/0000-0001-9959-6841; Buckley, John/0000-0002-4085-4743	Federation of Ophthalmic and Dispensing Opticians	Federation of Ophthalmic and Dispensing Opticians	Elvira Supuk was supported from a grant from the Federation of Ophthalmic and Dispensing Opticians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2003, AGE AGEING, V32, P26, DOI 10.1093/ageing/32.1.26; Adams WJ, 2001, NAT NEUROSCI, V4, P1063, DOI 10.1038/nn729; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Buckhurst PJ, 2010, CLIN EXP OPTOM, V93, P409, DOI 10.1111/j.1444-0938.2010.00515.x; Buckley JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019079; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; Chapman GJ, 2011, OPHTHAL PHYSL OPT, V31, P311, DOI 10.1111/j.1475-1313.2010.00807.x; Chapman GJ, 2010, OPHTHAL PHYSL OPT, V30, P281, DOI 10.1111/j.1475-1313.2010.00725.x; Cox A, 2005, OPHTHAL PHYSL OPT, V25, P357, DOI 10.1111/j.1475-1313.2005.00307.x; Crane BT, 2000, J NEUROPHYSIOL, V83, P38, DOI 10.1152/jn.2000.83.1.38; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Elliott DB, 2010, INVEST OPHTH VIS SCI, V51, P718, DOI 10.1167/iovs.09-4250; Evans BJW, 2004, OPHTHAL PHYSL OPT, V24, P161, DOI 10.1111/j.1475-1313.2004.00197.x; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; Fylan F, 2005, PATIENT EDUC COUNS, V56, P291, DOI 10.1016/j.pec.2004.03.003; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Howell-Duffy C, 2011, OPHTHAL PHYSL OPT, V31, P155, DOI 10.1111/j.1475-1313.2010.00803.x; JACK CIA, 1995, GERONTOLOGY, V41, P280; Johnson L, 2008, J AM GERIATR SOC, V56, P178, DOI 10.1111/j.1532-5415.2007.01485.x; Johnson L, 2007, INVEST OPHTH VIS SCI, V48, P1466, DOI 10.1167/iovs.06-0586; McGwin G, 2006, J AM GERIATR SOC, V54, P1089, DOI 10.1111/j.1532-5415.2006.00770.x; Patla AE, 2003, EXP BRAIN RES, V148, P133, DOI 10.1007/s00221-002-1246-y; Pesudovs K, 2003, BRIT J OPHTHALMOL, V87, P964, DOI 10.1136/bjo.87.8.964; Read SA, 2007, CLIN EXP OPTOM, V90, P5, DOI 10.1111/J.1444-0938.2007.00112.x; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Schwartz S, 2005, INVEST OPHTH VIS SCI, V46, P920, DOI 10.1167/iovs.04-0543; Startzell JK, 2000, J AM GERIATR SOC, V48, P567, DOI 10.1111/j.1532-5415.2000.tb05006.x; Werner J., 2002, GENDER HOUSEHOLD STA	31	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63351	10.1371/journal.pone.0063351	http://dx.doi.org/10.1371/journal.pone.0063351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717414	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700016
J	Zheng, YM; Cao, P; Fu, BJ; Hughes, JM; He, JZ				Zheng, Yuan-Ming; Cao, Peng; Fu, Bojie; Hughes, Jane M.; He, Ji-Zheng			Ecological Drivers of Biogeographic Patterns of Soil Archaeal Community	PLOS ONE			English	Article							BETA-DIVERSITY; NEUTRAL THEORY; RIBOSOMAL-RNA; BACTERIAL; ABUNDANCE; FOREST; MACROORGANISMS; MICROORGANISMS; DISPERSAL; CRENARCHAEOTA	Knowledge about the biogeography of organisms has long been a focus in ecological research, including the mechanisms that generate and maintain diversity. In this study, we targeted a microbial group relatively underrepresented in the microbial biogeographic literature, the soil Archaea. We surveyed the archaeal abundance and community composition using real-time quantitative PCR and T-RFLP approaches for 105 soil samples from 2 habitat types to identify the archaeal distribution patterns and factors driving these patterns. Results showed that the soil archaeal community was affected by spatial and environmental variables, and 79% and 51% of the community variation was explained in the non-flooded soil (NS) and flooded soil (FS) habitat, respectively, showing its possible biogeographic distribution. The diversity patterns of soil Archaea across the landscape were influenced by a combination of stochastic and deterministic processes. The contribution from neutral processes was higher than that from deterministic processes associated with environmental variables. The variables pH, sample depth and longitude played key roles in determining the archaeal distribution in the NS habitat, while sampling depth, longitude and NH4+-N were most important in the FS habitat. Overall, there might be similar ecological drivers in the soil archaeal community as in macroorganism communities.	[Zheng, Yuan-Ming; Cao, Peng; Fu, Bojie; He, Ji-Zheng] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Hughes, Jane M.; He, Ji-Zheng] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Griffith University	He, JZ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	jzhe@rcees.ac.cn	He, Ji-Zheng/A-4488-2009; hughes, jane m/C-5321-2008; Fu, Bojie/B-1493-2009; Zheng, Yuan-Ming/A-4491-2009	He, Ji-Zheng/0000-0002-9169-8058; 	Natural Science Foundation of China [41230857, 41025004]; CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services''	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services''(Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (41230857 and 41025004) and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brown J. H., 1998, BIOGEOGRAPHY; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cao P, 2012, FEMS MICROBIOL ECOL, V80, P146, DOI 10.1111/j.1574-6941.2011.01280.x; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Chase JM, 2003, ECOLOGICAL NICHE; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson PL, 1986, COMMUNITY ECOLOGY, P229; Chytry M, 2012, J BIOGEOGR, V39, P1101, DOI 10.1111/j.1365-2699.2011.02664.x; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Dumbrell AJ, 2010, ISME J, V4, P1078, DOI 10.1038/ismej.2010.48; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Kemnitz D, 2005, ENVIRON MICROBIOL, V7, P553, DOI 10.1111/j.1462-2920.2005.00723.x; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Lauber CL, 2012, APPL ENVIRON MICROB, V75, P5111; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2008, ECOLOGY, V89, P3238, DOI 10.1890/07-0272.1; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Locey KJ, 2010, J BIOGEOGR, V37, P1835, DOI 10.1111/j.1365-2699.2010.02357.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mazaris AD, 2010, J BIOGEOGR, V37, P1341, DOI 10.1111/j.1365-2699.2010.02294.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Samuels CL, 1997, TRENDS ECOL EVOL, V12, P427, DOI 10.1016/S0169-5347(97)01182-8; Sparks DL, 1996, METHODS SOIL ANAL 3, V37, P1085; Tian HQ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002464; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896	62	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63375	10.1371/journal.pone.0063375	http://dx.doi.org/10.1371/journal.pone.0063375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717418	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700017
J	Gao, LN; Schwartzman, J; Gibbs, A; Lisac, R; Kleinschmidt, R; Wilmot, B; Bottomly, D; Coleman, I; Nelson, P; McWeeney, S; Alumkal, J				Gao, Lina; Schwartzman, Jacob; Gibbs, Angela; Lisac, Robert; Kleinschmidt, Richard; Wilmot, Beth; Bottomly, Daniel; Coleman, Ilsa; Nelson, Peter; McWeeney, Shannon; Alumkal, Joshi			Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; GROWTH-INHIBITION; CELL-GROWTH; GENE; AMPLIFICATION; OVEREXPRESSION; ANTIANDROGEN; MAINTENANCE; ABIRATERONE; EXPRESSION	The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus. However, some patients do not benefit, and those tumors that do initially respond to ADT eventually progress. One recently described mechanism of such an effect is growth and survival-promoting effects of the AR that are exerted independently of the AR ligands, testosterone and dihydrotestosterone. However, specific ligand-independent AR target genes that account for this effect were not well characterized. We show here that c-Myc, which is a key mediator of ligand-independent prostate cancer growth, is a key ligand-independent AR target gene. Using microarray analysis, we found that c-Myc and AR expression levels strongly correlated with each other in tumors from patients with castration-resistant prostate cancer (CRPC) progressing despite ADT. We confirmed that AR directly regulates c-Myc transcription in a ligand-independent manner, that AR and c-Myc suppression reduces ligand-independent prostate cancer cell growth, and that ectopic expression of c-Myc attenuates the anti-growth effects of AR suppression. Importantly, treatment with the bromodomain inhibitor JQ1 suppressed c-Myc function and suppressed ligand-independent prostate cancer cell survival. Our results define a new link between two critical proteins in prostate cancer - AR and c-Myc - and demonstrate the potential of AR and c-Myc-directed therapies to improve prostate cancer control.	[Gao, Lina; Schwartzman, Jacob; Gibbs, Angela; Lisac, Robert; Kleinschmidt, Richard; Alumkal, Joshi] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA; [Wilmot, Beth; Bottomly, Daniel; McWeeney, Shannon] Oregon Clin & Translat Res Inst, Portland, OR USA; [Wilmot, Beth; Bottomly, Daniel; McWeeney, Shannon] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Coleman, Ilsa; Nelson, Peter] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA	Oregon Health & Science University; Oregon Health & Science University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Alumkal, J (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol Oncol, Portland, OR 97201 USA.	alumkalj@ohsu.edu		Schwartzman, Jacob/0000-0002-2640-8181; McWeeney, Shannon/0000-0001-8333-6607; Lisac, Robert/0000-0001-8164-8113	Oregon Clinical and Translational Research Institute; National Center for Research Resources [KL2 RR024141]; National Center for Advancing Translational Sciences of the National Institutes of Health; Pacific Northwest Prostate Cancer SPORE/National Cancer Institute [P50CA097186]; Department of Defense [PC093509]; Flight Attendant Medical Research Institute Young Clinical Scientist Award; Wayne D. Kuni & Joan E. Kuni Foundation Kuni Scholar Award; Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [P30CA069533, P50CA097186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024141] Funding Source: NIH RePORTER	Oregon Clinical and Translational Research Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Pacific Northwest Prostate Cancer SPORE/National Cancer Institute; Department of Defense(United States Department of Defense); Flight Attendant Medical Research Institute Young Clinical Scientist Award; Wayne D. Kuni & Joan E. Kuni Foundation Kuni Scholar Award; Prostate Cancer Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was made possible with support from the Oregon Clinical and Translational Research Institute, grant number KL2 RR024141 from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health (JA). This work was also supported by the Pacific Northwest Prostate Cancer SPORE/National Cancer Institute (P50CA097186) (JA, PN, IC), the Department of Defense (PC093509) (PSN), a Flight Attendant Medical Research Institute Young Clinical Scientist Award (JA), a Wayne D. Kuni & Joan E. Kuni Foundation Kuni Scholar Award (JA), and a Prostate Cancer Foundation Young Investigator Award (JA). With special thanks to Platt Electric, Bruce Burns, and The Burns Family Fund of the Oregon Community Foundation for their philanthropic support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard D, 2003, J CLIN INVEST, V112, P1724; Bradbury RH, 2011, BIOORG MED CHEM LETT, V21, P5442, DOI 10.1016/j.bmcl.2011.06.122; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gibbs A, 2009, P NATL ACAD SCI USA, V106, P16663, DOI 10.1073/pnas.0908908106; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Jenkins RB, 1997, CANCER RES, V57, P524; Karlou M, 2011, J CLIN ONCOL, V29; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Linja MJ, 2001, CANCER RES, V61, P3550; Loddick SA, 2012, CANC RES, V72; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Page ST, 2011, J CLIN ENDOCR METAB, V96, P430, DOI 10.1210/jc.2010-1865; Scher HI, 2012, N ENGL J MED; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Zhang YX, 2011, MOL CANCER THER, V10, P2309, DOI 10.1158/1535-7163.MCT-11-0329	45	107	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63563	10.1371/journal.pone.0063563	http://dx.doi.org/10.1371/journal.pone.0063563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704919	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200050
J	Hackett, CA; McLean, K; Bryan, GJ				Hackett, Christine A.; McLean, Karen; Bryan, Glenn J.			Linkage Analysis and QTL Mapping Using SNP Dosage Data in a Tetraploid Potato Mapping Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RESISTANCE; MAP; MARKERS; CONSTRUCTION; TUBEROSUM; SEGREGATION; DISSECTION; AFLP	New sequencing and genotyping technologies have enabled researchers to generate high density SNP genotype data for mapping populations. In polyploid species, SNP data usually contain a new type of information, the allele dosage, which is not used by current methodologies for linkage analysis and QTL mapping. Here we extend existing methodology to use dosage data on SNPs in an autotetraploid mapping population. The SNP dosages are inferred from allele intensity ratios using normal mixture models. The steps of the linkage analysis (testing for distorted segregation, clustering SNPs, calculation of recombination fractions and LOD scores, ordering of SNPs and inference of parental phase) are extended to use the dosage information. For QTL analysis, the probability of each possible offspring genotype is inferred at a grid of locations along the chromosome from the ordered parental genotypes and phases and the offspring dosages. A normal mixture model is then used to relate trait values to the offspring genotypes and to identify the most likely locations for QTLs. These methods are applied to analyse a tetraploid potato mapping population of parents and 190 offspring, genotyped using an Infinium 8300 Potato SNP Array. Linkage maps for each of the 12 chromosomes are constructed. The allele intensity ratios are mapped as quantitative traits to check that their position and phase agrees with that of the corresponding SNP. This analysis confirms most SNP positions, and eliminates some problem SNPs to give high-density maps for each chromosome, with between 74 and 152 SNPs mapped and between 100 and 300 further SNPs allocated to approximate bins. Low numbers of double reduction products were detected. Overall 3839 of the 5378 polymorphic SNPs can be assigned putative genetic locations. This methodology can be applied to construct high-density linkage maps in any autotetraploid species, and could also be extended to higher autopolyploids.	[Hackett, Christine A.] Biomath & Stat Scotland, Dundee, Scotland; [McLean, Karen; Bryan, Glenn J.] James Hutton Inst, Dundee, Scotland	James Hutton Institute; James Hutton Institute	Hackett, CA (corresponding author), Biomath & Stat Scotland, Dundee, Scotland.	Christine@bioss.ac.uk		Bryan, Glenn/0000-0002-7752-5740	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	The authors would like to acknowledge the financial support of the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], P IEEE; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bradshaw JE, 1998, THEOR APPL GENET, V97, P202, DOI 10.1007/s001220050886; Bradshaw JE, 2004, EUPHYTICA, V137, P13, DOI 10.1023/B:EUPH.0000040499.19190.fb; Bradshaw JE, 2004, GENETICS, V168, P983, DOI 10.1534/genetics.104.030056; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Bryan GJ, 2004, MOL BREEDING, V14, P105, DOI 10.1023/B:MOLB.0000037999.13581.9c; Bryan GJ, 2002, THEOR APPL GENET, V105, P68, DOI 10.1007/s00122-002-0873-9; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; de Boor C., 2001, APPL MATH SCI, V27; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Durbin R., 1998, BIOL SEQUENCE ANAL P; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Gar O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020463; Hackett CA, 1998, GENET RES, V71, P143, DOI 10.1017/S0016672398003188; Hackett CA, 2001, GENETICS, V159, P1819; Han YH, 2012, MOL BREEDING, V29, P489, DOI 10.1007/s11032-011-9566-x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; JANSEN RC, 1992, THEOR APPL GENET, V85, P252, DOI 10.1007/BF00222867; Kempthorne O, 1957, INTRO GENETIC STAT; Luo ZW, 2001, GENETICS, V157, P1369; Mather K, 1935, J GENET, V30, P53, DOI 10.1007/BF02982205; Mather K, 1936, J GENET, V32, P287, DOI 10.1007/BF02982683; McCord PH, 2011, THEOR APPL GENET, V122, P129, DOI 10.1007/s00122-010-1429-z; Meyer RC, 1998, MOL GEN GENET, V259, P150, DOI 10.1007/s004380050800; Ritchie ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002276; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serang O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030906; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; Song YH, 2011, GRASSL SCI, V57, P158, DOI 10.1111/j.1744-697X.2011.00223.x; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stein J, 2007, MOL BREEDING, V20, P153, DOI 10.1007/s11032-007-9083-0; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; vanderVoort JNAMR, 1997, MOL GEN GENET, V255, P438, DOI 10.1007/s004380050516; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; YU KF, 1993, GENOME, V36, P844, DOI 10.1139/g93-112	41	91	91	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63939	10.1371/journal.pone.0063939	http://dx.doi.org/10.1371/journal.pone.0063939			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704960	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200091
J	Majeed, H; Lampert, A; Ghazaryan, L; Gillor, O				Majeed, Hadeel; Lampert, Adam; Ghazaryan, Lusine; Gillor, Osnat			The Weak Shall Inherit: Bacteriocin-Mediated Interactions in Bacterial Populations	PLOS ONE			English	Article							ESCHERICHIA-COLI; FREQUENCY; SPITE; DIVERSITY; EVOLUTION; DYNAMICS; DEATH; GAME	Background: Evolutionary arms race plays a major role in shaping biological diversity. In microbial systems, competition often involves chemical warfare and the production of bacteriocins, narrow-spectrum toxins aimed at killing closely related strains by forming pores in their target's membrane or by degrading the target's RNA or DNA. Although many empirical and theoretical studies describe competitive exclusion of bacteriocin-sensitive strains by producers of bacteriocins, the dynamics among producers are largely unknown. Methodology/Principal findings: We used a reporter-gene assay to show that the bacterial response to bacteriocins' treatment mirrors the inflicted damage Potent bacteriocins are lethal to competing strains, but at sublethal doses can serve as strong inducing agents, enhancing their antagonists' bacteriocin production. In contrast, weaker bacteriocins are less toxic to their competitors and trigger mild bacteriocin expression. We used empirical and numerical models to explore the role of cross-induction in the arms race between bacteriocin-producing strains. We found that in well-mixed, unstructured environments where interactions are global, producers of weak bacteriocins are selectively advantageous and outcompete producers of potent bacteriocins. However, in spatially structured environments, where interactions are local, each producer occupies its own territory, and competition takes place only in "no man's lands'' between territories, resulting in much slower dynamics. Conclusion/Significance: The models we present imply that producers of potent bacteriocins that trigger a strong response in neighboring bacteriocinogenic strains are doomed, while producers of weak bacteriocins that trigger a mild response in bacteriocinogenic strains flourish. This counter-intuitive outcome might explain the preponderance of weak bacteriocin producers in nature. However, the described scenario is prolonged in spatially structured environments thus promoting coexistence, allowing migration and evolution, and maintaining bacterial diversity.	[Majeed, Hadeel; Ghazaryan, Lusine; Gillor, Osnat] Ben Gurion Univ Negev, J Blaustein Inst Desert Res, Zuckerberg Inst Water Res, Midreshet Ben Gurion, Israel; [Lampert, Adam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Ben Gurion University; Weizmann Institute of Science	Gillor, O (corresponding author), Ben Gurion Univ Negev, J Blaustein Inst Desert Res, Zuckerberg Inst Water Res, Sede Boqer Campus, Midreshet Ben Gurion, Israel.	gilloro@bgu.ac.il		Gillor, Osnat/0000-0003-0849-2241	National Institutes of Health [R01A1064588-01A2]; Israel Council of Higher Education; Israeli Ministry for Science and Technology for Women in Science [3-6485]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Council of Higher Education; Israeli Ministry for Science and Technology for Women in Science	This work was supported by the National Institutes of Health grant R01A1064588-01A2 (http://www.nih.gov/). HM is a recipient of a Ph.D. grant from the Israel Council of Higher Education and of a scholarship from the Israeli Ministry for Science and Technology for Women in Science Grant 3-6485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1979, GENETICS, V91, P627; Barnes B, 2007, MICROBIOL-SGM, V153, P2823, DOI 10.1099/mic.0.2007/007120-0; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; Gordon DM, 2006, MICROBIOL-SGM, V152, P3239, DOI 10.1099/mic.0.28690-0; Gordon DM, 1999, MICROBIOL-SGM, V145, P655, DOI 10.1099/13500872-145-3-655; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Inglis RF, 2009, P NATL ACAD SCI USA, V106, P5703, DOI 10.1073/pnas.0810850106; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lenski RE, 2002, P NATL ACAD SCI USA, V99, P556, DOI 10.1073/pnas.022641999; Majeed H, 2011, ISME J, V5, P71, DOI 10.1038/ismej.2010.90; Mulec J, 2003, J BACTERIOL, V185, P654, DOI 10.1128/JB.185.2.654-659.2003; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P369; Riley M.A., 2007, BACT EC EV; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; RILEY MA, 1992, J GEN MICROBIOL, V138, P1345, DOI 10.1099/00221287-138-7-1345; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; SUIT JL, 1983, P NATL ACAD SCI-BIOL, V80, P579, DOI 10.1073/pnas.80.2.579; Van Dyk TK, 1998, METH MOL B, V102, P85; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Walker D, 2004, J BACTERIOL, V186, P866, DOI 10.1128/JB.186.3.866-869.2004; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	37	32	33	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63837	10.1371/journal.pone.0063837	http://dx.doi.org/10.1371/journal.pone.0063837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704942	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200073
J	Panighini, A; Duranti, E; Santini, F; Maffei, M; Pizzorusso, T; Funel, N; Taddei, S; Bernardini, N; Ippolito, C; Virdis, A; Costa, M				Panighini, Anna; Duranti, Emiliano; Santini, Ferruccio; Maffei, Margherita; Pizzorusso, Tommaso; Funel, Niccola; Taddei, Stefano; Bernardini, Nunzia; Ippolito, Chiara; Virdis, Agostino; Costa, Mario			Vascular Dysfunction in a Mouse Model of Rett Syndrome and Effects of Curcumin Treatment	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; SYNAPTIC PLASTICITY; MECP2 DEFICIENCY; SMALL ARTERIES; MICE; EXPRESSION; NEURONS	Mutations in the coding sequence of the X-linked gene MeCP2 (Methyl CpG-binding protein) are present in around 80% of patients with Rett Syndrome, a common cause of intellectual disability in female and to date without any effective pharmacological treatment. A relevant, and so far unexplored feature of RTT patients, is a marked reduction in peripheral circulation. To investigate the relationship between loss of MeCP2 and this clinical aspect, we used the MeCP2 null mouse model B6.129SF1-MeCP2tm1Jae for functional and pharmacological studies. Functional experiments were performed on isolated resistance mesenteric vessels, mounted on a pressurized myograph. Vessels from female MeCP2(+/-) mice show a reduced endothelium-dependent relaxation, due to a reduced Nitric Oxide (NO) availability secondary to an increased Reactive Oxygen Species (ROS) generation. Such functional aspects are associated with an intravascular increase in superoxide anion production, and a decreased vascular eNOS expression. These alterations are reversed by curcumin administration (5% (w/w) dietary curcumin for 21 days), which restores endothelial NO availability, decreases intravascular ROS production and normalizes vascular eNOS gene expression. In conclusion our findings highlight alterations in the vascular/endothelial system in the absence of a correct function of MeCP2, and uncover related cellular/molecular mechanisms that are rescued by an anti-oxidant treatment.	[Panighini, Anna; Pizzorusso, Tommaso; Costa, Mario] Italian Natl Res Council CNR, Inst Neurosci, Pisa, Italy; [Costa, Mario] Scuola Normale Super Pisa, Pisa, Italy; [Santini, Ferruccio; Maffei, Margherita] Univ Hosp Pisa, Dept Endocrinol & Kidney, Pisa, Italy; [Maffei, Margherita] Dulbecco Telethon Inst, Rome, Italy; [Maffei, Margherita] CNR, Inst Food Sci, Avellino, Italy; [Duranti, Emiliano; Taddei, Stefano; Bernardini, Nunzia; Ippolito, Chiara; Virdis, Agostino] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Funel, Niccola] Univ Pisa, Dept Surg, Pisa, Italy; [Pizzorusso, Tommaso] Univ Florence, Inst Psychol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Pisa; University of Pisa; University of Florence	Virdis, A (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	agostino.virdis@med.unipi.it; costa@in.cnr.it	Santini, Ferruccio/J-9272-2018; Maffei, Margherita/I-2454-2018; Costa, Mario/AAC-2362-2022; Virdis, Agostino/K-5315-2016; Taddei, Stefano/AAB-2828-2019; Bernardini, Nunzia/AAC-4602-2021; Pizzorusso, Tommaso/D-1399-2013	Santini, Ferruccio/0000-0002-1706-0822; Maffei, Margherita/0000-0002-8534-2450; Pizzorusso, Tommaso/0000-0001-5614-0668; BERNARDINI, NUNZIA/0000-0001-9061-9402; Funel, Niccola/0000-0002-5028-2363; Ippolito, Chiara/0000-0001-8671-313X	MIUR (PRIN); PNR-CNR Aging Program; Epigenomics MIUR-CNR Flagship Project EPIGEN; Telethon Project [GGP09196]	MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); PNR-CNR Aging Program; Epigenomics MIUR-CNR Flagship Project EPIGEN; Telethon Project(Fondazione Telethon)	This work was supported by MIUR (PRIN 2008) and PNR-CNR Aging Program 2012-2014, Epigenomics MIUR-CNR Flagship Project EPIGEN, Telethon Project GGP09196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ataie A, 2010, PHARMACOL BIOCHEM BE, V96, P378, DOI 10.1016/j.pbb.2010.06.009; Atmaca M, 2004, EUR ARCH PSY CLIN N, V254, P231, DOI 10.1007/s00406-004-0484-3; Bissonnette JM, 2007, AUTON NEUROSCI-BASIC, V136, P82, DOI 10.1016/j.autneu.2007.04.007; Bjure J, 1997, EUR CHILD ADOLES PSY, V6, P64; Boggio Elena M, 2010, Front Synaptic Neurosci, V2, P28, DOI 10.3389/fnsyn.2010.00028; Bora-Tatar G, 2009, BIOORGAN MED CHEM, V17, P5219, DOI 10.1016/j.bmc.2009.05.042; Bumin G, 2003, J REHABIL MED, V35, P44, DOI 10.1080/16501970306107; Caballero IM, 2005, HUM MOL GENET, V14, pR19, DOI 10.1093/hmg/ddi102; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Coban D, 2012, MOL NUTR FOOD RES, V56, P1270, DOI 10.1002/mnfr.201100818; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Felice C, 2009, FREE RADICAL BIO MED, V47, P440, DOI 10.1016/j.freeradbiomed.2009.05.016; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Flammer AJ, 2012, CIRCULATION, V126, P753, DOI 10.1161/CIRCULATIONAHA.112.093245; FLAVAHAN NA, 1991, J PHARMACOL EXP THER, V256, P50; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Glaze DG, 2004, MENT RETARD DEV D R, V10, P154, DOI 10.1002/mrdd.20030; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kim DSHL, 2001, NEUROSCI LETT, V303, P57, DOI 10.1016/S0304-3940(01)01677-9; Lappalainen R, 1997, ACTA NEUROL SCAND, V95, P44, DOI 10.1111/j.1600-0404.1997.tb00067.x; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Lee JC, 2010, RADIAT RES, V173, P590, DOI 10.1667/RR1522.1; Li J, 2009, BIOMED CHROMATOGR, V23, P1201, DOI 10.1002/bmc.1244; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; Luscher TF, 1997, CLIN CARDIOL, V20, P3; Majithiya JB, 2005, J CARDIOVASC PHARM, V46, P697, DOI 10.1097/01.fjc.0000183720.85014.24; McCauley MD, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002982; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; O'Connor RD, 2009, BONE, V45, P346, DOI 10.1016/j.bone.2009.04.251; Pearson BL, 2012, BEHAV GENET, V42, P299, DOI 10.1007/s10519-011-9501-2; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Percy AK, 2011, ARCH NEUROL-CHICAGO, V68, P985, DOI 10.1001/archneurol.2011.149; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Servi M, 2013, CLIN HEMORHEOL MICRO; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Sierra C, 2001, BRAIN DEV-JPN, V23, pS236, DOI 10.1016/S0387-7604(01)00369-2; Smeets EEJ, 2011, MOL SYNDROMOL, V2, P113, DOI 10.1159/000337637; Sompamit K, 2009, EUR J PHARMACOL, V616, P192, DOI 10.1016/j.ejphar.2009.06.014; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Vanhoutte PM, 1996, PROG CARDIOVASC DIS, V39, P229, DOI 10.1016/S0033-0620(96)80003-X; Virdis A, 2003, ARTERIOSCL THROM VAS, V23, P1352, DOI 10.1161/01.ATV.0000083297.47245.DA; Virdis A, 2007, HYPERTENSION, V49, P679, DOI 10.1161/01.HYP.0000253085.56217.11; Virdis A, 2011, J AM COLL CARDIOL, V58, P238, DOI 10.1016/j.jacc.2011.01.050; Wang R, 2008, BRAIN RES, V1210, P84, DOI 10.1016/j.brainres.2008.01.104; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004	57	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64863	10.1371/journal.pone.0064863	http://dx.doi.org/10.1371/journal.pone.0064863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705018	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200172
J	Starostova, Z; Konarzewski, M; Kozlowski, J; Kratochvil, L				Starostova, Zuzana; Konarzewski, Marek; Kozlowski, Jan; Kratochvil, Lukas			Ontogeny of Metabolic Rate and Red Blood Cell Size in Eyelid Geckos: Species Follow Different Paths	PLOS ONE			English	Article							GENOME SIZE; BODY-MASS; ERYTHROCYTE SIZE; PASSERINE BIRDS; GENERAL-MODEL; C-VALUE; EVOLUTION; FISH; MORPHOLOGY; SELECTION	While metabolism is a fundamental feature of all organisms, the causes of its scaling with body mass are not yet fully explained. Nevertheless, observations of negative correlations between red blood cell (RBC) size and the rate of metabolism suggest that size variation of these cells responsible for oxygen supply may play a crucial role in determining metabolic rate scaling in vertebrates. Based on a prediction derived from the Cell Metabolism Hypothesis, metabolic rate should increase linearly with body mass in species with RBC size invariance, and slower than linearly when RBC size increases with body mass. We found support for that prediction in five species of eyelid geckos (family Eublepharidae) with different patterns of RBC size variation during ontogenetic growth. During ontogeny, metabolic rate increases nearly linearly with body mass in those species of eyelid geckos where there is no correlation between RBC size and body mass, whereas non-linearity of metabolic rate scaling is evident in those species with ontogenetic increase of RBC size. Our findings provide evidence that ontogenetic variability in RBC size, possibly correlating with sizes of other cell types, could have important physiological consequences and can contribute to qualitatively different shape of the intraspecific relationship between metabolic rate and body mass.	[Starostova, Zuzana] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Konarzewski, Marek] Univ Bialystok, Dept Anim Ecol, Bialystok, Poland; [Konarzewski, Marek] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Kozlowski, Jan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Kratochvil, Lukas] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic	Charles University Prague; University of Bialystok; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Jagiellonian University; Charles University Prague	Starostova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	zuzana.starostova@natur.cuni.cz	Starostová, Zuzana/F-3853-2010; Kratochvil, Lukas/M-2134-2019; Kozlowski, Jan/K-5549-2012; Kratochvíl, Lukáš/A-1997-2008; Konarzewski, Marek/AAR-9952-2020	Starostová, Zuzana/0000-0002-5251-1617; Kozlowski, Jan/0000-0002-7084-2030; Kratochvíl, Lukáš/0000-0002-3515-729X; Konarzewski, Marek/0000-0001-7428-6521	Czech Science Foundation [P505/10/P174, 206/09/0895]; Polish Ministry of Science and Higher Education [NN304172036, NN304 3902 33]; Polish National Science Center [2011/02/A/NZ8/00064]	Czech Science Foundation(Grant Agency of the Czech Republic); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Center	The research was supported by the Czech Science Foundation projects P505/10/P174 (to ZS) and 206/09/0895 (to LK), by Polish Ministry of Science and Higher Education grants NN304172036 (to JK), NN304 3902 33 (to MK) and Polish National Science Center grant 2011/02/A/NZ8/00064 to JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavar JR, 2010, P NATL ACAD SCI USA, V107, P15816, DOI 10.1073/pnas.1009974107; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brzek P, 2007, PHYSIOL BIOCHEM ZOOL, V80, P491, DOI 10.1086/520617; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calboli FCF, 2003, EVOLUTION, V57, P566, DOI 10.1111/j.0014-3820.2003.tb01548.x; Callier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045455; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Czarnoleski M, 2008, J EXP BIOL, V211, P391, DOI 10.1242/jeb.013169; Davies R, 2007, J EXP BIOL, V210, P3798, DOI 10.1242/jeb.003897; DAVISON J, 1955, BIOL BULL, V109, P407, DOI 10.2307/1539173; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; ELSE PL, 1985, J COMP PHYSIOL B, V156, P3, DOI 10.1007/BF00692920; Glazier DS, 2009, COMP BIOCHEM PHYS A, V153, P403, DOI 10.1016/j.cbpa.2009.03.020; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Goodman RM, 2010, INTEGR ZOOL, V5, P208, DOI 10.1111/j.1749-4877.2010.00206.x; Gregory TR, 2000, GENOME, V43, P895, DOI 10.1139/gen-43-5-895; Gregory TR, 2002, EVOLUTION, V56, P121; Gregory TR, 2001, BLOOD CELL MOL DIS, V27, P830, DOI 10.1006/bcmd.2001.0457; GREGORY TR, 2005, CELL SIZE DATABASE; Grenat PR, 2009, AMPHIBIA-REPTILIA, V30, P141, DOI 10.1163/156853809787392667; HULBERT AJ, 1991, AM J PHYSIOL, V261, pR561, DOI 10.1152/ajpregu.1991.261.3.R561; Kearney MR, 2012, AM NAT, V180, P546, DOI 10.1086/667860; Killen SS, 2007, MAR BIOL, V152, P1249, DOI 10.1007/s00227-007-0772-3; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Konarzewski M, 1995, EVOLUTION, V49, P1239, DOI 10.2307/2410448; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Kozlowski J, 2010, BIOL LETTERS, V6, P792, DOI 10.1098/rsbl.2010.0288; Kratochvil L, 2003, FOLIA ZOOL, V52, P317; Lay PA, 1999, FISH PHYSIOL BIOCHEM, V20, P31, DOI 10.1023/A:1007785202280; Maciak S, 2011, FUNCT ECOL, V25, P1072, DOI 10.1111/j.1365-2435.2011.01870.x; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Maxwell LK, 2003, COMP BIOCHEM PHYS A, V136, P301, DOI 10.1016/S1095-6433(03)00145-4; Moran D, 2007, COMP BIOCHEM PHYS A, V148, P611, DOI 10.1016/j.cbpa.2007.08.006; Pis T, 2008, COMP BIOCHEM PHYS A, V151, P211, DOI 10.1016/j.cbpa.2008.06.026; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P266; Snyder GK, 1999, AM ZOOL, V39, P189; Starostova Z, 2005, FUNCT ECOL, V19, P744, DOI 10.1111/j.1365-2435.2005.01020.x; Starostova Z, 2008, ZOOLOGY, V111, P377, DOI 10.1016/j.zool.2007.10.005; Starostova Z, 2009, AM NAT, V174, pE100, DOI 10.1086/603610; Streicher JW, 2012, J EXP BIOL, V215, P1137, DOI 10.1242/jeb.061143; Ugurtas IH, 2003, ZOOL STUD, V42, P173; vanVoorhies WA, 1996, EVOLUTION, V50, P1259, DOI 10.2307/2410666; Vijendravarma RK, 2011, J EVOLUTION BIOL, V24, P897, DOI 10.1111/j.1420-9101.2010.02225.x; Vinogradov AE, 1995, EVOLUTION, V49, P1249, DOI 10.1111/j.1558-5646.1995.tb04451.x; Vinogradov AE, 1997, EVOLUTION, V51, P220, DOI 10.1111/j.1558-5646.1997.tb02403.x; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Yagi M, 2010, P ROY SOC B-BIOL SCI, V277, P2793, DOI 10.1098/rspb.2010.0583	54	39	41	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64715	10.1371/journal.pone.0064715	http://dx.doi.org/10.1371/journal.pone.0064715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705003	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200157
J	Wadia, PR; Cabaton, NJ; Borrero, MD; Rubin, BS; Sonnenschein, C; Shioda, T; Soto, AM				Wadia, Perinaaz R.; Cabaton, Nicolas J.; Borrero, Michael D.; Rubin, Beverly S.; Sonnenschein, Carlos; Shioda, Toshi; Soto, Ana M.			Low-Dose BPA Exposure Alters the Mesenchymal and Epithelial Transcriptomes of the Mouse Fetal Mammary Gland	PLOS ONE			English	Article							XENOESTROGEN BISPHENOL-A; ESTROGEN-RECEPTORS ALPHA; ENVIRONMENTAL ESTROGENS; PERINATAL EXPOSURE; FOCAL ADHESIONS; IN-VITRO; EXPRESSION; CANCER; BETA; MORPHOGENESIS	Exposure of rodent fetuses to low doses of the endocrine disruptor bisphenol A (BPA) causes subtle morphological changes in the prenatal mammary gland and results in pre-cancerous and cancerous lesions during adulthood. To examine whether the BPA-induced morphological alterations of the fetal mouse mammary glands are a) associated with changes in mRNA expression reflecting estrogenic actions and/or b) dependent on the estrogen receptor alpha (ER alpha), we compared the transcriptomal effects of BPA and the steroidal estrogen ethinylestradiol (EE2) on fetal mammary tissues of wild type and ER alpha knock-out mice. Mammary glands from fetuses of dams exposed to vehicle, 250 ng BPA/kg BW/d or 10 ng EE2/kg BW/d from embryonic day (E) 8 were harvested at E19. Transcriptomal analyses on the ductal epithelium and periductal stroma revealed altered expression of genes involved in the focal adhesion and adipogenesis pathways in the BPA-exposed stroma while genes regulating the apoptosis pathway changed their expression in the BPA-exposed epithelium. These changes in gene expression correlated with previously reported histological changes in matrix organization, adipogenesis, and lumen formation resulting in enhanced maturation of the fat-pad and delayed lumen formation in the epithelium of BPA-exposed fetal mammary glands. Overall similarities in the transcriptomal effects of BPA and EE2 were more pronounced in the epithelium, than in the stroma. In addition, the effects of BPA and EE2 on the expression of various genes involved in mammary stromal-epithelial interactions were suppressed in the absence of ER alpha. These observations support a model whereby BPA and EE2 act directly on the stroma, which expresses ER alpha, ER beta and GPR30 in fetal mammary glands, and that the stroma, in turn, affects gene expression in the epithelium, where ER alpha and ER beta are below the level of detection at this stage of development.	[Wadia, Perinaaz R.; Cabaton, Nicolas J.; Borrero, Michael D.; Rubin, Beverly S.; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Shioda, Toshi] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA	Tufts University; Harvard University; Massachusetts General Hospital	Soto, AM (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.	ana.soto@tufts.edu			National Institute of Environmental Health Sciences [ES08314];  [FAS0703860];  [KG090515]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008314] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences grant ES08314 and its Supplement to Dr. Ana M. Soto and by the Susan G. Komen for the Cure grants FAS0703860 and KG090515 to Dr. Toshi Shioda. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayyanan A, 2011, MOL ENDOCRINOL, V25, P1915, DOI 10.1210/me.2011-1129; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; BERN HA, 1992, ADV MOD ENV, V21, P9; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Chung CY, 1996, MOL BIOL CELL, V7, P883, DOI 10.1091/mbc.7.6.883; DODDS E. C, 1936, NATURE [LONDON], V137, P996, DOI 10.1038/137996a0; Dupont S, 2000, DEVELOPMENT, V127, P4277; Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Garcia Y, 2008, BIOMATERIALS, V29, P857, DOI 10.1016/j.biomaterials.2007.10.053; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; KIMATA K, 1985, J EMBRYOL EXP MORPH, V89, P243; Lamartiniere CA, 2011, HORM MOL BIOL CLIN I, V5, P45, DOI 10.1515/HMBCI.2010.075; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; Lemmen JG, 1999, MECH DEVELOP, V81, P163, DOI 10.1016/S0925-4773(98)00223-8; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mangala LS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-33; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; MARKEY CM, 2003, EVOL DEV, V5, P1, DOI DOI 10.1016/S0960-0760(02)00272-8; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Prasanth GK, 2010, J APPL TOXICOL, V30, P769, DOI 10.1002/jat.1570; Quintas G, 2012, METABOLOMICS, V8, P86, DOI 10.1007/s11306-011-0292-5; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Ryo A, 2009, TRENDS BIOCHEM SCI, V34, P162, DOI 10.1016/j.tibs.2008.12.004; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Schlomm T, 2005, INT J ONCOL, V27, P713; Simian M, 2001, DEVELOPMENT, V128, P3117; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; SOTO AM, 1992, ADV MOD ENV, V21, P295; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vandenberg LN, 2007, ENDOCRINOLOGY, V148, P116, DOI 10.1210/en.2006-0561; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vandenberg LN, 2008, REPROD TOXICOL, V26, P210, DOI 10.1016/j.reprotox.2008.09.015; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wadia PR, 2007, ENVIRON HEALTH PERSP, V115, P592, DOI 10.1289/ehp.9640; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Zoeller RT, 2005, ENDOCRINOLOGY, V146, P607, DOI 10.1210/en.2004-1018	50	57	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63902	10.1371/journal.pone.0063902	http://dx.doi.org/10.1371/journal.pone.0063902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704952	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200083
J	Schmidt-Kassow, M; Deusser, M; Thiel, C; Otterbein, S; Montag, C; Reuter, M; Banzer, W; Kaiser, J				Schmidt-Kassow, Maren; Deusser, Marie; Thiel, Christian; Otterbein, Sascha; Montag, Christian; Reuter, Martin; Banzer, Winfried; Kaiser, Jochen			Physical Exercise during Encoding Improves Vocabulary Learning in Young Female Adults: A Neuroendocrinological Study	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; CHOICE-REACTION-TIME; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; WORKING-MEMORY; BDNF VAL66MET; RESISTANCE EXERCISE; INTENSITY EXERCISE; MUSICAL EXPERTISE; AEROBIC EXERCISE	Acute physical activity has been repeatedly shown to improve various cognitive functions. However, there have been no investigations comparing the effects of exercise during verbal encoding versus exercise prior to encoding on long-term memory performance. In this current psychoneuroendocrinological study we aim to test whether light to moderate ergometric bicycling during vocabulary encoding enhances subsequent recall compared to encoding during physical rest and encoding after being physically active. Furthermore, we examined the kinetics of brain-derived neurotrophic factor (BDNF) in serum which has been previously shown to correlate with learning performance. We also controlled for the BDNF val66met polymorphism. We found better vocabulary test performance for subjects that were physically active during the encoding phase compared to sedentary subjects. Post-hoc tests revealed that this effect was particularly present in initially low performers. BDNF in serum and BDNF genotype failed to account for the current result. Our data indicates that light to moderate simultaneous physical activity during encoding, but not prior to encoding, is beneficial for subsequent recall of new items.	[Schmidt-Kassow, Maren; Deusser, Marie; Otterbein, Sascha; Kaiser, Jochen] Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany; [Thiel, Christian; Banzer, Winfried] Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, D-60054 Frankfurt, Germany; [Montag, Christian; Reuter, Martin] Univ Bonn, Inst Personal & Biol Psychol, Bonn, Germany; [Reuter, Martin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany	Goethe University Frankfurt; Goethe University Frankfurt; University of Bonn; University of Bonn	Schmidt-Kassow, M (corresponding author), Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany.	schmidt-kassow@med.uni-frankfurt.de	Thiel, Christian/AAB-4695-2022; Meijer, Anna/K-5118-2016; Montag, Christian/H-6536-2019; Kaiser, Jochen/T-9184-2017	Thiel, Christian/0000-0003-4507-8787; Montag, Christian/0000-0001-8112-0837; Kaiser, Jochen/0000-0001-6740-5000	German Research Foundation [DFG SCHM 2693/1-1]; Goethe University Frankfurt/Main	German Research Foundation(German Research Foundation (DFG)); Goethe University Frankfurt/Main	The first author (MSK) was supported by a grant from the German Research Foundation (DFG SCHM 2693/1-1) and received intramural funding for the current project within the program "Funding for outstanding junior scientists'' by the Goethe University Frankfurt/Main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almela M, 2011, STRESS, V14, P117, DOI 10.3109/10253890.2010.514671; Audiffren M, 2009, ACUTE EXERCISE PSYCH, P3; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2009, J SPORT EXERCISE PSY, V31, P640, DOI 10.1123/jsep.31.5.640; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chobert J, 2011, J COGNITIVE NEUROSCI, V23, P3874, DOI 10.1162/jocn_a_00088; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Correa A, 2008, J NEUROPHYSIOL, V100, P1649, DOI 10.1152/jn.90656.2008; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Deeny SP, 2008, BIOL PSYCHOL, V78, P179, DOI 10.1016/j.biopsycho.2008.02.007; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; DUNBAR CC, 1992, MED SCI SPORT EXER, V24, P94; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eston R G, 1988, Br J Sports Med, V22, P153; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Farazdaghi GR, 2001, CLIN PHYSIOL, V21, P682, DOI 10.1046/j.1365-2281.2001.00373.x; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Frey I, 1999, SOZ PRAVENTIV MED, V44, P55, DOI 10.1007/BF01667127; Gatti R, 2011, SCAND J MED SCI SPOR, V21, P157, DOI 10.1111/j.1600-0838.2010.01252.x; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Gustafsson G, 2009, PSYCHIAT RES, V169, P244, DOI 10.1016/j.psychres.2008.06.030; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; HODGETTS V, 1991, J APPL PHYSIOL, V71, P445, DOI 10.1152/jappl.1991.71.2.445; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Janker P., 1996, ELEMENTS GEN PHONETI, V7, P94; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Kahneman D., 1973, ATTENTION EFFORT; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2000, Prog Brain Res, V127, P35; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Laing KR, 2012, AGE, V34, P1011, DOI 10.1007/s11357-011-9275-8; Lange K, 2010, INT J PSYCHOPHYSIOL, V78, P231, DOI 10.1016/j.ijpsycho.2010.08.003; LEVITT S, 1971, RES QUART, V42, P405, DOI 10.1080/10671188.1971.10615088; Macedonia M, 2011, HUM BRAIN MAPP, V32, P982, DOI 10.1002/hbm.21084; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; McMorris T, 2008, PHARMACOL BIOCHEM BE, V89, P106, DOI 10.1016/j.pbb.2007.11.007; McMorris T., 2009, EXERCISE COGNITIVE F, DOI [10.1002/9780470740668.ch2, DOI 10.1002/9780470740668.CH2]; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Netz Y, 2007, INT J SPORTS MED, V28, P82, DOI 10.1055/s-2006-924027; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otterbein S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051419; Ozan E, 2010, BRAIN RES BULL, V81, P61, DOI 10.1016/j.brainresbull.2009.06.022; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; Pluchino N, 2009, HUM REPROD, V24, P2303, DOI 10.1093/humrep/dep119; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Protopopescu X, 2008, HIPPOCAMPUS, V18, P985, DOI 10.1002/hipo.20468; Ruschemeyer SA, 2007, J COGNITIVE NEUROSCI, V19, P855, DOI 10.1162/jocn.2007.19.5.855; Salas CR, 2011, J COGN PSYCHOL, V23, P507, DOI 10.1080/20445911.2011.532207; Schmidt-Kassow M, 2012, NEUROREPORT, V23, P889, DOI 10.1097/WNR.0b013e32835946ca; Schmidt-Kassow M, 2010, NEUROSCI LETT, V482, P40, DOI 10.1016/j.neulet.2010.06.089; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P31, DOI 10.1097/WNR.0b013e32831b4287; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; Tang SW, 2008, NEUROSCI LETT, V431, P62, DOI 10.1016/j.neulet.2007.11.019; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	79	35	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64172	10.1371/journal.pone.0064172	http://dx.doi.org/10.1371/journal.pone.0064172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700461	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400048
J	Wang, VB; Chua, SL; Cao, B; Seviour, T; Nesatyy, VJ; Marsili, E; Kjelleberg, S; Givskov, M; Tolker-Nielsen, T; Song, H; Say, J; Loo, C; Yang, L				Wang, Victor Bochuan; Chua, Song-Lin; Cao, Bin; Seviour, Thomas; Nesatyy, Victor J.; Marsili, Enrico; Kjelleberg, Staffan; Givskov, Michael; Tolker-Nielsen, Tim; Song, Hao; Say, Joachim; Loo, Chye; Yang, Liang			Engineering PQS Biosynthesis Pathway for Enhancement of Bioelectricity Production in Pseudomonas aeruginosa Microbial Fuel Cells	PLOS ONE			English	Article							ELECTRICITY-GENERATION; QUINOLONE SIGNAL; BIOFILM DEVELOPMENT; ELECTRON-TRANSFER; DNA RELEASE; METABOLITES; SYSTEM; ANODES; MR-1; PA14	The biosynthesis of the redox shuttle, phenazines, in Pseudomonas aeruginosa, an ubiquitous microorganism in wastewater microflora, is regulated by the 2-heptyl-3,4-dihydroxyquinoline (PQS) quorum-sensing system. However, PQS inhibits anaerobic growth of P. aeruginosa. We constructed a P. aeruginosa strain that produces higher concentrations of phenazines under anaerobic conditions by over-expressing the PqsE effector in a PQS negative Delta pqsC mutant. The engineered strain exhibited an improved electrical performance in microbial fuel cells (MFCs) and potentiostat-controlled electrochemical cells with an approximate five-fold increase of maximum current density relative to the parent strain. Electrochemical analysis showed that the current increase correlates with an over-synthesis of phenazines. These results therefore demonstrate that targeting microbial cell-to-cell communication by genetic engineering is a suitable technique to improve power output of bioelectrochemical systems.	[Wang, Victor Bochuan; Chua, Song-Lin; Cao, Bin; Seviour, Thomas; Marsili, Enrico; Kjelleberg, Staffan; Givskov, Michael; Loo, Chye; Yang, Liang] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 639798, Singapore; [Chua, Song-Lin; Nesatyy, Victor J.] Natl Univ Singapore, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 117548, Singapore; [Yang, Liang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Cao, Bin] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore; [Wang, Victor Bochuan; Loo, Chye] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Song, Hao] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Givskov, Michael; Tolker-Nielsen, Tim] Univ Copenhagen, Panum Inst, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of New South Wales Sydney; University of Copenhagen	Yang, L (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 639798, Singapore.	yangliang@ntu.edu.sg	Kjelleberg, Staffan/C-9229-2015; Kjelleberg, Staffan/AAB-4641-2020; Song, Hao/G-6207-2010; Yang, Liang/C-8487-2011; Marsili, Enrico/A-8652-2008; Cao, Bin/AAA-3829-2021; Cao, Bin/H-2639-2012; Loo, Say Chye Joachim/A-2234-2011; Lin, Chua Song/AAQ-4765-2021	Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Song, Hao/0000-0001-5553-2539; Yang, Liang/0000-0002-2362-0128; Marsili, Enrico/0000-0003-3150-1564; Cao, Bin/0000-0002-9462-496X; Loo, Say Chye Joachim/0000-0001-5300-1275; Givskov, Michael/0000-0001-5004-8609; Tolker-Nielsen, Tim/0000-0002-9751-474X; Chua, Song Lin/0000-0001-7047-7451	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme; Nanyang Technological University, Singapore [M4320002.C70, M4080847.030]	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme(Ministry of Education, Singapore); Nanyang Technological University, Singapore(Nanyang Technological University)	This research is supported by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Programme and the Start-up Grants (M4320002.C70) and (M4080847.030) from Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Benincasa M, 2004, ANTON LEEUW INT J G, V85, P1, DOI 10.1023/B:ANTO.0000020148.45523.41; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Fan YZ, 2007, J POWER SOURCES, V171, P348, DOI 10.1016/j.jpowsour.2007.06.220; Fan YZ, 2011, BIOSENS BIOELECTRON, V26, P1908, DOI 10.1016/j.bios.2010.05.006; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Hou HJ, 2011, BIOSENS BIOELECTRON, V26, P2680, DOI 10.1016/j.bios.2010.06.037; Hou HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006570; Huang LP, 2008, APPL MICROBIOL BIOT, V80, P349, DOI 10.1007/s00253-008-1546-7; Kargi F, 2007, J CHEM TECHNOL BIOT, V82, P658, DOI 10.1002/jctb.1723; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Liu Y, 2010, BIOSENS BIOELECTRON, V25, P2167, DOI 10.1016/j.bios.2010.01.016; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley DR, 2006, CURR OPIN BIOTECH, V17, P327, DOI 10.1016/j.copbio.2006.04.006; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Park DH, 2003, BIOTECHNOL BIOENG, V81, P348, DOI 10.1002/bit.10501; Park DH, 2000, APPL ENVIRON MICROB, V66, P1292, DOI 10.1128/AEM.66.4.1292-1297.2000; Pham TH, 2008, APPL MICROBIOL BIOT, V80, P985, DOI 10.1007/s00253-008-1619-7; Qiao Y, 2008, CHEM COMMUN, P1290, DOI 10.1039/b719955d; Qiao Y, 2008, ACS NANO, V2, P113, DOI 10.1021/nn700102s; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P3401, DOI 10.1021/es048563o; Rampioni G, 2010, ENVIRON MICROBIOL, V12, P1659, DOI 10.1111/j.1462-2920.2010.02214.x; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Ren ZY, 2007, ENVIRON SCI TECHNOL, V41, P4781, DOI 10.1021/es070577h; Richter H, 2008, LANGMUIR, V24, P4376, DOI 10.1021/la703469y; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Schertzer JW, 2010, MOL MICROBIOL, V77, P1527, DOI 10.1111/j.1365-2958.2010.07303.x; Sund CJ, 2007, APPL MICROBIOL BIOT, V76, P561, DOI 10.1007/s00253-007-1038-1; Sund CJ, 2009, BIOSENS BIOELECTRON, V24, P3144, DOI 10.1016/j.bios.2009.03.019; Toyofuku M, 2010, MICROBES ENVIRON, V25, P1, DOI 10.1264/jsme2.ME09156; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; WRATTEN SJ, 1977, ANTIMICROB AGENTS CH, V11, P411, DOI 10.1128/AAC.11.3.411; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yong YC, 2011, BIOSENS BIOELECTRON, V30, P87, DOI 10.1016/j.bios.2011.08.032; Zhang T, 2006, CHEM COMMUN, P2257, DOI 10.1039/b600876c	49	56	59	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63129	10.1371/journal.pone.0063129	http://dx.doi.org/10.1371/journal.pone.0063129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700414	Green Published, gold			2022-12-25	WOS:000319966400012
J	Xu, W; Xu, J; Wang, Y; Tang, HD; Deng, YL; Ren, RJ; Wang, G; Niu, WQ; Ma, JF; Wu, YW; Zheng, JL; Chen, SD; Ding, JQ				Xu, Wei; Xu, Jun; Wang, Ying; Tang, Huidong; Deng, Yulei; Ren, Rujing; Wang, Gang; Niu, Wenquan; Ma, Jianfang; Wu, Yiwen; Zheng, Jialin; Chen, Shengdi; Ding, Jianqing			The Genetic Variation of SORCS1 Is Associated with Late-Onset Alzheimer's Disease in Chinese Han Population	PLOS ONE			English	Article							CANDIDATE GENES; LINKAGE PHASE; RECEPTOR; PROTEIN; MEMBER; TESTS; RISK	The variations of SORCS1 gene may play potential key roles in late-onset Alzheimer's disease (LOAD). To evaluate the relationship between the polymorphism of SORCS1 gene and LOAD in the ethnic Han Chinese, we conducted a case-control study to investigate the association between the single-nucleotide polymorphisms (SNPs) in intron 1 of SORCS1 and LOAD in Chinese Han population. Six reported SNPs in intron 1 of SORCS1 were analyzed by Snapshot, genotyping and haplotyping in 236 Chinese LOAD cases and 233 matched controls. The significant differences in frequencies of two SNPs (rs10884402, rs950809) were found between the two groups. In addition, haplotype analyses revealed that, in the LOAD group, the frequency of haplotypes C-C-G-T-C (alleles in order of rs17277986, rs6584777, rs10884402, rs7078098, rs950809 polymorphisms) were significantly higher (Psim<0.0001) while haplotype C-C-A-T-C, C-C-A-C-C, T-T-A-C-C were significantly lower (Psim<0.0001). Our data suggested that the genetic variation of the rs10884402 and rs950809 in intron 1 of SORCS1 was associated with the late-onset AD in the Chinese Han population.	[Xu, Wei; Wang, Ying; Tang, Huidong; Deng, Yulei; Ren, Rujing; Wang, Gang; Ma, Jianfang; Wu, Yiwen; Chen, Shengdi; Ding, Jianqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Xu, Wei; Wang, Ying; Tang, Huidong; Deng, Yulei; Ren, Rujing; Wang, Gang; Ma, Jianfang; Wu, Yiwen; Chen, Shengdi; Ding, Jianqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China; [Xu, Jun] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Zheng, Jialin] Univ Nebraska Med Ctr, Omaha, NE USA; [Chen, Shengdi; Ding, Jianqing] Chinese Acad Sci, Lab Neurodegenerat Dis, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chen, Shengdi; Ding, Jianqing] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Nebraska System; University of Nebraska Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, SD (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China.	chen_sd@medmail.com.cn; jqding18@yahoo.com	Ren, Rujing/AAW-4982-2021; Wang, Gang/W-5850-2019; XU, JUN/U-7975-2017	Wang, Gang/0000-0001-6500-5863; XU, JUN/0000-0001-7432-6781	National "Twelfth Five-Year" Plan for Science Technology [2012BAI10B03]; National Natural Science Foundation of China [81171200, 81028007]; Shanghai Key Project of Basic Science Research [09DZ1950400]; Key Project of Shanghai data collection and analysis, decision; Municipal Education Commission [12ZZ115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	National "Twelfth Five-Year" Plan for Science Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Project of Basic Science Research; Key Project of Shanghai data collection and analysis, decision; Municipal Education Commission; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National "Twelfth Five-Year" Plan for Science & Technology Support (No. 2012BAI10B03), National Natural Science Foundation of China (No. 81171200; No. 81028007, Shanghai Key Project of Basic Science Research (No. 09DZ1950400) and the Key Project of Shanghai data collection and analysis, decision to publish, or preparation of Municipal Education Commission (No. 12ZZ115). The funders had no role in study design, the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ashford JW, 2002, J ALZHEIMERS DIS, V4, P169, DOI 10.3233/JAD-2002-4307; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Carrasquillo MM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-54; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deng YL, 2012, HUM GENET; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gauthier S, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-13; Goedert M, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P195; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 2001, NEUROSCI LETT, V313, P83, DOI 10.1016/S0304-3940(01)02252-2; Hermey G, 1999, BIOCHEM BIOPH RES CO, V266, P347, DOI 10.1006/bbrc.1999.1822; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jellinger KA, 2006, J NEURAL TRANSM, V113, P1603, DOI 10.1007/s00702-006-0578-3; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lane RF, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-62; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Reitz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024588; Reitz C, 2011, ANN NEUROL, V69, P47, DOI 10.1002/ana.22308; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Wang HF, 2012, BRAIN RES, V1448, P111, DOI 10.1016/j.brainres.2012.01.067; Xie ZC, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-8	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63621	10.1371/journal.pone.0063621	http://dx.doi.org/10.1371/journal.pone.0063621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700427	Green Submitted, gold, Green Published			2022-12-25	WOS:000319966400023
J	Higgins, HM; Green, LE; Green, MJ; Kaler, J				Higgins, Helen M.; Green, Laura E.; Green, Martin J.; Kaler, Jasmeet			How Does Reviewing the Evidence Change Veterinary Surgeons' Beliefs Regarding the Treatment of Ovine Footrot? A Quantitative and Qualitative Study	PLOS ONE			English	Article							VIRULENT FOOTROT; CLINICAL-TRIAL; PENICILLIN-STREPTOMYCIN; SHEEP LAME; OXYTETRACYCLINE; ERYTHROMYCIN; RECOVERY; MEDICINE; TIME	Footrot is a widespread, infectious cause of lameness in sheep, with major economic and welfare costs. The aims of this research were: (i) to quantify how veterinary surgeons' beliefs regarding the efficacy of two treatments for footrot changed following a review of the evidence (ii) to obtain a consensus opinion following group discussions (iii) to capture complementary qualitative data to place their beliefs within a broader clinical context. Grounded in a Bayesian statistical framework, probabilistic elicitation (roulette method) was used to quantify the beliefs of eleven veterinary surgeons during two one-day workshops. There was considerable heterogeneity in veterinary surgeons' beliefs before they listened to a review of the evidence. After hearing the evidence, seven participants quantifiably changed their beliefs. In particular, two participants who initially believed that foot trimming with topical oxytetracycline was the better treatment, changed to entirely favour systemic and topical oxytetracycline instead. The results suggest that a substantial amount of the variation in beliefs related to differences in veterinary surgeons' knowledge of the evidence. Although considerable differences in opinion still remained after the evidence review, with several participants having non-overlapping 95% credible intervals, both groups did achieve a consensus opinion. Two key findings from the qualitative data were: (i) veterinary surgeons believed that farmers are unlikely to actively seek advice on lameness, suggesting a proactive veterinary approach is required (ii) more attention could be given to improving the way in which veterinary advice is delivered to farmers. In summary this study has: (i) demonstrated a practical method for probabilistically quantifying how veterinary surgeons' beliefs change (ii) revealed that the evidence that currently exists is capable of changing veterinary opinion (iii) suggested that improved transfer of research knowledge into veterinary practice is needed (iv) identified some potential obstacles to the implementation of veterinary advice by farmers.	[Higgins, Helen M.; Green, Martin J.; Kaler, Jasmeet] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Green, Laura E.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Nottingham; University of Warwick	Higgins, HM (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	helen.higgins@nottingham.ac.uk	Green, Laura/G-8345-2011; Green, Martin/F-7066-2011	Green, Laura/0000-0003-2957-8773; Green, Martin/0000-0002-6408-6443; Kaler, Jasmeet/0000-0002-3332-7064	Wellcome Trust [087797/Z/08/Z]; School of Veterinary Medicine and Science, University of Nottingham, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); School of Veterinary Medicine and Science, University of Nottingham, United Kingdom	HMH is funded by a Wellcome Trust clinical research training fellowship [087797/Z/08/Z] (http://www.wellcome.ac.uk). The School of Veterinary Medicine and Science, University of Nottingham, United Kingdom provided additional funding (http://www.nottingham.ac.uk/vet/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGLEY CV, 1987, J AM VET MED ASSOC, V191, P541; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; BULGIN MS, 1986, J AM VET MED ASSOC, V189, P194; CASEY RH, 1988, AUST VET J, V65, P258, DOI 10.1111/j.1751-0813.1988.tb14315.x; Duncan JS, 2012, VET REC, V170, P462, DOI 10.1136/vr.100363; EGERTON JR, 1968, AUST VET J, V44, P275, DOI 10.1111/j.1751-0813.1968.tb04982.x; Farm Animal Welfare Council, 2011, REP GOV OP LAM SHEEP; Garthwaite PH, 2005, J AM STAT ASSOC, V100, P680, DOI 10.1198/016214505000000105; Green LE, 2012, ANIM WELFARE, V21, P65, DOI 10.7120/096272812X13345905673728; GROGONOTHOMAS R, 1994, BRIT VET J, V150, P561, DOI 10.1016/S0007-1935(94)80041-3; GROGONOTHOMAS R, 1997, STUDY OVINE LAMENESS; Hardin LE, 2006, J VET MED EDUC, V33, P474, DOI 10.3138/jvme.33.3.474; Jansen J, 2010, J DAIRY SCI, V93, P1296, DOI 10.3168/jds.2009-2794; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P370, DOI 10.1016/j.jclinepi.2009.08.005; Jordan D, 1996, AUST VET J, V73, P211, DOI 10.1111/j.1751-0813.1996.tb10037.x; Kaler J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-12; Kaler J, 2010, J VET INTERN MED, V24, P420, DOI 10.1111/j.1939-1676.2009.0450.x; Kaler J, 2009, PREV VET MED, V92, P52, DOI 10.1016/j.prevetmed.2009.08.001; Kaler J, 2009, VET J, V180, P189, DOI 10.1016/j.tvjl.2007.12.028; MALECKI JC, 1987, AUST VET J, V64, P301, DOI 10.1111/j.1751-0813.1987.tb07331.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nieuwhof GJ, 2005, ANIM SCI, V81, P23, DOI 10.1079/ASC41010023; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Proctor A, 2011, VET REC, V169, P408, DOI 10.1136/vr.d5387; R Development Core Team, 2009, R LANG ENV STAT COMP; Rendell DK, 1997, AUST VET J, V75, P354, DOI 10.1111/j.1751-0813.1997.tb15712.x; Sagliyan A, 2008, J ANIM VET ADV, V7, P986; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Toews L, 2011, J VET MED EDUC, V38, P123, DOI 10.3138/jvme.38.2.123; VENNING CM, 1990, AUST VET J, V67, P258, DOI 10.1111/j.1751-0813.1990.tb07781.x; WARE JKW, 1994, AUST VET J, V71, P88, DOI 10.1111/j.1751-0813.1994.tb03336.x; Wassink GJ, 2010, PREV VET MED, V96, P93, DOI 10.1016/j.prevetmed.2010.05.006; Whay H. R., 2009, IMPROVING ANIMAL WEL	34	6	6	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64175	10.1371/journal.pone.0064175	http://dx.doi.org/10.1371/journal.pone.0064175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696869	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900072
J	Mu, XD; Usas, A; Tang, Y; Lu, AP; Wang, B; Weiss, K; Huard, J				Mu, Xiaodong; Usas, Arvydas; Tang, Ying; Lu, Aiping; Wang, Bing; Weiss, Kurt; Huard, Johnny			RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice	FASEB JOURNAL			English	Article						ROCK; mdx; utrophin; -SUP; intramyocellular lipid accumulation	DUCHENNE MUSCULAR-DYSTROPHY; FACTOR-KAPPA-B; INTRAMYOCARDIAL LIPID-ACCUMULATION; FATTY-ACID METABOLISM; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; SKELETAL-MUSCLE; INSULIN-RESISTANCE; PPAR-GAMMA; MDX MICE	Heterotopic ossification (HO) and fatty infiltration (FI) often occur in diseased skeletal muscle and have been previously described in various animal models of Duchenne muscular dystrophy (DMD); however, the pathological mechanisms remain largely unknown. Dystrophin-deficient mdx mice and dystrophin/utrophin double-knockout (dKO) mice are mouse models of DMD; however, mdx mice display a strong muscle regeneration capacity, while dKO mice exhibit a much more severe phenotype, which is similar to patients with DMD. Our results revealed that more extensive HO, but not FI, occurred in the skeletal muscle of dKO mice versus mdx mice, and RhoA activation specifically occurred at the sites of HO. Moreover, the gene expression of RhoA, BMPs, and several inflammatory factors were significantly up-regulated in muscle stem cells isolated from dKO mice; while inactivation of RhoA in the cells with RhoA/ROCK inhibitor Y-27632 led to reduced osteogenic potential and improved myogenic potential. Finally, inactivation of RhoA signaling in the dKO mice with Y-27632 improved muscle regeneration and reduced the expression of BMPs, inflammation, HO, and intramyocellular lipid accumulation in both skeletal and cardiac muscle. Our results revealed that RhoA represents a major molecular switch in the regulation of HO and muscle regeneration in dystrophic skeletal muscle of mice.Mu, X., Usas, A., Tang, Y., Lu, A., Wang, B., Weiss, K., Huard, J. RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.	[Mu, Xiaodong; Usas, Arvydas; Tang, Ying; Lu, Aiping; Wang, Bing; Weiss, Kurt; Huard, Johnny] Univ Pittsburgh, Dept Orthopaed Surg, Stem Cell Res Ctr, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huard, J (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Stem Cell Res Ctr, Bridgeside Point 2,Ste 206,450 Technol Dr, Pittsburgh, PA 15219 USA.	jhuard@pitt.edu			Henry J. Mankin endowed chair at the University of Pittsburgh; William F. and Jean W. Donaldson endowed chair at the Children's Hospital of Pittsburgh; NATIONAL INSTITUTE ON AGING [P30AG024827, P01AG043376] Funding Source: NIH RePORTER	Henry J. Mankin endowed chair at the University of Pittsburgh; William F. and Jean W. Donaldson endowed chair at the Children's Hospital of Pittsburgh; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported, in part, by the Henry J. Mankin endowed chair at the University of Pittsburgh, and the William F. and Jean W. Donaldson endowed chair at the Children's Hospital of Pittsburgh. The authors also thank Ms. Bria King and Mr. James Cummins for their editorial assistance in completing this manuscript.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Ahmad N, 2010, J ULTRAS MED, V29, P367, DOI 10.7863/jum.2010.29.3.367; Amin RH, 2010, AM J PHYSIOL-ENDOC M, V298, pE28, DOI 10.1152/ajpendo.00446.2009; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Axelsen LN, 2010, AM J PHYSIOL-REG I, V298, pR1560, DOI 10.1152/ajpregu.00392.2009; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Beqaj S, 2002, J CELL BIOL, V156, P893, DOI 10.1083/jcb.200107049; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Ciaraldi TP, 2002, ANN NY ACAD SCI, V967, P66; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Cox FM, 2011, RHEUMATOLOGY, V50, P1153, DOI 10.1093/rheumatology/ker001; Dahners LE, 2004, J AM ACAD ORTHOP SUR, V12, P139, DOI 10.5435/00124635-200405000-00001; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Demer LL, 2002, INT J EPIDEMIOL, V31, P737, DOI 10.1093/ije/31.4.737; Duan DS, 2006, HUM MOL GENET, V15, pR253, DOI 10.1093/hmg/ddl180; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Goto K, 2009, J PHARMACOL SCI, V110, P437, DOI 10.1254/jphs.09081FP; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; HOLNESS CL, 1993, BLOOD, V81, P1607; Hosoyama T, 2009, DIFFERENTIATION, V77, P350, DOI 10.1016/j.diff.2008.11.001; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hulver MW, 2004, P NUTR SOC, V63, P375, DOI 10.1079/PNS2004351; IONASESCU V, 1981, J NEUROL SCI, V50, P249, DOI 10.1016/0022-510X(81)90171-4; Isaac C, 2013, J ORTHOP RES, V31, P343, DOI 10.1002/jor.22236; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kikkawa N, 2009, CELL STRUCT FUNCT, V34, P77, DOI 10.1247/csf.08039; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Lu AP, 2012, MOL THER, V20, P661, DOI 10.1038/mt.2011.261; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mei M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-110; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Miljkovic-Gacic I, 2008, OBESITY, V16, P1854, DOI 10.1038/oby.2008.280; Momose M, 2001, NEUROMUSCULAR DISORD, V11, P464, DOI 10.1016/S0960-8966(01)00191-2; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Muntoni F, 2002, NEUROMUSCULAR DISORD, V12, pS162, DOI 10.1016/S0960-8966(02)00101-3; Nakayama Y, 2009, BIOCHEM BIOPH RES CO, V379, P288, DOI 10.1016/j.bbrc.2008.12.040; Neal B., 2000, COCHRANE DATABASE SY; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ruberg FL, 2007, CIRCULATION, V116, P1110, DOI 10.1161/CIRCULATIONAHA.107.721860; Saini-Chohan HK, 2012, J LIPID RES, V53, P4, DOI 10.1194/jlr.R012120; Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225; Santos A, 2010, CYTOTHERAPY, V12, P924, DOI 10.3109/14653241003774011; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schulze PC, 2009, J LIPID RES, V50, P2137, DOI 10.1194/jlr.R001115; Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Slice LW, 2000, BIOCHEM BIOPH RES CO, V276, P406, DOI 10.1006/bbrc.2000.3487; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Thibaud JL, 2007, NEUROMUSCULAR DISORD, V17, P575, DOI 10.1016/j.nmd.2007.03.013; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; Vasileiadis GI, 2011, ORTHOPEDICS, V34, P467, DOI 10.3928/01477447-20110427-23; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zhou H, 2011, ACTA PHARMACOL SIN, V32, P999, DOI 10.1038/aps.2011.54; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	72	28	31	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3619	3631		10.1096/fj.13-233460	http://dx.doi.org/10.1096/fj.13-233460			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23704088	Green Published			2022-12-25	WOS:000328840500021
J	Maree, FF; Blignaut, B; de Beer, TAP; Rieder, E				Maree, Francois F.; Blignaut, Belinda; de Beer, Tjaart A. P.; Rieder, Elizabeth			Analysis of SAT Type Foot-And-Mouth Disease Virus Capsid Proteins and the Identification of Putative Amino Acid Residues Affecting Virus Stability	PLOS ONE			English	Article							SPECIFICITY; RECEPTOR; ALPHA(V)BETA(3); NEUTRALIZATION; ADHESION; STRAINS; QUALITY; LOOP	Foot-and-mouth disease virus (FMDV) initiates infection by adhering to integrin receptors on target cells, followed by cell entry and disassembly of the virion through acidification within endosomes. Mild heating of the virions also leads to irreversible dissociation into pentamers, a characteristic linked to reduced vaccine efficacy. In this study, the structural stability of intra-and inter-serotype chimeric SAT2 and SAT3 virus particles to various conditions including low pH, mild temperatures or high ionic strength, was compared. Our results demonstrated that while both the SAT2 and SAT3 infectious capsids displayed different sensitivities in a series of low pH buffers, their stability profiles were comparable at high temperatures or high ionic strength conditions. Recombinant vSAT2 and intra-serotype chimeric viruses were used to map the amino acid differences in the capsid proteins of viruses with disparate low pH stabilities. Four His residues at the inter-pentamer interface were identified that change protonation states at pH 6.0. Of these, the H145 of VP3 appears to be involved in interactions with A141 in VP3 and K63 in VP2, and may be involved in orientating H142 of VP3 for interaction at the inter-pentamer interfaces.	[Maree, Francois F.; Blignaut, Belinda] Agr Res Council, Onderstepoort Vet Inst, Transboundary Anim Dis Programme, Pretoria, South Africa; [Maree, Francois F.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Blignaut, Belinda] Univ Pretoria, Dept Microbiol & Plant Pathol, Fac Agr & Nat Sci, ZA-0002 Pretoria, South Africa; [de Beer, Tjaart A. P.] Univ Pretoria, Bioinformat & Computat Biol Unit, ZA-0002 Pretoria, South Africa; [de Beer, Tjaart A. P.] European Bioinformat Inst, Cambridge, England; [Rieder, Elizabeth] ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY USA	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Pretoria; University of Pretoria; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA)	Maree, FF (corresponding author), Agr Res Council, Onderstepoort Vet Inst, Transboundary Anim Dis Programme, Pretoria, South Africa.	mareef@arc.agric.za	Maree, Francois/AAR-7418-2020	de Beer, Tjaart/0000-0001-5966-6091; Maree, Francois Frederick/0000-0002-8777-250X	Agricultural Research Council; Onderstepoort Veterinary Institute of South Africa; United States Department of Agriculture, Agricultural Research Service; Red meat Research and Development trust of SA; MSD Animal Health;  [58-3K95-M-894]	Agricultural Research Council; Onderstepoort Veterinary Institute of South Africa; United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Red meat Research and Development trust of SA; MSD Animal Health(Merck & CompanyIntervet International B.V.); 	Research findings documented in this manuscript are in part the result of a cooperative research and development agreement between the Agricultural Research Council, Onderstepoort Veterinary Institute of South Africa and the United States Department of Agriculture, Agricultural Research Service, entitled, "Genetic engineering of antigenically stable strains of foot-and-mouth disease virus for vaccine production'', agreement number 58-3K95-M-894. Additional financial support was received from the Red meat Research and Development trust of SA and MSD Animal Health (previously Intervet/Schering Plough), The Netherlands. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders were consulted in regards to the publication of the results and approved the manuscript for publication.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; AMADORI M, 1994, VACCINE, V12, P159, DOI 10.1016/0264-410X(94)90055-8; BACHRACH HL, 1968, ANNU REV MICROBIOL, V22, P201, DOI 10.1146/annurev.mi.22.100168.001221; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; Bastos ADS, 2003, J GEN VIROL, V84, P1595, DOI 10.1099/vir.0.18859-0; Bastos ADS, 2001, ARCH VIROL, V146, P1537, DOI 10.1007/s007050170077; Boettiger D, 2001, J BIOL CHEM, V276, P31684, DOI 10.1074/jbc.M103997200; BROWN F, 1963, NATURE, V199, P1168, DOI 10.1038/1991168a0; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; BURROUGHS JN, 1971, J GEN VIROL, V13, P73, DOI 10.1099/0022-1317-13-1-73; CARRILLO EC, 1984, VIROLOGY, V135, P542, DOI 10.1016/0042-6822(84)90208-3; Curry S, 1996, STRUCTURE, V4, P135, DOI 10.1016/S0969-2126(96)00017-2; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; CURRY S, 1995, J VIROL, V69, P430, DOI 10.1128/JVI.69.1.430-438.1995; DOEL TR, 1985, J BIOL STAND, V13, P335, DOI 10.1016/S0092-1157(85)80048-2; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Domingo E, 2002, COMP IMMUNOL MICROB, V25, P297, DOI 10.1016/S0147-9571(02)00027-9; Duque H, 2004, J VIROL, V78, P9773, DOI 10.1128/JVI.78.18.9773-9781.2004; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Knipe T, 1997, J VIROL, V71, P2851, DOI 10.1128/JVI.71.4.2851-2856.1997; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9; LEA S, 1995, STRUCTURE, V3, P571, DOI 10.1016/S0969-2126(01)00191-5; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LILJAS L, 1986, PROG BIOPHYS MOL BIO, V48, P1, DOI 10.1016/0079-6107(86)90008-8; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Maree FF, 2010, VIRUS RES, V153, P82, DOI 10.1016/j.virusres.2010.07.010; Mateo R, 2003, J BIOL CHEM, V278, P41019, DOI 10.1074/jbc.M304990200; Mateo R, 2007, J GEN VIROL, V88, P859, DOI 10.1099/vir.0.82521-0; Mateo R, 2007, J VIROL, V81, P1879, DOI 10.1128/JVI.01899-06; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; MATEU MG, 1995, VIRUS RES, V38, P1, DOI 10.1016/0168-1702(95)00048-U; Mateu MG, 1996, J BIOL CHEM, V271, P12814, DOI 10.1074/jbc.271.22.12814; Neff S, 2000, J VIROL, V74, P7298, DOI 10.1128/JVI.74.16.7298-7306.2000; *OFF INT EP, 2009, MAN DIAGN TESTS VACC; PAY TWF, 1978, 15 C OFF INT DES EP, P1; PEREIRA HG, 1978, BR VET J, V35, P167; PRESTON KJ, 1982, J BIOL STAND, V10, P35, DOI 10.1016/S0092-1157(82)80046-2; R Development Core Team, 2009, R FDN STAT COMP; Reguera J, 2005, J BIOL CHEM, V280, P17969, DOI 10.1074/jbc.M500867200; Reguera J, 2004, P NATL ACAD SCI USA, V101, P2724, DOI 10.1073/pnas.0307748101; RIEDER E, 1993, J VIROL, V67, P5139, DOI 10.1128/JVI.67.9.5139-5145.1993; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; ROSSMANN MG, 1997, STRUCTURAL BIOL VIRU, P105; RWEYEMAMU MM, 1984, J BIOL STAND, V12, P295, DOI 10.1016/S0092-1157(84)80009-8; Samuel AR, 2001, TRENDS GENET, V17, P421, DOI 10.1016/S0168-9525(01)02374-5; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TWOMEY T, 1995, VIROLOGY, V206, P69, DOI 10.1016/S0042-6822(95)80020-4; van Rensburg HG, 2004, J GEN VIROL, V85, P61, DOI 10.1099/vir.0.19509-0; Van Rensburg HG, 1999, VIRUS GENES, V19, P229, DOI 10.1023/A:1008140815045; van Vlijmen HWT, 1998, J MOL BIOL, V275, P295, DOI 10.1006/jmbi.1997.1418; VOSLOO W, 1995, EPIDEMIOL INFECT, V114, P203, DOI 10.1017/S0950268800052055	58	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e61612	10.1371/journal.pone.0061612	http://dx.doi.org/10.1371/journal.pone.0061612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717387	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700002
J	Yoseph, BP; Breed, E; Overgaard, CE; Ward, CJ; Liang, Z; Wagener, ME; Lexcen, DR; Lusczek, ER; Beilman, GJ; Burd, EM; Farris, AB; Guidot, DM; Koval, M; Ford, ML; Coopersmith, CM				Yoseph, Benyam P.; Breed, Elise; Overgaard, Christian E.; Ward, Christina J.; Liang, Zhe; Wagener, Maylene E.; Lexcen, Daniel R.; Lusczek, Elizabeth R.; Beilman, Greg J.; Burd, Eileen M.; Farris, Alton B.; Guidot, David M.; Koval, Michael; Ford, Mandy L.; Coopersmith, Craig M.			Chronic Alcohol Ingestion Increases Mortality and Organ Injury in a Murine Model of Septic Peritonitis	PLOS ONE			English	Article							ACUTE LUNG INJURY; CHRONIC ETHANOL INGESTION; INCREASED INTESTINAL PERMEABILITY; PSEUDOMONAS-AERUGINOSA PNEUMONIA; RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL APOPTOSIS; BARRIER DYSFUNCTION; CRITICALLY-ILL; CECAL LIGATION; INTENSIVE-CARE	Background: Patients admitted to the intensive care unit with alcohol use disorders have increased morbidity and mortality. The purpose of this study was to determine how chronic alcohol ingestion alters the host response to sepsis in mice. Methods: Mice were randomized to receive either alcohol or water for 12 weeks and then subjected to cecal ligation and puncture. Mice were sacrificed 24 hours post-operatively or followed seven days for survival. Results: Septic alcohol-fed mice had a significantly higher mortality than septic water-fed mice (74% vs. 41%, p = 0.01). This was associated with worsened gut integrity in alcohol-fed mice with elevated intestinal epithelial apoptosis, decreased crypt proliferation and shortened villus length. Further, alcohol-fed mice had higher intestinal permeability with decreased ZO-1 and occludin protein expression in the intestinal tight junction. The frequency of splenic and bone marrow CD4+ T cells was similar between groups; however, splenic CD4+ T cells in septic alcohol-fed mice had a marked increase in both TNF and IFN-gamma production following ex vivo stimulation. Neither the frequency nor function of CD8+ T cells differed between alcohol-fed and water-fed septic mice. NK cells were decreased in both the spleen and bone marrow of alcohol-fed septic mice. Pulmonary myeloperoxidase levels and BAL levels of G-CSF and TFG-beta were higher in alcohol-fed mice. Pancreatic metabolomics demonstrated increased acetate, adenosine, xanthine, acetoacetate, 3-hydroxybutyrate and betaine in alcohol-fed mice and decreased cytidine, uracil, fumarate, creatine phosphate, creatine, and choline. Serum and peritoneal cytokines were generally similar between alcohol-fed and water-fed mice, and there were no differences in bacteremia, lung wet to dry weight, or pulmonary, liver or splenic histology. Conclusions: When subjected to the same septic insult, mice with chronic alcohol ingestion have increased mortality. Alterations in intestinal integrity, the host immune response, and pancreatic metabolomics may help explain this differential response.	[Yoseph, Benyam P.; Breed, Elise; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Yoseph, Benyam P.; Breed, Elise; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA; [Overgaard, Christian E.; Ward, Christina J.; Guidot, David M.; Koval, Michael] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Overgaard, Christian E.; Ward, Christina J.; Guidot, David M.; Koval, Michael] Emory Univ, Sch Med, Emory Alcohol & Lung Biol Ctr, Atlanta, GA 30322 USA; [Wagener, Maylene E.; Ford, Mandy L.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Wagener, Maylene E.; Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Lexcen, Daniel R.; Lusczek, Elizabeth R.; Beilman, Greg J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Burd, Eileen M.; Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University of Minnesota System; University of Minnesota Twin Cities; Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA.	cmcoop3@emory.edu	Breed, Elise/G-2547-2017; Koval, Michael/C-6366-2015; Farris, Alton Brad/S-6041-2017	Breed, Elise/0000-0001-6468-8463; Koval, Michael/0000-0002-5422-5614; Farris, Alton Brad/0000-0001-5534-7763; Beilman, Gregory/0000-0001-5036-3027; Lusczek, Elizabeth/0000-0003-4680-965X	United States National Institutes of Health [T32GM095442, R01GM072808, P50AA013757, R01AI073707, R01AA017627, R01HL083120, T32AA013528]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, T32GM095442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013528, R01AA017627, P50AA013757] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the United States National Institutes of Health: T32GM095442, R01GM072808, P50AA013757, R01AI073707, R01AA017627, R01HL083120, T32AA013528. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amin PB, 2009, J SURG RES, V157, P187, DOI 10.1016/j.jss.2008.10.028; [Anonymous], 2013, WHO MAN SUBST AB FAC; Asai K, 2003, SCAND J GASTROENTERO, V38, P1154, DOI 10.1080/00365520310006252; BAKER CC, 1983, SURGERY, V94, P331; Ballas ZK, 2012, ALCOHOL CLIN EXP RES, V36, P826, DOI 10.1111/j.1530-0277.2011.01678.x; Barros FR, 2012, ALCOHOL ALCOHOLISM, V47, P677, DOI 10.1093/alcalc/ags081; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Best AM, 2007, BMC ANESTHESIOL, V7, P3, DOI [10.1186/1471-2253-7-3, DOI 10.1186/1471-2253-7-3]; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bromberg Z, 2008, CRIT CARE MED, V36, P246, DOI 10.1097/01.CCM.0000295473.56522.EF; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Choudhry Mashkoor A, 2008, J Emerg Trauma Shock, V1, P81, DOI 10.4103/0974-2700.43187; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Cook RT, 2007, ALCOHOL CLIN EXP RES, V31, P1746, DOI 10.1111/j.1530-0277.2007.00478.x; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; de RA, 2006, CHEST, V129, P1219, DOI [10.1378/chest.129.5.1219, DOI 10.1378/CHEST.129.5.1219]; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Delgado-Rodriguez M, 2003, BRIT J SURG, V90, P1287, DOI 10.1002/bjs.4186; Delgado-Rodriguez M, 2003, ADDICTION, V98, P611, DOI 10.1046/j.1360-0443.2003.00353.x; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Dominguez JA, 2010, CRIT CARE CLIN, V26, P549, DOI 10.1016/j.ccc.2010.04.005; DSouza NB, 1996, ALCOHOL CLIN EXP RES, V20, P156, DOI 10.1111/j.1530-0277.1996.tb01059.x; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; FERNANDEZSOLA J, 1995, ARCH INTERN MED, V155, P1649, DOI 10.1001/archinte.155.15.1649; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; Fink MP, 2005, CRIT CARE CLIN, V21, P177, DOI 10.1016/j.ccc.2005.01.005; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Gatt M, 2007, ALIMENT PHARM THER, V25, P741, DOI 10.1111/j.1365-2036.2006.03174.x; Gerke P, 1997, ALCOHOL ALCOHOLISM, V32, P179; Gika HG, 2012, J CHROMATOGR A, V1259, P128, DOI 10.1016/j.chroma.2012.02.053; GOLDBLUM SE, 1985, J APPL PHYSIOL, V59, P1978, DOI 10.1152/jappl.1985.59.6.1978; Guidot DM, 2005, J INVEST MED, V53, P235, DOI 10.2310/6650.2005.53506; Guidot DM, 2000, AM J PHYSIOL-LUNG C, V279, pL127, DOI 10.1152/ajplung.2000.279.1.L127; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Herzig DS, 2012, AM J RESP CRIT CARE, V185, P291, DOI 10.1164/rccm.201108-1560OC; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Holguin F, 1998, J CLIN INVEST, V101, P761, DOI 10.1172/JCI1396; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Husain KD, 2005, CRIT CARE MED, V33, P2350, DOI 10.1097/01.CCM.0000182797.89252.A3; Iskander KN, 2013, CRIT CARE MED, V41, P159, DOI 10.1097/CCM.0b013e3182676322; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Izquierdo-Garcia JL, 2011, INTENS CARE MED, V37, P2023, DOI 10.1007/s00134-011-2359-1; Joshi PC, 2005, J IMMUNOL, V175, P6837, DOI 10.4049/jimmunol.175.10.6837; Joshi PC, 2006, AM J PHYSIOL-LUNG C, V291, pL1150, DOI 10.1152/ajplung.00150.2006; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Lau K, 2008, ALCOHOL ALCOHOLISM, V43, P34, DOI [10.1093/alcalc/afm154, 10.1093/alcalc/agm154]; Li XL, 2011, J BURN CARE RES, V32, P489, DOI 10.1097/BCR.0b013e3182223c9e; Lin ZY, 2009, NMR BIOMED, V22, P601, DOI 10.1002/nbm.1373; Mason CM, 2000, ALCOHOL CLIN EXP RES, V24, P553, DOI 10.1111/j.1530-0277.2000.tb02024.x; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Maxson PM, 1999, MAYO CLIN PROC, V74, P448; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; Moss M, 2005, CLIN INFECT DIS, V41, pS490, DOI 10.1086/432003; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Moss M, 2000, AM J RESP CRIT CARE, V161, P414, DOI 10.1164/ajrccm.161.2.9905002; Moss M, 2006, LANCET, V368, P2231, DOI 10.1016/S0140-6736(06)69490-7; Pannequin J, 2007, MOL CANCER RES, V5, P1147, DOI 10.1158/1541-7786.MCR-07-0198; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Peres WAF, 2004, ALCOHOL, V33, P83, DOI 10.1016/j.alcohol.2004.05.001; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; R Core Team, 2012, R LANG ENV STAT COMP; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Santolaria F, 2011, EUR CYTOKINE NETW, V22, P1, DOI [10.1684/ecn.2011.0272, 10.1684/ecn.2011.0272_1]; Seitz HK, 1998, Z GASTROENTEROL, V36, P645; Smothers BA, 2004, ARCH INTERN MED, V164, P749, DOI 10.1001/archinte.164.7.749; Spies C, 2001, ALCOHOL CLIN EXP RES, V25, p164S, DOI 10.1111/j.1530-0277.2001.tb02392.x; Spies CD, 1996, ACTA ANAESTH SCAND, V40, P649, DOI 10.1111/j.1399-6576.1996.tb04505.x; Standiford TJ, 1997, ALCOHOL CLIN EXP RES, V21, P1212, DOI 10.1111/j.1530-0277.1997.tb04440.x; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Unsinger J, 2009, J LEUKOCYTE BIOL, V86, P219, DOI 10.1189/jlb.1008615; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; Velasquez A, 2002, ALCOHOL CLIN EXP RES, V26, P1245, DOI 10.1097/01.ALC.0000024269.05402.97; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wagner MC, 2012, ALCOHOL CLIN EXP RES, V36, P197, DOI 10.1111/j.1530-0277.2011.01599.x; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; WILMORE DW, 1988, SURGERY, V104, P917; Wu RQ, 2010, ALCOHOL CLIN EXP RES, V34, P1625, DOI 10.1111/j.1530-0277.2010.01248.x; Zhang H, 2009, ALCOHOL CLIN EXP RES, V33, P419, DOI 10.1111/j.1530-0277.2008.00852.x; Zhong W, 2010, AM J PHYSIOL-GASTR L, V299, pG643, DOI 10.1152/ajpgi.00515.2009; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009; Zivkovic AM, 2009, ALCOHOL CLIN EXP RES, V33, P751, DOI 10.1111/j.1530-0277.2008.00892.x	91	38	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62792	10.1371/journal.pone.0062792	http://dx.doi.org/10.1371/journal.pone.0062792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717394	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700006
J	Ji, WT; Lee, CI; Chen, JYF; Cheng, YP; Yang, SR; Chen, JH; Chen, HR				Ji, Wen-Tsai; Lee, Cheng-I; Chen, Jeff Yi-Fu; Cheng, Ya-Ping; Yang, Sheng-Ru; Chen, Jung-Hua; Chen, Hau-Ren			Areca Nut Extract Induces Pyknotic Necrosis in Serum-Starved Oral Cells via Increasing Reactive Oxygen Species and Inhibiting GSK3 beta: An Implication for Cytopathic Effects in Betel Quid Chewers	PLOS ONE			English	Article							CANCER CELLS; CYCLE ARREST; AUTOPHAGY; CARCINOMA; APOPTOSIS; EXPRESSION; STRESS; TAIWAN; DEATH; DNA	Areca nut has been proven to be correlated with various pathologic alterations in oral cavity. However, the mechanisms for such cytopathic effects are still elusive due mostly to the limitations of cell culture systems. Here we discovered that areca nut extract (ANE) induced production of autophagosome vacuoles in cells cultured with rich medium but induced pyknosis and ballooning, two morphological alterations frequently observed in betel quid chewers, in cells under a serum-free culture condition. Permeability of the serum-starved cells to propidium iodide (PI) confirmed ANE induced novel necrosis with pyknosis (pyknotic necrosis), providing a possible explanation for inflammatory infiltration in chewers' mucosa. In these serum-starved cells, ANE strongly induced reactive oxygen species (ROS), which acted as a key switch for the initiation of pyknotic necrosis. Calcium flux was also involved in the morphological alterations. Besides, inhibition of GSK3 beta by SB216763 significantly exacerbated the pyknotic necrosis either induced by ANE or H2O2 in serum-starved cells, suggesting that GSK3 beta is a critical regulator for ANE/ROS-mediated pyknotic necrosis. Interestingly, LC3-II transition and PARP cleavage were still detected in the serum-starved cells after ANE treatment, suggesting concurrent activation of apoptotic and autophagic pathways. Finally, insulin could counteract the effect of ANE-induced pyknotic necrosis. Taken together, these data provide a platform for studying ANE-induced cytopathogenesis and the first clinical implication for several pathological alterations, such as ballooning and inflammatory infiltration, in betel quid chewers.	[Ji, Wen-Tsai; Lee, Cheng-I; Cheng, Ya-Ping; Yang, Sheng-Ru; Chen, Jung-Hua; Chen, Hau-Ren] Natl Chung Cheng Univ, Coll Sci, Inst Mol Biol, Dept Life Sci, Chiayi, Taiwan; [Ji, Wen-Tsai; Lee, Cheng-I; Cheng, Ya-Ping; Yang, Sheng-Ru; Chen, Jung-Hua; Chen, Hau-Ren] Natl Chung Cheng Univ, Coll Sci, Inst Biomed Sci, Chiayi, Taiwan; [Chen, Jeff Yi-Fu] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan	National Chung Cheng University; National Chung Cheng University; Kaohsiung Medical University	Chen, HR (corresponding author), Natl Chung Cheng Univ, Coll Sci, Inst Mol Biol, Dept Life Sci, Chiayi, Taiwan.	biohrc@ccu.edu.tw			National Science Council [97-2311-B-194-001-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (97-2311-B-194-001-MY3). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MC, 2001, CARCINOGENESIS, V22, P1527, DOI 10.1093/carcin/22.9.1527; Chen JYF, 2008, NEOPLASIA, V10, P1393, DOI 10.1593/neo.08854; Chen SH, 2011, HEALTH POLICY PLANN, V26, P266, DOI 10.1093/heapol/czq041; Cheng HL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-126; Cheng YP, 2012, J BIOMEDICAL SCI, P19; Chiu CT, 2008, J DENT SCI, V3, P75; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fimia GM, 1996, J BIOL CHEM, V271, P15575, DOI 10.1074/jbc.271.26.15575; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Huang LW, 2012, TOXICOL APPL PHARM, V258, P199, DOI 10.1016/j.taap.2011.11.001; Huang TT, 2010, J FORMOS MED ASSOC, V109, P326, DOI 10.1016/S0929-6646(10)60060-5; Ji WT, 2012, CANCER SCI, V103, P1221, DOI 10.1111/j.1349-7006.2012.02294.x; Lin MH, 2010, ORAL ONCOL, V46, P822, DOI 10.1016/j.oraloncology.2010.08.002; Liu TY, 1996, MUTAT RES-GENET TOX, V367, P25, DOI 10.1016/S0165-1218(96)90018-X; Lu HH, 2010, AUTOPHAGY, V6, P725, DOI 10.4161/auto.6.6.12423; Lu SY, 2006, CARCINOGENESIS, V27, P1273, DOI 10.1093/carcin/bgi357; Reichart PA, 1998, J ORAL PATHOL MED, V27, P239, DOI 10.1111/j.1600-0714.1998.tb01949.x; Richard V, 2010, BBA-REV CANCER, V1806, P146, DOI 10.1016/j.bbcan.2010.06.004; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; Soderlund G, 2004, NEOPLASMA, V51, P1; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Trivedy CR, 2002, ADDICT BIOL, V7, P115, DOI 10.1080/13556210120091482; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wang CC, 2009, TOXICOL IN VITRO, V23, P1234, DOI 10.1016/j.tiv.2009.07.033; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	26	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63295	10.1371/journal.pone.0063295	http://dx.doi.org/10.1371/journal.pone.0063295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704899	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200028
J	Reis, AL; McCauley, JW				Reis, Ana Luisa; McCauley, John W.			The Influenza Virus Protein PB1-F2 Interacts with IKK beta and Modulates NF-kappa B Signalling	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; MITOCHONDRIAL-MEMBRANE; I INTERFERON; A VIRUSES; PATHOGENESIS; BINDING; PHOSPHORYLATION; EXPRESSION; SUBUNIT; P65	PB1-F2, a protein encoded by a second open reading frame of the influenza virus RNA segment 2, has emerged as a modulator of lung inflammatory responses but the molecular mechanisms underlying this are only poorly understood. Here we show that PB1-F2 inhibits the activation of NF-kappa B dependent signalling pathways in luciferase reporter assays. PB1-F2 proteins from four different viruses interact with IKK beta in yeast two-hybrid assays and by co-immunoprecipitation. PB1-F2 expression did not inhibit IKK beta kinase activity or NF-kappa B translocation into the nucleus, but NF-kappa B binding to DNA was severely impaired in PB1-F2 transfected cells as assessed by Electrophoretic Mobility Shift Assay. Neither the N-terminal 57 amino acid truncated forms nor the C-terminus of PB1-F2 were able to inhibit NF-kB dependent signalling, indicating that the full length protein is necessary for the inhibition.	[Reis, Ana Luisa; McCauley, John W.] MRC Natl Inst Med Res, Div Virol, London, England	MRC National Institute for Medical Research	McCauley, JW (corresponding author), MRC Natl Inst Med Res, Div Virol, London, England.	john.mccauley@nimr.mrc.ac.uk	Reis, Ana/AFR-1263-2022	Reis, Ana/0000-0003-1332-7822	Medical Research Council [U117585868]; Medical Research Council [MC_U117585868] Funding Source: researchfish; MRC [MC_U117585868] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council through programme U117585868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Gao SJ, 2012, CELL MICROBIOL, V14, P1849, DOI 10.1111/cmi.12005; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Gloire G, 2007, J BIOL CHEM, V282, P21308, DOI 10.1074/jbc.M610728200; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henkel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011112; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; McAuley JL, 2010, J VIROL, V84, P558, DOI 10.1128/JVI.01785-09; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meunier I, 2012, J VIROL, V86, P4271, DOI 10.1128/JVI.07243-11; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Schwabe RF, 2005, FASEB J, V19, P1758, DOI 10.1096/fj.05-3736fje; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tauber S, 2012, J GEN VIROL, V93, P840, DOI 10.1099/vir.0.039966-0; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Weeks-Gorospe JN, 2012, J VIROL, V86, P9035, DOI 10.1128/JVI.00369-12; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	54	27	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63852	10.1371/journal.pone.0063852	http://dx.doi.org/10.1371/journal.pone.0063852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704945	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200076
J	Reis, VM; Oliveira, LS; Passos, RMF; Viana, NB; Mermelstein, C; Sant'Anna, C; Pereira, RC; Paradas, WC; Thompson, FL; Amado, GM; Salgado, LT				Reis, Vanessa M.; Oliveira, Louisi S.; Passos, Raoni M. F.; Viana, Nathan B.; Mermelstein, Claudia; Sant'Anna, Celso; Pereira, Renato C.; Paradas, Wladimir C.; Thompson, Fabiano L.; Amado-Filho, Gilberto M.; Salgado, Leonardo T.			Traffic of Secondary Metabolites to Cell Surface in the Red Alga Laurencia dendroidea Depends on a Two-Step Transport by the Cytoskeleton	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; GRACILARIA-CHANGII GRACILARIALES; PHENOLIC-COMPOUNDS; VESICLE TRANSPORT; CHEMICAL ECOLOGY; RHODOPHYTA; ACTIN; LOCALIZATION; PHAEOPHYTA; CYTOPLASM	In Laurencia dendroidea, halogenated secondary metabolites are primarily located in the vacuole named the corps en cerise (CC). For chemical defence at the surface level, these metabolites are intracellularly mobilised through vesicle transport from the CC to the cell periphery for posterior exocytosis of these chemicals. The cell structures involved in this specific vesicle traffic as well as the cellular structures related to the positioning and anchoring of the CC within the cell are not well known. Here, we aimed to investigate the role of cytoskeletal elements in both processes. Cellular and molecular assays were conducted to i) determine the ultrastructural apparatus involved in the vesicle traffic, ii) localise cytoskeletal filaments, iii) evaluate the role of different cytoskeletal filaments in the vesicle transport, iv) identify the cytoskeletal filaments responsible for the positioning and anchoring of the CC, and v) identify the transcripts related to cytoskeletal activity and vesicle transport. Our results show that microfilaments are found within the connections linking the CC to the cell periphery, playing an essential role in the vesicle traffic at these connections, which means a first step of the secondary metabolites transport to the cell surface. After that, the microtubules work in the positioning of the vesicles along the cell periphery towards specific regions where exocytosis takes place, which corresponds to the second step of the secondary metabolites transport to the cell surface. In addition, microtubules are involved in anchoring and positioning the CC to the cell periphery. Transcriptomic analysis revealed the expression of genes coding for actin filaments, microtubules, motor proteins and cytoskeletal accessory proteins. Genes related to vesicle traffic, exocytosis and membrane recycling were also identified. Our findings show, for the first time, that actin microfilaments and microtubules play an underlying cellular role in the chemical defence of red algae.	[Reis, Vanessa M.; Passos, Raoni M. F.; Amado-Filho, Gilberto M.; Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Oliveira, Louisi S.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Viana, Nathan B.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, RJ, Brazil; [Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil; [Sant'Anna, Celso] Inst Nacl Metrol Qualidade & Tecnol Inmetro, Programas Dipro, Duque De Caxias, RJ, Brazil; [Pereira, Renato C.; Paradas, Wladimir C.] Univ Fed Fluminense, Dept Biol Marinha, Niteroi, RJ, Brazil	Jardim Botanico do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal Fluminense	Salgado, LT (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil.	lsalgado@jbrj.gov.br	Salgado, Leonardo T/F-1123-2013; Viana, Nathan/AAH-5868-2021; FILHO, GILBERTO M AMADO/I-1324-2012; Pereira, Renato Crespo/AAA-7832-2020; mermelstein, Claudia/C-1464-2010	Viana, Nathan/0000-0002-2528-0876; Thompson, Fabiano/0000-0002-7562-1683; mermelstein, Claudia/0000-0002-8897-8526	CNPq; FAPERJ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support for Leonardo T. Salgado, G. M. Amado Filho, Fabiano L. Thompson and Renato C. Pereira was received from CNPq (www.cnpq.br) and FAPERJ (www.faperj.br). A scholarship was granted to Vanessa M. Reis from CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Ackland JC, 2007, J PHYCOL, V43, P129, DOI 10.1111/j.1529-8817.2006.00311.x; Amsler C.D., 2008, ALGAL CHEM ECOLOGY; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Bayoudh S, 2001, J MICROSC-OXFORD, V203, P214, DOI 10.1046/j.1365-2818.2001.00843.x; Bianco EM, 2010, BRAZ J OCEANOGR, V58, P213, DOI 10.1590/S1679-87592010000300004; Blunt JW, 2012, NAT PROD REP, V29, P144, DOI 10.1039/c2np00090c; BRAWLEY SH, 1976, J CELL SCI, V20, P255; Cassano V, 2012, EUR J PHYCOL, V47, P67, DOI 10.1080/09670262.2011.647334; Collen PN, 2012, J APPL PHYCOL, V24, P641, DOI 10.1007/s10811-011-9681-4; Da Gama BAP, 2002, BIOFOULING, V18, P13, DOI 10.1080/08927010290017680; da Gama BAP, 2008, BOT MAR, V51, P191, DOI 10.1515/BOT.2008.027; Day B, 2011, ANNU REV PHYTOPATHOL, V49, P483, DOI 10.1146/annurev-phyto-072910-095426; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dworjanyn SA, 1999, MAR BIOL, V133, P727, DOI 10.1007/s002270050514; Erickson K.L., 1983, MARINE NATURAL PRODU, V5, P131; Falcao VDR, 2008, J APPL PHYCOL, V20, P9, DOI 10.1007/s10811-007-9174-7; Fan XL, 2007, J PHYCOL, V43, P1287, DOI 10.1111/j.1529-8817.2007.00415.x; GRABSKI S, 1994, J CELL BIOL, V126, P713, DOI 10.1083/jcb.126.3.713; Hawes C, 2010, CURR OPIN PLANT BIOL, V13, P731, DOI 10.1016/j.pbi.2010.10.004; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Ho CL, 2009, MAR BIOTECHNOL, V11, P513, DOI 10.1007/s10126-008-9166-x; Hou GC, 2004, PLANT J, V39, P113, DOI 10.1111/j.1365-313X.2004.02114.x; KAUR I, 1992, AQUAT BOT, V42, P375, DOI 10.1016/0304-3770(92)90056-O; Kim GH, 1999, J PHYCOL, V35, P806, DOI 10.1046/j.1529-8817.1999.3540806.x; Kostamo K, 2011, J EXP MAR BIOL ECOL, V404, P21, DOI 10.1016/j.jembe.2011.05.006; Lane AL, 2009, P NATL ACAD SCI USA, V106, P7314, DOI 10.1073/pnas.0812020106; Lee H, 2007, J MICROBIOL, V45, P541; Lewin J., 1966, PHYCOLOGIA, V6, P1, DOI [10.2216/i0031-8884-6-1-1.1, DOI 10.2216/I0031-8884-6-1-1.1]; Li L, 2008, J EXP BOT, V59, P3575, DOI 10.1093/jxb/ern207; Luder UH, 2004, PLANTA, V218, P928, DOI 10.1007/s00425-003-1176-3; Manning SR, 2010, MAR DRUGS, V8, P678, DOI 10.3390/md8030678; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nylund GM, 2007, MAR ECOL PROG SER, V329, P73, DOI 10.3354/meps329073; Paradas WC, 2010, BIOFOULING, V26, P277, DOI 10.1080/08927010903515122; Paul NA, 2006, J PHYCOL, V42, P637, DOI 10.1111/j.1529-8817.2006.00226.x; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; PELLEGRINI L, 1980, J CELL SCI, V41, P209; Pelletreau K. N., 2008, P121, DOI 10.1007/978-3-540-74181-7_6; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Pereira R. C., 2003, Braz. J. Biol., V63, P665, DOI 10.1590/S1519-69842003000400013; Petrasek J, 2009, CURR OPIN PLANT BIOL, V12, P728, DOI 10.1016/j.pbi.2009.09.010; Plastino EM, 1995, MANUAL METODOS FICOL, P430; Pontes B, 2011, BIOPHYS J, V101, P43, DOI 10.1016/j.bpj.2011.05.044; RAGAN MA, 1976, BOT MAR, V19, P145, DOI 10.1515/botm.1976.19.3.145; Russell Catherine A., 1996, Phycological Research, V44, P57, DOI 10.1111/j.1440-1835.1996.tb00038.x; Salgado LT, 2008, J STRUCT BIOL, V162, P345, DOI 10.1016/j.jsb.2008.01.015; Salgado LT, 2005, PROTOPLASMA, V225, P123, DOI 10.1007/s00709-004-0066-2; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schoenwaelder MEA, 2000, PLANT BIOLOGY, V2, P24, DOI 10.1055/s-2000-9178; Schoenwaelder MEA, 1999, EUR J PHYCOL, V34, P223, DOI 10.1017/S0967026299002140; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; Sudatti DB, 2008, J PHYCOL, V44, P584, DOI 10.1111/j.1529-8817.2008.00507.x; Teo SS, 2007, EUR J PHYCOL, V42, P41, DOI 10.1080/09670260601012461; von Stosch H., 1964, P INT SEAWEED S, V4, P142; Wilson SM, 2006, PHYCOL RES, V54, P15, DOI 10.1111/j.1440-1835.2006.00404.x; Wong PF, 2006, J PHYCOL, V42, P113, DOI 10.1111/j.1529-8817.2006.00182.x; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Yotsukura N, 2010, J APPL PHYCOL, V22, P443, DOI 10.1007/s10811-009-9477-y; YOUNG DN, 1980, J PHYCOL, V16, P182; Zarsky V, 2009, NEW PHYTOL, V183, P255, DOI 10.1111/j.1469-8137.2009.02880.x	64	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63929	10.1371/journal.pone.0063929	http://dx.doi.org/10.1371/journal.pone.0063929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704959	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200090
J	Zalesak, M; Francis, K; Gedeon, A; Gillis, J; Hvidsten, K; Kidder, P; Li, H; Martyn, D; Orne, L; Smith, A; Kwong, A				Zalesak, Martin; Francis, Kevin; Gedeon, Alex; Gillis, John; Hvidsten, Kyle; Kidder, Phyllis; Li, Hong; Martyn, Derek; Orne, Leslie; Smith, Amanda; Kwong, Ann			Current and Future Disease Progression of the Chronic HCV Population in the United States	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; COST-EFFECTIVENESS; LIVER-TRANSPLANTATION; INFECTED POPULATION; RISK; PREVALENCE; BURDEN; COHORT	Chronic hepatitis C virus (HCV) infection can lead to advanced liver disease (AdvLD), including cirrhosis, decompensated cirrhosis, and liver cancer. The aim of this study was to determine recent historical rates of HCV patient progression to AdvLD and to project AdvLD prevalence through 2015. We first determined total 2008 US chronic HCV prevalence from the National Health and Nutrition Evaluation Surveys. Next, we examined disease progression and associated non-pharmacological costs of diagnosed chronic HCV-infected patients between 2007-2009 in the IMS LifeLink and CMS Medicare claims databases. A projection model was developed to estimate AdvLD population growth through 2015 in patients diagnosed and undiagnosed as of 2008, using the 2007-2009 progression rates to generate a "worst case'' projection of the HCV-related AdvLD population (i.e., scenario where HCV treatment is the same in the forecasted period as it was before 2009). We found that the total diagnosed chronic HCV population grew from 983,000 to 1.19 million in 20072009, with patients born from 1945-1964 accounting for 75.0% of all patients, 83.7% of AdvLD patients, and 79.2% of costs in 2009, indicating that HCV is primarily a disease of the `` baby boomer'' population. Non-pharmacological costs grew from $7.22 billion to $8.63 billion, with the majority of growth derived from the 60,000 new patients that developed AdvLD in 2007-2009, 91.5% of whom were born between 1945 and 1964. The projection model estimated the total AdvLD population would grow from 195,000 in 2008 to 601,000 in 2015, with 73.5% of new AdvLD cases from patients undiagnosed as of 2008. AdvLD prevalence in patients diagnosed as of 2008 was projected to grow 6.5% annually to 303,000 patients in 2015. These findings suggest that strategies to diagnose and treat HCV-infected patients are urgently needed to increase the likelihood that progression is interrupted, particularly for patients born from 1945-1964.	[Zalesak, Martin; Francis, Kevin; Gedeon, Alex; Gillis, John; Li, Hong; Martyn, Derek; Orne, Leslie; Smith, Amanda] Trinity Partners LLC, Waltham, MA USA; [Hvidsten, Kyle; Kidder, Phyllis; Kwong, Ann] Vertex Pharmaceut Inc, Cambridge, MA USA	Vertex Pharmaceuticals	Zalesak, M (corresponding author), Trinity Partners LLC, Waltham, MA USA.	zalesakm@trinitypartners.com		Li, Hong/0000-0002-0458-0714	Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts	Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts(Vertex Pharmaceuticals)	This project was funded by Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts. While the study was funded by Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; CDC, 2012, MORBIDITY MORTALITY; CDC (Centers for Disease Control and Prevention), 2009, VIR HEP STAT SURV; Centers for Disease Control and Prevention, HEP C FAQS HLTH PROF; Centers for Medicare and Medicaid Services, 2012, NAT HLTH EXP DAT HIS; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Department of Health and Human Services, 2001, WHO IS EL MED; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Dorfman JD, 2007, WORLD J GASTROENTERO, V13, P781, DOI 10.3748/wjg.v13.i5.781; Drumright LN, 2011, J HEPATOL, V55, P45, DOI 10.1016/j.jhep.2010.10.028; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P924, DOI 10.1016/j.cgh.2010.06.032; Kershenobich D, 2011, LIVER INT, V31, P4, DOI 10.1111/j.1478-3231.2011.02535.x; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kucirka LM, 2011, AM J TRANSPLANT, V11, P1188, DOI 10.1111/j.1600-6143.2011.03460.x; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Leigh JP, 2001, ARCH INTERN MED, V161, P2231, DOI 10.1001/archinte.161.18.2231; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Louie KS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-86; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Maharshak N, 2011, WORLD J GASTROENTERO, V17, P5007, DOI 10.3748/wjg.v17.i45.5007; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; McHutchison JG, 2007, AM J MANAG CARE, V13, pS327; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Nasta Paola, 2011, Acta Biomed, V82, P115; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Neal KR, 2007, GUT, V56, P1098, DOI 10.1136/gut.2006.113217; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shepherd J, 2005, INT J TECHNOL ASSESS, V21, P47, DOI 10.1017/S0266462305050063; Sullivan SD, 2004, AM J GASTROENTEROL, V99, P1490, DOI 10.1111/j.1572-0241.2004.30286.x; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Tomaszewski KJ, 2012, AM J PUBLIC HEALTH, DOI [10.2105/AJPH.2011.300488, DOI 10.2105/AJPH.2011.300488.ACCESSED]; U.S. Census Bureau, 2012, 2012 STAT ABSTR NAT; US Census Bureau, 2011, POP EST NAT INT EST; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562	50	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63959	10.1371/journal.pone.0063959	http://dx.doi.org/10.1371/journal.pone.0063959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704962	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200093
J	de Sousa, E; Walter, LT; Higa, GSV; Augusto, O; Casado, N; Kihara, AH				de Sousa, Erica; Walter, Lais Takata; Vilar Higa, Guilherme Shigueto; Augusto, Otavio; Casado, Nocera; Kihara, Alexandre Hiroaki			Developmental and Functional Expression of miRNA-Stability Related Genes in the Nervous System	PLOS ONE			English	Article							GAP-JUNCTIONS; RETINA; MICRORNAS; TURNOVER; CELLS; HISTOGENESIS; NETWORKS; MEMORY; RANGE; MOUSE	In the nervous system, control of gene expression by microRNAs (miRNAs) has been investigated in fundamental processes, such as development and adaptation to ambient demands. The action of these short nucleotide sequences on specific genes depends on intracellular concentration, which in turn reflects the balance of biosynthesis and degradation. Whereas mechanisms underlying miRNA biogenesis has been investigated in recent studies, little is known about miRNA-stability related proteins. We first detected two genes in the retina that have been associated to miRNA stability, XRN2 and PAPD4. These genes are highly expressed during retinal development, however with distinct subcellular localization. We investigated whether these proteins are regulated during specific phases of the cell cycle. Combined analyses of nuclei position in neuroblastic layer and labeling using anti-cyclin D1 revealed that both proteins do not accumulate in S or M phases of the cell cycle, being poorly expressed in progenitor cells. Indeed, XRN2 and PAPD4 were observed mainly after neuronal differentiation, since low expression was also observed in astrocytes, endothelial and microglial cells. XRN2 and PAPD4 are expressed in a wide variety of neurons, including horizontal, amacrine and ganglion cells. To evaluate the functional role of both genes, we carried out experiments addressed to the retinal adaptation in response to different ambient light conditions. PAPD4 is upregulated after 3 and 24 hours of dark-adaptation, revealing that accumulation of this protein is governed by ambient light levels. Indeed, the fast and functional regulation of PAPD4 was not related to changes in gene expression, disclosing that control of protein levels occurs by post-transcriptional mechanisms. Furthermore, we were able to quantify changes in PAPD4 in specific amacrine cells after dark -adaptation, suggesting for circuitry-related roles in visual perception. In summary, in this study we first described the ontogenesis and functional expression of these two miRNA-stability related proteins in the retina.	[de Sousa, Erica; Walter, Lais Takata; Vilar Higa, Guilherme Shigueto; Augusto, Otavio; Casado, Nocera; Kihara, Alexandre Hiroaki] Univ Fed ABC, Ctr Matemat Comp & Cogn, Nucl Cognicao & Sistemas Complexos, St Andre, SP, Brazil; [Vilar Higa, Guilherme Shigueto; Kihara, Alexandre Hiroaki] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, BR-05508 Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Kihara, AH (corresponding author), Univ Fed ABC, Ctr Matemat Comp & Cogn, Nucl Cognicao & Sistemas Complexos, St Andre, SP, Brazil.	alexandrekihara@gmail.com	Kihara, Alexandre H/C-2458-2012; KIHARA, ALEXANDRE HIROAKI/T-9590-2019; Augusto, Ohara/D-3839-2012; Higa, Guilherme S. V./G-4282-2016; de Sousa, Erica/HGD-9751-2022	Kihara, Alexandre H/0000-0002-4027-7261; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Augusto, Ohara/0000-0002-7220-4286; Higa, Guilherme S. V./0000-0001-7006-9263; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal do ABC (UFABC)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do ABC (UFABC)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Universidade Federal do ABC (UFABC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Bredy TW, 2011, NEUROBIOL LEARN MEM, V96, P89, DOI 10.1016/j.nlm.2011.04.004; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Endeman D, 2010, J PHYSIOL-LONDON, V588, P435, DOI 10.1113/jphysiol.2009.179036; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Goldie BJ, 2012, MOL NEUROBIOL, V45, P99, DOI 10.1007/s12035-011-8222-0; Haverkamp S, 2000, J COMP NEUROL, V424, P1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kihara AH, 2008, DEV NEUROBIOL, V68, P1287, DOI 10.1002/dneu.20652; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kihara AH, 2009, J COMP NEUROL, V512, P651, DOI 10.1002/cne.21920; Kihara AH, 2006, NEUROSCI LETT, V393, P36, DOI 10.1016/j.neulet.2005.09.033; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kihara AH, 2010, INT J DEV NEUROSCI, V28, P39, DOI 10.1016/j.ijdevneu.2009.09.006; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Konopka W, 2011, NEUROSCIENTIST, V17, P468, DOI 10.1177/1073858411411721; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Publio R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006970; Ragan C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001090; Reiner O, 2012, J MOL NEUROSCI, V46, P516, DOI 10.1007/s12031-011-9633-0; Reuter T, 2011, VISION RES, V51, P2243, DOI 10.1016/j.visres.2011.08.021; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Santos-Bredariol AS, 2006, J COMP NEUROL, V494, P976, DOI 10.1002/cne.20861; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Vreugdenhil E, 2010, FRONT NEUROENDOCRIN, V31, P128, DOI 10.1016/j.yfrne.2009.08.001; Zhang C, 2003, J NEUROSCI RES, V73, P840, DOI 10.1002/jnr.10713; Zheng K, 2010, J NEUROSCI, V30, P8245, DOI 10.1523/JNEUROSCI.1169-10.2010	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e56908	10.1371/journal.pone.0056908	http://dx.doi.org/10.1371/journal.pone.0056908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700402	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400001
J	Shirazi, F; Kontoyiannis, DP				Shirazi, Fazal; Kontoyiannis, Dimitrios P.			Mitochondrial Respiratory Pathways Inhibition in Rhizopus oryzae Potentiates Activity of Posaconazole and Itraconazole via Apoptosis	PLOS ONE			English	Article							PATHOGENIC FUNGI; STRESS; MUCORMYCOSIS; RESISTANCE; INDUCTION; SYSTEMS	The incidence of mucormycosis has increased drastically in immunocompromised patients. Also the array of targets whose inhibition results in Mucorales death is limited. Recently, researchers identified mitochondria as important regulators of detoxification and virulence mechanisms in fungi. In this context, targeting the mitochondrial respiratory chain may provide a new platform for antifungal development. We hypothesized that targeting respiratory pathways potentiates triazoles activity via apoptosis. We found that simultaneous administration of antimycin A (AA) and benzohydroxamate (BHAM), inhibitors of classical and alternative mitochondrial pathways respectively, resulted in potent activity of posaconazole (PCZ) and itraconazole (ICZ) against Rhizopus oryzae. We observed cellular changes characteristic of apoptosis in R. oryzae cells treated with PCZ or ICZ in combination with AA and BHAM. The fungicidal activity of this combination against R. oryzae was correlated with intracellular reactive oxygen species accumulation (ROS), phosphatidylserine externalization, mitochondrial membrane depolarization, and increased caspase like activity. DNA fragmentation and condensation assays also revealed apoptosis of R. oryzae cells. These apoptotic features were prevented by the addition of the ROS scavenger N-acetylcysteine. Taken together, these findings suggest that the use of PCZ or ICZ in combination with AA and BHAM makes R. oryzae exquisitely sensitive to treatment with triazoles via apoptosis. This strategy may serve as a new model for the development of improved or novel antifungal agents.	[Shirazi, Fazal; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kontoyiannis, DP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, Houston, TX 77030 USA.	dkontoyi@mdanderson.org	Shirazi, Fazal/C-7398-2014	Shirazi, Fazal/0000-0002-6097-1779	National Institutes of Health through MD Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P484, DOI 10.1128/AAC.00956-09; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Chamilos G, 2006, ANTIMICROB AGENTS CH, V50, P744, DOI 10.1128/AAC.50.2.744-747.2006; Cho J, 2011, BBA-GEN SUBJECTS, V1810, P1246, DOI 10.1016/j.bbagen.2011.08.011; Cho J, 2011, BIOCHIMIE, V93, P1873, DOI 10.1016/j.biochi.2011.07.011; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A; Dinamarco TM, 2010, FUNGAL GENET BIOL, V47, P1055, DOI 10.1016/j.fgb.2010.07.006; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Hamilton AJ, 1999, MED MYCOL, V37, P375, DOI 10.1046/j.1365-280X.1999.00208.x; Hwang B, 2011, BIOCHEM BIOPH RES CO, V405, P267, DOI 10.1016/j.bbrc.2011.01.026; Jaeger T, 2006, BIOFACTORS, V27, P109, DOI 10.1002/biof.5520270110; Kim JH, 2006, J APPL MICROBIOL, V101, P181, DOI 10.1111/j.1365-2672.2006.02882.x; Kontoyiannis DP, 2000, J ANTIMICROB CHEMOTH, V46, P191, DOI 10.1093/jac/46.2.191; Kontoyiannis DP, 1999, ANTIMICROB AGENTS CH, V43, P2731, DOI 10.1128/AAC.43.11.2731; Kontoyiannis DP, 2005, PRINCIPLES PRACTICE, P2973; Lewis RE, 2012, CLIN INFECT DIS, V54, pS67, DOI 10.1093/cid/cir884; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martinez LR, 2012, ARCH MICROBIOL; Martins VD, 2011, J BIOENERG BIOMEMBR, V43, P81, DOI 10.1007/s10863-011-9331-1; Niimi K, 2004, ANTIMICROB AGENTS CH, V48, P1256, DOI 10.1128/AAC.48.4.1256-1271.2004; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Tian J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030147, 10.1371/journal.pone.0035164]; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Tudella VG, 2004, INT J BIOCHEM CELL B, V36, P162, DOI 10.1016/S1357-2725(03)00194-8; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wu XZ, 2010, BBA-GEN SUBJECTS, V1800, P439, DOI 10.1016/j.bbagen.2010.01.001; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	40	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63393	10.1371/journal.pone.0063393	http://dx.doi.org/10.1371/journal.pone.0063393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696824	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900041
J	Hofhuis, A; Herremans, T; Notermans, DW; Sprong, H; Fonville, M; van der Giessen, JWB; van Pelt, W				Hofhuis, Agnetha; Herremans, Tineke; Notermans, Daan W.; Sprong, Hein; Fonville, Manoj; van der Giessen, Joke W. B.; van Pelt, Wilfrid			A Prospective Study among Patients Presenting at the General Practitioner with a Tick Bite or Erythema Migrans in the Netherlands	PLOS ONE			English	Article							BURGDORFERI SENSU-STRICTO; IXODES-RICINUS TICKS; BORRELIA-BURGDORFERI; LYME BORRELIOSIS; RISK; SERODIAGNOSIS; DISEASE; TRANSMISSION; INFECTION; RECOMBINANT	Background: We performed a nationwide prospective study on the transmission risk for Borrelia to humans, investigating symptoms and serology at enrolment and three months after tick bites, and after standard treatment for erythema migrans (EM). Aiming to quantify the infection risk at point of care by physicians, we explored risk factors such as tick testing for Borrelia and assessment of the duration of the tick's blood meal. Methods and Findings: Questionnaires, blood samples and ticks from patients who consulted one of 307 general practitioners for tick bites (n = 327) or EM (n = 283) in 2007 and 2008, were collected at enrolment and three months later at follow-up. Borrelia burgdorferi sensu lato DNA was detected in 29.3% of 314 ticks, using PCR/reverse line blot and real-time PCR on the OspA gene. Seroconversion in C6 ELISA, IgM or IgG immunoblots for Borrelia-specific antibodies was observed in 3.2% of tick bite cases. Fourteen tick bite cases had evidence of early Borrelia infection, of which EM developed among seven cases. The risk of developing EM after tick bites was 2.6% (95% CI: 1.1%-5.0%), and the risk of either EM or seroconversion was 5.1% (95% CI: 2.9%-8.2%). Participants with Borrelia-positive ticks had a significantly higher risk of either EM or seroconversion (odds ratio 4.8, 95% CI: 1.1-20.4), and of seroconversion alone (odds ratio 11.1, 95% CI: 1.1-108.9). A third (34%) of the cases enrolled with EM did not recall preceding tick bites. Three EM cases (1%) reported persisting symptoms, three months after standard antibiotic treatment for EM. Conclusions: One out of forty participants developed EM within three months after tick bites. The infection risk can be assessed by tick testing for Borrelia at point of care by physicians. However, further refining is needed considering sensitivity and specificity of tick tests, accuracy of tick attachment time and engorgement.	[Hofhuis, Agnetha; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands; [Herremans, Tineke; Notermans, Daan W.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [Sprong, Hein; Fonville, Manoj; van der Giessen, Joke W. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Hofhuis, A (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands.	Agnetha.Hofhuis@rivm.nl		Sprong, Hein/0000-0002-0218-4320; Hofhuis, Agnetha/0000-0002-9579-2148	ministry of Health, Welfare and Sport of the Netherlands	ministry of Health, Welfare and Sport of the Netherlands	This study was financed by, and conducted on behalf of, the ministry of Health, Welfare and Sport of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; deMik EL, 1997, INT J EPIDEMIOL, V26, P451, DOI 10.1093/ije/26.2.451; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Estrada-Pena A., 2004, TICKS DOMESTIC ANIMA; Feder HM, 2006, CLIN DERMATOL, V24, P509, DOI 10.1016/j.clindermatol.2006.07.012; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Goettner G, 2005, J CLIN MICROBIOL, V43, P3602, DOI 10.1128/JCM.43.8.3602-3609.2005; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; Heikkila T, 2003, J INFECT DIS, V187, P1888, DOI 10.1086/375371; Hofhuis A, 2010, INFECTIEZIEKTEN B, V3, P84; Huegli D, 2011, TICKS TICK-BORNE DIS, V2, P129, DOI 10.1016/j.ttbdis.2011.05.002; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Jacobs J J W M, 2008, Ned Tijdschr Geneeskd, V152, P2022; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Letrilliart L, 2005, EPIDEMIOL INFECT, V133, P935, DOI 10.1017/S0950268805004413; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; Mogilyansky E, 2004, CLIN DIAGN LAB IMMUN, V11, P924, DOI 10.1128/CDLI.11.5.924-929.2004; Nahimana I, 2004, EUR J CLIN MICROBIOL, V23, P603, DOI 10.1007/s10096-004-1162-0; Orloski KA, 1998, AM J EPIDEMIOL, V147, P391; Philipp MT, 2003, J CLIN MICROBIOL, V41, P4955, DOI 10.1128/JCM.41.11.4955-4960.2003; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Robertson J, 2000, J CLIN MICROBIOL, V38, P2097; Smismans A, 2006, CLIN MICROBIOL INFEC, V12, P648, DOI 10.1111/j.1469-0691.2006.01448.x; Speelman P, 2004, Ned Tijdschr Geneeskd, V148, P659; Sprong H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-41; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle F, 2002, WIEN KLIN WOCHENSCHR, V114, P493; Strle F, 1996, CLIN INFECT DIS, V23, P61, DOI 10.1093/clinids/23.1.61; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Tijsse-Klasen E, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-42; Tjernberg I, 2007, EUR J CLIN MICROBIOL, V26, P37, DOI 10.1007/s10096-006-0239-3; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; Wielinga PR, 2006, APPL ENVIRON MICROB, V72, P7594, DOI 10.1128/AEM.01851-06; Wielinga PR, 2009, VECTOR-BORNE ZOONOT, V9, P119, DOI 10.1089/vbz.2008.0047; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; [No title captured], DOI DOI 10.2807/ESW.11.25.02978-EN	41	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64361	10.1371/journal.pone.0064361	http://dx.doi.org/10.1371/journal.pone.0064361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696884	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900087
J	Wu, CF; Liu, S; Lee, YC; Wang, R; Sun, S; Yin, F; Bornmann, WG; Yu-Lee, LY; Gallick, GE; Zhang, W; Lin, SH; Kuang, J				Wu, C. F.; Liu, S.; Lee, Y-C; Wang, R.; Sun, S.; Yin, F.; Bornmann, W. G.; Yu-Lee, L-Y; Gallick, G. E.; Zhang, W.; Lin, S-H; Kuang, J.			RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B	ONCOGENE			English	Article						RSK; Cdc25; activating phosphorylation; mitosis; G2/M transition; cell cycle	SIGNAL-REGULATED KINASE; XENOPUS OOCYTE MATURATION; ELEMENT-BINDING PROTEIN; CELL-CYCLE PROGRESSION; MAP KINASE; G(2)/M TRANSITION; DNA-DAMAGE; INHIBITORY KINASE; CANCER-CELLS; AURORA-A	Activation of the mitogen-activated protein kinase ( MAPK) cascade in mammalian cell lines positively regulates the G2/M transition. The molecular mechanism underlying this biological phenomenon remains poorly understood. Ribosomal S6 kinase (RSK) is a key downstream element of the MAPK cascade. Our previous studies established roles of RSK2 in Cdc25C activation during progesterone-induced meiotic maturation of Xenopus oocytes. In this study we demonstrate that both recombinant RSK and endogenous RSK in Xenopus egg extracts phosphorylate all three isoforms of human Cdc25 at a conserved motif near the catalytic domain. In human HEK293 and PC-3mm2 cell lines, RSK preferentially phosphorylates Cdc25A and Cdc25B in mitotic cells. Phosphorylation of the RSK sites in these Cdc25 isoforms increases their M-phase-inducing activities. Inhibition of RSK-mediated phosphorylation of Cdc25 inhibits G2/M transition. Moreover, RSK is likely to be more active in mitotic cells than in interphase cells, as evidenced by the phosphorylation status of T359/S363 in RSK. Together, these findings indicate that RSK promotes G2/M transition in mammalian cells through activating phosphorylation of Cdc25A and Cdc25B.	[Wu, C. F.; Wang, R.; Sun, S.; Bornmann, W. G.; Kuang, J.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Liu, S.; Yin, F.; Zhang, W.] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Lee, Y-C; Lin, S-H] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Sun, S.; Gallick, G. E.; Lin, S-H; Kuang, J.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Yu-Lee, L-Y] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Gallick, G. E.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Dept Genitourinary Med Oncol Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Beijing Normal University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	slin@mdanderson.org; jkuang@mdanderson.org	Liu, Shuaishuai/AAB-3256-2020; Wang, Ruoning/C-1683-2014		Department of Defense (DOD) Prostate Cancer Research Program (PCRP) [W81XWH-09-1-0274, W81XWH-09-1-0272]; National Natural Science Foundation of China [30300173]; Beijing Talents Foundation [20071D0503100293]; PCF Challenge grant; NCI [CA140388, CA 16672]; Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672] Funding Source: NIH RePORTER	Department of Defense (DOD) Prostate Cancer Research Program (PCRP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Talents Foundation; PCF Challenge grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense (DOD) Prostate Cancer Research Program (PCRP) grants W81XWH-09-1-0274 (JK) and W81XWH-09-1-0272 (S-HL), by grant 30300173 from the National Natural Science Foundation of China and grant 20071D0503100293 from the Beijing Talents Foundation (WZ), and a PCF Challenge grant and NCI CA140388 (GEG). DNA sequencing was performed by the DNA Analysis Facility of UT MD Anderson Cancer Center supported by NCI grant CA 16672. The Translational Chemistry Core Facility at the MD Anderson Cancer Center was supported by the Cancer Center support grant CA016672.	Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aressy B, 2008, CELL CYCLE, V7, P2234, DOI 10.4161/cc.7.14.6305; Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Bhatt RR, 2000, J BIOL CHEM, V275, P32983, DOI 10.1074/jbc.M006386200; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; Cangi MG, 2008, INT J CANCER, V123, P1466, DOI 10.1002/ijc.23659; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Castro A, 2001, BIOL CELL, V93, P15, DOI 10.1016/S0248-4900(01)01128-5; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Clark DE, 2005, CANCER RES, V65, P3108; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eisenmann KM, 2003, CANCER RES, V63, P8330; Foijer F, 2008, ONCOGENE, V27, P1142, DOI 10.1038/sj.onc.1210724; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; GABRIELLI BG, 1992, J BIOL CHEM, V267, P18040; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gebauer F, 1997, BIOESSAYS, V19, P23, DOI 10.1002/bies.950190106; GOTOH Y, 1995, MOL REPROD DEV, V42, P486, DOI 10.1002/mrd.1080420417; Harding A, 2003, J BIOL CHEM, V278, P16747, DOI 10.1074/jbc.M301015200; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Maller J L, 1985, Dev Biol (N Y 1985), V1, P289; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Moritz A., 2010, SCI SIGNAL, V24, P3; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nam HJ, 2008, CELL SIGNAL, V20, P1349, DOI 10.1016/j.cellsig.2008.03.008; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Palmer A, 2000, Prog Cell Cycle Res, V4, P131; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; RIME H, 1994, BIOL CELL, V82, P11, DOI 10.1016/0248-4900(94)90061-2; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; SETH A, 1992, J BIOL CHEM, V267, P24796; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; Varmeh S, 2008, MOL CANCER THER, V7, P3789, DOI 10.1158/1535-7163.MCT-08-0838; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wang RN, 2010, P NATL ACAD SCI USA, V107, P19885, DOI 10.1073/pnas.1003528107; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	64	18	20	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2385	2394		10.1038/onc.2013.182	http://dx.doi.org/10.1038/onc.2013.182			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23708659	Green Accepted			2022-12-25	WOS:000335451800011
J	Baldridge, RD; Xu, P; Graham, TR				Baldridge, Ryan D.; Xu, Peng; Graham, Todd R.			Type IV P-type ATPases Distinguish Mono-versus Diacyl Phosphatidylserine Using a Cytofacial Exit Gate in the Membrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASE; CRYSTAL-STRUCTURE; IDENTIFICATION; TRANSPORT; ACYLTRANSFERASE; SPECIFICITY; COMPLEX; INTERNALIZATION	Type IV P-type ATPases (P4-ATPases) use the energy from ATP to "flip" phospholipid across a lipid bilayer, facilitating membrane trafficking events and maintaining the characteristic plasma membrane phospholipid asymmetry. Preferred translocation substrates for the budding yeast P4-ATPases Dnf1 and Dnf2 include lysophosphatidylcholine, lysophosphatidylethanolamine, derivatives of phosphatidylcholine and phosphatidylethanolamine containing a 7-nitro-2-1,3-benzoxadiazol-4-yl (NBD) group on the sn-2 C6 position, and were presumed to include phosphatidylcholine and phosphatidylethanolamine species with two intact acyl chains. Wepreviously identified several mutations in Dnf1 transmembrane (TM) segments 1 through 4 that greatly enhance recognition and transport of NBD phosphatidylserine (NBD-PS). Here we show that most of these Dnf1 mutants cannot flip diacylated PS to the cytosolic leaflet to establish PS asymmetry. However, mutation of a highly conserved asparagine (Asn-550) inTM3allowed Dnf1 to restore plasma membrane PS asymmetry in a strain deficient for the P4-ATPase Drs2, the primary PS flippase. Moreover, Dnf1 N550 mutants could replace the Drs2 requirement for growth at low temperature. A screen for additional Dnf1 mutants capable of replacing Drs2 function identified substitutions of TM1 and 2 residues, within a region called the exit gate, that permit recognition of dually acylated PS. These TM1, 2, and 3 residues coordinate with the "proline + 4" residue within TM4 to determine substrate preference at the exit gate. Moreover, residues from Atp8a1, a mammalian ortholog of Drs2, in these positions allow PS recognition by Dnf1. These studies indicate that Dnf1 poorly recognizes diacylated phospholipid and define key substitutions enabling recognition of endogenous PS.	[Baldridge, Ryan D.; Xu, Peng; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu	Xu, Peng/O-8615-2014; Xu, Peng/A-1082-2015	Xu, Peng/0000-0001-7103-3692; Baldridge, Ryan/0000-0001-7158-7812	National Institutes of Health [GM62367]; Cellular and Molecular Microbiology Training Program [T32AI007611-11]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062367, R01GM107978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Microbiology Training Program; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62367 (to T. R. G.). This work was also supported by Cellular and Molecular Microbiology Training Program T32AI007611-11 (to R. D. B.), by Vanderbilt Ingram Cancer Center Grant P30 CA68485, and by Vanderbilt Digestive Disease Research Center Grant DK058404.	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; PALMGREN MG, 1994, J BIOL CHEM, V269, P3027; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Smriti, 2007, BIOCHEMISTRY-US, V46, P2249, DOI 10.1021/bi061333x; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Viehweger K, 2002, PLANT CELL, V14, P1509, DOI 10.1105/tpc.002329; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Wilson D. S., 2001, CURR PROTOC MOL BIOL, V51, P831; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Xu Q, 2012, FEBS LETT, V586, P1803, DOI 10.1016/j.febslet.2012.05.018; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	46	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19516	19527		10.1074/jbc.M113.476911	http://dx.doi.org/10.1074/jbc.M113.476911			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23709217	Green Published, hybrid			2022-12-25	WOS:000321515800018
J	Howard, MT; Carlson, BA; Anderson, CB; Hatfield, DL				Howard, Michael T.; Carlson, Bradley A.; Anderson, Christine B.; Hatfield, Dolph L.			Translational Redefinition of UGA Codons Is Regulated by Selenium Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; SELENOCYSTEINE TRANSFER-RNA; 3 UNTRANSLATED REGION; MESSENGER-RNA; DIETARY SELENIUM; RAT-LIVER; MEDIATED DECAY; SELENOPROTEIN; SEQUENCES; METHYLATION	Incorporation of selenium into similar to 25 mammalian selenoproteins occurs by translational recoding whereby in-frame UGA codons are redefined to encode the selenium containing amino acid, selenocysteine (Sec). Here we applied ribosome profiling to examine the effect of dietary selenium levels on the translational mechanisms controlling selenoprotein synthesis in mouse liver. Dietary selenium levels were shown to control gene-specific selenoprotein expression primarily at the translation level by differential regulation of UGA redefinition and Sec incorporation efficiency, although effects on translation initiation and mRNA abundance were also observed. Direct evidence is presented that increasing dietary selenium causes a vast increase in ribosome density downstream of UGA-Sec codons for a subset of selenoprotein mRNAs and that the selenium-dependent effects on Sec incorporation efficiency are mediated in part by the degree of Sec-tRNA([Ser]Sec) Um34 methylation. Furthermore, we find evidence for translation in the 5'-UTRs for a subset of selenoproteins and for ribosome pausing near the UGA-Sec codon in those mRNAs encoding the selenoproteins most affected by selenium availability. These data illustrate how dietary levels of the trace element selenium can alter the readout of the genetic code to affect the expression of an entire class of proteins.	[Howard, Michael T.; Anderson, Christine B.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Howard, MT (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	mhoward@genetics.utah.edu			National Institutes of Health (NIH) [21ES022716]; Intramural Research Program of the NIH, NCI, Center for Cancer Research; University of Utah; NATIONAL CANCER INSTITUTE [ZIABC010767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES022716] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH Grant R21ES022716; to M. T. H.) and the Intramural Research Program of the NIH, NCI, Center for Cancer Research (to D. L. H.). This work was also supported by a University of Utah Seed grant (to M. T. H.).	[Anonymous], 1979, CHINESE MED J-PEKING, V92, P477; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; CHRISTENSEN MJ, 1992, J NUTR, V122, P1620, DOI 10.1093/jn/122.8.1620; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fletcher JE, 2000, RNA, V6, P1573, DOI 10.1017/S1355838200000625; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Gu QP, 2002, BIOMETALS, V15, P411, DOI 10.1023/A:1020241032336; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kim JY, 2011, BIOCHEM BIOPH RES CO, V409, P814, DOI 10.1016/j.bbrc.2011.05.096; Kim LK, 2000, RNA, V6, P1306, DOI 10.1017/S1355838200000388; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEI XG, 1995, J NUTR, V125, P1438; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; Nuttall KL, 2006, ANN CLIN LAB SCI, V36, P409; SHEN QC, 1993, J BIOL CHEM, V268, P11463; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872	48	66	68	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19401	19413		10.1074/jbc.M113.481051	http://dx.doi.org/10.1074/jbc.M113.481051			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696641	Green Published, hybrid			2022-12-25	WOS:000321515800009
J	Cacao, EE; Nasrullah, A; Sherlock, T; Kemper, S; Kourentzi, K; Ruchhoeft, P; Stein, GE; Willson, RC				Cacao, Eliedonna E.; Nasrullah, Azeem; Sherlock, Tim; Kemper, Steven; Kourentzi, Katerina; Ruchhoeft, Paul; Stein, Gila E.; Willson, Richard C.			High-Resolution, High-Throughput, Positive-Tone Patterning of Poly(ethylene glycol) by Helium Beam Exposure through Stencil Masks	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; CHEMICAL NANOLITHOGRAPHY; MOLECULAR-CONFORMATION; PROTEIN ADSORPTION; LABELED DNA; ELECTRON; GOLD; PEO; LITHOGRAPHY	In this work, a collimated helium beam was used to activate a thiol-poly(ethylene glycol) (SH-PEG) monolayer on gold to selectively capture proteins in the exposed regions. Protein patterns were formed at high throughput by exposing a stencil mask placed in proximity to the PEG-coated surface to a broad beam of helium particles, followed by incubation in a protein solution. Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy (ATR-FTIR) spectra showed that SH-PEG molecules remain attached to gold after exposure to beam doses of 1.5-60 mu C/cm(2) and incubation in PBS buffer for one hour, as evidenced by the presence of characteristic ether and methoxy peaks at 1120 cm(-1) and 2870 cm(-1), respectively. X-ray Photoelectron Spectroscopy (XPS) spectra showed that increasing beam doses destroy ether (C-O) bonds in PEG molecules as evidenced by the decrease in carbon C1s peak at 286.6 eV and increased alkyl (C-C) signal at 284.6 eV. XPS spectra also demonstrated protein capture on beam-exposed PEG regions through the appearance of a nitrogen N1s peak at 400 eV and carbon C1s peak at 288 eV binding energies, while the unexposed PEG areas remained protein-free. The characteristic activities of avidin and horseradish peroxidase were preserved after attachment on beam-exposed regions. Protein patterns created using a 35 mu m mesh mask were visualized by localized formation of insoluble diformazan precipitates by alkaline phosphatase conversion of its substrate bromochloroindoyl phosphate-nitroblue tetrazolium (BCIP-NBT) and by avidin binding of biotinylated antibodies conjugated on 100 nm gold nanoparticles (AuNP). Patterns created using a mask with smaller 300 nm openings were detected by specific binding of 40 nm AuNP probes and by localized HRP-mediated deposition of silver nanoparticles. Corresponding BSA-passivated negative controls showed very few bound AuNP probes and little to no enzymatic formation of diformazan precipitates or silver nanoparticles.	[Cacao, Eliedonna E.; Kemper, Steven; Kourentzi, Katerina; Stein, Gila E.; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA; [Nasrullah, Azeem; Sherlock, Tim; Ruchhoeft, Paul] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77204 USA; [Ruchhoeft, Paul] Univ Houston, Dept Biomed Engn, Houston, TX USA; [Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Willson, Richard C.] Methodist Hosp, Res Inst, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Ruchhoeft, P (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77204 USA.	PRuchhoeft@uh.edu; willson@uh.edu	Stein, Gila E/P-1927-2016; Willson, richard/AAD-4832-2019	Stein, Gila E/0000-0002-3973-4496; 	National Institute of Allergy and Infectious Diseases/National Institutes of Health [U54 AI057156]; National Science Foundation [CMMI-0900743, CBET-1133965, CBET-0932971]; Alliance for Nanohealth Competitive Research Program [W81XWH-09-2-0139]; Welch Foundation [E-1264]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); Alliance for Nanohealth Competitive Research Program; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant No. U54 AI057156 from the National Institute of Allergy and Infectious Diseases/National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. Support was also provided by the National Science Foundation, Grant No. CMMI-0900743, CBET-1133965 and CBET-0932971, the Alliance for Nanohealth Competitive Research Program, Grant No. W81XWH-09-2-0139, and the Welch Foundation, Grant No. E-1264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besseling NAM, 1997, LANGMUIR, V13, P2113, DOI 10.1021/la960672w; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Bretagnol F, 2007, SENSOR ACTUAT B-CHEM, V123, P283, DOI 10.1016/j.snb.2006.08.040; Castle JE, 2001, J VAC SCI TECHNOL A, V19, P1170, DOI 10.1116/1.1378074; Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b; Christman KL, 2009, J AM CHEM SOC, V131, P521, DOI 10.1021/ja804767j; Coates J., 2006, ENCY ANAL CHEM APPL, DOI [10.1002/9780470027318.a5606, DOI 10.1002/9780470027318.A5606]; Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o; Feulner P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178302; Francis GD, 2009, DIAGN MOL PATHOL, V18, P88, DOI 10.1097/PDM.0b013e31816f6374; FRANKS J, 1974, VACUUM, V24, P489, DOI 10.1016/0042-207X(74)90015-3; Geyer W, 2001, J VAC SCI TECHNOL B, V19, P2732, DOI 10.1116/1.1421560; Golzhauser A, 2001, ADV MATER, V13, P806, DOI 10.1002/1521-4095(200106)13:11%3C803::AID-ADMA806%3E3.0.CO;2-W; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; Hainfeld JF, 2010, METHOD DETECTING TAR; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Harnett CK, 2000, APPL PHYS LETT, V76, P2466, DOI 10.1063/1.126378; Harnett CK, 2001, LANGMUIR, V17, P178, DOI 10.1021/la0009543; Hering KK, 2008, CHEMPHYSCHEM, V9, P867, DOI 10.1002/cphc.200700591; Heuberger M, 2004, LANGMUIR, V20, P9445, DOI 10.1021/la048384k; HOGG AM, 1983, INT J MASS SPECTROM, V49, P25, DOI 10.1016/0020-7381(83)85073-6; Hong Y, 2004, LANGMUIR, V20, P11123, DOI 10.1021/la048651m; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0; Krsko P., 2005, NANOFABRICATION TECH, V6002, P600201; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; Lee SW, 2010, J NANOSCI NANOTECHNO, V10, P3246, DOI 10.1166/jnn.2010.2266; Lu HB, 2000, LANGMUIR, V16, P1711, DOI 10.1021/la990221m; Lyon LA, 1998, ANAL CHEM, V70, P5177, DOI 10.1021/ac9809940; Silvan MM, 2007, CHEM VAPOR DEPOS, V13, P211, DOI 10.1002/cvde.200606580; Manso-Silvan M, 2004, SURF INTERFACE ANAL, V36, P733, DOI 10.1002/sia.1750; Moller R, 2005, NANO LETT, V5, P1475, DOI 10.1021/nl050824k; Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869; Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415; Nam JM, 2007, NAT PROTOC, V2, P1438, DOI 10.1038/nprot.2007.201; Nasrullah A, 2009, J VAC SCI TECHNOL B, V27, P2674, DOI 10.1116/1.3265462; Reynolds RA, 2000, J AM CHEM SOC, V122, P3795, DOI 10.1021/ja000133k; Riemenschneider L, 2005, NANO LETT, V5, P1643, DOI 10.1021/nl0484550; Rundqvist J, 2006, LANGMUIR, V22, P5100, DOI 10.1021/la052306v; Smith KH, 2011, CHEM SOC REV, V40, P4563, DOI 10.1039/c1cs15064b; Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P; Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3; Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952; Yoshimoto K, 2009, LANGMUIR, V25, P12243, DOI 10.1021/la901143h; Yun YH, 2009, SENSORS-BASEL, V9, P9275, DOI 10.3390/s91109275; Zharnikov M, 2002, J VAC SCI TECHNOL B, V20, P1793, DOI 10.1116/1.1514665	46	5	5	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e56835	10.1371/journal.pone.0056835	http://dx.doi.org/10.1371/journal.pone.0056835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717382	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300044
J	Bolhuis, H; Fillinger, L; Stal, LJ				Bolhuis, Henk; Fillinger, Lucas; Stal, Lucas J.			Coastal Microbial Mat Diversity along a Natural Salinity Gradient	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; GEL-ELECTROPHORESIS; COMMUNITY STRUCTURE; NITROGEN-FIXATION; PHOTOSYNTHESIS; OXYGEN; GENES; MANIPULATION; MIGRATION; SEDIMENT	The North Sea coast of the Dutch barrier island of Schiermonnikoog is covered by microbial mats that initiate a succession of plant communities that eventually results in the development of a densely vegetated salt marsh. The North Sea beach has a natural elevation running from the low water mark to the dunes resulting in gradients of environmental factors perpendicular to the beach. These gradients are due to the input of seawater at the low water mark and of freshwater from upwelling groundwater at the dunes and rainfall. The result is a natural and dynamic salinity gradient depending on the tide, rainfall and wind. We studied the microbial community composition in thirty three samples taken every ten meters along this natural salinity gradient by using denaturing gradient gel electrophoresis (DGGE) of rRNA gene fragments. We looked at representatives from each Domain of life (Bacteria, Archaea and Eukarya) and with a particular emphasis on Cyanobacteria. Analysis of the DGGE fingerprints together with pigment composition revealed three distinct microbial mat communities, a marine community dominated by diatoms as primary producers, an intermediate brackish community dominated by Cyanobacteria as primary producers and a freshwater community with Cyanobacteria and freshwater green algae.	[Bolhuis, Henk; Fillinger, Lucas; Stal, Lucas J.] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Bolhuis, H (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Dept Marine Microbiol, Yerseke, Netherlands.	henk.bolhuis@nioz.nl	Bolhuis, Henk/M-6677-2019; Bolhuis, Henk/S-2986-2019; Bolhuis, Henk/H-8535-2014	Bolhuis, Henk/0000-0002-4772-1898; Bolhuis, Henk/0000-0002-4772-1898; Fillinger, Lucas/0000-0001-5341-8097				Abed RMM, 2007, ENVIRON MICROBIOL, V9, P1384, DOI 10.1111/j.1462-2920.2007.01254.x; Bebout BM, 2002, ASTROBIOLOGY, V2, P383, DOI 10.1089/153110702762470491; BIANCHI TS, 1988, J EXP MAR BIOL ECOL, V122, P243, DOI 10.1016/0022-0981(88)90126-8; Bidigare R.R., 2005, ALGAL CULTURING TECH, P327; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Clements F.E., 1916, PLANT SUCCESSION ANA; Coelho H, 2011, EUR J PHYCOL, V46, P271, DOI 10.1080/09670262.2011.598242; Consalvey M, 2004, DIATOM RES, V19, P181; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; DEBOER PL, 1981, SEDIMENTOLOGY, V28, P129; Dechesne Arnaud, 2007, P87; DEWIT R, 1989, NETH J SEA RES, V23, P271, DOI 10.1016/0077-7579(89)90048-3; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Dijkman NA, 2010, J SEA RES, V63, P62, DOI 10.1016/j.seares.2009.10.002; Dillon JG, 2009, FEMS MICROBIOL ECOL, V68, P46, DOI 10.1111/j.1574-6941.2009.00647.x; Gleason HA, 1926, INDIVIDUALISTIC CONC; Green SJ, 2008, ISME J, V2, P457, DOI 10.1038/ismej.2008.6; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN, P37; Jonkers HM, 1998, MICROBIAL ECOL, V36, P93, DOI 10.1007/s002489900096; JORGENSEN BB, 1986, APPL ENVIRON MICROB, V51, P408; Krekeler D, 1997, ARCH MICROBIOL, V167, P369, DOI 10.1007/s002030050457; Looijen Rick C., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P210, DOI 10.1078/1433-8319-00071; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; MURRAY RE, 1986, APPL ENVIRON MICROB, V52, P1177, DOI 10.1128/AEM.52.5.1177-1182.1986; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nicol GW, 2003, ENVIRON MICROBIOL, V5, P152, DOI 10.1046/j.1462-2920.2003.00399.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Piquet AMT, 2008, FEMS MICROBIOL ECOL, V66, P352, DOI 10.1111/j.1574-6941.2008.00588.x; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; Rothrock MJ, 2005, ENVIRON MICROBIOL, V7, P593, DOI 10.1111/j.1462-2920.2005.00728.x; Schulz E., 1936, KIELER MEERESFORSCH, V1, P359; Severin I, 2008, ISME J, V2, P1077, DOI 10.1038/ismej.2008.63; Severin I, 2010, FEMS MICROBIOL ECOL, V73, P514, DOI 10.1111/j.1574-6941.2010.00925.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; Smith JM, 2008, ENVIRON MICROBIOL, V10, P386, DOI 10.1111/j.1462-2920.2007.01459.x; STAL LJ, 1985, FEMS MICROBIOL ECOL, V31, P111, DOI 10.1111/j.1574-6968.1985.tb01138.x; Stal LJ, 2010, ADV EXP MED BIOL, V675, P31, DOI 10.1007/978-1-4419-1528-3_3; TERBRAAK CJF, 1989, HYDROBIOLOGIA, V184, P169, DOI 10.1007/BF02392953; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; VANDERMAAREL E, 1990, J VEG SCI, V1, P135, DOI 10.2307/3236065; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Youssef NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012414	53	46	47	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63166	10.1371/journal.pone.0063166	http://dx.doi.org/10.1371/journal.pone.0063166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704895	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200024
J	Plumb, J; Robinson, L; Lea, S; Banyard, A; Blaikley, J; Ray, D; Bizzi, A; Volpi, G; Facchinetti, F; Singh, D				Plumb, Jonathan; Robinson, Laura; Lea, Simon; Banyard, Antonia; Blaikley, John; Ray, David; Bizzi, Andrea; Volpi, Giorgina; Facchinetti, Fabrizio; Singh, Dave			Evaluation of Glucocorticoid Receptor Function in COPD Lung Macrophages Using Beclomethasone-17-Monopropionate	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HISTONE DEACETYLASE ACTIVITY; AIRWAY INFLAMMATION; FK506-BINDING PROTEIN-51; NUCLEAR TRANSLOCATION; ALVEOLAR MACROPHAGES; CYTOKINE RELEASE; GENE-EXPRESSION; P38 MAPK; PHOSPHORYLATION	Previous studies of glucocorticoid receptor (GR) function in COPD lung macrophages have used dexamethasone to evaluate inhibition of cytokine production. We have now used the clinically relevant corticosteroid beclomethasone-17-monopropionate (17-BMP) to assess GR function in COPD lung macrophages, and investigated the transactivation of glucocorticoid sensitive genes and GR phosphorylation in addition to cytokine production. Lung macrophages were purified from surgically acquired lung tissue, from patients with COPD, smokers, and non-smokers. The transactivation of glucocorticoid sensitive genes (FKBP51 and GILZ) by 17-BMP were analysed by polymerase chain reaction. 17-BMP suppression of LPS-induced TNF alpha, IL-6 and CXCL8 was measured by ELISA and GR phosphorylation was measured by immunohistochemistry and Western blot. 17-BMP reduced cytokine release in a concentration dependent manner, with >70% inhibition of all cytokines, and no difference between COPD patients and controls. Similarly, the transactivation of FKBP51 and GILZ, and GR phosphorylation was similar between COPD patients and controls. In this context, GR function in COPD lung macrophages is unaltered. 17-BMP effectively suppresses cytokine production in COPD lung macrophages.	[Plumb, Jonathan; Robinson, Laura; Lea, Simon; Banyard, Antonia; Singh, Dave] Univ Manchester, Univ Hosp South Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res,Translat Res Facil, Manchester, Lancs, England; [Blaikley, John; Ray, David] Univ Manchester, Sch Med, Manchester, Lancs, England; [Bizzi, Andrea; Volpi, Giorgina; Facchinetti, Fabrizio] Chiesi Pharmaceut, Parma, Italy	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; Chiesi Pharmaceuticals Inc	Plumb, J (corresponding author), Univ Manchester, Univ Hosp South Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res,Translat Res Facil, Manchester, Lancs, England.	jonathan.plumb@manchester.ac.uk	Lea, Simon/U-3590-2019; Singh, Dave/AAH-4342-2020	Singh, Dave/0000-0001-8918-7075; Ray, David/0000-0002-4739-6773; Blaikley, John/0000-0001-7651-5682; Plumb, Jonathan/0000-0002-7877-8053	AstraZeneca; Boehringer Ingelheim; Chiesi; GlaxoSmithKline; Almirall; Forest; Pfizer; UCB; Novartis; Cipla; Chiesi Pharmaceuticals; EPSRC [EP/I037253/1] Funding Source: UKRI; MRC [G0601556] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I037253/1] Funding Source: researchfish; Medical Research Council [G0601556] Funding Source: researchfish	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chiesi(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Almirall(Almirall); Forest; Pfizer(Pfizer); UCB(UCB Pharma SA); Novartis(Novartis); Cipla; Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We have the following interests. Dr. Singh has received sponsorship to attend international meetings, honoraria for lecturing or attending advisory boards, and research grants from various pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Almirall, Forest, Pfizer, UCB, Novartis, and Cipla. Chiesi Pharmaceuticals funded this study and is the employer of Dr. Bizzi, Dr. Volpi and Dr. Facchinetti. Chiesi pharmaceutical provided a years salary for Dr Plumb. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed on-line in the guide for authors.	Acerbi D, 2007, PULM PHARMACOL THER, V20, P290, DOI 10.1016/j.pupt.2006.05.005; Adcock Ian M, 2005, Proc Am Thorac Soc, V2, P313, DOI 10.1513/pats.200504-035SR; Armstrong J, 2011, J PHARMACOL EXP THER, V338, P732, DOI 10.1124/jpet.111.180737; Armstrong J, 2009, CLIN EXP IMMUNOL, V158, P74, DOI 10.1111/j.1365-2249.2009.03986.x; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes Neil C, 2007, Prim Care Respir J, V16, P149, DOI 10.3132/pcrj.2007.00038; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Bourbeau J, 2007, THORAX, V62, P938, DOI 10.1136/thx.2006.071068; Brand P, 2005, J AEROSOL MED, V18, P45, DOI 10.1089/jam.2005.18.45; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Culpitt SV, 2003, AM J RESP CRIT CARE, V167, P24, DOI 10.1164/rccm.200204-298OC; Daley-Yates PT, 2001, BRIT J CLIN PHARMACO, V51, P400, DOI 10.1046/j.0306-5251.2001.01374.x; DiStefano A, 1996, AM J RESP CRIT CARE, V153, P629, DOI 10.1164/ajrccm.153.2.8564109; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; Fung P, 2006, ASSAY DRUG DEV TECHN, V4, P263, DOI 10.1089/adt.2006.4.263; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GOLD, GLOB IN CHRON OBSTR; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Kent L, 2008, CYTOKINE, V42, P205, DOI 10.1016/j.cyto.2008.02.001; Kent LM, 2009, J PHARMACOL EXP THER, V328, P458, DOI 10.1124/jpet.108.142950; Koch A, 2004, EUR RESPIR J, V23, P805, DOI 10.1183/09031936.04.00104304; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ratajczak T, 2003, CURR TOP MED CHEM, V3, P1348, DOI 10.2174/1568026033451934; Renda T, 2008, EUR RESPIR J, V31, P62, DOI 10.1183/09031936.00036707; SCHMIDT J, 1994, EUR J PHARMACOL, V260, P247, DOI 10.1016/0014-2999(94)90345-X; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P1037, DOI 10.1167/iovs.07-1279	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64257	10.1371/journal.pone.0064257	http://dx.doi.org/10.1371/journal.pone.0064257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704983	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200127
J	Stein, A; Kortemme, T				Stein, Amelie; Kortemme, Tanja			Improvements to Robotics-Inspired Conformational Sampling in Rosetta	PLOS ONE			English	Article							CYCLIC COORDINATE DESCENT; PROTEIN-PROTEIN DOCKING; STRUCTURE PREDICTION; OPTIMIZATION; DESIGN; SPACE; POLYPEPTIDES; REFINEMENT; PROGRESS; CLOSURE	To accurately predict protein conformations in atomic detail, a computational method must be capable of sampling models sufficiently close to the native structure. All-atom sampling is difficult because of the vast number of possible conformations and extremely rugged energy landscapes. Here, we test three sampling strategies to address these difficulties: conformational diversification, intensification of torsion and omega-angle sampling and parameter annealing. We evaluate these strategies in the context of the robotics-based kinematic closure (KIC) method for local conformational sampling in Rosetta on an established benchmark set of 45 12-residue protein segments without regular secondary structure. We quantify performance as the fraction of sub-Angstrom models generated. While improvements with individual strategies are only modest, the combination of intensification and annealing strategies into a new "next-generation KIC" method yields a four-fold increase over standard KIC in the median percentage of sub-Angstrom models across the dataset. Such improvements enable progress on more difficult problems, as demonstrated on longer segments, several of which could not be accurately remodeled with previous methods. Given its improved sampling capability, next-generation KIC should allow advances in other applications such as local conformational remodeling of multiple segments simultaneously, flexible backbone sequence design, and development of more accurate energy functions.	[Stein, Amelie] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stein, A (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA.	amelie.stein@ucsf.edu; kortemme@cgl.ucsf.edu	Kortemme, Tanja/AAN-3180-2021; Stein, Amelie/K-1417-2019	Stein, Amelie/0000-0002-5862-1681; Kortemme, Tanja/0000-0002-8494-680X	EMBO long-term fellowship [ALTF 698-2011]; National Institutes of Health [GM098101]; National Science Foundation [DBI-1262182]; University of California Lab Research Program [UCOP 118766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098101] Funding Source: NIH RePORTER	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California Lab Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AS was supported by an EMBO long-term fellowship (ALTF 698-2011). This work was supported by grants to TK from the National Institutes of Health (GM098101), the National Science Foundation (DBI-1262182) and the University of California Lab Research Program (UCOP 118766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Berkholz DS, 2012, P NATL ACAD SCI USA, V109, P449, DOI 10.1073/pnas.1107115108; Boomsma W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-159; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BRUCCOLERI RE, 1985, MACROMOLECULES, V18, P2767, DOI 10.1021/ma00154a069; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Felts AK, 2008, J CHEM THEORY COMPUT, V4, P855, DOI 10.1021/ct800051k; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Kapp GT, 2012, P NATL ACAD SCI USA, V109, P5277, DOI 10.1073/pnas.1114487109; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee J, 1997, J COMPUT CHEM, V18, P1222, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1222::AID-JCC10>3.0.CO;2-7; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Liwo A, 1999, P NATL ACAD SCI USA, V96, P5482, DOI 10.1073/pnas.96.10.5482; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Misura KMS, 2005, PROTEINS, V59, P15, DOI 10.1002/prot.20376; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Schrodinger L., 2020, PYMOL; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Ting D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000763; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Ulmschneider JP, 2003, J CHEM PHYS, V118, P4261, DOI 10.1063/1.1542611; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Zhao SW, 2011, PROTEINS, V79, P2920, DOI 10.1002/prot.23129	49	118	120	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63090	10.1371/journal.pone.0063090	http://dx.doi.org/10.1371/journal.pone.0063090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704889	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200018
J	Matthews, K; Chung, NPY; Klasse, PJ; Moutaftsi, M; Carter, D; Salazar, AM; Reed, SG; Sanders, RW; Moore, JP				Matthews, Katie; Chung, Nancy P. Y.; Klasse, Per Johan; Moutaftsi, Magda; Carter, Darrick; Salazar, Andre M.; Reed, Steven G.; Sanders, Rogier W.; Moore, John P.			Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses In Vitro by Activating Dermal Dendritic Cells	PLOS ONE			English	Article							ANTIBODY-RESPONSES; IMMUNE-RESPONSES; LANGERHANS CELLS; VACCINE; SUBSETS; GP120; SUPPRESSION; ALPHA; TLR4; SKIN	CD14(+) dermal DCs (CD14(+) DDCs) have a natural capacity to activate naive B-cells. Targeting CD14(+) DDCs is therefore a rational approach for vaccination strategies aimed at improving humoral responses towards poorly immunogenic antigens, for example, HIV-1 envelope glycoproteins (Env). Here, we show that two clinically relevant TLR ligand combinations, Hiltonol plus Resiquimod and Glucopyranosyl lipid A plus Resiquimod, potently activate CD14(+) DDCs, as shown by enhanced expression of multiple cytokines (IL-6, IL-10, IL-12p40 and TNF-alpha). Furthermore, the responses of CD14(+) DDCs to these TLR ligands were not compromised by the presence of HIV-1 gp120, which can drive immunosuppressive effects in vitro and in vivo. The above TLR ligand pairs were better than the individual agents at boosting the inherent capacity of CD14(+) DDCs to induce naive B-cells to proliferate and differentiate into CD27(+) CD38(+) B-cells that secrete high levels of immunoglobulins. CD14(+) DDCs stimulated by these TLR ligand combinations also promoted the differentiation of Th1 (IFN-gamma-secreting), but not Th17, CD4(+) T-cells. These observations may help to identify adjuvant strategies aimed at inducing better antibody responses to vaccine antigens, including, but not limited to HIV-1 Env.	[Matthews, Katie; Chung, Nancy P. Y.; Klasse, Per Johan; Sanders, Rogier W.; Moore, John P.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Moutaftsi, Magda] Bill & Melinda Gates Fdn, HIV Vaccine Initiat, Seattle, WA USA; [Carter, Darrick; Reed, Steven G.] Infect Dis Res Inst IDRI, Seattle, WA USA; [Salazar, Andre M.] Oncovir Inc, Washington, DC USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands	Cornell University; Bill & Melinda Gates Foundation; University of Amsterdam; Academic Medical Center Amsterdam	Moore, JP (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	jpm2003@med.cornell.edu	Klasse, P.J./AEX-0142-2022; Carter, Darrick/N-3304-2016	Klasse, P.J./0000-0001-8222-278X; Carter, Darrick/0000-0001-5901-3402	NIH [AI36082]; Bill and Melinda Gates Foundation [42387]; Vidi grant from the Netherlands Organization for Scientific Research (NWO); Starting Investigator Grant from the European Research Council [ERC-StG-2011-280829-SHEV]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036082, R37AI036082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Vidi grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Investigator Grant from the European Research Council(European Research Council (ERC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grant AI36082 to JPM and by funding from the Bill and Melinda Gates Foundation, under grant #42387 to SGR and DR. RWS is a recipient of a Vidi grant from the Netherlands Organization for Scientific Research (NWO) and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV). The funders had no role in the study design, data collection and analysis, decision to publish, or publication of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BANCHEREAU J, 2012, BLOOD; Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Bogunovic D, 2011, CANCER RES, V71, P5467, DOI 10.1158/0008-5472.CAN-10-3988; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; CHUNG NP, 2012, J IMMUNOL; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Hovav AH, 2009, J VIROL, V83, P10941, DOI 10.1128/JVI.00394-09; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Klasse PJ, 2012, AIDS RES HUM RETROV, V28, P1, DOI [10.1089/aid.2011.0053, 10.1089/AID.2011.0053]; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2009, HUM IMMUNOL, V70, P281, DOI 10.1016/j.humimm.2009.02.004; Liard C, 2011, VACCINE, V29, P6379, DOI 10.1016/j.vaccine.2011.04.080; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; MATTHEWS K, 2012, J IMMUNOL; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Teunissen MBM, 2012, CURR TOP MICROBIOL, V351, P25, DOI 10.1007/82_2011_169; Toapanta FR, 2007, CURR HIV RES, V5, P199, DOI 10.2174/157016207780077057; Ueno H, 2010, IMMUNOL CELL BIOL, V88, P376, DOI 10.1038/icb.2010.28; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; van Montfort T, 2012, EXPERT REV VACCINES, V11, P1175, DOI [10.1586/ERV.12.102, 10.1586/erv.12.102]	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63785	10.1371/journal.pone.0063785	http://dx.doi.org/10.1371/journal.pone.0063785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700434	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400031
J	Garcia, CC; Weston-Davies, W; Russo, RC; Tavares, LP; Rachid, MA; Alves, JC; Machado, AV; Ryffel, B; Nunn, MA; Teixeira, MM				Garcia, Cristiana C.; Weston-Davies, Wynne; Russo, Remo C.; Tavares, Luciana P.; Rachid, Milene A.; Alves-Filho, Jose C.; Machado, Alexandre V.; Ryffel, Bernhard; Nunn, Miles A.; Teixeira, Mauro M.			Complement C5 Activation during Influenza A Infection in Mice Contributes to Neutrophil Recruitment and Lung Injury	PLOS ONE			English	Article							TICK ORNITHODOROS-MOUBATA; T-CELL RESPONSES; VIRUS-INFECTION; EXTRACELLULAR TRAPS; FACTOR RECEPTOR; INHIBITOR; PATHWAY; IMMUNOPATHOLOGY; PNEUMONITIS; GENERATION	Influenza virus A (IAV) causes annual epidemics and intermittent pandemics that affect millions of people worldwide. Potent inflammatory responses are commonly associated with severe cases of IAV infection. The complement system, an important mechanism of innate and humoral immune responses to infections, is activated during primary IAV infection and mediates, in association with natural IgM, viral neutralization by virion aggregation and coating of viral hemmagglutinin. Increased levels of the anaphylatoxin C5a were found in patients fatally infected with the most recent H1N1 pandemic virus. In this study, our aim was to evaluate whether targeting C5 activation alters inflammatory lung injury and viral load in a murine model of IAV infection. To address this question C57Bl/6j mice were infected intranasally with 10(4) PFU of the mouse adapted Influenza A virus A/WSN/33 (H1N1) or inoculated with PBS (Mock). We demonstrated that C5a is increased in bronchoalveolar lavage fluid (BALF) upon experimental IAV infection. To evaluate the role of C5, we used OmCI, a potent arthropod-derived inhibitor of C5 activation that binds to C5 and prevents release of C5a by complement. OmCI was given daily by intraperitoneal injection from the day of IAV infection until day 5. Treatment with OmCI only partially reduced C5a levels in BALF. However, there was significant inhibition of neutrophil and macrophage infiltration in the airways, Neutrophil Extracellular Traps (NETs) formation, death of leukocytes, lung epithelial injury and overall lung damage induced by the infection. There was no effect on viral load. Taken together, these data suggest that targeting C5 activation with OmCI during IAV infection could be a promising approach to reduce excessive inflammatory reactions associated with the severe forms of IAV infections.	[Garcia, Cristiana C.; Russo, Remo C.; Tavares, Luciana P.; Rachid, Milene A.; Teixeira, Mauro M.] Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil; [Weston-Davies, Wynne] Varleigh Ltd, London, England; [Russo, Remo C.] Univ Fed Minas Gerais, ICB, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Rachid, Milene A.] Univ Fed Minas Gerais, ICB, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Alves-Filho, Jose C.] Univ Sao Paulo, Dept Farmacol, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Machado, Alexandre V.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Ryffel, Bernhard] CNRS, UMR7355, F-75700 Paris, France; [Ryffel, Bernhard] Univ Orleans, F-45067 Orleans, France; [Ryffel, Bernhard] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa; [Nunn, Miles A.] Ctr Ecol & Hydrol, Wallingford, Oxon, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; UK Centre for Ecology & Hydrology (UKCEH)	Teixeira, MM (corresponding author), Univ Fed Minas Gerais, ICB, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil.	mmtex@icb.ufmg.br	Rachid, Milene Alvarenga/C-3530-2017; Russo, Remo Castro/O-8980-2019; Machado, Alexandre M Vieira/G-2468-2012; Garcia, Cristiana Couto/AAE-4290-2022; Russo, Remo Castro/F-9048-2010; Garcia, Cristiana C/G-9509-2013; Alves-Filho, Jose Carlos/B-5814-2008; Teixeira, Mauro M/A-4587-2008	Rachid, Milene Alvarenga/0000-0002-3142-6552; Russo, Remo Castro/0000-0002-1715-3834; Machado, Alexandre M Vieira/0000-0003-1506-4093; Garcia, Cristiana Couto/0000-0002-4400-9141; Russo, Remo Castro/0000-0002-1715-3834; Garcia, Cristiana C/0000-0002-4400-9141; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Teixeira, Mauro M/0000-0002-6944-3008; Padua Tavares, Luciana/0000-0002-5319-0210	National Institute of Science and Technology in Dengue (INCT Dengue); National Institute of Science and Technology in Vaccines (INCTV) from CNPq/Fapemig; Natural Environment Research Council [CEH010021] Funding Source: researchfish	National Institute of Science and Technology in Dengue (INCT Dengue); National Institute of Science and Technology in Vaccines (INCTV) from CNPq/Fapemig; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors were funded by the National Institute of Science and Technology in Dengue (INCT Dengue) and the National Institute of Science and Technology in Vaccines (INCTV) from CNPq/Fapemig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt-Due A, 2011, J IMMUNOL, V187, P4913, DOI 10.4049/jimmunol.1101000; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171; Garcia CC, 2010, DISCOV MED, V10, P479; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Halstead SK, 2008, J PERIPHER NERV SYST, V13, P228, DOI 10.1111/j.1529-8027.2008.00181.x; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Kim AHJ, 2004, J IMMUNOL, V173, P2524, DOI 10.4049/jimmunol.173.4.2524; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lacerda-Queiroz N, 2012, AM J PATHOL, V180, P246, DOI 10.1016/j.ajpath.2011.09.038; Law S.K.A., 1995, COMPLEMENT; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Longhi MP, 2007, EUR J IMMUNOL, V37, P1266, DOI 10.1002/eji.200636755; Martin EL, 2010, AM J RESP CRIT CARE, V182, P762, DOI 10.1164/rccm.201001-0088OC; Monsalvo AC, 2010, NAT MED; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; Nataf S, 1999, J IMMUNOL, V162, P4018; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; O'Brien KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017377; Ohta R, MICROBIOL IMMUNOL; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Roversi P, 2013, IMMUNE COMP IN PRESS; Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC; Sanderson SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040303; Soltys J, 2009, ANN NEUROL, V65, P67, DOI 10.1002/ana.21536; Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106; Stoermer KA, 2011, VIROLOGY; Tran AT, 2013, J VIROL, V87, P1049, DOI 10.1128/JVI.02017-12; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Zhang JJ, 2009, J GEN VIROL, V90, P2751, DOI 10.1099/vir.0.014316-0; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	52	64	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64443	10.1371/journal.pone.0064443	http://dx.doi.org/10.1371/journal.pone.0064443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696894	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000319081900097
J	Peterson, NA; Anderson, TK; Yoshino, TP				Peterson, Nathan A.; Anderson, Tavis K.; Yoshino, Timothy P.			In Silico Analysis of the Fucosylation-Associated Genome of the Human Blood Fluke Schistosoma mansoni: Cloning and Characterization of the Fucosyltransferase Multigene Family	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; BIOMPHALARIA-GLABRATA; PROTEIN O-FUCOSYL-TRANSFERASE-1; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; CERCARIAL GLYCOCALYX; MEMBRANE-PROTEINS; GENE-EXPRESSION; MIXED MODELS	Fucosylated glycans of the parasitic flatworm Schistosoma mansoni play key roles in its development and immunobiology. In the present study we used a genome-wide homology-based bioinformatics approach to search for genes that contribute to fucosylated glycan expression in S. mansoni, specifically the alpha 2-, alpha 3-, and alpha 6-fucosyltransferases (FucTs), which transfer L-fucose from a GDP-L-fucose donor to an oligosaccharide acceptor. We identified and in silico characterized several novel schistosome FucT homologs, including six alpha 3-FucTs and six alpha 6-FucTs, as well as two protein O-FucTs that catalyze the unrelated transfer of L-fucose to serine and threonine residues of epidermal growth factor- and thrombospondin-type repeats. No alpha 2-FucTs were observed. Primary sequence analyses identified key conserved FucT motifs as well as characteristic transmembrane domains, consistent with their putative roles as fucosyltransferases. Most genes exhibit alternative splicing, with multiple transcript variants generated. A phylogenetic analysis demonstrated that schistosome alpha 3- and alpha 6-FucTs form monophyletic clades within their respective gene families, suggesting multiple gene duplications following the separation of the schistosome lineage from the main evolutionary tree. Quantitative decreases in steady-state transcript levels of some FucTs during early larval development suggest a possible mechanism for differential expression of fucosylated glycans in schistosomes. This study systematically identifies the complete repertoire of FucT homologs in S. mansoni and provides fundamental information regarding their genomic organization, genetic variation, developmental expression, and evolutionary history.	[Yoshino, Timothy P.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Peterson, Nathan A.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Anderson, Tavis K.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Yoshino, TP (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	yoshinot@vetmed.wisc.edu		Anderson, Tavis/0000-0002-3138-5535	National Institutes of Health [AI015503, AI061436]; NIH-NIAID [HHSN272201000005I]; NRSA predoctoral fellowship through the Cellular and Molecular Parasitology Training Grant [NIH T32 AI007414]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015503, R01AI061436, R22AI015503, R01AI015503, T32AI007414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NRSA predoctoral fellowship through the Cellular and Molecular Parasitology Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants AI015503 and AI061436 to TPY and NIH-NIAID schistosome supply contract no. HHSN272201000005I. NAP was supported by a NRSA predoctoral fellowship through the Cellular and Molecular Parasitology Training Grant NIH T32 AI007414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2009, J MOL EVOL, V69, P22, DOI 10.1007/s00239-009-9239-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACIC A, 1990, EXP PARASITOL, V71, P483, DOI 10.1016/0014-4894(90)90074-M; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Castillo MG, 2007, J PARASITOL, V93, P832, DOI 10.1645/GE-954R.1; Chandrasekaran EV, 2001, GLYCOBIOLOGY, V11, P353, DOI 10.1093/glycob/11.5.353; CHERNIN E, 1963, J PARASITOL, V49, P353, DOI 10.2307/3275797; CHIANG CP, 1988, EXP PARASITOL, V67, P63, DOI 10.1016/0014-4894(88)90009-4; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; de Vries T, 2001, GLYCOBIOLOGY, V11, p119R, DOI 10.1093/glycob/11.10.119R; DeBoseBoyd R, 1996, EXP PARASITOL, V82, P1, DOI 10.1006/expr.1996.0001; DeMarco R, 2006, MOL BIOCHEM PARASIT, V150, P123, DOI 10.1016/j.molbiopara.2006.07.002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupuy F, 1999, J BIOL CHEM, V274, P12257, DOI 10.1074/jbc.274.18.12257; Dupuy F, 2004, GLYCOBIOLOGY, V14, P347, DOI 10.1093/glycob/cwh053; Dupuy F, 2002, MOL BIOL EVOL, V19, P815, DOI 10.1093/oxfordjournals.molbev.a004138; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fitzpatrick JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000543; Gallet PF, 1998, GLYCOBIOLOGY, V8, P919, DOI 10.1093/glycob/8.9.919; Hahn UK, 2000, DEV COMP IMMUNOL, V24, P531, DOI 10.1016/S0145-305X(00)00017-3; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hokke CH, 2005, PARASITE IMMUNOL, V27, P257, DOI 10.1111/j.1365-3024.2005.00781.x; Hokke CH, 1998, GLYCOBIOLOGY, V8, P393, DOI 10.1093/glycob/8.4.393; Hokke CH, 2007, EXP PARASITOL, V117, P275, DOI 10.1016/j.exppara.2007.06.003; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Javaud C, 2000, MOL BIOL EVOL, V17, P1661, DOI 10.1093/oxfordjournals.molbev.a026265; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Khoo KH, 1997, GLYCOBIOLOGY, V7, P663, DOI 10.1093/glycob/7.5.663; KHOO KH, 1995, J BIOL CHEM, V270, P17114, DOI 10.1074/jbc.270.29.17114; Loriol C, 2006, GLYCOBIOLOGY, V16, P736, DOI 10.1093/glycob/cwj124; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Maddison WP, 2011, MESQUITE MODULAR SYS; MAKAARU CK, 1992, J BIOL CHEM, V267, P2251; Marques ETA, 1998, MOL BIOCHEM PARASIT, V93, P237, DOI 10.1016/S0166-6851(98)00033-4; Marques ETA, 2001, GLYCOBIOLOGY, V11, P249, DOI 10.1093/glycob/11.3.249; Martinez-Duncker I, 2003, GLYCOBIOLOGY, V13, p1C, DOI 10.1093/glycob/cwg113; Mollicone R, 2009, J BIOL CHEM, V284, P4723, DOI 10.1074/jbc.M809312200; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mourao MM, 2012, PARASITE IMMUNOL, V34, P151, DOI 10.1111/j.1365-3024.2011.01349.x; NANDURI J, 1991, J BIOL CHEM, V266, P1341; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Nguyen K, 2007, GLYCOBIOLOGY, V17, P586, DOI 10.1093/glycob/cwm023; NOLAND LE, 1946, AM MIDL NAT, V36, P467, DOI 10.2307/2421516; NYAME K, 1989, J BIOL CHEM, V264, P3235; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Peterson NA, 2009, INT J PARASITOL, V39, P1331, DOI 10.1016/j.ijpara.2009.06.002; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ram D, 2004, PARASITOLOGY, V129, P587, DOI 10.1017/S003118200400602X; Robijn MLM, 2005, PARASITOLOGY, V130, P67, DOI 10.1017/S0031182004006390; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Silva LL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-617; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thomas PG, 2004, CELL MICROBIOL, V6, P13, DOI 10.1046/j.1462-5822.2003.00337.x; Trottein F, 2000, MOL BIOCHEM PARASIT, V107, P279, DOI 10.1016/S0166-6851(00)00213-9; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; van der Wel H, 2002, J BIOL CHEM, V277, P46527; van Die I, 1999, FEBS LETT, V463, P189, DOI 10.1016/S0014-5793(99)01508-2; van Remoortere A, 2000, GLYCOBIOLOGY, V10, P601, DOI 10.1093/glycob/10.6.601; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Williams DL, 2007, EXP PARASITOL, V117, P246, DOI 10.1016/j.exppara.2007.05.001; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wuhrer M, 2002, EUR J BIOCHEM, V269, P481, DOI 10.1046/j.0014-2956.2001.02673.x; Wuhrer M, 2006, GLYCOBIOLOGY, V16, P991, DOI 10.1093/glycob/cwl020; XU XF, 1994, EXP PARASITOL, V79, P399, DOI 10.1006/expr.1994.1102; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818; YOSHINO TP, 1995, J PARASITOL, V81, P714, DOI 10.2307/3283960; Zerlotini A, 2009, NUCLEIC ACIDS RES, V37, pD579, DOI 10.1093/nar/gkn681	86	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63299	10.1371/journal.pone.0063299	http://dx.doi.org/10.1371/journal.pone.0063299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696810	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900024
J	Szepesi, Z; Bijata, M; Ruszczycki, B; Kaczmarek, L; Wlodarczyk, J				Szepesi, Zsuzsanna; Bijata, Monika; Ruszczycki, Blazej; Kaczmarek, Leszek; Wlodarczyk, Jakub			Matrix Metalloproteinases Regulate the Formation of Dendritic Spine Head Protrusions during Chemically Induced Long-Term Potentiation	PLOS ONE			English	Article							NMDA RECEPTOR ACTIVATION; SYNAPTIC LOCALIZATION; HEMOPEXIN DOMAIN; LATE-PHASE; MATRIX-METALLOPROTEINASE-9; MORPHOLOGY; PLASTICITY; CLEAVAGE; NEURON; MMP-9	Dendritic spines are are small membranous protrusions that extend from neuronal dendrites and harbor the majority of excitatory synapses. Increasing evidence has shown that matrix metalloproteinases (MMPs), a family of extracellularly acting and Zn2+-dependent endopeptidases, are able to rapidly modulate dendritic spine morphology. Spine head protrusions (SHPs) are filopodia-like processes that extend from the dendritic spine head, representing a form of postsynaptic structural remodeling in response to altered neuronal activity. Herein, we show that chemically induced long-term potentiation (cLTP) in dissociated hippocampal cultures upregulates MMP-9 activity that controls the formation of SHPs. Blocking of MMPs activity or microtubule dynamics abolishes the emergence of SHPs. In addition, autoactive recombinant MMP-9, promotes the formation of SHPs in organotypic hippocampal slices. Furthermore, spines with SHPs gained postsynaptic alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionic acid (AMPA) receptors upon cLTP and the synaptic delivery of AMPA receptors was controlled by MMPs. The present results strongly imply that MMP-9 is functionally involved in the formation of SHPs and the control of postsynaptic receptor distribution upon cLTP.	[Szepesi, Zsuzsanna; Bijata, Monika; Kaczmarek, Leszek; Wlodarczyk, Jakub] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Ruszczycki, Blazej] M Nencki Inst Expt Biol, Neurobiol Ctr, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Wlodarczyk, J (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	j.wlodarczyk@nencki.gov.pl	Ruszczycki, Blazej/AAC-6385-2020; Kaczmarek, Leszek/B-6171-2008; Wlodarczyk, Jakub/A-2253-2015; Kaczmarek, Leszek/AHA-0076-2022	Ruszczycki, Blazej/0000-0002-0262-1463; Kaczmarek, Leszek/0000-0002-7207-3490; Wlodarczyk, Jakub/0000-0001-8343-2340; Kaczmarek, Leszek/0000-0002-7207-3490; Bijata, Monika/0000-0003-0589-4771	ERA-NET NEURON MODDIFSYN; AXREGEN [214003]; Ministry of Science and Higher Education [IP2011 060671]; European Regional Development Fund [POIG 01.01.02.-00-008/08]	ERA-NET NEURON MODDIFSYN; AXREGEN; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Regional Development Fund(European Commission)	Research was supported by ERA-NET NEURON MODDIFSYN (J.W. and L.K.), AXREGEN grant 214003 (Z.S.), and Ministry of Science and Higher Education grant IP2011 060671 (J.W.). M.B. was partially supported by the European Regional Development Fund POIG 01.01.02.-00-008/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilousova TV, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03701.x; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Conant K, 2010, NEUROSCIENCE, V166, P508, DOI 10.1016/j.neuroscience.2009.12.061; Dityatev Alexander, 2006, V43, P69, DOI 10.1007/025; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Gardoni F, 2012, J CELL SCI, V125, P1401, DOI 10.1242/jcs.097576; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Karetko M, 2009, ACTA NEUROBIOL EXP, V69, P564; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Konopacki FA, 2007, NEUROSCIENCE, V150, P31, DOI 10.1016/j.neuroscience.2007.08.026; Malinverno M, 2010, J NEUROSCI, V30, P16343, DOI 10.1523/JNEUROSCI.1984-10.2010; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Michaluk P, 2011, J CELL SCI, V124, P3369, DOI 10.1242/jcs.090852; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nestor MW, 2007, J NEUROSCI, V27, P12817, DOI 10.1523/JNEUROSCI.2442-07.2007; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Ruszczycki B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-213; Segal M, 2002, PROG BRAIN RES, V136, P101; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Szklarczyk A, 2007, NEUROSCIENCE, V149, P87, DOI 10.1016/j.neuroscience.2007.07.032; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Verbich D, 2012, GLIA, V60, P1067, DOI 10.1002/glia.22335; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wojtowicz T, 2010, HIPPOCAMPUS, V20, P917, DOI 10.1002/hipo.20787; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	52	52	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63314	10.1371/journal.pone.0063314	http://dx.doi.org/10.1371/journal.pone.0063314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696812	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900026
J	Ai, J; Pascal, LE; O'Malley, KJ; Dar, JA; Isharwal, S; Qiao, Z; Ren, B; Rigatti, LH; Dhir, R; Xiao, W; Nelson, JB; Wang, Z				Ai, J.; Pascal, L. E.; O'Malley, K. J.; Dar, J. A.; Isharwal, S.; Qiao, Z.; Ren, B.; Rigatti, L. H.; Dhir, R.; Xiao, W.; Nelson, J. B.; Wang, Z.			Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model	ONCOGENE			English	Article						prostate cancer; EAF2/U19; Pten; knockout	INTRAEPITHELIAL NEOPLASIA; TUMOR ANGIOGENESIS; SUPPRESSOR GENE; CELL-SURVIVAL; CANCER; MICE; AKT; CARCINOMA; PATHWAY; ADENOCARCINOMA	Multiple genetic alterations are associated with prostate carcinogenesis. Tumor-suppressor genes phosphatase and tensin homolog deleted on chromosome 10 (Pten) and androgen upregulated gene 19 (U19), which encodes ELL-associated factor 2 (EAF2), are frequently inactivated or downregulated in advanced prostate cancers. Previous studies showed that EAF2 knockout caused tumors in multiple organs and prostatic intraepithelial neoplasia (PIN) in mice. However, EAF2-knockout mice did not develop prostate cancer even at 2 years of age. To further define the roles of EAF2 in prostate carcinogenesis, we crossed the Pten +/- and EAF2 +/- mice in the C57/BL6 background to generate EAF2 -/- Pten +/-, Pten +/-, EAF2 -/- and wild-type mice. The prostates from virgin male mice with the above four genotypes were analyzed at 7 weeks, 19 weeks and 12 months of age. Concomitant loss of EAF2 function and inactivation of one Pten allele induced spontaneous prostate cancer in 33% of the mice. Prostatic tissues from intact EAF2 -/- Pten +/- mice exhibited higher levels of phospho-Akt, -p44/42 and microvessel density. Moreover, phospho-Akt remained high after castration. Consistently, there was a synergistic increase in prostate epithelial proliferation in both intact and castrated EAF2 -/- Pten +/- mice. Using laser-capture microdissection coupled with real-time reverse transcription-PCR, we confirmed that co-downregulation of EAF2 and Pten occurred in > 50% clinical prostate cancer specimens with Gleason scores of 8-9 (n = 11), which is associated with poor prognosis. The above findings together demonstrated synergistic functional interactions and clinical relevance of concurrent EAF2 and Pten downregulation in prostate carcinogenesis.	[Ai, J.; Pascal, L. E.; O'Malley, K. J.; Dar, J. A.; Isharwal, S.; Ren, B.; Nelson, J. B.; Wang, Z.] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15232 USA; [Qiao, Z.] Harbin Med Univ, Affiliated Hosp 3, Dept Urol, Harbin, Peoples R China; [Rigatti, L. H.] Univ Pittsburgh, Sch Med, Div Lab Anim Resources, Pittsburgh, PA 15232 USA; [Dhir, R.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15232 USA; [Xiao, W.] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Wang, Z.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA; [Wang, Z.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Dept Urol, Suite G40,5200 Ctr Ave, Pittsburgh, PA 15232 USA.	wangz2@upmc.edu	Isharwal, Sudhir/I-4347-2019; Dar, Javid/D-6276-2015; Pascal, Laura E./AAH-5743-2019; Xiao, Wuhan/GLU-7352-2022	Dar, Javid/0000-0002-4102-6202; Pascal, Laura E./0000-0003-3840-1662; 	National Institutes of Health Grants [R01 CA 120386, 5 R37 DK51193, 1 P50 CA90386, T32 DK007774];  [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA120386, P50CA090386, P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007774, R37DK051193] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This investigation was supported in part by the National Institutes of Health Grants R01 CA 120386, 5 R37 DK51193, 1 P50 CA90386 and T32 DK007774. This project used the UPCI Animal Facility and Tissue and Research Pathology Services (TARPS), and was supported in part by award P30CA047904. We thank Marie Acquafondata, Aiyuan Zhang, Katie Leschak and Dawn Everard (University of Pittsburgh, Pittsburgh, PA) for excellent technical assistance. We also thank all members of the Wang laboratory for insightful discussion and critical reading of the manuscript. LEP is a Tippins Foundation Scholar.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Ahmad Imran, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000689; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; Bostwick DG, 1996, CANCER, V78, P330, DOI 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W; BOSTWICK DG, 1987, CANCER, V59, P788, DOI 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO;2-I; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Coffer PJ, 1998, BIOCHEM J, V335, P1; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Koul HK, 2004, ANN NY ACAD SCI, V1030, P243, DOI 10.1196/annals.1329.030; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Pascal LE, 2011, ANGIOGENESIS, V14, P331, DOI 10.1007/s10456-011-9217-1; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wan XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009118; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; WEIDNER N, 1993, AM J PATHOL, V143, P401; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698	41	23	24	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2286	2294		10.1038/onc.2013.190	http://dx.doi.org/10.1038/onc.2013.190			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23708662	Green Accepted			2022-12-25	WOS:000335451800002
J	Mukai, R; Ohshima, T				Mukai, R.; Ohshima, T.			HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm	ONCOGENE			English	Article						HTLV-1; ATL; HBZ; GADD34; nuclear export	CELL LEUKEMIA-VIRUS; BZIP FACTOR HBZ; LEUCINE-ZIPPER-FACTOR; MOLECULAR-MECHANISMS; BINDING-PROTEIN; TYPE-1 TAX; C-JUN; AUTOPHAGY; GENE; TRANSCRIPTION	Human T-cell leukemia virus type-1 (HTLV-1) infection causes adult T-cell leukemia (ATL). Modulation of the transcriptional control of cellular genes by HTLV-1 is thought to be associated with the development of ATL. The viral protein HTLV-1 basic leucine-zipper factor (HBZ) has been shown to dysregulate the activity of cellular transcription factors. Here, we demonstrate that HBZ is exported from the nucleus to the cytoplasm, where it activates the mammalian target of rapamycin (mTOR) signaling pathway through an association with growth arrest and DNA damage gene 34 (GADD34). The N-terminal region of HBZ interacts with the C-terminal region of GADD34. HBZ contains a functional nuclear export signal (NES) sequence within its N-terminal region and it is exported from the nucleus via the CRM1-dependent pathway. Nuclear export of HBZ is essential for its interaction with GADD34 and increased phosphorylation of S6 kinase, which is an established downstream target of the mTOR pathway. Starvation-induced autophagy is significantly suppressed by the overexpression of HBZ. These findings indicate that HBZ is actively exported to the cytoplasm, where it dysregulates the function of cellular factors.	[Mukai, R.; Ohshima, T.] Tokushima Bunri Univ, Fac Engn, Sanuki, Kagawa 7692193, Japan; [Ohshima, T.] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan	Tokushima Bunri University; Tokushima Bunri University	Ohshima, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa Campus,1314-1 Shido, Sanuki, Kagawa 7692193, Japan.	ohshimat@kph.bunri-u.ac.jp		Mukai, Risa/0000-0003-4669-4100; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Education, Culture, Sports, Science and Technology of Japan; research funds from the Takeda Science Foundation; Suzuken Memorial Foundation; Japanese Leukemia Research Foundation; JSPS	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); research funds from the Takeda Science Foundation; Suzuken Memorial Foundation; Japanese Leukemia Research Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Dr H. Miyoshi for providing the lentivirus-based transfection system. This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas 'Integrative Research Toward the Conquest of Cancer' from the Ministry of Education, Culture, Sports, Science and Technology of Japan. In addition, this work was supported, in part, by research funds from the Takeda Science Foundation, the Suzuken Memorial Foundation and the Japanese Leukemia Research Foundation. R. Mukai was supported by a Research Fellowship from JSPS for Young Scientists.	Alavian SM, 2011, J VIRAL HEPATITIS, V18, P821, DOI 10.1111/j.1365-2893.2011.01530.x; Albrecht B, 2002, MICROBIOL MOL BIOL R, V66, P396, DOI 10.1128/MMBR.66.3.396-406.2002; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bender C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-74; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bex F, 1998, MOL CELL BIOL, V18, P2392, DOI 10.1128/MCB.18.4.2392; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; Chuluunbaatar U, 2010, GENE DEV, V24, P2627, DOI 10.1101/gad.1978310; Furukawa Y, 2001, BLOOD, V97, P987, DOI 10.1182/blood.V97.4.987; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hivin P, 2005, J CELL SCI, V118, P1355, DOI 10.1242/jcs.01727; Isono O, 2008, J BIOL CHEM, V283, P34273, DOI 10.1074/jbc.M802527200; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kirkegaard K, 2009, CURR TOP MICROBIOL, V335, P323, DOI 10.1007/978-3-642-00302-8_16; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2011, AM J PHYSIOL-CELL PH, V301, pC213, DOI 10.1152/ajpcell.00067.2011; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Murata K, 2006, J VIROL, V80, P2495, DOI 10.1128/JVI.80.5.2495-2505.2006; Ohshima T, 2010, J CELL BIOCHEM, V111, P187, DOI 10.1002/jcb.22687; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Orvedahl A, 2009, CURR TOP MICROBIOL, V335, P267, DOI 10.1007/978-3-642-00302-8_13; Rende F, 2011, BLOOD, V117, P4855, DOI 10.1182/blood-2010-11-316463; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Simonis N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-26; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tamiya S, 1996, BLOOD, V88, P3065, DOI 10.1182/blood.V88.8.3065.bloodjournal8883065; Taniguchi Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-64; Taylor MP, 2009, AUTOPHAGY, V5, P870, DOI 10.4161/auto.9046; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077; Watanabe R, 2007, INT J MOL MED, V19, P475; Yasunaga J, 2011, INT J HEMATOL, V94, P435, DOI 10.1007/s12185-011-0937-1; Yoshida M, 2005, ONCOGENE, V24, P5931, DOI 10.1038/sj.onc.1208981; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yoshida M, 2008, J VIROL, V82, P9359, DOI 10.1128/JVI.00242-08; Yoshita M, 2012, CANCER SCI, V103, P369, DOI 10.1111/j.1349-7006.2011.02123.x; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	58	27	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2317	2328		10.1038/onc.2013.181	http://dx.doi.org/10.1038/onc.2013.181			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23708656				2022-12-25	WOS:000335451800005
J	Ishigami, T; Abe, K; Aoki, I; Minegishi, S; Ryo, A; Matsunaga, S; Matsuoka, K; Takeda, H; Sawasaki, T; Umemura, S; Endo, Y				Ishigami, Tomoaki; Abe, Kaito; Aoki, Ichiro; Minegishi, Shintaro; Ryo, Akihide; Matsunaga, Satoko; Matsuoka, Kazuhiro; Takeda, Hiroyuki; Sawasaki, Tatsuya; Umemura, Satoshi; Endo, Yaeta			Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels	FASEB JOURNAL			English	Article						autoimmune; cytokine; coronary heart disease; peripheral artery disease	PRENYLATED RAB ACCEPTOR; KINASE-C-ZETA; STIMULATED GLUT4 TRANSLOCATION; LOW-DENSITY-LIPOPROTEIN; CYCLIN D2 EXPRESSION; SNARE PROTEINS; 3T3-L1 ADIPOCYTES; BETA-CATENIN; AGGRAVATES ATHEROSCLEROSIS; REGULATED EXOCYTOSIS	Atherosclerotic diseases, such as coronary artery disease and peripheral artery disease, are systemic disorders and among the leading causes of mortality and morbidity throughout the world. However, the exact pathophysiological mechanisms underlying the development of atherosclerosis remain unknown; currently, atherosclerosis is thought to involve an inflammatory process. Systemic inflammatory reactions and accumulation of immune cells in atherosclerotic lesions in situ are considered essential. We have comprehensively analyzed autoantibodies in patients with atherosclerosis by means of a newly developed high-throughput autoantibody analysis system. A wide range of autoantibodies was found in sera from patients with atherosclerosis. After we statistically analyzed the titers of each autoantibody with conventional techniques, the results underwent text-mining analyses based on natural language processing. Combinatory analysis revealed a close association between anti-interleukin (IL)-5 antibody and atherosclerosis. Titers of anti-IL-5 antibodies and serum IL-5 concentrations were also closely associated with other risk factors, such as low-density lipoprotein cholesterol, serum creatinine, fasting plasma glucose, gender, and age, suggesting that suppressed IL-5 function mediated by autoantibodies in patients with atherosclerosis plays an important role in the disease process. To validate the clinical significance of these findings, we computed the specificity and sensitivity of titers of anti-IL-5 autoantibodies for human atherosclerosis. When antibody titers of 1.49 were assumed to predict the presence of atherosclerosis, the sensitivity was 95.0% and the specificity 91.0%, with an area under the curve of 0.940. Our results provide important clues to understanding the role of autoantibody-mediated immune reactions in human atherosclerosis and suggest novel therapeutic opportunities for management of the disease.Ishigami, T., Abe, K., Aoki, I., Minegishi, S., Ryo, A., Matsunaga, S., Matsuoka, K., Takeda, H., Sawasaki, T., Umemura, S., and Endo, Y. Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels.	[Ishigami, Tomoaki; Abe, Kaito; Minegishi, Shintaro; Umemura, Satoshi] Yokohama City Univ, Dept Med Sci & Cardiorenal Med, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Aoki, Ichiro] Yokohama City Univ, Dept Mol Pathol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Ryo, Akihide; Matsunaga, Satoko] Yokohama City Univ, Dept Microbiol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Matsuoka, Kazuhiro; Takeda, Hiroyuki; Sawasaki, Tatsuya; Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Div Proteomed Sci, Matsuyama, Ehime 790, Japan	Yokohama City University; Yokohama City University; Yokohama City University; Ehime University	Ishigami, T (corresponding author), Yokohama City Univ, Dept Med Sci & Cardiorenal Med, Grad Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	tommmish@hotmail.com	Kaito, Abe/CAG-2336-2022; Matsuoka, Kazuhiro/N-8419-2015	Kaito, Abe/0000-0003-2152-2572; Sawasaki, Tatsuya/0000-0002-7952-0556	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [0018590898]; Takeda Science Foundation; Novartis Foundation for Gerontological Research; Yokohama Foundation for Advancement of Medical Science; Grants-in-Aid for Scientific Research [25117719, 23591221] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Yokohama Foundation for Advancement of Medical Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We greatly appreciate Dr. Takai (Tokyo Medical and Dental University Graduate School of Medicine, Department of Computational Biology and Bioinfomatics) for her help and assessment in bioinformatics for our work. We also greatly appreciate Dr. Yamakado (The Center for Multiphasic Health Testing and Services of Mitsui Memorial Hospital) for providing sera from the age-matched control subjects. T.I. is supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) no. 0018590898, Takeda Science Foundation, Novartis Foundation for Gerontological Research, and Yokohama Foundation for Advancement of Medical Science.	Baluchamy S, 2005, VIRUS RES, V108, P69, DOI 10.1016/j.virusres.2004.08.004; Bazzoni G, 2005, J CELL SCI, V118, P623, DOI 10.1242/jcs.01661; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Bhatt D. L., JAMA, V304, P1350; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Braiman L, 2001, MOL CELL BIOL, V21, P7852, DOI 10.1128/MCB.21.22.7852-7861.2001; Bucci C, 2001, BIOCHEM BIOPH RES CO, V286, P815, DOI 10.1006/bbrc.2001.5466; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Calero M, 2002, BIOCHEM BIOPH RES CO, V290, P676, DOI 10.1006/bbrc.2001.6242; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chapman WW, 2009, J BIOMED INFORM, V42, P757, DOI 10.1016/j.jbi.2009.09.001; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; Cho S, 2009, J NEUROCHEM, V109, P126, DOI 10.1111/j.1471-4159.2009.05801.x; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; CRUTE BE, 1992, J NEUROCHEM, V59, P2017; Cutlip DE, 2004, CIRCULATION, V110, P1226, DOI 10.1161/01.CIR.0000140721.27004.4B; Daugherty A, 2004, J CLIN INVEST, V114, P317, DOI 10.1172/jci200422561; Drachman DB, 2003, J CLIN INVEST, V111, P797, DOI 10.1172/JCI200318180; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Duran A, 2004, EMBO J, V23, P4595, DOI 10.1038/sj.emboj.7600468; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; ESPEL E, 1983, BIOCHEM BIOPH RES CO, V117, P817, DOI 10.1016/0006-291X(83)91670-4; Evans DT, 2002, J VIROL, V76, P327, DOI 10.1128/JVI.76.1.327-337.2002; FEUERSTEIN N, 1991, J BIOL CHEM, V266, P16200; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Fritzius T, 2007, FEBS J, V274, P1552, DOI 10.1111/j.1742-4658.2007.05702.x; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Gougeon PY, 2002, J BIOL CHEM, V277, P36408, DOI 10.1074/jbc.M205026200; Gutierrez R, 2005, PLANT CELL PHYSIOL, V46, P166, DOI 10.1093/pcp/pci007; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Hao JC, 1997, J NEUROSCI, V17, P1596; Horton LE, 1997, ONCOGENE, V14, P491, DOI 10.1038/sj.onc.1200851; Huang TJ, 2001, BRIT J PHARMACOL, V134, P1029, DOI 10.1038/sj.bjp.0704344; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Jiang XZ, 2006, BIOCHEM BIOPH RES CO, V345, P1497, DOI 10.1016/j.bbrc.2006.05.055; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kinoshita S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S4; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lawson K, 2005, MOL CELL BIOCHEM, V274, P103, DOI 10.1007/s11010-005-3066-4; LEHRICH RW, 1994, J BIOL CHEM, V269, P32446; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Ling SZ, 2003, J PHYSIOL-LONDON, V553, P65, DOI 10.1113/jphysiol.2003.051631; Logan MR, 2002, J ALLERGY CLIN IMMUN, V109, P299, DOI 10.1067/mai.2002.121453; Macaulay SL, 1997, BIOCHEM J, V324, P217, DOI 10.1042/bj3240217; Mallat Z, 2009, J LIPID RES, V50, pS364, DOI 10.1194/jlr.R800092-JLR200; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; Margittai M, 1999, FEBS LETT, V446, P40, DOI 10.1016/S0014-5793(99)00028-9; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Matsuoka K, 2010, J PROTEOME RES, V9, P4264, DOI 10.1021/pr9010553; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Methe H, 2005, J AM COLL CARDIOL, V45, P1939, DOI 10.1016/j.jacc.2005.03.040; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Min SH, 2005, NEUROCHEM RES, V30, P955, DOI 10.1007/s11064-005-6177-0; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyao Y, 2009, BIOINFORMATICS, V25, P394, DOI 10.1093/bioinformatics/btn631; Miyashita H, 2003, ONCOL REP, V10, P1045; Ohmura-Hoshino M, 2004, VACCINE, V22, P3751, DOI 10.1016/j.vaccine.2004.03.034; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; PALVIMO J, 1988, BIOCHIM BIOPHYS ACTA, V952, P172, DOI 10.1016/0167-4838(88)90113-6; Perez-Branguli F, 1999, FEBS LETT, V458, P60, DOI 10.1016/S0014-5793(99)01120-5; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Reikhardt B A, 2003, Neurosci Behav Physiol, V33, P799, DOI 10.1023/A:1025101516128; Rosas M, 2006, J LEUKOCYTE BIOL, V80, P186, DOI 10.1189/jlb.1105636; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Sampi M, 2008, J AM COLL CARDIOL, V52, P1370, DOI 10.1016/j.jacc.2008.06.047; Sanchez MDP, 2002, PLANT MOL BIOL, V50, P167, DOI 10.1023/A:1016029001537; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2005, METH MOL B, V310, P131; Shimada K, 2009, CIRC J, V73, P994, DOI 10.1253/circj.CJ-09-0277; St-Denis Jean-Francois, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P153; Sun HC, 2005, J CANCER RES CLIN, V131, P284, DOI 10.1007/s00432-004-0645-9; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; TAKATSU K, 1994, ADV IMMUNOL, V57, P145, DOI 10.1016/S0065-2776(08)60673-2; Takatsu K, 2009, ADV IMMUNOL, V101, P191, DOI 10.1016/S0065-2776(08)01006-7; Takuma T, 2002, J BIOCHEM, V132, P729, DOI 10.1093/oxfordjournals.jbchem.a003280; Takuma T, 2000, ARCH ORAL BIOL, V45, P369, DOI 10.1016/S0003-9969(00)00004-2; Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tran GT, 2012, BLOOD, V119, P4441, DOI 10.1182/blood-2011-12-396101; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang Y, 2007, FEBS LETT, V581, P3069, DOI 10.1016/j.febslet.2007.05.072; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zhang X, 2005, J CLIN NEUROSCI, V12, P166, DOI 10.1016/j.jocn.2004.03.036; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff	114	15	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3437	3445		10.1096/fj.12-222653	http://dx.doi.org/10.1096/fj.12-222653			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23699176				2022-12-25	WOS:000328840500004
J	Ben, JJ; Zhang, Y; Zhou, RM; Zhang, HY; Zhu, XD; Li, XY; Zhang, HW; Li, N; Zhou, XD; Bai, H; Yang, Q; Li, DH; Xu, Y; Chen, Q				Ben, Jingjing; Zhang, Yan; Zhou, Rongmei; Zhang, Haiyang; Zhu, Xudong; Li, Xiaoyu; Zhang, Hanwen; Li, Nan; Zhou, Xiaodan; Bai, Hui; Yang, Qing; Li, Donghai; Xu, Yong; Chen, Qi			Major Vault Protein Regulates Class A Scavenger Receptor-mediated Tumor Necrosis Factor-alpha Synthesis and Apoptosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; ATHEROSCLEROSIS; CELLS; STRESS; RESISTANCE; INDUCTION; ENGAGEMENT; EXPRESSION; THERAPIES; CAVEOLIN	Atherosclerosis is considered a disease of chronic inflammation largely initiated and perpetuated by macrophage-dependent synthesis and release of pro-inflammatory mediators. Class A scavenger receptor (SR-A) expressed on macrophages plays a key role in this process. However, how SR-A-mediated pro-inflammatory response is modulated in macrophages remains ill defined. Here through immunoprecipitation coupled with mass spectrometry, we reported major vault protein (MVP) as a novel binding partner for SR-A. The interaction between SR-A and MVP was confirmed by immunofluorescence staining and chemical cross-linking assay. Treatment of macrophages with fucoidan, a SR-A ligand, led to a marked increase in TNF-alpha production, which was attenuated by MVP depletion. Further analysis revealed that SR-A stimulated TNF-alpha synthesis in macrophages via the caveolin- instead of clathrin-mediated endocytic pathway linked to p38 and JNK, but not ERK, signaling pathways. Importantly, fucoidan invoked an enrichment of MVP in lipid raft, a caveolin-reliant membrane structure, and enhanced the interaction among SR-A, caveolin, and MVP. Finally, we demonstrated that MVP elimination ameliorated SR-A-mediated apoptosis in macrophages. As such, MVP may fine-tune SR-A activity in macrophages which contributes to the development of atherosclerosis.	[Ben, Jingjing; Zhang, Yan; Zhou, Rongmei; Zhu, Xudong; Li, Xiaoyu; Zhang, Hanwen; Li, Nan; Zhou, Xiaodan; Bai, Hui; Yang, Qing; Xu, Yong; Chen, Qi] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Atherosclerosis Res Ctr, Nanjing 210029, Jiangsu, Peoples R China; [Ben, Jingjing; Xu, Yong; Chen, Qi] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Haiyang; Li, Donghai] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University	Chen, Q (corresponding author), Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Atherosclerosis Res Ctr, Nanjing 210029, Jiangsu, Peoples R China.	qichen@njmu.edu.cn			National Basic Research Program 973 [2012CB517503, 2011CB503903, 2012CB945003]; National Natural Science Foundation of China [81070120, 81230070, 81000118, 31000323, 31070672]; College Natural Science Foundation of Jiangsu [10KJB310005]; Qinglan Project of Jiangsu; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College Natural Science Foundation of Jiangsu; Qinglan Project of Jiangsu; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Basic Research Program 973 Grants 2012CB517503, 2011CB503903, and 2012CB945003, National Natural Science Foundation of China Grant 81070120, and National Natural Science Foundation of China Key Grant 81230070 (to Q. C.); National Natural Science Foundation of China Grant 81000118, College Natural Science Foundation of Jiangsu Grant 10KJB310005, and Qinglan Project of Jiangsu (to J. B.); National Natural Science Foundation of China Grants 31000323 and 31070672 (to D. L.); and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Ben JJ, 2009, J MOL CELL CARDIOL, V47, P646, DOI 10.1016/j.yjmcc.2009.08.011; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Cheng AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033917; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cuschieri J, 2007, ANTIOXID REDOX SIGN, V9, P1485, DOI 10.1089/ars.2007.1670; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hu Y, 2002, INT J CANCER, V97, P149, DOI 10.1002/ijc.1590; Ikeda R, 2008, EXP CELL RES, V314, P3017, DOI 10.1016/j.yexcr.2008.07.001; Kim E, 2006, FEBS J, V273, P793, DOI 10.1111/j.1742-4658.2006.05112.x; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Lara PC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-148; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Liang P, 2010, BIOCHEM CELL BIOL, V88, P445, DOI [10.1139/O09-166, 10.1139/o09-166]; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Nakamura T, 2002, BIOCHEM BIOPH RES CO, V290, P858, DOI 10.1006/bbrc.2001.6271; Oz HS, 2009, DIGEST DIS SCI, V54, P2561, DOI 10.1007/s10620-008-0673-4; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ryu SJ, 2008, CELL DEATH DIFFER, V15, P1673, DOI 10.1038/cdd.2008.96; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Usui HK, 2007, DIABETES, V56, P363, DOI 10.2337/db06-0359; Xu Y, 2012, NEUROSCIENCE, V218, P35, DOI 10.1016/j.neuroscience.2012.05.036; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	36	31	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20076	20084		10.1074/jbc.M112.449538	http://dx.doi.org/10.1074/jbc.M112.449538			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703615	Green Published, hybrid			2022-12-25	WOS:000321515800069
J	Costa, JA; Nguyen, DA; Leal-Pinto, E; Gordon, RE; Hanss, B				Costa, Justin A.; Nguyen, Dac A.; Leal-Pinto, Edgar; Gordon, Ronald E.; Hanss, Basil			Wicking: A Rapid Method for Manually Inserting Ion Channels into Planar Lipid Bilayers	PLOS ONE			English	Article							ALPHA-HEMOLYSIN; MEMBRANE INTERACTION; MICROFLUIDIC DEVICE; DNA-MOLECULES; PROTEIN; CLIC1; RECONSTITUTION; MANIPULATION; NCC27; FORM	The planar lipid bilayer technique has a distinguished history in electrophysiology but is arguably the most technically difficult and time-consuming method in the field. Behind this is a lack of experimental consistency between laboratories, the challenges associated with painting unilamellar bilayers, and the reconstitution of ion channels into them. While there has be a trend towards automation of this technique, there remain many instances where manual bilayer formation and subsequent membrane protein insertion is both required and advantageous. We have developed a comprehensive method, which we have termed "wicking", that greatly simplifies many experimental aspects of the lipid bilayer system. Wicking allows one to manually insert ion channels into planar lipid bilayers in a matter of seconds, without the use of a magnetic stir bar or the addition of other chemicals to monitor or promote the fusion of proteoliposomes. We used the wicking method in conjunction with a standard membrane capacitance test and a simple method of proteoliposome preparation that generates a heterogeneous mixture of vesicle sizes. To determine the robustness of this technique, we selected two ion channels that have been well characterized in the literature: CLIC1 and alpha-hemolysin. When reconstituted using the wicking technique, CLIC1 showed biophysical characteristics congruent with published reports from other groups; and alpha-hemolysin demonstrated Type A and B events when threading single stranded DNA through the pore. We conclude that the wicking method gives the investigator a high degree of control over many aspects of the lipid bilayer system, while greatly reducing the time required for channel reconstitution.	[Costa, Justin A.; Nguyen, Dac A.; Hanss, Basil] Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY USA; [Costa, Justin A.; Nguyen, Dac A.; Hanss, Basil] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Leal-Pinto, Edgar] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA; [Gordon, Ronald E.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA; [Nguyen, Dac A.] Mt Sinai Sch Med, NIH Med Scientist Training Program, New York, NY USA; [Nguyen, Dac A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Dept Syst Biol Dis & Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Icahn School of Medicine at Mount Sinai	Hanss, B (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY USA.	basil.hanss@mssm.edu		Costa, Justin/0000-0003-0687-9549	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH) [DK065838]; National Institute of General Medical Sciences [T32GM062754]; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institutes of Health (NIH) to BH (DK065838). JC is a trainee in the Integrated Pharmacological Sciences Training Program supported by grant T32GM062754 from the National Institute of General Medical Sciences. DN is supported by the NIH Medical Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOV VF, 1980, NATURE, V283, P585, DOI 10.1038/283585a0; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; BEAN RC, 1969, J GEN PHYSIOL, V53, P741, DOI 10.1085/jgp.53.6.741; Feigin AM, 1996, J MEMBRANE BIOL, V149, P41, DOI 10.1007/s002329900005; Fujii G, 1997, BIOCHEMISTRY-US, V36, P4959, DOI 10.1021/bi962894z; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2010, BIOCHEMISTRY-US, V49, P5278, DOI 10.1021/bi100111c; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hasan N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014238; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HLADKY SB, 1970, NATURE, V225, P451, DOI 10.1038/225451a0; Le Pioufle B, 2008, ANAL CHEM, V80, P328, DOI 10.1021/ac7016635; Mach T, 2008, ANAL BIOANAL CHEM, V390, P841, DOI 10.1007/s00216-007-1647-7; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034; Mathe J, 2005, P NATL ACAD SCI USA, V102, P12377, DOI 10.1073/pnas.0502947102; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; McNally B, 2008, NANO LETT, V8, P3418, DOI 10.1021/nl802218f; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Pastoriza-Gallego M, 2007, FEBS LETT, V581, P3371, DOI 10.1016/j.febslet.2007.06.036; Poulos JL, 2009, BIOSENS BIOELECTRON, V24, P1806, DOI 10.1016/j.bios.2008.08.041; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; Roskamp RF, 2008, CHEMPHYSCHEM, V9, P1920, DOI 10.1002/cphc.200800248; Simonsson L, 2011, J AM CHEM SOC, V133, P14027, DOI 10.1021/ja204589a; Suzuki H, 2007, BIOSENS BIOELECTRON, V22, P1111, DOI 10.1016/j.bios.2006.04.013; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; TIEN HT, 2000, MEMBRANE BIOPHYSICS; Toyama S, 1991, BIOPHYS J, V59, P934; Tulk BM, 2000, J BIOL CHEM, V275, P26986; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Vockenroth IK, 2008, LANGMUIR, V24, P496, DOI 10.1021/la7030279; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; WHITE SH, 1981, BIOPHYS J, V36, P449, DOI 10.1016/S0006-3495(81)84744-3; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2	36	10	10	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e60836	10.1371/journal.pone.0060836	http://dx.doi.org/10.1371/journal.pone.0060836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717384	Green Submitted, gold, Green Published			2022-12-25	WOS:000319435600001
J	Liu, G; Zhou, LZ; Zhang, LL; Luo, ZJ; Xu, WB				Liu, Gang; Zhou, Lizhi; Zhang, Lili; Luo, Zijun; Xu, Wenbin			The Complete Mitochondrial Genome of Bean Goose (Anser fabalis) and Implications for Anseriformes Taxonomy	PLOS ONE			English	Article							DABBLING DUCKS TRIBE; CONTROL REGION; GENE ORGANIZATION; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; COMPLETE SEQUENCE; CYTOCHROME-B; EVOLUTION; DNA; MORPHOLOGY	Mitochondrial DNA plays an important role in living organisms, and has been used as a powerful molecular marker in a variety of evolutionary studies. In this study, we determined the complete mtDNA of Bean goose (Anser fabalis), which is 16,688 bp long and contains 13 protein-coding genes, 2 rRNAs, 22 tRNAs and a control region. The arrangement is similar to that of typical Anseriform species. All protein-coding genes, except for Cyt b, ND5, COI, and COII, start with an ATG codon. The ATG start codon is also generally observed in the 12 other Anseriform species, including 2 Anser species, with sequenced mitochondrial genomes. TAA is the most frequent stop codon, one of three-TAA, TAG, and T- -commonly observed in Anseriformes. All tRNAs could be folded into canonical cloverleaf secondary structures except for tRNA(Ser) (AGY) and tRNA(Leu) (CUN), which are missing the dihydrouridine (DHU) arm. The control region of Bean goose mtDNA, with some conserved sequence boxes, such as F, E, D, and C, identified in its central domain. Phylogenetic analysis of complete mtDNA data for 13 Anseriform species supports the classification of them into four major branches: Anatinae, Anserinae, Dendrocygninae and Anseranatidae. Phylogenetic analyses were also conducted on 36 Anseriform birds using combined Cyt b, ND2, and COI sequences. The results clearly support the genus Somateria as an independent lineage classified in its own tribe, the Somaterini. Recovered topologies from both complete mtDNA and combined DNA sequences strongly indicate that Dendrocygninae is an independent subfamily within the family Anatidae and Anseranatidae represents an independent family. Based on the results of this study, we conclude that combining ND2, Cyt b, and COI sequence data is a workable solution at present for resolving phylogenetic relationships among Anseriform species in the absence of sufficient complete mtDNA data.	[Liu, Gang; Zhou, Lizhi; Zhang, Lili; Luo, Zijun] Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China; [Liu, Gang; Zhou, Lizhi; Zhang, Lili; Luo, Zijun] Anhui Univ, Anhui Biodivers Informat Ctr, Hefei 230039, Peoples R China; [Xu, Wenbin] Shengjin Lake Natl Nat Reserve Anhui Prov, Dongzhi, Peoples R China	Anhui University; Anhui University	Zhou, LZ (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China.	zhoulz@ahu.edu.cn	Zhou, Lizhi/AAF-4535-2021	Zhou, Lizhi/0000-0002-5702-4658	National Natural Science Foundation of China [31172117]; Graduate Student Innovation Research Projects of Anhui University [YQH100111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Research Projects of Anhui University	This research was supported by the National Natural Science Foundation of China (grant number 31172117) and the Graduate Student Innovation Research Projects of Anhui University (YQH100111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-67; Bucheli SR, 2005, MOL PHYLOGENET EVOL, V35, P380, DOI 10.1016/j.ympev.2005.02.003; Cao SY, 2006, MITOCHONDRION, V6, P186, DOI 10.1016/j.mito.2006.07.003; Castro J A, 1998, Int Microbiol, V1, P327; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Del Hoyo J, 1992, HDB BIRDS WORLD, V2; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Dickinsom EC, 2003, HAWARD MOORE COMPLET; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Eberhard JR, 2001, MOL BIOL EVOL, V18, P1330, DOI 10.1093/oxfordjournals.molbev.a003917; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; Guan X, 2009, ANIM GENET, V40, P134, DOI 10.1111/j.1365-2052.2008.01810.x; Haring E, 2001, MOL BIOL EVOL, V18, P1892, DOI 10.1093/oxfordjournals.molbev.a003730; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; IUCN, 2022, IUCN RED LIST THREAT; Johnson KP, 1999, P ROY SOC B-BIOL SCI, V266, P759, DOI 10.1098/rspb.1999.0702; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Ke Yang, 2010, Yichuan, V32, P951, DOI 10.3724/SP.J.1005.2010.00951; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumazawa Y, 2004, DNA RES, V11, P115, DOI 10.1093/dnares/11.2.115; Liu G, 2012, MOL BIOL REP, V39, P2139, DOI 10.1007/s11033-011-0961-5; LIVEZEY BC, 1991, AUK, V108, P471, DOI 10.2307/4088089; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Marshall HD, 1997, MOL BIOL EVOL, V14, P173, DOI 10.1093/oxfordjournals.molbev.a025750; Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; QUINN TW, 1993, J MOL EVOL, V37, P417; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Ruokonen M, 2000, J EVOLUTION BIOL, V13, P532, DOI 10.1046/j.1420-9101.2000.00184.x; SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853; SACCONE C, 1991, J MOL EVOL, V33, P83, DOI 10.1007/BF02100199; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Sibley CG, 1990, PHYLOGENY CLASSIFICA; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; SOUTHERN SO, 1988, J MOL EVOL, V28, P32, DOI 10.1007/BF02143495; Tong Xiao-Mei, 2006, Yichuan, V28, P769; [涂剑锋 TU Jian-feng], 2010, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V32, P38; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang R, 2010, MOL BIOL REP, V37, P3517, DOI 10.1007/s11033-009-9945-0	47	25	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63334	10.1371/journal.pone.0063334	http://dx.doi.org/10.1371/journal.pone.0063334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717412	gold, Green Submitted, Green Published			2022-12-25	WOS:000319435600011
J	Vilar-Sanz, A; Puig, S; Garcia-Lledo, A; Trias, R; Balaguer, MD; Colprim, J; Baneras, L				Vilar-Sanz, Ariadna; Puig, Sebastia; Garcia-Lledo, Arantzazu; Trias, Rosalia; Dolors Balaguer, M.; Colprim, Jesus; Baneras, Lluis			Denitrifying Bacterial Communities Affect Current Production and Nitrous Oxide Accumulation in a Microbial Fuel Cell	PLOS ONE			English	Article							NOSZ GENES; BIOLOGICAL DENITRIFICATION; GENOME SEQUENCES; REDUCTASE GENES; N2O EMISSIONS; NITRATE; CARBON; REMOVAL; NARG; NIRS	The biocathodic reduction of nitrate in Microbial Fuel Cells (MFCs) is an alternative to remove nitrogen in low carbon to nitrogen wastewater and relies entirely on microbial activity. In this paper the community composition of denitrifiers in the cathode of a MFC is analysed in relation to added electron acceptors (nitrate and nitrite) and organic matter in the cathode. Nitrate reducers and nitrite reducers were highly affected by the operational conditions and displayed high diversity. The number of retrieved species-level Operational Taxonomic Units (OTUs) for narG, napA, nirS and nirK genes was 11, 10, 31 and 22, respectively. In contrast, nitrous oxide reducers remained virtually unchanged at all conditions. About 90% of the retrieved nosZ sequences grouped in a single OTU with a high similarity with Oligotropha carboxidovorans nosZ gene. nirS-containing denitrifiers were dominant at all conditions and accounted for a significant amount of the total bacterial density. Current production decreased from 15.0 A.m(-3) NCC (Net Cathodic Compartment), when nitrate was used as an electron acceptor, to 14.1 A.m(-3) NCC in the case of nitrite. Contrarily, nitrous oxide (N2O) accumulation in the MFC was higher when nitrite was used as the main electron acceptor and accounted for 70% of gaseous nitrogen. Relative abundance of nitrite to nitrous oxide reducers, calculated as (qnirS+qnirK)/qnosZ, correlated positively with N2O emissions. Collectively, data indicate that bacteria catalysing the initial denitrification steps in a MFC are highly influenced by main electron acceptors and have a major influence on current production and N2O accumulation.	[Vilar-Sanz, Ariadna; Garcia-Lledo, Arantzazu; Trias, Rosalia; Baneras, Lluis] Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain; [Puig, Sebastia; Dolors Balaguer, M.; Colprim, Jesus] Univ Girona, Inst Environm, LEQUIA, Girona, Spain	Universitat de Girona; Universitat de Girona	Baneras, L (corresponding author), Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain.	lluis.banyeras@udg.edu	Colprim, Jesús/L-3087-2014; Balaguer Condom, M. Dolors/L-3025-2014; Bañeras, Lluis/K-6736-2017; Balaguer, M. Dolors/AAC-6114-2019; Trias, Rosalia/F-2243-2010; Puig, Sebastià/L-8562-2014	Colprim, Jesús/0000-0002-6000-069X; Balaguer Condom, M. Dolors/0000-0001-6231-2163; Bañeras, Lluis/0000-0001-6908-3658; Balaguer, M. Dolors/0000-0001-6231-2163; Trias, Rosalia/0000-0002-2849-495X; Puig, Sebastià/0000-0003-2995-1443	Universitat de Girona; Ministerio de Ciencia y Educacion; Spanish Government [CGL2009-08338, CSD2007-00055, CTQ2011-23632]	Universitat de Girona; Ministerio de Ciencia y Educacion(Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission)	A. V-S. and A. G-L. are recipients of pre-doctoral grants from the Universitat de Girona and the Ministerio de Ciencia y Educacion, respectively. This research was funded through grants from the Spanish Government (CGL2009-08338, CSD2007-00055 and CTQ2011-23632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Chen GW, 2008, APPL MICROBIOL BIOT, V79, P379, DOI 10.1007/s00253-008-1451-0; CLAUS G, 1985, APPL MICROBIOL BIOT, V22, P283; Clauwaert P, 2007, ENVIRON SCI TECHNOL, V41, P3354, DOI 10.1021/es062580r; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Eaton A. D., 2005, STANDARD METHODS EXA; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Etchebehere C, 2005, APPL ENVIRON MICROB, V71, P5642, DOI 10.1128/AEM.71.9.5642-5645.2005; Garcia-Lledo A, 2011, WATER RES, V45, P5621, DOI 10.1016/j.watres.2011.08.025; Green SJ, 2012, APPL ENVIRON MICROB, V78, P1039, DOI 10.1128/AEM.06435-11; Gregory KB, 2004, ENVIRON MICROBIOL, V6, P596, DOI 10.1111/j.1462-2920.2004.00593.x; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; He Z, 2009, ENVIRON SCI TECHNOL, V43, P3391, DOI 10.1021/es803492c; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Heylen K, 2006, APPL ENVIRON MICROB, V72, P2637, DOI 10.1128/AEM.72.4.2637-2643.2006; Horn MA, 2006, APPL ENVIRON MICROB, V72, P1019, DOI 10.1128/AEM.72.2.1019-1026.2006; Hu Z, 2013, ENVIRON SCI POLLUT R, V20, P1059, DOI 10.1007/s11356-012-1018-6; Huang LP, 2011, BIORESOURCE TECHNOL, V102, P316, DOI 10.1016/j.biortech.2010.06.096; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jourand P, 2004, INT J SYST EVOL MICR, V54, P2269, DOI 10.1099/ijs.0.02902-0; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kostka JE, 2012, J BACTERIOL, V194, P4461, DOI 10.1128/JB.00871-12; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DY, 2002, APPL ENVIRON MICROB, V68, P2140, DOI 10.1128/AEM.68.5.2140-2147.2002; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maltais-Landry G, 2009, ENVIRON POLLUT, V157, P748, DOI 10.1016/j.envpol.2008.11.019; Morales SE, 2010, ISME J, V4, P799, DOI 10.1038/ismej.2010.8; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Palmer K, 2012, APPL ENVIRON MICROB, V78, P5584, DOI 10.1128/AEM.00810-12; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Park HI, 2006, ENZYME MICROB TECH, V39, P453, DOI 10.1016/j.enzmictec.2005.11.028; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Philippot L, 2011, GLOBAL CHANGE BIOL, V17, P1497, DOI 10.1111/j.1365-2486.2010.02334.x; Pous N, 2013, J CHEM TECHNOL BIOT, V88, P1690, DOI 10.1002/jctb.4020; Puig S, 2008, WATER RES, V42, P557, DOI 10.1016/j.watres.2007.07.050; Puig S, 2011, BIORESOURCE TECHNOL, V102, P4462, DOI 10.1016/j.biortech.2010.12.100; Puig S, 2010, BIORESOURCE TECHNOL, V101, P9594, DOI 10.1016/j.biortech.2010.07.082; Randall C.W., 1992, WATER QUALITY MANAGE, V5; Reyes-Avila JS, 2004, WATER RES, V38, P3313, DOI 10.1016/j.watres.2004.04.035; Rosenbaum M, 2011, BIORESOURCE TECHNOL, V102, P324, DOI 10.1016/j.biortech.2010.07.008; Ruiz-Rueda O, 2009, FEMS MICROBIOL ECOL, V67, P308, DOI 10.1111/j.1574-6941.2008.00615.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt I, 2003, FEMS MICROBIOL REV, V27, P481, DOI 10.1016/S0168-6445(03)00039-1; SMITH RL, 1994, APPL ENVIRON MICROB, V60, P1949, DOI 10.1128/AEM.60.6.1949-1955.1994; Sovik AK, 2007, SCI TOTAL ENVIRON, V380, P28, DOI 10.1016/j.scitotenv.2006.10.007; Strycharz SM, 2011, BIOELECTROCHEMISTRY, V80, P142, DOI 10.1016/j.bioelechem.2010.07.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Torres CI, 2008, BIOTECHNOL BIOENG, V100, P872, DOI 10.1002/bit.21821; van Cleemput O, 1998, NUTR CYCL AGROECOSYS, V52, P187, DOI 10.1023/A:1009728125678; Virdis B, 2008, WATER RES, V42, P3013, DOI 10.1016/j.watres.2008.03.017; Virdis B, 2009, ENVIRON SCI TECHNOL, V43, P5144, DOI 10.1021/es8036302; Volland S, 2011, J BACTERIOL, V193, P5043, DOI 10.1128/JB.05619-11; Wrighton KC, 2010, ISME J, V4, P1443, DOI 10.1038/ismej.2010.66; Wunderlin P, 2012, WATER RES, V46, P1027, DOI 10.1016/j.watres.2011.11.080; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	63	67	70	1	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63460	10.1371/journal.pone.0063460	http://dx.doi.org/10.1371/journal.pone.0063460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717427	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600017
J	Bryant, EK; Dressen, AS; Bunker, CH; Hokanson, JE; Hamman, RF; Kamboh, MI; Demirci, FY				Bryant, Emily K.; Dressen, Amy S.; Bunker, Clareann H.; Hokanson, John E.; Hamman, Richard F.; Kamboh, M. Ilyas; Demirci, F. Yesim			A Multiethnic Replication Study of Plasma Lipoprotein Levels-Associated SNPs Identified in Recent GWAS	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-LIPIDS; GENETIC-LOCI; POPULATION; CHOLESTEROL; VARIANTS; TRIGLYCERIDES; DISEASE; TRAITS; RISK	Genome-wide association studies (GWAS) have identified a number of loci/SNPs associated with plasma total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels. The purpose of this study was to replicate 40 recent GWAS-identified HDL-C-related new loci in 3 epidemiological samples comprising U.S. non-Hispanic Whites (NHWs), U.S. Hispanics, and African Blacks. In each sample, the association analyses were performed with all 4 major lipid traits regardless of previously reported specific associations with selected SNPs. A total of 22 SNPs showed nominally significant association (p<0.05) with at least one lipid trait in at least one ethnic group, although not always with the same lipid traits reported as genome-wide significant in the original GWAS. The total number of significant loci was 10 for TC, 12 for LDL-C, 10 for HDL-C, and 6 for TG levels. Ten SNPs were significantly associated with more than one lipid trait in at least one ethnic group. Six SNPs were significantly associated with at least one lipid trait in more than one ethnic group, although not always with the same trait across various ethnic groups. For 25 SNPs, the associations were replicated with the same genome-wide significant lipid traits in the same direction in at least one ethnic group; at nominal significance for 13 SNPs and with a trend for association for 12 SNPs. However, the associations were not consistently present in all ethnic groups. This observation was consistent with mixed results obtained in other studies that also examined various ethnic groups.	[Bryant, Emily K.; Dressen, Amy S.; Bunker, Clareann H.; Kamboh, M. Ilyas; Demirci, F. Yesim] Univ Pittsburgh, GSPH, Pittsburgh, PA 15213 USA; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Kamboh, MI (corresponding author), Univ Pittsburgh, GSPH, Pittsburgh, PA 15213 USA.	kamboh@pitt.edu; fyd1@pitt.edu		Kamboh, M. Ilyas/0000-0002-3453-1438; Demirci, F. Yesim/0000-0001-6907-9843	National Heart, Lung and Blood Institute (NHLBI) [HL084613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084613] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Demirci FY, 2010, ANN NUTR METAB, V56, P59, DOI 10.1159/000268019; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keebler ME, 2009, CIRC-CARDIOVASC GENE, V2, P238, DOI 10.1161/CIRCGENETICS.108.829473; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Lanktree MB, 2009, J LIPID RES, V50, P1487, DOI 10.1194/jlr.P900008-JLR200; Musunuru K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036473; Plenge RM, 2011, ARTHRITIS RHEUM-US, V63, P2839, DOI 10.1002/art.30509; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	23	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63469	10.1371/journal.pone.0063469	http://dx.doi.org/10.1371/journal.pone.0063469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717430	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700025
J	Huoviala, P; Rantala, MJ				Huoviala, Paavo; Rantala, Markus J.			A Putative Human Pheromone, Androstadienone, Increases Cooperation between Men	PLOS ONE			English	Article							IBERIAN ROCK LIZARDS; ULTIMATUM GAME; BRAIN RESPONSE; SEX-PHEROMONE; FEMALE MICE; MALE ODOR; SIGNALS; ATTRACTIVENESS; TESTOSTERONE; WOMEN	Androstadienone, a component of male sweat, has been suggested to function as a human pheromone, an airborne chemical signal causing specific responses in conspecifics. In earlier studies androstadienone has been reported to increase attraction, affect subjects' mood, cortisol levels and activate brain areas linked to social cognition, among other effects. However, the existing psychological evidence is still relatively scarce, especially regarding androstadienone's effects on male behaviour. The purpose of this study was to look for possible behavioural effects in male subjects by combining two previously distinct branches of research: human pheromone research and behavioural game theory of experimental economics. Forty male subjects participated in a mixed-model, double-blind, placebo-controlled experiment. The participants were exposed to either androstadienone or a control stimulus, and participated in ultimatum and dictator games, decision making tasks commonly used to measure cooperation and generosity quantitatively. Furthermore, we measured participants' salivary cortisol and testosterone levels during the experiment. Salivary testosterone levels were found to positively correlate with cooperative behaviour. After controlling for the effects of participants' baseline testosterone levels, androstadienone was found to increase cooperative behaviour in the decision making tasks. To our knowledge, this is the first study to show that androstadienone directly affects behaviour in human males.	[Huoviala, Paavo; Rantala, Markus J.] Univ Turku, Dept Behav Sci & Philosophy, Turku, Finland; [Rantala, Markus J.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Turku; University of Turku	Rantala, MJ (corresponding author), Univ Turku, Dept Behav Sci & Philosophy, Turku, Finland.	markus.rantala@utu.fi		Huoviala, Paavo/0000-0002-6072-7979	Academy of Finland [2608001]	Academy of Finland(Academy of Finland)	The study was financially supported by the Academy of Finland (grant number 2608001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Camerer C, 2003, BEHAV GAME THEORY; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Farrelly Daniel, 2007, EVOLUTIONARY PSYCHOL, V5, P313, DOI DOI 10.1177/147470490700500205; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Gulyas B, 2004, NEUROCHEM INT, V44, P595, DOI 10.1016/j.neuint.2003.10.003; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hummer TA, 2009, HORM BEHAV, V55, P548, DOI 10.1016/j.yhbeh.2009.01.002; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; KAVALIERS M, 1995, P ROY SOC B-BIOL SCI, V261, P31, DOI 10.1098/rspb.1995.0113; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Millet K, 2009, BRIT J PSYCHOL, V100, P151, DOI 10.1348/000712608X324359; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; Penn D, 1998, ETHOLOGY, V104, P685, DOI 10.1111/j.1439-0310.1998.tb00102.x; Piferi RL, 2000, INT J PSYCHOPHYSIOL, V37, P207, DOI 10.1016/S0167-8760(00)00102-1; Rantala MJ, 2002, P ROY SOC B-BIOL SCI, V269, P1681, DOI 10.1098/rspb.2002.2056; Ruther J, 2009, P ROY SOC B-BIOL SCI, V276, P3303, DOI 10.1098/rspb.2009.0738; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Saxton TK, 2008, HORM BEHAV, V54, P597, DOI 10.1016/j.yhbeh.2008.06.001; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; STYLIANOU M, 1961, J BIOL CHEM, V236, P692; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Zaatari D, 2007, EVOL HUM BEHAV, V28, P223, DOI 10.1016/j.evolhumbehav.2007.02.002; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330	39	30	30	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62499	10.1371/journal.pone.0062499	http://dx.doi.org/10.1371/journal.pone.0062499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717389	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700003
J	Iismaa, SE; Aplin, M; Holman, S; Yiu, TW; Jackson, K; Burchfield, JG; Mitchell, CJ; O'Reilly, L; Davenport, A; Cantley, J; Schmitz-Peiffer, C; Biden, TJ; Cooney, GJ; Graham, RM				Iismaa, Siiri E.; Aplin, Mark; Holman, Sara; Yiu, Ting W.; Jackson, Kristy; Burchfield, James G.; Mitchell, Christopher J.; O'Reilly, Liam; Davenport, Aimee; Cantley, James; Schmitz-Peiffer, Carsten; Biden, Trevor J.; Cooney, Gregory J.; Graham, Robert M.			Glucose Homeostasis in Mice Is Transglutaminase 2 Independent	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; RAT PANCREATIC-ISLETS; GTP-BINDING PROTEIN; FUNCTIONAL-CHARACTERIZATION; TISSUE TRANSGLUTAMINASE; YOUNG MODY; RECEPTOR; G(H); INHIBITION; DISORDERS	Transglutaminase type 2 (TG2) has been reported to be a candidate gene for maturity onset diabetes of the young (MODY) because three different mutations that impair TG2 transamidase activity have been found in 3 families with MODY. TG2 null (TG2(-/-)) mice have been reported to be glucose intolerant and have impaired glucose-stimulated insulin secretion (GSIS). Here we rigorously evaluated the role of TG2 in glucose metabolism using independently generated murine models of genetic TG2 disruption, which show no compensatory enhanced expression of other TGs in pancreatic islets or other tissues. First, we subjected chow- or fat-fed congenic SV129 or C57BL/6 wild type (WT) and TG2(-/-) littermates, to oral glucose gavage. Blood glucose and serum insulin levels were similar for both genotypes. Pancreatic islets isolated from these animals and analysed in vitro for GSIS and cholinergic potentiation of GSIS, showed no significant difference between genotypes. Results from intraperitoneal glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) were similar for both genotypes. Second, we directly investigated the role of TG2 transamidase activity in insulin secretion using a coisogenic model that expresses a mutant form of TG2 (TG2(R579A)), which is constitutively active for transamidase activity. Intraperitoneal GTTs and ITTs revealed no significant differences between WT and TG2(R579A/R579A) mice. Given that neither deletion nor constitutive activation of TG2 transamidase activity altered basal responses, or responses to a glucose or insulin challenge, our data indicate that glucose homeostasis in mice is TG2 independent, and question a link between TG2 and diabetes.	[Iismaa, Siiri E.; Aplin, Mark; Holman, Sara; Yiu, Ting W.; Jackson, Kristy; Graham, Robert M.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Sydney, NSW, Australia; [Burchfield, James G.; Mitchell, Christopher J.; O'Reilly, Liam; Davenport, Aimee; Cantley, James; Schmitz-Peiffer, Carsten; Biden, Trevor J.; Cooney, Gregory J.] Garvan Inst Med Res, Diabet & Obes Div, Sydney, NSW, Australia; [Iismaa, Siiri E.; Yiu, Ting W.; Graham, Robert M.] Univ New S Wales, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; Garvan Institute of Medical Research; University of New South Wales Sydney	Iismaa, SE (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Sydney, NSW, Australia.	s.iismaa@victorchang.edu.au; b.graham@victorchang.edu.au	Biden, Trevor/AAW-2829-2021; Burchfield, James/C-1779-2019; Iismaa, Siiri/C-9300-2013	Burchfield, James/0000-0002-6609-6151; Cantley, James/0000-0003-2509-1271; Schmitz-Peiffer, Carsten/0000-0001-7330-7255; Jackson, Kristy/0000-0002-4707-4096; Iismaa, Siiri/0000-0003-2409-7356; Biden, Trevor/0000-0001-5211-0234	National Health and Medical Research Council of Australia [142000, 459406]; Victor Chang Cardiac Research Institute's	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victor Chang Cardiac Research Institute's	This study was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/grants) grants 142000 (SEI, RMG), 459406 (RMG, SEI) and the Victor Chang Cardiac Research Institute's (http://www.victorchang.org.au/home/study-careers/research/prince-christian-fellowship/) Prince Christian Fellowship (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; Brennan K, 2011, ADV PROTOCOLS ANIMAL, P535; BUNGAY PJ, 1984, BIOCHEM J, V219, P819, DOI 10.1042/bj2190819; Calkins MJ, 2010, EXP NEUROL, V224, P307, DOI 10.1016/j.expneurol.2010.04.008; Cantley J, 2011, DIABETOLOGIA, V54, P380, DOI 10.1007/s00125-010-1962-y; Carpenter L, 2004, DIABETES, V53, P53, DOI 10.2337/diabetes.53.1.53; Chen SH, 1996, J BIOL CHEM, V271, P32385, DOI 10.1074/jbc.271.50.32385; DAVIES PJA, 1984, DIABETES CARE, V7, P35; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Dupuis M, 2004, J BIOL CHEM, V279, P19257, DOI 10.1074/jbc.M314299200; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GOMIS R, 1983, BIOCHIM BIOPHYS ACTA, V760, P384, DOI 10.1016/0304-4165(83)90378-1; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Iismaa SE, 2000, J BIOL CHEM, V275, P18259, DOI 10.1074/jbc.M000583200; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; IM MJ, 1990, J BIOL CHEM, V265, P18952; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; LEE SK, 1995, PANCREAS, V11, P206, DOI 10.1097/00006676-199508000-00016; Leiter EH, 2002, DIABETOLOGIA, V45, P296, DOI 10.1007/s00125-001-0743-z; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Park ES, 1998, BIOCHEM J, V331, P283, DOI 10.1042/bj3310283; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; Salter NW, 2012, J MOL ENDOCRINOL, V48, P203, DOI 10.1530/JME-11-0064; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Vezza R, 1999, J BIOL CHEM, V274, P12774, DOI 10.1074/jbc.274.18.12774; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905; Zhang ZB, 2003, CIRC RES, V92, P1153, DOI 10.1161/01.RES.0000071749.22027.45	39	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63346	10.1371/journal.pone.0063346	http://dx.doi.org/10.1371/journal.pone.0063346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717413	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700015
J	Tamir, S; Zuris, JA; Agranat, L; Lipper, CH; Conlan, AR; Michaeli, D; Harir, Y; Paddock, ML; Mittler, R; Cabantchik, ZI; Jennings, PA; Nechushtai, R				Tamir, Sagi; Zuris, John A.; Agranat, Lily; Lipper, Colin H.; Conlan, Andrea R.; Michaeli, Dorit; Harir, Yael; Paddock, Mark L.; Mittler, Ron; Cabantchik, Zvi Ioav; Jennings, Patricia A.; Nechushtai, Rachel			Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic Drugs	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PROTEIN; CRYSTAL-STRUCTURE; HUMAN MITONEET; IRON; THIAZOLIDINEDIONE; CELLS; GLUTATHIONE; LIGANDS; STRESS; MICE	Nutrient-deprivation autophagy factor-1 (NAF-1) (synonyms: Cisd2, Eris, Miner1, and Noxp70) is a [2Fe-2S] cluster protein immune-detected both in endoplasmic reticulum (ER) and mitochondrial outer membrane. It was implicated in human pathology (Wolfram Syndrome 2) and in BCL-2 mediated antagonization of Beclin 1-dependent autophagy and depression of ER calcium stores. To gain insights about NAF-1 functions, we investigated the biochemical properties of its 2Fe-2S cluster and sensitivity of those properties to small molecules. The structure of the soluble domain of NAF-1 shows that it forms a homodimer with each protomer containing a [2Fe-2S] cluster bound by 3 Cys and one His. NAF-1 has shown the unusual abilities to transfer its 2Fe-2S cluster to an apo-acceptor protein (followed in vitro by spectrophotometry and by native PAGE electrophoresis) and to transfer iron to intact mitochondria in cell models (monitored by fluorescence imaging with iron fluorescent sensors targeted to mitochondria). Importantly, the drug pioglitazone abrogates NAF-1's ability to transfer the cluster to acceptor proteins and iron to mitochondria. Similar effects were found for the anti-diabetes and longevity-promoting antioxidant resveratrol. These results reveal NAF-1 as a previously unidentified cell target of anti-diabetes thiazolidinedione drugs like pioglitazone and of the natural product resveratrol, both of which interact with the protein and stabilize its labile [2Fe-2S] cluster.	[Tamir, Sagi; Agranat, Lily; Michaeli, Dorit; Harir, Yael; Cabantchik, Zvi Ioav; Nechushtai, Rachel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Zuris, John A.; Lipper, Colin H.; Conlan, Andrea R.; Paddock, Mark L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Zuris, John A.; Lipper, Colin H.; Conlan, Andrea R.; Paddock, Mark L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Mittler, Ron] Univ N Texas, Dept Biol, Denton, TX 76203 USA	Hebrew University of Jerusalem; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Texas System; University of North Texas Denton	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu; rachel@vms.huji.ac.il	Mittler, Ron/ABE-6496-2020		Israel Science Foundation (ISF) [ISF 863/09, ISF 141/06]; Canadian Friends of the Hebrew University [ISF 214/08]; European Union; Cell and Molecular Genetics Training (CMG) [2T32GM007240-29]; National Institutes of Health (NIH) [GM54038]; NIH [GM101467]; Heme and Blood Proteins Training [5T32DK007233-34]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054038, R01GM101467, R01GM054038, T32GM007240] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); Canadian Friends of the Hebrew University; European Union(European Commission); Cell and Molecular Genetics Training (CMG); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heme and Blood Proteins Training; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: the Israel Science Foundation (ISF) grant ISF 863/09 awarded to RN; ISF 141/06 and a grant from the Canadian Friends of the Hebrew University awarded to ZIC; ISF 214/08 and the European Union Grant FP7-Marie Curie 447 awarded to RM; the Cell and Molecular Genetics Training (CMG) grant 2T32GM007240-29 awarded to ARC; National Institutes of Health (NIH) GM54038 and NIH GM101467 to PAJ; and the Heme and Blood Proteins Training grant 5T32DK007233-34 to JAZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Boucquey M, 2006, J NEUROCHEM, V99, P657, DOI 10.1111/j.1471-4159.2006.04093.x; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chang NC, 2012, HUM MOL GENET, V21, P2277, DOI 10.1093/hmg/dds048; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2010, ANN NY ACAD SCI, V1201, P58, DOI 10.1111/j.1749-6632.2010.05619.x; Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Fish A, 2005, J MOL BIOL, V350, P599, DOI 10.1016/j.jmb.2005.04.071; Gardner OS, 2005, J BIOL CHEM, V280, P10109, DOI 10.1074/jbc.M410445200; Geldenhuys WJ, 2011, BIOORG MED CHEM LETT, V21, P5498, DOI 10.1016/j.bmcl.2011.06.111; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Hu YS, 2011, J ENDOCRINOL, V208, pR1, DOI 10.1677/JOE-10-0393; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Shvartsman M, 2007, AM J PHYSIOL-CELL PH, V293, pC1383, DOI 10.1152/ajpcell.00054.2007; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wu G, 2002, BIOCHEMISTRY-US, V41, P5024, DOI 10.1021/bi016073s; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	27	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e61202	10.1371/journal.pone.0061202	http://dx.doi.org/10.1371/journal.pone.0061202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717386	gold, Green Published			2022-12-25	WOS:000320362700001
J	Volkow, ND; Tomasi, D; Wang, GJ; Telang, F; Fowler, JS; Goldstein, RZ; Klein, N; Wong, C; Swanson, JM; Shumay, E				Volkow, Nora D.; Tomasi, Dardo; Wang, Gene-Jack; Telang, Frank; Fowler, Joanna S.; Goldstein, Rita Z.; Klein, Nelly; Wong, Christopher; Swanson, James M.; Shumay, Elena			Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism	PLOS ONE			English	Article							E TYPE-4 ALLELE; DEFICIT/HYPERACTIVITY DISORDER; DIFFERENTIAL SUSCEPTIBILITY; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; GENETIC-VARIATION; HEALTHY-SUBJECTS; DRD4 GENE; D4 GENE; PERSONALITY	Aging is associated with reductions in brain glucose metabolism in some cortical and subcortical regions, but the rate of decrease varies significantly between individuals, likely reflecting genetic and environmental factors and their interactions. Here we test the hypothesis that the variant of the dopamine receptor D4 (DRD4) gene (VNTR in exon 3), which has been associated with novelty seeking and sensitivity to environmental stimuli (negative and positive) including the beneficial effects of physical activity on longevity, influence the effects of aging on the human brain. We used positron emission tomography (PET) and [F-18]fluoro-D-glucose ((18)FDG) to measure brain glucose metabolism (marker of brain function) under baseline conditions (no stimulation) in 82 healthy individuals (age range 22-55 years). We determined their DRD4 genotype and found an interaction with age: individuals who did not carry the 7-repeat allele (7R-, n = 53) had a significant (p<0.0001) negative association between age and relative glucose metabolism (normalized to whole brain glucose metabolism) in frontal (r = -0.52), temporal (r = -0.51) and striatal regions (r = -0.47, p<0.001); such that older individuals had lower metabolism than younger ones. In contrast, for carriers of the 7R allele (7R+ n = 29), these correlations with age were not significant and they only showed a positive association with cerebellar glucose metabolism (r = +0.55; p = 0.002). Regression slopes of regional brain glucose metabolism with age differed significantly between the 7R+ and 7R- groups in cerebellum, inferior temporal cortex and striatum. These results provide evidence that the DRD4 genotype might modulate the associations between regional brain glucose metabolism and age and that the carriers of the 7R allele appear to be less sensitive to the effects of age on brain glucose metabolism.	[Volkow, Nora D.; Tomasi, Dardo] NIDA, NIH, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Wong, Christopher] NIAAA, NIH, Bethesda, MD USA; [Wang, Gene-Jack; Fowler, Joanna S.; Goldstein, Rita Z.; Klein, Nelly; Shumay, Elena] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; University of California System; University of California Irvine	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Alia-Klein, Nelly/C-3154-2013; Tomasi, Dardo/J-2127-2015		National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bak LK, 2009, J NEUROCHEM, V109, P87, DOI 10.1111/j.1471-4159.2009.05943.x; Bakermans-Kranenburg MJ, 2007, J CHILD PSYCHOL PSYC, V48, P1160, DOI 10.1111/j.1469-7610.2007.01801.x; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Boals A, 2011, PSYCHOL HEALTH, V26, P1049, DOI 10.1080/08870446.2010.529139; Borroto-Escuela DO, 2011, BIOCHEM BIOPH RES CO, V404, P928, DOI 10.1016/j.bbrc.2010.12.083; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Buchman AS, 2008, AM J GERIAT PSYCHIAT, V16, P697, DOI 10.1097/JGP.0b013e31817945f6; BUCHMAN AS, 2012, AM J GERIATR PSYCHIA; Capitanio JP, 2008, BRAIN BEHAV IMMUN, V22, P647, DOI 10.1016/j.bbi.2008.02.002; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Das D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020177; DESANTI S, 1995, PSYCHIAT QUART, V66, P357, DOI 10.1007/BF02238755; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gillespie NA, 2003, PERS INDIV DIFFER, V35, P1931, DOI 10.1016/S0191-8869(03)00042-4; Glantz S.A., 2002, PRIMER BIOSTATISTICS; GONZALEZ S, 2011, MOL PSYCHIAT; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Helms CM, 2008, PHARMACOL BIOCHEM BE, V90, P387, DOI 10.1016/j.pbb.2008.03.013; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Kieling R., 2011, CURR TOP BEHAV NEURO, V9, P1, DOI [10.1007/7854_2010_115, DOI 10.1007/7854_2010_115]; Kim IJ, 2009, ACTA RADIOL, V50, P1169, DOI 10.3109/02841850903258058; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kramer UM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-150; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Michaelides M, 2010, EUR J NEUROSCI, V32, P668, DOI 10.1111/j.1460-9568.2010.07319.x; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Park A, 2011, J ABNORM PSYCHOL, V120, P585, DOI 10.1037/a0022648; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 2010, NEUROIMAGE, V49, P169, DOI 10.1016/j.neuroimage.2009.07.025; Rimajova M, 2008, J ALZHEIMERS DIS, V13, P137; Rosenbloom MH, 2011, NEUROLOGY, V76, P1789, DOI 10.1212/WNL.0b013e31821cccad; Sheese BE, 2007, DEV PSYCHOPATHOL, V19, P1039, DOI 10.1017/S0954579407000521; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Swanson J, 2000, P NATL ACAD SCI USA, V97, P4754, DOI 10.1073/pnas.080070897; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Volkow ND, 2011, MOL PSYCHIATR, V16, P818, DOI 10.1038/mp.2011.30; VOLKOW ND, 1986, J CEREBR BLOOD F MET, V6, P441, DOI 10.1038/jcbfm.1986.77; Volkow ND, 2000, AM J PSYCHIAT, V157, P75, DOI 10.1176/ajp.157.1.75; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; Wang HX, 2009, NEUROLOGY, V72, P253, DOI 10.1212/01.wnl.0000339485.39246.87; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zahr NM, 2008, CEREB CORTEX, V18, P2241, DOI 10.1093/cercor/bhm250	61	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63492	10.1371/journal.pone.0063492	http://dx.doi.org/10.1371/journal.pone.0063492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717434	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700027
J	Cifola, I; Pietrelli, A; Consolandi, C; Severgnini, M; Mangano, E; Russo, V; De Bellis, G; Battaglia, C				Cifola, Ingrid; Pietrelli, Alessandro; Consolandi, Clarissa; Severgnini, Marco; Mangano, Eleonora; Russo, Vincenzo; De Bellis, Gianluca; Battaglia, Cristina			Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR-1; KINASE PATHWAY; MUTATIONS; EXPRESSION; GALANIN; BRAF; METALLOPROTEINASE; IDENTIFICATION	Cutaneous malignant melanoma is the most fatal skin cancer and although improved comprehension of its pathogenic pathways allowed to realize some effective molecular targeted therapies, novel targets and drugs are still needed. Aiming to add genetic information potentially useful for novel targets discovery, we performed an extensive genomic characterization by whole-exome sequencing and SNP array profiling of six cutaneous melanoma cell lines derived from metastatic patients. We obtained a total of 3,325 novel coding single nucleotide variants, including 2,172 non-synonymous variants. We catalogued the coding mutations according to Sanger COSMIC database and to a manually curated list including genes involved in melanoma pathways identified by mining recent literature. Besides confirming the presence of known melanoma driver mutations (BRAF(V600E), NRAS(Q61R)), we identified novel mutated genes involved in signalling pathways crucial for melanoma pathogenesis and already addressed by current targeted therapies (such as MAPK and glutamate pathways). We also identified mutations in four genes (MUC19, PAICS, RBMXL1, KIF23) never reported in melanoma, which might deserve further investigations. All data are available to the entire research community in our Melanoma Exome Database (at https://155.253.6.64/MExDB/). In summary, these cell lines are valuable biological tools to improve the genetic comprehension of this complex cancer disease and to study functional relevance of individual mutational events, and these findings could provide insights potentially useful for identification of novel therapeutic targets for cutaneous malignant melanoma.	[Cifola, Ingrid; Pietrelli, Alessandro; Consolandi, Clarissa; Severgnini, Marco; Mangano, Eleonora; De Bellis, Gianluca; Battaglia, Cristina] CNR, Inst Biomed Technol, Milan, Italy; [Russo, Vincenzo] Ist Sci San Raffaele, Canc Gene Therapy Unit, I-20132 Milan, Italy; [Battaglia, Cristina] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Cifola, I (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ingrid.cifola@itb.cnr.it	Pietrelli, Alessandro/J-4389-2016; Mangano, Eleonora/P-7028-2018; Russo, Vincenzo/K-5650-2016; Battaglia, Cristina/E-5166-2017; Severgnini, Marco/F-5832-2013; De Bellis, Gianluca/H-9725-2013	Pietrelli, Alessandro/0000-0003-0241-8542; Mangano, Eleonora/0000-0002-4040-4654; Russo, Vincenzo/0000-0003-1592-5041; Battaglia, Cristina/0000-0003-3025-9657; Severgnini, Marco/0000-0001-8655-1206; De Bellis, Gianluca/0000-0002-1622-4477; CIFOLA, INGRID/0000-0003-2819-1171	Cariplo Foundation grant (Genomic, epigenetic and transcriptional analysis of cancer by next-generation sequencing) [2006.0771]; PhD School of Molecular Medicine of University of Milan	Cariplo Foundation grant (Genomic, epigenetic and transcriptional analysis of cancer by next-generation sequencing); PhD School of Molecular Medicine of University of Milan	This work was supported by Cariplo Foundation grant (Genomic, epigenetic and transcriptional analysis of cancer by next-generation sequencing, Rif. 2006.0771) and by PhD School of Molecular Medicine of University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bozic M, 2011, J AM SOC NEPHROL, V22, P1099, DOI 10.1681/ASN.2010070701; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Choi JS, 2009, INT J CANCER, V124, P1258, DOI 10.1002/ijc.24023; D'Abaco GM, 2006, NEUROSURGERY, V58, P179, DOI 10.1227/01.NEU.0000192363.84287.8B; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Dutton-Regester K, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00975.x; El Hour M, 2010, ONCOGENE, V29, P3025, DOI 10.1038/onc.2010.49; Flaherty K, 2012, ONCOGENE; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoeflich KP, 2006, INT J ONCOL, V29, P839; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jia M, 2010, PROTEOM CLIN APPL, V4, P816, DOI 10.1002/prca.201000006; Kanazawa T, 2007, ONCOGENE, V26, P5762, DOI 10.1038/sj.onc.1210384; Kim YS, 2011, BIOCHEM BIOPH RES CO, V404, P96, DOI 10.1016/j.bbrc.2010.11.071; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee HJ, 2011, CLIN CANCER RES, V17, P7080, DOI 10.1158/1078-0432.CCR-11-0098; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; Lo PHY, 2007, ONCOGENE, V26, P148, DOI 10.1038/sj.onc.1209767; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Marin YE, 2005, NEUROPHARMACOLOGY, V49, P70, DOI 10.1016/j.neuropharm.2005.05.018; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitsukawa K, 2008, CELL MOL LIFE SCI, V65, P1796, DOI 10.1007/s00018-008-8153-8; Moncada-Pazos A, 2009, J CELL SCI, V122, P2906, DOI 10.1242/jcs.050468; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Orgaz JL, 2012, PIGMENT CELL MELANOM; Park SY, 2011, VIRCHOWS ARCH, V458, P73, DOI 10.1007/s00428-010-1013-6; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Scrima M, 2012, AM J PATHOL, V180, P1202, DOI 10.1016/j.ajpath.2011.11.038; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stepulak A, 2005, P NATL ACAD SCI USA, V102, P15605, DOI 10.1073/pnas.0507679102; Takada H, 2005, ONCOGENE, V24, P8051, DOI 10.1038/sj.onc.1208952; Tamura H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-220; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Walia V, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00976.x; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wei XM, 2010, MOL CANCER RES, V8, P1513, DOI 10.1158/1541-7786.MCR-10-0262; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wittau N, 2000, ONCOGENE, V19, P4199, DOI 10.1038/sj.onc.1203777	60	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63597	10.1371/journal.pone.0063597	http://dx.doi.org/10.1371/journal.pone.0063597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704925	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200056
J	Cusumano, A; Peri, E; Amodeo, V; McNeil, JN; Colazza, S				Cusumano, Antonino; Peri, Ezio; Amodeo, Valentina; McNeil, Jeremy N.; Colazza, Stefano			Intraguild Interactions between Egg Parasitoids: Window of Opportunity and Fitness Costs for a Facultative Hyperparasitoid	PLOS ONE			English	Article							VIRIDULA L HETEROPTERA; NEZARA-VIRIDULA; TRISSOLCUS-BASALIS; INTRINSIC COMPETITION; INTERSPECIFIC INTERACTIONS; GUILD PREDATION; HYMENOPTERA; PENTATOMIDAE; MECHANISMS; SECONDARY	We investigated intraguild interactions between two egg parasitoids of Nezara viridula (L.) (Heteroptera: Pentatomidae), Ooencyrtus telenomicida (Vassiliev) (Hymenoptera: Encyrtidae) and Trissolcus basalis (Wollaston) (Hymenoptera: Platygastridae), as the former has the potential to be a facultative hyperparasitoid of the latter. We assessed the suitability of N. viridula eggs for the development of O. telenomicida as a function of egg age when they were unparasitized, or had been attacked by T. basalis at different times prior to exposure to O. telenomicida females. Ooencyrtus telenomicida can exploit healthy N. viridula host eggs up to 5 days of age, just prior to the emergence of N. viridula. This window of opportunity can be extended for an additional 6-7 days through interspecific competition or facultative hyperparasitism. While there are minor fitness costs for O. telenomicida as the result of interspecific larval competition, those costs are greater with facultative hyperparasitism. In choice assays O. telenomicida females discriminated between different quality N. viridula eggs, avoiding those where their progeny would have to develop as facultative hyperparasitoids of T. basalis. Results are discussed with respect to the possible effects that the costs of intraguild parasitism might have on biological control programmes.	[Cusumano, Antonino; Peri, Ezio; Amodeo, Valentina; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [McNeil, Jeremy N.] Univ Western Ontario, Dept Biol, London, ON, Canada	University of Palermo; Western University (University of Western Ontario)	Peri, E (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	ezio.peri@unipa.it	Cusumano, Antonino/L-7375-2015	Cusumano, Antonino/0000-0001-9663-9164; colazza, stefano/0000-0001-8023-7814; PERI, Ezio/0000-0002-1095-7258	Italian Ministry of Education, University and Research (MIUR)	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by the project of the Italian Ministry of Education, University and Research (MIUR) 2007. The authors now declare that no additional external funding was received for this study. "Enhancing foraging behavior of insect egg parasitoids: the role of the volatile organic compounds and the epicuticular layers of the plants.''	Amarasekare P, 2000, J ANIM ECOL, V69, P201, DOI 10.1046/j.1365-2656.2000.00378.x; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; BIN F, 1993, PHYSIOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-3032.1993.tb00443.x; Boivin G, 2006, PROG BIOL CONTROL, V3, P123; Borer ET, 2007, ECOLOGY, V88, P2681, DOI 10.1890/06-1707.1; Brodeur J, 2000, PARASITOID POPULATION BIOLOGY, P163; Burgio G, 2002, BIOL CONTROL, V24, P110, DOI 10.1016/S1049-9644(02)00023-3; BUSCHMAN LL, 1980, FLA ENTOMOL, V63, P154, DOI 10.2307/3494669; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Colazza S, 2009, NATURWISSENSCHAFTEN, V96, P975, DOI 10.1007/s00114-009-0548-3; Conti Eric, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/651015; Correa-Ferreira SB, 1986, AN SOC ENTOMOL BRAS, V5, P189; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; CRAIG TP, 1990, ECOLOGY, V71, P1471, DOI 10.2307/1938284; Cusumano A, 2012, BIOCONTROL, V57, P719, DOI 10.1007/s10526-012-9451-5; Cusumano A, 2012, ENTOMOL EXP APPL, V143, P155, DOI 10.1111/j.1570-7458.2012.01236.x; Cusumano A, 2011, BIOCONTROL, V56, P173, DOI 10.1007/s10526-010-9320-z; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; Denno RF, 2004, ECOL ENTOMOL, V29, P566, DOI 10.1111/j.0307-6946.2004.00628.x; Ehler LE, 2002, BIOCONTROL, V47, P309, DOI 10.1023/A:1014895028451; Finke DL, 2002, ECOLOGY, V83, P643, DOI 10.1890/0012-9658(2002)083[0643:IPDICS]2.0.CO;2; Gariepy TD, 2012, BIOL CONTROL, V60, P26, DOI 10.1016/j.biocontrol.2011.06.011; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Grandgirard J, 2002, ENTOMOL EXP APPL, V103, P239, DOI 10.1023/A:1021193329749; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Harvey JA, 2011, OIKOS, V120, P226, DOI 10.1111/j.1600-0706.2010.18744.x; Harvey JA, 2009, J ANIM ECOL, V78, P686, DOI 10.1111/j.1365-2656.2008.01516.x; Harvey JA, 2009, ENTOMOL EXP APPL, V130, P238, DOI 10.1111/j.1570-7458.2008.00816.x; HAWKINS CP, 1989, ANNU REV ENTOMOL, V34, P423, DOI 10.1146/annurev.en.34.010189.002231; Hayward A, 2005, BASIC APPL ECOL, V6, P435, DOI 10.1016/j.baae.2005.07.003; Hoffmann M. P., 1991, California Agriculture, V45, P20; Hokyo N., 1965, NANKI SEIBUTSU, V7, P1; KFIR R, 1981, Journal of the Entomological Society of Southern Africa, V44, P151; Lo Giudice D, 2011, J CHEM ECOL, V37, P622, DOI 10.1007/s10886-011-9957-9; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Nakashima Y, 2006, J CHEM ECOL, V32, P1989, DOI 10.1007/s10886-006-9123-y; Nicol CMY, 1999, ENTOMOL EXP APPL, V90, P83, DOI 10.1023/A:1003546731081; Perez-Lachaud G, 2004, BIOL CONTROL, V30, P149, DOI 10.1016/j.biocontrol.2004.03.003; Peri E, 2006, J EXP BIOL, V209, P3629, DOI 10.1242/jeb.02416; Peri E, 2011, BIOCONTROL, V56, P163, DOI 10.1007/s10526-010-9323-9; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Raak-van Den Berg CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040681; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; ROSENHEIM JA, 1993, OECOLOGIA, V96, P439, DOI 10.1007/BF00317517; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Shaw Mark R., 1994, P111; SHEPARD BM, 1994, J AGR ENTOMOL, V11, P375; StatSoft, 2001, STAT PER WIND US MAN; TAKASU K, 1993, ANN ENTOMOL SOC AM, V86, P117, DOI 10.1093/aesa/86.1.117; Ueno T, 1999, RES POPUL ECOL, V41, P47, DOI 10.1007/PL00011982; VANALPHEN JJM, 1983, NETH J ZOOL, V33, P497, DOI 10.1163/002829683X00228; VOLKOFF N, 1992, INT J INSECT MORPHOL, V21, P323, DOI 10.1016/0020-7322(92)90027-K; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; Wang XG, 2004, ENVIRON ENTOMOL, V33, P1313, DOI 10.1603/0046-225X-33.5.1313; Wang XG, 2004, BIOL CONTROL, V31, P227, DOI 10.1016/j.biocontrol.2004.04.019; ZWOLFER H, 1971, P405	57	19	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64768	10.1371/journal.pone.0064768	http://dx.doi.org/10.1371/journal.pone.0064768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705009	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200163
J	de la Morena-Barrio, ME; Buil, A; Anton, AI; Martinez-Martinez, I; Minano, A; Gutierrez-Gallego, R; Navarro-Fernandez, J; Aguila, S; Souto, JC; Vicente, V; Soria, JM; Corral, J				Eugenia de la Morena-Barrio, Maria; Buil, Alfonso; Isabel Anton, Ana; Martinez-Martinez, Irene; Minano, Antonia; Gutierrez-Gallego, Ricardo; Navarro-Fernandez, Jose; Aguila, Sonia; Carlos Souto, Juan; Vicente, Vicente; Manuel Soria, Jose; Corral, Javier			Identification of Antithrombin-Modulating Genes. Role of LARGE, a Gene Encoding a Bifunctional Glycosyltransferase, in the Secretion of Proteins?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLYCOSYLATION; THROMBOSIS; SUSCEPTIBILITY; DYSTROGLYCAN; DEFICIENCY; EXPRESSION; MUTATIONS; PATHWAY	The haemostatic relevance of antithrombin together with the low genetic variability of SERPINC1, and the high heritability of plasma levels encourage the search for modulating genes. We used a hypothesis-free approach to identify these genes, evaluating associations between plasma antithrombin and 307,984 polymorphisms in the GAIT study (352 individuals from 21 Spanish families). Despite no SNP reaching the genome wide significance threshold, we verified milder positive associations in 307 blood donors from a different cohort. This validation study suggested LARGE, a gene encoding a protein with xylosyltransferase and glucuronyltransferase activities that forms heparin-like linear polysaccharides, as a potential modulator of antithrombin based on the significant association of one SNPs, rs762057, with anti-FXa activity, particularly after adjustment for age, sex and SERPINC1 rs2227589 genotype, all factors influencing antithrombin levels (p = 0.02). Additional results sustained this association. LARGE silencing inHepG2 and HEK-EBNA cells did not affect SERPINC1 mRNA levels but significantly reduced the secretion of antithrombin with moderate intracellular retention. Milder effects were observed on alpha 1-antitrypsin, prothrombin and transferrin. Our study suggests LARGE as the first known modifier of plasma antithrombin, and proposes a new role for LARGE in modulating extracellular secretion of certain glycoproteins.	[Eugenia de la Morena-Barrio, Maria; Isabel Anton, Ana; Martinez-Martinez, Irene; Minano, Antonia; Navarro-Fernandez, Jose; Aguila, Sonia; Vicente, Vicente; Corral, Javier] Univ Murcia, Reg Campus Int Excellence Campus MareNostrum, HU Morales Meseguer, Serv Hematol & Oncol Med,Ctr Reg Hemodonac, Murcia, Spain; [Isabel Anton, Ana; Manuel Soria, Jose] Inst Invest St Pau IIB St, Unitat Genom Malalties Complexes, Barcelona, Spain; [Gutierrez-Gallego, Ricardo] PRBB, IMIM Parc Salut Mar, Neurosci Res Program, Bioanal Grp, Barcelona, Spain; [Gutierrez-Gallego, Ricardo] Pompeu Fabra Univ, PRBB, Dept Expt & Hlth Sci, Barcelona, Spain; [Carlos Souto, Juan] Inst Invest St Pau IIB St, Unitat Hemostasia & Trombosis, Barcelona, Spain	University of Murcia; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Pompeu Fabra University	Corral, J (corresponding author), Univ Murcia, Reg Campus Int Excellence Campus MareNostrum, HU Morales Meseguer, Serv Hematol & Oncol Med,Ctr Reg Hemodonac, Murcia, Spain.	javier.corral@carm.es	de la Morena-Barrio, ME/AAG-5103-2021; Vicente, Vicente/L-6185-2019; Martínez-Martínez, Irene/AAM-8862-2020; Aguila, Sonia/Q-2822-2019; Soria Fernández, José Manuel/AAD-6761-2019; Anton, Ana I. I/M-2962-2018	de la Morena-Barrio, ME/0000-0001-7426-4947; Vicente, Vicente/0000-0002-4278-3264; Martínez-Martínez, Irene/0000-0002-1067-6464; Aguila, Sonia/0000-0001-5794-5177; Soria Fernández, José Manuel/0000-0002-6226-4293; Anton, Ana I. I/0000-0003-1527-6096; Corral, Javier/0000-0003-0288-1107; Gutierrez Gallego, Ricardo/0000-0001-9639-2181; Buil, Alfonso/0000-0002-3097-1014	Fundacion Seneca de la Region de Murcia [04515/GERM/06]; Spanish Ministerio de Ciencia y Tecnologia [SAF2009-08993]; Fondo Europeo de Desarrollo Regional de la Union Europea FEDER [SAF2008/01859, RECAVA RD06/0014/0039, RD06/0014/0016]; Spanish Instituto de Salud Carlos III [PI-08/0756, PI-11/0184, FI09/00190]; Centre National du Genotypage (Evry, France); "Programa d' Estabilitzacio d'Investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut" (Generalitat de Catalunya)	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo Europeo de Desarrollo Regional de la Union Europea FEDER; Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Centre National du Genotypage (Evry, France); "Programa d' Estabilitzacio d'Investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut" (Generalitat de Catalunya)(Generalitat de Catalunya)	This study was supported partially by 04515/GERM/06 (Fundacion Seneca de la Region de Murcia), SAF2009-08993 and SAF2008/01859 (Spanish Ministerio de Ciencia y Tecnologia & Fondo Europeo de Desarrollo Regional de la Union Europea FEDER), PI-08/0756, PI-11/0184 and RECAVA RD06/0014/0039 & RD06/0014/0016 (Spanish Instituto de Salud Carlos III & Fondo Europeo de Desarrollo Regional de la Union Europea FEDER), and Centre National du Genotypage (Evry, France). MEMB is a holder of a predoctoral research grant from Spanish Instituto de Salud Carlos III (FI09/00190). IMM is a researcher from Fundacion para la Formacion e Investigacion Sanitarias. JNF is a postdoctoral researcher of the University of Murcia. JM Soria was supported by "Programa d' Estabilitzacio d'Investigadors de la Direccio d'Estrategia i Coordinacio del Departament de Salut" (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Anton AI, 2009, HAEMATOL-HEMATOL J, V94, P589, DOI 10.3324/haematol.2008.000604; Baker M, 2008, NATURE, V451, P516, DOI 10.1038/451516a; Bayston TA, 1997, THROMB HAEMOSTASIS, V78, P339; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BROZE GJ, 1993, BLOOD, V82, P1679; Buil A, 2010, BLOOD, V115, P4644, DOI 10.1182/blood-2010-01-263038; CONLON MG, 1994, THROMB HAEMOSTASIS, V72, P551; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; de la Morena-Barrio ME, 2012, THROMB HAEMOSTASIS, V107, P430, DOI 10.1160/TH11-10-0701; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Guerrero JA, 2011, HAEMATOL-HEMATOL J, V96, P1335, DOI 10.3324/haematol.2011.042077; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; Hu YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016866; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Llop E, 2007, PROTEOMICS, V7, P4278, DOI 10.1002/pmic.200700572; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; Martinez-Martinez I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/haematol.2009.015487; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Morange PE, 2011, J THROMB HAEMOST, V9, P258, DOI 10.1111/j.1538-7836.2011.04311.x; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; Oudot-Mellakh T, 2012, BRIT J HAEMATOL, V157, P230, DOI 10.1111/j.1365-2141.2011.09025.x; SMITH JW, 1987, J BIOL CHEM, V262, P11964; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; TAIT RC, 1993, BRIT J HAEMATOL, V84, P476, DOI 10.1111/j.1365-2141.1993.tb03104.x; Westrick RJ, 2009, J THROMB HAEMOST, V7, P132, DOI 10.1111/j.1538-7836.2009.03362.x; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131	33	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64998	10.1371/journal.pone.0064998	http://dx.doi.org/10.1371/journal.pone.0064998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705025	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200179
J	Jain, V; Baitharu, I; Prasad, D; Ilavazhagan, G				Jain, Vishal; Baitharu, Iswar; Prasad, Dipti; Ilavazhagan, Govindasamy			Enriched Environment Prevents Hypobaric Hypoxia Induced Memory Impairment and Neurodegeneration: Role of BDNF/PI3K/GSK3 beta Pathway Coupled with CREB Activation	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; NEUROTROPHIC FACTOR; HIGH-ALTITUDE; PHOSPHATIDYLINOSITOL 3-KINASE; COMPLEX ENVIRONMENT; SYNAPTIC PLASTICITY; NEURONAL APOPTOSIS; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; ISCHEMIC-INJURY	Adverse environmental conditions such as hypobaric hypoxia (HH) cause memory impairment by affecting cellular machinery leading to neurodegeneration. Providing enriched environment (EE) is found to be beneficial for curing several neurodegenerative disorders. The protective role of EE in preventing HH induced neuronal death has been reported previously but the involved mechanism is still not clearly understood. The present study is an attempt to verify the impact of EE on spatial memory during HH and also to explore the possible role of neurotrophin in EE mediated neuroprotection. Signaling mechanism involved in neuroprotection was also explored. Male Sprague Dawley rats were simulated to HH condition in an Animal Decompression Chamber at an altitude of 25000 feet in standard and enriched cages for 7 days. Spatial memory was assessed through Morris Water Maze. Role of different neurotrophins was explored by gene silencing and inhibitors for their respective receptors. Further, using different blockers signaling pathway was also explored. Finding of the present study suggested that EE prevents HH mediated memory impairment and neurodegeneration. Also brain-derived neurotrophic factor (BDNF) plays a major role in EE mediated neuroprotection and it effectively prevented neurodegeneration by activating PI3K/AKT pathway resulting in GSK3 beta inactivation which further inhibits apoptosis. Moreover GSK3 beta phosphorylation and hence its inactivation upregulates CREB phosphorylation which may also accounts for activation of survival machinery in cells and provides neuroprotection. From these observations it can be postulated that EE has a therapeutic potential in amelioration of HH induced memory impairment and neurodegeneration. Hence it may be used as a non invasive and non pharmacological intervention against various neurological disorders.	[Jain, Vishal; Baitharu, Iswar; Prasad, Dipti] Def Inst Physiol & Allied Sci, Dept Neurobiol, Delhi, India; [Ilavazhagan, Govindasamy] Hindustan Univ, Dept Res, Madras, Tamil Nadu, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Hindustan Institute of Technology & Science	Ilavazhagan, G (corresponding author), Hindustan Univ, Dept Res, Madras, Tamil Nadu, India.	ilavazhagang@hotmail.com	Baitharu, Iswar/AAM-3530-2021	Baitharu, Iswar/0000-0002-3046-2076	Defence Research and Development Organization (DRDO), Ministry of Defence India	Defence Research and Development Organization (DRDO), Ministry of Defence India	Financial support was received from the Defence Research and Development Organization (DRDO), Ministry of Defence India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KH, 2002, DEV NEUROSCI-BASEL, V24, P382, DOI 10.1159/000069043; Aggleton JP, 2005, Q J EXP PSYCHOL-B, V58, P218, DOI 10.1080/02724990444000131; Almli LM, 2001, DEV BRAIN RES, V132, P121, DOI 10.1016/S0165-3806(01)00302-9; Banderet LF, 1998, INT J AVIAT PSYCHOL, V8, P319; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CONNOR JR, 1982, EXP NEUROL, V78, P466, DOI 10.1016/0014-4886(82)90064-4; Countryman RA, 2005, NEUROBIOL LEARN MEM, V84, P175, DOI 10.1016/j.nlm.2005.07.005; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hetman M, 2000, J NEUROSCI, V20, P2567; Hota SK, 2008, EXP NEUROL, V212, P5, DOI 10.1016/j.expneurol.2008.01.030; Hota SK, 2008, J NEUROSCI RES, V86, P1142, DOI 10.1002/jnr.21554; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Jain V, 2012, CELL MOL NEUROBIOL, V32, P599, DOI 10.1007/s10571-012-9807-5; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; Lee EHY, 2003, EUR J NEUROSCI, V18, P2842, DOI 10.1111/j.1460-9568.2003.03032.x; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Maiti P, 2007, BRAIN RES, V1175, P1, DOI 10.1016/j.brainres.2007.06.106; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Muthuraju S, 2009, BEHAV BRAIN RES, V203, P1, DOI 10.1016/j.bbr.2009.03.026; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nitta A, 1999, J NEUROSCI RES, V57, P227, DOI 10.1002/(SICI)1097-4547(19990715)57:2<227::AID-JNR8>3.3.CO;2-5; Ortega F, 2010, CELL MOL LIFE SCI, V67, P1723, DOI 10.1007/s00018-010-0278-x; Park SY, 2002, MOL BRAIN RES, V107, P9, DOI 10.1016/S0169-328X(02)00421-7; Pereira LO, 2009, BRAIN RES, V1247, P188, DOI 10.1016/j.brainres.2008.10.017; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sifonios L, 2009, NEUROSCIENCE, V164, P929, DOI 10.1016/j.neuroscience.2009.08.059; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tauber SC, 2009, J NEUROSCI RES, V87, P1877, DOI 10.1002/jnr.22010; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Waters NS, 1997, J NEUROSCI, V17, P7967; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	47	67	70	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62235	10.1371/journal.pone.0062235	http://dx.doi.org/10.1371/journal.pone.0062235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704876	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200005
J	Mosconi, MW; Luna, B; Kay-Stacey, M; Nowinski, CV; Rubin, LH; Scudder, C; Minshew, N; Sweeney, JA				Mosconi, Matthew W.; Luna, Beatriz; Kay-Stacey, Margaret; Nowinski, Caralynn V.; Rubin, Leah H.; Scudder, Charles; Minshew, Nancy; Sweeney, John A.			Saccade Adaptation Abnormalities Implicate Dysfunction of Cerebellar-Dependent Learning Mechanisms in Autism Spectrum Disorders (ASD)	PLOS ONE			English	Article							PURKINJE-CELLS; SUPERIOR COLLICULUS; OCULOMOTOR VERMIS; INFANTILE-AUTISM; EYE-MOVEMENTS; COMMUNICATION DEFICITS; ADAPTIVE MODIFICATION; POSTERIOR-FOSSA; MOTOR; CHILDREN	The cerebellar vermis (lobules VI-VII) has been implicated in both postmortem and neuroimaging studies of autism spectrum disorders (ASD). This region maintains the consistent accuracy of saccadic eye movements and plays an especially important role in correcting systematic errors in saccade amplitudes such as those induced by adaptation paradigms. Saccade adaptation paradigms have not yet been used to study ASD. Fifty-six individuals with ASD and 53 age-matched healthy controls performed an intrasaccadic target displacement task known to elicit saccadic adaptation reflected in an amplitude reduction. The rate of amplitude reduction and the variability of saccade amplitude across 180 adaptation trials were examined. Individuals with ASD adapted slower than healthy controls, and demonstrated more variability of their saccade amplitudes across trials prior to, during and after adaptation. Thirty percent of individuals with ASD did not significantly adapt, whereas only 6% of healthy controls failed to adapt. Adaptation rate and amplitude variability impairments were related to performance on a traditional neuropsychological test of manual motor control. The profile of impaired adaptation and reduced consistency of saccade accuracy indicates reduced neural plasticity within learning circuits of the oculomotor vermis that impedes the fine-tuning of motor behavior in ASD. These data provide functional evidence of abnormality in the cerebellar vermis that converges with previous reports of cellular and gross anatomic dysmorphology of this brain region in ASD.	[Mosconi, Matthew W.; Sweeney, John A.] Univ Texas Southwestern, Dept Psychiat, Dallas, TX USA; [Mosconi, Matthew W.; Sweeney, John A.] Univ Texas Southwestern, Dept Pediat, Dallas, TX USA; [Luna, Beatriz] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Luna, Beatriz] Univ Pittsburgh, Sch Med, Dept Psychol, Pittsburgh, PA USA; [Kay-Stacey, Margaret] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Nowinski, Caralynn V.] Univ Illinois, Off Vice President Res, Urbana, IL 61801 USA; [Rubin, Leah H.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Scudder, Charles] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Scudder, Charles] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Minshew, Nancy] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Minshew, Nancy] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mosconi, MW (corresponding author), Univ Texas Southwestern, Dept Psychiat, Dallas, TX USA.	Matt.Mosconi@UTSouthwestern.edu	Mosconi, Matt/L-1885-2018	Mosconi, Matt/0000-0002-1981-6777; Sweeney, John/0000-0003-1752-2828	NIMH [MH092696]; NICHD Collaborative Program of Excellence in Autism [HD35469]; Autism Center of Excellence [HD055751, HD055748]; Autism Speaks and the National Alliance for Autism Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751, P50HD055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092696] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD Collaborative Program of Excellence in Autism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Autism Center of Excellence; Autism Speaks and the National Alliance for Autism Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIMH MH092696, the NICHD Collaborative Program of Excellence in Autism HD35469, Autism Center of Excellence awards HD055751 and HD055748, Autism Speaks and the National Alliance for Autism Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Akshoomoff N, 2004, J AM ACAD CHILD PSY, V43, P349, DOI 10.1097/00004583-200403000-00018; Alahyane N, 2005, ANN NY ACAD SCI, V1039, P558, DOI 10.1196/annals.1325.067; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Allen G, 2003, AM J PSYCHIAT, V160, P262, DOI 10.1176/appi.ajp.160.2.262; Amaral GD, 2011, AUTISM SPECTRUM DISO; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ARIN D M, 1991, Neurology, V41, P307; Asperger H., 1991, AUTISM ASPERGER SYND, P37, DOI [10.1017/CBO9780511526770.002, DOI 10.1017/CBO9780511526770.002]; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bhat AN, 2012, INFANT BEHAV DEV, V35, P838, DOI 10.1016/j.infbeh.2012.07.019; Bhat AN, 2011, PHYS THER, V91, P1116, DOI 10.2522/ptj.20100294; Bryson SE, 2007, J AUTISM DEV DISORD, V37, P12, DOI 10.1007/s10803-006-0328-2; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Desmurget M, 2000, EXP BRAIN RES, V132, P243, DOI 10.1007/s002210000342; Desmurget M, 1998, NAT NEUROSCI, V1, P524, DOI 10.1038/2241; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; Developmental Disabilities Monitoring Network, 2012, MMWR SURVEILL SUMM, V61, P1; Dewey D, 2007, J INT NEUROPSYCH SOC, V13, P246, DOI 10.1017/S1355617707070270; Diedrichsen J, 2005, J NEUROPHYSIOL, V93, P801, DOI 10.1152/jn.00662.2004; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; Gaymard B, 2001, EUR J NEUROSCI, V14, P554, DOI 10.1046/j.0953-816x.2001.01669.x; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; Greco CM, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-2; Green D, 2002, J CHILD PSYCHOL PSYC, V43, P655, DOI 10.1111/1469-7610.00054; Haas RH, 1996, J CHILD NEUROL, V11, P84, DOI 10.1177/088307389601100204; Hardan AY, 2001, J AM ACAD CHILD PSY, V40, P666, DOI 10.1097/00004583-200106000-00011; Havermann K, 2010, J NEUROPHYSIOL, V103, P3302, DOI 10.1152/jn.00970.2009; HOLTTUM JR, 1992, BIOL PSYCHIAT, V32, P1091, DOI 10.1016/0006-3223(92)90189-7; Ignashchenkova A, 2009, J NEUROPHYSIOL, V102, P3156, DOI 10.1152/jn.00659.2009; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; ITO M, 1989, NEUROSCI RES, V7, P168, DOI 10.1016/0168-0102(89)90058-8; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Izawa J, 2012, AUTISM RES, V5, P124, DOI 10.1002/aur.1222; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Kanner L, 1943, NERV CHILD, V2, P217; Kaufmann WE, 2003, J CHILD NEUROL, V18, P463, DOI 10.1177/08830738030180070501; Kojima Y, 2011, BRAIN RES, V1401, P30, DOI 10.1016/j.brainres.2011.05.027; Larson JCG, 2008, BRAIN, V131, P2894, DOI 10.1093/brain/awn226; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luna B, 2007, BIOL PSYCHIAT, V61, P474, DOI 10.1016/j.biopsych.2006.02.030; MacAskill MR, 2002, BRAIN, V125, P1570, DOI 10.1093/brain/awf168; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; Minshew NJ, 1999, NEUROLOGY, V52, P917, DOI 10.1212/WNL.52.5.917; Mitchell SR, 2009, AM J PSYCHIAT, V166, P917, DOI 10.1176/appi.ajp.2009.08101538; Mosconi MW, 2010, ARCH GEN PSYCHIAT, V67, P830, DOI 10.1001/archgenpsychiatry.2010.87; Mostofsky SH, 2004, NEUROCASE, V10, P60, DOI 10.1080/13554790490960503; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Muller RA, 2003, AM J PSYCHIAT, V160, P1847, DOI 10.1176/appi.ajp.160.10.1847; Nowinski CV, 2005, PSYCHIAT RES, V137, P11, DOI 10.1016/j.psychres.2005.07.005; OHTSUKA K, 1995, J NEUROPHYSIOL, V74, P1828, DOI 10.1152/jn.1995.74.5.1828; Ozonoff S, 2008, J AUTISM DEV DISORD, V38, P644, DOI 10.1007/s10803-007-0430-0; Piven J, 1997, NEUROLOGY, V49, P546, DOI 10.1212/WNL.49.2.546; Provost Beth, 2007, Phys Occup Ther Pediatr, V27, P21, DOI 10.1300/J006v27n03_03; Quessy S, 2010, J NEUROSCI, V30, P14235, DOI 10.1523/JNEUROSCI.3111-10.2010; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; ROSENHALL U, 1988, J LARYNGOL OTOL, V102, P435, DOI 10.1017/S0022215100105286; Salman MS, 2006, J CHILD NEUROL, V21, P1025, DOI 10.1177/7010.2006.00238; Scott JA, 2009, AUTISM RES, V2, P246, DOI 10.1002/aur.97; Scudder CA, 2003, J NEUROPHYSIOL, V90, P1011, DOI 10.1152/jn.00193.2002; Scudder CA, 1998, J NEUROPHYSIOL, V79, P704, DOI 10.1152/jn.1998.79.2.704; Soetedjo R, 2009, J NEUROSCI, V29, P15213, DOI 10.1523/JNEUROSCI.4296-09.2009; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Straube A, 2001, NEUROLOGY, V57, P2105, DOI 10.1212/WNL.57.11.2105; Sutera S, 2007, J AUTISM DEV DISORD, V37, P98, DOI 10.1007/s10803-006-0340-6; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; Takarae Y, 2004, J NEUROL NEUROSUR PS, V75, P1359, DOI 10.1136/jnnp.2003.022491; Takarae Y, 2007, PSYCHIAT RES-NEUROIM, V156, P117, DOI 10.1016/j.pscychresns.2007.03.008; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Webb SJ, 2009, PSYCHIAT RES-NEUROIM, V172, P61, DOI 10.1016/j.pscychresns.2008.06.001; Wechsler D., 1999, WECHSLER ABBREVIATED; Whitney ER, 2008, CEREBELLUM, V7, P406, DOI 10.1007/s12311-008-0043-y; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yip J, 2008, J NEUROSCI RES, V86, P525, DOI 10.1002/jnr.21520; Yip J, 2007, ACTA NEUROPATHOL, V113, P559, DOI 10.1007/s00401-006-0176-3	91	54	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63709	10.1371/journal.pone.0063709	http://dx.doi.org/10.1371/journal.pone.0063709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704934	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200065
J	Tanikawa, C; Matsuo, K; Kubo, M; Takahashi, A; Ito, H; Tanaka, H; Yatabe, Y; Yamao, K; Kamatani, N; Tajima, K; Nakamura, Y; Matsuda, K				Tanikawa, Chizu; Matsuo, Keitaro; Kubo, Michiaki; Takahashi, Atsushi; Ito, Hidemi; Tanaka, Hideo; Yatabe, Yasushi; Yamao, Kenji; Kamatani, Naoyuki; Tajima, Kazuo; Nakamura, Yusuke; Matsuda, Koichi			Impact of PSCA Variation on Gastric Ulcer Susceptibility	PLOS ONE			English	Article							STEM-CELL ANTIGEN; HELICOBACTER-PYLORI INFECTION; GENOME-WIDE ASSOCIATION; DUODENAL-ULCER; PEPTIC-ULCER; GENETIC POLYMORPHISMS; BLADDER-CANCER; ERADICATION; POPULATION; EXPRESSION	Peptic ulcer is one of the most common gastrointestinal disorders with complex etiology. Recently we conducted the genome wide association study for duodenal ulcer and identified disease susceptibility variations at two genetic loci corresponding to the Prostate stem cell antigen (PSCA) gene and the ABO blood group (ABO) gene. Here we investigated the association of these variations with gastric ulcer in two Japanese case-control sample sets, a total of 4,291 gastric ulcer cases and 22,665 controls. As a result, a C-allele of rs2294008 at PSCA increased the risk of gastric ulcer with odds ratio (OR) of 1.13 (P value of 5.85x10(-7)) in an additive model. On the other hand, SNP rs505922 on ABO exhibited inconsistent result between two cohorts. Our finding implies presence of the common genetic variant in the pathogenesis of gastric and duodenal ulcers.	[Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Matsuo, Keitaro; Ito, Hidemi; Tanaka, Hideo; Tajima, Kazuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Aichi, Japan; [Yatabe, Yasushi] Aichi Canc Ctr, Res Inst, Dept Pathol & Mol Diagnost, Aichi, Japan; [Yamao, Kenji] Aichi Canc Ctr, Res Inst, Dept Gastroenterol, Aichi, Japan; [Kamatani, Naoyuki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	University of Tokyo; Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center; RIKEN; University of Chicago; University of Chicago; University of Chicago	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Matsuo, Keitaro/H-6758-2019; Kubo, Michiaki/N-7947-2015; Tanaka, Hideo/A-8145-2016; YATABE, Yasushi/J-6461-2014; Matsuda, Koichi/D-4597-2011	Matsuo, Keitaro/0000-0003-1761-6314; YATABE, Yasushi/0000-0003-1788-559X; Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of Japan [Priority Areas of Cancer] [17015018]; Ministry of Education, Culture, Sports, Science and Technology of Japan [Innovative Areas] [221S0001]; Ministry of Health, Welfare and Labours of Japan [H24-3-G002, H23-Application(cancer)-G002]	Ministry of Education, Culture, Sports, Science and Technology of Japan [Priority Areas of Cancer]; Ministry of Education, Culture, Sports, Science and Technology of Japan [Innovative Areas]; Ministry of Health, Welfare and Labours of Japan	The Aichi part of the study was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan [Priority Areas of Cancer (No. 17015018) and Innovative Areas (No. 221S0001)] and from Ministry of Health, Welfare and Labours of Japan [H24-3-G002 and H23-Application(cancer)-G002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; ARAKI S, 1985, J EPIDEMIOL COMMUN H, V39, P82, DOI 10.1136/jech.39.1.82; Argent RH, 2007, CLIN INFECT DIS, V45, P1204, DOI 10.1086/522177; Arisawa T, 2007, INT J MOL MED, V20, P373; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; Brenner H, 2000, GASTROENTEROLOGY, V118, P31, DOI 10.1016/S0016-5085(00)70411-2; Brenner H, 1998, BRIT MED J, V316, P665, DOI 10.1136/bmj.316.7132.665; Breslow N E, 1987, IARC Sci Publ, P1; Chen TS, 2005, J CLIN GASTROENTEROL, V39, P699, DOI 10.1097/01.mcg.0000173854.55172.ee; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Furuta T, 2001, CLIN PHARMACOL THER, V69, P158, DOI 10.1067/mcp.2001.113959; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CANCER RES, V65, P9495, DOI 10.1158/0008-5472.CAN-05-2086; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Hopkins RJ, 1996, GASTROENTEROLOGY, V110, P1244, DOI 10.1053/gast.1996.v110.pm8613015; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kawaguchi T, 2010, JPN J CLIN ONCOL, V40, P319, DOI 10.1093/jjco/hyp181; Kohaar I, 2013, J NATL CANCER I, V105, P69, DOI 10.1093/jnci/djs458; Lanas A, 2001, GENES IMMUN, V2, P415, DOI 10.1038/sj.gene.6363798; Leung WK, 2006, SCAND J GASTROENTERO, V41, P274, DOI 10.1080/00365520510024269; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Marra E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-129; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; MARSHALL BJ, 1988, LANCET, V2, P1437; Michel M, 2004, BLOOD, V103, P890, DOI 10.1182/blood-2003-03-0900; Montalban C, 2001, GUT, V49, P584, DOI 10.1136/gut.49.4.584; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohara T, 2003, HEPATO-GASTROENTEROL, V50, P1774; Ono H, 2012, GENE CHROMOSOME CANC, V51, P30, DOI 10.1002/gcc.20928; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raff AB, 2009, CANCER LETT, V277, P126, DOI 10.1016/j.canlet.2008.08.034; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rokkas T, 2007, HELICOBACTER, V12, P32, DOI 10.1111/j.1523-5378.2007.00563.x; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; SCHLEMPER RJ, 1993, SCAND J GASTROENTERO, V28, P33, DOI 10.3109/00365529309101573; Schlesinger P K, 1992, J Assoc Acad Minor Phys, V3, P70; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	42	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63698	10.1371/journal.pone.0063698	http://dx.doi.org/10.1371/journal.pone.0063698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704932	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200063
J	Yang, JG; Lu, CL; Yan, L; Tang, XR; Li, W; Yang, YJ; Hu, DY				Yang, Jingang; Lu, Changlin; Yan, Li; Tang, Xinran; Li, Wei; Yang, Yuejin; Hu, Dayi			The Association between Atherosclerotic Renal Artery Stenosis and Acute Kidney Injury in Patients Undergoing Cardiac Surgery	PLOS ONE			English	Article							OFF-PUMP; ASCENDING AORTA; BYPASS SURGERY; CARDIOPULMONARY BYPASS; RISK-FACTORS; FAILURE; DISEASE; REVASCULARIZATION; DYSFUNCTION; SCORE	Background: Atherosclerotic renal artery stenosis (ARAS) and coronary artery disease (CAD) commonly co-exist. Some patients with unidentified ARAS may undergo cardiac surgery. While acute kidney injury (AKI) is a frequent and serious complication of cardiac surgery, we aim to evaluate the influence of ARAS on the occurrence of postoperative AKI in patients with normal or near-normal baseline renal function following cardiac surgery. Methods: A total of 212 consecutive patients undergoing aortography after coronary angiography and cardiac surgery were retrospectively studied for their preoperative and intraoperative conditions. AKI was defined as an absolute increase in serum creatinine of more than or equal to 0.3 mg/dl (>= 26.4 mu mol/l) or a percentage increase in creatinine of more than or equal to 50% (1.5-fold from baseline) after cardiac surgery. A propensity score-adjusted logistic regression models was used in estimating the effect of ARAS on the risk of postoperative AKI. Results: ARAS (>= 50%) was observed in 50 (23.6%) patients, and 83 (39.2%) developed AKI after cardiac surgery. A correlation existed between renal artery patency and preoperative-to-postoperative %Delta Cr in patients with ARAS (r = 0.297, P<0.0001). The propensity score-adjusted regression model showed the occurrence of postoperative AKI in patients with ARAS was significantly higher than those without ARAS (OR 2.858, 95% CI 1.260-6.480, P = 0.011). Conclusion: ARAS is associated with postoperative AKI in patients with normal or near-normal baseline renal function after cardiac surgery.	[Yang, Jingang; Tang, Xinran; Li, Wei; Yang, Yuejin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yang, Jingang; Tang, Xinran; Li, Wei; Yang, Yuejin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lu, Changlin] Capital Med Univ, Beijing Tongren Hosp, Ctr Cardiovasc, Beijing, Peoples R China; [Yan, Li] Hebei Gen Hosp, Dept Cardiol, Shijiazhuang, Hebei Province, Peoples R China; [Hu, Dayi] Peking Univ, Peoples Hosp, Ctr Heart, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Peking University	Yang, JG (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	jingangyang@126.com			Beijing Nova Program [2006B52]	Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by Beijing Nova Program (2006B52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Ahmadi H, 2009, MED PRIN PRACT, V18, P300, DOI 10.1159/000215728; Ascione R, 2001, ANN THORAC SURG, V72, P2020, DOI 10.1016/S0003-4975(01)03250-7; Banbury MK, 2003, ANN THORAC SURG, V76, P508, DOI 10.1016/S0003-4975(03)00530-7; Barbash IM, 2012, AM HEART J, V163, P1031, DOI 10.1016/j.ahj.2012.01.009; BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104; Bloor GK, 1996, J CARDIOTHOR VASC AN, V10, P899, DOI 10.1016/S1053-0770(96)80053-X; BORIONI R, 1994, ANN THORAC SURG, V58, P1788, DOI 10.1016/0003-4975(94)91701-9; BRANDRUPWOGNSEN G, 1995, THORAC CARDIOV SURG, V43, P77, DOI 10.1055/s-2007-1013775; Brown JR, 2007, CIRCULATION, V116, pI139, DOI 10.1161/CIRCULATIONAHA.106.677070; Chertow GM, 1997, CIRCULATION, V95, P878; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Conlon PJ, 2005, RENAL FAILURE, V27, P81, DOI 10.1081/JDI-200042779; Davila-Roman VG, 1999, J THORAC CARDIOV SUR, V117, P111, DOI 10.1016/S0022-5223(99)70475-7; DONOFRIO A, 2011, CONGESTIVE HEART S1, V16, pS32; Elmistekawy E, 2012, J THORAC CARDIOV SUR, V143, P85, DOI 10.1016/j.jtcvs.2011.09.035; Erentug V, 2005, J CARDIAC SURG, V20, P345, DOI 10.1111/j.1540-8191.2005.200444.x; Halkos ME, 2009, ANN THORAC SURG, V88, P746, DOI 10.1016/j.athoracsur.2009.05.078; HARDING MB, 1992, J AM SOC NEPHROL, V2, P1608; HOSODA Y, 1991, J CARDIOVASC SURG, V32, P301; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Kim KB, 2002, ANN THORAC SURG, V74, pS1377; Koivuviita N, 2012, NEPHROL DIAL TRANSPL, V27, P3843, DOI 10.1093/ndt/gfs301; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Martin-Ucar AE, 2002, J ENDOVASC THER, V9, P218, DOI 10.1583/1545-1550(2002)009<0218:PSPFRA>2.0.CO;2; Massoudy P, 2008, NEPHROL DIAL TRANSPL, V23, P2853, DOI 10.1093/ndt/gfn153; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murphy TP, 2002, J VASC INTERV RADIOL, V13, P1187, DOI 10.1016/S1051-0443(07)61964-2; Rahmanian PB, 2011, EUR J CARDIO-THORAC, V40, P701, DOI 10.1016/j.ejcts.2010.12.051; Rodrigues AJ, 2009, REV BRAS CIR CARDIOV, V24, P441, DOI 10.1590/S0102-76382009000500003; Rokkas C K, 1998, Semin Thorac Cardiovasc Surg, V10, P240; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Seabra VF, 2010, CLIN J AM SOC NEPHRO, V5, P1734, DOI 10.2215/CJN.02800310; Shaw A, 2008, NEPHRON PHYSIOL, V109, pP55, DOI 10.1159/000142937; Shumway SJ, 2003, ANN THORAC SURG, V76, P515; Shurrab AE, 2001, BRIT J RADIOL, V74, P213, DOI 10.1259/bjr.74.879.740213; SIGMON DH, 1993, HYPERTENSION, V22, P237, DOI 10.1161/01.HYP.22.2.237; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; van Straten AHM, 2010, EUR J CARDIO-THORAC, V37, P106, DOI 10.1016/j.ejcts.2009.06.048; WAREING TH, 1992, J THORAC CARDIOV SUR, V103, P453; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Yang JG, 2004, HYPERTENS RES, V27, P339, DOI 10.1291/hypres.27.339; Yang JG, 2010, J ATHEROSCLER THROMB, V17, P395, DOI 10.5551/jat.3061; Yang Jingang, 2002, Zhonghua Nei Ke Za Zhi, V41, P24; Zheng B, 2011, CHINESE MED J-PEKING, V124, P1453, DOI 10.3760/cma.j.issn.0366-6999.2011.10.003	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64104	10.1371/journal.pone.0064104	http://dx.doi.org/10.1371/journal.pone.0064104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700459	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200116
J	Yu, ZH; Gao, WM; Jiang, EZ; Lu, F; Zhang, L; Shi, ZR; Wang, XX; Chen, LB; Lv, TF				Yu, Zhenghong; Gao, Weimin; Jiang, Enze; Lu, Fang; Zhang, Luo; Shi, Zhaorong; Wang, Xinxing; Chen, Longbang; Lv, Tangfeng			Interaction between IGF-IR and ER Induced by E2 and IGF-I	PLOS ONE			English	Article							GROWTH-FACTOR-I; ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; PROLIFERATION; PHOSPHORYLATION; MODULATION; ACTIVATION; ESTRADIOL; APOPTOSIS; CELLS	Estrogen receptor (ER) is a nuclear receptor and the insulin-like growth factor-I (IGF-I) receptor (IGF-IR) is a transmembrane tyrosine kinase receptor. Estrogen and IGF-I are known to have synergistic effects on the growth of breast cancer cells. Recently, non-nuclear effects of ER have been under investigation. To study the mechanism involved in this process, we have used MCF-7 breast cancer cell lines transfected with IGF-IR anti-sense cDNA (SX13, MCF-7(SX13)) that resulted in 50% reduction of IGF-IR. In MCF-7 cells, estradiol (E2) and IGF-I induced the rapid association of ER to IGF-IR, however, the interaction was abrogated in MCF-7(SX13) cells. In addition, NWTB3 cells (NIH3T3 cells overexpressing IGF-IR) were transiently transfected with ER alpha, the ER-IGF-IR interaction was induced by both E2 and IGF-I. Moreover, ER alpha regulated the IGF-I signaling pathways through phosphorylation of ERK1/2 and Akt and the interaction of ER-IGF-IR potentiated the cell growth. Finally, E2 and IGF-I stimulated translocation of ER from the nucleus to the cytoplasm. Taken together, these findings reveal that the interaction of the ER and IGF-IR is important for the non-genomic effects of ER.	[Yu, Zhenghong; Zhang, Luo; Wang, Xinxing; Chen, Longbang] Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Gao, Weimin; Lv, Tangfeng] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Jiang, Enze] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Lu, Fang] Nanjing Foreign Language Sch, Nanjing, Jiangsu, Peoples R China; [Shi, Zhaorong] Jinling Hosp, Hosp Off, Nanjing, Jiangsu, Peoples R China; [Lv, Tangfeng] Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China	Texas Tech University System; Texas Tech University; Nanjing University	Yu, ZH (corresponding author), Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.	m_fish@189.cn; lvtangfeng_1114@yahoo.com.cn	Wang, Xinxing/AAU-6356-2021					Ahmad S, 1999, BIOCHEM PHARMACOL, V58, P425, DOI 10.1016/S0006-2952(99)00125-2; Arnal JF, 2001, CLIN EXP PHARMACOL P, V28, P1032, DOI 10.1046/j.1440-1681.2001.03589.x; Baker SE, 2002, GENETICS, V162, P285; Bartella V, 2012, CELL SIGNAL, V24, P1515, DOI 10.1016/j.cellsig.2012.03.012; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Clark VP, 2001, HUM BRAIN MAPP, V14, P116, DOI 10.1002/hbm.1046; Contois LW, 2012, J BIOL CHEM, V287, P1779, DOI 10.1074/jbc.M111.267732; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Hall JM, 2000, MOL ENDOCRINOL, V14, P2010, DOI 10.1210/me.14.12.2010; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kawabe Y, 2002, GENE, V285, P291, DOI 10.1016/S0378-1119(01)00887-3; KLEINMAN D, 1995, ENDOCRINOLOGY, V136, P2531, DOI 10.1210/en.136.6.2531; LeRoith D, 2000, ENDOCRINOLOGY, V141, P1287, DOI 10.1210/en.141.4.1287; Lisztwan J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2113; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Stoll BA, 2002, ANN ONCOL, V13, P191, DOI 10.1093/annonc/mdf059; Zhu L, 2007, P NATL ACAD SCI USA, V104, P15847, DOI 10.1073/pnas.0705749104	28	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62642	10.1371/journal.pone.0062642	http://dx.doi.org/10.1371/journal.pone.0062642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704881	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200010
J	Barnett, C; Salter, M; Chevallier, C; Robertson, N; Berard, O; Burns, KC				Barnett, Craig; Salter, Matt; Chevallier, Clement; Robertson, Nicola; Berard, Otis; Burns, Kevin C.			The Ability of North Island Robins to Discriminate between Humans Is Related to Their Behavioural Type	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; SEX-DIFFERENCES; GREAT TITS; REPEATABILITY; PERSONALITY; BOLDNESS; BIRDS; HERITABILITY; TEMPERAMENT; RESPONSES	Animals are able to learn to identify persistent threats to themselves and their offspring. For example, birds are able to quickly learn to discriminate between humans that have previously threatened their nests from humans with whom they have had no prior experience. However, no study has yet examined whether a bird's ability to discriminate between humans is related to the bird's underlying behavioural type. In this study, we examined whether there were differences among North Island (NI) robins (Petroica longipes), based on their underlying behavioural type, in their abilities to discriminate between familiar and novel human observers. Using a simple feeding experiment, we timed how long it took birds to attack a food item placed next to an observer on each of 7 days. On the eighth day, a different observer timed the birds. We found that birds could be split into two behaviour types based on their attack behaviour: fast attackers (latencies <20 sec) and slow attackers (latencies >20 secs). Interestingly, the fast birds did not increase their attack latency in response to the novel observer whereas the slow attackers did. This result, for the first time, demonstrates that a bird's ability to discriminate between humans can vary among birds based on their behavioural type.	[Barnett, Craig; Salter, Matt; Robertson, Nicola; Berard, Otis; Burns, Kevin C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Barnett, Craig] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo 171, Japan; [Chevallier, Clement] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada	Victoria University Wellington; Rikkyo University; University of Quebec	Barnett, C (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	optimalforager@hotmail.com	Robertson, Nicola/GWR-2021-2022	Chevallier, Clement/0000-0002-0956-5978; Burns, K.C./0000-0002-4938-2877; Barnett, Craig/0000-0001-5941-8370	School of Biological Sciences at Victoria University of Wellington	School of Biological Sciences at Victoria University of Wellington	This research was partially funded by the School of Biological Sciences at Victoria University of Wellington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2010, R LANG ENV STAT COMP; Barnett CA, 2012, ETHOLOGY, V118, P984, DOI 10.1111/j.1439-0310.2012.02092.x; Barnett CA, 2011, ETHOLOGY, V117, P28, DOI 10.1111/j.1439-0310.2010.01844.x; Belguermi A, 2011, ANIM COGN, V14, P909, DOI 10.1007/s10071-011-0420-7; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BENUS RF, 1990, BEHAVIOUR, V112, P176, DOI 10.1163/156853990X00185; BOYSEN ST, 1986, J COMP PSYCHOL, V100, P321, DOI 10.1037/0735-7036.100.3.321; BUITRON D, 1983, BEHAVIOUR, V87, P209, DOI 10.1163/156853983X00435; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2011, CURR ZOOL, V57, P491, DOI 10.1093/czoolo/57.4.491; Caro T., 2005, ANTIPREDATOR DEFENCE; Chervet Noemie, 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/321729; Cockrem JF, 2002, GEN COMP ENDOCR, V125, P248, DOI 10.1006/gcen.2001.7749; Coleman K, 2005, AM J PRIMATOL, V65, P63, DOI 10.1002/ajp.20097; Cornell HN, 2012, P ROY SOC B-BIOL SCI, V279, P499, DOI 10.1098/rspb.2011.0957; David M, 2012, ETHOLOGY, V118, P932, DOI 10.1111/j.1439-0310.2012.02085.x; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; EAST M, 1981, IBIS, V123, P223, DOI 10.1111/j.1474-919X.1981.tb00930.x; Ellenberg U, 2009, ANIM BEHAV, V77, P289, DOI 10.1016/j.anbehav.2008.09.021; Emery NJ, 2006, P ROY SOC LOND B BIO, V275, P1811; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Ferrari MCO, 2008, P ROY SOC B-BIOL SCI, V275, P1811, DOI 10.1098/rspb.2008.0305; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; GRUBB TC, 1977, CONDOR, V79, P271, DOI 10.2307/1367175; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; KNIGHT RL, 1986, ANIM BEHAV, V34, P561, DOI 10.1016/S0003-3472(86)80125-7; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Levey DJ, 2009, P NATL ACAD SCI USA, V106, P8959, DOI 10.1073/pnas.0811422106; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; Matzel LD, 2003, J NEUROSCI, V23, P6423; MCLEAN IG, 1991, CURR ORNITHOL, V8, P173; Mercado, 2011, INT J COMP PSYCHOL, V24, P4, DOI DOI 10.1016/J.JEBDP.2005.01.011; MERRITT PG, 1984, J FIELD ORNITHOL, V55, P252; Range F, 2006, BEHAV PROCESS, V73, P100, DOI 10.1016/j.beproc.2006.04.002; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Remes V, 2012, BIOL CONSERV, V148, P54, DOI 10.1016/j.biocon.2012.01.063; Shettleworth S. J., 2009, COGNITION EVOLUTION; Sih Andrew, 2010, P516; Silverin B, 1998, POULT AVIAN BIOL REV, V9, P153; Sinn DL, 2010, BEHAV ECOL SOCIOBIOL, V64, P693, DOI 10.1007/s00265-009-0887-2; SLOBODCHIKOFF CN, 1991, ANIM BEHAV, V42, P713, DOI 10.1016/S0003-3472(05)80117-4; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Starling-Windhof A, 2011, BIOL INVASIONS, V13, P1021, DOI 10.1007/s10530-010-9886-5; Steiger S, 2008, TRENDS ECOL EVOL, V23, P355, DOI 10.1016/j.tree.2008.01.014; Taylor AA, 1998, APPL ANIM BEHAV SCI, V58, P13, DOI 10.1016/S0168-1591(97)00061-0; Thaker M, 2010, AM NAT, V175, P50, DOI 10.1086/648558; Tibbetts EA, 2008, TRENDS ECOL EVOL, V23, P356, DOI 10.1016/j.tree.2008.03.007; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Van Horik J, 2007, ANIM BEHAV, V73, P1043, DOI 10.1016/j.anbehav.2006.07.014; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; WALTERS JR, 1990, WILSON BULL, V102, P49; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018	58	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64487	10.1371/journal.pone.0064487	http://dx.doi.org/10.1371/journal.pone.0064487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700482	Green Published, gold			2022-12-25	WOS:000319966400058
J	Ling, N; Zhang, WW; Wang, DS; Mao, JG; Huang, QW; Guo, SW; Shen, QR				Ling, Ning; Zhang, Wenwen; Wang, Dongsheng; Mao, Jiugeng; Huang, Qiwei; Guo, Shiwei; Shen, Qirong			Root Exudates from Grafted-Root Watermelon Showed a Certain Contribution in Inhibiting Fusarium oxysporum f. sp niveum	PLOS ONE			English	Article							BIOORGANIC FERTILIZER; VERTICILLIUM-DAHLIAE; PHENOLIC-ACIDS; CINNAMIC ACID; ROOTSTOCK; GROWTH; WILT; RESISTANCE; CUCUMBER; IDENTIFICATION	Grafting watermelon onto bottle gourd rootstock is commonly used method to generate resistance to Fusarium oxysporum f. sp. niveum (FON), but knowledge of the effect of the root exudates of grafted watermelon on this soil-borne pathogen in rhizosphere remains limited. To investigate the root exudate profiles of the own-root bottle gourd, grafted-root watermelon and own-root watermelon, recirculating hydroponic culture system was developed to continuously trap these root exudates. Both conidial germination and growth of FON were significantly decreased in the presence of root exudates from the grafted-root watermelon compared with the own-root watermelon. HPLC analysis revealed that the composition of the root exudates released by the grafted-root watermelon differed not only from the own-root watermelon but also from the bottle gourd rootstock plants. We identified salicylic acid in all 3 root exudates, chlorogenic acid and caffeic acid in root exudates from own-root bottle gourd and grafted-root watermelon but not own-root watermelon, and abundant cinnamic acid only in own-root watermelon root exudates. The chlorogenic and caffeic acid were candidates for potentiating the enhanced resistance of the grafted watermelon to FON, therefore we tested the effects of the two compounds on the conidial germination and growth of FON. Both phenolic acids inhibited FON conidial germination and growth in a dose-dependent manner, and FON was much more susceptible to chlorogenic acid than to caffeic acid. In conclusion, the key factor in attaining the resistance to Fusarium wilt is grafting on the non-host root stock, however, the root exudates profile also showed some contribution in inhibiting FON. These results will help to better clarify the disease resistance mechanisms of grafted-root watermelon based on plant-microbe communication and will guide the improvement of strategies against Fusarium-mediated wilt of watermelon plants.	[Ling, Ning; Zhang, Wenwen; Huang, Qiwei; Guo, Shiwei; Shen, Qirong] Nanjing Agr Univ, Jiangsu Key Lab, Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Ling, Ning; Zhang, Wenwen; Huang, Qiwei; Guo, Shiwei; Shen, Qirong] Nanjing Agr Univ, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Wang, Dongsheng; Mao, Jiugeng] Nanjing Inst Vegetable Sci, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University	Shen, QR (corresponding author), Nanjing Agr Univ, Jiangsu Key Lab, Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China.	shenqirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Ling, Ning/AAF-3633-2019	Ling, Ning/0000-0003-1250-4073	Nature Science Foundation of China [31272255]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Nature Science Foundation of China (31272255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; BANWART WL, 1985, J CHEM ECOL, V11, P383, DOI 10.1007/BF01411424; Beekrum S, 2003, FOOD ADDIT CONTAM, V20, P490, DOI 10.1080/0265203031000098678; Blum U, 1996, J NEMATOL, V28, P259; Cao Y, 2011, BIOL FERT SOILS, V47, P495, DOI 10.1007/s00374-011-0556-2; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Colla G, 2010, ENVIRON EXP BOT, V68, P283, DOI 10.1016/j.envexpbot.2009.12.005; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; Hao WY, 2010, PLANT SOIL, V336, P485, DOI 10.1007/s11104-010-0505-0; Hao ZP, 2007, SCI HORTIC-AMSTERDAM, V112, P315, DOI 10.1016/j.scienta.2006.12.030; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; Ling N, 2012, APPL SOIL ECOL, V59, P13, DOI 10.1016/j.apsoil.2012.05.001; Ling N, 2011, EUR J SOIL BIOL, V47, P374, DOI 10.1016/j.ejsobi.2011.08.009; Ling N, 2011, PLANT SOIL, V341, P485, DOI 10.1007/s11104-010-0660-3; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu Na, 2012, African Journal of Agricultural Research, V7, P2791, DOI 10.5897/AJAR11.2113; Liu N, 2009, HORTSCIENCE, V44, P2058, DOI 10.21273/HORTSCI.44.7.2058; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Ponts N, 2011, PHYTOPATHOLOGY, V101, P929, DOI 10.1094/PHYTO-09-10-0230; Rouphael Y, 2010, SCI HORTIC-AMSTERDAM, V127, P172, DOI 10.1016/j.scienta.2010.09.001; Samapundo S, 2007, FOOD MICROBIOL, V24, P465, DOI 10.1016/j.fm.2006.10.003; Si Y, 2010, J EXP BOT, V61, P1635, DOI 10.1093/jxb/erq031; STAMP NE, 1992, ENTOMOL EXP APPL, V64, P135, DOI 10.1111/j.1570-7458.1992.tb01603.x; Thies JA, 2010, PLANT DIS, V94, P1195, DOI 10.1094/PDIS-09-09-0640; Turhan A, 2012, HORTIC ENVIRON BIOTE, V53, P336, DOI 10.1007/s13580-012-0034-2; Wu FZ, 2010, ALLELOPATHY J, V25, P403; Wu HS, 2009, SOIL SCI SOC AM J, V73, P1150, DOI 10.2136/sssaj2008.0266; Wu HS, 2008, CHEMOSPHERE, V74, P45, DOI 10.1016/j.chemosphere.2008.09.027; Yang YJ, 2012, PLANT PHYSIOL BIOCH, V58, P54, DOI 10.1016/j.plaphy.2012.05.026; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; Ye SF, 2006, ENVIRON EXP BOT, V56, P255, DOI 10.1016/j.envexpbot.2005.02.010; Yetisir H, 2003, PHYTOPARASITICA, V31, P163, DOI 10.1007/BF02980786; YU JQ, 1994, J CHEM ECOL, V20, P21, DOI 10.1007/BF02065988; Yu JQ, 2000, PLANT SOIL, V223, P149, DOI 10.1023/A:1004829512147; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010; Zhou BL, 2010, ALLELOPATHY J, V25, P393	40	68	77	5	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63383	10.1371/journal.pone.0063383	http://dx.doi.org/10.1371/journal.pone.0063383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700421	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400019
J	Luck, GW; Carter, A; Smallbone, L				Luck, Gary W.; Carter, Andrew; Smallbone, Lisa			Changes in Bird Functional Diversity across Multiple Land Uses: Interpretations of Functional Redundancy Depend on Functional Group Identity	PLOS ONE			English	Article							USE INTENSIFICATION; SPECIES RICHNESS; ECOSYSTEM; BIODIVERSITY; TRAIT; FRAMEWORK; CONSEQUENCES; IMPACTS; INDEXES; LEVEL	Examinations of the impact of land-use change on functional diversity link changes in ecological community structure driven by land modification with the consequences for ecosystem function. Yet, most studies have been small-scale, experimental analyses and primarily focussed on plants. There is a lack of research on fauna communities and at large-scales across multiple land uses. We assessed changes in the functional diversity of bird communities across 24 land uses aligned along an intensification gradient. We tested the hypothesis that functional diversity is higher in less intensively used landscapes, documented changes in diversity using four diversity metrics, and examined how functional diversity varied with species richness to identify levels of functional redundancy. Functional diversity, measured using a dendogram-based metric, increased from high to low intensity land uses, but observed values did not differ significantly from randomlygenerated expected values. Values for functional evenness and functional divergence did not vary consistently with landuse intensification, although higher than expected values were mostly recorded in high intensity land uses. A total of 16 land uses had lower than expected values for functional dispersion and these were mostly low intensity native vegetation sites. Relations between functional diversity and bird species richness yielded strikingly different patterns for the entire bird community vs. particular functional groups. For all birds and insectivores, functional evenness, divergence and dispersion showed a linear decline with increasing species richness suggesting substantial functional redundancy across communities. However, for nectarivores, frugivores and carnivores, there was a significant hump-shaped or non-significant positive linear relationship between these functional measures and species richness indicating less redundancy. Hump-shaped relationships signify that the most functionally diverse communities occur at intermediate levels of species richness. Interpretations of redundancy thus vary for different functional groups and related ecosystem functions (e.g. pollination), and can be substantially different to relationships involving entire ecological communities.	[Luck, Gary W.; Carter, Andrew; Smallbone, Lisa] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia	Charles Sturt University	Luck, GW (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia.	galuck@csu.edu.au	Carter, Andrew/AAB-1807-2019	Carter, Andrew/0000-0001-5496-6706; Luck, Gary/0000-0002-7266-5568	Australia Research Council Discovery [DP0986566]; Future Fellowship [FT0990436]	Australia Research Council Discovery(Australian Research Council); Future Fellowship(Australian Research Council)	Funding support for this project was provided by an Australia Research Council Discovery Grant (DP0986566) and Future Fellowship (FT0990436) to Gary Luck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaum N, 2011, BIODIVERS CONSERV, V20, P2333, DOI 10.1007/s10531-011-9995-1; BROWN JH, 1978, AM ZOOL, V18, P687; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gerisch M, 2012, OIKOS, V121, P508, DOI 10.1111/j.1600-0706.2011.19749.x; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Luck GW, 2008, FOREST ECOL MANAG, V255, P2688, DOI 10.1016/j.foreco.2008.01.029; Luck GW, 2013, AUSTRAL ECOL, V38, P111, DOI 10.1111/j.1442-9993.2012.02383.x; Luck GW, 2012, J ANIM ECOL, V81, P1065, DOI 10.1111/j.1365-2656.2012.01974.x; Luck GW, 2010, GLOBAL ECOL BIOGEOGR, V19, P673, DOI 10.1111/j.1466-8238.2010.00545.x; MANLY BFJ, 1995, ECOLOGY, V76, P1109, DOI 10.2307/1940919; Mason NWH, 2008, J ANIM ECOL, V77, P285, DOI 10.1111/j.1365-2656.2007.01350.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Mayfield MM, 2006, J ECOL, V94, P522, DOI 10.1111/j.1365-2745.2006.01108.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Naeem S, 2002, ECOLOGY, V83, P2925; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x	45	119	121	8	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63671	10.1371/journal.pone.0063671	http://dx.doi.org/10.1371/journal.pone.0063671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696844	gold, Green Published			2022-12-25	WOS:000319107900053
J	Mital, J; Miller, NJ; Dorward, DW; Dooley, CA; Hackstadt, T				Mital, Jeffrey; Miller, Natalie J.; Dorward, David W.; Dooley, Cheryl A.; Hackstadt, Ted			Role for Chlamydial Inclusion Membrane Proteins in Inclusion Membrane Structure and Biogenesis	PLOS ONE			English	Article							ENDOGENOUSLY SYNTHESIZED SPHINGOMYELIN; GOLGI-APPARATUS; INFECTED-CELLS; HOST-CELL; TRACHOMATIS; INCA; IDENTIFICATION; POLYMORPHISMS; SPHINGOLIPIDS; CHOLESTEROL	The chlamydial inclusion membrane is extensively modified by the insertion of type III secreted effector proteins. These inclusion membrane proteins (Incs) are exposed to the cytosol and share a common structural feature of a long, bi-lobed hydrophobic domain but little or no primary amino acid sequence similarity. Based upon secondary structural predictions, over 50 putative inclusion membrane proteins have been identified in Chlamydia trachomatis. Only a limited number of biological functions have been defined and these are not shared between chlamydial species. Here we have ectopically expressed several C. trachomatis Incs in HeLa cells and find that they induce the formation of morphologically distinct membranous vesicular compartments. Formation of these vesicles requires the bi-lobed hydrophobic domain as a minimum. No markers for various cellular organelles were observed in association with these vesicles. Lipid probes were incorporated by the Inc-induced vesicles although the lipids incorporated were dependent upon the specific Inc expressed. Co-expression of Inc pairs indicated that some colocalized in the same vesicle, others partially overlapped, and others did not associate at all. Overall, it appears that Incs may have an intrinsic ability to induce membrane formation and that individual Incs can induce membranous structures with unique properties.	[Mital, Jeffrey; Miller, Natalie J.; Dooley, Cheryl A.; Hackstadt, Ted] NIAID, Host Parasite Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Mital, Jeffrey] Quinnipiac Univ, Dept Biomed Sci, Hamden, CT USA; [Dorward, David W.] NIAID, Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Quinnipiac University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hackstadt, T (corresponding author), NIAID, Host Parasite Interact Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	Ted_Hackstadt@NIH.Gov		Hackstadt, Ted/0000-0003-1367-5528	Intramural Research Program of the NIAID/NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000567, ZICAI001052] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Belland RJ, 2001, P NATL ACAD SCI USA, V98, P13984, DOI 10.1073/pnas.241377698; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; Brunelle BW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r42; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Chen CQ, 2006, INFECT IMMUN, V74, P4826, DOI 10.1128/IAI.00081-06; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; GRAYSTON JT, 1993, J INFECT DIS, V168, P1231, DOI 10.1093/infdis/168.5.1231; Hackstadt T, 1999, CHLAMYDIA, P101; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; Lutter EI, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/362104; Lutter EI, 2010, INFECT IMMUN, V78, P3678, DOI 10.1128/IAI.00515-10; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; MURRAY ES, 1964, J INFECT DIS, V114, P1, DOI 10.1093/infdis/114.1.1; Nigg C, 1944, J EXP MED, V79, P497, DOI 10.1084/jem.79.5.497; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rockey DD, 1997, MOL MICROBIOL, V24, P217, DOI 10.1046/j.1365-2958.1997.3371700.x; ROCKEY DD, 1994, INFECT IMMUN, V62, P106, DOI 10.1128/IAI.62.1.106-112.1994; ROCKEY DD, 1995, MOL MICROBIOL, V15, P617, DOI 10.1111/j.1365-2958.1995.tb02371.x; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Schachter J, 1999, CHLAMYDIA, P139; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Starnbach MN, 2003, J IMMUNOL, V171, P4742, DOI 10.4049/jimmunol.171.9.4742; Stephens RS, 1999, CHLAMYDIA, P9; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stothard DR, 2003, INFECT IMMUN, V71, P1200, DOI 10.1128/IAI.71.3.1200-1208.2003; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; Sykes JE, 2005, CLIN TECH SMALL AN P, V20, P129, DOI 10.1053/j.ctsap.2004.12.018; Toh H, 2003, DNA RES, V10, P9, DOI 10.1093/dnares/10.1.9; Tse SML, 2005, J BIOL CHEM, V280, P25210, DOI 10.1074/jbc.M501980200; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Wolf K, 2001, CELL MICROBIOL, V3, P145, DOI 10.1046/j.1462-5822.2001.00098.x; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	64	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63426	10.1371/journal.pone.0063426	http://dx.doi.org/10.1371/journal.pone.0063426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696825	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900044
J	Bohr, S; Patel, SJ; Vasko, R; Shen, KY; Huang, GF; Yarmush, ML; Berthiaume, F				Bohr, Stefan; Patel, Suraj J.; Vasko, Radovan; Shen, Keyue; Huang, Guofeng; Yarmush, Martin L.; Berthiaume, Francois			Highly Upregulated Lhx2 in the Foxn1(-/-) Nude Mouse Phenotype Reflects a Dysregulated and Expanded Epidermal Stem Cell Niche	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; SKIN EPITHELIAL-CELLS; IMMUNOHISTOCHEMICAL EXPRESSION; PROMOTES DIFFERENTIATION; BETA-CATENIN; IN-VITRO; KERATINOCYTES; CD34; SHH; CD200	Hair cycling is a prime example of stem cell dependent tissue regeneration and replenishment, and its regulatory mechanisms remain poorly understood. In the present study, we evaluated the effect of a blockage in terminal keratinocytic lineage differentiation in the Foxn1(-/-) nude phenotype on the epithelial progeny. Most notably we found a constitutive upregulation of LIM homeobox protein 2 (Lhx2), a marker gene of epithelial stem cellness indispensible for hair cycle progression. However, histological evidence along with an erratic, acyclic rise of otherwise suppressed CyclinD1 levels along with several key markers of keratinocyte lineage differentiation indicate a frustrated expansion of epithelial stem cell niches in skin. In addition, CD49f/CD34/CD200-based profiling demonstrated highly significant shifts in subpopulations of epithelial progeny. Intriguingly this appeared to include the expansion of Oct4+ stem cells in dermal fractions of skin isolates in the Foxn1 knock-out opposed to wild type. Overall our findings indicate that the Foxn1(-/-) phenotype has a strong impact on epithelial progeny and thus offers a promising model to study maintenance and regulation of stem cell niches within skin not feasible in other in vitro or in vivo models.	[Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Huang, Guofeng; Yarmush, Martin L.] Harvard Univ, Shriners Hosp Children, Sch Med, Ctr Engn Med, Boston, MA 02115 USA; [Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Huang, Guofeng; Yarmush, Martin L.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Vasko, Radovan] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Yarmush, Martin L.; Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, New Brunswick, NJ 08903 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York Medical College; Rutgers State University New Brunswick	Bohr, S (corresponding author), Harvard Univ, Shriners Hosp Children, Sch Med, Ctr Engn Med, Boston, MA 02115 USA.	bohrs@partners.org	Berthiaume, Francois/ABD-2139-2020	Yarmush, Martin/0000-0003-4986-8444	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany) [GZ:BO3468/2-1]	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany)(German Research Foundation (DFG))	This work was funded by the Shriners Hospitals for Children. S. Bohr is a recipient of a Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award (GZ:BO3468/2-1). S. J. Patel was supported by a Shriners Hospital for Children postdoctoral fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2012, ANN DERMATOL, V24, P26, DOI 10.5021/ad.2012.24.1.26; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Cui CY, 2011, CELL CYCLE, V10, P3379, DOI 10.4161/cc.10.19.17669; Fan CX, 2011, SKIN RES TECHNOL, V17, P387, DOI 10.1111/j.1600-0846.2011.00508.x; Gallego MI, 2002, DEV BIOL, V249, P131, DOI 10.1006/dbio.2002.0761; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Goldstein J, 2012, CELL MOL LIFE SCI; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Michno K, 2003, DEV BIOL, V264, P153, DOI 10.1016/S0012-1606(03)00401-9; Mill P, 2005, DEV CELL, V9, P293, DOI 10.1016/j.devcel.2005.05.009; Mill P, 2003, GENES DEV, V17, P282; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mukhopadhyay A, 2012, DEV BIOL; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Olszewski Waldemar L, 2004, Ann Transplant, V9, P34; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V345, P581, DOI 10.1016/j.bbrc.2006.04.142; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P1063, DOI 10.1016/j.bbrc.2006.02.028; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P28, DOI 10.1016/j.bbrc.2006.01.104; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Pascucci L, 2006, VET DERMATOL, V17, P244, DOI 10.1111/j.1365-3164.2006.00527.x; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Plikus MV, 2012, SEMIN CELL DEV BIOL; Poblet E, 2008, BRIT J DERMATOL, V159, P646, DOI 10.1111/j.1365-2133.2008.08741.x; Poblet E, 2006, CLIN EXP DERMATOL, V31, P807, DOI 10.1111/j.1365-2230.2006.02255.x; Poblet E, 2003, J INVEST DERMATOL, V121, P1220, DOI 10.1046/j.1523-1747.2003.12550_2.x; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rodius S, 2007, J CELL PHYSIOL, V212, P439, DOI 10.1002/jcp.21040; Rosenblum MD, 2006, J DERMATOL SCI, V41, P165, DOI 10.1016/j.jdermsci.2005.11.003; Rosenblum MD, 2005, J INVEST DERMATOL, V125, P1130, DOI 10.1111/j.0022-202X.2005.23948.x; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Samuelov L, 2012, J INVEST DERMATOL; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Streckfuss-Bomeke K, 2012, EUR HEART J, DOI 10.1093/eurheartj/ehs203; Suzuki K, 2009, DEVELOPMENT, V136, P367, DOI 10.1242/dev.021295; Teillet MA, 1998, P NATL ACAD SCI USA, V95, P11733, DOI 10.1073/pnas.95.20.11733; Terunuma A, 2008, J INVEST DERMATOL, V128, P1332, DOI 10.1038/sj.jid.5701154; Terunuma A, 2007, STEM CELLS, V25, P664; Tiede S, 2006, BIOESSAYS, V28, P1157, DOI 10.1002/bies.20506; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Widelitz Randall B, 2008, Organogenesis, V4, P123; Xing YZ, 2011, ACTA HISTOCHEM, V113, P608, DOI 10.1016/j.acthis.2010.06.006; Xu XW, 2003, AM J PATHOL, V163, P969, DOI 10.1016/S0002-9440(10)63456-6; Zhou SY, 2010, CURR EYE RES, V35, P978, DOI 10.3109/02713683.2010.516465	61	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64223	10.1371/journal.pone.0064223	http://dx.doi.org/10.1371/journal.pone.0064223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696871	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900074
J	Brazdil, M; Janecek, J; Klimes, P; Marecek, R; Roman, R; Jurak, P; Chladek, J; Daniel, P; Rektor, I; Halamek, J; Plesinger, F; Jirsa, V				Brazdil, Milan; Janecek, Jiri; Klimes, Petr; Marecek, Radek; Roman, Robert; Jurak, Pavel; Chladek, Jan; Daniel, Pavel; Rektor, Ivan; Halamek, Josef; Plesinger, Filip; Jirsa, Viktor			On the Time Course of Synchronization Patterns of Neuronal Discharges in the Human Brain during Cognitive Tasks	PLOS ONE			English	Article							TOP-DOWN; WORKING-MEMORY; HIGH-FREQUENCY; VISUAL-CORTEX; DYNAMICS; INTEGRATION; GAMMA; COMMUNICATION; POTENTIALS; ATTENTION	Using intracerebral EEG recordings in a large cohort of human subjects, we investigate the time course of neural cross-talk during a simple cognitive task. Our results show that human brain dynamics undergo a characteristic sequence of synchronization patterns across different frequency bands following a visual oddball stimulus. In particular, an initial global reorganization in the delta and theta bands (2-8 Hz) is followed by gamma (20-95 Hz) and then beta band (12-20 Hz) synchrony.	[Brazdil, Milan; Marecek, Radek; Roman, Robert; Chladek, Jan; Daniel, Pavel; Rektor, Ivan] Masaryk Univ, Behav & Social Neurosci Res Grp, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Brazdil, Milan; Marecek, Radek; Daniel, Pavel; Rektor, Ivan] Masaryk Univ, St Annes Univ Hosp, Dept Neurol, Brno Epilepsy Ctr, Brno, Czech Republic; [Brazdil, Milan; Marecek, Radek; Daniel, Pavel; Rektor, Ivan] Masaryk Univ, Fac Med, Brno, Czech Republic; [Janecek, Jiri; Klimes, Petr; Jurak, Pavel; Chladek, Jan; Halamek, Josef; Plesinger, Filip] Acad Sci Czech Republ, Inst Sci Instruments, CS-61264 Brno, Czech Republic; [Roman, Robert] Masaryk Univ, Fac Med, Dept Physiol, Brno, Czech Republic; [Jirsa, Viktor] Aix Marseille Univ, INSERM, UMR1106, Inst Neurosci Syst, Marseille, France	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Masaryk University Brno; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Brazdil, M (corresponding author), Masaryk Univ, Behav & Social Neurosci Res Grp, CEITEC Cent European Inst Technol, Brno, Czech Republic.	mbrazd@med.muni.cz	Plešinger, Filip/G-1449-2014; Klimes, Petr/D-6818-2012; Klimes, Petr/AAO-3115-2020; Halamek, Josef/D-5110-2012; Roman, Robert/E-3337-2012; Jurak, Pavel/AAO-3084-2020; Marecek, Radek/AAM-4984-2020; Rektor, Ivan IR/G-9480-2014; Jurák, Pavel/G-1466-2014; Brazdil, Milan/D-6836-2012; Halamek, Josef/M-3836-2019; Chladek, Jan/B-2600-2009; Jirsa, Viktor/M-4630-2016; Chladek, Jan/AAK-2231-2021	Plešinger, Filip/0000-0003-2875-3541; Klimes, Petr/0000-0002-0232-9518; Klimes, Petr/0000-0002-0232-9518; Halamek, Josef/0000-0001-8986-796X; Roman, Robert/0000-0003-0689-5610; Jurak, Pavel/0000-0002-3793-5075; Jurák, Pavel/0000-0002-3793-5075; Halamek, Josef/0000-0001-8986-796X; Chladek, Jan/0000-0002-9500-0657; Jirsa, Viktor/0000-0002-8251-8860; Chladek, Jan/0000-0002-9500-0657; Marecek, Radek/0000-0001-8399-3455; Brazdil, Milan/0000-0001-7979-2343	"CEITEC - Central European Institute of Technology" from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; GACR [P103/11/0933]; Application laboratories of advanced microtechnologies and nanotechnologies [CZ.1.05/2.1.00/01.0017]; "Research and Development for Innovations" Operational Programme; European Regional Development Fund	"CEITEC - Central European Institute of Technology" from European Regional Development Fund; GACR(Grant Agency of the Czech Republic); Application laboratories of advanced microtechnologies and nanotechnologies; "Research and Development for Innovations" Operational Programme; European Regional Development Fund(European Commission)	The study was supported by the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund and grant GACR P103/11/0933. The technical part of the study was supported by the project "Application laboratories of advanced microtechnologies and nanotechnologies" (CZ.1.05/2.1.00/01.0017), co-funded by the "Research and Development for Innovations" Operational Programme, the European Regional Development Fund, and the state budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axmacher N, 2008, J NEUROSCI, V28, P7304, DOI 10.1523/JNEUROSCI.1778-08.2008; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Brazdil M, 1999, NEUROPHYSIOL CLIN, V29, P339, DOI 10.1016/S0987-7053(99)90047-3; Brazdil M, 2009, HUM BRAIN MAPP, V30, P138, DOI 10.1002/hbm.20491; Bressler SL, 1996, BEHAV BRAIN RES, V76, P37, DOI 10.1016/0166-4328(95)00187-5; Bruns A, 2004, INT J PSYCHOPHYSIOL, V51, P97, DOI 10.1016/j.ijpsycho.2003.07.001; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2007, FRONT NEUROSCI-SWITZ, V1, P185, DOI 10.3389/neuro.01.1.1.014.2007; Canolty RT, 2012, J NEUROPHYSIOL, V107, P2020, DOI 10.1152/jn.00610.2011; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Halgren E, 1986, FRONTIERS CLIN NEURO, V3, P269; Korzeniewska A, 2008, HUM BRAIN MAPP, V29, P1170, DOI 10.1002/hbm.20458; Kukleta M, 2009, PHYSIOL RES, V58, P725, DOI 10.33549/physiolres.931629; Kukleta M, 2009, PHYSIOL RES, V58, P139, DOI 10.33549/physiolres.931404; Lachaux JP, 2000, EUR J NEUROSCI, V12, P2608, DOI 10.1046/j.1460-9568.2000.00163.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; McCarthy G, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P331; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Singer W, 2009, COGN NEURODYNAMICS, V3, P189, DOI 10.1007/s11571-009-9087-z; Talairach J, 1967, ATLAS ANATOMIE STERE; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal JR, 2012, J NEUROSCI, V32, P6421, DOI 10.1523/JNEUROSCI.4363-11.2012; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wood C C, 1980, Prog Brain Res, V54, P51, DOI 10.1016/S0079-6123(08)61605-2; Wood GG, 1985, SOC NEURSC ABSTR, V11, P879	50	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63293	10.1371/journal.pone.0063293	http://dx.doi.org/10.1371/journal.pone.0063293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696809	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900023
J	Cattepoel, S; Schaub, A; Ender, M; Gaida, A; Kropf, A; Guggisberg, U; Nolte, MW; Fabri, L; Adlard, PA; Finkelstein, DI; Bolli, R; Miescher, SM				Cattepoel, Susann; Schaub, Alexander; Ender, Miriam; Gaida, Annette; Kropf, Alain; Guggisberg, Ursula; Nolte, Marc W.; Fabri, Louis; Adlard, Paul A.; Finkelstein, David I.; Bolli, Reinhard; Miescher, Sylvia M.			Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; IGG ANTIBODIES; IMMUNOGLOBULIN; PEPTIDE; OLIGOMERS; CELLS	Intravenous immunoglobulin (IVIG) has been proposed as a potential therapeutic for Alzheimer's disease (AD) and its efficacy is currently being tested in mild-to-moderate AD. Earlier studies reported the presence of anti-amyloid beta (A beta) antibodies in IVIG. These observations led to clinical studies investigating the potential role of IVIG as a therapeutic agent in AD. Also, IVIG is known to mediate beneficial effects in chronic inflammatory and autoimmune conditions by interfering with various pathological processes. Therefore, we investigated the effects of IVIG and purified polyclonal A beta -specific antibodies (pAbs-A beta) on aggregation, toxicity and phagocytosis of A beta in vitro, thus elucidating some of the potential mechanisms of action of IVIG in AD patients. We report that both IVIG and pAbs-A beta specifically bound to A beta and inhibited its aggregation in a dose-dependent manner as measured by Thioflavin T assay. Additionally, IVIG and the purified pAbs-A beta inhibited A beta-induced neurotoxicity in the SH-SY5Y human neuroblastoma cell line and prevented A beta binding to rat primary cortical neurons. Interestingly, IVIG and pAbs-A beta also increased the number of phagocytosing cells as well as the amount of phagocytosed fibrillar A beta by BV-2 microglia. Phagocytosis of A beta depended on receptor-mediated endocytosis and was accompanied by upregulation of CD11b expression. Importantly, we could also show that Privigen dose-dependently reversed A beta-mediated LTP inhibition in mouse hippocampal slices. Therefore, our in vitro results suggest that IVIG may have an impact on different processes involved in AD pathogenesis, thereby promoting further understanding of the effects of IVIG observed in clinical studies.	[Cattepoel, Susann; Schaub, Alexander; Ender, Miriam; Gaida, Annette; Kropf, Alain; Guggisberg, Ursula; Bolli, Reinhard; Miescher, Sylvia M.] CSL Behring AG, Bern, Switzerland; [Nolte, Marc W.] CSL Behring GmbH, Marburg, Germany; [Fabri, Louis] CSL Ltd, Melbourne, Vic, Australia; [Adlard, Paul A.; Finkelstein, David I.] Mental Hlth Res Inst, Parkville, Vic, Australia	CSL; CSL; CSL; Florey Institute of Neuroscience & Mental Health	Cattepoel, S (corresponding author), CSL Behring AG, Bern, Switzerland.	susann.cattepoel@cslbehring.com	Finkelstein, David/B-9617-2009	Finkelstein, David/0000-0002-8167-4917; fabri, louis/0000-0003-4033-3304	CSL Behring AG	CSL Behring AG	The study was fully funded by CSL Behring AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO;2-5; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brazil MI, 2000, J BIOL CHEM, V275, P16941, DOI 10.1074/jbc.M000937200; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dalakas MC, 2002, NEUROLOGY, V59, pS13, DOI 10.1212/WNL.59.12_suppl_6.S13; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2013, LANCET NEUROL, V12, P233, DOI 10.1016/S1474-4422(13)70014-0; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fillit H, 2009, NEUROLOGY, V73, P180, DOI 10.1212/WNL.0b013e3181ae7aaf; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Frautschy SA, 1998, AM J PATHOL, V152, P307; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Husemann J, 2001, ARTERIOSCL THROM VAS, V21, P1301, DOI 10.1161/hq0801.095150; Istrin G, 2006, J NEUROSCI RES, V84, P434, DOI 10.1002/jnr.20886; Kaveri SV, 2008, NEW ENGL J MED, V359, P307, DOI 10.1056/NEJMcibr0803649; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee YT, 2001, BLOOD, V98, P1914, DOI 10.1182/blood.V98.6.1914; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; McGeer EG, 1999, CURR PHARM DESIGN, V5, P821; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; Pul R, 2011, EXPERT OPIN BIOL TH, V11, P343, DOI 10.1517/14712598.2011.552884; Puli L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-105; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Robak T, 2009, HEMATOLOGY, V14, P227, DOI 10.1179/102453309X439773; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Stein MR, 2009, J CLIN IMMUNOL, V29, P137, DOI 10.1007/s10875-008-9231-2; Webster SD, 2001, J IMMUNOL, V166, P7496, DOI 10.4049/jimmunol.166.12.7496; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Weksler ME, 2009, TRENDS IMMUNOL, V30, P344, DOI 10.1016/j.it.2009.03.011; Wilcock DM, 2004, NEUROBIOL DIS, V15, P11, DOI 10.1016/j.nbd.2003.09.015	56	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63162	10.1371/journal.pone.0063162	http://dx.doi.org/10.1371/journal.pone.0063162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696796	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900012
J	Isozumi, Y; Arai, R; Fujimoto, K; Koyama, T				Isozumi, Yu; Arai, Reina; Fujimoto, Kazumi; Koyama, Takatoshi			Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma	PLOS ONE			English	Article							TISSUE FACTOR; DEXAMETHASONE; THALIDOMIDE; BORTEZOMIB; THROMBOSIS; EXPRESSION; BILAYERS; BINDING; ALPHA; CELLS	We investigated the procoagulant effects of lenalidomide (Len)-based regimens in vitro focusing on tissue factor (TF) and phosphatidylserine (PS). We examined the effects of a pharmacological concentration of Len with or without the corticosteroid dexamethasone (Dex) and the proteasome inhibitor bortezomib (Bor) using the human vascular endothelial cell line EAhy926 and the monocytic cell lines THP-1 and U937. Cell-surface procoagulant activity (PCA) was induced by Dexcontaining regimens in all lines. Expression of TF antigen on the cell surface and of TF mRNA was markedly increased by Dex-containing regimens. PS exposure was increased modestly by a Len-based regimen. PS exposure was increased modestly in EAhy926 cells, and markedly increased in THP-1 and U937 cells by Bor-containing treatment. An anti-TF monoclonal antibody almost completely blocked the induced PCA. When Len is given in combination with Dex, PCA may be induced on endothelial cells and monocytes through TF expression and PS exposure.	[Isozumi, Yu; Arai, Reina; Fujimoto, Kazumi; Koyama, Takatoshi] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Koyama, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo, Japan.	koyama.lmg@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [22590519] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a research grant for TK from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Aue G, 2011, AM J HEMATOL, V86, P835, DOI 10.1002/ajh.22114; Bach RR, 2006, ARTERIOSCL THROM VAS, V26, P456, DOI 10.1161/01.ATV.0000202656.53964.04; Barosi G, 2012, ANN HEMATOL, V91, P875, DOI 10.1007/s00277-012-1445-y; Cesarman-Maus G, 2012, LEUKEMIA, V26, P1671, DOI 10.1038/leu.2012.43; CHARLES B, 1993, DEV PHARMACOL THERAP, V20, P205, DOI 10.1159/000457564; Coppola A, 2011, SEMIN THROMB HEMOST, V37, P928, DOI 10.1055/s-0031-1297372; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gandhi AK, 2010, CURR CANCER DRUG TAR, V10, P155; Hiroi T, 2009, ARTERIOSCL THROM VAS, V29, P1587, DOI 10.1161/ATVBAHA.109.191957; Hoshi A, 2011, BLOOD COAGUL FIBRIN, V22, P532, DOI 10.1097/MBC.0b013e328348629d; Iida S, 2010, INT J HEMATOL, V92, P118, DOI 10.1007/s12185-010-0624-7; Klein U, 2009, ANN HEMATOL, V88, P67, DOI 10.1007/s00277-008-0561-1; Kumar S, 2012, BLOOD, V119, P4375, DOI 10.1182/blood-2011-11-395749; Larocca A, 2012, BLOOD, V119, P933, DOI 10.1182/blood-2011-03-344333; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Morrissey JH, 2009, J THROMB HAEMOST, V7, P169, DOI 10.1111/j.1538-7836.2009.03390.x; Ohsawa M, 2000, CIRCULATION, V102, P2867; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Quach H, 2012, AM J HEMATOL, V87, P1089, DOI 10.1002/ajh.23234; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; TAIT JF, 1989, J BIOL CHEM, V264, P7944; Valsami S, 2011, THROMB RES, V127, P264, DOI 10.1016/j.thromres.2010.11.018	24	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64369	10.1371/journal.pone.0064369	http://dx.doi.org/10.1371/journal.pone.0064369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696885	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900088
J	Liu, DL; Chang, CH; Rossi, EA; Cardillo, TM; Goldenberg, DM				Liu, Donglin; Chang, Chien-Hsing; Rossi, Edmund A.; Cardillo, Thomas M.; Goldenberg, David M.			Interferon-lambda 1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells	PLOS ONE			English	Article							IFN-LAMBDA; MULTIFUNCTIONAL STRUCTURES; SIGNAL-TRANSDUCTION; DEFINED COMPOSITION; GENETIC-VARIATION; LOCK METHOD; ALPHA; CANCER; IL28B; EXPRESSION	The type III interferons (IFNs), comprising IFN-lambda 1, IFN-lambda 2, and IFN-lambda 3, behave similarly to IFN-alpha in eliciting antiviral, antitumor, and immune-modulating activities. Due to their more restricted cellular targets, IFN-lambda s are attractive as potential alternatives to existing therapeutic regimens based on IFN-alpha s. We have applied the DOCK-AND-LOCK (TM) method to improve the anti-proliferative potency of IFN-lambda 1 up to 1,000-fold in targeted cancer cell lines by tethering stabilized Fab dimers, derived from hRS7 (humanized anti-Trop-2), hMN-15 (humanized anti-CEACAM6), hL243 (humanized anti-HLA-DR), and c225 (chimeric anti-EGFR), to IFN-lambda 1 site-specifically, resulting in novel immunocytokines designated (E1)-lambda 1, (15)-lambda 1, (C2)-lambda 1, and (c225)-lambda 1, respectively. Targeted delivery of IFN-lambda 1 via (15)-lambda 1 or (c225)-lambda 1 to respective antigen-expressing cells also significantly increased antiviral activity when compared with non-targeting (C2)-lambda 1, as demonstrated in human lung adenocarcinoma cell line A549 by (15)-lambda 1 against encephalomyocarditis virus (EC50 = 22.2 pM versus 223 pM), and in human hepatocarcinoma cell line Huh-7 by (c225)-lambda 1 against hepatitis C virus (EC50 = 0.56 pM versus 91.2 pM). These promising results, which are attributed to better localization and stronger binding of IFN-lambda 1 to antibody-targeted cells, together with the favorable pharmacokinetic profile of (E1)-lambda 1 in mice (T-1/2 = 8.6 h), support further investigation of selective prototypes as potential antiviral and antitumor therapeutic agents.	[Liu, Donglin; Chang, Chien-Hsing; Rossi, Edmund A.; Goldenberg, David M.] IBC Pharmaceut Inc, Morris Plains, NJ USA; [Chang, Chien-Hsing; Cardillo, Thomas M.; Goldenberg, David M.] Immunomedics Inc, Morris Plains, NJ USA; [Goldenberg, David M.] Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA	Immunomedics Inc	Goldenberg, DM (corresponding author), IBC Pharmaceut Inc, Morris Plains, NJ USA.	dmg.gscancer@att.net						Abushahba W, 2010, CANCER IMMUNOL IMMUN, V59, P1059, DOI 10.1007/s00262-010-0831-3; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Blight K.J., 2006, HEPATITIS C VIRUSES, P311; Byrnes-Blake KA, 2012, J INTERF CYTOK RES, V32, P198, DOI 10.1089/jir.2011.0075; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Grace MJ, 2005, J BIOL CHEM, V280, P6327, DOI 10.1074/jbc.M412134200; Guenterberg KD, 2010, MOL CANCER THER, V9, P510, DOI 10.1158/1535-7163.MCT-09-0461; Hsu CS, 2011, P NATL ACAD SCI USA, V108, P3719, DOI 10.1073/pnas.1100349108; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; Miller DM, 2009, ANN NY ACAD SCI, V1182, P80, DOI 10.1111/j.1749-6632.2009.05241.x; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; Muir AJ, 2010, HEPATOLOGY, V52, P822, DOI 10.1002/hep.23743; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Ramos EL, 2010, J INTERF CYTOK RES, V30, P591, DOI 10.1089/jir.2010.0066; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Rossi DL, 2011, BIOTECHNOL PROGR, V27, P766, DOI 10.1002/btpr.584; Rossi EA, 2006, P NATL ACAD SCI USA, V103, P6841, DOI 10.1073/pnas.0600982103; Rossi EA, 2011, BLOOD, V118, P1877, DOI 10.1182/blood-2011-03-343145; Rossi EA, 2009, BLOOD, V114, P3864, DOI 10.1182/blood-2009-06-228890; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Witte K, 2009, GENES IMMUN, V10, P702, DOI 10.1038/gene.2009.72; Witte K, 2010, CYTOKINE GROWTH F R, V21, P237, DOI 10.1016/j.cytogfr.2010.04.002; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Zeuzem S, 2011, J HEPATOL, V54, pS538, DOI 10.1016/S0168-8278(11)61362-7; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zitzmann K, 2006, BIOCHEM BIOPH RES CO, V344, P1334, DOI 10.1016/j.bbrc.2006.04.043	49	6	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63940	10.1371/journal.pone.0063940	http://dx.doi.org/10.1371/journal.pone.0063940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696859	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900063
J	Wobke, TK; von Knethen, A; Steinhilber, D; Sorg, BL				Woebke, Thea K.; von Knethen, Andreas; Steinhilber, Dieter; Sorg, Bernd L.			CD69 Is a TGF-beta/1 alpha,25-dihydroxyvitamin D-3 Target Gene in Monocytes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVATION ANTIGEN CD69; NECROSIS-FACTOR-ALPHA; VITAMIN-D-RECEPTOR; T-CELL ACTIVATION; C-TYPE LECTIN; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; 5-LIPOXYGENASE EXPRESSION; MESSENGER-RNA	CD69 is a transmembrane lectin that can be expressed on most hematopoietic cells. In monocytes, it has been functionally linked to the 5-lipoxygenase pathway in which the leukotrienes, a class of highly potent inflammatory mediators, are produced. However, regarding CD69 gene expression and its regulatory mechanisms in monocytes, only scarce data are available. Here, we report that CD69 mRNA expression, analogous to that of 5-lipoxygenase, is induced by the physiologic stimuli transforming growth factor-beta (TGF-beta) and 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3) in monocytic cells. Comparison with T-and B-cell lines showed that the effect was specific for monocytes. CD69 expression levels were increased in a concentration-dependent manner, and kinetic analysis revealed a rapid onset of mRNA expression, indicating that CD69 is a primary TGF-beta/1 alpha,25(OH)(2)D-3 target gene. PCR analysis of different regions of the CD69 mRNA revealed that de novo transcription was initiated and proximal and distal parts were induced concomitantly. In common with 5-lipoxygenase, no activation of 0.7 kb or similar to 2.3 kb promoter fragments by TGF-beta and 1 alpha,25(OH)(2)D-3 could be observed in transient reporter assays for CD69. Analysis of mRNA stability using a transcription inhibitor and a 3'UTR reporter construct showed that TGF-beta and 1 alpha,25(OH)(2)D-3 do not influence CD69 mRNA stability. Functional knockdown of Smad3 clearly demonstrated that upregulation of CD69 mRNA, in contrast to 5-LO, depends on Smad3. Comparative studies with different inhibitors for mitogen activated protein kinases (MAPKs) revealed that MAPK signalling is involved in CD69 gene regulation, whereas 5-lipoxygenase gene expression was only partly affected. Mechanistically, we found evidence that CD69 gene upregulation depends on TAK1-mediated p38 activation. In summary, our data indicate that CD69 gene expression, conforming with 5-lipoxygenase, is regulated monocyte-specifically by the physiologic stimuli TGF-beta and 1 alpha,25(OH)(2)D-3 on mRNA level, although different mechanisms account for the upregulation of each gene.	[Woebke, Thea K.; Steinhilber, Dieter; Sorg, Bernd L.] Goethe Univ Frankfurt, Inst Pharmaceut Chem, ZAFES, D-60054 Frankfurt, Germany; [von Knethen, Andreas] Goethe Univ Frankfurt, Fac Med, Inst Biochem Pathobiochem 1, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Sorg, BL (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, ZAFES, D-60054 Frankfurt, Germany.	b.sorg@pharmchem.uni-frankfurt.de	Sánchez-Margalet, Victor/AAB-9986-2021; Steinhilber, Dieter/J-3221-2012	Sánchez-Margalet, Victor/0000-0001-8638-8680; 	Goethe University, Frankfurt am Main, Germany	Goethe University, Frankfurt am Main, Germany	The study has been funded by the Goethe University, Frankfurt am Main, Germany. (www.uni-frankfurt.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNGS M, 1994, BIOCHEM BIOPH RES CO, V205, P1572, DOI 10.1006/bbrc.1994.2846; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Bury Y, 2001, J INVEST DERMATOL, V116, P785, DOI 10.1046/j.1523-1747.2001.01332.x; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Carlberg C, 2007, DERMATOL CLIN, V25, P515, DOI 10.1016/j.det.2007.06.004; Castellanos MD, 2002, EUR J IMMUNOL, V32, P3108; Castellanos MD, 1997, J IMMUNOL, V159, P5463; CEBRIAN M, 1989, EUR J IMMUNOL, V19, P809, DOI 10.1002/eji.1830190505; DEMARIA R, 1994, J EXP MED, V180, P1999, DOI 10.1084/jem.180.5.1999; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Heberden C, 1998, GEN PHARMACOL-VASC S, V30, P145, DOI 10.1016/S0306-3623(97)00271-1; Herdick M, 2000, CHEM BIOL, V7, P885, DOI 10.1016/S1074-5521(00)00036-3; JAKOBSSON PJ, 1992, P NATL ACAD SCI USA, V89, P3521, DOI 10.1073/pnas.89.8.3521; Kanies CL, 2008, MOL CANCER RES, V6, P1124, DOI 10.1158/1541-7786.MCR-07-2095; Karimi K, 1999, J LEUKOCYTE BIOL, V65, P854, DOI 10.1002/jlb.65.6.854; Klan N, 2003, BIOTECHNIQUES, V34, P142, DOI 10.2144/03341rr05; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; MORIKAWA M, 1990, IN VITRO CELL DEV B, V26, P682; Mu Y, 2011, CELL TISSUE RES; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Newton R, 1997, FEBS LETT, V418, P135, DOI 10.1016/S0014-5793(97)01362-8; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Ramirez R, 1996, CELL IMMUNOL, V172, P192, DOI 10.1006/cimm.1996.0232; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; SANTIS AG, 1995, EUR J IMMUNOL, V25, P2142, DOI 10.1002/eji.1830250804; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Seuter S, 2006, BIOCHEM BIOPH RES CO, V348, P1403, DOI 10.1016/j.bbrc.2006.08.011; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; STEINHILBER D, 1993, P NATL ACAD SCI USA, V90, P5984, DOI 10.1073/pnas.90.13.5984; TESTA U, 1993, J IMMUNOL, V150, P2418; Werz O, 1996, PHARMAZIE, V51, P893; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yim D, 2002, IMMUNOGENETICS, V54, P276, DOI 10.1007/s00251-002-0464-6; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; ZHANG DE, 1994, J IMMUNOL, V153, P3276; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64635	10.1371/journal.pone.0064635	http://dx.doi.org/10.1371/journal.pone.0064635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696902	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900104
J	Chung, SD; Lin, HC				Chung, Shiu-Dong; Lin, Herng-Ching			Association between Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Anxiety Disorder: A Population-Based Study	PLOS ONE			English	Article							CHRONIC IDIOPATHIC PROSTATITIS; INSURANCE RESEARCH DATABASE; INTERSTITIAL CYSTITIS; PANIC DISORDER; RISK-FACTORS; PREVALENCE; MEN; DEPRESSION; DIAGNOSES; TAIWAN	Background: this case-control study utilized a population-based dataset to examine the association of chronic prostatitis/ chronic pelvic pain syndrome (CP/CPPS) with prior anxiety disorder (AD) by comparing the risk of prior AD between subjects with CP/CPPS and matched controls in Taiwan. Methods: We study used data sourced from the Taiwan Longitudinal Health Insurance Database. The cases comprised 8,088 subjects with CP/CPPS and 24,264 randomly matched subjects as controls. We used a conditional logistic regression to calculate the odds ratio (OR) for having been previously diagnosed with AD between subjects with and without CP/CPPS. Results: Of the 24 similar to 264 sampled subjects, 2309 (7.1%) had received an AD diagnosis before the index date; AD was found in 930 (11.5%) cases and 1379 (5.7%) controls (p<0.001). The conditional logistic regression analysis revealed that compared to controls, the OR for prior AD among cases was 2.10 (95% CI = 1.92,2.29, p<0.001) after adjusting for diabetes, hypertension, hyperlipidemia, and sexually transmitted diseases. Our results show that CP/CPPS was consistently and significantly associated with prior AD in all age groups (18 similar to 39, 40 similar to 59, and >59 years). In particular, subjects aged 40 similar to 59 years had the highest adjusted OR (of 2.53) for prior AD among cases compared to controls. Conclusions: We concluded that CP/CPPS is associated with previously diagnosed AD. Urologists should be alert for the association between CP/CPPS and AD in subjects suffering from AD.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	henry11111@tmu.edu.tw						Ahn SG, 2012, KOREAN J UROL, V53, P643, DOI 10.4111/kju.2012.53.9.643; Anderson RU, 2008, J UROLOGY, V179, P956, DOI 10.1016/j.juro.2007.10.084; BERGER RE, 1989, J UROLOGY, V141, P328, DOI 10.1016/S0022-5347(17)40757-9; Berghuis JP, 1996, J PSYCHOSOM RES, V41, P313, DOI 10.1016/S0022-3999(96)00157-2; Blok BFM, 2002, UROLOGY, V59, P13, DOI 10.1016/S0090-4295(01)01633-8; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Clemens JQ, 2008, J UROLOGY, V180, P1378, DOI 10.1016/j.juro.2008.06.032; Clemens JQ, 2007, J UROLOGY, V178, P1333, DOI 10.1016/j.juro.2007.05.140; Collins MM, 2002, J UROLOGY, V167, P1363, DOI 10.1016/S0022-5347(05)65301-3; DELAROSETTE JJMCH, 1992, EUR UROL, V22, P14; GATENBECK L, 1987, PROSTATE, V11, P69, DOI 10.1002/pros.2990110109; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Lutgendorf SK, 2002, J UROLOGY, V167, P1338, DOI 10.1016/S0022-5347(05)65295-0; Marciniak MD, 2005, DEPRESS ANXIETY, V21, P178, DOI 10.1002/da.20074; Marques L, 2011, EXPERT REV NEUROTHER, V11, P313, DOI [10.1586/ern.10.122, 10.1586/ERN.10.122]; McLaughlin TP, 2006, J CLIN PSYCHIAT, V67, P1187, DOI 10.4088/JCP.v67n0803; MILLER HC, 1988, UROLOGY, V32, P507, DOI 10.1016/S0090-4295(98)90030-9; Motrich RD, 2007, SCAND J IMMUNOL, V66, P217, DOI 10.1111/j.1365-3083.2007.01971.x; Parsons CL, 2003, UROLOGY, V62, P976, DOI 10.1016/S0090-4295(03)00774-X; Pontari MA, 2005, BJU INT, V96, P559, DOI 10.1111/j.1464-410X.2005.05684.x; Pontari MA, 2008, J UROLOGY, V179, pS61, DOI 10.1016/j.juro.2008.03.139; Schneider H, 2003, ANDROLOGIA, V35, P258, DOI 10.1046/j.1439-0272.2003.00586.x; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spanos C, 1997, J UROLOGY, V157, P669, DOI 10.1016/S0022-5347(01)65247-9; Weissman MM, 2004, ARCH GEN PSYCHIAT, V61, P273, DOI 10.1001/archpsyc.61.3.273; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E	28	18	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64630	10.1371/journal.pone.0064630	http://dx.doi.org/10.1371/journal.pone.0064630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145XK	23691256	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700113
J	Futahashi, R; Tanaka, K; Tanahashi, M; Nikoh, N; Kikuchi, Y; Lee, BL; Fukatsu, T				Futahashi, Ryo; Tanaka, Kohjiro; Tanahashi, Masahiko; Nikoh, Naruo; Kikuchi, Yoshitomo; Lee, Bok Luel; Fukatsu, Takema			Gene Expression in Gut Symbiotic Organ of Stinkbug Affected by Extracellular Bacterial Symbiont	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; DROSOPHILA-MELANOGASTER; INSECT DEFENSIN; LYSOZYME LOCUS; CATHEPSIN-B; MIDGUT; FAMILY; PURIFICATION; WOLBACHIA; SEQUENCE	The bean bug Riptortus pedestris possesses a specialized symbiotic organ in a posterior region of the midgut, where numerous crypts harbor extracellular betaproteobacterial symbionts of the genus Burkholderia. Second instar nymphs orally acquire the symbiont from the environment, and the symbiont infection benefits the host by facilitating growth and by occasionally conferring insecticide resistance. Here we performed comparative transcriptomic analyses of insect genes expressed in symbiotic and non-symbiotic regions of the midgut dissected from Burkholderia-infected and uninfected R. pedestris. Expression sequence tag analysis of cDNA libraries and quantitative reverse transcription PCR identified a number of insect genes expressed in symbiosis-or aposymbiosis-associated patterns. For example, genes up-regulated in symbiotic relative to aposymbiotic individuals, including many cysteine-rich secreted protein genes and many cathepsin protease genes, are likely to play a role in regulating the symbiosis. Conversely, genes up-regulated in aposymbiotic relative to symbiotic individuals, including a chicken-type lysozyme gene and a defensin-like protein gene, are possibly involved in regulation of non-symbiotic bacterial infections. Our study presents the first transcriptomic data on gut symbiotic organ of a stinkbug, which provides initial clues to understanding of molecular mechanisms underlying the insect-bacterium gut symbiosis and sheds light on several intriguing commonalities between endocellular and extracellular symbiotic associations.	[Futahashi, Ryo; Tanaka, Kohjiro; Tanahashi, Masahiko; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan; [Kikuchi, Yoshitomo] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Hokkaido Ctr, Sapporo, Hokkaido, Japan; [Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Pusan, South Korea	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Pusan National University	Futahashi, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	ryo-futahashi@aist.go.jp	Kikuchi, Yoshitomo/M-7564-2018; Futahashi, Ryo/I-2825-2018	Kikuchi, Yoshitomo/0000-0002-1651-2532; Futahashi, Ryo/0000-0003-4791-7054	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Global Research Laboratory (GRL) program; Japan Society for the Promotion of Science (JSPS)	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Global Research Laboratory (GRL) program; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), the Global Research Laboratory (GRL) program, and the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bourtzis K, 2003, CONT T ENT, P217; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CHALK R, 1994, INSECT BIOCHEM MOLEC, V24, P403, DOI 10.1016/0965-1748(94)90033-7; Chevalier F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S1; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; ENGSTROM P, 1984, EMBO J, V3, P3347, DOI 10.1002/j.1460-2075.1984.tb02302.x; Fujita AI, 2004, PHYSIOL ENTOMOL, V29, P305, DOI 10.1111/j.0307-6962.2004.00393.x; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P1129, DOI 10.1016/S0965-1748(99)00104-6; Glasgow H, 1914, BIOL BULL-US, V26, P101, DOI 10.2307/1536004; GOODCHILD A. J. P., 1963, PROC ZOOL SOC LONDON, V141, P851; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; HOFFMANN JA, 1992, IMMUNOL TODAY, V13, P411, DOI 10.1016/0167-5699(92)90092-L; HOUSEMAN JG, 1983, COMP BIOCHEM PHYS B, V75, P509, DOI 10.1016/0305-0491(83)90367-X; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2008, MICROBIAL ECOLOGY RE; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kikuchi Y, 2011, APPL ENVIRON MICROB, V77, P4075, DOI 10.1128/AEM.00358-11; Koiwa H, 2000, FEBS LETT, V471, P67, DOI 10.1016/S0014-5793(00)01368-5; Kollien AH, 2003, ARCH INSECT BIOCHEM, V53, P134, DOI 10.1002/arch.10090; Kopacek P, 1999, INSECT BIOCHEM MOLEC, V29, P989, DOI 10.1016/S0965-1748(99)00075-2; Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kutsukake M, 2004, P NATL ACAD SCI USA, V101, P11338, DOI 10.1073/pnas.0402462101; KYLSTEN P, 1992, MOL GEN GENET, V232, P335, DOI 10.1007/BF00266235; LEMOS FJA, 1993, INSECT BIOCHEM MOLEC, V23, P533, DOI 10.1016/0965-1748(93)90062-W; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mittapalli O, 2006, J INSECT PHYSIOL, V52, P1143, DOI 10.1016/j.jinsphys.2006.08.007; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moriyama M, 2012, APPL ENTOMOL ZOOL, V47, P233, DOI 10.1007/s13355-012-0112-z; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nakamura Y, 2011, INSECT MOL BIOL, V20, P279, DOI 10.1111/j.1365-2583.2010.01056.x; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSELL VW, 1991, ARCH INSECT BIOCHEM, V17, P67, DOI 10.1002/arch.940170202; Schuh R.T., 1995, TRUE BUGS WORLD HEMI; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Shigenobu S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1952; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Stougaard J, 2000, PLANT PHYSIOL, V124, P531, DOI 10.1104/pp.124.2.531; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tautz D, 2010, MOL ECOL, V19, P1, DOI 10.1111/j.1365-294X.2009.04489.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Vigneron A, 2012, BMC MICROBIOL, P12; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; XI ZY, 2008, BMC GENOMICS, V9; Zhang Y, 2009, ARCH INSECT BIOCHEM, V70, P18, DOI 10.1002/arch.20258	80	53	54	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64557	10.1371/journal.pone.0064557	http://dx.doi.org/10.1371/journal.pone.0064557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691247	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400133
J	Cui, GY; Freeman, CS; Knotts, T; Prince, CZ; Kuang, C; McCarty, NA				Cui, Guiying; Freeman, Cody S.; Knotts, Taylor; Prince, Chengyu Z.; Kuang, Christopher; McCarty, Nael A.			Two Salt Bridges Differentially Contribute to the Maintenance of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; VOLTAGE SENSOR; PORE ARCHITECTURE; PERMEANT IONS; ACTIVATION; MUTATIONS; ALTER; TRANSPORTER; INHIBITION; DOMAINS	Previous studies have identified two salt bridges in human CFTR chloride ion channels, Arg(352)-Asp(993) and Arg(347)-Asp(924), that are required for normal channel function. In the present study, we determined how the two salt bridges cooperate to maintain the open pore architecture of CFTR. Our data suggest that Arg(347) not only interacts with Asp(924) but also interacts with Asp(993). The tripartite interaction Arg(347)-Asp(924)-Asp(993) mainly contributes to maintaining a stable s2 open subconductance state. The Arg352-Asp993 salt bridge, in contrast, is involved in stabilizing both the s2 and full (f) open conductance states, with the main contribution being to the f state. The s1 subconductance state does not require either salt bridge. In confirmation of the role of Arg(352) and Asp(993), channels bearing cysteines at these sites could be latched into a full open state using the bifunctional cross-linker 1,2-ethanediyl bismethanethiosulfonate, but only when applied in the open state. Channels remained latched open even after washout of ATP. The results suggest that these interacting residues contribute differently to stabilizing the open pore in different phases of the gating cycle.	[McCarty, Nael A.] Emory Univ, Sch Med, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Cyst Fibrosis Res Ctr,Dept Pediat, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA)	McCarty, NA (corresponding author), Emory Univ, Sch Med, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Cyst Fibrosis Res Ctr,Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	namccar@emory.edu			National Institutes of Health Grant [R01-DK056481]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056481, R01DK075016] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK056481 (to N. M.).	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dawson DC, 1997, J GEN PHYSIOL, V110, P337, DOI 10.1085/jgp.110.4.337; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Fuller MD, 2007, J BIOL CHEM, V282, P37545, DOI 10.1074/jbc.M708079200; Fuller MD, 2005, BIOPHYS J, V89, P3960, DOI 10.1529/biophysj.105.060731; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; MARCHAIS D, 1979, J PHYSIOL-LONDON, V297, P9, DOI 10.1113/jphysiol.1979.sp013025; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Moroni A, 2006, NAT CHEM BIOL, V2, P572, DOI 10.1038/nchembio1106-572; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1992, BIOCHIM BIOPHYS ACTA, V1101, P221, DOI 10.1016/0005-2728(92)90230-Y; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200	35	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20758	20767		10.1074/jbc.M113.476226	http://dx.doi.org/10.1074/jbc.M113.476226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709221	Green Published, hybrid			2022-12-25	WOS:000321715100060
J	Jones, TE; de Pouplana, LR; Alexander, RW				Jones, Thomas E.; Ribas de Pouplana, Llus; Alexander, Rebecca W.			Evidence for Late Resolution of the AUX Codon Box in Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; AMINO-ACID SPECIFICITIES; ZINC-BINDING DOMAIN; TRANSLATIONAL FIDELITY; LYSIDINE SYNTHETASE; MAXIMUM-LIKELIHOOD; GENOMIC SEQUENCE; STRUCTURAL BASIS; ACCEPTOR STEM; GENETIC-CODE	Recognition strategies for tRNA aminoacylation are ancient and highly conserved, having been selected very early in the evolution of the genetic code. In most cases, the trinucleotide anticodons of tRNA are important identity determinants for aminoacylation by cognate aminoacyl-tRNA synthetases. However, a degree of ambiguity exists in the recognition of certain tRNA(Ile) isoacceptors that are initially transcribed with the methionine-specifying CAU anticodon. In most organisms, the C34 wobble position in these tRNA(Ile) precursors is rapidly modified to lysidine to prevent recognition by methionyl-tRNA synthetase (MRS) and production of a chimeric Met-tRNA(Ile) that would compromise translational fidelity. In certain bacteria, however, lysidine modification is not required for MRS rejection, indicating that this recognition strategy is not universally conserved and may be relatively recent. To explore the actual distribution of lysidine-dependent tRNA(Ile) rejection by MRS, we have investigated the ability of bacterial MRSs from different clades to differentiate cognate tRNA(CAU)(Met) from near-cognate tRNA(CAU)(Ile). Discrimination abilities vary greatly and appear unrelated to phylogenetic or structural features of the enzymes or sequence determinants of the tRNA. Our data indicate that tRNA(Ile) identity elements were established late and independently in different bacterial groups. We propose that the observed variation in MRS discrimination ability reflects differences in the evolution of genetic code machineries of emerging bacterial clades.	[Jones, Thomas E.; Alexander, Rebecca W.] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Jones, Thomas E.; Ribas de Pouplana, Llus] Inst Catalana Reserca Estudis Avancats, Barcelona 08010, Catalonia, Spain	Wake Forest University; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, Barcelona 08208, Catalonia, Spain.	lluisribas@irbbarcelona.org; alexanr@wfu.edu			National Science Foundation [MCB-0448243]; Spanish Ministry of Science and Technology [BIO2009-09776]; ICREA Funding Source: Custom	National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	This work was supported by National Science Foundation Grant MCB-0448243 (to R. W. A.) and Spanish Ministry of Science and Technology Grant BIO2009-09776 (to L. R. d. P.).	Banerjee P, 2009, BIOCHEMISTRY-US, V48, P10113, DOI 10.1021/bi9012275; Brown JR, 2003, EMBO REP, V4, P692, DOI 10.1038/sj.embor.embor881; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; de Pouplana LR, 2000, CELL MOL LIFE SCI, V57, P865, DOI 10.1007/PL00000729; Fabret C, 2011, MOL MICROBIOL, V80, P1062, DOI 10.1111/j.1365-2958.2011.07630.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FOURMY D, 1995, BIOCHEMISTRY-US, V34, P15681, DOI 10.1021/bi00048a012; FOURMY D, 1993, J MOL BIOL, V231, P1078, DOI 10.1006/jmbi.1993.1353; FOURMY D, 1993, J MOL BIOL, V231, P1068, DOI 10.1006/jmbi.1993.1352; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Jones TE, 2008, MOL CELL, V29, P401, DOI 10.1016/j.molcel.2007.12.021; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; KOWALD A, 1993, J THEOR BIOL, V160, P493, DOI 10.1006/jtbi.1993.1032; Kuratani M, 2007, STRUCTURE, V15, P1642, DOI 10.1016/j.str.2007.09.020; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; MEINNEL T, 1993, J MOL BIOL, V229, P26, DOI 10.1006/jmbi.1993.1005; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; NAGEL GM, 1991, P NATL ACAD SCI USA, V88, P8121, DOI 10.1073/pnas.88.18.8121; Nakanishi K, 2009, NATURE, V461, P1144, DOI 10.1038/nature08474; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SCHULMAN LH, 1991, PROG NUCL ACID RES M, V41, P23; Sherlin LD, 2001, RNA, V7, P1671; Silva FJ, 2006, NUCLEIC ACIDS RES, V34, P6015, DOI 10.1093/nar/gkl739; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Taniguchi T, 2013, NUCLEIC ACIDS RES, V41, P2621, DOI 10.1093/nar/gks1344; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P4291, DOI 10.1093/nar/27.21.4291	40	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19625	19632		10.1074/jbc.M112.449249	http://dx.doi.org/10.1074/jbc.M112.449249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696642	Green Published, hybrid			2022-12-25	WOS:000321515800028
J	Bonander, N; Jamshad, M; Oberthur, D; Clare, M; Barwell, J; Hu, K; Farquhar, MJ; Stamataki, Z; Harris, HJ; Dierks, K; Dafforn, TR; Betzel, C; McKeating, JA; Bill, RM				Bonander, Nicklas; Jamshad, Mohammed; Oberthuer, Dominik; Clare, Michelle; Barwell, James; Hu, Ke; Farquhar, Michelle J.; Stamataki, Zania; Harris, Helen J.; Dierks, Karsten; Dafforn, Timothy R.; Betzel, Christian; McKeating, Jane A.; Bill, Roslyn M.			Production, Purification and Characterization of Recombinant, Full-Length Human Claudin-1	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; STRUCTURAL-CHARACTERIZATION; TRANSMEMBRANE PROTEIN; TETRASPANIN PROTEINS; MEMBRANE-PROTEINS; CD81; ENTRY; ASSOCIATION; INFECTION; RECEPTOR	The transmembrane domain proteins of the claudin superfamily are the major structural components of cellular tight junctions. One family member, claudin-1, also associates with tetraspanin CD81 as part of a receptor complex that is essential for hepatitis C virus (HCV) infection of the liver. To understand the molecular basis of claudin-1/CD81 association we previously produced and purified milligram quantities of functional, full-length CD81, which binds a soluble form of HCV E2 glycoprotein (sE2). Here we report the production, purification and characterization of claudin-1. Both yeast membrane-bound and detergent-extracted, purified claudin-1 were antigenic and recognized by specific antibodies. Analytical ultracentrifugation demonstrated that extraction with n-octyl-beta-D-glucopyranoside yielded monodispersed, dimeric pools of claudin-1 while extraction with profoldin-8 or n-decylphosphocholine yielded a dynamic mixture of claudin-1 oligomers. Neither form bound sE2 in line with literature expectations, while further functional analysis was hampered by the finding that incorporation of claudin-1 into proteoliposomes rendered them intractable to study. Dynamic light scattering demonstrated that claudin-1 oligomers associate with CD81 in vitro in a defined molar ratio of 1:2 and that complex formation was enhanced by the presence of cholesteryl hemisuccinate. Attempts to assay the complex biologically were limited by our finding that claudin-1 affects the properties of proteoliposomes. We conclude that recombinant, correctly-folded, full-length claudin-1 can be produced in yeast membranes, that it can be extracted in different oligomeric forms that do not bind sE2 and that a dynamic preparation can form a specific complex with CD81 in vitro in the absence of any other cellular components. These findings pave the way for the structural characterization of claudin-1 alone and in complex with CD81.	[Bonander, Nicklas; Jamshad, Mohammed; Clare, Michelle; Barwell, James; Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Bonander, Nicklas] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Oberthuer, Dominik; Dierks, Karsten; Betzel, Christian] Univ Hamburg, Inst Biochem & Mol Biol, Lab Struct Biol Infect & Inflammat, Hamburg, Germany; [Oberthuer, Dominik] Deutsch Elektronen Synchrotron DESY, Ctr Free Electron Laser Sci, Hamburg, Germany; [McKeating, Jane A.] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England; [McKeating, Jane A.] Univ Birmingham, NIHR Ctr Liver Dis, Birmingham, W Midlands, England; [Dafforn, Timothy R.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Aston University; Chalmers University of Technology; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Birmingham; University of Birmingham; University of Birmingham	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Aston Triangle, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk	Betzel, Christian/G-8105-2018; Bill, Roslyn M/D-4554-2012; Oberthuer, Dominik/AAG-5059-2021; Stamataki, Zania/P-4681-2019; Dafforn, Tim/A-9072-2015	Betzel, Christian/0000-0002-3879-5019; Bill, Roslyn M/0000-0003-1331-0852; Oberthuer, Dominik/0000-0002-0894-9590; Stamataki, Zania/0000-0003-3823-4497; Dafforn, Tim/0000-0003-2257-6679; McKeating, Jane/0000-0002-7229-5886	OptiCryst [LSHG-CT-2006-037793]; E-MeP [LSHG-CT-2004-504601]; Wellcome Trust [14101]; BBSRC; MRC; Royal Society Dorothy Hodgkin Fellowship; Wellcome Trust ISSF award; Rontgen-Angstrom-Cluster [05K12GU3]; German Federal Ministry of Education and Research (BMBF); Biotechnology and Biological Sciences Research Council, UK [BB/H016651/1]; Janssen; MRC [G0801976, G1100247] Funding Source: UKRI; Medical Research Council [G1100247, G0801976] Funding Source: researchfish	OptiCryst; E-MeP; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); Wellcome Trust ISSF award(Wellcome Trust); Rontgen-Angstrom-Cluster; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Commission (via contracts LSHG-CT-2006-037793 (OptiCryst) and LSHG-CT-2004-504601 (E-MeP)), the Wellcome Trust (Grant 14101) and BBSRC to RMB, and by Wellcome Trust and MRC grants to JAM. MC is supported by a BBSRC studentship with Janssen. ZS is supported by a Royal Society Dorothy Hodgkin Fellowship and a Wellcome Trust ISSF award. DO and CB are supported by the Rontgen-Angstrom-Cluster (Project 05K12GU3) and the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Michelle Clare is supported by grant BB/H016651/1 from the Biotechnology and Biological Sciences Research Council, UK, which is co-sponsored by Janssen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bonander Nicklas, 2012, Methods Mol Biol, V866, P1, DOI 10.1007/978-1-61779-770-5_1; Bonander N, 2011, BIOCHEM SOC T, V39, P537, DOI 10.1042/BST0390537; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Davis C, 2012, CELLULAR MI IN PRESS; Dierks K, 2008, CRYST GROWTH DES, V8, P1628, DOI 10.1021/cg701067r; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Harris HJ, 2013, CELL MICROBIOL, V15, P430, DOI 10.1111/cmi.12047; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jamshad M, 2008, PROTEIN EXPRES PURIF, V57, P206, DOI 10.1016/j.pep.2007.10.013; Jamshad M, 2011, BIOCHEM SOC T, V39, P813, DOI 10.1042/BST0390813; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LORBER B, 1990, BIOCHIM BIOPHYS ACTA, V1023, P254, DOI 10.1016/0005-2736(90)90421-J; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Ma JC, 2008, J APPL CRYSTALLOGR, V41, P1150, DOI 10.1107/S0021889808033797; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Oberthuer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033545; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; RENSHAW PF, 1983, J LIPID RES, V24, P47; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmitz K. S., 1990, INTRO DYNAMIC LIGHT; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Simons K, 2011, P NATL ACAD SCI; Singh Shweta, 2012, Methods Mol Biol, V866, P197, DOI 10.1007/978-1-61779-770-5_17; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Werkmeister E, 2013, CELL MICROBIOL; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002	54	8	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64517	10.1371/journal.pone.0064517	http://dx.doi.org/10.1371/journal.pone.0064517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704991	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000319330200145
J	della Vergiliana, JFV; Lansley, SM; Porcel, JM; Bielsa, S; Brown, JS; Creaney, J; Temple, SEL; Waterer, GW; Lee, YCG				della Vergiliana, Julius F. Varano; Lansley, Sally M.; Porcel, Jose M.; Bielsa, Silvia; Brown, Jeremy S.; Creaney, Jenette; Temple, Suzanna E. L.; Waterer, Grant W.; Lee, Y. C. Gary			Bacterial Infection Elicits Heat Shock Protein 72 Release from Pleural Mesothelial Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN-70 HSP70; PARAPNEUMONIC EFFUSIONS; INFLAMMATORY RESPONSE; CYTOKINE PRODUCTION; MURINE MACROPHAGES; EXPRESSION; EMPYEMA; PATHWAY; CONTAMINATION	Heat shock protein 70 (HSP70) has been implicated in infection-related processes and has been found in body fluids during infection. This study aimed to determine whether pleural mesothelial cells release HSP70 in response to bacterial infection in vitro and in mouse models of serosal infection. In addition, the in vitro cytokine effects of the HSP70 isoform, Hsp72, on mesothelial cells were examined. Further, Hsp72 was measured in human pleural effusions and levels compared between non-infectious and infectious patients to determine the diagnostic accuracy of pleural fluid Hsp72 compared to traditional pleural fluid parameters. We showed that mesothelial release of Hsp72 was significantly raised when cells were treated with live and heat-killed Streptococcus pneumoniae. In mice, intraperitoneal injection of S. pneumoniae stimulated a 2-fold increase in Hsp72 levels in peritoneal lavage (p < 0.01). Extracellular Hsp72 did not induce or inhibit mediator release from cultured mesothelial cells. Hsp72 levels were significantly higher in effusions of infectious origin compared to non-infectious effusions (p < 0.05). The data establish that pleural mesothelial cells can release Hsp72 in response to bacterial infection and levels are raised in infectious pleural effusions. The biological role of HSP70 in pleural infection warrants exploration.	[della Vergiliana, Julius F. Varano; Lansley, Sally M.; Lee, Y. C. Gary] Univ Western Australia, Lung Inst Western Australia, Sch Med & Pharmacol, Pleural Dis Unit,Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Porcel, Jose M.; Bielsa, Silvia] Arnau de Vilanova Univ Hosp, Biomed Res Inst Lleida, Dept Internal Med, Pleural Dis Unit, Lleida, Spain; [Brown, Jeremy S.] Ctr Resp Res, London, England; [Brown, Jeremy S.] UCL, London, England; [Creaney, Jenette] Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Temple, Suzanna E. L.; Waterer, Grant W.] Royal Perth Hosp, Resp Dept, Perth, WA, Australia; [Lee, Y. C. Gary] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia	University of Western Australia; University of London; University College London; University of London; University College London; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Lee, YCG (corresponding author), Univ Western Australia, Lung Inst Western Australia, Sch Med & Pharmacol, Pleural Dis Unit,Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia.	gary.lee@uwa.edu.au	Lee, Y C Gary/H-5264-2014; Waterer, Grant/AAG-2385-2021	Bielsa, Silvia/0000-0001-6888-4162; Brown, Jeremy/0000-0002-5650-5361; Lee, Yun Chor Gary/0000-0002-0036-511X	Royal Perth Hospital Medical Research Foundation; Cancer Council Western Australia; Westcare; Sir Charles Gairdner Research Advisory Committee; New South Wales Dust Disease Board; University of Western Australia; UCLH/UCL Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre	Royal Perth Hospital Medical Research Foundation; Cancer Council Western Australia(Cancer Council Western Australia); Westcare; Sir Charles Gairdner Research Advisory Committee; New South Wales Dust Disease Board; University of Western Australia; UCLH/UCL Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This project was supported, in part, by a Royal Perth Hospital Medical Research Foundation grant. Y.C. Gary Lee receives research funding from project grants from Cancer Council Western Australia, Westcare, Sir Charles Gairdner Research Advisory Committee, and the New South Wales Dust Disease Board. Sally M. Lansley receives a research grant from the University of Western Australia. Jeremy S. Brown is supported by the UCLH/UCL Biomedical Research Centre, which receives a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Brims FJH, 2010, EUR RESPIR REV, V19, P220, DOI 10.1183/09059180.00005610; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Davies HE, 2009, AM J RESP CRIT CARE, V180, P437, DOI 10.1164/rccm.200811-1729OC; Elstrand MB, 2009, INT J GYNECOL PATHOL, V28, P211, DOI 10.1097/PGP.0b013e31818b0f5e; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Gao BC, 2004, BIOCHEM BIOPH RES CO, V317, P1149, DOI 10.1016/j.bbrc.2004.03.160; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Giraldo E, 2010, BRAIN BEHAV IMMUN, V24, P672, DOI 10.1016/j.bbi.2010.02.003; Guo H, 2010, PROSTATE CANC PROSTA; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hecker JG, 2008, CELL STRESS CHAPERON, V13, P435, DOI 10.1007/s12192-008-0039-z; Ianaro A, 2001, FEBS LETT, V508, P61, DOI 10.1016/S0014-5793(01)03035-6; Ianaro A, 2001, FEBS LETT, V499, P239, DOI 10.1016/S0014-5793(01)02569-8; Kang Rui, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P346; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Koegelenberg CFN, 2008, RESPIRATION, V75, P241, DOI 10.1159/000117172; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lansley SM, 2010, J CELL MOL MED, V15, P2095; Lee YCG, 2005, AM J PHYSIOL-LUNG C, V288, pL734, DOI 10.1152/ajplung.00173.2004; Light Richard W, 2006, Proc Am Thorac Soc, V3, P75, DOI 10.1513/pats.200510-113JH; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Lisboa T, 2011, RESPIROLOGY, V16, P598, DOI 10.1111/j.1440-1843.2011.01964.x; Luo XJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2399; Luo XJ, 2008, CELL STRESS CHAPERON, V13, P365, DOI 10.1007/s12192-008-0036-2; Madden J, 2010, CELL BIOL TOXICOL, V26, P215, DOI 10.1007/s10565-009-9134-x; MISTRY Y, 1992, INFECT IMMUN, V60, P3105, DOI 10.1128/IAI.60.8.3105-3110.1992; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Riesenhuber A, 2011, PERITON DIALYSIS INT, V31, P332, DOI 10.3747/pdi.2009.00206; Sahn SA, 2007, CLIN INFECT DIS, V45, P1480, DOI 10.1086/522996; SCHWAN WR, 1994, P NATL ACAD SCI USA, V91, P6428, DOI 10.1073/pnas.91.14.6428; Singleton KD, 2006, AM J PHYSIOL-LUNG C, V290, pL956, DOI 10.1152/ajplung.00466.2005; Suzuki T, 2000, INT J ORAL MAX SURG, V29, P301, DOI 10.1034/j.1399-0020.2000.290414.x; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Tobin CL, 2012, CURR OPIN PULM MED, V18, P321, DOI 10.1097/MCP.0b013e328352c673; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Van Molle W, 2007, CANCER RES, V67, P7301, DOI 10.1158/0008-5472.CAN-06-4010; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Wheeler Derek S, 2005, Pediatr Crit Care Med, V6, P308, DOI 10.1097/01.PCC.0000161075.97355.2E; Wood KL, 2010, J HEART LUNG TRANSPL, V29, P786, DOI 10.1016/j.healun.2010.03.004; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200; Zou N, 2008, AM J PHYSIOL-HEART C, V294, pH2805, DOI 10.1152/ajpheart.00299.2008	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63873	10.1371/journal.pone.0063873	http://dx.doi.org/10.1371/journal.pone.0063873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704948	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200079
J	Hall, H; Jewett, M; Landeck, N; Nilsson, N; Schagerlof, U; Leanza, G; Kirik, D				Hall, Helene; Jewett, Michael; Landeck, Natalie; Nilsson, Nathalie; Schagerlof, Ulrika; Leanza, Giampiero; Kirik, Deniz			Characterization of Cognitive Deficits in Rats Overexpressing Human Alpha-Synuclein in the Ventral Tegmental Area and Medial Septum Using Recombinant Adeno-Associated Viral Vectors	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINE NEURONS; LEWY BODIES; ALZHEIMERS-DISEASE; MOUSE MODEL; MICE; IMPAIRMENT; DEGENERATION; PATHOLOGY; MIDBRAIN	Intraneuronal inclusions containing alpha-synuclein (a-syn) constitute one of the pathological hallmarks of Parkinson's disease (PD) and are accompanied by severe neurodegeneration of A9 dopaminergic neurons located in the substantia nigra. Although to a lesser extent, A10 dopaminergic neurons are also affected. Neurodegeneration of other neuronal populations, such as the cholinergic, serotonergic and noradrenergic cell groups, has also been documented in PD patients. Studies in human post-mortem PD brains and in rodent models suggest that deficits in cholinergic and dopaminergic systems may be associated with the cognitive impairment seen in this disease. Here, we investigated the consequences of targeted overexpression of a-syn in the mesocorticolimbic dopaminergic and septohippocampal cholinergic pathways. Rats were injected with recombinant adeno-associated viral vectors encoding for either human wild-type a-syn or green fluorescent protein (GFP) in the ventral tegmental area and the medial septum/vertical limb of the diagonal band of Broca, two regions rich in dopaminergic and cholinergic neurons, respectively. Histopathological analysis showed widespread insoluble a-syn positive inclusions in all major projections areas of the targeted nuclei, including the hippocampus, neocortex, nucleus accumbens and anteromedial striatum. In addition, the rats overexpressing human a-syn displayed an abnormal locomotor response to apomorphine injection and exhibited spatial learning and memory deficits in the Morris water maze task, in the absence of obvious spontaneous locomotor impairment. As losses in dopaminergic and cholinergic immunoreactivity in both the GFP and a-syn expressing animals were mild-to-moderate and did not differ from each other, the behavioral impairments seen in the a-syn overexpressing animals appear to be determined by the long term persisting neuropathology in the surviving neurons rather than by neurodegeneration.	[Hall, Helene; Jewett, Michael; Landeck, Natalie; Nilsson, Nathalie; Schagerlof, Ulrika; Kirik, Deniz] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Jewett, Michael; Leanza, Giampiero] Univ Trieste, Ctr Neurosci, Dept Life Sci Basic Res & Integrat Neurosci, Trieste, Italy	Lund University; University of Trieste	Hall, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	helene.hall@med.lu.se	Landeck, Natalie/AAR-8915-2020	Landeck, Natalie/0000-0002-8399-4009; LEANZA, Giampiero/0000-0002-8609-2561; Nilsson, Nathalie/0000-0002-5236-3263	European Research Council [TreatPD 242932]; Swedish Research Council [2008-3092, 2009-2318]; Swedish Foundation for Strategic Research (Parkinson's models for translational research)	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research (Parkinson's models for translational research)	This study was supported by grants from the European Research Council (TreatPD 242932), the Swedish Research Council (2008-3092, 2009-2318) and the Swedish Foundation for Strategic Research (Parkinson's models for translational research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 1999, J NEUROL NEUROSUR PS, V67, P492, DOI 10.1136/jnnp.67.4.492; Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bosboom JLW, 2004, J NEURAL TRANSM, V111, P1303, DOI 10.1007/s00702-004-0168-1; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, J NEUROL SCI, V248, P255, DOI 10.1016/j.jns.2006.05.011; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Decressac M, 2012, NEUROBIOL DIS, V45, P939, DOI 10.1016/j.nbd.2011.12.013; DUBOIS B, 1983, BRAIN RES, V288, P213; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Koprich JB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-43; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Maingay M, 2006, NEUROBIOL DIS, V23, P522, DOI 10.1016/j.nbd.2006.04.007; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mattila PM, 2001, ACTA NEUROPATHOL, V102, P160; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; NAKANO I, 1984, ANN NEUROL, V15, P415, DOI 10.1002/ana.410150503; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PERRY EK, 1985, J NEUROL NEUROSUR PS, V48, P413, DOI 10.1136/jnnp.48.5.413; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Szego EM, 2013, NEUROBIOL AGING, V34, P589, DOI 10.1016/j.neurobiolaging.2012.04.012; Szego EM, 2011, J NEUROL SCI, V310, P90, DOI 10.1016/j.jns.2011.06.048; Tanji K, 2010, ACTA NEUROPATHOL, V120, P145, DOI 10.1007/s00401-010-0676-z; Ulusoy A, 2010, P NATL ACAD SCI USA, V107, P13159, DOI 10.1073/pnas.1003432107; Ulusoy A, 2009, MOL THER, V17, P1574, DOI 10.1038/mt.2009.142; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wisman LAB, 2008, J NEUROSCI, V28, P7797, DOI 10.1523/JNEUROSCI.1885-08.2008; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x	47	34	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64844	10.1371/journal.pone.0064844	http://dx.doi.org/10.1371/journal.pone.0064844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705016	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200170
J	Li, LH; Yen, MY; Ho, CC; Wu, P; Wang, CC; Maurya, PK; Chen, PS; Chen, W; Hsieh, WY; Chen, HW				Li, Lan-Hui; Yen, Muh-Yong; Ho, Chao-Chi; Wu, Ping; Wang, Chien-Chun; Maurya, Pawan Kumar; Chen, Pai-Shan; Chen, Wei; Hsieh, Wan-Yu; Chen, Huei-Wen			Non-Cytotoxic Nanomaterials Enhance Antimicrobial Activities of Cefmetazole against Multidrug-Resistant Neisseria gonorrhoeae	PLOS ONE			English	Article							SILVER NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; PARTICLE-SIZE; MECHANISM; CELLS; STRATEGIES; NANOSILVER; IONS	The emergence and spread of antibiotic-resistant Neisseria gonorrhoeae has led to difficulties in treating patients, and novel strategies to prevent and treat this infection are urgently needed. Here, we examined 21 different nanomaterials for their potential activity against N. gonorrhoeae (ATCC 49226). Silver nanoparticles (Ag NPs, 120 nm) showed the greatest potency for reducing N. gonorrhoeae colony formation (MIC: 12.5 mu g/ml) and possessed the dominant influence on the antibacterial activity with their properties of the nanoparticles within a concentration range that did not induce cytotoxicity in human fibroblasts or epithelial cells. Electron microscopy revealed that the Ag NPs significantly reduced bacterial cell membrane integrity. Furthermore, the use of clinical isolates of multidrug-resistant N. gonorrhoeae showed that combined treatment with 120 nm Ag NPs and cefmetazole produced additive effects. This is the first report to screen the effectiveness of nanomaterials against N. gonorrhoeae, and our results indicate that 120 nm Ag NPs deliver low levels of toxicity to human epithelial cells and could be used as an adjuvant with antibiotic therapy, either for topical use or as a coating for biomaterials, to prevent or treat multidrug-resistant N. gonorrhoeae.	[Li, Lan-Hui; Wu, Ping; Hsieh, Wan-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan; [Li, Lan-Hui; Yen, Muh-Yong; Wang, Chien-Chun] Taipei City Hosp, Kunming Branch, Taipei, Taiwan; [Yen, Muh-Yong] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Ho, Chao-Chi] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Ho, Chao-Chi] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wu, Ping] Natl Yang Ming Univ, Sch Med, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Maurya, Pawan Kumar] Amity Univ, Amity Inst Biotechnol, Lucknow, Uttar Pradesh, India; [Chen, Pai-Shan] Natl Taiwan Univ, Coll Med, Dept & Grad Inst Forens Med, Taipei, Taiwan; [Chen, Wei] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan	National Taiwan University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Chen, HW (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei, Taiwan.	shwchen@ntu.edu.tw	Chen, Wei/M-4793-2019	Chen, Wei/0000-0002-2909-3023; Chen, Pai-Shan/0000-0002-2047-4276; HO, CHAO-CHI/0000-0002-8156-2413; CHEN, HUEI-WEN/0000-0001-5051-9896	National Science Council [NSC101-2325-B-002-047]; National Taiwan University Cutting-Edge Steering Research Project [NTU CESRP-10R71602C2, 100R705057]; Research and Diagnostic Center, Centers for Disease Control (CDC), Taiwan; Microarray Core Facility of National Taiwan University-Center of Genomic Medicine (NTUCGM); Clinical Laboratory of Taipei City Hospital Kunming Branch	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project; Research and Diagnostic Center, Centers for Disease Control (CDC), Taiwan; Microarray Core Facility of National Taiwan University-Center of Genomic Medicine (NTUCGM); Clinical Laboratory of Taipei City Hospital Kunming Branch	This study was supported by the National Science Council (NSC101-2325-B-002-047), National Taiwan University Cutting-Edge Steering Research Project (NTU CESRP-10R71602C2 and 100R705057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the technical supports on SEM and TEM by the Joint Center for Instruments and Researches, College of Bioresources and Agriculture at National Taiwan University; ICP-MS by Instrumentation Center at National Tsing-Hua University. The authors also thank the supporting from the Research and Diagnostic Center, Centers for Disease Control (CDC), Taiwan, the Microarray Core Facility of National Taiwan University-Center of Genomic Medicine (NTUCGM) and Clinical Laboratory of Taipei City Hospital Kunming Branch.	Abdel-Mohsen AM, 2012, INT J BIOL MACROMOL, V50, P1245, DOI 10.1016/j.ijbiomac.2012.03.018; Blecher K, 2011, VIRULENCE, V2, P395, DOI 10.4161/viru.2.5.17035; Centers for Disease Control and Prevention (CDC), 2010, MMWR-MORBID MORTAL W, V59, P49; Chen MW, 2011, INT J NANOMED, V6, P2873, DOI 10.2147/IJN.S23945; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Cortivo R, 2010, NANOMEDICINE-UK, V5, P641, DOI 10.2217/NNM.10.32; Danilczuk M, 2006, SPECTROCHIM ACTA A, V63, P189, DOI 10.1016/j.saa.2005.05.002; dos Santos CA, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-43; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Engel LS, 2009, EMERGEN MED, V41, P18; Fayaz AM, 2012, INT J NANOMED, V7, P5007, DOI 10.2147/IJN.S34973; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Hyun JS, 2008, TOXICOL LETT, V179, P130; Jain J, 2009, MOL PHARMACEUT, V6, P1388, DOI 10.1021/mp900056g; Kim ES, 2009, J MICROBIOL BIOTECHN, V19, P1576, DOI 10.4014/jmb.0903.03015; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kong H, 2008, BIOMACROMOLECULES, V9, P2677, DOI 10.1021/bm800574x; Kurek A, 2011, POL J MICROBIOL, V60, P3, DOI 10.33073/pjm-2011-001; Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI [10.1186/1477-3155-8-1, 10.1186/1477-3155-8-15]; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Makepeace BL, 2001, INFECT IMMUN, V69, P1909, DOI 10.1128/IAI.69.3.1909-1913.2001; Miura N, 2009, BIOCHEM BIOPH RES CO, V390, P733, DOI 10.1016/j.bbrc.2009.10.039; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; National Committee for Clinical Laboratory Standards, 2004, METH ANT SUSC TEST A; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001; Powers CM, 2011, ENVIRON HEALTH PERSP, V119, P37, DOI 10.1289/ehp.1002337; Ruden S, 2009, ANTIMICROB AGENTS CH, V53, P3538, DOI 10.1128/AAC.01106-08; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sotiriou GA, 2013, SMALL; Sotiriou GA, 2010, ENVIRON SCI TECHNOL, V44, P5649, DOI 10.1021/es101072s; Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171; Trop M, 2006, J TRAUMA, V60, P648, DOI 10.1097/01.ta.0000208126.22089.b6; U.S. Centers for Disease Control and Prevention, 2006, MMWR RECOMM REP, V55, P42; Vlachou E, 2007, BURNS, V33, P979, DOI 10.1016/j.burns.2007.07.014; Wang CC, 1999, MED CLIN N AM, V83, P975; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005; World Health Organization Department of Reproductive Health and Research, 2011, WHORHR1114 DEP REPR; YANG CY, 1994, J DENT RES, V73, P1407, DOI 10.1177/00220345940730080301	45	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64794	10.1371/journal.pone.0064794	http://dx.doi.org/10.1371/journal.pone.0064794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705013	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200167
J	Povlsen, JA; Lofgren, B; Dalgas, C; Birkler, RID; Johannsen, M; Stottrup, NB; Botker, HE				Povlsen, Jonas Agerlund; Lofgren, Bo; Dalgas, Christian; Birkler, Rune Isak Dupont; Johannsen, Mogens; Stottrup, Nicolaj Brejnholt; Botker, Hans Erik			Protection against Myocardial Ischemia-Reperfusion Injury at Onset of Type 2 Diabetes in Zucker Diabetic Fatty Rats Is Associated with Altered Glucose Oxidation	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; TRICARBOXYLATE CYCLE; ELECTRON-TRANSPORT; METABOLIC-FATE; HEART; GLYCOLYSIS; CARDIOPROTECTION; SHUTTLE; ACTIVATION; INFARCTION	Background: Inhibition of glucose oxidation during initial reperfusion confers protection against ischemia-reperfusion (IR) injury in the heart. Mitochondrial metabolism is altered with progression of type 2 diabetes (T2DM). We hypothesized that the metabolic alterations present at onset of T2DM induce cardioprotection by metabolic shutdown during IR, and that chronic alterations seen in late T2DM cause increased IR injury. Methods: Isolated perfused hearts from 6 (prediabetic), 12 (onset of T2DM) and 24 (late T2DM) weeks old male Zucker diabetic fatty rats (ZDF) and their age-matched heterozygote controls were subjected to 40 min ischemia/120 min reperfusion. IR injury was assessed by TTC-staining. Myocardial glucose metabolism was evaluated by glucose tracer kinetics (glucose uptake-, glycolysis-and glucose oxidation rates), myocardial microdialysis (metabolomics) and tissue glycogen measurements. Results: T2DM altered the development in sensitivity towards IR injury compared to controls. At late diabetes ZDF hearts suffered increased damage, while injury was decreased at onset of T2DM. Coincident with cardioprotection, oxidation of exogenous glucose was decreased during the initial and normalized after 5 minutes of reperfusion. Metabolomic analysis of citric acid cycle intermediates demonstrated that cardioprotection was associated with a reversible shutdown of mitochondrial glucose metabolism during ischemia and early reperfusion at onset of but not at late type 2 diabetes. Conclusions: The metabolic alterations of type 2 diabetes are associated with protection against IR injury at onset but detrimental effects in late diabetes mellitus consistent with progressive dysfunction of glucose oxidation. These findings may explain the variable efficacy of cardioprotective interventions in individuals with type 2 diabetes.	[Povlsen, Jonas Agerlund; Lofgren, Bo; Dalgas, Christian; Stottrup, Nicolaj Brejnholt; Botker, Hans Erik] Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark; [Povlsen, Jonas Agerlund; Lofgren, Bo; Dalgas, Christian; Stottrup, Nicolaj Brejnholt; Botker, Hans Erik] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Birkler, Rune Isak Dupont; Johannsen, Mogens] Aarhus Univ, Dept Forens Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Povlsen, JA (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Aarhus N, Denmark.	jonas.povlsen@ki.au.dk	Johannsen, Mogens/O-7964-2019; Johannsen, Mogens/E-5374-2011	Johannsen, Mogens/0000-0002-2548-7025; Johannsen, Mogens/0000-0002-2548-7025; Botker, Hans Erik/0000-0001-6358-8962	Fondation Leducq [06CVD]; The Danish Heart Foundation; Danish Research Council [11-108354]; The Danish Strategic Research Council [11-1115818]; The A.P. Moller and Chastine Mc-Kinney Moller Foundation; The Foundation in Memory of Asta Florida Bolding Renee Andersen; Novo Nordisk Foundation; Institute of Clinical Medicine, Aarhus University; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Fondation Leducq(Leducq Foundation); The Danish Heart Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); The Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); The A.P. Moller and Chastine Mc-Kinney Moller Foundation; The Foundation in Memory of Asta Florida Bolding Renee Andersen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Institute of Clinical Medicine, Aarhus University; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported financially by Fondation Leducq (Grant no. 06CVD, www.fondationleducq.org), The Danish Heart Foundation (http://www.hjerteforeningen.dk), the Danish Research Council (11-108354, http://en.fi.dk), The Danish Strategic Research Council (11-1115818, http://en.fi.dk), The A.P. Moller and Chastine Mc-Kinney Moller Foundation (www.apmollerfonde.dk), The Foundation in Memory of Asta Florida Bolding Renee Andersen, Novo Nordisk Foundation (www.novonordiskfonden.dk/en), and Institute of Clinical Medicine, Aarhus University (http://clin.au.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Balakumar P, 2012, CELL SIGNAL, V24, P53, DOI 10.1016/j.cellsig.2011.09.007; Baynes J, 2009, OXID MED CELL LONGEV, V2, P328, DOI 10.4161/oxim.2.5.9831; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; Bolukoglu H, 1996, AM J PHYSIOL-HEART C, V270, pH817, DOI 10.1152/ajpheart.1996.270.3.H817; Bonen A, 2009, AM J PHYSIOL-REG I, V297, pR1202, DOI 10.1152/ajpregu.90820.2008; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; BOTKER HE, 1995, J MOL CELL CARDIOL, V27, P1325, DOI 10.1016/S0022-2828(05)82395-8; Bradamante S, 2000, BBA-MOL BASIS DIS, V1502, P363, DOI 10.1016/S0925-4439(00)00060-0; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Byrne CJ, 2012, CIRCULATION, V125, P1256, DOI 10.1161/CIRCULATIONAHA.111.055392; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; Chen H, 2006, CLIN EXP PHARMACOL P, V33, P910, DOI 10.1111/j.1440-1681.2006.04463.x; Chen Q, 2006, J PHARMACOL EXP THER, V316, P200, DOI 10.1124/jpet.105.091702; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Dalgas C, 2012, CLIN EXP PHARMACOL P, V39, P878, DOI 10.1111/j.1440-1681.2012.05749.x; Doenst T, 2000, J NUCL MED, V41, P488; Ebrahim Z, 2007, PHARMACOL RES, V55, P42, DOI 10.1016/j.phrs.2006.10.004; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; FINEGAN BA, 1995, AM J PHYSIOL-HEART C, V269, pH1767, DOI 10.1152/ajpheart.1995.269.5.H1767; Fredersdorf S, 2004, CARDIOVASC PATHOL, V13, P11, DOI 10.1016/S1054-8807(03)00109-1; Gaster M, 2009, BIOCHEM BIOPH RES CO, V387, P651, DOI 10.1016/j.bbrc.2009.07.064; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Jensen RV, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0285-1; KATZ J, 1967, BIOCHEMISTRY-US, V6, P1, DOI 10.1021/bi00853a001; Kocsis GF, 2012, AM J PHYSIOL-HEART C, V303, pH1229, DOI 10.1152/ajpheart.00379.2012; Kupai K, 2009, AM J PHYSIOL-HEART C, V297, pH1729, DOI 10.1152/ajpheart.00484.2009; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lofgren B, 2010, EXP PHYSIOL, V95, P140, DOI 10.1113/expphysiol.2009.049452; LOPASCHUK GD, 1993, J PHARMACOL EXP THER, V264, P135; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; Naito Z, 2003, EXP MOL PATHOL, V74, P23, DOI 10.1016/S0014-4800(03)80005-9; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; Nielsen TT, 2011, CARDIOVASC RES, V91, P382, DOI 10.1093/cvr/cvr051; Oliveira PJ, 2005, CURR DIABETES REV, V1, P11, DOI 10.2174/1573399052952578; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; Povlsen JA, 2009, CLIN EXP PHARMACOL P, V36, P892, DOI 10.1111/j.1440-1681.2009.05166.x; Ralphe JC, 2005, AM J PHYSIOL-HEART C, V288, pH2521, DOI 10.1152/ajpheart.00991.2004; RANDLE PJ, 1970, BIOCHEM J, V117, P677, DOI 10.1042/bj1170677; Ravingerova TA, 2003, MOL CELL BIOCHEM, V249, P167, DOI 10.1023/A:1024751109196; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Sarkozy M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-16; Schroeder MA, 2009, FASEB J, V23, P2529, DOI 10.1096/fj.09-129171; SPEECHLYDICK ME, 1994, CARDIOVASC RES, V28, P1025, DOI 10.1093/cvr/28.7.1025; Stottrup NB, 2010, CARDIOVASC RES, V88, P257, DOI 10.1093/cvr/cvq205; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; Tosaki A, 1996, CARDIOVASC RES, V31, P526; Ungi I, 2005, CHEST, V128, P1623, DOI 10.1378/chest.128.3.1623; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Vogt AM, 2002, J BIOL CHEM, V277, P24411, DOI 10.1074/jbc.M201138200; Wang PP, 2004, AM J PHYSIOL-ENDOC M, V286, pE725, DOI 10.1152/ajpendo.00295.2003; Xu G, 2004, EXP MOL PATHOL, V76, P57, DOI 10.1016/j.yexmp.2003.08.003; Yakubu-Madus FE, 1999, DIABETES, V48, P1093, DOI 10.2337/diabetes.48.5.1093; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	60	34	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64093	10.1371/journal.pone.0064093	http://dx.doi.org/10.1371/journal.pone.0064093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704975	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200114
J	Samaranayake, YH; Cheung, BPK; Yau, JYY; Yeung, SKW; Samaranayake, LP				Samaranayake, Yuthika Hemamala; Cheung, Becky P. K.; Yau, Joyce Y. Y.; Yeung, Shadow K. W.; Samaranayake, Lakshman P.			Human Serum Promotes Candida albicans Biofilm Growth and Virulence Gene Expression on Silicone Biomaterial	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; IN-VITRO; TISSUE-DAMAGE; WILD-TYPE; MODEL; ADHERENCE; ADHESIN; FAMILY; EFG1; MORPHOGENESIS	Objectives: Systemic candidal infections are a common problem in hospitalized patients due to central venous catheters fabricated using silicone biomaterial (SB). We therefore evaluated the effect of human serum on C. albicans biofilm morphology, growth, and the expression of virulence-related genes on SB in vitro. Methods: We cultivated C. albicans SC5314 (wild-type strain, WT) and its derivative HLC54 (hyphal mutant, HM) for 48 h in various conditions, including the presence or absence of SB discs, and human serum. The growth of planktonic and biofilm cells of both strains was monitored at three time points by a tetrazolium salt reduction assay and by scanning electron microscopy. We also analyzed by RT-PCR its expression of the virulence-related genes ALS3, HWP1, EAP1, ECE1, SAP1 - SAP10, PLB1, PLB2, PLC and PLD. Results: At each time point, planktonic cells of WT strain cultured in yeast nitrogen base displayed a much higher expression of EAP1 and HWP1, and a moderately higher ALS3 expression, than HM cells. In planktonic cells, expression of the ten SAP genes was higher in the WT strain initially, but were highly expressed in the HM strain by 48 h. Biofilm growth of both strains on SB was promoted in the presence of human serum than in its absence. Significant upregulation of ALS3, HWP1, EAP1, ECE1, SAP1, SAP4, SAP6 - SAP10, PLB1, PLB2 and PLC was observed for WT biofilms grown on serum-treated SB discs for at least one time point, compared with biofilms on serum-free SB discs. Conclusions: Human serum stimulates C. albicans biofilm growth on SB discs and upregulates the expression of virulence genes, particularly adhesion genes ALS3 and HWP1, and hydrolase-encoding genes SAP, PLB1 and PLB2. This response is likely to promote the colonization of this versatile pathogen within the human host.	[Samaranayake, Yuthika Hemamala; Cheung, Becky P. K.; Yau, Joyce Y. Y.; Yeung, Shadow K. W.; Samaranayake, Lakshman P.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Samaranayake, LP (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	lakshman@hkucc.hku.hk	/K-4947-2018	/0000-0002-9122-336X	Research Grants Council of the University of Hong Kong (HKU) [201109176041]	Research Grants Council of the University of Hong Kong (HKU)	This study was funded by the Research Grants Council of the University of Hong Kong (HKU, Project code: 201109176041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Borg-von Zepelin M, 1999, J INVEST DERMATOL, V113, P747, DOI 10.1046/j.1523-1747.1999.00747.x; Cao YY, 2005, ANTIMICROB AGENTS CH, V49, P584, DOI 10.1128/AAC.49.2.584-589.2005; Cauda R, 2009, DRUGS, V69, P33, DOI 10.2165/11315520-000000000-00000; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Chen YC, 2002, MICROBIOL-SGM, V148, P3743, DOI 10.1099/00221287-148-11-3743; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493; Dolan JW, 2004, MED MYCOL, V42, P439, DOI 10.1080/13693780410001657162; Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0; Hilmioglu S, 2007, MYCOSES, V50, P282, DOI 10.1111/j.1439-0507.2007.01359.x; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; HUBE B, 1994, MOL MICROBIOL, V14, P87, DOI 10.1111/j.1365-2958.1994.tb01269.x; Hube B, 2001, MICROBIOL-SGM, V147, P1997, DOI 10.1099/00221287-147-8-1997; Ibrahim AS, 1998, INFECT IMMUN, V66, P3003, DOI 10.1128/IAI.66.6.3003-3005.1998; Jayatilake JAMS, 2006, J ORAL PATHOL MED, V35, P484, DOI 10.1111/j.1600-0714.2006.00435.x; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kunze D, 2005, MICROBIOL-SGM, V151, P3381, DOI 10.1099/mic.0.28353-0; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Lachke SA, 2000, INFECT IMMUN, V68, P884, DOI 10.1128/IAI.68.2.884-895.2000; Li F, 2003, EUKARYOT CELL, V2, P1266, DOI 10.1128/EC.2.6.1266-1273.2003; Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07; Liu HP, 2002, INT J MED MICROBIOL, V292, P299, DOI 10.1078/1438-4221-00215; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Marchais V, 2005, FEMS MICROBIOL LETT, V245, P25, DOI 10.1016/j.femsle.2005.02.014; Mendes A, 2007, BIOL PHARM BULL, V30, P1813, DOI 10.1248/bpb.30.1813; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Nikawa H, 2000, MYCOSES, V43, P139, DOI 10.1046/j.1439-0507.2000.00564.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; O'Connor L, 2005, MOL CELL PROBE, V19, P153, DOI 10.1016/j.mcp.2004.10.007; Odds F. C., 1994, ASM News (Washington), V60, P313; RADD I, 1993, J INFECT DIS, V168, P400, DOI 10.1093/infdis/168.2.400; Ramage G, 2001, Am Clin Lab, V20, P42; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; SAMARANAYAKE LP, 1980, ARCH ORAL BIOL, V25, P611, DOI 10.1016/0003-9969(80)90076-X; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Samaranayake YH, 2005, J MED MICROBIOL, V54, P583, DOI 10.1099/jmm.0.45762-0; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; SHEPHERD MG, 1980, CAN J MICROBIOL, V26, P21, DOI 10.1139/m80-004; Snide JL, 2006, 8 ASM C CAND CAND DE; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Taylor BN, 2005, INFECT IMMUN, V73, P7061, DOI 10.1128/IAI.73.10.7061-7063.2005; Thein ZM, 2007, ARCH ORAL BIOL, V52, P1200, DOI 10.1016/j.archoralbio.2007.06.007; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; WHITE TC, 1995, J BACTERIOL, V177, P5215, DOI 10.1128/jb.177.18.5215-5221.1995; Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07; Zhao X, 2005, MICROBIOL-SGM, V151, P1619, DOI 10.1099/mic.0.27763-0; Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0	72	42	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62902	10.1371/journal.pone.0062902	http://dx.doi.org/10.1371/journal.pone.0062902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704884	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200013
J	Tseng, WY; Huang, YS; Chiang, NY; Chou, YP; Wu, YJJ; Luo, SF; Kuo, CF; Lin, KM; Lin, HH				Tseng, Wen-Yi; Huang, Yi-Shu; Chiang, Nien-Yi; Chou, Yeh-Pin; Wu, Yeong-Jian Jan; Luo, Shue-Fen; Kuo, Chang-Fu; Lin, Ko-Ming; Lin, Hsi-Hsien			Increased Soluble CD4 in Serum of Rheumatoid Arthritis Patients Is Generated by Matrix Metalloproteinase (MMP)-Like Proteinases	PLOS ONE			English	Article							CYTOKINE RECEPTOR GENERATION; ACTIVATION ANTIGEN CD69; CELL-SURFACE; INFLAMMATORY RESPONSES; VIRUS-INFECTION; KINASE P56LCK; L-SELECTIN; MOLECULES; MECHANISMS; EXPRESSION	Higher soluble CD4 (sCD4) levels in serum have been detected in patients of infectious and chronic inflammatory diseases. However, how and why sCD4 is produced remains poorly understood. We establish sensitive ELISA and WB assays for sCD4 detection in conditioned medium of in vitro cell culture system and serum of chronic inflammatory patients. Serum samples from patients with systemic lupus erythematosus (SLE) (n = 79), rheumatoid arthritis (RA) (n = 59), ankylosing spondylitis (AS) (n = 25), gout (n = 31), and normal controls (n = 99) were analyzed using ELISA for sCD4 detection. Results from each assay were analyzed by the Kruskal-Wallis test. Dunn's multiple comparison post-test was then applied between groups. We confirm that cells expressing exogenous CD4 produce sCD4 in a constitutive and PMA-induced manner. Importantly, sCD4 production in a heterologous expression system is inhibited by GM6001 and TAPI-0, suggesting receptor shedding by matrix metalloproteinase (MMP)-like proteinases. Moreover, similar findings are recapitulated in human primary CD4(+) T cells. Finally, we show that serum sCD4 levels are increased in patients of chronic inflammatory diseases including RA and SLE, but not in those with gout. Intriguingly, sCD4 levels in RA patients are correlated positively with the disease activities and higher sCD4 levels seem to associate with poor prognosis. Taken together, we conclude that CD4 is shed from cell surface by a MMP-like sheddase and sCD4 level is closely related with the inflammatory condition in certain chronic diseases. Hence, sCD4 might be considered an important parameter for RA disease progression with potential diagnostic importance.	[Tseng, Wen-Yi; Wu, Yeong-Jian Jan] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Keelung, Taiwan; [Tseng, Wen-Yi] Chang Gung Mem Hosp Keelung, Grad Inst Clin Med, Tao Yuan, Taiwan; [Huang, Yi-Shu; Chiang, Nien-Yi; Lin, Hsi-Hsien] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Chou, Yeh-Pin; Wu, Yeong-Jian Jan; Luo, Shue-Fen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan; [Chou, Yeh-Pin] Chang Gung Mem Hosp Kaohsiung, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Luo, Shue-Fen; Kuo, Chang-Fu] Chang Gung Mem Hosp Linkou, Div Rheumatol Allergy & Immunol, Linkou, Taiwan; [Lin, Ko-Ming] Chang Gung Mem Hosp Chiayi, Div Rheumatol Allergy & Immunol, Chiayi, Taiwan; [Lin, Hsi-Hsien] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, HH (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	hhlin@mail.cgu.edu.tw	Kuo, Chang-Fu/Q-1714-2016; LIN, Hsi-Hsien/N-1488-2015; Huang, I-Shu/S-9341-2017	Kuo, Chang-Fu/0000-0002-9770-5730; Jan Wu, Yeong-Jian/0000-0002-5444-4729; Huang, I-Shu/0000-0001-8770-9298	National Science Council, Taiwan [NSC98-2320-B-182-028-MY3, NSC101-2320-B-182-029-MY3]; Chang Gung Memorial Hospital [CMRPG670381, CMRPG280431, CMRPG891331, CMRPD190553]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from National Science Council, Taiwan (NSC98-2320-B-182-028-MY3 and NSC101-2320-B-182-029-MY3 to H.-H. Lin), and Chang Gung Memorial Hospital (CMRPG670381 and CMRPG280431 to W.-Y. Tseng, CMRPG891331 to Y.-P. Chou, and CMRPD190553 to H.-H. Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Davies JQ, 2007, J BIOL CHEM, V282, P27343, DOI 10.1074/jbc.M704096200; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Giusca SE, ROM J MORPHOL EMBRYO, V51, P215; Goto H, 1996, SCAND J IMMUNOL, V43, P690, DOI 10.1046/j.1365-3083.1996.d01-264.x; HAMANN J, 1993, J IMMUNOL, V150, P4920; Hepburn TW, 2003, RHEUMATOLOGY, V42, P54, DOI 10.1093/rheumatology/keg030; HEY AS, 1994, J IMMUNOL, V152, P4542; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Lai HY, CHANG GUNG MED J, V34, P468; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Marcante R, 1991, Allergol Immunopathol (Madr), V19, P99; Matsumoto Y, 1998, NEPHRON, V78, P490, DOI 10.1159/000044981; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Nadali G, 1997, LEUKEMIA LYMPHOMA, V26, P99, DOI 10.3109/10428199709058606; NORTH ME, 1991, CLIN EXP IMMUNOL, V86, P252; Ohkubo T, 2001, J INT MED RES, V29, P488, DOI 10.1177/147323000102900604; PEAKMAN M, 1992, J INFECT DIS, V165, P799, DOI 10.1093/infdis/165.5.799; Ridgeway W, 1996, IMMUNOLOGIST, V4, P203; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Sato S, 1996, ARCH DERMATOL RES, V288, P358, DOI 10.1007/s004030050063; SAWADA S, 1993, J CLIN LAB ANAL, V7, P141, DOI 10.1002/jcla.1860070303; SAWADA S, 1992, AM J MED, V92, P134, DOI 10.1016/0002-9343(92)90103-I; Strand V, 2007, NAT REV DRUG DISCOV, V6, P75, DOI 10.1038/nrd2196; SYMONS JA, 1991, CLIN IMMUNOL IMMUNOP, V60, P72, DOI 10.1016/0090-1229(91)90113-O; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YONEYAMA A, 1995, BRIT J HAEMATOL, V89, P47, DOI 10.1111/j.1365-2141.1995.tb08912.x; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	41	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63963	10.1371/journal.pone.0063963	http://dx.doi.org/10.1371/journal.pone.0063963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700441	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200094
J	Zhai, G; Grubbs, CJ; Stockard, CR; Umphrey, HR; Beasley, TM; Kim, H				Zhai, Guihua; Grubbs, Clinton J.; Stockard, Cecil R.; Umphrey, Heidi R.; Beasley, T. Mark; Kim, Hyunki			Diffusion Weighted Imaging Evaluated the Early Therapy Effect of Tamoxifen in an MNU-Induced Mammary Cancer Rat Model	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY; EXPRESSION; APOPTOSIS; SEQUENCE; TUMORS; CELLS; BCL-2; ER	Purpose: To assess the optimal time point of diffusion-weighted imaging (DWI) for early prognosis of breast cancer following tamoxifen therapy using a methylnitrosourea (MNU)-induced ER-positive breast-cancer model. Methods: Two groups of Sprague-Dawley rats (n = 15 for group 1; n = 10 for group 2) were used. All animals (50 days old) were intravenously injected with MNU (50 mg/kg body weight) to induce ER-positive mammary tumors. When tumors were approximately 2 cm in diameter, DWI was performed on days 0, 3, and 7, and intratumoral apparent diffusion coefficient (ADC) values were measured. Therapy started on day 0 with tamoxifen (10 mg/kg diet) and continued for 4 weeks for group 1, but only 1 week for group 2, while tumor volume was measured by caliper twice weekly. All animals of group 2 were euthanized on day 7 after imaging, and Ki-67, TUNEL, ER alpha, and ER beta staining were performed on tumor tissue. Results: DW images of MNU-induced mammary tumors were successfully obtained with minimal motion artifact. For group 1, ADC change for 3 days after therapy initiation (ADC(3D)) was significantly correlated with tumor-volume change until day 11, but the significant correlation between ADC change for 7 days (ADC(7D)) and the tumor-volume change was observed until day 18. Similarly, for group 2, either ADC(7D) or ADC(3D) was significantly correlated with the tumor-volume change, but the higher significance was observed for ADC(7D). Furthermore, ADC(7D) was significantly correlated with apoptotic (TUNEL stained), proliferative (Ki-67 stained), and ERb-positive cell densities, but ADC(3D) was not significantly correlated with any of those. Conclusions: ADC(7D) might be a more reliable surrogate imaging biomarker than ADC(3D) to assess effectiveness of tamoxifen therapy for ER-positive breast cancer, which may enable personalized treatment. The significant correlation between ADC(7D) and ER beta-positive cell density suggests that ER beta may play an important role as a therapeutic indicator of tamoxifen.	[Zhai, Guihua; Umphrey, Heidi R.; Kim, Hyunki] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Grubbs, Clinton J.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Stockard, Cecil R.; Kim, Hyunki] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kim, H (corresponding author), Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA.	Hyunki@uab.edu			National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program [CA13148-35]; National Institutes of Health [2P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	National Cancer Institute UAB Comprehensive Cancer Center Junior Faculty Development Grant Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The National Cancer Institute CA13148-35 UAB Comprehensive Cancer Center Junior Faculty Development Grant Program and the National Institutes of Health grant 2P30CA013148. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briest Susanne, 2009, Clin Adv Hematol Oncol, V7, P185; Brown JM, 1998, CANCER RES, V58, P1408; Buzdar AU, 2008, DRUG TODAY, V44, P679, DOI [10.1358/dot.2008.44.9.1269854, 10.1358/dot.2008.44.9.1256862]; Chhieng DC, 2002, CANCER CYTOPATHOL, V96, P232, DOI 10.1002/cncr.10714; Christov K, 2003, BREAST CANCER RES TR, V77, P253, DOI 10.1023/A:1021804121171; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Grubbs CJ, 2003, CANCER LETT, V201, P17, DOI 10.1016/S0304-3835(03)00461-0; Gruvberger-Saal SK, 2007, CLIN CANCER RES, V13, P1987, DOI 10.1158/1078-0432.CCR-06-1823; Henriksen K, 2009, ACTA ONCOL, V48, P522, DOI 10.1080/02841860802676383; HERTZOG C, 1985, CHILD DEV, V56, P787, DOI 10.1111/j.1467-8624.1985.tb00153.x; Hompland T, 2012, CANCER RES, V72, P4899, DOI 10.1158/0008-5472.CAN-12-0903; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Kim H, 2008, RADIOLOGY, V248, P844, DOI 10.1148/radiol.2483071740; Kim H, 2012, MOL CANCER THER, V11, P405, DOI 10.1158/1535-7163.MCT-11-0581; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuo WH, 2008, ULTRASOUND MED BIOL, V34, P857, DOI 10.1016/j.ultrasmedbio.2007.11.011; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Miller WR, 2006, BRIT J CANCER, V94, P1333, DOI 10.1038/sj.bjc.6603082; Murata Y, 2010, ONCOL LETT, V1, P293, DOI 10.3892/ol_00000052; Neter J., 1996, APPL LINEAR STAT MOD; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Park SH, 2012, EUR RADIOL, V22, P18, DOI 10.1007/s00330-011-2236-x; Pritchard KI, 2003, CLIN CANCER RES, V9, p460S; Razandi M., 2012, ONCOGENE; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; ROSE DP, 1992, CANCER RES, V52, P5386; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Thomassin-Naggara I, 2012, EUROPEAN J RADIOLOGY; Wang Xiao-hong, 2010, Zhonghua Zhong Liu Za Zhi, V32, P539; Zhang GJ, 1999, CLIN CANCER RES, V5, P2971; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	33	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64445	10.1371/journal.pone.0064445	http://dx.doi.org/10.1371/journal.pone.0064445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700476	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200135
J	Felix, R; Crottes, D; Delalande, A; Fauconnier, J; Lebranchu, Y; Le Guennec, JY; Velge-Roussel, F				Felix, Romain; Crottes, David; Delalande, Anthony; Fauconnier, Jeremy; Lebranchu, Yvon; Le Guennec, Jean-Yves; Velge-Roussel, Florence			The Orai-1 and STIM-1 Complex Controls Human Dendritic Cell Maturation (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							TYPE-1 RYANODINE RECEPTORS; INTERLEUKIN-12 PRODUCTION; MOLECULAR-BASIS; CA2+ ENTRY; CHANNEL; ACTIVATION; CRAC; IDENTIFICATION; DEFICIENCY; EXPRESSION	Ca2+ signaling plays an important role in the function of dendritic cells (DC), the professional antigen presenting cells. Here, we described the role of Calcium released activated (CRAC) channels in the maturation and cytokine secretion of human DC. Recent works identified STIM1 and Orai1 in human T lymphocytes as essential for CRAC channel activation. We investigated Ca2+ signaling in human DC maturation by imaging intracellular calcium signaling and pharmalogical inhibitors. The DC response to inflammatory mediators or PAMPs (Pathogen-associated molecular patterns) is due to a depletion of intracellular Ca2+ stores that results in a store-operated Ca2+ entry (SOCE). This Ca2+ influx was inhibited by 2-APB and exhibited a Ca2+ permeability similar to the CRAC (Calcium-Released Activated Calcium), found in T lymphocytes. Depending on the PAMPs used, SOCE profiles and amplitudes appeared different, suggesting the involvement of different CRAC channels. Using siRNAi, we identified the STIM1 and Orai1 protein complex as one of the main pathways for Ca2+ entry for LPS- and TNF-alpha-induced maturation in DC. Cytokine secretions also seemed to be SOCE-dependent with profile differences depending on the maturating agents since IL-12 and IL10 secretions appeared highly sensitive to 2-APB whereas IFN-gamma was less affected. Altogether, these results clearly demonstrate that human DC maturation and cytokine secretions depend on SOCE signaling involving STIM1 and Orai1 proteins.	[Felix, Romain; Crottes, David; Lebranchu, Yvon; Velge-Roussel, Florence] Univ Tours, EA Cellules Dendrit Immunomodulat & Greffes 4245, IFR Agents Transmissibles & Infectiol 136, UFR Med, Tours, France; [Delalande, Anthony] CNRS, Ctr Biophys Mol, UPR 4301, F-45071 Orleans, France; [Delalande, Anthony] Inst Natl Sante & Rech Med, Tours, France; [Fauconnier, Jeremy; Le Guennec, Jean-Yves] Inst Natl Sante & Rech Med U637, Montpellier, France; [Lebranchu, Yvon] CHRU Tours, Serv Nephrol & Immunol Clin, Tours, France; [Velge-Roussel, Florence] UFR Sci Pharmaceut, Tours, France	Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours	Velge-Roussel, F (corresponding author), Univ Tours, EA Cellules Dendrit Immunomodulat & Greffes 4245, IFR Agents Transmissibles & Infectiol 136, UFR Med, Tours, France.	florence.velge-roussel@univ-tours.fr	LE GUENNEC, Jean-Yves/P-1067-2016; Crottès, David/AAC-2180-2022; FELIX, Romain/N-7727-2016; Jeremy, Jeremy/N-6233-2018	Crottès, David/0000-0002-4038-6345; Jeremy, Jeremy/0000-0003-2748-0983; Delalande, Anthony/0000-0001-8280-4616	French Ministere de la recherche	French Ministere de la recherche(Ministry of Research, France)	This work was supported by a doctoral fellowship from French Ministere de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; BAIXERAS E, 1993, IMMUNOL REV, V132, P5, DOI 10.1111/j.1600-065X.1993.tb00836.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandyopadhyay BC, 2011, J LEUKOCYTE BIOL, V89, P57, DOI 10.1189/jlb.0610381; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bell D, 1999, ADV IMMUNOL, V72, P255, DOI 10.1016/S0065-2776(08)60023-1; Braun MC, 2001, MICROBES INFECT, V3, P99, DOI 10.1016/S1286-4579(00)01357-5; Cabral MD, 2010, AM J RESP CRIT CARE, V181, P1310, DOI [10.1164/rccm.200907-1166oc, 10.1164/rccm.200907-1166OC]; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Cai XJ, 2007, J MOL BIOL, V368, P1284, DOI 10.1016/j.jmb.2007.03.022; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Faries MB, 2001, BLOOD, V98, P2489, DOI 10.1182/blood.V98.8.2489; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; Herrmann TL, 2005, J LEUKOCYTE BIOL, V78, P1397, DOI 10.1189/jlb.0205105; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Ito T, 2005, INT J HEMATOL, V81, P188, DOI 10.1532/IJH97.05012; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Lagaraine C, 2005, INT IMMUNOL, V17, P351, DOI 10.1093/intimm/dxh215; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pigozzi D, 2006, CELL CALCIUM, V39, P401, DOI 10.1016/j.ceca.2006.01.003; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rossi M, 2005, J IMMUNOL, V175, P1373, DOI 10.4049/jimmunol.175.3.1373; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Valera I, 2008, J IMMUNOL, V180, P5727, DOI 10.4049/jimmunol.180.8.5727	41	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e61595	10.1371/journal.pone.0061595	http://dx.doi.org/10.1371/journal.pone.0061595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700407	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400006
J	Nygardas, M; Paavilainen, H; Muther, N; Nagel, CH; Roytta, M; Sodeik, B; Hukkanen, V				Nygardas, Michaela; Paavilainen, Henrik; Muether, Nadine; Nagel, Claus-Henning; Roytta, Matias; Sodeik, Beate; Hukkanen, Veijo			A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; RELAPSING MULTIPLE-SCLEROSIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REGULATORY T-CELLS; BACTERIAL ARTIFICIAL CHROMOSOMES; IL-6 SIGNAL TRANSDUCER; SPINAL-CORD-INJURY; OLIGODENDROCYTE SURVIVAL; MEDIATED DEMYELINATION	Herpes simplex virus type 1 (HSV-1) has properties that can be exploited for the development of gene therapy vectors. The neurotropism of HSV enables delivery of therapeutic genes to the nervous system. Using a bacterial artificial chromosome (BAC), we constructed an HSV-1(17(+))-based replicative vector deleted of the neurovirulence gene gamma(1)34.5, and expressing leukemia inhibitory factor (LIF) as a transgene for treatment of experimental autoimmune encephalomyelitis (EAE). EAE is an inducible T-cell mediated autoimmune disease of the central nervous system (CNS) and is used as an animal model for multiple sclerosis. Demyelination and inflammation are hallmarks of both diseases. LIF is a cytokine that has the potential to limit demyelination and oligodendrocyte loss in CNS autoimmune diseases and to affect the T-cell mediated autoimmune response. In this study SJL/J mice, induced for EAE, were treated with a HSV-LIF vector intracranially and the subsequent changes in disease parameters and immune responses during the acute disease were investigated. Replicating HSV-LIF and its DNA were detected in the CNS during the acute infection, and the vector spread to the spinal cord but was non-virulent. The HSV-LIF significantly ameliorated the EAE and contributed to a higher number of oligodendrocytes in the brains when compared to untreated mice. The HSV-LIF therapy also induced favorable changes in the expression of immunoregulatory cytokines and T-cell population markers in the CNS during the acute disease. These data suggest that BAC-derived HSV vectors are suitable for gene therapy of CNS disease and can be used to test the therapeutic potential of immunomodulatory factors for treatment of EAE.	[Nygardas, Michaela; Paavilainen, Henrik; Hukkanen, Veijo] Univ Turku, Dept Virol, Turku, Finland; [Roytta, Matias] Univ Turku, Dept Pathol, Turku, Finland; [Muether, Nadine; Nagel, Claus-Henning; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany	University of Turku; University of Turku; Hannover Medical School	Nygardas, M (corresponding author), Univ Turku, Dept Virol, Turku, Finland.	michaela.nygardas@utu.fi; veijo.hukkanen@utu.fi	Sodeik, Beate/C-9732-2010	Sodeik, Beate/0000-0003-4650-3036	Academy of Finland [118366, 128915]; German Research Foundation; EU 6th Framework Program (EU-NEST AXON SUPPORT) [12702]; Turku Doctoral Programme of Biomedical Sciences; Turku University Foundation; Medicinska Understodsforeningen Liv och Halsa; Finnish MS foundation; Maud Kuistila Memorial Foundation; German Academic Exchange Service (DAAD); Alfred Kordelin Foundation; FinPharma Doctoral program - Drug Discovery section	Academy of Finland(Academy of Finland); German Research Foundation(German Research Foundation (DFG)); EU 6th Framework Program (EU-NEST AXON SUPPORT); Turku Doctoral Programme of Biomedical Sciences; Turku University Foundation; Medicinska Understodsforeningen Liv och Halsa; Finnish MS foundation; Maud Kuistila Memorial Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alfred Kordelin Foundation; FinPharma Doctoral program - Drug Discovery section	This study was supported by the Academy of Finland (grant number 118366 and 128915 to VH, www.aka.fi) and the German Research Foundation (DFG Excellence Cluster EXC 62, REBIRTH -From Regenerative Biology to Reconstructive Therapy to BS, www.dfg.de) and the EU 6th Framework Program (EU-NEST AXON SUPPORT, contract number 12702 to BS, ec.europa.eu/research/fp6/index_en.cfm). MN has been funded by Turku Doctoral Programme of Biomedical Sciences (www.tubs.utu.fi), Turku University Foundation (www.turunyliopistosaatio.fi), Medicinska Understodsforeningen Liv och Halsa (www.livochhalsa.fi), The Finnish MS foundation (http://www.ms-saatio.fi), the Maud Kuistila Memorial Foundation (www.maudkuistilanmuistosaatio.fi) and the German Academic Exchange Service (DAAD, www.daad.de). HP has been funded by the Alfred Kordelin Foundation (www.kordelin.fi) and FinPharma Doctoral program - Drug Discovery section (http://fpdp.fi). The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adler H, 2003, REV MED VIROL, V13, P111, DOI 10.1002/rmv.380; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; Berges BK, 2007, MOL THER, V15, P20, DOI 10.1038/sj.mt.6300018; Broberg E, 2001, GENE THER, V8, P769, DOI 10.1038/sj.gt.3301465; Broberg EK, 2002, J INTERF CYTOK RES, V22, P641, DOI 10.1089/10799900260100123; BROWN MA, 1994, CYTOKINE, V6, P300, DOI 10.1016/1043-4666(94)90027-2; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Campadelli-Fiume G, 2011, REV MED VIROL, V21, P213, DOI 10.1002/rmv.691; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; CUA DJ, 1995, J IMMUNOL, V155, P4052; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Frampton AR, 2005, GENE THER, V12, P891, DOI 10.1038/sj.gt.3302545; Furlan R, 1998, HUM GENE THER, V9, P2605, DOI 10.1089/hum.1998.9.17-2605; Gao W, 2009, CELL CYCLE, V8, P1444, DOI 10.4161/cc.8.9.8348; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Gierasch WW, 2006, J VIROL METHODS, V135, P197, DOI 10.1016/j.jviromet.2006.03.014; Gresle MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047379; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hukkanen V, 2000, J CLIN MICROBIOL, V38, P3214, DOI 10.1128/JCM.38.9.3214-3218.2000; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kesari S, 1998, J GEN VIROL, V79, P525, DOI 10.1099/0022-1317-79-3-525; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mahic M, 2008, SCAND J IMMUNOL, V68, P391, DOI 10.1111/j.1365-3083.2008.02148.x; Manservigi Roberto, 2010, Open Virol J, V4, P123, DOI 10.2174/1874357901004030123; Markovitz NS, 1997, J VIROL, V71, P5560, DOI 10.1128/JVI.71.7.5560-5569.1997; Martino G, 2001, TRENDS IMMUNOL, V22, P483, DOI 10.1016/S1471-4906(01)01990-1; Martuza RL, 2000, J CLIN INVEST, V105, P841, DOI 10.1172/JCI9744; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Nygardas M, 2011, GENE THER, V18, P646, DOI 10.1038/gt.2011.4; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sandbaumhuter M, 2013, CELL MICROBIOL, V15, P248, DOI 10.1111/cmi.12075; Slaets H, 2008, PROTEOMICS, V8, P1237, DOI 10.1002/pmic.200700641; Slaets H, 2010, MOL THER, V18, P684, DOI 10.1038/mt.2009.311; Sugiura S, 2000, EUR J NEUROSCI, V12, P457, DOI 10.1046/j.1460-9568.2000.00922.x; Vanderlocht J, 2006, J NEUROSCI RES, V83, P763, DOI 10.1002/jnr.20781; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; WHITLEY RJ, 1993, J CLIN INVEST, V91, P2837, DOI 10.1172/JCI116527; YOSHIDA T, 1993, DEV BRAIN RES, V76, P147, DOI 10.1016/0165-3806(93)90132-T; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051	59	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64200	10.1371/journal.pone.0064200	http://dx.doi.org/10.1371/journal.pone.0064200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700462	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400049
J	Pak, J; Lee, JH; Lee, SH				Pak, Jaewoo; Lee, Jung Hun; Lee, Sang Hee			A Novel Biological Approach to Treat Chondromalacia Patellae	PLOS ONE			English	Article							STEM-CELL THERAPY; ADIPOSE-TISSUE; STROMAL CELLS; CARTILAGE	Mesenchymal stem cells from several sources (bone marrow, synovial tissue, cord blood, and adipose tissue) can differentiate into variable parts (bones, cartilage, muscle, and adipose tissue), representing a promising new therapy in regenerative medicine. In animal models, mesenchymal stem cells have been used successfully to regenerate cartilage and bones. However, there have been no follow-up studies on humans treated with adipose-tissue-derived stem cells (ADSCs) for the chondromalacia patellae. To obtain ADSCs, lipoaspirates were obtained from lower abdominal subcutaneous adipose tissue. The stromal vascular fraction was separated from the lipoaspirates by centrifugation after treatment with collagenase. The stem-cell-containing stromal vascular fraction was mixed with calcium chloride-activated platelet rich plasma and hyaluronic acid, and this ADSCs mixture was then injected under ultrasonic guidance into the retro-patellar joints of all three patients. Patients were subjected to pre-and post-treatment magnetic resonance imaging (MRI) scans. Pre-and post-treatment subjective pain scores and physical therapy assessments measured clinical changes. One month after the injection of autologous ADSCs, each patient's pain improved 50-70%. Three months after the treatment, the patients' pain improved 80-90%. The pain improvement persisted over 1 year, confirmed by telephone follow ups. Also, all three patients did not report any serious side effects. The repeated magnetic resonance imaging scans at three months showed improvement of the damaged tissues (softened cartilages) on the patellae-femoral joints. In patients with chondromalacia patellae who have continuous anterior knee pain, percutaneous injection of autologous ADSCs may play an important role in the restoration of the damaged tissues (softened cartilages). Thus, ADSCs treatment presents a glimpse of a new promising, effective, safe, and non-surgical method of treatment for chondromalacia patellae.	[Pak, Jaewoo; Lee, Jung Hun] Stems Med Clin, Seoul, South Korea; [Lee, Jung Hun; Lee, Sang Hee] Myongji Univ, Dept Biol Sci, Natl Leading Res Lab, Yongin, Gyeonggido, South Korea	Myongji University	Lee, SH (corresponding author), Myongji Univ, Dept Biol Sci, Natl Leading Res Lab, Yongin, Gyeonggido, South Korea.	sangheelee@mju.ac.kr	Lee, Jung Hun/GYU-7134-2022; Lee, Sang Hee/A-3200-2012	Lee, Sang Hee/0000-0002-5660-7122; pak, jaewoo/0000-0001-6589-7849	National-Research-Foundation-MEST [2012-0008737]; Marine-Extreme-Genome-Research-Center-MLTM; Next-Generation-BioGreen21-RDA [SA00005735]	National-Research-Foundation-MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Marine-Extreme-Genome-Research-Center-MLTM; Next-Generation-BioGreen21-RDA	This work was supported by grants from the National-Research-Foundation-MEST (2012-0008737), Marine-Extreme-Genome-Research-Center-MLTM, and Next-Generation-BioGreen21-RDA (SA00005735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Brody LT, 1998, J ORTHOP SPORT PHYS, V28, P336, DOI 10.2519/jospt.1998.28.5.336; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Johnstone B, 1999, CLIN ORTHOP RELAT R, pS156, DOI 10.1097/00003086-199910001-00017; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nevo Z, 1998, CELL TRANSPLANT, V7, P63, DOI 10.1016/S0963-6897(97)00066-3; Noel Daniele, 2002, Curr Opin Investig Drugs, V3, P1000; Pak J, 2012, PAIN PHYSICIAN, V15, P75; Pak Jaewoo, 2011, J Med Case Rep, V5, P296, DOI 10.1186/1752-1947-5-296; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Richardson DW, 2003, INFLAMM RES, V52, P39, DOI 10.1007/s000110300012; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327; Wittstein JR, 2009, SKELETAL RADIOL, V38, P895, DOI 10.1007/s00256-009-0698-6; Wu W, 2007, J ORAL MAXIL SURG, V65, P1951, DOI 10.1016/j.joms.2006.11.044; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	21	39	39	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64569	10.1371/journal.pone.0064569	http://dx.doi.org/10.1371/journal.pone.0064569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700485	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400061
J	Russ, AE; Peters, JS; McNabb, WC; Barnett, MPG; Anderson, RC; Park, Z; Zhu, ST; Maclean, P; Young, W; Reynolds, GW; Roy, NC				Russ, Anna E.; Peters, Jason S.; McNabb, Warren C.; Barnett, Matthew P. G.; Anderson, Rachel C.; Park, Zaneta; Zhu, Shuotun; Maclean, Paul; Young, Wayne; Reynolds, Gordon W.; Roy, Nicole C.			Gene Expression Changes in the Colon Epithelium Are Similar to Those of Intact Colon during Late Inflammation in Interleukin-10 Gene Deficient Mice	PLOS ONE			English	Article							DELTA INTRAEPITHELIAL LYMPHOCYTES; BOWEL-DISEASE; MATRIX METALLOPROTEINASES; EXPERIMENTAL COLITIS; OLEIC-ACID; MICRODISSECTION; GENOME; MUCOSA; RNA; PLASMALOGENS	In addition to their role in absorption and secretion, epithelial cells play an important role in the protection of the colon mucosa from the resident microbiota and are important for the maintenance of homeostasis. Microarray analysis of intact colon samples is widely used to gain an overview of the cellular pathways and processes that are active in the colon during inflammation. Laser microdissection of colon epithelial cells allows a more targeted analysis of molecular pathways in the mucosa, preceding and during inflammation, with potentially increased sensitivity to changes in specific cell populations. The aim of this study was to investigate the molecular changes that occur in early and late inflammation stages in colon epithelium of a mouse model of inflammatory bowel diseases. Microarray analysis of intact colon samples and microdissected colon epithelial cell samples from interleukin-10 gene deficient and control mice at 6 and 12 weeks of age was undertaken. Results of gene set enrichment analysis showed that more immune-related pathways were identified between interleukin-10 gene deficient and control mice at 6 weeks of age in epithelial cells than intact colon. This suggests that targeting epithelial cells could increase sensitivity for detecting immune changes that occur early in the inflammatory process. However, in the later stages of inflammation, microarray analyses of intact colon and epithelium both provide a similar overview of gene expression changes in the colon mucosa at the pathway level.	[Russ, Anna E.; Peters, Jason S.; Barnett, Matthew P. G.; Anderson, Rachel C.; Young, Wayne; Roy, Nicole C.] AgRes Grasslands, Food & Biobased Prod Grp, Food Nutr & Hlth Team, Palmerston North, New Zealand; [Russ, Anna E.; Reynolds, Gordon W.] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [McNabb, Warren C.; Roy, Nicole C.] Massey Univ, Riddet Inst, Palmerston North, New Zealand; [McNabb, Warren C.] AgRes Grasslands, Palmerston North, New Zealand; [Park, Zaneta; Maclean, Paul] AgResearch, Bioinformat & Stat, Hamilton, New Zealand; [Zhu, Shuotun] Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr, Auckland 1, New Zealand; [Zhu, Shuotun] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand	AgResearch - New Zealand; Massey University; Massey University; AgResearch - New Zealand; AgResearch - New Zealand; University of Auckland; University of Auckland	Roy, NC (corresponding author), AgRes Grasslands, Food & Biobased Prod Grp, Food Nutr & Hlth Team, Palmerston North, New Zealand.	nicole.roy@agresearch.co.nz	Barnett, Matthew PG/E-8539-2011; Roy, Nicole C/AAP-5016-2020	Barnett, Matthew PG/0000-0002-5186-5579; Young, Wayne/0000-0003-0464-2062; McNabb, Warren/0000-0003-2514-6551; roy, nicole clemence/0000-0002-6744-9705; Maclean, Paul/0000-0001-8898-8276; Anderson, Rachel/0000-0003-2191-0655	MSI [C11X1009]; Massey University Doctoral Scholarship	MSI; Massey University Doctoral Scholarship	The work described in this paper is part of Nutrigenomics New Zealand (http://www.nutrigenomics.org.nz), a collaboration between AgResearch Limited, Plant & Food Research and The University of Auckland, which is largely funded by The New Zealand Ministry of Business, Innovation, and Employment (http://www.mbie.govt.nz/),and its predecessors the New Zealand Ministry for Science & Innovation (MSI) and the New Zealand Foundation for Research, Science & Technology (FRST). This work was primarily supported by funding from the MSI contract C11X1009. Anna Russ was supported by a Massey University Doctoral Scholarship during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brosche T, 1998, EXP GERONTOL, V33, P363, DOI 10.1016/S0531-5565(98)00014-X; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; DIECKGRAEFE BK, 2001, PHYSIOL GENOMICS, V2001, P1; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edmunds SJ, 2012, BRIT J NUTR, V108, P113, DOI 10.1017/S0007114511005241; Engelmann B, 2004, BIOCHEM SOC T, V32, P147, DOI 10.1042/BST0320147; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Flanagan K, 2008, J IMMUNOL, V180, P3874, DOI 10.4049/jimmunol.180.6.3874; Funke B, 2011, INFLAMM BOWEL DIS, V17, P1943, DOI 10.1002/ibd.21572; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gill HS, 2001, MED MICROBIOL IMMUN, V190, P97, DOI 10.1007/s004300100095; Hansen JJ, 2009, INFLAMM BOWEL DIS, V15, P890, DOI 10.1002/ibd.20850; Hooper LV, 2004, CURR OPIN MICROBIOL, V7, P290, DOI 10.1016/j.mib.2004.04.004; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Knoch B, 2010, BIOTECHNOL J, V5, P1226, DOI 10.1002/biot.201000066; Knoch B, 2010, PPAR RES, V2010, DOI 10.1155/2010/621069; Knoch B, 2010, MOL NUTR FOOD RES, V54, pS62, DOI 10.1002/mnfr.200900543; Knoch B, 2009, J NUTRIGENET NUTRIGE, V2, P9, DOI 10.1159/000134292; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Mannick EE, 2004, CLIN IMMUNOL, V112, P247, DOI 10.1016/j.clim.2004.03.014; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mesko B, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-15; Moens E, 2012, IMMUNOLOGY, V135, P1, DOI 10.1111/j.1365-2567.2011.03506.x; Morgan AR, 2011, HUM IMMUNOL, V72, P1117, DOI 10.1016/j.humimm.2011.08.011; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Murdoch C, 2000, BLOOD, V95, P3032; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nygaard V, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-147; O'Neil D, 2003, ADV EXP MED BIOL, V520, P252; Oliveros JC, 2007, VENNY INTERACTIVE TO; Park EI, 1997, J NUTR, V127, P566, DOI 10.1093/jn/127.4.566; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; REEVES PG, 1989, J NUTR, V119, P1081, DOI 10.1093/jn/119.8.1081; Reeves PG, 1997, J NUTR, V127, pS838; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; von Lampe B, 2000, GUT, V47, P63, DOI 10.1136/gut.47.1.63; Walch A, 2001, HISTOCHEM CELL BIOL, V115, P269; Wang YD, 2006, WORLD J GASTROENTERO, V12, P6050, DOI 10.3748/wjg.v12.i37.6050; Yang SK, 1997, GASTROENTEROLOGY, V113, P1214, DOI 10.1053/gast.1997.v113.pm9322516	59	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63251	10.1371/journal.pone.0063251	http://dx.doi.org/10.1371/journal.pone.0063251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700416	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400014
J	Serra-Cobo, J; Lopez-Roig, M; Segui, M; Sanchez, LP; Nadal, J; Borras, M; Lavenir, R; Bourhy, H				Serra-Cobo, Jordi; Lopez-Roig, Marc; Segui, Magdalena; Pilar Sanchez, Luisa; Nadal, Jacint; Borras, Miquel; Lavenir, Rachel; Bourhy, Herve			Ecological Factors Associated with European Bat Lyssavirus Seroprevalence in Spanish Bats	PLOS ONE			English	Article							RABIES; HOST; VIRUS; INFECTION; TRANSMISSION; PHYLOGENY; EVOLUTION; DYNAMICS; COLONIES; EXPOSURE	Bats have been proposed as major reservoirs for diverse emerging infectious viral diseases, with rabies being the best known in Europe. However, studies exploring the ecological interaction between lyssaviruses and their natural hosts are scarce. This study completes our active surveillance work on Spanish bat colonies that began in 1992. Herein, we analyzed ecological factors that might affect the infection dynamics observed in those colonies. Between 2001 and 2011, we collected and tested 2,393 blood samples and 45 dead bats from 25 localities and 20 bat species. The results for dead confirmed the presence of EBLV-1 RNA in six species analyzed (for the first time in Myotis capaccinii). Samples positive for European bat lyssavirus-1 (EBLV-1)-neutralizing antibodies were detected in 68% of the localities sampled and in 13 bat species, seven of which were found for the first time (even in Myotis daubentonii, a species to date always linked to EBLV-2). EBLV-1 seroprevalence (20.7%) ranged between 11.1 and 40.2% among bat species and seasonal variation was observed, with significantly higher antibody prevalence in summer (July). EBLV-1 seroprevalence was significantly associated with colony size and species richness. Higher seroprevalence percentages were found in large multispecific colonies, suggesting that intra-and interspecific contacts are major risk factors for EBLV-1 transmission in bat colonies. Although bat-roosting behavior strongly determines EBLV-1 variability, we also found some evidence that bat phylogeny might be involved in bat-species seroprevalence. The results of this study highlight the importance of life history and roost ecology in understanding EBLV-1-prevalence patterns in bat colonies and also provide useful information for public health officials.	[Serra-Cobo, Jordi; Lopez-Roig, Marc; Segui, Magdalena] Govern Illes Balears, Ctr Recerca Infecc Viriques, Illes Balears CRIVIB, Fundacio Invest Sanitaria Illes Balears,Conseller, Palma De Mallorca, Spain; [Serra-Cobo, Jordi; Lopez-Roig, Marc; Nadal, Jacint] Univ Barcelona, Fac Biol, IRBIO, Barcelona, Spain; [Serra-Cobo, Jordi; Lopez-Roig, Marc; Nadal, Jacint] Univ Barcelona, Fac Biol, Dept Biol Anim, Barcelona, Spain; [Pilar Sanchez, Luisa] CIBERESP, Ctr Nacl Epidemiol, Inst Salud Carlos III, Madrid, Spain; [Borras, Miquel] Unitat Toxicol Expt & Ecotoxicol, Barcelona, Spain; [Lavenir, Rachel; Bourhy, Herve] Inst Pasteur, Unite Dynam Lyssavirus & Adaptat Hote, Paris, France	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Serra-Cobo, J (corresponding author), Govern Illes Balears, Ctr Recerca Infecc Viriques, Illes Balears CRIVIB, Fundacio Invest Sanitaria Illes Balears,Conseller, Palma De Mallorca, Spain.	serracobo@areambiental.com	Serra-Cobo, Jordi/G-4673-2016		Conselleria de Salut, FamA-lia i Benestar Social, Govern de les Illes Balears [PI 32/2009]; Researchers Stabilization Program and Technical Support Research; Intensification of Research Activity in the National Health System of the Ministry of Health (Instituto de Salud Carlos III), Instituto de Salud Carlos III [EMER 07/051]; RABMEDCONTROL UE project [517727]; PREDEMICS UE project [278433]	Conselleria de Salut, FamA-lia i Benestar Social, Govern de les Illes Balears; Researchers Stabilization Program and Technical Support Research; Intensification of Research Activity in the National Health System of the Ministry of Health (Instituto de Salud Carlos III), Instituto de Salud Carlos III; RABMEDCONTROL UE project; PREDEMICS UE project	This work was financed by the Conselleria de Salut, FamA-lia i Benestar Social, Govern de les Illes Balears (PI 32/2009), the Researchers Stabilization Program and Technical Support Research, and Intensification of Research Activity in the National Health System of the Ministry of Health (Instituto de Salud Carlos III), Instituto de Salud Carlos III (EMER 07/051), RABMEDCONTROL UE project No. 517727, and PREDEMICS UE project No. 278433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Amengual B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000566; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x; Botvinkin AD, 2003, EMERG INFECT DIS, V9, P1623, DOI 10.3201/eid0912.030374; BOURHY H, 1990, METHODES LAB DIAGNOS; BROSSET A, 1990, MAMMALIA, V54, P207; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Christe P, 2000, ECOL LETT, V3, P207; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Delmas O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002057; Dietz C, 2004, ILLUSTRATED IDENTIFI; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Echevarria JE, 2001, J CLIN MICROBIOL, V39, P3678, DOI 10.1128/JCM.39.10.3678-3683.2001; Fox J., 2019, CAR COMPANION APPL R; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Gouilh MA, 2011, INFECT GENET EVOL, V11, P1690, DOI 10.1016/j.meegid.2011.06.021; Harris SL, 2006, BIOL CONSERV, V131, P193, DOI 10.1016/j.biocon.2006.04.006; Hutterer R., 2005, BAT MIGRATIONS EUROP; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Kuzmin IV, 2010, VIRUS RES, V149, P197, DOI 10.1016/j.virusres.2010.01.018; Lumlertdacha B, 2005, EMERG INFECT DIS, V11, P232, DOI 10.3201/eid1102.040691; Marston DA, 2012, EMERG INFECT DIS, V18, P664, DOI 10.3201/eid1804.111553; Megali A, 2010, ARCH VIROL, V155, P1655, DOI 10.1007/s00705-010-0750-9; MOHR W, 1957, Med Klin, V52, P1057; Muller T, 2007, ARCH VIROL, V152, P273, DOI 10.1007/s00705-006-0853-5; NIKOLIC M, 1956, WHO B, V14, P801; Nokireki T., 2011, Rabies Bulletin Europe, V35, P8; Picard-Meyer E, 2011, VET MICROBIOL, V151, P390, DOI 10.1016/j.vetmic.2011.03.034; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2008, R LANG ENV STAT COMP; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; RACEY PA, 2009, ECOLOGICAL BEHAV MET; Sanchez Serrano L. P., 1999, Boletin Epidemiologico Semanal, V7, P149; SANCHEZSERRANO LP, 2003, EURO SURVEILL, V7; Serra-Cobo J, 1998, ACTA THERIOL, V43, P271, DOI 10.4098/AT.arch.98-22; Serra-Cobo J, 2002, EMERG INFECT DIS, V8, P413, DOI 10.3201/eid0804.010263; Serra-Cobo J., 2008, Boletin Epidemiologico Semanal, V16, P169; SERRACOBO J, 2008, SCIVEE TV; SERRACOBO J, 2009, BATS SCI MYTH; Smreczak M, 2009, B VET I PULAWY, V53, P589; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Turmelle AS, 2010, VECTOR-BORNE ZOONOT, V10, P165, DOI 10.1089/vbz.2008.0163; Van der Poel WHM, 2005, EMERG INFECT DIS, V11, P1854, DOI 10.3201/eid1112.041200; Vazquez-Moron S, 2008, EMERG INFECT DIS, V14, P1263, DOI [10.3201/eid1408.080068, 10.3201/1408.080068]; Vazquez-Moron S, 2011, EMERG INFECT DIS, V17, P520, DOI 10.3201/eid1703.100894; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520	56	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64467	10.1371/journal.pone.0064467	http://dx.doi.org/10.1371/journal.pone.0064467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700480	Green Submitted, Green Published, gold			2022-12-25	WOS:000319966400056
J	Sonawani, A; Niazi, S; Idicula-Thomas, S				Sonawani, Archana; Niazi, Sarfaraj; Idicula-Thomas, Susan			In Silico Study on Binding Specificity of Gonadotropins and Their Receptors: Design of a Novel and Selective Peptidomimetic for Human Follicle Stimulating Hormone Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LEUCINE-RICH REPEATS; BETA-STRANDS; FORCE-FIELD; LIGANDS; PEPTIDE; FOLLITROPIN; VALIDATION; INHIBITORS; EXODOMAIN	Gonadotropins bind to specific receptors in spite of sharing a high level of sequence and structural similarity. This specific binding is crucial for maintaining the reproductive health of an organism. In this study, residues that dictate the receptor binding specificity of the gonadotropins (FSH and LH) have been identified using combination of in silico methods. Docking studies (ZDOCK), based on the systematic replacement of these residues, confirmed its importance in receptor binding. An interesting observation is that the relative positioning of the residues conferring binding specificity varied for the gonadotropin-receptor complexes. This spatial difference of the key residues could be exploited for design of specific modulators. Based on the identified residues, we have rationally designed a peptidomimetic (FSHP) that displays good binding affinity and specificity for hFSHR. FSHP was developed by screening 3.9 million compounds using pharmacophore-shape similarity followed by fragment-based approach. It was observed that FSHP and hFSHa can share the same receptor binding site thereby mimicking the native hFSHR-FSH interactions. FSHP also displayed higher binding affinity to hFSHR as compared to two reported hFSHR antagonists. MD simulation studies on hFSHR-FSHP complex revealed that FSHP is conformationally rigid and the intermolecular interactions are maintained during the course of simulation.	[Sonawani, Archana; Niazi, Sarfaraj; Idicula-Thomas, Susan] Natl Inst Res Reprod Hlth, Indian Council Med Res, Biomed Informat Ctr, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Idicula-Thomas, S (corresponding author), Natl Inst Res Reprod Hlth, Indian Council Med Res, Biomed Informat Ctr, Mumbai, Maharashtra, India.	thomass@nirrh.res.in	Niazi, Sarfaraj/L-7222-2015	Niazi, Sarfaraj/0000-0002-0136-3108	Department of Biotechnology; Government of India [NIRRH/M/77/12, BT/PR12904/BID/07/301/2009]	Department of Biotechnology; Government of India(Department of Biotechnology (DBT) India)	This work (NIRRH/M/77/12) has been supported by grant from Department of Biotechnology; Government of India (BT/PR12904/BID/07/301/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; [Anonymous], 2011, GLID VERS 5 7; [Anonymous], 2011, LIGPREP VERS 2 5; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Ballet S, 2006, J MED CHEM, V49, P3990, DOI 10.1021/jm0603264; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bhagwanth S, 2013, BEILSTEIN J ORG CHEM, V9, P204, DOI 10.3762/bjoc.9.24; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Bruns C, 2002, EUR J ENDOCRINOL, V146, P707, DOI 10.1530/eje.0.1460707; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; *CHEMOFF, 2004, CHEMOFFICE 2004; Chopineau M, 1997, J ENDOCRINOL, V152, P371, DOI 10.1677/joe.0.1520371; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DIAS JA, 1994, J BIOL CHEM, V269, P25289; Engel JB, 2012, ANTICANCER RES, V32, P2063; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Floris M, 2012, MOL INFORM, V31, P12, DOI 10.1002/minf.201100093; Floris M, 2011, NUCLEIC ACIDS RES, V39, pW261, DOI 10.1093/nar/gkr287; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; *GOLD, 2010, GOLD VERS 5 0 US GUI; Gonzalez-Ruiz D, 2006, CURR MED CHEM, V13, P2607, DOI 10.2174/092986706778201530; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess S, 2008, J MED CHEM, V51, P1026, DOI 10.1021/jm701093y; Hruby VJ, 2013, ANNU REV PHARMACOL, V53, P557, DOI 10.1146/annurev-pharmtox-010510-100456; Hruby VJ, 2000, CURR MED CHEM, V7, P945, DOI 10.2174/0929867003374499; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar TR, 2005, REPRODUCTION, V130, P293, DOI 10.1530/rep.1.00660; *LLC, 2011, MAESTR VERS 9 2; Loving K, 2009, J COMPUT AID MOL DES, V23, P541, DOI 10.1007/s10822-009-9268-1; Masciocchi J, 2009, NUCLEIC ACIDS RES, V37, pD284, DOI 10.1093/nar/gkn727; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Nambi P, 2003, ASSAY DRUG DEV TECHN, V1, P305, DOI 10.1089/15406580360545116; NOCE T, 1989, J MOL ENDOCRINOL, V3, P129, DOI 10.1677/jme.0.0030129; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Pierce AC, 2004, J MED CHEM, V47, P2768, DOI 10.1021/jm030543u; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Shacham S, 2001, MED RES REV, V21, P472, DOI 10.1002/med.1019; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Van Durme J, 2006, MOL ENDOCRINOL, V20, P2247, DOI 10.1210/me.2006-0020; van Straten N, 2009, ANNU REP MED CHEM, V44, P171, DOI 10.1016/S0065-7743(09)04408-X; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Vischer HF, 2003, MOL ENDOCRINOL, V17, P1972, DOI 10.1210/me.2003-0172; Vischer HF, 2003, J BIOL CHEM, V278, P15505, DOI 10.1074/jbc.M300634200; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wrobel J, 2002, BIOORGAN MED CHEM, V10, P639, DOI 10.1016/S0968-0896(01)00324-8; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	62	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64475	10.1371/journal.pone.0064475	http://dx.doi.org/10.1371/journal.pone.0064475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700481	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400057
J	Zhu, Y; Li, H; Li, KH; Zhao, XF; An, T; Hu, XM; Park, J; Huang, H; Bin, Y; Qiang, BQ; Yuan, JG; Peng, XZ; Qiu, MS				Zhu, Ying; Li, Hong; Li, Kehan; Zhao, Xiaofeng; An, Tai; Hu, Xuemei; Park, Jinsil; Huang, Hao; Bin, Yin; Qiang, Boqin; Yuan, Jiangang; Peng, Xiaozhong; Qiu, Mengsheng			Necl-4/SynCAM-4 Is Expressed in Myelinating Oligodendrocytes but Not Required for Axonal Myelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION; PROTEIN; CNS; MEMBRANE; ASSOCIATION; TSLC1	The timing and progression of axonal myelination are precisely controlled by intercellular interactions between neurons and glia in development. Previous in vitro studies demonstrated that Nectin like 4 (Necl-4, also known as cell adhesion molecule Cadm-4 or SynCAM-4) plays an essential role in axonal myelination by Schwann cells in the peripheral nervous system (PNS). However, the role of Necl-4 protein in axonal myelination in the developing central nervous system (CNS) has remained unknown. In this study, we discovered upregulation of Necl-4 expression in mature oligodendrocytes at perinatal stages when axons undergo active myelination. We generated Necl4 gene knockout mice, but found that disruption of Necl-4 gene did not affect oligodendrocyte differentiation and myelin formation in the CNS. Surprisingly, disruption of Necl-4 had no significant effect on axonal myelination in the PNS either. Therefore, our results demonstrated that Necl-4 is dispensable for axonal myelination in the developing nervous system.	[Zhu, Ying; Li, Hong; Zhao, Xiaofeng; Hu, Xuemei; Park, Jinsil; Qiu, Mengsheng] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Li, Kehan; An, Tai; Bin, Yin; Qiang, Boqin; Yuan, Jiangang; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Li, Kehan; An, Tai; Bin, Yin; Qiang, Boqin; Yuan, Jiangang; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhao, Xiaofeng; Huang, Hao; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Dev & Regenerat Biol, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	University of Louisville; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hangzhou Normal University	Peng, XZ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	pengxiaozhong@pumc.edu.cn; m0qiu001@yahoo.com	Huang, Hao/M-6127-2019; Huang, Hao/O-8809-2017	Huang, Hao/0000-0001-7346-7056; Huang, Hao/0000-0001-7346-7056	National Multiple Sclerosis Society [RG 3275]; National Institutes of Health [R01 NS037717]; National Natural Sciences Foundation of China [30828004, 31071879, 31000488]; Zhejiang Provincial Natural Science Foundation of China [Z2100730]; Major Project of Science and Technology Department of Zhejiang Province [Y2111122]; Program for New Century Excellent Talents in University [NCET-070505]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037717] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Major Project of Science and Technology Department of Zhejiang Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Multiple Sclerosis Society (RG 3275) and National Institutes of Health (R01 NS037717), the National Natural Sciences Foundation of China (grants 30828004, 31071879, 31000488); Zhejiang Provincial Natural Science Foundation of China (Z2100730), Major Project of Science and Technology Department of Zhejiang Province (Y2111122) and the Program for New Century Excellent Talents in University (NCET-070505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Benninger Y, 2006, J NEUROSCI, V26, P7665, DOI 10.1523/JNEUROSCI.0444-06.2006; Bhat RV, 1996, GLIA, V17, P169; Boiko T, 2006, J CELL BIOL, V172, P799, DOI 10.1083/jcb.200602101; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; McKee KK, 2012, J CELL SCI; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Park J, 2008, J NEUROSCI, V28, P12815, DOI 10.1523/JNEUROSCI.2665-08.2008; Qi YC, 2001, DEVELOPMENT, V128, P2723; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Southwood C, 2004, J NEUROSCI, V24, P11215, DOI 10.1523/JNEUROSCI.3479-04.2004; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Yageta M, 2002, CANCER RES, V62, P5129; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zhou Y, 2005, BBA-BIOMEMBRANES, V1669, P142, DOI 10.1016/j.bbamem.2005.01.013	25	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64264	10.1371/journal.pone.0064264	http://dx.doi.org/10.1371/journal.pone.0064264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700466	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400051
J	Cabeza, JM; Acosta, J; Ales, E				Cabeza, Jose M.; Acosta, Jorge; Ales, Eva			Mechanisms of Granule Membrane Recapture following Exocytosis in Intact Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; FROG NEUROMUSCULAR JUNCTION; HIGH-CALCIUM CONCENTRATIONS; KISS-AND-RUN; FUSION PORE; SECRETORY VESICLE; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; COMPOUND EXOCYTOSIS; HISTAMINE-RELEASE	In secretory cells, several exocytosis-coupled forms of endocytosis have been proposed including clathrin-mediated endocytosis, kiss-and-run endocytosis, cavicapture, and bulk endocytosis. These forms of endocytosis can be induced under different conditions, but their detailed molecular mechanisms and functions are largely unknown. We studied exocytosis and endocytosis in mast cells with both perforated-patch and whole-cell configurations of the patch clamp technique using cell capacitance measurements in combination with amperometric serotonin detection. We found that intact mast cells exhibit an early endocytosis that follows exocytosis induced by compound 48/80. Direct observation of individual exocytic and endocytic events showed a higher percentage of capacitance flickers (27.3%) and off-steps (11.4%) in intact mast cells than in dialyzed cells (5.4% and 2.9%, respectively). Moreover, we observed a type of endocytosis of large pieces of membrane that were likely formed by cumulative fusion of several secretory granules with the cell membrane. We also identified "large-capacitance flickers" that occur after large endocytosis events. Pore conductance analysis indicated that these transient events may represent "compound cavicapture," most likely due to the flickering of a dilated fusion pore. Using fluorescence imaging of individual exocytic and endocytic events we observed that granules can fuse to granules already fused with the plasma membrane, and then the membranes and dense cores of fused granules are internalized. Altogether, our results suggest that stimulated exocytosis in intact mast cells is followed by several forms of compensatory endocytosis, including kiss-and-run endocytosis and a mechanism for efficient retrieval of the compound membrane of several secretory granules through a single membrane fission event.	[Cabeza, Jose M.; Acosta, Jorge; Ales, Eva] Univ Seville, Fac Med, Dept Fisiol Med & Biofis, E-41009 Seville, Spain	University of Sevilla	Ales, E (corresponding author), Univ Seville, Fac Med, Dpto Fisiol Med & Biofis, Av Sanchez Pizjuan 4, E-41009 Seville, Spain.	eales@us.es	Acosta-Lopez, Jorge/H-6271-2015; Ales, Eva/E-6315-2010	Acosta-Lopez, Jorge/0000-0003-1349-4495; Ales, Eva/0000-0002-5536-4616; Cabeza Fernandez, Jose Maria/0000-0002-1784-6219	Ministerio de Ciencia e Innovacion ISCIII; Fondos FEDER Grant [PI11/00257]	Ministerio de Ciencia e Innovacion ISCIII(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos FEDER Grant	This work was supported by the Ministerio de Ciencia e Innovacion ISCIII and Fondos FEDER Grant PI11/00257 (to E.A.).	Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ANDERSON P, 1973, ACTA PHYSIOL SCAND, V88, P359, DOI 10.1111/j.1748-1716.1973.tb05465.x; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BLOOM GD, 1967, ACTA PHYSIOL SCAND, V71, P257, DOI 10.1111/j.1748-1716.1967.tb03733.x; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; FERNANDEZ JM, 1987, FEBS LETT, V216, P89, DOI 10.1016/0014-5793(87)80762-7; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Fulop T, 2006, BIOCHEM J, V399, P111, DOI 10.1042/BJ20060654; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; LINDAU M, 1986, NATURE, V319, P150, DOI 10.1038/319150a0; Lollike K, 2002, J LEUKOCYTE BIOL, V71, P973; Cabeza JM, 2010, TRAFFIC, V11, P1579, DOI 10.1111/j.1600-0854.2010.01120.x; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; OBERHAUSER AF, 1992, BIOPHYS J, V61, P800, DOI 10.1016/S0006-3495(92)81884-2; Oberhauser AF, 1996, BIOPHYS J, V71, P1131, DOI 10.1016/S0006-3495(96)79315-3; OBERHAUSER AF, 1995, J PHYSIOLOGY-PARIS, V89, P71, DOI 10.1016/0928-4257(96)80553-5; Paillart C, 2003, J NEUROSCI, V23, P4092; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; ROHLICH P, 1971, ACTA BIOL ACAD SCI H, V22, P197; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; Segovia M, 2010, P NATL ACAD SCI USA, V107, P19032, DOI 10.1073/pnas.1014070107; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Xue L, 2011, ACTA PHARMACOL SIN, V32, P280, DOI 10.1038/aps.2010.212	53	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20293	20305		10.1074/jbc.M113.459065	http://dx.doi.org/10.1074/jbc.M113.459065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709219	hybrid, Green Published			2022-12-25	WOS:000321715100018
J	Zheng, CL; Page, RC; Das, V; Nix, JC; Wigren, E; Misra, S; Zhang, B				Zheng, Chunlei; Page, Richard C.; Das, Vaijayanti; Nix, Jay C.; Wigren, Edvard; Misra, Saurav; Zhang, Bin			Structural Characterization of Carbohydrate Binding by LMAN1 Protein Provides New Insight into the Endoplasmic Reticulum Export of Factors V (FV) and VIII (FVIII)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-GOLGI TRANSPORT; CRYSTAL-STRUCTURE; LECTIN ERGIC-53; COMBINED DEFICIENCY; RECOGNITION DOMAIN; RECEPTOR COMPLEX; MOLECULAR-BASIS; ER EXPORT; RELEASE; PH	LMAN1 (ERGIC-53) is a key mammalian cargo receptor responsible for the export of a subset of glycoproteins from the endoplasmic reticulum. Together with its soluble coreceptor MCFD2, LMAN1 transports coagulation factors V (FV) and VIII (FVIII). Mutations in LMAN1 or MCFD2 cause the genetic bleeding disorder combined deficiency of FV and FVIII (F5F8D). The LMAN1 carbohydrate recognition domain (CRD) binds to both glycoprotein cargo and MCFD2 in a Ca2+-dependent manner. To understand the biochemical basis and regulation of LMAN1 binding to glycoprotein cargo, we solved crystal structures of the LMAN1-CRD bound to Man-alpha-1,2-Man, the terminal carbohydrate moiety of high mannose glycans. Our structural data, combined with mutagenesis and in vitro binding assays, define the central mannose-binding site on LMAN1 and pinpoint histidine 178 and glycines 251/252 as critical residues for FV/FVIII binding. We also show that mannobiose binding is relatively independent of pH in the range relevant for endoplasmic reticulum-to-Golgi traffic, but is sensitive to lowered Ca2+ concentrations. The distinct LMAN1/MCFD2 interaction is maintained at these lowered Ca2+ concentrations. Our results suggest that compartmental changes in Ca2+ concentration regulate glycoprotein cargo binding and release from the LMAN1 center dot MCFD2 complex in the early secretory pathway.	[Zheng, Chunlei; Das, Vaijayanti; Zhang, Bin] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; [Page, Richard C.; Misra, Saurav] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Berkeley, CA 94720 USA; [Wigren, Edvard] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Cleveland Clinic Foundation; Cleveland Clinic Foundation; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Karolinska Institutet	Zhang, B (corresponding author), Cleveland Clin Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE50, Cleveland, OH 44195 USA.	zhangb@ccf.org		Zheng, Chunlei/0000-0002-9737-461X; Page, Richard/0000-0002-3006-3171; Misra, Saurav/0000-0002-1385-8554	National Institutes of Health [HL094505, GM080271, T32 HL007914]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094505, T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094505 (to B. Z.) and GM080271 (to S. M.) and Postdoctoral Fellowship T32 HL007914 (to R. C. P.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to C. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; Arias-Moreno X, 2008, J BIOL CHEM, V283, P22670, DOI 10.1074/jbc.M802153200; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Byrne SL, 2010, J MOL BIOL, V396, P130, DOI 10.1016/j.jmb.2009.11.023; Cho S, 2011, TRAFFIC, V12, P42, DOI 10.1111/j.1600-0854.2010.01132.x; Cunningham MA, 2003, J THROMB HAEMOST, V1, P2360, DOI 10.1046/j.1538-7836.2003.00415.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guy JE, 2008, J MOL BIOL, V381, P941, DOI 10.1016/j.jmb.2008.06.042; Hauri HP, 2000, J CELL SCI, V113, P587; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Kogler E. J., 2008, THESIS U BASEL; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Montero M, 1997, J CELL BIOL, V139, P601, DOI 10.1083/jcb.139.3.601; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishio M, 2010, P NATL ACAD SCI USA, V107, P4034, DOI 10.1073/pnas.0908526107; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Olson LJ, 2008, J BIOL CHEM, V283, P10124, DOI 10.1074/jbc.M708994200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Wigren E, 2010, FEBS LETT, V584, P878, DOI 10.1016/j.febslet.2010.02.009; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Zheng CL, 2010, BLOOD, V116, P5698, DOI 10.1182/blood-2010-04-278325; Zheng CL, 2010, BLOOD, V115, P1081, DOI 10.1182/blood-2009-09-241877	49	31	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20499	20509		10.1074/jbc.M113.461434	http://dx.doi.org/10.1074/jbc.M113.461434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709226	hybrid, Green Published			2022-12-25	WOS:000321715100037
J	Dickson, CF; Rich, AM; D'Avigdor, WMH; Collins, DAT; Lowry, JA; Mollan, TL; Khandros, E; Olson, JS; Weiss, MJ; Mackay, JP; Lay, PA; Gell, DA				Dickson, Claire F.; Rich, Anne M.; D'Avigdor, William M. H.; Collins, Daniel A. T.; Lowry, Jason A.; Mollan, Todd L.; Khandros, Eugene; Olson, John S.; Weiss, Mitchell J.; Mackay, Joel P.; Lay, Peter A.; Gell, David A.			alpha-Hemoglobin-stabilizing Protein (AHSP) Perturbs the Proximal Heme Pocket of Oxy-alpha-hemoglobin and Weakens the Iron-Oxygen Bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCATTERING XAFS ANALYSES; SITE MOLECULAR-STRUCTURE; CARBON-MONOXIDE COMPLEX; HUMAN ADULT HEMOGLOBIN; RED-BLOOD-CELLS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; ACTIVE-SITE; BETA-THALASSEMIA; NITRIC-OXIDE	alpha-Hemoglobin (alpha Hb)-stabilizing protein (AHSP) is a molecular chaperone that assists hemoglobin assembly. AHSP induces changes in alpha Hb heme coordination, but how these changes are facilitated by interactions at the alpha Hb center dot AHSP interface is not well understood. To address this question we have used NMR, x-ray absorption spectroscopy, and ligand binding measurements to probe alpha Hb conformational changes induced by AHSP binding. NMR chemical shift analyses of free CO-alpha Hb and CO-alpha Hb center dot AHSP indicated that the seven helical elements of the native alpha Hb structure are retained and that the heme Fe(II) remains coordinated to the proximal His-87 side chain. However, chemical shift differences revealed alterations of the F, G, and H helices and the heme pocket of CO-alpha Hb bound to AHSP. Comparisons of iron-ligand geometry using extended x-ray absorption fine structure spectroscopy showed that AHSP binding induces a small 0.03 angstrom lengthening of the Fe-O-2 bond, explaining previous reports that AHSP decreases alpha Hb O-2 affinity roughly 4-fold and promotes autooxidation due primarily to a 3-4-fold increase in the rate of O-2 dissociation. Pro-30 mutations diminished NMR chemical shift changes in the proximal heme pocket, restored normal O-2 dissociation rate and equilibrium constants, and reduced O-2-alpha Hb autooxidation rates. Thus, the contacts mediated by Pro-30 in wild-type AHSP promote alpha Hb autooxidation by introducing strain into the proximal heme pocket. As a chaperone, AHSP facilitates rapid assembly of alpha Hb into Hb when beta Hb is abundant but diverts alpha Hb to a redox resistant holding state when beta Hb is limiting.	[Dickson, Claire F.; Collins, Daniel A. T.; Gell, David A.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Rich, Anne M.; Lay, Peter A.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [D'Avigdor, William M. H.; Lowry, Jason A.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Mollan, Todd L.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Khandros, Eugene; Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA	University of Tasmania; University of Sydney; University of Sydney; Rice University; University of Pennsylvania	Gell, DA (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	david.gell@utas.edu.au	Lay, Peter A/B-4698-2014; Weiss, Mitchell J/W-9814-2018; Mackay, Joel/D-6834-2011	Lay, Peter A/0000-0002-3232-2720; Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403; Collins, Daniel/0000-0001-5261-8054; Gell, David/0000-0003-0382-1181; Mackay, Joel/0000-0001-7508-8033	National Institutes of Health (NIH) [HL47020, GM35649, HL110900]; Institute of Biosciences and Bioengineering NIH [GM008362]; Australian Research Council (ARC); National Health and Medical Research Council; Robert A. Welch Foundation [C-0612]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020, P01HL110900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008362] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Biosciences and Bioengineering NIH; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants HL47020, GM35649, and HL110900 (all to J. S. O.) and Institute of Biosciences and Bioengineering NIH Biotechnology Predoctoral Training Grant GM008362 (to T. L. M.). This work was also supported by the Australian Research Council (ARC) (to P. A. L., J. P. M., and D. A. G.), an ARC Australian Professorial Fellowship (to P. A. L.), a National Health and Medical Research Council Senior Research Fellowship (to J. P. M.), and Robert A. Welch Foundation Grant C-0612 (to J. S. O. and T. L. M.).	Amer J, 2003, EUR J HAEMATOL, V70, P84, DOI 10.1034/j.1600-0609.2003.00011.x; ANTONINI E, 1966, J MOL BIOL, V17, P29, DOI 10.1016/S0022-2836(66)80092-X; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; BEYCHOK S, 1967, J BIOL CHEM, V242, P2460; BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; BRUNORI M, 1966, J BIOL CHEM, V241, P5238; BUCCI E, 1965, J BIOL CHEM, V240, pP551; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Capece L, 2006, J AM CHEM SOC, V128, P12455, DOI 10.1021/ja0620033; Chance MR, 1996, BIOCHEMISTRY-US, V35, P9014, DOI 10.1021/bi9605503; CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4; DALVIT C, 1987, J MOL BIOL, V194, P329, DOI 10.1016/0022-2836(87)90379-2; DALVIT C, 1987, FEBS LETT, V213, P289, DOI 10.1016/0014-5793(87)81507-7; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; dos Santos CO, 2004, EXP HEMATOL, V32, P157, DOI 10.1016/j.exphem.2003.11.002; Eaton W A, 1981, Methods Enzymol, V76, P175; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; ELLIS PJ, 1995, J SYNCHROTRON RADIAT, V2, P190, DOI 10.1107/S0909049595006789; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; George GN, 2012, J SYNCHROTRON RADIAT, V19, P875, DOI 10.1107/S090904951203943X; GERACI G, 1969, BIOCHEMISTRY-US, V8, P1848, DOI 10.1021/bi00833a011; Geraci G, 1981, Methods Enzymol, V76, P262; GILL FM, 1973, J CLIN INVEST, V52, P3057, DOI 10.1172/JCI107504; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Giordano PC, 2007, HEMOGLOBIN, V31, P179, DOI 10.1080/03630260701289490; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Goddard TD, 2006, SPARKY; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Hasnain SS, 1999, J SYNCHROTRON RADIAT, V6, P852, DOI 10.1107/S0909049599006792; JAMESON GB, 1980, J AM CHEM SOC, V102, P3224, DOI 10.1021/ja00529a055; JOSHI W, 1983, J LAB CLIN MED, V102, P46; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005; Levina A, 2005, COORDIN CHEM REV, V249, P141, DOI 10.1016/j.ccr.2004.10.008; Li R, 2000, J INORG BIOCHEM, V82, P93, DOI 10.1016/S0162-0134(00)00151-3; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; Lukin JA, 2000, P NATL ACAD SCI USA, V97, P10354, DOI 10.1073/pnas.190254697; MARTINEAU L, 1992, EUR J BIOCHEM, V205, P661, DOI 10.1111/j.1432-1033.1992.tb16826.x; Mollan TL, 2013, J BIOL CHEM, V288, P4288, DOI 10.1074/jbc.M112.412064; Mollan TL, 2012, J BIOL CHEM, V287, P11338, DOI 10.1074/jbc.M111.313247; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nasimuzzaman M, 2010, AM J HEMATOL, V85, P820, DOI 10.1002/ajh.21829; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PELTON JG, 1993, PROTEIN SCI, V2, P543; REED CA, 1977, P NATL ACAD SCI USA, V74, P1780, DOI 10.1073/pnas.74.5.1780; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Rich A. M., 1997, THESIS U SYDNEY SYDN; Rich AM, 1998, INORG CHEM, V37, P5743, DOI 10.1021/ic9714549; Rich AM, 1998, J AM CHEM SOC, V120, P10827, DOI 10.1021/ja980253g; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SCHULMAN HM, 1974, BIOCHEM BIOPH RES CO, V56, P220, DOI 10.1016/S0006-291X(74)80337-2; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simplaceanu V, 2000, BIOPHYS J, V79, P1146, DOI 10.1016/S0006-3495(00)76368-5; SPIRO TG, 1974, J AM CHEM SOC, V96, P338, DOI 10.1021/ja00809a004; Srinoun K, 2009, HAEMATOL-HEMATOL J, V94, P1211, DOI 10.3324/haematol.2009.005827; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; TOMODA A, 1978, BIOCHEM J, V171, P329, DOI 10.1042/bj1710329; Tran ATT, 2004, BBA-PROTEINS PROTEOM, V1701, P75, DOI 10.1016/j.bbapap.2004.06.003; Tran ATT, 2003, BBA-PROTEINS PROTEOM, V1650, P59, DOI 10.1016/S1570-9639(03)00202-4; VALDES R, 1977, J BIOL CHEM, V252, P74; Vasseur C, 2011, AM J HEMATOL, V86, P199, DOI 10.1002/ajh.21918; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; ZHANG Y, 1992, J AM CHEM SOC, V114, P9189, DOI 10.1021/ja00049a062; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	85	12	12	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19986	20001		10.1074/jbc.M112.437509	http://dx.doi.org/10.1074/jbc.M112.437509			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696640	hybrid, Green Published			2022-12-25	WOS:000321515800063
J	Kriz, Z; Klusak, J; Kristofikova, Z; Koca, J				Kriz, Zdenek; Klusak, Jiri; Kristofikova, Zdena; Koca, Jaroslav			How Ionic Strength Affects the Conformational Behavior of Human and Rat Beta Amyloids - A Computational Study	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ALZHEIMERS-DISEASE; FIBRIL FORMATION; PROTEIN; PEPTIDE; RECOGNITION; MICROSCOPY; PATTERN; MODELS	Progressive cerebral deposition of amyloid beta occurs in Alzheimers disease and during the aging of certain mammals (human, monkey, dog, bear, cow, cat) but not others (rat, mouse). It is possibly due to different amino acid sequences at positions 5, 10 and 13. To address this issue, we performed series of 100 ns long trajectories (each trajectory was run twice with different initial velocity distribution) on amyloid beta (1-42) with the human and rat amino acid sequence in three different environments: water with only counter ions, water with NaCl at a concentration of 0.15 M as a model of intracellular Na+ concentration at steady state, and water with NaCl at a concentration of 0.30 M as a model of intracellular Na+ concentration under stimulated conditions. We analyzed secondary structure stability, internal hydrogen bonds, and residual fluctuation. It was observed that the change in ionic strength affects the stability of internal hydrogen bonds. Increasing the ionic strength increases atomic fluctuation in the hydrophobic core of the human amyloid, and decreases the atomic fluctuation in the case of rat amyloid. The secondary structure analyses show a stable a-helix part between residues 10 and 20. However, C-terminus of investigated amyloids is much more flexible showing no stable secondary structure elements. Increasing ionic strength of the solvent leads to decreasing stability of the secondary structural elements. The difference in conformational behavior of the three amino acids at position 5, 10 and 13 for human and rat amyloids significantly changes the conformational behavior of the whole peptide.	[Kriz, Zdenek; Koca, Jaroslav] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Kriz, Zdenek; Klusak, Jiri; Koca, Jaroslav] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic; [Kristofikova, Zdena] Prague Psychiat Ctr, Alzheimer Dis Ctr, Prague, Czech Republic	Masaryk University Brno; Masaryk University Brno	Koca, J (corresponding author), Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic.	jkoca@chemi.muni.cz	Koca, Jaroslav/E-4460-2012	Koca, Jaroslav/0000-0002-2780-4901	Grant Agency of the Czech Republic [305/09/0457]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]; Czech Science Foundation [GD301/09/H004]; European Community from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; "Capacities" specific programme [286154]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); European Community from the European Regional Development Fund; "Capacities" specific programme	This work was financially supported by the Grant Agency of the Czech Republic grant number 305/09/0457. The access to the MetaCentrum computing facilities provided under the programme "Projects of Large Infrastructure for Research, Development, and Innovations" LM2010005 funded by the Ministry of Education, Youth, and Sports of the Czech Republic is gratefully acknowledged. The work was also financially supported by the Czech Science Foundation (GD301/09/H004), by the European Community's Seventh Framework Programme (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund and from the "Capacities" specific programme (Contract No. 286154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; Case DA, 2011, AMBER; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Dominy BN, 2002, J MOL BIOL, V319, P541, DOI 10.1016/S0022-2836(02)00259-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Florova P, 2010, J CHEM THEORY COMPUT, V6, P3569, DOI 10.1021/ct1003687; Grubmuller H., 1996, SOLVATE PROGRAM CREA; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192; Losic D, 2006, J STRUCT BIOL, V155, P104, DOI 10.1016/j.jsb.2006.02.013; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Milton NGN, 1999, BIOCHEM J, V344, P293, DOI 10.1042/0264-6021:3440293; Milton NGN, 2001, NEUROREPORT, V12, P2561, DOI 10.1097/00001756-200108080-00054; Otyepka M, 2006, J BIOL CHEM, V281, P7271, DOI 10.1074/jbc.M509699200; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Pawlik M, 1999, NEUROBIOL AGING, V20, P47, DOI 10.1016/S0197-4580(99)00017-2; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Prokop M, 2008, BIOINFORMATICS, V24, P1955, DOI 10.1093/bioinformatics/btn344; Rauk A, 2008, DALTON T, P1273, DOI 10.1039/b718601k; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schladitz C, 1999, BIOPHYS J, V77, P3305, DOI 10.1016/S0006-3495(99)77161-4; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shafrir Y, 2010, PROTEINS, V78, P3458, DOI 10.1002/prot.22832; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Sklenovsky P, 2008, J MOL MODEL, V14, P747, DOI 10.1007/s00894-008-0300-5; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Wang H, 2000, ADV IND CON; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Yao ZX, 2002, FASEB J, V16, P1677, DOI 10.1096/fj.02-0285fje; Zidar J, 2011, J PHYS CHEM B, V115, P2075, DOI 10.1021/jp109025b	43	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e62914	10.1371/journal.pone.0062914	http://dx.doi.org/10.1371/journal.pone.0062914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717395	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600004
J	Du, Y; Liu, H; He, YQ; Liu, YW; Yang, CX; Zhou, MQ; Wang, WJ; Cui, L; Hu, JJ; Gao, F				Du, Yan; Liu, Hua; He, Yiqing; Liu, Yiwen; Yang, Cuixia; Zhou, Muqing; Wang, Wenjuan; Cui, Lian; Hu, Jiajie; Gao, Feng			The Interaction between LYVE-1 with Hyaluronan on the Cell Surface May Play a Role in the Diversity of Adhesion to Cancer Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PERICELLULAR MATRIX; TUMOR-CELLS; EXPRESSION; CD44; LYMPHANGIOGENESIS; MECHANISM; ACID; INVASIVENESS; METASTASIS	Hyaluronan (HA), a simple disaccharide unit, can polymerize and is considered a primary component of the extracellular matrix, which has a wide range of biological functions. In recent years, HA was found on the surface of tumor cells. According to previous reports, differing HA content on the cell surface of tumor cells is closely related to lymph node metastases, but the mechanisms mediating this process remained unclear. This research intended to study the surface content of HA on tumor cells and analyze cell adhesive changes caused by the interaction between HA and its lymphatic endothelial receptor (LYVE-1). We screened and observed high HA content on HS-578T breast cells and low HA content on MCF-7 breast cells through particle exclusion, immunofluorescence and flow cytometry experiments. The expression of LYVE-1, the lymph-vessel specific HA receptor, was consistent with our previous report and enhanced the adhesion of HA(high)-HS-578T cells to COS-7(LYVE-1(+)) through HA in cell static adhesion and dynamic parallel plate flow chamber experiments. MCF-7 breast cells contain little HA on the surface; however, our results showed little adhesion difference between MCF-7 cells and COS-7(LYVE-1(+)) and COS-7(LYVE-1(-)) cells. Similar results were observed concerning the adhesion of HS-578T cells or MCF-7 cells to SVEC4-10 cells. Furthermore, we observed for the first time that the cell surface HA content of high transfer tumor cells was rich, and we visualized the cross-linking of HA cable structures, which may activate LYVE-1 on lymphatic endothelial cells, promoting tumor adhesion. In summary, high-low cell surface HA content of tumor cells through the interaction with LYVE-1 leads to adhesion differences.	[Du, Yan; He, Yiqing; Liu, Yiwen; Yang, Cuixia; Wang, Wenjuan; Cui, Lian; Hu, Jiajie; Gao, Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai 200030, Peoples R China; [Liu, Hua; Zhou, Muqing; Gao, Feng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Clin Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Mol Biol Lab, Shanghai 200030, Peoples R China.	gao3507@126.com	liu, yi/GXE-9662-2022		shanghai Committee of Science and Technology [10411950500]; National Natural Science Foundation of China [81071814, 81172027, 81272479]; Program of Shanghai Subject Chief Scientist [11XD1404000]	shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist	This research was supported by the shanghai Committee of Science and Technology (No. 10411950500), the National Natural Science Foundation of China (81071814, 81172027, 81272479) and the Program of Shanghai Subject Chief Scientist (11XD1404000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO J, 1995, ANN NY ACAD SCI, V748, P148; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 2009, J BIOL CHEM; Cai B, 2012, J APPL PHYSIOL, V113, P1141, DOI 10.1152/japplphysiol.00479.2012; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Du Y, 2011, CLIN INVEST MED, V34, pE45; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hou WH, 2012, FEBS LETT, V586, P1480, DOI 10.1016/j.febslet.2012.04.001; Itano N, 1999, CANCER RES, V59, P2499; Jacobs AL, 1997, CANCER RES, V57, P5148; Jojovic M, 2002, CANCER LETT, V188, P181, DOI 10.1016/S0304-3835(02)00037-X; KIMATA K, 1983, CANCER RES, V43, P1347; Lanisnik Rizner T, 2011, CHEM BIOL INTERACT; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li LZ, 2011, ADV EXP MED BIOL, V701, P137, DOI 10.1007/978-1-4419-7756-4_19; LUSCINSKAS FW, 1994, J CELL BIOL, V125, P1417, DOI 10.1083/jcb.125.6.1417; Mattila MMT, 2002, INT J CANCER, V98, P946, DOI 10.1002/ijc.10283; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; PINTAR JE, 1978, DEV BIOL, V67, P444, DOI 10.1016/0012-1606(78)90211-7; SCHOR SL, 1989, IN VITRO CELL DEV B, V25, P737; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; TOOLE BP, 1971, DEV BIOL, V26, P28, DOI 10.1016/0012-1606(71)90104-7; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; UNDERHILL CB, 1989, CIBA FDN S, V143, P87; Wang Fang, 2011, Chinese Journal of Pathology, V40, P99, DOI 10.3760/cma.j.jssn.0529-5807.2011.02.007; Williams CSM, 2003, J PATHOL, V200, P195, DOI 10.1002/path.1343; Zeng GF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-113; ZHANG LR, 1995, CANCER RES, V55, P428; Zheng FJ, 2012, ASIAN PAC J CANCER P, V13, P3751, DOI 10.7314/APJCP.2012.13.8.3751; Zia MK, 2007, INT J MOL MED, V20, P605	40	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63463	10.1371/journal.pone.0063463	http://dx.doi.org/10.1371/journal.pone.0063463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717428	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700023
J	Teuber, J; Mueller, B; Fukabori, R; Lang, D; Albrecht, A; Stork, O				Teuber, Jan; Mueller, Bettina; Fukabori, Ryoji; Lang, Daniel; Albrecht, Anne; Stork, Oliver			The Ubiquitin Ligase Praja1 Reduces NRAGE Expression and Inhibits Neuronal Differentiation of PC12 Cells	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; EXONIC SPLICING ENHANCERS; NEURITE OUTGROWTH; INTERACTING PROTEIN; FAMILY PROTEIN; RING-H2 MOTIF; TGF-BETA; GENE; IDENTIFICATION; ACTIVATION	Evidence suggests that regulated ubiquitination of proteins plays a critical role in the development and plasticity of the central nervous system. We have previously identified the ubiquitin ligase Praja1 as a gene product induced during fear memory consolidation. However, the neuronal function of this enzyme still needs to be clarified. Here, we investigate its involvement in the nerve growth factor (NGF)-induced differentiation of rat pheochromocytoma (PC12) cells. Praja1 colocalizes with cytoskeleton components and the neurotrophin receptor interacting MAGE homologue (NRAGE). We observed an enhanced expression of Praja1 after 3 days of NGF treatment and a suppression of neurite formation upon Praja1 overexpression in stably transfected PC12 cell lines, which was associated with a proteasome-dependent reduction of NRAGE levels. Our data suggest that Praja1, through ubiquitination and degradation of NRAGE, inhibits neuronal differentiation. The two murine isoforms, Praja1.1 and Praja1.2, appear to be functionally homologous in this respect.	[Teuber, Jan; Mueller, Bettina; Fukabori, Ryoji; Lang, Daniel; Albrecht, Anne; Stork, Oliver] Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany; [Stork, Oliver] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University	Stork, O (corresponding author), Univ Magdeburg, Inst Biol, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany.	oliver.stork@ovgu.de	Albrecht, Anne/GNP-7475-2022	Albrecht, Anne/0000-0001-8613-2968; Fukabori, Ryoji/0000-0001-7534-8237; Stork, Oliver/0000-0003-4285-7507	federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences); German Research Foundation [SFB854 TP10]; Studienstiftung des deutschen Volkes	federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences); German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by grants from the federal state of Sachsonia-Anhalt (Center for Behavioral Brain Sciences) and the German Research Foundation (SFB854 TP10 to OS). JT was supported through a scholarship of the Studienstiftung des deutschen Volkes, and DL was a graduate student of the graduate school GRK1167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Althini S, 2003, BIOCHEM BIOPH RES CO, V307, P632, DOI 10.1016/S0006-291X(03)01236-1; Barrett GL, 2005, NEUROSCIENCE, V133, P381, DOI 10.1016/j.neuroscience.2005.01.067; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Feng ZH, 2010, J NEUROSCI RES, V88, P1822, DOI 10.1002/jnr.22340; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Ito H, 2002, J NEUROSCI RES, V69, P653, DOI 10.1002/jnr.10359; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Johnston JA, 2004, PROG NEUROBIOL, V73, P227, DOI 10.1016/j.pneurobio.2004.05.004; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kendall SE, 2005, MOL CELL BIOL, V25, P7711, DOI 10.1128/MCB.25.17.7711-7724.2005; Kishino T, 1997, NAT GENET, V15, P411, DOI 10.1038/ng0497-411d; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Laser H, 2003, J NEUROSCI RES, V74, P906, DOI 10.1002/jnr.10806; Loch CM, 2011, CELL BIOCHEM BIOPHYS, V60, P127, DOI 10.1007/s12013-011-9180-x; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Masuda Y, 2001, J BIOL CHEM, V276, P5331, DOI 10.1074/jbc.M008590200; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mishra L, 2005, CANCER BIOL THER, V4, P694, DOI 10.4161/cbt.4.7.2015; Mishra L, 1997, ONCOGENE, V15, P2361, DOI 10.1038/sj.onc.1201405; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAYAMA M, 1995, J NEUROSCI, V15, P5238; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Obin M, 1999, J BIOL CHEM, V274, P11789, DOI 10.1074/jbc.274.17.11789; Reddy EM, 2010, EXP CELL RES, V316, P2220, DOI 10.1016/j.yexcr.2010.05.030; Saha T, 2006, ONCOGENE, V25, P693, DOI 10.1038/sj.onc.1209123; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stork O, 2004, J BIOL CHEM, V279, P45773, DOI 10.1074/jbc.M403552200; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Wieland I, 2007, CLIN GENET, V72, P506, DOI 10.1111/j.1399-0004.2007.00905.x; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Williams ME, 2003, J BIOL CHEM, V278, P17483, DOI 10.1074/jbc.M300415200; Xue B, 2005, BIOCHEM BIOPH RES CO, V336, P247, DOI 10.1016/j.bbrc.2005.08.069; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	48	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63067	10.1371/journal.pone.0063067	http://dx.doi.org/10.1371/journal.pone.0063067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717400	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700009
J	Chapa, J; Bourgo, RJ; Greene, GL; Kulkarni, S; An, G				Chapa, Joaquin; Bourgo, Ryan J.; Greene, Geoffrey L.; Kulkarni, Swati; An, Gary			Examining the Pathogenesis of Breast Cancer Using a Novel Agent-Based Model of Mammary Ductal Epithelium Dynamics	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; STEROID-HORMONE LEVELS; ATHYMIC NUDE-MICE; IN-SITU DCIS; E-CADHERIN; GLAND DEVELOPMENT; PROGESTERONE-RECEPTOR; CELL-PROLIFERATION; KNOWLEDGE REPRESENTATION; TUMOR-SUPPRESSOR	The study of the pathogenesis of breast cancer is challenged by the long time-course of the disease process and the multifactorial nature of generating oncogenic insults. The characterization of the longitudinal pathogenesis of malignant transformation from baseline normal breast duct epithelial dynamics may provide vital insight into the cascading systems failure that leads to breast cancer. To this end, extensive information on the baseline behavior of normal mammary epithelium and breast cancer oncogenesis was integrated into a computational model termed the Ductal Epithelium Agent-Based Model (DEABM). The DEABM is composed of computational agents that behave according to rules established from published cellular and molecular mechanisms concerning breast duct epithelial dynamics and oncogenesis. The DEABM implements DNA damage and repair, cell division, genetic inheritance and simulates the local tissue environment with hormone excretion and receptor signaling. Unrepaired DNA damage impacts the integrity of the genome within individual cells, including a set of eight representative oncogenes and tumor suppressors previously implicated in breast cancer, with subsequent consequences on successive generations of cells. The DEABM reproduced cellular population dynamics seen during the menstrual cycle and pregnancy, and demonstrated the oncogenic effect of known genetic factors associated with breast cancer, namely TP53 and Myc, in simulations spanning similar to 40 years of simulated time. Simulations comparing normal to BRCA1-mutant breast tissue demonstrated rates of invasive cancer development similar to published epidemiologic data with respect to both cumulative incidence over time and estrogen-receptor status. Investigation of the modeling of ER alpha-positive (ER+) tumorigenesis led to a novel hypothesis implicating the transcription factor and tumor suppressor RUNX3. These data suggest that the DEABM can serve as a potentially valuable framework to augment the traditional investigatory workflow for future hypothesis generation and testing of the mechanisms of breast cancer oncogenesis.	[Chapa, Joaquin] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Bourgo, Ryan J.; Greene, Geoffrey L.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Kulkarni, Swati; An, Gary] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Kulkarni, S (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	skulkarni@surgery.bsd.uchicago.edu; docgca@aol.com		An, Gary/0000-0003-4549-9004				Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Altekruse SF, 2010, SEER CANC STAT REV 1; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G., 2009, AGENT BASED MODELS T; An G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000390; An G, 2009, MATH BIOSCI, V217, P43, DOI 10.1016/j.mbs.2008.10.001; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; An GC, 2009, MATH BIOSCI, V217, P53, DOI 10.1016/j.mbs.2008.08.013; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Angeloni SV, 2004, J ENDOCRINOL, V180, P497, DOI 10.1677/joe.0.1800497; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Balci O, 1998, HANDBOOK OF SIMULATION, P335; Balci O., 2001, ACM T MODEL COMPUT S, V11, P352, DOI DOI 10.1145/508366.508369; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bankhead A, 2007, J THEOR BIOL, V246, P491, DOI 10.1016/j.jtbi.2007.01.011; BERG J, 1995, CANCER S, V75, P139; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; CALEFFI M, 1994, CANCER, V73, P2147, DOI 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5; CATTORETTI G, 1988, INT J CANCER, V41, P178, DOI 10.1002/ijc.2910410204; Chen LF, 2012, J CELL BIOCHEM, V113, P1470, DOI 10.1002/jcb.24074; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; CHIMGE NO, 2012, ONCOGENE; Clarke RB, 1997, CANCER RES, V57, P4987; Clarke RB, 1997, BREAST CANCER RES TR, V45, P121, DOI 10.1023/A:1005805831460; Colleoni M, 2012, ANN ONCOL, V23, P1428, DOI 10.1093/annonc/mdr461; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; EASTON DF, 1995, AM J HUM GENET, V56, P265; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Engelberg JA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-110; Feuerhake F, 2000, CELL TISSUE RES, V299, P47, DOI 10.1007/s004410050005; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; GAUTSCHI JR, 1971, J CELL BIOL, V51, P653, DOI 10.1083/jcb.51.3.653; Geyer FC, 2009, INT J SURG PATHOL, V17, P285, DOI 10.1177/1066896908328577; GOING JJ, 1988, AM J PATHOL, V130, P193; Gorski JJ, 2009, CLIN CANCER RES, V15, P1514, DOI 10.1158/1078-0432.CCR-08-0640; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Haslam SZ, 2008, ENDOCRINOLOGY, V149, P2098, DOI 10.1210/en.2007-1398; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Huang B, 2012, ONCOGENE, V31, P527, DOI 10.1038/onc.2011.252; Hynes NE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2406; Kaiser MI, 2011, HIST PHIL LIFE SCI, V33, P453; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; KENNEDY RC, 2006, VERIFICATION VALIDAT; Khan SA, 2002, INT J CANCER, V102, P334, DOI 10.1002/ijc.10737; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Kim M, 2012, SURG INFECT, V13, P18, DOI 10.1089/sur.2011.057; Kim SHJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-122; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; LAIDLAW IJ, 1995, ENDOCRINOLOGY, V136, P164, DOI 10.1210/en.136.1.164; LARSSON O, 1993, CELL BIOL INT, V17, P565, DOI 10.1006/cbir.1993.1100; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee E, 2011, J CLIN ONCOL, V29, P4373, DOI 10.1200/JCO.2010.33.6446; LESTER SC, 2005, ROBBINS COTRAN PATHO, P1065; Liu YL, 2002, BREAST CANCER RES, V4, P9, DOI 10.1186/bcr417; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Masciari S, 2012, BREAST CANCER RES TR, V133, P1125, DOI 10.1007/s10549-012-1993-9; McCave EJ, 2010, J MAMMARY GLAND BIOL, V15, P291, DOI 10.1007/s10911-010-9190-0; MEYER JS, 1982, CANCER, V50, P746, DOI 10.1002/1097-0142(19820815)50:4<746::AID-CNCR2820500420>3.0.CO;2-A; Nakopoulou L, 2000, HISTOPATHOLOGY, V36, P313; Nass SJ, 2000, CANCER RES, V60, P4346; Navarrete MAH, 2005, BREAST CANCER RES, V7, pR306, DOI 10.1186/bcr994; Norton KA, 2010, J THEOR BIOL, V263, P393, DOI 10.1016/j.jtbi.2009.11.024; OLEARY P, 1991, CLIN CHEM, V37, P667; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Palmieri C, 2004, J MOL ENDOCRINOL, V33, P35, DOI 10.1677/jme.0.0330035; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rucker EB, 2011, GENESIS, V49, P24, DOI 10.1002/dvg.20691; Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33; Sharma P, 2006, BREAST CANCER RES TR, V100, P71, DOI 10.1007/s10549-006-9234-8; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; SODERQVIST G, 1993, AM J OBSTET GYNECOL, V168, P874; Soldin OP, 2005, FERTIL STERIL, V84, P701, DOI 10.1016/j.fertnstert.2005.02.045; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stern JR, 2012, WOUND REPAIR REGEN, V20, P862, DOI 10.1111/j.1524-475X.2012.00852.x; STERN JR, 2013, J SURG RES; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stoelzle T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-63; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Subramaniam MM, 2009, BREAST CANCER RES TR, V113, P113, DOI 10.1007/s10549-008-9917-4; Taylor D, 2009, BREAST CANCER RES TR, V118, P161, DOI 10.1007/s10549-009-0322-4; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; Umekita Y, 2007, IN VIVO, V21, P535; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wilensky U., 2009, INTRO AGENT BASED MO; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Young P, 2002, MOL CELL NEUROSCI, V21, P341, DOI 10.1006/mcne.2002.1177	108	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64091	10.1371/journal.pone.0064091	http://dx.doi.org/10.1371/journal.pone.0064091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704974	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200113
J	Kawahara, E; Maenaka, S; Shimada, E; Nishimura, Y; Sakurai, H				Kawahara, Ei; Maenaka, Shiori; Shimada, Eri; Nishimura, Yoshihiro; Sakurai, Hiroshi			Dynamic Regulation of Extracellular Signal-Regulated Kinase (ERK) by Protein Phosphatase 2A Regulatory Subunit B56 gamma 1 in Nuclei Induces Cell Migration	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MAP KINASE; CARCINOMA-CELL; TYROSINE PHOSPHORYLATION; SUSTAINED ACTIVATION; TRUNCATED ISOFORM; B56 SUBUNIT; GENE IEX-1; CYCLIN D1; B-BETA	Extracellular signal-regulated kinase (ERK) signalling plays a central role in various biological processes, including cell migration, but it remains unknown what factors directly regulate the strength and duration of ERK activation. We found that, among the B56 family of protein phosphatase 2A (PP2A) regulatory subunits, B56 gamma 1 suppressed EGF-induced cell migration on collagen, bound to phosphorylated-ERK, and dephosphorylated ERK, whereas B56 alpha 1 and B56 beta 1 did not. B56 gamma 1 was immunolocalized in nuclei. The IER3 protein was immediately highly expressed in response to costimulation of cells with EGF and collagen. Knockdown of IER3 inhibited cell migration and enhanced dephosphorylation of ERK. Analysis of the time course of PP2A-B56 gamma 1 activity following the costimulation showed an immediate loss of phosphatase activity, followed by a rapid increase in activity, and this activity then remained at a stable level that was lower than the original level. Our results indicate that the strength and duration of the nuclear ERK activation signal that is initially induced by ERK kinase (MEK) are determined at least in part by modulation of the phosphatase activity of PP2A-B56 gamma 1 through two independent pathways.	[Kawahara, Ei; Maenaka, Shiori; Shimada, Eri; Nishimura, Yoshihiro; Sakurai, Hiroshi] Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Kawahara, E (corresponding author), Kanazawa Univ, Dept Clin Lab Sci, Kanazawa, Ishikawa, Japan.	kawahara@staff.kanazawa-u.ac.jp	Kawahara, Ei/C-3233-2015; SAKURAI, Hiroshi/L-3693-2015; Kawahara, Ei/AAD-5189-2020	Kawahara, Ei/0000-0002-8571-5448; Sakurai, Hiroshi/0000-0002-0336-2301	Kanazawa University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748, P50HD055751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092696] Funding Source: NIH RePORTER	Kanazawa University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this project was provided by Kanazawa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Bae D, 2009, BIOCHEM BIOPH RES CO, V385, P523, DOI 10.1016/j.bbrc.2009.05.082; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chajry N, 1996, EUR J BIOCHEM, V235, P97, DOI 10.1111/j.1432-1033.1996.00097.x; CHARLES CH, 1993, ONCOGENE, V8, P797; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dozier C, 2004, BIOL CELL, V96, P509, DOI 10.1016/j.biolcel.2004.04.010; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Garcia J, 2002, EMBO J, V21, P5151, DOI 10.1093/emboj/cdf488; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; Hashigasako A, 2004, J BIOL CHEM, V279, P26445, DOI 10.1074/jbc.M314254200; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Isoda M, 2011, DEV CELL, V21, P506, DOI 10.1016/j.devcel.2011.06.029; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Ito A, 2003, AM J PATHOL, V162, P479, DOI 10.1016/S0002-9440(10)63842-4; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Joslin EJ, 2007, J CELL SCI, V120, P3688, DOI 10.1242/jcs.010488; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Kawahara E, 2005, CELL BIOL INT, V29, P521, DOI 10.1016/j.cellbi.2005.02.006; Kawahara E, 2002, EXP CELL RES, V272, P84, DOI 10.1006/excr.2001.5399; KAWAHARA E, 1993, JPN J CANCER RES, V84, P409, DOI 10.1111/j.1349-7006.1993.tb00151.x; Kawahara E, 1999, CELL BIOL INT, V23, P163, DOI 10.1006/cbir.1998.0331; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Ma J, 2007, ONCOGENE, V26, P5145, DOI 10.1038/sj.onc.1210323; MAIER GD, 1995, INT J CANCER, V61, P54, DOI 10.1002/ijc.2910610110; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; MORINO N, 1995, J BIOL CHEM, V270, P269, DOI 10.1074/jbc.270.1.269; Mukhopadhyay NK, 2004, ANN THORAC SURG, V78, P450, DOI 10.1016/j.athoracsur.2004.01.042; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakada N, 2005, CELL PHYSIOL BIOCHEM, V15, P19, DOI 10.1159/000083635; Noordman Yvet E, 2006, J Mol Signal, V1, P4, DOI 10.1186/1750-2187-1-4; Ortega-Lazaro JC, 2003, CYTOGENET GENOME RES, V103, P345, DOI 10.1159/000076823; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pitman MR, 2011, INT J BIOCHEM CELL B, V43, P342, DOI 10.1016/j.biocel.2010.11.001; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tian YC, 2007, EXP CELL RES, V313, P2367, DOI 10.1016/j.yexcr.2007.03.022; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Van Kanegan MJ, 2009, MOL CELL BIOL, V29, P662, DOI 10.1128/MCB.01242-08; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; YEBRA M, 1995, MOL BIOL CELL, V6, P841, DOI 10.1091/mbc.6.7.841; YOUNG MRI, 1993, INT J CANCER, V54, P1036, DOI 10.1002/ijc.2910540629; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	74	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63729	10.1371/journal.pone.0063729	http://dx.doi.org/10.1371/journal.pone.0063729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704935	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200066
J	Wang, HY; Wen, CF; Chiu, YH; Lee, IN; Kao, HY; Lee, IC; Ho, WH				Wang, Hue-Yu; Wen, Ching-Feng; Chiu, Yu-Hsien; Lee, I-Nong; Kao, Hao-Yun; Lee, I-Chen; Ho, Wen-Hsien			Leuconostoc Mesenteroides Growth in Food Products: Prediction and Sensitivity Analysis by Adaptive-Network-Based Fuzzy Inference Systems	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; ESCHERICHIA-COLI O157-H7; MODELING TECHNIQUE; BACTERIAL-GROWTH; WATER ACTIVITY; TEMPERATURE; PERFORMANCE; PARAMETERS; ANFIS	Background: An adaptive-network-based fuzzy inference system (ANFIS) was compared with an artificial neural network (ANN) in terms of accuracy in predicting the combined effects of temperature (10.5 to 24.5 degrees C), pH level (5.5 to 7.5), sodium chloride level (0.25% to 6.25%) and sodium nitrite level (0 to 200 ppm) on the growth rate of Leuconostoc mesenteroides under aerobic and anaerobic conditions. Methods: The ANFIS and ANN models were compared in terms of six statistical indices calculated by comparing their prediction results with actual data: mean absolute percentage error (MAPE), root mean square error (RMSE), standard error of prediction percentage (SEP), bias factor (B-f), accuracy factor (A(f)), and absolute fraction of variance (R-2). Graphical plots were also used for model comparison. Conclusions: The learning-based systems obtained encouraging prediction results. Sensitivity analyses of the four environmental factors showed that temperature and, to a lesser extent, NaCl had the most influence on accuracy in predicting the growth rate of Leuconostoc mesenteroides under aerobic and anaerobic conditions. The observed effectiveness of ANFIS for modeling microbial kinetic parameters confirms its potential use as a supplemental tool in predictive mycology. Comparisons between growth rates predicted by ANFIS and actual experimental data also confirmed the high accuracy of the Gaussian membership function in ANFIS. Comparisons of the six statistical indices under both aerobic and anaerobic conditions also showed that the ANFIS model was better than all ANN models in predicting the four kinetic parameters. Therefore, the ANFIS model is a valuable tool for quickly predicting the growth rate of Leuconostoc mesenteroides under aerobic and anaerobic conditions.	[Wang, Hue-Yu] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan; [Wen, Ching-Feng] Kaohsiung Med Univ, Ctr Fundamental Sci, Kaohsiung, Taiwan; [Chiu, Yu-Hsien; Lee, I-Nong; Kao, Hao-Yun; Lee, I-Chen; Ho, Wen-Hsien] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Ho, WH (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	whho@kmu.edu.tw	Wen, Ching-Feng/AAD-6334-2020; Kao, Hao-Yun/AAZ-5597-2021; Hao-Yun, Kao/AGD-6394-2022	Wen, Ching-Feng/0000-0001-8900-761X; Kao, Hao-Yun/0000-0002-9390-9314; 	Chi-Mei Medical Center [101CM-KMU-09]; Kaohsiung University Research Foundation; National Science Council, Taiwan, Republic of China [NSC 101-2320-B-037-022]	Chi-Mei Medical Center; Kaohsiung University Research Foundation; National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant 101CM-KMU-09 from the Chi-Mei Medical Center and Kaohsiung University Research Foundation and by grant NSC 101-2320-B-037-022 from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; AlaKorpela M, 1995, NMR BIOMED, V8, P235, DOI 10.1002/nbm.1940080603; BUCHANAN RL, 1994, INT J FOOD MICROBIOL, V23, P317, DOI 10.1016/0168-1605(94)90160-0; Dantigny P, 2005, INT J FOOD MICROBIOL, V100, P187, DOI 10.1016/j.ijfoodmicro.2004.10.013; Efron B., 1994, INTRO BOOTSTRAP; Ertunc HM, 2008, INT J REFRIG, V31, P1426, DOI 10.1016/j.ijrefrig.2008.03.007; Garcia-Gimeno RM, 2005, INT J FOOD MICROBIOL, V105, P317, DOI 10.1016/j.ijfoodmicro.2005.04.013; Garcia-Gimeno RM, 2003, J FOOD SCI, V68, P639, DOI 10.1111/j.1365-2621.2003.tb05723.x; Geeraerd AH, 1998, INT J FOOD MICROBIOL, V44, P49, DOI 10.1016/S0168-1605(98)00127-5; Gibson AM, 1997, TRENDS FOOD SCI TECH, V8, P353, DOI 10.1016/S0924-2244(97)01065-0; Hajmeer MN, 1997, INT J FOOD MICROBIOL, V34, P51, DOI 10.1016/S0168-1605(96)01169-5; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Ho WH, 2011, EXPERT SYST APPL, V38, P13050, DOI 10.1016/j.eswa.2011.04.109; Ho WH, 2011, EXPERT SYST APPL, V38, P6319, DOI 10.1016/j.eswa.2010.11.110; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Ho WH, 2010, IEEE T AUTOM SCI ENG, V7, P143, DOI 10.1109/TASE.2009.2023673; intVeld JHJH, 1996, INT J FOOD MICROBIOL, V33, P1, DOI 10.1016/0168-1605(96)01139-7; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9; Lo SP, 2003, J MATER PROCESS TECH, V142, P665, DOI 10.1016/S0924-0136(03)00687-3; Lou W, 2001, J AGR FOOD CHEM, V49, P1799, DOI 10.1021/jf000650m; Lou WG, 2001, FOOD RES INT, V34, P573, DOI 10.1016/S0963-9969(01)00074-6; MATLAB Documentation, 2002, FUZZ TOOLB US GUID M; Murphy PA, 2006, J FOOD SCI, V71, pR51, DOI 10.1111/j.1750-3841.2006.00052.x; Panagou EZ, 2009, EXPERT SYST APPL, V36, P121, DOI 10.1016/j.eswa.2007.09.022; Parra R, 2004, J APPL MICROBIOL, V97, P429, DOI 10.1111/j.1365-2672.2004.02320.x; Patriarca A, 2001, INT J FOOD MICROBIOL, V68, P61, DOI 10.1016/S0168-1605(01)00470-6; Piscaglia F, 2006, EUR J GASTROEN HEPAT, V18, P1255, DOI 10.1097/01.meg.0000243885.55562.7e; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; Ross T, 1996, J APPL BACTERIOL, V81, P501, DOI 10.1111/j.1365-2672.1996.tb03539.x; ROSS T, 1994, INT J FOOD MICROBIOL, V23, P241, DOI 10.1016/0168-1605(94)90155-4; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; Tsai JT, 2006, IEEE T NEURAL NETWOR, V17, P69, DOI 10.1109/TNN.2005.860885; Zurera-Cosano G, 2006, FOOD CONTROL, V17, P429, DOI 10.1016/j.foodcont.2005.02.003	34	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64995	10.1371/journal.pone.0064995	http://dx.doi.org/10.1371/journal.pone.0064995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705023	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200177
J	Zhang, DH; Cui, Y; Shen, HT; Xing, LX; Cui, JF; Wang, J; Zhang, XH				Zhang, Donghui; Cui, Yu; Shen, Haitao; Xing, Lingxiao; Cui, Jinfeng; Wang, Juan; Zhang, Xianghong			Sterigmatocystin-Induced DNA Damage Triggers G(2) Arrest via an ATM/p53-Related Pathway in Human Gastric Epithelium GES-1 Cells In Vitro	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CYCLE ARREST; ATM ACTIVATION; APOPTOSIS; P53; CHECKPOINT; INDUCTION; DEOXYNIVALENOL; PROGRESSION; ZEARALENONE	Sterigmatocystin (ST), which is commonly detected in food and feed commodities, is a mutagenic and carcinogenic mycotoxin that has been recognized as a possible human carcinogen. Our previous study showed that ST can induce G(2) phase arrest in GES-1 cells in vitro and that the MAPK and PI3K signaling pathways are involved in the ST-induced G(2) arrest. It is now widely accepted that DNA damage plays a critical role in the regulation of cell cycle arrest and apoptosis. In response to DNA damage, a complex signaling network is activated in eukaryotic cells to trigger cell cycle arrest and facilitate DNA repair. To further explore the molecular mechanism through which ST induces G(2) arrest, the current study was designed to precisely dissect the role of DNA damage and the DNA damage sensor ataxia telangiectasia-mutated (ATM)/p53-dependent pathway in the ST-induced G(2) arrest in GES-1 cells. Using the comet assay, we determined that ST induces DNA damage, as evidenced by the formation of DNA comet tails, in GES-1 cells. We also found that ST induces the activation of ATM and its downstream molecules, Chk2 and p53, in GES-1 cells. The ATM pharmacological inhibitor caffeine was found to effectively inhibit the activation of the ATM-dependent pathways and to rescue the ST-induced G(2) arrest in GES-1 cells, which indicating its ATM-dependent characteristic. Moreover, the silencing of the p53 expression with siRNA effectively attenuated the ST-induced G(2) arrest in GES-1 cells. We also found that ST induces apoptosis in GES-1 cells. Thus, our results show that the ST-induced DNA damage activates the ATM/53-dependent signaling pathway, which contributes to the induction of G(2) arrest in GES-1 cells.	[Zhang, Donghui; Cui, Yu; Shen, Haitao; Xing, Lingxiao; Wang, Juan; Zhang, Xianghong] Hebei Med Univ, Pathol Lab, Shijiazhuang, Peoples R China; [Zhang, Donghui; Cui, Jinfeng; Zhang, Xianghong] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, XH (corresponding author), Hebei Med Univ, Pathol Lab, Shijiazhuang, Peoples R China.	zhangxianghong2008@163.com	cui, yu/CAF-5802-2022	cui, yu/0000-0003-4577-5080	Special funds of National Natural Science Foundation of China [81041072]; General Program of National Natural Science Foundation of China [81171889]; Natural Science Foundation of Hebei Province of China [C2010000479, C2009001108]	Special funds of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province)	This work was supported by Special funds of National Natural Science Foundation of China (Grant No. 81041072), General Program of National Natural Science Foundation of China (Grant No. 81171889) and Natural Science Foundation of Hebei Province of China (Grant No. C2010000479 and C2009001108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; Ahuja YR, 1999, PROTOC J CYTOL GENET, V34, P57; Ayed-Boussema I, 2008, TOXICOL IN VITRO, V22, P1671, DOI 10.1016/j.tiv.2008.06.016; Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Chen CY, 2008, FOOD CHEM TOXICOL, V46, P2476, DOI 10.1016/j.fct.2008.04.016; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Cui JF, 2010, TOXICOL LETT, V193, P152, DOI 10.1016/j.toxlet.2009.12.019; CURRY PT, 1984, MUTAT RES, V137, P111, DOI 10.1016/0165-1218(84)90099-5; Davis AJ, 2010, CELL CYCLE, V9, P2529, DOI 10.4161/cc.9.13.12148; Dujka ME, 2010, ONCOGENE, V29, P957, DOI 10.1038/onc.2009.394; FUJII K, 1976, CANCER RES, V36, P1615; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; GOPALAKRISHNAN S, 1992, BIOCHEMISTRY-US, V31, P10790, DOI 10.1021/bi00159a021; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Huang Xiang-hua, 2004, Zhonghua Zhongliu Zazhi, V26, P705; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karagiannis TC, 2004, CELL MOL LIFE SCI, V61, P2137, DOI 10.1007/s00018-004-4174-0; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kosakowska-Cholody T, 2005, MOL CANCER THER, V4, P1617, DOI 10.1158/1535-7163.MCT-05-0170; Kusunoki Masahiro, 2011, Environmental Health and Preventive Medicine, V16, P224, DOI 10.1007/s12199-010-0190-x; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leonce S, 2006, CANCER RES, V66, P7203, DOI 10.1158/0008-5472.CAN-05-3946; Ma F, 2003, SCAND J GASTROENTERO, V38, P360, DOI 10.1080/0036552031001699; Madan E, 2011, ONCOTARGET, V2, P948; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; PURCHASE IF, 1973, TOXICOL APPL PHARM, V26, P274, DOI 10.1016/0041-008X(73)90262-7; RABIE CJ, 1977, APPL ENVIRON MICROB, V33, P1023, DOI 10.1128/AEM.33.5.1023-1025.1977; Ravindran J, 2011, APOPTOSIS, V16, P145, DOI 10.1007/s10495-010-0554-0; Reijula K, 2003, FRONT BIOSCI-LANDMRK, V8, pS232, DOI 10.2741/978; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Skladanowski A, 2002, APOPTOSIS, V7, P347, DOI 10.1023/A:1016127513947; SPEIT G, 2004, METH MOL B, V291, P85; Stewart ZA, 2001, CHEM RES TOXICOL, V14, P243, DOI 10.1021/tx000199t; Sttina R, 1986, FOLIA BIOL PRAHA, V32, P406; Versilovskis A, 2010, MOL NUTR FOOD RES, V54, P136, DOI 10.1002/mnfr.200900345; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Xie TX, 2000, INT J ONCOL, V17, P737; Xing X, 2011, MOL NUTR FOOD RES, V55, P749, DOI 10.1002/mnfr.201000344; Yang H, 2008, TOXICOLOGY, V243, P145, DOI 10.1016/j.tox.2007.10.002; Zhu H, 2009, NEOPLASIA, V11, P1226, DOI 10.1593/neo.09986	57	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65044	10.1371/journal.pone.0065044	http://dx.doi.org/10.1371/journal.pone.0065044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705030	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200184
J	Muhlenbruch, K; Jeppesen, C; Joost, HG; Boeing, H; Schulze, MB				Muehlenbruch, Kristin; Jeppesen, Charlotte; Joost, Hans-Georg; Boeing, Heiner; Schulze, Matthias B.			The Value of Genetic Information for Diabetes Risk Prediction - Differences According to Sex, Age, Family History and Obesity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2; RECLASSIFICATION; SCORE; IMPROVEMENT; ADULTHOOD; VARIANTS; DIETARY; LOCI; AREA	Background: Genome-wide association studies have identified numerous single nucleotide polymorphisms associated with type 2 diabetes through the past years. In previous studies, the usefulness of these genetic markers for prediction of diabetes was found to be limited. However, differences may exist between substrata of the population according to the presence of major diabetes risk factors. This study aimed to investigate the added predictive value of genetic information (42 single nucleotide polymorphisms) in subgroups of sex, age, family history of diabetes, and obesity. Methods: A case-cohort study (random subcohort N = 1,968; incident cases: N = 578) within the European Prospective Investigation into Cancer and Nutrition Potsdam study was used. Prediction models without and with genetic information were evaluated in terms of the area under the receiver operating characteristic curve and the integrated discrimination improvement. Stratified analyses included subgroups of sex, age (<50 or >= 50 years), family history (positive if either father or mother or a sibling has/had diabetes), and obesity (BMI< or >= 30 kg/m(2)). Results: A genetic risk score did not improve prediction above classic and metabolic markers, but - compared to a non-invasive prediction model - genetic information slightly improved the area under the receiver operating characteristic curve (difference [95%-CI]: 0.007 [0.002-0.011]). Stratified analyses showed stronger improvement in the older age group (0.010 [0.002-0.018]), the group with a positive family history (0.012 [0.000-0.023]) and among obese participants (0.015 [-0.005-0.034]) compared to the younger participants (0.005 [-0.004-0.014]), participants with a negative family history (0.003 [-0.001-0.008]) and non-obese (0.007 [0.000-0.014]), respectively. No difference was found between men and women. Conclusion: There was no incremental value of genetic information compared to standard non-invasive and metabolic markers. Our study suggests that inclusion of genetic variants in diabetes risk prediction might be useful for subgroups with already manifest risk factors such as older age, a positive family history and obesity.	[Muehlenbruch, Kristin; Jeppesen, Charlotte; Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Joost, Hans-Georg] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Muehlenbruch, Kristin; Jeppesen, Charlotte; Joost, Hans-Georg; Schulze, Matthias B.] German Ctr Diabet Res, Neuherberg, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schulze, MB (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.	mschulze@dife.de	Joost, Hans-Georg/J-4462-2013; Schulze, Matthias B/AAH-6906-2021	Joost, Hans-Georg/0000-0002-5860-606X; Schulze, Matthias B/0000-0002-0830-5277; Muhlenbruch, Kristin/0000-0001-6188-2017	German Federal Ministry of Education and Research (BMBF); Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05F02]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission)	This work was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam Study was supported by German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; de Miguel-Yanes JM, 2011, DIABETES CARE, V34, P121, DOI 10.2337/dc10-1265; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Franks PW, 2012, DIABETOLOGIA, V55, P2555, DOI 10.1007/s00125-012-2683-1; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muhlenbruch K, 2013, EUR J EPIDEMIOL, V28, P25, DOI 10.1007/s10654-012-9744-0; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; THOMAS SB, 1997, INT J EPIDEMIOL S1, pS59; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vassy JL, 2012, DIABETOLOGIA, V55, P2604, DOI 10.1007/s00125-012-2637-7; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; 1997, INT J EPIDEMIOL S1, V26, pS71	29	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64307	10.1371/journal.pone.0064307	http://dx.doi.org/10.1371/journal.pone.0064307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700469	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400052
J	Sun, XQ; Zhang, MX; Yu, JY; Jin, Y; Ling, B; Du, JP; Li, GH; Qin, QM; Cai, QN				Sun, Xiao-Qin; Zhang, Mao-Xin; Yu, Jing-Ya; Jin, Yu; Ling, Bing; Du, Jin-Ping; Li, Gui-Hua; Qin, Qing-Ming; Cai, Qing-Nian			Glutathione S-Transferase of Brown Planthoppers (Nilaparvata lugens) Is Essential for Their Adaptation to Gramine-Containing Host Plants	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; INDOLE ALKALOIDS; RNA INTERFERENCE; DETOXIFICATION ENZYMES; SECONDARY METABOLITES; PHYTOPHAGOUS INSECTS; ACYRTHOSIPHON-PISUM; MOLECULAR-CLONING; PEA APHID; GENE	Plants have evolved complex processes to ward off attacks by insects. In parallel, insects have evolved mechanisms to thwart these plant defenses. To gain insight into mechanisms that mediate this arms race between plants and herbivorous insects, we investigated the interactions between gramine, a toxin synthesized by plants of the family Gramineae, and glutathione S transferase (GST), an enzyme found in insects that is known to detoxify xenobiotics. Here, we demonstrate that rice (Oryza sativa), a hydrophytic plant, also produces gramine and that rice resistance to brown planthoppers (Nilaparvata lugens, BPHs) is highly associated with in planta gramine content. We also show that gramine is a toxicant that causes BPH mortality in vivo and that knockdown of BPH GST gene nlgst1-1 results in increased sensitivity to diets containing gramine. These results suggest that the knockdown of key detoxification genes in sap-sucking insects may provide an avenue for increasing their sensitivity to natural plant-associated defense mechanisms.	[Sun, Xiao-Qin; Yu, Jing-Ya; Jin, Yu; Cai, Qing-Nian] China Agr Univ, Coll Agron & Biotechnol, Beijing 100094, Peoples R China; [Zhang, Mao-Xin; Ling, Bing] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Du, Jin-Ping] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Li, Gui-Hua; Qin, Qing-Ming] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China; [Qin, Qing-Ming] Jilin Univ, Key Lab Zoonosis Res, Minist Educ, Inst Zoonosis, Changchun 130023, Peoples R China	China Agricultural University; South China Agricultural University; Huazhong Agricultural University; Jilin University; Jilin University	Qin, QM (corresponding author), Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China.	qmqin@jlu.edu.cn; caiqn@cau.edu.cn	gh, Li/AES-0505-2022; Cai, Qing-Nian/A-1015-2016	Jin, Yu/0000-0003-2557-8565	China Agricultural University [KYCX2011010]; Agricultural Division, Jilin University [4305050102QW, 4305050102QX]	China Agricultural University; Agricultural Division, Jilin University	This work was supported by Innovation Fund for Graduate Student (grant no. KYCX2011010) from China Agricultural University and partly supported by the start-up funding (4305050102QW and 4305050102QX) from Agricultural Division, Jilin University to QMQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi K, 2003, PHYSIOL ENTOMOL, V28, P232, DOI 10.1046/j.1365-3032.2003.00329.x; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; BECK SD, 1965, ANNU REV ENTOMOL, V10, P207, DOI 10.1146/annurev.en.10.010165.001231; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullangpoti V, 2006, Commun Agric Appl Biol Sci, V71, P475; Cai QN, 2009, J CHEM ECOL, V35, P320, DOI 10.1007/s10886-009-9603-y; Cai QN, 2004, J APPL ENTOMOL, V128, P517, DOI 10.1111/j.1439-0418.2004.00770.x; Castaneda LE, 2010, J EVOLUTION BIOL, V23, P2474, DOI 10.1111/j.1420-9101.2010.02112.x; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; CORCUERA LJ, 1993, PHYTOCHEMISTRY, V33, P741, DOI 10.1016/0031-9422(93)85267-U; CORCUERA LJ, 1984, PHYTOCHEMISTRY, V23, P539, DOI 10.1016/S0031-9422(00)80376-3; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Figueroa CC, 1999, J CHEM ECOL, V25, P2465, DOI 10.1023/A:1020870023736; FRANCIOSA H, 1995, INSECT BIOCHEM MOLEC, V25, P311, DOI 10.1016/0965-1748(94)00053-K; Francis F, 2005, ARCH INSECT BIOCHEM, V58, P166, DOI 10.1002/arch.20049; Ghaffar MBAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022137; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Heinrichs E. A., 1985, GENETIC EVALUATION I; HEMINGWAY J, 1991, PESTIC BIOCHEM PHYS, V39, P49, DOI 10.1016/0048-3575(91)90213-6; Horgan F., 2009, PLANTHOPPERS NEW THR, P281; HOULT AHC, 1993, J CHEM ECOL, V19, P2245, DOI 10.1007/BF00979661; Ishikawa Y, 2000, APPL ENTOMOL ZOOL, V35, P251, DOI 10.1303/aez.2000.251; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jena KK, 2010, RICE, V3, P161, DOI 10.1007/s12284-010-9050-y; KANEHISA K, 1990, APPL ENTOMOL ZOOL, V25, P251, DOI 10.1303/aez.25.251; Kim CS, 2008, Z NATURFORSCH C, V63, P755; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; KOYAMA K, 1980, JPN J APPL ENTOMOL Z, V24, P117, DOI 10.1303/jjaez.24.117; LEE KW, 1991, INSECT BIOCHEM, V21, P353, DOI 10.1016/0020-1790(91)90001-U; LESZCZYNSKI B, 1989, ENTOMOL EXP APPL, V52, P135, DOI 10.1007/BF00163247; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Liu ZW, 2006, PEST MANAG SCI, V62, P279, DOI 10.1002/ps.1169; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nagadhara D, 2003, PLANT BIOTECHNOL J, V1, P231, DOI 10.1046/j.1467-7652.2003.00022.x; Nathan SS, 2007, CHEMOSPHERE, V67, P80, DOI 10.1016/j.chemosphere.2006.09.045; NODA H, 1991, J GEN VIROL, V72, P2425, DOI 10.1099/0022-1317-72-10-2425; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; POWELL KS, 1993, ENTOMOL EXP APPL, V66, P119, DOI 10.1007/BF02382280; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Su C.C., 2002, CHIN J GENET, V29, P332; Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; VANDERHEIJDEN R, 1987, J CHROMATOGR, V396, P287, DOI 10.1016/S0021-9673(01)94066-X; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang T, 1999, ANAL BIOCHEM, V269, P198, DOI 10.1006/abio.1999.4022; Wang Y, 2006, EUR J ENTOMOL, V103, P255, DOI 10.14411/eje.2006.030; Xu XF, 2002, THEOR APPL GENET, V104, P248, DOI 10.1007/s00122-001-0777-0; Yang ZF, 2006, B ENTOMOL RES, V96, P53, DOI 10.1079/BER2005400; Yang ZF, 2005, ARCH INSECT BIOCHEM, V59, P59, DOI 10.1002/arch.20055; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; YU SJ, 1993, ARCH INSECT BIOCHEM, V24, P21, DOI 10.1002/arch.940240103; Yuan JS, 2008, PLANT J, V55, P491, DOI 10.1111/j.1365-313X.2008.03524.x; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhao Ying, 2004, Yingyong Shengtai Xuebao, V15, P2161; Zhou Yi-hong, 2003, Nanjing Nongye Daxue Xuebao, V26, P24; Zhu-Salzman Keyan, 2005, Insect Science, V12, P3, DOI 10.1111/j.1672-9609.2005.00002.x; ZUNIGA GE, 1986, ENTOMOL EXP APPL, V40, P259, DOI 10.1007/BF00293708	70	31	33	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64026	10.1371/journal.pone.0064026	http://dx.doi.org/10.1371/journal.pone.0064026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700450	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400042
J	Casimiro, S; Mohammad, KS; Pires, R; Tato-Costa, J; Alho, I; Teixeira, R; Carvalho, A; Ribeiro, S; Lipton, A; Guise, TA; Costa, L				Casimiro, Sandra; Mohammad, Khalid S.; Pires, Ricardo; Tato-Costa, Joana; Alho, Irina; Teixeira, Rui; Carvalho, Antonio; Ribeiro, Sofia; Lipton, Allan; Guise, Theresa A.; Costa, Luis			RANKL/RANK/MMP-1 Molecular Triad Contributes to the Metastatic Phenotype of Breast and Prostate Cancer Cells In Vitro	PLOS ONE			English	Article							KAPPA-B RANK; FUNCTIONAL RECEPTOR ACTIVATOR; OSTEOCLAST DIFFERENTIATION; BONE METASTASES; MATRIX METALLOPROTEINASES; EXPRESSION; OSTEOPROTEGERIN; LIGAND; TUMOR; MIGRATION	The osteolytic nature of bone metastasis results from a tumor-driven increased bone resorption. Bone remodeling is orchestrated by the molecular triad RANK-RANKL-OPG. This process is dysregulated in bone metastases, mostly via induction of RANKL by tumor-derived factors. These factors increase expression of RANKL, which induce osteoclast formation, function, and survival, thereby increasing bone resorption. RANK is unexpectedly expressed by cancer cells, and the activation of RANKL-RANK pathway correlates with an increased invasive phenotype. To investigate the interaction between RANK expression in human breast and prostate cancer cells and their pro-metastatic phenotype we analyzed the activation of RANKL-RANK pathway and its effects on cell migration, invasion, gene expression in vitro, and osteolysis-inducing ability in vivo. RANKL activates kinase signaling pathways, stimulates cell migration, increases cell invasion, and upregulates MMP-1 expression. In vivo, MMP-1 knockdown resulted in smaller x-ray osteolytic lesions and osteoclastogenesis, and decreased tumor burden. Therefore, RANKL inhibition in bone metastatic disease may decrease the levels of the osteoclastogenesis inducer MMP-1, contributing to a better clinical outcome.	[Casimiro, Sandra; Pires, Ricardo; Tato-Costa, Joana; Alho, Irina; Teixeira, Rui; Carvalho, Antonio; Ribeiro, Sofia; Costa, Luis] Fac Med Lisbon, Inst Med Mol, Clin & Translat Oncol Res Unit, Lisbon, Portugal; [Casimiro, Sandra] Fac Med Lisbon, Inst Med Mol, Histol Unit, Lisbon, Portugal; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ, Dept Med, Div Endocrinol, Bloomington, IN USA; [Lipton, Allan] Penn State Hershey Med Ctr, Hershey, PA USA; [Costa, Luis] Hosp Santa Maria, Dept Oncol, Ctr Hosp Lisboa Norte, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universidade de Lisboa; Hospital Santa Maria	Casimiro, S (corresponding author), Fac Med Lisbon, Inst Med Mol, Clin & Translat Oncol Res Unit, Lisbon, Portugal.	scasimiro@fm.ul.pt	Mohammad, Khalid/AAE-9569-2022; Casimiro, Sandra/J-3332-2013; Mohammad, Khalid/AFE-4205-2022; Costa, Luis AM/E-5117-2015; Ribeiro, Sofia/AAJ-7010-2020	Ribeiro, Sofia/0000-0002-6465-2070; Duarte, Irina/0000-0002-3190-7479; Tato Costa, Joana/0000-0001-7091-0083; Costa, Luis/0000-0002-4782-7318; Casimiro, Sandra/0000-0002-6917-4477; Teixeira, Rui Lourenco/0000-0001-7324-4522	National Institutes of Health (National Cancer Institute) [CA69158, CA143057]; FCT [SFRH/BPD/34801/2007, SFRH/BD/45219/2008, SFRH/BD/44716/2008]; NATIONAL CANCER INSTITUTE [R01CA069158, U01CA143057, R29CA069158] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported in part by grants from the National Institutes of Health (National Cancer Institute) CA69158 and CA143057 (to TAG and KM); and FCT Fellowships SFRH/BPD/34801/2007, SFRH/BD/45219/2008 and SFRH/BD/44716/2008 (to SC, JT-C and IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Bhatia P, 2005, CLIN CANCER RES, V11, P162; Bohn OL, 2010, INT J CLIN EXP PATHO, V3, P139; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Casimiro S, 2012, CLIN EXP METASTAS, V29, P155, DOI 10.1007/s10585-011-9438-0; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Costa L, 2011, BONE, V48, pS25, DOI 10.1016/j.bone.2010.10.068; Costa L, 2002, J CLIN ONCOL, V20, P850, DOI 10.1200/JCO.20.3.850; Costa LA, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.1024; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Dougall WC, 2010, BONE CANCER: PROGRESSION AND THERAPEUTIC APPROACHES, P385, DOI 10.1016/B978-0-12-374895-9.00032-3; Eck SM, 2009, BREAST CANCER RES TR, V116, P79, DOI 10.1007/s10549-008-0085-3; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Klein A, 2009, CANCER LETT, V276, P212, DOI 10.1016/j.canlet.2008.11.017; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mori K, 2007, J PATHOL, V211, P555, DOI 10.1002/path.2140; Mori K, 2007, BONE, V40, P981, DOI 10.1016/j.bone.2006.11.006; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Owen S, 2013, ANTICANCER RES, V33, P199; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Santini D, 2010, J CELL PHYSL; Santini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019234; Santini D, 2011, J CELL PHYSIOL, V226, P780, DOI 10.1002/jcp.22402; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Tometsko M, 2004, J BONE MINER RES, V19, pS25; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Wilson TJ, 2008, BBA-REV CANCER, V1785, P85, DOI 10.1016/j.bbcan.2007.11.001; Zhang LY, 2012, ONCOL LETT, V3, P395, DOI 10.3892/ol.2011.487	43	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63153	10.1371/journal.pone.0063153	http://dx.doi.org/10.1371/journal.pone.0063153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696795	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900011
J	Amorim, CEG; Bisso-Machado, R; Ramallo, V; Bortolini, MC; Bonatto, SL; Salzano, FM; Hunemeier, T				Guerra Amorim, Carlos Eduardo; Bisso-Machado, Rafael; Ramallo, Virginia; Bortolini, Maria Catira; Bonatto, Sandro Luis; Salzano, Francisco Mauro; Huenemeier, Tabita			A Bayesian Approach to Genome/Linguistic Relationships in Native South Americans	PLOS ONE			English	Article							POPULATION-GENETICS; COEVOLUTION; LANGUAGES; MODELS; DIVERSITY; EVOLUTION; PATTERNS; GENOMICS; PROGRAMS; HISTORY	The relationship between the evolution of genes and languages has been studied for over three decades. These studies rely on the assumption that languages, as many other cultural traits, evolve in a gene-like manner, accumulating heritable diversity through time and being subjected to evolutionary mechanisms of change. In the present work we used genetic data to evaluate South American linguistic classifications. We compared discordant models of language classifications to the current Native American genome-wide variation using realistic demographic models analyzed under an Approximate Bayesian Computation (ABC) framework. Data on 381 STRs spread along the autosomes were gathered from the literature for populations representing the five main South Amerindian linguistic groups: Andean, Arawakan, Chibchan-Paezan, Macro-Je, and Tupi. The results indicated a higher posterior probability for the classification proposed by J.H. Greenberg in 1987, although L. Campbell's 1997 classification cannot be ruled out. Based on Greenberg's classification, it was possible to date the time of Tupi-Arawakan divergence (2.8 kya), and the time of emergence of the structure between present day major language groups in South America (3.1 kya).	[Guerra Amorim, Carlos Eduardo; Bisso-Machado, Rafael; Ramallo, Virginia; Bortolini, Maria Catira; Salzano, Francisco Mauro; Huenemeier, Tabita] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Bonatto, Sandro Luis] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Salzano, FM (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	francisco.salzano@ufrgs.br	Hünemeier, Tábita/F-4181-2011; Bisso-Machado, Rafael/F-4184-2011; Bonatto, Sandro L/A-1240-2010; Salzano, Francisco M/L-7916-2015	Bisso-Machado, Rafael/0000-0003-1384-8054; Bonatto, Sandro L/0000-0002-0064-467X; Hunemeier, Tabita/0000-0002-3156-2079	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, PRONEX), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, PRONEX), Brazil	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, PRONEX), Brazil. These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELAAR WFH, 1989, LINGUA, V78, P249; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Beaumont MA, 2002, GENETICS, V162, P2025; Bolnick DA, 2004, AM J HUM GENET, V75, P519; Brown CH, 2010, P NATL ACAD SCI USA, V107, pE34, DOI 10.1073/pnas.0914859107; Callegari-Jacques SM, 2011, AM J PHYS ANTHROPOL, V145, P371, DOI 10.1002/ajpa.21505; Campbell Lyle, 1997, AM INDIAN LANGUAGES; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Durr M, 1995, STUDIES HONOR HEINZ, P102; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2002, AM J PHYS ANTHROPOL, V117, P68, DOI 10.1002/ajpa.10015; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Greenberg J.H., 2007, AMERIND ETYMOLOGICAL; Greenberg JosephH., 1987, LANGUAGES AM; Hornborg A, 2005, CURR ANTHROPOL, V46, P589, DOI 10.1086/431530; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Hunley K, 2012, P ROY SOC B-BIOL SCI, V279, P2281, DOI 10.1098/rspb.2011.2296; Janda R.D., 2008, HDB HIST LINGUISTICS, P262; Jay F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016227; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Loukotka ., 1968, CLASSIFICATION S AM; MATISOFF JA, 1990, LANGUAGE, V66, P106, DOI 10.2307/415281; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Noelli FS, 1998, ANTIQUITY, V72, P648, DOI 10.1017/S0003598X00087068; OROURKE DH, 1986, ANN HUM BIOL, V13, P13, DOI 10.1080/03014468600008171; Perreault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045150; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; R_Development_Core_Team, 2011, R LANG ENV STAT COMP; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reali F, 2010, P ROY SOC B-BIOL SCI, V277, P429, DOI 10.1098/rspb.2009.1513; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Rodrigues, 1986, LINGUAS BRASILEIRAS; Salzano FM, 2005, CURR ANTHROPOL, V46, pS121, DOI 10.1086/497667; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; Trask RL, 1999, NOSTRATIC EXAMINING, P157; Urban G., 1998, HIST INDIOS BRASIL, P87; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; [No title captured]	49	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64099	10.1371/journal.pone.0064099	http://dx.doi.org/10.1371/journal.pone.0064099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	146HW	23696865	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900069
J	Hu, D; Hu, GH; Zhu, J; Shen, Y; Kang, HY; Hong, SL				Hu, Di; Hu, Guohua; Zhu, Jing; Shen, Yang; Kang, Houyong; Hong, Suling			Association between Polymorphisms of the IL-23R Gene and Allergic Rhinitis in a Chinese Han Population	PLOS ONE			English	Article							INTERLEUKIN-23 RECEPTOR GENE; GENOME-WIDE ASSOCIATION; T-CELLS; ASTHMA; DISEASE; IL23R; SUSCEPTIBILITY; PATHOGENESIS; METAANALYSIS; PSORIASIS	Objective: Polymorphism of the interleukin-23 receptor gene corresponds with susceptibility to several immune-related diseases. For the terminal differentiation of IL-17-producing effector T-helper cells in vivo, the interleukin-23 receptor gene is of vital importance. As shown recently, Th17 cells probably have a great influence on the pathogenesis of allergic airway diseases. Our intention was to establish an association between polymorphisms in the IL-23R gene and allergic rhinitis (AR) in the Chinese Han population. Methods: We included 358 AR patients and 407 control Chinese subjects in a case-control comparison. The study involved obtaining blood samples for DNA extraction genotyping and determination of 4 selected single-nucleotide polymorphisms in IL-23R by performing PCR restriction fragment length polymorphism analysis (PCR-RFLP). Results: A substantially growing prevalence of the homozygous rs7517847 GG genotype and G allele appeared in the AR patients unlike that observed in the control individuals (P<0.001). In addition, substantially high frequencies of the GGCA and GGCG haplotypes were observed in the AR patients, unlike that observed in the control individuals (P<0.05). The results suggest that the AGTG haplotype may provide protection against AR (P<0.001). Conclusions: To the best of our knowledge, this is the first study to demonstrate an important association between polymorphisms in IL-23R and AR in the Chinese Han population. A strong association between rs7517847 in a SNP of IL-23R, and AR was identified.	[Hu, Di; Hu, Guohua; Zhu, Jing; Shen, Yang; Kang, Houyong; Hong, Suling] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China	Chongqing Medical University	Hong, SL (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China.	icehudi@sina.com			Nature Science Foundation of China [81271061]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Nature Science Foundation of China (81271061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2009, ALLERGY, V64, P969, DOI 10.1111/j.1398-9995.2009.02059.x; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Ciprandi G, 2009, ALLERGY, V64, P1375, DOI 10.1111/j.1398-9995.2009.02010.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Gaddam SL, 2012, GENET TEST MOL BIOMA, V16, P632, DOI 10.1089/gtmb.2011.0255; Genuneit J, 2009, CLIN EXP ALLERGY, V39, P1875, DOI 10.1111/j.1365-2222.2009.03364.x; GLAS J, 2010, PLOS ONE, V5; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Hi G, 2012, AM J RHINOL ALLERGY; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Karaderi T, 2009, RHEUMATOLOGY, V48, P386, DOI 10.1093/rheumatology/ken501; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Safrany E, 2009, CURR MED CHEM, V16, P3766, DOI 10.2174/092986709789104975; Shen J, 2011, J HUAZHONG U SCI-MED, V31, P433, DOI 10.1007/s11596-011-0469-1; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang M, 2012, HUM IMMUNOL, V73, P647, DOI 10.1016/j.humimm.2012.03.010; Zhang XY, 2006, IMMUNOGENETICS, V57, P934, DOI 10.1007/s00251-005-0067-0; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021769; Zhu KJ, 2012, INFLAMM RES, V61, P1149, DOI 10.1007/s00011-012-0509-8	29	21	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63858	10.1371/journal.pone.0063858	http://dx.doi.org/10.1371/journal.pone.0063858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696856	gold, Green Submitted, Green Published			2022-12-25	WOS:000319081900060
J	Ng, YP; Chen, YW; Hu, YQ; Ip, FCF; Ip, NY				Ng, Yu Pong; Chen, Yuewen; Hu, Yueqing; Ip, Fanny C. F.; Ip, Nancy Y.			Olean-12-Eno[2,3-c] [1,2,5]Oxadiazol-28-Oic Acid (OEOA) Induces G(1) Cell Cycle Arrest and Differentiation in Human Leukemia Cell Lines	PLOS ONE			English	Article							MATRIX-ASSOCIATED PROTEIN; SUPPRESSES TUMOR-GROWTH; ERYTHROID-DIFFERENTIATION; OLEANOLIC ACID; REGULATED NUCLEAR; BCR-ABL; URSOLIC ACID; DERIVATIVES; MECHANISMS; RESISTANCE	Oleanolic acid (3 beta-hydroxy-olea-12-en-28-oic acid) is a natural pentacyclic triterpenoic acid found in many fruits, herbs and medicinal plants. In the past decade, increasing evidence has suggested that oleanolic acid exhibits inhibitory activities against different types of cancer including skin cancer and colon cancer, but not leukemia. We report here that a derivative of oleanolic acid, olean-12-eno[2,3-c] [1,2,5]oxadiazol-28-oic acid (designated OEOA) effectively blocks the proliferation of human leukemia cells. OEOA significantly reduces cell proliferation without inducing cell death in three types of leukemia cell lines, including K562, HEL and Jurket. Moreover, exposure of K562 cells to OEOA results in G(1) cell cycle arrest, with a concomitant induction of cyclin-dependent kinase inhibitor p27 and downregulation of cyclins and Cdks that are essential for cell cycle progression. Interestingly, OEOA also enhances erythroid differentiation in K562 cells through suppressing the expression of Bcr-Abl and phosphorylation of Erk1/2. These findings identify a novel chemical entity for further development as therapeutics against leukemia.	[Ng, Yu Pong; Chen, Yuewen; Hu, Yueqing; Ip, Fanny C. F.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Yu Pong; Hu, Yueqing; Ip, Fanny C. F.; Ip, Nancy Y.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China; [Chen, Yuewen; Ip, Fanny C. F.; Ip, Nancy Y.] Ji Nan Univ, JNU HKUST Joint Lab, Guangzhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Jinan University	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk		Ip, Nancy Yuk-Yu/0000-0002-2763-8907	National Basic Research Program of China (973 Program); Shenzhen Peacock Plan; Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; Innovation and Technology Fund [State Key Laboratory] [(ITCPT/17-9)]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen Peacock Plan; Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); Innovation and Technology Fund [State Key Laboratory]	This study is supported in part by the National Basic Research Program of China (973 Program), Shenzhen Peacock Plan, Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), and Innovation and Technology Fund [State Key Laboratory (ITCPT/17-9)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Baraniskin A, 2012, CARCINOGENESIS, V33, P732, DOI 10.1093/carcin/bgs020; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Brognara E, 2011, EUR J PHARMACOL, V672, P30, DOI 10.1016/j.ejphar.2011.09.024; Brozik A, 2006, ANN NY ACAD SCI, V1090, P344, DOI 10.1196/annals.1378.038; Bueno-da-Silva AEB, 2003, CELL DEATH DIFFER, V10, P592, DOI 10.1038/sj.cdd.4401210; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cao T, 2005, MED HYPOTHESES, V65, P1202, DOI 10.1016/j.mehy.2005.06.011; Chen J, 2006, BIOORG MED CHEM LETT, V16, P2915, DOI 10.1016/j.bmcl.2006.03.009; Cheung WMW, 2001, J BIOL CHEM, V276, P17083, DOI 10.1074/jbc.M010802200; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; CRISSMAN HA, 1982, CYTOMETRY, V3, P84, DOI 10.1002/cyto.990030204; Decker T, 2002, LEUKEMIA, V16, P327, DOI 10.1038/sj.leu.2402389; Fukuchi Y, 2006, ONCOL REP, V16, P1099; Furtado RA, 2008, TOXICOL PATHOL, V36, P576, DOI 10.1177/0192623308317423; Guilhot F, 2012, CURR OPIN HEMATOL, V19, P102, DOI 10.1097/MOH.0b013e32834ff610; Hsi ED, 2012, SEMIN ONCOL, V39, P74, DOI 10.1053/j.seminoncol.2011.11.007; Jabbour E, 2011, HEMATOL ONCOL CLIN N, V25, P981, DOI 10.1016/j.hoc.2011.09.004; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Koschmieder S, 2007, BLOOD, V110, P3695, DOI 10.1182/blood-2006-11-058941; Kowalski R, 2007, J AGR FOOD CHEM, V55, P656, DOI 10.1021/jf0625858; Lampronti I, 2003, EUR J HAEMATOL, V71, P189, DOI 10.1034/j.1600-0609.2003.00113.x; Landi M, 2009, EUR J MED CHEM, V44, P745, DOI 10.1016/j.ejmech.2008.05.001; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202; Li N, 2012, J CHROMATOGR SCI, V50, P885, DOI 10.1093/chromsci/bms086; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Lu XM, 2007, J PHARM PHARMACOL, V59, P1087, DOI 10.1211/jpp.59.8.0005; Moosavi MA, 2007, INT J BIOCHEM CELL B, V39, P1685, DOI 10.1016/j.biocel.2007.04.016; Nagano K, 2006, ONCOGENE, V25, P493, DOI 10.1038/sj.onc.1208996; Naka K, 2010, CANCER SCI, V101, P1577, DOI 10.1111/j.1349-7006.2010.01584.x; National Cancer Institute, 2012, LEUKEMIA; Olsson I, 1996, EUR J HAEMATOL, V57, P1; Ovesna Z, 2004, NEOPLASMA, V51, P327; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Rangatia J, 2006, LEUKEMIA, V20, P68, DOI 10.1038/sj.leu.2403999; Ribera JM, 2011, CURR OPIN ONCOL, V23, P692, DOI 10.1097/CCO.0b013e32834bb854; Saunthararajah Y, 2012, SEMIN ONCOL, V39, P97, DOI 10.1053/j.seminoncol.2011.11.011; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Shaffer BC, 2012, DRUG RESIST UPDATE, V15, P62, DOI 10.1016/j.drup.2012.02.001; Sogno I, 2009, RECENT RESULTS CANC, V181, P209; Sultana N, 2008, J ENZYM INHIB MED CH, V23, P739, DOI [10.1080/14756360701633187, 10.1080/14756360701633187 ]; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186	50	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63580	10.1371/journal.pone.0063580	http://dx.doi.org/10.1371/journal.pone.0063580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696836	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900044
J	Sbardella, E; Petsas, N; Tona, F; Prosperini, L; Raz, E; Pace, G; Pozzilli, C; Pantano, P				Sbardella, Emilia; Petsas, Nikolaos; Tona, Francesca; Prosperini, Luca; Raz, Eytan; Pace, Gianvito; Pozzilli, Carlo; Pantano, Patrizia			Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; VOXEL-BASED MORPHOMETRY; DIFFUSION-TENSOR-MRI; STATUS SCALE EDSS; GRAY-MATTER; FUNCTIONAL TOPOGRAPHY; CORTICAL ATROPHY; HUMAN CEREBELLUM; BRAIN ATROPHY; AXONAL LOSS	Background: Multiple sclerosis (MS) is characterized by demyelinating and degenerative processes within the central nervous system. Unlike conventional MRI, new advanced imaging techniques improve pathological specificity and better highlight the relationship between anatomical damage and clinical impairment. Objective: To investigate the relationship between clinical disability and both grey (GM) and white matter (WM) regional damage in MS patients. Methods: Thirty-six relapsing remitting-MS patients and 25 sex- and age-matched controls were enrolled. All patients were clinically evaluated by the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite (MSFC) scale, which includes the 9-hole peg test (9HPT), the timed 25-feet walking test (T25FW) and the paced auditory serial addition test (PASAT). All subjects were imaged by a 3.0 T scanner: dual-echo fast spin-echo, 3DT1-weighted and diffusion-tensor imaging (DTI) sequences were acquired. Voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) analyses were run for regional GM and WM assessment, respectively. T2 lesion volumes were also calculated, by using a semi-automated technique. Results: Brain volumetric assessment of GM and DTI measures revealed significant differences between patients and controls. In patients, different measures of WM damage correlated each-other (p<0.0001), whereas none of them correlated with GM volume. In patients, focal GM atrophy and widespread WM damage significantly correlated with clinical measures. In particular, VBM analysis revealed a significant correlation (p<0.05) between GM volume and 9HPT in cerebellum and between GM volume and PASAT in orbito-frontal cortex. TBSS showed significant correlations between DTI metrics with 9HPT and PASAT scores in many WM bundles (p<0.05), including corpus callosum, internal capsule, posterior thalamic radiations, cerebral peduncles. Conclusions: Selective GM atrophy and widespread WM tracts damage are associated with functional impairment of upper-limb motion and cognition. The combined analysis of volumetric and DTI data may help to better understand structural alterations underlying physical and cognitive dysfunction in MS.	[Sbardella, Emilia; Petsas, Nikolaos; Tona, Francesca; Prosperini, Luca; Raz, Eytan; Pace, Gianvito; Pozzilli, Carlo; Pantano, Patrizia] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy; [Sbardella, Emilia; Petsas, Nikolaos] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Sbardella, E (corresponding author), Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy.	emilia.sbardella@uniroma1.it	Sbardella, Emilia/K-2167-2016; Prosperini, Luca/K-5712-2016; tona, francesca/J-4792-2016; Raz, Eytan/I-5738-2012; Patrizia, Pantano/C-8214-2009; Pozzilli, Carlo/AAC-3270-2022	Sbardella, Emilia/0000-0002-9129-9065; tona, francesca/0000-0001-9802-2248; Raz, Eytan/0000-0003-2998-8481; Patrizia, Pantano/0000-0001-9659-8294; Pozzilli, Carlo/0000-0002-6360-4798; Prosperini, Luca/0000-0003-3237-6267	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/26]; Merck Serono; Biogen Idec; Sanofi-Aventis; Bayer Schering; Novartis	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Merck Serono(Merck & Company); Biogen Idec(Biogen); Sanofi-Aventis(Sanofi-Aventis); Bayer Schering(Bayer AG); Novartis(Novartis)	This study was partially supported by Fondazione Italiana Sclerosi Multipla (FISM) grant 2010/R/26. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; LP received consulting fees from Merck Serono, and lecture and consulting fees from Biogen Idec. CP received consulting and lecture fees from Sanofi-Aventis, Biogen Idec, Bayer Schering, Merck Serono, and Novartis; he also received research funding from Sanofi-Aventis, Merck Serono, and Bayer Schering. Other authors declare no disclosures. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alusi SH, 2001, BRAIN, V124, P1576, DOI 10.1093/brain/124.8.1576; Anderson VM, 2009, MULT SCLER, V15, P811, DOI 10.1177/1352458508101934; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Bodini B, 2009, HUM BRAIN MAPP, V30, P2852, DOI 10.1002/hbm.20713; Bonzano L, 2011, NEUROIMAGE, V57, P495, DOI 10.1016/j.neuroimage.2011.04.037; Bushara KO, 2001, NEUROREPORT, V12, P2483, DOI 10.1097/00001756-200108080-00039; Ceccarelli A, 2008, NEUROIMAGE, V42, P315, DOI 10.1016/j.neuroimage.2008.04.173; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; GLICKSTEIN M, 1994, J COMP NEUROL, V349, P51, DOI 10.1002/cne.903490105; Goodkin DE, 1998, MULT SCLER, V4, P480, DOI 10.1177/135245859800400604; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Henry RG, 2008, J NEUROL NEUROSUR PS, V79, P1236, DOI 10.1136/jnnp.2007.134825; Kern KC, 2011, NEUROIMAGE, V55, P1169, DOI 10.1016/j.neuroimage.2010.10.077; Khaleeli Z, 2007, NEUROIMAGE, V37, P253, DOI 10.1016/j.neuroimage.2007.04.056; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; KURTZKE JF, 1972, ACTA NEUROL SCAND, V48, P19, DOI 10.1111/j.1600-0404.1972.tb07525.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lin X, 2005, J NEUROL SCI, V237, P13, DOI 10.1016/j.jns.2005.04.019; Liu YO, 2012, EUR J RADIOL, V81, P2826, DOI 10.1016/j.ejrad.2011.11.022; Llufriu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037167; Metwalli NS, 2010, BRAIN RES, V1348, P156, DOI 10.1016/j.brainres.2010.05.067; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Morgen K, 2007, NEUROIMAGE, V37, P937, DOI 10.1016/j.neuroimage.2007.05.045; Onu M, 2012, EUR J RADIOL, V81, pE386, DOI 10.1016/j.ejrad.2011.12.014; Paolillo A, 2000, J NEUROL SCI, V174, P85, DOI 10.1016/S0022-510X(00)00259-8; Pirko I, 2007, NEUROLOGY, V68, P634, DOI 10.1212/01.wnl.0000250267.85698.7a; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Prinster A, 2010, MULT SCLER, V16, P45, DOI 10.1177/1352458509351896; Raz E, 2010, RADIOLOGY, V257, P448, DOI 10.1148/radiol.10100626; Raz E, 2010, RADIOLOGY, V254, P227, DOI 10.1148/radiol.2541090817; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Rudick R, 2003, MULT SCLER, V9, P210, DOI 10.1191/1352458503ms892rr; Sastre-Garriga J, 2009, J NEUROL SCI, V282, P120, DOI 10.1016/j.jns.2008.12.019; Sbardella E, 2011, MULT SCLER J, V17, P1432, DOI 10.1177/1352458511414602; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Sigal T, 2012, J NEUROIMAGING, V22, P33, DOI 10.1111/j.1552-6569.2010.00556.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tortorella P, 2006, J NEUROL, V253, P903, DOI 10.1007/s00415-006-0129-8; Uitdehaag BMJ, 2002, MULT SCLER, V8, P366, DOI 10.1191/1352458502ms835oa; Wilson M, 2003, J NEUROL NEUROSUR PS, V74, P203, DOI 10.1136/jnnp.74.2.203; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	56	74	76	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63250	10.1371/journal.pone.0063250	http://dx.doi.org/10.1371/journal.pone.0063250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696802	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900017
J	Han, J; Hou, W; Lu, CS; Goldstein, LA; Stolz, DB; Watkins, SC; Rabinowich, H				Han, Jie; Hou, Wen; Lu, Caisheng; Goldstein, Leslie A.; Stolz, Donna B.; Watkins, Simon C.; Rabinowich, Hannah			Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; TARGETING AUTOPHAGY; APOPTOSIS; TRAIL; TUMORIGENESIS; RECEPTOR; CELLS; DISRUPTION; RESISTANCE; INDUCTION	Beclin-1 is a key regulator of autophagy that functions in the context of two phase-specific complexes in the initiation and maturation of autophagosomes. Its known interacting proteins include autophagy effectors, Bcl-2 family members, and organelle membrane anchor proteins. Here we report a newly identified interaction between Beclin-1 and the protein tyrosine kinase receptor Her2. We demonstrate that in Her2-expressing breast carcinoma cells that do not succumb to lapatinib, this Her1/2 inhibitor disrupts the cell surface interaction between Her2 and Beclin-1. The data suggest that the ensuing autophagic response is correlatively associated with the release of Beclin-1 from its complex with Her2 and with the subsequent increase in cytosolic Beclin-1. Upon its interaction with Her2, Beclin-1 up-regulates the phosphorylation levels of Her2 and Akt. The Beclin-1 evolutionarily conserved domain is required both for the interaction of Beclin-1 with Her2 and for the increased Her2 and Akt phosphorylation. These findings shed new light on mechanisms involved in lapatinib-mediated autophagy in Her2-expressing breast carcinoma cell lines and in Beclin-1 signaling in these cells.	[Han, Jie; Hou, Wen; Lu, Caisheng; Goldstein, Leslie A.; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Stolz, Donna B.; Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavilion Rm G17C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [RO1 CA134776]; Department of Defense Grant [W81XWH-12-1-0228]; The Pittsburgh Foundation; NATIONAL CANCER INSTITUTE [R01CA134776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Grant(United States Department of Defense); The Pittsburgh Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA134776 (to H.R.). This work was also supported by Department of Defense Grant W81XWH-12-1-0228 (to H.R.) and The Pittsburgh Foundation (to J.H.).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Calabretta B, 2011, LEUKEMIA LYMPHOMA, V52, P54, DOI 10.3109/10428194.2010.546913; Chaachouay H, 2011, RADIOTHER ONCOL, V99, P287, DOI 10.1016/j.radonc.2011.06.002; Chen YS, 2011, DIS ESOPHAGUS, V24, P437, DOI 10.1111/j.1442-2050.2010.01156.x; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hou W, 2008, AUTOPHAGY, V4, P940, DOI 10.4161/auto.6769; Huang H. L., 2011, PLOS ONE, V6; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Ito H, 2005, INT J ONCOL, V26, P1401; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; John S, 2008, CANCER RES, V68, P7855, DOI 10.1158/0008-5472.CAN-07-5875; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lainey E, 2011, BIOCHEM PHARMACOL, V82, P1457, DOI 10.1016/j.bcp.2011.05.011; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Pulaski BA, 2001, CURRENT PROTOCOLS IM; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reilly RT, 2000, CANCER RES, V60, P3569; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	50	46	50	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20315	20325		10.1074/jbc.M113.461350	http://dx.doi.org/10.1074/jbc.M113.461350			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703612	Green Published, hybrid			2022-12-25	WOS:000321715100020
J	Fujita, M; Ieguchi, K; Cedano-Prieto, DM; Fong, A; Wilkerson, C; Chen, JQ; Wu, M; Lo, SH; Cheung, ATW; Wilson, MD; Cardiff, RD; Borowsky, AD; Takada, YK; Takada, Y				Fujita, Masaaki; Ieguchi, Katsuaki; Cedano-Prieto, Dora M.; Fong, Andrew; Wilkerson, Charles; Chen, Jane Q.; Wu, Mac; Lo, Su-Hao; Cheung, Anthony T. W.; Wilson, Machelle D.; Cardiff, Robert D.; Borowsky, Alexander D.; Takada, Yoko K.; Takada, Yoshikazu			An Integrin Binding-defective Mutant of Insulin-like Growth Factor-1 (R36E/R37E IGF1) Acts as a Dominant-negative Antagonist of the IGF1 Receptor (IGF1R) and Suppresses Tumorigenesis but Still Binds to IGF1R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX-FORMATION; HUMAN BREAST-CANCER; ALPHA-V-BETA-3; DOMAIN; CELLS; ALPHA-6-BETA-4; MECHANISM; SYSTEM; MODEL	Insulin-like growth factor-1 (IGF1) is a major therapeutic target for cancer. We recently reported that IGF1 directly binds to integrins (alpha v beta 3 and alpha 6 beta 4) and induces ternary complex formation (integrin-IGF1-IGF1 receptor (IGF1R)) and that the integrin binding-defective mutant of IGF1 (R36E/R37E) is defective in signaling and ternary complex formation. These findings predict that R36E/R37E competes with WT IGF1 for binding to IGF1R and inhibits IGF signaling. Here, we described that excess R36E/R37E suppressed cell viability increased by WT IGF1 in vitro in non-transformed cells. We studied the effect of R36E/R37E on viability and tumorigenesis in cancer cell lines. We did not detect an effect of WTIGF1 or R36E/R37E in cancer cells under anchorage-dependent conditions. However, under anchorage-independent conditions, WT IGF1 enhanced cell viability and induced signals, whereas R36E/R37E did not. Notably, excess R36E/R37E suppressed cell viability and signaling induced by WTIGF1 under anchorage-independent conditions. Using cancer cells stably expressing WTIGF1 or R36E/R37E, we determined that R36E/R37E suppressed tumorigenesis in vivo, whereas WT IGF1 markedly enhanced it. R36E/R37E suppressed the binding of WT IGF1 to the cell surface and the subsequent ternary complex formation induced by WT IGF1. R36E/R37E suppressed activation of IGF1R by insulin. WT IGF1, but not R36E/R37E, induced ternary complex formation with the IGF1R/insulin receptor hybrid. These findings suggest that 1) IGF1 induces signals under anchorage-independent conditions and that 2) R36E/R37E acts as a dominant-negative inhibitor of IGF1R (IGF1 decoy). Our results are consistent with a model in which ternary complex formation is critical for IGF signaling.	[Fujita, Masaaki; Ieguchi, Katsuaki; Cedano-Prieto, Dora M.; Fong, Andrew; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Fujita, Masaaki; Ieguchi, Katsuaki; Cedano-Prieto, Dora M.; Lo, Su-Hao; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Fong, Andrew; Wilkerson, Charles; Chen, Jane Q.; Cheung, Anthony T. W.; Cardiff, Robert D.; Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Dept Pathol, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Wu, Mac] Univ Calif Davis, Sch Med, Dept Surg, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Wilson, Machelle D.] Univ Calif Davis, Sch Med, Div Biostat, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), UC Davis Sch Med, Dept Dermatol, Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Borowsky, Alexander D/S-5404-2017	Wilson, Machelle/0000-0003-1734-2755; CEDANO-PRIETO, DORA MARIA/0000-0002-4204-2175; Lo, Su Hao/0000-0002-2675-9387; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015, HL096640]; United States Department of Defense [W81XWH-10-10312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA13015 (to Y. T.) and HL096640 (to M. W.). This work also was supported by United States Department of Defense Grant W81XWH-10-10312 (to Y. T.).	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; Chaves J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0b013e32834258a1; Cheung ATW, 1997, INT J ONCOL, V11, P69; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Mira E, 1999, ENDOCRINOLOGY, V140, P1657, DOI 10.1210/en.140.4.1657; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Pandini G, 1999, CLIN CANCER RES, V5, P1935; PAPA V, 1993, CANCER RES, V53, P3736; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Vella V, 2001, J CLIN PATHOL-MOL PA, V54, P121, DOI 10.1136/mp.54.3.121; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	30	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19593	19603		10.1074/jbc.M113.470872	http://dx.doi.org/10.1074/jbc.M113.470872			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696648	hybrid, Green Published			2022-12-25	WOS:000321515800025
J	Mikati, MA; Grintsevich, EE; Reisler, E				Mikati, Mouna A.; Grintsevich, Elena E.; Reisler, Emil			Drebrin-induced Stabilization of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINE MORPHOGENESIS; F-ACTIN; MENTAL-RETARDATION; CROSS-LINKING; BRAIN PROTEIN; DOWN-SYNDROME; IN-VIVO; BINDING; POLYMERIZATION; TROPOMYOSIN	Drebrin is a mammalian neuronal protein that binds to and organizes filamentous actin (F-actin) in dendritic spines, the receptive regions of most excitatory synapses that play a crucial role in higher brain functions. Here, the structural effects of drebrin on F-actin were examined in solution. Depolymerization and differential scanning calorimetry assays show that F-actin is stabilized by the binding of drebrin. Drebrin inhibits depolymerization mainly at the barbed end of F-actin. Full-length drebrin and its C-terminal truncated constructs were used to clarify the domain requirements for these effects. The actin binding domain of drebrin decreases the intrastrand disulfide cross-linking of Cys-41 (in the DNase I binding loop) to Cys-374 (C-terminal) but increases the interstrand disulfide cross-linking of Cys-265 (hydrophobic loop) to Cys-374 in the yeast mutants Q41C and S265C, respectively. We also demonstrate, using solution biochemistry methods and EM, the rescue of filament formation by drebrin in different cases of longitudinal interprotomer contact perturbation: the T203C/C374S yeast actin mutant and grimelysin-cleaved skeletal actin (between Gly-42 and Val-43). Additionally, we show that drebrin rescues the polymerization of V266G/L267G, a hydrophobic loop yeast actin mutant with an impaired lateral interface formation between the two filament strands. Overall, our data suggest that drebrin stabilizes actin filaments through its effect on their interstrand and intrastrand contacts.	[Mikati, Mouna A.; Grintsevich, Elena E.; Reisler, Emil] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Reisler, Emil] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Reisler, E (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 407 Charles E Young Dr East, Los Angeles, CA 90095 USA.	reisler@mbi.ucla.edu			United States Public Health Service Grant [GM 077190]; UCLA Molecular Biology Institute Whitcome Pre-doctoral Training Program; National Institutes of Health [1S10RR23057]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); UCLA Molecular Biology Institute Whitcome Pre-doctoral Training Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grant GM 077190 (to E. R.). This work was also supported by the UCLA Molecular Biology Institute Whitcome Pre-doctoral Training Program (to M. A. M.).; We thank Dr. Peter Rubenstein for the yeast cell line-expressing actin mutant V266G/L267G. We also thank Dr. M. Quinlan for the heterodimeric capping protein, Dr. S. Khaitlina for grimelysin, and the Electron Imaging Center for Nano Machines at the California Nano Systems Institute, University of California Los Angeles, for the use of instruments (supported in part by National Institutes of Health Grant 1S10RR23057).	Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; Bozhokina E, 2008, BIOCHEM BIOPH RES CO, V367, P888, DOI 10.1016/j.bbrc.2008.01.003; Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; Cheng C Yan, 2011, Spermatogenesis, V1, P291; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Ikeda K, 1996, DEV BRAIN RES, V91, P227, DOI 10.1016/0165-3806(95)00181-6; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ishikawa R, 2007, BIOCHEM BIOPH RES CO, V359, P398, DOI 10.1016/j.bbrc.2007.05.123; Kim E, 2000, J MOL BIOL, V299, P421, DOI 10.1006/jmbi.2000.3727; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Kostyukova AS, 2008, ADV EXP MED BIOL, V644, P283; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pivovarova AV, 2010, FEBS J, V277, P3812, DOI 10.1111/j.1742-4658.2010.07782.x; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Quintero-Monzon O, 2005, MOL BIOL CELL, V16, P3128, DOI 10.1091/mbc.E05-01-0059; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; SHIRAO T, 1986, DEV BRAIN RES, V29, P233, DOI 10.1016/0165-3806(86)90099-4; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takahashi H, 2003, J NEUROSCI, V23, P6586; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wen KK, 2000, J BIOL CHEM, V275, P40594, DOI 10.1074/jbc.M007201200; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031	46	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19926	19938		10.1074/jbc.M113.472647	http://dx.doi.org/10.1074/jbc.M113.472647			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696644	hybrid, Green Published			2022-12-25	WOS:000321515800058
J	Chaudhury, S; Abdulhameed, MDM; Singh, N; Tawa, GJ; D'haeseleer, PM; Zemla, AT; Navid, A; Zhou, CE; Franklin, MC; Cheung, J; Rudolph, MJ; Love, J; Graf, JF; Rozak, DA; Dankmeyer, JL; Amemiya, K; Daefler, S; Wallqvist, A				Chaudhury, Sidhartha; Abdulhameed, Mohamed Diwan M.; Singh, Narender; Tawa, Gregory J.; D'haeseleer, Patrik M.; Zemla, Adam T.; Navid, Ali; Zhou, Carol E.; Franklin, Matthew C.; Cheung, Jonah; Rudolph, Michael J.; Love, James; Graf, John F.; Rozak, David A.; Dankmeyer, Jennifer L.; Amemiya, Kei; Daefler, Simon; Wallqvist, Anders			Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; ACCURATE DOCKING; SYSTEMS BIOLOGY; DRUG DISCOVERY; INHIBITORS; DATABASE; ENZYME; PREDICTION; TULAREMIA	In the future, we may be faced with the need to provide treatment for an emergent biological threat against which existing vaccines and drugs have limited efficacy or availability. To prepare for this eventuality, our objective was to use a metabolic network-based approach to rapidly identify potential drug targets and prospectively screen and validate novel small-molecule antimicrobials. Our target organism was the fully virulent Francisella tularensis subspecies tularensis Schu S4 strain, a highly infectious intracellular pathogen that is the causative agent of tularemia and is classified as a category A biological agent by the Centers for Disease Control and Prevention. We proceeded with a staggered computational and experimental workflow that used a strain-specific metabolic network model, homology modeling and X-ray crystallography of protein targets, and ligand- and structure-based drug design. Selected compounds were subsequently filtered based on physiological-based pharmacokinetic modeling, and we selected a final set of 40 compounds for experimental validation of antimicrobial activity. We began screening these compounds in whole bacterial cell-based assays in biosafety level 3 facilities in the 20th week of the study and completed the screens within 12 weeks. Six compounds showed significant growth inhibition of F. tularensis, and we determined their respective minimum inhibitory concentrations and mammalian cell cytotoxicities. The most promising compound had a low molecular weight, was non-toxic, and abolished bacterial growth at 13 mu M, with putative activity against pantetheine-phosphate adenylyltransferase, an enzyme involved in the biosynthesis of coenzyme A, encoded by gene coaD. The novel antimicrobial compounds identified in this study serve as starting points for lead optimization, animal testing, and drug development against tularemia. Our integrated in silico/in vitro approach had an overall 15% success rate in terms of active versus tested compounds over an elapsed time period of 32 weeks, from pathogen strain identification to selection and validation of novel antimicrobial compounds.	[Chaudhury, Sidhartha; Abdulhameed, Mohamed Diwan M.; Singh, Narender; Tawa, Gregory J.; Wallqvist, Anders] USA, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr,Med Res & Mat Comma, Ft Detrick, MD USA; [D'haeseleer, Patrik M.; Zemla, Adam T.; Navid, Ali; Zhou, Carol E.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Franklin, Matthew C.; Cheung, Jonah; Rudolph, Michael J.; Love, James] New York Struct Biol Ctr, New York, NY USA; [Graf, John F.] GE Co, GE Global Res, Diagnost & Biomed Technol, Computat Biol & Biostat Lab, Niskayuna, NY USA; [Rozak, David A.; Dankmeyer, Jennifer L.; Amemiya, Kei] USA, Bacteriol Div, Med Res Inst Infect Dis, Ft Detrick, MD USA; [Daefler, Simon] Mt Sinai Sch Med, New York, NY USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; General Electric; Icahn School of Medicine at Mount Sinai	Wallqvist, A (corresponding author), USA, Dept Def Biotechnol, High Performance Comp Software Applicat Inst, Telemed & Adv Technol Res Ctr,Med Res & Mat Comma, Ft Detrick, MD USA.	awallqvist@bhsai.org	wallqvist, anders/W-2584-2019; Navid, Ali/A-1336-2013; AbdulHameed, Mohamed Diwan M/O-3088-2015	wallqvist, anders/0000-0002-9775-7469; Navid, Ali/0000-0003-2560-6984; AbdulHameed, Mohamed Diwan M/0000-0003-1483-4084; Graf, John/0000-0002-0396-9867	Defense Threat Reduction Agency [TMTI0004.09.BH.T, HDTRA1-08-C-0052, TMTI10049.09.RD.T, W911SR-11-C-0014]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency through projects TMTI0004.09.BH.T, HDTRA1-08-C-0052, TMTI10049.09.RD.T, and W911SR-11-C-0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bostrom J, 2001, J COMPUT AID MOL DES, V15, P1137, DOI 10.1023/A:1015930826903; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chavali AK, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-27; Chavali AK, 2012, TRENDS MICROBIOL, V20, P113, DOI 10.1016/j.tim.2011.12.004; De Pascalis R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002494; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dias MVB, 2007, CURR DRUG TARGETS, V8, P437; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Fang X, 2011, MOL BIOSYST, V7, P2622, DOI 10.1039/c1mb05106g; Fang X, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-160; Fang X, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-92; Fatumo S, 2011, INFECT GENET EVOL, V11, P708, DOI 10.1016/j.meegid.2011.04.013; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; Graf JF, 2012, J PHARMACOKINET PHAR, V39, P37, DOI 10.1007/s10928-011-9229-x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hassan M, 2006, MOL DIVERS, V10, P283, DOI 10.1007/s11030-006-9041-5; IMSANDE J, 1961, J BIOL CHEM, V236, P1494; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Kim HU, 2012, BIOTECHNOL J, V7, P330, DOI 10.1002/biot.201100159; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Miller JR, 2010, CHEM BIOL DRUG DES, V75, P444, DOI 10.1111/j.1747-0285.2010.00957.x; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller JH, 1941, P SOC EXP BIOL MED, V48, P330, DOI 10.3181/00379727-48-13311; Nicholls A, 2005, J COMPUT AID MOL DES, V19, P661, DOI 10.1007/s10822-005-9019-x; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Papin JA, 2012, DRUG DISCOV TODAY; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Raghunathan A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-118; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Rockx-Brouwer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037752; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schmitt DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031172; Scholl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033637; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; Thomas MG, 2003, BIOORG MED CHEM LETT, V13, P423, DOI 10.1016/S0960-894X(02)00957-5; Umamaheswari Amineni, 2010, Genomics Proteomics & Bioinformatics, V8, P246, DOI 10.1016/S1672-0229(10)60026-5; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	70	9	9	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63369	10.1371/journal.pone.0063369	http://dx.doi.org/10.1371/journal.pone.0063369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704901	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200030
J	Ladage, D; Yaniz-Galende, E; Rapti, K; Ishikawa, K; Tilemann, L; Shapiro, S; Takewa, Y; Muller-Ehmsen, J; Schwarz, M; Garcia, MJ; Sanz, J; Hajjar, RJ; Kawase, Y				Ladage, Dennis; Yaniz-Galende, Elisa; Rapti, Kleopatra; Ishikawa, Kiyotake; Tilemann, Lisa; Shapiro, Scott; Takewa, Yoshiaki; Muller-Ehmsen, Jochen; Schwarz, Martin; Garcia, Mario J.; Sanz, Javier; Hajjar, Roger J.; Kawase, Yoshiaki			Stimulating Myocardial Regeneration with Periostin Peptide in Large Mammals Improves Function Post-Myocardial Infarction but Increases Myocardial Fibrosis	PLOS ONE			English	Article							CARDIAC STEM-CELLS; MYOCYTE PROLIFERATION; PROGENITOR CELLS; HEART; CARDIOMYOCYTES; PROTEIN; REPAIR; EXPRESSION	Aims: Mammalian myocardium has a finite but limited capacity to regenerate. Experimentally stimulating proliferation of cardiomyocytes with extracellular regeneration factors like periostin enhances cardiac repair in rodents. The aim of this study was to develop a safe method for delivering regeneration factors to the heart and to test the functional and structural effects of periostin peptide treatment in a large animal model of myocardial infarction (MI). Methods and Results: We developed a controlled release system to deliver recombinant periostin peptide into the pericardial space. A single application of this method was performed two days after experimental MI in swine. Animals were randomly assigned to receive either saline or periostin peptide. Experimental groups were compared at baseline, day 2, 1 month and 3 months. Treatment with periostin peptide increased the EF from 31% to 41% and decreased by 22% the infarct size within 12 weeks. Periostin peptide-treated animals had newly formed myocardium strips within the infarct scar, leading to locally improved myocardial function. In addition the capillary density was increased in animals receiving periostin. However, periostin peptide treatment increased myocardial fibrosis in the remote region at one week and 12 weeks post-treatment. Conclusion: Our study shows that myocardial regeneration through targeted peptides is possible. However, in the case of periostin the effects on cardiac fibrosis may limit its clinical application as a viable therapeutic strategy.	[Ladage, Dennis; Yaniz-Galende, Elisa; Rapti, Kleopatra; Ishikawa, Kiyotake; Tilemann, Lisa; Shapiro, Scott; Takewa, Yoshiaki; Schwarz, Martin; Hajjar, Roger J.; Kawase, Yoshiaki] Mt Sinai Sch Med, Dept Cardiol, Cardiovasc Res Ctr, New York, NY 10029 USA; [Ladage, Dennis; Muller-Ehmsen, Jochen] Univ Hosp Cologne, Ctr Heart, Cologne, Germany; [Garcia, Mario J.; Sanz, Javier] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai	Ladage, D (corresponding author), Mt Sinai Sch Med, Dept Cardiol, Cardiovasc Res Ctr, New York, NY 10029 USA.	dennis.ladage@mssm.edu	Sanz, Javier/J-7251-2016; Ishikawa, Kiyotake/I-6013-2015	Ladage, Dennis/0000-0002-4512-0917; ishikawa, kiyotake/0000-0002-8287-3483	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	DL was supported by a personal stipend from the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Borg TK, 2007, CIRC RES, V101, P230, DOI 10.1161/CIRCRESAHA.107.159103; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ibanez B, 2007, CIRCULATION, V115, P2909, DOI 10.1161/circulationaha.106.679639; ISHIMORI S, 1967, J NEUROSURG, V27, P315, DOI 10.3171/jns.1967.27.4.0315; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Kajstura J, 2012, CIRC RES, V111, P894, DOI 10.1161/CIRCRESAHA.112.273649; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Palumbo R, 2004, BIOCHEM PHARMACOL, V68, P1165, DOI 10.1016/j.bcp.2004.03.048; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Polizzotti BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036788; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Schachinger V, 2009, EUR J HEART FAIL, V11, P973, DOI 10.1093/eurjhf/hfp113; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028	41	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e59656	10.1371/journal.pone.0059656	http://dx.doi.org/10.1371/journal.pone.0059656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700403	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400002
J	Sturrock, HJW; Novotny, JM; Kunene, S; Dlamini, S; Zulu, Z; Cohen, JM; Hsiang, MS; Greenhouse, B; Gosling, RD				Sturrock, Hugh J. W.; Novotny, Joe M.; Kunene, Simon; Dlamini, Sabelo; Zulu, Zulisile; Cohen, Justin M.; Hsiang, Michelle S.; Greenhouse, Bryan; Gosling, Roly D.			Reactive Case Detection for Malaria Elimination: Real-Life Experience from an Ongoing Program in Swaziland	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSMISSION; INFECTIONS; BRAZIL; RISK	As countries move towards malaria elimination, methods to identify infections among populations who do not seek treatment are required. Reactive case detection, whereby individuals living in close proximity to passively detected cases are screened and treated, is one approach being used by a number of countries including Swaziland. An outstanding issue is establishing the epidemiologically and operationally optimal screening radius around each passively detected index case. Using data collected between December 2009 and June 2012 from reactive case detection (RACD) activities in Swaziland, we evaluated the effect of screening radius and other risk factors on the probability of detecting cases by reactive case detection. Using satellite imagery, we also evaluated the household coverage achieved during reactive case detection. Over the study period, 250 cases triggered RACD, which identified a further 74 cases, showing the value of RACD over passive surveillance alone. Results suggest that the odds of detecting a case within the household of the index case were significantly higher than in neighbouring households (odds ratio (OR) 13, 95% CI 3.1-54.4). Furthermore, cases were more likely to be detected when RACD was conducted within a week of the index presenting at a health facility (OR 8.7, 95% CI 1.1-66.4) and if the index household had not been sprayed with insecticide (OR sprayed vs not sprayed 0.11, 95% CI 0.03-0.46). The large number of households missed during RACD indicates that a 1 km screening radius may be impractical in such resource limited settings such as Swaziland. Future RACD in Swaziland could be made more effective by achieving high coverage amongst individuals located near to index cases and in areas where spraying has not been conducted. As well as allowing the programme to implement RACD more rapidly, this would help to more precisely define the optimal screening radius.	[Sturrock, Hugh J. W.; Hsiang, Michelle S.; Gosling, Roly D.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Novotny, Joe M.; Cohen, Justin M.] Clinton Hlth Access Initiat, Mbabane, Swaziland; [Kunene, Simon; Dlamini, Sabelo; Zulu, Zulisile] Swaziland Natl Malaria Control Programme, Manzini, Swaziland; [Hsiang, Michelle S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Greenhouse, Bryan] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sturrock, HJW (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	SturrockH@globalhealth.ucsf.edu	Dlamini, Sabelo Nick/AAC-2213-2020	Dlamini, Sabelo Nick/0000-0002-4165-580X; Sturrock, Hugh/0000-0002-0029-3101; Cohen, Justin/0000-0003-4481-6784; Greenhouse, Bryan/0000-0003-0287-9111	Bill & Melinda Gates Foundation; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [P0045532]; Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship [P0049395]; NIH/NIAID [AI076614]; Doris Duke Clinical Scientist Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI101012, K23AI076614] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Bill & Melinda Gates Foundation. MH is supported by a National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) K23 Award [#P0045532] and a Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Fellowship [#P0049395]. BG is supported by a NIH/NIAID K23 Award [#AI076614] and is a recipient of a Doris Duke Clinical Scientist Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SAF EFF SINGL DOS PR; [Anonymous], 2010, R LANG ENV STAT COMP; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cohen JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-61; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Enk MJ, 2008, AM J TROP MED HYG, V78, P140, DOI 10.4269/ajtmh.2008.78.140; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; *MALERA CONS GROUP, 2011, PLOS MED, V0008; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; MUIRHEADTHOMSON RC, 1954, BRIT MED J, V1, P68, DOI 10.1136/bmj.1.4853.68; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; StataCorp, 2011, STAT STAT SOFTW REL; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; WHO, 2012, DIS SURV MAL EL OP M; YEKUTIEL P, 1960, Bull World Health Organ, V22, P669	27	87	87	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63830	10.1371/journal.pone.0063830	http://dx.doi.org/10.1371/journal.pone.0063830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700437	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400034
J	Agarwal, S; Al-Keilani, MS; Alqudah, MAY; Sibenaller, ZA; Ryken, TC; Assem, M				Agarwal, Supreet; Al-Keilani, Maha S.; Alqudah, Mohammad A. Y.; Sibenaller, Zita A.; Ryken, Timothy C.; Assem, Mahfoud			Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma	PLOS ONE			English	Article							SECRETASE-MEDIATED CLEAVAGE; GROWTH-FACTOR RECEPTOR; BETA-CATENIN; GAMMA-SECRETASE; SUPPRESSOR LOCI; CELL-ADHESION; CADHERIN; KAPPA; PTPRK	Poor prognosis and resistance to therapy in malignant gliomas is mainly due to the highly dispersive nature of glioma cells. This dispersive characteristic results from genetic alterations in key regulators of cell migration and diffusion. A better understanding of these regulatory signals holds promise to improve overall survival and response to therapy. Using mapping arrays to screen for genomic alterations in gliomas, we recently identified alterations of the protein tyrosine phosphatase receptor type kappa gene (PTPRK) that correlate to patient outcomes. These PTPRK alterations are very relevant to glioma biology as PTPRK can directly sense cell-cell contact and is a dephosphorylation regulator of tyrosine phosphorylation signaling, which is a major driving force behind tumor development and progression. Subsequent sequencing of the full length PTPRK transcripts revealed novel PTPRK gene deletion and missense mutations in numerous glioma biopsies. PTPRK mutations were cloned and expressed in PTPRK-null malignant glioma cells. The effect of these mutations on PTPRK anti-oncogenic function and their association with response to anti-glioma therapeutics, such as temozolomide and tyrosine kinase inhibitors, was subsequently analyzed using in vitro cell-based assays. These genetic variations altered PTPRK activity and its post-translational processing. Reconstitution of wild-type PTPRK in malignant glioma cell lines suppressed cell growth and migration by inhibiting EGFR and beta-catenin signaling and improved the effect of conventional therapies for glioma. However, PTPRK mutations abrogated tumor suppressive effects of wild-type PTPRK and altered sensitivity of glioma cells to chemotherapy.	[Agarwal, Supreet; Al-Keilani, Maha S.; Alqudah, Mohammad A. Y.; Assem, Mahfoud] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Sibenaller, Zita A.; Ryken, Timothy C.] Univ Iowa, Dept Neurosurg & Radiat Oncol, Iowa City, IA USA; [Ryken, Timothy C.] Iowa Spine & Brain Inst, Dept Neurosurg, Waterloo, IA USA	University of Iowa; University of Iowa	Assem, M (corresponding author), Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA.	mahfoud-assem@uiowa.edu	agarwal, supreet/AAI-7296-2021	Alqudah, Mohammad/0000-0001-7210-7964	Institute of Clinical and Translational Science at the University of Iowa; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) [UL1RR024979]; American Cancer Society [IRG-77-004-34]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER	Institute of Clinical and Translational Science at the University of Iowa; National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Institute of Clinical and Translational Science at the University of Iowa award. This publication was made possible by Grant Number UL1RR024979 from the National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CTSA or NIH. This research was supported through the Institutional Research Grant Number IRG-77-004-34 from the American Cancer Society, administered through The Holden Comprehensive Cancer Center at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Assem M, 2012, OMICS, V16, P113, DOI 10.1089/omi.2011.0031; Barghorn A, 2001, AM J PATHOL, V158, P1903, DOI 10.1016/S0002-9440(10)64658-5; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Burgoyne AM, 2009, CANCER RES, V69, P6960, DOI 10.1158/0008-5472.CAN-09-0863; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; CHAMBERS TC, 1993, J BIOL CHEM, V268, P4592; Chang CY, 2011, J NEURO-ONCOL, V105, P507, DOI 10.1007/s11060-011-0632-3; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Chuaqui R, 2001, GYNECOL ONCOL, V80, P364, DOI 10.1006/gyno.2000.6087; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Erdenebayar N, 2009, BIOCHEM BIOPH RES CO, V390, P489, DOI 10.1016/j.bbrc.2009.09.117; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Fenstermaker Robert A, 2004, Cancer Control, V11, P181; Flavell JR, 2008, BLOOD, V111, P292, DOI 10.1182/blood-2006-11-059881; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Nakamura M, 2003, CANCER RES, V63, P737; Norden AD, 2006, NEUROLOGIST, V12, P279, DOI 10.1097/01.nrl.0000250928.26044.47; Novellino L, 2008, CELL SIGNAL, V20, P872, DOI 10.1016/j.cellsig.2007.12.024; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Overmeyer JH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-69; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Ramis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038770; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; Sathornsumetee S, 2009, EXPERT OPIN INV DRUG, V18, P277, DOI [10.1517/13543780802692603, 10.1517/13543780802692603 ]; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Utsunomiya T, 2001, ONCOLOGY-BASEL, V61, P226, DOI 10.1159/000055379; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200	34	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e62852	10.1371/journal.pone.0062852	http://dx.doi.org/10.1371/journal.pone.0062852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696788	gold, Green Published			2022-12-25	WOS:000319081900005
J	Huang, HM; Hsiao, G; Fan, CK; Lin, CL; Leu, SJ; Chiang, BL; Lee, YL				Huang, Huei-Mei; Hsiao, George; Fan, Chia-Kwung; Lin, Chu-Lun; Leu, Sy-Jye; Chiang, Bor-Luen; Lee, Yueh-Lun			Notch Ligand Delta-Like 4-Pretreated Dendritic Cells Alleviate Allergic Airway Responses by Enhancing IL-10 Production	PLOS ONE			English	Article							T-CELL; IMMUNE-SYSTEM; DIFFERENTIATION; MATURATION; CYTOKINES; DISEASE; PATHOGENESIS; INDUCTION; TOLERANCE; MATURE	The Notch pathway plays a role in the processes of cell proliferation, differentiation, and apoptosis, which affect the development and function of various organs. Dendritic cells (DCs), as professional antigen-presenting cells (APCs), induce T cell activation and promote T cell differentiation by antigen stimulation. Research has shown that Notch ligand delta-like 4 (Dll4) in APCs is associated with stimulation of a Th1-type response. However, the regulatory roles of Dll4 in the activation and function of DCs have yet to be clearly elucidated. In this study, we demonstrated that activation of Dll4-pretreated bone marrow-derived DCs by performing ovalbumin (OVA) stimulation expressed a high level of interleukin (IL)-10 without diminishing IL-12 production. By contrast, the proinflammatory cytokines, IL-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha, decreased in Dll4-pretreated DCs by performing either lipopolysaccharide (LPS) or OVA stimulation. Compared to fully mature DCs, lower levels of MHC class II CD40 and higher levels of CD80 and CD86 molecules were expressed in these semi-mature like DCs. Dll4 Notch signaling also enhanced Notch ligand mRNA expression of Dll1, Dll4, and Jagged1 in DCs. Dll4-modified DCs exhibited a reduced capacity to stimulate the proliferation of OVA-specific CD4(+) T cells, but actively promoted large amounts of IL-10 production in these activated T cells. Furthermore, immunomodulatory effects of Dll4-modified DCs were examined in an established asthmatic animal model. After adoptive transfer of OVA-pulsed plus Dll4-pretreated DCs in OVA-immunized mice, OVA challenge induced lower OVA-specific immunoglobulin E (IgE) and higher IgG(2a) antibody production, lower eotaxin, keratinocyte-derived chemokine (KC), IL-5, and IL-13 release in bronchial alveolar lavage fluid, attenuated airway hyper-responsiveness, and promoted higher IL-10 and interferon (IFN)-gamma production in the spleen. In summary, our findings elucidate the new role of Dll4 in the phenotype and function of DCs and provide a novel approach for manipulating T cell-driven deleterious immune diseases.	[Huang, Huei-Mei; Lin, Chu-Lun] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Hsiao, George] Taipei Med Univ, Dept Pharmacol, Coll Med, Taipei, Taiwan; [Fan, Chia-Kwung] Taipei Med Univ, Dept Parasitol, Coll Med, Taipei, Taiwan; [Leu, Sy-Jye; Lee, Yueh-Lun] Taipei Med Univ, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; National Taiwan University	Lee, YL (corresponding author), Taipei Med Univ, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan.	yllee@tmu.edu.tw		Fan, Chia-Kwung/0000-0001-5579-8169; CHIANG, BOR-LUEN/0000-0002-6705-0286	National Science Council, Taiwan [NSC 99-2314-B-038-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (NSC 99-2314-B-038-002-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2002, IMMUNOL REV, V187, P75, DOI 10.1034/j.1600-065X.2002.18707.x; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Borowski C, 2002, CURR OPIN IMMUNOL, V14, P200, DOI 10.1016/S0952-7915(02)00322-9; Bugeon L, 2008, J IMMUNOL, V181, P8189, DOI 10.4049/jimmunol.181.12.8189; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Cheng PY, 2007, BLOOD, V109, P507, DOI 10.1182/blood-2006-05-025601; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Dallman MJ, 2005, CURR OPIN IMMUNOL, V17, P259, DOI 10.1016/j.coi.2005.04.002; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Enk AH, 2005, IMMUNOL LETT, V99, P8, DOI 10.1016/j.imlet.2005.01.011; Fukushima A, 2008, IMMUNOL LETT, V121, P140, DOI 10.1016/j.imlet.2008.10.006; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Huang MT, 2009, J IMMUNOL, V183, P4745, DOI 10.4049/jimmunol.0804371; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Ito T, 2012, J LEUKOCYTE BIOL, V92, P59, DOI 10.1189/jlb.1011529; Jang S, 2010, J IMMUNOL, V185, P5835, DOI 10.4049/jimmunol.1000175; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Raymond Tracy, 2007, Proc Am Thorac Soc, V4, P635, DOI 10.1513/pats.200706-067TH; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Sauma D, 2011, SCAND J IMMUNOL, V74, P62, DOI 10.1111/j.1365-3083.2011.02541.x; Schaller MA, 2007, J EXP MED, V204, P2925, DOI 10.1084/jem.20070661; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Suchting S, 2009, CELL, V137, P988, DOI 10.1016/j.cell.2009.05.024; Sultana DA, 2010, SEMIN IMMUNOL, V22, P254, DOI 10.1016/j.smim.2010.04.011; Sun J, 2008, J IMMUNOL, V180, P1655, DOI 10.4049/jimmunol.180.3.1655; Tsukumo S, 2004, J IMMUNOL, V173, P7109, DOI 10.4049/jimmunol.173.12.7109; Wakui M, 2007, BIOCHEM BIOPH RES CO, V358, P596, DOI 10.1016/j.bbrc.2007.04.175; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719	46	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63613	10.1371/journal.pone.0063613	http://dx.doi.org/10.1371/journal.pone.0063613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696838	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900046
J	Meng, W; McElroy, JP; Volinia, S; Palatini, J; Warner, S; Ayers, LW; Palanichamy, K; Chakravarti, A; Lautenschlaeger, T				Meng, Wei; McElroy, Joseph P.; Volinia, Stefano; Palatini, Jeff; Warner, Sarah; Ayers, Leona W.; Palanichamy, Kamalakannan; Chakravarti, Arnab; Lautenschlaeger, Tim			Comparison of MicroRNA Deep Sequencing of Matched Formalin-Fixed Paraffin-Embedded and Fresh Frozen Cancer Tissues	PLOS ONE			English	Article							EXPRESSION; APOPTOSIS; SAMPLES; CELLS; PCR	MicroRNAs regulate several aspects of tumorigenesis and cancer progression. Most cancer tissues are archived formalin-fixed and paraffin-embedded (FFPE). While microRNAs are a more stable form of RNA thought to withstand FFPE-processing and degradation there is only limited evidence for the latter assumption. We examined whether microRNA profiling can be successfully conducted on FFPE cancer tissues using SOLiD ligation based sequencing. Tissue storage times (2-9 years) appeared to not affect the number of detected microRNAs in FFPE samples compared to matched frozen samples (paired t-test p>0.7). Correlations of microRNA expression values were very high across microRNAs in a given sample (Pearson's r = 0.71-0.95). Higher variance of expression values among samples was associated with higher correlation coefficients between FFPE and frozen tissues. One of the FFPE samples in this study was degraded for unknown reasons with a peak read length of 17 nucleotides compared to 21 in all other samples. The number of detected microRNAs in this sample was within the range of microRNAs detected in all other samples. Ligation-based microRNA deep sequencing on FFPE cancer tissues is feasible and RNA degradation to the degree observed in our study appears to not affect the number of microRNAs that can be quantified.	[Meng, Wei; Palanichamy, Kamalakannan; Chakravarti, Arnab; Lautenschlaeger, Tim] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Meng, Wei; Palatini, Jeff; Warner, Sarah; Palanichamy, Kamalakannan; Chakravarti, Arnab; Lautenschlaeger, Tim] Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA; [McElroy, Joseph P.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Volinia, Stefano] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Palatini, Jeff; Warner, Sarah] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Ayers, Leona W.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chakravarti, A (corresponding author), Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.	Arnab.Chakravarti@osumc.edu; TL@osumc.edu	Volinia, Stefano/AAA-9264-2019; Palanichamy, Kamalakannan/Z-1376-2019; Meng, Wei/J-2753-2015; Palanichamy, Kamalakannan/E-3807-2011; Volinia, Stefano/A-3029-2010	Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Palatini, Jeffrey/0000-0001-9280-4417	Department of Radiation Oncology and the Comprehensive Cancer Center; The Ohio State University; National Center For Advancing Translational Sciences [8UL1TR000090-05]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	Department of Radiation Oncology and the Comprehensive Cancer Center; The Ohio State University(Ohio State University); National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funding from the Department of Radiation Oncology and the Comprehensive Cancer Center, and, by the Biostatistics Core and by Microarray shared resource at The Ohio State University. The work was supported by Award Number Grant 8UL1TR000090-05 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Ferruelo A, 2011, INT J CLIN EXP PATHO, V4, P156; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00684; Lake SL, 2012, INVEST OPHTHALMOL VI; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li S, 2012, BREAST CANCER RES TR, V136, P77, DOI 10.1007/s10549-012-2166-6; Lin J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.134; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Norden-Krichmar TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022870; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Soares Ana Raquel, 2012, Methods Mol Biol, V822, P189, DOI 10.1007/978-1-61779-427-8_13; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang W, 2012, CANCER; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522	37	64	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64393	10.1371/journal.pone.0064393	http://dx.doi.org/10.1371/journal.pone.0064393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696889	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900092
J	Nakaima, Y; Watanabe, K; Koyama, T; Miura, O; Fukuda, T				Nakaima, Yukana; Watanabe, Ken; Koyama, Takatoshi; Miura, Osamu; Fukuda, Tetsuya			CD137 Is Induced by the CD40 Signal on Chronic Lymphocytic Leukemia B Cells and Transduces the Survival Signal via NF-kappa B Activation	PLOS ONE			English	Article							T-LYMPHOCYTES; SOLUBLE FORM; 4-1BB; LIGAND; PROLIFERATION; PROMOTES; RECEPTOR; BAFF; DIFFERENTIATION; NF-KAPPA-B2	CD137 is a member of the tumor necrosis factor receptor family that is expressed on activated T cells. This molecule provides a co-stimulatory signal that enhances the survival, and differentiation of cells, and has a crucial role in the development of CD8 cytotoxic T cells and anti-tumor immunity. Here we report that CD137 expression is also induced on normal or malignant human B cells by CD40 ligation by its ligand CD154. This CD137 induction was more prominent in chronic lymphocytic leukemia (CLL) cells than in other types of B cells. CD137 stimulation on B cells by its ligand induced the nuclear translocation of p52 (a non-canonical NF-kappa B factor). In agreement with this finding, expression of the survival factor BCL-XL was upregulated. Consequently, the CD137 signal augmented the survival of CD154-stimulated CLL B cells in vitro. This unexpected induction of CD137 on B cells by CD40 signal may influence the clinical course of CLL.	[Nakaima, Yukana; Watanabe, Ken; Miura, Osamu; Fukuda, Tetsuya] Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Nakaima, Yukana; Koyama, Takatoshi] Tokyo Med & Dent Univ, Lab Mol Genet Hematol, Grad Sch Hlth Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Fukuda, T (corresponding author), Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Tokyo, Japan.	fuku.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054	Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan (O.M., T.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Buechele C, 2012, EUR J IMMUNOL, V42, P737, DOI 10.1002/eji.201141920; Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; de Jong D, 2011, BEST PRACT RES CL HA, V24, P135, DOI 10.1016/j.beha.2011.02.007; Dicker F, 2005, BLOOD, V105, P3193, DOI 10.1182/blood-2003-10-3684; Dicker F, 2006, BLOOD, V108, P3450, DOI 10.1182/blood-2006-04-017749; Endo T, 2007, BLOOD, V109, P703, DOI 10.1182/blood-2006-06-027755; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Furtner M, 2005, LEUKEMIA, V19, P883, DOI 10.1038/sj.leu.2403675; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Houot R, 2009, BLOOD, V114, P3431, DOI 10.1182/blood-2009-05-223958; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; Lin W, 2008, BLOOD, V112, P699, DOI 10.1182/blood-2007-11-122465; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; LOTZ M, 1994, J EXP MED, V179, P999, DOI 10.1084/jem.179.3.999; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Mellstedt H, 2006, CANCER IMMUNOL IMMUN, V55, P210, DOI 10.1007/s00262-005-0675-4; Michel J, 1998, EUR J IMMUNOL, V28, P290, DOI 10.1002/(SICI)1521-4141(199801)28:01<290::AID-IMMU290>3.0.CO;2-S; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Sabbagh L, 2008, J IMMUNOL, V180, P8093, DOI 10.4049/jimmunol.180.12.8093; Scielzo C, 2011, LEUKEMIA, V25, P1760, DOI 10.1038/leu.2011.149; SETAREH M, 1995, GENE, V164, P311, DOI 10.1016/0378-1119(95)00349-B; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilcox RA, 2004, BLOOD, V103, P177, DOI 10.1182/blood-2003-06-2184; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64425	10.1371/journal.pone.0064425	http://dx.doi.org/10.1371/journal.pone.0064425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696891	Green Submitted, gold, Green Published			2022-12-25	WOS:000319081900094
J	Rabinovich, M; Tristan, I; Varona, P				Rabinovich, Mikhail; Tristan, Irma; Varona, Pablo			Neural Dynamics of Attentional Cross-Modality Control	PLOS ONE			English	Article							WORKING-MEMORY; TRANSIENT DYNAMICS; CELL ASSEMBLIES; NETWORKS; NEUROSCIENCE; INHIBITION; MECHANISMS; SEQUENCES; SYSTEMS; MODELS	Attentional networks that integrate many cortical and subcortical elements dynamically control mental processes to focus on specific events and make a decision. The resources of attentional processing are finite. Nevertheless, we often face situations in which it is necessary to simultaneously process several modalities, for example, to switch attention between players in a soccer field. Here we use a global brain mode description to build a model of attentional control dynamics. This model is based on sequential information processing stability conditions that are realized through nonsymmetric inhibition in cortical circuits. In particular, we analyze the dynamics of attentional switching and focus in the case of parallel processing of three interacting mental modalities. Using an excitatory-inhibitory network, we investigate how the bifurcations between different attentional control strategies depend on the stimuli and analyze the relationship between the time of attention focus and the strength of the stimuli. We discuss the interplay between attention and decision-making: in this context, a decision-making process is a controllable bifurcation of the attention strategy. We also suggest the dynamical evaluation of attentional resources in neural sequence processing.	[Rabinovich, Mikhail; Tristan, Irma] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Varona, Pablo] Univ Autonoma Madrid, Grp Neurocomputac Biol, Dpto Ingn Informat, Escuela Politecn Super, Madrid, Spain	University of California System; University of California San Diego; Autonomous University of Madrid	Varona, P (corresponding author), Univ Autonoma Madrid, Grp Neurocomputac Biol, Dpto Ingn Informat, Escuela Politecn Super, Madrid, Spain.	pablo.varona@uam.es	Varona, Pablo/B-5583-2012	Varona, Pablo/0000-0002-1754-8991; Rabinovich, Mikhail I./0000-0003-4499-5348	ONR [N00014-07-1-074]; UC-MEXUS-CONACYT; MINECO [TIN2012-30883]	ONR(Office of Naval Research); UC-MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MINECO(Spanish Government)	MIR acknowledges support from ONR grant N00014-07-1-074. IT acknowledges support from the UC-MEXUS-CONACYT Fellowship. PV was supported by MINECO TIN2012-30883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraimovich VS, 2012, COMPUT NEUROSCI-MIT, P313; Afraimovich VS, 2004, INT J BIFURCAT CHAOS, V14, P1195, DOI 10.1142/S0218127404009806; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Baldauf D, 2010, J VISION, V9, P255, DOI [10.1167/9.8.255, DOI 10.1167/9.8.255]; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bick C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218101; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Bystritsky A, 2012, J PSYCHIATR RES, V46, P428, DOI 10.1016/j.jpsychires.2011.10.013; Calvert G., 2004, HDB MULTISENSORY PRO; Chen YC, 2010, COGNITION, V114, P389, DOI 10.1016/j.cognition.2009.10.012; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Deco G, 2005, PROG NEUROBIOL, V76, P236, DOI 10.1016/j.pneurobio.2005.08.004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dieter KC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00155; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Duncan J, 1998, PHILOS T ROY SOC B, V353, P1307, DOI 10.1098/rstb.1998.0285; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fingelkurts AA, 2010, PHYS LIFE REV, V7, P195, DOI 10.1016/j.plrev.2010.04.001; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gottlieb J, 2010, TRENDS COGN SCI, V14, P240, DOI 10.1016/j.tics.2010.03.001; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Hernandez-Bermejo B, 1998, J PHYS A-MATH GEN, V31, P2415, DOI 10.1088/0305-4470/31/10/016; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Humphries MD, 2010, PLOS COMPUTATIONAL B, V6, P16; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kiyonaga A, 2013, PSYCHON B REV, V20, P228, DOI 10.3758/s13423-012-0359-y; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Kraus N, 2012, ANN NY ACAD SCI, V1252, P100, DOI 10.1111/j.1749-6632.2012.06463.x; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lee K, 2008, J COMPUT SCI TECH-CH, V23, P874, DOI 10.1007/s11390-008-9171-6; Lewis MD, 2005, BEHAV BRAIN SCI, V28, P169, DOI 10.1017/S0140525X0500004X; Li L, 2009, BRAIN RES, V1282, P84, DOI 10.1016/j.brainres.2009.05.078; Liu JK, 2009, J NEUROSCI, V29, P13172, DOI 10.1523/JNEUROSCI.2358-09.2009; Lustig C, 2005, MEMORY, V13, P441, DOI 10.1080/09658210344000404; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Meehan TP, 2012, NEUROSCI BIOBEHAV R, V36, P2232, DOI 10.1016/j.neubiorev.2012.08.002; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mirman D, 2008, COGNITIVE SCI, V32, P398, DOI 10.1080/03640210701864063; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Nee DE, 2009, NEUROIMAGE, V45, P963, DOI 10.1016/j.neuroimage.2009.01.005; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; O'Reilly RC, 2010, CURR OPIN NEUROBIOL, V20, P257, DOI 10.1016/j.conb.2010.01.008; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Rabinovich MI, 2012, COMPUT NEUROSCI-MIT, P1; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Rabinovich MI, 2006, BIOL CYBERN, V95, P519, DOI 10.1007/s00422-006-0121-5; Rabinovich MI, 2012, PHYS LIFE REV, V9, P51, DOI 10.1016/j.plrev.2011.11.002; Rabinovich MI, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00024; Rabinovich MI, 2010, DYNAM SYST, V25, P433, DOI 10.1080/14689367.2010.515396; Reeves A, 2005, VISION RES, V45, P3343, DOI 10.1016/j.visres.2005.07.041; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Scimeca JM, 2012, NEURON, V75, P380, DOI 10.1016/j.neuron.2012.07.014; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Senkowski D, 2008, NEUROIMAGE, V43, P379, DOI 10.1016/j.neuroimage.2008.06.046; Sridharan D, 2007, NEURON, V55, P521, DOI 10.1016/j.neuron.2007.07.003; Stormer VS, 2009, P NATL ACAD SCI USA, V106, P22456, DOI 10.1073/pnas.0907573106; STONE E, 1990, SIAM J APPL MATH, V50, P726, DOI 10.1137/0150043; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Strigo IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015093; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tiesinga P, 2009, NEURON, V63, P727, DOI 10.1016/j.neuron.2009.09.009; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Wiener M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00031; Xiao DM, 2000, J DIFFER EQUATIONS, V164, P1, DOI 10.1006/jdeq.1999.3729; Zeeman EC, 2003, T AM MATH SOC, V355, P713, DOI 10.1090/S0002-9947-02-03103-3; Zeeman M.L., 1993, DYNAM STABIL SYST, V8, P189	84	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64406	10.1371/journal.pone.0064406	http://dx.doi.org/10.1371/journal.pone.0064406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696890	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900093
J	Shi, JJ; Hu, J; Zhou, Q; Du, YH; Jiang, CZ				Shi, Jiejun; Hu, Jian; Zhou, Qing; Du, Yanhua; Jiang, Cizhong			PEpiD: A Prostate Epigenetic Database in Mammals	PLOS ONE			English	Article							DNA METHYLATION; CPG-ISLAND; EXPRESSION; ANDROGEN	Epigenetic mechanisms play key roles in initiation and progression of prostate cancer by changing gene expression. The Prostate Epigenetic Database (PEpiD: http://wukong.tongji.edu.cn/pepid) archives the three extensively characterized epigenetic mechanisms DNA methylation, histone modification, and microRNA implicated in prostate cancer of human, mouse, and rat. PEpiD uses a distinct color scheme to present the three types of epigenetic data and provides a user-friendly interface for flexible query. The retrieved information includes Refseq ID, gene symbol, gene alias, genomic loci of epigenetic changes, tissue source, experimental method, and supportive references. The change of histone modification (hyper or hypo) and the corresponding gene expression change (up or down) are also indicated. A graphic view of DNA methylation with exon-intron structure and predicted CpG islands is provided as well. Moreover, the prostate-related ENCODE tracks (DNA methylation, histone modifications, chromatin remodelers), and other key transcription factors with reported roles in prostate are displayed in the browser as well. The reversibility of epigenetic aberrations has made them potential markers for diagnosis and prognosis, and targets for treatment of cancers. This curated information will improve our understanding of epigenetic mechanisms of gene regulation in prostate cancer, and serve as an important resource for epigenetic research in prostate cancer.	[Shi, Jiejun; Hu, Jian; Zhou, Qing; Du, Yanhua; Jiang, Cizhong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai Peoples Hosp 10, Dept Bioinformat,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Jiang, CZ (corresponding author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai Peoples Hosp 10, Dept Bioinformat,Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn	Shi, Jiejun/P-3329-2019	Shi, Jiejun/0000-0001-9777-1183	Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405]; National Natural Science Foundation of China [91019017, 31271373]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405 to CJ]; and the National Natural Science Foundation of China [91019017, 31271373 to CJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoreira C, 2003, NUCLEIC ACIDS RES, V31, P75, DOI 10.1093/nar/gkg093; BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Jarrard DF, 1998, CANCER RES, V58, P5310; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li LC, 2003, NUCLEIC ACIDS RES, V31, P291, DOI 10.1093/nar/gkg008; Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849; Nelson PS, 2002, NUCLEIC ACIDS RES, V30, P218, DOI 10.1093/nar/30.1.218; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64289	10.1371/journal.pone.0064289	http://dx.doi.org/10.1371/journal.pone.0064289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696878	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900081
J	Vasilyeva, I; Biscontri, RG; Enns, MW; Metge, CJ; Alessi-Severini, S				Vasilyeva, Irina; Biscontri, Robert G.; Enns, Murray W.; Metge, Colleen J.; Alessi-Severini, Silvia			Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study	PLOS ONE			English	Article							DRUG-INDUCED PARKINSONISM; ATYPICAL ANTIPSYCHOTICS; OLDER-ADULTS; ADVERSE EVENTS; RISK; MORTALITY; DEMENTIA; MEDICATIONS; COHORT; TRENDS	Background: Despite concerns over the potential for severe adverse events, antipsychotic medications remain the mainstay of treatment of behaviour disorders and psychosis in elderly patients. Second-generation antipsychotic agents (SGAs; e.g., risperidone, olanzapine, quetiapine) have generally shown a better safety profile compared to the first-generation agents (FGAs; e.g., haloperidol and phenothiazines), particularly in terms of a lower potential for involuntary movement disorders. Risperidone, the only SGA with an official indication for the management of inappropriate behaviour in dementia, has emerged as the antipsychotic most commonly prescribed to older patients. Most clinical trials evaluating the risk of movement disorders in elderly patients receiving antipsychotic therapy have been of limited sample size and/or of relatively short duration. A few observational studies have produced inconsistent results. Methods: A population-based retrospective cohort study of all residents of the Canadian province of Manitoba aged 65 and over, who were dispensed antipsychotic medications for the first time during the time period from April 1, 2000 to March 31, 2007, was conducted using Manitoba's Department of Health's administrative databases. Cox proportional hazards models were used to determine the risk of extrapyramidal symptoms (EPS) in new users of risperidone compared to new users of FGAs. Results: After controlling for potential confounders (demographics, comorbidity and medication use), risperidone use was associated with a lower risk of EPS compared to FGAs at 30, 60, 90 and 180 days (adjusted hazard ratios [HR] 0.38, 95% CI: 0.22-0.67; 0.45, 95% CI: 0.28-0.73; 0.50, 95% CI: 0.33-0.77; 0.65, 95% CI: 0.45-0.94, respectively). At 360 days, the strength of the association weakened with an adjusted HR of 0.75, 95% CI: 0.54-1.05. Conclusions: In a large population of elderly patients the use of risperidone was associated with a lower risk of EPS compared to FGAs.	[Vasilyeva, Irina; Metge, Colleen J.; Alessi-Severini, Silvia] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada; [Biscontri, Robert G.] Univ Manitoba, Asper Sch Business, Dept Accounting & Finance, Winnipeg, MB, Canada; [Enns, Murray W.] Univ Manitoba, Dept Psychiat, Fac Med, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Alessi-Severini, S (corresponding author), Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada.	alessise@cc.umanitoba.ca	Metge, Colleen/G-7727-2016	Metge, Colleen/0000-0001-9170-3294; Alessi-Severini, Silvia/0000-0002-6543-7719; Enns, Murray/0000-0002-8375-0151	Manitoba Medical Service Foundation; Manitoba Health Research Council Graduate Studentship Award	Manitoba Medical Service Foundation; Manitoba Health Research Council Graduate Studentship Award	This work was funded in part by a grant from the Manitoba Medical Service Foundation. Irina Vasilyeva was supported by the Manitoba Health Research Council Graduate Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini S, 2008, PSYCHIAT SERV, V59, P547, DOI 10.1176/ps.2008.59.5.547; AVORN J, 1995, AM J MED, V99, P48, DOI 10.1016/S0002-9343(99)80104-1; Ballard C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003476.pub2; Ballard C, 2011, EXPERT OPIN DRUG SAF, V10, P35, DOI 10.1517/14740338.2010.506711; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; Canadian Institute for Health Information, 2009, ANT US SEN AN FOC DR; Chan WC, 2011, CURR OPIN PSYCHIATR, V24, P455, DOI 10.1097/YCO.0b013e32834a3f47; Drug safety update, ANT US ELD PEOPL DEM; Esper CD, 2008, MOVEMENT DISORD, V23, P401, DOI 10.1002/mds.21854; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Gurevich A, 2012, J NUTR HEALTH AGING, V16, P557, DOI 10.1007/s12603-012-0057-5; HE H, 1995, INT CLIN PSYCHOPHARM, V10, P19, DOI 10.1097/00004850-199503000-00003; Health Canada, ZYPREXA OL CER ADV E; Health Canada, IMP DRUG SAF INF RIS; Health Canada, INCR MORT ASS US AT; Kales HC, 2007, AM J PSYCHIAT, V164, P1568, DOI 10.1176/appi.ajp.2007.06101710; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Kleijer BC, 2009, J PSYCHOPHARMACOL, V23, P909, DOI 10.1177/0269881108093583; Lee PE, 2005, J AM GERIATR SOC, V53, P1374, DOI 10.1111/j.1532-5415.2005.53418.x; Leslie DL, 2012, AM J MANAG CARE, V18, pE109; Liperoti R, 2009, J CLIN PSYCHIAT, V70, P1340, DOI 10.4088/JCP.08m04597yel; Martinez C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002080; McDonagh M., 2010, DRUG CLASS REV ATYPI; Mehta S, 2010, J CLIN PSYCHIAT, V71, P689, DOI 10.4088/JCP.09m05817yel; Milton JC, 2008, BMJ-BRIT MED J, V336, P606, DOI 10.1136/bmj.39503.424653.80; Peluso MJ, 2012, BRIT J PSYCHIAT, V200, P387, DOI 10.1192/bjp.bp.111.101485; Pratt N, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-72; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Reid R., 1999, MEASURING MORBIDITY; Rochon PA, 2005, ARCH INTERN MED, V165, P1882, DOI 10.1001/archinte.165.16.1882; Rochon PA, 2008, ARCH INTERN MED, V168, P1090, DOI 10.1001/archinte.168.10.1090; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schulze J, 2013, EUR NEUROPSYCHOPHARM, V23, P1034, DOI 10.1016/j.euroneuro.2013.02.001; Seeman P, 2002, CAN J PSYCHIAT, V47, P27, DOI 10.1177/070674370204700106; Setoguchi S, 2008, J AM GERIATR SOC, V56, P1644, DOI 10.1111/j.1532-5415.2008.01839.x; Sitar DS, 2008, GERIATRIC CLIN PHARM; Stahl S., 2003, PRIM CARE COMPANION, V5, P9; STARFIELD B, 1991, HEALTH SERV RES, V26, P53; Thanvi B, 2009, POSTGRAD MED J, V85, P322, DOI 10.1136/pgmj.2008.073312; The Manitoba Centre for Health Policy, CONC ADJ CLIN GROUP; Trifiro G, 2007, PHARMACOEPIDEM DR S, V16, P538, DOI 10.1002/pds.1334; U.S, FOOD DRUG ADM FDA RE; Valiyeva E, 2008, CAN MED ASSOC J, V179, P438, DOI 10.1503/cmaj.071540; Vasilyeva I, 2013, J CLIN PSYCHOPHARM, V33, P24, DOI 10.1097/JCP.0b013e31827934a4; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; WEINER JP, 1991, MED CARE, V29, P452, DOI 10.1097/00005650-199105000-00006; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	49	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64217	10.1371/journal.pone.0064217	http://dx.doi.org/10.1371/journal.pone.0064217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696870	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900073
J	Xie, X; Piao, L; Cavey, GS; Old, M; Teknos, TN; Mapp, AK; Pan, Q				Xie, X.; Piao, L.; Cavey, G. S.; Old, M.; Teknos, T. N.; Mapp, A. K.; Pan, Q.			Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis	ONCOGENE			English	Article						Head and neck cancer; protein kinase C; p300; cancer stem cells; cancer-initiating cells	SQUAMOUS-CELL CARCINOMA; STEM-LIKE CELLS; SELF-RENEWAL; KAPPA-B; PLURIPOTENCY; EXPRESSION; HEAD; PROGRESSION; ACTIVATION; PREDICTS	Emerging evidence indicates that Nanog is intimately involved in tumorigenesis, in part, through regulation of the cancer-initiating cell (CIC) population. However, the regulation and role of Nanog in tumorigenesis are still poorly understood. In this study, human Nanog was identified to be phosphorylated by human protein kinase C epsilon at multiple residues, including T200 and T280. Our work indicated that phosphorylation at T200 and T280 modulates Nanog function through several regulatory mechanisms. Results with phosphorylation-insensitive and phosphorylation-mimetic mutant Nanog revealed that phosphorylation at T200 and T280 enhance Nanog protein stability. Moreover, phosphorylation-insensitive T200A and T280A mutant Nanog had a dominant-negative function to inhibit endogenous Nanog transcriptional activity. Inactivation of Nanog was due to impaired homodimerization, DNA binding, promoter occupancy and p300, a transcriptional co-activator, recruitment resulting in a defect in target gene-promoter activation. Ectopic expression of phosphorylation-insensitive T200A or T280A mutant Nanog reduced cell proliferation, colony formation, invasion, migration and the CIC population in head and neck squamous cell carcinoma (HNSCC) cells. The in vivo cancer-initiating ability was severely compromised in HNSCC cells expressing phosphorylation-insensitive T200A or T280A mutant Nanog; 87.5% (14/16), 12.5% (1/8), and 0% (0/8) for control, T200A, and T280A, respectively. Nanog occupied the Bmi1 promoter to directly transactivate and regulate Bmi1. Genetic ablation and rescue experiments demonstrated that Bmi1 is a critical downstream signaling node for the pleiotropic, pro-oncogenic effects of Nanog. Taken together, our study revealed, for the first time, that post-translational phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis.	[Xie, X.; Piao, L.; Old, M.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Xie, X.; Piao, L.; Old, M.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA; [Xie, X.; Piao, L.; Old, M.; Teknos, T. N.; Pan, Q.] Ohio State Univ, Ctr Comprehens Canc, Richard J Solove Res Inst, Columbus, OH 43210 USA; [Cavey, G. S.] Van Andel Res Inst, Grand Rapids, MI USA; [Cavey, G. S.] Southwest Michigan Innovat Ctr, Kalamazoo, MI USA; [Mapp, A. K.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Van Andel Institute; University of Michigan System; University of Michigan	Pan, Q (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Otolaryngol Head & Neck Surg, 442 Tzagournis Med Res,420 West 12th Ave, Columbus, OH 43210 USA.	Quintin.Pan@osumc.edu	, Dr Anna Mapp/GPX-8261-2022; Old, Matthew/J-2315-2017; Pan, Quintin/E-3808-2011	Old, Matthew/0000-0003-1795-5877; 	National Cancer Institute at the National Institutes of Health [R01CA135096]; American Cancer Society [RSG0821901]; Michelle Theado Memorial Grant from The Joan Bisesi Fund for Head and Neck Oncology Research; Sloman Foundation; Arthur G. James Cancer Hospital, The Ohio State University Comprehensive Cancer Center; Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA135096] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Michelle Theado Memorial Grant from The Joan Bisesi Fund for Head and Neck Oncology Research; Sloman Foundation; Arthur G. James Cancer Hospital, The Ohio State University Comprehensive Cancer Center; Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the National Cancer Institute at the National Institutes of Health (R01CA135096); American Cancer Society (RSG0821901); The Michelle Theado Memorial Grant from The Joan Bisesi Fund for Head and Neck Oncology Research; The Sloman Foundation; and Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center.	Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Choijamts B, 2011, STEM CELLS, V29, P1485, DOI 10.1002/stem.711; Das S, 2011, J BIOL CHEM, V286, P42690, DOI 10.1074/jbc.M111.290189; Do HJ, 2009, J CELL BIOCHEM, V106, P1079, DOI 10.1002/jcb.22089; Germann M, 2012, STEM CELLS, V30, P1076, DOI 10.1002/stem.1087; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Han JH, 2012, CANCER LETT, V321, P80, DOI 10.1016/j.canlet.2012.02.021; Hayry V, 2010, BRIT J CANCER, V102, P892, DOI 10.1038/sj.bjc.6605544; Ho BT, 2012, J BIOL CHEM, V287, P18656, DOI 10.1074/jbc.M111.322883; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Lavial F, 2012, GENE DEV, V26, P1445, DOI 10.1101/gad.188193.112; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Liu AG, 2013, INT J ONCOL, V42, P1399, DOI 10.3892/ijo.2013.1826; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Niggeweg R, 2006, PROTEOMICS, V6, P41, DOI 10.1002/pmic.200501332; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Steen H, 2001, ANAL CHEM, V73, P1440, DOI 10.1021/ac001318c; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Vormittag L, 2009, INT J RADIAT ONCOL, V73, P913, DOI 10.1016/j.ijrobp.2008.10.040; Vrzalikova K, 2008, J CANCER RES CLIN, V134, P1037, DOI 10.1007/s00432-008-0361-y; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Yu CC, 2011, ORAL ONCOL, V47, P202, DOI 10.1016/j.oraloncology.2010.12.001; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang Y, 2012, CANCER LETT, V322, P70, DOI 10.1016/j.canlet.2012.02.010	44	35	39	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2040	2052		10.1038/onc.2013.173	http://dx.doi.org/10.1038/onc.2013.173			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23708658	Green Accepted			2022-12-25	WOS:000334599100004
J	Jung, JI; Ladd, TB; Kukar, T; Price, AR; Moore, BD; Koo, EH; Golde, TE; Felsenstein, KM				Jung, Joo In; Ladd, Thomas B.; Kukar, Thomas; Price, Ashleigh R.; Moore, Brenda D.; Koo, Edward H.; Golde, Todd E.; Felsenstein, Kevin M.			Steroids as gamma-secretase modulators	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid; A beta; cholesterol metabolites	AMYLOID PRECURSOR PROTEIN; A-BETA; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; PLAQUE-FORMATION; PEPTIDE; DEPOSITION; A-BETA-42; PRESENILIN; TARGET	Aggregation and accumulation of A(42) play an initiating role in Alzheimer's disease (AD); thus, selective lowering of A(42) by -secretase modulators (GSMs) remains a promising approach to AD therapy. Based on evidence suggesting that steroids may influence A production, we screened 170 steroids at 10 M for effects on A(42) secreted from human APP-overexpressing Chinese hamster ovary cells. Many acidic steroids lowered A(42), whereas many nonacidic steroids actually raised A(42). Studies on the more potent compounds showed that A(42)-lowering steroids were bonafide GSMs and A(42)-raising steroids were inverse GSMs. The most potent steroid GSM identified was 5-cholanic acid (EC50=5.7 M; its endogenous analog lithocholic acid was virtually equipotent), and the most potent inverse GSM identified was 4-androsten-3-one-17-carboxylic acid ethyl ester (EC50=6.25 M). In addition, we found that both estrogen and progesterone are weak inverse GSMs with further complex effects on APP processing. These data suggest that certain endogenous steroids may have the potential to act as GSMs and add to the evidence that cholesterol, cholesterol metabolites, and other steroids may play a role in modulating A production and thus risk for AD. They also indicate that acidic steroids might serve as potential therapeutic leads for drug optimization/development.Jung, J. I., Ladd, T. B., Kukar, T., Price, A. R., Moore, B. D., Koo, E. H., Golde, T. E., Felsenstein, K. M. Steroids as -secretase modulators.	[Jung, Joo In; Ladd, Thomas B.; Price, Ashleigh R.; Moore, Brenda D.; Golde, Todd E.; Felsenstein, Kevin M.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Jung, Joo In; Ladd, Thomas B.; Price, Ashleigh R.; Moore, Brenda D.; Golde, Todd E.; Felsenstein, Kevin M.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Kukar, Thomas] Emory Univ, Sch Med, Dept Pharmacol & Neurol, Atlanta, GA USA; [Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University; University of California System; University of California San Diego	Felsenstein, KM (corresponding author), Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	kfelsenstein0@ufl.edu	Kukar, Thomas/AAW-2612-2021	Moore, Brenda/0000-0002-9685-6561; Kukar, Thomas/0000-0002-3750-6262; Visconti, Ashleigh/0000-0002-7371-136X	U.S. National Institutes of Health [AG-20206]; Coins for Alzheimer's Research Trust; Rotarians in the southeastern United States; NATIONAL INSTITUTE ON AGING [P01AG020206, R00AG032362] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coins for Alzheimer's Research Trust; Rotarians in the southeastern United States; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by funds from U.S. National Institutes of Health grant AG-20206 and the Coins for Alzheimer's Research Trust, supported by Rotarians in the southeastern United States. The authors are extremely grateful to Dr. Rong Wang (Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA) for the use of the PE Biosystems Voyager DE STR MALDI-TOF mass spectrometer. The authors also thank Dr. Yong Ran for technical support in performing the notch inhibition assay. The authors are also grateful to Gideon Shapiro and Kristi Ayers for critical reading of the manuscript.	Amtul Z, 2010, NEUROSCIENCE, V169, P781, DOI 10.1016/j.neuroscience.2010.05.031; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Bhattacharyya R, 2010, BBA-MOL CELL BIOL L, V1801, P960, DOI 10.1016/j.bbalip.2010.04.003; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Chang D, 1997, ADV EXP MED BIOL, V429, P261; Crump CJ, 2011, ACS CHEM NEUROSCI, V2, P705, DOI 10.1021/cn200098p; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fukuchi J, 2005, J STEROID BIOCHEM, V94, P311, DOI 10.1016/j.jsbmb.2004.11.012; Gijsen HJ, 2012, INT J ALZHEIMERS DIS, V2012; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; Golde TE, 2001, DRUG DISCOV TODAY, V6, P1049, DOI 10.1016/S1359-6446(01)01965-1; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hall A, 2010, BIOORG MED CHEM LETT, V20, P1306, DOI 10.1016/j.bmcl.2009.08.072; Haskell SG, 1997, J CLIN EPIDEMIOL, V50, P1249, DOI 10.1016/S0895-4356(97)00169-8; Hubbs JL, 2012, J MED CHEM, V55, P9270, DOI 10.1021/jm300976b; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JAFFE AB, 1994, J BIOL CHEM, V269, P13065; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jayaraman A, 2012, ENDOCRINOLOGY, V153, P5467, DOI 10.1210/en.2012-1464; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar T, 2008, CURR TOP MED CHEM, V8, P47, DOI 10.2174/156802608783334042; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lessard C., 2012, SOC NEUR ANN M, V750, pE66; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Loureiro RM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt173; Manthey D, 2001, EUR J BIOCHEM, V268, P4285, DOI 10.1046/j.1432-1327.2001.02346.x; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; McLendon C, 2000, FASEB J, V14, P2383; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Nunes AF, 2012, MOL NEUROBIOL, V45, P440, DOI 10.1007/s12035-012-8256-y; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Popp J, 2012, J NEUROCHEM, V123, P310, DOI 10.1111/j.1471-4159.2012.07893.x; Prasanthi JRP, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-1; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rivkin A, 2010, BIOORG MED CHEM LETT, V20, P1269, DOI 10.1016/j.bmcl.2009.11.101; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Steven G. Y., J PHYSL, V92, P289; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Suzuki T, 2008, J PHARMACOL SCI, V107, P285, DOI 10.1254/jphs.08006FP; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Tognolini M, 2012, CHEMMEDCHEM, V7, P1071, DOI 10.1002/cmdc.201200102; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Zall A, 2011, BIOORGAN MED CHEM, V19, P4903, DOI 10.1016/j.bmc.2011.06.062	65	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3775	3785		10.1096/fj.12-225649	http://dx.doi.org/10.1096/fj.12-225649			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23716494	Green Published			2022-12-25	WOS:000328840500035
J	Terrando, N; Gomez-Galan, M; Yang, T; Carlstrom, M; Gustavsson, D; Harding, RE; Lindskog, M; Eriksson, LI				Terrando, Niccolo; Gomez-Galan, Marta; Yang, Ting; Carlstrom, Mattias; Gustavsson, Daniel; Harding, Ralph E.; Lindskog, Maria; Eriksson, Lars I.			Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline	FASEB JOURNAL			English	Article						inflammation; resolution; long-term potentiation; astrocytes; dementia	LONG-TERM POTENTIATION; INFLAMMATION-RESOLUTION; LIPID MEDIATORS; CIRCUITS; INTERLEUKIN-1-BETA; NEUROINFLAMMATION; INFECTION; MEMORY	Hospitalization for major surgery or critical illness often associates with cognitive decline. Inflammation and dysregulation of the innate immune system can exert broad effects in the periphery and central nervous system (CNS), yet the mechanisms underlying memory impairment after surgery remain poorly understood and without effective therapy. Endogenous regulation of acute inflammation is providing novel approaches to treat several disease states including sepsis, pain, obesity and diabetes. Resolvins are potent endogenous lipid mediators biosynthesized during the resolution phase of acute inflammation that display immunoresolvent actions. Here, using a mouse model of surgery-induced cognitive decline we report that orthopedic surgery affects hippocampal neuronal-glial function, including synaptic transmission and plasticity. Systemic prophylaxis with aspirin-triggered resolvin D1 (AT-RvD1: 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid, as little as 100 ng dose per mouse) improved memory decline following surgery and abolished signs of synaptic dysfunction. Moreover, delayed administration 24 h after surgery also attenuated signs of neuronal dysfunction postoperatively. AT-RvD1 also limited peripheral damage by modulating the release of systemic interleukin (IL)-6 and improved other clinical markers of tissue injury. Collectively, these results demonstrate a novel role of AT-RvD1 in modulating the proinflammatory milieu after aseptic injury and protecting the brain from neuroinflammation, synaptic dysfunction and cognitive decline. These findings provide novel and safer approaches to treat postoperative cognitive decline and potentially other forms of memory dysfunctions.Terrando, N., Gomez-Galan, M., Yang, T., Carlstrom, M., Gustavsson, D., Harding, R. E., Lindskog, M., Eriksson, L. I. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline.	[Terrando, Niccolo; Gomez-Galan, Marta; Yang, Ting; Carlstrom, Mattias; Gustavsson, Daniel; Eriksson, Lars I.] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Gomez-Galan, Marta; Lindskog, Maria] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Harding, Ralph E.] Carl Vinson Vet Affairs Med Ctr, Dept Surg, Dublin, GA USA; [Eriksson, Lars I.] Karolinska Univ Hosp, Dept Anesthesiol Surg Serv & Intens Care Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Terrando, N (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svart Vag 2, S-17177 Stockholm, Sweden.	niccolo.terrando@ki.se	Lindskog, Maria/F-1729-2011; Carlström, Mattias/E-7350-2015; Terrando, Niccolo/Y-4349-2019	Lindskog, Maria/0000-0002-4178-2825; Carlström, Mattias/0000-0001-9923-8729; Terrando, Niccolo/0000-0003-1803-5853; Gomez-Galan, Marta/0000-0002-8355-9795	European Society of Anaesthesiology; Karolinska Institutet Foundations; Thorsten Soderberg Foundation (Stockholm, Sweden); Stockholm County Council (Stockholm, Sweden); Research Council for Medicine, Sweden	European Society of Anaesthesiology; Karolinska Institutet Foundations(Karolinska Institutet); Thorsten Soderberg Foundation (Stockholm, Sweden); Stockholm County Council (Stockholm, Sweden)(Stockholm County Council); Research Council for Medicine, Sweden	The authors thank Michel Goiny and Anette Ebberyd for excellent technical support; Lena Sandlund for assistance with the liver enzymes measurement. This work was funded by a research grant program of the European Society of Anaesthesiology; Research Council for Medicine, Sweden; Karolinska Institutet Foundations; Thorsten Soderberg Foundation (Stockholm, Sweden); and the Stockholm County Council (Stockholm, Sweden).	Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Carlstrom M, 2013, ACTA PHYSIOL, V207, P732, DOI 10.1111/apha.12079; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24; Gomez-Galan M, 2013, MOL PSYCHIATR, V18, P582, DOI 10.1038/mp.2012.10; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Liu Guanghao, 2012, Am J Neurodegener Dis, V1, P60; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Norling LV, 2011, J IMMUNOL, V186, P5543, DOI 10.4049/jimmunol.1003865; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tang JXX, 2013, ANN SURG, V257, P439, DOI 10.1097/SLA.0b013e318269d623; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2011, MAYO CLIN PROC, V86, P885, DOI 10.4065/mcp.2011.0332; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726	41	107	109	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3564	3571		10.1096/fj.13-230276	http://dx.doi.org/10.1096/fj.13-230276			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23709617				2022-12-25	WOS:000328840500016
J	Plitzko, B; Ott, G; Reichmann, D; Henderson, CJ; Wolf, CR; Mendel, R; Bittner, F; Clement, B; Havemeyer, A				Plitzko, Birte; Ott, Gudrun; Reichmann, Debora; Henderson, Colin J.; Wolf, C. Roland; Mendel, Ralf; Bittner, Florian; Clement, Bernd; Havemeyer, Antje			The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b(5) in N-Reductive Metabolism in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETOXIFICATION; HYDROXYLAMINE; PROTEIN; MARC; RAT; BENZAMIDOXIME; PURIFICATION; PEROXISOMES; ACTIVATION; EXPRESSION	The mitochondrial amidoxime reducing component mARC is a recently discovered molybdenum enzyme in mammals. mARC is not active as a standalone protein, but together with the electron transport proteins NADH-cytochrome b(5) reductase (CYB5R) and cytochrome b(5) (CYB5), it catalyzes the reduction of N-hydroxylated compounds such as amidoximes. The mARC-containing enzyme system is therefore considered to be responsible for the activation of amidoxime prodrugs. All hitherto analyzed mammalian genomes code for two mARC genes (also referred to as MOSC1 and MOSC2), which share high sequence similarities. By RNAi experiments in two different human cell lines, we demonstrate for the first time that both mARC proteins are capable of reducing N-hydroxylated substrates in cell metabolism. The extent of involvement is highly dependent on the expression level of the particular mARC protein. Furthermore, the mitochondrial isoform of CYB5 (CYB5B) is clearly identified as an essential component of the mARC-containing N-reductase system in human cells. The participation of the microsomal isoform (CYB5A) in N-reduction could be excluded by siRNA-mediated down-regulation in HEK-293 cells and knock-out in mice. Using heme-free apo-CYB5, the contribution of mitochondrial CYB5 to N-reductive catalysis was proven to strictly depend on heme. Finally, we created recombinant CYB5B variants corresponding to four nonsynonymous single nucleotide polymorphisms (SNPs). Investigated mutations of the heme protein seemed to have no significant impact on N-reductive activity of the reconstituted enzyme system.	[Plitzko, Birte; Ott, Gudrun; Clement, Bernd; Havemeyer, Antje] Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany; [Reichmann, Debora; Mendel, Ralf; Bittner, Florian] Braunschweig Univ Technol, Dept Plant Biol, D-38023 Braunschweig, Germany; [Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland	University of Kiel; Braunschweig University of Technology; University of Dundee	Havemeyer, A (corresponding author), Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ahavemeyer@pharmazie.uni-kiel.de	Henderson, Colin/AAE-7141-2019	Henderson, Colin/0000-0002-4764-639X; Wolf, Charles Roland/0000-0002-6969-0113	Deutsche Forschungsgemeinschaft (DFG) [CL56/9-1, ME 1266/24-1]; Cancer Research UK [10822] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants CL56/9-1 and ME 1266/24-1.	Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; Aslibekyan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048663; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BERNHEIM ML, 1972, ENZYMOLOGIA, V43, P167; BORGESE N, 1993, FEBS LETT, V325, P70, DOI 10.1016/0014-5793(93)81416-W; Clement B, 2005, DRUG METAB DISPOS, V33, P1740, DOI 10.1124/dmd.105.005249; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; Estabrook R W, 1978, Methods Enzymol, V52, P212; Froriep D, 2013, XENOBIOTICA, V43, P780, DOI 10.3109/00498254.2013.767481; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2011, DRUG METAB REV, V43, P524, DOI 10.3109/03602532.2011.608682; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; KADLUBAR FF, 1974, ARCH BIOCHEM BIOPHYS, V162, P83, DOI 10.1016/0003-9861(74)90107-6; Klein JM, 2012, J BIOL CHEM, V287, P42795, DOI 10.1074/jbc.M112.419424; Kotrbova V, 2009, PROTEIN EXPRES PURIF, V66, P203, DOI 10.1016/j.pep.2009.03.011; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; Kurian JR, 2007, PHARMACOGENET GENOM, V17, P597, DOI 10.1097/FPC.0b013e328011aaff; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; McLaughlin LA, 2010, MOL PHARMACOL, V78, P269, DOI 10.1124/mol.110.064246; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Rhoads K, 2011, TOXICOL SCI, V121, P245, DOI 10.1093/toxsci/kfr073; RodriguezMaranon MJ, 1996, BIOCHEMISTRY-US, V35, P16378, DOI 10.1021/bi961895o; Sacco JC, 2012, PHARMACOGENET GENOM, V22, P733, DOI 10.1097/FPC.0b013e328357a735; Sacco JC, 2010, PHARMACOGENET GENOM, V20, P26, DOI 10.1097/FPC.0b013e3283343296; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200	40	33	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20228	20237		10.1074/jbc.M113.474916	http://dx.doi.org/10.1074/jbc.M113.474916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703616	Green Published, hybrid			2022-12-25	WOS:000321715100012
J	Chehade, MH; Loiseau, L; Lombard, M; Pecqueur, L; Ismail, A; Smadja, M; Golinelli-Pimpaneau, B; Mellot-Draznieks, C; Hamelin, O; Aussel, L; Kieffer-Jaquinod, S; Labessan, N; Barras, F; Fontecave, M; Pierrel, F				Chehade, Mahmoud Hajj; Loiseau, Laurent; Lombard, Murielle; Pecqueur, Ludovic; Ismail, Alexandre; Smadja, Myriam; Golinelli-Pimpaneau, Beatrice; Mellot-Draznieks, Caroline; Hamelin, Olivier; Aussel, Laurent; Kieffer-Jaquinod, Sylvie; Labessan, Natty; Barras, Frederic; Fontecave, Marc; Pierrel, Fabien			ubiI, a New Gene in Escherichia coli Coenzyme Q Biosynthesis, Is Involved in Aerobic C5-hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; UBIQUINONE BIOSYNTHESIS; IDENTIFICATION; YEAST; DEFICIENCY; COMPLEXES; SUBSTRATE; MUTATION; KINASE; MUTANT	Coenzyme Q (ubiquinone or Q) is a redox-active lipid found in organisms ranging from bacteria to mammals in which it plays a crucial role in energy-generating processes. Q biosynthesis is a complex pathway that involves multiple proteins. In this work, we show that the uncharacterized conserved visC gene is involved in Q biosynthesis in Escherichia coli, and we have renamed it ubiI. Based on genetic and biochemical experiments, we establish that the UbiI protein functions in the C5-hydroxylation reaction. A strain deficient in ubiI has a low level of Q and accumulates a compound derived from the Q biosynthetic pathway, which we purified and characterized. We also demonstrate that UbiI is only implicated in aerobic Q biosynthesis and that an alternative enzyme catalyzes the C5-hydroxylation reaction in the absence of oxygen. We have solved the crystal structure of a truncated form of UbiI. This structure shares many features with the canonical FAD-dependent para-hydroxybenzoate hydroxylase and represents the first structural characterization of a monooxygenase involved in Q biosynthesis. Site-directed mutagenesis confirms that residues of the flavin binding pocket of UbiI are important for activity. With our identification of UbiI, the three monooxygenases necessary for aerobic Q biosynthesis in E. coli are known.	[Chehade, Mahmoud Hajj; Hamelin, Olivier; Pierrel, Fabien] CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France; [Chehade, Mahmoud Hajj; Hamelin, Olivier; Pierrel, Fabien] CNRS, UMR5249, F-38054 Grenoble, France; [Chehade, Mahmoud Hajj; Hamelin, Olivier; Pierrel, Fabien] Univ Grenoble 1, UMR5249, F-38041 Grenoble, France; [Loiseau, Laurent; Aussel, Laurent; Barras, Frederic] Aix Marseille Univ, Lab Chim Bacterienne, UMR7283, Inst Microbiol Mediterranee, F-13009 Marseille, France; [Lombard, Murielle; Pecqueur, Ludovic; Ismail, Alexandre; Smadja, Myriam; Golinelli-Pimpaneau, Beatrice; Mellot-Draznieks, Caroline; Labessan, Natty; Fontecave, Marc] CNRS, Coll France, FRE3488, Lab Chim Proc Biol, F-75005 Paris, France; [Kieffer-Jaquinod, Sylvie] Univ Grenoble 1, CEA, INSERM, Lab Biol Grande Echelle,U1038, F-38054 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pierrel, F (corresponding author), CEA Grenoble, IRTSV, Lab Chim & Biol Met, Bat K,P272,17 Rue Martyrs, F-38054 Grenoble 9, France.	fabien.pierrel@cea.fr	Lombard, Murielle/E-4974-2019; PIERREL, Fabien/M-6016-2014; Golinelli, Beatrice/ABB-8347-2021	Lombard, Murielle/0000-0002-4775-3494; PIERREL, Fabien/0000-0003-2083-3002; Golinelli, Beatrice/0000-0001-8248-4704; Aussel, Laurent/0000-0001-5239-4556; Barras, Frederic/0000-0003-3458-2574; Pecqueur, Ludovic/0000-0002-0396-699X	Agence Nationale de la Recherche [JCJC SVSE 8-2011]; Sup'Biotech	Agence Nationale de la Recherche(French National Research Agency (ANR)); Sup'Biotech	This work was supported by Agence Nationale de la Recherche Grant JCJC SVSE 8-2011, Project pABACoQ (to F. P.) and Sup'Biotech (to A. I.).	ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4750, DOI 10.1021/bi00615a024; ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4745, DOI 10.1021/bi00615a023; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; CORRELL CC, 1992, SCIENCE, V258, P1604, DOI 10.1126/science.1280857; COX GB, 1969, J BACTERIOL, V99, P450, DOI 10.1128/JB.99.2.450-458.1969; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; NAKAHIGASHI K, 1992, J BACTERIOL, V174, P7352, DOI 10.1128/jb.174.22.7352-7359.1992; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; PALFEY BA, 1994, BIOCHEMISTRY-US, V33, P1545, DOI 10.1021/bi00172a035; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	31	33	35	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20085	20092		10.1074/jbc.M113.480368	http://dx.doi.org/10.1074/jbc.M113.480368			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23709220	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000321515800070
J	Alekseeva, L; Rault, L; Almeida, S; Legembre, P; Edmond, V; Azevedo, V; Miyoshi, A; Even, S; Taieb, F; Arlot-Bonnemains, Y; Le Loir, Y; Berkova, N				Alekseeva, Ludmila; Rault, Lucie; Almeida, Sintia; Legembre, Patrick; Edmond, Valerie; Azevedo, Vasco; Miyoshi, Anderson; Even, Sergine; Taieb, Frederic; Arlot-Bonnemains, Yannick; Le Loir, Yves; Berkova, Nadia			Staphylococcus aureus-Induced G2/M Phase Transition Delay in Host Epithelial Cells Increases Bacterial Infective Efficiency	PLOS ONE			English	Article							DNA-DAMAGE; CYCLE ARREST; MAC-T; TOXIN; APOPTOSIS; PROTEIN; GROWTH; DIFFERENTIATION; ACTIVATION; VIRULENCE	Staphylococcus aureus is a highly versatile, opportunistic pathogen and the etiological agent of a wide range of infections in humans and warm-blooded animals. The epithelial surface is its principal site of colonization and infection. In this work, we investigated the cytopathic effect of S. aureus strains from human and animal origins and their ability to affect the host cell cycle in human HeLa and bovine MAC-T epithelial cell lines. S. aureus invasion slowed down cell proliferation and induced a cytopathic effect, resulting in the enlargement of host cells. A dramatic decrease in the number of mitotic cells was observed in the infected cultures. Flow cytometry analysis revealed an S. aureus-induced delay in the G2/M phase transition in synchronous HeLa cells. This delay required the presence of live S. aureus since the addition of the heat-killed bacteria did not alter the cell cycle. The results of Western blot experiments showed that the G2/M transition delay was associated with the accumulation of inactive cyclin-dependent kinase Cdk1, a key inducer of mitosis entry, and with the accumulation of unphosphorylated histone H3, which was correlated with a reduction of the mitotic cell number. Analysis of S. aureus proliferation in asynchronous, G1- and G2-phase-enriched HeLa cells showed that the G2 phase was preferential for bacterial infective efficiency, suggesting that the G2 phase delay may be used by S. aureus for propagation within the host. Taken together, our results divulge the potential of S. aureus in the subversion of key cellular processes such as cell cycle progression, and shed light on the biological significance of S. aureus-induced host cell cycle alteration.	[Alekseeva, Ludmila] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Alekseeva, Ludmila; Rault, Lucie; Almeida, Sintia; Even, Sergine; Le Loir, Yves; Berkova, Nadia] INRA, Unite Mixte Rech 1253, Rennes, France; [Alekseeva, Ludmila; Rault, Lucie; Almeida, Sintia; Even, Sergine; Le Loir, Yves; Berkova, Nadia] AGROCAMPUS OUEST, Unite Mixte Rech 1253, Rennes, France; [Almeida, Sintia; Azevedo, Vasco; Miyoshi, Anderson] Univ Fed Minas Gerais, Dept Biol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Legembre, Patrick; Edmond, Valerie] Univ Rennes 1, Inst Rech Sante, Inst Rech Sante Environm & Travail, U1085, Rennes, France; [Taieb, Frederic] INRA, Inst Natl Sante & Rech Med, USC U1043, Toulouse, France; [Arlot-Bonnemains, Yannick] Univ Rennes 1, CNRS, Unite Mixte Rech 6290, Rennes, France	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; INRAE; Institut Agro; Agrocampus Ouest; Universidade Federal de Minas Gerais; Universite de Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Berkova, N (corresponding author), INRA, Unite Mixte Rech 1253, Rennes, France.	nadia.berkova@rennes.inra.fr	Legembre, Patrick/U-1882-2019; Almeida, Sintia/K-1217-2012; Azevedo, Vasco/B-1556-2019; Azevedo, Vasco A.C/F-4315-2011; legembre, patrick/L-3475-2016; LE LOIR, Yves/AAD-1879-2021	Legembre, Patrick/0000-0001-6649-8049; Almeida, Sintia/0000-0003-0270-9059; Azevedo, Vasco/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; legembre, patrick/0000-0001-6649-8049; taieb, frederic/0000-0001-9612-2069; Le Loir, Yves/0000-0002-0355-1065; Berkova, Nadia/0000-0001-6246-5549	Animal Health Department of INRA; MRI INRA; CAPES-COFECUB [720/11]	Animal Health Department of INRA; MRI INRA; CAPES-COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by a grant from the Animal Health Department of INRA. LA is the recipient of a fellowship from MRI INRA. SA is the recipient of a CAPES-COFECUB grant (Project 720/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; Barratt RA, 1998, CANCER RES, V58, P2639; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; Berkova N, 2006, INT IMMUNOL, V18, P139, DOI 10.1093/intimm/dxh356; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Brunet J, 2008, CELL MICROBIOL, V10, P908, DOI 10.1111/j.1462-5822.2007.01093.x; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castro J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-9; Chen XP, 2011, ORGAN BEHAV HUM DEC, V114, P1, DOI 10.1016/j.obhdp.2010.11.001; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Comayras C, 1997, INFECT IMMUN, V65, P5088, DOI 10.1128/IAI.65.12.5088-5095.1997; Dego OK, 2002, VET QUART, V24, P181, DOI 10.1080/01652176.2002.9695135; Ding SZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009875; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Gray MC, 2011, CELL MICROBIOL, V13, P123, DOI 10.1111/j.1462-5822.2010.01525.x; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Heimer SR, 2010, VIRULENCE, V1, P223, DOI 10.4161/viru.1.4.11466; Hess BJ, 2003, J SURG RES, V114, P42, DOI 10.1016/S0022-4804(03)00314-7; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; JELINEK DF, 1985, J IMMUNOL, V134, P1690; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Marechal C, 2009, J MICROBIOL METH, V79, P131, DOI 10.1016/j.mimet.2009.08.017; Le Marechal C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027354; Lutzow YCS, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-18; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Martinez-Pulgarin S, 2009, MICROBIOL-SGM, V155, P1505, DOI 10.1099/mic.0.025544-0; MATTHEWS KR, 1994, J DAIRY SCI, V77, P2959, DOI 10.3168/jds.S0022-0302(94)77237-4; McKillip JL, 1998, APPL ENVIRON MICROB, V64, P4264; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Mou XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026544; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Orosz L, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-47; OWEN TA, 1989, J CELL PHYSIOL, V139, P424, DOI 10.1002/jcp.1041390227; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Steeneveld W, 2011, J DAIRY SCI, V94, P174, DOI 10.3168/jds.2010-3367; SUGAI M, 1992, J BIOL CHEM, V267, P2600; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vautor E, 2003, VET MICROBIOL, V96, P69, DOI 10.1016/S0378-1135(03)00207-4; Vautor E, 2009, VET MICROBIOL, V133, P105, DOI 10.1016/j.vetmic.2008.06.006; Wu WN, 2011, J VIROL, V85, P10300, DOI 10.1128/JVI.05164-11; ZAVIZION B, 1995, J DAIRY SCI, V78, P277, DOI 10.3168/jds.S0022-0302(95)76635-8	57	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63279	10.1371/journal.pone.0063279	http://dx.doi.org/10.1371/journal.pone.0063279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717407	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600007
J	Rusine, J; Ondoa, P; Asiimwe-Kateera, B; Boer, KR; Uwimana, JM; Mukabayire, O; Zaaijer, H; Mugabekazi, J; Reiss, P; van de Wijgert, JH				Rusine, John; Ondoa, Pascale; Asiimwe-Kateera, Brenda; Boer, Kimberly R.; Uwimana, Jean Marie; Mukabayire, Odette; Zaaijer, Hans; Mugabekazi, Julie; Reiss, Peter; van de Wijgert, Janneke H.			High Seroprevalence of HBV and HCV Infection in HIV-Infected Adults in Kigali, Rwanda	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SUB-SAHARAN AFRICA; COINFECTION; EPIDEMIOLOGY; ANTIBODY; COHORT	Background: Data on prevalence and incidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in Rwanda are scarce. Methods: HBV status was assessed at baseline and Month 12, and anti-HCV antibodies at baseline, in a prospective cohort study of HIV-infected patients in Kigali, Rwanda: 104 men and 114 women initiating antiretroviral therapy (ART) at baseline, and 200 women not yet eligible for ART. Results: Baseline prevalence of active HBV infection (HBsAg positive), past or occult HBV infection (anti-HBc positive and HBsAg negative) and anti-HCV was 5.2%, 42.9%, and 5.7%, respectively. The active HBV incidence rate was 4.2/1,000 person years (PY). In a multivariable logistic regression model using baseline data, participants with WHO stage 3 or 4 HIV disease were 4.19 times (95% CI 1.21-14.47) more likely to have active HBV infection, and older patients were more likely to have evidence of past exposure to HBV (aRR 1.03 per year; 95% CI 1.01-1.06). Older age was also positively associated with having anti-HCV antibodies (aOR 1.09; 95% CI 1.04-1.14) while having a higher baseline HIV viral load was negatively associated with HCV (aOR 0.60; 95% CI 0.40-0.98). The median CD4 increase during the first 12 months of ART was lower for those with active HBV infection or anti-HCV at baseline. Almost all participants (88%) with active HBV infection who were on ART were receiving lamivudine monotherapy for HBV. Conclusion: HBV and HCV are common in HIV-infected patients in Rwanda. Regular HBsAg screening is needed to ensure that HIV-HBV co-infected patients receive an HBV-active ART regimen, and the prevalence of occult HBV infection should be determined. Improved access to HBV vaccination is recommended. Active HCV prevalence and incidence should be investigated further to determine whether HCV RNA PCR testing should be introduced in Rwanda.	[Rusine, John; Ondoa, Pascale; Boer, Kimberly R.; Reiss, Peter; van de Wijgert, Janneke H.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Rusine, John; Ondoa, Pascale; Boer, Kimberly R.; Reiss, Peter; van de Wijgert, Janneke H.] AIGHD, Amsterdam, Netherlands; [Rusine, John; Asiimwe-Kateera, Brenda; Boer, Kimberly R.] INTERACT Program, Kigali, Rwanda; [Rusine, John; Uwimana, Jean Marie; Mukabayire, Odette] Natl Reference Lab, Kigali, Rwanda; [Boer, Kimberly R.] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands; [Mugabekazi, Julie] KUTH, Kigali, Rwanda; [Zaaijer, Hans] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke H.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool	van de Wijgert, JH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vandewijgert@liv.ac.uk	Asiimwe-Kateera, Brenda/H-3378-2019	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Asiimwe Kateera, Brenda/0000-0001-6134-1042	Netherlands-African Partnership for Capacity Development; Clinical Interventions against Poverty-related Diseases (NACCAP) of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European and Developing Countries Clinical Trials Partnership (EDCTP)	Netherlands-African Partnership for Capacity Development; Clinical Interventions against Poverty-related Diseases (NACCAP) of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European and Developing Countries Clinical Trials Partnership (EDCTP)	This work was part of the INTERACT Program funded by the Netherlands-African Partnership for Capacity Development and Clinical Interventions against Poverty-related Diseases (NACCAP) of the Netherlands Organisation for Scientific Research - The Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO; URL: http://www.nwo.nl/nwohome.nsf/pages/NWOP_5VWBMM_Eng). Funding was also received from the European and Developing Countries Clinical Trials Partnership (EDCTP) as part of a project entitled: 'Preparing for Phase III vaginal microbicide trials in Rwanda and Kenya: Preparedness studies, capacity building, and strengthening of medical referral systems' (CT_ct_05_33070_001; URL: http://www.edctp.org/). The views expressed in this paper are those of the authors and do not necessarily represent the official position of NWO-WOTRO or EDCTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2003, J HEPATOL, V39, pS64, DOI 10.1016/S0168-8278(03)00141-7; Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Chadwick D, 2012, J ANTIMICROB CHEMOTH, V67, P2939, DOI 10.1093/jac/dks333; Chadwick D, 2013, AIDS, V27, P139, DOI 10.1097/QAD.0b013e3283589879; Di Bisceglie AM, 2010, ANTIVIR THER, V15, P499, DOI 10.3851/IMP1494; Diop-Ndiaye H, 2008, J MED VIROL, V80, P1332, DOI 10.1002/jmv.21236; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Harania RS, 2008, AIDS, V22, P1221, DOI 10.1097/QAD.0b013e32830162a8; HOFFMAN CJ, 2009, CLIN INFECT DIS, V49, P1268; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Ladep N G, 2007, Niger J Med, V16, P231; Laurent C, 2010, HIV MED, V11, P85, DOI 10.1111/j.1468-1293.2009.00742.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Nakwagala F N, 2002, East Afr Med J, V79, P68; Nebbia G, 2007, J MED VIROL, V79, P1464, DOI 10.1002/jmv.20954; Nunez M, 2006, AIDS RES HUM RETROV, V22, P842, DOI 10.1089/aid.2006.22.842; Omland LH, 2008, HIV MED, V9, P300, DOI 10.1111/j.1468-1293.2008.00564.x; Otegbayo JA, 2008, ANN HEPATOL, V7, P152, DOI 10.1016/S1665-2681(19)31872-1; Pirillo MF, 2007, J MED VIROL, V79, P1797, DOI 10.1002/jmv.21007; Rao HY, 2012, J GASTROEN HEPATOL, V27, P526, DOI 10.1111/j.1440-1746.2011.06880.x; *RWAND MIN HLTH, 2011, NAT HIV CAR TREATM G; Seremba E, 2010, J MED VIROL, V82, P1371, DOI 10.1002/jmv.21817; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; van Bommel F, 2006, HEPATOLOGY, V44, P318, DOI 10.1002/hep.21253; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B	34	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63303	10.1371/journal.pone.0063303	http://dx.doi.org/10.1371/journal.pone.0063303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717409	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700014
J	Buckley, AM; Spencer, J; Maclellan, LM; Candlish, D; Irvine, JJ; Douce, GR				Buckley, Anthony M.; Spencer, Janice; Maclellan, Lindsay M.; Candlish, Denise; Irvine, June J.; Douce, Gillian R.			Susceptibility of Hamsters to Clostridium difficile Isolates of Differing Toxinotype	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; STRAINS; INFECTION; DIVERSITY; SPORES; PREVALENCE; VIRULENCE; REVEALS; DISEASE	Clostridium difficile is the most commonly associated cause of antibiotic associated disease (AAD), which caused similar to 21,000 cases of AAD in 2011 in the U.K. alone. The golden Syrian hamster model of CDI is an acute model displaying many of the clinical features of C. difficile disease. Using this model we characterised three clinical strains of C. difficile, all differing in toxinotype; CD1342 (PaLoc negative), M68 (toxinotype VIII) & BI-7 (toxinotype III). The naturally occurring non-toxic strain colonised all hamsters within 1-day post challenge (d.p.c.) with high-levels of spores being shed in the faeces of animals that appeared well throughout the entire experiment. However, some changes including increased neutrophil influx and unclotted red blood cells were observed at early time points despite the fact that the known C. difficile toxins (TcdA, TcdB and CDT) are absent from the genome. In contrast, hamsters challenged with strain M68 resulted in a 45% mortality rate, with those that survived challenge remaining highly colonised. It is currently unclear why some hamsters survive infection, as bacterial & toxin levels and histology scores were similar to those culled at a similar time-point. Hamsters challenged with strain BI-7 resulted in a rapid fatal infection in 100% of the hamsters approximately 26 hr post challenge. Severe caecal pathology, including transmural neutrophil infiltrates and extensive submucosal damage correlated with high levels of toxin measured in gut filtrates ex vivo. These data describes the infection kinetics and disease outcomes of 3 clinical C. difficile isolates differing in toxin carriage and provides additional insights to the role of each toxin in disease progression.	[Buckley, Anthony M.; Spencer, Janice; Maclellan, Lindsay M.; Candlish, Denise; Irvine, June J.; Douce, Gillian R.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland	University of Glasgow	Douce, GR (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland.	Gillian.Douce@Glasgow.ac.uk		Buckley, Anthony/0000-0002-2790-0717; Douce, Gillian/0000-0002-6654-7346	Wellcome Trust [086418]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors gratefully acknowledge the support of the Wellcome Trust (grant number 086418 awarded to Dr G. Douce & Prof. B. Wren). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JM, 2001, J ANTIMICROB CHEMOTH, V48, pS15; Arvand M, 2009, EUROSURVEILLANCE, V14, P27; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Brouwer MSM, 2012, J BACTERIOL, V194, P2125, DOI 10.1128/JB.00122-12; Buckley AM, 2011, J MED MICROBIOL, V60, P1174, DOI 10.1099/jmm.0.028514-0; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Casas V, 2011, FUTURE MICROBIOL, V6, P1461, DOI [10.2217/fmb.11.124, 10.2217/FMB.11.124]; Drudy D, 2007, CLIN MICROBIOL INFEC, V13, P298, DOI 10.1111/j.1469-0691.2006.01634.x; Duerden BI, 2011, ANAEROBE, V17, P175, DOI 10.1016/j.anaerobe.2010.12.004; Elliott B, 2011, J MED MICROBIOL, V60, P1108, DOI 10.1099/jmm.0.031062-0; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Guerrero DM, 2012, AM J INFECT CONTROL, V40, P556, DOI 10.1016/j.ajic.2011.08.002; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Huang H, 2009, CLIN MICROBIOL INFEC, V15, P1170, DOI 10.1111/j.1469-0691.2009.02992.x; KAMIYA S, 1989, J MED MICROBIOL, V28, P217, DOI 10.1099/00222615-28-3-217; Kim H, 2008, J CLIN MICROBIOL, V46, P1116, DOI 10.1128/JCM.01188-07; Kim H, 2010, KOREAN J LAB MED, V30, P491, DOI 10.3343/kjlm.2010.30.5.491; Kim J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-109; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; NERANDZIC MM, 2012, INFECT IMMUN, V80, P2704; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Ogura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r138; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; PETRELLA LA, 2012, DECREASED CURE INCRE; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Steiner TS, 1997, CLIN DIAGN LAB IMMUN, V4, P719, DOI 10.1128/CDLI.4.6.719-722.1997; Stoesser N, 2011, J CLIN MICROBIOL, V49, P3994, DOI 10.1128/JCM.05349-11; Vesteinsdottir I, 2012, EUR J CLIN MICROBIOL, V31, P2601, DOI 10.1007/s10096-012-1603-0; Villano SA, 2012, ANTIMICROB AGENTS CH, V56, P5224, DOI 10.1128/AAC.00913-12; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1; Wilcox MH, 1996, J HOSP INFECT, V34, P23, DOI 10.1016/S0195-6701(96)90122-X	47	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64121	10.1371/journal.pone.0064121	http://dx.doi.org/10.1371/journal.pone.0064121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704976	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000319330200118
J	Jeong, YH; Park, CH; Jang, GH; Jeong, YI; Hwang, IS; Jeong, YW; Kim, YK; Shin, T; Kim, NH; Hyun, SH; Jeung, EB; Hwang, WS				Jeong, Young-Hee; Park, Chi-Hun; Jang, Gun-Hyuk; Jeong, Yeun-Ik; Hwang, In-Sung; Jeong, Yeon-woo; Kim, Yu-Kyung; Shin, Taeyoung; Kim, Nam-Hyung; Hyun, Sang-Hwan; Jeung, Eui-Bae; Hwang, Woo-Suk			Production of Multiple Transgenic Yucatan Miniature Pigs Expressing Human Complement Regulatory Factors, Human CD55, CD59, and H-Transferase Genes	PLOS ONE			English	Article							EX-VIVO MODEL; HUMAN ALPHA-1,2-FUCOSYL-TRANSFERASE; HUMAN DAF; XENOTRANSPLANTATION; KNOCKOUT; COMBINATION; GENERATION; PROTEINS; SURVIVAL; VECTORS	The present study was conducted to generate transgenic pigs coexpressing human CD55, CD59, and H-transferase (HT) using an IRES-mediated polycistronic vector. The study focused on hyperacute rejection (HAR) when considering clinical xenotransplantation as an alternative source for human organ transplants. In total, 35 transgenic cloned piglets were produced by somatic cell nuclear transfer (SCNT) and were confirmed for genomic integration of the transgenes from umbilical cord samples by PCR analysis. Eighteen swine umbilical vein endothelial cells (SUVEC) were isolated from umbilical cord veins freshly obtained from the piglets. We observed a higher expression of transgenes in the transgenic SUVEC (Tg SUVEC) compared with the human umbilical vein endothelial cells (HUVEC). Among these genes, HT and hCD59 were expressed at a higher level in the tested Tg organs compared with non-Tg control organs, but there was no difference in hCD55 expression between them. The transgenes in various organs of the Tg clones revealed organ-specific and spatial expression patterns. Using from 0 to 50% human serum solutions, we performed human complement-mediated cytolysis assays. The results showed that, overall, the Tg SUVEC tested had greater survival rates than did the non-Tg SUVEC, and the Tg SUVEC with higher HT expression levels tended to have more down-regulated alpha-Gal epitope expression, resulting in greater protection against cytotoxicity. By contrast, several Tg SUVEC with low CD55 expression exhibited a decreased resistance response to cytolysis. These results indicated that the levels of HT expression were inversely correlated with the levels of alpha-Gal epitope expression and that the combined expression of hCD55, hCD59, and HT proteins in SUVECs markedly enhances a protective response to human serum-mediated cytolysis. Taken together, these results suggest that combining a polycistronic vector system with SCNT methods provides a fast and efficient alternative for the generation of transgenic large animals with multiple genetic modifications.	[Jeong, Young-Hee; Park, Chi-Hun; Jang, Gun-Hyuk; Jeong, Yeun-Ik; Hwang, In-Sung; Jeong, Yeon-woo; Kim, Yu-Kyung; Shin, Taeyoung; Hwang, Woo-Suk] Sooam Biotech Res Fdn, Seoul, South Korea; [Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Hyun, Sang-Hwan; Jeung, Eui-Bae] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea	Chungbuk National University; Chungbuk National University	Hwang, WS (corresponding author), Sooam Biotech Res Fdn, Seoul, South Korea.	hwangws@sooam.org	Park, Chi-Hun/J-1258-2019	Park, Chi-Hun/0000-0002-7618-9028	Next-Generation BioGreen 21 Program Rural Development Administration, Republic of Korea [PJ00832303]	Next-Generation BioGreen 21 Program Rural Development Administration, Republic of Korea	This work was supported by a grant of Next-Generation BioGreen 21 Program (No. PJ00832303) Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; BRENNER P, 2000, TRANSPL INT S1, V1, pS508; Bucher P, 2005, TRANSPL INT, V18, P894, DOI 10.1111/j.1432-2277.2005.00124.x; Byrne G, 1997, TRANSPLANTATION, V63, P149, DOI 10.1097/00007890-199701150-00027; Candotti F, 2000, CANCER GENE THER, V7, P574, DOI 10.1038/sj.cgt.7700153; CARRINGTON CA, 1995, TRANSPLANT P, V27, P321; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chen CG, 1998, TRANSPLANTATION, V65, P832, DOI 10.1097/00007890-199803270-00011; CHENG L, 1993, P NATL ACAD SCI USA, V90, P4455, DOI 10.1073/pnas.90.10.4455; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Costa C, 2002, XENOTRANSPLANTATION, V9, P45, DOI 10.1034/j.1399-3089.2002.0o142.x; Cowan PJ, 1998, TRANSPLANTATION, V65, P826, DOI 10.1097/00007890-199803270-00010; Cowan PJ, 2000, TRANSPLANTATION, V69, P2504, DOI 10.1097/00007890-200006270-00008; COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964; Deng W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019986; Diamond LE, 2001, TRANSPLANTATION, V71, P132, DOI 10.1097/00007890-200101150-00021; Diamond LE, 1996, TRANSPLANTATION, V61, P1241, DOI 10.1097/00007890-199604270-00021; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Knosalla C, 2009, AM J TRANSPLANT, V9, P1006, DOI 10.1111/j.1600-6143.2009.02602.x; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; LANGFORD GA, 1994, TRANSPLANT P, V26, P1400; Lee JH, 2006, TRANSPL P, V38, P1618, DOI 10.1016/j.transproceed.2006.02.129; Li SZ, 2009, XENOTRANSPLANTATION, V16, P27, DOI 10.1111/j.1399-3089.2009.00509.x; Liu BQ, 2008, SCI CHINA SER C, V51, P199, DOI 10.1007/s11427-008-0019-7; Menoret S, 2004, TRANSPLANTATION, V77, P1468, DOI 10.1097/01.TP.0000111758.35048.EA; Niemann H, 2000, ANIM REPROD SCI, V60, P277, DOI 10.1016/S0378-4320(00)00091-9; Park CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051398; Petersen B, 2009, COMP IMMUNOL MICROB, V32, P91, DOI 10.1016/j.cimid.2007.11.014; Pizzato M, 1998, GENE THER, V5, P1003, DOI 10.1038/sj.gt.3300670; Prather RS, 2008, BIOTECHNOL GENET ENG, V25, P245; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Ramirez P, 2000, TRANSPLANTATION, V70, P989, DOI 10.1097/00007890-200010150-00001; SANDRIN MS, 1995, NAT MED, V1, P1261, DOI 10.1038/nm1295-1261; Sprangers B, 2008, KIDNEY INT, V74, P14, DOI 10.1038/ki.2008.135; Tseng YL, 2005, TRANSPLANTATION, V80, P1493, DOI 10.1097/01.tp.0000181397.41143.fa; Zhou CY, 2005, XENOTRANSPLANTATION, V12, P142, DOI 10.1111/j.1399-3089.2005.00209.x	45	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63241	10.1371/journal.pone.0063241	http://dx.doi.org/10.1371/journal.pone.0063241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704897	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200026
J	Kenyon, C; Buyze, J; Colebunders, R				Kenyon, Chris; Buyze, Jozefien; Colebunders, Robert			HIV Prevalence by Race Co-Varies Closely with Concurrency and Number of Sex Partners in South Africa	PLOS ONE			English	Article							CAPE-TOWN; HEALTH; RISK; DIFFERENTIALS; POPULATION; BEHAVIORS; EPIDEMICS; TALE; MEN	Background: HIV prevalence differs by more than an order of magnitude between South Africa's racial groups. Comparing the sexual behaviors and other risk factors for HIV transmission between the different races may shed light on the determinants of South Africa's generalized HIV epidemic. Methods: Five nationally representative and one city-representative population-based surveys of sexual behavior were used to assess the extent to which various risk factors co-varied with HIV prevalence by race in South Africa. Results: In 2004, the prevalence of HIV was 0.5%, 1%, 3.2% and 19.9% in 15-49 year old whites, Indians, coloureds and blacks respectively. The risk factors which co-varied with HIV prevalence by race in the six surveys were age of sexual debut (in five out of five surveys for men and three out of six surveys for women), age gap (zero surveys in men and three in women), mean number of sex partners in the previous year (five surveys in men and three in women) and concurrent partnerships (five surveys in men and one in women). Condom usage and circumcision were both more prevalent in the high HIV prevalence groups. The reported prevalence of concurrency was 6 to 17 times higher in the black as opposed to the white men in the five surveys. Conclusions: The differences in sexual behavior in general, and the prevalence of concurrency and the number of sexual partners in particular, offer a plausible and parsimonious cause to explain a part of the differing prevalences of HIV between South Africa's racial groups.	[Kenyon, Chris] Inst Trop Med, HIV STD Unit, B-2000 Antwerp, Belgium; [Kenyon, Chris] Univ Cape Town, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Buyze, Jozefien] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Clin HIV STI Unit, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Cape Town; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Kenyon, C (corresponding author), Inst Trop Med, HIV STD Unit, B-2000 Antwerp, Belgium.	chriskenyon0@gmail.com	Buyze, Jozefien/B-8550-2014	Buyze, Jozefien/0000-0001-6780-380X; Kenyon, Chris/0000-0002-2557-8998				[Anonymous], 2009, CONS CONC SEX PARTN; Badri M, 2010, S AFRICAN J HIV MED, V10, P29; BIGGAR RJ, 1992, AM J PUBLIC HEALTH, V82, P1506, DOI 10.2105/AJPH.82.11.1506; Buve A, 2012, AIDS, V26, P1203, DOI 10.1097/QAD.0b013e328353bc36; Colvin M, 2007, KWAZULU NATAL HIV IM; Delate R, 2010, 2 NAT HIV COMM SURV; Department of Health, 1999, S AFR DEM HLTH SURV; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Epstein H, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-13; Fraser-Hurt N., 2011, HIV EPIDEMIC S AFRIC, DOI [10/3589/7038.pdf?sequence=1&isAllowed=y, DOI 10/3589/7038.PDF?SEQUENCE=1&ISALLOWED=Y]; Glynn JR, 2012, AIDS, V26, P977, DOI 10.1097/QAD.0b013e328350fc1f; Gourvenec D, 2009, 5 IAS C CAP TOWN; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; HEAIDS, 2010, HIV PREV REL FACT HI; Helleringer S, 2011, AIDS, V25, P503, DOI 10.1097/QAD.0b013e3283434485; Johnson LF, 2009, AIDS, V23, P1583, DOI 10.1097/QAD.0b013e32832d407e; Kenyon C, 2013, INT J INFECT DIS, V17, pE286, DOI 10.1016/j.ijid.2012.12.020; Kenyon C, 2012, INT J INFECT DIS, V16, pE826, DOI 10.1016/j.ijid.2012.05.008; Kenyon C, 2012, J ADOLESCENT HEALTH, V50, P208, DOI 10.1016/j.jadohealth.2011.09.016; Kenyon C, 2010, S AFR J HIV MED, P22; Kenyon C, 2009, AJAR-AFR J AIDS RES, V8, P243, DOI 10.2989/AJAR.2009.8.3.1.922; Kirby D, 2008, SEX TRANSM INFECT, V84, pII35, DOI 10.1136/sti.2008.029892; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lam D, 2006, CAPE AREA PANEL STUD; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Leclerc-Madlala S, 2009, SEX HEALTH, V6, P103, DOI 10.1071/SH08032; Mah TL, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-33; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Maughan-Brown B, 2013, SEXUAL HLTH IN PRESS; Maughan-Brown B, 2012, SEX TRANSM DIS, V39, P537, DOI 10.1097/OLQ.0b013e31824cc0c1; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2011, J ADOLESCENT HEALTH, V49, P237, DOI 10.1016/j.jadohealth.2010.10.002; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; Shisana O, 2002, S AFRICAN NATL HIV P; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O, 2009, S AFRICAN NATL HIV P; Smith M. K., 2002, Gender and Development, V10, P63, DOI 10.1080/13552070215914; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8	46	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64080	10.1371/journal.pone.0064080	http://dx.doi.org/10.1371/journal.pone.0064080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704973	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200112
J	Kim, J; Buckett, PD; Wessling-Resnick, M				Kim, Jonghan; Buckett, Peter D.; Wessling-Resnick, Marianne			Absorption of Manganese and Iron in a Mouse Model of Hemochromatosis	PLOS ONE			English	Article							HFE-DEFICIENT MICE; HEREDITARY HEMOCHROMATOSIS; OLFACTORY TRANSPORT; METAL-TRANSPORTER; DIETARY IRON; RAT-BRAIN; EXPRESSION; MUTATION; LIVER; FERROPORTIN	Hereditary hemochromatosis, an iron overload disease associated with excessive intestinal iron absorption, is commonly caused by loss of HFE gene function. Both iron and manganese absorption are regulated by iron status, but the relationships between the transport pathways of these metals and how they are affected by HFE-associated hemochromatosis remain poorly understood. Loss of HFE function is known to alter the intestinal expression of DMT1 (divalent metal transporter-1) and Fpn (ferroportin), transporters that have been implicated in absorption of both iron and manganese. Although the influence of HFE deficiency on dietary iron absorption has been characterized, potential effects on manganese metabolism have yet to be explored. To investigate the role of HFE in manganese absorption, we characterized the uptake and distribution of the metal in Hfe(-/-) knockout mice after intravenous, intragastric, and intranasal administration of Mn-54. These values were compared to intravenous and intragastric administration of Fe-59. Intestinal absorption of Fe-59 was increased and clearance of injected Fe-59 was also increased in Hfe(-/-) mice compared to controls. Hfe(-/-) mice displayed greater intestinal absorption of Mn-54 compared to wild-type Hfe(+/+) control mice. After intravenous injection, the distribution of Fe-59 to heart and liver was greater in Hfe(-/-) mice but no remarkable differences were observed for Mn-54. Although olfactory absorption of Mn-54 into blood was unchanged in Hfe(-/-) mice, higher levels of intranasally-instilled Mn-54 were associated with Hfe(-/-) brain compared to controls. These results show that manganese transport and metabolism can be modified by HFE deficiency.	[Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Kim, Jonghan; Buckett, Peter D.; Wessling-Resnick, Marianne] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Northeastern University; Harvard University; Harvard T.H. Chan School of Public Health	Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.	j.kim@neu.edu; wessling@hsph.harvard.edu			NIH [R03 DA027030, K99/R00 ES017781, P30 ES000002]; Yerby Fellowship from the Harvard School of Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES017781, R01ES014638, P30ES000002, R00ES017781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerby Fellowship from the Harvard School of Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants R03 DA027030 (MWR) and K99/R00 ES017781 and P30 ES000002 (JK) from the NIH and the Yerby Fellowship from the Harvard School of Public Health (JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Andersen ME, 1999, NEUROTOXICOLOGY, V20, P161; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; BARBEAU A, 1984, NEUROTOXICOLOGY, V5, P13; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; BONILLA E, 1984, EXP NEUROL, V84, P696, DOI 10.1016/0014-4886(84)90216-4; Bradley LA, 1998, J MED SCREEN, V5, P34, DOI 10.1136/jms.5.1.34; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chaudhury C, 2006, J NUTR, V136, P2993, DOI 10.1093/jn/136.12.2993; Chua ACG, 1996, BIOL TRACE ELEM RES, V55, P39, DOI 10.1007/BF02784167; COTZIAS GC, 1958, PHYSIOL REV, V38, P503, DOI 10.1152/physrev.1958.38.3.503; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; DONALDSON J, 1987, NEUROTOXICOLOGY, V8, P451; Dorman DC, 2002, J TOXICOL ENV HEAL A, V65, P1493, DOI 10.1080/00984100290071630; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Griffiths WJH, 2001, GASTROENTEROLOGY, V120, P1420, DOI 10.1053/gast.2001.24050; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haynes EN, 2010, NEUROTOXICOLOGY, V31, P468, DOI 10.1016/j.neuro.2009.10.011; Henn BC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-97; Herrmann T, 2004, J MOL MED, V82, P39, DOI 10.1007/s00109-003-0508-x; Hojyo S, 2013, HAEMATOLOGICA; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033533; Kim J, 2011, AM J PHYSIOL-LUNG C, V300, pL659, DOI 10.1152/ajplung.00343.2010; Kumara VMR, 2012, AM J PHYSIOL-LUNG C, V302, pL1280, DOI 10.1152/ajplung.00004.2012; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Li L, 2011, BIOL TRACE ELEM RES, V143, P1581, DOI 10.1007/s12011-011-8967-3; Lucchini R, 1997, ENVIRON RES, V73, P175, DOI 10.1006/enrs.1997.3702; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Merryweather-Clarke AT, 2000, GENET TEST, V4, P183, DOI 10.1089/10906570050114902; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nong A, 2008, J TOXICOL ENV HEAL A, V71, P413, DOI 10.1080/15287390701838697; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Rodrigues P, 2006, INT J EXP PATHOL, V87, P317, DOI 10.1111/j.1365-2613.2006.00491.x; Roels HA, 2012, NEUROTOXICOLOGY, V33, P872, DOI 10.1016/j.neuro.2012.03.009; Rolfs A, 2002, AM J PHYSIOL-GASTR L, V282, pG598, DOI 10.1152/ajpgi.00371.2001; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Simpson RJ, 2003, GUT, V52, P510, DOI 10.1136/gut.52.4.510; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; Tran TT, 2002, NEUROTOXICOLOGY, V23, P645, DOI 10.1016/S0161-813X(02)00068-2; Trinder D, 2002, P NATL ACAD SCI USA, V99, P5622, DOI 10.1073/pnas.082112299; Turoczi T, 2003, CIRC RES, V92, P1240, DOI 10.1161/01.RES.0000076890.59807.23; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0; Zoller H, 2001, GASTROENTEROLOGY, V120, P1412, DOI 10.1053/gast.2001.24033	63	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64944	10.1371/journal.pone.0064944	http://dx.doi.org/10.1371/journal.pone.0064944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705020	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200174
J	Koritzer, J; Boxhammer, V; Schafer, A; Shimizu, T; Klampfl, TG; Li, YF; Welz, C; Schwenk-Zieger, S; Morfill, GE; Zimmermann, JL; Schlegel, J				Koeritzer, Julia; Boxhammer, Veronika; Schaefer, Andrea; Shimizu, Tetsuji; Klaempfl, Tobias G.; Li, Yang-Fang; Welz, Christian; Schwenk-Zieger, Sabina; Morfill, Gregor E.; Zimmermann, Julia L.; Schlegel, Juergen			Restoration of Sensitivity in Chemo - Resistant Glioma Cells by Cold Atmospheric Plasma	PLOS ONE			English	Article							NONTHERMAL PLASMA; ADJUVANT TEMOZOLOMIDE; PROMOTER METHYLATION; MELANOMA-CELLS; METHYLTRANSFERASE; GLIOBLASTOMA; MGMT; DECONTAMINATION; CHEMORESISTANCE; INACTIVATION	Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Despite multimodal treatments including surgery, chemotherapy and radiotherapy the prognosis remains poor and relapse occurs regularly. The alkylating agent temozolomide (TMZ) has been shown to improve the overall survival in patients with malignant gliomas, especially in tumors with methylated promoter of the O6-methylguanine-DNA-methyltransferase (MGMT) gene. However, intrinsic and acquired resistance towards TMZ makes it crucial to find new therapeutic strategies aimed at improving the prognosis of patients suffering from malignant gliomas. Cold atmospheric plasma is a new auspicious candidate in cancer treatment. In the present study we demonstrate the anti-cancer properties of different dosages of cold atmospheric plasma (CAP) both in TMZ-sensitive and TMZ-resistant cells by proliferation assay, immunoblotting, cell cycle analysis, and clonogenicity assay. Importantly, CAP treatment restored the responsiveness of resistant glioma cells towards TMZ therapy. Concomitant treatment with CAP and TMZ led to inhibition of cell growth and cell cycle arrest, thus CAP might be a promising candidate for combination therapy especially for patients suffering from GBMs showing an unfavorable MGMT status and TMZ resistance.	[Koeritzer, Julia; Boxhammer, Veronika; Shimizu, Tetsuji; Klaempfl, Tobias G.; Li, Yang-Fang; Morfill, Gregor E.; Zimmermann, Julia L.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Schaefer, Andrea; Schlegel, Juergen] Tech Univ Munich, Dept Neuropathol, D-80290 Munich, Germany; [Welz, Christian; Schwenk-Zieger, Sabina] Univ Munich, Dept Head & Neck Canc, Munich, Germany	Max Planck Society; Technical University of Munich; University of Munich	Koritzer, J (corresponding author), Max Planck Inst Extraterr Phys, D-85748 Garching, Germany.	koeritzer@mpe.mpg.de	Shimizu, Tetsuji/L-1478-2018	Shimizu, Tetsuji/0000-0001-9432-1152; Schlegel, Jurgen/0000-0002-5544-2717; Li, Yangfang/0000-0002-5346-3741	Max Planck Institute for Extraterrestrial Physics, Garching, Germany [M.TT.A.EXT00002]	Max Planck Institute for Extraterrestrial Physics, Garching, Germany	The work was supported by the grant (M.TT.A.EXT00002) of the Max Planck Institute for Extraterrestrial Physics, Garching, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Baxter HC, 2005, J GEN VIROL, V86, P2393, DOI 10.1099/vir.0.81016-0; Baxter HC, 2006, IEEE T PLASMA SCI, V34, P1337, DOI 10.1109/TPS.2006.878387; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Bobola MS, 1996, CLIN CANCER RES, V2, P735; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Carmo A, 2011, ONCOL LETT, V2, P1165, DOI 10.3892/ol.2011.406; Danson S J, 2001, Expert Rev Anticancer Ther, V1, P13, DOI 10.1586/14737140.1.1.13; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Hahnel M, 2010, PLASMA PROCESS POLYM, V7, P244, DOI 10.1002/ppap.200900076; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Isbary G, 2012, BR J DERMATOL; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11; Morfill GE, 2009, NEW J PHYS, V11; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shimizu T, 2012, APPL ENV MICROBIOL; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vandamme M, 2011, INT J CANC; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; Weiler M, 2010, INT J RADIAT ONCOL, V77, P670, DOI 10.1016/j.ijrobp.2009.05.031; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Whittaker AG, 2004, J HOSP INFECT, V56, P37, DOI 10.1016/j.jhin.2003.09.019; Zhang JH, 2010, ONCOLOGY-BASEL, V78, P103, DOI 10.1159/000306139; Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	41	152	156	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64498	10.1371/journal.pone.0064498	http://dx.doi.org/10.1371/journal.pone.0064498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704990	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200144
J	Lloyd, MW; Campbell, L; Neel, MC				Lloyd, Michael W.; Campbell, Lesley; Neel, Maile C.			The Power to Detect Recent Fragmentation Events Using Genetic Differentiation Methods	PLOS ONE			English	Article							ENDEMIC ASTRAGALUS-BIBULLATUS; HABITAT FRAGMENTATION; POPULATION-STRUCTURE; SEED BANK; FOREST FRAGMENTATION; PATCH SIZE; F-ST; LANDSCAPE CONNECTIVITY; DIVERSITY; PLANT	Habitat loss and fragmentation are imminent threats to biological diversity worldwide and thus are fundamental issues in conservation biology. Increased isolation alone has been implicated as a driver of negative impacts in populations associated with fragmented landscapes. Genetic monitoring and the use of measures of genetic divergence have been proposed as means to detect changes in landscape connectivity. Our goal was to evaluate the sensitivity of Wright's F-st, Hedrick' G'(st), Sherwin's MI, and Jost's D to recent fragmentation events across a range of population sizes and sampling regimes. We constructed an individual-based model, which used a factorial design to compare effects of varying population size, presence or absence of overlapping generations, and presence or absence of population sub-structuring. Increases in population size, overlapping generations, and population sub-structuring each reduced F-st, G'(st), MI, and D. The signal of fragmentation was detected within two generations for all metrics. However, the magnitude of the change in each was small in all cases, and when Ne was >100 individuals it was extremely small. Multi-generational sampling and population estimates are required to differentiate the signal of background divergence from changes in F-st, G'(st), MI, and D associated with fragmentation. Finally, the window during which rapid change in F-st, G'(st), MI, and D between generations occurs can be small, and if missed would lead to inconclusive results. For these reasons, use of F-st, G'(st), MI, or D for detecting and monitoring changes in connectivity is likely to prove difficult in real-world scenarios. We advocate use of genetic monitoring only in conjunction with estimates of actual movement among patches such that one could compare current movement with the genetic signature of past movement to determine there has been a change.	[Lloyd, Michael W.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Lloyd, MW (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	mlloyd13@umd.edu	Campbell, Lesley G/G-5866-2012; Lloyd, Michael/C-8430-2017	Campbell, Lesley G/0000-0002-6263-5170; Lloyd, Michael/0000-0003-1021-8129				ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2006, CONNECTIVITY CONSERV, DOI DOI 10.1017/CBO9780511754821.001; Avise J.C., 2004, MOL MARKERS NATURAL; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Barrett LG, 2005, MOL ECOL, V14, P4169, DOI 10.1111/j.1365-294X.2005.02726.x; Baskauf CJ, 1998, ANN MO BOT GARD, V85, P90, DOI 10.2307/2991999; Bazinet AL, 2007, FUTURE GENER COMP SY, V23, P517, DOI 10.1016/j.future.2006.07.009; Belisle M, 2002, CONSERV ECOL, V5; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Bowers MA, 1999, LANDSCAPE ECOL, V14, P381, DOI 10.1023/A:1008014426117; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Bruna EM, 2005, ECOLOGY, V86, P1816, DOI 10.1890/04-1716; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2003, ECOGRAPHY, V26, P692, DOI 10.1034/j.1600-0587.2003.03525.x; Bullock JM, 2004, ACTA OECOL, V25, P35, DOI 10.1016/j.actao.2003.10.005; Burkey Tormod V., 2006, Songklanakarin Journal of Science and Technology, V28, P9; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Cale PG, 2003, BIOL CONSERV, V109, P237, DOI 10.1016/S0006-3207(02)00152-0; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Coates DJ, 2001, BIOL CONSERV, V97, P251, DOI 10.1016/S0006-3207(00)00123-3; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Diniz JAF, 2002, CONSERV BIOL, V16, P924, DOI 10.1046/j.1523-1739.2002.00295.x; Dooley JL, 1998, ECOLOGY, V79, P969, DOI 10.1890/0012-9658(1998)079[0969:DRTHFE]2.0.CO;2; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; England PR, 2010, CONSERV GENET, V11, P2425, DOI 10.1007/s10592-010-0112-x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 1998, ECOSYSTEMS, V1, P197, DOI 10.1007/s100219900015; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; Fox LR, 2006, PLANT ECOL, V183, P157, DOI 10.1007/s11258-005-9014-2; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; GUSTAFSON EJ, 1994, LANDSCAPE URBAN PLAN, V29, P117, DOI 10.1016/0169-2046(94)90022-1; Hall P, 1996, CONSERV BIOL, V10, P757, DOI 10.1046/j.1523-1739.1996.10030757.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hanfling B, 2004, CONSERV GENET, V5, P247, DOI 10.1023/B:COGE.0000030008.20492.2c; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hoffman EA, 2004, MOL ECOL, V13, P271, DOI 10.1046/j.1365-294X.2003.02057.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hovel KA, 2001, ECOLOGY, V82, P1814; Ims RA, 1999, J ANIM ECOL, V68, P839, DOI 10.1046/j.1365-2656.1999.00336.x; Jaeger JAG, 2000, LANDSCAPE ECOL, V15, P115, DOI 10.1023/A:1008129329289; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Jules ES, 1998, ECOLOGY, V79, P1645, DOI 10.1890/0012-9658(1998)079[1645:HFADCF]2.0.CO;2; Kahmen S, 2008, ANN BOT-LONDON, V101, P541, DOI 10.1093/aob/mcm311; Kalamees R, 1997, FOLIA GEOBOT PHYTOTX, V32, P1, DOI 10.1007/BF02803879; KELLY D, 1989, J ECOL, V77, P785, DOI 10.2307/2260985; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; KIMURA M, 1963, EVOLUTION, V17, P279, DOI 10.2307/2406157; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Krauss J, 2004, MOL ECOL, V13, P311, DOI 10.1046/j.1365-294X.2003.02072.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li WX, 2008, J PARASITOL, V94, P643, DOI 10.1645/GE-1034.1; Matern A, 2009, CONSERV GENET, V10, P391, DOI 10.1007/s10592-008-9606-1; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; McGarigal K., 2002, FRAGSTATS SPATIAL PA; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meldgaard T, 2003, CONSERV GENET, V4, P735, DOI 10.1023/B:COGE.0000006115.14106.de; Meyer CFJ, 2009, BIOTROPICA, V41, P95, DOI 10.1111/j.1744-7429.2008.00443.x; Morris AB, 2002, AM J BOT, V89, P29, DOI 10.3732/ajb.89.1.29; Myers DS, 2008, GRID COMPUTING FOR BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P71; Myers DS, 2003, J PARALLEL DISTR COM, V63, P578, DOI 10.1016/S0743-7315(03)00004-2; Neel MC, 2004, LANDSCAPE ECOL, V19, P435, DOI 10.1023/B:LAND.0000030521.19856.cb; NEI M, 1978, GENETICS, V89, P583; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Nunney L, 2002, AM NAT, V160, P195, DOI 10.1086/341017; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Parker M, 2002, BIOL CONSERV, V105, P217, DOI 10.1016/S0006-3207(01)00184-7; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Patten MA, 2005, EVOL ECOL RES, V7, P235; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Robledo-Arnuncio JJ, 2006, GENETICS, V173, P1033, DOI 10.1534/genetics.105.052035; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Saura S, 2001, PHOTOGRAMM ENG REM S, V67, P1027; Schiller JR, 2000, WETLANDS, V20, P386, DOI 10.1672/0277-5212(2000)020[0386:TEODDI]2.0.CO;2; Schumaker NH, 1996, ECOLOGY, V77, P1210, DOI 10.2307/2265590; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Taylor PD, 2006, CONNECTIVITY CONSERV, P29, DOI DOI 10.1017/CBO9780511754821.003; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Urban DL, 2005, ECOLOGY, V86, P1996, DOI 10.1890/04-0918; Vitalis R, 2004, AM NAT, V163, P295, DOI 10.1086/381041; Wallace L.E., 2002, PLANT SPEC BIOL, V17, P37; Walters CJ, 1986, ADAPTIVE MANAGEMENT, Vx; Waples RS, 2002, GENETICS, V161, P783; Weber MHW, 2008, DISTRIBUTED GRID COM, P71; Weekley CW, 2007, CAN J BOT, V85, P621, DOI 10.1139/B07-061; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Whittaker JC, 2003, GENETICS, V164, P781; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wunsch M, 1998, MAR ECOL PROG SER, V169, P277, DOI 10.3354/meps169277; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 1999, CONSERV BIOL, V13, P256, DOI 10.1046/j.1523-1739.1999.013002256.x; YOUNG AG, 1994, HEREDITY, V72, P201, DOI 10.1038/hdy.1994.27; ZAMMIT C, 1990, OECOLOGIA, V84, P24, DOI 10.1007/BF00665590	141	18	18	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63981	10.1371/journal.pone.0063981	http://dx.doi.org/10.1371/journal.pone.0063981			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704965	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200097
J	Ma, XF; Liu, P; Yan, H; Sun, H; Liu, XY; Zhou, F; Li, L; Chen, Y; Muthana, MM; Chen, X; Wang, PG; Zhang, LW				Ma, Xiaofeng; Liu, Pi; Yan, Hui; Sun, Hong; Liu, Xiaoyan; Zhou, Feng; Li, Lei; Chen, Yi; Muthana, Musleh M.; Chen, Xi; Wang, Peng G.; Zhang, Lianwen			Substrate Specificity Provides Insights into the Sugar Donor Recognition Mechanism of O-GlcNAc Transferase (OGT)	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; MODIFIED PROTEINS; REPEAT DOMAIN; CROSS-TALK; NUCLEAR; GLYCOSYLATION; GLCNACYLATION; EXPRESSION; ROLES	O-Linked beta-N-acetylglucosaminyl transferase (OGT) plays an important role in the glycosylation of proteins, which is involved in various cellular events. In human, three isoforms of OGT (short OGT [sOGT]; mitochondrial OGT [mOGT]; and nucleocytoplasmic OGT [ncOGT]) share the same catalytic domain, implying that they might adopt a similar catalytic mechanism, including sugar donor recognition. In this work, the sugar-nucleotide tolerance of sOGT was investigated. Among a series of uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) analogs tested using the casein kinase II (CKII) peptide as the sugar acceptor, four compounds could be used by sOGT, including UDP-6-deoxy-GlcNAc, UDP-GlcNPr, UDP-6-deoxy-GalNAc and UDP-4-deoxy-GlcNAc. Determined values of Km showed that the substitution of the N-acyl group, deoxy modification of C6/C4-OH or epimerization of C4-OH of the GlcNAc in UDP-GlcNAc decreased its affinity to sOGT. A molecular docking study combined with site-directed mutagenesis indicated that the backbone carbonyl oxygen of Leu653 and the hydroxyl group of Thr560 in sOGT contributed to the recognition of the sugar moiety via hydrogen bonds. The close vicinity between Met501 and the N-acyl group of GlcNPr, as well as the hydrophobic environment near Met501, were responsible for the selective binding of UDP-GlcNPr. These findings illustrate the interaction of OGT and sugar nucleotide donor, providing insights into the OGT catalytic mechanism.	[Ma, Xiaofeng; Liu, Pi; Yan, Hui; Sun, Hong; Liu, Xiaoyan; Zhou, Feng; Li, Lei; Wang, Peng G.; Zhang, Lianwen] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ma, Xiaofeng; Liu, Pi; Yan, Hui; Sun, Hong; Liu, Xiaoyan; Zhou, Feng; Li, Lei; Wang, Peng G.; Zhang, Lianwen] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Chen, Yi; Muthana, Musleh M.; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Nankai University; Nankai University; University of California System; University of California Davis	Wang, PG (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	pwang@nankai.edu.cn; lianwen@nankai.edu.cn	WANG, Peng/GSN-5263-2022; Chen, Xi/H-1811-2018	Chen, Xi/0000-0002-3160-614X	National Basic Research Program of China (973 Program) [2012CB910300]; National Natural Science Foundation of China [30970644]; National Institutes of Health (NIH) [R01HD065122]; National Science Foundation (NSF) [CHE-1012511]; Division Of Chemistry [1012511] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065122] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Basic Research Program of China (973 Program, grant No. 2012CB910300) (to Peng George Wang), National Natural Science Foundation of China (30970644) (to Lianwen Zhang), National Institutes of Health (NIH) grant R01HD065122 and National Science Foundation (NSF) grant CHE-1012511 (to Xi Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cai L, 2009, CHEM COMMUN, P2944, DOI 10.1039/b904853g; Chen Y, 2011, CHEM COMMUN, V47, P10815, DOI 10.1039/c1cc14034e; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Delano W. L., 2004, PYMOL USERS GUIDE; GRIFFITH LS, 1995, BIOCHEM BIOPH RES CO, V213, P424, DOI 10.1006/bbrc.1995.2149; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Gurcel C, 2008, ANAL BIOANAL CHEM, V390, P2089, DOI 10.1007/s00216-008-1950-y; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kanno T, 2010, NEUROCHEM RES, V35, P782, DOI 10.1007/s11064-010-0135-1; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mayer A, 2011, BIOORG MED CHEM LETT, V21, P1199, DOI 10.1016/j.bmcl.2010.12.090; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Morris G., 2012, USER GUIDE AUTODOCK; Muthana MM, 2012, CHEM COMMUN, V48, P2728, DOI 10.1039/c2cc17577k; Oliveira FG, 2006, BIOORGAN MED CHEM, V14, P6001, DOI 10.1016/j.bmc.2006.05.017; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	43	18	19	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63452	10.1371/journal.pone.0063452	http://dx.doi.org/10.1371/journal.pone.0063452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700425	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200041
J	Pena, MJR; Bennett, JVC; Soler, OM; Mayorga, LS; Michaut, MA				Rodriguez Pena, Marcelo J.; Castillo Bennett, Jimena V.; Soler, Osvaldo M.; Mayorga, Luis S.; Michaut, Marcela A.			MARCKS Protein Is Phosphorylated and Regulates Calcium Mobilization during Human Acrosomal Exocytosis	PLOS ONE			English	Article							C-KINASE-SUBSTRATE; CORTICAL F-ACTIN; RAB3A TRIGGERS; RELEASE; DEGRANULATION; PROGESTERONE; SPERMATOZOA; ACTIVATION; SECRETION; INTERPLAY	Acrosomal exocytosis is a calcium-regulated exocytosis that can be triggered by PKC activators. The involvement of PKC in acrosomal exocytosis has not been fully elucidated, and it is unknown if MARCKS, the major substrate for PKC, participates in this exocytosis. Here, we report that MARCKS is expressed in human spermatozoa and localizes to the sperm head and the tail. Calcium-and phorbol ester-triggered acrosomal exocytosis in permeabilized sperm was abrogated by different anti-MARCKS antibodies raised against two different domains, indicating that the protein participates in acrosomal exocytosis. Interestingly, an anti-phosphorylated MARCKS antibody was not able to inhibit secretion. Similar results were obtained using recombinant proteins and phospho-mutants of MARCKS effector domain (ED), indicating that phosphorylation regulates MARCKS function in acrosomal exocytosis. It is known that unphosphorylated MARCKS sequesters PIP2. This phospholipid is the precursor for IP3, which in turn triggers release of calcium from the acrosome during acrosomal exocytosis. We found that PIP2 and adenophostin, a potent IP3-receptor agonist, rescued MARCKS inhibition in permeabilized sperm, suggesting that MARCKS inhibits acrosomal exocytosis by sequestering PIP2 and, indirectly, MARCKS regulates the intracellular calcium mobilization. In non-permeabilized sperm, a permeable peptide of MARCKS ED also inhibited acrosomal exocytosis when stimulated by a natural agonist such as progesterone, and pharmacological inducers such as calcium ionophore and phorbol ester. The preincubation of human sperm with the permeable MARCKS ED abolished the increase in calcium levels caused by progesterone, demonstrating that MARCKS regulates calcium mobilization. In addition, the phosphorylation of MARCKS increased during acrosomal exocytosis stimulated by the same activators. Altogether, these results show that MARCKS is a negative modulator of the acrosomal exocytosis, probably by sequestering PIP2, and that it is phosphorylated during acrosomal exocytosis.	[Rodriguez Pena, Marcelo J.; Soler, Osvaldo M.; Michaut, Marcela A.] Univ Nacl Cuyo, Reprod Biol Lab, RA-5500 Mendoza, Argentina; [Rodriguez Pena, Marcelo J.; Castillo Bennett, Jimena V.; Soler, Osvaldo M.; Mayorga, Luis S.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Histol & Embriol, Lab Biol Celular & Mol, RA-5500 Mendoza, Argentina; [Michaut, Marcela A.] Univ Nacl Cuyo, Inst Ciencias Basicas, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza	Michaut, MA (corresponding author), Univ Nacl Cuyo, Reprod Biol Lab, RA-5500 Mendoza, Argentina.	mmichaut@gmail.com	Michaut, Marcela Alejandra/D-3725-2015	Michaut, Marcela Alejandra/0000-0002-0528-6605; Mayorga, Luis S/0000-0002-5995-0671; Castillo Bennett, Jimena/0000-0001-8651-7083	National Institutes of Health Research [R01 TW007571]; Fogarty International Center; Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas Y Tecnicas; Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Technologica, Argentina; CONICET, Argentina; Facultad de Ciencias Medicas, Universidad Nacional de Cuyo, Argentina; NIH/Fogarty Training Grant [5-D43TW00671]; FOGARTY INTERNATIONAL CENTER [R01TW007571, D43TW000671] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas Y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Technologica, Argentina; CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Facultad de Ciencias Medicas, Universidad Nacional de Cuyo, Argentina; NIH/Fogarty Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health Research Grant # R01 TW007571, funded by the Fogarty International Center, and Universidad Nacional de Cuyo grant to MAM, and grants from Consejo Nacional de Investigaciones Cientificas Y Tecnicas and Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Technologica, Argentina, to LSM and MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank A. Medero and M. Furlan for technical assistance; Dr. Claudia N. Tomes for critical reading of the manuscript, and Dr. Jae-Won Soh for MARCKS plasmid. M. R. P. and J. C. B. are thankful to CONICET, Argentina for fellowships. O. S. is thankful to Facultad de Ciencias Medicas, Universidad Nacional de Cuyo, Argentina for fellowship. M.A.M. is thankful to Dr. Karen Schindler, Dr. Carmen Williams, Dr. Richard Shultz, and NIH/Fogarty Training Grant 5-D43TW00671 for support in preparing MARCKS mutants at University of Pennsylvania, USA.	Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Belmonte SA, 2005, DEV BIOL, V285, P393, DOI 10.1016/j.ydbio.2005.07.001; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; DEJONGE CJ, 1991, J ANDROL, V12, P62; Doreian BW, 2009, MOL BIOL CELL, V20, P3142, DOI 10.1091/mbc.E09-03-0197; Elzagallaai A, 2001, BRIT J HAEMATOL, V112, P593, DOI 10.1046/j.1365-2141.2001.02642.x; Gadi D, 2011, MOL BIOL CELL, V22, P4908, DOI 10.1091/mbc.E11-07-0614; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Lopez CI, 2012, BBA-MOL CELL BIOL L, V1821, P1186, DOI 10.1016/j.bbalip.2012.05.001; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Mosevitsky M, 2011, ACTA HISTOCHEM, V113, P13, DOI 10.1016/j.acthis.2009.07.002; Mosevitsky MI, 2012, ACTA HISTOCHEM, V114, P237, DOI 10.1016/j.acthis.2011.06.009; O'Toole CMB, 1996, MOL HUM REPROD, V2, P921, DOI 10.1093/molehr/2.12.921; OSMAN RA, 1989, BIOCHEM BIOPH RES CO, V160, P828, DOI 10.1016/0006-291X(89)92508-4; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; ROLDAN ERS, 1994, BIOCHEM J, V297, P225, DOI 10.1042/bj2970225; Rose SD, 2001, J BIOL CHEM, V276, P36757, DOI 10.1074/jbc.M006518200; Salli U, 2003, BIOL REPROD, V69, P2053, DOI 10.1095/biolreprod.103.017640; Salli U, 2000, BIOL REPROD, V63, P12, DOI 10.1095/biolreprod63.1.12; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; SISTINA Y, 1993, J REPROD FERTIL, V99, P335; Suhaiman L, 2010, J BIOL CHEM, V285, P16302, DOI 10.1074/jbc.M109.072439; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Takashi S, 2006, AM J RESP CELL MOL, V34, P647, DOI 10.1165/rcmb.2006-0030RC; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Vazquez JM, 1997, MOL REPROD DEV, V48, P95, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;95::AID-MRD12&gt;3.0.CO;2-V; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Yanagimachi R., 1994, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166	48	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64551	10.1371/journal.pone.0064551	http://dx.doi.org/10.1371/journal.pone.0064551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704996	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200150
J	Zhang, S; Li, F; Younes, M; Liu, H; Chen, CY; Yao, QZ				Zhang, Sheng; Li, Feng; Younes, Mamoun; Liu, Hao; Chen, Changyi; Yao, Qizhi			Reduced Selenium-Binding Protein 1 in Breast Cancer Correlates with Poor Survival and Resistance to the Anti-Proliferative Effects of Selenium	PLOS ONE			English	Article							CELL-PROLIFERATION; EXPRESSION; ESTROGEN; CARCINOMA; CARCINOGENESIS; ASSOCIATION	Supplemental dietary selenium is associated with reduced incidence of many cancers. The antitumor function of selenium is thought to be mediated through selenium-binding protein 1 (SELENBP1). However, the significance of SELENBP1 expression in breast cancer is still largely unknown. A total of 95 normal and tumor tissues assay and 12 breast cancer cell lines were used in this study. We found that SELENBP1 expression in breast cancer tissues is reduced compared to normal control. Low SELENBP1 expression in ER+ breast cancer patients was significantly associated with poor survival (p<0.01), and SELENBP1 levels progressively decreased with advancing clinical stages of breast cancer. 17-beta estradiol (E2) treatment of high SELENBP1-expressing ER+ cell lines led to a down-regulation of SELENBP1, a result that did not occur in ER- cell lines. However, after ectopic expression of ER in an originally ER- cell line, down-regulation of SELENBP1 upon E2 treatment was observed. In addition, selenium treatment resulted in reduced cell proliferation in endogenous SELENBP1 high cells; however, after knocking-down SELENBP1, we observed no significant reduction in cell proliferation. Similarly, selenium has no effect on inhibition of cell proliferation in low endogenous SELENBP1 cells, but the inhibitory effect is regained following ectopic SELENBP1 expression. Furthermore, E2 treatment of an ER silenced high endogenous SELENBP1 expressing cell line showed no abolishment of cell proliferation inhibition upon selenium treatment. These data indicate that SELENBP1 expression is regulated via estrogen and that the cell proliferation inhibition effect of selenium treatment is dependent on the high level of SELENBP1 expression. Therefore, the expression level of SELENBP1 could be an important marker for predicting survival and effectiveness of selenium supplementation in breast cancer. This is the first study to reveal the importance of monitoring SELENBP1 expression as a potential biomarker in contributing to breast cancer prevention and treatment.	[Zhang, Sheng; Li, Feng; Chen, Changyi; Yao, Qizhi] Baylor Coll Med, Mol Surgeon Res Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Yao, Qizhi] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Younes, Mamoun] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Liu, Hao] Baylor Coll Med, Div Biostat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Yao, QZ (corresponding author), Baylor Coll Med, Mol Surgeon Res Ctr, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	qizhiyao@bcm.edu		Younes, Mamoun/0000-0001-9618-3451				ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; BANSAL MP, 1990, CARCINOGENESIS, V11, P2071, DOI 10.1093/carcin/11.11.2071; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Brown LM, 2006, MOL CARCINOGEN, V45, P613, DOI 10.1002/mc.20193; Chang PWG, 1997, J CELL BIOCHEM, V64, P217, DOI 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Giometti CS, 2000, ELECTROPHORESIS, V21, P2162; Gruvberger S, 2001, CANCER RES, V61, P5979; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jemal A, 2011, CA CANC J CLIN; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; KYPRIANOU N, 1991, CANCER RES, V51, P162; Lai TC, 2010, J PROTEOME RES, V9, P1302, DOI 10.1021/pr900825t; LANFEAR J, 1993, CARCINOGENESIS, V14, P335, DOI 10.1093/carcin/14.3.335; Lee SO, 2005, CANCER RES, V65, P3487, DOI 10.1158/0008-5472.CAN-04-3267; Li LS, 2004, PROTEOMICS, V4, P3394, DOI 10.1002/pmic.200400901; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Li ZS, 2009, BREAST CANCER RES TR, V118, P33, DOI 10.1007/s10549-008-0216-x; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Raucci R, 2011, BBA-PROTEINS PROTEOM, V1814, P513, DOI 10.1016/j.bbapap.2011.02.006; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Surai PF, 2006, SELENIUM NUTR HLTH; Sutherland RL, 1998, J MAMMARY GLAND BIOL, V3, P63, DOI 10.1023/A:1018774302092; Suzuki T, 2006, ENDOCR-RELAT CANCER, V13, P233, DOI 10.1677/erc.1.01075; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; WANG TTY, 1995, CANCER RES, V55, P2487; Wulfkuhle JD, 2002, CANCER RES, V62, P6740; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang MH, 1998, CANCER RES, V58, P3150; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zhang J, 2011, MED ONCOL, V28, P481, DOI 10.1007/s12032-010-9482-7; Zhang P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-80	38	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63702	10.1371/journal.pone.0063702	http://dx.doi.org/10.1371/journal.pone.0063702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704933	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200064
J	Bushman, JD; Zhou, Q; Shyng, SL				Bushman, Jeremy D.; Zhou, Qing; Shyng, Show-Ling			A Kir6.2 Pore Mutation Causes Inactivation of ATP-Sensitive Potassium Channels by Disrupting PIP2-Dependent Gating	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PIP2; RECTIFIER K+ CHANNELS; SULFONYLUREA RECEPTOR; CONGENITAL HYPERINSULINISM; G-PROTEINS; MECHANISM; ACTIVATION; SUBUNIT; MODULATION; INHIBITION	In the absence of intracellular nucleotides, ATP-sensitive potassium (K-ATP) channels exhibit spontaneous activity via a phosphatidylinositol-4,5-bisphosphate (PIP2)-dependent gating process. Previous studies show that stability of this activity requires subunit-subunit interactions in the cytoplasmic domain of Kir6.2; selective mutagenesis and disease mutations at the subunit interface result in time-dependent channel inactivation. Here, we report that mutation of the central glycine in the pore-lining second transmembrane segment (TM2) to proline in Kir6.2 causes K-ATP channel inactivation. Unlike C-type inactivation, a consequence of selectivity filter closure, in many K+ channels, the rate of inactivation in G156P channels was insensitive to changes in extracellular ion concentrations or ion species fluxing through the pore. Instead, the rate of G156P inactivation decreased with exogenous application of PIP2 and increased when PIP2-channel interaction was inhibited with neomycin or poly-L-lysine. These findings indicate the G156P mutation reduces the ability of PIP2 to stabilize the open state of K-ATP channels, similar to mutations in the cytoplasmic domain that produce inactivation. Consistent with this notion, when PIP2-dependent open state stability was substantially increased by addition of a second gain-of-function mutation, G156P inactivation was abolished. Importantly, bath application and removal of Mg2+-free ATP or a nonhydrolyzable analog of ATP, which binds to the cytoplasmic domain of Kir6.2 and causes channel closure, recover G156P channel from inactivation, indicating crosstalk between cytoplasmic and transmembrane domains. The G156P mutation provides mechanistic insight into the structural and functional interactions between the pore and cytoplasmic domains of Kir6.2 during gating.	[Bushman, Jeremy D.; Zhou, Qing; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	shyngs@ohsu.edu			NIH [1F31NS065688, R01DK066485]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Fellowship 1F31NS065688 to JDB and R01DK066485 to SLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderemane-Ali F, 2013, J BIOL CHEM, V288, P10951, DOI 10.1074/jbc.A112.382085; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; An HL, 2012, J BIOL CHEM, V287, P42278, DOI 10.1074/jbc.M112.418640; ASHCROFT FM, 1989, J PHYSIOL-LONDON, V408, P413, DOI 10.1113/jphysiol.1989.sp017467; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bushman JD, 2010, J BIOL CHEM, V285, P6012, DOI 10.1074/jbc.M109.085860; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; Loechner KJ, 2011, DIABETES, V60, P209, DOI 10.2337/db10-0731; Loussouarn G, 2001, J BIOL CHEM, V276, P29098, DOI 10.1074/jbc.M102365200; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Proks P, 2005, EMBO REP, V6, P470, DOI 10.1038/sj.embor.7400393; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SPRUCE AE, 1987, J PHYSIOL-LONDON, V382, P213, DOI 10.1113/jphysiol.1987.sp016364; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	60	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63733	10.1371/journal.pone.0063733	http://dx.doi.org/10.1371/journal.pone.0063733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700433	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400030
J	Zhou, M; Zhang, GQ; Ren, GP; Gnanadurai, CW; Li, ZG; Chai, QQ; Yang, Y; Leyson, CM; Wu, WX; Cui, M; Fu, ZF				Zhou, Ming; Zhang, Guoqing; Ren, Guiping; Gnanadurai, Clement W.; Li, Zhenguang; Chai, Qingqing; Yang, Yang; Leyson, Christina M.; Wu, Wenxue; Cui, Min; Fu, Zhen F.			Recombinant Rabies Viruses Expressing GM-CSF or Flagellin Are Effective Vaccines for Both Intramuscular and Oral Immunizations	PLOS ONE			English	Article							CONFERS PROTECTIVE IMMUNITY; MUCOSAL ADJUVANT ACTIVITY; DENDRITIC CELLS; BACTERIAL FLAGELLIN; RESPIRATORY CHALLENGE; SINGLE IMMUNIZATION; HUMAN ADENOVIRUS; PROTEIN VACCINE; FUSION PROTEIN; PUBLIC-HEALTH	Our previous studies indicated that recombinant rabies viruses (rRABV) expressing chemokines or cytokines (including GMCSF) could enhance the immunogenicity by recruiting and/or activating dendritic cells (DC). In this study, bacterial flagellin was cloned into the RABV genome and recombinant virus LBNSE-Flagellin was rescued. To compare the immunogenicity of LBNSE-Flagellin with recombinant virus expressing GMCSF (LBNSE-GMCSF), mice were immunized with each of these rRABVs by intramuscular (i.m.) or oral route. The parent virus (LBNSE) without expression of any foreign molecules was included for comparison. The i.m.-immunized mice were bled at three weeks after the immunization for the measurement of virus neutralizing antibody (VNA) and then challenged with 50 LD50 challenge virus standard (CVS-24). Orally immunized mice were boosted after three weeks and then bled and challenged one week after the booster immunization. It was found that both LBNSE-GMCSF and LBNSE-Flagellin recruited/activated more DCs and B cells in the periphery, stimulated higher levels of adaptive immune responses (VNA), and protected more mice against challenge infection than the parent virus LBNSE in both the i.m. and the orally immunized groups. Together, these studies suggest that recombinant RABV expressing GM-CSF or flagellin are more immunogenic than the parent virus in both i.m. and oral immunizations.	[Zhou, Ming; Cui, Min; Fu, Zhen F.] Huazhong Agr Univ, Coll Anim Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhou, Ming; Zhang, Guoqing; Ren, Guiping; Gnanadurai, Clement W.; Li, Zhenguang; Chai, Qingqing; Yang, Yang; Leyson, Christina M.; Fu, Zhen F.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Zhou, Ming; Wu, Wenxue] China Agr Univ, Minist Agr, Key Lab Zoonosis, Coll Vet Med, Beijing 100094, Peoples R China	Huazhong Agricultural University; University System of Georgia; University of Georgia; China Agricultural University; Ministry of Agriculture & Rural Affairs	Fu, ZF (corresponding author), Huazhong Agr Univ, Coll Anim Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	zhenfu@uga.edu	Zhou, Ming/K-7968-2017; cui, min/HGD-8340-2022; zhang, guoqing/GXG-4800-2022	Zhou, Ming/0000-0001-7012-017X	USA Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI-051560]; China Department of Sciences and Technology (863 program) [2011AA10A212]; China Department of Agriculture (special fund for Agro-scientific research in the Public Interest) [201303042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051560] Funding Source: NIH RePORTER	USA Public Health Service grant from the National Institute of Allergy and Infectious Diseases; China Department of Sciences and Technology (863 program); China Department of Agriculture (special fund for Agro-scientific research in the Public Interest); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported partially by USA Public Health Service grant AI-051560 from the National Institute of Allergy and Infectious Diseases, China Department of Sciences and Technology (863 program, #2011AA10A212), and China Department of Agriculture (special fund for Agro-scientific research in the Public Interest, 201303042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHOMO HO, 1990, VET RES COMMUN, V14, P415, DOI 10.1007/BF00343220; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Ahmed M, 2010, J VIROL, V84, P12093, DOI 10.1128/JVI.00406-10; AMANN R, 2012, J VIROL; BAER GM, 1975, AM J EPIDEMIOL, V101, P160, DOI 10.1093/oxfordjournals.aje.a112080; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; BLACK JG, 1973, CAN VET J, V14, P206; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; CHARLTON KM, 1992, ARCH VIROL, V123, P169, DOI 10.1007/BF01317147; Clark KA, 1996, J AM VET MED ASSOC, V208, P1827; Cliquet F, 2004, DEV BIOLOGICALS, V119, P185; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; Dato V., 2009, Morbidity and Mortality Weekly Report, V58, P1204; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; ESH JB, 1982, J AM VET MED ASSOC, V180, P1336; Estrada R, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-23; Faber M, 2007, J VIROL, V81, P7041, DOI 10.1128/JVI.00357-07; Farley Susan, 2012, Morbidity and Mortality Weekly Report, V61, P777; Fearneyhough MG, 1998, J AM VET MED ASSOC, V212, P498; Flamand A, 1993, Trends Microbiol, V1, P317, DOI 10.1016/0966-842X(93)90010-O; Fu ZF, 1997, VACCINE, V15, pS20, DOI 10.1016/S0264-410X(96)00312-X; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Hanlon CA, 2002, J WILDLIFE DIS, V38, P420, DOI 10.7589/0090-3558-38.2.420; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; LAFAY F, 1994, VACCINE, V12, P317, DOI 10.1016/0264-410X(94)90095-7; LEE F, 1985, P NATL ACAD SCI USA, V82, P4360, DOI 10.1073/pnas.82.13.4360; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Levi R, 1996, VACCINE, V14, P85, DOI 10.1016/0264-410X(95)00088-I; Li JW, 2006, VIROLOGY, V356, P147, DOI 10.1016/j.virol.2006.07.037; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacInnes CD, 2001, J WILDLIFE DIS, V37, P119, DOI 10.7589/0090-3558-37.1.119; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; MCEWEN J, 1992, VACCINE, V10, P405, DOI 10.1016/0264-410X(92)90071-Q; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mempel M, 2003, J INVEST DERMATOL, V120, P356, DOI 10.1046/j.1523-1747.2003.12074.x; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Monaco F, 2006, DEV BIOLOGICALS, V125, P233; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nigg AJ, 2009, PHARMACOTHERAPY, V29, P1182, DOI 10.1592/phco.29.10.1182; Niin E, 2006, DEV BIOLOGICALS, V125, P145; Orciari LA, 2001, VACCINE, V19, P4511, DOI 10.1016/S0264-410X(01)00186-4; Pino O, 2005, INFECT IMMUN, V73, P6763, DOI 10.1128/IAI.73.10.6763-6770.2005; Rasalingam P, 2005, VIRUS RES, V111, P55, DOI 10.1016/j.virusres.2005.03.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robbins AH, 1998, J AM VET MED ASSOC, V213, P1407; Roscoe DE, 1998, J WILDLIFE DIS, V34, P752, DOI 10.7589/0090-3558-34.4.752; RUPPRECHT CE, 1988, REV INFECT DIS, V10, pS803; Rupprecht CE, 2001, NEW ENGL J MED, V345, P582, DOI 10.1056/NEJMoa010560; Rupprecht CE, 2005, VIRUS RES, V111, P101, DOI 10.1016/j.virusres.2005.03.017; RUPPRECHT CE, 1995, EMERG INFECT DIS, V1, P107, DOI 10.3201/eid0104.950401; SCHNEIDER LG, 1988, REV INFECT DIS, V10, pS654; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Stohr K, 1996, VET REC, V139, P32, DOI 10.1136/vr.139.2.32; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Vos A, 2001, J GEN VIROL, V82, P2191, DOI 10.1099/0022-1317-82-9-2191; WANDELER AI, 1988, REV INFECT DIS, V10, pS649; Wen YJ, 2011, J VIROL, V85, P1634, DOI 10.1128/JVI.01552-10; WINKLER WG, 1976, AM J EPIDEMIOL, V104, P294, DOI 10.1093/oxfordjournals.aje.a112302; Wu XF, 2011, EXPERT REV VACCINES, V10, P1597, DOI [10.1586/ERV.11.140, 10.1586/erv.11.140]; Yuan ZG, 2009, VACCINE, V27, P5247, DOI 10.1016/j.vaccine.2009.06.062; Yuan ZG, 2008, VACCINE, V26, P1314, DOI 10.1016/j.vaccine.2007.12.050; Zhao L, 2010, J VIROL, V84, P9642, DOI 10.1128/JVI.00326-10	71	39	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63384	10.1371/journal.pone.0063384	http://dx.doi.org/10.1371/journal.pone.0063384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700422	gold, Green Submitted, Green Published			2022-12-25	WOS:000319966400020
J	Di Paola, D; Raelson, J; Rampakakis, E; Basik, M; Zannis-Hadjopoulos, M; Bradley, WEC				Di Paola, Domenic; Raelson, John; Rampakakis, Emmanouil; Basik, Mark; Zannis-Hadjopoulos, Maria; Bradley, W. Edward C.			Monoallelic Chromatin Conformation Flanking Long-Range Silenced Domains in Cancer-Derived and Normal Cells	PLOS ONE			English	Article							DNA METHYLATION; INACTIVATION; EXPRESSION; DISEASE; EPIMUTATIONS; MECHANISMS; PROMOTER	Epigenetic inactivation of chromatin plays an important role in determining cell phenotype in both normal and cancer cells, but our knowledge is still incomplete with respect to any potential monoallelic nature of the phenomenon. We have genotyped DNA isolated from chromatin of two colorectal cancer-derived lines and a culture of normal human intestinal epithelial cells (HIEC), which was immunoprecipitated with antibodies to acetylated vs. methylated histone H3K9, and presented the data as B allele frequency differences over multiple single-nucleotide polymorphism (SNP) moving window averages. [B allele is an arbitrary term defined as one of the two alleles at any given SNP, named A and B]. Three different validation tests confirmed that peaks exhibiting differences represented monoallelic domains. These complementary tests confirmed the following: 1) genes in the regions of high B allele frequency difference were expressed monoallelically; 2) in normal cells all five imprinting control regions which carried heterozygous SNPs were characterized by B allele difference peaks; and 3) the haplotypes in the B allele difference peaks were faithfully maintained in the chromatin immunoprecipitated with the respective antibodies. In both samples most of the monoallelic domains were found at the boundaries between regions of open and closed chromatin. With respect to the cancer line, this supports the established concept of conformation spreading, but the results from the normal cells were unexpected. Since these cells were polyclonal, the monoallelic structures were probably not determined by random choice as occurs in X-inactivation, so we propose that epigenetic inactivation in some domains may be heritable and polymorphic in normal human cells.	[Di Paola, Domenic; Rampakakis, Emmanouil; Zannis-Hadjopoulos, Maria; Bradley, W. Edward C.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Raelson, John] Genizon Biosci, St Laurent, PQ, Canada; [Di Paola, Domenic; Rampakakis, Emmanouil; Zannis-Hadjopoulos, Maria] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Basik, Mark; Zannis-Hadjopoulos, Maria; Bradley, W. Edward C.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Bradley, W. Edward C.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; McGill University; Universite de Montreal	Bradley, WEC (corresponding author), McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada.	edward.bradley@umontreal.ca		Rampakakis, Emmanouil/0000-0002-7427-8246	Cancer Research Society; Internal funds of the Goodman Cancer Centre, McGill University; Fonds de Recherche en Sante du Quebec	Cancer Research Society; Internal funds of the Goodman Cancer Centre, McGill University; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	The work was supported by grants from the Cancer Research Society and Internal funds of the Goodman Cancer Centre, McGill University. DDP was a recipient of a fellowship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornsson HT, 2004, COLD SPRING HARB SYM, V69, P447, DOI 10.1101/sqb.2004.69.447; BRADLEY WEC, 1983, MOL CELL BIOL, V3, P1172, DOI 10.1128/MCB.3.7.1172; BRADLEY WEC, 1979, J CELL PHYSIOL, V101, P325, DOI 10.1002/jcp.1041010212; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Clark SJ, 2007, HUM MOL GENET, V16, pR88, DOI 10.1093/hmg/ddm051; Desloges N, 1998, J CELL BIOCHEM, V71, P536; Di Paola D, 2012, J CELL BIOCHEM, V113, P1333, DOI 10.1002/jcb.24006; DOBROVIC A, 1988, SOMAT CELL MOLEC GEN, V14, P55, DOI 10.1007/BF01535049; Dobrovic A, 2009, INT J BIOCHEM CELL B, V41, P34, DOI 10.1016/j.biocel.2008.09.006; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; GRANT SG, 1989, AM J HUM GENET, V45, P619; Hitchins MP, 2010, ADV GENET, V70, P201, DOI [10.1016/S0065-2660(10)70008-0, 10.1016/B978-0-12-380866-0.60008-3]; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Pappas JJ, 2008, GENE CHROMOSOME CANC, V47, P978, DOI 10.1002/gcc.20603; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Sharp AJ, 2002, HUM MOL GENET, V11, P3145, DOI 10.1093/hmg/11.25.3145	19	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63190	10.1371/journal.pone.0063190	http://dx.doi.org/10.1371/journal.pone.0063190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696799	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900015
J	Kato, H; Katoh, R; Kitamura, M				Kato, Hironori; Katoh, Ryohei; Kitamura, Masanori			Dual Regulation of Cadmium-Induced Apoptosis by mTORC1 through Selective Induction of IRE1 Branches in Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; FREE-RADICALS; CELL-DEATH; ACTIVATION; ER; PHOSPHORYLATION; ANTIOXIDANTS; GENERATION; TOXICITY	Cadmium (Cd) causes generation of reactive oxygen species (ROS) that trigger renal tubular injury. We found that rapamycin, an inhibitor of mTORC1, attenuated Cd-induced apoptosis in renal tubular cells. Knockdown of Raptor, a positive regulator of mTORC1, also had the similar effect. However, rapamycin did not alter generation of ROS, suggesting that mTORC1 is a target downstream of ROS. Indeed, ROS caused activation of mTORC1, which contributed to induction of a selective branch of the unfolded protein response (UPR); i.e., the IRE1 pathway. Although Cd triggered three major UPR pathways, activation of mTORC1 by Cd did not contribute to induction of the PERK-eIF2 alpha and ATF6 pathways. Consistently, knockdown of Raptor caused suppression of JNK without affecting the PERK-eIF2 alpha pathway in Cd-exposed cells. Knockdown of TSC2, a negative regulator of mTORC1, caused activation of mTORC1 and enhanced Cd induction of the IRE1-JNK pathway and apoptosis without affecting other UPR branches. Inhibition of IRE1 alpha kinase led to suppression of JNK activity and apoptosis in Cd-treated cells. Dominant-negative inhibition of JNK also suppressed Cd-induced apoptosis. In contrast, inhibition of IRE1 alpha endoribonuclease activity or downstream XBP1 modestly enhanced Cd-induced apoptosis. In vivo, administration with rapamycin suppressed activation of mTORC1 and JNK, but not eIF2 alpha, in the kidney of Cd-treated mice. It was correlated with attenuation of tubular injury and apoptotic cell death in the tubules. These results elucidate dual regulation of Cd-induced renal injury by mTORC1 through selective induction of IRE1 signaling.	[Kato, Hironori; Kitamura, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo, Yamanashi, Japan; [Katoh, Ryohei] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pathol, Chuo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Kitamura, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo, Yamanashi, Japan.	masanori@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [19651024, 40610283]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 19651024 to M. Kitamura; No. 40610283 to H. Kato). (http://www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Figueiredo-Pereira ME, 1998, J BIOL CHEM, V273, P12703, DOI 10.1074/jbc.273.21.12703; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Lam D, 2009, P NATL ACAD SCI USA, V106, P11978, DOI 10.1073/pnas.0900608106; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lind Y, 1997, FOOD CHEM TOXICOL, V35, P891, DOI 10.1016/S0278-6915(97)00068-9; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ognjanovic BI, 2010, REPROD TOXICOL, V29, P191, DOI 10.1016/j.reprotox.2009.11.009; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Pathak N, 2006, TOXICOLOGY, V220, P26, DOI 10.1016/j.tox.2005.11.027; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Sugawara M, 2002, EXP BIOL MED, V227, P141, DOI 10.1177/153537020222700209; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang Z, 2012, TOXICOL APPL PHARM, V259, P236, DOI 10.1016/j.taap.2012.01.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	43	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64344	10.1371/journal.pone.0064344	http://dx.doi.org/10.1371/journal.pone.0064344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696882	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900085
J	Rainard, P; Cunha, P; Bougarn, S; Fromageau, A; Rossignol, C; Gilbert, FB; Berthon, P				Rainard, Pascal; Cunha, Patricia; Bougarn, Salim; Fromageau, Angelina; Rossignol, Christelle; Gilbert, Florence B.; Berthon, Patricia			T Helper 17-Associated Cytokines Are Produced during Antigen-Specific Inflammation in the Mammary Gland	PLOS ONE			English	Article							IMMUNE-MEDIATED INFLAMMATION; EPITHELIAL-CELLS; ESCHERICHIA-COLI; INTRAMAMMARY INFECTION; IL-17 EXPRESSION; MOUSE MODEL; IFN-GAMMA; INTERLEUKIN-17; TH17; NEUTROPHILS	Infectious mastitis cuts down milk production profitability and is a major animal welfare problem. Bacteria-induced inflammation in the mammary gland (MG) is driven by innate immunity, but adaptive immunity can modulate the innate response. Several studies have shown that it is possible to elicit inflammation in the MG by sensitization to an antigen subsequently infused into the lumen of the gland. The objective of our study was to characterize the inflammation triggered in the MG of cows sensitized to ovalbumin, by identifying the cytokines and chemokines likely to play a part in the reaction. Among immunized cows, responders mobilized locally high numbers of leukocytes. An overexpression of the genes encoding IL-17a, IL-17F, IL-21, IL-22 and INF-gamma was found in milk cell RNA extracts in the early phase of the inflammatory response. At the protein level, IL-17A was detected in milk as soon as the first sampling time (8 h post-challenge), and both IL-17A and IFN-gamma concentrations peaked at 12 to 24 h post-challenge. In mammary tissue from challenged quarters, overexpression of the genes encoding IL-17A, IL-17F, IL-21, IL-22, IL-26 and IFN-gamma was observed. Neutrophil-attracting chemokines (CXCL3 and CXCL8) were found in milk, and overexpressed transcripts of chemokines attracting lymphocytes and other mononuclear leukocytes (CXCL10, CCL2, CCL5, CCL20) were detected in mammary tissue. Expression of IL-17A, as revealed by immunohistochemistry, was located in epithelial cells, in leukocytes in the connective tissue and in association with the epithelium, and in migrated alveolar leukocytes of challenged quarters. Altogether, these results show that antigen-specific inflammation in the MG was characterized by the production of IL-17 and IFN-gamma. The orientation of the inflammatory response induced by the antigen-specific response has the potential to strongly impact the outcome of bacterial infections of the MG.	[Rainard, Pascal; Cunha, Patricia; Bougarn, Salim; Fromageau, Angelina; Rossignol, Christelle; Gilbert, Florence B.; Berthon, Patricia] INRA, Infectiol & Publ Hlth Res Unit, Nouzilly, France; [Rainard, Pascal; Cunha, Patricia; Bougarn, Salim; Fromageau, Angelina; Rossignol, Christelle; Gilbert, Florence B.; Berthon, Patricia] Univ Tours, Infectiol & Publ Hlth Res Unit, Nouzilly, France	INRAE; Universite de Tours	Rainard, P (corresponding author), INRA, Infectiol & Publ Hlth Res Unit, Nouzilly, France.	Pascal.Rainard@tours.inra.fr		Rainard, Pascal/0000-0002-5477-2626; bougarn, salim/0000-0003-1132-6615	Pfizer Animal Health; Institute (INRA - Institut Scientifique de Recherche Agronomique)	Pfizer Animal Health; Institute (INRA - Institut Scientifique de Recherche Agronomique)	This work was funded in part by Pfizer Animal Health. Pfizer's contribution to the experimental costs came as a supplement to the authors' Institute (INRA - Institut Scientifique de Recherche Agronomique) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SL, 2011, J MAMMARY GLAND BIOL, V16, P291, DOI 10.1007/s10911-011-9230-4; Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Andoh A, 2002, J IMMUNOL, V169, P1683, DOI 10.4049/jimmunol.169.4.1683; APPELBERG R, 1992, IMMUNOLOGY, V75, P414; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Bannerman DD, 2004, CLIN DIAGN LAB IMMUN, V11, P463, DOI 10.1128/CDLI.11.3.463-472.2004; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Bonnefont CMD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-208; Bougarn S, 2011, J DAIRY SCI, V94, P2425, DOI 10.3168/jds.2010-3859; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Brand B, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-24; Brodlie M, 2011, EUR RESPIR J, V37, P1378, DOI 10.1183/09031936.00067110; Burvenich C, 2007, J DAIRY SCI, V90, pE39, DOI 10.3168/jds.2006-696; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Caruso R, 2007, GASTROENTEROLOGY, V132, P166, DOI 10.1053/j.gastro.2006.09.053; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; DECUENINCK BJ, 1979, INT ARCH ALLER A IMM, V59, P394, DOI 10.1159/000232286; DECUENINCK BJ, 1982, AM J VET RES, V43, P1696; Donnelly RP, 2010, CYTOKINE GROWTH F R, V21, P393, DOI 10.1016/j.cytogfr.2010.09.001; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Fantini MC, 2008, MUCOSAL IMMUNOL, V1, P110, DOI 10.1038/mi.2007.17; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Ghannam S, 2011, J IMMUNOL, V186, P1411, DOI 10.4049/jimmunol.1000597; Ghilardi N, 2007, SEMIN IMMUNOL, V19, P383, DOI 10.1016/j.smim.2007.10.016; Griesbeck-Zilch B, 2009, J DAIRY SCI, V92, P4621, DOI 10.3168/jds.2008-1954; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Herbelin C, 1997, J DAIRY SCI, V80, P2025, DOI 10.3168/jds.S0022-0302(97)76147-2; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Lim HW, 2008, J IMMUNOL, V180, P122, DOI 10.4049/jimmunol.180.1.122; Loverre A, 2011, AM J TRANSPLANT, V11, P1248, DOI 10.1111/j.1600-6143.2011.03529.x; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Nguyen CQ, 2008, ARTHRITIS RHEUM-US, V58, P734, DOI 10.1002/art.23214; NONNECKE BJ, 1984, AM J REPROD IMMUNOL, V6, P9, DOI 10.1111/j.1600-0897.1984.tb00101.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Persson K, 1996, VET IMMUNOL IMMUNOP, V53, P73, DOI 10.1016/0165-2427(96)05561-4; PERSSON K, 1993, VET IMMUNOL IMMUNOP, V37, P99, DOI 10.1016/0165-2427(93)90058-C; Rainard P, 1997, VET RES, V28, P231; Rainard P, 1998, VET RES, V29, P73; Rainard P, 2010, CLIN VACCINE IMMUNOL, V17, P848, DOI 10.1128/CVI.00447-09; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Riollet C, 2000, INFLAMM RES, V49, P486, DOI 10.1007/s000110050621; Riollet C, 2006, J INTERF CYTOK RES, V26, P141, DOI 10.1089/jir.2006.26.141; Schalm OW, 1971, BOVINE MASTITIS, P94; Shuster DE, 1997, INFECT IMMUN, V65, P3286, DOI 10.1128/IAI.65.8.3286-3292.1997; Suzuki S, 2007, INT ARCH ALLERGY IMM, V143, P89, DOI 10.1159/000101413; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vordermeier HM, 2009, CLIN VACCINE IMMUNOL, V16, P1443, DOI 10.1128/CVI.00229-09; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wellnitz O, 2011, J DAIRY SCI, V94, P5405, DOI 10.3168/jds.2010-3931; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Zheng JM, 2006, INFECT IMMUN, V74, P1907, DOI 10.1128/IAI.74.3.1907-1915.2006; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	69	47	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63471	10.1371/journal.pone.0063471	http://dx.doi.org/10.1371/journal.pone.0063471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696826	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900035
J	Wang, GJ; Volkow, ND; Wigal, T; Kollins, SH; Newcorn, JH; Telang, F; Logan, J; Jayne, M; Wong, CT; Han, H; Fowler, JS; Zhu, W; Swanson, JM				Wang, Gene-Jack; Volkow, Nora D.; Wigal, Timothy; Kollins, Scott H.; Newcorn, Jeffrey H.; Telang, Frank; Logan, Jean; Jayne, Millard; Wong, Christopher T.; Han, Hao; Fowler, Joanna S.; Zhu, Wei; Swanson, James M.			Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; METHYLPHENIDATE TREATMENT; BEHAVIORAL SENSITIZATION; ORAL METHYLPHENIDATE; COCAINE; RATS; ADULTS; ADHD; STRIATUM; EXPOSURE	Objective: Brain dopamine dysfunction in attention deficit/hyperactivity disorder (ADHD) could explain why stimulant medications, which increase dopamine signaling, are therapeutically beneficial. However while the acute increases in dopamine induced by stimulant medications have been associated with symptom improvement in ADHD the chronic effects have not been investigated. Method: We used positron emission tomography and [C-11] cocaine (dopamine transporter radioligand) to measure dopamine transporter availability in the brains of 18 never-medicated adult ADHD subjects prior to and after 12 months of treatment with methylphenidate and in 11 controls who were also scanned twice at 12 months interval but without stimulant medication. Dopamine transporter availability was quantified as non-displaceable binding potential using a kinetic model for reversible ligands. Results: Twelve months of methylphenidate treatment increased striatal dopamine transporter availability in ADHD (caudate, putamen and ventral striatum: +24%, p<0.01); whereas there were no changes in control subjects retested at 12-month interval. Comparisons between controls and ADHD participants revealed no significant difference in dopamine transporter availability prior to treatment but showed higher dopamine transporter availability in ADHD participants than control after long-term treatment (caudate: p<0.007; putamen: p<0.005). Conclusion: Upregulation of dopamine transporter availability during long- term treatment with methylphenidate may decrease treatment efficacy and exacerbate symptoms while not under the effects of the medication. Our findings also suggest that the discrepancies in the literature regarding dopamine transporter availability in ADHD participants (some studies reporting increases, other no changes and other decreases) may reflect, in part, differences in treatment histories.	[Wang, Gene-Jack] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Wang, Gene-Jack; Logan, Jean; Fowler, Joanna S.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA; [Wang, Gene-Jack; Newcorn, Jeffrey H.; Fowler, Joanna S.] Mt Sinai Sch Med, Dept Psychol, New York, NY USA; [Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD USA; [Volkow, Nora D.; Telang, Frank; Jayne, Millard; Wong, Christopher T.] NIAAA, Intramural Res Program, Neuroimaging Lab, Upton, NY USA; [Wigal, Timothy; Swanson, James M.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Kollins, Scott H.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Han, Hao; Zhu, Wei] SUNY Stony Brook, Dept Math & Appl Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of California System; University of California Irvine; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, GJ (corresponding author), SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA.	gjwang@bnl.gov	Han, Hao/D-5618-2015; Kollins, Scott/AAD-6291-2020	Han, Hao/0000-0002-9387-7279; Kollins, Scott/0000-0001-6847-6935; Logan, Jean/0000-0002-6993-9994; Newcorn, Jeffrey/0000-0001-8993-9337	National Institutes of Health [R01MH66961]; Orexigen Therapeutics Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550, Z01AA000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Orexigen Therapeutics Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The work was supported by the National Institutes of Health: R01MH66961 to Dr. GJW. The PET study was carried out at Brookhaven National Laboratory with infrastructure support from the U.S. Department of Energy Office of Biological and Environmental Research (DE-ACO2-76CH00016), M01RR10710 (the General Clinical Research Center of Stony Brook University). An Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism (Z01AA000550) supported Drs. NDV and FT and Mr. MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. GJW received research funding from the Orexigen Therapeutics Inc.; Dr. NDV reports no competing interests; Dr. TW reports no competing interests; Dr. SHK reports no competing interests; Dr. JHN reports no competing interests; Dr. FT reports no competing interests; Dr. JL reports no competing interests; Mr. MJ reports no competing interests; Mr. CTW reports no competing interests; Mr. HH reports no competing interests; Dr. JSF reports no competing interests; Dr. WZ reports no competing interests; Dr. JMS reports no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALEXOFF DL, 1995, NUCL MED BIOL, V22, P893, DOI 10.1016/0969-8051(95)00042-V; Andersen SL, 2002, NAT NEUROSCI, V5, P13, DOI 10.1038/nn777; Brandon CL, 2001, NEUROPSYCHOPHARMACOL, V25, P651, DOI 10.1016/S0893-133X(01)00281-0; Conners CK, 1998, J CLIN PSYCHIAT, V59, P24; Crawford CA, 1998, PSYCHOPHARMACOLOGY, V136, P34, DOI 10.1007/s002130050536; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; KOFF JM, 1994, J PHARMACOL EXP THER, V268, P277; Krause J, 2005, EUR ARCH PSY CLIN N, V255, P428, DOI 10.1007/s00406-005-0602-x; Kuczenski R, 2002, J NEUROSCI, V22, P7264; Little KY, 1999, AM J PSYCHIAT, V156, P238; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Malison RT, 1998, AM J PSYCHIAT, V155, P832; MCNAMARA CG, 1993, PHARMACOL BIOCHEM BE, V45, P729, DOI 10.1016/0091-3057(93)90532-X; Rosa-Neto P, 2005, NEUROIMAGE, V25, P868, DOI 10.1016/j.neuroimage.2004.11.031; Schenk S, 2002, PHARMACOL BIOCHEM BE, V72, P651, DOI 10.1016/S0091-3057(02)00735-9; Sproson EJ, 2001, J PSYCHOPHARMACOL, V15, P67, DOI 10.1177/026988110101500202; Swanson James M, 2012, Int J Educ Psychol Assess, V10, P51; Swanson JM, 2009, J CHILD PSYCHOL PSYC, V50, P180, DOI 10.1111/j.1469-7610.2008.02062.x; SWANSON JM, 1983, PEDIATRICS, V72, P49; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Volkow ND, 2013, J NEUROSCIE IN PRESS; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	29	80	80	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e63023	10.1371/journal.pone.0063023	http://dx.doi.org/10.1371/journal.pone.0063023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23696790	Green Published, gold			2022-12-25	WOS:000319052700016
J	Liu, ZH; Cai, TF; Zhu, Q; Deng, MC; Li, JY; Zhou, X; Zhang, F; Li, D; Li, J; Liu, Y; Hu, WJ; Liang, SP				Liu, Zhonghua; Cai, Tianfu; Zhu, Qi; Deng, Meichun; Li, Jiayan; Zhou, Xi; Zhang, Fan; Li, Dan; Li, Jing; Liu, Yu; Hu, Weijun; Liang, Songping			Structure and Function of Hainantoxin-III, a Selective Antagonist of Neuronal Tetrodotoxin-sensitive Voltage-gated Sodium Channels Isolated from the Chinese Bird Spider Ornithoctonus hainana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUWENTOXIN-IV; DOMAIN-II; PROTX-II; MOLECULAR-MECHANISMS; SECONDARY STRUCTURE; TARANTULA TOXINS; SCORPION TOXINS; RECEPTOR-SITE; CYSTINE KNOT; ACTIVATION	In the present study, we investigated the structure and function of hainantoxin-III (HNTX-III), a 33-residue polypeptide from the venom of the spider Ornithoctonus hainana. It is a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels. HNTX-III suppressed Nav1.7 current amplitude without significantly altering the activation, inactivation, and repriming kinetics. Short extreme depolarizations partially activated the toxin-bound channel, indicating voltage-dependent inhibition of HNTX-III. HNTX-III increased the deactivation of the Nav1.7 current after extreme depolarizations. The HNTX-III.Nav1.7 complex was gradually dissociated upon prolonged strong depolarizations in a voltage-dependent manner, and the unbound toxin rebound to Nav1.7 after a long repolarization. Moreover, analysis of chimeric channels showed that the DIIS3-S4 linker was critical for HNTX-III binding to Nav1.7. These data are consistent with HNTX-III interacting with Nav1.7 site 4 and trapping the domain II voltage sensor in the closed state. The solution structure of HNTX-III was determined by two-dimensional NMR and shown to possess an inhibitor cystine knot motif. Structural analysis indicated that certain basic, hydrophobic, and aromatic residues mainly localized in the C terminus may constitute an amphiphilic surface potentially involved in HNTX-III binding to Nav1.7. Taken together, our results show that HNTX-III is distinct from beta-scorpion toxins and other beta-spider toxins in its mechanism of action and binding specificity and affinity. The present findings contribute to our understanding of the mechanism of toxin-sodium channel interaction and provide a useful tool for the investigation of the structure and function of sodium channel isoforms and for the development of analgesics.	[Liu, Zhonghua; Cai, Tianfu; Zhu, Qi; Li, Jiayan; Zhou, Xi; Zhang, Fan; Li, Dan; Li, Jing; Hu, Weijun; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China; [Deng, Meichun] Cent S Univ, Sch Life Sci, Dept Biochem, Changsha 410013, Hunan, Peoples R China; [Liu, Yu] Hunan Inst Sci & Technol, Coll Chem & Chem Engn, Yueyang 414006, Hunan, Peoples R China	Hunan Normal University; Central South University; Hunan Institute of Science & Technology	Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.	liuzh@hunnu.edu.cn; liangsp@hunnu.edu.cn			National Basic Research Program of China (973 Program) [2010CB529801, 2012CB22305]; National Science Foundation [31070699, 31170746, 31100764]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Basic Research Program of China (973 Program) Grants 2010CB529801 and 2012CB22305 (to S. L.) and National Science Foundation Projects 31070699 and 31170746 (to Z. L.) and 31100764 (to M. D.).	Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Billen B, 2010, J BIOL CHEM, V285, P18545, DOI 10.1074/jbc.M110.125211; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; GRAY WR, 1993, PROTEIN SCI, V2, P1749, DOI 10.1002/pro.5560021018; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; He QZ, 2010, TOXICON, V56, P644, DOI 10.1016/j.toxicon.2010.05.013; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Lee CH, 2008, CHANNELS, V2, P407, DOI 10.4161/chan.2.6.7429; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Liu Y, 2012, J PEPT SCI, V18, P643, DOI 10.1002/psc.2451; Liu Z, 2003, CELL MOL LIFE SCI, V60, P972, DOI 10.1007/s00018-003-2354-x; Liu ZH, 2013, PROTEIN PEPTIDE LETT, V20, P761, DOI 10.2174/0929866511320070005; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Priest BT, 2007, TOXICON, V49, P194, DOI 10.1016/j.toxicon.2006.09.014; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Wang MC, 2012, PEPTIDES, V34, P19, DOI 10.1016/j.peptides.2011.10.029; Wang W, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-16; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Wilson MJ, 2011, J PHARMACOL EXP THER, V338, P687, DOI 10.1124/jpet.110.178343; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509	57	46	49	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20392	20403		10.1074/jbc.M112.426627	http://dx.doi.org/10.1074/jbc.M112.426627			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703613	Green Published, hybrid			2022-12-25	WOS:000321715100027
J	Naito, T; Nishio, SY; Iwasa, Y; Yano, T; Kumakawa, K; Abe, S; Ishikawa, K; Kojima, H; Namba, A; Oshikawa, C; Usami, S				Naito, Takehiko; Nishio, Shin-ya; Iwasa, Yoh-ichiro; Yano, Takuya; Kumakawa, Kozo; Abe, Satoko; Ishikawa, Kotaro; Kojima, Hiromi; Namba, Atsushi; Oshikawa, Chie; Usami, Shin-ichi			Comprehensive Genetic Screening of KCNQ4 in a Large Autosomal Dominant Nonsyndromic Hearing Loss Cohort: Genotype-Phenotype Correlations and a Founder Mutation	PLOS ONE			English	Article							EAST ASIANS; DEAFNESS; CONNEXIN-26; IMPAIRMENT	The present study of KCNQ4 mutations was carried out to 1) determine the prevalence by unbiased population-based genetic screening, 2) clarify the mutation spectrum and genotype/phenotype correlations, and 3) summarize clinical characteristics. In addition, a review of the reported mutations was performed for better understanding of this deafness gene. The screening using 287 probands from unbiased Japanese autosomal dominant nonsyndromic hearing loss (ADNSHL) families identified 19 families with 7 different disease causing mutations, indicating that the frequency is 6.62% (19/287). While the majority were private mutations, one particular recurrent mutation, c.211delC, was observed in 13 unrelated families. Haplotype analysis in the vicinity of c.211delC suggests existence of a common ancestor. The majority of the patients showed all frequency, but high-frequency predominant, sensorineural hearing loss. The present study adds a new typical audiogram configuration characterized by mid-frequency predominant hearing loss caused by the p.V230E mutation. A variant at the N-terminal site (c.211delC) showed typical ski-slope type audiogram configuration. Concerning clinical features, onset age was from 3 to 40 years old, and mostly in the teens, and hearing loss was gradually progressive. Progressive nature is a common feature of patients with KCNQ4 mutations regardless of the mutation type. In conclusion, KCNQ4 mutations are frequent among ADNSHL patients, and therefore screening of the gene and molecular confirmation of these mutations have become important in the diagnosis of these conditions.	[Naito, Takehiko; Nishio, Shin-ya; Iwasa, Yoh-ichiro; Yano, Takuya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Kumakawa, Kozo; Abe, Satoko] Toranomon Gen Hosp, Dept Otolaryngol, Tokyo, Japan; [Ishikawa, Kotaro] Jichi Med Univ, Dept Otorhinolaryngol, Mibu, Tochigi, Japan; [Kojima, Hiromi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan; [Namba, Atsushi] Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 036, Japan; [Oshikawa, Chie] Kyushu Univ, Sch Med, Dept Otorhinolaryngol, Fukuoka 812, Japan	Shinshu University; Toranomon Hospital; Jichi Medical University; Jikei University; Hirosaki University; Kyushu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Ministry of Health, Labour and Welfare of Japan; Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare; Ministry of Education, Science and Culture of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (S. U.), by the Acute Profound Deafness Research Committee of the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/) (S. U.), by a Health and Labour Sciences Research Grant for Research on Specific Diseases (Vestibular Disorders) from the Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) (S. U.), and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita J, 2001, J HUM GENET, V46, P355, DOI 10.1007/s100380170053; Arnett J, 2011, ARCH OTOLARYNGOL, V137, P54, DOI 10.1001/archoto.2010.234; Baek JI, 2010, BIOCH BIOPHYSICA ACT, P536; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Dominguez LM, 2012, APPL CLIN GENET, V5, P97, DOI 10.2147/TACG.S35525; Hildebrand MS, 2008, GENET MED, V10, P297, DOI 10.1097/GIM.0b013e318187e106; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Miyagawa M, 2012, PLOS ONE IN PRESS; Moteki H, 2012, J HUM GENET IN PRESS, V21; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Park HJ, 2010, J HUM GENET, V55, P59, DOI 10.1038/jhg.2009.114; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1	18	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63231	10.1371/journal.pone.0063231	http://dx.doi.org/10.1371/journal.pone.0063231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717403	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600006
J	Hartel, T; von Wehrden, H				Hartel, Tibor; von Wehrden, Henrik			Farmed Areas Predict the Distribution of Amphibian Ponds in a Traditional Rural Landscape	PLOS ONE			English	Article							BOMBINA-VARIEGATA POPULATION; DISTRIBUTION MODELS; AVAILABILITY; BIODIVERSITY; RESTORATION; COMMUNITY; DYNAMICS; CATTLE; FISH; BUFO	Background: Traditional rural landscapes of Eastern Europe are undergoing major changes due to agricultural intensification, land abandonment, change in agricultural practices and infrastructural development. Small man-made ponds are important yet vulnerable components of rural landscapes. Despite their important role for biodiversity, these ponds tend to be excluded from conservation strategies. Methodology/Findings: Our study was conducted in a traditional rural landscape in Eastern Europe. The aim of this study is twofold: (i) to model the distribution of four major man-made pond types and (ii) to present the importance of man-made ponds for the endangered Yellow Bellied Toad (Bombina variegata) and the Common Toad (Bufo bufo). Six environmental variables were used to model pond distribution: Corine landcover, the heterogeneity of the landcover, slope, road distance, distance to closest village and the human population density. Land cover heterogeneity was the most important driver for the distribution of fishponds. Areas used for agriculture with significant areas of natural vegetation were the most important predictors for the distribution of temporary ponds. In addition, areas covered by transitional woodland and scrub were important for the open cattle ponds. Bombina variegata was found predominantly in the temporary ponds (e. g. ponds created by cattle and buffalo, dirt road ponds and concrete ponds created for livestock drinking) and Bufo bufo in fishponds. Conclusions/Significance: Our Maxent models revealed that the highest probability of occurrence for amphibian ponds was in areas used as farmland. The traditional farming practices combined with a low level of infrastructure development produces a large number of amphibian ponds. The challenge is to harmonize economic development and the maintenance of high densities of ponds in these traditional rural landscapes.	[Hartel, Tibor; von Wehrden, Henrik] Leuphana Univ Luneburg, Fac Sustainabil, Inst Ecol, Luneburg, Germany; [Hartel, Tibor] Sapientia Univ, Dept Environm Sci, Cluj Napoca, Romania; [Hartel, Tibor] Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania; [von Wehrden, Henrik] Leuphana Univ Luneburg, Ctr Methods, Luneburg, Germany; [von Wehrden, Henrik] Res Inst Wildlife Ecol, Vienna, Austria	Leuphana University Luneburg; Sapientia Hungarian University of Transylvania; Ovidius University; Leuphana University Luneburg	Hartel, T (corresponding author), Leuphana Univ Luneburg, Fac Sustainabil, Inst Ecol, Luneburg, Germany.	hartel.tibor@gmail.com	Tibor, Hartel/B-3440-2012		European Regional Development Fund (ERDF) through Sectorial Operational Plan - Environment (POS Mediu) under the project "For nature and local communities - the basis for a Natura integrated management in Hartibaciu -Tarnava Mare - Olt area''; Alexander von Humboldt Foundation via a Sofja Kovalevskaja Award; Alexander von Humboldt Foundation	European Regional Development Fund (ERDF) through Sectorial Operational Plan - Environment (POS Mediu) under the project "For nature and local communities - the basis for a Natura integrated management in Hartibaciu -Tarnava Mare - Olt area''; Alexander von Humboldt Foundation via a Sofja Kovalevskaja Award(Alexander von Humboldt Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Data collection was made with the support of European Regional Development Fund (ERDF) through Sectorial Operational Plan - Environment (POS Mediu) under the project "For nature and local communities - the basis for a Natura 2000 integrated management in Hartibaciu -Tarnava Mare - Olt area.'' The authors gratefully acknowledge support for the processing of spatial data. Data processing was conducted as part of a larger research project at Leuphana University Lueneburg, which was externally funded by the Alexander von Humboldt Foundation via a Sofja Kovalevskaja Award to Professor Joern Fischer. The research stay of TH in Germany and the publication of this manuscript were supported by Alexander von Humboldt Foundation. The publication of the collected data was approved by the World Wild Fund (WWF) - the leader of this project with the condition to mention the funding source in the Acknowledgments. The funders had no role in study design, data collection, analysis and the preparation.	Barandun J, 1998, COPEIA, P497, DOI 10.2307/1447450; Barandun Jonas, 1997, Amphibia-Reptilia, V18, P143, DOI 10.1163/156853897X00035; Barbaro L, 2001, BIODIVERS CONSERV, V10, P119, DOI 10.1023/A:1016629507196; Beebee TJC, 1997, BIOL CONSERV, V81, P215, DOI 10.1016/S0006-3207(97)00002-5; Benton T, 2011, NATURE, V480, P39, DOI 10.1038/480039d; Boix D, 2012, HYDROBIOLOGIA, V689, P1, DOI 10.1007/s10750-012-1015-2; Boll S, 2002, THESIS JULIUS MAXIMI; Boothby J, 1997, AQUAT CONSERV, V7, P127; Briggs J, 1994, BRIT WILDLIFE, V5, P273; Briggs Lars, 2001, Freshwater Forum, V17, P63; Crochet PA, 2004, BIOL CONSERV, V119, P297, DOI 10.1016/j.biocon.2003.12.004; Curado N, 2011, BIOL CONSERV, V144, P1610, DOI 10.1016/j.biocon.2011.02.011; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Demeter L, 2007, ANN LIMNOL-INT J LIM, V43, P101, DOI 10.1051/limn/2007016; Denoel M, 2007, ECOL APPL, V17, P302, DOI 10.1890/1051-0761(2007)017[0302:LTANC]2.0.CO;2; Dolman PM, 2008, CONSERV LETT, V5, P11; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dorner B, 1910, AZ ERDELYI SZASZOK M; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Feder M. E., 1992, ENV PHYSL AMPHIBIANS; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; Gollmann G, 1998, CURRENT STUDIES HERP, P139; Grootjans AP, 2002, HYDROBIOLOGIA, V478, P181, DOI 10.1023/A:1021086832201; Halley JM, 1996, J APPL ECOL, V33, P455, DOI 10.2307/2404977; Hartel T, 2008, NORTH-WEST J ZOOL, V4, P79; Hartel T, 2008, APPL HERPETOL, V5, P1, DOI 10.1163/157075408783489248; Hartel Tibor, 2007, Acta Zoologica Lituanica, V17, P56; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Hartel T, 2011, FRESHWATER BIOL, V56, P2288, DOI 10.1111/j.1365-2427.2011.02655.x; Hartel T, 2010, BIOL CONSERV, V143, P1118, DOI 10.1016/j.biocon.2010.02.006; Hull Andrew, 1997, P101; Jahn K, 1996, NATURSCHUTZREPORT, V11, P3246; Jeffries MJ, 2012, HYDROBIOLOGIA, V689, P11, DOI 10.1007/s10750-011-0678-4; Lofvenhaft K, 2004, LANDSCAPE URBAN PLAN, V68, P403, DOI 10.1016/S0169-2046(03)00154-3; Manteifel YB, 2002, ARCH HYDROBIOL, V153, P657; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Paracchini M.L., 2008, JRC SCI TECHNICAL RE, DOI DOI 10.2788/8891; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Plaiasu R, 2012, HERPETOL J, V22, P13; Putfarken D, 2008, APPL ANIM BEHAV SCI, V111, P54, DOI 10.1016/j.applanim.2007.05.012; Pyke CR, 2005, CONSERV BIOL, V19, P1619, DOI 10.1111/j.1523-1739.2005.00233.x; Scheffer M, 2006, OIKOS, V112, P227, DOI 10.1111/j.0030-1299.2006.14145.x; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; SINSCH U, 1995, AUST J ECOL, V20, P351, DOI 10.1111/j.1442-9993.1995.tb00550.x; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	52	44	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63649	10.1371/journal.pone.0063649	http://dx.doi.org/10.1371/journal.pone.0063649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704928	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200059
J	Vanderhasselt, MA; De Raedt, R; Brunoni, AR; Campanha, C; Baeken, C; Remue, J; Boggio, PS				Vanderhasselt, Marie-Anne; De Raedt, Rudi; Brunoni, Andre R.; Campanha, Camila; Baeken, Chris; Remue, Jonathan; Boggio, Paulo S.			tDCS over the Left Prefrontal Cortex Enhances Cognitive Control for Positive Affective Stimuli	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; IMPROVING WORKING-MEMORY; MAJOR DEPRESSION; NEGATIVE AFFECT; CONFLICT; STROOP; VALIDATION; VOLUNTEERS; PANAS; MOOD	Transcranial Direct Current Stimulation (tDCS) is a neuromodulation technique with promising results for enhancing cognitive information processes. So far, however, research has mainly focused on the effects of tDCS on cognitive control operations for non-emotional material. Therefore, our aim was to investigate the effects on cognitive control considering negative versus positive material. For this sham-controlled, within-subjects study, we selected a homogeneous sample of twenty-five healthy participants. By using behavioral measures and event related potentials (ERP) as indexes, we aimed to investigate whether a single session of anodal tDCS of the left dorsolateral prefrontal cortex (DLPFC) would have specific effects in enhancing cognitive control for positive and negative valenced stimuli. After tDCS over the left DLPFC (and not sham control stimulation), we observed more negative N450 amplitudes along with faster reaction times when inhibiting a habitual response to happy compared to sad facial expressions. Gender did not influence the effects of tDCS on cognitive control for emotional information. In line with the Valence Theory of side-lateralized activity, this stimulation protocol might have led to a left dominant (relative to right) prefrontal cortical activity, resulting in augmented cognitive control specifically for positive relative to negative stimuli. To verify that tDCS induces effects that are in line with all aspects of the well known Valence Theory, future research should investigate the effects of tDCS over the left vs. right DLPFC on cognitive control for emotional information.	[Vanderhasselt, Marie-Anne; De Raedt, Rudi; Remue, Jonathan] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Brunoni, Andre R.] Univ Sao Paulo, Clin Res Ctr, Univ Hosp, Sao Paulo, Brazil; [Brunoni, Andre R.] Univ Sao Paulo, Inst Psychol, Dept Neurosci, Sao Paulo, Brazil; [Campanha, Camila; Boggio, Paulo S.] Univ Prebiteriana Mackenzie, Social & Cognit Neurosci Lab, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Campanha, Camila; Boggio, Paulo S.] Univ Prebiteriana Mackenzie, Dev Disorders Program, Ctr Hlth & Biol Sci, Sao Paulo, Brazil; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; [Baeken, Chris] Univ Brussels, Brussels, Belgium; [Baeken, Chris] Univ Hosp UZBrussel, Dept Psychiat, Brussels, Belgium	Ghent University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Ghent University	Vanderhasselt, MA (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	MarieAnne.Vanderhasselt@UGent.be	Boggio, Paulo S/K-6272-2012; Baeken, Chris/D-6790-2013; De Raedt, Rudi/A-3269-2012; Remue, Jonathan/A-8112-2013; Brunoni, Andre R./H-8394-2012; Baeken, Chris/E-2074-2013	Boggio, Paulo S/0000-0002-6109-0447; De Raedt, Rudi/0000-0001-6781-4808; Remue, Jonathan/0000-0001-7012-6221; Brunoni, Andre R./0000-0002-6310-3571; Vanderhasselt, Marie-Anne/0000-0002-4045-1055	Research Foundation Flanders (FWO) [FWO08/PDO/168]; Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; CNPq [305718/2009-6]; FAPESP [2010/20063-9];  [BOF10/GOA/014]	Research Foundation Flanders (FWO)(FWO); Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control"; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); 	MAV (FWO08/PDO/168) is a postdoctoral research fellow of the Research Foundation Flanders (FWO). Preparation of this paper was also supported by Grant BOF10/GOA/014 for a Concerted Research Action of Ghent University (awarded to RDR). This work was also supported by the Ghent University Multidisciplinary Research Partnership "The integrative neuroscience of behavioral control" (CB). PSB is supported by a CNPq researcher grant (305718/2009-6). CC is supported by a PhD grant (FAPESP 2010/20063-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Baeken C, 2008, CLIN NEUROPHYSIOL, V119, P568, DOI 10.1016/j.clinph.2007.11.044; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2005, MOVEMENT DISORD, V20, P1178, DOI 10.1002/mds.20508; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brunoni AR, 2013, PSYCHONEURO IN PRESS; Campanella S, 2012, PSYCHIAT RES; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; De Raedt R, 2013, BIOL PSYCHO IN PRESS; Dutra S, 2012, J PSYCHIAT NEUROSCIE; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Lundqvist D., 1998, KAROLINSKA DIRECTED; Miniussi C, 2010, CORTEX, V46, P128, DOI 10.1016/j.cortex.2009.03.004; Mosimann UP, 2000, PSYCHIAT RES, V94, P251, DOI 10.1016/S0165-1781(00)00146-3; Mulquiney PG, 2011, CLIN NEUROPHYSIOL, V122, P2384, DOI 10.1016/j.clinph.2011.05.009; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2000, PSYCHOPHYSIOLOGY, V37, P179, DOI 10.1111/1469-8986.3720179; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2	30	66	67	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62219	10.1371/journal.pone.0062219	http://dx.doi.org/10.1371/journal.pone.0062219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704874	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200003
J	Zhao, L; Zhang, Y; Ji, PF; Zhang, XF; Zhao, ZX; Hou, GY; Huo, LH; Liu, GM; Li, C; Xu, P; Sun, XW				Zhao, Lan; Zhang, Yan; Ji, Peifeng; Zhang, Xiaofeng; Zhao, Zixia; Hou, Guangyuan; Huo, Linhe; Liu, Guiming; Li, Chao; Xu, Peng; Sun, Xiaowen			A Dense Genetic Linkage Map for Common Carp and Its Integration with a BAC-Based Physical Map	PLOS ONE			English	Article							CATFISH ICTALURUS-PUNCTATUS; COMPARATIVE GENOME ANALYSIS; CYPRINUS-CARPIO; END SEQUENCES; ATLANTIC SALMON; MICROSATELLITES; L.; CONSTRUCTION; GENERATION; IMPACT	Background: Common carp (Cyprinus carpio) is one of the most important aquaculture species with an annual global production of 3.4 million metric tons. It is also an important ornamental species as well as an important model species for aquaculture research. To improve the economically important traits of this fish, a number of genomic resources and genetic tools have been developed, including several genetic maps and a bacterial artificial chromosome (BAC)-based physical map. However, integrated genetic and physical maps are not available to study quantitative trait loci (QTL) and assist with fine mapping, positional cloning and whole genome sequencing and assembly. The objective of this study was to integrate the currently available BAC-based physical and genetic maps. Results: The genetic map was updated with 592 novel markers, including 312 BAC-anchored microsatellites and 130 SNP markers, and contained 1,209 genetic markers on 50 linkage groups, spanning 3,565.9 cM in the common carp genome. An integrated genetic and physical map of the common carp genome was then constructed, which was composed of 463 physical map contigs and 88 single BACs. Combined lengths of the contigs and single BACs covered a physical length of 498.75 Mb, or around 30% of the common carp genome. Comparative analysis between common carp and zebrafish genomes was performed based on the integrated map, providing more insights into the common carp specific whole genome duplication and segmental rearrangements in the genome. Conclusion: We integrated a BAC-based physical map to a genetic linkage map of common carp by anchoring BAC-associated genetic markers. The density of the genetic linkage map was significantly increased. The integrated map provides a tool for both genetic and genomic studies of common carp, which will help us to understand the genomic architecture of common carp and facilitate fine mapping and positional cloning of economically important traits for genetic improvement and modification.	[Zhao, Lan; Zhang, Yan; Ji, Peifeng; Zhao, Zixia; Hou, Guangyuan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Gen, Beijing, Peoples R China; [Zhang, Xiaofeng; Li, Chao; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China; [Zhao, Lan] Dalian Ocean Univ, Coll Life Sci & Technol, Dalian, Peoples R China; [Huo, Linhe; Liu, Guiming] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Dalian Ocean University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Gen, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Sun, Xiaowen/F-1516-2014; Zhao, Zi-Xia/AAM-8065-2021; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Peng/0000-0002-1531-5078; Zhao, Lan/0000-0003-2681-7695	National Department Public Benefit Research Foundation [200903045]; National High-tech Research & Development Program of China [2009AA10Z105, 2011AA100401]; China Ministry of Agriculture "948'' Program [2010-Z11, 2011-G12]; Research Foundation of Chinese Academy of Fishery Sciences [2009B002]	National Department Public Benefit Research Foundation; National High-tech Research & Development Program of China; China Ministry of Agriculture "948'' Program; Research Foundation of Chinese Academy of Fishery Sciences	This study was supported by the grants from National Department Public Benefit Research Foundation (No. 200903045), National High-tech Research & Development Program of China (No. 2009AA10Z105 and 2011AA100401), China Ministry of Agriculture "948'' Program (No. 2010-Z11 and 2011-G12) and Research Foundation of Chinese Academy of Fishery Sciences (No. 2009B002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Henkel CV, 2012, ZEBRAFISH, V9, P59, DOI 10.1089/zeb.2012.0773; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Katagiri T, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-89; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kroupova H, 2010, ENVIRON TOXICOL CHEM, V29, P535, DOI 10.1002/etc.84; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Liu D, 2010, MAR BIOTECHNOL, V12, P186, DOI 10.1007/s10126-009-9212-3; Liu H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-592; Lorenz S, 2010, ANIM GENET, V41, P48, DOI 10.1111/j.1365-2052.2009.01963.x; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Neilan BA, 1997, NUCLEIC ACIDS RES, V25, P2938, DOI 10.1093/nar/25.14.2938; Ng SHS, 2005, GENOMICS, V86, P396, DOI 10.1016/j.ygeno.2005.06.001; Ninwichian P, 2012, G3-GENES GENOM GENET, V2, P1233, DOI 10.1534/g3.112.003962; Ohno S., 1970, EVOLUTION GENE DUPLI; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Somridhivej B, 2008, AQUACULTURE, V275, P76, DOI 10.1016/j.aquaculture.2008.01.013; Sonesson AK, 2007, GENET SEL EVOL, V39, P301, DOI 10.1051/gse:2007005; Sun X, 2004, AQUACULTURE, V238, P8; Van Campenhout K, 2009, ENVIRON TOXICOL CHEM, V28, P209, DOI 10.1897/08-136.1; Wan YM, 2012, MOL BIOL REP, V39, P2215, DOI 10.1007/s11033-011-0970-4; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Wang SL, 2007, MAR BIOTECHNOL, V9, P701, DOI 10.1007/s10126-007-9021-5; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2006, ANIM GENET, V37, P321, DOI 10.1111/j.1365-2052.2006.01453.x; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yue GH, 2004, AQUACULTURE, V234, P85, DOI 10.1016/j.aquaculture.2003.12.021; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027612; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhang Y, 2011, MAR BIOTECHNOL, V13, P376, DOI 10.1007/s10126-010-9307-x; Zhang YJ, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-169; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x; Zhou Jianfeng, 2004, Genetika, V40, P1389	52	25	27	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63928	10.1371/journal.pone.0063928	http://dx.doi.org/10.1371/journal.pone.0063928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704958	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200089
J	Perreault, M; Feng, G; Will, S; Gareski, T; Kubasiak, D; Marquette, K; Vugmeyster, Y; Unger, TJ; Jones, J; Qadri, A; Hahm, S; Sun, Y; Rohde, CM; Zwijnenberg, R; Paulsen, J; Gimeno, RE				Perreault, Mylene; Feng, Guo; Will, Sarah; Gareski, Tiffany; Kubasiak, David; Marquette, Kimberly; Vugmeyster, Yulia; Unger, Thaddeus J.; Jones, Juli; Qadri, Ariful; Hahm, Seung; Sun, Ying; Rohde, Cynthia M.; Zwijnenberg, Raphael; Paulsen, Janet; Gimeno, Ruth E.			Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y; OBESITY; RECEPTORS; DELETION; AGONISTS; NEURONS; PROTEIN; POTENT	Strong genetic data link the Tyrosine kinase receptor B (TrkB) and its major endogenous ligand brain-derived neurotrophic factor (BDNF) to the regulation of energy homeostasis, with loss-of-function mutations in either gene causing severe obesity in both mice and humans. It has previously been reported that peripheral administration of the endogenous TrkB agonist ligand neurotrophin-4 (NT-4) profoundly decreases food intake and body weight in rodents, while paradoxically increasing these same parameters in monkeys. We generated a humanized TrkB agonist antibody, TAM-163, and characterized its therapeutic potential in several models of type 2 diabetes and obesity. In vitro, TAM-163 bound to human and rodent TrkB with high affinity, activated all aspects of the TrkB signaling cascade and induced TrkB internalization and degradation in a manner similar to BDNF. In vivo, peripheral administration of TAM-163 decreased food intake and/or body weight in mice, rats, hamsters, and dogs, but increased food intake and body weight in monkeys. The magnitude of weight change was similar in rodents and non-human primates, occurred at doses where there was no appreciable penetration into deep structures of the brain, and could not be explained by differences in exposures between species. Rather, peripherally administered TAM-163 localized to areas in the hypothalamus and the brain stem located outside the blood-brain barrier in a similar manner between rodents and non-human primates, suggesting differences in neuroanatomy across species. Our data demonstrate that a TrkB agonist antibody, administered peripherally, causes species-dependent effects on body weight similar to the endogenous TrkB ligand NT-4. The possible clinical utility of TrkB agonism in treating weight regulatory disorder, such as obesity or cachexia, will require evaluation in man.	[Perreault, Mylene; Feng, Guo; Will, Sarah; Gareski, Tiffany; Kubasiak, David; Unger, Thaddeus J.; Jones, Juli; Qadri, Ariful; Hahm, Seung; Gimeno, Ruth E.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Marquette, Kimberly; Sun, Ying; Paulsen, Janet] Pfizer Inc, GBT, Cambridge, MA USA; [Vugmeyster, Yulia] Pfizer Inc, PDM, Andover, MA USA; [Rohde, Cynthia M.] Pfizer Inc, DSRD, Andover, MA USA; [Zwijnenberg, Raphael] Pfizer Inc, Ft Dodge Anim Hlth, Princeton, NJ USA	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Perreault, M (corresponding author), Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA.	mylene.perreault@pfizer.com						Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Ganong WF, 2000, CLIN EXP PHARMACOL P, V27, P422, DOI 10.1046/j.1440-1681.2000.03259.x; Gray J, 2006, DANCING TIMES, V96, P55; Grove KL, 2003, MOL BRAIN RES, V113, P133, DOI 10.1016/S0169-328X(03)00093-7; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Lin JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001900; Menyhert J, 2007, ENDOCRINOLOGY, V148, P4276, DOI 10.1210/en.2007-0390; MURAGAKI Y, 1995, J COMP NEUROL, V356, P387, DOI 10.1002/cne.903560306; Nakagawa T, 2003, INT J OBESITY, V27, P557, DOI 10.1038/sj.ijo.0802265; Nakagawa T, 2002, DIABETES-METAB RES, V18, P185, DOI 10.1002/dmrr.290; Picha KM, 2008, DIABETES, V57, P1926, DOI 10.2337/db07-1775; Qian MD, 2006, J NEUROSCI, V26, P9394, DOI 10.1523/JNEUROSCI.1118-06.2006; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Shibayama E, 1996, AM J PATHOL, V148, P1807; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Tsao D, 2008, ENDOCRINOLOGY, V149, P1038, DOI 10.1210/en.2007-1166; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vugmeyster Y, 2010, J PHARM SCI-US, V99, P1028, DOI 10.1002/jps.21855; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Wellmer A, 2001, J PERIPHER NERV SYST, V6, P204, DOI 10.1046/j.1529-8027.2001.01019.x; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Zhang J, 2006, NEUROSIGNALS, V15, P26, DOI 10.1159/000094385; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200	28	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e62616	10.1371/journal.pone.0062616	http://dx.doi.org/10.1371/journal.pone.0062616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700410	Green Submitted, gold, Green Published			2022-12-25	WOS:000319966400008
J	Perrin, RJ; Payton, JE; Malone, JP; Gilmore, P; Davis, AE; Xiong, CJ; Fagan, AM; Townsend, RR; Holtzman, DM				Perrin, Richard J.; Payton, Jacqueline E.; Malone, James P.; Gilmore, Petra; Davis, Alan E.; Xiong, Chengjie; Fagan, Anne M.; Townsend, R. Reid; Holtzman, David M.			Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation	PLOS ONE			English	Article							DIFFERENTIAL PROTEIN EXPRESSION; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; ENTORHINAL CORTEX; PREDICTION; DIAGNOSIS; DECLINE; MARKERS; MS/MS	Background: Biomarkers are required for pre-symptomatic diagnosis, treatment, and monitoring of neurodegenerative diseases such as Alzheimer's disease. Cerebrospinal fluid (CSF) is a favored source because its proteome reflects the composition of the brain. Ideal biomarkers have low technical and inter-individual variability (subject variance) among control subjects to minimize overlaps between clinical groups. This study evaluates a process of multi-affinity fractionation (MAF) and quantitative label-free liquid chromatography tandem mass spectrometry (LC-MS/MS) for CSF biomarker discovery by (1) identifying reparable sources of technical variability, (2) assessing subject variance and residual technical variability for numerous CSF proteins, and (3) testing its ability to segregate samples on the basis of desired biomarker characteristics. Methods/Results: Fourteen aliquots of pooled CSF and two aliquots from six cognitively normal individuals were randomized, enriched for low-abundance proteins by MAF, digested endoproteolytically, randomized again, and analyzed by nano-LC-MS. Nano-LC-MS data were time and m/z aligned across samples for relative peptide quantification. Among 11,433 aligned charge groups, 1360 relatively abundant ones were annotated by MS2, yielding 823 unique peptides. Analyses, including Pearson correlations of annotated LC-MS ion chromatograms, performed for all pairwise sample comparisons, identified several sources of technical variability: i) incomplete MAF and keratins; ii) globally- or segmentally-decreased ion current in isolated LC-MS analyses; and iii) oxidized methionine-containing peptides. Exclusion of these sources yielded 609 peptides representing 81 proteins. Most of these proteins showed very low coefficients of variation (CV<5%) whether they were quantified from the mean of all or only the 2 most-abundant peptides. Unsupervised clustering, using only 24 proteins selected for high subject variance, yielded perfect segregation of pooled and individual samples. Conclusions: Quantitative label-free LC-MS/MS can measure scores of CSF proteins with low technical variability and can segregate samples according to desired criteria. Thus, this technique shows potential for biomarker discovery for neurological diseases.	[Perrin, Richard J.] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA; [Payton, Jacqueline E.] Washington Univ, Sch Med, Div Lab & Genom Med, St Louis, MO USA; [Perrin, Richard J.; Payton, Jacqueline E.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Townsend, R. Reid; Holtzman, David M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Xiong, Chengjie] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Perrin, Richard J.; Xiong, Chengjie; Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimer Dis Res Ctr, St Louis, MO USA; [Perrin, Richard J.; Fagan, Anne M.; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Perrin, RJ (corresponding author), Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA.	rperrin@path.wustl.edu			National Institute of Aging of the National Institutes of Health (NIH) [1RC1AG035654, P01-AG026276, P01-AG03991, P50-AG05681]; National Institute of Neurological Disorders and Stroke of the NIH [1P30NS057105]; National Center for Research Resources of the NIH [P41RR000954, UL1 RR024992]; NIH Roadmap for Medical Research, NIH Neuroscience Blueprint Core Grant [P30 NS057105]; Silvio O.Conte Digestive Diseases Core Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri; Center Support Grant [P30 DK52574]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681, RC1AG035654, P01AG026276] Funding Source: NIH RePORTER	National Institute of Aging of the National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke of the NIH; National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research, NIH Neuroscience Blueprint Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silvio O.Conte Digestive Diseases Core Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri; Center Support Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported with grants 1RC1AG035654, P01-AG026276, P01-AG03991, P50-AG05681 from the National Institute of Aging of the National Institutes of Health (NIH) and from the National Institute of Neurological Disorders and Stroke of the NIH (1P30NS057105). The Proteomics Core Laboratory is supported with grants P41RR000954 and UL1 RR024992 from the National Center for Research Resources of the NIH, and NIH Roadmap for Medical Research, NIH Neuroscience Blueprint Core Grant P30 NS057105 to Washington University, and the Silvio O.Conte Digestive Diseases Core Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, which is supported in part by Center Support Grant P30 DK52574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Boja E, 2011, J PROTEOME RES, V10, P66, DOI 10.1021/pr100532g; Carlson NE, 2008, NEUROLOGY, V70, P828, DOI 10.1212/01.wnl.0000280577.43413.d9; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Choe LH, 2002, ELECTROPHORESIS, V23, P2247, DOI 10.1002/1522-2683(200207)23:14<2247::AID-ELPS2247>3.0.CO;2-M; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; Deutsch EW, 2008, PHYSIOL GENOMICS, V33, P18, DOI 10.1152/physiolgenomics.00298.2007; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2012, BIOMARK MED, V6, P455, DOI [10.2217/bmm.12.42, 10.2217/BMM.12.42]; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Hansson Sara Folkesson, 2004, Proteome Sci, V2, P7, DOI 10.1186/1477-5956-2-7; Holtzman DM, 2011, SCI TRANSL MED, V3; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Neubert H, 2008, J PROTEOME RES, V7, P2270, DOI 10.1021/pr700705u; Ogata Y, 2007, PROTEOMICS, V7, P3726, DOI 10.1002/pmic.200700455; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; Roche SL, 2010, PEDIATR TRANSPLANT, V14, P159, DOI 10.1111/j.1399-3046.2009.01205.x; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Tang KQ, 2004, J AM SOC MASS SPECTR, V15, P1416, DOI 10.1016/j.jasms.2004.04.034; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tolboom N, 2009, J NUCL MED, V50, P1464, DOI 10.2967/jnumed.109.064360; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	61	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64314	10.1371/journal.pone.0064314	http://dx.doi.org/10.1371/journal.pone.0064314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700471	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400054
J	Thuring, A; Brannstrom, KJ; Ewerlof, M; Hernandez-Andrade, E; Ley, D; Lingman, G; Liuba, K; Marsal, K; Jansson, T				Thuring, Ann; Brannstrom, K. Jonas; Ewerlof, Maria; Hernandez-Andrade, Edgar; Ley, David; Lingman, Goran; Liuba, Karina; Marsal, Karel; Jansson, Tomas			Operator Auditory Perception and Spectral Quantification of Umbilical Artery Doppler Ultrasound Signals	PLOS ONE			English	Article							FLOW VELOCITY WAVEFORMS; BLOOD-FLOW; FETAL ANEMIA; RESISTANCE; MODEL	Objective: An experienced sonographer can by listening to the Doppler audio signals perceive various timbres that distinguish different types of umbilical artery flow despite an unchanged pulsatility index (PI). Our aim was to develop an objective measure of the Doppler audio signals recorded from fetoplacental circulation in a sheep model. Methods: Various degrees of pathological flow velocity waveforms in the umbilical artery, similar to those in human complicated pregnancies, were induced by microsphere embolization of the placental bed (embolization model, 7 lamb fetuses, 370 Doppler recordings) or by fetal hemodilution (anemia model, 4 lamb fetuses, 184 recordings). A subjective 11-step operator auditory scale (OAS) was related to conventional Doppler parameters, PI and time average mean velocity (TAM), and to sound frequency analysis of Doppler signals (sound frequency with the maximum energy content [MAX(peak)] and frequency band at maximum level minus 15 dB [MAX(peak-15dB)] over several heart cycles). Results: We found a negative correlation between the OAS and PI: median Rho -0.73 (range -0.35- -0.94) and -0.68 (range -0.57- -0.78) in the two lamb models, respectively. There was a positive correlation between OAS and TAM in both models: median Rho 0.80 (range 0.58-0.95) and 0.90 (range 0.78-0.95), respectively. A strong correlation was found between TAM and the results of sound spectrum analysis; in the embolization model the median r was 0.91 (range 0.88-0.97) for MAX(peak) and 0.91 (range 0.82-0.98) for MAX(peak-15 dB). In the anemia model, the corresponding values were 0.92 (range 0.78-0.96) and 0.96 (range 0.89-0.98), respectively. Conclusion: Audio-spectrum analysis reflects the subjective perception of Doppler sound signals in the umbilical artery and has a strong correlation to TAM-velocity. This information might be of importance for clinical management of complicated pregnancies as an addition to conventional Doppler parameters.	[Thuring, Ann; Lingman, Goran; Liuba, Karina; Marsal, Karel] Lund Univ, Dept Obstet & Gynecol, Clin Sci Lund, Lund, Sweden; [Brannstrom, K. Jonas] Lund Univ, Dept Logoped Phoniatr & Audiol, Lund, Sweden; [Ewerlof, Maria; Jansson, Tomas] Lund Univ, Dept Biomed Engn, Clin Sci Lund, Lund, Sweden; [Hernandez-Andrade, Edgar] Wayne State Univ, Perinatol Res Branch, NICHHD, NIH, Detroit, MI USA; [Ley, David] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden	Lund University; Lund University; Lund University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Lund University	Thuring, A (corresponding author), Lund Univ, Dept Obstet & Gynecol, Clin Sci Lund, Lund, Sweden.	ann.thuring@med.lu.se	Ewerlöf, Maria/GYU-7608-2022	Ewerlöf, Maria/0000-0001-8128-871X	Swedish government; Swedish Research Council [14940]	Swedish government; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Ann Thuring, K. Jonas Brannstrom and David Ley were supported by the grants to researchers in the Public Health Service from the Swedish government. The study was supported by the Swedish Research Council (grant No. 14940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, ULTRASOUND OBST GYN, V25, P444, DOI 10.1002/uog.1880; Alcantara JI, 1996, J ACOUST SOC AM, V100, P2382, DOI 10.1121/1.417948; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; EIKNES SH, 1982, J BIOMED ENG, V4, P28, DOI 10.1016/0141-5425(82)90023-1; EIKNES SH, 1984, ULTRASOUND MED BIOL, V10, P329, DOI 10.1016/0301-5629(84)90167-4; Fastl H., 2007, PSYCHOACOUSTICS, Vthird; GOSLING RG, 1971, ANGIOLOGY, V22, P52, DOI 10.1177/000331977102200109; GUDMUNDSSON S, 1988, ACTA OBSTET GYN SCAN, V67, P347, DOI 10.3109/00016348809004234; Jensen JA., 1996, ESTIMATION BLOOD VEL; Madazli R, 2003, PLACENTA, V24, P510, DOI 10.1053/plac.2002.0945; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Marsal K, 2009, BEST PRACT RES CL OB, V23, P857, DOI 10.1016/j.bpobgyn.2009.08.011; Moraes R., 1995, J VASCULAR INVEST, V1, P126; MORROW RJ, 1989, AM J OBSTET GYNECOL, V161, P1055, DOI 10.1016/0002-9378(89)90783-7; NICOLAIDES KH, 1990, AM J OBSTET GYNECOL, V162, P209, DOI 10.1016/0002-9378(90)90852-X; Reference manual: HDI 5000 ultrasound system, 2000, ATL ULTR, P15; THOMPSON RS, 1990, ULTRASOUND MED BIOL, V16, P449, DOI 10.1016/0301-5629(90)90167-B; Thompson RS, 1986, ULTRASOUND MED BIOL, V11, P845; TRUDINGER BJ, 1985, BRIT J OBSTET GYNAEC, V92, P23, DOI 10.1111/j.1471-0528.1985.tb01044.x; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64033	10.1371/journal.pone.0064033	http://dx.doi.org/10.1371/journal.pone.0064033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700452	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400044
J	Ali, AH; Belachew, T; Yami, A; Ayen, WY				Ali, Alima Hassen; Belachew, Tefera; Yami, Alemeshet; Ayen, Wubeante Yenet			Anti-Tuberculosis Drug Induced Hepatotoxicity among TB/HIV Co-Infected Patients at Jimma University Hospital, Ethiopia: Nested Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; ANTIRETROVIRAL THERAPY; HIV; TUBERCULOSIS; TOXICITY; MANAGEMENT; RIFAMPICIN; HEPATITIS; SEVERITY; CARE	Background: This study was carried out to determine the incidence and predictors of anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia. Methods/Principal Findings: A nested case-control study was conducted by reviewing charts of all TB/HIV co-infected patients who commenced anti-TB treatment from January 2008 to December 2011 at Jimma University Hospital. Patients who had developed hepatotoxicity after at least 5 days of standard doses of anti-TB drug therapy were labeled as "cases" and those without hepatotoxicity were "controls". Each case with anti-TB drug induced hepatotoxicity was compared with 3 controls selected randomly from the cohort. From a cohort of 296 TB/HIV co-infected patients 8 were excluded from the study as the causality between anti-TB drugs and hepatotoxicity was not confirmed, 33 had developed hepatotoxicity. On bivariate logistic regression analysis, body mass index (BMI) <18.5 Kg/m(2) [P = 0.01; OR (95% CI): 3.6 (1.4-9.5)], disseminated pulmonary TB [P = 0.00; OR (95% CI): 5.6 (2.2-14.6)], CD4 count <= 50 [P = 0.016; OR (95% CI): 3.6(1.27-10.23)] and WHO stage 4 [P = 0.004, OR (95%CI): 3.8 (1.68-8.77)] were significantly associated with anti-TB drug induced hepatotoxicity. Predictor variables with p-value <0.05 by bivariate analysis were analyzed using multivariable logistic regression analysis and identified disseminated pulmonary TB [P = 0.001; AOR (95%CI) = 5.6 (2.1-15.0)] and BMI <18.5 [P = 0.014; AOR (95%CI) = 3.6 (1.3-10.1)] as independent predictors of anti-TB drug induced hepatotoxicity. Conclusions: The incidence of anti-TB drug induced hepatotoxicity was 11.5%. The results suggest that in the presence of disseminated pulmonary TB and/or BMI <18.5 Kg/m(2), TB/HIV co-infected patients should be closely followed for the occurrence of hepatotoxicity during the intensive phase of TB treatment to prevent morbidity and mortality.	[Ali, Alima Hassen; Ayen, Wubeante Yenet] Jimma Univ, Sch Pharm, Jimma, Ethiopia; [Belachew, Tefera] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia; [Yami, Alemeshet] Jimma Univ, Dept Internal Med, Jimma, Ethiopia	Jimma University; Jimma University; Jimma University	Ayen, WY (corresponding author), Jimma Univ, Sch Pharm, Jimma, Ethiopia.	wubeante.yenet@ju.edu.et	Belachew, Tefera/AAO-5877-2020		Jimma University Student Research Program	Jimma University Student Research Program	This work was as partial fulfilment of the requirements for the degree of Master science in clinical pharmacy by Alima Hassen. The study was funded by Jimma University Student Research Program, and the program did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Burman WJ, 2005, CLIN CHEST MED, V26, P283, DOI 10.1016/j.ccm.2005.02.002; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P1112, DOI 10.1164/ajrccm.164.7.2109052; Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167; Durand F, 1996, DRUG SAFETY, V15, P394, DOI 10.2165/00002018-199615060-00004; Javadi MR, 2007, PHARMACOEPIDEM DR S, V16, P1104, DOI 10.1002/pds.1468; Kalsi SS, 2011, OPEN ACCESS EMERG M, V3, P87, DOI 10.2147/OAEM.S24963; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Khalili H, 2009, DARU, V17, P163; Khoharo HK, 2010, J LIAQUAT UNIV MED H, V9, P84; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Makhlouf HA, 2008, HEPATOL INT, V2, P353, DOI 10.1007/s12072-008-9085-y; Manosuthi W, 2006, AIDS, V20, P131, DOI 10.1097/01.aids.0000196181.18916.9b; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Marzuki OA, 2008, SINGAP MED J, V49, P688; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; NIN, 1989, BMI MORT RAT 10 YEAR; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; PARTHASARATHY R, 1986, TUBERCLE, V67, P99, DOI 10.1016/0041-3879(86)90003-6; Pukenyte E, 2007, INT J TUBERC LUNG D, V11, P78; Senaratne W. V., 2006, CEYLON MEDICAL JOURNAL, V51, P9; Shakya R, 2004, ANN PHARMACOTHER, V38, P1074, DOI 10.1345/aph.1D525; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sharifzadeh M, 2005, PHARMACOL RES, V51, P353, DOI 10.1016/j.phrs.2004.10.009; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; de Lima MDS, 2012, CAD SAUDE PUBLICA, V28, P698, DOI 10.1590/S0102-311X2012000400009; Tahaoglu K, 2001, INT J TUBERC LUNG D, V5, P65; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Walker UA, 2007, CURR OPIN HIV AIDS, V2, P293, DOI 10.1097/COH.0b013e328122dbaa; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	32	26	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64622	10.1371/journal.pone.0064622	http://dx.doi.org/10.1371/journal.pone.0064622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696901	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900103
J	Bae, C; Kim, SM; Lee, DJ; Choi, D				Bae, Chungyun; Kim, Su-min; Lee, Dong Ju; Choi, Doil			Multiple Classes of Immune-Related Proteases Associated with the Cell Death Response in Pepper Plants	PLOS ONE			English	Article							TOBACCO RATTLE VIRUS; NICOTIANA-BENTHAMIANA; GENOME SEQUENCE; PROLYL AMINOPEPTIDASE; PSEUDOMONAS-SYRINGAE; NEGATIVE REGULATOR; POSITIVE REGULATOR; CYSTEINE PROTEASES; ASPARTIC PROTEASE; GENE-FUNCTION	Proteases regulate a large number of biological processes in plants, such as metabolism, physiology, growth, and defense. In this study, we carried out virus-induced gene silencing assays with pepper cDNA clones to elucidate the biological roles of protease superfamilies. A total of 153 representative protease genes from pepper cDNA were selected and cloned into a Tobacco rattle virus-ligation independent cloning vector in a loss-of-function study. Silencing of 61 proteases resulted in altered phenotypes, such as the inhibition of shoot growth, abnormal leaf shape, leaf color change, and lethality. Furthermore, the silencing experiments revealed that multiple proteases play a role in cell death and immune response against avirulent and virulent pathogens. Among these 153 proteases, 34 modulated the hypersensitive cell death response caused by infection with an avirulent pathogen, and 16 proteases affected disease symptom development caused by a virulent pathogen. Specifically, we provide experimental evidence for the roles of multiple protease genes in plant development and immune defense following pathogen infection. With these results, we created a broad sketch of each protease function. This information will provide basic information for further understanding the roles of the protease superfamily in plant growth, development, and defense.	[Bae, Chungyun; Kim, Su-min; Choi, Doil] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea; [Lee, Dong Ju] Chonnam Natl Univ, Higher Educ Ctr Bioregulator Res, Kwangju, South Korea	Seoul National University (SNU); Chonnam National University	Choi, D (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea.	doil@snu.ac.kr	Choi, Doil/F-5002-2011		National Research Foundation of the Korea Ministry of Education, Science and Technology [2010-0015105]; Agricultural Genome Center of Biogreen21 for the Next Generation Program, RDA of the Korean Government [PJ008199012012]	National Research Foundation of the Korea Ministry of Education, Science and Technology; Agricultural Genome Center of Biogreen21 for the Next Generation Program, RDA of the Korean Government	This work was supported by grants from the National Research Foundation of the Korea Ministry of Education, Science and Technology (project number 2010-0015105), and the Agricultural Genome Center of Biogreen21 for the Next Generation Program, RDA of the Korean Government (project number PJ008199012012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; Baek KH, 2008, PLANT PATHOLOGY J, V24, P367, DOI 10.5423/PPJ.2008.24.4.367; BARTA TM, 1992, J BACTERIOL, V174, P3021, DOI 10.1128/JB.174.9.3021-3029.1992; Becraft PW, 2000, DEVELOPMENT, V127, P4039; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Chen FQ, 1997, PLANT MOL BIOL, V35, P821, DOI 10.1023/A:1005833207707; Chung E, 2004, MOL CELLS, V17, P377; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Johnson KL, 2005, PLANT J, V44, P114, DOI 10.1111/j.1365-313X.2005.02514.x; Kang S, 2010, PLANT PATHOLOGY J, V26, P402, DOI 10.5423/PPJ.2010.26.4.402; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kieselbach T, 2003, PHYSIOL PLANTARUM, V119, P337, DOI 10.1034/j.1399-3054.2003.00199.x; Kim H, 2008, I S MOD ANAL SIM COM, P181, DOI 10.1186/1471-2229-8-101; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Mahon CS, 2009, MICROBIOL-SGM, V155, P3673, DOI 10.1099/mic.0.030940-0; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Mendieta JR, 2006, MICROBIOL-SGM, V152, P2039, DOI 10.1099/mic.0.28816-0; Piszczek E, 2007, ACTA PHYSIOL PLANT, V29, P391, DOI 10.1007/s11738-007-0086-6; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Rogers HJ, 2005, CURR TOP DEV BIOL, V71, P225, DOI 10.1016/S0070-2153(05)71007-3; Ross S, 2005, PLANT PHYSIOL, V137, P623, DOI 10.1104/pp.104.056861; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Shindo T, 2008, MOL PLANT PATHOL, V9, P119, DOI [10.1111/j.1364-3703.2007.00439.x, 10.1111/J.1364-3703.2007.00439.X]; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Snoeijers SS, 2000, EUR J PLANT PATHOL, V106, P493, DOI 10.1023/A:1008720704105; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Szawlowska U, 2012, BIOCHEM BIOPH RES CO, V419, P104, DOI 10.1016/j.bbrc.2012.01.140; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; Tanaka H, 2007, DEVELOPMENT, V134, P1643, DOI 10.1242/dev.003533; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; TURNER JG, 1984, PHYSIOL PLANT PATHOL, V25, P55, DOI 10.1016/0048-4059(84)90017-1; TURNER JG, 1982, PHYSIOL PLANT PATHOL, V20, P223, DOI 10.1016/0048-4059(82)90087-X; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Wan JX, 1998, PLANT J, V15, P459, DOI 10.1046/j.1365-313X.1998.00224.x; Wang CC, 2006, FUNCTIONAL PLANT BIO, V33, pCC; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Willemoes M, 2005, FEBS J, V272, P856, DOI 10.1111/j.1742-4658.2004.04525.x; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Xia YJ, 2004, EMBO J, V23, P980, DOI 10.1038/sj.emboj.7600086; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang P, 2007, PLANT J, V51, P441, DOI 10.1111/j.1365-313X.2007.03154.x; Yeom SI, 2012, PLANT J, V69, P755, DOI 10.1111/j.1365-313X.2011.04828.x; Yi SY, 2010, NEW PHYTOL, V185, P701, DOI 10.1111/j.1469-8137.2009.03095.x; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; Yoon J, 2009, NEW PHYTOL, V184, P71, DOI 10.1111/j.1469-8137.2009.02967.x; Zhong R, 2003, PLANT J, V34, P802, DOI 10.1046/j.1365-313X.2003.01772.x; Zhu H, 2012, PLANT PHYSL	65	9	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63533	10.1371/journal.pone.0063533	http://dx.doi.org/10.1371/journal.pone.0063533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696830	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900038
J	Nooh, MM; Naren, AP; Kim, SJ; Xiang, YK; Bahouth, SW				Nooh, Mohammed M.; Naren, Anjaparavanda P.; Kim, Sung-Jin; Xiang, Yang K.; Bahouth, Suleiman W.			SAP97 Controls the Trafficking and Resensitization of the Beta-1-Adrenergic Receptor through Its PDZ2 and I3 Domains	PLOS ONE			English	Article							HUMAN BETA(1)-ADRENERGIC RECEPTOR; SYNAPSE-ASSOCIATED PROTEIN-97; D-ASPARTATE RECEPTORS; AMPA RECEPTORS; MEMBRANE TRAFFICKING; GLUTAMATE RECEPTORS; CARDIAC MYOCYTES; KINASE; PHOSPHORYLATION; SUBUNIT	Previous studies have determined that the type-1 PDZ sequence at the extreme carboxy-terminus of the beta(1)-adrenergic receptor (beta(1)-AR) binds SAP97 and AKAP79 to organize a scaffold involved in trafficking of the beta(1)-AR. In this study we focused on characterizing the domains in SAP97 that were involved in recycling and resensitization of the beta(1)-AR in HEK-293 cells. Using a SAP97 knockdown and rescue strategy, we determined that PDZ-deletion mutants of SAP97 containing PDZ2 rescued the recycling and resensitization of the beta(1)-AR. Among the three PDZs of SAP97, PDZ2 displayed the highest affinity in binding to the beta(1)-AR. Expression of isolated PDZ2, but not the other PDZs, inhibited the recycling of the beta(1)-AR by destabilizing the macromolecular complex involved in trafficking and functional resensitization of the beta(1)-AR. In addition to its PDZs, SAP97 contains other protein interacting domains, such as the I3 sequence in the SRC homology-3 (SH3) domain, which binds to AKAP79. Deletion of I3 from SAP97 (DI3-SAP97) did not affect the binding of SAP97 to the beta(1)-AR. However, DI3-SAP97 could not rescue the recycling of the beta(1)-AR because it failed to incorporate AKAP79/PKA into the SAP97-beta(1)-AR complex. Therefore, bipartite binding of SAP97 to the beta(1)-AR and to AKAP79 is necessary for SAP97-mediated effects on recycling, externalization and functional resensitization of the beta(1)-AR. These data establish a prominent role for PDZ2 and I3 domains of SAP97 in organizing the beta(1)-adrenergic receptosome involved in connecting the beta(1)-AR to trafficking and signaling networks.	[Nooh, Mohammed M.; Bahouth, Suleiman W.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Nooh, Mohammed M.] Cairo Univ, Sch Pharm, Dept Biochem, Cairo, Egypt; [Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Kim, Sung-Jin; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Davis	Bahouth, SW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	sbahouth@uthsc.edu		Nooh, Mohammed/0000-0001-9794-4099	National Institutes of Health [HL-085848, HL-82846, 12EIA8410007]; NATIONAL EYE INSTITUTE [P30EY013080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846, R01HL085848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant by HL-085848 to SWB and HL-82846, AHA 12EIA8410007 to (YKX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Devic E, 2001, MOL PHARMACOL, V60, P577; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gardner LA, 2011, CELL SIGNAL, V23, P46, DOI 10.1016/j.cellsig.2010.07.020; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; He JQ, 2004, J BIOL CHEM, V279, P50190, DOI 10.1074/jbc.M404876200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Liu Y, 2007, BIOCHEMISTRY-US, V46, P10864, DOI 10.1021/bi700879k; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mori K, 1998, J HUM GENET, V43, P123, DOI 10.1007/s100380050052; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; STILES GL, 1984, PHYSIOL REV, V64, P661, DOI 10.1152/physrev.1984.64.2.661; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wang L, 2005, J BIOL CHEM, V280, P26992, DOI 10.1074/jbc.M503555200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu HJ, 1998, J CELL SCI, V111, P2365; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63379	10.1371/journal.pone.0063379	http://dx.doi.org/10.1371/journal.pone.0063379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696820	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900032
J	Soda, K; Kano, Y; Chiba, F; Koizumi, K; Miyaki, Y				Soda, Kuniyasu; Kano, Yoshihiko; Chiba, Fumihiro; Koizumi, Kei; Miyaki, Yuichiro			Increased Polyamine Intake Inhibits Age-Associated Alteration in Global DNA Methylation and 1,2-Dimethylhydrazine-Induced Tumorigenesis	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE ODC; ADENOSYL-L-METHIONINE; SPERMINE SYNTHASE; SACCHAROMYCES-CEREVISIAE; NATURAL POLYAMINE; LFA-1 EXPRESSION; CELL-ADHESION; GROWTH; MOUSE; RAT	Polyamines (spermine and spermidine) play many important roles in cellular function and are supplied from the intestinal lumen. We have shown that continuous high polyamine intake inhibits age-associated pathologies in mice. The mechanism by which polyamines elicit these effects was examined. Twenty-four week old Jc1:ICR male mice were fed one of three experimental chows containing different polyamine concentrations. Lifetime intake of high polyamine chow, which had a polyamine content approximately three times higher than regular chow, elevated polyamine concentrations in whole blood, suppressed age-associated increases in pro-inflammatory status, decreased age-associated pathological changes, inhibited age-associated global alteration in DNA methylation status and reduced the mortality in aged mice. Exogenous spermine augmented DNA methyltransferase activity in Jurkat and HT-29 cells and inhibited polyamine deficiency-induced global alteration in DNA methylation status in vitro. In addition, increased polyamine intake was associated with a decreased incidence of colon tumors in BALB/c mice after 1,2-demethylhydrazine administration; 12 mice (60%) in the low polyamine group developed tumors, compared with only 5 mice (25%) in the high polyamine group (Fisher's exact probability = 0.027, p = 0.025). However, increased polyamine intake accelerated the growth of established tumors; maximal tumor diameter in the Low and High groups was 3.85 +/- 0.90 mm and 5.50 +/- 1.93 mm, respectively (Mann-Whitney test, p = 0.039). Spermine seems to play important roles in inhibiting age-associated and polyamine-deficient induced abnormal gene methylation as well as pathological changes including tumorigenesis.	[Soda, Kuniyasu] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Res Inst, Saitama, Japan; [Soda, Kuniyasu; Kano, Yoshihiko; Chiba, Fumihiro] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; [Koizumi, Kei; Miyaki, Yuichiro] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan	Jichi Medical University; Jichi Medical University; Hamamatsu University School of Medicine	Soda, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Res Inst, Saitama, Japan.	soda@jichi.ac.jp			JKA through its promotion funds from KEIRIN RACE	JKA through its promotion funds from KEIRIN RACE	This publication was subsidized by JKA through its promotion funds from KEIRIN RACE (http://www.keirin-autorace.or.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYER HS, 1992, J LAB CLIN MED, V119, P38; BINH PNT, 2010, NUTR DIETARY SUPPLEM, V3, P1; Brodal BP, 1999, J NUTR BIOCHEM, V10, P700, DOI 10.1016/S0955-2863(99)00058-3; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P13869, DOI 10.1073/pnas.1835918100; CHIRICOLO M, 1995, GERONTOLOGY, V41, P227; CLIFFORD A, 1995, CANCER RES, V55, P1680; DANZIN C, 1982, BIOCHEM J, V202, P175, DOI 10.1042/bj2020175; DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0; Ding ZM, 1999, J IMMUNOL, V163, P5029; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Fujisawa S, 2005, ANTICANCER RES, V25, P965; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HIBSHOOSH H, 1991, ONCOGENE, V6, P739; Kano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056056; Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015; Lorenz B, 1998, HUM MOL GENET, V7, P541, DOI 10.1093/hmg/7.3.541; Lu QJ, 2002, BLOOD, V99, P4503, DOI 10.1182/blood.V99.12.4503; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; MAMONT PS, 1981, BIOCHEM J, V196, P411, DOI 10.1042/bj1960411; Mamont PS, EUR J BIOCH, V123, P499; Newton GL, 1996, RADIAT RES, V145, P776, DOI 10.2307/3579370; OBrien TG, 1997, CANCER RES, V57, P2630; ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34; PAPAZAFIRI P, 1987, BIOCHEM J, V242, P479, DOI 10.1042/bj2420479; Phan Nguyen Thanh Binh, 2010, Health, V2, P1390, DOI 10.4236/health.2010.212206; PORTER CW, 1990, BIOCHEM J, V268, P207, DOI 10.1042/bj2680207; POWERS DC, 1992, CELL IMMUNOL, V141, P444, DOI 10.1016/0008-8749(92)90162-I; Romanenko EB, 1998, BIOCHEMISTRY-MOSCOW+, V63, P159; RUSSELL DH, 1983, CRC CR REV CL LAB SC, V18, P261; SHAIN SA, 1986, ENDOCRINOLOGY, V119, P1830, DOI 10.1210/endo-119-4-1830; Soda K, 2005, J IMMUNOL, V175, P237, DOI 10.4049/jimmunol.175.1.237; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Soda K, 2009, J NUTR SCI VITAMINOL, V55, P361, DOI 10.3177/jnsv.55.361; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; Wacholtz MC, J EXP MED, V170, P431; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Werther WA, 1996, J IMMUNOL, V157, P4986; WHITE R, 1983, J BIOL CHEM, V258, P8943; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Yamamoto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012554; Yamamoto F, 2004, MOL GENET GENOMICS, V271, P678, DOI 10.1007/s00438-004-1017-5; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3	48	64	68	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64357	10.1371/journal.pone.0064357	http://dx.doi.org/10.1371/journal.pone.0064357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696883	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900086
J	Liao, Q; Zeng, Z; Guo, X; Li, X; Wei, F; Zhang, W; Li, X; Chen, P; Liang, F; Xiang, B; Ma, J; Wu, M; Tang, H; Deng, M; Zeng, X; Tang, K; Xiong, W; Li, G				Liao, Q.; Zeng, Z.; Guo, X.; Li, X.; Wei, F.; Zhang, W.; Li, X.; Chen, P.; Liang, F.; Xiang, B.; Ma, J.; Wu, M.; Tang, H.; Deng, M.; Zeng, X.; Tang, K.; Xiong, W.; Li, G.			LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation	ONCOGENE			English	Article						nasopharyngeal carcinoma; tumor-associated macrophages; interleukin-6; LPLUNC1; signal transducer and activator of transcription 3	TUMOR-ASSOCIATED MACROPHAGES; CANCER-RELATED INFLAMMATION; UPPER AIRWAYS; INTERLEUKIN-6; EXPRESSION; MICROENVIRONMENT; PLUNC; GENE; PROGRESSION; INITIATION	Tumor-associated macrophage (TAM)-related chronic inflammation and interleukin-6 (IL-6) contribute to the progression of nasopharyngeal carcinoma (NPC). In this study, we characterized TAMs and IL-6 expression in 212 biopsied NPC and 119 non-tumor nasopharyngeal epithelium (NPE) tissues by tissue array. In comparison with that in the NPE tissues, more TAM infiltrates and a higher density of IL-6 expression were detected in NPC tissues, which were associated with the poor survival of NPC patients. In contrast, little or no LPLUNC1, a regulator of inflammation, expression was detected in NPC tissues, and the levels of LPLUNC1 expression in the NPC were associated negatively with the numbers of TAMs and the levels of IL-6 expression, but positively with the survival of NPC patients. Induction of LPLUNC1 overexpression in NPC cells mitigated lipopolysaccharide (LPS)-induced IL-6, IL-8, tumor necrosis factor-alpha and IL-1 beta expression or treatment of THP-1 macrophages with LPLUNC1 inhibited spontaneous and LPS-induced IL-6 expression in vitro. IL-6-promoted NPC cell proliferation in a dose- and time-dependent manner, accompanied by increasing cyclin D1 and Bcl-2 expression and the Stat3 activation, but inhibiting Bax and p21 expression. Induction of LPLUNC1 overexpression inhibited NPC cell proliferation, induced NPC cell arrest, promoted NPC cell apoptosis even after IL-6 stimulation and inhibited the growth of implanted NPC tumors in vivo, which were associated with decreasing cyclin D1 and Bcl-2 expression and the Janus kinase 2 (JAK2)/Stat3 activation, but enhancing Bax and p21 expression. These results suggest that LPLUNC1 can inhibit inflammation and NPC growth by downregulating the Stat3 pathway.	[Liao, Q.; Zeng, Z.; Li, X.; Ma, J.; Wu, M.; Xiong, W.; Li, G.] Cent S Univ, Xiangya Sch Med, Hunan Prov Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Liao, Q.; Zeng, Z.; Li, X.; Ma, J.; Wu, M.; Xiong, W.; Li, G.] Cent S Univ, Xiangya Sch Med, Affiliated Tumor Hosp, Changsha 410013, Hunan, Peoples R China; [Liao, Q.; Zeng, Z.; Li, X.; Li, X.; Ma, J.; Wu, M.; Xiong, W.; Li, G.] Cent S Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China; [Liao, Q.; Zeng, Z.; Guo, X.; Li, X.; Wei, F.; Zhang, W.; Chen, P.; Liang, F.; Xiang, B.; Ma, J.; Wu, M.; Tang, H.; Deng, M.; Zeng, X.; Tang, K.; Xiong, W.; Li, G.] Cent S Univ, Canc Res Inst, Minist Hlth, Key Lab Carcinogenesis, Changsha 410013, Hunan, Peoples R China; [Liao, Q.; Zeng, Z.; Guo, X.; Li, X.; Wei, F.; Zhang, W.; Chen, P.; Liang, F.; Xiang, B.; Ma, J.; Wu, M.; Tang, H.; Deng, M.; Zeng, X.; Tang, K.; Xiong, W.; Li, G.] Cent S Univ, Canc Res Inst, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410013, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University	Xiong, W (corresponding author), Cent S Univ, Xiangya Sch Med, Hunan Prov Tumor Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	xiongwei@xysm.net; ligy@xysm.net		Zeng, Xi/0000-0001-6835-9691	National High Technology Research and Development Program of China [2012AA02A206]; National Natural Science Foundation of China [91229122, 81071644, 81172189, 81101509, 81171930, 81272254, 81272298]; 111 project [111-2-12]; Program for New Century Excellent Talents in University [NCET-11-0520]; Hunan Province Natural Sciences Foundation of China [10JJ7003]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Hunan Province Natural Sciences Foundation of China(Natural Science Foundation of Hunan Province)	This study was supported by grants from the National High Technology Research and Development Program of China (2012AA02A206), the National Natural Science Foundation of China (91229122, 81071644, 81172189, 81101509, 81171930, 81272254 and 81272298), the 111 project (111-2-12), the Program for New Century Excellent Talents in University (NCET-11-0520) and the Hunan Province Natural Sciences Foundation of China (10JJ7003).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Ataie-Kachoie P, 2013, CYTOKINE GROWTH F R, V24, P163, DOI 10.1016/j.cytogfr.2012.09.001; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Becker C, 2005, CELL CYCLE, V4, P217; Bingle CD, 2000, BBA-GENE STRUCT EXPR, V1493, P363, DOI 10.1016/S0167-4781(00)00196-2; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Bingle CD, 2010, HISTOCHEM CELL BIOL, V133, P505, DOI 10.1007/s00418-010-0683-0; Bingle L, 2011, BIOCHEM SOC T, V39, P1023, DOI 10.1042/BST0391023; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Canny G, 2008, TRENDS IMMUNOL, V29, P541, DOI 10.1016/j.it.2008.07.012; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; Chow KC, 2003, ONCOL REP, V10, P813; Cocco C, 2012, IMMUNOTHERAPY-UK, V4, P667, DOI 10.2217/imt.12.56; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; Fan SQ, 2006, HUM PATHOL, V37, P593, DOI 10.1016/j.humpath.2006.01.010; Fukuda Koji, 2012, Front Biosci (Schol Ed), V4, P787; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hsiao JR, 2003, BRIT J CANCER, V89, P344, DOI 10.1038/sj.bjc.6601003; Hsu HS, 2012, LUNG CANCER, V75, P167, DOI 10.1016/j.lungcan.2011.07.001; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Kim SR, 2009, BIOCHEM BIOPH RES CO, V387, P342, DOI 10.1016/j.bbrc.2009.07.022; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Liao Q, 2011, J CANCER RES CLIN, V138, P57; Lin CM, 2010, J AGR FOOD CHEM, V58, P7082, DOI 10.1021/jf100421w; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Motilva V, 2012, CURR PHARM DESIGN, V18, P3829, DOI 10.2174/138161212802083671; Musa M, 2012, CELL TISSUE RES, V350, P455, DOI 10.1007/s00441-012-1490-9; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Rodriguez-Vita J, 2010, CYTOKINE GROWTH F R, V21, P61, DOI 10.1016/j.cytogfr.2009.11.006; Sgambato A, 2010, EUR REV MED PHARMACO, V14, P263; Shih J, 2006, J CANC MOL, V2, P6; Shin OS, 2011, J INFECT DIS, V204, P1349, DOI 10.1093/infdis/jir544; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Takayama H, 2009, J UROLOGY, V181, P1894, DOI 10.1016/j.juro.2008.11.090; Tan EL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-227; Vargas PA, 2008, ORAL DIS, V14, P613, DOI 10.1111/j.1601-0825.2007.01429.x; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; Yang YX, 2007, MOL IMMUNOL, V44, P984, DOI 10.1016/j.molimm.2006.03.013; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang BC, 2003, GENE CHROMOSOME CANC, V38, P80, DOI 10.1002/gcc.10247; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020965	55	98	104	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2098	2109		10.1038/onc.2013.161	http://dx.doi.org/10.1038/onc.2013.161			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23708661				2022-12-25	WOS:000334599100009
J	Huang, BW; Ray, PD; Iwasaki, K; Tsuji, Y				Huang, Bo-Wen; Ray, Paul D.; Iwasaki, Kenta; Tsuji, Yoshiaki			Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4	FASEB JOURNAL			English	Article						arsenic; histone methylation; antioxidant; oxidative stress	ANTIOXIDANT-RESPONSIVE ELEMENT; OXIDATIVE STRESS; REACTIVE OXYGEN; H-GENE; HISTONE H3; INDUCED APOPTOSIS; RECEPTOR FUNCTION; IRON HOMEOSTASIS; IN-VIVO; METHYLATION	Antioxidant genes such as ferritin are transcriptionally activated in oxidative stress via the antioxidant responsive element (ARE), to which nuclear factor-E2-related factor 2 (Nrf2) binds and activates transcription. Histone modification plays a cooperative and essential role in transcriptional regulation; however, its role in antioxidant gene transcription remains elusive. Arsenic exposure activated ferritin transcription via the ARE concomitant with increased methylation of histones H4Arg3 (H4R3) and H3Arg17 (H3R17). To test our hypothesis that histone H4R3 and H3R17 methylation regulates ferritin transcription, H4R3 and H3R17 protein arginine (R) methyltransferases 1 and 4 (PRMT1 and PRMT4) were investigated. Arsenic exposure of human HaCaT keratinocytes induced nuclear accumulation of PRMT1 and PRMT4, histone H4R3 and H3R17 methylation proximal to the ARE, but not to the non-ARE regions of ferritin genes. PRMT1 or PRMT4 knockdown did not block Nrf2 nuclear accumulation but inhibited Nrf2 binding to the AREs by approximate to 40% (P<0.05), thus diminishing ferritin transcription in HaCaT and human primary keratinocytes and fibroblasts, causing enhanced cellular susceptibility to arsenic toxicity as evidenced by 2-fold caspase 3 activation. Focused microarray further characterized several oxidative stress response genes are subject to PRMT1 or PRMT4 regulation. Collectively, PRMT1 and PRMT4 regulate the ARE and cellular antioxidant response to arsenic.Huang, B.-W., Ray, P. D., Iwasaki, K., Tsuji, Y. Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4.	[Huang, Bo-Wen; Ray, Paul D.; Tsuji, Yoshiaki] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Iwasaki, Kenta] Nagoya Univ, Sch Med, Dept Appl Immunol, Nagoya, Aichi 466, Japan	University of North Carolina; North Carolina State University; Nagoya University	Tsuji, Y (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	ytsuji@ncsu.edu		Iwasaki, Kenta/0000-0003-3229-5192	U.S. National Institutes of Health (NIH) from National Institute of General Medical Sciences [R01GM088392, RO1GM095550]; NIH from National Institute of Environmental Health Sciences [T32ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095550, R01GM088392] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) from National Institute of General Medical Sciences; NIH from National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by U.S. National Institutes of Health (NIH) grants R01GM088392 and RO1GM095550 from the National Institute of General Medical Sciences to Y.T. P. D. R. was supported by NIH training grant T32ES007046 from the National Institute of Environmental Health Sciences.	ALAM J, 1995, J BIOL CHEM, V270, P11977, DOI 10.1074/jbc.270.20.11977; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Feng Q, 2009, J BIOL CHEM, V284, P36167, DOI 10.1074/jbc.M109.065524; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hsu CH, 2012, ONCOGENE, V31, P2335, DOI 10.1038/onc.2011.415; Huang X, 2003, MUTAT RES-FUND MOL M, V533, P153, DOI 10.1016/j.mrfmmm.2003.08.023; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JH, 2013, ONCOGENE, V32, P514, DOI 10.1038/onc.2012.59; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin W, 2006, J BIOCHEM MOL BIOL, V39, P304; Litt M, 2009, BIOSCIENCE REP, V29, P131, DOI 10.1042/BSR20080176; MacKenzie EL, 2008, FREE RADICAL BIO MED, V44, P1762, DOI 10.1016/j.freeradbiomed.2008.01.031; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Mackenzie EL, 2008, BIOCHEM J, V411, P107, DOI 10.1042/BJ20071544; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ohta K, 2007, BIOCHEM J, V402, P559, DOI 10.1042/BJ20061194; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Reichard JF, 2010, EPIGENOMICS-UK, V2, P87, DOI [10.2217/epi.09.45, 10.2217/EPI.09.45]; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Teyssier C, 2010, TRENDS ENDOCRIN MET, V21, P181, DOI 10.1016/j.tem.2009.11.002; Theil EC, 2006, J INORG BIOCHEM, V100, P2074, DOI 10.1016/j.jinorgbio.2006.09.011; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tsuji Y, 2005, ONCOGENE, V24, P7567, DOI 10.1038/sj.onc.1208901; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; TSUJI Y, 1995, MOL CELL BIOL, V15, P5152; Tsuji Y, 1999, J BIOL CHEM, V274, P7501, DOI 10.1074/jbc.274.11.7501; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wu J, 2006, FREE RADICAL BIO MED, V40, P444, DOI 10.1016/j.freeradbiomed.2005.08.035; Wu JC, 2012, P NATL ACAD SCI USA, V109, P5675, DOI 10.1073/pnas.1114905109; Xie Y, 2009, J BIOL CHEM, V284, P9199, DOI 10.1074/jbc.M806193200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhang J, 2007, BIOCHEM J, V404, P459, DOI 10.1042/BJ20061611; Zhang JY, 2006, MOL CELL BIOL, V26, P7942, DOI 10.1128/MCB.00700-06; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304	68	29	30	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3763	3774		10.1096/fj.12-226043	http://dx.doi.org/10.1096/fj.12-226043			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23699174	Green Published			2022-12-25	WOS:000328840500034
J	Liu, GL; Sengupta, PK; Jamal, B; Yang, HY; Bouchie, MP; Lindner, V; Varelas, X; Kukuruzinska, MA				Liu, Gangli; Sengupta, Pritam K.; Jamal, Basem; Yang, Hsiao-Ying; Bouchie, Meghan P.; Lindner, Volkhard; Varelas, Xaralabos; Kukuruzinska, Maria A.			N-Glycosylation Induces the CTHRC1 Protein and Drives Oral Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX REPEAT; E-CADHERIN; MOLECULAR PATHOGENESIS; SIGNALING PATHWAY; BETA-CATENIN; GENE DPAGT1; EXPRESSION; PROMOTES; CARCINOMA; GROWTH	Oral squamous cell carcinoma (OSCC) is one of the most pernicious malignancies, but the mechanisms underlying its development and progression are poorly understood. One of the key pathways implicated in OSCC is the canonical Wnt/beta-catenin signaling pathway. Previously, we reported that canonical Wnt signaling functions in a positive feedback loop with the DPAGT1 gene, a principal regulator of the metabolic pathway of protein N-glycosylation, to hyperglycosylate E-cadherin and reduce intercellular adhesion. Here, we show that in OSCC, DPAGT1 and canonical Wnt signaling converge to up-regulate CTHRC1 (collagen triple helix repeat containing 1), an N-glycoprotein implicated in tumor invasion and metastasis. We found that in human OSCC specimens, amplification of the levels of CTHRC1 was associated with its hyperglycosylation. Partial inhibition of DPAGT1 expression in OSCC CAL27 cells reduced CTHRC1 abundance by increasing protein turnover, indicating that N-glycosylation stabilizes CTHRC1. Additionally, canonical Wnt signaling promoted beta-catenin/T-cell factor transcriptional activity at the CTHRC1 promoter to further elevate CTHRC1 levels. We demonstrate that DPAGT1 promotes cell migration and drives the localization of CTHRC1 to cells at the leading edge of a wound front coincident with drastic changes in cell morphology. We propose that in OSCC, dysregulation of canonical Wnt signaling and DPAGT1-dependent N-glycosylation induces CTHRC1, thereby driving OSCC cell migration and tumor spread.	[Liu, Gangli] Shandong Univ, Sch Stomatol, Jinan 250100, Shandong, Peoples R China; [Sengupta, Pritam K.; Yang, Hsiao-Ying; Bouchie, Meghan P.; Kukuruzinska, Maria A.] Boston Univ, Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Jamal, Basem] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia; [Lindner, Volkhard] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Varelas, Xaralabos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Shandong University; Boston University; King Abdulaziz University; Maine Medical Center; Boston University	Kukuruzinska, MA (corresponding author), Dept Mol & Cell Biol, Boston Univ Med Campus,72 E Concord St,E428, Boston, MA 02118 USA.	mkukuruz@bu.edu	Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541; Jamal, Basem/0000-0003-0021-8651; Kukukruzinska, Maria/0000-0001-5314-1454	National Institutes of Health [R01 DE15304]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE15304.	Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Guturi KKN, 2012, J BIOL CHEM, V287, P18287, DOI 10.1074/jbc.M111.324798; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Huang GTJ, 1998, MOL CELL BIOCHEM, V181, P97, DOI 10.1023/A:1006877929614; Jamal B, 2012, ORAL ONCOL, V48, P523, DOI 10.1016/j.oraloncology.2012.01.010; Katoh M, 2005, ONCOL REP, V14, P1583; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mendelsohn R, 2007, CANCER RES, V67, P9771, DOI 10.1158/0008-5472.CAN-06-4580; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Park EH, 2013, CARCINOGENESIS, V34, P694, DOI 10.1093/carcin/bgs378; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Perez-Sayans M, 2012, ORAL ONCOL, V48, P56, DOI 10.1016/j.oraloncology.2011.09.001; Polakis P, 2000, GENE DEV, V14, P1837; Priyadarsini RV, 2012, ORAL ONCOL, V48, P33, DOI 10.1016/j.oraloncology.2011.08.008; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sengupta PK, 2013, J CELL SCI, V126, P484, DOI 10.1242/jcs.113035; Sengupta PK, 2010, J BIOL CHEM, V285, P31164, DOI 10.1074/jbc.M110.149195; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shibamoto S, 1998, GENES CELLS, V3, P659; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang P, 2012, CANCER SCI, V103, P1327, DOI 10.1111/j.1349-7006.2012.02292.x; Watanabe S, 2011, GLYCOBIOLOGY, V21, P482, DOI 10.1093/glycob/cwq186; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015	41	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20217	20227		10.1074/jbc.M113.473785	http://dx.doi.org/10.1074/jbc.M113.473785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703614	Green Published, hybrid			2022-12-25	WOS:000321715100011
J	Lindemann, C; Lupilova, N; Muller, A; Warscheid, B; Meyer, HE; Kuhlmann, K; Eisenacher, M; Leichert, LI				Lindemann, Claudia; Lupilova, Nataliya; Mueller, Alexandra; Warscheid, Bettina; Meyer, Helmut E.; Kuhlmann, Katja; Eisenacher, Martin; Leichert, Lars I.			Redox Proteomics Uncovers Peroxynitrite-sensitive Proteins That Help Escherichia coli to Overcome Nitrosative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALPAIN ACTIVATOR PROTEIN; ASPARAGINE SYNTHETASE-B; EXPRESSION; INHIBITOR; NITRATION; RESPONSES; TOXICITY; SWITCHES; ENZYME	Peroxynitrite is a highly reactive chemical species with antibacterial properties that are synthesized in immune cells. In a proteomic approach, we identified specific target proteins of peroxynitrite-induced modifications in Escherichia coli. Although peroxynitrite caused a fairly indiscriminate nitration of tyrosine residues, reversible modifications of protein thiols were highly specific. We used a quantitative redox proteomic method based on isotope-coded affinity tag chemistry and identified four proteins consistently thiol-modified in cells treated with peroxynitrite as follows: AsnB, FrmA, MaeB, and RidA. All four were required for peroxynitrite stress tolerance in vivo. Three of the identified proteins were modified at highly conserved cysteines, and MaeB and FrmA are known to be directly involved in the oxidative and nitrosative stress response in E. coli. In in vitro studies, we could show that the activity of RidA, a recently discovered enamine/imine deaminase, is regulated in a specific manner by the modification of its single conserved cysteine. Mutation of this cysteine 107 to serine generated a constitutively active protein that was not susceptible to peroxynitrite.	[Lindemann, Claudia; Lupilova, Nataliya; Mueller, Alexandra; Meyer, Helmut E.; Kuhlmann, Katja; Eisenacher, Martin; Leichert, Lars I.] Ruhr Univ Bochum, Med Proteome Ctr, D-44780 Bochum, Germany; [Warscheid, Bettina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg	Leichert, LI (corresponding author), Ruhr Univ Bochum, Med Proteome Ctr, Univ Str 150, D-44780 Bochum, Germany.	lars.leichert@ruhr-uni-bochum.de	Eisenacher, Martin/J-8044-2014; Leichert, Lars I./B-4762-2009	Eisenacher, Martin/0000-0003-2687-7444; Leichert, Lars I./0000-0002-5666-9681; Warscheid, Bettina/0000-0001-5096-1975; Baumann, Alexandra/0000-0002-6527-5262	"NRW-Ruckkehrerprogramm" of the German State of North Rhine-Westphalia; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; P.U.R.E. Project of the German State of North Rhine-Westphalia, Germany; Excellence Initiative of the German State Government [EXC 294 BIOSS]	"NRW-Ruckkehrerprogramm" of the German State of North Rhine-Westphalia; Excellence Initiative of the German Federal Government; P.U.R.E. Project of the German State of North Rhine-Westphalia, Germany; Excellence Initiative of the German State Government	This work was supported in part by a grant from the "NRW-Ruckkehrerprogramm" of the German State of North Rhine-Westphalia (to L. I. L.).; Supported by grants from the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS).; Supported by the P.U.R.E. Project of the German State of North Rhine-Westphalia, Germany.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P7450; Brandes N, 2007, MOL MICROBIOL, V66, P901, DOI 10.1111/j.1365-2958.2007.05964.x; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brandes N, 2011, J BIOL CHEM, V286, P41893, DOI 10.1074/jbc.M111.296236; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1487, DOI 10.1089/ars.2012.4742; Conte Lo M., 2012, OXIDATIVE STRESS RED, P1; Creighton T. E., 1990, PROTEIN STRUCTURE PR, P155; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Held JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.013037; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Leichert L. I., 2013, OXIDATIVE STRESS RED, P157; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Lindemann Claudia, 2012, Methods Mol Biol, V893, P387, DOI 10.1007/978-1-61779-885-6_24; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marla SS, 1997, P NATL ACAD SCI USA, V94, P14243, DOI 10.1073/pnas.94.26.14243; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Schmiedeknecht G, 1996, EUR J BIOCHEM, V242, P339, DOI 10.1111/j.1432-1033.1996.0339r.x; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Volz K, 1999, PROTEIN SCI, V8, P2428; Wang H, 2012, J PROTEOME RES, V11, P412, DOI 10.1021/pr200918f; Wilkins MR, 1999, METH MOL B, V112, P531; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Wong C, 2000, BIOTECHNIQUES, V28, P426, DOI 10.2144/00283bm07; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	49	26	27	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19698	19714		10.1074/jbc.M113.457556	http://dx.doi.org/10.1074/jbc.M113.457556			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696645	Green Published, hybrid			2022-12-25	WOS:000321515800040
J	Gordon, DM; Dektar, KN; Pinter-Wollman, N				Gordon, Deborah M.; Dektar, Katherine N.; Pinter-Wollman, Noa			Harvester Ant Colony Variation in Foraging Activity and Response to Humidity	PLOS ONE			English	Article							FIRE ANT; ECOLOGY; SIZE; PERSONALITY; FOOD; AGGRESSION; PHEROMONE; CONFLICT; BEHAVIOR; SCALE	Collective behavior is produced by interactions among individuals. Differences among groups in individual response to interactions can lead to ecologically important variation among groups in collective behavior. Here we examine variation among colonies in the foraging behavior of the harvester ant, Pogonomyrmex barbatus. Previous work shows how colonies regulate foraging in response to food availability and desiccation costs: the rate at which outgoing foragers leave the nest depends on the rate at which foragers return with food. To examine how colonies vary in response to humidity and in foraging rate, we performed field experiments that manipulated forager return rate in 94 trials with 17 colonies over 3 years. We found that the effect of returning foragers on the rate of outgoing foragers increases with humidity. There are consistent differences among colonies in foraging activity that persist from year to year.	[Gordon, Deborah M.; Dektar, Katherine N.; Pinter-Wollman, Noa] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dmgordon@stanford.edu			NSF [IOS-0718631]; Stanford University	NSF(National Science Foundation (NSF)); Stanford University(Stanford University)	The work was funded by NSF grant IOS-0718631 to DMG, and by a grant from the CleanSlate program at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; [Anonymous], 2010, ANT ENCOUNTERS INTER, Vviii; Azcarate FM, 2007, J INSECT BEHAV, V20, P315, DOI 10.1007/s10905-007-9074-3; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Bourke AFG, 1999, J EVOLUTION BIOL, V12, P245, DOI 10.1046/j.1420-9101.1999.00028.x; Brown MJF, 2000, BEHAV ECOL SOCIOBIOL, V47, P195, DOI 10.1007/s002650050011; Buhl J, 2005, BEHAV ECOL SOCIOBIOL, V58, P9, DOI 10.1007/s00265-004-0906-2; Burd M, 2010, ECOL ENTOMOL, V35, P464, DOI 10.1111/j.1365-2311.2010.01202.x; CASSILL DL, 1995, ANIM BEHAV, V50, P801, DOI 10.1016/0003-3472(95)80140-5; Cole BJ, 2010, BEHAV ECOL, V21, P337, DOI 10.1093/beheco/arp193; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; CRIST TO, 1994, OIKOS, V69, P37, DOI 10.2307/3545281; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dupuy F, 2006, ANIM BEHAV, V72, P1081, DOI 10.1016/j.anbehav.2006.03.011; Foitzik S, 2004, BEHAV ECOL SOCIOBIOL, V55, P484, DOI 10.1007/s00265-003-0718-9; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; Gordon DM, 2011, BEHAV ECOL, V22, P225, DOI 10.1093/beheco/arq172; GORDON DM, 1992, BEHAV ECOL SOCIOBIOL, V31, P417, DOI 10.1007/BF00170609; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; Gordon DM, 2002, AM NAT, V159, P509, DOI 10.1086/339461; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Ingram KK, 2013, J ANIMAL EC IN PRESS; LIGHTON JRB, 1988, P NATL ACAD SCI USA, V85, P4765, DOI 10.1073/pnas.85.13.4765; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Lott D., 1991, INTRASPECIFIC VARIAT; Mailleux AC, 2011, INSECT SOC, V58, P559, DOI 10.1007/s00040-011-0177-7; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; MUNGER JC, 1984, ECOLOGY, V65, P1077, DOI 10.2307/1938315; Muscedere ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031618; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Papoulis A, 1984, PROBABILITY RANDOM V; Pinter-Wollman N, 2012, BEHAV ECOL, V23, P1022, DOI 10.1093/beheco/ars066; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; Torney C, 2009, P NATL ACAD SCI USA, V106, P22055, DOI 10.1073/pnas.0907929106; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Yamagata N, 2006, P ROY SOC B-BIOL SCI, V273, P2219, DOI 10.1098/rspb.2006.3565	52	37	38	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63363	10.1371/journal.pone.0063363	http://dx.doi.org/10.1371/journal.pone.0063363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717415	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600012
J	Biela, I; Tidten-Luksch, N; Immekus, F; Glinca, S; Nguyen, TXP; Gerber, HD; Heine, A; Klebe, G; Reuter, K				Biela, Inna; Tidten-Luksch, Naomi; Immekus, Florian; Glinca, Serghei; Tran Xuan Phong Nguyen; Gerber, Hans-Dieter; Heine, Andreas; Klebe, Gerhard; Reuter, Klaus			Investigation of Specificity Determinants in Bacterial tRNA-Guanine Transglycosylase Reveals Queuine, the Substrate of Its Eucaryotic Counterpart, as Inhibitor	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RIBOSYLTRANSFERASE-ISOMERASE; SHIGELLA-FLEXNERI; QUEUOSINE; SEQUENCE; RECOGNITION; MECHANISM; BINDING	Bacterial tRNA-guanine transglycosylase (Tgt) catalyses the exchange of the genetically encoded guanine at the wobble position of tRNAs(His,Tyr,Asp,Asn) by the premodified base preQ(1), which is further converted to queuine at the tRNA level. As eucaryotes are not able to synthesise queuine de novo but acquire it through their diet, eucaryotic Tgt directly inserts the hypermodified base into the wobble position of the tRNAs mentioned above. Bacterial Tgt is required for the efficient pathogenicity of Shigella sp, the causative agent of bacillary dysentery and, hence, it constitutes a putative target for the rational design of anti-Shigellosis compounds. Since mammalian Tgt is known to be indirectly essential to the conversion of phenylalanine to tyrosine, it is necessary to create substances which only inhibit bacterial but not eucaryotic Tgt. Therefore, it seems of utmost importance to study selectivity-determining features within both types of proteins. Homology models of Caenorhabditis elegans Tgt and human Tgt suggest that the replacement of Cys158 and Val233 in bacterial Tgt (Zymomonas mobilis Tgt numbering) by valine and accordingly glycine in eucaryotic Tgt largely accounts for the different substrate specificities. In the present study we have created mutated variants of Z. mobilis Tgt in order to investigate the impact of a Cys158Val and a Val233Gly exchange on catalytic activity and substrate specificity. Using enzyme kinetics and X-ray crystallography, we gained evidence that the Cys158Val mutation reduces the affinity to preQ1 while leaving the affinity to guanine unaffected. The Val233Gly exchange leads to an enlarged substrate binding pocket, that is necessary to accommodate queuine in a conformation compatible with the intermediately covalently bound tRNA molecule. Contrary to our expectations, we found that a priori queuine is recognised by the binding pocket of bacterial Tgt without, however, being used as a substrate.	[Biela, Inna; Tidten-Luksch, Naomi; Immekus, Florian; Glinca, Serghei; Tran Xuan Phong Nguyen; Gerber, Hans-Dieter; Heine, Andreas; Klebe, Gerhard; Reuter, Klaus] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany	Philipps University Marburg	Reuter, K (corresponding author), Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.	reuterk@staff.uni-marburg.de		Glinca, Serghei/0000-0002-0394-8468	Philipps-University of Marburg; German Research Foundation (Graduiertenkolleg "Protein Function at the Atomic Level'' and DFG) [KL1204/11-1]	Philipps-University of Marburg; German Research Foundation (Graduiertenkolleg "Protein Function at the Atomic Level'' and DFG)(German Research Foundation (DFG))	This work was supported by the Philipps-University of Marburg and the German Research Foundation (Graduiertenkolleg "Protein Function at the Atomic Level'' and DFG grant KL1204/11-1). The travel costs to the BESSY II synchrotron in Berlin were covered by the Helmhotz-Zentrum Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boland C, 2009, J BIOL CHEM, V284, P18218, DOI 10.1074/jbc.M109.002477; Brenk R, 2003, CHEMBIOCHEM, V4, P1066, DOI 10.1002/cbic.200300644; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YC, 2011, NUCLEIC ACIDS RES, V39, P2834, DOI 10.1093/nar/gkq1188; Chen YC, 2010, RNA, V16, P958, DOI 10.1261/rna.1997610; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chikwana VM, 2012, J BIOL CHEM, V287, P30560, DOI 10.1074/jbc.M112.388538; CURNOW AW, 1993, BIOCHEMISTRY-US, V32, P5239, DOI 10.1021/bi00070a036; CURNOW AW, 1995, J BIOL CHEM, V270, P17264, DOI 10.1074/jbc.270.29.17264; Deshpande KL, 2001, GENE, V265, P205, DOI 10.1016/S0378-1119(01)00368-7; Durand JMB, 2000, MOL MICROBIOL, V35, P924, DOI 10.1046/j.1365-2958.2000.01767.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESWAR N, 2000, CURRENT PROTOCOLS S, V15; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FREY B, 1988, J BACTERIOL, V170, P2078, DOI 10.1128/jb.170.5.2078-2082.1988; Garcia GA, 2009, BIOCHEMISTRY-US, V48, P11243, DOI 10.1021/bi901501a; Gerber HD, 2012, ORG BIOMOL CHEM, V10, P8660, DOI 10.1039/c2ob26387d; Goodenough-Lashua DM, 2003, BIOORG CHEM, V31, P331, DOI 10.1016/S0045-2068(03)00069-5; Gradler U, 1999, FEBS LETT, V454, P142, DOI 10.1016/S0014-5793(99)00793-0; Gradler U, 2001, J MOL BIOL, V306, P455, DOI 10.1006/jmbi.2000.4256; Grimm C, 2006, BIOCHEM BIOPH RES CO, V351, P695, DOI 10.1016/j.bbrc.2006.10.096; Hurt JK, 2007, NUCLEIC ACIDS RES, V35, P4905, DOI 10.1093/nar/gkm473; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; Kohler PC, 2009, CHEM-EUR J, V15, P10809, DOI 10.1002/chem.200901270; Kung FL, 1998, FEBS LETT, V431, P427, DOI 10.1016/S0014-5793(98)00801-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mathews I, 2005, PROTEINS, V59, P869, DOI 10.1002/prot.20419; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P2301, DOI 10.1021/bi9001437; Meyer EA, 2006, HELV CHIM ACTA, V89, P573, DOI 10.1002/hlca.200690062; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; OKADA N, 1979, J BIOL CHEM, V254, P3061; Oliva R, 2007, RNA, V13, P1427, DOI 10.1261/rna.574407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Phillips G, 2008, J BACTERIOL, V190, P7876, DOI 10.1128/JB.00874-08; Rakovich T, 2011, J BIOL CHEM, V286, P19354, DOI 10.1074/jbc.M111.219576; Ritschel T, 2009, CHEMMEDCHEM, V4, P2012, DOI 10.1002/cmdc.200900343; Ritschel T, 2009, J MOL BIOL, V393, P833, DOI 10.1016/j.jmb.2009.07.040; Ritschel T, 2009, CHEMBIOCHEM, V10, P716, DOI 10.1002/cbic.200800782; Romier C, 1997, FEBS LETT, V416, P93, DOI 10.1016/S0014-5793(97)01175-7; Romier C, 1996, PROTEINS, V24, P516; Romier C, 1996, EMBO J, V15, P2850, DOI 10.1002/j.1460-2075.1996.tb00646.x; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Stengl B, 2005, CHEMBIOCHEM, V6, P1926, DOI 10.1002/cbic.200500063; Thomas CE, 2011, BIOCHEM BIOPH RES CO, V410, P34, DOI 10.1016/j.bbrc.2011.05.100; Tidten N, 2007, J MOL BIOL, V374, P764, DOI 10.1016/j.jmb.2007.09.062; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Van Lanen SG, 2003, J BIOL CHEM, V278, P10491, DOI 10.1074/jbc.M207727200; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976	60	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64240	10.1371/journal.pone.0064240	http://dx.doi.org/10.1371/journal.pone.0064240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704982	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200126
J	Dhar, MS; Gupta, V; Virdi, JS				Dhar, Mahesh Shanker; Gupta, Vatika; Virdi, Jugsharan Singh			Detection, Distribution and Characterization of Novel Superoxide Dismutases from Yersinia enterocolitica Biovar 1A	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; EXPRESSION; PURIFICATION; GROWTH; COPPER; GENE; SODA; IDENTIFICATION	Background: Superoxide dismutases (SODs) cause dismutation of superoxide radicals to hydrogen peroxide and oxygen. Besides protecting the cells against oxidative damage by endogenously generated oxygen radicals, SODs play an important role in intraphagocytic survival of pathogenic bacteria. The complete genome sequences of Yersinia enterocolitica strains show presence of three different sod genes. However, not much is known about the types of SODs present in Y. enterocolitica, their characteristics and role in virulence and intraphagocytic survival of this organism. Methodology/Principal Findings: This study reports detection and distribution of the three superoxide dismutase (sodA, sodB and sodC) genes in 59 strains of Y. enterocolitica and related species. The majority (94%) of the strains carried all three genes and constitutive expression of sodA and sodB was detected in 88% of the strains. Expression of sodC was not observed in any of the strains. The sodA, sodB and sodC genes of Y. enterocolitica were cloned in pET28a (+) vector. Recombinant SodA (82 kDa) and SodB (21 kDa) were expressed as homotetramer and monomer respectively, and showed activity over a broad range of pH (3.0-8.0) and temperature (4-70 degrees C). SodA and SodB showed optimal activity at 4 degrees C under acidic pH of 6.0 and 4.0 respectively. The secondary structures of recombinant SodA and SodB were studied using circular dichroism. Production of YeSodC was not observed even after cloning and expression in E. coli BL21(DE3) cells. A SodA(-) SodB(-) Escherichia coli strain which was unable to grow in medium supplemented with paraquat showed normal growth after complementation with Y. enterocolitica SodA or SodB. Conclusions/Significance: This is the first report on the distribution and characterization of superoxide dismutases from Y. enterocolitica. The low pH optima of both SodA and SodB encoded by Y. enterocolitica seem to implicate their role in acidic environments such as the intraphagocytic vesicles.	[Dhar, Mahesh Shanker; Gupta, Vatika; Virdi, Jugsharan Singh] Univ Delhi, Dept Microbiol, Microbial Pathogen Lab, New Delhi, India	University of Delhi	Virdi, JS (corresponding author), Univ Delhi, Dept Microbiol, Microbial Pathogen Lab, South Campus, New Delhi, India.	virdi_dusc@rediffmail.com	; Virdi, Jugsharan Singh/L-8241-2015	Dhar, Mahesh shanker/0000-0002-2006-3581; Virdi, Jugsharan Singh/0000-0002-6282-0018				Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Battistoni A, 1996, BIOCHEM J, V320, P713, DOI 10.1042/bj3200713; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BEYER WF, 1991, J BIOL CHEM, V266, P303; Bollag D.M., 1996, PROTEIN METHODS; Bond CJ, 2000, ACTA CRYSTALLOGR D, V56, P1359, DOI 10.1107/S0907444900009537; Bordo D, 1999, J MOL BIOL, V285, P283, DOI 10.1006/jmbi.1998.2267; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castellano I, 2006, BIOCHIMIE, V88, P1377, DOI 10.1016/j.biochi.2006.04.005; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; DOHERTY A, 1995, FOOD MICROBIOL, V12, P251, DOI 10.1016/S0740-0020(95)80105-7; Edwards RA, 1998, J BIOL INORG CHEM, V3, P161, DOI 10.1007/s007750050217; Ekanayake PM, 2006, COMP BIOCHEM PHYS B, V145, P318, DOI 10.1016/j.cbpb.2006.08.004; Esposito L, 2008, BBA-PROTEINS PROTEOM, V1784, P1601, DOI 10.1016/j.bbapap.2008.04.024; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Goverde RLJ, 1998, MOL MICROBIOL, V28, P555, DOI 10.1046/j.1365-2958.1998.00816.x; Grant T, 1999, INFECT IMMUN, V67, P4367, DOI 10.1128/IAI.67.9.4367-4375.1999; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; HANNA MO, 1977, J FOOD PROTECT, V40, P689, DOI 10.4315/0362-028X-40.10.689; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HEIKKILA RE, 1976, J BIOL CHEM, V251, P2182; Holovska K, 2002, VET MED-CZECH, V47, P38, DOI 10.17221/5801-VETMED; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Kim CH, 1998, CLIN VACCINE IMMUNOL, V5, P6784; Kim KA, 2000, INFECT IMMUN, V68, P3861, DOI 10.1128/IAI.68.7.3861-3866.2000; LAH MS, 1995, BIOCHEMISTRY-US, V34, P1646, DOI 10.1021/bi00005a021; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Leclere V, 2001, MICROBIOL-SGM, V147, P3105, DOI 10.1099/00221287-147-11-3105; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; Liu P, 2007, ACTA CRYSTALLOGR F, V63, P1003, DOI 10.1107/S1744309107054127; LUMSDEN J, 1976, BIOCHIM BIOPHYS ACTA, V438, P380, DOI 10.1016/0005-2744(76)90255-2; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Merlino A, 2012, BIOCHIMIE, V94, P768, DOI 10.1016/j.biochi.2011.11.008; Mingde Z, 1993, FAGOPYRUM, V13, P31; MISRA HP, 1978, ARCH BIOCHEM BIOPHYS, V189, P317, DOI 10.1016/0003-9861(78)90218-7; Mori M, 2008, BIOCHEMISTRY-US, V47, P12954, DOI 10.1021/bi801252e; Na J, 2011, B KOREAN CHEM SOC, V32, P2405, DOI 10.5012/bkcs.2011.32.7.2405; PARKER MW, 1988, J MOL BIOL, V199, P649, DOI 10.1016/0022-2836(88)90308-7; Pedersen HL, 2009, ACTA CRYSTALLOGR F, V65, P84, DOI 10.1107/S1744309109001110; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; REVEILLAUD I, 1991, MOL CELL BIOL, V11, P632, DOI 10.1128/MCB.11.2.632; Revell PA, 2001, FEMS MICROBIOL LETT, V205, P159, DOI [10.1111/j.1574-6968.2001.tb10941.x, 10.1016/S0378-1097(01)00476-1]; RINGE D, 1983, P NATL ACAD SCI-BIOL, V80, P3879, DOI 10.1073/pnas.80.13.3879; Roggenkamp A, 1997, INFECT IMMUN, V65, P4705, DOI 10.1128/IAI.65.11.4705-4710.1997; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; SCHININA ME, 1987, FEBS LETT, V221, P87, DOI 10.1016/0014-5793(87)80357-5; Singh I, 2003, CURR SCI INDIA, V84, P1353; SMITH MW, 1992, J MOL EVOL, V34, P175; Smith SG, 1996, MOL PLANT MICROBE IN, V9, P584, DOI 10.1094/MPMI-9-0584; STALLINGS WC, 1985, J BIOL CHEM, V260, P6424; STEINMAN HM, 1993, J BACTERIOL, V175, P1198, DOI 10.1128/JB.175.4.1198-1202.1993; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tarhan L, 2000, TURK J CHEM, V24, P109; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; TOORA S, 1994, FOOD MICROBIOL, V11, P369, DOI 10.1006/fmic.1994.1042; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Wang X, 2008, J IND MICROBIOL BIOT, V35, P133, DOI 10.1007/s10295-007-0274-9; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889; Yun YS, 2004, EXTREMOPHILES, V8, P237, DOI 10.1007/s00792-004-0383-6; ZHU DH, 1995, FREE RADICAL BIO MED, V18, P179, DOI 10.1016/0891-5849(94)00113-X	68	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63919	10.1371/journal.pone.0063919	http://dx.doi.org/10.1371/journal.pone.0063919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704955	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200086
J	Han, SW; Kim, HP; Shin, JY; Jeong, EG; Lee, WC; Lee, KH; Won, JK; Kim, TY; Oh, DY; Im, SA; Bang, YJ; Jeong, SY; Park, KJ; Park, JG; Kang, GH; Seo, JS; Kim, JI; Kim, TY				Han, Sae-Won; Kim, Hwang-Phill; Shin, Jong-Yeon; Jeong, Eun-Goo; Lee, Won-Chul; Lee, Kyung-Hun; Won, Jae-Kyung; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Seo, Jeong-Sun; Kim, Jong-Il; Kim, Tae-You			Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing	PLOS ONE			English	Article							HUMAN BREAST; INSTABILITY; MUTATIONS; VARIANTS; PLUS; KRAS	Recent advance in sequencing technology has enabled comprehensive profiling of genetic alterations in cancer. We have established a targeted sequencing platform using next-generation sequencing (NGS) technology for clinical use, which can provide mutation and copy number variation data. NGS was performed with paired-end library enriched with exons of 183 cancer-related genes. Normal and tumor tissue pairs of 60 colorectal adenocarcinomas were used to test feasibility. Somatic mutation and copy number alteration were analyzed. A total of 526 somatic non-synonymous sequence variations were found in 113 genes. Among these, 278 single nucleotide variations were 232 different somatic point mutations. 216 SNV were 79 known single nucleotide polymorphisms in the dbSNP. 32 indels were 28 different indel mutations. Median number of mutated gene per tumor was 4 (range 0-23). Copy number gain (>X2 fold) was found in 65 genes in 40 patients, whereas copy number loss (<X0.5 fold) was found in 103 genes in 39 patients. The most frequently altered genes (mutation and/or copy number alteration) were APC in 35 patients (58%), TP53 in 34 (57%), and KRAS in 24 (40%). Altered gene list revealed ErbB signaling pathway as the most commonly involved pathway (25 patients, 42%). Targeted sequencing platform using NGS technology is feasible for clinical use and provides comprehensive genetic alteration data.	[Han, Sae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Han, Sae-Won; Kim, Hwang-Phill; Jeong, Eun-Goo; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Shin, Jong-Yeon; Lee, Won-Chul; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea; [Shin, Jong-Yeon; Kim, Jong-Il] Psoma Therapeut Inc, Seoul, South Korea; [Lee, Won-Chul; Seo, Jeong-Sun; Kim, Jong-Il; Kim, Tae-You] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Won, Jae-Kyung; Kang, Gyeong Hoon] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Macrogen, Inc.; Seoul National University (SNU)	Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	kimty@snu.ac.kr	KIM, JONG-IL/D-1019-2011; Lee, Won-Chul/D-5789-2012; Seo, Jeong-Sun/J-2763-2012; Kang, Gyeong Hoon/F-1051-2010; Bang, Yung Jue/J-2759-2012	KIM, JONG-IL/0000-0002-7240-3744; Lee, Won-Chul/0000-0001-8052-2420; Kang, Gyeong Hoon/0000-0003-2380-6675; Bang, Yung Jue/0000-0001-6000-4597; Won, Jae-Kyung/0000-0003-1459-8093	Korean Healthcare Technology RAMP;D project, Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea [A091081]	Korean Healthcare Technology RAMP;D project, Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea	This study was supported by a grant from the Korean Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kim JH, 2009, VIRCHOWS ARCH, V455, P485, DOI 10.1007/s00428-009-0857-0; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	27	58	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64271	10.1371/journal.pone.0064271	http://dx.doi.org/10.1371/journal.pone.0064271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700467	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200129
J	Heid, H; Rickelt, S; Zimbelmann, R; Winter, S; Schumacher, H; Dorflinger, Y				Heid, Hans; Rickelt, Steffen; Zimbelmann, Ralf; Winter, Stefanie; Schumacher, Heiderose; Doerflinger, Yvette			Lipid Droplets, Perilipins and Cytokeratins - Unravelled Liaisons in Epithelium-Derived Cells	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; INTERMEDIATE-FILAMENTS; PAT-FAMILY; ADIPOSE CONVERSION; TUMOR-CELLS; VIMENTIN; EXPRESSION; ADIPOPHILIN; CHOLESTEROL; MEMBRANE	Lipid droplets (LDs) are spherical accumulations of apolar lipids and other hydrophobic substances and are generally surrounded by a thin cortical layer of specific amphiphilic proteins (APs). These APs segregate the LDs from the mostly polar components of the cytoplasm. We have studied LDs in epithelium-derived cell cultures and in particular characterized proteins from the perilipin (PLIN) gene family - in mammals consisting of the proteins Perilipin, Adipophilin, TIP47, S3-12 and MLDP/OXPAT (PLIN 1-5). Using a large number of newly generated and highly specific mono- and polyclonal antibodies specific for individual APs, and using improved LD isolation methods, we have enriched and characterized APs in greater detail and purity. The majority of lipid-AP complexes could be obtained in the top layer fractions of density gradient centrifugation separations of cultured cells, but APs could also be detected in other fractions within such separations. The differently sized LD complexes were analyzed using various biochemical methods and mass spectrometry as well as immunofluorescence and electron- in particular immunoelectron-microscopy. Moreover, by immunoprecipitation, protein-protein binding assays and by immunoelectron microscopy we identified a direct linkage between LD-binding proteins and the intermediate-sized filaments (IF) cytokeratins 8 and 18 (also designated as keratins K8 and K18). Specifically, in gradient fractions of higher density supposedly containing small LDs, we received as co-precipitations cytidylyl-, palmitoyl- and cholesterol transferases and other specific enzymes involved in lipid metabolism. So far, common proteomic studies have used LDs from top layer fractions only and did not report on these transferases and other enzymes. In addition to findings of short alternating hydrophobic/hydrophilic segments within the PLIN protein family, we propose and discuss a model for the interaction of LD-coating APs with IF proteins.	[Heid, Hans; Rickelt, Steffen; Zimbelmann, Ralf; Winter, Stefanie; Schumacher, Heiderose; Doerflinger, Yvette] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Heid, H (corresponding author), German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany.	h.heid@dkfz.de		Rickelt, Steffen/0000-0002-5224-7764	Bundesministerium fur Bildung und Forschung in the framework "Zellbasierte, regenerative Medizin" START-MSC [01 GN 0942]	Bundesministerium fur Bildung und Forschung in the framework "Zellbasierte, regenerative Medizin" START-MSC(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung in the framework "Zellbasierte, regenerative Medizin" START-MSC (STAndardization for Regenerative Therapy - Mesenchymal Stem Cells; W. Franke and H. Heid, DKFZ) Grant 01 GN 0942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355; ALMAHBOBI G, 1993, J REPROD FERTIL, V98, P209; ALMAHBOBI G, 1995, CELL TISSUE RES, V281, P387, DOI 10.1007/s004410050436; ALMAHBOBI G, 1992, J CELL SCI, V101, P383; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Buers I, 2011, HISTOL HISTOPATHOL, V26, P631, DOI 10.14670/HH-26.631; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Evans RM, 1998, BIOESSAYS, V20, P79, DOI 10.1002/(SICI)1521-1878(199801)20:1<79::AID-BIES11>3.3.CO;2-I; Evans Robert M., 1994, Trends in Cell Biology, V4, P149, DOI 10.1016/0962-8924(94)90189-9; Franke WW, 2011, INT J CANCER, V129, P2588, DOI 10.1002/ijc.26227; FRANKE WW, 1987, CELL, V49, P131, DOI 10.1016/0092-8674(87)90763-X; FRANKE WW, 1969, HISTOCHEMISTRY, V19, P162, DOI 10.1007/BF00281096; FRANKE WW, 1981, EXP CELL RES, V134, P345, DOI 10.1016/0014-4827(81)90435-3; Fujimoto T., 2011, COLD SPRING HARB PER, V3; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; Graham JM, 1996, ATHEROSCLEROSIS, V124, P125, DOI 10.1016/0021-9150(96)05797-8; Hall PF, 1997, MICROSC RES TECHNIQ, V36, P463, DOI 10.1002/(SICI)1097-0029(19970315)36:6<463::AID-JEMT4>3.0.CO;2-J; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Holwell TA, 1999, J LIPID RES, V40, P1440; HSIEH K, 2012, J CELL SCI; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794; KNAPP AC, 1986, J CELL BIOL, V103, P657, DOI 10.1083/jcb.103.2.657; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Lee TF, 2010, J CELL PHYSIOL, V223, P648, DOI 10.1002/jcp.22063; Leung CL, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-6; Lieber JG, 1996, J CELL SCI, V109, P3047; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Rickelt S, 2009, INT J CANCER, V125, P2036, DOI 10.1002/ijc.24552; Robenek H, 2005, J BIOL CHEM, V280, P26330, DOI 10.1074/jbc.M413312200; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; SARRIA AJ, 1992, J BIOL CHEM, V267, P19455; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Sawle A, 2002, J LIPID RES, V43, P335; Scherer PE, 1998, NAT BIOTECHNOL, V16, P581, DOI 10.1038/nbt0698-581; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Schweitzer S C, 1998, Subcell Biochem, V31, P437; Smith CJ, 1999, TRENDS CELL BIOL, V9, P335, DOI 10.1016/S0962-8924(99)01631-1; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; STRAUB BK, 2012, HISTOPATHOLOGY; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Tanaka S, 2012, INT J CLIN EXP PATHO, V5, P824; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Urahama Y, 2008, AM J PATHOL, V173, P1286, DOI 10.2353/ajpath.2008.080137; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Yao M, 2007, CLIN CANCER RES, V13, P152, DOI 10.1158/1078-0432.CCR-06-1877; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	65	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63061	10.1371/journal.pone.0063061	http://dx.doi.org/10.1371/journal.pone.0063061			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704888	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200017
J	Kouse, AB; Righetti, F; Kortmann, J; Narberhaus, F; Murphy, ER				Kouse, Andrew B.; Righetti, Francesco; Kortmann, Jens; Narberhaus, Franz; Murphy, Erin R.			RNA-Mediated Thermoregulation of Iron-Acquisition Genes in Shigella dysenteriae and Pathogenic Escherichia coli	PLOS ONE			English	Article							HEME RECEPTOR; AEROBACTIN GENES; TRANSPORT-SYSTEM; BORDETELLA-AVIUM; EXPRESSION; VIRULENCE; IDENTIFICATION; GENETICS; FLEXNERI; PROTEIN	The initiation, progression and transmission of most bacterial infections is dependent upon the ability of the invading pathogen to acquire iron from each of the varied environments encountered during the course of a natural infection. In total, 95% of iron within the human body is complexed within heme, making heme a potentially rich source of host-associated nutrient iron for invading bacteria. As heme is encountered only within the host, pathogenic bacteria often regulate synthesis of heme utilization factors such that production is maximal under host-associated environmental conditions. This study examines the regulated production of ShuA, an outer-membrane receptor required for the utilization of heme as a source of nutrient iron by Shigella dysenteriae, a pathogenic bacterium that causes severe diarrheal diseases in humans. Specifically, the impact of the distinct environmental temperatures encountered during infection within a host (37 degrees C) and transmission between hosts (25 degrees C) on shuA expression is investigated. We show that shuA expression is subject to temperature-dependent post-transcriptional regulation resulting in increased ShuA production at 37 degrees C. The observed thermoregulation is mediated by nucleic acid sequences within the 59 untranslated region. In addition, we have identified similar nucleotide sequences within the 59 untranslated region of the orthologous chuA transcript of enteropathogenic E. coli and have demonstrated that it also functions to confer temperature-dependent post-transcriptional regulation. In both function and predicted structure, the regulatory element within the shuA and chuA 59 untranslated regions closely resembles a FourU RNA thermometer, a zipper-like RNA structure that occludes the Shine-Dalgarno sequence at low temperatures. Increased production of ShuA and ChuA in response to the host body temperature allows for maximal production of these heme acquisition factors within the environment where S. dysenteriae and pathogenic E. coli strains would encounter heme, a host-specific iron source.	[Kouse, Andrew B.] Ohio Univ, Dept Biol, Mol Cell Biol Program, Athens, OH 45701 USA; [Righetti, Francesco; Kortmann, Jens; Narberhaus, Franz] Ruhr Univ Bochum, Bochum, Germany; [Murphy, Erin R.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University; Ruhr University Bochum; University System of Ohio; Ohio University	Murphy, ER (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	murphy@oucom.ohiou.edu	Taylor, Graham/A-4027-2012	Narberhaus, Franz/0000-0002-8552-5310; Murphy, Erin/0000-0002-5716-4829; Righetti, Francesco/0000-0003-4903-2321	Ohio University Heritage College of Osteopathic Medicine; Department of Biomedical Sciences (ERM); German Research Foundation [SPP1258]	Ohio University Heritage College of Osteopathic Medicine; Department of Biomedical Sciences (ERM); German Research Foundation(German Research Foundation (DFG))	This work was supported by Ohio University Heritage College of Osteopathic Medicine and by the Department of Biomedical Sciences (ERM) and by the German Research Foundation (priority program SPP1258; FN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Battisti JM, 2006, INFECT IMMUN, V74, P3251, DOI 10.1128/IAI.00245-06; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Burkhard KA, 2008, BIOCHEMISTRY-US, V47, P7977, DOI 10.1021/bi801005u; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; CALIN A, 1979, WESTERN J MED, V131, P205; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Headley V, 1997, INFECT IMMUN, V65, P818, DOI 10.1128/IAI.65.2.818-821.1997; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Hoffmann H, 2001, INT J MED MICROBIOL, V291, P227, DOI 10.1078/1438-4221-00123; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kirby AE, 2001, INFECT IMMUN, V69, P6951, DOI 10.1128/IAI.69.11.6951-6961.2001; Klinkert B, 2012, J BIOTECHNOL, V160, P55, DOI 10.1016/j.jbiotec.2012.01.007; Klinkert B, 2009, CELL MOL LIFE SCI, V66, P2661, DOI 10.1007/s00018-009-0041-3; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LAWLOR KM, 1984, J BACTERIOL, V160, P266, DOI 10.1128/JB.160.1.266-272.1984; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mills M, 1997, INFECT IMMUN, V65, P5358, DOI 10.1128/IAI.65.12.5358-5363.1997; MILLS M, 1995, J BACTERIOL, V177, P3004, DOI 10.1128/jb.177.11.3004-3009.1995; Murphy ER, 2002, INFECT IMMUN, V70, P5390, DOI 10.1128/IAI.70.10.5390-5403.2002; Murphy ER, 2007, INFECT IMMUN, V75, P3470, DOI 10.1128/IAI.00112-07; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Narberhaus F, 2002, ARCH MICROBIOL, V178, P404, DOI 10.1007/s00203-002-0481-8; Niyogi SK, 2005, J MICROBIOL, V43, P133; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Okeke IN, 2004, J CLIN MICROBIOL, V42, P36, DOI 10.1128/JCM.42.1.36-44.2004; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Paulley JT, 2007, INFECT IMMUN, V75, P5248, DOI 10.1128/IAI.00460-07; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; PAYNE SM, 1980, J BACTERIOL, V143, P1420, DOI 10.1128/JB.143.3.1420-1424.1980; PAYNE SM, 1983, J BACTERIOL, V155, P949, DOI 10.1128/JB.155.3.949-955.1983; Rinnenthal J, 2011, NUCLEIC ACIDS RES, V39, P8258, DOI 10.1093/nar/gkr314; Rinnenthal J, 2010, NUCLEIC ACIDS RES, V38, P3834, DOI 10.1093/nar/gkq124; ROGERS HJ, 1973, INFECT IMMUN, V7, P445, DOI 10.1128/IAI.7.3.445-456.1973; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; Runyen-Janecky LJ, 2003, INFECT IMMUN, V71, P1919, DOI 10.1128/IAI.71.4.1919-1928.2003; SCHMITT MP, 1988, J BACTERIOL, V170, P5579, DOI 10.1128/jb.170.12.5579-5587.1988; SCHMITT MP, 1991, J BACTERIOL, V173, P816, DOI 10.1128/jb.173.2.816-825.1991; Seekircher S, 2012, PLOS PATHOG, V8, P1; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Smith AM, 2010, RNA BIOL, V7, P104, DOI 10.4161/rna.7.1.10757; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Taylor CM, 2008, PEDIATR NEPHROL, V23, P1425, DOI 10.1007/s00467-008-0820-3; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vokes SA, 1999, MOL MICROBIOL, V33, P63, DOI 10.1046/j.1365-2958.1999.01448.x; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wyckoff EE, 1998, MOL MICROBIOL, V28, P1139, DOI 10.1046/j.1365-2958.1998.00873.x; Wyckoff EE, 2005, J BACTERIOL, V187, P5658, DOI 10.1128/JB.187.16.5658-5664.2005; Wyckoff E, 2009, BIOMETALS, V22, P43, DOI 10.1007/s10534-008-9188-x	59	51	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63781	10.1371/journal.pone.0063781	http://dx.doi.org/10.1371/journal.pone.0063781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704938	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200069
J	Mu, XX; Lin, S; Yang, JH; Chen, C; Chen, Y; Herzig, MC; Washburn, K; Halff, GA; Walter, CA; Sun, BC; Sun, LZ				Mu, Xiaoxin; Lin, Shu; Yang, Junhua; Chen, Chen; Chen, Yun; Herzig, Maryanne C.; Washburn, Kenneth; Halff, Glenn A.; Walter, Christi A.; Sun, Beicheng; Sun, Lu-Zhe			TGF-beta Signaling Is Often Attenuated during Hepatotumorigenesis, but Is Retained for the Malignancy of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PLASMA TRANSFORMING GROWTH-FACTOR-BETA-1; RECEPTOR-TYPE-II; TUMOR-SUPPRESSOR; EXPRESSION; LIVER; INHIBITOR; SURVIVAL; PROTEIN; SMAD4	The role of transforming growth factor-beta (TGF-beta) signaling in hepatocarcinogenesis remains controversial. We aimed to reveal TGF-beta signaling status in human and murine tissues of hepatocellular carcinoma (HCC) and the mechanisms that mediate TGF-beta's role in regulating HCC malignancy. Here, TGF-beta pathway component expression and activation in human and murine HCC tissues were measured with quantitative RT-PCR and Western blotting assays. The role of TGF-beta receptor and Smad signaling in the growth and survival of several HCC cell lines was determined with several in vitro and in vivo approaches. We found that TGF-beta receptor II (T beta RII) expression was downregulated in two different HCC patient cohorts. Consistently, Smad3 phosphorylation was also downregulated in HCC tissues in comparison to that in adjacent normal tissues. Interestingly, many HCC cell lines were sensitive to TGF-beta and growth-inhibited by exogenous TGF-beta. However, stable knockdown of T beta RII inhibited cell growth on plastic and in soft agar, and induced apoptosis resulting in suppressed subcutaneous tumor growth and metastatic potential in vivo. Furthermore, knockdown of Smad4 also led to a significant inhibition of growth on plastic and in soft agar with concomitant increase of apoptosis, PTEN expression, and reduced nuclear accumulation of linker region-phosphorylated Smad3. Taken together, TGF-beta signaling pathway plays a dichotomous role in hepatocellular carcinogenesis. It appears to suppress HCC development, but is retained for HCC cell survival and malignancy. Furthermore, Smad4 can mediate both growth inhibitory activity induced by exogenous TGF-beta and the survival activity induced by autocrine TGF-beta revealing a delicate selection of the two opposing activities of TGF-beta during HCC evolution.	[Mu, Xiaoxin; Chen, Chen; Chen, Yun; Sun, Beicheng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Mu, Xiaoxin; Lin, Shu; Yang, Junhua; Herzig, Maryanne C.; Walter, Christi A.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Washburn, Kenneth; Halff, Glenn A.] Univ Texas Hlth Sci Ctr San Antonio, Transplant Ctr, San Antonio, TX 78229 USA; [Walter, Christi A.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Canc Ctr, San Antonio, TX 78229 USA; [Walter, Christi A.] Audie Murphy Hosp, South Texas Vet Hlth Care Syst, San Antonio, TX USA	Nanjing Medical University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Sun, BC (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	sunbc@njmu.edu.cn; sunl@uthscsa.edu	, LuZhe/AAW-4095-2021; Washburn, William/Q-5677-2016; Lin, Shu/C-3790-2013		NIH [R01CA75253, R01CA79683]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (UTHSCSA) through the NCI Cancer Center Support Grant [2 P30 CA054174-17]; National Science Foundation for Distinguished Young Scholars of China Grant [81225017]; NATIONAL CANCER INSTITUTE [R01CA079683, P30CA054174, R01CA075253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (UTHSCSA) through the NCI Cancer Center Support Grant; National Science Foundation for Distinguished Young Scholars of China Grant(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH Grants R01CA75253 and R01CA79683, the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio (UTHSCSA) through the NCI Cancer Center Support Grant 2 P30 CA054174-17, and the National Science Foundation for Distinguished Young Scholars of China Grant No.81225017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1016/0270-9139(95)90530-8; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; Chen CG, 1997, J BIOL CHEM, V272, P12862, DOI 10.1074/jbc.272.19.12862; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; FRIDMAN R, 1990, P NATL ACAD SCI USA, V87, P6698, DOI 10.1073/pnas.87.17.6698; Furuta K, 1999, INT J CANCER, V81, P851, DOI 10.1002/(SICI)1097-0215(19990611)81:6<851::AID-IJC2>3.0.CO;2-D; Gourley C, 2005, INT J ONCOL, V26, P1681; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; ITO N, 1995, CANCER LETT, V89, P45, DOI 10.1016/0304-3835(94)03651-X; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kawate S, 1999, INT J ONCOL, V14, P127; Kawate S, 2001, INT J MOL MED, V8, P49; Kiss A, 1997, CLIN CANCER RES, V3, P1059; Lei XF, 2002, ONCOGENE, V21, P7514, DOI 10.1038/sj.onc.1205966; Lei XF, 2007, EXP CELL RES, V313, P1687, DOI 10.1016/j.yexcr.2007.02.016; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Li DM, 1997, CANCER RES, V57, P2124; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Lin S, 2011, J BIOL CHEM, V286, P44023, DOI 10.1074/jbc.M111.265397; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuzaki K, 2000, CANCER RES, V60, P1394; Matsuzaki K, 2000, HEPATOLOGY, V32, P218, DOI 10.1053/jhep.2000.9145; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Mishra S, 2011, PROSTATE, V71, P1441, DOI 10.1002/pros.21361; Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; SHIRAI Y, 1994, CANCER, V73, P2275, DOI 10.1002/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Yakicier MC, 1999, ONCOGENE, V18, P4879, DOI 10.1038/sj.onc.1202866; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou ZQ, 2001, P NATL ACAD SCI USA, V98, P12566, DOI 10.1073/pnas.221232998	43	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63436	10.1371/journal.pone.0063436	http://dx.doi.org/10.1371/journal.pone.0063436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704908	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200038
J	Namouchi, A; Karboul, A; Fabre, M; Gutierrez, MC; Mardassi, H				Namouchi, Amine; Karboul, Anis; Fabre, Michel; Gutierrez, Maria Cristina; Mardassi, Helmi			Evolution of Smooth Tubercle Bacilli PE and PE_PGRS Genes: Evidence for a Prominent Role of Recombination and Imprint of Positive Selection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; PHYLOGENETIC ANALYSIS; DNA-SEQUENCES; NUCLEOTIDE SUBSTITUTION; DETECTING RECOMBINATION; ADAPTIVE EVOLUTION; GENOMIC ANALYSIS; IMMUNE-RESPONSE; PE-PGRS33 GENE; PROTEINS	Background: PE and PE_PGRS are two mycobateria-restricted multigene families encoding membrane associated and secreted proteins that have expanded mainly in the pathogenic species, notably the Mycobacterium tuberculosis complex (MTBC). Several lines of evidence attribute to PE and PE_PGRS genes critical roles in mycobacterial pathogenicity. To get more insight into the nature of these genes, we sought to address their evolutionary trajectories in the group of smooth tubercle bacilli (STB), the putative ancestor of the clonal MTBC. Methodology/Principal Findings: By focussing on six polymorphic STB PE/PE_PGRS genes, we demonstrate significant incongruence among single gene genealogies and detect strong signals of recombination using various approaches. Coalescent-based estimation of population recombination and mutation rates (rho and theta, respectively) indicates that the two mechanisms are of roughly equal importance in generating diversity (rho/theta = 1.457), a finding in a marked contrast to house keeping genes (HKG) whose evolution is chiefly brought about by mutation (rho/theta = 0.012). In comparison to HKG, we found 15 times higher mean rate of nonsynonymous substitutions, with strong evidence of positive selection acting on PE_PGRS62 (dN/dS = 1.42), a gene that has previously been shown to be essential for mycobacterial survival in macrophages and granulomas. Imprint of positive selection operating on specific amino acid residues or along branches of PE_PGRS62 phylogenetic tree was further demonstrated using maximum likelihood- and covarion-based approaches, respectively. Strikingly, PE_PGR62 proved highly conserved in present-day MTBC strains. Conclusions/Significance: Overall the data indicate that, in STB, PE/PE_PGRS genes have undergone a strong diversification process that is speeded up by recombination, with evidence of positive selection. The finding that positive selection involved an essential PE_PGRS gene whose sequence appears to be driven to fixation in present-day MTBC strains lends further support to the critical role of PE/PE_PGRS genes in the evolution of mycobacterial pathogenicity.	[Namouchi, Amine; Karboul, Anis; Mardassi, Helmi] Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Unit Typing & Genet Mycobacteria, Tunis, Tunisia; [Fabre, Michel] HIA Percy, Lab Biol Clin, Clamart, France; [Gutierrez, Maria Cristina] Inst Pasteur, Dept Infect & Epidemiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mardassi, H (corresponding author), Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Unit Typing & Genet Mycobacteria, Tunis, Tunisia.	helmi.merdassi@pasteur.rns.tn	Gutierrez, Cristina/B-5597-2012	Gutierrez, Cristina/0000-0002-5567-5908	Tunisian Ministry of Higher Education and Scientific Research	Tunisian Ministry of Higher Education and Scientific Research	This work has received funding from the Tunisian Ministry of Higher Education and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brisse S, 2006, PLOS PATHOG, V2, P812, DOI 10.1371/journal.ppat.0020095; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; CANETTI G, 1970, LILLE MED, V15, P280; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Chen TA, 2010, MICROB PATHOGENESIS, V49, P311, DOI 10.1016/j.micpath.2010.07.004; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Fabre M, 2004, J CLIN MICROBIOL, V42, P3248, DOI 10.1128/JCM.42.7.3248-3255.2004; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gordon SV, 2001, TUBERCULOSIS, V81, P157, DOI 10.1054/tube.2000.0269; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hebert AM, 2007, INFECT IMMUN, V75, P5798, DOI 10.1128/IAI.00335-07; Huang Y, 2012, VET MICROBIOL, V160, P117, DOI 10.1016/j.vetmic.2012.05.011; HUDSON RR, 1985, GENETICS, V111, P147; Hughes AL, 2002, EMERG INFECT DIS, V8, P1342, DOI 10.3201/eid0811.020064; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Jha SS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-100; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; Koeck JL, 2011, CLIN MICROBIOL INFEC, V17, P1013, DOI 10.1111/j.1469-0691.2010.03347.x; Koh KW, 2009, INFECT IMMUN, V77, P3337, DOI 10.1128/IAI.01175-08; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Liberles DA, 2001, MOL BIOL EVOL, V18, P2040, DOI 10.1093/oxfordjournals.molbev.a003745; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Machowski EE, 2007, J BACTERIOL, V189, P2190, DOI 10.1128/JB.01647-06; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; McVean G, 2002, GENETICS, V160, P1231; Mehta PK, 2006, MICROB PATHOGENESIS, V40, P139, DOI 10.1016/j.micpath.2005.12.002; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Reed FA, 2006, GENETICS, V172, P2011, DOI 10.1534/genetics.105.052183; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Siltberg J, 2002, J EVOLUTION BIOL, V15, P588, DOI 10.1046/j.1420-9101.2002.00416.x; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith NH, 2006, PLOS PATHOG, V2, P809, DOI 10.1371/journal.ppat.0020098; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Talarico S, 2005, J CLIN MICROBIOL, V43, P4954, DOI 10.1128/JCM.43.10.4954-4960.2005; Talarico S, 2008, TUBERCULOSIS, V88, P283, DOI 10.1016/j.tube.2008.01.001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Wang J, 2011, TUBERCULOSIS, V91, P287, DOI 10.1016/j.tube.2011.05.001; WHO, 2011, GLOB TURB CONTR 2010; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	90	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64718	10.1371/journal.pone.0064718	http://dx.doi.org/10.1371/journal.pone.0064718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705005	Green Published, gold			2022-12-25	WOS:000319330200159
J	Zhang, M; Feng, Y; Wang, J; Zhao, JW; Li, T; He, M; Yang, DH; Nosjean, O; Boutin, J; Renard, P; Wang, MW				Zhang, Meng; Feng, Yang; Wang, Jia; Zhao, Jianwei; Li, Ting; He, Min; Yang, Dehua; Nosjean, Olivier; Boutin, Jean; Renard, Pierre; Wang, Ming-Wei			High-Throughput Screening for GPR119 Modulators Identifies a Novel Compound with Anti-Diabetic Efficacy in db/db Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; RECEPTOR; AGONISTS; G-PROTEIN-COUPLED-RECEPTOR-119; PATHOGENESIS; SECRETION; DISCOVERY; RELEASE; NIDDM	G protein-coupled receptor 119 (GPR119) is highly expressed in pancreatic beta cells and enteroendocrine cells. It is involved in glucose-stimulated insulin secretion and glucagon-like peptide-1 (GLP-1) release, thereby representing a promising target for the treatment of type 2 diabetes. Although a number of GPR119 agonists were developed, no positive allosteric modulator (PAM) to this receptor has been reported. Here we describe a high-throughput assay for screening GPR119 PAMs and agonists simultaneously. Following screening of a small molecule compound library containing 312,000 synthetic and natural product-derived samples, one potent GPR119 agonist with novel chemical structure, MW1219, was identified. Exposure of MIN6 and GLUTag cells to MW1219 enhanced glucose-stimulated insulin secretion and GLP-1 release; once-daily oral dosing of MW1219 for 6 weeks in diabetic db/db mice reduced hemoglobin A1c (HbA1c) and improved plasma glucose, insulin and GLP-1 levels; it also increased glucose tolerance. The results demonstrate that MW1219 is capable of effectively controlling blood glucose level and may have the potential to be developed as a new class of anti-diabetic agents.	[Zhang, Meng; Feng, Yang; Li, Ting; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Wang, Jia; Zhao, Jianwei; He, Min; Wang, Ming-Wei] Chinese Natl Cpd Lib, Shanghai, Peoples R China; [Nosjean, Olivier; Boutin, Jean; Renard, Pierre] Les Labs Servier, Neuilly Sur Seine, France	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Servier	Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	wangmw@mail.shcnc.ac.cn	Boutin, Jean Albert/W-9103-2019; Yang, Dehua/S-6156-2017; Yang, Dehua/M-5789-2019	Boutin, Jean Albert/0000-0003-0068-7204; 	Ministry of Health of China [2012ZX09304011, 2013ZX09507002]; Shanghai Science and Technology Development Fund [11DZ2292200]; Les Laboratories Servier (France)	Ministry of Health of China; Shanghai Science and Technology Development Fund; Les Laboratories Servier (France)	This work was supported in part by grants from the Ministry of Health of China (2012ZX09304011 and 2013ZX09507002), Shanghai Science and Technology Development Fund (11DZ2292200) and Les Laboratories Servier (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Chu ZL, 2010, MOL ENDOCRINOL, V24, P161, DOI 10.1210/me.2009-0239; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; Lan H, 2012, BRIT J PHARMACOL, V165, P2799, DOI 10.1111/j.1476-5381.2011.01754.x; Lauffer L, 2008, ENDOCRINOLOGY, V149, P2035, DOI 10.1210/en.2008-0182; May LT, 2004, CURR PHARM DESIGN, V10, P2003, DOI 10.2174/1381612043384303; Meier Juris J, 2004, Curr Opin Investig Drugs, V5, P402; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Sakamoto Y, 2006, BIOCHEM BIOPH RES CO, V351, P474, DOI 10.1016/j.bbrc.2006.10.076; Semple G, 2008, J MED CHEM, V51, P5172, DOI 10.1021/jm8006867; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Williams C, 2004, NAT REV DRUG DISCOV, V3, P125, DOI 10.1038/nrd1306; Yoshida S, 2010, BIOCHEM BIOPH RES CO, V400, P745, DOI 10.1016/j.bbrc.2010.08.141; Young AA, 1996, METABOLISM, V45, P1, DOI 10.1016/S0026-0495(96)90192-4; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	23	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63861	10.1371/journal.pone.0063861	http://dx.doi.org/10.1371/journal.pone.0063861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704946	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200077
J	Hoffecker, BM; Raffield, LM; Kamen, DL; Nowling, TK				Hoffecker, Brett M.; Raffield, Laura M.; Kamen, Diane L.; Nowling, Tamara K.			Systemic Lupus Erythematosus and Vitamin D Deficiency Are Associated with Shorter Telomere Length among African Americans: A Case-Control Study	PLOS ONE			English	Article							REVISED CRITERIA; DISEASE-ACTIVITY; CELLS; CLASSIFICATION; PREVALENCE; ANTIBODIES; MORTALITY; INNATE; DAMAGE; INDEX	Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that disproportionately affects African American females. The causes of SLE are unknown but postulated to be a combination of genetic predisposition and environmental triggers. Vitamin D deficiency is one of the possible environmental triggers. In this study we evaluated relationships between vitamin D status, cellular aging (telomere length) and anti-telomere antibodies among African American Gullah women with SLE. The study population included African American female SLE patients and unaffected controls from the Sea Island region of South Carolina. Serum 25-hydroxyvitamin D levels were measured using a nonchromatographic radioimmunoassay. Telomere length was measured in genomic DNA of peripheral blood mononuclear cells (PBMCs) by monochrome multiplex quantitative PCR. Anti-telomere antibody levels were measured by enzyme-linked immunosorbent assay (ELISA). Patients with SLE had significantly shorter telomeres and higher anti-telomere antibody titers compared to age-and gender-matched unaffected controls. There was a positive correlation between anti-telomere antibody levels and disease activity among patients and a significant correlation of shorter telomeres with lower 25-hydroxyvitamin D levels in both patients and controls. In follow-up examination of a subset of the patients, the patients who remained vitamin D deficient tended to have shorter telomeres than those patients whose 25-hydroxyvitamin D levels were repleted. Increasing 25-hydroxyvitamin D levels in African American patients with SLE may be beneficial in maintaining telomere length and preventing cellular aging. Moreover, anti-telomere antibody levels may be a promising biomarker of SLE status and disease activity.	[Hoffecker, Brett M.; Raffield, Laura M.; Kamen, Diane L.; Nowling, Tamara K.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Nowling, Tamara K.] Ralph H Johnson Vet Affairs Med Ctr, Med Res Serv, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kamen, DL (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.	kamend@musc.edu; nowling@musc.edu		Raffield, Laura/0000-0002-7892-193X	Medical Research Service, Veterans Affairs Medical Center [BX000115]; National Institutes of Health (NIH) [AR053376, K23 AR052364]; South Carolina Clinical & Translational Research (SCTR) Institute; Medical University of South Carolina, (NIH/NCRR) [UL1 RR029882]; NIAMS [P60 AR062755]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052364, R03AR053376, P60AR062755] Funding Source: NIH RePORTER	Medical Research Service, Veterans Affairs Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical & Translational Research (SCTR) Institute; Medical University of South Carolina, (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by VA Merit Review grant BX000115 from the Medical Research Service, Veterans Affairs Medical Center and National Institutes of Health (NIH) grant AR053376 awarded to TKN, NIH grant K23 AR052364 awarded to DLK and by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, (NIH/NCRR UL1 RR029882), and NIAMS grant P60 AR062755 (DLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; ALARCON GS, 1983, ARTHRITIS RHEUM, V26, P238, DOI 10.1002/art.1780260226; Alvarez-Rodriguez L, 2012, J LEUKOCYTE BIOL, V91, P829, DOI 10.1189/jlb.1011523; Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; Beier F, 2007, LUPUS, V16, P955, DOI 10.1177/0961203307084299; Ben-Zvi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009193; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Calvo-Alen J, 1995, J Clin Rheumatol, V1, P260, DOI 10.1097/00124743-199510000-00002; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chebel A, 2009, AGING CELL, V8, P52, DOI 10.1111/j.1474-9726.2008.00448.x; Gilkeson GS, 2011, LUPUS, V20, P1095, DOI 10.1177/0961203311404915; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002; Hathcock KS, 2005, IMMUNOL REV, V205, P104, DOI 10.1111/j.0105-2896.2005.00267.x; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hollis BW, 2000, CLIN CHEM, V46, P1657; Honda M, 2001, CLIN IMMUNOL, V99, P211, DOI 10.1006/clim.2001.5023; Kamen DL, 2008, ARTHRITIS RHEUM, V58, P1237, DOI 10.1002/art.23416; Kamen DL, 2010, J MOL MED, V88, P441, DOI 10.1007/s00109-010-0590-9; Kamen Diane L, 2008, Curr Rheumatol Rep, V10, P273, DOI 10.1007/s11926-008-0044-3; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Kurosaka D, 2003, LUPUS, V12, P591, DOI 10.1191/0961203303lu426oa; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Ouyang Q, 2007, ANN NY ACAD SCI, V1106, P240, DOI 10.1196/annals.1392.001; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Salonen EM, 2004, ANN RHEUM DIS, V63, P1250, DOI 10.1136/ard.2003.011890; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tew MB, 2001, ARTHRITIS RHEUM, V44, P981, DOI 10.1002/1529-0131(200104)44:4<981::AID-ANR158>3.3.CO;2-S; Vila LM, 2004, RHEUMATOLOGY, V43, P358, DOI 10.1093/rheumatology/keh048; Wallace DJ, 2000, LUPUS, V9, P328, DOI 10.1191/096120300678828343; Wu CH, 2007, LUPUS, V16, P265, DOI 10.1177/0961203307077155; Zhao GX, 2012, J HYPERTENS, V30, P284, DOI 10.1097/HJH.0b013e32834e1f0a; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	41	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63725	10.1371/journal.pone.0063725	http://dx.doi.org/10.1371/journal.pone.0063725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700431	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400028
J	Mikkola, TS; Gissler, M; Merikukka, M; Tuomikoski, P; Ylikorkala, O				Mikkola, Tomi S.; Gissler, Mika; Merikukka, Marko; Tuomikoski, Pauliina; Ylikorkala, Olavi			Sex Differences in Age-Related Cardiovascular Mortality	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; NATURAL MENOPAUSE; RISK-FACTORS; FINLAND; TRENDS; VALIDITY; HORMONES; COHORT; DEATH	Introduction: Sex-related physiological differences result in different expressions of diseases for men and women. Data are contradicting regarding the increase in the female risk for cardiovascular disease (CVD) at mid-life. Thus, we studied possible sex differences in age-adjusted mortality for CVD and non-vascular diseases stratifying our findings by specific age groups. Methods: Over one million deaths (1 080 910) reported to the Finnish nationwide Causes of Death Register in 1986-2009 were analyzed. A total of 247 942 male deaths and 278 752 female deaths were of CVD origin, the remaining deaths were non-vascular. The annual mortality rates were calculated per 100 000 mid-year population, separately for men and women in 5-year age categories. Results: The age-standardized risk of death from CVD was 80% higher for men (442/100 000) than for women (246/100 000). After age 45-54 the male CVD mortality rate elevated parallel to the non-vascular mortality, whereas in women the CVD mortality elevated considerably more rapidly than the non-vascular mortality from age 60 years onwards. Conclusions: Heart disease mortality in men accelerates at a relatively young age, but in women the risk shows a steep increase at approximately 60 years of age. These data emphasize the need to identify and prevent risk factors for CVD, especially in women in their mid-life years.	[Mikkola, Tomi S.; Tuomikoski, Pauliina; Ylikorkala, Olavi] Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Mikkola, Tomi S.] Folkhalsan Res Ctr, Helsinki, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Merikukka, Marko] Natl Inst Hlth & Welf, Oulu, Finland	University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Mikkola, TS (corresponding author), Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland.	tomi.mikkola@hus.fi		Gissler, Mika/0000-0001-8254-7525; Mikkola, Tomi/0000-0003-2049-088X	Paivikki and Sakari Sohlberg Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Finska Lakaresallskapet; Orion-Farmos Research Foundation; Paavo Nurmi Foundation; special governmental grant for health sciences research; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Paivikki and Sakari Sohlberg Foundation; Emil Aaltonen Foundation; Finnish Medical Foundation; Finska Lakaresallskapet; Orion-Farmos Research Foundation; Paavo Nurmi Foundation; special governmental grant for health sciences research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by unrestricted grants from the Paivikki and Sakari Sohlberg Foundation, the Emil Aaltonen Foundation, the Finnish Medical Foundation, Finska Lakaresallskapet, the Orion-Farmos Research Foundation, the Paavo Nurmi Foundation, and a special governmental grant for health sciences research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Charchar FJ, 2003, TRENDS ENDOCRIN MET, V14, P163, DOI 10.1016/S1043-2760(03)00032-8; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Joakimsen O, 2000, J CLIN EPIDEMIOL, V53, P525, DOI 10.1016/S0895-4356(99)00197-3; KALIN MF, 1990, STEROIDS, V55, P330, DOI 10.1016/0039-128X(90)90058-J; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Lahti RA, 1998, FORENSIC SCI INT, V91, P109, DOI 10.1016/S0379-0738(97)00180-1; Lehto Hanna-Riikka, 2007, BMC Cardiovasc Disord, V7, P35, DOI 10.1186/1471-2261-7-35; Lin JW, 2010, J CLIN ENDOCR METAB, V95, P4258, DOI 10.1210/jc.2010-0332; McCarthy JJ, 2007, NUTR METAB CARDIOVAS, V17, P153, DOI 10.1016/j.numecd.2006.01.005; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; The Editorial Committee for Health Statistics in the Nordic Countries, HLTH STAT NORD COUNT; Tom SE, 2012, J WOMENS HEALTH, V21, P10, DOI 10.1089/jwh.2011.2745; Towfighi A, 2009, ARCH INTERN MED, V169, P1762, DOI 10.1001/archinternmed.2009.318; Tunstall-Pedoe H, 1998, LANCET, V351, P1425, DOI 10.1016/S0140-6736(97)11321-6; Vaartjes I, 2011, HEART, V97, P569, DOI 10.1136/hrt.2010.206565; Vaidya D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5170; vanderSchouw YT, 1996, LANCET, V347, P714, DOI 10.1016/S0140-6736(96)90075-6; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Witteman JC, 1988, LANCET, V352, P407	28	85	86	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63347	10.1371/journal.pone.0063347	http://dx.doi.org/10.1371/journal.pone.0063347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700418	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400016
J	Tseng, YT; Chang, CH; Wang, SM; Huang, KJ; Wang, CT				Tseng, Ying-Tzu; Chang, Chia-Hui; Wang, Shiu-Mei; Huang, Kuo-Jung; Wang, Chin-Tien			Identifying SARS-CoV Membrane Protein Amino Acid Residues Linked to Virus-Like Particle Assembly	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; CARBOXY-TERMINAL DOMAIN; MOUSE HEPATITIS-VIRUS; NUCLEOCAPSID PROTEIN; MOLECULAR-BIOLOGY; GOLGI-COMPLEX; AVIAN CORONAVIRUS; ENVELOPE PROTEIN; PI-STACKING; SURFACE	Severe acute respiratory syndrome coronavirus (SARS-CoV) membrane (M) proteins are capable of self-assembly and release in the form of membrane-enveloped vesicles, and of forming virus-like particles (VLPs) when coexpressed with SARS-CoV nucleocapsid (N) protein. According to previous deletion analyses, M self-assembly involves multiple M sequence regions. To identify important M amino acid residues for VLP assembly, we coexpressed N with multiple M mutants containing substitution mutations at the amino-terminal ectodomain, carboxyl-terminal endodomain, or transmembrane segments. Our results indicate that a dileucine motif in the endodomain tail (218LL219) is required for efficient N packaging into VLPs. Results from cross-linking VLP analyses suggest that the cysteine residues 63, 85 and 158 are not in close proximity to the M dimer interface. We noted a significant reduction in M secretion due to serine replacement for C158, but not for C63 or C85. Further analysis suggests that C158 is involved in M-N interaction. In addition to mutations of the highly conserved 107-SWWSFNPE-114 motif, substitutions at codons W19, W57, P58, W91, Y94 or F95 all resulted in significantly reduced VLP yields, largely due to defective M secretion. VLP production was not significantly affected by a tryptophan replacement of Y94 or F95 or a phenylalanine replacement of W19, W57 or W91. Combined, these results indicate the involvement of specific M amino acids during SARS-CoV virus assembly, and suggest that aromatic residue retention at specific positions is critical for M function in terms of directing virus assembly.	[Tseng, Ying-Tzu; Huang, Kuo-Jung; Wang, Chin-Tien] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chang, Chia-Hui] Natl Yang Ming Univ, Inst Publ Hlth, Sch Med, Taipei 112, Taiwan; [Wang, Shiu-Mei; Wang, Chin-Tien] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, CT (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	chintien@ym.edu.tw			Taipei Veterans General Hospital [V98C1-021, V99C1-013]; National Science Council, Taiwan [NSC 97-2320-B-010-002-MY3, 100-2320-B-010-015-MY3]; Ministry of Education, Aim for the Top University Plan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by Grants V98C1-021 and V99C1-013 from Taipei Veterans General Hospital, by Grant NSC 97-2320-B-010-002-MY3 and 100-2320-B-010-015-MY3 from the National Science Council, Taiwan, and by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai BK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002685; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Chang YF, 2007, J MOL BIOL, V370, P585, DOI 10.1016/j.jmb.2007.05.020; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; de Haan CAM, 1998, ADV EXP MED BIOL, V440, P367; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Fang XN, 2005, J BIOCHEM MOL BIOL, V38, P381; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Godeke GJ, 2000, J VIROL, V74, P1566, DOI 10.1128/JVI.74.3.1566-1571.2000; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; Ho Y, 2004, BIOCHEM BIOPH RES CO, V318, P833, DOI 10.1016/j.bbrc.2004.04.111; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Hu Yongwu, 2003, Genomics Proteomics & Bioinformatics, V1, P118; Huang Y, 2004, J VIROL, V78, P12557, DOI 10.1128/JVI.78.22.12557-12565.2004; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Lai M M, 1987, Adv Exp Med Biol, V218, P7; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; Luo HB, 2006, INT J BIOCHEM CELL B, V38, P589, DOI 10.1016/j.biocel.2005.10.022; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; MACHAMER CE, 1990, P NATL ACAD SCI USA, V87, P6944, DOI 10.1073/pnas.87.18.6944; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; McDermott J, 1996, J VIROL, V70, P5106, DOI 10.1128/JVI.70.8.5106-5114.1996; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; Sambrook J., 2001, MOL CLONING LAB MANU; Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; TO LT, 1991, VET MICROBIOL, V29, P361, DOI 10.1016/0378-1135(91)90143-4; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; TOOZE J, 1985, EUR J CELL BIOL, V37, P203; Tseng YT, 2010, J BIOL CHEM, V285, P12862, DOI 10.1074/jbc.M109.030270; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Voss D, 2006, FEBS LETT, V580, P968, DOI 10.1016/j.febslet.2006.01.026; Voss D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-79; Wang SM, 2008, J BIOMED SCI, V15, P719, DOI 10.1007/s11373-008-9265-8; World Health Organization, 2004, WORLD HLTH REP 2004; Yu IM, 2005, J BIOL CHEM, V280, P23280, DOI 10.1074/jbc.M501015200; Ziebuhr J, 2004, CURR OPIN MICROBIOL, V7, P412, DOI 10.1016/j.mib.2004.06.007	62	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64013	10.1371/journal.pone.0064013	http://dx.doi.org/10.1371/journal.pone.0064013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700447	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400040
J	Bansal, R; Karanth, KP				Bansal, Rohini; Karanth, K. Praveen			Phylogenetic Analysis and Molecular Dating Suggest That Hemidactylus anamallensis Is Not a Member of the Hemidactylus Radiation and Has an Ancient Late Cretaceous Origin	PLOS ONE			English	Article							C-MOS; GEKKONIDAE; REPTILIA; LIZARDS	Background of the Work: The phylogenetic position and evolution of Hemidactylus anamallensis (family Gekkonidae) has been much debated in recent times. In the past it has been variously assigned to genus Hoplodactylus (Diplodactylidae) as well as a monotypic genus 'Dravidogecko' (Gekkonidae). Since 1995, this species has been assigned to Hemidactylus, but there is much disagreement between authors regarding its phylogenetic position within this genus. In a recent molecular study H. anamallensis was sister to Hemidactylus but appeared distinct from it in both mitochondrial and nuclear markers. However, this study did not include genera closely allied to Hemidactylus, thus a robust evaluation of this hypothesis was not undertaken. Methods: The objective of this study was to investigate the phylogenetic position of H. anamallensis within the gekkonid radiation. To this end, several nuclear and mitochondrial markers were sequenced from H. anamallensis, selected members of the Hemidactylus radiation and genera closely allied to Hemidactylus. These sequences in conjunction with published sequences were subjected to multiple phylogenetic analyses. Furthermore the nuclear dataset was also subjected to molecular dating analysis to ascertain the divergence between H. anamallensis and related genera. Results and Conclusion: Results showed that H. anamallensis lineage was indeed sister to Hemidactylus group but was separated from the rest of the Hemidactylus by a long branch. The divergence estimates supported a scenario wherein H. anamallensis dispersed across a marine barrier to the drifting peninsular Indian plate in the late Cretaceous whereas Hemidactylus arrived on the peninsular India after the Indian plate collided with the Eurasian plate. Based on these molecular evidence and biogeographical scenario we suggest that the genus Dravidogecko should be resurrected.	[Bansal, Rohini; Karanth, K. Praveen] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Karanth, KP (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India.	karanth@ces.iisc.ernet.in			Ministry of Environment and Forest; Department of Science and Technology, Government of India [SR/SO/AS-57/2009]	Ministry of Environment and Forest; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This research was supported by a grant from the Ministry of Environment and Forest and Department of Science and Technology, Government of India (SR/SO/AS-57/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrakhmatov KY, 1996, NATURE, V384, P450, DOI 10.1038/384450a0; Bansal R, 2010, MOL PHYLOGENET EVOL, V57, P459, DOI 10.1016/j.ympev.2010.06.008; Bauer Aaron M., 1995, Asiatic Herpetological Research, V6, P30; Bauer AM, 2010, MOL PHYLOGENET EVOL, V57, P343, DOI 10.1016/j.ympev.2010.06.014; Bauer AM, 2008, HAMADRYAD, V32, P90; Bohme W., 1984, Salamandra, V20, P212; Briggs JC, 2003, J BIOGEOGR, V30, P381, DOI 10.1046/j.1365-2699.2003.00809.x; Carranza S, 2006, MOL PHYLOGENET EVOL, V38, P531, DOI 10.1016/j.ympev.2005.07.012; Chatterjee S, 1999, P INDIAN NATL SCI A, V65, P397; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Feng J, 2007, ZOOL SCI, V24, P656, DOI 10.2108/zsj.24.656; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Gunther A, 1875, P ZOOL SOC LOND; Han D, 2004, BIOL J LINN SOC, V83, P353, DOI 10.1111/j.1095-8312.2004.00393.x; Kluge A. G., 1967, Bulletin of the American Museum of Natural History, V135, P1; Kluge Arnold G., 1995, American Museum Novitates, V3139, P1; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P320, DOI 10.1006/mpev.1999.0641; Nielsen SV, 2011, MOL PHYLOGENET EVOL, V59, P1, DOI 10.1016/j.ympev.2010.12.007; Nydam RL, 2000, J VERTEBR PALEONTOL, V20, P285, DOI 10.1671/0272-4634(2000)020[0285:ANTOHL]2.0.CO;2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell A.P., 1976, Linnean Soc Symp Ser, V3, P217; RUSSELL A P, 1990, Memoirs of the Queensland Museum, V29, P453; RUSSELL AP, 1977, ZBL VET MED C, V6, P332, DOI 10.1111/j.1439-0264.1977.tb00443.x; RUSSELL AP, 1979, COPEIA, P1, DOI 10.2307/1443723; Russell AP, 1972, THESIS U LONDON ENGL; Saint KM, 1998, MOL PHYLOGENET EVOL, V10, P259, DOI 10.1006/mpev.1998.0515; Sambrook J, 2001, MOL CLONING LAB MANU, P623; Smith M. A., 1933, Records of the Indian Museum, V35, P9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strauch A, 1887, MEMOIRS ACAD IMPERIA, V7, p[2, 1]; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAPPONNIER P, 1981, EARTH PLANET SC LETT, V52, P355, DOI 10.1016/0012-821X(81)90189-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uetz P, 2013, REPTILE DATABASE; UNDERWOOD GARTH, 1954, PROC ZOOL SOC LONDON, V124, P469; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; Zug George R., 2007, Proceedings of the California Academy of Sciences, V58, P387	43	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e60615	10.1371/journal.pone.0060615	http://dx.doi.org/10.1371/journal.pone.0060615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696785	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000319081900002
J	Duhoux, A; Delye, C				Duhoux, Arnaud; Delye, Christophe			Reference Genes to Study Herbicide Stress Response in Lolium sp.: Up-Regulation of P450 Genes in Plants Resistant to Acetolactate-Synthase Inhibitors	PLOS ONE			English	Article							SITE-BASED RESISTANCE; QUANTITATIVE RT-PCR; HOUSEKEEPING GENES; ACETYL-COENZYME; EXPRESSION; VALIDATION; GENOME; CARBOXYLASE; GUIDELINES	Variation in the expression of numerous genes is at the basis of plant response to environmental stresses. Non-target-site-based resistance to herbicides (NTSR), the major threat to grass weed chemical control, is governed by a subset of the genes involved in herbicide stress response. Quantitative PCR assays allowing reliable comparison of gene expression are thus key to identify genes governing NTSR. This work aimed at identifying a set of reference genes with a stable expression to be used as an internal standard for the normalisation of quantitative PCR data in studies investigating NTSR to herbicides inhibiting acetolactate synthase (ALS) in the major grass weed Lolium sp. Gene expression stability was assessed in plants resistant or sensitive to two ALS inhibitors, subjected or not to herbicide stress. Using three complementary approaches implemented in the programs BestKeeper, NormFinder and geNorm, cap-binding protein, glyceraldehyde-3-phosphate-dehydrogenase and ubiquitin were identified as the most suitable reference genes. This reference gene set can probably be used to study herbicide response in other weed species. It was used to compare the expression of the genes encoding two herbicide target enzymes (ALS and acetyl-coenzyme A carboxylase) and five cytochromes P450 (CYP) with potential herbicide-degrading activity between plants resistant or sensitive to ALS inhibitors. Overall, herbicide application enhanced CYP gene expression. Constitutive up-regulation of all CYP genes observed in resistant plants compared to sensitive plants suggested enhanced secondary metabolism in the resistant plants. Comprehensive transcriptome studies associated to gene expression analyses using the reference gene set validated here are required to unravel NTSR genetic determinants.	[Duhoux, Arnaud; Delye, Christophe] INRA, Agroecol UMR1347, F-21034 Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Delye, C (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	delye@dijon.inra.fr			Arvalis - Institut du Vegetal	Arvalis - Institut du Vegetal	This work was supported by funding from Arvalis - Institut du Vegetal (http://www.arvalisinstitutduvegetal.fr) to AD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Busi R, 2011, HEREDITY, V106, P817, DOI 10.1038/hdy.2010.124; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cummins I, 2009, PLANT BIOTECHNOL J, V7, P807, DOI 10.1111/j.1467-7652.2009.00445.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2009, WEED RES, V49, P326, DOI 10.1111/j.1365-3180.2009.00700.x; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; Dombrowski JE, 2009, PLANT SCI, V176, P390, DOI 10.1016/j.plantsci.2008.12.005; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Heap I., 2013, INT SURVEY HERBICIDE; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Inui H, 2001, PESTIC BIOCHEM PHYS, V71, P156, DOI 10.1006/pest.2001.2574; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Lei Z, 2007, MOL BREEDING, V68, P19; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Ovesna J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041886; Petit Cecile, 2012, BMC Res Notes, V5, P18, DOI 10.1186/1756-0500-5-18; Petit C, 2010, PLANT SCI, V178, P501, DOI 10.1016/j.plantsci.2010.03.007; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeifer M, 2013, PLANT PHYSIOL, V161, P571, DOI 10.1104/pp.112.207282; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; SNUSTAD DP, 1992, PLANT CELL, V4, P549, DOI 10.1105/tpc.4.5.549; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Tsujii H, 2004, INT S CYT P450 BIOD, P69; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Werk-Reichhart D., 2000, GENOME BIOL, V1	36	46	59	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63576	10.1371/journal.pone.0063576	http://dx.doi.org/10.1371/journal.pone.0063576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696834	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900042
J	Gaardbo, JC; Hartling, HJ; Ronit, A; Thorsteinsson, K; Madsen, HO; Springborg, K; Gjerdrum, LMR; Birch, C; Laye, M; Ullum, H; Andersen, AB; Nielsen, SD				Gaardbo, Julie Christine; Hartling, Hans J.; Ronit, Andreas; Thorsteinsson, Kristina; Madsen, Hans Ole; Springborg, Karoline; Gjerdrum, Lise Mette Rahbek; Birch, Carsten; Laye, Matthew; Ullum, Henrik; Andersen, Ase Bengaard; Nielsen, Susanne Dam			Different Immunological Phenotypes Associated with Preserved CD4+T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; T-CELLS; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; DISEASE PROGRESSION; THYMIC OUTPUT; RECEPTOR; INDIVIDUALS; EXPRESSION; RESPONSES	Background: HIV-infected controllers control viral replication and maintain normal CD4+ T cell counts. Long Term Non-Progressors (LTNP) also maintain normal CD4+ T cell counts, but have on-going viral replication. We hypothesized that different immunological mechanisms are responsible for preserved CD4+ T cell counts in controllers and LTNP. Methods: 25 HIV-infected controllers and 14 LTNP were included in this cross-sectional study. For comparison, 25 progressors and 34 healthy controls were included. Production and destruction of T cells were addressed by determination of T cell receptor excision circles (TREC), recent thymic emigrants, naive cells, immune activation, senescence and apoptosis. Furthermore, telomere length was determined, and the amount of lymphoid tissue in tonsil biopsies was quantified. Results: Controllers presented with partly preserved thymic output, preserved expression of the IL-7 receptor and IL-7 receptor density, and lower levels of destruction of cells than progressors resembling HIV-negative healthy controls. In contrast, LTNP appeared much like progressors, and different from controllers in immune activation, senescence, and apoptosis. Interestingly, CD8+ RTE, TREC and telomere length were partly preserved. Finally, both controllers and LTNP displayed decreased amounts of lymphoid tissue compared to healthy controls. Conclusions: Controllers presented with an immunological profile different from LTNP. While controllers resembled healthy controls, LTNP were similar to progressors, suggesting different immunological mechanisms to be responsible for preserved CD4+ T cell counts in LTNP and controllers. However, both controllers and LTNP presented with reduced amounts of lymphoid tissue despite preserved CD4+ T cell counts, indicating HIV to cause damage even in non-progressors.	[Gaardbo, Julie Christine; Hartling, Hans J.; Ronit, Andreas; Birch, Carsten; Nielsen, Susanne Dam] Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, Viroimmunol Res Grp, DK-2100 Copenhagen, Denmark; [Gaardbo, Julie Christine; Hartling, Hans J.; Ronit, Andreas; Madsen, Hans Ole; Birch, Carsten; Ullum, Henrik] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Thorsteinsson, Kristina] Univ Copenhagen Hosp, Hvidovre Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Springborg, Karoline] Univ Copenhagen Hosp, Rigshosp, Dept Otorhinolaryngol, DK-2100 Copenhagen, Denmark; [Gjerdrum, Lise Mette Rahbek] Univ Copenhagen Hosp, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Laye, Matthew] Univ Copenhagen Hosp, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Andersen, Ase Bengaard] Univ Southern Denmark, Odense Hosp, Dept Infect Dis, Odense, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Nielsen, SD (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Infect Dis, Viroimmunol Res Grp, DK-2100 Copenhagen, Denmark.	sdn@dadlnet.dk	Madsen, Hans O/Q-2035-2015; Laye, Matthew J/AAQ-1897-2020	Madsen, Hans O/0000-0001-5551-4787; Laye, Matthew J/0000-0003-3214-3113; Hartling, Hans Jakob/0000-0002-4886-0419; Nielsen, Susanne Dam/0000-0001-6391-7455; Gjerdrum, Lise Mette Rahbek/0000-0003-4377-3209; Ullum, Henrik/0000-0001-7306-9058	University of Copenhagen; Novo Nordisk Foundation; Augustinus Foundation; Danish Medical Association; Novo Nordisk Fonden [NNF10OC1013203] Funding Source: researchfish	University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation; Danish Medical Association; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by University of Copenhagen, Novo Nordisk Foundation, Augustinus Foundation and Danish Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bello G, 2009, J MED VIROL, V81, P1681, DOI 10.1002/jmv.21565; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Broussard SR, 2001, J VIROL, V75, P2262, DOI 10.1128/JVI.75.5.2262-2275.2001; Carbone J, 2003, AIDS, V17, P133, DOI 10.1097/00002030-200301030-00021; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Fang RHT, 2005, AIDS, V19, P663, DOI 10.1097/01.aids.0000166089.93574.5a; Franceschi C, 1997, CELL DEATH DIFFER, V4, P815, DOI 10.1038/sj.cdd.4400305; Gaardbo JC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/161584; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kamya P, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-20; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Kitchen CR, 2013, C RETR OPP INF CROI; Laye MJ, 2012, J APPL PHYSIOL, V112, P773, DOI 10.1152/japplphysiol.00997.2011; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Marchetti G, 2009, HIV MED, V10, P422, DOI 10.1111/j.1468-1293.2009.00710.x; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Mozos A, 2007, JAIDS-J ACQ IMM DEF, V46, P529, DOI 10.1097/QAI.0b013e31815b69ae; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PARK LS, 1990, J EXP MED, V171, P1073, DOI 10.1084/jem.171.4.1073; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Richardson MW, 2003, AIDS, V17, P915, DOI 10.1097/00002030-200304110-00018; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Ruiz-Mateos E, 2010, CURR HIV RES, V8, P471, DOI 10.2174/157016210793499268; Sanchez J, 2013, C RETR OPP INF CROI; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; Whittall T, 2011, CLIN EXP IMMUNOL, V166, P208, DOI 10.1111/j.1365-2249.2011.04463.x; Wolthers KC, 1996, SCIENCE, V274, P1543, DOI 10.1126/science.274.5292.1543; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Yang Y, 2012, AIDS, V26, P701, DOI 10.1097/QAD.0b013e3283519b22; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63744	10.1371/journal.pone.0063744	http://dx.doi.org/10.1371/journal.pone.0063744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696852	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900057
J	O'Rourke, M; Traweger, A; Lusa, L; Stupica, D; Maraspin, V; Barrett, PN; Strle, F; Livey, I				O'Rourke, Maria; Traweger, Andreas; Lusa, Lara; Stupica, Dasa; Maraspin, Vera; Barrett, P. Noel; Strle, Franc; Livey, Ian			Quantitative Detection of Borrelia burgdorferi sensu lato in Erythema Migrans Skin Lesions Using Internally Controlled Duplex Real Time PCR	PLOS ONE			English	Article							EARLY LYME-DISEASE; CEREBROSPINAL-FLUID; SEQUENCE-ANALYSIS; ASSAY; DIAGNOSIS; STRAINS; PATIENT; SAMPLES; OSPA; DNA	B. burgdorferi sensu stricto, B. afzelii, B. garinii and B. bavariensis are the principal species which account for Lyme borreliosis (LB) globally. We have developed an internally controlled duplex quantitative real time PCR assay targeting the Borrelia 16S rRNA and the human RNAseP genes. This assay is well-suited for laboratory confirmation of suspected cases of LB and will be used to assess the efficacy of a vaccine against LB in clinical trials. The assay is highly specific, successfully detecting DNA extracted from 83 diverse B. burgdorferi sensu lato strains representing all major species causing LB, while 21 unrelated microbial species and human genomic DNA tested negative. The assay was highly reproducible and sensitive, with a lower limit of detection of 6 copies per PCR reaction. Together with culture, the assay was used to evaluate paired 3 mm skin biopsy samples taken from 121 patients presenting with solitary erythema migrans (EM) lesion. PCR testing identified more positive biopsy samples than culture (77.7% PCR positive versus 55.1% culture positive) and correctly identified all specimens scored as culture positive. OspA-based typing identified the majority of isolates as B. afzelii (96.8%) and the bacterial load was significantly higher in culture positive biopsies than in culture negative biopsies (P<0.001). The quantitative data also enabled relationships between Borrelia burden and patient symptoms to be evaluated. The bacterial load was significantly higher among patients with systemic symptoms than without (P = 0.02) and was significantly higher for biopsies retrieved from patients with EM lesions with central clearing (P<0.001). 16S copy numbers were moderately lower in samples from patients reporting a history of LB (P = 0.10). This is the first quantitative PCR study of human skin biopsies predominantly infected with B. afzelii and the first study to demonstrate a clear relationship between clinical symptoms in B. afzelii-infected patients and Borrelia burden.	[O'Rourke, Maria; Traweger, Andreas; Barrett, P. Noel; Livey, Ian] Baxter Biosci, Vaccine R&D, Orth, Austria; [Lusa, Lara] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Stupica, Dasa; Maraspin, Vera; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Traweger, Andreas] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Inst Tendon & Bone Regenerat, Salzburg, Austria	University of Ljubljana; University Medical Centre Ljubljana; Paracelsus Private Medical University	O'Rourke, M (corresponding author), Baxter Biosci, Vaccine R&D, Orth, Austria.	maria_o'rourke@baxter.com	Lusa, Lara/C-6692-2015; Traweger, Andreas/M-1460-2015	Lusa, Lara/0000-0002-8981-2421; Traweger, Andreas/0000-0002-0220-4766; Stupica, Dasa/0000-0001-8927-2683	Baxter; Slovenian Research Agency [P3-0296, J3-3636]	Baxter; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was funded by Baxter and supported in part by the Slovenian Research Agency (Grant Numbers P3-0296 and J3-3636). Baxter employees were involved in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. The Slovenian Research Agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Brettschneider S, 1998, J CLIN MICROBIOL, V36, P2658, DOI 10.1128/JCM.36.9.2658-2665.1998; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Chen CY, 2008, SEX TRANSM INFECT, V84, P273, DOI 10.1136/sti.2007.029058; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Germer J, 1999, MOL DIAGN, V4, P185, DOI 10.1016/S1084-8592(99)80022-8; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Lopes de Carvalho I, 2008, CLIN RHEUMATOL, V27, P1587, DOI 10.1007/s10067-008-1012-z; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; NADELMAN RB, 1993, AM J MED, V94, P583, DOI 10.1016/0002-9343(93)90208-7; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Nowakowski J, 2001, CLIN INFECT DIS, V33, P2023, DOI 10.1086/324490; Pahl A, 1999, J CLIN MICROBIOL, V37, P1958, DOI 10.1128/JCM.37.6.1958-1963.1999; Pau CP, 2010, J VIROL METHODS, V164, P55, DOI 10.1016/j.jviromet.2009.11.027; PFISTER HW, 1986, LANCET, V2, P984; Picken MM, 1997, J CLIN PATHOL-MOL PA, V50, P186, DOI 10.1136/mp.50.4.186; R Development Core Team, 2009, R FDN STAT COMP; Rijpkema Sjoerd G. T., 1997, Clin Microbiol Infect, V3, P109; Rudenko N, 2009, FEMS MICROBIOL LETT, V292, P274, DOI 10.1111/j.1574-6968.2009.01498.x; Rudenko N, 2008, J CLIN MICROBIOL, V46, P3540, DOI 10.1128/JCM.01032-08; Ruzic-Sabljic E, 2002, WIEN KLIN WOCHENSCHR, V114, P544; Ruzic-Sabljic E, 2001, J MED MICROBIOL, V50, P896, DOI 10.1099/0022-1317-50-10-896; Saidac DS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-43; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Straubinger RK, 2000, J CLIN MICROBIOL, V38, P2191; Strle F, 1999, ANN INTERN MED, V130, P32, DOI 10.7326/0003-4819-130-1-199901050-00006; Strle F, 2011, VECTOR-BORNE ZOONOT, V11, P1253, DOI 10.1089/vbz.2010.0230; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10; WILL G, 1995, MED MICROBIOL IMMUN, V184, P73, DOI 10.1007/BF00221390; Wormser GP, 2006, WIEN KLIN WOCHENSCHR, V118, P634, DOI 10.1007/s00508-006-0688-9; ZUMSTEIN G, 1992, MED MICROBIOL IMMUN, V181, P57, DOI 10.1007/BF00189424	43	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63968	10.1371/journal.pone.0063968	http://dx.doi.org/10.1371/journal.pone.0063968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696863	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900067
J	Prabhakar, S; Goto, J; Zuang, X; Sena-Esteves, M; Bronson, R; Brockmann, J; Gianni, D; Wojtkiewicz, GR; Chen, JW; Stemmer-Rachamimov, A; Kwiatkowski, DJ; Breakefield, XO				Prabhakar, Shilpa; Goto, June; Zuang, Xuan; Sena-Esteves, Miguel; Bronson, Roderick; Brockmann, Jillian; Gianni, Davide; Wojtkiewicz, Gregory R.; Chen, John W.; Stemmer-Rachamimov, Anat; Kwiatkowski, David J.; Breakefield, Xandra O.			Stochastic Model of Tsc1 Lesions in Mouse Brain	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MTOR PATHWAY; GIANT-CELLS; RAPAMYCIN; ACTIVATION; MANAGEMENT; SURVIVAL; DEFICITS; MICE	Tuberous sclerosis complex (TSC) is an autosomal dominant disorder due to mutations in either TSC1 or TSC2 that affects many organs with hamartomas and tumors. TSC-associated brain lesions include subependymal nodules, subependymal giant cell astrocytomas and tubers. Neurologic manifestations in TSC comprise a high frequency of mental retardation and developmental disorders including autism, as well as epilepsy. Here, we describe a new mouse model of TSC brain lesions in which complete loss of Tsc1 is achieved in multiple brain cell types in a stochastic pattern. Injection of an adeno-associated virus vector encoding Cre recombinase into the cerebral ventricles of mice homozygous for a Tsc1 conditional allele on the day of birth led to reduced survival, and pathologic findings of enlarged neurons, cortical heterotopias, subependymal nodules, and hydrocephalus. The severity of clinical and pathologic findings as well as survival was shown to be dependent upon the dose and serotype of Cre virus injected. Although several other models of TSC brain disease exist, this model is unique in that the pathology reflects a variety of TSC-associated lesions involving different numbers and types of cells. This model provides a valuable and unique addition for therapeutic assessment.	[Prabhakar, Shilpa; Zuang, Xuan; Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA; [Prabhakar, Shilpa; Zuang, Xuan; Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Radiol, Ctr Mol Imaging Res, Boston, MA 02114 USA; [Prabhakar, Shilpa; Zuang, Xuan; Breakefield, Xandra O.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Goto, June; Kwiatkowski, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Sena-Esteves, Miguel; Gianni, Davide] Univ Massachusetts, Sch Med, Dept Neurol, Gene Therapy Ctr, Worcester, MA USA; [Bronson, Roderick] Harvard Univ, Sch Med, Rodent Histopathol Core Facil, Boston, MA USA; [Brockmann, Jillian; Stemmer-Rachamimov, Anat] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Wojtkiewicz, Gregory R.; Chen, John W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Breakefield, XO (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA.	breakefield@hms.harvard.edu	; Wojtkiewicz, Gregory/L-3660-2018	Goto, June/0000-0002-4000-9750; Wojtkiewicz, Gregory/0000-0002-3148-8411	NIH/NINDS [NS24279-23, R01NS070835, R01NS072167]; DOD Army Grant [W81XWH-13-1-0076]; NATIONAL CANCER INSTITUTE [K08CA136983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070835, R01NS072167, P01NS024279] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD Army Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NINDS NS24279-23, R01NS070835, R01NS072167 and DOD Army Grant W81XWH-13-1-0076 for the Award Mechanism: Exploration - Hypothesis Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderl S, 2011, HUM MOL GENET, V20, P4597, DOI 10.1093/hmg/ddr393; Beaumont TL, 2012, CHILD NERV SYST, V28, P963, DOI 10.1007/s00381-012-1785-x; Berhouma M, 2010, WORLD J PEDIATR, V6, P103, DOI 10.1007/s12519-010-0025-2; Boer K, 2010, BRAIN PATHOL, V20, P704, DOI 10.1111/j.1750-3639.2009.00341.x; BORDARIER C, 1994, BRAIN DEV-JPN, V16, P467, DOI 10.1016/0387-7604(94)90010-8; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Doherty C, 2005, J CHILD NEUROL, V20, P837, DOI 10.1177/08830738050200101301; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; European Chromosome 16 Tuberous Sclerosis C, 1993, CELL, V75; Feliciano DM, 2012, HUM MOL GENET, V21, P799, DOI 10.1093/hmg/ddr511; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; Franz DN, 2012, LANCET, VS0140-6736, P61134; Goto J, 2011, PROCNATLACADSCI US; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Katz JS, 2012, J NEUROSURG-PEDIATR, V9, P406, DOI 10.3171/2011.12.PEDS11418; Krueger DA, N ENGL J MED, V363, P1801; Kwiatkowski D.J., 2010, TUBEROUS SCLEROSIS C; Liang MC, 2010, ONCOGENE, V29, P1588, DOI 10.1038/onc.2009.452; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Sahin M, 2012, CURR OPIN NEUROBIOL, V22, P895, DOI 10.1016/j.conb.2012.04.008; Tyburczy ME, 2010, AM J PATHOL, V176, P1878, DOI 10.2353/ajpath.2010.090950; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Winterkorn EB, 2007, NEUROLOGY, V68, P62, DOI 10.1212/01.wnl.0000250330.44291.54; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yuan E, 2012, HUM MOL GENET, V21, P4286, DOI 10.1093/hmg/dds262; Zhou J, 2011, GENE DEV, V25, P1595, DOI 10.1101/gad.16750211	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64224	10.1371/journal.pone.0064224	http://dx.doi.org/10.1371/journal.pone.0064224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696872	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900075
J	Tan, SS; Maul, THB; Mennie, NR				Tan, Shern Shiou; Maul, Tomas Henrique Bode; Mennie, Neil Russell			Measuring the Performance of Visual to Auditory Information Conversion	PLOS ONE			English	Article							RECOGNITION	Background: Visual to auditory conversion systems have been in existence for several decades. Besides being among the front runners in providing visual capabilities to blind users, the auditory cues generated from image sonification systems are still easier to learn and adapt to compared to other similar techniques. Other advantages include low cost, easy customizability, and universality. However, every system developed so far has its own set of strengths and weaknesses. In order to improve these systems further, we propose an automated and quantitative method to measure the performance of such systems. With these quantitative measurements, it is possible to gauge the relative strengths and weaknesses of different systems and rank the systems accordingly. Methodology: Performance is measured by both the interpretability and also the information preservation of visual to auditory conversions. Interpretability is measured by computing the correlation of inter image distance (IID) and inter sound distance (ISD) whereas the information preservation is computed by applying Information Theory to measure the entropy of both visual and corresponding auditory signals. These measurements provide a basis and some insights on how the systems work. Conclusions: With an automated interpretability measure as a standard, more image sonification systems can be developed, compared, and then improved. Even though the measure does not test systems as thoroughly as carefully designed psychological experiments, a quantitative measurement like the one proposed here can compare systems to a certain degree without incurring much cost. Underlying this research is the hope that a major breakthrough in image sonification systems will allow blind users to cost effectively regain enough visual functions to allow them to lead secure and productive lives.	[Tan, Shern Shiou; Maul, Tomas Henrique Bode] Univ Nottingham, Sch Comp Sci, Semenyih, Selangor, Malaysia; [Mennie, Neil Russell] Univ Nottingham, Sch Psychol, Semenyih, Selangor, Malaysia	University of Nottingham Malaysia; University of Nottingham Malaysia	Tan, SS (corresponding author), Univ Nottingham, Sch Comp Sci, Malaysia Campus, Semenyih, Selangor, Malaysia.	shernshiou@gmail.com		Maul, Tomas/0000-0002-3563-1115; Mennie, Neil/0000-0002-9261-7969	Malaysian Ministry of Higher Education Malaysia (MOHE) under the Fundamental Research Grant Scheme (FRGS)	Malaysian Ministry of Higher Education Malaysia (MOHE) under the Fundamental Research Grant Scheme (FRGS)	This work was partly supported by the Malaysian Ministry of Higher Education Malaysia (MOHE) under the Fundamental Research Grant Scheme (FRGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bologna G, 2008, IJCNN; Dakopoulos D, 2010, IEEE T SYST MAN CY C, V40, P25, DOI 10.1109/TSMCC.2009.2021255; Deville B, 2009, HUMAN MACHINE INTERA; Kramer G., 1994, AUDITORY DISPLAY, P1; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; Najjar LJ, 1996, J ED MULTIMEDIA HYPE; Pampalk E, 2004, P 5 INT C MUS INF RE, V4; Payling D, 2007, HUE MUSIC CREATING T; Peleg S, 1989, UNIFIED APPROACH CHA; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; REPPERGER DW, 1995, IEEE T SYST MAN CYB, V25, P1392, DOI 10.1109/21.464442; Rubner Y, 2000, INT J COMPUTER VISIO, V40; Seung-Yeo W, 2006, INT COMP MUS C NEW O; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Shimojo M, 1999, IEEE T SYST MAN CY A, V29, P637, DOI 10.1109/3468.798067; STONEMAN Z, 1983, DEV PSYCHOL, V19, P56, DOI 10.1037/0012-1649.19.1.56; Sumiya H, 1999, SEALING TECHNOLOGY; Tan SS, 2010, IEEE INT C CYB INT S; World Health Organization, 2011, VIS IMP BLINDN	22	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63042	10.1371/journal.pone.0063042	http://dx.doi.org/10.1371/journal.pone.0063042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696791	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900007
J	Deming, DA; Leystra, AA; Nettekoven, L; Sievers, C; Miller, D; Middlebrooks, M; Clipson, L; Albrecht, D; Bacher, J; Washington, MK; Weichert, J; Halberg, RB				Deming, D. A.; Leystra, A. A.; Nettekoven, L.; Sievers, C.; Miller, D.; Middlebrooks, M.; Clipson, L.; Albrecht, D.; Bacher, J.; Washington, M. K.; Weichert, J.; Halberg, R. B.			PIK3CA and APC mutations are synergistic in the development of intestinal cancers	ONCOGENE			English	Article						colon cancer; APC; PI3K; PIK3CA; mouse models	COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; BETA-CATENIN; TUMOR-SUPPRESSOR; KINASE; GENE; PHOSPHORYLATION; PATHWAY; INSULIN; COLON	Human colorectal cancers are known to possess multiple mutations, though how these mutations interact in tumor development and progression has not been fully investigated. We have previously described the FCPIK3ca* murine colon cancer model, which expresses a constitutively activated phosphoinositide-3 kinase (PI3K) in the intestinal epithelium. The expression of this dominantly active form of PI3K results in hyperplasia and invasive mucinous adenocarcinomas. These cancers form via a non-canonical mechanism of tumor initiation that is mediated through activation of PI3K and not through aberrations in WNT signaling. Since the Adenomatous Polyposis Coli (APC) gene is mutated in the majority of human colon cancers and often occurs simultaneously with PIK3CA mutations, we sought to better understand the interaction between APC and PIK3CA mutations in the mammalian intestine. In this study, we have generated mice in which the expression of a constitutively active PI3K and the loss of APC occur simultaneously in the distal small intestine and colon. Here, we demonstrate that expression of a dominant active PI3K synergizes with loss of APC activity resulting in a dramatic change in tumor multiplicity, size, morphology and invasiveness. Activation of the PI3K pathway is not able to directly activate WNT signaling through the nuclear localization of CTNNB1 (beta-catenin) in the absence of aberrant WNT signaling. Alterations at the transcriptional level, including increased CCND1, may be the etiology of synergy between these activated pathways.	[Deming, D. A.] Univ Wisconsin, Dept Med, Div Hematol & Oncol, Madison, WI 53792 USA; [Leystra, A. A.; Clipson, L.] Univ Wisconsin, Dept Oncol, Madison, WI 53792 USA; [Nettekoven, L.; Miller, D.; Middlebrooks, M.; Albrecht, D.; Halberg, R. B.] Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI 53792 USA; [Sievers, C.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Bacher, J.] Promega Corp, Madison, WI USA; [Washington, M. K.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Washington, M. K.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Weichert, J.] Univ Wisconsin, Dept Radiol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Promega Corporation; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison	Halberg, RB (corresponding author), Univ Wisconsin, Dept Med, Ctr Clin Sci, 600 Highland Ave,K4-532, Madison, WI 53792 USA.	rbhalberg@medicine.wisc.edu		Sievers, Chelsie/0000-0003-0088-753X	Conquer Cancer Foundation of the American Society of Clinical Oncology through A Young Investigator Award; National Cancer Institute of the US National Institutes of Health [T32 CA009614, P50 CA095103, R01 CA123438, P30 CA014520]; UW Division of Gastroenterology and Hepatology; UW Department of Medicine; UW School of Medicine and Public Health; NATIONAL CANCER INSTITUTE [T32CA009135, R01CA123438, P30CA014520, T32CA009614, P50CA095103] Funding Source: NIH RePORTER	Conquer Cancer Foundation of the American Society of Clinical Oncology through A Young Investigator Award; National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UW Division of Gastroenterology and Hepatology; UW Department of Medicine; UW School of Medicine and Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ella Ward and Jane Weeks in Experimental Pathology at the UW Carbone Cancer Center for their technical assistance. This project was supported by the Conquer Cancer Foundation of the American Society of Clinical Oncology through A Young Investigator Award (DAD); the National Cancer Institute of the US National Institutes of Health through T32 CA009614 (DAD), P50 CA095103 (Gastrointestinal Specialized Program of Research Excellence Grant, Vanderbilt Ingram Cancer Center), R01 CA123438 (RBH), P30 CA014520 (Core Grant, University of Wisconsin Carbone Cancer Center); and start-up funds (RBH) from the UW Division of Gastroenterology and Hepatology, the UW Department of Medicine, and the UW School of Medicine and Public Health.	American Cancer Society, 2012, CANC FACTS FIG 2012; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Boland CR, 1998, CANCER RES, V58, P5248; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Des Guetz G, 2009, EUR J CANCER, V45, P1890, DOI 10.1016/j.ejca.2009.04.018; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Kinzler K.W., 2002, GENETIC BASIS HUMAN, V2, P583; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tanwar PS, 2011, CANCER RES, V71, P1584, DOI 10.1158/0008-5472.CAN-10-3166; Velho S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-255; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	32	44	46	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2245	2254		10.1038/onc.2013.167	http://dx.doi.org/10.1038/onc.2013.167			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23708654	Green Accepted			2022-12-25	WOS:000334996000010
J	Rice, AJ; Alvarez, FJD; Schultz, KM; Klug, CS; Davidson, AL; Pinkett, HW				Rice, Austin J.; Alvarez, Frances J. D.; Schultz, Kathryn M.; Klug, Candice S.; Davidson, Amy L.; Pinkett, Heather W.			EPR Spectroscopy of MolB(2)C(2)-A Reveals Mechanism of Transport for a Bacterial Type II Molybdate Importer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; ESCHERICHIA-COLI; BINDING-PROTEIN; BTUCD-F; ATP; INSIGHTS; POWER	In bacteria, ATP-binding cassette (ABC) transporters are vital for the uptake of nutrients and cofactors. Based on differences in structure and activity, ABC importers are divided into two types. Type I transporters have been well studied and employ a tightly regulated alternating access mechanism. Less is known about Type II importers, but much of what we do know has been observed in studies of the vitamin B-12 importer BtuC(2)D(2). MolB(2)C(2) (formally known as HI1470/71) is also a Type II importer, but its substrate, molybdate, is similar to 10-fold smaller than vitamin B12. To understand mechanistic differences among Type II importers, we focused our studies on MolBC, for which alternative conformations may be required to transport its relatively small substrate. To investigate the mechanism of MolBC, we employed disulfide cross-linking and EPR spectroscopy. From these studies, we found that nucleotide binding is coupled to a conformational shift at the periplasmic gate. Unlike the larger conformational changes in BtuCD-F, this shift in MolBC-A is akin to unlocking a swinging door: allowing just enough space for molybdate to slip into the cell. The lower cytoplasmic gate, identified in BtuCD-F as "gate I," remains open throughout the MolBC-A mechanism, and cytoplasmic gate II closes in the presence of nucleotide. Combining our results, we propose a peristaltic mechanism for MolBC-A, which gives new insight in the transport of small substrates by a Type II importer.	[Rice, Austin J.; Davidson, Amy L.; Pinkett, Heather W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Alvarez, Frances J. D.; Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Schultz, Kathryn M.; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Medical College of Wisconsin	Pinkett, HW (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	h-pinkett@northwestern.edu	Pinkett, Heather Wendy/M-9235-2014	Alvarez, Frances/0000-0001-9742-6064	National Science Foundation [MCB1121872]; National Institutes of Health [S10 RR022422, P41 EB001980, GM070515]; National Institutes of Health Molecular Biophysics Training Grant from NIGMS [T32 GM008382]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382, R01GM070515, R56GM070515] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Molecular Biophysics Training Grant from NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by in part by National Science Foundation Grant MCB1121872. DEER instrumentation was funded by National Institutes of Health Grant S10 RR022422. DEER spectroscopy was carried out at the National Biomedical EPR Center, which is supported by National Institutes of Health Grant P41 EB001980.; Supported in part by National Institutes of Health Molecular Biophysics Training Grant T32 GM008382 from NIGMS.; Supported by National Institutes of Health Grant GM070515.	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dean M, 2001, J LIPID RES, V42, P1007; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Holland I. B., 2003, ABC PROTEINS BACTERI; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417	31	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21228	21235		10.1074/jbc.M113.483495	http://dx.doi.org/10.1074/jbc.M113.483495			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23709218	Green Published, hybrid			2022-12-25	WOS:000322014400044
J	Mamenko, M; Zaika, OL; Boukelmoune, N; Berrout, J; O'Neil, RG; Pochynyuk, O				Mamenko, Mykola; Zaika, Oleg L.; Boukelmoune, Nabila; Berrout, Jonathan; O'Neil, Roger G.; Pochynyuk, Oleh			Discrete Control of TRPV4 Channel Function in the Distal Nephron by Protein Kinases A and C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; PRINCIPAL CELLS; CALCIUM-ENTRY; K+ SECRETION; FLOW; KIDNEY; LOCALIZATION; TRAFFICKING; INHIBITION; ACTIVATION	We have recently documented that the Ca2+-permeable TRPV4 channel, which is abundantly expressed in distal nephron cells, mediates cellular Ca2+ responses to elevated luminal flow. In this study, we combined Fura-2-based [Ca2+](i) imaging with immunofluorescence microscopy in isolated split-opened distal nephrons of C57BL/6 mice to probe the molecular determinants of TRPV4 activity and subcellular distribution. We found that activation of the PKC pathway with phorbol 12-myristate 13-acetate significantly increased [Ca2+](i) responses to flow without affecting the subcellular distribution of TRPV4. Inhibition of PKC with bisindolylmaleimide I diminished cellular responses to elevated flow. In contrast, activation of the PKA pathway with forskolin did not affect TRPV4-mediated [Ca2+](i) responses to flow but markedly shifted the subcellular distribution of the channel toward the apical membrane. These actions were blocked with the specific PKA inhibitor H-89. Concomitant activation of the PKA and PKC cascades additively enhanced the amplitude of flow-induced [Ca2+](i) responses and greatly increased basal [Ca2+](i) levels, indicating constitutive TRPV4 activation. This effect was precluded by the selective TRPV4 antagonist HC-067047. Therefore, the functional status of the TRPV4 channel in the distal nephron is regulated by two distinct signaling pathways. Although the PKA-dependent cascade promotes TRPV4 trafficking and translocation to the apical membrane, the PKC-dependent pathway increases the activity of the channel on the plasma membrane.	[Mamenko, Mykola; Zaika, Oleg L.; Boukelmoune, Nabila; Berrout, Jonathan; O'Neil, Roger G.; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715; Boukelmoune, Nabila/0000-0001-5098-6187	National Institutes of Health from NIDDK [DK095029]; S&R Foundation Ryuji Ueno award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095029] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; S&R Foundation Ryuji Ueno award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK095029 from NIDDK (to O.P.). This work was also supported by an S&R Foundation Ryuji Ueno award (to O.P.).	Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; Dietrich A, 2010, J AM SOC NEPHROL, V21, P736, DOI 10.1681/ASN.2009090948; Du J, 2012, J AM SOC NEPHROL, V23, P1172, DOI 10.1681/ASN.2011100972; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Galizia L, 2012, J CELL BIOCHEM, V113, P580, DOI 10.1002/jcb.23382; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Goel M, 2010, AM J PHYSIOL-RENAL, V298, pF988, DOI 10.1152/ajprenal.00586.2009; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; Liu W, 2009, AM J PHYSIOL-RENAL, V297, pF904, DOI 10.1152/ajprenal.90685.2008; Mamenko M, 2012, HYPERTENSION, V60, P1234, DOI 10.1161/HYPERTENSIONAHA.112.200469; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Pluznick JL, 2006, AM J PHYSIOL-RENAL, V291, pF517, DOI 10.1152/ajprenal.00118.2006; Pochynyuk O, 2013, PFLUG ARCH EUR J PHY, V465, P177, DOI 10.1007/s00424-012-1190-z; Siroky BJ, 2006, AM J PHYSIOL-RENAL, V290, pF1320, DOI 10.1152/ajprenal.00463.2005; Taniguchi J, 1998, J MEMBRANE BIOL, V164, P35, DOI 10.1007/s002329900391; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Yamaguchi T, 1997, AM J KIDNEY DIS, V30, P703, DOI 10.1016/S0272-6386(97)90496-0; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zaika O, 2011, AM J PHYSIOL-RENAL, V300, pF1105, DOI 10.1152/ajprenal.00606.2010	40	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20306	20314		10.1074/jbc.M113.466797	http://dx.doi.org/10.1074/jbc.M113.466797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709216	Green Published, hybrid			2022-12-25	WOS:000321715100019
J	Yadav, PK; Yamada, K; Chiku, T; Koutmos, M; Banerjee, R				Yadav, Pramod Kumar; Yamada, Kazuhiro; Chiku, Taurai; Koutmos, Markos; Banerjee, Ruma			Structure and Kinetic Analysis of H2S Production by Human Mercaptopyruvate Sulfurtransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; THIOREDOXIN; ACID; RAT; RHODANESE; DEFENSE	Mercaptopyruvate sulfurtransferase (MST) is a source of endogenous H2S, a gaseous signaling molecule implicated in a wide range of physiological processes. The contribution of MST versus the other two H2S generators, cystathionine beta-synthase and gamma-cystathionase, has been difficult to evaluate because many studies on MST have been conducted at high pH and have used varied reaction conditions. In this study, we have expressed, purified, and crystallized human MST in the presence of the substrate 3-mercaptopyruvate (3-MP). The kinetics of H2S production by MST from 3-MP was studied at pH 7.4 in the presence of various physiological persulfide acceptors: cysteine, dihydrolipoic acid, glutathione, homocysteine, and thioredoxin, and in the presence of cyanide. The crystal structure of MST reveals a mixture of the product complex containing pyruvate and an active site cysteine persulfide (Cys(248)-SSH) and a nonproductive intermediate in which 3-MP is covalently linked via a disulfide bond to an active site cysteine. The crystal structure analysis allows us to propose a detailed mechanism for MST in which an Asp-His-Ser catalytic triad is positioned to activate the nucleophilic cysteine residue and participate in general acid-base chemistry, whereas our kinetic analysis indicates that thioredoxin is likely to be the major physiological persulfide acceptor for MST.	[Yadav, Pramod Kumar; Chiku, Taurai; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Yamada, Kazuhiro; Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA	Banerjee, R (corresponding author), Univ Michigan, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684; Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Abe K, 1996, J NEUROSCI, V16, P1066; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alphey MS, 2003, J BIOL CHEM, V278, P48219, DOI 10.1074/jbc.M307187200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CRAWHALL JC, 1968, SCIENCE, V160, P419, DOI 10.1126/science.160.3826.419; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; HOLMGREN A, 2008, REDOX BIOCH; JARABAK R, 1978, ARCH BIOCHEM BIOPHYS, V185, P458, DOI 10.1016/0003-9861(78)90189-3; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KATAOKA H, 1993, J CHROMATOGR-BIOMED, V615, P197, DOI 10.1016/0378-4347(93)80333-Y; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Linden DR, 2010, ANTIOXID REDOX SIGN, V12, P1135, DOI 10.1089/ars.2009.2885; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; Nagahara N, 2004, BIOCHIMIE, V86, P723, DOI 10.1016/j.biochi.2004.08.002; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1996, J BIOL CHEM, V271, P27395, DOI 10.1074/jbc.271.44.27395; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RETEY J, 1990, ANGEW CHEM INT EDIT, V29, P355, DOI 10.1002/anie.199003551; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2011, BIOCHEMISTRY-US, V50, P419, DOI 10.1021/bi1010893; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Turanov AA, 2010, METHOD ENZYMOL, V474, P245, DOI 10.1016/S0076-6879(10)74014-3; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Whitfield NL, 2008, AM J PHYSIOL-REG I, V294, pR1930, DOI 10.1152/ajpregu.00025.2008; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Yadav PK, 2012, J BIOL CHEM, V287, P43464, DOI 10.1074/jbc.M112.414722; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	44	153	155	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20002	20013		10.1074/jbc.M113.466177	http://dx.doi.org/10.1074/jbc.M113.466177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23698001	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000321515800064
J	Madura, F; Rizkallah, PJ; Miles, KM; Holland, CJ; Bulek, AM; Fuller, A; Schauenburg, AJA; Miles, JJ; Liddy, N; Sami, M; Li, Y; Hossain, M; Baker, BM; Jakobsen, BK; Sewell, AK; Cole, DK				Madura, Florian; Rizkallah, Pierre J.; Miles, Kim M.; Holland, Christopher J.; Bulek, Anna M.; Fuller, Anna; Schauenburg, Andrea J. A.; Miles, John J.; Liddy, Nathaniel; Sami, Malkit; Li, Yi; Hossain, Moushumi; Baker, Brian M.; Jakobsen, Bent K.; Sewell, Andrew K.; Cole, David K.			T-cell Receptor Specificity Maintained by Altered Thermodynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; HIGH-AFFINITY; PEPTIDE-MHC; DIRECTED EVOLUTION; CRYSTAL-STRUCTURES; CROSS-REACTIVITY; STRUCTURAL BASIS; TCR-BINDING; CRYSTALLIZATION; RECOGNITION	The T-cell receptor (TCR) recognizes peptides bound to major histocompatibility molecules (MHC) and allows T-cells to interrogate the cellular proteome for internal anomalies from the cell surface. The TCR contacts both MHC and peptide in an interaction characterized by weak affinity (K-D = 100 nM to 270 mu M). We used phage-display to produce a melanoma-specific TCR (alpha 24 beta 17) with a 30,000-fold enhanced binding affinity (K-D = 0.6 nM) to aid our exploration of the molecular mechanisms utilized to maintain peptide specificity. Remarkably, although the enhanced affinity was mediated primarily through new TCR-MHC contacts, alpha 24 beta 17 remained acutely sensitive to modifications at every position along the peptide backbone, mimicking the specificity of the wild type TCR. Thermodynamic analyses revealed an important role for solvation in directing peptide specificity. These findings advance our understanding of the molecular mechanisms that can govern the exquisite peptide specificity characteristic of TCR recognition.	[Madura, Florian; Rizkallah, Pierre J.; Miles, Kim M.; Holland, Christopher J.; Bulek, Anna M.; Fuller, Anna; Schauenburg, Andrea J. A.; Miles, John J.; Liddy, Nathaniel; Sewell, Andrew K.; Cole, David K.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Miles, John J.] Queensland Inst Med Res, Human Immun Lab, Brisbane, Qld 4006, Australia; [Liddy, Nathaniel; Sami, Malkit; Li, Yi; Jakobsen, Bent K.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England; [Miles, John J.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Hossain, Moushumi; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Cardiff University; QIMR Berghofer Medical Research Institute; University of Queensland; University of Notre Dame	Cole, DK (corresponding author), Cardiff Univ, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk	Baker, Brian/B-4584-2009; Rizkallah, Pierre J/A-5367-2012; Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022	Baker, Brian/0000-0002-0864-0964; Rizkallah, Pierre J/0000-0002-9290-0369; Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; Fuller, Anna/0000-0002-8655-6741	UK Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Tenovus Foundation; National Institute of General Medical Sciences, National Institutes of Health [GM067079]; Tenovus Ph.D. studentship; Research Councils UK fellowship; Australian National Health and Medical Research Council (NHMRC) career development fellowship; Wellcome Trust Research Career Development Fellowship [WT095767]; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Foundation; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Tenovus Ph.D. studentship; Research Councils UK fellowship(UK Research & Innovation (UKRI)); Australian National Health and Medical Research Council (NHMRC) career development fellowship(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Cancer Care; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BB/H001085/1), a studentship from the Tenovus Foundation and in part by the National Institute of General Medical Sciences, National Institutes of Health (GM067079).; Funded by a Tenovus Ph.D. studentship.; Supported by a Research Councils UK fellowship.; Supported by an Australian National Health and Medical Research Council (NHMRC) career development fellowship.; Supported by Wellcome Trust Research Career Development Fellowship (WT095767). To whom correspondence should be addressed. Tel.: 442920687006; E-mail: coledk@cf.ac.uk.	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1665; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cole DK, 2006, EUR J IMMUNOL, V36, P170, DOI 10.1002/eji.200535424; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gostick E, 2007, EUR J IMMUNOL, V37, P479, DOI 10.1002/eji.200636243; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Holland CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00629; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	52	28	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18766	18775		10.1074/jbc.M113.464560	http://dx.doi.org/10.1074/jbc.M113.464560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23698002	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000321335800012
J	Panyukov, VV; Ozoline, ON				Panyukov, Valeriy V.; Ozoline, Olga N.			Promoters of Escherichia coli versus Promoter Islands: Function and Structure Comparison	PLOS ONE			English	Article							RNA-POLYMERASE; H-NS; TRANSCRIPTIONAL REGULATION; BINDING SITES; GENE-TRANSFER; DNA-BINDING; RPOH GENE; GENOME; IDENTIFICATION; REGIONS	Expression of bacterial genes takes place under the control of RNA polymerase with exchangeable sigma-subunits and multiple transcription factors. A typical promoter region contains one or several overlapping promoters. In the latter case promoters have the same or different sigma-specificity and are often subjected to different regulatory stimuli. Genes, transcribed from multiple promoters, have on average higher expression levels. However, recently in the genome of Escherichia coli we found 78 regions with an extremely large number of potential transcription start points (promoter islands, PIs). It was shown that all PIs interact with RNA polymerase in vivo and are able to form transcriptionally competent open complexes both in vitro and in vivo but their transcriptional activity measured by oligonucleotide microarrays was very low, if any. Here we confirmed transcriptional defectiveness of PIs by analyzing the 5 ' -end specific RNA-seq data, but showed their ability to produce short oligos (9-14 bases). This combination of functional properties indicated a deliberate suppression of transcriptional activity within PIs. According to our data this suppression may be due to a specific conformation of the DNA double helix, which provides an ideal platform for interaction with both RNA polymerase and the histone-like nucleoid protein H-NS. The genomic DNA of E. coli contains therefore several dozen sites optimized by evolution for staying in a heterochromatin-like state. Since almost all promoter islands are associated with horizontally acquired genes, we offer them as specific components of bacterial evolution involved in acquisition of foreign genetic material by turning off the expression of toxic or useless aliens or by providing optimal promoter for beneficial genes. The putative molecular mechanism underlying the appearance of promoter islands within recipient genomes is discussed.	[Panyukov, Valeriy V.] Russian Acad Sci, Inst Math Problems Biol, Dept Bioinformat, Pushchino 142292, Moscow Region, Russia; [Ozoline, Olga N.] Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Pushchino 142292, Moscow Region, Russia; [Ozoline, Olga N.] Pushchino State Inst Nat Sci, Dept Cell Biol, Pushchino, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Ozoline, ON (corresponding author), Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Pushchino 142292, Moscow Region, Russia.	ozoline@rambler.ru	Panyukov, Valery/O-1812-2013	Panyukov, Valery/0000-0003-1813-7403	Russian Foundation for Basic Research [10-04-01218, 12-07-00530, 13-04-00997]; Ministry of Education and Science of the Russian Federation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The work has been supported by Russian Foundation for Basic Research (grants No. 10-04-01218, No. 12-07-00530, and 13-04-00997), and by the Ministry of Education and Science of the Russian Federation (project "Multiple promoters as indicators of overlapping transcription and alternative coding''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR HM, 1987, J BACTERIOL, V169, P3435, DOI 10.1128/jb.169.8.3435-3440.1987; Bolshoy A, 2000, GENOME RES, V10, P1185, DOI 10.1101/gr.10.8.1185; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Dominguez-Cuevas P, 2005, J BIOL CHEM, V280, P41315, DOI 10.1074/jbc.M505415200; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Friedel M, 2009, NUCLEIC ACIDS RES, V37, pD37, DOI 10.1093/nar/gkn597; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hertz GZ, 1996, METHOD ENZYMOL, V273, P30; Huang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033759; Huerta AM, 2006, MOL BIOL EVOL, V23, P997, DOI 10.1093/molbev/msk004; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Janaszak A, 2009, FEMS MICROBIOL LETT, V291, P65, DOI 10.1111/j.1574-6968.2008.01436.x; Janaszak A, 2007, MICROBIOL-SGM, V153, P111, DOI 10.1099/mic.0.2006/000463-0; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kallipolitis BH, 1998, MOL MICROBIOL, V29, P1091, DOI 10.1046/j.1365-2958.1998.00999.x; Kenter AL, 2012, SEMIN IMMUNOL, V24, P281, DOI 10.1016/j.smim.2012.06.001; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Lee SJ, 2001, J BIOL CHEM, V276, P30064, DOI 10.1074/jbc.M102886200; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maciag A, 2011, NUCLEIC ACIDS RES, V39, P5338, DOI 10.1093/nar/gkr129; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Ozolin' O n, 2004, Mol Biol (Mosk), V38, P786; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Ozoline ON, 1999, NUCLEIC ACIDS RES, V27, P4768, DOI 10.1093/nar/27.24.4768; PANYUKOV V, 2011, MATH BIOL BIOINFORMA, V6, pT36; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Petit V, 2009, PHILOS T R SOC B, V364, P705, DOI 10.1098/rstb.2008.0272; Price MN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r4; Prieto AI, 2012, NUCLEIC ACIDS RES, V40, P3524, DOI 10.1093/nar/gkr1236; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; SHAVKUNOV KS, 2011, J BIOMOL STRUCT DYN, V28, P1128; Sponer J, 1997, BIOPHYS J, V73, P76, DOI 10.1016/S0006-3495(97)78049-4; Tutukina MN, 2007, J BIOINF COMPUT BIOL, V5, P549, DOI 10.1142/S0219720007002801; Tututkina M N, 2010, Mol Biol (Mosk), V44, P497; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; WANG QP, 1989, J BIOL CHEM, V264, P7338; Yus E, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.16; Zahrl D, 2006, J BACTERIOL, V188, P6611, DOI 10.1128/JB.00632-06	66	20	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62601	10.1371/journal.pone.0062601	http://dx.doi.org/10.1371/journal.pone.0062601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717391	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700005
J	Berisha, SZ; Hsu, J; Robinet, P; Smith, JD				Berisha, Stela Z.; Hsu, Jeffrey; Robinet, Peggy; Smith, Jonathan D.			Transcriptome Analysis of Genes Regulated by Cholesterol Loading in Two Strains of Mouse Macrophages Associates Lysosome Pathway and ER Stress Response with Atherosclerosis Susceptibility	PLOS ONE			English	Article							LIVER X RECEPTOR; E-DEFICIENT MICE; FOAM CELLS; HEMATOPOIETIC STEM; PROGENITOR CELLS; TRANSPORT; APOPTOSIS; METABOLISM; EXPRESSION; EFFLUX	Cholesterol loaded macrophages in the arterial intima are the earliest histological evidence of atherosclerosis. Studies of mouse models of atherosclerosis have shown that the strain background can have a significant effect on lesion development. We have previously shown that DBA/2 ApoE(-/-) mice have aortic root lesions 10-fold larger than AKR ApoE(-/-) mice. The current study analyzes the response to cholesterol loading of macrophages from these two strains. Macrophages from the atherosclerosis susceptible DBA/2 strain had significantly higher levels of total and esterified cholesterol compared to atherosclerosis resistant AKR macrophages, while free cholesterol levels were higher in AKR cells. Gene expression profiles were obtained and data were analyzed for strain, cholesterol loading, and strain-cholesterol loading interaction effects by a fitted linear model. Pathway and transcriptional motif enrichment were identified by gene set enrichment analysis. In addition to observed strain differences in basal gene expression, we identified many transcripts whose expression was significantly altered in response to cholesterol loading, including P2ry13 and P2ry14, Trib3, Hyal1, Vegfa, Ccr5, Ly6a, and Ifit3. Eight pathways were significantly enriched in transcripts regulated by cholesterol loading, among which the lysosome and cytokine-cytokine receptor interaction pathways had the highest number of significantly regulated transcripts. Of the differentially regulated transcripts with a strain-cholesterol loading interaction effect, we identified three genes known to participate in the endoplasmic reticulum (ER) stress response, Ddit3, Trib3 and Atf4. These three transcripts were highly up-regulated by cholesterol in AKR and either down-regulated or unchanged in loaded DBA/2 macrophages, thus associating a robust ER stress response with atherosclerosis resistance. We identified significant transcripts with strain, loading, or strain-loading interaction effect that reside within previously described quantitative trait loci as atherosclerosis modifier candidate genes. In conclusion, we characterized several strain and cholesterol induced differences that may lead to new insights into cellular cholesterol metabolism and atherosclerosis.	[Berisha, Stela Z.; Hsu, Jeffrey; Robinet, Peggy; Smith, Jonathan D.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Hsu, Jeffrey; Smith, Jonathan D.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Smith, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	smithj4@ccf.org	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health grant [HL098193]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088088] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant HL098193 to JDS (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaili K, 2010, EXPERT REV CARDIOVAS, V8, P413, DOI [10.1586/erc.10.4, 10.1586/ERC.10.4]; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; Bolstad B, 2005, BIOINFORMATICS COMPU; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; DeBose-Boyd RA, 2011, COLD SPRING HARB PER, V3, P10; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dorum G, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1418; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Hsu J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005421; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Li CM, 2002, GENOMICS, V79, P218, DOI 10.1006/geno.2002.6686; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moreno PR, 2009, J AM COLL CARDIOL, V53, P2315, DOI 10.1016/j.jacc.2009.02.057; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Prudente S, 2012, ENDOCR REV, V33, P526, DOI 10.1210/er.2011-1042; Robinet P, 2013, ARTERIOSCLE IN PRESS; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shang YY, 2010, CLIN EXP PHARMACOL P, V37, P51, DOI 10.1111/j.1440-1681.2009.05229.x; Shang YY, 2009, FEBS J, V276, P2752, DOI 10.1111/j.1742-4658.2009.06998.x; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tiwari RL, 2008, MED RES REV, V28, P483, DOI 10.1002/med.20118; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wang ZH, 2012, DIABETES, V61, P463, DOI 10.2337/db11-0518; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	54	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65003	10.1371/journal.pone.0065003	http://dx.doi.org/10.1371/journal.pone.0065003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705026	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200180
J	Bonvallot, N; Tremblay-Franco, M; Chevrier, C; Canlet, C; Warembourg, C; Cravedi, JP; Cordier, S				Bonvallot, Nathalie; Tremblay-Franco, Marie; Chevrier, Cecile; Canlet, Cecile; Warembourg, Charline; Cravedi, Jean-Pierre; Cordier, Sylvaine			Metabolomics Tools for Describing Complex Pesticide Exposure in Pregnant Women in Brittany (France)	PLOS ONE			English	Article							PRENATAL EXPOSURE; URINE SAMPLES; AMINO-ACIDS; METABONOMICS; METABOLISM; BLOOD; ORGANOPHOSPHORUS; TECHNOLOGIES; MOTHERS; AGE	Background: The use of pesticides and the related environmental contaminations can lead to human exposure to various molecules. In early-life, such exposures could be responsible for adverse developmental effects. However, human health risks associated with exposure to complex mixtures are currently under-explored. Objective: This project aims at answering the following questions: What is the influence of exposures to multiple pesticides on the metabolome? What mechanistic pathways could be involved in the metabolic changes observed? Methods: Based on the PELAGIE cohort (Brittany, France), 83 pregnant women who provided a urine sample in early pregnancy, were classified in 3 groups according to the surface of land dedicated to agricultural cereal activities in their town of residence. Nuclear magnetic resonance-based metabolomics analyses were performed on urine samples. Partial Least Squares Regression-Discriminant Analysis (PLS-DA) and polytomous regressions were used to separate the urinary metabolic profiles from the 3 exposure groups after adjusting for potential confounders. Results: The 3 groups of exposure were correctly separated with a PLS-DA model after implementing an orthogonal signal correction with pareto standardizations (R2 = 90.7% and Q2 = 0.53). After adjusting for maternal age, parity, body mass index and smoking habits, the most statistically significant changes were observed for glycine, threonine, lactate and glycerophosphocholine (upward trend), and for citrate (downward trend). Conclusion: This work suggests that an exposure to complex pesticide mixtures induces modifications of metabolic fingerprints. It can be hypothesized from identified discriminating metabolites that the pesticide mixtures could increase oxidative stress and disturb energy metabolism.	[Bonvallot, Nathalie] Natl Inst Hlth & Med Res, INSERM, UMR 1085, IRSET,Res Inst Environm & Occupat Hlth, Rennes, France; [Bonvallot, Nathalie] EHESP Sch Publ Hlth Rennes, Paris, France; [Bonvallot, Nathalie; Tremblay-Franco, Marie; Canlet, Cecile; Cravedi, Jean-Pierre] Univ Toulouse, Natl Inst Agr Res INRA UMR Toxalim 1331, Res Ctr Food Toxicol, INP,ENVT,EIP,UPS,UMR1331, Toulouse, France; [Chevrier, Cecile; Warembourg, Charline; Cordier, Sylvaine] INSERM UMR 1085 IRSET, Rennes, France; [Chevrier, Cecile; Warembourg, Charline; Cordier, Sylvaine] Univ Rennes 1, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Bonvallot, N (corresponding author), Natl Inst Hlth & Med Res, INSERM, UMR 1085, IRSET,Res Inst Environm & Occupat Hlth, Rennes, France.	nathalie.bonvallot@ehesp.fr	Chevrier, Cecile/J-9170-2015; Warembourg, Charline/AAP-5498-2020; Cordier, Sylvaine/X-7440-2019; Cordier, Sylvaine/F-7919-2013; Bonvallot, Nathalie/J-9378-2015; Bonvallot, Nathalie/ABF-7860-2020	Chevrier, Cecile/0000-0003-3101-8222; Warembourg, Charline/0000-0003-2716-9167; Bonvallot, Nathalie/0000-0002-8070-6008; Bonvallot, Nathalie/0000-0002-8070-6008; Cordier, Sylvaine/0000-0002-2349-2277	EHESP-School of Public Health (Young researchers); French Ministry for Environment and sustainable development (Antiopes, INERIS)	EHESP-School of Public Health (Young researchers); French Ministry for Environment and sustainable development (Antiopes, INERIS)	This work was supported by grants from the EHESP-School of Public Health (Young researchers, www.ehesp.fr) and the French Ministry for Environment and sustainable development (Antiopes, INERIS, http://www.ineris.fr/dossiers-thematiques-ineris/509). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram HC, 2009, METABOLISM, V58, P1039, DOI 10.1016/j.metabol.2009.03.011; Boehm G, 1998, PEDIATR RES, V44, P900, DOI 10.1203/00006450-199812000-00013; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185; Bradman A, 2011, INT J ENV RES PUB HE, V8, P1061, DOI 10.3390/ijerph8041061; Bretagne Agreste, 2009, ENQ PRAT CULT 2006 P; Chevrier C, 2011, ENVIRON HEALTH PERSP, V119, P1034, DOI 10.1289/ehp.1002775; Clayton CA, 2003, J EXPO ANAL ENV EPID, V13, P100, DOI 10.1038/sj.jea.7500261; D'Adamo P, 2010, AMINO ACIDS, V38, P65, DOI 10.1007/s00726-008-0205-8; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61; Eriksson L., 2006, MULTI MEGAVARIATE 1; Eskenazi B, 2008, BASIC CLIN PHARMACOL, V102, P228, DOI 10.1111/j.1742-7843.2007.00171.x; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; Gu HW, 2009, NMR BIOMED, V22, P826, DOI 10.1002/nbm.1395; Gunier RB, 2011, ENVIRON HEALTH PERSP, V119, P970, DOI 10.1289/ehp.1002532; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kochhar S, 2006, ANAL BIOCHEM, V352, P274, DOI 10.1016/j.ab.2006.02.033; Kuo CH, 2012, CHEM RES TOXICOL, V25, P676, DOI 10.1021/tx200465e; Lee JE, 2012, TOXICOL APPL PHARM, V263, P148, DOI 10.1016/j.taap.2012.06.005; Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002; Li HY, 2011, TOXICOL IND HEALTH, V27, P579, DOI 10.1177/0748233710393400; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Petit C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-71; Petrat F, 2012, BRIT J PHARMACOL, V165, P2059, DOI 10.1111/j.1476-5381.2011.01711.x; Rauch SA, 2012, ENVIRON HEALTH PERSP, V120, P1055, DOI 10.1289/ehp.1104615; Regnault TRH, 2005, PLACENTA, V26, pS52, DOI 10.1016/j.placenta.2005.01.003; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Schreinemachers DM, 2003, ENVIRON HEALTH PERSP, V111, P1259, DOI 10.1289/ehp.5830; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Tea I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029947; Munoz-Quezada MT, 2012, ENVIRON INT, V47, P28, DOI 10.1016/j.envint.2012.06.002; Verwaest KA, 2011, BBA-MOL BASIS DIS, V1812, P1371, DOI 10.1016/j.bbadis.2011.08.001; Vlaanderen J, 2010, OCCUP ENVIRON MED, V67, P136, DOI 10.1136/oem.2008.042788; Ward MH, 2006, ENVIRON HEALTH PERSP, V114, P893, DOI 10.1289/ehp.8770; Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Wolff MS, 2007, PEDIATR RES, V61, P243, DOI 10.1203/pdr.0b013e31802d77f0; Xiang HY, 2000, ENVIRON RES, V82, P160, DOI 10.1006/enrs.1999.4009	42	42	45	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64433	10.1371/journal.pone.0064433	http://dx.doi.org/10.1371/journal.pone.0064433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704985	Green Published, gold			2022-12-25	WOS:000319330200134
J	Jiang, KZ; Zhang, H; Wang, JM; Li, F; Qian, MR				Jiang, Kezhi; Zhang, Hu; Wang, Jianmei; Li, Fei; Qian, Mingrong			Fragmentation of Deprotonated Diacylhydrazine Derivatives in Electrospray Ionization Tandem Mass Spectrometry: Generation of Acid Anions via Intramolecular Rearrangement	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; LIQUID-CHROMATOGRAPHY; NEGATIVE-ION; METHOXYFENOZIDE RESIDUES; ECDYSONE AGONISTS; TEBUFENOZIDE; VEGETABLES; PESTICIDES; MECHANISM; PEPTIDES	The gas-phase fragmentation pathways of deprotonated diacylhydrazine derivatives (R-1(C=O)-N(t-Bu)NH(C=O)R-2, Compounds 1-6) were investigated by the combination of electrospray ionization tandem mass spectrometry (ESI-MS/MS) and theoretical calculations. Upon collisional activation, the deprotonated molecular ions [M - H](-) dissociate in two reaction channels, both of which involve intramolecular rearrangement. The main product ion is confirmed to be an anionic acid species, [R-1-CO2](-), generated through intramolecular rearrangement of [M - H](-) initiated by the nucleophilic attack of the amide O6 on the carbonyl C2 (Path-1). The minor fragment channel (Path-2) involves methylpropene elimination of the precursor ion, followed by a similar nucleophilic displacement reaction to produce another acid anion [ R-2-CO2](-). Density functional theory calculations at the B3LYP/6-31+G(d,p) level indicate that Path-1 is more favorable than Path-2 for dissociation of the deprotonated halofenozide.	[Jiang, Kezhi; Li, Fei] Hangzhou Normal Univ, Key Lab Organosilicon Chem & Mat Technol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hu; Wang, Jianmei; Qian, Mingrong] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Zhejiang Academy of Agricultural Sciences	Qian, MR (corresponding author), Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China.	qianmr@mail.zaas.ac.cn	Wang, Jianmei/HHZ-0585-2022		National Natural Science Foundation of China [21205025, 21207118]; National Science Foundation of Zhejiang Province [Y4100020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Zhejiang Province	This work received financial support from the National Natural Science Foundation of China (No. 21205025, No. 21207118) and the National Science Foundation of Zhejiang Province (No. Y4100020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami M, 2001, MASS SPECTROM REV, V20, P195, DOI 10.1002/mas.10005; Alex A, 2009, RAPID COMMUN MASS SP, V23, P2619, DOI 10.1002/rcm.4163; Araujo L, 2010, ANAL LETT, V43, P2340, DOI 10.1080/00032711003717372; Bandu ML, 2006, INT J MASS SPECTROM, V251, P40, DOI 10.1016/j.ijms.2006.01.004; Bonacci G, 2011, J AM SOC MASS SPECTR, V22, P1534, DOI 10.1007/s13361-011-0185-x; BUDZIKIEWICZ H, 1986, MASS SPECTROM REV, V5, P345, DOI 10.1002/mas.1280050402; Cataldi TRI, 2010, ANAL CHEM, V82, P5686, DOI 10.1021/ac100703w; Cazorla-Reyes R, 2011, TALANTA, V85, P183, DOI 10.1016/j.talanta.2011.03.048; Dai L, 2008, CHINESE J ANAL CHEM, V36, P87; Doohan RA, 2011, J AM SOC MASS SPECTR, V22, P1052, DOI 10.1007/s13361-011-0102-3; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; George M, 2011, INT J MASS SPECTROM, V306, P232, DOI 10.1016/j.ijms.2011.01.007; Hall GL, 2004, J AGR FOOD CHEM, V52, P672, DOI 10.1021/jf030591n; Hu N, 2008, RAPID COMMUN MASS SP, V22, P2715, DOI 10.1002/rcm.3672; Kanawati B, 2007, INT J MASS SPECTROM, V266, P97, DOI 10.1016/j.ijms.2007.07.014; Kanawati B, 2010, RAPID COMMUN MASS SP, V24, P1198, DOI 10.1002/rcm.4504; Kanawati B, 2009, INT J MASS SPECTROM, V288, P6, DOI 10.1016/j.ijms.2009.07.010; Lee JH, 2010, ANAL CHIM ACTA, V674, P64, DOI 10.1016/j.aca.2010.06.016; Liu XG, 2011, ANAL BIOANAL CHEM, V401, P1051, DOI 10.1007/s00216-011-5148-3; Nakagawa Y, 2005, VITAM HORM, V73, P131, DOI 10.1016/S0083-6729(05)73005-3; Qian L, 2008, PESTIC BIOCHEM PHYS, V91, P175, DOI 10.1016/j.pestbp.2008.03.011; Qian MR, 2012, ANAL BIOANAL CHEM, V402, P2451, DOI 10.1007/s00216-011-5699-3; Ramesh M, 2011, RAPID COMMUN MASS SP, V25, P1949, DOI 10.1002/rcm.5076; RETNAKARAN A, 1995, INSECT BIOCHEM MOLEC, V25, P109, DOI 10.1016/0965-1748(94)00037-I; Retnakaran A, 2003, ARCH INSECT BIOCHEM, V54, P187, DOI 10.1002/arch.10116; Rifai A, 2011, J MASS SPECTROM, V46, P1079, DOI 10.1002/jms.1991; Sannino A, 2004, J CHROMATOGR A, V1036, P161, DOI 10.1016/j.chroma.2004.02.078; Sundaram M, 2002, INSECT BIOCHEM MOLEC, V32, P225, DOI 10.1016/S0965-1748(01)00111-4; Timonen J, 2009, EUR J MASS SPECTROM, V15, P595, DOI 10.1255/ejms.1019; Volmer DA, 2010, RAPID COMMUN MASS SP, V24, P3499, DOI 10.1002/rcm.4802; Wang HY, 2006, J AM SOC MASS SPECTR, V17, P253, DOI 10.1016/j.jasms.2005.11.001; Wang TF, 2009, RAPID COMMUN MASS SP, V23, P1669, DOI 10.1002/rcm.4061; Williams BJ, 2011, J AM SOC MASS SPECTR, V22, P1622, DOI 10.1007/s13361-011-0165-1; Zhang JY, 2004, J MASS SPECTROM, V39, P295, DOI 10.1002/jms.582; Zhou YP, 2007, J AM SOC MASS SPECTR, V18, P1813, DOI 10.1016/j.jasms.2007.07.012	35	3	3	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63097	10.1371/journal.pone.0063097	http://dx.doi.org/10.1371/journal.pone.0063097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704891	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200020
J	Kim, Y; Suktitipat, B; Yanek, LR; Faraday, N; Wilson, AF; Becker, DM; Becker, LC; Mathias, RA				Kim, Yoonhee; Suktitipat, Bhoom; Yanek, Lisa R.; Faraday, Nauder; Wilson, Alexander F.; Becker, Diane M.; Becker, Lewis C.; Mathias, Rasika A.			Targeted Deep Resequencing Identifies Coding Variants in the PEAR1 Gene That Play a Role in Platelet Aggregation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RARE VARIANTS; HUMAN GENOME; HERITABILITY; ASPIRIN; AGGREGABILITY; ASSOCIATION; ACTIVATION; TESTS	Platelet aggregation is heritable, and genome-wide association studies have detected strong associations with a common intronic variant of the platelet endothelial aggregation receptor1 (PEAR1) gene both in African American and European American individuals. In this study, we used a sequencing approach to identify additional exonic variants in PEAR1 that may also determine variability in platelet aggregation in the GeneSTAR Study. A 0.3 Mb targeted region on chromosome 1q23.1 including the entire PEAR1 gene was Sanger sequenced in 104 subjects (45% male, 49% African American, age = 52 +/- 13) selected on the basis of hyper- and hypo- aggregation across three different agonists (collagen, epinephrine, and adenosine diphosphate). Single-variant and multi-variant burden tests for association were performed. Of the 235 variants identified through sequencing, 61 were novel, and three of these were missense variants. More rare variants (MAF<5%) were noted in African Americans compared to European Americans (108 vs. 45). The common intronic GWAS-identified variant (rs12041331) demonstrated the most significant association signal in African Americans (p = 4.020 x 10(-4)); no association was seen for additional exonic variants in this group. In contrast, multi-variant burden tests indicated that exonic variants play a more significant role in European Americans (p = 0.0099 for the collective coding variants compared to p = 0.0565 for intronic variant rs12041331). Imputation of the individual exonic variants in the rest of the GeneSTAR European American cohort (N = 1,965) supports the results noted in the sequenced discovery sample: p = 3.56 x 10(-4), 2.27 x 10(-7), 5.20 x 10(-5) for coding synonymous variant rs56260937 and collagen, epinephrine and adenosine diphosphate induced platelet aggregation, respectively. Sequencing approaches confirm that a common intronic variant has the strongest association with platelet aggregation in African Americans, and show that exonic variants play an additional role in platelet aggregation in European Americans.	[Kim, Yoonhee; Suktitipat, Bhoom; Wilson, Alexander F.] NHGRI, Genometr Sect, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [Kim, Yoonhee; Suktitipat, Bhoom; Yanek, Lisa R.; Becker, Diane M.; Becker, Lewis C.; Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University	Mathias, RA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA.	rmathias@jhmi.edu	Wilson, Alexander F./Q-6910-2019; Suktitipat, Bhoom/H-4239-2019	Suktitipat, Bhoom/0000-0001-8034-7757	National Heart, Lung, and Blood Institute [HL72518, HL087698]; National Center for Research Resources [M01-RR000052]; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; MOSAIC award from The Johns Hopkins University Provosts Office; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107446, U01HL072518, R01HL087698] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000200] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MOSAIC award from The Johns Hopkins University Provosts Office; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by grants from the National Heart, Lung, and Blood Institute, (HL72518 and HL087698), and the National Center for Research Resources (M01-RR000052) and by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. R.A. Mathias was supported in part by the MOSAIC award from The Johns Hopkins University Provosts Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2009, PLOS GENET, V2009, DOI [10.1101/pdb.ip71, DOI 10.1101/PDB.IP71]; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Faraday N, 2007, CIRCULATION, V115, P2490, DOI 10.1161/CIRCULATIONAHA.106.667584; Faraday N, 2011, BLOOD, V118, P3367, DOI 10.1182/blood-2010-11-320788; FUSTER V, 1993, CIRCULATION, V87, P659, DOI 10.1161/01.CIR.87.2.659; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herrera-Galeano JE, 2008, ARTERIOSCL THROM VAS, V28, P1484, DOI 10.1161/ATVBAHA.108.168971; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shaw E, 2009, CURR ATHEROSCLER REP, V11, P289, DOI 10.1007/s11883-009-0044-4; Suktitipat B, 2012, HUM HERED, V74, P17, DOI 10.1159/000341636	21	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64179	10.1371/journal.pone.0064179	http://dx.doi.org/10.1371/journal.pone.0064179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704978	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200120
J	Kriticos, DJ; Morin, L; Leriche, A; Anderson, RC; Caley, P				Kriticos, Darren J.; Morin, Louise; Leriche, Agathe; Anderson, Robert C.; Caley, Peter			Combining a Climatic Niche Model of an Invasive Fungus with Its Host Species Distributions to Identify Risks to Natural Assets: Puccinia psidii Sensu Lato in Australia	PLOS ONE			English	Article							POTENTIAL GEOGRAPHIC RANGE; EUCALYPTUS RUST; PLANT; DISEASE; AREAS; TEMPERATURE; SYSTEM	Puccinia psidii sensu lato (s.l.) is an invasive rust fungus threatening a wide range of plant species in the family Myrtaceae. Originating from Central and South America, it has invaded mainland USA and Hawai'i, parts of Asia and Australia. We used CLIMEX to develop a semi-mechanistic global climatic niche model based on new data on the distribution and biology of P. psidii s.l. The model was validated using independent distribution data from recently invaded areas in Australia, China and Japan. We combined this model with distribution data of its potential Myrtaceae host plant species present in Australia to identify areas and ecosystems most at risk. Myrtaceaeous species richness, threatened Myrtaceae and eucalypt plantations within the climatically suitable envelope for P. psidii s.l in Australia were mapped. Globally the model identifies climatically suitable areas for P. psidii s.l. throughout the wet tropics and sub-tropics where moist conditions with moderate temperatures prevail, and also into some cool regions with a mild Mediterranean climate. In Australia, the map of species richness of Myrtaceae within the P. psidii s.l. climatic envelope shows areas where epidemics are hypothetically more likely to be frequent and severe. These hotspots for epidemics are along the eastern coast of New South Wales, including the Sydney Basin, in the Brisbane and Cairns areas in Queensland, and in the coastal region from the south of Bunbury to Esperance in Western Australia. This new climatic niche model for P. psidii s.l. indicates a higher degree of cold tolerance; and hence a potential range that extends into higher altitudes and latitudes than has been indicated previously. The methods demonstrated here provide some insight into the impacts an invasive species might have within its climatically suited range, and can help inform biosecurity policies regarding the management of its spread and protection of valued threatened assets.	[Kriticos, Darren J.; Morin, Louise; Leriche, Agathe; Caley, Peter] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia; [Kriticos, Darren J.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Anderson, Robert C.] Univ Hawaii, Coll Trop Agr & Human Resources, Honolulu, HI 96822 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Hawaii System	Kriticos, DJ (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	Darren.kriticos@csiro.au	Leriche, Agathe/C-3151-2008; Morin, Louise/B-4822-2009; Kriticos, Darren J/A-4170-2008; Caley, Peter/D-8638-2011	Leriche, Agathe/0000-0001-9646-5344; Kriticos, Darren J/0000-0003-2599-8105; Caley, Peter/0000-0002-8077-6460; Morin, Louise/0000-0002-9515-2255	Commonwealth Scientific and Industrial Research Organisation Biosecurity Flagship; Sustainable Agriculture Flagships; New Zealand's Foundation for Research, Science Technology [CO2X0501]; etter Border Biosecurity (B3) programme	Commonwealth Scientific and Industrial Research Organisation Biosecurity Flagship; Sustainable Agriculture Flagships; New Zealand's Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology); etter Border Biosecurity (B3) programme	This work was partially funded by the Commonwealth Scientific and Industrial Research Organisation Biosecurity Flagship and Sustainable Agriculture Flagships, and New Zealand's Foundation for Research, Science & Technology through contract CO2X0501, the Better Border Biosecurity (B3) programme (www.b3nz.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, LAND USE AUSTR VERS; Anderson R. C., 2012, BASELINE ANAL DISTRI; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; BARBOUR MG, 1967, ECOLOGY, V48, P861, DOI 10.2307/1933746; Bonde MR, 2007, PHYTOPATHOLOGY, V97, P997, DOI 10.1094/PHYTO-97-8-0997; Booth TH, 2000, AGR ECOSYST ENVIRON, V82, P295, DOI 10.1016/S0167-8809(00)00233-4; Booth TH, 2012, AUSTRALAS PLANT PATH, V41, P425, DOI 10.1007/s13313-012-0130-x; Brasier C. M., 1994, Bulletin OEPP, V24, P221, DOI 10.1111/j.1365-2338.1994.tb01063.x; Brockerhoff EG, 2012, PLOS ONE, V8; CABI, 2005, DISTR MAPS PLANT DIS; Carnegie AJ, 2010, AUSTRALAS PLANT PATH, V39, P463, DOI 10.1071/AP10102; Carnegie AJ, 2011, AUSTRALAS PLANT PATH, V40, P346, DOI 10.1007/s13313-011-0066-6; Chiani R. G., 1959, Bol argent. for., V17, P10; Coelho Lisias, 2001, Summa Phytopathologica, V27, P295; Coutinho TA, 1998, PLANT DIS, V82, P819, DOI 10.1094/PDIS.1998.82.7.819; de Villiers M, 2013, B ENTOMOL RES, V103, P60, DOI 10.1017/S0007485312000454; Department of Sustainability Environment Water Population and Communities, 2009, EPBC ACT LIST THREAT; Elith J, 2013, AUSTRALAS PLANT PATH, V42, P43, DOI 10.1007/s13313-012-0178-7; Eyre D., 2012, Bulletin OEPP, V42, P48, DOI [10.1111/epp.2549, 10.1111/j.1365-2338.2012.02549.x]; FAO, 2006, INT STAND PHYT MEAS; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferreira F. A., 1983, Revista Arvore, V7, P91; Ferreira F.A., 1981, FITOPATOL BRAS, V6, P603; Gavran M., 2010, AUSTR PLANTATIONS 20; GIT Forestry Consulting, 2008, GLOB EUC MAP; Glen M, 2007, AUSTRALAS PLANT PATH, V36, P1, DOI 10.1071/AP06088; Gommes R, 2004, EUROPEAN SOC AGRONOM, V26; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hoddle MS, 2004, CROP PROT, V23, P691, DOI 10.1016/j.cropro.2003.11.017; Hutchinson M., 2009, ANUCLIM 6 0 USERS GU; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Kawanishi T, 2009, J GEN PLANT PATHOL, V75, P428, DOI 10.1007/s10327-009-0202-0; Keatley MR, 2002, INT J CLIMATOL, V22, P1769, DOI 10.1002/joc.822; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2007, J APPL ECOL, V44, P853, DOI 10.1111/j.1365-2664.2007.01331.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Kriticos DJ, 2008, 200928 MAF BIOS NZ S; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; Lanoiselet V, 2002, AUSTRALAS PLANT PATH, V31, P1, DOI 10.1071/AP01070; MacLachlan JD, 1938, PHYTOPATHOLOGY, V28, P157; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; MARLATT RB, 1979, PLANT DIS REP, V63, P510; McCarthy HR, 2011, ECOL APPL, V21, P3115, DOI 10.1890/11-0048.1; Mellano V, 2006, HLTH GARD HLTH HOME, V1, P3; Morin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035434; Myerscough Peter J., 1998, Cunninghamia, V5, P787; NSW Department of Primary Industries, 2012, FIELD HOSTS MYRTL RU; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Queensland Department of Agriculture Fisheries and Forestry, 2012, LIST HOST PLANTS AFF; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; RUIZ R A R, 1989, Fitopatologia Brasileira, V14, P55; Schroeder TA, 1986, RAINFALL ATLAS HAWAI, pR76; Simpson JA, 2006, AUSTRALAS PLANT PATH, V35, P549, DOI 10.1071/AP06057; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tessmann D. J., 2002, Fitopatologia Brasileira, V27, P538, DOI 10.1590/S0100-41582002000500017; Uchida J, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524C; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodall GS, 1998, J EXP BOT, V49, P79, DOI 10.1093/jexbot/49.318.79; Xavier Aloisio, 2010, Agron. Costarricense, V34, P93; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; [Zhuang Jianyun 庄剑云], 2011, [菌物学报, Mygosystema], V30, P853	70	56	60	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64479	10.1371/journal.pone.0064479	http://dx.doi.org/10.1371/journal.pone.0064479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704988	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200141
J	Moussa, S; Jenabian, MA; Gody, JC; Leal, J; Gresenguet, G; Le Faou, A; Belec, L				Moussa, Sandrine; Jenabian, Mohammad-Ali; Gody, Jean Chrysostome; Leal, Josiane; Gresenguet, Gerard; Le Faou, Alain; Belec, Laurent			Adaptive HIV-Specific B Cell-Derived Humoral Immune Defenses of the Intestinal Mucosa in Children Exposed to HIV via Breast-Feeding	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; ANTIRETROVIRAL DRUGS; RESISTANCE MUTATIONS; HIV-1-INFECTED WOMEN; HIV-1-SPECIFIC IGG; VIRAL TRANSCYTOSIS; MILK TRANSMISSION	Background: We evaluated whether B cell-derived immune defenses of the gastro-intestinal tract are activated to produce HIV-specific antibodies in children continuously exposed to HIV via breast-feeding. Methods: Couples of HIV-1-infected mothers (n = 14) and their breastfed non HIV-infected (n = 8) and HIV-infected (n = 6) babies, and healthy HIV-negative mothers and breastfed babies (n = 10) as controls, were prospectively included at the Complexe Pediatrique of Bangui, Central African Republic. Immunoglobulins (IgA, IgG and IgM) and anti-gp160 antibodies from mother's milk and stools of breastfed children were quantified by ELISA. Immunoaffinity purified anti-gp160 antibodies were characterized functionally regarding their capacity to reduce attachment and/or infection of R5- and X4- tropic HIV-1 strains on human colorectal epithelial HT29 cells line or monocyte-derived-macrophages (MDM). Results: The levels of total IgA and IgG were increased in milk of HIV-infected mothers and stools of HIV-exposed children, indicating the activation of B cell-derived mucosal immunity. Breast milk samples as well as stool samples from HIV-negative and HIV-infected babies exposed to HIV by breast-feeding, contained high levels of HIV-specific antibodies, mainly IgG antibodies, less frequently IgA antibodies, and rarely IgM antibodies. Relative ratios of excretion by reference to lactoferrin calculated for HIV-specific IgA, IgG and IgM in stools of HIV-exposed children were largely superior to 1, indicating active production of HIV-specific antibodies by the intestinal mucosa. Antibodies to gp160 purified from pooled stools of HIV-exposed breastfed children inhibited the attachment of HIV-1NDK on HT29 cells by 63% and on MDM by 77%, and the attachment of HIV-1JRCSF on MDM by 40%; and the infection of MDM by HIV-1JRCSF by 93%. Conclusions: The intestinal mucosa of children exposed to HIV by breast-feeding produces HIV-specific antibodies harbouring in vitro major functional properties against HIV. These observations lay the conceptual basis for the design of a prophylactic vaccine against HIV in exposed children.	[Moussa, Sandrine; Leal, Josiane; Le Faou, Alain] Inst Pasteur, Lab Retrovirus VIH, Bangui, Cent Afr Republ; [Jenabian, Mohammad-Ali; Belec, Laurent] Hop Europe Georges Pompidou, AP HP, Virol Lab, Paris, France; [Gody, Jean Chrysostome] Complexe Pediat, Bangui, Cent Afr Republ; [Gresenguet, Gerard] Fac Sci Sante Bangui, Unite Rech & Intervent Malad Sexuellement Transmi, Dept Sante Publ, Bangui, Cent Afr Republ; [Belec, Laurent] Fac Med Paris Descartes, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Moussa, S (corresponding author), Inst Pasteur, Lab Retrovirus VIH, Bangui, Cent Afr Republ.	sandmoussa@hotmail.com		Le Faou, Alain/0000-0003-3243-7330	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	External funding sources were received for this study by a french research organism (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, J HUM LACT, V27, P171, DOI 10.1177/0890334410395761; Alexander R, 2007, CURR HIV RES, V5, P588, DOI 10.2174/157016207782418452; Artenstein AW, 1997, J INFECT DIS, V175, P265, DOI 10.1093/infdis/175.2.265; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Becquart P, 2000, J INFECT DIS, V181, P532, DOI 10.1086/315255; Becquart P, 1999, AIDS, V13, P1323, DOI 10.1097/00002030-199907300-00008; Becquart P, 2007, VIROLOGY, V363, P256, DOI 10.1016/j.virol.2007.02.003; BELEC L, 1989, J INFECT DIS, V160, P385, DOI 10.1093/infdis/160.3.385; BELEC L, 1995, J INFECT DIS, V172, P691, DOI 10.1093/infdis/172.3.691; BELEC L, 1990, PEDIATRICS, V85, P1022; Belec L, 2001, J INFECT DIS, V184, P1412, DOI 10.1086/324375; Belec L, 2012, ADV EXP MED BIOL, V743, P139, DOI 10.1007/978-1-4614-2251-8_10; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Bobat R, 1997, AIDS, V11, P1627, DOI 10.1097/00002030-199713000-00012; Bouhlal H, 2002, J IMMUNOL, V169, P3301, DOI 10.4049/jimmunol.169.6.3301; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BULTERYS M, 1995, AIDS, V9, P93; Bunders M, 2010, AIDS RES HUM RETROV, V26, P967, DOI 10.1089/aid.2009.0241; Carthagena Laetitia, 2011, Open Virol J, V5, P27, DOI 10.2174/1874357901105010027; Charpentier C, 2012, AIDS RES HUM RETROV, V28, P87, DOI [10.1089/aid.2011.0035, 10.1089/AID.2011.0035]; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chomont N, 2008, VIROLOGY, V370, P246, DOI 10.1016/j.virol.2007.09.006; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Cummins AG, 1997, IMMUNOL CELL BIOL, V75, P419, DOI 10.1038/icb.1997.67; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; DUPRAT C, 1994, PEDIATR INFECT DIS J, V13, P603, DOI 10.1097/00006454-199407000-00004; Ekpini ER, 1997, LANCET, V349, P1054, DOI 10.1016/S0140-6736(96)06444-6; Eslahpazir J, 2008, CLIN VACCINE IMMUNOL, V15, P872, DOI 10.1128/CVI.00463-07; FANTINI J, 1992, J VIROL, V66, P580, DOI 10.1128/JVI.66.1.580-585.1992; Farquhar C, 2008, CLIN EXP IMMUNOL, V153, P37, DOI 10.1111/j.1365-2249.2008.03664.x; Farquhar C, 2003, CLIN EXP IMMUNOL, V134, P367, DOI 10.1111/j.1365-2249.2003.02292.x; Filipp D, 2001, P NATL ACAD SCI USA, V98, P603, DOI 10.1073/pnas.98.2.603; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Fouda GG, 2011, J VIROL, V85, P9555, DOI 10.1128/JVI.05174-11; Fowler MG, 2002, J ACQ IMMUN DEF SYND, V30, P230, DOI [10.1097/00042560-200206010-00012, 10.1097/01.QAI.0000018364.28828.14]; Gody JC, 2008, JAIDS-J ACQ IMM DEF, V49, P566, DOI 10.1097/QAI.0b013e318183acae; GOLDMAN AS, 1990, PEDIATR RES, V27, P252, DOI 10.1203/00006450-199003000-00009; GOLDMAN AS, 1993, PEDIATR INFECT DIS J, V12, P664, DOI 10.1097/00006454-199308000-00008; Haimovici F, 1997, J ACQ IMMUN DEF SYND, V15, P185, DOI 10.1097/00042560-199707010-00001; HANSON LA, 1984, ANN ALLERGY, V53, P576; Hasselrot K, 2009, CRIT REV IMMUNOL, V29, P369, DOI 10.1615/CritRevImmunol.v29.i5.10; Hirbod T, 2007, J INTERN MED, V262, P44, DOI 10.1111/j.1365-2796.2007.01822.x; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; HOCINI H, 1995, SCAND J IMMUNOL, V42, P269, DOI 10.1111/j.1365-3083.1995.tb03653.x; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; ISRAEL ZR, 1995, J MED PRIMATOL, V24, P53, DOI 10.1111/j.1600-0684.1995.tb00146.x; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; John-Stewart GC, 2009, J INFECT DIS, V199, P889, DOI 10.1086/597120; JONARD PP, 1984, J CLIN INVEST, V74, P525, DOI 10.1172/JCI111450; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kourtis AP, 2003, LANCET INFECT DIS, V3, P786, DOI 10.1016/S1473-3099(03)00832-6; Kuhn L, 2006, J PEDIATR-US, V149, P611, DOI 10.1016/j.jpeds.2006.06.017; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Laibe S, 2003, CLIN CHEM LAB MED, V41, P134, DOI 10.1515/CCLM.2003.022; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langhorst J, 2012, DRUG TODAY, V48, P149, DOI 10.1358/dot.2012.48.2.1732555; Lehman DA, 2007, REV MED VIROL, V17, P381, DOI 10.1002/rmv.543; Lepage P, 2012, ADV EXP MED BIOL, V743, P121, DOI 10.1007/978-1-4614-2251-8_9; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Lewis P, 1998, J INFECT DIS, V177, P34, DOI 10.1086/513816; Long KZ, 2011, J NUTR, V141, P957, DOI 10.3945/jn.110.132134; Lu FX, 2000, CLIN IMMUNOL, V97, P59, DOI 10.1006/clim.2000.4910; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McGhee, 1994, MUCOSAL IMMUNOLOGY, P439; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Mestecky J, 2011, AIDS RES HUM RETROV, V27, P469, DOI 10.1089/aid.2010.0169; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Moog C, 2008, AIDS, V22, P1461, DOI 10.1097/QAD.0b013e3282fdf625; Moussa S, 2010, AIDS RES HUM RETROV, V26, P1247, DOI 10.1089/aid.2010.0091; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; OGRA PL, 1995, ANN NY ACAD SCI, V754, P97, DOI 10.1111/j.1749-6632.1995.tb44442.x; Permar SR, 2010, J VIROL, V84, P8209, DOI 10.1128/JVI.00656-10; Pfefferkorn MD, 2010, J PEDIATR GASTR NUTR, V51, P425, DOI 10.1097/MPG.0b013e3181d67e8f; Raux M, 1999, AIDS RES HUM RETROV, V15, P1365, DOI 10.1089/088922299310070; Richardson BA, 2003, J INFECT DIS, V187, P736, DOI 10.1086/374272; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Ruggeri FM, 1998, J VIROL, V72, P2708, DOI 10.1128/JVI.72.4.2708-2714.1998; Saidi H, 2007, J LEUKOCYTE BIOL, V81, P642, DOI 10.1189/jlb.0406278; Saidi H, 2006, J IMMUNOL, V177, P5540, DOI 10.4049/jimmunol.177.8.5540; Saidi Hela, 2008, AIDS Res Ther, V5, P10, DOI 10.1186/1742-6405-5-10; Saidi H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-28; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Semba RD, 1999, NUTR REV, V57, P146; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shearer G, 2010, J INFECT DIS, V202, pS329, DOI 10.1086/655974; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; SPIK G, 1982, ACTA PAEDIATR SCAND, V71, P979, DOI 10.1111/j.1651-2227.1982.tb09560.x; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Tugizov SM, 2012, J VIROL, V86, P2556, DOI 10.1128/JVI.06578-11; UNAIDS, 2011, GLOB HIV AIDS RESP E; Van de Perre P, 1999, AIDS, V13, P1133, DOI 10.1097/00002030-199906180-00018; Van de Perre P, 2000, ANN NY ACAD SCI, V918, P122; VANDEPERRE P, 1993, LANCET, V341, P914, DOI 10.1016/0140-6736(93)91210-D; VANDEPERRE P, 1988, J PEDIATR-US, V113, P1039, DOI 10.1016/S0022-3476(88)80578-X; WHO, 2010, REC ANT THER HIV INF; WHO, 2010, ANT THER HIV INF BAB; Wilson C, 2005, INFECT DIS FETUS NEW, P37; WOLFF H, 1992, J ACQ IMMUN DEF SYND, V5, P65; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334	112	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63408	10.1371/journal.pone.0063408	http://dx.doi.org/10.1371/journal.pone.0063408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704905	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200035
J	Schriner, SE; Lee, K; Truong, S; Salvadora, KT; Maler, S; Nam, A; Lee, T; Jafari, M				Schriner, Samuel E.; Lee, Kevin; Truong, Stephanie; Salvadora, Kathyrn T.; Maler, Steven; Nam, Alexander; Lee, Thomas; Jafari, Mahtab			Extension of Drosophila Lifespan by Rhodiola rosea through a Mechanism Independent from Dietary Restriction	PLOS ONE			English	Article							CALORIC RESTRICTION; STRESS RESISTANCE; OXIDATIVE STRESS; RHESUS-MONKEYS; FAT-BODY; MELANOGASTER; MICE; CELLS; OVEREXPRESSION; EXPRESSION	Rhodiola rosea has been extensively used to improve physical and mental performance and to protect against stress. We, and others, have reported that R. rosea can extend lifespan in flies, worms, and yeast. However, its molecular mechanism is currently unknown. Here, we tested whether R. rosea might act through a pathway related to dietary restriction (DR) that can extend lifespan in a range of model organisms. While the mechanism of DR itself is also unknown, three molecular pathways have been associated with it: the silent information regulator 2 (SIR2) proteins, insulin and insulin-like growth factor signaling (IIS), and the target of rapamycin (TOR). In flies, DR is implemented through a reduction in dietary yeast content. We found that R. rosea extract extended lifespan in both sexes independent of the yeast content in the diet. We also found that the extract extended lifespan when the SIR2, IIS, or TOR pathways were genetically perturbed. Upon examination of water and fat content, we found that R. rosea decreased water content and elevated fat content in both sexes, but did not sensitize flies to desiccation or protect them against starvation. There were some sex-specific differences in response to R. rosea. In female flies, the expression levels of glycolytic genes and dSir2 were down-regulated, and NADH levels were decreased. In males however, R. rosea provided no protection against heat stress and had no effect on the major heat shock protein HSP70 and actually down-regulated the mitochondrial HSP22. Our findings largely rule out an elevated general resistance to stress and DR-related pathways as mechanistic candidates. The latter conclusion is especially relevant given the limited potential for DR to improve human health and lifespan, and presents R. rosea as a potential viable candidate to treat aging and age-related diseases in humans.	[Schriner, Samuel E.; Lee, Kevin; Truong, Stephanie; Salvadora, Kathyrn T.; Maler, Steven; Nam, Alexander; Lee, Thomas; Jafari, Mahtab] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Jafari, M (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA.	mjafari@uci.edu			National Institutes of Health [AT004987]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by an National Institutes of Health R21 grant, AT004987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abidov M, 2003, B EXP BIOL MED+, V136, P585, DOI 10.1023/B:BEBM.0000020211.24779.15; Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476; Archer MA, 2007, PHYSIOL BIOCHEM ZOOL, V80, P386, DOI 10.1086/518354; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Bayliak MM, 2011, PHYTOMEDICINE, V18, P1262, DOI 10.1016/j.phymed.2011.06.010; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boon-Niermeijer EK, 2000, PHYTOMEDICINE, V7, P389, DOI 10.1016/S0944-7113(00)80060-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6; Humphrey DM, 2009, EXP GERONTOL, V44, P316, DOI 10.1016/j.exger.2009.02.001; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2011, EXP GERONTOL, V46, P148, DOI 10.1016/j.exger.2010.12.001; Jafari M, 2007, REJUV RES, V10, P587, DOI 10.1089/rej.2007.0560; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kelly G S, 2001, Altern Med Rev, V6, P293; Kim SH, 2006, BIOFACTORS, V26, P209, DOI 10.1002/biof.5520260306; Lee KS, 2010, REJUV RES, V13, P561, DOI 10.1089/rej.2010.1031; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Magwere T, 2006, J GERONTOL A-BIOL, V61, P36, DOI 10.1093/gerona/61.1.36; MARTIN GM, 1989, GENOME, V31, P390, DOI 10.1139/g89-059; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Matsumura H., 1980, METHOD ENZYMOL, V69, P465, DOI DOI 10.1016/S0076-6879(80)69045-4; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Panossian A, 2010, PHYTOMEDICINE, V17, P481, DOI 10.1016/j.phymed.2010.02.002; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Schriner SE, 2012, BIOGERONTOLOGY, V13, P105, DOI 10.1007/s10522-011-9357-0; Schriner SE, 2009, FREE RADICAL RES, V43, P836, DOI 10.1080/10715760903089724; Schriner SE, 2009, FREE RADICAL BIO MED, V47, P577, DOI 10.1016/j.freeradbiomed.2009.05.025; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Spindler SR, 2006, AGING CELL, V5, P39, DOI 10.1111/j.1474-9726.2006.00194.x; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; UDINTSEV SN, 1991, EUR J CANCER, V27, P1182, DOI 10.1016/0277-5379(91)90323-6; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9	48	35	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63886	10.1371/journal.pone.0063886	http://dx.doi.org/10.1371/journal.pone.0063886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704949	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200080
J	Bjursell, M; Wedin, M; Admyre, T; Hermansson, M; Bottcher, G; Goransson, M; Linden, D; Bamberg, K; Oscarsson, J; Bohlooly-Y, M				Bjursell, Mikael; Wedin, Marianne; Admyre, Therese; Hermansson, Majlis; Bottcher, Gerhard; Goransson, Melker; Linden, Daniel; Bamberg, Krister; Oscarsson, Jan; Bohlooly-Y, Mohammad			Ageing Fxr Deficient Mice Develop Increased Energy Expenditure, Improved Glucose Control and Liver Damage Resembling NASH	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; FAMILIAL INTRAHEPATIC CHOLESTASIS; BILE-ACID-HOMEOSTASIS; HIGH-FAT DIET; NUCLEAR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; INSULIN SENSITIVITY; GENE-EXPRESSION; KNOCKOUT MICE; PPAR-ALPHA	Nuclear receptor subfamily 1, group H, member 4 (Nr1h4, FXR) is a bile acid activated nuclear receptor mainly expressed in the liver, intestine, kidney and adrenal glands. Upon activation, the primary function is to suppress cholesterol 7 alpha-hydroxylase (Cyp7a1), the rate-limiting enzyme in the classic or neutral bile acid synthesis pathway. In the present study, a novel Fxr deficient mouse line was created and studied with respect to metabolism and liver function in ageing mice fed chow diet. The Fxr deficient mice were similar to wild type mice in terms of body weight, body composition, energy intake and expenditure as well as behaviours at a young age. However, from 15 weeks of age and onwards, the Fxr deficient mice had almost no body weight increase up to 39 weeks of age mainly because of lower body fat mass. The lower body weight gain was associated with increased energy expenditure that was not compensated by increased food intake. Fasting levels of glucose and insulin were lower and glucose tolerance was improved in old and lean Fxr deficient mice. However, the Fxr deficient mice displayed significantly increased liver weight, steatosis, hepatocyte ballooning degeneration and lobular inflammation together with elevated plasma levels of ALT, bilirubin and bile acids, findings compatible with non-alcoholic steatohepatitis (NASH) and cholestasis. In conclusion, ageing Fxr deficient mice display late onset leanness associated with elevated energy expenditure and improved glucose control but develop severe NASH-like liver pathology.	[Bjursell, Mikael; Wedin, Marianne; Admyre, Therese; Hermansson, Majlis; Bottcher, Gerhard; Goransson, Melker; Linden, Daniel; Bamberg, Krister; Oscarsson, Jan; Bohlooly-Y, Mohammad] AstraZeneca R&D, Molndal, Sweden	AstraZeneca	Bjursell, M (corresponding author), AstraZeneca R&D, Molndal, Sweden.	mikael.bjursell@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded by AstraZeneca, the employer of Mikael Bjursell, Marianne Wedin, Therese Admyre, Majlis Hermansson, Gerhard Bottcher, Melker Goransson, Daniel Linden, Krister Bamberg, Jan Oscarsson, Mohammad Bohlooly-Y. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; Bjursell M, 2005, BIOCHEM BIOPH RES CO, V326, P759, DOI 10.1016/j.bbrc.2004.11.116; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Boufker HI, 2011, BONE, V49, P1219, DOI 10.1016/j.bone.2011.08.013; Cariou B, 2005, FEBS LETT, V579, P4076, DOI 10.1016/j.febslet.2005.06.033; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chen F, 2004, GASTROENTEROLOGY, V126, P756, DOI 10.1053/j.gastro.2003.12.013; Dufer M, 2012, DIABETES, V61, P1479, DOI 10.2337/db11-0815; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Figge A, 2004, J BIOL CHEM, V279, P2790, DOI 10.1074/jbc.M307363200; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hashidume T, 2011, BIOSCI BIOTECH BIOCH, V75, P1702, DOI 10.1271/bbb.110224; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Inoue M, 2011, J CLIN BIOCHEM NUTR, V48, P161, DOI 10.3164/jcbn.09-122GFR; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lian F, 2011, BIOCHEM J, V438, P315, DOI 10.1042/BJ20102096; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Malaguarnera L, 2005, J HEPATOL, V42, P585, DOI 10.1016/j.jhep.2004.11.040; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; van Dijk TH, 2009, J BIOL CHEM, V284, P10315, DOI 10.1074/jbc.M807317200; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Ye DW, 2012, GUT, V61, P1058, DOI 10.1136/gutjnl-2011-300269; Zhang YQ, 2006, ARTERIOSCL THROM VAS, V26, P2316, DOI 10.1161/01.ATV.0000235697.35431.05; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	49	45	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64721	10.1371/journal.pone.0064721	http://dx.doi.org/10.1371/journal.pone.0064721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700488	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400064
J	Lim, K; Kulakova, L; Galkin, A; Herzberg, O				Lim, Kap; Kulakova, Liudmila; Galkin, Andrey; Herzberg, Osnat			Crystal Structures of Carbamate Kinase from Giardia lamblia Bound with Citric Acid and AMP-PNP	PLOS ONE			English	Article							STATE ANALOG COMPLEX; ANGSTROM RESOLUTION; ARGININE; ENZYME; MECHANISMS; EXPRESSION; PHOSPHATE; ALIGNMENT; PROTEINS; PROGRAM	The parasite Giardia lamblia utilizes the L-arginine dihydrolase pathway to generate ATP from L-arginine. Carbamate kinase (CK) catalyzes the last step in this pathway, converting ADP and carbamoyl phosphate to ATP and ammonium carbamate. Because the L-arginine pathway is essential for G. lamblia survival and absent in high eukaryotes including humans, the enzyme is a potential target for drug development. We have determined two crystal structures of G. lamblia CK (glCK) with bound ligands. One structure, in complex with a nonhydrolyzable ATP analog, adenosine 5'-adenylyl-beta,gamma-imidodiphosphate (AMP-PNP), was determined at 2.6 angstrom resolution. The second structure, in complex with citric acid bound in the postulated carbamoyl phosphate binding site, was determined in two slightly different states at 2.1 and 2.4 angstrom resolution. These structures reveal conformational flexibility of an auxiliary domain (amino acid residues 123-170), which exhibits open or closed conformations or structural disorder, depending on the bound ligand. The structures also reveal a smaller conformational change in a region associated the AMP-PNP adenine binding site. The protein residues involved in binding, together with a model of the transition state, suggest that catalysis follows an in-line, predominantly dissociative, phosphotransfer reaction mechanism, and that closure of the flexible auxiliary domain is required to protect the transition state from bulk solvent.	[Lim, Kap; Kulakova, Liudmila; Galkin, Andrey; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	osnat@umd.edu		Herzberg, Osnat/0000-0003-2823-7627	NIH [R56AI059733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R56AI059733. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Brown DM, 1998, INT J PARASITOL, V28, P149, DOI 10.1016/S0020-7519(97)00172-0; Chen Catherine Z, 2012, Curr Chem Genomics, V6, P93, DOI 10.2174/1875397301206010093; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galkin A, 2010, ACTA CRYSTALLOGR F, V66, P386, DOI 10.1107/S1744309110004665; Gallego P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047886; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Li EQ, 2006, J IMMUNOL, V176, P516, DOI 10.4049/jimmunol.176.1.516; Lim K, 2010, BIOCHEMISTRY-US, V49, P2031, DOI 10.1021/bi9020988; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Minotto L, 1999, MOL BIOCHEM PARASIT, V98, P43, DOI 10.1016/S0166-6851(98)00141-8; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Pauling L., 1960, NATURE CHEM BOND, V3rd; Raijmann L, 1973, ENZYMES, P97; Ramon-Maique S, 2010, J MOL BIOL, V397, P1261, DOI 10.1016/j.jmb.2010.02.038; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Thoden JB, 1999, BIOCHEMISTRY, V38; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yousef MS, 2002, ACTA CRYSTALLOGR D, V58, P2009, DOI 10.1107/S0907444902014683	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64004	10.1371/journal.pone.0064004	http://dx.doi.org/10.1371/journal.pone.0064004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700444	gold, Green Submitted, Green Published			2022-12-25	WOS:000319966400039
J	Liu, YH; Xu, Y; Wen, YB; Guan, K; Ling, WH; He, LP; Su, YX; Chen, YM				Liu, Yan-hua; Xu, Ying; Wen, Ya-bin; Guan, Ke; Ling, Wen-hua; He, Li-ping; Su, Yi-xiang; Chen, Yu-ming			Association of Weight-Adjusted Body Fat and Fat Distribution with Bone Mineral Density in Middle-Aged Chinese Adults: A Cross-Sectional Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ABDOMINAL VISCERAL FAT; OSTEOPOROTIC FRACTURES; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; LEAN MASS; WOMEN; MEN; OBESITY	Background: Although it is well established that a higher body weight is protective against osteoporosis, the effects of body fat and fat distribution on bone mineral density (BMD) after adjustment for body weight remains uncertain. To examine the relationship between body fat and fat distribution and BMD beyond its weight-bearing effect in middle-aged Chinese adults. Method: The study had a community-based cross-sectional design and involved 1,767 women and 698 men aged 50-75 years. The BMD of the lumbar spine, total hip, and whole body, and the fat mass (FM) and percentage fat mass (% FM) of the total body and segments of the body were measured by dual-energy X-ray absorptiometry. General information on the participants was collected using structured questionnaire interviews. Result: After adjusting for potential confounders, an analysis of covariance showed the weight-adjusted (WA-) total FM (or % FM) to be negatively associated with BMD in all of the studied sites (P < 0.05) in both women and men. The unfavorable effects of WA-total FM were generally more substantial in men than in women, and the whole body was the most sensitive site related to FM, followed by the total hip and the lumbar spine, in both genders. The mean BMD of the lumbar spine, total hip, and whole body was 3.93%, 3.01%, and 3.65% (in women) and 5.02%, 5.57%, 6.03% (in men) lower in the highest quartile (vs. lowest quartile) according to the WA-total FM (all p < 0.05). Similar results were noted among the groups for WA-total FM%. In women, abdominal fat had the most unfavorable association with BMD, whereas in men it was limb fat. Conclusion: FM (or % FM) is inversely associated with BMD beyond its weight-bearing effect. Abdominal fat in women and limb fat in men seems to have the greatest effect on BMD.	[Liu, Yan-hua; Xu, Ying; Wen, Ya-bin; Guan, Ke; Ling, Wen-hua; He, Li-ping; Su, Yi-xiang; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Su, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	suyx@mail.sysu.edu.cn; chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; liu, yan/HCI-5542-2022	chen, Yu-ming/0000-0003-1658-5528	5010 Program for Clinical Researches of Sun Yat-sen University [2007032]; National Natural Science Foundation of China [81130052, 81072299]	5010 Program for Clinical Researches of Sun Yat-sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was jointly supported by the 5010 Program for Clinical Researches of Sun Yat-sen University (No. 2007032) and the National Natural Science Foundation of China (No. 81130052, 81072299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikan S, 2012, J CLIN DENSITOM, V15, P186, DOI 10.1016/j.jocd.2011.11.005; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bhupathiraju SN, 2011, AM J CLIN NUTR, V94, P1063, DOI 10.3945/ajcn.111.016030; Biver E, 2011, J CLIN ENDOCR METAB, V96, P2703, DOI 10.1210/jc.2011-0047; Casanueva FF, 2010, CLIN ENDOCRINOL, V73, P35, DOI 10.1111/j.1365-2265.2009.03727.x; Chanprasertyothin Suwannee, 2005, Journal of the Medical Association of Thailand, V88, P655; Chen YM, 2010, OSTEOPOROSIS INT, V21, P939, DOI 10.1007/s00198-009-1029-4; Choi HS, 2010, CALCIFIED TISSUE INT, V87, P218, DOI 10.1007/s00223-010-9398-4; Cole ZA, 2012, BONE, V50, P562, DOI 10.1016/j.bone.2011.05.005; Cui LH, 2007, J BONE MINER METAB, V25, P165, DOI 10.1007/s00774-006-0747-3; Goh VHH, 2010, AGING MALE, V13, P265, DOI 10.3109/13685538.2010.489623; Gonnelli S, 2012, J CLIN DENSITOM, DOI [10.1016/j.jocd.2012.02.013, DOI 10.1016/J.J0CD.2012.02.013]; Guney E, 2003, OBES SURG, V13, P383, DOI 10.1381/096089203765887705; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Huang JS, 2001, AIDS, V15, P975, DOI 10.1097/00002030-200105250-00005; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Katzmarzyk PT, 2012, BONE, V50, P576, DOI 10.1016/j.bone.2011.04.012; Kim JH, 2012, OSTEOPOROSIS INT, V23, P2009, DOI 10.1007/s00198-011-1808-6; Kim KC, 2010, YONSEI MED J, V51, P857, DOI 10.3349/ymj.2010.51.6.857; Lee HR, 2011, KOREAN J FAM MED, V32, P219, DOI 10.4082/kjfm.2011.32.4.219; Lee J, 2012, J KOREAN MED SCI, V27, P184, DOI 10.3346/jkms.2012.27.2.184; Lekamwasam S, 2009, J BONE MINER METAB, V27, P83, DOI 10.1007/s00774-008-0006-x; Lord J, 2006, BJOG-INT J OBSTET GY, V113, P1203, DOI 10.1111/j.1471-0528.2006.00973.x; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Miyawaki T, 2004, INTERNAL MED, V43, P1138, DOI 10.2169/internalmedicine.43.1138; Moseley KF, 2011, CLIN ENDOCRINOL, V74, P565, DOI 10.1111/j.1365-2265.2010.03965.x; Muraki S, 2004, OSTEOPOROSIS INT, V15, P724, DOI 10.1007/s00198-004-1600-y; Napoli N, 2010, BONE, V47, P1001, DOI 10.1016/j.bone.2010.08.010; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Ohnishi H, 2008, HYPERTENS RES, V31, P1385, DOI 10.1291/hypres.31.1385; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Sandeep S, 2010, INDIAN J MED RES, V131, P629; Savgan-Gurol E, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-86; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Sukumar D, 2011, OSTEOPOROSIS INT, V22, P635, DOI 10.1007/s00198-010-1305-3; Suzuki Takao, 2011, Clin Calcium, V21, P722, DOI CliCa1105722729; Thomas T, 2002, J BONE MINER RES, V17, P1563, DOI 10.1359/jbmr.2002.17.9.1563; van der Leeuw J, 2013, MENOPAUSE, V20, P409, DOI 10.1097/gme.0b013e31827212a5; Weiss LA, 2006, J BONE MINER RES, V21, P758, DOI 10.1359/JBMR.060206; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yoo HJ, 2012, J BONE MINER METAB, V30, P47, DOI 10.1007/s00774-011-0283-7; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	48	37	38	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63339	10.1371/journal.pone.0063339	http://dx.doi.org/10.1371/journal.pone.0063339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700417	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400015
J	Magliano, DC; Bargut, TCL; de Carvalho, SN; Aguila, MB; Mandarim-de-Lacerda, CA; Souza-Mello, V				Magliano, D'Angelo Carlo; Lonzetti Bargut, Thereza Cristina; de Carvalho, Simone Nunes; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa			Peroxisome Proliferator-Activated Receptors-Alpha and Gamma Are Targets to Treat Offspring from Maternal Diet-Induced Obesity in Mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; PPAR-ALPHA; HEPATIC STEATOSIS; GENE-EXPRESSION; C57BL/6 MICE; X-RECEPTOR; BEZAFIBRATE; LIVER	Aim: The aim of the present study was to evaluate whether activation of peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma by Bezafibrate (BZ) could attenuate hepatic and white adipose tissue (WAT) abnormalities in male offspring from diet-induced obese dams. Materials and Methods: C57BL/6 female mice were fed a standard chow (SC; 10% lipids) diet or a high-fat (HF; 49% lipids) diet for 8 weeks before mating and during gestation and lactation periods. Male offspring received SC diet at weaning and were subdivided into four groups: SC, SC/BZ, HF and HF/BZ. Treatment with BZ (100 mg/Kg diet) started at 12 weeks of age and was maintained for three weeks. Results: The HF diet resulted in an overweight phenotype and an increase in oral glucose intolerance and fasting glucose of dams. The HF offspring showed increased body mass, higher levels of plasmatic and hepatic triglycerides, higher levels of pro-inflammatory and lower levels of anti-inflammatory adipokines, impairment of glucose metabolism, abnormal fat pad mass distribution, higher number of larger adipocytes, hepatic steatosis, higher expression of lipogenic proteins concomitant to decreased expression of PPARalpha and carnitine palmitoyltransferase I (CPT-1) in liver, and diminished expression of PPARgamma and adiponectin in WAT. Treatment with BZ ameliorated the hepatic and WAT abnormalities generated by diet-induced maternal obesity, with improvements observed in the structural, biochemical and molecular characteristics of the animals' livers and epididymal fat. Conclusion: Diet-induced maternal obesity lead to alterations in metabolism, hepatic lipotoxicity and adverse liver and WAT remodeling in the offspring. Targeting PPAR with Bezafibrate has beneficial effects reducing the alterations, mainly through reduction of WAT inflammatory state through PPARgamma activation and enhanced hepatic beta-oxidation due to increased PPARalpha/PPARgamma ratio in liver.	[Magliano, D'Angelo Carlo; Lonzetti Bargut, Thereza Cristina; de Carvalho, Simone Nunes; Aguila, Marcia Barbosa; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa] Univ Estado Rio De Janeiro, Lab Morphometry Metab & Cardiovasc Dis, Biomed Ctr, Inst Biol, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Lab Morphometry Metab & Cardiovasc Dis, Biomed Ctr, Inst Biol, Rio De Janeiro, Brazil.	mandarim@uerj.br	Souza-Mello, Vanessa/E-3463-2014; Aguila, Marcia Barbosa/ABF-6505-2020; Magliano, D'Angelo Carlo/U-7364-2019; Mandarim-de-Lacerda, Carlos A/F-7125-2012; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia/P-2349-2019; Souza-Mello, Vanessa/D-5092-2013; Bargut, Thereza/AAK-4649-2020	Souza-Mello, Vanessa/0000-0002-2510-9569; Aguila, Marcia Barbosa/0000-0003-3994-4589; Magliano, D'Angelo Carlo/0000-0002-0575-961X; Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Bargut, Thereza/0000-0001-9218-3104; Carvalho, Simone/0000-0003-3310-2970	CNPq (Brazilian Council of Science and Technology) [470727/2009-8, 472033/2011-5]; FAPERJ (Rio de Janeiro State Foundation for Scientific Research) [E-26/102.289/2010]	CNPq (Brazilian Council of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Rio de Janeiro State Foundation for Scientific Research)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support was provided by the agencies CNPq (Brazilian Council of Science and Technology, www.cnpq.br), grant number 470727/2009-8 for CAML and 472033/2011-5 for VSM; and FAPERJ (Rio de Janeiro State Foundation for Scientific Research, www.faperj.br), grant number E-26/102.289/2010 for VSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila M.B., 2010, INSULIN RESISTANCE S, P1; Barbosa-da-Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039837; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cabrero A, 2003, METABOLISM, V52, P652, DOI 10.1053/meta.2003.50100; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Catta-Preta M, 2012, NUTRITION, V28, P212, DOI 10.1016/j.nut.2011.05.011; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Christodoulides C, 2010, MOL CELL ENDOCRINOL, V318, P61, DOI 10.1016/j.mce.2009.09.014; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fernandes-Santos C, 2009, NUTRITION, V25, P818, DOI 10.1016/j.nut.2008.12.010; Festi D, 2004, Obes Rev, V5, P27, DOI 10.1111/j.1467-789X.2004.00126.x; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Gregorio BM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.042; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kudoh A, 2011, LIFE SCI, V88, P1055, DOI 10.1016/j.lfs.2011.04.001; Kwon EY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-450; Lee HJ, 2002, BIOCHEM BIOPH RES CO, V296, P293, DOI 10.1016/S0006-291X(02)00822-7; Lee JK, 2010, KOREAN J PHYSIOL PHA, V14, P185, DOI 10.4196/kjpp.2010.14.3.185; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Peters JM, 2003, BBA-MOL CELL BIOL L, V1632, P80, DOI 10.1016/S1388-1981(03)00065-9; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Souza-Mello V, 2007, BRIT J NUTR, V98, P1159, DOI 10.1017/S0007114507771878; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Takahashi S, 2006, PHARMACOL RES, V53, P501, DOI 10.1016/j.phrs.2006.03.019; Tenenbaum A, 2008, ADV CARDIOL, V45, P127, DOI 10.1159/000115192; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Tenenbaum H, 2007, ATHEROSCLEROSIS, V194, P265, DOI 10.1016/j.atherosclerosis.2006.08.005; Teramoto T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-29; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Vickers MH, 2001, J ENDOCRINOL, V170, P323, DOI 10.1677/joe.0.1700323; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269	55	58	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64258	10.1371/journal.pone.0064258	http://dx.doi.org/10.1371/journal.pone.0064258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700465	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400050
J	O'Neill, T; Guaraldi, G; Orlando, G; Carli, F; Garlassi, E; Zona, S; Despres, JP; Ross, R				O'Neill, Trevor; Guaraldi, Giovanni; Orlando, Gabriella; Carli, Federica; Garlassi, Elisa; Zona, Stefano; Despres, Jean-Pierre; Ross, Robert			Combined Use of Waist and Hip Circumference to Identify Abdominally Obese HIV-Infected Patients at Increased Health Risk	PLOS ONE			English	Article							OPPOSITE ASSOCIATIONS; THIGH CIRCUMFERENCES; CARDIOVASCULAR RISK; FAT DISTRIBUTION; GLUCOSE-LEVELS; HEART-DISEASE; ALL-CAUSE; MORTALITY; MEN; LIPODYSTROPHY	Objectives: To determine whether for a given waist circumference (WC), a larger hip circumference (HC) was associated with a reduced risk of insulin resistance, type 2 diabetes (T2D), hypertension and cardiovascular disease (CVD) in HIV-infected patients. A second objective was to determine whether, for a given WC, the addition of HC improved upon estimates of abdominal adiposity, in particular visceral adipose tissue (VAT), compared to those obtained by WC alone. Methods: HIV-infected men (N = 1481) and women (N = 841) were recruited between 2005 and 2009. WC and HC were obtained using standard techniques and abdominal adiposity was measured using computed tomography. Results: After control for WC and covariates, HC was negatively associated with risk of insulin resistance (p < 0.05) and T2D [Men: OR = 0.91 (95% CI: 0.86-0.96); Women: OR = 0.91 (95% CI: 0.84-0.98)]. For a given WC, HC was also negatively associated with a lower risk of hypertension (p < 0.05) and CVD [OR = 0.94 (95% CI: 0.88-0.99)] in men, but not women. Although HC was negatively associated with VAT in men and women after control for WC (p < 0.05), the addition of HC did not substantially improve upon the prediction of VAT compared to WC alone. Conclusions: The identification of HIV-infected individuals at increased health risk by WC alone is substantially improved by the addition of HC. Estimates of visceral adipose tissue by WC are not substantially improved by the addition of HC and thus variation in visceral adiposity may not be the conduit by which HC identifies increased health risk.	[O'Neill, Trevor; Ross, Robert] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Guaraldi, Giovanni; Orlando, Gabriella; Carli, Federica; Garlassi, Elisa; Zona, Stefano] Univ Modena & Reggio Emilia, Dept Med, Metab Clin, Infect & Trop Dis Unit, Modena, Italy; [Despres, Jean-Pierre] Hop Laval, Res Ctr, Quebec Heart Inst, Quebec City, PQ, Canada	Queens University - Canada; Universita di Modena e Reggio Emilia; Laval University	Ross, R (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	rossr@queensu.ca	Guaraldi, Giovanni/J-9467-2018; Orlando, Gabriella/K-3954-2018	Orlando, Gabriella/0000-0002-4590-9045; Zona, Stefano/0000-0003-3451-2744; Guaraldi, Giovanni/0000-0002-5724-3914				American Diabetes Association, 1999, DIABETES CARE, V22, pS1; Andersen O, 2003, METABOLISM, V52, P1343, DOI 10.1016/S0026-0495(03)00201-4; Bacchetti P, 2005, JAIDS-J ACQ IMM DEF, V40, P121, DOI 10.1097/01.qai.0000182230.47819.aa; Bacchetti P, 2006, JAIDS-J ACQ IMM DEF, V42, P562; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Caron-Debarle M, 2010, TRENDS MOL MED, V16, P218, DOI 10.1016/j.molmed.2010.03.002; de Koning L, 2010, DIABETOLOGIA, V53, P1322, DOI 10.1007/s00125-010-1710-3; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gabriella O, 2012, JAIDS-J ACQ IMM DEF, V59, P494, DOI 10.1097/QAI.0b013e31824c8397; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Kuk JL, 2007, AM J CLIN NUTR, V85, P1540, DOI 10.1093/ajcn/85.6.1540; Lake JE, 2011, AIDS CARE, V23, P929, DOI 10.1080/09540121.2010.543885; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Mynarcik DC, 2000, J ACQ IMMUN DEF SYND, V25, P312, DOI 10.1097/00126334-200012010-00004; Parker ED, 2009, AM J EPIDEMIOL, V169, P837, DOI 10.1093/aje/kwn395; Sakai Y, 2005, J INTERN MED, V257, P194, DOI 10.1111/j.1365-2796.2004.01432.x; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; Seidell JC, 1997, J INTERN MED, V242, P401, DOI 10.1046/j.1365-2796.1997.00235.x; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; Snijder MB, 2003, OBES RES, V11, P104, DOI 10.1038/oby.2003.18; Tien PC, 2003, JAIDS-J ACQ IMM DEF, V34, P461, DOI 10.1097/00126334-200312150-00003; Villarroya F, 2010, BBA-MOL CELL BIOL L, V1801, P392, DOI 10.1016/j.bbalip.2009.09.018; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e62538	10.1371/journal.pone.0062538	http://dx.doi.org/10.1371/journal.pone.0062538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700409	Green Published, gold			2022-12-25	WOS:000319966400007
J	Lian, S; Lee, JS; Cho, WK; Yu, J; Kim, MK; Choi, HS; Kim, KH				Lian, Sen; Lee, Jong-Seung; Cho, Won Kyong; Yu, Jisuk; Kim, Mi-Kyeong; Choi, Hong-Soo; Kim, Kook-Hyung			Phylogenetic and Recombination Analysis of Tomato Spotted Wilt Virus	PLOS ONE			English	Article							GENETIC-VARIABILITY; RNA RECOMBINATION; GLOBE ARTICHOKES; TOSPOVIRUS; TSWV; REASSORTMENT; RESISTANCE; EVOLUTION; SEQUENCE; SEGMENT	Tomato spotted wilt virus (TSWV) severely damages and reduces the yield of many economically important plants worldwide. In this study, we determined the whole-genome sequences of 10 TSWV isolates recently identified from various regions and hosts in Korea. Phylogenetic analysis of these 10 isolates as well as the three previously sequenced isolates indicated that the 13 Korean TSWV isolates could be divided into two groups reflecting either two different origins or divergences of Korean TSWV isolates. In addition, the complete nucleotide sequences for the 13 Korean TSWV isolates along with previously sequenced TSWV RNA segments from Korea and other countries were subjected to phylogenetic and recombination analysis. The phylogenetic analysis indicated that both the RNA L and RNA M segments of most Korean isolates might have originated in Western Europe and North America but that the RNA S segments for all Korean isolates might have originated in China and Japan. Recombination analysis identified a total of 12 recombination events among all isolates and segments and five recombination events among the 13 Korea isolates; among the five recombinants from Korea, three contained the whole RNA L segment, suggesting reassortment rather than recombination. Our analyses provide evidence that both recombination and reassortment have contributed to the molecular diversity of TSWV.	[Lian, Sen; Lee, Jong-Seung; Cho, Won Kyong; Yu, Jisuk; Kim, Kook-Hyung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lian, Sen; Lee, Jong-Seung; Cho, Won Kyong; Yu, Jisuk; Kim, Kook-Hyung] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea; [Cho, Won Kyong; Kim, Kook-Hyung] Seoul Natl Univ, Inst Agr & Life Sci, Seoul, South Korea; [Kim, Mi-Kyeong; Choi, Hong-Soo] Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, KH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	kookkim@snu.ac.kr	Cho, Won Kyong/I-5098-2012	Cho, Won Kyong/0000-0002-8416-5173	Next-Generation BioGreen 21 Program [PJ00819801]; Rural Development Administration; National Research Foundation [20110012328]; Ministry of Education, Science, and Technology (MEST); Vegetable Breeding Research Center through Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [710001-03]; Brain Korea 21 Project	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation; Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Vegetable Breeding Research Center through Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported in part by grants from the Next-Generation BioGreen 21 Program (No. PJ00819801), Rural Development Administration; the National Research Foundation grant (No. 20110012328) funded by the Ministry of Education, Science, and Technology (MEST); and the Vegetable Breeding Research Center (No. 710001-03) through Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. SL, JSL, WKC, and JY were supported by research fellowships from the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FIELDS VIROLOGY; Aramburu J, 2003, PLANT PATHOL, V52, P407, DOI 10.1046/j.1365-3059.2003.00829.x; Bruyere A, 2000, J VIROL, V74, P4214, DOI 10.1128/JVI.74.9.4214-4219.2000; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; BUJARSKI JJ, 1986, NATURE, V321, P528, DOI 10.1038/321528a0; CHAO L, 1991, J THEOR BIOL, V153, P229, DOI 10.1016/S0022-5193(05)80424-2; CHAO L, 1988, J THEOR BIOL, V133, P99, DOI 10.1016/S0022-5193(88)80027-4; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; DEHAAN P, 1991, J GEN VIROL, V72, P2207, DOI 10.1099/0022-1317-72-9-2207; ElSayed AI, 2012, BIOCHIMIE, V94, P1764, DOI 10.1016/j.biochi.2012.04.007; Escriu F, 2007, PLOS PATHOG, V3, P67, DOI 10.1371/journal.ppat.0030008; Fraile A, 1997, J VIROL, V71, P934, DOI 10.1128/JVI.71.2.934-940.1997; Gagarinova AG, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-143; GONSALVES D, 1986, PLANT DIS, V70, P501, DOI 10.1094/PD-70-501; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Heinze C, 2001, MICROBIOLOGICA, V24, P175; Henderson WW, 1995, VIROLOGY, V214, P602, DOI 10.1006/viro.1995.0071; Hu ZZ, 2011, ARCH VIROL, V156, P1905, DOI 10.1007/s00705-011-1078-9; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; IWAKI M, 1984, PLANT DIS, V68, P1006, DOI 10.1094/PD-69-1006; Jonson MG, 2009, ARCH VIROL, V154, P1705, DOI 10.1007/s00705-009-0493-7; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Koike S.T., 2007, VEGETABLE DIS COLOR; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; Lee JS, 2011, ARCH VIROL, V156, P725, DOI 10.1007/s00705-011-0935-x; Marongiu G, 2011, ACTA HORTIC, P281, DOI 10.17660/ActaHortic.2011.917.39; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mateus C, 2012, SPAN J AGRIC RES, V10, P191, DOI 10.5424/sjar/2012101-508-10; MILNE RG, 1984, INTERVIROLOGY, V22, P72, DOI 10.1159/000149536; Moritz G, 2004, VIRUS RES, V100, P143, DOI 10.1016/j.virusres.2003.12.022; PALIWAL YC, 1974, CAN J BOT, V52, P1177, DOI 10.1139/b74-151; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; PRESSING J, 1984, J MOL EVOL, V20, P135, DOI 10.1007/BF02257374; Prins M, 1998, TRENDS MICROBIOL, V6, P31, DOI 10.1016/S0966-842X(97)01173-6; Qiu WP, 1998, VIROLOGY, V244, P186, DOI 10.1006/viro.1998.9131; Qiu WP, 1999, PHYTOPATHOLOGY, V89, P575, DOI 10.1094/PHYTO.1999.89.7.575; Revers F, 1996, J GEN VIROL, V77, P1953, DOI 10.1099/0022-1317-77-8-1953; ROBINSON DJ, 1987, J GEN VIROL, V68, P2551, DOI 10.1099/0022-1317-68-10-2551; Seo JK, 2009, VIROLOGY, V393, P91, DOI 10.1016/j.virol.2009.07.007; Sherman JM, 1998, PLANT DIS, V82, P407, DOI 10.1094/PDIS.1998.82.4.407; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Snippe M, 2007, VIROLOGY, V357, P115, DOI 10.1016/j.virol.2006.06.037; Soellick TR, 2000, P NATL ACAD SCI USA, V97, P2373, DOI 10.1073/pnas.030548397; Stenger DC, 1997, PHYTOPATHOLOGY, V87, P737, DOI 10.1094/PHYTO.1997.87.7.737; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tentchev D, 2011, J GEN VIROL, V92, P961, DOI 10.1099/vir.0.029082-0; Testa M, 2011, ACTA HORTIC, P297, DOI 10.17660/ActaHortic.2011.917.42; Teycheney PY, 2005, J GEN VIROL, V86, P3179, DOI 10.1099/vir.0.81197-0; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Tsompana M, 2005, MOL ECOL, V14, P53, DOI 10.1111/j.1365-294X.2004.02392.x; Turturo C, 2005, J GEN VIROL, V86, P217, DOI 10.1099/vir.0.80395-0; Ullman Diane E., 1997, P539; WHITE PS, 1995, VIROLOGY, V207, P334, DOI 10.1006/viro.1995.1088; Wilson CR, 1998, PLANT PATHOL, V47, P171, DOI 10.1046/j.1365-3059.1998.00227.x	55	52	60	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63380	10.1371/journal.pone.0063380	http://dx.doi.org/10.1371/journal.pone.0063380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696821	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900040
J	Dangi-Garimella, S; Sahai, V; Ebine, K; Kumar, K; Munshi, HG				Dangi-Garimella, Surabhi; Sahai, Vaibhav; Ebine, Kazumi; Kumar, Krishan; Munshi, Hidayatullah G.			Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HMGA PROTEINS; TUMOR GRADE; ACETYLATION; SITES; TRANSCRIPTION; INHIBITORS; GROWTH; REPAIR; P300	Pancreatic ductal adenocarcinoma (PDAC) is associated with a pronounced collagen-rich stromal reaction that has been shown to contribute to chemo-resistance. We have previously shown that PDAC cells are resistant to gemcitabine chemotherapy in the collagen microenvironment because of increased expression of the chromatin remodeling protein high mobility group A2 (HMGA2). We have now found that human PDAC tumors display higher levels of histone H3K9 and H3K27 acetylation in fibrotic regions. We show that relative to cells grown on tissue culture plastic, PDAC cells grown in three-dimensional collagen gels demonstrate increased histone H3K9 and H3K27 acetylation, along with increased expression of p300, PCAF and GCN5 histone acetyltransferases (HATs). Knocking down HMGA2 attenuates the effect of collagen on histone H3K9 and H3K27 acetylation and on collagen-induced p300, PCAF and GCN5 expression. We also show that human PDAC tumors with HMGA2 demonstrate increased histone H3K9 and H3K27 acetylation. Additionally, we show that cells in three-dimensional collagen gels demonstrate increased protection against gemcitabine. Significantly, downregulation of HMGA2 or p300, PCAF and GCN5 HATs sensitizes the cells to gemcitabine in three-dimensional collagen. Overall, our results increase our understanding of how the collagen microenvironment contributes to chemo-resistance in vitro and identify HATs as potential therapeutic targets against this deadly cancer.	[Dangi-Garimella, Surabhi; Sahai, Vaibhav; Ebine, Kazumi; Kumar, Krishan; Munshi, Hidayatullah G.] Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown VA Med Ctr, Chicago, IL 60611 USA; [Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Dangi-Garimella, S (corresponding author), Northwestern Univ, Dept Med, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.	surabhiyd@gmail.com; h-munshi@northwestern.edu			National Cancer Institute [R01CA126888]; Department of Veterans Affairs Merit Grant [I01BX001363]; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute Grant # R01CA126888 Department of Veterans Affairs Merit Grant # I01BX001363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384047, 10.1517/14728222.12.11.1457 , 10.1517/14728220802384013]; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Eliseeva ED, 2007, MOL CANCER THER, V6, P2391, DOI 10.1158/1535-7163.MCT-07-0159; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; HARRIS CC, 1974, CANCER RES, V34, P3461; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jacobetz MA, 2012, GUT; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Li AYJ, 2011, MOL CELL BIOL, V31, P2605, DOI 10.1128/MCB.05447-11; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Ouaissi M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/315939; Palmieri D, 2011, ONCOGENE, V30, P3024, DOI 10.1038/onc.2011.21; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Richards DA, 2006, ANN ONCOL, V17, P1096, DOI 10.1093/annonc/mdl081; Santer FR, 2011, MOL CANCER THER, V10, P1644, DOI 10.1158/1535-7163.MCT-11-0182; Schneider Gunter, 2011, J Gastrointest Cancer, V42, P85, DOI 10.1007/s12029-011-9257-1; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang G, PLOS ONE, V7; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Yu KR, 2013, STEM CELL RES, V10, P156, DOI 10.1016/j.scr.2012.11.002; Zha L, 2012, MOL CELL BIOCHEM, V364, P243, DOI 10.1007/s11010-012-1224-z	50	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64566	10.1371/journal.pone.0064566	http://dx.doi.org/10.1371/journal.pone.0064566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696899	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900102
J	Liu, SK; Li, Q; Liu, ZJ				Liu, Shikai; Li, Qi; Liu, Zhanjiang			Genome-Wide Identification, Characterization and Phylogenetic Analysis of 50 Catfish ATP-Binding Cassette (ABC) Transporter Genes	PLOS ONE			English	Article							RNA-SEQ ANALYSIS; SULFONYLUREA RECEPTORS; FAMILY; RESISTANCE; EVOLUTION; EFFLUX; TRANSCRIPTOME; TRANSLATION; DUPLICATION; MODULATION	Background: Although a large set of full-length transcripts was recently assembled in catfish, annotation of large gene families, especially those with duplications, is still a great challenge. Most often, complexities in annotation cause mis-identification and thereby much confusion in the scientific literature. As such, detailed phylogenetic analysis and/or orthology analysis are required for annotation of genes involved in gene families. The ATP-binding cassette (ABC) transporter gene superfamily is a large gene family that encodes membrane proteins that transport a diverse set of substrates across membranes, playing important roles in protecting organisms from diverse environment. Methodology/Principal Findings: In this work, we identified a set of 50 ABC transporters in catfish genome. Phylogenetic analysis allowed their identification and annotation into seven subfamilies, including 9 ABCA genes, 12 ABCB genes, 12 ABCC genes, 5 ABCD genes, 2 ABCE genes, 4 ABCF genes and 6 ABCG genes. Most ABC transporters are conserved among vertebrates, though cases of recent gene duplications and gene losses do exist. Gene duplications in catfish were found for ABCA1, ABCB3, ABCB6, ABCC5, ABCD3, ABCE1, ABCF2 and ABCG2. Conclusion/Significance: The whole set of catfish ABC transporters provide the essential genomic resources for future biochemical, toxicological and physiological studies of ABC drug efflux transporters. The establishment of orthologies should allow functional inferences with the information from model species, though the function of lineage-specific genes can be distinct because of specific living environment with different selection pressure.	[Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Liu, Shikai; Li, Qi] Ocean Univ China, Coll Fisheries, Shellfish Genet & Breeding Lab, Qingdao, Peoples R China	Auburn University System; Auburn University; Auburn University System; Auburn University; Ocean University of China	Liu, ZJ (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Liu, Zhanjiang/R-9633-2019; Liu, Shikai/AAO-2247-2021; Liu, Shikai/D-4664-2013	Liu, Shikai/0000-0001-5777-489X; Liu, Shikai/0000-0001-5777-489X	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) [2009-35205-05101, 2010-65205-20356, 2012-67015-19410]; China Scholarship Council	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA); China Scholarship Council(China Scholarship Council)	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-35205-05101 and 2010-65205-20356 and 2012-67015-19410 from the USDA National Institute of Food and Agriculture (NIFA). Shikai Liu was supported by a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Annilo T, 2003, MAMM GENOME, V14, P7, DOI 10.1007/s00335-002-2229-9; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Bryan J, 1999, BBA-BIOMEMBRANES, V1461, P285, DOI 10.1016/S0005-2736(99)00164-9; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kusuhara H, 2007, PFLUG ARCH EUR J PHY, V453, P735, DOI 10.1007/s00424-006-0134-x; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Leprohon P, 2006, EUKARYOT CELL, V5, P1713, DOI 10.1128/EC.00152-06; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li G, 2007, GENOMICS, V89, P385, DOI 10.1016/j.ygeno.2006.07.015; Li P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-177; Liu SK, 2013, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-595; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Liu SM, 2011, BMC GENOMICS, P12; Moitra K, 2011, PLOS ONE, P6; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Nelson JS, 1984, FISHES WORLD; Oram JF, 2001, J LIPID RES, V42, P1173; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Shani N, 1998, METHOD ENZYMOL, V292, P753; Sheps JA, 2004, GENOME BIOL, P5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, P11; Sturm A, 2009, BMC GENOMICS, P10; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sun H, 2000, NAT GENET, V26, P242, DOI 10.1038/79994; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tsybovsky Y, 2010, ADV EXP MED BIOL, V703, P105, DOI 10.1007/978-1-4419-5635-4_8; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Vasiliou Vasilis, 2009, Hum Genomics, V3, P281; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Xie XD, 2012, MOL BIOL REP, V39, P7281, DOI 10.1007/s11033-012-1558-3; Xiong J, 2010, BMC EVOLUTIONARY BIO, P10; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhao ZY, 2007, GENETICS, V175, P1407, DOI 10.1534/genetics.106.066720; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068	75	38	39	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63895	10.1371/journal.pone.0063895	http://dx.doi.org/10.1371/journal.pone.0063895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696857	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900061
J	Zhang, Z; Zhao, ZW; Liu, YF; Wang, W; Wu, Y; Ding, JP				Zhang, Zheng; Zhao, Zhiwen; Liu, Yongfeng; Wang, Wei; Wu, Ying; Ding, Jiuping			Kinetic Model of Nav1.5 Channel Provides a Subtle Insight into Slow Inactivation Associated Excitability in Cardiac Cells	PLOS ONE			English	Article							MUSCLE SODIUM-CHANNEL; SCN5A MUTATIONS; NA+ CHANNELS; VENTRICULAR MYOCYTES; GIANT-AXONS; CHANNELOPATHIES; SKELETAL; CURRENTS; ACTIVATION; EXPRESSION	Voltage-gated sodium channel Nav1.5 has been linked to the cardiac cell excitability and a variety of arrhythmic syndromes including long QT, Brugada, and conduction abnormalities. Nav1.5 exhibits a slow inactivation, corresponding to a duration-dependent bi-exponential recovery, which is often associated with various arrhythmia syndromes. However, the gating mechanism of Nav1.5 and the physiological role of slow inactivation in cardiac cells remain elusive. Here a 12-state two-step inactivation Markov model was successfully developed to depict the gating kinetics of Nav1.5. This model can simulate the Nav1.5 channel in not only steady state processes, but also various transient processes. Compared with the simpler 8-state model, this 12-state model is well-behaved in simulating and explaining the processes of slow inactivation and slow recovery. This model provides a good framework for further studying the gating mechanism and physiological role of sodium channel in excitable cells.	[Zhang, Zheng; Zhao, Zhiwen; Liu, Yongfeng; Wang, Wei; Wu, Ying; Ding, Jiuping] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wu, Y (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China.	wuying2010@mail.hust.edu.cn; jpding@mail.hust.edu.cn	Liu, Yongfeng/ABG-1361-2020	Liu, Yongfeng/0000-0002-8649-7892	Chinese National Natural Science Foundation [30971179, 31170814, 31028006]; Ministry of Science and Technology [2010CB529804]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work is supported by Chinese National Natural Science Foundation (30971179, 31170814, 31028006), the Ministry of Science and Technology (2010CB529804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Clancy CE, 2004, BIOPHYS J, V86, P2606, DOI 10.1016/S0006-3495(04)74315-5; Cummins TR, 1996, BIOPHYS J, V71, P227, DOI 10.1016/S0006-3495(96)79219-6; DOERR T, 1990, PFLUG ARCH EUR J PHY, V416, P230, DOI 10.1007/BF00392058; GOLDMAN L, 1972, J GEN PHYSIOL, V59, P659, DOI 10.1085/jgp.59.6.659; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Jarecki BW, 2010, J CLIN INVEST, V120, P369, DOI 10.1172/JCI40801; Kambouris NG, 1998, J PHYSIOL-LONDON, V512, P693, DOI 10.1111/j.1469-7793.1998.693bd.x; KIYOSUE T, 1989, CIRC RES, V64, P389, DOI 10.1161/01.RES.64.2.389; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; LIU YM, 1992, BIOPHYS J, V63, P654, DOI 10.1016/S0006-3495(92)81635-1; Magyar J, 2004, CARDIOVASC RES, V64, P477, DOI 10.1016/j.cardiores.2004.07.014; Milescu LS, 2008, BIOPHYS J, V95, P66, DOI 10.1529/biophysj.107.118190; Milescu LS, 2010, J NEUROSCI, V30, P12113, DOI 10.1523/JNEUROSCI.0445-10.2010; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; Moran O, 2000, FEBS LETT, V473, P132, DOI 10.1016/S0014-5793(00)01518-0; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; Sheets MF, 1999, J PHYSIOL-LONDON, V514, P425, DOI 10.1111/j.1469-7793.1999.425ae.x; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Viswanathan PC, 2004, TRENDS CARDIOVAS MED, V14, P28, DOI 10.1016/j.tcm.2003.10.001; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; Wang DW, 2002, CIRCULATION, V105, P341, DOI 10.1161/hc0302.102592; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035208; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D; ZILBERTER YI, 1994, BIOPHYS J, V67, P153, DOI 10.1016/S0006-3495(94)80464-3	42	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64286	10.1371/journal.pone.0064286	http://dx.doi.org/10.1371/journal.pone.0064286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696876	gold, Green Submitted, Green Published			2022-12-25	WOS:000319081900079
J	Cappello, P; Blaser, H; Gorrini, C; Lin, DCC; Elia, AJ; Wakeham, A; Haider, S; Boutros, PC; Mason, JM; Miller, NA; Youngson, B; Done, SJ; Mak, TW				Cappello, P.; Blaser, H.; Gorrini, C.; Lin, D. C. C.; Elia, A. J.; Wakeham, A.; Haider, S.; Boutros, P. C.; Mason, J. M.; Miller, N. A.; Youngson, B.; Done, S. J.; Mak, T. W.			Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells	ONCOGENE			English	Article						kinase; aneuploidy; cell cycle; breast cancer; cell death; metastasis	POTENTIAL THERAPEUTIC TARGET; HISTONE H3 PHOSPHORYLATION; PROTEIN-KINASE; SPINDLE CHECKPOINT; TUMORIGENIC GROWTH; CYCLE REGULATION; EXPRESSION; NIMA; REGULATOR; SURVIVAL	Breast cancer is the most common solid tumor and the second most common cause of death in women. Despite a large body of literature and progress in breast cancer research, many molecular aspects of this complex disease are still poorly understood, hindering the design of specific and effective therapeutic strategies. To identify the molecules important in breast cancer progression and metastasis, we tested the in vivo effects of inhibiting the functions of various kinases and genes involved in the regulation/modulation of the cytoskeleton by downregulating them in mouse PyMT mammary tumor cells and human breast cancer cell lines. These kinases and cytoskeletal regulators were selected based on their prognostic values for breast cancer patient survival. PyMT tumor cells, in which a selected gene was stably knocked down were injected into the tail veins of mice, and the formation of tumors in the lungs was monitored. One of the several genes found to be important for tumor growth in the lungs was NIMA-related kinases 2 (Nek2), a cell cycle-related protein kinase. Furthermore, Nek2 was also important for tumor growth in the mammary fat pad. In various human breast cancer cell lines, Nek2 knockdown induced aneuploidy and cell cycle arrest that led to cell death. Significantly, the breast cancer cell line most sensitive to Nek2 depletion was of the triple negative breast cancer subtype. Our data indicate that Nek2 has a pivotal role in breast cancer growth at primary and secondary sites, and thus may be an attractive and novel therapeutic target for this disease	[Cappello, P.; Blaser, H.; Gorrini, C.; Elia, A. J.; Wakeham, A.; Done, S. J.; Mak, T. W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada; [Cappello, P.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Lin, D. C. C.; Mason, J. M.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, MaRS Ctr, Toronto, ON M5G 2M9, Canada; [Haider, S.; Boutros, P. C.] Ontario Inst Canc Res, Informat & Biocomp Platform, Toronto, ON, Canada; [Miller, N. A.; Youngson, B.; Done, S. J.] Univ Hlth Network, Lab Med Program, Toronto, ON M5G 2M9, Canada; [Miller, N. A.; Youngson, B.; Done, S. J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Turin; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Mak, TW (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, 620 Univ Ave,Suite 706, Toronto, ON M5G 2M9, Canada.	tmak@uhnresearch.ca	Cappello, Paola/J-3127-2018	Cappello, Paola/0000-0002-5321-7794; Done, Susan/0000-0002-1770-988X; Gorrini, Chiara/0000-0002-5239-6671; Boutros, Paul/0000-0003-0553-7520; Youngson, Bruce/0000-0001-6526-8081	Canadian Institutes of Health Research [179815]; Ontario Institute for Cancer Research through Government of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research through Government of Ontario	We thank Dr Mary Saunders for the insightful scientific editing. This work was supported by grant no. 179815 from the Canadian Institutes of Health Research to TWM. This work was also performed with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario.	Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; Dey N, 2012, CURR DRUG TARGETS, V13, P1510, DOI 10.2174/138945012803530116; Di Agostino S, 2002, DEVELOPMENT, V129, P1715; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Ferretti C, 2010, CELL CYCLE, V9, P4174, DOI 10.4161/cc.9.20.13457; Fiskus W, 2012, BREAST CANCER RES TR, V135, P433, DOI 10.1007/s10549-012-2171-9; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gennari A, 2005, CANCER, V104, P1742, DOI 10.1002/cncr.21359; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hayward DG, 2010, J BIOMOL SCREEN, V15, P918, DOI 10.1177/1087057110376537; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Hu KJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3107; Ikui AE, 2005, CELL CYCLE, V4, P1385, DOI 10.4161/cc.4.10.2061; Innocenti P, 2012, J MED CHEM, V55, P3228, DOI 10.1021/jm201683b; Kim YH, 2002, BIOCHEM BIOPH RES CO, V290, P730, DOI 10.1006/bbrc.2001.6212; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Kolodner RD, 2011, SCIENCE, V333, P942, DOI 10.1126/science.1211154; Komatsu M, 2013, INT J ONCOL, V42, P478, DOI 10.3892/ijo.2012.1744; Lee J, 2013, INT J ONCOL, V42, P839, DOI 10.3892/ijo.2013.1788; Liu QD, 2010, EXP MOL PATHOL, V88, P225, DOI 10.1016/j.yexmp.2009.12.004; Loddo M, 2009, BRIT J CANCER, V100, P959, DOI 10.1038/sj.bjc.6604924; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Reddy KB, 2011, CURR ONCOL, V18, pE173; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Romanelli A, 2012, MOL CANCER THER, V11, P2693, DOI 10.1158/1535-7163.MCT-12-0441-T; Shaukat Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047447; Shibata H, 2011, CANCER SCI, V102, P1882, DOI 10.1111/j.1349-7006.2011.02016.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Wang SL, 2012, J CELL BIOCHEM, V113, P1904, DOI 10.1002/jcb.24059; Yunokawa M, 2012, CANCER SCI, V103, P1665, DOI 10.1111/j.1349-7006.2012.02359.x; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001	45	76	79	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2375	2384		10.1038/onc.2013.183	http://dx.doi.org/10.1038/onc.2013.183			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23708664	Green Submitted			2022-12-25	WOS:000335451800010
J	Gottenberg, JE; Seror, R; Miceli-Richard, C; Benessiano, J; Devauchelle-Pensec, V; Dieude, P; Dubost, JJ; Fauchais, AL; Goeb, V; Hachulla, E; Hatron, PY; Larroche, C; Le Guern, V; Morel, J; Perdriger, A; Puechal, X; Rist, S; Saraux, A; Sene, D; Sibilia, J; Vittecoq, O; Nocturne, G; Ravaud, P; Mariette, X				Gottenberg, Jacques-Eric; Seror, Raphaele; Miceli-Richard, Corinne; Benessiano, Joelle; Devauchelle-Pensec, Valerie; Dieude, Philippe; Dubost, Jean-Jacques; Fauchais, Anne-Laure; Goeb, Vincent; Hachulla, Eric; Hatron, Pierre Yves; Larroche, Claire; Le Guern, Veronique; Morel, Jacques; Perdriger, Aleth; Puechal, Xavier; Rist, Stephanie; Saraux, Alain; Sene, Damien; Sibilia, Jean; Vittecoq, Olivier; Nocturne, Gaetane; Ravaud, Philippe; Mariette, Xavier			Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjogren's Syndrome. Data at Enrollment in the Prospective ASSESS Cohort	PLOS ONE			English	Article							CELL-ACTIVATING FACTOR; B-LYMPHOCYTE STIMULATOR; RHEUMATOID-ARTHRITIS; RITUXIMAB TREATMENT; CIRCULATING LEVELS; INCREASED RISK; FACTOR GENE; BAFF; EXPRESSION; MICROGLOBULIN	Objectives: To analyze the clinical and immunological characteristics at enrollment in a large prospective cohort of patients with primary Sjogren's syndrome (pSS) and to investigate the association between serum BAFF, beta2-microglobulin and free light chains of immunoglobulins and systemic disease activity at enrollment. Methods: Three hundred and ninety five patients with pSS according to American-European Consensus Criteria were included from fifteen centers of Rheumatology and Internal Medicine in the "Assessment of Systemic Signs and Evolution of Sjogren's Syndrome'' (ASSESS) 5-year prospective cohort. At enrollment, serum markers were assessed as well as activity of the disease measured with the EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI). Results: Patient median age was 58 (25th-75th : 51-67) and median disease duration was 5 (2-9) years. Median ESSDAI at enrollment was 2 (0-7) with 30.9% of patients having features of systemic involvement. Patients with elevated BAFF, beta2-microglobulin and kappa, lambda FLCS had higher ESSDAI scores at enrollment (4 [2-11] vs 2 [0-7], P = 0.03; 4 [1-11] vs 2 [0-7], P< 0.0001); 4 [2-10] vs 2 [0-6.6], P< 0.0001 and 4 [2-8.2] vs 2 [0-7.0], P = 0.02, respectively). In multivariate analysis, increased beta2-microglobulin, kappa and lambda FLCs were associated with a higher ESSDAI score. Median BAFF and beta2-microglobulin were higher in the 16 patients with history of lymphoma (1173.3(873.1-3665.5) vs 898.9 (715.9-1187.2) pg/ml, P = 0.01 and 2.6 (2.2-2.9) vs 2.1 (1.8-2.6) mg/l, P = 0.04, respectively). Conclusion: In pSS, higher levels of beta2-microglobulin and free light chains of immunoglobulins are associated with increased systemic disease activity.	[Gottenberg, Jacques-Eric; Sibilia, Jean] Univ Strasbourg, Rheumatol Ctr Natl Reference Malad Autoimmunes Ra, INSERM, UMRS Federat Med Translat Strasbourg 1109,Strasbo, Strasbourg, France; [Seror, Raphaele; Miceli-Richard, Corinne; Nocturne, Gaetane; Mariette, Xavier] Univ Paris 11, Hop Bicetre, Assistance Publ Hop Paris, INSERM,U1012, Paris, France; [Benessiano, Joelle] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Ctr Ressources Biol, F-75877 Paris, France; [Devauchelle-Pensec, Valerie; Saraux, Alain] Brest Univ Hosp, Brest, France; [Dieude, Philippe] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, F-75877 Paris, France; [Dubost, Jean-Jacques] Clermont Ferrand Hosp, Clermont Ferrand, France; [Fauchais, Anne-Laure] Limoges Hosp, Limoges, France; [Goeb, Vincent] Amiens Univ Hosp, Amiens, France; [Hachulla, Eric; Hatron, Pierre Yves] Lille Univ Hosp, Lille, France; [Larroche, Claire] Hop Avicenne, Assistance Publ Hop Paris, F-93009 Bobigny, France; [Le Guern, Veronique; Puechal, Xavier] Hop Cochin, Assistance Publ Hop Paris, F-75674 Paris, France; [Morel, Jacques] Montpellier Univ Hosp, Montpellier, France; [Perdriger, Aleth] Rennes Univ Hosp, Rennes, France; [Rist, Stephanie] Orleans Hosp, Orleans, France; [Sene, Damien] Hop Lariboisiere, Assistance Publ Hop Paris, F-75475 Paris, France; [Vittecoq, Olivier] Rouen Univ Hosp, Rouen, France; [Ravaud, Philippe] Univ Paris 05, Hotel Dieu Hosp, Assistance Publ Hop Paris, INSERM,U378,Ctr Clin Epidemiol,Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU Limoges; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; CHU Rennes; Universite de Rennes; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Gottenberg, JE (corresponding author), Univ Strasbourg, Rheumatol Ctr Natl Reference Malad Autoimmunes Ra, INSERM, UMRS Federat Med Translat Strasbourg 1109,Strasbo, Strasbourg, France.	jacques-eric.gottenberg@chru-strasbourg.fr; xavier.mariette@bct.aphp.fr	Puéchal, Xavier/P-1555-2017; SEROR, Raphaele/E-2283-2017; ravaud, philippe/C-1694-2009; sene, damien/R-3970-2017; HACHULLA, ERIC/R-8488-2018	Puéchal, Xavier/0000-0003-3573-9203; SEROR, Raphaele/0000-0002-5523-1856; sene, damien/0000-0001-8640-4580; HACHULLA, ERIC/0000-0001-7432-847X; Ravaud, Philippe/0000-0001-8264-9206; Nocturne, Gaetane/0000-0001-6809-0733; Dieude, Philippe/0000-0002-4814-0307; Fauchais, Anne Laure/0000-0002-0489-8570; Goeb, Vincent/0000-0002-3807-545X; Sibilia, Jean/0000-0002-1601-4795	French Society of Rheumatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060804] Funding Source: NIH RePORTER	French Society of Rheumatology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The French Society of Rheumatology provided a grant to the cohort. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P723, DOI 10.1002/art.21650; Candon S, 2009, ANN RHEUM DIS, V68, P1208, DOI 10.1136/ard.2008.095257; Emmerich F, 2007, BRIT J HAEMATOL, V136, P309, DOI 10.1111/j.1365-2141.2006.06431.x; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gottenberg JE, 2007, ANN RHEUM DIS, V66, P23, DOI 10.1136/ard.2006.052159; Gottenberg JE, 2012, CURR PHARM BIOTECHNO, V13, P2022, DOI 10.2174/138920112802273128; Gottenberg JE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1884; Gottenberg JE, 2005, ANN RHEUM DIS, V64, P1050, DOI 10.1136/ard.2004.030643; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Gragnani L, 2011, ARTHRITIS RHEUM-US, V63, P1446, DOI 10.1002/art.30274; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Lavie F, 2008, SCAND J IMMUNOL, V67, P185, DOI 10.1111/j.1365-3083.2007.02049.x; Lavie F, 2007, ANN RHEUM DIS, V66, P700, DOI 10.1136/ard.2006.060772; Mackaya F, 2007, CURR OPIN RHEUMATOL, V19, P406, DOI 10.1097/BOR.0b013e328277ef4c; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Mariette X, 2010, CURR OPIN RHEUMATOL, V22, P471, DOI 10.1097/BOR.0b013e32833c36c5; MICHALSKI JP, 1975, NEW ENGL J MED, V293, P1228, DOI 10.1056/NEJM197512112932404; MOUTSOPOULOS HM, 1983, J IMMUNOL, V130, P2663; Nossent JC, 2008, RHEUMATOLOGY, V47, P1311, DOI 10.1093/rheumatology/ken246; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Novak AJ, 2004, BLOOD, V104, P2247, DOI 10.1182/blood-2004-02-0762; Novak AJ, 2009, CANCER RES, V69, P4217, DOI 10.1158/0008-5472.CAN-08-4915; Pers JO, 2007, ARTHRITIS RHEUM, V56, P1464, DOI 10.1002/art.22603; Pertovaara M, 2011, ANN RHEUM DIS, V70, P2236, DOI 10.1136/ard.2011.153098; Quartuccio L, 2012, RHEUMATOLOGY     AUG; Sellam J, 2007, ANN RHEUM DIS, V66, P790, DOI 10.1136/ard.2006.065656; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2011, ANN RHEUM DIS, V70, P880, DOI 10.1136/2009.110619corr1; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Tzioufas AG, 1996, ARTHRITIS RHEUM, V39, P767, DOI 10.1002/art.1780390508; Voulgarelis M, 2008, RHEUM DIS CLIN N AM, V34, P921, DOI 10.1016/j.rdc.2008.08.006	34	126	129	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e59868	10.1371/journal.pone.0059868	http://dx.doi.org/10.1371/journal.pone.0059868			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717383	gold, Green Submitted, Green Published			2022-12-25	WOS:000319385300043
J	Escaramis, G; Tornador, C; Bassaganyas, L; Rabionet, R; Tubio, JMC; Martinez-Fundichely, A; Caceres, M; Gut, M; Ossowski, S; Estivill, X				Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Gut, Marta; Ossowski, Stephan; Estivill, Xavier			PeSV-Fisher: Identification of Somatic and Non-Somatic Structural Variants Using Next Generation Sequencing Data	PLOS ONE			English	Article							COPY NUMBER VARIATION; COMBINATORIAL ALGORITHMS; READ ALIGNMENT; GENOME; CHROMOTHRIPSIS; REARRANGEMENTS; INSERTIONS	Next-generation sequencing technologies expedited research to develop efficient computational tools for the identification of structural variants (SVs) and their use to study human diseases. As deeper data is obtained, the existence of higher complexity SVs in some genomes becomes more evident, but the detection and definition of most of these complex rearrangements is still in its infancy. The full characterization of SVs is a key aspect for discovering their biological implications. Here we present a pipeline (PeSV-Fisher) for the detection of deletions, gains, intra- and inter-chromosomal translocations, and inversions, at very reasonable computational costs. We further provide comprehensive information on co-localization of SVs in the genome, a crucial aspect for studying their biological consequences. The algorithm uses a combination of methods based on paired-reads and read-depth strategies. PeSV-Fisher has been designed with the aim to facilitate identification of somatic variation, and, as such, it is capable of analysing two or more samples simultaneously, producing a list of non-shared variants between samples. We tested PeSV-Fisher on available sequencing data, and compared its behaviour to that of frequently deployed tools (BreakDancer and VariationHunter). We have also tested this algorithm on our own sequencing data, obtained from a tumour and a normal blood sample of a patient with chronic lymphocytic leukaemia, on which we have also validated the results by targeted re-sequencing of different kinds of predictions. This allowed us to determine confidence parameters that influence the reliability of breakpoint predictions.	[Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Estivill, Xavier] Ctr Genom Regulat CRG, Genet Causes Dis Grp, Barcelona, Spain; [Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Ossowski, Stephan; Estivill, Xavier] UPF, Barcelona, Spain; [Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Escaramis, Georgia; Tornador, Cristian; Bassaganyas, Laia; Rabionet, Raquel; Tubio, Jose M. C.; Martinez-Fundichely, Alexander; Caceres, Mario; Ossowski, Stephan; Estivill, Xavier] Hosp Mar Med Res Inst IMIM, Barcelona, Spain; [Martinez-Fundichely, Alexander] CHUS, Galician Fdn Genom Med SERGAS, Santiago De Compostela, Spain; [Martinez-Fundichely, Alexander; Caceres, Mario] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [Caceres, Mario] ICREA, Barcelona, Spain; [Gut, Marta] Natl Ctr Genom Anal CNAG CRG, Barcelona, Spain; [Ossowski, Stephan] CRG, Genom & Epigen Variat Dis Grp, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Complexo Hospitalario Universitario de Santiago de Compostela; Autonomous University of Barcelona; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Estivill, X (corresponding author), Ctr Genom Regulat CRG, Genet Causes Dis Grp, Barcelona, Spain.	xavier.estivill@crg.eu	Tubio, Jose M.C./H-5076-2015; Estivill, Xavier/A-3125-2013; rabionet, raquel/A-7407-2009; Tornador, Cristian/S-2197-2018; Ossowski, Stephan/E-2139-2011; Escaramis, Georgia/B-2997-2015; Rabionet, Raquel/C-8379-2009; Cáceres, Mario/A-6379-2009; Escaramis, Georgia/AAR-5586-2020; Martinez-Fundichely, Alexander/AAR-7309-2020	Tubio, Jose M.C./0000-0003-3540-2459; Estivill, Xavier/0000-0002-0723-2256; rabionet, raquel/0000-0001-5006-8140; Tornador, Cristian/0000-0002-6437-9270; Ossowski, Stephan/0000-0002-7416-9568; Escaramis, Georgia/0000-0002-5416-3177; Rabionet, Raquel/0000-0001-5006-8140; Cáceres, Mario/0000-0002-7736-3251; Martinez-Fundichely, Alexander/0000-0002-7660-5511; BASSAGANYAS, LAIA/0000-0002-4575-0214	AGAUR (Generalitat de Catalunya) [2009 SGR 1502]; CIBERESP (Instituto de Salud Carlos III); ESGI (European Commission) [262055_ESGI]; ENGAGE (European Commission) [ENGAGE_201413]; TECHGENE (European Commission) [TECHGENE_223143]; GEUVADIS (European Commission) [261123_GEUVADIS]; NOVADIS (Ministerio de Ciencia y Technologia) [SAF2008-00357]; Galicia Government Xunta de Galicia (Spain) [10PXIB918057]; MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperacion, Spain); Ramon y Cajal (Ministerio de Educacion y Ciencia) [BFU2007-60930]; ICREA Funding Source: Custom	AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); CIBERESP (Instituto de Salud Carlos III); ESGI (European Commission); ENGAGE (European Commission); TECHGENE (European Commission); GEUVADIS (European Commission); NOVADIS (Ministerio de Ciencia y Technologia); Galicia Government Xunta de Galicia (Spain); MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperacion, Spain); Ramon y Cajal (Ministerio de Educacion y Ciencia)(Spanish Government); ICREA(ICREA)	This work was supported by AGAUR (Generalitat de Catalunya, 2009 SGR 1502) (X.E.); CIBERESP (Instituto de Salud Carlos III) (G.E.); ESGI (European Commission, 262055_ESGI) (R.R., X.E.), ENGAGE (European Commission, ENGAGE_201413), TECHGENE (European Commission, TECHGENE_223143), and GEUVADIS (European Commission, 261123_GEUVADIS) (X.E.); NOVADIS (Ministerio de Ciencia y Technologia, SAF2008-00357) (X.E.); Galicia Government Xunta de Galicia (Spain) through the project number 10PXIB918057 (J.M.C.T.); MAEC-AEC1 Predoctoral Fellowship (Ministerio de Asuntos Exteriores y Cooperacion, Spain) (A.M.F.); and Ramon y Cajal position and grant BFU2007-60930 (Ministerio de Educacion y Ciencia) (M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Hormozdiari F, 2010, BIOINFORMATICS, V26, pi350, DOI 10.1093/bioinformatics/btq216; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; MARCOSOLA S, 2012, NAT METHODS; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Qi J, 2011, NUCLEIC ACIDS RES, V39, pW567, DOI 10.1093/nar/gkr506; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sindi SS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r22; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wong K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r128; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	44	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63377	10.1371/journal.pone.0063377	http://dx.doi.org/10.1371/journal.pone.0063377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704902	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200031
J	Hruschka, DJ; Henrich, J				Hruschka, Daniel J.; Henrich, Joseph			Institutions, Parasites and the Persistence of In-group Preferences	PLOS ONE			English	Article							INTERGROUP BIAS; ORIGINS; CULTURE; SELF; COLLECTIVISM; UNCERTAINTY; PREVALENCE; CORRUPTION; EVOLUTION; EXCHANGE	Much research has established reliable cross-population differences in motivations to invest in one's in-group. We compare two current historical-evolutionary hypotheses for this variation based on (1) effective large-scale institutions and (2) pathogen threats by analyzing cross-national differences (N = 122) in in-group preferences measured in three ways. We find that the effectiveness of government institutions correlates with favoring in-group members, even when controlling for pathogen stress and world region, assessing reverse causality, and providing a check on endogeneity with an instrumental variable analysis. Conversely, pathogen stress shows inconsistent associations with in-group favoritism when controlling for government effectiveness. Moreover, pathogen stress shows little to no association with in-group favoritism within major world regions whereas government effectiveness does. These results suggest that variation in in-group preferences across contemporary nation-states is more consistent with a generalized response to institutions that meet basic needs rather than an evolved response dedicated to pathogens.	[Hruschka, Daniel J.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Henrich, Joseph] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Henrich, Joseph] Univ British Columbia, Dept Econ, Vancouver, BC V6T 1W5, Canada	Arizona State University; Arizona State University-Tempe; University of British Columbia; University of British Columbia	Hruschka, DJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	dhruschk@asu.edu			National Science Foundation [BCS-1150813]; Program in Cultural Anthropology; Program in Social Psychology Program; Program in Decision, Risk, and Management Sciences; University of Chicago; Templeton Foundation New Science of Virtues Grant; Canadian Institute For Advanced Research (CIFAR)	National Science Foundation(National Science Foundation (NSF)); Program in Cultural Anthropology; Program in Social Psychology Program; Program in Decision, Risk, and Management Sciences; University of Chicago(University of Chicago); Templeton Foundation New Science of Virtues Grant; Canadian Institute For Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR))	DJH acknowledges support from the National Science Foundation grant BCS-1150813, jointly funded by the Programs in Cultural Anthropology, Social Psychology Program and Decision, Risk, and Management Sciences, as well as support from the University of Chicago and Templeton Foundation New Science of Virtues Grant. JH acknowledges support from the Canadian Institute For Advanced Research (CIFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Alesina A., 2004, FIGHTING POVERTY US; Alesina A, 2010, J ECON GROWTH, V15, P93, DOI 10.1007/s10887-010-9052-z; Algan Y, 2010, AM ECON REV, V100, P2060, DOI 10.1257/aer.100.5.2060; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Currie TE, 2012, BEHAV BRAIN SCI, V35, P83, DOI 10.1017/S0140525X11000963; de Barra M, 2012, BEHAV BRAIN SCI, V35, P85, DOI 10.1017/S0140525X11000975; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P99, DOI 10.1017/S0140525X11001774; Fisman R, 2007, J POLIT ECON, V115, P1020, DOI 10.1086/527495; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; GEERTZ C, 1978, AM ECON REV, V68, P28; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Gelman A., 2007, DATA ANAL USING REGR; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Guiso L, 2006, J ECON PERSPECT, V20, P23, DOI 10.1257/jep.20.2.23; Hackman J, 2013, EVOLUTION HUMAN BEHA; HAMPDENTURNER CM, 2000, BUILDING CROSS CULTU; Heine S.J., 2008, CULTURAL PSYCHOL; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Hofstede G., 2016, CULTURES CONSEQUENCE, V34, P108; Hohman ZP, 2011, EUR J SOC PSYCHOL, V41, P751, DOI 10.1002/ejsp.818; House Robert., 2004, CULTURE LEADERSHIP; Hruschka D. J., 2010, FRIENDSHIP DEV ECOLO; Inglehart R., 2004, HUMAN BELIEFS VALUES; Johnson S, 2011, HITHER THOU SHALT CO; Kaplan H.S., 2005, MORAL SENTIMENTS MAT, P75; Kaplan HS, 2012, P ROYAL SOC B; KOLLOCK P, 1994, AM J SOCIOL, V100, P313, DOI 10.1086/230539; Kranton RE, 1996, AM ECON REV, V86, P830; LIPSET S, 2000, CULTURE MATTERS VALU; Lomnitz Larissa, 1977, NETWORKS MARGINALITY; Lopez-Claros A, 2005, GLOBAL COMPETITIVENE; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; McNeill William H., 1977, PLAGUES PEOPLES; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P97, DOI 10.1037//0022-3514.81.1.97; MILLER JG, 1992, J PERS SOC PSYCHOL, V62, P541, DOI 10.1037/0022-3514.62.4.541; Murray DR, 2010, J CROSS CULT PSYCHOL, V41, P99, DOI 10.1177/0022022109349510; Navarrete CD, 2004, GROUP PROCESS INTERG, V7, P370, DOI 10.1177/1368430204046144; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norris Pippa, 2004, SACRED SECULAR RELIG; Proulx T, 2010, SOC PERSONAL PSYCHOL, V4, P889, DOI 10.1111/j.1751-9004.2010.00304.x; Realo A, 2008, J CROSS CULT PSYCHOL, V39, P447, DOI 10.1177/0022022108318096; Sachs J.D., 2003, I DONT RULE DIRECT E; Schaller M, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P1; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Schwartz S. H., 2009, QUOD ERAT DEMONSTRAN, P1; Sugiyama LS, 2004, AM J PHYS ANTHROPOL, V123, P371, DOI 10.1002/ajpa.10325; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; Triandis H.C., 2018, INDIVIDUALISM COLLEC, DOI [10.4324/9780429499845, DOI 10.4324/9780429499845]; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Trompenaars F., 1998, RIDING WAVES; Van de Vliert E, 2012, BEHAV BRAIN SCI, V35, P94, DOI 10.1017/S0140525X11001075; Van de Vliert E, 2011, J CROSS CULT PSYCHOL, V42, P494, DOI 10.1177/0022022110381120; Weber Max., 1951, RELIG CHINA CONFUCIA; World Bank, 2011, WORLD BANK IND; World Bank, 2011, WORLD BANK GOV IND	62	63	64	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63642	10.1371/journal.pone.0063642	http://dx.doi.org/10.1371/journal.pone.0063642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704926	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200057
J	Lamoureux, L; Simon, SLR; Plews, M; Ruddat, V; Brunet, S; Graham, C; Czub, S; Knox, JD				Lamoureux, Lise; Simon, Sharon L. R.; Plews, Margot; Ruddat, Viola; Brunet, Simone; Graham, Catherine; Czub, Stefanie; Knox, J. David			Urine Proteins Identified by Two-Dimensional Differential Gel Electrophoresis Facilitate the Differential Diagnoses of Scrapie	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; QUAKING-INDUCED CONVERSION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PRION PROTEIN; TRANSTHYRETIN AMYLOIDOSIS; PLASMINOGEN-ACTIVATOR; EXPERIMENTAL-DESIGN; EXPRESSION; MICE	The difficulty in developing a diagnostic assay for Creutzfeldt - Jakob disease (CJD) and other transmissible spongiform encephalopathies (TSEs) stems in part from the fact that the infectious agent is an aberrantly folded form of an endogenous cellular protein. This precludes the use of the powerful gene based technologies currently applied to the direct detection of other infectious agents. To circumvent this problem our research objective has been to identify a set of proteins exhibiting characteristic differential abundance in response to TSE infection. The objective of the present study was to assess the disease specificity of differentially abundant urine proteins able to identify scrapie infected mice. Two-dimensional differential gel electrophoresis was used to analyze longitudinal collections of urine samples from both prion-infected mice and a transgenic mouse model of Alzheimer's disease. The introduction of fluorescent dyes, that allow multiple samples to be co-resolved and visualized on one two dimensional gel, have increased the accuracy of this methodology for the discovery of robust protein biomarkers for disease. The accuracy of a small panel of differentially abundant proteins to correctly classify an independent naive sample set was determined. The results demonstrated that at the time of clinical presentation the differential abundance of urine proteins were capable of identifying the prion infected mice with 87% sensitivity and 93% specificity. The identity of the diagnostic differentially abundant proteins was investigated by mass spectrometry.	[Lamoureux, Lise; Simon, Sharon L. R.; Plews, Margot; Brunet, Simone; Knox, J. David] Publ Hlth Agcy Canada, Prion Lab Serv Sect, Winnipeg, MB, Canada; [Graham, Catherine; Czub, Stefanie] Canadian Food Inspect Agcy, Natl Anim Dis Ctr, Lethbridge, AB, Canada; [Ruddat, Viola] GE Healthcare, San Francisco, CA USA; [Knox, J. David] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; Canadian Food Inspection Agency; General Electric; University of Manitoba	Knox, JD (corresponding author), Publ Hlth Agcy Canada, Prion Lab Serv Sect, Winnipeg, MB, Canada.	david.knox@phac-aspc.gc.ca			Public Health Agency of Canada; Alberta Prion Research Institute	Public Health Agency of Canada; Alberta Prion Research Institute	The work was supported by the Public Health Agency of Canada and the Alberta Prion Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Basora N, 2010, EXP CELL RES, V316, P1454, DOI 10.1016/j.yexcr.2010.02.033; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Carriero MV, 2009, FRONT BIOSCI-LANDMRK, V14, P3782, DOI [10.2735/3488, 10.2741/3488]; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Cepek L, 2007, DEMENT GERIATR COGN, V23, P22, DOI 10.1159/000096589; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; de Bruin A, 2007, EXP DERMATOL, V16, P468, DOI 10.1111/j.1600-0625.2007.00557.x; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Ferone G, 2013, HUM MOL GENET, V22, P531, DOI 10.1093/hmg/dds464; Friedman David B, 2007, Methods Mol Biol, V367, P219; Gmitterova K, 2009, NEURODEGENER DIS, V6, P263, DOI 10.1159/000237221; Gmitterova K, 2009, NEUROBIOL AGING, V30, P1842, DOI 10.1016/j.neurobiolaging.2008.01.007; Han SH, 2011, J ALZHEIMERS DIS, V25, P77, DOI 10.3233/JAD-2011-102145; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Li XY, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-79; Li XY, 2011, J NEUROSCI, V31, P12483, DOI 10.1523/JNEUROSCI.2417-11.2011; Lobato L, 2012, CLIN J AM SOC NEPHRO, V7, P1337, DOI 10.2215/CJN.08720811; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Love S, 2011, J CELL MOL MED; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Mori K, 2002, ARCH HISTOL CYTOL, V65, P359, DOI 10.1679/aohc.65.359; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Olivry T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032072; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden AH, 2012, J GEN VIROL, V93, P438, DOI 10.1099/vir.0.033365-0; Plews M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-6; Plews M, 2010, FREE RADICAL BIO MED, V49, P1417, DOI 10.1016/j.freeradbiomed.2010.07.025; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; Rocha A, 2011, TRANSPL P, V43, P189, DOI 10.1016/j.transproceed.2010.11.014; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sanchez D, 2002, MECH DEVELOP, V117, P293, DOI 10.1016/S0925-4773(02)00202-2; Schauer-Vukasinovic V, 2001, Biochim Biophys Acta, V1524, P51; Sheehan JJ, 2007, J NEUROSCI, V27, P1738, DOI 10.1523/JNEUROSCI.4987-06.2007; Simon SLR, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-23; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016804; Skrzypiec AE, 2009, BIOL PSYCHIAT, V66, P785, DOI 10.1016/j.biopsych.2009.05.021; Steinacker P, 2010, J ALZHEIMERS DIS, V22, P119, DOI 10.3233/JAD-2010-100030; Suzuki M, 2002, J BIOL CHEM, V277, P8022, DOI 10.1074/jbc.M108545200; Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	49	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64044	10.1371/journal.pone.0064044	http://dx.doi.org/10.1371/journal.pone.0064044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704971	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200109
J	Yasukawa, A; Hosoki, K; Toda, M; Miyake, Y; Matsushima, Y; Matsumoto, T; Boveda-Ruiz, D; Gil-Bernabe, P; Nagao, M; Sugimoto, M; Hiraguchi, Y; Tokuda, R; Naito, M; Takagi, T; D'Alessandro-Gabazza, CN; Suga, S; Kobayashi, T; Fujisawa, T; Taguchi, O; Gabazza, EC				Yasukawa, Atsushi; Hosoki, Koa; Toda, Masaaki; Miyake, Yasushi; Matsushima, Yuki; Matsumoto, Takahiro; Boveda-Ruiz, Daniel; Gil-Bernabe, Paloma; Nagao, Mizuho; Sugimoto, Mayumi; Hiraguchi, Yukiko; Tokuda, Reiko; Naito, Masahiro; Takagi, Takehiro; D'Alessandro-Gabazza, Corina N.; Suga, Shigeru; Kobayashi, Tetsu; Fujisawa, Takao; Taguchi, Osamu; Gabazza, Esteban C.			Eosinophils Promote Epithelial to Mesenchymal Transition of Bronchial Epithelial Cells	PLOS ONE			English	Article							TGF-BETA; SUBEPITHELIAL FIBROSIS; PULMONARY-FIBROSIS; ASTHMA; MECHANISMS; EXPRESSION; DISEASE; PROTEIN; MOUSE; MICE	Eosinophilic inflammation and remodeling of the airways including subepithelial fibrosis and myofibroblast hyperplasia are characteristic pathological findings of bronchial asthma. Epithelial to mesenchymal transition (EMT) plays a critical role in airway remodelling. In this study, we hypothesized that infiltrating eosinophils promote airway remodelling in bronchial asthma. To demonstrate this hypothesis we evaluated the effect of eosinophils on EMT by in vitro and in vivo studies. EMT was assessed in mice that received intra-tracheal instillation of mouse bone marrow derived eosinophils and in human bronchial epithelial cells co-cultured with eosinophils freshly purified from healthy individuals or with eosinophilic leukemia cell lines. Intra-tracheal instillation of eosinophils was associated with enhanced bronchial inflammation and fibrosis and increased lung concentration of growth factors. Mice instilled with eosinophils pre-treated with transforming growth factor(TGF)-beta 1 siRNA had decreased bronchial wall fibrosis compared to controls. EMT was induced in bronchial epithelial cells co-cultured with human eosinophils and it was associated with increased expression of TGF-beta 1 and Smad3 phosphorylation in the bronchial epithelial cells. Treatment with anti-TGF-beta 1 antibody blocked EMT in bronchial epithelial cells. Eosinophils induced EMT in bronchial epithelial cells, suggesting their contribution to the pathogenesis of airway remodelling.	[Yasukawa, Atsushi; Hosoki, Koa; Toda, Masaaki; Miyake, Yasushi; Matsushima, Yuki; Matsumoto, Takahiro; Boveda-Ruiz, Daniel; Gil-Bernabe, Paloma; D'Alessandro-Gabazza, Corina N.; Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan; [Naito, Masahiro; Takagi, Takehiro; Kobayashi, Tetsu; Taguchi, Osamu] Mie Univ, Grad Sch Med, Dept Pulm & Crit Care Med, Tsu, Mie 514, Japan; [Hosoki, Koa; Nagao, Mizuho; Sugimoto, Mayumi; Hiraguchi, Yukiko; Tokuda, Reiko; Suga, Shigeru; Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan	Mie University; Mie University	Gabazza, EC (corresponding author), Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan.	gabazza@clin.medic.mie-u.ac.jp	Suga, Shigeru/GPK-7811-2022	Gabazza, Esteban/0000-0001-5748-1499; Hosoki, Koa/0000-0003-4228-2176	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Burt AD, LIVER TRANSPL, V16, P567; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cho JY, KOREAN J INTERN MED, V26, P367; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Fujisawa T, 2000, J ALLERGY CLIN IMMUN, V106, P507; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hamasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042655; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kariyawasam HH, 2007, CURR OPIN IMMUNOL, V19, P681, DOI 10.1016/j.coi.2007.07.021; Koller DY, 1997, J ALLERGY CLIN IMMUN, V99, P752, DOI 10.1016/S0091-6749(97)80007-3; Lan HY, INT J BIOL SCI, V7, P1056; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Ma KL, J CELL BIOCH, V112, P1585; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; ROCHE WR, 1989, LANCET, V1, P520; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945; Takagi T, AM J RESP CELL MOL B, V46, P397; Takagi T, 2011, AM J RESP CRIT CARE, V183, P31, DOI 10.1164/rccm.201001-0107OC; Venge P, 2010, CLIN RESPIR J, V4, P15, DOI 10.1111/j.1752-699X.2010.00192.x; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yasui H, 2001, AM J RESP CRIT CARE, V163, P1660, DOI 10.1164/ajrccm.163.7.9911068; Yokote K, 2006, TRENDS CARDIOVAS MED, V16, P240, DOI 10.1016/j.tcm.2006.04.005	38	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64281	10.1371/journal.pone.0064281	http://dx.doi.org/10.1371/journal.pone.0064281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700468	Green Published, Green Submitted			2022-12-25	WOS:000319330200130
J	Zhao, HM; Karman, J; Jiang, JL; Zhang, JH; Gumlaw, N; Lydon, J; Zhou, Q; Qiu, HW; Jiang, CW; Cheng, SH; Zhu, YX				Zhao, Hongmei; Karman, Jozsef; Jiang, Ji-Lei; Zhang, Jinhua; Gumlaw, Nathan; Lydon, John; Zhou, Qun; Qiu, Huawei; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang			A Bispecific Protein Capable of Engaging CTLA-4 and MHCII Protects Non-Obese Diabetic Mice from Autoimmune Diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; GROWTH-FACTOR-BETA; NOD MOUSE; TGF-BETA; DENDRITIC CELLS; NEGATIVE REGULATOR; POTENTIAL ROLE; CUTTING EDGE	Crosslinking ligand-engaged cytotoxic T lymphocyte antigen-4 (CTLA-4) to the T cell receptor (TCR) with a bispecific fusion protein (BsB) comprised of a mutant mouse CD80 and lymphocyte activation antigen-3 (LAG-3) has been shown to attenuate TCR signaling and to direct T-cell differentiation toward Foxp(3+) regulatory T cells (Tregs) in an allogenic mixed lymphocyte reaction (MLR). Here, we show that antigen-specific Tregs can also be induced in an antigen-specific setting in vitro. Treatment of non-obese diabetic (NOD) female mice between 9-12 weeks of age with a short course of BsB elicited a transient increase of Tregs in the blood and moderately delayed the onset of autoimmune type 1 diabetes (T1D). However, a longer course of treatment (10 weeks) of 4-13 weeks-old female NOD animals with BsB significantly delayed the onset of disease or protected animals from developing diabetes, with only 13% of treated animals developing diabetes by 35 weeks of age compared to 80% of the animals in the control group. Histopathological analysis of the pancreata of the BsB-treated mice that remained non-diabetic revealed the preservation of insulin-producing beta-cells despite the presence of different degrees of insulitis. Thus, a bifunctional protein capable of engaging CTLA-4 and MHCII and indirectly co-ligating CTLA-4 to the TCR protected NOD mice from developing T1D.	[Zhao, Hongmei; Karman, Jozsef; Jiang, Ji-Lei; Zhang, Jinhua; Gumlaw, Nathan; Lydon, John; Zhou, Qun; Qiu, Huawei; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Zhu, YX (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	yunxiang.zhu@genzyme.com	zhou, qun/AAU-7592-2020; Cheng, Seng H/AAC-6564-2022	zhou, qun/0000-0001-6271-3143; 	Genzyme Corporation, a Sanofi Company	Genzyme Corporation, a Sanofi Company	The work is entirely funded by Genzyme Corporation, a Sanofi Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andre-Schmutz I, 1999, EUR J IMMUNOL, V29, P245, DOI 10.1002/(SICI)1521-4141(199901)29:01<245::AID-IMMU245>3.3.CO;2-F; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Baroja ML, 2002, J IMMUNOL, V168, P5070, DOI 10.4049/jimmunol.168.10.5070; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blair PJ, 1998, J IMMUNOL, V160, P12; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Fife BT, 2006, J CLIN INVEST, V116, P2252, DOI 10.1172/JCI27856; Gonzalez-Rey E, 2006, ARTHRITIS RHEUM-US, V54, P864, DOI 10.1002/art.21652; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Karman J, 2012, J BIOL CHEM, V287, P11098, DOI 10.1074/jbc.M111.283705; Kastner L, 2010, J IMMUNOL, V185, P5778, DOI 10.4049/jimmunol.0901948; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Lee MH, 2010, J IMMUNOL, V185, P2493, DOI 10.4049/jimmunol.1001036; Leiter Edward H, 2001, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1509s24; Linsley PS, 1996, CURR BIOL, V6, P398, DOI 10.1016/S0960-9822(02)00506-7; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; McDevitt H, 1996, HORM METAB RES, V28, P287, DOI 10.1055/s-2007-979794; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Ohata J, 2007, ARTHRITIS RHEUM, V56, P2947, DOI 10.1002/art.22846; Onodera T, 2009, J IMMUNOL, V183, P5608, DOI 10.4049/jimmunol.0804116; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; Qu HQ, 2009, GENES IMMUN, V10, pS27, DOI 10.1038/gene.2009.88; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zhou Q, 2011, BIOCONJUGATE CHEM, V22, P741, DOI 10.1021/bc1005416	66	3	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63530	10.1371/journal.pone.0063530	http://dx.doi.org/10.1371/journal.pone.0063530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704916	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200047
J	McKuen, MJ; Dahl, G; Fields, KA				McKuen, Mary J.; Dahl, Gerhard; Fields, Kenneth A.			Assessing a Potential Role of Host Pannexin 1 during Chlamydia trachomatis Infection	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; INFLAMMASOME; INCLUSION; MEMBRANE; ATP; ACTIVATION; CHANNELS; CELLS; INHIBITION; EXPRESSION	Pannexin 1 (Panx1) is a plasma membrane channel glycoprotein that plays a role in innate immune response through association with the inflammasome complex. Probenecid, a classic pharmacological agent for gout, has also been used historically in combination therapy with antibiotics to prevent cellular drug efflux and has been reported to inhibit Panx1. As the inflammasome has been implicated in the progression of Chlamydia infections, and with chlamydial infections at record levels in the US, we therefore investigated whether probenecid would have a direct effect on Chlamydia trachomatis development through inhibition of Panx1. We found chlamydial development to be inhibited in a dose-dependent, yet reversible manner in the presence of probenecid. Drug treatment induced an aberrant chlamydial morphology consistent with persistent bodies. Although Panx1 was shown to localize to the chlamydial inclusion, no difference was seen in chlamydial development during infection of cells derived from wild-type and Panx1 knockout mice. Therefore, probenecid may inhibit C. trachomatis growth by an as yet unresolved mechanism.	[McKuen, Mary J.; Fields, Kenneth A.] Univ Miami, Miller Sch Med, Dept Microbiol, Miami, FL 33136 USA; [McKuen, Mary J.; Fields, Kenneth A.] Univ Miami, Miller Sch Med, Dept Immunol, Miami, FL 33136 USA; [Dahl, Gerhard] Univ Miami, Miller Sch Med, Dept Physiol, Miami, FL 33136 USA; [Dahl, Gerhard] Univ Miami, Miller Sch Med, Dept Biophys, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Fields, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol, Miami, FL 33136 USA.	Kfields@med.miami.edu			National Institutes of Health, NIAID [AI065530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065530] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KAF and MJM are supported by funding (AI065530) from the National Institutes of Health, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Balakrishnan A, 2009, MICROBIOL RES, V164, P338, DOI 10.1016/j.micres.2007.05.002; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bao XF, 2011, MICROBIOL-SGM, V157, P2569, DOI 10.1099/mic.0.049668-0; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Batteiger BE, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P1, DOI 10.1128/9781555817329.ch1; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bevan CD, 2003, J INT MED RES, V31, P45, DOI 10.1177/147323000303100108; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Di Virgilio F., 1989, METHOD CELL BIOL, P453; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; FURNESS G, 1960, J GEN MICROBIOL, V23, P613, DOI 10.1099/00221287-23-3-613; Gollapudi S, 1997, CANCER CHEMOTH PHARM, V40, P150, DOI 10.1007/s002800050640; GRIESHABER S, 2002, CELL MICROBIOL; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Haggerty CL, 2007, CLIN INFECT DIS, V44, P953, DOI 10.1086/512191; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KEELING DJ, 1991, BIOCHIM BIOPHYS ACTA, V1115, P42, DOI 10.1016/0304-4165(91)90009-6; Kokes M, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P170, DOI 10.1128/9781555817329.ch8; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Nagarajan UM, 2012, J IMMUNOL, V188, P2866, DOI 10.4049/jimmunol.1103461; ORIEL JD, 1976, J INFECT DIS, V133, P568, DOI 10.1093/infdis/133.5.568; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Qiu F, 2011, FEBS LETT, V585, P3430, DOI 10.1016/j.febslet.2011.09.033; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Sweet DH, 2005, TOXICOL APPL PHARM, V204, P198, DOI 10.1016/j.taap.2004.10.016; Thacker JD, 2012, ANTIMICROB AGENTS CH, V56, P1921, DOI 10.1128/AAC.06372-11; TOOMEY KE, 1990, REV INFECT DIS, V12, pS645; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63732	10.1371/journal.pone.0063732	http://dx.doi.org/10.1371/journal.pone.0063732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700432	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400029
J	Liu, XL; Wu, HF; Ji, CL; Wei, L; Zhao, JM; Yu, JB				Liu, Xiaoli; Wu, Huifeng; Ji, Chenglong; Wei, Lei; Zhao, Jianmin; Yu, Junbao			An Integrated Proteomic and Metabolomic Study on the Chronic Effects of Mercury in Suaeda salsa under an Environmentally Relevant Salinity	PLOS ONE			English	Article							LASER-DESORPTION/IONIZATION-TIME; PROTEIN DISULFIDE-ISOMERASE; OXIDATIVE STRESS; ASPARTATE-AMINOTRANSFERASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; ARABIDOPSIS; TOLERANCE; RESPONSES; IDENTIFICATION	As an environmental contaminant, mercury is of great concern due to its high risk to environmental and human health. The halophyte Suaeda salsa is the dominant plant in the intertidal zones of the Yellow River Delta (YRD) where has been contaminated by mercury in some places. This study aimed at evaluating the chronic effects of mercury (Hg2+, 20 mu g L-1) and the influence of an environmentally relevant salinity (NaCl, 500 mM) on mercury-induced effects in S. salsa. A total of 43 protein spots with significant changes were identified in response to Hg2+, salinity and combined Hg2+ and salinity. These proteins can be categorized into diverse functional classes, related to metabolic processes, photosynthesis, stress response, protein fate, energy metabolism, signaling pathways and immunosuppression. Metabolic responses demonstrated that Hg2+ could disturb protein and energy metabolisms in S. salsa co-exposed with or without salinity. In addition, both antagonistic and synergistic effects between Hg2+ and salinity were confirmed by differential levels of proteins (magnesium-chelatase and ribulose-l,5-bisphosphate carboxylase/oxygenase) and metabolites (valine, malonate, asparagine, glycine, fructose and glucose) in S. salsa. These findings suggest that a combination of proteomics and metabolomics can provide insightful information of environmental contaminant-induced effects in plants at molecular levels.	[Liu, Xiaoli; Wu, Huifeng; Ji, Chenglong; Wei, Lei; Zhao, Jianmin; Yu, Junbao] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Zone Environm Proc, Yantai, Shandong, Peoples R China; [Liu, Xiaoli; Wu, Huifeng; Ji, Chenglong; Wei, Lei; Zhao, Jianmin; Yu, Junbao] YICCAS, Shandong Prov Key Lab Coastal Zone Environm Proc, Yantai, Shandong, Peoples R China; [Liu, Xiaoli; Ji, Chenglong; Wei, Lei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wu, HF (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Zone Environm Proc, Yantai, Shandong, Peoples R China.	hfwu@yic.ac.cn	Liu, Xiaoli/HGE-7614-2022; Wu, Huifeng/E-4886-2016	Wu, Huifeng/0000-0002-4042-8103; Yu, Junbao/0000-0002-3433-3538	National Science & Technology Pillar Program in "12th Five Year'' Period [2011BAC02B01]; 100 Talents Program of the Chinese Academy of Sciences	National Science & Technology Pillar Program in "12th Five Year'' Period; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Project of National Science & Technology Pillar Program in "12th Five Year'' Period (2011BAC02B01) and The 100 Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ado K, 2006, BBA-PROTEINS PROTEOM, V1764, P586, DOI 10.1016/j.bbapap.2006.01.015; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Baginsky S, 2009, MOL PLANT, V2, P1141, DOI 10.1093/mp/ssp058; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Daviss B, 2005, SCIENTIST, V19, P25; Elbaz A, 2010, ECOTOXICOLOGY, V19, P1285, DOI 10.1007/s10646-010-0514-z; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fernandez-Garcia N, 2011, PLANT CELL ENVIRON, V34, P821, DOI 10.1111/j.1365-3040.2011.02285.x; Fukayama H, 2010, PLANT PHYSIOL BIOCH, V48, P808, DOI 10.1016/j.plaphy.2010.08.002; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Ghosh S, 2001, PLANT SCI, V160, P1171, DOI 10.1016/S0168-9452(01)00361-2; Gonzalez LMG, 2012, PLANT CELL ENVIRON, V35, P682, DOI 10.1111/j.1365-3040.2011.02444.x; Graiia X, 1992, J BIOL CHEM, V267, P12797; GREENWAY H, 1972, PLANT PHYSIOL, V49, P256, DOI 10.1104/pp.49.2.256; Hajheidari M, 2005, PROTEOMICS, V5, P950, DOI 10.1002/pmic.200401101; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Huang DJ, 2005, PLANT SCI, V169, P776, DOI 10.1016/j.plantsci.2005.05.034; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Li MJ, 2009, J BIOSCIENCES, V34, P227, DOI 10.1007/s12038-009-0027-1; Li R., 2001, ACTA SEDIMENTOLOGICA, V19, P622; Li X, 2007, JIANGSU ENV SCI TECH, V20, P53; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; Liu XL, 2011, CLEAN-SOIL AIR WATER, V39, P720, DOI 10.1002/clen.201000515; Liu XL, 2011, ECOTOXICOLOGY, V20, P1422, DOI 10.1007/s10646-011-0699-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDONALD RC, 1993, PLANT PHYSIOL, V102, P173, DOI 10.1104/pp.102.1.173; Marquez V, 2011, J MOL BIOL, V405, P1215, DOI 10.1016/j.jmb.2010.11.055; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; McDonagh B, 2007, PROTEOMICS, V7, P3395, DOI 10.1002/pmic.200700241; Moghaieb REA, 2004, PLANT SCI, V166, P1345, DOI 10.1016/j.plantsci.2004.01.016; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nagaoka S, 2003, J EXP BOT, V54, P2231, DOI 10.1093/jxb/erg241; Nazarbeygi E., 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P70; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Patra M, 2004, ENVIRON EXP BOT, V52, P199, DOI 10.1016/j.envexpbot.2004.02.009; Pedras MSC, 2010, PHYTOCHEMISTRY, V71, P581, DOI 10.1016/j.phytochem.2009.12.008; Peel GJ, 2010, PHYTOCHEMISTRY, V71, P404, DOI 10.1016/j.phytochem.2009.11.002; Poynton HC, 2011, ENVIRON SCI TECHNOL, V45, P3710, DOI 10.1021/es1037222; Przybyla-Zawislak B, 1998, EUR J BIOCHEM, V258, P736, DOI 10.1046/j.1432-1327.1998.2580736.x; Purohit PV, 2004, OMICS, V8, P118, DOI 10.1089/1536231041388348; Qin AG, 2011, MOL BIOL REP, V38, P1557, DOI 10.1007/s11033-010-0264-2; Raman SB, 2004, PLANT SCI, V167, P961, DOI 10.1016/j.plantsci.2004.06.019; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sauer M, 2006, PROTEOMICS, V6, P2530, DOI 10.1002/pmic.200500564; Schultz CJ, 1998, GENETICS, V149, P491; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Tilton GB, 2006, PLANT MOL BIOL, V61, P629, DOI 10.1007/s11103-006-0037-4; Tullius MV, 2002, INFECT IMMUN, V70, P2853, DOI 10.1128/IAI.70.6.2853-2861.2002; Urano J, 2000, FEBS LETT, V466, P107, DOI 10.1016/S0014-5793(99)01768-8; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; WADSWORTH GJ, 1993, PLANT MOL BIOL, V21, P993, DOI 10.1007/BF00023598; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wei D, 2011, FISH SHELLFISH IMMUN, V30, P720, DOI 10.1016/j.fsi.2010.12.028; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu HF, 2005, ANAL BIOCHEM, V340, P99, DOI 10.1016/j.ab.2005.01.057; Wu HF, 2010, AQUAT TOXICOL, V100, P339, DOI 10.1016/j.aquatox.2010.08.005; Xu CY, 2007, J SAF ENV, V1, P37; Yadav SK, 2007, PROTEIN EXPRES PURIF, V51, P126, DOI 10.1016/j.pep.2006.07.007; Zhang HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020862; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhang W, 2012, ENVIRON INT, V42, P20, DOI 10.1016/j.envint.2011.03.002; Zhang XL., 2001, HEILONGJIANG ENV J, V25, P87; Zhao H.L., 2010, J ANHUI AGRICUL SCI, V38, P14350	75	37	41	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64041	10.1371/journal.pone.0064041	http://dx.doi.org/10.1371/journal.pone.0064041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696864	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900068
J	Mechelli, R; Umeton, R; Policano, C; Annibali, V; Coarelli, G; Ricigliano, VAG; Vittori, D; Fornasiero, A; Buscarinu, MC; Romano, S; Salvetti, M; Ristori, G				Mechelli, Rosella; Umeton, Renato; Policano, Claudia; Annibali, Viviana; Coarelli, Giulia; Ricigliano, Vito A. G.; Vittori, Danila; Fornasiero, Arianna; Buscarinu, Maria Chiara; Romano, Silvia; Salvetti, Marco; Ristori, Giovanni		Int Multiple Sclerosis Genetics; Wellcome Trust Case Control	A "Candidate-Interactome" Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; D-RECEPTOR BINDING; SUSCEPTIBILITY LOCI; VIRUS-INFECTION; GENETIC RISK; NETWORK; MAP	Though difficult, the study of gene-environment interactions in multifactorial diseases is crucial for interpreting the relevance of non-heritable factors and prevents from overlooking genetic associations with small but measurable effects. We propose a "candidate interactome" (i.e. a group of genes whose products are known to physically interact with environmental factors that may be relevant for disease pathogenesis) analysis of genome-wide association data in multiple sclerosis. We looked for statistical enrichment of associations among interactomes that, at the current state of knowledge, may be representative of gene-environment interactions of potential, uncertain or unlikely relevance for multiple sclerosis pathogenesis: Epstein-Barr virus, human immunodeficiency virus, hepatitis B virus, hepatitis C virus, cytomegalovirus, HHV8-Kaposi sarcoma, H1N1-influenza, JC virus, human innate immunity interactome for type I interferon, autoimmune regulator, vitamin D receptor, aryl hydrocarbon receptor and a panel of proteins targeted by 70 innate immune-modulating viral open reading frames from 30 viral species. Interactomes were either obtained from the literature or were manually curated. The P values of all single nucleotide polymorphism mapping to a given interactome were obtained from the last genome-wide association study of the International Multiple Sclerosis Genetics Consortium & the Wellcome Trust Case Control Consortium, 2. The interaction between genotype and Epstein Barr virus emerges as relevant for multiple sclerosis etiology. However, in line with recent data on the coexistence of common and unique strategies used by viruses to perturb the human molecular system, also other viruses have a similar potential, though probably less relevant in epidemiological terms.	[Mechelli, Rosella; Umeton, Renato; Policano, Claudia; Annibali, Viviana; Coarelli, Giulia; Ricigliano, Vito A. G.; Vittori, Danila; Fornasiero, Arianna; Buscarinu, Maria Chiara; Romano, Silvia; Salvetti, Marco; Ristori, Giovanni; Int Multiple Sclerosis Genetics; Wellcome Trust Case Control] Univ Roma La Sapienza, Fac Med & Psychol, Ctr Expt Neurol Therapies, S Andrea Hosp Site,Dept Neurosci Mental Hlth & Se, Rome, Italy	Sapienza University Rome	Salvetti, M (corresponding author), Univ Roma La Sapienza, Fac Med & Psychol, Ctr Expt Neurol Therapies, S Andrea Hosp Site,Dept Neurosci Mental Hlth & Se, Rome, Italy.	marco.salvetti@uniroma1.it	Montalban, Xavier/J-5938-2016; Buscarinu, Maria Chiara/K-3040-2016; Esposito, Federica/K-6537-2016; Goris, An/L-5852-2019; Saarela, Janna S/E-5369-2014; Myhr, Kjell-Morten/H-1528-2018; Brown, Matthew A/E-5749-2010; Kermode, Allan/G-3568-2019; Bergamaschi, Laura/ABE-1175-2020; Goris, An/F-2943-2010; Kockum, Ingrid/O-8781-2018; Palmer, Colin NA/C-7053-2008; Mechelli, Rosella/AAB-4967-2022; Liu, Jianjun/AAK-4989-2020; Leone, Maurizio A./J-4130-2016; Bellenguez, Céline/X-4004-2019; Romano, Silvia/P-7984-2015; Salvi, Erika/AAA-1415-2019; Franke, Andre/B-2151-2010; de Bakker, Paul IW/B-8730-2009; Boneschi, Filippo Martinelli/H-8592-2012; D'Alfonso, Sandra/K-7295-2014; Salvetti, Marco/K-3836-2016; Brassat, David/L-2173-2014; Spurkland, Anne/L-3369-2019; Belllenguez, Céline/Y-3183-2018; Zipp, Frauke/C-9968-2015; Bramon, Elvira/HHC-3809-2022; Galimberti, Daniela/N-7209-2019; Blackwell, Jenefer M/H-3015-2015; Piccio, Laura/AAE-1706-2020; Dubois, Benedicte/A-4338-2019; Macciardi, Fabio/N-3768-2014; Jankowski, Janusz/H-2706-2012; Wood, Nicholas/C-2505-2009; Scott, Rodney/B-2827-2013; Clerget-Darpoux, Francoise/I-4825-2017	Montalban, Xavier/0000-0002-0098-9918; Buscarinu, Maria Chiara/0000-0002-4839-1528; Esposito, Federica/0000-0003-2550-0805; Goris, An/0000-0002-1276-6682; Myhr, Kjell-Morten/0000-0002-0980-510X; Brown, Matthew A/0000-0003-0538-8211; Kermode, Allan/0000-0002-4476-4016; Goris, An/0000-0002-1276-6682; Kockum, Ingrid/0000-0002-0867-4726; Palmer, Colin NA/0000-0002-6415-6560; Liu, Jianjun/0000-0002-3255-3019; Leone, Maurizio A./0000-0002-6339-5738; Bellenguez, Céline/0000-0002-1240-7874; Romano, Silvia/0000-0003-0499-8843; Salvi, Erika/0000-0002-2724-2291; Franke, Andre/0000-0003-1530-5811; de Bakker, Paul IW/0000-0001-7735-7858; D'Alfonso, Sandra/0000-0002-3983-9925; Spurkland, Anne/0000-0003-4421-0766; Belllenguez, Céline/0000-0002-1240-7874; Zipp, Frauke/0000-0002-1231-1928; Bramon, Elvira/0000-0003-1369-5983; Galimberti, Daniela/0000-0002-9284-5953; Piccio, Laura/0000-0002-8760-109X; Mycko, Marcin/0000-0002-2226-1784; Kilpatrick, Trevor/0000-0003-3999-085X; Olsson, Tomas/0000-0002-2938-1877; Sellebjerg, Finn/0000-0002-1333-9623; RUBIO, JUSTIN/0000-0003-3750-917X; Ricigliano, Vito A. G./0000-0002-8860-3548; Lechner-Scott, Jeannette/0000-0002-3850-447X; Dubois, Benedicte/0000-0003-0604-8702; Winkelmann, Juliane/0000-0003-2667-9691; Butzkueven, Helmut/0000-0003-3940-8727; Reynolds, Richard/0000-0003-4622-4694; Saarela, Janna/0000-0002-0853-6219; Gomez, Refujia/0000-0003-0730-8019; martinelli boneschi, filippo/0000-0002-9955-1368; Alfredsson, Lars/0000-0003-1688-6697; RISTORI, Giovanni/0000-0002-6598-6777; Patsopoulos, Nikolaos/0000-0003-3757-8941; Villoslada, Pablo/0000-0002-8735-6119; Sorensen, Per Soelberg/0000-0002-2818-3780; Giannoulatou, Eleni/0000-0002-7084-6736; Plomin, Robert/0000-0002-0756-3629; Comabella Lopez, Manuel/0000-0002-2373-6657; D'hooghe, Marie/0000-0002-0917-4176; McCauley, Jacob/0000-0002-1805-1733; Macciardi, Fabio/0000-0003-0537-4266; Gillman, Matthew S./0000-0002-2340-6930; Schulze, Christian/0000-0002-1442-1987; Walters, James/0000-0002-6980-4053; Mechelli, Rosella/0000-0001-5842-3100; Corvin, Aiden/0000-0001-6717-4089; Foote, Simon/0000-0002-9142-2107; Moutsianas, Loukas/0000-0001-5453-345X; Jankowski, Janusz/0000-0003-2130-9181; Cross, Anne/0000-0003-0829-7569; Stankovich, Jim/0000-0001-9344-7749; Wason, James/0000-0002-4691-126X; Selmaj, Krzysztof/0000-0003-1213-7218; Lima Bomfim, Izaura/0000-0003-0890-3872; Link, Jenny/0000-0002-6134-9404; Wood, Nicholas/0000-0002-9500-3348; Rapa, Anna/0000-0002-5523-5224; Umeton, Renato/0000-0002-5561-6932; Murray, Dianna/0000-0003-3481-825X; Cavalla, Paola/0000-0003-4589-4864; Pirinen, Matti/0000-0002-1664-1350; Baranzini, Sergio/0000-0003-0067-194X; Scott, Rodney/0000-0001-7724-3404; Glessner, Joseph/0000-0001-5131-2811; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Sulonen, Anna-Maija/0000-0002-5518-1975; FORNASIERO, Arianna/0000-0002-4025-0034	Italian Multiple Sclerosis Foundation [2007/R/17, 2011/R/31]; Medical Research Council [G0801418B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	Italian Multiple Sclerosis Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Italian Multiple Sclerosis Foundation grants (2007/R/17 and 2011/R/31) to MS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; An DS, 2001, J VIROL, V75, P3488, DOI 10.1128/JVI.75.7.3488-3489.2001; Ascherio A, 2001, NEW ENGL J MED, V344, P327, DOI 10.1056/NEJM200102013440502; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; BERGER JR, 1989, NEUROLOGY, V39, P324, DOI 10.1212/WNL.39.3.324; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Confavreux C, 2001, NEW ENGL J MED, V344, P319, DOI 10.1056/NEJM200102013440501; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Gonzalez-Duarte A, 2011, J NEUROVIROL, V17, P504, DOI 10.1007/s13365-011-0054-1; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Hernan MA, 2004, NEUROLOGY, V63, P838, DOI 10.1212/01.WNL.0000138433.61870.82; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; JOHNSON RT, 1994, ANN NEUROL, V36, pS54, DOI 10.1002/ana.410360715; Kakalacheva K, 2011, FEBS LETT, V585, P3724, DOI 10.1016/j.febslet.2011.04.006; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Loebermann M, 2012, NAT REV NEUROL, V8, P143, DOI 10.1038/nrneurol.2012.8; Mikaeloff Y, 2009, NEUROLOGY, V72, P873, DOI 10.1212/01.wnl.0000335762.42177.07; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2012, MULT SCLER; Pesole G, 2008, GENE, V417, P1, DOI 10.1016/j.gene.2008.03.010; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rios D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-238; Ristori G, 2006, ANN NEUROL, V59, P27, DOI 10.1002/ana.20683; Sawcer S, 2012, ANN NEUROL, V72, P502, DOI 10.1002/ana.23613; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Stajich Jason E., 2007, V406, P535; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Torkildsen O, 2008, ARCH NEUROL-CHICAGO, V65, P809, DOI 10.1001/archneur.65.6.809; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322	40	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63300	10.1371/journal.pone.0063300	http://dx.doi.org/10.1371/journal.pone.0063300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696811	Green Accepted, Green Published, gold			2022-12-25	WOS:000319081900025
J	Yang, XY; Cheyette, BNR				Yang, XiaoYong; Cheyette, Benjamin N. R.			SEC14 and Spectrin Domains 1 (Sestd1) and Dapper Antagonist of Catenin 1 (Dact1) Scaffold Proteins Cooperatively Regulate the Van Gogh-like 2 (Vangl2) Four-pass Transmembrane Protein and Planar Cell Polarity (PCP) Pathway during Embryonic Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL-TUBE DEFECTS; BETA-CATENIN; CONVERGENT EXTENSION; WNT; RHO; MUTATIONS; FRODO; HOMOLOG; CELSR1	The planar cell polarity (PCP) pathway is a conserved non-canonical (beta-catenin-independent) branch of Wnt signaling crucial to embryogenesis, during which it regulates cell polarity and polarized cell movements. Disruption of PCP components in mice, including Vangl2 and Dact1, results in defective neural tube closure and other developmental defects. Here, we show that Sestd1 is a novel binding partner of Vangl2 and Dact1. The Sestd1-Dact1 interface is formed by circumscribed regions of Sestd1 (the carboxyl-terminal region) and Dact1 (the amino-terminal region). Remarkably, we show that loss of Sestd1 precisely phenocopies loss of Dact1 during embryogenesis in mice, leading to a spectrum of birth malformations, including neural tube defects, a shortened and/or curly tail, no genital tubercle, blind-ended colons, hydronephrotic kidneys, and no bladder. Moreover, as with Dact1, a knock-out mutation at the Sestd1 locus exhibits reciprocal genetic rescue interactions during development with a semidominant mutation at the Vangl2 locus. Consistent with this, examination of Wnt pathway activities in Sestd1 mutant mouse embryonic tissue reveals disrupted PCP pathway biochemistry similar to that characterized in Dact1 mutant embryos. The Sestd1 protein is a divergent member of the Trio family of GTPase regulatory proteins that lacks a guanine nucleotide exchange factor domain. Nonetheless, in cell-based assays the Sestd1-Dact1 interaction can induce Rho GTPase activation. Together, our data indicate that Sestd1 cooperates with Dact1 in Vangl2 regulation and in the PCP pathway during mammalian embryonic development.	[Yang, XiaoYong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cheyette, BNR (corresponding author), Univ Calif San Francisco, MC 2611,Rock Hall,Rm 284D,1550 4th St, San Francisco, CA 94158 USA.	bc@ucsf.edu	Cheyette, Benjamin/K-5535-2014	Cheyette, Benjamin/0000-0001-9934-7941	National Institutes of Health [R01HD055300]; National Institute of Mental Health [T32 MH089920]; Department of Psychiatry and the Center for Neurobiology and Psychiatry; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH089920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Psychiatry and the Center for Neurobiology and Psychiatry; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD055300 (to B.N.R.C.) and Grant T32 MH089920 from the National Institute of Mental Health (to X.Y.Y.). This work was also supported by the Department of Psychiatry and the Center for Neurobiology and Psychiatry at the University of California San Francisco.	Barrow JR, 2006, SEMIN CELL DEV BIOL, V17, P185, DOI 10.1016/j.semcdb.2006.04.002; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De Marco P, 2011, BIOFACTORS, V37, P261, DOI 10.1002/biof.170; Detrait ER, 2005, NEUROTOXICOL TERATOL, V27, P515, DOI 10.1016/j.ntt.2004.12.007; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Kibar Z, 2011, CLIN GENET, V80, P76, DOI 10.1111/j.1399-0004.2010.01515.x; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Okerlund ND, 2010, J NEUROSCI, V30, P4362, DOI 10.1523/JNEUROSCI.0354-10.2010; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; PAULI RM, 1994, AM J MED GENET, V50, P154, DOI 10.1002/ajmg.1320500206; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Sato T, 2003, GENOMICS, V82, P218, DOI 10.1016/S0888-7543(03)00071-5; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Tada M, 2012, CURR TOP DEV BIOL, V101, P77, DOI 10.1016/B978-0-12-394592-1.00004-1; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	47	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20111	20120		10.1074/jbc.M113.465427	http://dx.doi.org/10.1074/jbc.M113.465427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23696638	Green Published, hybrid			2022-12-25	WOS:000321715100002
J	Javadi, M; Richmond, TD; Huang, K; Barber, DL				Javadi, Mojib; Richmond, Terri D.; Huang, Kai; Barber, Dwayne L.			CBL Linker Region and RING Finger Mutations Lead to Enhanced Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Signaling via Elevated Levels of JAK2 and LYN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; PROTEIN-TYROSINE KINASE; COMMON BETA-SUBUNIT; ACQUIRED UNIPARENTAL DISOMY; ACUTE MYELOID-LEUKEMIA; ACTIVATED T-CELLS; C-CBL; PROTOONCOGENE PRODUCT; GROWTH-FACTOR; FACTOR-RECEPTOR	Juvenile myelomonocytic leukemia (JMML) is characterized by hypersensitivity to granulocyte-macrophage colony-stimulating factor (GM-CSF). SHP2, NF-1, KRAS, and NRAS are mutated in JMML patients, leading to aberrant regulation of RAS signaling. A subset of JMML patients harbor CBL mutations associated with 11q acquired uniparental disomy. Many of these mutations are in the linker region and the RING finger of CBL, leading to a loss of E3 ligase activity. We investigated the mechanism by which CBL-Y371H, a linker region mutant, and CBL-C384R, a RING finger mutant, lead to enhanced GM-CSF signaling. Expression of CBL mutants in the TF-1 cell line resulted in enhanced survival in the absence of GM-CSF. Cells expressing CBL mutations displayed increased phosphorylation of GM-CSF receptor beta c subunit in response to stimulation, although expression of total GM-CSFR beta c was lower. This suggested enhanced kinase activity downstream of GM-CSFR. JAK2 and LYN kinase expression is elevated in CBL-Y371H and CBL-C384R mutant cells, resulting in enhanced phosphorylation of CBL and S6 in response to GM-CSF stimulation. Incubation with the JAK2 inhibitor, TG101348, abolished the increased phosphorylation of GM-CSFR beta c in cells expressing CBL mutants, whereas treatment with the SRC kinase inhibitor dasatinib resulted in equalization of GM-CSFR beta c phosphorylation signal between wild type CBL and CBL mutant samples. Dasatinib treatment inhibited the elevated phosphorylation of CBL-Y371H and CBL-C384R mutants. Our study indicates that CBL linker and RING finger mutants lead to enhanced GM-CSF signaling due to elevated kinase expression, which can be blocked using small molecule inhibitors targeting specific downstream pathways.	[Javadi, Mojib; Richmond, Terri D.; Barber, Dwayne L.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2M9, Canada; [Javadi, Mojib; Richmond, Terri D.; Huang, Kai; Barber, Dwayne L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Barber, Dwayne L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Barber, DL (corresponding author), Ontario Canc Inst, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	dbarber@uhnres.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150	Canadian Institutes of Health Research Grant FRN [42428]	Canadian Institutes of Health Research Grant FRN(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant FRN#42428.	Anderson SM, 1997, J BIOL CHEM, V272, P739, DOI 10.1074/jbc.272.2.739; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Andoniou CE, 1996, ONCOGENE, V12, P1981; Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Bhattacharyya SP, 2001, IMMUNOL LETT, V75, P131, DOI 10.1016/S0165-2478(00)00289-3; BRIZZI MF, 1994, J BIOL CHEM, V269, P31680; Chan RJ, 2009, LEUKEMIA RES, V33, P355, DOI 10.1016/j.leukres.2008.08.022; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; DombroskyFerlan PM, 1997, ONCOGENE, V14, P2019, DOI 10.1038/sj.onc.1201031; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; EMANUEL PD, 1991, BLOOD, V77, P925; Fernandes MS, 2010, J BIOL CHEM, V285, P32596, DOI 10.1074/jbc.M110.106161; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Grishin A, 2000, ONCOGENE, V19, P97, DOI 10.1038/sj.onc.1203254; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hercus TR, 2012, GROWTH FACTORS, V30, P63, DOI 10.3109/08977194.2011.649919; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; KALRA R, 1994, BLOOD, V84, P3435; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Kyo S, 2003, GENES CELLS, V8, P825, DOI 10.1046/j.1365-2443.2003.00679.x; Lei JT, 2011, J BIOL CHEM, V286, P40091, DOI 10.1074/jbc.M111.273482; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI Y, 1995, J IMMUNOL, V155, P2165; Liu YC, 1997, J BIOL CHEM, V272, P168; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Marengere LEM, 1997, J IMMUNOL, V159, P70; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; MIYAUCHI J, 1994, BLOOD, V83, P2248; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; Naccache PH, 1997, J LEUKOCYTE BIOL, V62, P901, DOI 10.1002/jlb.62.6.901; Nagao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027397; Naramura M, 2010, P NATL ACAD SCI USA, V107, P16274, DOI 10.1073/pnas.1007575107; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; ODAI H, 1995, J BIOL CHEM, V270, P10800, DOI 10.1074/jbc.270.18.10800; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Sawasdikosol S, 1996, J IMMUNOL, V157, P110; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Side LE, 1998, BLOOD, V92, P267, DOI 10.1182/blood.V92.1.267.413a31_267_272; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Uddin S, 1996, BIOCHEM BIOPH RES CO, V225, P833, DOI 10.1006/bbrc.1996.1259; Wang L, 2002, ONCOGENE, V21, P5346, DOI 10.1038/sj.onc.1205670; Watanabe S, 1996, J ALLERGY CLIN IMMUN, V98, pS183, DOI 10.1016/S0091-6749(96)70065-9; Wei S, 1996, J IMMUNOL, V157, P5155; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407	82	20	20	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19459	19470		10.1074/jbc.M113.475087	http://dx.doi.org/10.1074/jbc.M113.475087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696637	hybrid, Green Published			2022-12-25	WOS:000321515800014
J	Zgaga, L; Agakov, F; Theodoratou, E; Farrington, SM; Tenesa, A; Dunlop, MG; McKeigue, P; Campbell, H				Zgaga, Lina; Agakov, Felix; Theodoratou, Evropi; Farrington, Susan M.; Tenesa, Albert; Dunlop, Malcolm G.; McKeigue, Paul; Campbell, Harry			Model Selection Approach Suggests Causal Association between 25-Hydroxyvitamin D and Colorectal Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SOLAR ULTRAVIOLET-B; VITAMIN-D REDUCE; MENDELIAN RANDOMIZATION; INSTRUMENTAL VARIABLES; SUSCEPTIBILITY LOCI; BREAST-CANCER; RISK; INFERENCE; METAANALYSIS	Introduction: Vitamin D deficiency has been associated with increased risk of colorectal cancer (CRC), but causal relationship has not yet been confirmed. We investigate the direction of causation between vitamin D and CRC by extending the conventional approaches to allow pleiotropic relationships and by explicitly modelling unmeasured confounders. Methods: Plasma 25-hydroxyvitamin D (25-OHD), genetic variants associated with 25-OHD and CRC, and other relevant information was available for 2645 individuals (1057 CRC cases and 1588 controls) and included in the model. We investigate whether 25-OHD is likely to be causally associated with CRC, or vice versa, by selecting the best modelling hypothesis according to Bayesian predictive scores. We examine consistency for a range of prior assumptions. Results: Model comparison showed preference for the causal association between low 25-OHD and CRC over the reverse causal hypothesis. This was confirmed for posterior mean deviances obtained for both models (11.5 natural log units in favour of the causal model), and also for deviance information criteria (DIC) computed for a range of prior distributions. Overall, models ignoring hidden confounding or pleiotropy had significantly poorer DIC scores. Conclusion: Results suggest causal association between 25-OHD and colorectal cancer, and support the need for randomised clinical trials for further confirmations.	[Zgaga, Lina; Agakov, Felix; Theodoratou, Evropi; McKeigue, Paul; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Zgaga, Lina; Farrington, Susan M.; Tenesa, Albert; Dunlop, Malcolm G.; Campbell, Harry] Univ Edinburgh, Western Gen Hosp, Colon Canc Genet Grp & Acad Coloproctol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Agakov, Felix] Pharmat Ltd, Edinburgh, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Zagreb; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Zgaga, L (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	lina.zgaga@ed.ac.uk; harry.campbell@ed.ac.uk	Campbell, Harry/E-2959-2010; Dunlop, Malcolm G/F-1973-2011; Theodoratou, Evropi/C-3430-2014; Farrington, Susan M/C-7319-2013; Farrington, Susan M/Q-2710-2019; Zgaga, Lina/Q-9415-2018	Campbell, Harry/0000-0002-6169-6262; Dunlop, Malcolm G/0000-0002-3033-5851; Theodoratou, Evropi/0000-0001-5887-9132; Farrington, Susan M/0000-0001-5955-7389; Zgaga, Lina/0000-0003-4089-9703; Agakov, Felix/0000-0003-4280-9062; Tenesa, Albert/0000-0003-4884-4475	Cancer Research UK [C348/A12076]; Scottish Government Chief Scientist Office [CZH/4/529]; Cancer Research UK Fellowship [C31250/A10107]; MRC [MC_PC_U127527198, G0800604, MR/K018647/1, MC_U127527198] Funding Source: UKRI; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127527198, MC_PC_U127527198, G0800604] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4, CZH/4/529] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Scottish Government Chief Scientist Office; Cancer Research UK Fellowship(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by Programme Grants funding from Cancer Research UK (C348/A12076) and Scottish Government Chief Scientist Office (CZH/4/529). ET is funded by Cancer Research UK Fellowship (C31250/A10107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agakov F, 2011, J EPIDEMIOL COMMUN H, V65, pA10, DOI 10.1136/jech.2011.142976a.20; Agakov F., 2011, JSCI, V9, P1; Agakov FV, 2010, ADV NEURAL INFORM PR, V23, P28; Bochud M, 2010, INT J ENV RES PUB HE, V7, P711, DOI 10.3390/ijerph7030711; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Gelman A., 2004, BAYESIAN DATA ANAL; Grant WB, 2006, ANTICANCER RES, V26, P2687; Grant WB, 2009, DERM-ENDOCRINOL, V1, P17, DOI 10.4161/derm.1.1.7388; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; Knox S, 2009, ANN CLIN BIOCHEM, V46, P226, DOI 10.1258/acb.2009.008206; Lagunova Z, 2010, MOL NUTR FOOD RES, V54, P1127, DOI 10.1002/mnfr.200900512; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Lamprecht SA, 2001, ANN NY ACAD SCI, V952, P73, DOI 10.1111/j.1749-6632.2001.tb02729.x; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lauritzen S.L, 1996, GRAPHICAL MODELS; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawson A.B, 2013, BAYESIAN DIS MAPPING, Vsecond; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; MacKay D. J. C., 2003, INFORM THEORY INFERE; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; McKeigue PM, 2010, INT J EPIDEMIOL, V39, P907, DOI 10.1093/ije/dyp397; McLean R, 1991, AM STAT, V45; Mohr SB, 2012, DERM-ENDOCRINOL, V4, P152, DOI 10.4161/derm.20449; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Neuhouser ML, 2012, AM J EPIDEMIOL, V175, P673, DOI 10.1093/aje/kwr350; Nitsch D, 2006, AM J EPIDEMIOL, V163, P397, DOI 10.1093/aje/kwj062; Palmer TM, 2012, STAT METHODS MED RES, V21, P223, DOI 10.1177/0962280210394459; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Seeger MW, 2008, J MACH LEARN RES, V9, P759; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sleiman PMA, 2010, CLIN CHEM, V56, P723, DOI 10.1373/clinchem.2009.141564; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stock JH, 2001, INT ENCY SOCIAL BEHA; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Theodoratou E, 2012, PLOS ONE; Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785; Thomas DC, 2004, INT J EPIDEMIOL, V33, P21, DOI 10.1093/ije/dyh048; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trostel P, 2002, LABOUR ECON, V9, P1, DOI 10.1016/S0927-5371(01)00052-5; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Whittaker J., 1990, GRAPHICAL MODELS APP; Winn J, 2012, CAUSALITY GATES, P1314; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zgaga L, 2011, J NUTR, V141, P1535, DOI 10.3945/jn.111.140012	64	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63475	10.1371/journal.pone.0063475	http://dx.doi.org/10.1371/journal.pone.0063475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717431	Green Published, Green Submitted, gold			2022-12-25	WOS:000319385300037
J	Massom, R; Reid, P; Stammerjohn, S; Raymond, B; Fraser, A; Ushio, S				Massom, Robert; Reid, Philip; Stammerjohn, Sharon; Raymond, Ben; Fraser, Alexander; Ushio, Shuki			Change and Variability in East Antarctic Sea Ice Seasonality, 1979/80-2009/10	PLOS ONE			English	Article							MERTZ GLACIER POLYNYA; SOUTHERN-OCEAN; CLIMATE-CHANGE; INTERANNUAL VARIABILITY; CONTINENTAL-SLOPE; PENINSULA REGION; INDIAN-OCEAN; WATER MASSES; ADELIE LAND; CIRCULATION	Recent analyses have shown that significant changes have occurred in patterns of sea ice seasonality in West Antarctica since 1979, with wide-ranging climatic, biological and biogeochemical consequences. Here, we provide the first detailed report on long-term change and variability in annual timings of sea ice advance, retreat and resultant ice season duration in East Antarctica. These were calculated from satellite-derived ice concentration data for the period 1979/80 to 2009/10. The pattern of change in sea ice seasonality off East Antarctica comprises mixed signals on regional to local scales, with pockets of strongly positive and negative trends occurring in near juxtaposition in certain regions e.g., Prydz Bay. This pattern strongly reflects change and variability in different elements of the marine "icescape'', including fast ice, polynyas and the marginal ice zone. A trend towards shorter sea-ice duration (of 1 to 3 days per annum) occurs in fairly isolated pockets in the outer pack from similar to 95-110 degrees E, and in various near-coastal areas that include an area of particularly strong and persistent change near Australia's Davis Station and between the Amery and West Ice Shelves. These areas are largely associated with coastal polynyas that are important as sites of enhanced sea ice production/melt. Areas of positive trend in ice season duration are more extensive, and include an extensive zone from 160-170 degrees E (i.e., the western Ross Sea sector) and the near-coastal zone between 40-100 degrees E. The East Antarctic pattern is considerably more complex than the well-documented trends in West Antarctica e.g., in the Antarctic Peninsula-Bellingshausen Sea and western Ross Sea sectors.	[Massom, Robert; Raymond, Ben] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia; [Massom, Robert; Raymond, Ben; Fraser, Alexander] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Sandy Bay, Tas, Australia; [Reid, Philip] Ctr Australian Weather & Climate Res, Australian Bur Meteorol, Hobart, Tas, Australia; [Stammerjohn, Sharon] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Ushio, Shuki] Natl Inst Polar Res, Tachikawa, Tokyo, Japan	Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Colorado System; University of Colorado Boulder; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Massom, R (corresponding author), Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia.	R.Massom@utas.edu.au	Fraser, Alexander/AFO-7186-2022	Fraser, Alexander/0000-0003-1924-0015; Massom, Robert/0000-0003-1533-5084; STAMMERJOHN, SHARON/0000-0002-1697-8244	Australian Government's Cooperative Research Centre programme through the ACE CRC; AAS [3024, 4116]; AAD CPC [18]; Grants-in-Aid for Scientific Research [24651016] Funding Source: KAKEN; Directorate For Geosciences [1440435] Funding Source: National Science Foundation	Australian Government's Cooperative Research Centre programme through the ACE CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); AAS; AAD CPC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work was supported by the Australian Government's Cooperative Research Centre programme through the ACE CRC, and contributes to AAS Projects 3024 and 4116 and AAD CPC Project 18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is dedicated to our dear friend and colleague Neil Adams. This analysis forms a contribution to the joint Japanese-Australian (JST-DIISR) project "Establishing a Benchmark to Assess Climate Change Impact in the Eastern Antarctic Marine System'', and we are grateful to the project leaders Dr Mitsuo Fukuchi (NIPR, Japan) and Dr So Kawaguchi (AAD, Australia) for their support. We are grateful to an anonymous reviewer, the editor Dr Peter Strutton and Dr Tania Raymond for their highly constructive comments which greatly improved the paper. MODIS data were obtained from the NASA Level 1 Atmosphere Archive and Distribution System (LAADS) (http://ladsweb.nascom.nasa.gov/). Satellite sea ice concentration data were obtained from the NASA Earth Observing System Distributed Active Archive Center (DAAC) at the U.S. National Snow and Ice Data Center, University of Colorado, Boulder (http://www.nsidc.org). This work was supported by the Australian Government's Cooperative Research Centre programme through the ACE CRC, and contributes to AAS Project 4116.	Allison I, 1997, AUST J PHYS, V50, P759, DOI 10.1071/P96113; Amante C., 2009, NGDC24 NOAA NESDIS; Arbetter TE, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001837; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035624; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Barber DG, 2007, ELSEV OCEANOGR SERIE, V74, P1, DOI 10.1016/S0422-9894(06)74001-6; Bindoff N.L., 2000, PAPERS P ROYAL SOC T, V133, P51; Bindoff NL, 2000, DEEP-SEA RES PT II, V47, P2299, DOI 10.1016/S0967-0645(00)00038-2; Comiso JC, 1996, J GEOPHYS RES-OCEANS, V101, P18297, DOI 10.1029/96JC01500; Comiso JC, 2010, SEA ICE, P205, DOI DOI 10.1002/9781444317145.CH6; Comiso JC, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006391; Delille B, 2007, LIMNOL OCEANOGR, V52, P1367, DOI 10.4319/lo.2007.52.4.1367; Dieckmann GS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033540; Dinniman MS, 2012, J CLIMATE, V25, P4799, DOI 10.1175/JCLI-D-11-00307.1; Ducklow Hugh, 2012, P121; Fraser AD, 2012, J CLIMATE, V25, P1137, DOI 10.1175/JCLI-D-10-05032.1; Galton-Fenzi B, 2009, THESIS U TASMANIA HO; Giles AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004139; Gloersen P, 1992, NASA SPECIAL PUBLICA, V511; GORDON AL, 1981, J GEOPHYS RES-OCEANS, V86, P4193, DOI 10.1029/JC086iC05p04193; Heil P, 1999, J GEOPHYS RES-OCEANS, V104, P15789, DOI 10.1029/1999JC900076; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Kern S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038062; Kimura N, 2004, J METEOROL SOC JPN, V82, P1223, DOI 10.2151/jmsj.2004.1223; Kimura N, 2007, J OCEANOGR, V63, P685, DOI 10.1007/s10872-007-0060-3; Kimura N, 2011, TELLUS A, V63, P828, DOI 10.1111/j.1600-0870.2011.00526.x; LUBIN D., 2006, POLAR REMOTE SENSING, V1; Maksym T, 2012, OCEANOGRAPHY, V25, P140, DOI 10.5670/oceanog.2012.88; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Martinson DG, 2012, PALAEOGEOGR PALAEOCL, V335, P71, DOI 10.1016/j.palaeo.2011.04.007; Massom RA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001354; Massom RA, 2001, ANN GLACIOL, V33, P391, DOI 10.3189/172756401781818518; Massom RA, 1999, REMOTE SENS ENVIRON, V68, P61, DOI 10.1016/S0034-4257(98)00100-X; Massom RA, 1998, ANN GLACIOL, V27, P420; Massom RA, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004239; Massom RA, 2006, J CLIMATE, V19, P3544, DOI 10.1175/JCLI3805.1; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Massom RA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006083; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; McCartney MS, 2007, PROG OCEANOGR, V75, P675, DOI 10.1016/j.pocean.2007.02.008; McClintock J, 2008, AM SCI, V96, P302; Meijers AJS, 2010, DEEP-SEA RES PT II, V57, P723, DOI 10.1016/j.dsr2.2009.04.019; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Nicol S, 2000, DEEP-SEA RES PT II, V47, P2281, DOI 10.1016/S0967-0645(00)00026-6; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Nihashi S, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2003JC002235; Nihashi S, 2001, J GEOPHYS RES-OCEANS, V106, P16767, DOI 10.1029/2000JC000399; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; PARKINSON CL, 1998, ANTAR RES S, V74, P173; Perovich DK, 2011, OCEANOGRAPHY, V24, P162, DOI 10.5670/oceanog.2011.68; Perovich DK, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034007; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Raymond B, 2012, ANTARCTIC ECOSYSTEMS, DOI [10.1002/9781444347241.ch8, DOI 10.1002/9781444347241.CH8]; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Rintoul Sr, 1998, ANTARCT RES SER, V75, P151; Rintoul SR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004541; Smith MB, 2011, POLAR SCI, V5, P104, DOI 10.1016/j.polar.2011.04.007; Speer K, 2012, SO OCEAN OBSERVING S; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Tamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1820; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Tchernia P., 1984, POLAR REC, V22, P263, DOI [DOI 10.1017/, 10.1017/S0032247400005386, DOI 10.1017/S0032247400005386]; Thomas D.N., 2010, SEA ICE, V2nd; Ushio S, 2006, ANN GLACIOL, V44, P177, DOI 10.3189/172756406781811835; Wadhams P., 2000, ICE OCEAN, DOI [10.1201/9781482283082, DOI 10.1201/9781482283082]; Watkins AB, 1999, GEOPHYS RES LETT, V26, P1481, DOI 10.1029/1999GL900292; Williams GD, 2010, DEEP-SEA RES PT II, V57, P738, DOI 10.1016/j.dsr2.2009.04.020; Williams GD, 2010, DEEP SEA RES 2, V57, P9; Young NW, 1997, ESA SP PUBL, V414, P1007	75	72	72	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64756	10.1371/journal.pone.0064756	http://dx.doi.org/10.1371/journal.pone.0064756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705008	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200162
J	Navarro, A; Munoz, C; Gaya, A; Diaz-Beya, M; Gel, B; Tejero, R; Diaz, T; Martinez, A; Monzo, M				Navarro, Alfons; Munoz, Carmen; Gaya, Anna; Diaz-Beya, Marina; Gel, Bernat; Tejero, Rut; Diaz, Tania; Martinez, Antonio; Monzo, Mariano			MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients	PLOS ONE			English	Article							BINDING-SITE POLYMORPHISM; HUMAN CANCER; PROGNOSTIC-FACTORS; GENETIC-VARIATION; MICRORNA; DISEASE; DICER; CELL; PHARMACOGENOMICS; EXPRESSION	Background: In recent years, microRNA (miRNA) pathways have emerged as a crucial system for the regulation of tumorogenesis. miR-SNPs are a novel class of single nucleotide polymorphisms that can affect miRNA pathways. Design and Methods: We analyzed eight miR-SNPs by allelic discrimination in 141 patients with Hodgkin lymphoma and correlated the results with treatment-related toxicity, response, disease-free survival (DFS) and overall survival (OS). Results: The KRT81 (rs3660) GG genotype was associated with an increased risk of neurological toxicity (P = 0.016), while patients with XPO5 (rs11077) AA or CC genotypes had a higher rate of bleomycin-associated pulmonary toxicity (P = 0.048). Both miR-SNPs emerged as independent factors in the multivariate analysis. The XPO5 AA and CC genotypes were also associated with a lower response rate (P = 0.036). XPO5 (P = 0.039) and TRBP (rs784567) (P = 0.022) genotypes emerged as prognostic markers for DFS, and XPO5 was also associated with OS (P = 0.033). In the multivariate analysis, only XPO5 emerged as an independent prognostic factor for DFS (HR: 2.622; 95% CI 1.039-6.620; P = 0.041). Given the influence of XPO5 and TRBP as individual markers, we then investigated the combined effect of these miR-SNPs. Patients with both the XPO5 AA/CC and TRBP TT/TC genotypes had the shortest DFS (P = 0.008) and OS (P = 0.008). Conclusion: miR-SNPs can add useful prognostic information on treatment-related toxicity and clinical outcome in Hodgkin lymphoma and can be used to identify patients likely to be chemoresistant or to relapse.	[Navarro, Alfons; Munoz, Carmen; Tejero, Rut; Diaz, Tania; Monzo, Mariano] Univ Barcelona, Sch Med, IDIBAPS, Human Anat Unit,Mol Oncol & Embryol Lab, Barcelona, Spain; [Gaya, Anna; Diaz-Beya, Marina] Hosp Clin Barcelona, IDIBAPS, Dept Hematol, Barcelona, Spain; [Diaz-Beya, Marina] Josep Carreras Leukaemia Res Inst, Barcelona, Spain; [Gel, Bernat] Inst Predict & Personalized Med Canc IMPPC, Hereditary Canc Program, Badalona, Spain; [Martinez, Antonio] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona; Hospital Clinic de Barcelona	Navarro, A (corresponding author), Univ Barcelona, Sch Med, IDIBAPS, Human Anat Unit,Mol Oncol & Embryol Lab, Barcelona, Spain.	anavarroponz@ub.edu	Gel Moreno, Bernat/B-8806-2016; Martinez, Antonio/D-8188-2012; Navarro, Alfons/C-2453-2015; MARTINEZ, ANTONIO/AAB-2633-2020	Gel Moreno, Bernat/0000-0001-8878-349X; Martinez, Antonio/0000-0003-0790-9017; Navarro, Alfons/0000-0001-6071-0926; MARTINEZ, ANTONIO/0000-0003-0790-9017; Tejero-Villalba, Rut/0000-0001-5134-4813; MONZO, MARIANO/0000-0003-2322-4851; Diaz-Beya, Marina/0000-0001-9624-2597	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III [FIS-PI0900547]; Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Sociedad Espanola de Hematologia y Hemoterapia (SEHH)	This work was supported by a grant from Fondo de Investigaciones Sanitarias/Instituto de Salud Carlos III (FIS-PI0900547). Rut Tejero is an APIF fellow of the University of Barcelona. Marina Diaz-Beya is supported by Sociedad Espanola de Hematologia y Hemoterapia (SEHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani R, 2011, HEMATOL-AM SOC HEMAT, P310, DOI 10.1182/asheducation-2011.1.310; Armitage JO, 2010, NEW ENGL J MED, V363, P653, DOI 10.1056/NEJMra1003733; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bertino JR, 2007, PHARMACOGENOMICS, V8, P1625, DOI 10.2217/14622416.8.12.1625; Blum KA, 2010, ANN ONCOL, V21, P2246, DOI 10.1093/annonc/mdq211; Boni V, 2011, PHARMACOGENOMICS J, V11, P429, DOI 10.1038/tpj.2010.58; Campayo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022509; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; Cordano P, 2005, BRIT J HAEMATOL, V128, P493, DOI 10.1111/j.1365-2141.2004.05353.x; COX DR, 1972, J R STAT SOC B, V34, P187; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Draube A, 2006, CLIN LYMPHOMA MYELOM, V6, P458, DOI 10.3816/CLM.2006.n.026; Duggan DB, 2003, J CLIN ONCOL, V21, P607, DOI 10.1200/JCO.2003.12.086; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; de Larrea CF, 2012, CLIN CANCER RES, V18, P3697, DOI 10.1158/1078-0432.CCR-12-0191; Fung HC, 2002, HEMATOL ONCOL, V20, P1, DOI 10.1002/hon.683; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hsi ED, 2008, LEUKEMIA LYMPHOMA, V49, P1668, DOI 10.1080/10428190802163339; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Josting A, 2000, CURR OPIN ONCOL, V12, P403, DOI 10.1097/00001622-200009000-00004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LONGO DL, 1986, J CLIN ONCOL, V4, P1295, DOI 10.1200/JCO.1986.4.9.1295; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Monroy CM, 2011, MOL CARCINOGEN, V50, P825, DOI 10.1002/mc.20747; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Nie K, 2008, AM J PATHOL, V173, P242, DOI 10.2353/ajpath.2008.080009; Ribrag V, 2009, BLOOD, V113, P3307, DOI 10.1182/blood-2008-03-148874; Roberts R, 2008, J CARDIOVASC TRANSL, V1, P11, DOI 10.1007/s12265-007-9001-1; Rueda A, 2006, CLIN LYMPHOMA MYELOM, V6, P389, DOI 10.3816/CLM.2006.n.015; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; Sul JK, 2006, SEMIN ONCOL, V33, P324, DOI 10.1053/j.seminoncol.2006.03.006; Van Vlierberghe P, 2009, BRIT J HAEMATOL, V147, P686, DOI 10.1111/j.1365-2141.2009.07909.x; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yazbeck Victor, 2006, Future Oncol, V2, P533, DOI 10.2217/14796694.2.4.533; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480	58	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64716	10.1371/journal.pone.0064716	http://dx.doi.org/10.1371/journal.pone.0064716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705004	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200158
J	Niibori-Nambu, A; Midorikawa, U; Mizuguchi, S; Hide, T; Nagai, M; Komohara, Y; Nagayama, M; Hirayama, M; Kobayashi, D; Tsubota, N; Takezaki, T; Makino, K; Nakamura, H; Takeya, M; Kuratsu, J; Araki, N				Niibori-Nambu, Akiko; Midorikawa, Uichi; Mizuguchi, Souhei; Hide, Takuichiro; Nagai, Minako; Komohara, Yoshihiro; Nagayama, Megumi; Hirayama, Mio; Kobayashi, Daiki; Tsubota, Nobuyuki; Takezaki, Tatsuya; Makino, Keishi; Nakamura, Hideo; Takeya, Motohiro; Kuratsu, Junichi; Araki, Norie			Glioma Initiating Cells Form a Differentiation Niche Via the Induction of Extracellular Matrices and Integrin alpha V	PLOS ONE			English	Article							STEM; GLIOBLASTOMA; FIBRONECTIN; MIGRATION	Glioma initiating cells (GICs) are considered responsible for the therapeutic resistance and recurrence of malignant glioma. To clarify the molecular mechanism of GIC maintenance/differentiation, we established GIC clones having the potential to differentiate into malignant gliomas, and subjected to DNA microarray/iTRAQ based integrated proteomics. 21,857 mRNAs and 8,471 proteins were identified and integrated into a gene/protein expression analysis chart. Gene Ontology analysis revealed that the expression of cell adhesion molecules, including integrin subfamilies, such as alpha 2 and alpha, and extracellular matrices (ECMs), such as collagen IV (COL4), laminin alpha 2 (LAMA2), and fibronectin 1 (FN), was significantly upregulated during serum-induced GIC differentiation. This differentiation process, accompanied by the upregulation of MAPK as well as glioma specific proteins in GICs, was dramatically accelerated in these ECM (especially FN)-coated dishes. Integrin alpha V blocking antibody and RGD peptide significantly suppressed early events in GIC differentiation, suggesting that the coupling of ECMs to integrin alpha V is necessary for GIC differentiation. In addition, the expression of integrin alpha V and its strong ligand FN was prominently increased in glioblastomas developed from mouse intracranial GIC xenografts. Interestingly, during the initial phase of GIC differentiation, the RGD treatment significantly inhibited GIC proliferation and raised their sensitivity against anti-cancer drug temozolomide (TMZ). We also found that combination treatments of TMZ and RGD inhibit glioma progression and lead the longer survival of mouse intracranial GIC xenograft model. These results indicate that GICs induce/secrete ECMs to develop microenvironments with serum factors, namely differentiation niches that further stimulate GIC differentiation and proliferation via the integrin recognition motif RGD. A combination of RGD treatment with TMZ could have the higher inhibitory potential against the glioma recurrence that may be regulated by the GICs in the differentiation niche. This study provides a new perspective for developing therapeutic strategies against the early onset of GIC-associated glioma.	[Niibori-Nambu, Akiko; Midorikawa, Uichi; Mizuguchi, Souhei; Nagai, Minako; Nagayama, Megumi; Hirayama, Mio; Kobayashi, Daiki; Tsubota, Nobuyuki; Araki, Norie] Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto, Japan; [Midorikawa, Uichi] Sharp Co Ltd, Healthcare Syst Labs, Chiba, Japan; [Hide, Takuichiro; Tsubota, Nobuyuki; Takezaki, Tatsuya; Makino, Keishi; Nakamura, Hideo; Kuratsu, Junichi] Kumamoto Univ, Dept Neurosurg, Grad Sch Med Sci, Kumamoto, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan	Kumamoto University; Hisense; Sharp Corporation; Kumamoto University; Kumamoto University	Araki, N (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Kumamoto, Japan.	nori@gpo.kumamoto-u.ac.jp		Kobayashi, Daiki/0000-0003-4131-5220	Ministry of Health, Labor and Welfare of Japan; Houga Research [23659693]; Exploratory Research for Young Scientists from Ministry of Education, Science, Sports, and Culture of Japan [22700905]; COE project B of Kumamoto University; Grants-in-Aid for Scientific Research [25293312, 24700981] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Houga Research; Exploratory Research for Young Scientists from Ministry of Education, Science, Sports, and Culture of Japan; COE project B of Kumamoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan (NA), Houga Research (NA) (grant number 23659693), Exploratory Research for Young Scientists (B) (A.NN) (grant number 22700905) from the Ministry of Education, Science, Sports, and Culture of Japan; and from the COE project B of Kumamoto University for proteomic research and education (NA) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Chang HC, 2010, CELL TRANSPLANTATION; Cosset EC, 2011, INT J CANC; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fukushima Y, 2007, J NEUROSURG, V107, P578, DOI 10.3171/JNS-07/09/0578; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hirayama M, 2013, MOL CELLULAR PROTEOM; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Ohka F, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878425; Ohnishi T, 1998, CLIN EXP METASTAS, V16, P729, DOI 10.1023/A:1006532812408; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Pimton P, 2011, CELL ADHES MIGR, V5, P73, DOI 10.4161/cam.5.1.13704; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Rich JN, 2007, CELL STEM CELL, V1, P353, DOI 10.1016/j.stem.2007.09.011; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, ANN ONCOL, V16, P64, DOI 10.1093/annonc/mdi834; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039	26	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e59558	10.1371/journal.pone.0059558	http://dx.doi.org/10.1371/journal.pone.0059558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704872	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200001
J	Sporbert, A; Cseresnyes, Z; Heidbreder, M; Domaing, P; Hauser, S; Kaltschmidt, B; Kaltschmidt, C; Heilemann, M; Widera, D				Sporbert, Anje; Cseresnyes, Zoltan; Heidbreder, Meike; Domaing, Petra; Hauser, Stefan; Kaltschmidt, Barbara; Kaltschmidt, Christian; Heilemann, Mike; Widera, Darius			Simple Method for Sub-Diffraction Resolution Imaging of Cellular Structures on Standard Confocal Microscopes by Three-Photon Absorption of Quantum Dots	PLOS ONE			English	Article							STEM-CELLS; HIV	This study describes a simple technique that improves a recently developed 3D sub-diffraction imaging method based on three-photon absorption of commercially available quantum dots. The method combines imaging of biological samples via tri-exciton generation in quantum dots with deconvolution and spectral multiplexing, resulting in a novel approach for multi-color imaging of even thick biological samples at a 1.4 to 1.9-fold better spatial resolution. This approach is realized on a conventional confocal microscope equipped with standard continuous-wave lasers. We demonstrate the potential of multi-color tri-exciton imaging of quantum dots combined with deconvolution on viral vesicles in lentivirally transduced cells as well as intermediate filaments in three-dimensional clusters of mouse-derived neural stem cells (neurospheres) and dense microtubuli arrays in myotubes formed by stacks of differentiated C2C12 myoblasts.	[Sporbert, Anje; Cseresnyes, Zoltan; Domaing, Petra] Max Delbruck Ctr Mol Med, Confocal & Photon Microscopy Core Facil 2, Berlin, Germany; [Heidbreder, Meike] Univ Wurzburg, Dept Biotechnol & Biophys, D-97070 Wurzburg, Germany; [Hauser, Stefan; Kaltschmidt, Barbara; Widera, Darius] Univ Bielefeld, D-33615 Bielefeld, Germany; [Kaltschmidt, Barbara; Kaltschmidt, Christian; Widera, Darius] Univ Bielefeld, LiMiTec, D-33615 Bielefeld, Germany; [Heilemann, Mike] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; University of Bielefeld; University of Bielefeld; Goethe University Frankfurt	Sporbert, A (corresponding author), Max Delbruck Ctr Mol Med, Confocal & Photon Microscopy Core Facil 2, Berlin, Germany.	asporb@mdc-berlin.de; darius.widera@uni-bielefeld.de	Cseresnyes, Zoltan/AAG-4266-2020; Widera, Darius/J-4237-2012	Widera, Darius/0000-0003-1686-130X; Cseresnyes, Zoltan/0000-0002-6574-2588; Heilemann, Mike/0000-0002-9821-3578; Hauser, Stefan/0000-0002-1022-7482	DFG Grant [NI 1167/3-1]; BMBF (FORSYS) [0315262, 01GN1006A]; DFG, The German Research Foundation; FiF grant of the University of Bielefeld; Deutsche Forschungsgemeinschaft (DFG); Open Access Publication Funds of Bielefeld University Library	DFG Grant(German Research Foundation (DFG)); BMBF (FORSYS)(Federal Ministry of Education & Research (BMBF)); DFG, The German Research Foundation(German Research Foundation (DFG)); FiF grant of the University of Bielefeld; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	AS and ZC are supported by a DFG Grant for Core Facilities (NI 1167/3-1). MiHeidbreder and MHeilemann are grateful for funding by the BMBF (FORSYS, grant nr. 0315262). SH and BK are supported by the BMBF (grant nr. BMBF, grant: 01GN1006A.). CK is grateful for funding by the DFG, The German Research Foundation. DW was supported by a FiF grant of the University of Bielefeld. The authors acknowledge the support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Fisher B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087403; Franceschetti A, 2007, J PHYS CHEM C, V111, P6154, DOI 10.1021/jp070223c; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Heidbreder M, 2010, BBA-MOL CELL RES, V1803, P1224, DOI 10.1016/j.bbamcr.2010.06.004; Heilemann M, 2010, J BIOTECHNOL, V149, P243, DOI 10.1016/j.jbiotec.2010.03.012; Hennig S, 2009, NANO LETT, V9, P2466, DOI 10.1021/nl9012387; Huang B, 2010, CURR OPIN CHEM BIOL, V14, P10, DOI 10.1016/j.cbpa.2009.10.013; Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244; Kaltschmidt C, 2012, STEM CELL REV; Kontrogianni-Konstantopoulos A, 2006, AM J PHYSIOL-CELL PH, V290, pC626, DOI 10.1152/ajpcell.00442.2005; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; Martin I, 2012, STEM CELL REV; Muranyi W, 2012, HISTOCHEM CELL BIOL; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Pereira CF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-84; Prins KC, 2012, JOVE-J VIS EXP, DOI 10.3791/3757; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Sibarita JB, 2005, ADV BIOCHEM ENG BIOT, V95, P201, DOI 10.1007/b102215; vanKempen GMP, 1996, IEEE ENG MED BIOL, V15, P76, DOI 10.1109/51.482846; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64	24	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64023	10.1371/journal.pone.0064023	http://dx.doi.org/10.1371/journal.pone.0064023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700448	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200106
J	Su, RJ; Baylink, DJ; Neises, A; Kiroyan, JB; Meng, XM; Payne, KJ; Tschudy-Seney, B; Duan, YY; Appleby, N; Kearns-Jonker, M; Gridley, DS; Wang, J; Lau, KHW; Zhang, XB				Su, Rui-Jun; Baylink, David J.; Neises, Amanda; Kiroyan, Jason B.; Meng, Xianmei; Payne, Kimberly J.; Tschudy-Seney, Benjamin; Duan, Yuyou; Appleby, Nancy; Kearns-Jonker, Mary; Gridley, Daila S.; Wang, Jun; Lau, K. -H. William; Zhang, Xiao-Bing			Efficient Generation of Integration-Free iPS Cells from Human Adult Peripheral Blood Using BCL-XL Together with Yamanaka Factors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; CORD BLOOD; LENTIVIRAL VECTOR; GENE-EXPRESSION; HIV VECTORS; T-CELLS; DIFFERENTIATION; PLASMID	The ability to efficiently generate integration-free induced pluripotent stem cells (iPSCs) from the most readily available source-peripheral blood-has the potential to expedite the advances of iPSC-based therapies. We have successfully generated integration-free iPSCs from cord blood (CB) CD34(+) cells with improved oriP/EBNA1-based episomal vectors (EV) using a strong spleen focus forming virus ( SFFV) long terminal repeat (LTR) promoter. Here we show that Yamanaka factors (OCT4, SOX2, MYC, and KLF4)-expressing EV can also reprogram adult peripheral blood mononuclear cells (PBMNCs) into pluripotency, yet at a very low efficiency. We found that inclusion of BCL-XL increases the reprogramming efficiency by approximately 10-fold. Furthermore, culture of CD3(-)/CD19(-) cells or T/B cell-depleted MNCs for 4-6 days led to the generation of 20-30 iPSC colonies from 1 ml PB, an efficiency that is substantially higher than previously reported. PB iPSCs express pluripotency markers, form teratomas, and can be induced to differentiate in vitro into mesenchymal stem cells, cardiomyocytes, and hepatocytes. Used together, our optimized factor combination and reprogramming strategy lead to efficient generation of integration-free iPSCs from adult PB. This discovery has potential applications in iPSC banking, disease modeling and regenerative medicine.	[Su, Rui-Jun; Baylink, David J.; Neises, Amanda; Kiroyan, Jason B.; Meng, Xianmei; Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Su, Rui-Jun; Payne, Kimberly J.; Appleby, Nancy; Kearns-Jonker, Mary] Loma Linda Univ, Div Anat, Loma Linda, CA 92350 USA; [Su, Rui-Jun; Payne, Kimberly J.] Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Tschudy-Seney, Benjamin; Duan, Yuyou] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Dept Internal Med, Sacramento, CA 95817 USA; [Gridley, Daila S.] Loma Linda Univ, Dept Radiat Med, Loma Linda, CA 92350 USA; [Wang, Jun] Loma Linda Univ, Dept Pathol, Loma Linda, CA 92350 USA; [Lau, K. -H. William] Jerry L Pettis Mem VA Med Ctr, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University; University of California System; University of California Davis; Loma Linda University; Loma Linda University	Zhang, XB (corresponding author), Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA.	xzhang@llu.edu	Payne, Kimberly/AAS-6814-2020; Duan, Yuyou/L-2301-2015; Gridley, Daila S/P-7711-2015	Payne, Kimberly/0000-0002-7025-5821; Duan, Yuyou/0000-0002-1402-7402; Kearns-Jonker, Mary/0000-0002-8989-3698; Lau, Kin-Hing/0000-0003-1109-5052; Zhang, Xiao-Bing/0000-0003-4319-6181	NSF Grant [MRI-DBI 0923559]; Loma Linda University (LLU) School of Medicine; Loma Linda University; GRASP Award; Department of Defense (DOD) Concept Award [W81XWH-11-1-0607]; United States Army Medical Research Acquisition Activity (USAMRAA) Grant [W81XWH-12-1-0023]; Division of Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine at LLU; Radiation Research Laboratories in the Department of Radiation Medicine at LLU	NSF Grant(National Science Foundation (NSF)); Loma Linda University (LLU) School of Medicine; Loma Linda University; GRASP Award; Department of Defense (DOD) Concept Award; United States Army Medical Research Acquisition Activity (USAMRAA) Grant; Division of Anatomy; Department of Basic Sciences; Center for Health Disparities and Molecular Medicine at LLU; Radiation Research Laboratories in the Department of Radiation Medicine at LLU	Imaging was performed in the LLUSM Advanced Imaging and Microscopy Core that is supported by NSF Grant No. MRI-DBI 0923559 (Sean M Wilson) and the Loma Linda University (LLU) School of Medicine. The authors thank Monica Rubalcava for technical support in confocal imaging.; This work was supported by Loma Linda University (LLU) GRASP Award (XBZ), and Department of Defense (DOD) Concept Award W81XWH-11-1-0607 (XBZ), United States Army Medical Research Acquisition Activity (USAMRAA) Grant W81XWH-12-1-0023 (DJB), and the Division of Anatomy, the Department of Basic Sciences, the Center for Health Disparities and Molecular Medicine at LLU (KJP and RJS) and Radiation Research Laboratories in the Department of Radiation Medicine at LLU (DSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bai H, 2012, STEM CELL RES, V8, P26, DOI 10.1016/j.scr.2011.08.002; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Daley GQ, 2012, CELL, V151, P1151, DOI 10.1016/j.cell.2012.11.016; De Palma M, 2005, BLOOD, V105, P2307, DOI 10.1182/blood-2004-03-0798; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hu KJ, 2011, BLOOD, V117, pE109, DOI 10.1182/blood-2010-07-298331; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jaenisch R, 2012, CELL STEM CELL, V11, P744, DOI 10.1016/j.stem.2012.11.005; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Jin ZB, 2012, STEM CELL TRANSL MED, V1, P503, DOI 10.5966/sctm.2012-0005; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Meng XM, 2013, CELL RES, V23, P658, DOI 10.1038/cr.2013.40; Meng XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037569; Meng XM, 2012, MOL THER, V20, P408, DOI 10.1038/mt.2011.258; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042855; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rajesh D, 2011, BLOOD, V118, P1797, DOI 10.1182/blood-2011-01-332064; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Su RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059908; Surani MA, 2012, CELL STEM CELL, V11, P748, DOI 10.1016/j.stem.2012.11.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Williams DA, 1999, ANN NY ACAD SCI, V872, P109, DOI 10.1111/j.1749-6632.1999.tb08457.x; Williams DA, 1999, ANN NY ACAD SCI, V872, P113; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173; Zhang XB, 2007, STEM CELLS, V25, P2074, DOI 10.1634/stemcells.2006-0742; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	85	59	71	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64496	10.1371/journal.pone.0064496	http://dx.doi.org/10.1371/journal.pone.0064496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704989	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200143
J	Giampa, C; Montagna, E; Dato, C; Melone, MAB; Bernardi, G; Fusco, FR				Giampa, Carmela; Montagna, Elena; Dato, Clemente; Melone, Mariarosa A. B.; Bernardi, Giorgio; Fusco, Francesca Romana			Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; WILD-TYPE HUNTINGTIN; BLOOD-BRAIN; CELLULAR-LOCALIZATION; CORTICAL-NEURONS; BINDING-PROTEIN; RAT; TRANSCRIPTION; CREB; NEUROINFLAMMATION	Loss of huntingtin-mediated BDNF gene transcription has been shown to occur in HD and thus contribute to the degeneration of the striatum. Several studies have indicated that an increase in BDNF levels is associated with neuroprotection and amelioration of neurological signs in animal models of HD. In a recent study, an increase in BDNF mRNA and protein levels was recorded in mice administered recombinant BDNF peripherally. Chronic, indwelling osmotic mini-pumps containing either recombinant BDNF or saline were surgically placed in R6/2 or wild-type mice from 4 weeks of age until euthanasia. Neurological evaluation (paw clasping, rotarod performance, locomotor activity in an open field) was performed. After transcardial perfusion, histological and immunohistochemical studies were performed. We found that BDNF-treated R6/2 mice survived longer and displayed less severe signs of neurological dysfunction than the vehicle treated ones. Primary outcome measures such as brain volume, striatal atrophy, size and morphology of striatal neurons, neuronal intranuclear inclusions and microglial reaction confirmed a neuroprotective effect of the compound. BDNF was effective in increasing significantly the levels of activated CREB and of BDNF the striatal spiny neurons. Moreover, systemically administered BDNF increased the synthesis of BDNF as demonstrated by RT-PCR, and this might account for the beneficial effects observed in this model.	[Giampa, Carmela; Montagna, Elena; Dato, Clemente; Bernardi, Giorgio; Fusco, Francesca Romana] European Ctr Brain Res, Lab Neuroanat, Santa Lucia Fdn IRCCS Hosp, Rome, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Melone, Mariarosa A. B.] Univ Naples 2, Div Neurol, Dept Clin & Expt Med & Surg, Naples, Italy; [Melone, Mariarosa A. B.] CNR, Inst Prot Biochem, I-80125 Naples, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Fusco, FR (corresponding author), European Ctr Brain Res, Lab Neuroanat, Santa Lucia Fdn IRCCS Hosp, Rome, Italy.	f.fusco@hsantalucia.it	Melone, Mariarosa Anna Beatrice/N-6788-2015; Fusco, Francesca R/K-1080-2018; terracciano, chiara/C-2955-2018	Melone, Mariarosa Anna Beatrice/0000-0002-7213-9277; Fusco, Francesca R/0000-0003-2226-523X; terracciano, chiara/0000-0002-1853-5578; , Giampa/0000-0002-1763-5665	Italian Department of Health [RC12C]	Italian Department of Health	The work has been supported by grant RC12C of the Italian Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Ciammola A, 2007, AM J MED GENET B, V144B, P574, DOI 10.1002/ajmg.b.30501; Conner JM, 1997, J NEUROSCI, V17, P2295; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; FigueredoCardenas G, 1997, EXP NEUROL, V146, P444, DOI 10.1006/exnr.1997.6549; Fusco FR, 1999, J NEUROSCI, V19, P1189; Fusco FR, 2003, EUR J NEUROSCI, V18, P1093, DOI 10.1046/j.1460-9568.2003.02844.x; Fusco FR, 2012, NEUROBIOL DIS, V46, P225, DOI 10.1016/j.nbd.2012.01.011; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Giampa C, 2006, EUR J NEUROSCI, V23, P11, DOI 10.1111/j.1460-9568.2005.04545.x; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giampa C, 2009, EUR J NEUROSCI, V29, P902, DOI 10.1111/j.1460-9568.2009.06649.x; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Givalois L, 2006, J ENDOCRINOL, V188, P425, DOI 10.1677/joe.1.06578; Harry GJ, 2008, EXPERT OPIN DRUG MET, V4, P1265, DOI [10.1517/17425255.4.10.1265, 10.1517/17425255.4.10.1265 ]; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Moller T, 2006, SEMIN THROMB HEMOST, V32, P69, DOI 10.1055/s-2006-939556; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Nakao N, 1995, DEV BRAIN RES, V90, P92, DOI 10.1016/0165-3806(96)83489-4; Pan WH, 1999, ADV DRUG DELIVER REV, V36, P291, DOI 10.1016/S0169-409X(98)00086-6; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perez-Navarro E, 2000, J NEUROCHEM, V75, P2190, DOI 10.1046/j.1471-4159.2000.0752190.x; Petersen A, 2001, BRAIN RES BULL, V56, P331, DOI 10.1016/S0361-9230(01)00580-9; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Sakane T, 1997, PHARMACEUT RES, V14, P1085, DOI 10.1023/A:1012117815460; SALIN T, 1995, NEUROSCI LETT, V194, P181, DOI 10.1016/0304-3940(95)11772-O; Schmidt HD, 2010, NEUROPSYCHOPHARMACOL, V35, P2378, DOI 10.1038/npp.2010.114; Schmidt Heath D, 2008, Drug Discov Today Ther Strateg, V5, P151, DOI 10.1016/j.ddstr.2008.10.003; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; WILSON RS, 1987, J CLIN EXP NEUROPSYC, V9, P147, DOI 10.1080/01688638708405354; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1992, J NEUROSCI, V12, P4793; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	56	65	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64037	10.1371/journal.pone.0064037	http://dx.doi.org/10.1371/journal.pone.0064037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700454	Green Submitted, Green Published, gold			2022-12-25	WOS:000319966400045
J	Gunawan, A; Sahadevan, S; Neuhoff, C; Grosse-Brinkhaus, C; Gad, A; Frieden, L; Tesfaye, D; Tholen, E; Looft, C; Uddin, MJ; Schellander, K; Cinar, MU				Gunawan, Asep; Sahadevan, Sudeep; Neuhoff, Christiane; Grosse-Brinkhaus, Christine; Gad, Ahmed; Frieden, Luc; Tesfaye, Dawit; Tholen, Ernst; Looft, Christian; Uddin, Muhammad Jasim; Schellander, Karl; Cinar, Mehmet Ulas			RNA Deep Sequencing Reveals Novel Candidate Genes and Polymorphisms in Boar Testis and Liver Tissues with Divergent Androstenone Levels	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; MATURE DOMESTIC BOAR; ENTIRE MALE PIGS; 16-ANDROSTENE STEROIDS; EXPRESSION PROFILES; CARCASS QUALITY; ADIPOSE-TISSUE; MEAT QUALITY; TAINT	Boar taint is an unpleasant smell and taste of pork meat derived from some entire male pigs. The main causes of boar taint are the two compounds androstenone (5 alpha-androst-16-en-3-one) and skatole (3-methylindole). It is crucial to understand the genetic mechanism of boar taint to select pigs for lower androstenone levels and thus reduce boar taint. The aim of the present study was to investigate transcriptome differences in boar testis and liver tissues with divergent androstenone levels using RNA deep sequencing (RNA-Seq). The total number of reads produced for each testis and liver sample ranged from 13,221,550 to 33,206,723 and 12,755,487 to 46,050,468, respectively. In testis samples 46 genes were differentially regulated whereas 25 genes showed differential expression in the liver. The fold change values ranged from -4.68 to 2.90 in testis samples and -2.86 to 3.89 in liver samples. Differentially regulated genes in high androstenone testis and liver samples were enriched in metabolic processes such as lipid metabolism, small molecule biochemistry and molecular transport. This study provides evidence for transcriptome profile and gene polymorphisms of boars with divergent androstenone level using RNA-Seq technology. Digital gene expression analysis identified candidate genes in flavin monooxygenease family, cytochrome P450 family and hydroxysteroid dehydrogenase family. Moreover, polymorphism and association analysis revealed mutation in IRG6, MX1, IFIT2, CYP7A1, FMO5 and KRT18 genes could be potential candidate markers for androstenone levels in boars. Further studies are required for proving the role of candidate genes to be used in genomic selection against boar taint in pig breeding programs.	[Gunawan, Asep; Sahadevan, Sudeep; Neuhoff, Christiane; Grosse-Brinkhaus, Christine; Gad, Ahmed; Frieden, Luc; Tesfaye, Dawit; Tholen, Ernst; Looft, Christian; Uddin, Muhammad Jasim; Schellander, Karl; Cinar, Mehmet Ulas] Univ Bonn, Inst Anim Sci, Bonn, Germany; [Gunawan, Asep] Bogor Agr Univ, Fac Anim Sci, Dept Anim Prod & Technol, Bogor, Indonesia; [Gad, Ahmed] Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt; [Uddin, Muhammad Jasim] Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh, Bangladesh	University of Bonn; Bogor Agricultural University; Egyptian Knowledge Bank (EKB); Cairo University; Bangladesh Agricultural University (BAU)	Cinar, MU (corresponding author), Univ Bonn, Inst Anim Sci, Bonn, Germany.	ucin@itw.uni-bonn.de	Gunawan, Asep/GON-4264-2022; Gad, Ahmed/M-7273-2013; Uddin, Muhammad Jasim/P-8497-2019; Uddin, Muhammad Jasim/N-3866-2013; Große-Brinkhaus, Christine/AAF-6712-2020	Gad, Ahmed/0000-0001-9741-2105; Uddin, Muhammad Jasim/0000-0002-6732-5534; Große-Brinkhaus, Christine/0000-0002-6190-4463; Gunawan, Asep/0000-0003-0468-2443	Federal Ministry of Food, Agriculture and Consumer Protection, Germany (BMELV); Federal Institute of Agriculture and Food, Germany (BLE); State of North Rhine Westphalia; programme USL "Umweltvertragliche und Standortgerechte Landwirtschaft"	Federal Ministry of Food, Agriculture and Consumer Protection, Germany (BMELV); Federal Institute of Agriculture and Food, Germany (BLE); State of North Rhine Westphalia; programme USL "Umweltvertragliche und Standortgerechte Landwirtschaft"	This work was financially supported by the Federal Ministry of Food, Agriculture and Consumer Protection, Germany (BMELV), the Federal Institute of Agriculture and Food, Germany (BLE) and State of North Rhine Westphalia with the programme USL "Umweltvertragliche und Standortgerechte Landwirtschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluwe M, 2011, ANIMAL, V5, P1283, DOI 10.1017/S1751731111000164; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANDRESEN O, 1974, ACTA ENDOCRINOL-COP, V76, P377; [Anonymous], 2011, EFFECT ANDROSTENONE; Baker ME, 2001, MOL CELL ENDOCRINOL, V171, P211, DOI 10.1016/S0303-7207(00)00414-7; Bauer BK, 2010, BIOL REPROD, V83, P791, DOI 10.1095/biolreprod.110.085936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bonneau M, 1998, MEAT SCI, V49, pS257, DOI 10.1016/S0309-1740(98)00089-8; Cashman JR, 2005, BIOCHEM BIOPH RES CO, V338, P599, DOI 10.1016/j.bbrc.2005.08.009; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Chang H, 2009, BIOL REPROD, V81, P842, DOI 10.1095/biolreprod.109.077446; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Cinar MU, 2012, MOL BIOL REP, V39, P4809, DOI 10.1007/s11033-011-1274-4; Davis AM, 1998, P SOC EXP BIOL MED, V217, P466, DOI 10.3181/00379727-217-44259; Davis SM, 1999, J ANIM SCI, V77, P1230; Doran E, 2004, CHEM-BIOL INTERACT, V147, P141, DOI 10.1016/j.cbi.2003.12.002; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Fischer J, 2011, ANAL CHEM, V83, P6785, DOI 10.1021/ac201465q; Frieden L, 2011, BREEDING REDUCED BOA; Glenn KL, 2007, J ANIM BREED GENET, V124, P35, DOI 10.1111/j.1439-0388.2007.00631.x; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; GOWER DB, 1972, J STEROID BIOCHEMIST, V3, P45, DOI 10.1016/0022-4731(72)90011-8; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Grindflek E, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-4; Haugen JE, 2012, MEAT SCI, V90, P9, DOI 10.1016/j.meatsci.2011.07.005; KATKOV T, 1970, BIOCHEM J, V117, P533, DOI 10.1042/bj1170533; Kayan A, 2011, MEAT SCI, V89, P76, DOI 10.1016/j.meatsci.2011.04.001; Kayan A, 2011, MEAT SCI, V88, P755, DOI 10.1016/j.meatsci.2011.03.009; Khandelwal P, 2012, MOL VIS, V18, P1055; KWAN TK, 1985, FEBS LETT, V183, P359, DOI 10.1016/0014-5793(85)80810-3; Lee GJ, 2005, ANIM GENET, V36, P14, DOI 10.1111/j.1365-2052.2004.01214.x; Leung MCK, 2010, ANIM BIOTECHNOL, V21, P77, DOI 10.1080/10495390903500607; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moe M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-405; Moe M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-29; Morlein D, 2012, MEAT SCI; Morozumi T, 2001, BIOCHEM GENET, V39, P251, DOI 10.1023/A:1010230715605; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nicolau-Solano SI, 2006, J ANIM SCI, V84, P2809, DOI 10.2527/jas.2005-595; Pauly C, 2008, ANIMAL, V2, P1707, DOI 10.1017/S1751731108002826; Ponsuksili S, 2011, J LIPID RES, V52, P668, DOI 10.1194/jlr.M013342; Quintanilla R, 2003, J ANIM SCI, V81, P385; Ren DR, 2009, J ANIM SCI, V87, P17, DOI 10.2527/jas.2008-0923; Rizner TL, 2003, ENDOCRINOLOGY, V144, P2922, DOI 10.1210/en.2002-0032; Robic A, 2011, ANIM GENET, V42, P662, DOI 10.1111/j.1365-2052.2011.02195.x; Robic A, 2008, GENET SEL EVOL, V40, P129, DOI 10.1051/gse:2007040; Rozen S, 2000, Methods Mol Biol, V132, P365; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sellier P, 2000, LIVEST PROD SCI, V63, P265, DOI 10.1016/S0301-6226(99)00127-X; Sendler E, 2011, ANAL BIOCHEM, V419, P317, DOI 10.1016/j.ab.2011.08.013; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinclair PA, 2005, J ANIM SCI, V83, P358; Sinclair PA, 2005, J STEROID BIOCHEM, V96, P79, DOI 10.1016/j.jsbmb.2005.01.030; Sinclair PA, 2005, J STEROID BIOCHEM, V96, P217, DOI 10.1016/j.jsbmb.2005.02.017; Tajet H., 2006, ACTA VET SCAND, V48, pS9, DOI [DOI 10.1186/1751-0147-48-S1-S9, 10.1186/1751-0147-48-S1-S9]; Wackers F, 2011, J FOOD SCI, V76, pS41, DOI 10.1111/j.1750-3841.2010.01887.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wesoly Raffael, 2012, Animals (Basel), V2, P221, DOI 10.3390/ani2020221; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; ZDS, 2003, RICHTL FUER STAT MAS	69	33	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63259	10.1371/journal.pone.0063259	http://dx.doi.org/10.1371/journal.pone.0063259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696805	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900019
J	Stinson, K; Jennings, K; Myer, L				Stinson, Kathryn; Jennings, Karen; Myer, Landon			Integration of Antiretroviral Therapy Services into Antenatal Care Increases Treatment Initiation during Pregnancy: A Cohort Study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SOUTH-AFRICA; CAPE-TOWN; HIV CARE; WOMEN; PREVENTION; SETTINGS; LILONGWE; MALAWI; TIME	Objectives: Initiation of antiretroviral therapy (ART) during pregnancy is critical to promote maternal health and prevent mother-to-child HIV transmission (PMTCT). The separation of services for antenatal care (ANC) and ART may hinder antenatal ART initiation. We evaluated ART initiation during pregnancy under different service delivery models in Cape Town, South Africa. Methods: A retrospective cohort study was conducted using routinely collected clinic data. Three models for ART initiation in pregnancy were evaluated ART 'integrated' into ANC, ART located 'proximal' to ANC, and ART located some distance away from ANC ('distal'). Kaplan-Meier methods and Poisson regression were used to examine the association between service delivery model and antenatal ART initiation. Results: Among 14 617 women seeking antenatal care in the three services, 30% were HIV-infected and 17% were eligible for ART based on CD4 cell count <200 cells/mu L. A higher proportion of women started ART antenatally in the integrated model compared to the proximal or distal models (55% vs 38% vs 45%, respectively, global p = 0.003). After adjusting for age and gestation at first ANC visit, women who at the integrated service were significantly more likely to initiate ART antenatally (rate ratio 1.33; 95% confidence interval: 1.09-1.64) compared to women attending the distal model; there was no difference between the proximal and distal models in antenatal ART initiation however (p = 0.704). Conclusions: Integration of ART initiation into ANC is associated with higher levels of ART initiation in pregnancy. This and other forms of service integration may represent a valuable intervention to enhance PMTCT and maternal health.	[Stinson, Kathryn; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Jennings, Karen] City Hlth Directorate, Cape Town, South Africa	University of Cape Town	Stinson, K (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa.	kathryn.stinson@uct.ac.za			International Leadership Award from the Elizabeth Glaser Pediatric AIDS Foundation	International Leadership Award from the Elizabeth Glaser Pediatric AIDS Foundation	Landon Myer is supported by an International Leadership Award from the Elizabeth Glaser Pediatric AIDS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah F, 2005, CONTINUING MED ED, V23, P261; Abrahams N, 2001, J MIDWIFERY WOM HEAL, V46, P240, DOI 10.1016/S1526-9523(01)00138-6; Abrams EJ, 2007, AM J OBSTET GYNECOL, V197, pS101, DOI 10.1016/j.ajog.2007.03.068; [Anonymous], 2007, S AFR DEM HLTH SURV; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Chen JY, 2010, JAIDS-J ACQ IMM DEF, V54, P102, DOI 10.1097/QAI.0b013e3181c080bf; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Church K, 2010, AIDS, V24, P189, DOI 10.1097/QAD.0b013e328333aeb3; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coutsoudis A, 2010, AIDS, V24, P2859, DOI 10.1097/QAD.0b013e32834041b7; Department of Health of the Western Cape, 2009, POL GUID PREV MOTH T; Ferguson L, 2012, JAIDS-J ACQ IMM DEF, V60, pE90, DOI 10.1097/QAI.0b013e318253258a; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Hussain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027907; Katz IT, 2011, AIDS, V25, P2177, DOI 10.1097/QAD.0b013e32834b6464; Kennedy Gail, 2011, SYSTEMATIC REV INTEG; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Msellati P., 2009, SOC SCI MED, V69, P809; Myer L, 2005, REPROD HEALTH MATTER, V13, P136, DOI 10.1016/S0968-8080(05)25185-6; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Myer L, 2011, JAIDS-J ACQ IMM DEF, V58, P125, DOI 10.1097/QAI.0b013e31822ad573; Nachega JB, 2012, AIDS, V26; National Department of Health, 2008, POLICY IMPLEMENTATIO, P1; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Rosenfield A, 2001, AM J PUBLIC HEALTH, V91, P703, DOI 10.2105/AJPH.91.5.703; Shigayeva A, 2010, HEALTH POLICY PLANN, V25, pi4, DOI 10.1093/heapol/czq060; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Suthar AB, 2013, B WORLD HEALTH ORGAN, V91, P46, DOI 10.2471/BLT.12.107003; Tsague L, 2010, BMC PUBLIC HEALTH, P10; van der Merwe K, 2006, J ACQ IMMUN DEF SYND, V43, P578; Weigel R, 2012, TROP MED INT HEALTH, V17, P751, DOI 10.1111/j.1365-3156.2012.02980.x; World Health Organization, 2012, PROGR UPD US ANT DRU	35	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63328	10.1371/journal.pone.0063328	http://dx.doi.org/10.1371/journal.pone.0063328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696814	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900028
J	Wang, GC; Huang, Y; Wang, EL; Yu, YQ; Zhang, W				Wang, Guocheng; Huang, Yao; Wang, Enli; Yu, Yongqiang; Zhang, Wen			Modeling Soil Organic Carbon Change across Australian Wheat Growing Areas, 1960-2010	PLOS ONE			English	Article							VERTICAL-DISTRIBUTION; CLIMATE-CHANGE; CROPLANDS; TILLAGE; TURNOVER; NITROGEN; BIOMASS; MATTER	Soil organic carbon (SOC) dynamics in Australian wheat-growing areas were simulated from 1960 to 2010 using Agro-C, a calibrated and validated biogeophysical model. Previously published data from field measurements were used to parameterize the Agro-C model. Model simulations show a decreasing trend in SOC over the last 50 years, mainly attributable to relatively low organic carbon (C) inputs. The rate of decrease in SOC tended to slow in the last two decades due primarily to an increase in wheat yields, which resulted in an increase in C input. Overall, we estimate that Australian wheat-growing areas, covering an area of 15.09 million hectares (Mha), lost 156 (86-222, 95% confidence interval) Tg C in the topsoil (to 30 cm depth) from 1960 to 2010. Approximately 80% of the SOC loss occurred in the period between the 1960s and the 1980s. Spatially, the SOC loss in areas with relatively high temperature and low precipitation, such as Queensland, the northern part of New South Wales and Western Australia, was more significant than that in other areas. We suggest that the loss of SOC could be halted, or even reversed, with an additional input of organic C into the soil at a minimum rate of 0.4 Mg ha(-1) yr(-1).	[Wang, Guocheng; Huang, Yao; Yu, Yongqiang; Zhang, Wen] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing, Peoples R China; [Huang, Yao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Wang, Guocheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Enli] Commonwealth Sci & Ind Res Org, Land & Water, Canberra, ACT, Australia	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Huang, Y (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing, Peoples R China.	huangy@mail.iap.ac.cn	Zhang, Wen/AAH-6060-2020; WANG, YUE/GWQ-9256-2022; Wang, Guocheng/M-3857-2013; Wang, Yuesi/AAF-3186-2019; Wang, Enli/K-7478-2012; huang, yao/GWR-5388-2022; Wang, Guocheng/AAJ-6674-2020; Huang, Yao/GQH-3308-2022; LAPC, IAP/AAI-6991-2020; Huang, Yao/O-6832-2014; Yu, Yongqiang/C-9661-2011	Zhang, Wen/0000-0001-6670-3057; Wang, Enli/0000-0002-6653-5791; Wang, Guocheng/0000-0002-4141-4395; Huang, Yao/0000-0002-0192-1421; LAPC, IAP/0000-0002-0025-3484; Yu, Yongqiang/0000-0002-9345-2211	National Basic Research Program of China on Global Change [2010CB50604]; National Natural Science Foundation of China [41075108]	National Basic Research Program of China on Global Change(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by the National Basic Research Program of China on Global Change (2010CB50604) and the National Natural Science Foundation of China (41075108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACLUMP (Australian Collaborative Land Use and Management Program), 2010, LAND US LAND MAN INF; Anderson G., 2009, IMPACT TILLAGE PRACT; Barrett DJ, 2001, GLOBAL CHANGE BIOL, V7, P883, DOI 10.1046/j.1354-1013.2001.00449.x; Brady N.C, 2000, NATURE PROPERTIES SO; D'Emden Llewellyn, 2009, REPORT SA NO TILL FA; Dalal RC, 2001, AUST J SOIL RES, V39, P435, DOI 10.1071/SR99042; DAVIDSON EA, 1993, BIOGEOCHEMISTRY, V20, P161, DOI 10.1007/BF00000786; Falloon P, 2006, SOIL USE MANAGE, V22, P274, DOI 10.1111/j.1475-2743.2006.00028.x; Henderson B, 2001, ASRIS CONTINENTALSCA; Huang Y, 2009, AGR FOREST METEOROL, V149, P106, DOI 10.1016/j.agrformet.2008.07.013; Huang Y, 2007, ECOL APPL, V17, P692, DOI 10.1890/05-1792; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI 10.1098/rstb.1990.0177; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johnston RM, 2003, AUST J SOIL RES, V41, P1021, DOI 10.1071/SR02033; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li CS, 2003, ECOL APPL, V13, P327, DOI 10.1890/1051-0761(2003)013[0327:MSOCCI]2.0.CO;2; LI CS, 1994, GLOBAL BIOGEOCHEM CY, V8, P237, DOI 10.1029/94GB00767; Luo ZK, 2011, AGR FOREST METEOROL, V151, P1529, DOI 10.1016/j.agrformet.2011.06.011; Luo ZK, 2010, GEODERMA, V155, P211, DOI 10.1016/j.geoderma.2009.12.012; Mermut AR, 2001, GEODERMA, V100, P403, DOI 10.1016/S0016-7061(01)00030-1; Ogle SM, 2010, GLOBAL CHANGE BIOL, V16, P810, DOI 10.1111/j.1365-2486.2009.01951.x; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Pink B., 2012, YB AUSTR; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Qin Z, 2010, SCI CHINA LIFE SCI, V53, P868, DOI 10.1007/s11427-010-4023-3; R Core Team, 2018, R LANG ENV STAT COMP; Sanderman J., 2009, SOIL CARBON SEQUESTR; Shi XZ, 2010, CLIMATIC CHANGE, V102, P579, DOI 10.1007/s10584-009-9704-1; Skjemstad JO, 2004, AUST J SOIL RES, V42, P79, DOI 10.1071/SR03013; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Steed Graham R., 1994, P231; Tullberg JN, 2001, AUST J SOIL RES, V39, P249, DOI 10.1071/SR00019; Ugalde D, 2007, SOIL TILL RES, V97, P318, DOI 10.1016/j.still.2007.09.018; Wade LJ., 2010, EH GRAHAM CTR MONOGR; Wang EL, 2008, AGR FOREST METEOROL, V148, P1743, DOI 10.1016/j.agrformet.2008.06.004; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Yu S, 2003, SCI AGR SINICA, V2, P1007; Yu YQ, 2012, GLOBAL PLANET CHANGE, V82-83, P115, DOI 10.1016/j.gloplacha.2011.12.005; [于永强 YU Yongqiang], 2006, [地理与地理信息科学, Geography and geo-information science], V22, P83	41	19	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63324	10.1371/journal.pone.0063324	http://dx.doi.org/10.1371/journal.pone.0063324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696813	gold, Green Submitted, Green Published			2022-12-25	WOS:000319081900027
J	Zhang, AH; Sun, H; Han, Y; Yan, GL; Wang, XJ				Zhang, Aihua; Sun, Hui; Han, Ying; Yan, Guangli; Wang, Xijun			Urinary Metabolic Biomarker and Pathway Study of Hepatitis B Virus Infected Patients Based on UPLC-MS System	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; LIVER; DRUG; DISCOVERY	Hepatitis B virus (HBV) is the fatal consequence of chronic hepatitis, and lack of biomarkers has been a long standing bottleneck in the clinical diagnosis. Metabolomics concerns with comprehensive analysis of small molecules and provides a powerful approach to discover biomarkers in biological systems. Here, we present metabolomics analysis applying ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. (UPLC-Q-TOF-HDMS) to determine metabolite alterations in HBV patients. Most important permutations are elaborated using multivariate statistical analysis and network analysis that was used to select the metabolites for the noninvasive diagnosis of HBV. In this study, the total 11 urinary differential metabolites were identified and contributed to HBV progress involving several key metabolic pathways by using pathway analysis with MetPA, which are promising biomarker candidates for diagnostic research. More importantly, of 11 altered metabolites, 4 metabolite markers were effective for the diagnosis of human HBV, achieved a satisfactory accuracy, sensitivity and specificity, respectively. It demonstrates that metabolomics has the potential as a non-invasive tool to evaluate the potential of these metabolites in the early diagnosis of HBV patients. These findings may be promising to yield a valuable insight into the pathophysiology of HBV and to advance the approaches of diagnosis, treatment, and prevention.	[Wang, Xijun] Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem, Key Lab Chinmed, Harbin, Peoples R China; Key Pharmacometabol Platform Chinese Med, Harbin, Peoples R China	Heilongjiang University of Chinese Medicine	Wang, XJ (corresponding author), Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem, Key Lab Chinmed, Harbin, Peoples R China.	xijunwangls@126.com	Wang, Xijun/C-4477-2014	Wang, Xijun/0000-0002-0949-3492	Key Program of Natural Science Foundation of State [90709019]; National Specific Program on the Subject of Public Welfare [200807014]; National Key Subject of Drug Innovation [2009ZX09502-005]; National Program on Key Basic Research Project of China [2005CB523406]	Key Program of Natural Science Foundation of State(National Natural Science Foundation of China (NSFC)); National Specific Program on the Subject of Public Welfare; National Key Subject of Drug Innovation; National Program on Key Basic Research Project of China(National Basic Research Program of China)	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No. 90709019), the National Specific Program on the Subject of Public Welfare (Grant No. 200807014), National Key Subject of Drug Innovation (Grant No. 2009ZX09502-005), and National Program on Key Basic Research Project of China (Grant No. 2005CB523406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantonico A, 2010, ANAL BIOANAL CHEM, V398, P2493, DOI 10.1007/s00216-010-3850-1; Chen JH, 2012, MOL BIOSYST, V8, P871, DOI 10.1039/c2mb05454j; Dove ADM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049379; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Hall JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049510; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Meissen JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046770; van Wietmarschen HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044331; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130; Wang XJ, 2013, J PHARMACEUT BIOMED, V74, P22, DOI 10.1016/j.jpba.2012.10.009; Wang XJ, 2012, MOL CELL PROTEOMICS, V11, P370, DOI 10.1074/mcp.M111.016006; Wang XJ, 2012, OMICS, V16, P414, DOI 10.1089/omi.2011.0138; Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wong VWS, 2012, J HEPATOL, V56, P533, DOI 10.1016/j.jhep.2011.09.013; Zhang A, 2013, OBES REV, V14, P344, DOI 10.1111/obr.12011; Zhang AH, 2013, CLIN CHIM ACTA, V418, P86, DOI 10.1016/j.cca.2012.12.024; Zhang AH, 2013, ANALYST, V138, P353, DOI 10.1039/c2an36382h; Zhang AH, 2012, CLIN CHIM ACTA, V414, P65, DOI 10.1016/j.cca.2012.08.016; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; Zhang AH, 2012, ANALYST, V137, P4200, DOI 10.1039/c2an35780a; Zhang AH, 2012, J PROTEOMICS, V75, P1079, DOI 10.1016/j.jprot.2011.10.027; Zheng DH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048451, 10.1371/journal.pone.0049495]	26	60	62	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64381	10.1371/journal.pone.0064381	http://dx.doi.org/10.1371/journal.pone.0064381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696887	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900090
J	Zhou, C; Liu, GB; Wang, LJ; Lu, YX; Yuan, L; Zheng, L; Chen, F; Peng, FL; Li, XN				Zhou, Chang; Liu, Guobing; Wang, Lijing; Lu, Yanxia; Yuan, Li; Zheng, Lin; Chen, Fang; Peng, Fanli; Li, Xuenong			MiR-339-5p Regulates the Growth, Colony Formation and Metastasis of Colorectal Cancer Cells by Targeting PRL-1	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; TYROSINE PHOSPHATASE; MICRORNAS; EXPRESSION; INVASION; MIGRATION; PROTEIN; SRC; PROGRESSION; PATHWAYS	MicroRNAs (miRNAs) have been suggested to play a vital role in regulate tumor progression and invasion. However, the expression of miR-339-5p in colorectal cancer and its effects are not known. Here, we report that miR-339-5p is a tumor suppressor by regulating expression of PRL-1. In this study, we showed that downregulated miR-339-5p levels in colorectal cancer tissues and highly invasive CRC cell lines. Furthermore, enhancing the expression of miR-339-5p inhibited CRC cell growth, migration and invasion in vitro and suppressed tumor growth in vivo. We then screened and identified a novel miR-339-5p target, phosphatases of regenerating liver-1 1 (PRL-1), and it was further confirmed by luciferase assay. Overexpression of miR-339-5p would also reduce the expression of PRL-1 mRNA and protein. The reduced PRL-1 expression was associated with low expression of phosphorylated-extracellular signal-regulatedkinase1/2 (p-ERK1/2). Conversely, reduction of miR-339-5p by inhibitors in cells stimulated these phenotypes. In conclusion, our results demonstrate that miR-339-5p functions as a tumor suppressor and plays a role in inhibiting growth and metastasis of CRC cells through targeting PRL-1 and regulating p-ERK1/2. These findings suggest that miR-339-5p may be useful as a new potential therapeutic target for CRC.	[Zhou, Chang; Lu, Yanxia; Yuan, Li; Zheng, Lin; Chen, Fang; Peng, Fanli; Li, Xuenong] Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhou, Chang; Lu, Yanxia; Yuan, Li; Zheng, Lin; Chen, Fang; Peng, Fanli; Li, Xuenong] Southern Med Univ, Key Lab Mol Tumor Pathol Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhou, Chang] Guangdong Pharmaceut Univ, Dept Anat & Histol, Guangzhou, Guangdong, Peoples R China; [Liu, Guobing] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Wang, Lijing] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangdong Pharmaceutical University; Southern Medical University - China; Guangdong Pharmaceutical University	Li, XN (corresponding author), Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	nfydlxn@126.com			National Natural Science Foundation of China [30871156, 81272758]; Science and Technology Project of Guangdong Province [2009B030803041]; Natural Science Foundation of Guangdong Province [8151051501000057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The study is supported by National Natural Science Foundation of China (No 30871156, No 81272758), Science and Technology Project of Guangdong Province (2009B030803041), and Natural Science Foundation of Guangdong Province (No 8151051501000057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Lopez JA, 2011, BIOCHEM BIOPH RES CO, V409, P513, DOI 10.1016/j.bbrc.2011.05.036; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Almeida MI, 2012, GASTROENTEROLOGY, V142, P886, DOI 10.1053/j.gastro.2011.12.047; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai YP, 2011, J BIOL CHEM, V286, P42316, DOI 10.1074/jbc.M111.286302; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Janakiram NB, 2008, ACTA PHARMACOL SIN, V29, P1, DOI 10.1111/j.1745-7254.2008.00742.x; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kurkjian C, 2008, CLIN COLORECTAL CANC, V7, P321, DOI 10.3816/CCC.2008.n.042; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reich R, 2011, INT J MOL SCI, V12, P1133, DOI 10.3390/ijms12021133; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Uchino K, 2013, MOL THER, V21, P610, DOI 10.1038/mt.2012.269; Ueda R, 2009, P NATL ACAD SCI US; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu ZS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-542; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	39	66	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63142	10.1371/journal.pone.0063142	http://dx.doi.org/10.1371/journal.pone.0063142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696794	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900010
J	Yara, S; Lavoie, JC; Beaulieu, JF; Delvin, E; Amre, D; Marcil, V; Seidman, E; Levy, E				Yara, Sabrina; Lavoie, Jean-Claude; Beaulieu, Jean-Francois; Delvin, Edgard; Amre, Devendra; Marcil, Valerie; Seidman, Ernest; Levy, Emile			Iron-Ascorbate-Mediated Lipid Peroxidation Causes Epigenetic Changes in the Antioxidant Defense in Intestinal Epithelial Cells: Impact on Inflammation (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							INDUCED OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; IN-VITRO; HYDROGEN-PEROXIDE; GENE-EXPRESSION; OXYGEN RADICALS; CACO-2 CELLS; PROMOTER HYPERMETHYLATION; GLUTATHIONE-PEROXIDASE; ULCERATIVE-COLITIS	Introduction: The gastrointestinal tract is frequently exposed to noxious stimuli that may cause oxidative stress, inflammation and injury. Intraluminal pro-oxidants from ingested nutrients especially iron salts and ascorbic acid frequently consumed together, can lead to catalytic formation of oxygen-derived free radicals that ultimately overwhelm the cellular antioxidant defense and lead to cell damage. Hypothesis: Since the mechanisms remain sketchy, efforts have been exerted to evaluate the role of epigenetics in modulating components of endogenous enzymatic antioxidants in the intestine. To this end, Caco-2/15 cells were exposed to the iron-ascorbate oxygen radical-generating system. Results: Fe/Asc induced a significant increase in lipid peroxidation as reflected by the elevated formation of malondialdehyde along with the alteration of antioxidant defense as evidenced by raised superoxide dismutase 2 (SOD2) and diminished glutathione peroxidase (GPx) activities and genes. Consequently, there was an up-regulation of inflammatory processes illustrated by the activation of NF-kappa B transcription factor, the higher production of interleukin-6 and cycloxygenase-2 as well as the decrease of l kappa B. Assessment of promoter's methylation revealed decreased levels for SOD2 and increased degree for GPx2. On the other hand, pre-incubation of Caco-2/15 cells with 5-Aza-2 '-deoxycytidine, a demethylating agent, or Trolox antioxidant normalized the activities of SOD2 and GPx, reduced lipid peroxidation and prevented inflammation. Conclusion: Redox and inflammatory modifications in response to Fe/Asc -mediated lipid peroxidation may implicate epigenetic methylation.	[Yara, Sabrina; Levy, Emile] Univ Montreal, Dept Nutr, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Lavoie, Jean-Claude; Amre, Devendra] Univ Montreal, Dept Pediat, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Beaulieu, Jean-Francois; Seidman, Ernest; Levy, Emile] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Cellular Biol, Canadian Inst Hlth Res Team Digest Epithelium, Sherbrooke, PQ J1K 2R1, Canada; [Delvin, Edgard] Univ Montreal, Dept Biochem, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada; [Marcil, Valerie; Seidman, Ernest] McGill Univ, Res Inst, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Sherbrooke; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University	Levy, E (corresponding author), Univ Montreal, Dept Nutr, CHU St Justine, Res Ctr, Montreal, PQ H3C 3J7, Canada.	emile.levy@recherche-ste-justine.qc.ca	AMRE, DEVENDRA K/D-4988-2015; Lavoie, Jean-claude/K-2701-2016	Lavoie, Jean-claude/0000-0002-5910-0300	J. A. DeSeve Research Chair in Nutrition	J. A. DeSeve Research Chair in Nutrition	This study was supported by the J. A. DeSeve Research Chair in Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2010, J NUTR, V140, P812, DOI 10.3945/jn.109.110353; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; BABBS CF, 1992, FREE RADICAL BIO MED, V13, P169, DOI 10.1016/0891-5849(92)90079-V; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; Bernotti S, 2003, AM J PHYSIOL-GASTR L, V285, pG898, DOI 10.1152/ajpgi.00042.2003; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brunet S, 2000, FREE RADICAL BIO MED, V28, P46, DOI 10.1016/S0891-5849(99)00197-5; Cartron PF, 2012, EUR J CANCER, V48, P2431, DOI 10.1016/j.ejca.2012.01.002; Chen BS, 2011, CANCER LETT, V309, P37, DOI 10.1016/j.canlet.2011.05.013; Choudhuri S, 2010, TOXICOL APPL PHARM, V245, P378, DOI 10.1016/j.taap.2010.03.022; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; Courtois F, 2002, J NUTR, V132, P1289, DOI 10.1093/jn/132.6.1289; Courtois F, 2000, AM J PHYSIOL-GASTR L, V279, pG12, DOI 10.1152/ajpgi.2000.279.1.G12; Couto MR, 2012, CELL BIOL TOXICOL, V28, P369, DOI 10.1007/s10565-012-9228-8; CYR A, 2012, ANTIOXID REDOX SIGNA; Da Costa LA, 2012, PROG MOL BIOL TRANSL, V108, P179, DOI 10.1016/B978-0-12-398397-8.00008-3; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Denis MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053725; Fatima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041533; Fearn RA, 2006, ENVIRON TOXICOL PHAR, V21, P168, DOI 10.1016/j.etap.2005.06.002; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Grenier E, 2007, AM J PHYSIOL-GASTR L, V293, pG1178, DOI 10.1152/ajpgi.00295.2007; GRISHAM MB, 1988, DIGEST DIS SCI, V33, pS6, DOI 10.1007/BF01538126; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005; Hodge DR, 2005, CANCER BIOL THER, V4, P585, DOI 10.4161/cbt.4.5.1704; Intarasunanont P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-31; Jiang MH, 2012, AGING CELL, V11, P29, DOI 10.1111/j.1474-9726.2011.00757.x; Kankuri E, 2001, INFLAMMATION, V25, P301, DOI 10.1023/A:1012860509440; Karatug A, 2012, PEPTIDES, V33, P101, DOI 10.1016/j.peptides.2011.11.003; KINLEN LJ, 1983, BMJ-BRIT MED J, V286, P1081, DOI 10.1136/bmj.286.6371.1081; Korkmaz Ahmet, 2009, Interdiscip Toxicol, V2, P219, DOI 10.2478/v10102-009-0020-4; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Levy E, 2007, AM J PHYSIOL-GASTR L, V293, pG1252, DOI 10.1152/ajpgi.00369.2007; Levy E, 2011, ARTERIOSCL THROM VAS, V31, P2692, DOI 10.1161/ATVBAHA.111.233908; Li RG, 2009, B ENVIRON CONTAM TOX, V82, P419, DOI 10.1007/s00128-008-9599-y; Li Y, 2012, CARCINOGENESIS, V33, P1889, DOI 10.1093/carcin/bgs214; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Marcil V, 2010, J BIOL CHEM, V285, P40448, DOI 10.1074/jbc.M110.155358; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nadif R, 2005, FREE RADICAL RES, V39, P1345, DOI 10.1080/10715760500306711; Nishiyama R, 2005, MOL CANCER RES, V3, P617, DOI 10.1158/1541-7786.MCR-05-0146; Ntimbane Thierry, 2009, Clin Biochem Rev, V30, P153; O'Sullivan AM, 2012, FOOD CHEM, V134, P1137, DOI 10.1016/j.foodchem.2012.02.205; Okayasu I, 2012, PATHOL INT, V62, P368, DOI 10.1111/j.1440-1827.2012.02807.x; Ozkaya D, 2011, CELL BIOCHEM FUNCT, V29, P287, DOI 10.1002/cbf.1749; PARKS DA, 1989, GUT, V30, P293, DOI 10.1136/gut.30.3.293; PARKS DA, 1988, AM J PHYSIOL, V254, pG768, DOI 10.1152/ajpgi.1988.254.5.G768; PARKS DA, 1983, SURGERY, V94, P415; Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Precourt LP, 2012, AM J PHYSIOL-GASTR L, V303, pG623, DOI 10.1152/ajpgi.00039.2012; Precourt LP, 2009, INT J BIOCHEM CELL B, V41, P1628, DOI 10.1016/j.biocel.2009.02.013; Rosenblum JS, 1996, P NATL ACAD SCI USA, V93, P4471, DOI 10.1073/pnas.93.9.4471; Rubas W, 1996, J PHARM SCI, V85, P165, DOI 10.1021/js950267+; Ryan Julie L, 2010, Infect Agent Cancer, V5, P27, DOI 10.1186/1750-9378-5-27; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; Sefi M, 2011, J ETHNOPHARMACOL, V135, P243, DOI 10.1016/j.jep.2011.02.029; Simon-Assman P, 2007, CELL BIOL TOXICOL, V23, P241, DOI 10.1007/s10565-006-0175-0; Singh KP, 2012, CANCER LETT, V316, P62, DOI 10.1016/j.canlet.2011.10.022; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Taha R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011817; Thaler R, 2009, BRIT J NUTR, V101, P743, DOI 10.1017/S0007114508047685; Trudel K, 2005, J CELL BIOCHEM, V96, P404, DOI 10.1002/jcb.20542; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Welch KD, 2002, FREE RADICAL BIO MED, V32, P577, DOI 10.1016/S0891-5849(02)00760-8; Williams MV, 2006, J BIOL CHEM, V281, P10127, DOI 10.1074/jbc.M600178200; Yanagisawa Y, 2002, BBA-GENE STRUCT EXPR, V1577, P457, DOI 10.1016/S0167-4781(02)00482-7; Zhai XH, 2013, MOL NUTR FOOD RES, V57, P249, DOI 10.1002/mnfr.201200536; Zhang JF, 2013, EXP THER MED, V5, P735, DOI 10.3892/etm.2013.901; Zhang WJ, 2010, EXP BIOL MED, V235, P633, DOI 10.1258/ebm.2009.009229; Zhao XM, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.014; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	87	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63456	10.1371/journal.pone.0063456	http://dx.doi.org/10.1371/journal.pone.0063456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717425	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700022
J	Bosque, PJ; Boyer, PJ; Mishra, P				Bosque, Patrick J.; Boyer, Philip J.; Mishra, Priya			A 43-kDa TDP-43 Species Is Present in Aggregates Associated with Frontotemporal Lobar Degeneration	PLOS ONE			English	Article							DNA-BINDING PROTEIN-43; C-TERMINAL FRAGMENTS; TARDBP MUTATIONS; PRION; DISEASE; INCLUSIONS; PHOSPHORYLATION; NEUROPATHOLOGY; CLEAVAGE; BRAIN	The transactive response DNA-binding protein (TDP-43) is a major component of the abnormal intracellular inclusions that occur in two common neurodegenerative diseases of humans: (1) a subtype of frontotemporal lobar degeneration and (2) amyotrophic lateral sclerosis. Genetics, experiments in cultured cells and animals, and analogy with other neurodegenerative diseases indicate that the process of TDP-43 aggregation is fundamental to the pathogenesis of these 2 diseases, but the process by which this aggregation occurs is not understood. Biochemical fractionation has revealed truncated, phosphorylated and ubiquitinated forms of TDP-43 in a detergent-insoluble fraction from diseased CNS tissue, while these forms are absent from controls. However, a large amount of the normally predominant 43-kDa form of TDP-43 is present in the detergent-insoluble fraction even from control brains, so it has not been possible to determine if this form of TDP-43 is part of pathological aggregates in frontotemporal lobe degeneration. We used semi-denaturing detergent-agarose gel electrophoresis to isolate high molecular weight aggregates containing TDP-43 that are present in the cerebral cortex of individuals with frontotemporal lobar degeneration but not that of controls. These aggregates include the same covalently modified forms of TDP-43 seen in detergent-insoluble extracts. In addition, aggregates include a 43-kDa TDP-43 species. This aggregated 43-kDa form of TDP-43 is absent or present only at low levels in controls. The presence of 43-kDa TDP-43 in aggregates raises the possibility that covalent modification is not a primary step in the pathogenic aggregation of TDP-43 associated with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.	[Bosque, Patrick J.; Mishra, Priya] Denver Hlth Med Ctr, Div Neurol, Denver, CO USA; [Bosque, Patrick J.; Mishra, Priya] Univ Denver, Eleanor Roosevelt Inst, Denver, CO USA; [Bosque, Patrick J.; Boyer, Philip J.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Boyer, Philip J.] Univ Colorado, Sch Med, Dept Neuropathol, Aurora, CO USA	Denver Health Medical Center; University of Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bosque, PJ (corresponding author), Denver Hlth Med Ctr, Div Neurol, Denver, CO USA.	patrick.bosque@dhha.org			National Institutes of Health grant [R21 NS054754-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054754] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were funded by National Institutes of Health grant R21 NS054754-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MATHEMATICA; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hoffman MD, 2008, ANAL CHIM ACTA, V627, P50, DOI 10.1016/j.aca.2008.03.032; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim YS, 2001, J BIOL CHEM, V276, P1626, DOI 10.1074/jbc.M007766200; Knopman DS, 2011, J MOL NEUROSCI; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Liu T, 2008, J PROTEOME RES, V7, P4256, DOI 10.1021/pr800182b; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P551, DOI 10.1007/s00401-006-0123-3; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Ritchie DL, 2004, NEUROPATH APPL NEURO, V30, P360, DOI 10.1111/j.1365-2990.2003.00544.x; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Seelaar H, 2010, J NEUROL, V257, P747, DOI 10.1007/s00415-009-5404-z; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Taniguchi S, 2004, NEUROPATH APPL NEURO, V30, P1, DOI 10.1046/j.0305-1846.2003.00481.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urwin H, 2010, ACTA NEUROPATHOL, V120, P33, DOI 10.1007/s00401-010-0698-6; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	39	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62301	10.1371/journal.pone.0062301	http://dx.doi.org/10.1371/journal.pone.0062301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704877	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200006
J	Gaquerel, E; Kotkar, H; Onkokesung, N; Galis, I; Baldwin, IT				Gaquerel, Emmanuel; Kotkar, Hemlata; Onkokesung, Nawaporn; Galis, Ivan; Baldwin, Ian T.			Silencing an N-Acyltransferase-Like Involved in Lignin Biosynthesis in Nicotiana attenuata Dramatically Alters Herbivory-Induced Phenolamide Metabolism	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MEDIATED DEFENSES; DOWN-REGULATION; PATHWAY; ACCUMULATION; EVOLUTION; SHIKIMATE; GENES	In a transcriptomic screen of Manduca sexta-induced N-acyltransferases in leaves of Nicotiana attenuata, we identified an N-acyltransferase gene sharing a high similarity with the tobacco lignin-biosynthetic hydroxycinnamoyl-CoA: shikimate/quinate hydroxycinnamoyl transferase (HCT) gene whose expression is controlled by MYB8, a transcription factor that regulates the production of phenylpropanoid polyamine conjugates (phenolamides, PAs). To evaluate the involvement of this HCT-like gene in lignin production as well as the resulting crosstalk with PA metabolism during insect herbivory, we transiently silenced (by VIGs) the expression of this gene and performed non-targeted (UHPLC-ESI/TOF-MS) metabolomics analyses. In agreement with a conserved function of N. attenuata HCT-like in lignin biogenesis, HCT-silenced plants developed weak, soft stems with greatly reduced lignin contents. Metabolic profiling demonstrated large shifts (up to 12% deregulation in total extracted ions in insect-attacked leaves) due to a large diversion of activated coumaric acid units into the production of developmentally and herbivory-induced coumaroyl-containing PAs (N', N ''-dicoumaroylspermidine, N', N ''-coumaroylputrescine, etc) and to minor increases in the most abundant free phenolics (chlorogenic and cryptochlorogenic acids), all without altering the production of well characterized herbivory-responsive caffeoyl-and feruloyl-based putrescine and spermidine PAs. These data are consistent with a strong metabolic tension, exacerbated during herbivory, over the allocation of coumaroyl-CoA units among lignin and unusual coumaroyl-containing PAs, and rule out a role for HCT-LIKE in tuning the herbivory-induced accumulation of other PAs. Additionally, these results are consistent with a role for lignification as an induced anti-herbivore defense.	[Gaquerel, Emmanuel; Kotkar, Hemlata; Onkokesung, Nawaporn; Galis, Ivan; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany; [Kotkar, Hemlata] Natl Chem Lab, CSIR, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India; [Galis, Ivan] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Max Planck Society; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Okayama University	Gaquerel, E (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	egaquerel@ice.mpg.de; baldwin@ice.mpg.de	Galis, Ivan/F-5734-2011; Baldwin, Ian T/K-1809-2013; Gaquerel, Emmanuel/I-2503-2014; Gaquerel, Emmanuel/ABE-6313-2020	Gaquerel, Emmanuel/0000-0003-0796-6417; Gaquerel, Emmanuel/0000-0003-0796-6417; Galis, Ivan/0000-0001-9840-8845; Onkokesung, Nawaporn/0000-0002-5094-5788; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; European Research Council [293926]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Max Planck Society. The Max Planck Society also provided a Max Planck-India Visiting Fellowship for H. Kotkar to conduct experiments at MPI-CE in Jena. The work of Emmanuel Gaquerel is funded by Advanced Grant No 293926 of the European Research Council to Ian T. Baldwin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2002, PLANT PHYSIOL, V128, P844, DOI 10.1104/pp.010698; Bassard JE, 2010, PHYTOCHEMISTRY, V71, P1808, DOI 10.1016/j.phytochem.2010.08.003; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; BLECHERT S, 1995, P NATL ACAD SCI USA, V92, P4099, DOI 10.1073/pnas.92.10.4099; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Diezel C, 2011, PLANT PHYSIOL, V155, P1936, DOI 10.1104/pp.110.170936; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Galis I, 2006, PLANT J, V46, P573, DOI 10.1111/j.1365-313X.2006.02719.x; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Mitra S, 2008, PLANT PHYSIOL, V148, P1128, DOI 10.1104/pp.108.124354; MUELLER MJ, 1993, P NATL ACAD SCI USA, V90, P7490, DOI 10.1073/pnas.90.16.7490; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Onkokesung N, 2012, PLANT PHYSIOL, V158, P389, DOI 10.1104/pp.111.187229; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Sansone SA, 2007, NAT BIOTECHNOL, V25, P844, DOI 10.1038/nbt0807-846b; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-171; Sundin L, 2012, PLANT CELL; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	32	17	17	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62336	10.1371/journal.pone.0062336	http://dx.doi.org/10.1371/journal.pone.0062336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704878	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200007
J	Maurin, H; Seymour, CM; Lechat, B; Borghgraef, P; Devijver, H; Jaworski, T; Schmidt, MV; Kuegler, S; Van Leuven, F				Maurin, Herve; Seymour, Claire Marie; Lechat, Benoit; Borghgraef, Peter; Devijver, Herman; Jaworski, Tomasz; Schmidt, Mathias V.; Kuegler, Sebastian; Van Leuven, Fred			Tauopathy Differentially Affects Cell Adhesion Molecules in Mouse Brain: Early Down-Regulation of Nectin-3 in Stratum Lacunosum Moleculare	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; UP-REGULATION; MEMORY; TAU; NCAM; CA1; HIPPOCAMPUS	Cell adhesion molecules are important structural substrates, required for synaptic plasticity and synaptogenesis. CAMs differ widely in their expression throughout different brain regions and their specific structural and functional roles in the brain remain to be elucidated. Here, we investigated selected cell adhesion molecules for alterations in expression levels and neuronal localization in validated mouse models for Alzheimer's disease that mimic the age-related progression of amyloid accumulation and tauopathy. Among the cell adhesion molecules analyzed, Nectin-3 expression was affected most and specifically in all mouse models with tauopathy. In particular was Nectin-3 depleted from the specific region of the hippocampus, known as the stratum lacunosum and moleculare, in mice that express wild-type or mutant human protein Tau, either chronically or sub-acutely. Tauopathy progresses from the entorhinal cortex to the hippocampus by unknown mechanisms that could involve transport by the myelinated axons of the temporoammonic and perforant pathways. The decreased expression of Nectin-3 in the stratum lacunosum moleculare is an early marker of impaired transport, and eventual synaptic problems, caused by beginning tauopathy.	[Maurin, Herve; Seymour, Claire Marie; Lechat, Benoit; Borghgraef, Peter; Devijver, Herman; Jaworski, Tomasz; Van Leuven, Fred] KULeuven, Dept Human Genet, Expt Genet Grp LEGTEGG, Louvain, Belgium; [Schmidt, Mathias V.] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Kuegler, Sebastian] Mol Physiol Brain CMPB, Gottingen, Germany	KU Leuven; Max Planck Society	Van Leuven, F (corresponding author), KULeuven, Dept Human Genet, Expt Genet Grp LEGTEGG, Louvain, Belgium.	fred.vanleuven@med.kuleuven.be	Seymour, Claire M/B-6758-2008	Schmidt, Mathias/0000-0002-3788-2268; Jaworski, Tomasz/0000-0002-6387-9249	Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap Techniek (IWT); EEC 6th & 7th Framework Program (MEMStick); EEC 6th & 7th Framework Program (neuroGSK3); EEC 6th & 7th Framework Program (EURON); EEC 6th & 7th Framework Program (NEURAD); de Rooms-fund; KULeuven-Research Fund; KULeuven-ResearchDevelopment; Marie Curie fellowship [MEST CT 2005/020013 NEURAD]	Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Instituut Wetenschap Techniek (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EEC 6th & 7th Framework Program (MEMStick); EEC 6th & 7th Framework Program (neuroGSK3); EEC 6th & 7th Framework Program (EURON); EEC 6th & 7th Framework Program (NEURAD); de Rooms-fund; KULeuven-Research Fund(KU Leuven); KULeuven-ResearchDevelopment; Marie Curie fellowship(European Commission)	The authors thank many collaborators and fellow scientists for technical assistance, advice, materials, and scientific and moral support. These investigations were funded and supported by Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut Wetenschap & Techniek (IWT); EEC 6th & 7th Framework Programs (MEMStick, neuroGSK3, EURON, NEURAD); de Rooms-fund; KULeuven-Research Fund; KULeuven-Research&Development. HM acknowledges Marie Curie fellowship MEST CT 2005/020013 NEURAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Braak E, 1997, ACTA NEUROPATHOL, V93, P323, DOI 10.1007/s004010050622; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chung SH, 2009, BMB REP, V42, P467, DOI 10.5483/BMBRep.2009.42.8.467; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Florian C, 2006, LEARN MEMORY, V13, P335, DOI 10.1101/lm.187506; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Foley AG, 2000, J NEUROCHEM, V74, P2607, DOI 10.1046/j.1471-4159.2000.0742607.x; FOX GB, 1995, J NEUROCHEM, V65, P2796; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Ito HT, 2012, HIPPOCAMPUS, V22, P372, DOI 10.1002/hipo.20909; Jaworski T, 2010, INT J ALZHEIMERS DIS, V2010; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Jaworski T, 2010, BBA-MOL BASIS DIS, V1802, P808, DOI 10.1016/j.bbadis.2010.03.005; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kajiwara R, 2008, HIPPOCAMPUS, V18, P266, DOI 10.1002/hipo.20385; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kerchner GA, 2012, NEUROIMAGE, V63, P194, DOI 10.1016/j.neuroimage.2012.06.048; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Kunzi V, 2002, J NEUROSCI, V22, P7471; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Lim ST, 2008, J COMP NEUROL, V507, P1228, DOI 10.1002/cne.21608; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; MACKIE K, 1989, J NEUROSCI, V9, P1883; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; MIZUTANI T, 1995, NEUROSCI LETT, V184, P141, DOI 10.1016/0304-3940(94)11190-T; Moechars D, 1999, NEUROSCIENCE, V91, P819, DOI 10.1016/S0306-4522(98)00599-5; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Muyllaert D, 2006, REV NEUROL-FRANCE, V162, P903, DOI 10.1016/S0035-3787(06)75098-6; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; REYES AA, 1991, MOL CELL BIOL, V11, P1654, DOI 10.1128/MCB.11.3.1654; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Seymour CM, 2008, NEUROSCIENCE, V157, P813, DOI 10.1016/j.neuroscience.2008.09.041; SPACEK J, 1974, J ANAT, V117, P487; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takashima Akihiko, 2012, Front Mol Neurosci, V5, P47, DOI 10.3389/fnmol.2012.00047; Tanghe A, 2010, INT J ALZHEIMERS DIS, V2010; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; WITTER MP, 1988, NEUROSCI LETT, V85, P193, DOI 10.1016/0304-3940(88)90350-3; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zelano J, 2006, EXP NEUROL, V201, P461, DOI 10.1016/j.expneurol.2006.04.026	72	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63589	10.1371/journal.pone.0063589	http://dx.doi.org/10.1371/journal.pone.0063589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704923	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200054
J	Stegger, M; Aziz, M; Chroboczek, T; Price, LB; Ronco, T; Kiil, K; Skov, RL; Laurent, F; Andersen, PS				Stegger, Marc; Aziz, Maliha; Chroboczek, Tomasz; Price, Lance B.; Ronco, Troels; Kiil, Kristoffer; Skov, Robert L.; Laurent, Frederic; Andersen, Paal S.			Genome Analysis of Staphylococcus aureus ST291, a Double Locus Variant of ST398, Reveals a Distinct Genetic Lineage	PLOS ONE			English	Article							COMMUNITY; SEQUENCE; INFECTIONS; SPREAD; HOST	Staphylococcus aureus ST291 has been reported as a homologue recombinant double locus variant of the livestock associated S. aureus ST398. However, whole genome sequencing show that ST291 is a unique genetic lineage with highly variable content within its accessory genome compared to both human and livestock associated genome sequenced CC398s.	[Stegger, Marc; Ronco, Troels; Kiil, Kristoffer; Skov, Robert L.; Andersen, Paal S.] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Stegger, Marc; Aziz, Maliha; Price, Lance B.; Andersen, Paal S.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA; [Price, Lance B.] George Washington Univ, Dept Environm & Occupat Hlth, Washington, DC USA; [Chroboczek, Tomasz; Laurent, Frederic] Hop Croix Rousse, Inserm U851, Natl Reference Ctr Staphylococci, Bacteriol Lab, F-69317 Lyon, France	Statens Serum Institut; Translational Genomics Research Institute; George Washington University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Stegger, M (corresponding author), Statens Serum Inst, DK-2300 Copenhagen, Denmark.	mtg@ssi.dk	Andersen, Paal S/H-2087-2015; Skov, Robert/ABB-3105-2020; Chroboczek, Jadwiga/M-6554-2014; Laurent, Frederic/M-4719-2014; LAURENT, Frederic/AGM-0706-2022	Andersen, Paal S/0000-0001-5656-0427; Skov, Robert/0000-0002-6079-5381; Stegger, Marc/0000-0003-0321-1180; laurent, frederic/0000-0003-0609-9091				Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Cafiso V, 2010, EUR J CLIN MICROBIOL, V29, P1277, DOI 10.1007/s10096-010-1000-5; Green SM, 2010, J MED MICROBIOL, V59, P1084, DOI 10.1099/jmm.0.018986-0; Hallin PF, 2009, STAND GENOMIC SCI, V1, P204, DOI 10.4056/sigs.28177; Havaei SA, 2011, J CLIN MICROBIOL, V49, P3990, DOI 10.1128/JCM.05445-11; Kechrid A, 2011, CLIN MICROBIOL INFEC, V17, P1020, DOI 10.1111/j.1469-0691.2010.03367.x; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; Mediavilla JR, 2012, EMERG INFECT DIS, V18, P700, DOI 10.3201/eid1804.111419; Moon SY, 2010, MICROB DRUG RESIST, V16, P217, DOI 10.1089/mdr.2010.0010; Munro P, 2010, INFECT IMMUN, V78, P3404, DOI 10.1128/IAI.00319-10; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tokajian S, 2011, ISRN MICROBIOLOGY, V2011; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x	26	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63008	10.1371/journal.pone.0063008	http://dx.doi.org/10.1371/journal.pone.0063008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704886	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200015
J	Tram, E; Savas, S; Ozcelik, H				Tram, Eric; Savas, Sevtap; Ozcelik, Hilmi			Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2	PLOS ONE			English	Article							OVARIAN-CANCER; DEPENDENT PHOSPHORYLATION; FUNCTIONAL-ANALYSIS; SEQUENCE VARIANTS; IN-VIVO; BREAST; KINASE; ATM; MUTATIONS; GENE	Mutations in BRCA1 and BRCA2 are responsible for a large proportion of breast-ovarian cancer families. Protein-truncating mutations have been effectively used in the clinical management of familial breast cancer due to their deleterious impact on protein function. However, the majority of missense variants identified throughout the genes continue to pose an obstacle for predictive informative testing due to low frequency and lack of information on how they affect BRCA1/2 function. Phosphorylation of BRCA1 and BRCA2 play an important role in their function as regulators of DNA repair, transcription and cell cycle in response to DNA damage but whether missense variants of uncertain significance (VUS) are able to disrupt this important process is not known. Here we employed a novel approach using NetworKIN which predicts in vivo kinase-substrate relationship, and evolutionary conservation algorithms SIFT, PolyPhen and Align-GVGD. We evaluated whether 191 BRCA1 and 43 BRCA2 VUS from the Breast Cancer Information Core (BIC) database can functionally alter the consensus phosphorylation motifs and abolish kinase recognition and binding to sites known to be phosphorylated in vivo. Our results show that 13.09% (25/191) BRCA1 and 13.95% (6/43) BRCA2 VUS altered the phosphorylation of BRCA1 and BRCA2. We highlight six BRCA1 (K309T, S632N, S1143F, Q1144H, Q1281P, S1542C) and three BRCA2 (S196I, T207A, P3292L) VUS as potentially clinically significant. These occurred rarely (n<2 in BIC), mutated evolutionarily conserved residues and abolished kinase binding to motifs established in the literature involved in DNA repair, cell cycle regulation, transcription or response to DNA damage. Additionally in vivo phosphorylation sites identified via through-put methods are also affected by VUS and are attractive targets for studying their biological and functional significance. We propose that rare VUS affecting phosphorylation may be a novel and important mechanism for which BRCA1 and BRCA2 functions are disrupted in breast cancer.	[Tram, Eric; Savas, Sevtap; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Ozcelik, Hilmi] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Tram, Eric; Savas, Sevtap; Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ozcelik, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred A Litwin Ctr Canc Genet, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ozcelik@lunenfeld.ca		Savas, Sevtap/0000-0002-7324-938X	Canadian Breast Cancer Foundation (CBCF), Toronto, Canada; Canadian Institutes of Health Research (CIHR), Toronto, Canada	Canadian Breast Cancer Foundation (CBCF), Toronto, Canada; Canadian Institutes of Health Research (CIHR), Toronto, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (CBCF) (HO) and Canadian Institutes of Health Research (CIHR) (HO), Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaroe J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2472; Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Anglesio MS, 2004, HUM MOL GENET, V13, P2061, DOI 10.1093/hmg/ddh215; Au WWY, 2007, CELL SIGNAL, V19, P1879, DOI 10.1016/j.cellsig.2007.04.010; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Chen L, 2010, J PROTEOME RES, V9, P174, DOI 10.1021/pr900338q; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fleming MA, 2003, P NATL ACAD SCI USA, V100, P1151, DOI 10.1073/pnas.0237285100; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hayes F, 2000, CANCER RES, V60, P2411; Hinton CV, 2007, EXP CELL RES, V313, P1735, DOI 10.1016/j.yexcr.2007.03.008; Hjerrild M, 2004, J PROTEOME RES, V3, P426, DOI 10.1021/pr0341033; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Humphrey JS, 1997, P NATL ACAD SCI USA, V94, P5820, DOI 10.1073/pnas.94.11.5820; Johnson LN, 1996, CURR OPIN STRUC BIOL, V6, P762, DOI 10.1016/S0959-440X(96)80005-4; Kehn K, 2007, ONCOGENE, V26, P5060, DOI 10.1038/sj.onc.1210319; Kreegipuu A, 1998, FEBS LETT, V430, P45, DOI 10.1016/S0014-5793(98)00503-1; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Monteiro ANA, 2006, CANCER RES, V66, P1897, DOI 10.1158/0008-5472.CAN-05-3034; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Brien KA, 1999, BIOCHEM BIOPH RES CO, V260, P658, DOI 10.1006/bbrc.1999.0892; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramus SJ, 2009, MOL ONCOL, V3, P138, DOI 10.1016/j.molonc.2009.02.001; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sankaran S, 2007, CANCER RES, V67, P11186, DOI 10.1158/0008-5472.CAN-07-2578; Savas S, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-107; Savas S, 2007, PHYSIOL GENOMICS, V29, P109, DOI 10.1152/physiolgenomics.00226.2006; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu B, 2002, CANCER RES, V62, P4588; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	74	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62468	10.1371/journal.pone.0062468	http://dx.doi.org/10.1371/journal.pone.0062468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704879	Green Published, gold, Green Accepted			2022-12-25	WOS:000319330200008
J	Yang, M; Virassamy, B; Vijayaraj, SL; Lim, Y; Saadipour, K; Wang, YJ; Han, YC; Zhong, JH; Morales, CR; Zhou, XF				Yang, Miao; Virassamy, Balaji; Vijayaraj, Swarna Lekha; Lim, Yoon; Saadipour, Khalil; Wang, Yan-Jiang; Han, Yan-Chuang; Zhong, Jin-Hua; Morales, Carlos R.; Zhou, Xin-Fu			The Intracellular Domain of Sortilin Interacts with Amyloid Precursor Protein and Regulates Its Lysosomal and Lipid Raft Trafficking	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; BETA-SECRETASE; GOLGI; APP; PHOSPHORYLATION; SORLA/LR11; RECEPTORS; NEURONS; BINDING	The processing of Amyloid precursor protein (APP) is multifaceted, comprising of protein transport, internalization and sequential proteolysis. However, the exact mechanism of APP intracellular trafficking and distribution remains unclear. To determine the interaction between sortilin and APP and the effect of sortilin on APP trafficking and processing, we studied the binding site and its function by mapping experiments, colocalization, coimmunoprecipitation and sucrose gradient fractionation. We identified for the first time that sortilin interacts with APP at both N- and C-terminal regions. The sortilin-FLVHRY (residues 787-792) and APP-NPTYKFFE (residues 759-766) motifs are crucial for the C-terminal interaction. We also found that lack of the FLVHRY motif reduces APP lysosomal targeting and increases APP distribution in lipid rafts in co-transfected HEK293 cells. These results are consistent with our in vivo data where sortilin knockout mice showed a decrease of APP lysosomal distribution and an increase of APP in lipid rafts. We further confirmed that overexpression of sortilin-FLVHRY mutants failed to rescue the lysosomal degradation of APP. Thus, our data suggests that sortilin is implicated in APP lysosomal and lipid raft targeting via its carboxyl-terminal F/YXXXXF/Y motif. Our study provides new molecular insights into APP trafficking and processing.	[Yang, Miao; Lim, Yoon; Han, Yan-Chuang; Zhong, Jin-Hua; Zhou, Xin-Fu] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Yang, Miao; Virassamy, Balaji; Vijayaraj, Swarna Lekha; Saadipour, Khalil; Zhou, Xin-Fu] Flinders Univ South Australia, Dept Human Physiol, Adelaide, SA, Australia; [Wang, Yan-Jiang] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China; [Morales, Carlos R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	University of South Australia; Flinders University South Australia; Army Medical University; McGill University	Yang, M (corresponding author), Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	miao.yang@unisa.edu.au	Wang, Yanjiang/F-3703-2012; Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/F-4119-2013	Wang, Yanjiang/0000-0002-6227-6112; Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175; Lim, Yoon/0000-0003-1110-1969	NHMRC [595937, 488022]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by NHMRC grants (595937, 488022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; De Strooper B, 2000, J CELL SCI, V113, P1857; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Hampe W, 2001, HUM GENET, V108, P529, DOI 10.1007/s004390100504; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Kaether C, 2004, J CELL BIOL, V167, P809, DOI 10.1083/jcb.200410090; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kwon S, 2011, J BIOL CHEM, V286, P21876, DOI 10.1074/jbc.M111.228262; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Lorenzen A, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-11; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/603052, DOI 10.4061/2011/603052]; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yang M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195347	46	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63049	10.1371/journal.pone.0063049	http://dx.doi.org/10.1371/journal.pone.0063049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704887	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000319330200016
J	Agrawal, V; Smart, K; Jilling, T; Hirsch, E				Agrawal, Varkha; Smart, Keith; Jilling, Tamas; Hirsch, Emmet			Surfactant Protein (SP)-A Suppresses Preterm Delivery and Inflammation via TLR2	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE PRODUCTION; TOLL-LIKE RECEPTORS; CELLULAR-RESPONSE; MURINE MODEL; LABOR; INFECTION; FETAL; MACROPHAGES; ACTIVATION	Toll like receptors (TLRs) are pattern-recognition molecules that initiate the innate immune response to pathogens. Pulmonary surfactant protein (SP)-A is an endogenously produced ligand for TLR2 and TLR4. SP-A has been proposed as a fetally produced signal for the onset of parturition in the mouse. We examined the effect of interactions between SP-A and the pathogenic TLR agonists lipopolysaccharide (LPS), peptidoglycan (PGN) and polyinosinic:cytidylic acid (poly(I:C)) (ligands for TLR4, TLR2 and TLR3, respectively) on the expression of inflammatory mediators and preterm delivery. Three types of mouse macrophages (the cell line RAW 264.7, and fresh amniotic fluid and peritoneal macrophages, including macrophages from TLR4 and TLR2 knockout mice) were treated for up to 7 hours with pathogenic TLR agonists with or without SP-A. SP-A alone had no effect upon inflammatory mediators in mouse macrophages and did not independently induce preterm labor. SP-A significantly suppressed TLR ligand-induced expression of inflammatory mediators (interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha and the chemokine CCL5) via a TLR2 dependent mechanism. In a mouse inflammation-induced preterm delivery model, intrauterine administration of SP-A significantly inhibited preterm delivery, suppressed the expression of proinflammatory mediators and enhanced the expression of the CXCL1 and anti-inflammatory mediator IL-10. We conclude that SP-A acts via TLR2 to suppress TLR ligand-induced preterm delivery and inflammatory responses.	[Agrawal, Varkha; Smart, Keith; Hirsch, Emmet] NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Evanston, IL USA; [Hirsch, Emmet] Univ Chicago, Pritzker Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Jilling, Tamas] NorthShore Univ HealthSyst, Dept Pediat, Evanston, IL USA	NorthShore University Health System; University of Chicago; NorthShore University Health System	Agrawal, V (corresponding author), NorthShore Univ HealthSyst, Dept Obstet & Gynecol, Evanston, IL USA.	varkhaagrawal@gmail.com		Jilling, Tamas/0000-0002-6200-3851	NIH [1R01 HD056118, 3R01HD056118-03S1]; March of Dimes Birth Defects Foundation [21-FY10-202]; Satter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056118] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); Satter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded in part by NIH (#1R01 HD056118 and 3R01HD056118-03S1), the March of Dimes Birth Defects Foundation (#21-FY10-202) and the Satter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BLAU H, 1994, AM J PHYSIOL, V266, pL148, DOI 10.1152/ajplung.1994.266.2.L148; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; DING AH, 1987, J IMMUNOL, V139, P1971; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Filipovich Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.038; Garcia-Verdugo I, 2008, BIOL REPROD, V79, P348, DOI 10.1095/biolreprod.108.068338; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gibson A T, 1997, Br J Hosp Med, V58, P381; Goldmann T, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-8; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Hirsch E, 1999, AM J OBSTET GYNECOL, V180, P429, DOI 10.1016/S0002-9378(99)70227-9; HIRSCH E, 1995, AM J OBSTET GYNECOL, V172, P1598, DOI 10.1016/0002-9378(95)90503-0; Hussain S, 2003, AM J RESP CELL MOL, V28, P520, DOI 10.1165/rcmb.2002-0072OC; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Ilievski V, 2010, BIOL REPROD, V83, P767, DOI 10.1095/biolreprod.110.085464; Kankavi O, 2007, ANIM REPROD SCI, V98, P259, DOI 10.1016/j.anireprosci.2006.03.009; Kim CJ, 2006, AM J OBSTET GYNECOL, V195, P829, DOI 10.1016/j.ajog.2006.06.052; Koga K, 2009, J OBSTET GYNAECOL RE, V35, P191, DOI 10.1111/j.1447-0756.2008.00963.x; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; KREMLEV SG, 1994, AM J PHYSIOL-LUNG C, V267, pL712, DOI 10.1152/ajplung.1994.267.6.L712; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; Lee DC, 2010, J IMMUNOL, V184, P6479, DOI 10.4049/jimmunol.0903867; Leong ASY, 2008, REPROD SCI, V15, P59, DOI 10.1177/1933719107309646; Li LP, 2010, MOL HUM REPROD, V16, P267, DOI 10.1093/molehr/gap106; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; MIYAMURA K, 1994, BBA-LIPID LIPID MET, V1210, P303, DOI 10.1016/0005-2760(94)90233-X; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Mussalli GM, 1999, J SOC GYNECOL INVEST, V6, P188, DOI 10.1016/S1071-5576(99)00013-1; Salminen A, 2011, CYTOKINE, V56, P442, DOI 10.1016/j.cyto.2011.07.025; Sano H, 1999, J IMMUNOL, V163, P387; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Thaxton J. E., 2010, INFECT DIS OBSTET GY, V2010; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhao TZ, 2009, NEUROL SCI, V30, P379, DOI 10.1007/s10072-009-0123-x	41	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63990	10.1371/journal.pone.0063990	http://dx.doi.org/10.1371/journal.pone.0063990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700442	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400038
J	Virkkala, R; Heikkinen, RK; Fronzek, S; Leikola, N				Virkkala, Raimo; Heikkinen, Risto K.; Fronzek, Stefan; Leikola, Niko			Climate Change, Northern Birds of Conservation Concern and Matching the Hotspots of Habitat Suitability with the Reserve Network	PLOS ONE			English	Article							PROTECTED AREAS; POTENTIAL IMPACTS; SPECIES DISTRIBUTIONS; LAND-USE; PROJECTED IMPACTS; ENVELOPE MODELS; BIODIVERSITY; MANAGEMENT; DIVERSITY; PATTERNS	National reserve networks are one of the most important means of species conservation, but their efficiency may be diminished due to the projected climatic changes. Using bioclimatic envelope models and spatial data on habitats and conservation areas, we studied how efficient the reserve network will be in preserving 100 forest, mire, marshland, and alpine bird species of conservation concern in Finland in 2051-2080 under three different climate scenarios. The occurrences of the studied bird species were related to the amount of habitat preferred by each species in the different boreal zones. We employed a novel integrated habitat suitability index that takes into account both the species' probability of occurrence from the bioclimatic models and the availability of suitable habitat. Using this suitability index, the distribution of the topmost 5% suitability squares ("hotspots'') in the four bird species groups in the period 1971-2000 and under the three scenarios were compared with the location of reserves with the highest amounts of the four habitats to study the efficiency of the network. In species of mires, marshlands, and Arctic mountains, a high proportion of protected habitat was included in the 5% hotspots in the scenarios in 2051-2080, showing that protected areas cover a high proportion of occurrences of bird species. In contrast, in forests in the southern and middle boreal zones, only a small proportion of the protected habitat was included in the 5% hotspots, indicating that the efficiency of the protected area network will be insufficient for forest birds in the future. In the northern boreal zone, the efficiency of the reserve network in forests was highly dependent on the strength of climate change varying between the scenarios. Overall, there is no single solution to preserving biodiversity in a changing climate, but several future pathways should be considered.	[Virkkala, Raimo; Heikkinen, Risto K.] Finnish Environm Inst, Nat Environm Ctr, Ecosyst Change Unit, Helsinki, Finland; [Fronzek, Stefan] Finnish Environm Inst, Climate Change Programme, Helsinki, Finland; [Leikola, Niko] Finnish Environm Inst, Nat Environm Ctr, Biodivers Unit, Helsinki, Finland	Finnish Environment Institute; Finnish Environment Institute; Finnish Environment Institute	Virkkala, R (corresponding author), Finnish Environm Inst, Nat Environm Ctr, Ecosyst Change Unit, Helsinki, Finland.	raimo.virkkala@ymparisto.fi	Heikkinen, Risto K./AAN-6257-2020; Virkkala, Raimo/AAN-6178-2020; Fronzek, Stefan/W-5724-2019	Heikkinen, Risto K./0000-0003-4190-5108; Fronzek, Stefan/0000-0003-2478-8050	Academy of Finland in the Research Programme on Climate Change (FICCA) in the project A-LA-CARTE	Academy of Finland in the Research Programme on Climate Change (FICCA) in the project A-LA-CARTE	The work was partly funded by the Academy of Finland in the Research Programme on Climate Change (FICCA) in the project A-LA-CARTE led by Tim Carter. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aapala K, 2008, WIS US FUT PEATL P 1, P1; Alagador D, 2011, BIOL CONSERV, V144, P811, DOI 10.1016/j.biocon.2010.11.011; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2004, BIRDS EUR UN STAT AS; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; BirdLife International, 2004, BIRDL CONSERV SER, V12; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brommer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043648; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; Denoel M, 2008, AQUAT CONSERV, V18, P714, DOI 10.1002/aqc.853; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ervin Jamison, 2011, BIODIVERSITY-OTTAWA, V12, P2, DOI 10.1080/14888386.2011.564850; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forsman JT, 2003, J BIOGEOGR, V30, P55, DOI 10.1046/j.1365-2699.2003.00812.x; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Heath MF, 2000, IMPORTANT BIRD AREAS, V8; Heikkinen RK, 2006, DIVERS DISTRIB, V12, P502, DOI 10.1111/j.1366-9516.2006.00284.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hof AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052574; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huntley B, 2012, DIVERS DISTRIB, V18, P769, DOI 10.1111/j.1472-4642.2012.00890.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jylha K, 2004, BOREAL ENVIRON RES, V9, P127; Kharouba HM, 2010, BIOL CONSERV, V143, P1094, DOI 10.1016/j.biocon.2010.02.002; Kuhlmann M, 2012, DIVERS DISTRIB, V18, P885, DOI 10.1111/j.1472-4642.2011.00877.x; Kujala H, 2011, BIOL CONSERV, V144, P2450, DOI 10.1016/j.biocon.2011.06.023; Lehmann A, 2003, ECOL MODEL, V160, P165, DOI 10.1016/S0304-3800(02)00354-X; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Mawdsley J, 2011, WIRES CLIM CHANGE, V2, P498, DOI 10.1002/wcc.127; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; McClean CJ, 2006, DIVERS DISTRIB, V12, P645, DOI 10.1111/j.1472-4642.2006.00290.x; McCullagh P, 1989, GEN LINEAR MODELS; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; Ohlemuller R, 2006, GLOBAL CHANGE BIOL, V12, P1788, DOI 10.1111/j.1365-2486.2006.01231.x; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parviainen M, 2008, J BIOGEOGR, V35, P1888, DOI 10.1111/j.1365-2699.2008.01922.x; Parviainen M, 2009, BIOL CONSERV, V142, P2501, DOI 10.1016/j.biocon.2009.05.030; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Platts PJ, 2008, ECOL MODEL, V218, P121, DOI 10.1016/j.ecolmodel.2008.06.028; Poiani KA, 2011, BIODIVERS CONSERV, V20, P185, DOI 10.1007/s10531-010-9954-2; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Pyke CR, 2005, BIOL CONSERV, V125, P1, DOI 10.1016/j.biocon.2004.08.004; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rassi P., 2001, 2000 RED LIST FINNIS; Rassi P., 2010, 2010 RED LIST FINNIS; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; Ridgeway G., 1999, COMPUT SCI STAT, P172; Sieck Mungla, 2011, BMC Ecology, V11, P12, DOI 10.1186/1472-6785-11-12; Simila M., 2012, ECOLOGICAL RESTORATI; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vaisanen R. A., 1998, DISTRIBUTION NUMBERS; Valkama J., 2011, 3 FINNISH BREEDING B; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Virkkala R, 2005, J BIOGEOGR, V32, P1957, DOI 10.1111/j.1365-2699.2005.01326.x; VIRKKALA R, 1994, CONSERV BIOL, V8, P532, DOI 10.1046/j.1523-1739.1994.08020532.x; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Virkkala R, 2007, BIOL CONSERV, V134, P361, DOI 10.1016/j.biocon.2006.08.006; Virkkala R, 2013, BIODIVERS CONSERV, V22, P459, DOI 10.1007/s10531-012-0423-y; Virkkala R, 2012, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.3.3635; Virkkala R, 2011, BOREAL ENVIRON RES, V16, P2; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Wiens JA, 2011, BIOL CONSERV, V144, P2119, DOI 10.1016/j.biocon.2011.05.002; Willis SG, 2009, ENVIRON MANAGE, V43, P836, DOI 10.1007/s00267-008-9125-3	105	21	22	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63376	10.1371/journal.pone.0063376	http://dx.doi.org/10.1371/journal.pone.0063376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700420	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400018
J	Diaz-Castillo, C				Diaz-Castillo, Carlos			Females and Males Contribute in Opposite Ways to the Evolution of Gene Order in Drosophila	PLOS ONE			English	Article							STRAND BREAK REPAIR; P-ELEMENT EXCISION; END-JOINING REPAIR; HOMOLOGOUS RECOMBINATION; GENOME ORGANIZATION; NEIGHBORING GENES; INTERPHASE NUCLEI; Z CHROMOSOME; DNA-REPAIR; CONSERVATION	An intriguing association between the spatial layout of chromosomes within nuclei and the evolution of chromosome gene order was recently uncovered. Chromosome regions with conserved gene order in the Drosophila genus are larger if they interact with the inner side of the nuclear envelope in D. melanogaster somatic cells. This observation opens a new door to understand the evolution of chromosomes in the light of the dynamics of the spatial layout of chromosomes and the way double-strand breaks are repaired in D. melanogaster germ lines. Chromosome regions at the nuclear periphery in somatic cell nuclei relocate to more internal locations of male germ line cell nuclei, which might prefer a gene order-preserving mechanism to repair double-strand breaks. Conversely, chromosome regions at the nuclear periphery in somatic cells keep their location in female germ line cell nuclei, which might be inaccessible for cellular machinery that causes gene order-disrupting chromosome rearrangements. Thus, the gene order stability for genome regions at the periphery of somatic cell nuclei might result from the active repair of double-strand breaks using conservative mechanisms in male germ line cells, and the passive inaccessibility for gene order-disrupting factors at the periphery of nuclei of female germ line cells. In the present article, I find evidence consistent with a DNA break repair-based differential contribution of both D. melanogaster germ lines to the stability/disruption of gene order. The importance of germ line differences for the layout of chromosomes and DNA break repair strategies with regard to other genomic patterns is briefly discussed.				crlsdiazcastillo@gmail.com	Diaz-Castillo, Carlos/I-8554-2012	Diaz-Castillo, Carlos/0000-0001-5099-3619				Arib G, 2011, CURR OPIN CELL BIOL, V23, P346, DOI 10.1016/j.ceb.2010.12.005; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; Ashburner M, 2005, DROSOPHILA LAB HDB, Vxxviii; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Bellaiche Y, 1999, GENETICS, V152, P1037; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2002, GENETICS, V161, P1169; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Cardoso-Moreira MM, 2010, TRENDS GENET, V26, P243, DOI 10.1016/j.tig.2010.03.002; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; de Vosse DWV, 2011, WIRES SYST BIOL MED, V3, P147, DOI 10.1002/wsbm.101; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Diaz-Castillo C, 2012, FLY AUSTIN, P6; Diaz-Castillo C, 2012, MOL BIOL EVOL, V29, P2105, DOI 10.1093/molbev/mss096; Diaz-Castillo C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002475; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Federico C, 2006, CHROMOSOMA, V115, P123, DOI 10.1007/s00412-005-0039-z; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; GETHMANN RC, 1988, J HERED, V79, P344, DOI 10.1093/oxfordjournals.jhered.a110526; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kupper K, 2007, CHROMOSOMA, V116, P285, DOI 10.1007/s00412-007-0098-4; KURKULOS M, 1994, GENETICS, V136, P1001; Leduc F, 2008, SYST BIOL REPROD MED, V54, P3, DOI 10.1080/19396360701876823; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; MacKenzie A, 2004, BIOESSAYS, V26, P1217, DOI 10.1002/bies.20117; Mahajan Milind C., 2006, Briefings in Functional Genomics & Proteomics, V5, P62, DOI 10.1093/bfgp/ell001; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mayr C, 2003, CHROMOSOME RES, V11, P471, DOI 10.1023/A:1024978711705; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; McVey M, 2004, GENETICS, V168, P2067, DOI 10.1534/genetics.104.033902; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Min BS, 2004, P NATL ACAD SCI USA, V101, P8906, DOI 10.1073/pnas.0403000101; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mongin E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-203; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Poyatos JF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r233; Preston CR, 2006, GENETICS, V172, P1055, DOI 10.1534/genetics.105.050138; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Ranz JM, 2012, MOL BIOL EVOL, V29, P13, DOI 10.1093/molbev/msr178; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Romeijn RJ, 2005, GENETICS, V169, P795, DOI 10.1534/genetics.104.033464; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Saccone S, 2002, GENE, V300, P169, DOI 10.1016/S0378-1119(02)01038-7; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; STAVELEY BE, 1995, GENETICS, V139, P1321; Steglich B, 2011, NUCLEUS, P3; Strissel PL, 1998, BLOOD, V92, P3793, DOI 10.1182/blood.V92.10.3793.422a24_3793_3803; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; TAKASUISHIKAWA E, 1992, MOL GEN GENET, V232, P17, DOI 10.1007/BF00299132; Tanabe H, 2005, CYTOGENET GENOME RES, V108, P255, DOI 10.1159/000080824; Van't Hof AE, 2013, HEREDITY, V110, P283, DOI 10.1038/hdy.2012.84; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Wang J, 2012, J MOL EVOL, V74, P113, DOI 10.1007/s00239-012-9499-y; WARD WS, 1994, J CELL BIOCHEM, V55, P77, DOI 10.1002/jcb.240550109; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Wojtczak A, 2008, PROTOPLASMA, V233, P263, DOI 10.1007/s00709-008-0010-y; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323; Zuleger N, 2011, NUCLEUS-PHILA, V2, P339, DOI 10.4161/nucl.2.5.17846	83	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64491	10.1371/journal.pone.0064491	http://dx.doi.org/10.1371/journal.pone.0064491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696898	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900101
J	Takahashi, T; Song, JS; Suzuki, T; Kawaoka, Y				Takahashi, Tadanobu; Song, Jiasheng; Suzuki, Takashi; Kawaoka, Yoshihiro			Mutations in NA That Induced Low pH-Stability and Enhanced the Replication of Pandemic (H1N1) 2009 Influenza A Virus at an Early Stage of the Pandemic	PLOS ONE			English	Article							DIVALENT-CATION REQUIREMENTS; SIALIDASE ACTIVITY; NEURAMINIDASE	An influenza A virus that originated in pigs caused a pandemic in 2009. The sialidase activity of the neuraminidase (NA) of previous pandemic influenza A viruses are stable at low pH (<= 5). Here, we identified the amino acids responsible for this property. We found differences in low-pH stability at pH 5.0 among pandemic (H1N1) 2009 viruses, which enhanced the replication of these viruses. Low-pH-stable NA enhancement of virus replication may have contributed to the rapid worldwide spread and adaptation to humans of pandemic (H1N1) 2009 viruses during the early stages of the 2009 pandemic.	[Takahashi, Tadanobu; Song, Jiasheng; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Takahashi, Tadanobu; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Takahashi, Tadanobu; Suzuki, Takashi] Global COE Program Innovat Human Hlth Sci, Shizuoka, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Shizuoka; University of Tokyo; Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp; kawaokay@svm.vetmed.wisc.edu			MEXT/JSPS KAKENHI [23590549]; Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science; ERATO (Japan Science and Technology Agency); Ministries of Education, Culture, Sports, Science, and Technology; Health, Labor, and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases from the Ministries of Education, Culture, Sports, Science, and Technology; National Institute of Allergy and Infectious Disease Public Health Service	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Ministries of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health, Labor, and Welfare of Japan; Japan Initiative for Global Research Network on Infectious Diseases from the Ministries of Education, Culture, Sports, Science, and Technology; National Institute of Allergy and Infectious Disease Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by a MEXT/JSPS KAKENHI Grant (Number C; 23590549), by a Sasakawa Scientific Research Grant from The Japan Science Society, by a SRI (Shizuoka Research Institute) academic research grant, by the Global COE Program from the Japan Society for the Promotion of Science, by ERATO (Japan Science and Technology Agency), by a grant-in-aid for Specially Promoted Research from the Ministries of Education, Culture, Sports, Science, and Technology, by grants-in-aid from Health, Labor, and Welfare of Japan, by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministries of Education, Culture, Sports, Science, and Technology, and by National Institute of Allergy and Infectious Disease Public Health Service research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brett IC, 2006, J BIOCHEM, V139, P439, DOI 10.1093/jb/mvj051; Johansson BE, 2003, J BIOCHEM, V134, P345, DOI 10.1093/jb/mvg151; Li CJ, 2011, J VIROL, V85, P10955, DOI 10.1128/JVI.05792-11; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Li QL, 2010, CONSTRUCTIVE COMPUTATION IN STOCHASTIC MODELS WITH APPLICATIONS: THE RG-FACTORIZATION, P1; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Sakabe S, 2011, VIRUS RES, V158, P124, DOI 10.1016/j.virusres.2011.03.022; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2012, FEBS OPEN BIO, V2, P261, DOI 10.1016/j.fob.2012.08.007; Takahashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015556; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	17	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64439	10.1371/journal.pone.0064439	http://dx.doi.org/10.1371/journal.pone.0064439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696893	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900096
J	Foster, SR; Porrello, ER; Purdue, B; Chan, HW; Voigt, A; Frenzel, S; Hannan, RD; Moritz, KM; Simmons, DG; Molenaar, P; Roura, E; Boehm, U; Meyerhof, W; Thomas, WG				Foster, Simon R.; Porrello, Enzo R.; Purdue, Brooke; Chan, Hsiu-Wen; Voigt, Anja; Frenzel, Sabine; Hannan, Ross D.; Moritz, Karen M.; Simmons, David G.; Molenaar, Peter; Roura, Eugeni; Boehm, Ulrich; Meyerhof, Wolfgang; Thomas, Walter G.			Expression, Regulation and Putative Nutrient-Sensing Function of Taste GPCRs in the Heart	PLOS ONE			English	Article							RECEPTORS; PROTEIN; CELLS; GENE; METABOLITES; ACTIVATION; GUSTDUCIN; CALCIUM; RISK	G protein-coupled receptors (GPCRs) are critical for cardiovascular physiology. Cardiac cells express>100 nonchemosensory GPCRs, indicating that important physiological and potential therapeutic targets remain to be discovered. Moreover, there is a growing appreciation that members of the large, distinct taste and odorant GPCR families have specific functions in tissues beyond the oronasal cavity, including in the brain, gastrointestinal tract and respiratory system. To date, these chemosensory GPCRs have not been systematically studied in the heart. We performed RT-qPCR taste receptor screens in rodent and human heart tissues that revealed discrete subsets of type 2 taste receptors (TAS2/Tas2) as well as Tas1r1 and Tas1r3 (comprising the umami receptor) are expressed. These taste GPCRs are present in cultured cardiac myocytes and fibroblasts, and by in situ hybridization can be visualized across the myocardium in isolated cardiac cells. Tas1r1 genetargeted mice (Tas1r1(Cre)/Rosa26(tdRFP)) strikingly recapitulated these data. In vivo taste receptor expression levels were developmentally regulated in the postnatal period. Intriguingly, several Tas2rs were upregulated in cultured rat myocytes and in mouse heart in vivo following starvation. The discovery of taste GPCRs in the heart opens an exciting new field of cardiac research. We predict that these taste receptors may function as nutrient sensors in the heart.	[Foster, Simon R.; Porrello, Enzo R.; Purdue, Brooke; Chan, Hsiu-Wen; Moritz, Karen M.; Simmons, David G.; Thomas, Walter G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Voigt, Anja; Frenzel, Sabine; Meyerhof, Wolfgang] German Inst Human Nutr DIfE Potsdam Rehbruecke, Dept Mol Genet, Nuthetal, Germany; [Hannan, Ross D.] Univ Melbourne, Peter MacCallum Canc Ctr, Sir Peter MacCallum Dept Oncol, Div Res,Oncogen Signaling & Growth Control Progra, Melbourne, Vic, Australia; [Molenaar, Peter] Univ Queensland, Sch Med, Sch Biomed Sci, Fac Hlth,Queensland Univ Technol, Brisbane, Qld, Australia; [Roura, Eugeni] Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Boehm, Ulrich] Univ Hamburg, Ctr Mol Neurobiol, Inst Neural Signal Transduct, Hamburg, Germany	University of Queensland; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Peter Maccallum Cancer Center; University of Melbourne; Queensland University of Technology (QUT); University of Queensland; University of Queensland; University of Hamburg	Thomas, WG (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	w.thomas@uq.edu.au	Thomas, Walter/I-2208-2015; Simmons, David G/C-5983-2009; Molenaar, Peter/J-1198-2012; Roura, Eugeni/A-7101-2011; Chan, Hsiu-Wen/G-2665-2010; Moritz, Karen/G-2508-2015; Foster, Simon R./I-1552-2014	Thomas, Walter/0000-0003-0685-2952; Simmons, David G/0000-0002-4115-9371; Molenaar, Peter/0000-0002-7122-4656; Roura, Eugeni/0000-0002-9073-9946; Moritz, Karen/0000-0002-8085-0034; Foster, Simon R./0000-0003-3034-1351; Purdue, Brooke/0000-0001-7618-7180; Hannan, Ross/0000-0002-2166-4493; Porrello, Enzo/0000-0001-6105-7463	National Health and Medical Research Council of Australia [APP631443]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (APP631443 to WGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao H, 2012, ATHEROSCLEROSIS, V220, P456, DOI 10.1016/j.atherosclerosis.2011.11.037; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Deng HY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00373; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Duffy VB, 2004, APPETITE, V43, P5, DOI 10.1016/j.appet.2004.02.007; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Insel PA, 2012, BRIT J PHARMACOL, V165, P1613, DOI 10.1111/j.1476-5381.2011.01434.x; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jeon TI, 2011, BIOCHEM J, V438, P33, DOI 10.1042/BJ20110009; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee RJ, 2012, J CLIN INVEST; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moore-Morris T, 2009, MOL PHARMACOL, V75, P1108, DOI 10.1124/mol.108.054155; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Smith NJ, 2012, FRONTIERS ENDOCRINOL, V3; Snead AN, 2012, FASEB J; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Tang CM, 2004, TRENDS CARDIOVAS MED, V14, P94, DOI 10.1016/j.tcm.2003.12.007; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tonack S, 2012, AM J PHYSL HEART CIR; Toyono T, 2007, BBA-GENE STRUCT EXPR, V1769, P641, DOI 10.1016/j.bbaexp.2007.08.003; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wen SP, 2011, ENDOCRINOLOGY, V152, P1515, DOI 10.1210/en.2010-1208; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Young RL, 2009, GUT, V58, P337, DOI 10.1136/gut.2008.148932	46	97	99	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64579	10.1371/journal.pone.0064579	http://dx.doi.org/10.1371/journal.pone.0064579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23696900	Green Published, gold			2022-12-25	WOS:000319052700108
J	Balashov, SP; Petrovskaya, LE; Imasheva, ES; Lukashev, EP; Dioumaev, AK; Wang, JM; Sychev, SV; Dolgikh, DA; Rubin, AB; Kirpichnikov, MP; Lanyi, JK				Balashov, Sergei P.; Petrovskaya, Lada E.; Imasheva, Eleonora S.; Lukashev, Evgeniy P.; Dioumaev, Andrei K.; Wang, Jennifer M.; Sychev, Sergey V.; Dolgikh, Dmitriy A.; Rubin, Andrei B.; Kirpichnikov, Mikhail P.; Lanyi, Janos K.			LYSINE 96 FACILITATES REPROTONATION OF THE SCHIFF BASE IN THE PHOTOCYCLE OF A RETINAL PROTEIN FROM EXIGUOBACTERIUM SIBIRICUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRIVEN PROTON PUMP; ASPARTIC ACID-96; BACTERIORHODOPSIN MUTANTS; VIBRATIONAL SPECTROSCOPY; STRUCTURAL-CHANGES; RELEASE; PK(A); TRANSLOCATION; WATER; RHODOPSIN	A lysine instead of the usual carboxyl group is in place of the internal proton donor to the retinal Schiff base in the light-driven proton pump of Exiguobacterium sibiricum (ESR). The involvement of this lysine in proton transfer is indicated by the finding that its substitution with alanine or other residues slows reprotonation of the Schiff base (decay of the M intermediate) by more than 2 orders of magnitude. In these mutants, the rate constant of the M decay linearly decreases with a decrease in proton concentration, as expected if reprotonation is limited by the uptake of a proton from the bulk. In wild type ESR, M decay is biphasic, and the rate constants are nearly pH-independent between pH6 and 9. Proton uptake occurs after M formation but before M decay, which is especially evident in D2O and at high pH. Proton uptake is biphasic; the amplitude of the fast phase decreases with a pK(a) of 8.5 +/- 0.3, which reflects the pKa of the donor during proton uptake. Similarly, the fraction of the faster component of M decay decreases and the slower one increases, with a pK(a) of 8.1 +/- 0.2. The data therefore suggest that the reprotonation of the Schiff base in ESR is preceded by transient protonation of an initially unprotonated donor, which is probably the is an element of-amino group of Lys-96 or a water molecule in its vicinity, and it facilitates proton delivery from the bulk to the reaction center of the protein.	[Balashov, Sergei P.; Imasheva, Eleonora S.; Dioumaev, Andrei K.; Wang, Jennifer M.; Lanyi, Janos K.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Petrovskaya, Lada E.; Sychev, Sergey V.; Dolgikh, Dmitriy A.; Kirpichnikov, Mikhail P.] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Lukashev, Evgeniy P.; Dolgikh, Dmitriy A.; Rubin, Andrei B.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow 119991, Russia	University of California System; University of California Irvine; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University	Balashov, SP (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	balashov@uci.edu; lpetr65@yahoo.com; jklanyi@uci.edu	Petrovskaya, Lada/S-1118-2016; Dolgikh, Dmitry A/F-2369-2014	Kirpichnikov, Mikhail/0000-0001-8170-1607; Dolgikh, Dmitry/0000-0002-9880-7202; Petrovskaya, Lada/0000-0002-0217-9708	National Institutes of Health [GM29498]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DEFG03-86ER13525]; Federal Targeted Program on Scientific and Scientific-Pedagogical Staff of Innovative Russia; Molecular and Cell Biology Program of Russian Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029498, R01GM029498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy; Federal Targeted Program on Scientific and Scientific-Pedagogical Staff of Innovative Russia; Molecular and Cell Biology Program of Russian Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29498 (to J. K. L. and S. P. B.). This work was also supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy Grant DEFG03-86ER13525 (to J. K. L. and S. P. B.), the Federal Targeted Program on Scientific and Scientific-Pedagogical Staff of Innovative Russia (to L. E. P.), and the Molecular and Cell Biology Program of Russian Academy of Science (to D. A. D.).	AMES JB, 1990, BIOCHEMISTRY-US, V29, P7181, DOI 10.1021/bi00483a005; Balashov SP, 2012, BIOCHEMISTRY-US, V51, P5748, DOI 10.1021/bi300409m; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Balashov SP, 1999, BIOCHEMISTRY-US, V38, P2026, DOI 10.1021/bi981926a; Balashov SP, 1997, BIOCHEMISTRY-US, V36, P8671, DOI 10.1021/bi970744y; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; BOUSCHE O, 1991, J BIOL CHEM, V266, P11063; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Brown LS, 1996, P NATL ACAD SCI USA, V93, P1731, DOI 10.1073/pnas.93.4.1731; Brown LS, 2000, BIOCHEMISTRY-US, V39, P938, DOI 10.1021/bi9921900; CAO Y, 1993, BIOCHEMISTRY-US, V32, P10239, DOI 10.1021/bi00089a046; CAO Y, 1991, BIOCHEMISTRY-US, V30, P10972, DOI 10.1021/bi00109a023; CAO Y, 1993, BIOCHEMISTRY-US, V32, P1981, DOI 10.1021/bi00059a015; Dioumaev AK, 1997, BIOPHYS CHEM, V67, P1, DOI 10.1016/S0301-4622(96)02268-5; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Dioumaev AK, 2013, J PHYS CHEM B, V117, P7235, DOI 10.1021/jp402430w; DRACHEV LA, 1987, FEBS LETT, V226, P139, DOI 10.1016/0014-5793(87)80567-7; FAHMY K, 1992, PHOTOCHEM PHOTOBIOL, V56, P1073, DOI 10.1111/j.1751-1097.1992.tb09731.x; Fan Y, 2011, BBA-BIOENERGETICS, V1807, P1457, DOI 10.1016/j.bbabio.2011.07.005; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; Harms MJ, 2008, PROTEIN SCI, V17, P833, DOI 10.1110/ps.073397708; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HEGEMANN P, 1985, EMBO J, V4, P2347, DOI 10.1002/j.1460-2075.1985.tb03937.x; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; Imasheva ES, 2006, PHOTOCHEM PHOTOBIOL, V82, P1406, DOI 10.1562/2006-01-15-RA-776; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; KHORANA HG, 1979, P NATL ACAD SCI USA, V76, P5046, DOI 10.1073/pnas.76.10.5046; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; LEWIS A, 1974, P NATL ACAD SCI USA, V71, P4462, DOI 10.1073/pnas.71.11.4462; LOZIER RH, 1976, BIOCHIM BIOPHYS ACTA, V440, P545, DOI 10.1016/0005-2728(76)90041-4; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; MILLER A, 1990, BIOCHIM BIOPHYS ACTA, V1020, P57, DOI 10.1016/0005-2728(90)90093-J; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Misra S, 1997, BIOCHEMISTRY-US, V36, P4875, DOI 10.1021/bi962673t; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; OVCHINNIKOV YA, 1979, FEBS LETT, V100, P219, DOI 10.1016/0014-5793(79)80338-5; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; Rangarajan R, 2007, BIOCHEMISTRY-US, V46, P12679, DOI 10.1021/bi700955x; Rodrigues DF, 2006, EXTREMOPHILES, V10, P285, DOI 10.1007/s00792-005-0497-5; Schobert B, 2003, J MOL BIOL, V330, P553, DOI 10.1016/S0022-2836(03)00576-X; SUBRAMANIAM S, 1992, J BIOL CHEM, V267, P25730; SZARAZ S, 1994, BIOPHYS J, V67, P1706, DOI 10.1016/S0006-3495(94)80644-7; TITTOR J, 1989, EMBO J, V8, P3477, DOI 10.1002/j.1460-2075.1989.tb08512.x; Vishnivetskaya T, 2000, EXTREMOPHILES, V4, P165, DOI 10.1007/s007920070031; ZIMANYI L, 1993, BIOCHEMISTRY-US, V32, P7669, DOI 10.1021/bi00081a010; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	58	28	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21254	21265		10.1074/jbc.M113.465138	http://dx.doi.org/10.1074/jbc.M113.465138			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23696649	hybrid, Green Published			2022-12-25	WOS:000322014400046
J	Brash, AR; Boeglin, WE; Stec, DF; Voehler, M; Schneider, C; Cha, JK				Brash, Alan R.; Boeglin, William E.; Stec, Donald F.; Voehler, Markus; Schneider, Claus; Cha, Jin K.			Isolation and Characterization of Two Geometric Allene Oxide Isomers Synthesized from 9S-Hydroperoxylinoleic Acid by Cytochrome P450 CYP74C3 STEREOCHEMICAL ASSIGNMENT OF NATURAL FATTY ACID ALLENE OXIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE; CORAL; BIOSYNTHESIS; MECHANISM; PRODUCTS; PATHWAY; HYDROPEROXIDE; CONFIGURATION; ARACHIDONATE; METABOLISM	Specialized cytochromes P450 or catalase-related hemoproteins transform fatty acid hydroperoxides to allene oxides, highly reactive epoxides leading to cyclopentenones and other products. The stereochemistry of the natural allene oxides is incompletely defined, as are the structural features required for their cyclization. We investigated the transformation of 9S-hydroperoxylinoleic acid with the allene oxide synthase CYP74C3, a reported reaction that unexpectedly produces an allene oxide-derived cyclopentenone. Using biphasic reaction conditions at 0 degrees C, we isolated the initial products and separated two allene oxide isomers by HPLC at -15 degrees C. One matched previously described allene oxides in its UV spectrum (lambda(max) 236 nm) and NMR spectrum (defining a 9,10-epoxy-octadec-10,12Z-dienoate). The second was a novel stereoisomer (UV lambda(max) 239 nm) with distinctive NMR chemical shifts. Comparison of NOE interactions of the epoxy proton at C9 in the two allene oxides (and the equivalent NOE experiment in 12,13-epoxy allene oxides) allowed assignment at the isomeric C10 epoxy-ene carbon as Z in the new isomer and the E configuration in all previously characterized allene oxides. The novel 10Z isomer spontaneously formed a cis-cyclopentenone at room temperature in hexane. These results explain the origin of the cyclopentenone, provide insights into the mechanisms of allene oxide cyclization, and define the double bond geometry in naturally occurring allene oxides.	[Brash, Alan R.; Boeglin, William E.; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Stec, Donald F.; Voehler, Markus] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Stec, Donald F.; Voehler, Markus] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Cha, Jin K.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Wayne State University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health Grant [GM-074888]; National Science Foundation (NSF) grant [CHE-1212879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888 (to A. R. B.). This work was also supported by National Science Foundation (NSF) grant CHE-1212879 (to J. K. C.).	BAERTSCHI SW, 1988, BIOCHEMISTRY-US, V27, P18, DOI 10.1021/bi00401a004; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1989, J AM CHEM SOC, V111, P1891, DOI 10.1021/ja00187a060; BRASH AR, 1987, J BIOL CHEM, V262, P15829; BRASH AR, 1988, P NATL ACAD SCI USA, V85, P3382, DOI 10.1073/pnas.85.10.3382; Chang ZZ, 2008, ACTA CRYSTALLOGR F, V64, P668, DOI 10.1107/S1744309108017545; COREY EJ, 1987, J AM CHEM SOC, V109, P289, DOI 10.1021/ja00235a053; COREY EJ, 1988, TETRAHEDRON LETT, V29, P2555, DOI 10.1016/S0040-4039(00)86110-9; CROMBIE L, 1991, J CHEM SOC PERK T 1, P577, DOI 10.1039/p19910000577; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; Grechkin AN, 2008, CHEMBIOCHEM, V9, P2498, DOI 10.1002/cbic.200800331; GRECHKIN AN, 1994, BBA-LIPID LIPID MET, V1213, P199, DOI 10.1016/0005-2760(94)90027-2; GRECHKIN AN, 1991, EUR J BIOCHEM, V199, P451, DOI 10.1111/j.1432-1033.1991.tb16143.x; Grechkin AN, 2000, BIOCHEM J, V352, P501, DOI 10.1042/0264-6021:3520501; Hamberg M, 2000, LIPIDS, V35, P353, DOI 10.1007/s11745-000-532-z; HAMBERG M, 1987, BIOCHIM BIOPHYS ACTA, V920, P76, DOI 10.1016/0005-2760(87)90313-4; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hess BA, 1999, J AM CHEM SOC, V121, P5603, DOI 10.1021/ja990728j; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Itoh A, 2002, J BIOL CHEM, V277, P46051, DOI 10.1074/jbc.M207234200; Medvedeva NV, 2005, RUSS J BIOORG CHEM+, V31, P595, DOI 10.1007/s11171-005-0083-8; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; PAN ZQ, 1995, J BIOL CHEM, V270, P8487, DOI 10.1074/jbc.270.15.8487; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Thomas CP, 2013, CHEM PHYS LIPIDS, V167, P21, DOI 10.1016/j.chemphyslip.2013.01.002; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Watanabe K, 2003, CHEM PHARM BULL, V51, P909; Yu ZY, 2007, LIPIDS, V42, P491, DOI 10.1007/s11745-007-3054-4	30	22	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20797	20806		10.1074/jbc.M113.482521	http://dx.doi.org/10.1074/jbc.M113.482521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23709224	Green Published, hybrid			2022-12-25	WOS:000322014400004
J	Zhao, J; Li, H; Winterton, SL; Liu, ZQ				Zhao, Jing; Li, Hu; Winterton, Shaun L.; Liu, Zhiqi			Ancestral Gene Organization in the Mitochondrial Genome of Thyridosmylus langii (McLachlan, 1870) (Neuroptera: Osmylidae) and Implications for Lacewing Evolution	PLOS ONE			English	Article							COMPOSITIONAL HETEROGENEITY; PHYLOGENETIC UTILITY; RNA GENES; INSECTA; SEQUENCES; DNA; COMPILATION; LEPIDOPTERA; HYMENOPTERA; PATTERNS	The first complete mitochondrial genome of the lacewing family Osmylidae (Thyridosmylus langii (McLachlan, 1870)) (Neuroptera) was sequenced in this study. The genome is a circular molecule of 16,221 bp containing the typical 37 genes but is arranged in the same order as that of the putative ancestor of hexapod and lacks translocation of trnC as shared by all previously sequenced neuropteran mtDNAs. This reveals that trnC translocation does not represent an organizational synapomorphy in the mitochondrion for the entire Neuroptera clade. Comparative analysis of neuropteran tRNA genes reveals a relatively slow and conserved evolution of the mitochondrion throughout the order. Secondary structure models of the ribosomal RNA genes of T. langii largely agree with those proposed for other insect orders. Nevertheless, domain I of T. langii rrnL is consisted of nine helices rather than eight helices which is typical for neuropteran rrnL. Protein-coding genes have typical mitochondrial start codons, with the exception of COI, which uses the TCG start codon also found in Ithonidae and Chrysopidae. Like other neuropteran insects, the control region is the most AT-rich region and comparatively simple, with little evidence of conserved blocks or long tandem repeats. Considering the issues of base-compositional and branch length heterogeneity, we used a range of phylogenetic approaches to recover neuropteridan relationships and explored the effect of method choice on recovery of monophyly of Neuropterida: ((Neuroptera + Megaloptera) + Raphidioptera). The monophyly of Neuroptera and the more basal position of Osmylidae were also recovered by different datasets and phylogenetic methods.	[Zhao, Jing; Li, Hu; Liu, Zhiqi] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Winterton, Shaun L.] Calif Dept Food & Agr, Sacramento, CA 95814 USA	China Agricultural University; California Department of Food & Agriculture	Liu, ZQ (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	zhiqiliu@cau.edu.cn	li, hu/N-7159-2013; Winterton, Shaun L/C-3804-2009		National Natural Foundation of China [31071962, 201103022, 31272352]; Direct For Biological Sciences [1144119] Funding Source: National Science Foundation	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants from the National Natural Foundation of China (No. 31071962, No. 201103022, and No. 31272352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2009, GENOME, V52, P31, DOI 10.1139/G08-098; Beutel RG, 2010, ORG DIVERS EVOL, V10, P311, DOI 10.1007/s13127-010-0024-0; Beutel RG, 2010, ZOOL J LINN SOC-LOND, V158, P533, DOI 10.1111/j.1096-3642.2009.00560.x; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOYCE TM, 1989, GENETICS, V123, P825; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Erler S, 2010, BIOL J LINN SOC, V99, P296, DOI 10.1111/j.1095-8312.2009.01365.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Haruyama N, 2011, MOL BIOL REP, V38, P3367, DOI 10.1007/s11033-010-0444-0; Hua JM, 2009, MOL BIOL REP, V36, P1757, DOI 10.1007/s11033-008-9379-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Kumar S, 2001, GENETICS, V158, P1321; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li HF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042626, 10.1371/journal.pone.0048872]; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045925; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mueller RL, 2005, MOL BIOL EVOL, V22, P2104, DOI 10.1093/molbev/msi204; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAND DM, 1993, J MOL EVOL, V37, P281, DOI 10.1007/BF00175505; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; STANTON DJ, 1994, GENETICS, V137, P233; TA H, 1999, BIOEDIT USER FRIENDL, P95; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Winterton Shaun L., 2003, Entomologische Abhandlungen (Dresden), V61, P158; Winterton SL, 2010, ANN ENTOMOL SOC AM, V103, P511, DOI 10.1603/AN10026; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6	59	31	33	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e62943	10.1371/journal.pone.0062943	http://dx.doi.org/10.1371/journal.pone.0062943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717397	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600005
J	Banelli, B; Merlo, DF; Allemanni, G; Forlani, A; Romani, M				Banelli, Barbara; Merlo, Domenico Franco; Allemanni, Giorgio; Forlani, Alessandra; Romani, Massimo			Clinical Potentials of Methylator Phenotype in Stage 4 High-Risk Neuroblastoma: An Open Challenge	PLOS ONE			English	Article							DNA METHYLATION; ABERRANT METHYLATION; GENE; CLASSIFICATION; CANCER	Approximately 20% of stage 4 high-risk neuroblastoma patients are alive and disease-free 5 years after disease onset while the remaining experience rapid and fatal progression. Numerous findings underline the prognostic role of methylation of defined target genes in neuroblastoma without taking into account the clinical and biological heterogeneity of this disease. In this report we have investigated the methylation of the PCDHB cluster, the most informative member of the "Methylator Phenotype'' in neuroblastoma, hypothesizing that if this epigenetic mark can predict overall and progression free survival in high-risk stage 4 neuroblastoma, it could be utilized to improve the risk stratification of the patients, alone or in conjunction with the previously identified methylation of the SFN gene (14.3.3sigma) that can accurately predict outcome in these patients. We have utilized univariate and multivariate models to compare the prognostic power of PCDHB methylation in terms of overall and progression free survival, quantitatively determined by pyrosequencing, with that of other markers utilized for the patients' stratification utilizing methylation thresholds calculated on neuroblastoma at stage 1-4 and only on stage 4, high-risk patients. Our results indicate that PCDHB accurately distinguishes between high-and intermediate/low risk stage 4 neuroblastoma in agreement with the established risk stratification criteria. However PCDHB cannot predict outcome in the subgroup of stage 4 patients at high-risk whereas methylation levels of SFN are suggestive of a "methylation gradient'' associated with tumor aggressiveness as suggested by the finding of a higher threshold that defines a subset of patients with an extremely severe disease (OS <24 months). Because of the heterogeneity of neuroblastoma we believe that clinically relevant methylation markers should be selected and tested on homogeneous groups of patients rather than on patients at all stages.	[Banelli, Barbara; Merlo, Domenico Franco; Allemanni, Giorgio; Forlani, Alessandra; Romani, Massimo] IRCCS AOU San Martino IST, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST	Banelli, B (corresponding author), IRCCS AOU San Martino IST, Genoa, Italy.	barbara.banelli@istge.it	Banelli, Barbara/Y-1151-2019; Merlo, Domenico Franco/ABI-1345-2020	Banelli, Barbara/0000-0003-1505-7141; Merlo, Domenico Franco/0000-0002-1832-4754	Italian Ministry of Health; Italian Ministry of Health [GR-2008-1143408]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health, core grant "Ricerca Corrente" to the IRCCS AOU San Martino-IST. B.B. is the recipient of the "Young Investigators'' grant GR-2008-1143408 from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, CANCER RES, V65, P828; Abe M, 2008, ONCOLOGY-BASEL, V74, P50, DOI 10.1159/000139124; Abe M, 2007, CANCER LETT, V247, P253, DOI 10.1016/j.canlet.2006.05.001; Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Banelli B, 2005, CANCER LETT, V228, P37, DOI 10.1016/j.canlet.2005.02.049; Banelli B, 2005, ONCOGENE, V24, P5619, DOI 10.1038/sj.onc.1208722; Banelli B, 2012, LAB INVEST, V92, P458, DOI 10.1038/labinvest.2011.169; Banelli B, 2010, INT J CANCER, V126, P656, DOI 10.1002/ijc.24768; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Gonzalez-Gomez P, 2003, EUR J CANCER, V39, P1478, DOI 10.1016/S0959-8049(03)00312-5; Hoebeeck J, 2009, CANCER LETT, V273, P336, DOI 10.1016/j.canlet.2008.08.019; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 2009, CANCER SCI, V100, P787, DOI 10.1111/j.1349-7006.2009.01095.x	26	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63253	10.1371/journal.pone.0063253	http://dx.doi.org/10.1371/journal.pone.0063253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717404	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700011
J	Albacker, CE; Storer, NY; Langdon, EM; DiBiase, A; Zhou, Y; Langenau, DM; Zon, LI				Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Langenau, David M.; Zon, Leonard I.			The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish	PLOS ONE			English	Article							CELLULAR SENESCENCE; RAS GENES; CYCLIN B1; N-RAS; CELLS; TUMORS; RECRUITMENT; MUTATIONS; DIFFERENTIATION; METHYLATION	Epigenetics, or the reversible and heritable marks of gene regulation not including DNA sequence, encompasses chromatin modifications on both the DNA and histones and is as important as the DNA sequence itself. Chromatin-modifying factors are playing an increasingly important role in tumorigenesis, particularly among pediatric rhabdomyosarcomas (RMS), revealing potential novel therapeutic targets. We performed an overexpression screen of chromatin-modifying factors in a KRAS(G12D)-driven zebrafish model for RMS. Here, we describe the identification of a histone H3 lysine 9 histone methyltransferase, SUV39H1, as a suppressor of embryonal RMS formation in zebrafish. This suppression is specific to the histone methyltransferase activity of SUV39H1, as point mutations in the SET domain lacked the effect. SUV39H1-overexpressing and control tumors have a similar proliferation rate, muscle differentiation state, and tumor growth rate. Strikingly, SUV39H1-overexpressing fish initiate fewer tumors, which results in the observed suppressive phenotype. We demonstrate that the delayed tumor onset occurs between 5 and 7 days post fertilization. Gene expression profiling at these stages revealed that in the context of KRAS(G12D) overexpression, SUV39H1 may suppress cell cycle progression. Our studies provide evidence for the role of SUV39H1 as a tumor suppressor.	[Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA USA; [Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Albacker, Colleen E.; Storer, Narie Y.; Langdon, Erin M.; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Harvard Stem Cell Inst,Dana Farber Canc Inst, Boston, MA 02115 USA; [Langenau, David M.] Massachusetts Gen Hosp, Dept Pathol, Harvard Stem Cell Inst, Charlestown, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Zon, LI (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA USA.	zon@enders.tch.harvard.edu	Langenau, David/GXI-0197-2022	Langenau, David/0000-0001-6664-8318	NIH grant [T32 HL07623]; NATIONAL CANCER INSTITUTE [R01CA103846, R01CA154923] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by NIH grant T32 HL07623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Brien DO, 2012, HISTOL HISTOPATHOL, V27, P13, DOI 10.14670/HH-27.13; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen YY, 2006, GENE CHROMOSOME CANC, V45, P583, DOI 10.1002/gcc.20322; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; DeCristofaro MF, 1999, ONCOGENE, V18, P7559, DOI 10.1038/sj.onc.1203168; Farina A, 1996, ONCOGENE, V13, P1287; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Huss R, 2000, CYTOKINE, V12, P1195, DOI 10.1006/cyto.1999.0732; Langenau DM, 2008, ONCOGENE, V27, P4242, DOI 10.1038/onc.2008.56; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Le XN, 2013, DEVELOPMENT, V140, P2354, DOI 10.1242/dev.088427; Li ZY, 2007, J BIOL CHEM, V282, P18872, DOI 10.1074/jbc.M609448200; Machado I, 2012, HUM PATHOL; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Martinelli S, 2009, GENE CHROMOSOME CANC, V48, P975, DOI 10.1002/gcc.20702; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Qualman SJ, 1998, PEDIATR DEVEL PATHOL, V1, P550, DOI 10.1007/s100249900076; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Ruymann FB, 2000, CANCER INVEST, V18, P223, DOI 10.3109/07357900009031827; Schildhaus HU, 2011, HUM PATHOL, V42, P1667, DOI 10.1016/j.humpath.2010.12.025; Schwienbacher C, 1998, P NATL ACAD SCI USA, V95, P3873, DOI 10.1073/pnas.95.7.3873; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Smith ACH, 2010, BLOOD, V115, P3296, DOI 10.1182/blood-2009-10-246488; STRATTON MR, 1989, CANCER RES, V49, P6324; Uno K, 2002, GENE CHROMOSOME CANC, V34, P33, DOI 10.1002/gcc.10052; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51	40	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64969	10.1371/journal.pone.0064969	http://dx.doi.org/10.1371/journal.pone.0064969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705022	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200176
J	Andrei, C; Zerulla, D				Andrei, Codrin; Zerulla, Dominic			Optimisation of Ruthenium Dye Sensitised Solar Cells Efficiency via Sn Diffusion into the TiO2 Mesoporous Layer	PLOS ONE			English	Article							PHOTOCATALYTIC ACTIVITY; CONVERSION EFFICIENCY; ELECTRIC-POWER; SURFACE-AREA; ZINC-OXIDE; THIN-FILM; LIGHT; ELECTROLYTE	Dye sensitised solar cells (DSCs) typically include a mesoporous titanium dioxide (TiO2) scaffold, sensitised with an adsorbed dye, as the main active element responsible for the photon absorption and charge separation functionalities. The sintering process employed in the TiO2 active layer fabrication plays a crucial role in the formation of the nanoparticle (NP) scaffold and hence in the performance of a dye sensitised solar cell, as it allows the particles to form efficient inter-crystalline electric contacts providing high electron conductivity. Furthermore, the DSC design requires a conductive transparent top electrode which is typically made of fluorinated stannic oxide. Here we report on a highly spatially resolved scanning electron microscopy study in conjunction with focussed ion beam milling and energy dispersive X-ray (EDX) mapping of the distribution of all relevant elements within a DSC subsequent to a classical sintering process in the range of 350 degrees C-550 degrees C. Additionally, the article provides quantitative results regarding the found Sn diffusion and its effect on efficiency confirmed via J-V measurements. The effective spatial resolution of the EDX studies was calculated by Monte Carlo simulations of the electron trajectories and X-ray emission region. This permits to construct a model for the migration of Sn from the transparent conductive oxide into the TiO2 scaffold, resulting in alterations in the composition of the complex system which has a direct effect on the DSC performance. J-V measurements conclude that sintering temperature of 500 degrees C is close to the optimum regarding Sn diffusion enhancement of DSCs. Sintering temperatures above 500 degrees C were causing a drop in the DSC efficiency and are therefore not recommended. In order to optimize the DSC efficiency, the results are summarized by a model that explains how the efficiency varies with the Sn diffusion process.	[Andrei, Codrin; Zerulla, Dominic] Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Lab, Dublin 2, Ireland; [Zerulla, Dominic] Univ Coll Dublin, Strateg Res Cluster Solar Energy Convers, Dublin 2, Ireland	University College Dublin; University College Dublin	Zerulla, D (corresponding author), Univ Coll Dublin, Sch Phys, Plasmon & Ultrafast NanoOpt Lab, Dublin 2, Ireland.	dominic.zerulla@ucd.ie	Zerulla, Dominic/L-6090-2018	Zerulla, Dominic/0000-0001-8479-9654	Irish Research Council [RS/2010/2943]; Romanian American Foundation; Science Foundation Ireland [11/RFP/MTR/3113, 07/SRC/B1160]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Romanian American Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors acknowledge support from Irish Research Council RS/2010/2943, Romanian American Foundation and Science Foundation Ireland 11/RFP/MTR/3113. They also acknowledge and thank Science Foundation Ireland for their funding of the Strategic Research Cluster in Solar Energy Conversion grant no. 07/SRC/B1160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrei C, 2010, PHYS CHEM CHEM PHYS, V12, P7241, DOI 10.1039/c000072h; Brown MD, 2011, NANO LETT, V11, P438, DOI 10.1021/nl1031106; Cao YA, 2004, NEW J CHEM, V28, P218, DOI 10.1039/b306845e; Chiba Y, 2006, JPN J APPL PHYS 2, V45, pL638, DOI 10.1143/JJAP.45.L638; DAREEDWARDS MP, 1980, FARADAY DISCUSS, V70, P285, DOI 10.1039/dc9807000285; DESILVESTRO J, 1985, J AM CHEM SOC, V107, P2988, DOI 10.1021/ja00296a035; DO YR, 1994, J SOLID STATE CHEM, V108, P198, DOI 10.1006/jssc.1994.1031; Doyle G, 2007, APPL PHYS A-MATER, V89, P351, DOI 10.1007/s00339-007-4126-2; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; Duan YD, 2012, J PHYS CHEM C, V116, P8888, DOI 10.1021/jp212517k; DUNG DH, 1984, HELV CHIM ACTA, V67, P1012; Gerischer H., 1968, PHYS CHEM, V72, P437; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P85, DOI 10.1002/pip.880; Ito S, 2005, CHEM COMMUN, P4351, DOI 10.1039/b505718c; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Kamat PV, 2008, J PHYS CHEM C, V112, P18737, DOI 10.1021/jp806791s; Lin J, 1999, J CATAL, V183, P368, DOI 10.1006/jcat.1999.2409; Meen TH, 2009, J PHYS CHEM SOLIDS, V70, P472, DOI 10.1016/j.jpcs.2008.12.002; NAMBA S, 1965, J PHYS CHEM-US, V69, P774, DOI 10.1021/j100887a010; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Nazeeruddin MK, 2003, J PHYS CHEM B, V107, P8981, DOI 10.1021/jp022656f; Nazeeruddin MK, 1997, CHEM COMMUN, P1705, DOI 10.1039/a703277c; O'Reilly T, 2013, ADV EN MAT IN PRESS; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; OTTERMANN C, 1993, MATER RES SOC SYMP P, V308, P69, DOI 10.1557/PROC-308-69; PECHY P, 1995, J CHEM SOC CHEM COMM, P65, DOI 10.1039/c39950000065; Shi D, 2008, J PHYS CHEM C, V112, P17046, DOI 10.1021/jp808018h; Smestad GP, 1998, J CHEM EDUC, V75, P752, DOI 10.1021/ed075p752; Tachibana Y, 2001, J PHYS CHEM B, V105, P7424, DOI 10.1021/jp010173q; TSUBOMURA H, 1976, NATURE, V261, P402, DOI 10.1038/261402a0; VLACHOPOULOS N, 1988, J AM CHEM SOC, V110, P1216, DOI 10.1021/ja00212a033; Williamson A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3633349; Xin BF, 2009, APPL SURF SCI, V255, P5896, DOI 10.1016/j.apsusc.2009.01.027; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Zheng SK, 2002, VACUUM, V65, P155, DOI 10.1016/S0042-207X(01)00424-9; Zhu K, 2006, J PHYS CHEM B, V110, P25174, DOI 10.1021/jp065284+	37	0	0	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63923	10.1371/journal.pone.0063923	http://dx.doi.org/10.1371/journal.pone.0063923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704956	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200087
J	Hooda, J; Cadinu, D; Alam, MM; Shah, A; Cao, TM; Sullivan, LA; Brekken, R; Zhang, L				Hooda, Jagmohan; Cadinu, Daniela; Alam, Md Maksudul; Shah, Ajit; Cao, Thai M.; Sullivan, Laura A.; Brekken, Rolf; Zhang, Li			Enhanced Heme Function and Mitochondrial Respiration Promote the Progression of Lung Cancer Cells	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; IN-SITU; METABOLISM; EXPRESSION; DEFICIENCY; OXYGEN; ALPHA; IDENTIFICATION; HEPATOCYTES; INHIBITION	Lung cancer is the leading cause of cancer-related mortality, and about 85% of the cases are non-small-cell lung cancer (NSCLC). Importantly, recent advance in cancer research suggests that altering cancer cell bioenergetics can provide an effective way to target such advanced cancer cells that have acquired mutations in multiple cellular regulators. This study aims to identify bioenergetic alterations in lung cancer cells by directly measuring and comparing key metabolic activities in a pair of cell lines representing normal and NSCLC cells developed from the same patient. We found that the rates of oxygen consumption and heme biosynthesis were intensified in NSCLC cells. Additionally, the NSCLC cells exhibited substantially increased levels in an array of proteins promoting heme synthesis, uptake and function. These proteins include the rate-limiting heme biosynthetic enzyme ALAS, transporter proteins HRG1 and HCP1 that are involved in heme uptake, and various types of oxygen-utilizing hemoproteins such as cytoglobin and cytochromes. Several types of human tumor xenografts also displayed increased levels of such proteins. Furthermore, we found that lowering heme biosynthesis and uptake, like lowering mitochondrial respiration, effectively reduced oxygen consumption, cancer cell proliferation, migration and colony formation. In contrast, lowering heme degradation does not have an effect on lung cancer cells. These results show that increased heme flux and function are a key feature of NSCLC cells. Further, increased generation and supply of heme and oxygen-utilizing hemoproteins in cancer cells will lead to intensified oxygen consumption and cellular energy production by mitochondrial respiration, which would fuel cancer cell proliferation and progression. The results show that inhibiting heme and respiratory function can effectively arrest the progression of lung cancer cells. Hence, understanding heme function can positively impact on research in lung cancer biology and therapeutics.	[Hooda, Jagmohan; Cadinu, Daniela; Alam, Md Maksudul; Shah, Ajit; Cao, Thai M.; Zhang, Li] Univ Texas Dallas, Dept Mol & Cell Biol, Ctr Syst Biol, Richardson, TX 75083 USA; [Sullivan, Laura A.; Brekken, Rolf] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, L (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, Ctr Syst Biol, Richardson, TX 75083 USA.	li.zhang@utdallas.edu	Shah, Ajit/AAT-5242-2020; Hooda, Jagmohan/I-7134-2019; Zhang, Li/L-5206-2013; shah, Ajit/J-3114-2019	Hooda, Jagmohan/0000-0001-5001-6092; Zhang, Li/0000-0001-9242-0763; shah, Ajit/0000-0001-5059-1011	Cecil H. and Ida Green funds; NCI SPORE [P50CA70907]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Cecil H. and Ida Green funds; NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Cecil H. and Ida Green funds (LZ) and the NCI SPORE P50CA70907 grant (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ANDERSON KE, 2001, METABOLIC MOL BASES, P2991; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; CHANCE B, 1965, J GEN PHYSIOL, V49, P163, DOI 10.1085/jgp.49.1.163; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chernova T, 2006, MOL PHARMACOL, V69, P697, DOI 10.1124/mol.105.016675; Chernova T, 2007, J NEUROSCI, V27, P8475, DOI 10.1523/JNEUROSCI.0792-07.2007; Dailey HA, 1990, BIOSYNTHESIS HEME CH, P183; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; Dang TN, 2010, GLIA, V58, P55, DOI 10.1002/glia.20901; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DEMATTEIS F, 1983, FEBS LETT, V159, P127, DOI 10.1016/0014-5793(83)80430-X; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Escobar M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806506; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Guppy M, 2002, BIOCHEM J, V364, P309, DOI 10.1042/bj3640309; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kaambre T, 2012, J BIOENERG BIOMEMBR, V44, P539, DOI 10.1007/s10863-012-9457-9; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Labbe-Bois R, 1990, BIOSYNTHESIS HEME CH, P235; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Minami S, 1923, BIOCHEM Z, V142, P94; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Organization WH, 2011, CANCER; Ortiz de Montellano PR, 2009, WILEY ENCY CHEM BIOL, P240; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sangodkar J, 2010, MT SINAI J MED, V77, P597, DOI 10.1002/msj.20226; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Sengupta A, 2005, MOL BRAIN RES, V137, P23, DOI 10.1016/j.molbrainres.2005.02.007; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; SHEDLOFSKY SI, 1987, BIOCHEM J, V248, P229, DOI 10.1042/bj2480229; Sly WS, 2009, METABOLIC MOL BASES, P1; Sullivan LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012031; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Wallace KB, 2000, ANNU REV PHARMACOL, V40, P353, DOI 10.1146/annurev.pharmtox.40.1.353; Warburg O. H., 1930, METABOLISM TUMOURS I; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yao XA, 2010, BIOCHEM BIOPH RES CO, V403, P30, DOI 10.1016/j.bbrc.2010.10.101; Ye WZ, 2004, BIOCHEM BIOPH RES CO, V315, P546, DOI 10.1016/j.bbrc.2004.01.092; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhang L, 2011, HEME BIOL SECRET LIF; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	63	73	74	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63402	10.1371/journal.pone.0063402	http://dx.doi.org/10.1371/journal.pone.0063402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704904	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200034
J	Karppi, J; Kurl, S; Ronkainen, K; Kauhanen, J; Laukkanen, JA				Karppi, Jouni; Kurl, Sudhir; Ronkainen, Kimmo; Kauhanen, Jussi; Laukkanen, Jari A.			Serum Carotenoids Reduce Progression of Early Atherosclerosis in the Carotid Artery Wall among Eastern Finnish Men	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; LOS-ANGELES-ATHEROSCLEROSIS; DISEASE RISK FACTOR; MYOCARDIAL-INFARCTION; BETA-CAROTENE; PLASMA-LEVELS; ANTIOXIDANT; LYCOPENE; DIETARY	Background: Several previous epidemiologic studies have shown that high blood levels of carotenoids may be protective against early atherosclerosis, but results have been inconsistent. We assessed the association between atherosclerotic progression, measured by intima-media thickness of the common carotid artery wall, and serum levels of carotenoids. Methods: We studied the effect of carotenoids on progression of early atherosclerosis in a population-based study. The association between concentrations of serum carotenoids, and intima-media thickness of the common carotid artery wall was explored in 840 middle-aged men (aged 46-65 years) from Eastern Finland. Ultrasonography of the common carotid arteries were performed at baseline and 7-year follow-up. Serum levels of carotenoids were analyzed at baseline. Changes in mean and maximum intima media thickness of carotid artery wall were related to baseline serum carotenoid levels in covariance analyses adjusted for covariates. Results: In a covariance analysis with adjustment for age, ultrasound sonographer, maximum intima media thickness, examination year, body mass index, systolic blood pressure, smoking, physical activity, serum LDL cholesterol, family history of coronary heart disease, antihypertensive medication and serum high sensitivity C-reactive protein, 7-year change in maximum intima media thickness was inversely associated with lycopene (p = 0.005), alpha-carotene (p = 0.002) and beta-carotene (p = 0.019), respectively. Conclusions: The present study shows that high serum concentrations of carotenoids may be protective against early atherosclerosis.	[Karppi, Jouni; Kurl, Sudhir; Ronkainen, Kimmo; Kauhanen, Jussi; Laukkanen, Jari A.] Univ Eastern Finland, Dept Med, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Karppi, Jouni; Kurl, Sudhir; Laukkanen, Jari A.] Lapland Cent Hosp, Dept Internal Med, Rovaniemi, Finland	University of Eastern Finland	Karppi, J (corresponding author), Univ Eastern Finland, Dept Med, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	jouni.karppi@uef.fi	Kauhanen, Jussi/ABC-4064-2021; Laukkanen, Jari A/I-4528-2017; Laukkanen, Jari Antero/N-2196-2019	Laukkanen, Jari A/0000-0002-3738-1586; Laukkanen, Jari Antero/0000-0002-3738-1586	EVO funding of Lapland Central Hospital; Orion-Farmos Research Foundation	EVO funding of Lapland Central Hospital; Orion-Farmos Research Foundation	This work was supported by the EVO funding of Lapland Central Hospital and Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabro P, 2009, SEMIN IMMUNOPATHOL, V31, P79, DOI 10.1007/s00281-009-0149-4; Cantrell A, 2003, ARCH BIOCHEM BIOPHYS, V412, P47, DOI 10.1016/S0003-9861(03)00014-6; D'Odorico A, 2000, ATHEROSCLEROSIS, V153, P231, DOI 10.1016/S0021-9150(00)00403-2; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Dwyer JH, 2004, ARTERIOSCL THROM VAS, V24, P313, DOI 10.1161/01.ATV.0000109955.80818.8a; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Gale CR, 2001, AM J CLIN NUTR, V74, P402; Gianetti J, 2002, AM HEART J, V143, P467, DOI 10.1067/mhj.2002.120776; GRINES CL, 1995, CIRCULATION, V91, P298, DOI 10.1161/01.CIR.91.2.298; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Iannuzzi A, 2002, AM J CLIN NUTR, V76, P582, DOI 10.1093/ajcn/76.3.582; Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9; Karppi J, 2011, J INTERN MED, V270, P478, DOI 10.1111/j.1365-2796.2011.02401.x; Kritchevsky SB, 1998, AM J CLIN NUTR, V68, P726, DOI 10.1093/ajcn/68.3.726; KRITCHEVSKY SB, 1995, CIRCULATION, V92, P2142, DOI 10.1161/01.CIR.92.8.2142; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Laukkanen JA, 2006, EUR J CARDIOV PREV R, V13, P421, DOI 10.1097/00149831-200606000-00019; Lidebjer C, 2007, NUTR METAB CARDIOVAS, V17, P448, DOI 10.1016/j.numecd.2006.02.006; Mildel J, 2007, MOL NUTR FOOD RES, V51, P956, DOI 10.1002/mnfr.200600271; Poulsen HE, 2000, FREE RADICAL RES, V33, pS33; Riccioni G, 2011, J BIOL REG HOMEOS AG, V25, P435; Riccioni G, 2007, EXPERT OPIN INV DRUG, V16, P25, DOI 10.1517/13543784.16.1.25; Riccioni G, 2009, EUR J CARDIOV PREV R, V16, P351, DOI 10.1097/HJR.0b013e328325d807; Rissanen TH, 2003, AM J CLIN NUTR, V77, P133, DOI 10.1093/ajcn/77.1.133; SALONEN JT, 1993, LANCET, V341, P1158, DOI 10.1016/0140-6736(93)93184-3; SALONEN JT, 1993, CIRCULATION, V87, P56; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; THURNHAM DI, 1988, CLIN CHEM, V34, P377; Wei W, 2001, AM J PUBLIC HEALTH, V91, P258, DOI 10.2105/AJPH.91.2.258; Young AJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P20, DOI 10.1006/abbi.2000.2149; Zou ZY, 2011, ATHEROSCLEROSIS, V219, P789, DOI 10.1016/j.atherosclerosis.2011.08.006; Zwaka TP, 2001, CIRCULATION, V103, P1194	37	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64107	10.1371/journal.pone.0064107	http://dx.doi.org/10.1371/journal.pone.0064107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700460	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200117
J	Leveque, P; Desmet, C; Dos Santos-Goncalvez, AM; Beun, S; Leprince, JG; Leloup, G; Gallez, B				Leveque, Philippe; Desmet, Celine; Maria Dos Santos-Goncalvez, Ana; Beun, Sebastien; Leprince, Julian G.; Leloup, Gaetane; Gallez, Bernard			Influence of Free Radicals Signal from Dental Resins on the Radio-Induced Signal in Teeth in EPR Retrospective Dosimetry	PLOS ONE			English	Article							TOOTH ENAMEL; RESTORATIVE MATERIALS; BIOLOGICAL DOSIMETRY; BIODOSIMETRY; CASUALTIES; IRRADIATION; HEALTH; EXPOSURE; NETWORK	In case of radiological accident, retrospective dosimetry is needed to reconstruct the absorbed dose of overexposed individuals not wearing personal dosimeters at the onset of the incident. In such a situation, emergency mass triage will be required. In this context, it has been shown that Electron Paramagnetic Resonance (EPR) spectroscopy would be a rapid and sensitive method, on the field deployable system, allowing dose evaluation of a great number of people in a short time period. This methodology uses tooth enamel as a natural dosimeter. Ionising radiations create stable free radicals in the enamel, in a dose dependent manner, which can be detected by EPR directly in the mouth with an appropriate resonator. Teeth are often subject to restorations, currently made of synthetic dimethacrylate-based photopolymerizable composites. It is known that some dental composites give an EPR signal which is likely to interfere with the dosimetric signal from the enamel. So far, no information was available about the occurrence of this signal in the various composites available on the market, the magnitude of the signal compared to the dosimetric signal, nor its evolution with time. In this study, we conducted a systematic characterization of the signal (intensity, kinetics, interference with dosimetric signal) on 19 most widely used composites for tooth restoration, and on 14 experimental resins made with the most characteristic monomers found in commercial composites. Although a strong EPR signal was observed in every material, a rapid decay of the signal was noted. Six months after the polymerization, the signal was negligible in most composites compared to a 3 Gy dosimetric signal in a tooth. In some cases, a stable atypical signal was observed, which was still interfering with the dosimetric signal.	[Leveque, Philippe; Desmet, Celine; Gallez, Bernard] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium; [Leveque, Philippe; Leprince, Julian G.; Leloup, Gaetane; Gallez, Bernard] Catholic Univ Louvain, Ctr Res & Engn Biomat CRIBIO, B-1200 Brussels, Belgium; [Leprince, Julian G.; Leloup, Gaetane] Catholic Univ Louvain, Inst Condensed Matter & Nanosci Bio & Soft Matter, Louvain, Belgium; [Maria Dos Santos-Goncalvez, Ana; Beun, Sebastien; Leprince, Julian G.; Leloup, Gaetane] Catholic Univ Louvain, Sch Dent & Stomatol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Gallez, B (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Res Grp, B-1200 Brussels, Belgium.	Bernard.gallez@uclouvain.be	Leprince, Julian/O-7942-2019; Leprince, Julian G/A-8489-2012; LEVEQUE, Philippe/N-8749-2014	Leprince, Julian/0000-0001-7396-0019; LEVEQUE, Philippe/0000-0003-3687-436X	The National Institutes of Health [U19AI091173]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091173] Funding Source: NIH RePORTER	The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by The National Institutes of Health, grant number U19AI091173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsbury EA, 2011, RADIAT PROT DOSIM, V147, P573, DOI 10.1093/rpd/ncq499; ANNO GH, 1989, HEALTH PHYS, V56, P821, DOI 10.1097/00004032-198906000-00001; Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Blakely WE, 2009, RADIAT RES, V171, P127, DOI 10.1667/RR1549.1; Bushberg JT, 2007, J EMERG MED, V32, P71, DOI 10.1016/j.jemermed.2006.05.034; COLE T, 1963, NATURE, V200, P700, DOI 10.1038/200700a0; Coleman CN, 2009, ANN EMERG MED, V53, P213, DOI 10.1016/j.annemergmed.2007.12.021; Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263; Fattibene P, 2010, APPL RADIAT ISOTOPES, V68, P2033, DOI 10.1016/j.apradiso.2010.05.016; Gomez JA, 2011, RADIAT RES, V176, P259, DOI 10.1667/RR2503.1; Grace MB, 2010, HEALTH PHYS, V98, P172, DOI 10.1097/01.HP.0000348001.60905.c0; Hafer N, 2010, HEALTH PHYS, V98, P903, DOI 10.1097/HP.0b013e3181bbc4df; Jiao L, 2007, J RADIAT RES, V48, P21, DOI 10.1269/jrr.0616; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Kulka U, 2012, RADIAT PROT DOSIM, V151, P621, DOI 10.1093/rpd/ncs157; Leonard A, 2005, RADIAT PROT DOSIM, V115, P448, DOI 10.1093/rpd/nci061; Leprince J, 2010, J ORAL REHABIL, V37, P364, DOI 10.1111/j.1365-2842.2010.02066.x; Leprince JG, 2010, J DENT RES, V89, P1494, DOI 10.1177/0022034510384624; Leprince JG, 2012, DENT MAT; Leprince J, 2009, ACTA BIOMATER, V5, P2518, DOI 10.1016/j.actbio.2009.04.034; Nyberg AG, 2011, INT J ENV RES PUB HE, V8, P4521, DOI 10.3390/ijerph8124521; Sholom S, 2010, HEALTH PHYS, V98, P360, DOI 10.1097/01.HP.0000348002.69740.bd; Sideridou I, 2003, BIOMATERIALS, V24, P655, DOI 10.1016/S0142-9612(02)00380-0; Swartz HM, 2012, HEALTH PHYS, V103, P255, DOI 10.1097/HP.0b013e3182588d92; SWARTZ HM, 1965, RADIAT RES, V24, P579, DOI 10.2307/3571876; Truffier-Boutry D, 2003, J POLYM SCI POL CHEM, V41, P1691, DOI 10.1002/pola.10692; Williams BB, 2011, INT J RADIAT BIOL, V87, P766, DOI 10.3109/09553002.2011.583316; Wojcik A, 2010, RADIAT PROT DOSIM, V138, P397, DOI 10.1093/rpd/ncp279	28	4	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62225	10.1371/journal.pone.0062225	http://dx.doi.org/10.1371/journal.pone.0062225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704875	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200004
J	Turczynska, KM; Bhattachariya, A; Sall, J; Goransson, O; Sward, K; Hellstrand, P; Albinsson, S				Turczynska, Karolina M.; Bhattachariya, Anirban; Sall, Johanna; Goransson, Olga; Sward, Karl; Hellstrand, Per; Albinsson, Sebastian			Stretch-Sensitive Down-Regulation of the miR-144/451 Cluster in Vascular Smooth Muscle and Its Role in AMP-Activated Protein Kinase Signaling	PLOS ONE			English	Article							CELL DIFFERENTIATION; CONTRACTILE DIFFERENTIATION; ACTIN POLYMERIZATION; HYPERTENSIVE-RATS; DEPENDENT GROWTH; EXPRESSION; PRESSURE; WALL; PROLIFERATION; MICRORNAS	Vascular smooth muscle cells are constantly exposed to mechanical force by the blood pressure, which is thought to regulate smooth muscle growth, differentiation and contractile function. We have previously shown that the expression of microRNAs (miRNAs), small non-coding RNAs, is essential for regulation of smooth muscle phenotype including stretch-dependent contractile differentiation. In this study, we have investigated the effect of mechanical stretch on miRNA expression and the role of stretch-sensitive miRNAs for intracellular signaling in smooth muscle. MiRNA array analysis, comparing miRNA levels in stretched versus non-stretched portal veins, revealed a dramatic decrease in the miR-144/451 cluster level. Because this miRNA cluster is predicted to target AMPK pathway components, we next examined activation of this pathway. Diminished miR-144/451 expression was inversely correlated with increased phosphorylation of AMPK alpha at Thr172 in stretched portal vein. Similar to the effect of stretch, contractile differentiation could be induced in non-stretched portal veins by the AMPK activator, AICAR. Transfection with miR-144/451 mimics reduced the protein expression level of mediators in the AMPK pathway including MO25 alpha, AMPK and ACC. This effect also decreased AICAR-induced activation of the AMPK signaling pathway. In conclusion, our results suggest that stretch-induced activation of AMPK in vascular smooth muscle is in part regulated by reduced levels of miR-144/451 and that this effect may play a role in promoting contractile differentiation of smooth muscle cells.	[Turczynska, Karolina M.; Bhattachariya, Anirban; Sall, Johanna; Goransson, Olga; Sward, Karl; Hellstrand, Per; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Albinsson, S (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	sebastian.albinsson@med.lu.se	Albinsson, Sebastian/B-4105-2010; Säll, Johanna/C-1083-2015; Bhattachariya, Anirban/H-5566-2013	Albinsson, Sebastian/0000-0001-6936-3967; Säll, Johanna/0000-0001-7337-4140; Bhattachariya, Anirban/0000-0002-7687-3786; Sward, Karl/0000-0002-7255-5510; Goransson, Olga/0000-0002-7209-8022	Swedish Research Council; Heart and Lung Foundation; Greta and Johan Kock's Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Magnus Bergvall Foundation; Lars Hierta Memorial Foundation; Jeansson Foundation; Marie Curie Initial Training Network Small Artery Remodelling (SmArt) from the European Union	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Greta and Johan Kock's Foundation; Crafoord Foundation; Royal Physiographic Society; Ake Wiberg Foundation; Tore Nilson Foundation; Magnus Bergvall Foundation; Lars Hierta Memorial Foundation; Jeansson Foundation; Marie Curie Initial Training Network Small Artery Remodelling (SmArt) from the European Union	This work has been supported by The Swedish Research Council, The Heart and Lung Foundation, The Greta and Johan Kock's Foundation, The Crafoord Foundation; The Royal Physiographic Society; The Ake Wiberg Foundation; The Tore Nilson Foundation; The Magnus Bergvall Foundation, The Lars Hierta Memorial Foundation, The Jeansson Foundation. KT is supported by the Marie Curie Initial Training Network Small Artery Remodelling (SmArt) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2008, AM J PHYSIOL-CELL PH, V294, pC271, DOI 10.1152/ajpcell.00297.2007; Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018869; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birukov KG, 1998, ARTERIOSCL THROM VAS, V18, P922, DOI 10.1161/01.ATV.18.6.922; Carnevale D, 2012, CARDIOVASC RES, V93, P200, DOI 10.1093/cvr/cvr288; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041574; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fox JC, 2012, AM J PHYSL HEART CIR; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gormand A, 2011, J CELL BIOCHEM, V112, P1364, DOI 10.1002/jcb.23053; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Kawahara S, 2005, J CARDIOVASC PHARM, V45, P367, DOI 10.1097/01.fjc.0000157454.60939.43; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Komatsu R, 1998, CIRCULATION, V98, P224, DOI 10.1161/01.CIR.98.3.224; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Song JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047657; Song L, 2012, ARCH BIOCHEM BIOPHYS, V528, P204, DOI 10.1016/j.abb.2012.08.015; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wesselman JPM, 2001, HYPERTENSION, V37, P955, DOI 10.1161/01.HYP.37.3.955; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442; Zeidan A, 2003, ARTERIOSCL THROM VAS, V23, P1528, DOI 10.1161/01.ATV.0000090129.75275.C2; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007	41	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65135	10.1371/journal.pone.0065135	http://dx.doi.org/10.1371/journal.pone.0065135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705032	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200187
J	Weber, TA; Koob, S; Heide, H; Wittig, I; Head, B; van der Bliek, A; Brandt, U; Mittelbronn, M; Reichert, AS				Weber, Tobias A.; Koob, Sebastian; Heide, Heinrich; Wittig, Ilka; Head, Brian; van der Bliek, Alexander; Brandt, Ulrich; Mittelbronn, Michel; Reichert, Andreas S.			APOOL Is a Cardiolipin-Binding Constituent of the Mitofilin/MINOS Protein Complex Determining Cristae Morphology in Mammalian Mitochondria	PLOS ONE			English	Article							INNER MEMBRANE; ATP SYNTHASE; RESPIRATORY-CHAIN; COILED-COIL; ORGANIZATION; ULTRASTRUCTURE; BIOGENESIS; COMPONENT; APOPTOSIS; TOPOLOGY	Mitochondrial cristae morphology is highly variable and altered under numerous pathological conditions. The protein complexes involved are largely unknown or only insufficiently characterized. Using complexome profiling we identified apolipoprotein O (APOO) and apolipoprotein O-like protein (APOOL) as putative components of the Mitofilin/MINOS protein complex which was recently implicated in determining cristae morphology. We show that APOOL is a mitochondrial membrane protein facing the intermembrane space. It specifically binds to cardiolipin in vitro but not to the precursor lipid phosphatidylglycerol. Overexpression of APOOL led to fragmentation of mitochondria, a reduced basal oxygen consumption rate, and altered cristae morphology. Downregulation of APOOL impaired mitochondrial respiration and caused major alterations in cristae morphology. We further show that APOOL physically interacts with several subunits of the MINOS complex, namely Mitofilin, MINOS1, and SAMM50. We conclude that APOOL is a cardiolipin-binding component of the Mitofilin/MINOS protein complex determining cristae morphology in mammalian mitochondria. Our findings further assign an intracellular role to a member of the apolipoprotein family in mammals.	[Weber, Tobias A.; Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany; [Weber, Tobias A.; Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Zentrum Mol Med, D-60054 Frankfurt, Germany; [Heide, Heinrich; Wittig, Ilka; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, D-60054 Frankfurt, Germany; [Head, Brian; van der Bliek, Alexander] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Goethe University Frankfurt	Reichert, AS (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60054 Frankfurt, Germany.	Andreas.Reichert@bmls-institute.de	Reichert, Andreas/A-4090-2012; Brandt, Ulrich/C-4406-2008; Brandt, Ulrich/GLV-1242-2022	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811; Mittelbronn, Michel/0000-0002-2998-052X; Reichert, Andreas/0000-0001-9340-3113	Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG [EXC 115]; Deutsche Forschungsgemeinschaft [SFB815]; BMBF [01GM1113B]	Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the the Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project EXC 115 (AR, TW, UB, IW), by the Deutsche Forschungsgemeinschaft SFB815 Project Z1 (UB, HH, IW) and The BMBF 01GM1113B- mitoNET (IW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collins MO, 2008, PROTOCOL EXCHANGE, DOI [10.1038/nprot.2008.1123, DOI 10.1038/NPR0T.2008.1123]; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DAEMS WT, 1966, J ULTRA MOL STRUCT R, V16, P123, DOI 10.1016/S0022-5320(66)80027-8; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Gilkerson RW, 2003, FEBS LETT, V546, P355, DOI 10.1016/S0014-5793(03)00633-1; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; HJERTEN S, 1962, ANAL BIOCHEM, V3, P109, DOI 10.1016/0003-2697(62)90100-8; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Korner C, 2012, MOL BIOL CELL, V23, P2143, DOI 10.1091/mbc.E11-10-0831; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 1997, TRENDS BIOCHEM SCI, V22, P37, DOI 10.1016/S0968-0004(96)30050-9; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Nijstad N, 2011, BBA-MOL CELL BIOL L, V1811, P294, DOI 10.1016/j.bbalip.2011.01.008; Odgren PR, 1996, J CELL SCI, V109, P2253; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Strecker V, 2010, PROTEOMICS, V10, P3379, DOI 10.1002/pmic.201000343; Stroud DA, 2012, MOL BIOL CELL; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Wriessnegger T, 2009, BBA-MOL CELL BIOL L, V1791, P166, DOI 10.1016/j.bbalip.2008.12.017; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	59	106	111	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63683	10.1371/journal.pone.0063683	http://dx.doi.org/10.1371/journal.pone.0063683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704930	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200061
J	Xapelli, S; Agasse, F; Sarda-Arroyo, L; Bernardino, L; Santos, T; Ribeiro, FF; Valero, J; Braganca, J; Schitine, C; Reis, RAD; Sebastiao, AM; Malva, JO				Xapelli, Sara; Agasse, Fabienne; Sarda-Arroyo, Laura; Bernardino, Liliana; Santos, Tiago; Ribeiro, Filipa F.; Valero, Jorge; Braganca, Jose; Schitine, Clarissa; de Melo Reis, Ricardo A.; Sebastiao, Ana M.; Malva, Joao O.			Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; ADULT NEUROGENESIS; FUNCTIONAL IDENTIFICATION; NEURONAL DIFFERENTIATION; PROLIFERATION; BRAIN; CB2; ANANDAMIDE; EXPRESSION; MIGRATION	The endocannabinoid system has been implicated in the modulation of adult neurogenesis. Here, we describe the effect of type 1 cannabinoid receptor (CB1R) activation on self-renewal, proliferation and neuronal differentiation in mouse neonatal subventricular zone (SVZ) stem/progenitor cell cultures. Expression of CB1R was detected in SVZ-derived immature cells (Nestin-positive), neurons and astrocytes. Stimulation of the CB1R by (R)-(+)-Methanandamide (R-m-AEA) increased self-renewal of SVZ cells, as assessed by counting the number of secondary neurospheres and the number of Sox2+/+ cell pairs, an effect blocked by Notch pathway inhibition. Moreover, R-m-AEA treatment for 48 h, increased proliferation as assessed by BrdU incorporation assay, an effect mediated by activation of MAPK-ERK and AKT pathways. Surprisingly, stimulation of CB1R by R-m-AEA also promoted neuronal differentiation (without affecting glial differentiation), at 7 days, as shown by counting the number of NeuN-positive neurons in the cultures. Moreover, by monitoring intracellular calcium concentrations ([Ca2+](i)) in single cells following KCl and histamine stimuli, a method that allows the functional evaluation of neuronal differentiation, we observed an increase in neuronal-like cells. This proneurogenic effect was blocked when SVZ cells were co-incubated with R-m-AEA and the CB1R antagonist AM 251, for 7 days, thus indicating that this effect involves CB1R activation. In accordance with an effect on neuronal differentiation and maturation, R-m-AEA also increased neurite growth, as evaluated by quantifying and measuring the number of MAP2-positive processes. Taken together, these results demonstrate that CB1R activation induces proliferation, self-renewal and neuronal differentiation from mouse neonatal SVZ cell cultures.	[Xapelli, Sara; Agasse, Fabienne; Sarda-Arroyo, Laura; Bernardino, Liliana; Santos, Tiago; Valero, Jorge; Schitine, Clarissa; de Melo Reis, Ricardo A.] Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, Coimbra, Portugal; [Xapelli, Sara; Ribeiro, Filipa F.; Sebastiao, Ana M.] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Xapelli, Sara; Ribeiro, Filipa F.; Sebastiao, Ana M.] Univ Lisbon, Inst Mol Med, Unit Neurosci, P-1699 Lisbon, Portugal; [Bernardino, Liliana] Univ Beira Interior, Hlth Sci Res Ctr, Covilha, Portugal; [Braganca, Jose] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Faro, Portugal; [Schitine, Clarissa; de Melo Reis, Ricardo A.] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Neurochem Lab, Rio De Janeiro, Brazil; [Malva, Joao O.] Univ Coimbra, Fac Med Polo 3, Ctr Res Environm Genet & Oncobiol CIMAGO, Coimbra, Portugal	Universidade de Coimbra; Universidade de Lisboa; Universidade de Lisboa; Universidade da Beira Interior; Universidade do Algarve; Universidade Federal do Rio de Janeiro; Universidade de Coimbra	Agasse, F (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, Coimbra, Portugal.	fabienneagasse@yahoo.fr; jomalva@fmed.uc.pt	Valero, Jorge/I-4478-2013; Agasse, Fabienne/ABF-6566-2021; Valero, Jorge/AAG-8053-2019; Braganca, Jose/F-4410-2012; de Melo Reis, Ricardo A/E-9962-2011; Ribeiro, Filipa/S-1079-2018; Malva, Joao/L-3557-2014	Valero, Jorge/0000-0001-6072-3313; Agasse, Fabienne/0000-0002-2206-6196; Valero, Jorge/0000-0001-6072-3313; Braganca, Jose/0000-0001-9566-400X; de Melo Reis, Ricardo A/0000-0001-9689-4085; Sebastiao, Ana M/0000-0001-9030-6115; Bernardino, Liliana/0000-0003-3395-5973; Xapelli, Sara/0000-0001-6854-2509; Ribeiro, Filipa/0000-0002-4006-7328; Malva, Joao/0000-0002-5438-4447; Santos, Tiago/0000-0003-0237-499X	Fundacao para a Ciencia e a Tecnologia - Portugal [POCTI/SAU-NEU/68465/2006, PTDC/SAU-NEU/104415/2008, PTDC/SAU-NEU/101783/2008, POCTI/SAU-NEU/110838/2009]; Fundacao Calouste Gulbenkian [96542]; Fundacao para a Ciencia e Tecnologia; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/104415/2008, PTDC/SAU-NEU/101783/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia - Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	The work was funded by Fundacao para a Ciencia e a Tecnologia - Portugal (www.fct.mctes.pt), projects POCTI/SAU-NEU/68465/2006; PTDC/SAU-NEU/104415/2008; PTDC/SAU-NEU/101783/2008, POCTI/SAU-NEU/110838/2009 and by Fundacao Calouste Gulbenkian (project no 96542). Sara Xapelli, Liliana Bernardino, Filipa F. Ribeiro and Jorge Valero are supported with fellowships from Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600; Agasse Fabienne, 2007, P81, DOI 10.1007/978-0-387-70830-0_4; Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Aguado T, 2007, J BIOL CHEM, V282, P23892, DOI 10.1074/jbc.M700678200; Al-Hayani A, 2001, NEUROPHARMACOLOGY, V41, P1000, DOI 10.1016/S0028-3908(01)00145-9; Arevalo-Martin A, 2007, EUR J NEUROSCI, V26, P1548, DOI 10.1111/j.1460-9568.2007.05782.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bernardino L, 2012, STEM CELLS; Compagnucci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054271; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Grade S, 2010, REJUV RES, V13, P27, DOI 10.1089/rej.2009.0889; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Hill MN, 2010, HIPPOCAMPUS, V20, P513, DOI 10.1002/hipo.20647; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kim S, 2004, CELL MOL NEUROBIOL, V24, P343, DOI 10.1023/B:CEMN.0000022767.74774.38; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Learish RD, 2000, DEV BRAIN RES, V122, P97; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Onaivi ES, 2009, INT REV NEUROBIOL, V88, P335, DOI 10.1016/S0074-7742(09)88012-4; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romero J, 2009, CNS NEUROL DISORD-DR, V8, P440, DOI 10.2174/187152709789824589; Rosa AI, 2010, J NEUROSCI, V30, P4573, DOI 10.1523/JNEUROSCI.5597-09.2010; Rubio-Araiz A, 2008, MOL CELL NEUROSCI, V38, P374, DOI 10.1016/j.mcn.2008.03.010; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Soltys J, 2010, BIOCHEM BIOPH RES CO, V400, P21, DOI 10.1016/j.bbrc.2010.07.129; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tanveer R, 2012, J BIOL CHEM, V287, P34709, DOI 10.1074/jbc.M112.350678; Temple S, 1999, CURR BIOL, V9, pR397, DOI 10.1016/S0960-9822(99)80252-8; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Weiss S, 1996, J NEUROSCI, V16, P7599; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Wolf SA, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-12; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Wu M, 2009, J CELL BIOCHEM, V107, P264, DOI 10.1002/jcb.22122; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	59	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63529	10.1371/journal.pone.0063529	http://dx.doi.org/10.1371/journal.pone.0063529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704915	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200046
J	Zhang, HY; Miao, HM; Wei, LB; Li, C; Zhao, RH; Wang, CY				Zhang, Haiyang; Miao, Hongmei; Wei, Libin; Li, Chun; Zhao, Ruihong; Wang, Cuiying			Genetic Analysis and QTL Mapping of Seed Coat Color in Sesame (Sesamum indicum L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE MAP; AFLP MARKERS; FUSARIUM-WILT; INHERITANCE; IDENTIFICATION; RESISTANCE; DISTORTION; CROSSES	Seed coat color is an important agronomic trait in sesame, as it is associated with seed biochemical properties, antioxidant content and activity and even disease resistance of sesame. Here, using a high-density linkage map, we analyzed genetic segregation and quantitative trait loci (QTL) for sesame seed coat color in six generations (P-1, P-2, F-1, BC1, BC2 and F-2). Results showed that two major genes with additive-dominant-epistatic effects and polygenes with additive-dominant-epistatic effects were responsible for controlling the seed coat color trait. Average heritability of the major genes in the BC1, BC2 and F-2 populations was 89.30%, 24.00%, and 91.11% respectively, while the heritability of polygenes was low in the BC1 (5.43%), in BC2 (0.00%) and in F-2 (0.89%) populations. A high-density map was constructed using 724 polymorphic markers. 653 SSR, AFLP and RSAMPL loci were anchored in 14 linkage groups (LG) spanning a total of 1,216.00 cM. The average length of each LG was 86.86 cM and the marker density was 1.86 cM per marker interval. Four QTLs for seed coat color, QTL1-1, QTL11-1, QTL11-2 and QTL13-1, whose heritability ranged from 59.33%-69.89%, were detected in F-3 populations using CIM and MCIM methods. Alleles at all QTLs from the black-seeded parent tended to increase the seed coat color. Results from QTLs mapping and classical genetic analysis among the P-1, P-2, F-1, BC1, BC2 and F-2 populations were comparatively consistent. This first QTL analysis and high-density genetic linkage map for sesame provided a good foundation for further research on sesame genetics and molecular marker-assisted selection (MAS).	[Zhang, Haiyang; Miao, Hongmei; Wei, Libin; Li, Chun; Zhao, Ruihong; Wang, Cuiying] Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China	Henan Academy of Agricultural Sciences	Zhang, HY (corresponding author), Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China.	zhy@hnagri.org.cn	Miao, Hongmei/AAQ-7525-2021		China National "973'' Project [2011CB109304]; China Agriculture Research System (CARS15)	China National "973'' Project(National Basic Research Program of China); China Agriculture Research System (CARS15)	This work was supported by China National "973'' Project (2011CB109304) and the earmarked fund for the China Agriculture Research System (CARS15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashri A., 1998, Plant Breeding Reviews, V16, P179; Baydar Hasan, 2000, Turkish Journal of Biology, V24, P503; BECKER J, 1995, MOL GEN GENET, V249, P65, DOI 10.1007/BF00290237; Bernatzky R, 1988, MOL MAPPING PLANT CH, P157; Bert PF, 1999, THEOR APPL GENET, V99, P445, DOI 10.1007/s001220051256; BUDOWSKI P, 1951, CHEM REV, V48, P125, DOI 10.1021/cr60149a005; Castiglioni P, 1999, THEOR APPL GENET, V99, P425, DOI 10.1007/s001220051253; Durst C. E., 1930, Bulletin. Illinois Agricultural Experiment Station, V356, P239; El-Bramawy Mohamed A. S., 2006, Plant Protection Science, V42, P99; El-Bramawy Mohamed Abd El-Hamid Sayid, 2008, Journal of Plant Protection Research, V48, P397, DOI 10.2478/v10045-008-0049-y; Falusi O, 2010, AFR J BIOTECH, V6; FAURE S, 1993, THEOR APPL GENET, V87, P517, DOI 10.1007/BF00215098; Fishman L, 2001, GENETICS, V159, P1701; Gai Junyi, 2007, Frontiers of Agriculture in China, V1, P1, DOI 10.1007/s11703-007-0001-3; Gai JY, 1998, THEOR APPL GENET, V97, P1162, DOI 10.1007/s001220051005; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Haanstra JPW, 1999, THEOR APPL GENET, V99, P254, DOI 10.1007/s001220051231; He FongFa, 1994, Journal of Southwest Agricultural University, V16, P573; He XH, 2001, ACTA AGRON SIN, V27, P469; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Kanu P.J., 2011, AM J BIOCH MOL BIOL, V1, P145, DOI [10.3923/ajbmb.2011.145.157, DOI 10.3923/AJBMB.2011.145.157]; Li Ji-Suo, 2006, Yichuan, V28, P458; Li YuSheng, 2008, Acta Agronomica Sinica, V34, P1728, DOI 10.1016/S1875-2780(09)60007-9; Luo X, 2008, ACTA AGR BOREALI SIN, V23, P288; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; McCallum J, 1997, J AM SOC HORTIC SCI, V122, P218, DOI 10.21273/JASHS.122.2.218; McKay JW, 1936, J HERED, V27, P110, DOI 10.1093/oxfordjournals.jhered.a104182; Monforte AJ, 2004, THEOR APPL GENET, V108, P750, DOI 10.1007/s00122-003-1483-x; NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043; Nandi S, 1997, MOL GEN GENET, V255, P1, DOI 10.1007/s004380050468; Negi MS, 2000, THEOR APPL GENET, V101, P146, DOI 10.1007/s001220051463; Nikaido A, 1999, GENES GENET SYST, V74, P55, DOI 10.1266/ggs.74.55; Njiti VN, 2002, THEOR APPL GENET, V104, P294, DOI 10.1007/s001220100682; NOHARA SIGEROKU, 1933, JOUR COLL AGRIC IMP UNIV TOKYO, V12, P227; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Quijada P, 1994, AGRONOMIA TROPICAL, V44; Saeidi G, 1997, J HERED, V88, P466, DOI 10.1093/oxfordjournals.jhered.a023138; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sakata Y, 2006, THEOR APPL GENET, V112, P243, DOI [10.1007/s00122-005-0121-1, 10.1007/s00122-005-0193-y]; Shahidi F, 2006, FOOD CHEM, V99, P478, DOI 10.1016/j.foodchem.2005.08.009; SIKKA S. M., 1947, Indian Journal of Genetics and Plant Breeding, V7, P35; SWENSON S. P., 1942, JOUR AMER SOC AGRON, V34, P452; Tan YD, 2001, GENETICS, V157, P1277; Tian LuShen, 2009, Scientia Agricultura Sinica, V42, P3987; Van Ooijen JW, 2001, JOINMAPR 3 0 SOFTWAR, P1; VANDENBERG A, 1990, J HERED, V81, P484, DOI 10.1093/oxfordjournals.jhered.a111030; VANECK HJ, 1995, MOL BREEDING, V1, P397, DOI 10.1007/BF01248417; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang S., 2007, WINDOWS QTL CARTOGRA; Wei LB, 2012, CHIN B BOT IN PRESS; Wei LB, 2009, GENES GENOM, V31, P199, DOI 10.1007/BF03191152; Wei Xin, 2008, Scientia Agricultura Sinica, V41, P2235; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; ZENG ZB, 1994, GENETICS, V136, P1457; Zewdie Y, 2003, J HERED, V94, P355, DOI 10.1093/jhered/esg063; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y; Zhang YM, 2003, GENETIC SYSTEM QUANT, P120; Zhang YM, 2001, ACTA AGRONOMICA SINI, V27, P787; Zhang YM, 2009, GENETICA, V136, P311, DOI 10.1007/s10709-008-9313-3; Wen-Jing Z, 2012, RICE SCI, V19, P202, DOI 10.1016/S1672-6308(12)60041-9	64	55	64	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63898	10.1371/journal.pone.0063898	http://dx.doi.org/10.1371/journal.pone.0063898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704951	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200082
J	Zhu, ML; Xu, C; Yu, JG; Wu, YJ; Li, CG; Zhang, MM; Jin, ZD; Li, ZS				Zhu, Maoling; Xu, Can; Yu, Jianguo; Wu, Yijun; Li, Chunguang; Zhang, Minmin; Jin, Zhendong; Li, Zhaoshen			Differentiation of Pancreatic Cancer and Chronic Pancreatitis Using Computer-Aided Diagnosis of Endoscopic Ultrasound (EUS) Images: A Diagnostic Test	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SUPPORT VECTOR MACHINE; OVARIAN TUMOR-ANALYSIS; GUIDED FNA; MATHEMATICAL-MODELS; BREAST-LESIONS; NORMAL TISSUE; MASSES; VALIDATION; MALIGNANCY	Background: Differentiating pancreatic cancer (PC) from normal tissue by computer-aided diagnosis of EUS images were quite useful. The current study was designed to investigate the feasibility of using computer-aided diagnostic (CAD) techniques to extract EUS image parameters for the differential diagnosis of PC and chronic pancreatitis (CP). Methodology/Principal Findings: This study recruited 262 patients with PC and 126 patients with CP. Typical EUS images were selected from the sample sets. Texture features were extracted from the region of interest using computer-based techniques. Then the distance between class algorithm and sequential forward selection (SFS) algorithm were used for a better combination of features; and, later, a support vector machine (SVM) predictive model was built, trained, and validated. Overall, 105 features of 9 categories were extracted from the EUS images for pattern classification. Of these features, the 16 were selected as a better combination of features. Then, SVM predictive model was built and trained. The total cases were randomly divided into a training set and a testing set. The training set was used to train the SVM, and the testing set was used to evaluate the performance of the SVM. After 200 trials of randomised experiments, the average accuracy, sensitivity, specificity, the positive and negative predictive values of pancreatic cancer were 94.2 +/- 0.1749%, 96.25 +/- 0.4460%, 93.38 +/- 0.2076%, 92.21 +/- 0.4249% and 96.68 +/- 0.1471%, respectively. Conclusions/Significance: Digital image processing and computer-aided EUS image differentiation technologies are highly accurate and non-invasive. This technology provides a kind of new and valuable diagnostic tool for the clinical determination of PC.	[Zhu, Maoling] Shanghai Jiao Tong Univ, Peoples Hosp Shanghai 1, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Xu, Can; Zhang, Minmin; Jin, Zhendong; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Yu, Jianguo; Wu, Yijun] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China; [Li, Chunguang] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Fudan University; Naval Medical University	Jin, ZD (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.	jinzhd@163.com; lizhshdr@yeah.net						Das A, 2008, GASTROINTEST ENDOSC, V67, P861, DOI 10.1016/j.gie.2007.08.036; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Eloubeidi MA, 2003, CANCER CYTOPATHOL, V99, P285, DOI 10.1002/cncr.11643; Fritscher-Ravens A, 2002, AM J GASTROENTEROL, V97, P2768; Fujita H, 2008, COMPUT METH PROG BIO, V92, P238, DOI 10.1016/j.cmpb.2008.04.003; GARRA BS, 1993, ULTRASONIC IMAGING, V15, P267, DOI 10.1006/uimg.1993.1017; Goh KL, 2012, J DIGEST DIS, V13, P389, DOI 10.1111/j.1751-2980.2012.00609.x; Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3; Hasan MK, 2012, GASTROINTEST ENDOSC, V22, pvii; Hasan Muhammad K, 2012, Gastrointest Endosc Clin N Am, V22, P155, DOI 10.1016/j.giec.2012.04.016; Hewitt MJ, 2012, GASTROINTEST ENDOSC, V75, P319, DOI 10.1016/j.gie.2011.08.049; Horwhat JD, 2006, GASTROINTEST ENDOSC, V63, P966, DOI 10.1016/j.gie.2005.09.028; Levman J, 2008, IEEE T MED IMAGING, V27, P688, DOI 10.1109/TMI.2008.916959; Mavroforakis ME, 2006, ARTIF INTELL MED, V37, P145, DOI 10.1016/j.artmed.2006.03.002; Nishikawa RM, 2012, AM J ROENTGENOL, V198, P708, DOI 10.2214/AJR.11.6423; Norton ID, 2001, GASTROINTEST ENDOSC, V54, P625, DOI 10.1067/mge.2001.118644; Othman MO, 2012, GASTROENTEROL CLIN N, V41, P179, DOI 10.1016/j.gtc.2011.12.014; Prachayakul Varayu, 2012, J Med Assoc Thai, V95 Suppl 2, pS68; Sahai AV, 2002, GASTROINTEST ENDOSC, V56, pS76, DOI 10.1067/mge.2002.127701; Van Holsbeke C, 2007, CLIN CANCER RES, V13, P4440, DOI 10.1158/1078-0432.CCR-06-2958; Van Holsbeke C, 2009, CLIN CANCER RES, V15, P684, DOI 10.1158/1078-0432.CCR-08-0113; Varadarajulu S, 2005, GASTROINTEST ENDOSC, V62, P728, DOI 10.1016/j.gie.2005.06.051; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Xu QA, 2011, HEPATOB PANCREAT DIS, V10, P128, DOI 10.1016/S1499-3872(11)60021-0; Zhang MM, 2010, GASTROINTEST ENDOSC, V72, P978, DOI 10.1016/j.gie.2010.06.042	25	51	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63820	10.1371/journal.pone.0063820	http://dx.doi.org/10.1371/journal.pone.0063820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704940	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200071
J	Cao, RY; Dong, DY; Liu, RJ; Han, JF; Wang, GC; Zhao, H; Li, XF; Deng, YQ; Zhu, SY; Wang, XY; Lin, F; Zhang, FJ; Chen, W; Qin, ED; Qin, CF				Cao, Rui-Yuan; Dong, Da-Yong; Liu, Rui-Ju; Han, Jian-Feng; Wang, Guang-Chuan; Zhao, Hui; Li, Xiao-Feng; Deng, Yong-Qiang; Zhu, Shun-Ya; Wang, Xiao-Yu; Lin, Fang; Zhang, Fu-Jun; Chen, Wei; Qin, E-De; Qin, Cheng-Feng			Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; NEWBORN MICE; IN-VITRO; PROTECTION; RECEPTOR; RESPONSES; VACCINES; DISEASE	The emerging human enterovirus 71 (EV71) represents a growing threat to public health, and no vaccine or specific antiviral is currently available. Human intravenous immunoglobulin (IVIG) is clinical used in treating severe EV71 infections. However, the discovery of antibody dependent enhancement (ADE) of EV71 infection illustrates the complex roles of antibody in controlling EV71 infection. In this study, to identify the distinct role of each IgG subclass on neutralization and enhancement of EV71 infection, different lots of pharmaceutical IVIG preparations manufactured from Chinese donors were used for IgG subclass fractionation by pH gradient elution with the protein A-conjugated affinity column. The neutralization and ADE capacities on EV71 infection of each purified IgG subclass were then assayed, respectively. The neutralizing activity of human IVIG is mainly mediated by IgG1 subclass and to less extent by IgG2 subclass. Interestingly, IgG3 fraction did not have neutralizing activity but enhanced EV71 infection in vitro. These results revealed the different roles of human IgG subclasses on EV71 infection, which is of critical importance for the rational design of immunotherapy and vaccines against severe EV71 diseases.	[Cao, Rui-Yuan; Dong, Da-Yong; Han, Jian-Feng; Wang, Guang-Chuan; Zhao, Hui; Li, Xiao-Feng; Deng, Yong-Qiang; Zhu, Shun-Ya; Wang, Xiao-Yu; Lin, Fang; Chen, Wei; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Liu, Rui-Ju] Liaocheng Peoples Hosp, Liaocheng, Peoples R China; [Lin, Fang] Second Artillery Gen Hosp, Beijing, Peoples R China; [Zhang, Fu-Jun] Rizhao Hosp Tradit Chinese Med, Rizhao, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Guangchuan/0000-0001-5315-1599	Beijing Natural Science Foundation [7112108, 7122129]; National Natural Science Foundation of China [81000721, 31270195]; Beijing Nova Program of Science and Technology [2010B041]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program of Science and Technology	This work was supported by Beijing Natural Science Foundation (numbers 7112108 and 7122129), and National Natural Science Foundation of China (numbers 81000721 and 31270195). C.F. Qin was supported by the Beijing Nova Program of Science and Technology (number 2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABZUG MJ, 1995, CLIN INFECT DIS, V20, P1201, DOI 10.1093/clinids/20.5.1201; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Brouwer KC, 2004, J INFECT DIS, V190, P1192, DOI 10.1086/422850; Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002; Cao RY, 2010, CLIN INFECT DIS, V50, P125, DOI 10.1086/649012; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; DUHAMEL RC, 1979, J IMMUNOL METHODS, V31, P211, DOI 10.1016/0022-1759(79)90133-9; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Han JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-106; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; HOCART MJ, 1990, J MED VIROL, V30, P92, DOI 10.1002/jmv.1890300203; Hofmeister Y, 2011, J VIROL, V85, P1896, DOI 10.1128/JVI.02155-10; Huisman W, 2009, VACCINE, V27, P505, DOI 10.1016/j.vaccine.2008.10.087; Jelley-Gibbs DM, 1999, HUM IMMUNOL, V60, P469, DOI 10.1016/S0198-8859(99)00023-3; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; Mori S, 2008, VIROLOGY, V375, P141, DOI 10.1016/j.virol.2008.01.033; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024; Sauter P, 2007, VIRUS RES, V125, P183, DOI 10.1016/j.virusres.2007.01.001; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shih SR, 2004, J NEUROVIROL, V10, P293, DOI 10.1080/13550280490499551; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2010, CLIN VACCINE IMMUNOL, V17, P1517, DOI 10.1128/CVI.00108-10; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368	37	41	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64024	10.1371/journal.pone.0064024	http://dx.doi.org/10.1371/journal.pone.0064024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700449	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400041
J	Chao, SH; Huang, HY; Chang, CH; Yang, CH; Cheng, WS; Kang, YH; Watanabe, K; Tsai, YC				Chao, Shiou-Huei; Huang, Hui-Yu; Chang, Chuan-Hsiung; Yang, Chih-Hsien; Cheng, Wei-Shen; Kang, Ya-Huei; Watanabe, Koichi; Tsai, Ying-Chieh			Microbial Diversity Analysis of Fermented Mung Beans (Lu-Doh-Huang) by Using Pyrosequencing and Culture Methods	PLOS ONE			English	Article							HUMAN INTESTINAL BACTERIA; SEQUENCE-ANALYSIS; RADIX-ASTRAGALI; HEPATOTOXICITY; IDENTIFICATION; TRANSFORMATION; ANTIOXIDANT; METABOLISM; PHES; RPOA	In Taiwanese alternative medicine Lu-doh-huang (also called Pracparatum mungo), mung beans are mixed with various herbal medicines and undergo a 4-stage process of anaerobic fermentation. Here we used high-throughput sequencing of the 16S rRNA gene to profile the bacterial community structure of Lu-doh-huang samples. Pyrosequencing of samples obtained at 7 points during fermentation revealed 9 phyla, 264 genera, and 586 species of bacteria. While mung beans were inside bamboo sections (stages 1 and 2 of the fermentation process), family Lactobacillaceae and genus Lactobacillus emerged in highest abundance; Lactobacillus plantarum was broadly distributed among these samples. During stage 3, the bacterial distribution shifted to family Porphyromonadaceae, and Butyricimonas virosa became the predominant microbial component. Thereafter, bacterial counts decreased dramatically, and organisms were too few to be detected during stage 4. In addition, the microbial compositions of the liquids used for soaking bamboo sections were dramatically different: Exiguobacterium mexicanum predominated in the fermented soybean solution whereas B. virosa was predominant in running spring water. Furthermore, our results from pyrosequencing paralleled those we obtained by using the traditional culture method, which targets lactic acid bacteria. In conclusion, the microbial communities during Lu-doh-huang fermentation were markedly diverse, and pyrosequencing revealed a complete picture of the microbial consortium.	[Chao, Shiou-Huei; Kang, Ya-Huei; Tsai, Ying-Chieh] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Huang, Hui-Yu] Shih Chien Univ, Dept Food Sci Nutr & Nutraceut Biotechnol, Taipei, Taiwan; [Chang, Chuan-Hsiung; Yang, Chih-Hsien] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Chang, Chuan-Hsiung; Yang, Chih-Hsien; Cheng, Wei-Shen] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Watanabe, Koichi] Yakult Cent Inst Microbiol Res, Tokyo, Japan	National Yang Ming Chiao Tung University; Shih Chien University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Yakult Honsha Company, Limited	Tsai, YC (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	tsaiyc@ym.edu.tw		Watanabe, Koichi/0000-0001-9482-1448	National Science Council [NSC 99-2321-B-010-001-MY3]; High-throughput Genome Analysis Core Facility [NSC-100-2319-B-010-001]	National Science Council(Ministry of Science and Technology, Taiwan); High-throughput Genome Analysis Core Facility	This work was supported by the National Science Council (NSC 99-2321-B-010-001-MY3), and High-throughput Genome Analysis Core Facility (NSC-100-2319-B-010-001) for pyrosequencing and Bioinformatics Consortium of Taiwan (NSC 100-2319-B-010-002) for bioinformatics analysis of National Core Facility Program for Biotechnology in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; Cai Q.Y, 2012, CHINESE J EXP TRADIT, V18, P119; Chao SH, 2008, INT J FOOD MICROBIOL, V123, P134, DOI 10.1016/j.ijfoodmicro.2007.12.010; Chao SH, 2009, INT J FOOD MICROBIOL, V135, P203, DOI 10.1016/j.ijfoodmicro.2009.07.032; Chi H, 2005, BIOL PHARM BULL, V28, P2102, DOI 10.1248/bpb.28.2102; CHU HC, 2007, SAFETY EVALUATION LI; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Eum HA, 2011, AFR J TRADIT COMPLEM, V8, P312; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hsu MF, 2009, J ETHNOPHARMACOL, V125, P474, DOI 10.1016/j.jep.2009.07.011; HUYSMANS E, 1986, NUCLEIC ACIDS RES, V14, pR73, DOI 10.1093/nar/14.suppl.r73; Kim BG, 2011, APPL BIOCHEM BIOTECH, V165, P1107, DOI 10.1007/s12010-011-9328-6; Kim DH, 1998, BIOL PHARM BULL, V21, P360; Kim DH, 1999, ARCH PHARM RES, V22, P30, DOI 10.1007/BF02976432; Kobashi K., 1997, Bioscience and Microflora, V16, P1; Kuo DH, 2010, FOOD CHEM, V123, P1007, DOI 10.1016/j.foodchem.2010.05.052; Lee DS, 2002, ARCH PHARM RES, V25, P165, DOI 10.1007/BF02976558; LI Y, 2010, J CHENGDU U TRADIT C, V33, P69; LIU CW, 2007, PHELLINUS LINTEUS PR; LONGUET-HIGGINS M S, 1971, Theoretical Population Biology, V2, P271, DOI 10.1016/0040-5809(71)90020-7; Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936; Mekseepralard C, 2010, PHYTOTHER RES, V24, P1514, DOI 10.1002/ptr.3158; Naser SM, 2007, INT J SYST EVOL MICR, V57, P2777, DOI 10.1099/ijs.0.64711-0; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Otieno DO, 2007, J APPL MICROBIOL, V103, P601, DOI 10.1111/j.1365-2672.2006.03245.x; PENG HP, 2007, ANTIOXIDANT ACTIVITI; Sakamoto N, 2011, INT J FOOD MICROBIOL, V144, P352, DOI 10.1016/j.ijfoodmicro.2010.10.017; Sato Y, 2007, BIOL PHARM BULL, V30, P145, DOI 10.1248/bpb.30.145; Sheih IC, 2011, J AGR FOOD CHEM, V59, P6520, DOI 10.1021/jf2011547; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; Trinh HT, 2007, J MICROBIOL BIOTECHN, V17, P1127; Vanhaecke L, 2008, APPL ENVIRON MICROB, V74, P1469, DOI 10.1128/AEM.02064-07; Wang Y.N., 2010, WORLD SCI TECHNOLOGY, V12, P437, DOI [10.3969/j.issn.1674-3849.2010.03.026, DOI 10.3969/J.ISSN.1674-3849.2010.03.026]; WANG YC, 2007, FUNCTIONAL STUDIES L; Yoon Sang Yeon, 1994, Archives of Pharmacal Research (Seoul), V17, P438, DOI 10.1007/BF02979122; Yuan D, 2008, CHEM PHARM BULL, V56, P1, DOI 10.1248/cpb.56.1	38	9	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63816	10.1371/journal.pone.0063816	http://dx.doi.org/10.1371/journal.pone.0063816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700436	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400033
J	Casjens, S; Eckert, A; Woitalla, D; Ellrichmann, G; Turewicz, M; Stephan, C; Eisenacher, M; May, C; Meyer, HE; Bruning, T; Pesch, B				Casjens, Swaantje; Eckert, Angelika; Woitalla, Dirk; Ellrichmann, Gisa; Turewicz, Michael; Stephan, Christian; Eisenacher, Martin; May, Caroline; Meyer, Helmut E.; Bruening, Thomas; Pesch, Beate			Diagnostic Value of the Impairment of Olfaction in Parkinson's Disease	PLOS ONE			English	Article							ODOR IDENTIFICATION; DYSFUNCTION; DISCRIMINATION; SMELL; PREVALENCE; DEFICITS; ADULTS; TESTS	Background: Olfactory impairment is increasingly recognized as an early symptom in the development of Parkinson's disease. Testing olfactory function is a non-invasive method but can be time-consuming which restricts its application in clinical settings and epidemiological studies. Here, we investigate odor identification as a supportive diagnostic tool for Parkinson's disease and estimate the performance of odor subsets to allow a more rapid testing of olfactory impairment. Methodology/Principal Findings: Odor identification was assessed with 16 Sniffin' sticks in 148 Parkinson patients and 148 healthy controls. Risks of olfactory impairment were estimated with proportional odds models. Random forests were applied to classify Parkinson and non-Parkinson patients. Parkinson patients were rarely normosmic (identification of more than 12 odors; 16.8%) and identified on average seven odors whereas the reference group identified 12 odors and showed a higher prevalence of normosmy (31.1%). Parkinson patients with rigidity dominance had a twofold greater prevalence of olfactory impairment. Disease severity was associated with impairment of odor identification (per score point of the Hoehn and Yahr rating OR 1.87, 95% CI 1.26-2.77). Age-related impairment of olfaction showed a steeper gradient in Parkinson patients. Coffee, peppermint, and anise showed the largest difference in odor identification between Parkinson patients and controls. Random forests estimated a misclassification rate of 22.4% when comparing Parkinson patients with healthy controls using all 16 odors. A similar rate (23.8%) was observed when only the three aforementioned odors were applied. Conclusions/Significance: Our findings indicate that testing odor identification can be a supportive diagnostic tool for Parkinson's disease. The application of only three odors performed well in discriminating Parkinson patients from controls, which can facilitate a wider application of this method as a point-of-care test.	[Casjens, Swaantje; Eckert, Angelika; Bruening, Thomas; Pesch, Beate] Inst Ruhr Univ Bochum IPA, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany; [Woitalla, Dirk; Ellrichmann, Gisa] Ruhr Univ Bochum, St Josef Hosp, Neurol Clin, Bochum, Germany; [Turewicz, Michael; Stephan, Christian; Eisenacher, Martin; May, Caroline; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Pesch, B (corresponding author), Inst Ruhr Univ Bochum IPA, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany.	pesch@ipa-dguv.de	Eisenacher, Martin/J-8044-2014; Brüning, Thomas/G-8120-2015; Turewicz, Michael/M-5026-2019; Casjens, Swaantje/AAP-8856-2020	Eisenacher, Martin/0000-0003-2687-7444; Brüning, Thomas/0000-0001-9560-5464; Turewicz, Michael/0000-0003-0737-1114; Casjens, Swaantje/0000-0002-0148-8859	European Regional Development Fond (ERDF) of the European Union; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkCHIP) [FZ 280381102]; P.U.R.E. (Protein Unit for Research in Europe), a project of the Federal State Northrhine Westphalia, Germany	European Regional Development Fond (ERDF) of the European Union; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkCHIP); P.U.R.E. (Protein Unit for Research in Europe), a project of the Federal State Northrhine Westphalia, Germany	This work was supported by the European Regional Development Fond (ERDF) of the European Union and the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen (ParkCHIP, FZ 280381102). Part of this work was also funded from P.U.R.E. (Protein Unit for Research in Europe), a project of the Federal State Northrhine Westphalia, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesveldt S, 2008, RHINOLOGY, V46, P131; Boesveldt S, 2008, MOVEMENT DISORD, V23, P1984, DOI 10.1002/mds.22155; Boesveldt S, 2011, RHINOLOGY, V49, P324, DOI 10.4193/Rhino10.155; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks DJ, 1998, ANN NEUROL, V44, pS10, DOI 10.1002/ana.410440704; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Damholdt MF, 2011, MOVEMENT DISORD, V26, P2045, DOI 10.1002/mds.23782; Doty RL, 2011, PSYCHOL AGING, V26, P864, DOI 10.1037/a0023263; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2009, EXPERT REV NEUROTHER, V9, P1773, DOI [10.1586/ern.09.115, 10.1586/ERN.09.115]; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, J NEUROL, V257, P1316, DOI 10.1007/s00415-010-5516-5; Iijima M, 2011, EUR J NEUROL, V18, P425, DOI 10.1111/j.1468-1331.2010.03167.x; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Morley JF, 2011, MOVEMENT DISORD, V26, P2051, DOI 10.1002/mds.23792; Mueller C, 2006, AM J RHINOL, V20, P113, DOI 10.1177/194589240602000121; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; R Core Team, 2021, R LANG ENV STAT COMP; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; STERN MB, 1994, NEUROLOGY, V44, P266, DOI 10.1212/WNL.44.2.266; Tissingh G, 2001, MOVEMENT DISORD, V16, P41, DOI 10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Verbaan D, 2008, NEUROLOGY, V71, P1877, DOI 10.1212/01.wnl.0000336651.48596.c7	36	38	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64735	10.1371/journal.pone.0064735	http://dx.doi.org/10.1371/journal.pone.0064735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696904	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900106
J	Jelenkovic, A; Silventoinen, K; Tynelius, P; Myrskyla, M; Rasmussen, F				Jelenkovic, Aline; Silventoinen, Karri; Tynelius, Per; Myrskylae, Mikko; Rasmussen, Finn			Association of Birth Order with Cardiovascular Disease Risk Factors in Young Adulthood: A Study of One Million Swedish Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MULTIVARIATE GENETIC-ANALYSIS; POPULATION-BASED COHORT; BLOOD-PRESSURE; MUSCULAR STRENGTH; MUSCLE STRENGTH; BODY-COMPOSITION; GRIP STRENGTH; RAPID GROWTH; MORTALITY	Background: Birth order has been suggested to be linked to several cardiovascular disease (CVD) risk factors, but the evidence is still inconsistent. We aim to determine the associations of birth order with body mass index (BMI), muscle strength and blood pressure. Further we will analyse whether these relationships are affected by family characteristics. Methods: BMI, elbow flexion, hand grip and knee extension strength and systolic and diastolic blood pressure were measured at conscription examination in 1 065 710 Swedish young men born between 1951 and 1975. The data were analysed using linear multivariate and fixed effects regression models; the latter compare siblings and account for genetic and social factors shared by brothers. Results: Fixed effect regression analysis showed that birth order was inversely associated with BMI: second and third born had 0.8% and 1.1% (p<0.001) lower BMI than first-born, respectively. The association pattern differed among muscle strengths. After adjustment for BMI, first-born presented lower elbow flexion and hand grip strength than second-born (-5.9 N and -3.8 N, respectively, p<0.001). Knee extension strength was inversely related to birth order though not always significantly. The association between birth order and blood pressure was not significant. Conclusions: Birth order is negatively associated with BMI and knee extension strength, positively with elbow flexion and hand grip strength, and is not associated with blood pressure among young men. Although the effects are small, the link between birth order and some CVD risk factors is already detectable in young adulthood.	[Jelenkovic, Aline] Univ Pais Vasco Euskal Herriko Unibertsitatea, Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Jelenkovic, Aline] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Jelenkovic, Aline; Silventoinen, Karri] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Myrskylae, Mikko] Max Planck Inst Demog Res, Rostock, Germany	University of Basque Country; Basque Foundation for Science; University of Helsinki; University of Helsinki; Karolinska Institutet; Max Planck Society	Jelenkovic, A (corresponding author), Univ Pais Vasco Euskal Herriko Unibertsitatea, Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	aline.jelenkovic@helsinki.fi	Jelenkovic, Aline/L-1753-2014	Jelenkovic, Aline/0000-0002-6191-8371; Rasmussen, Finn/0000-0001-7915-7809; Tynelius, Per/0000-0001-8155-7406; Silventoinen, Karri/0000-0003-1759-3079	Basque Governments Department of Education, Universities and Research	Basque Governments Department of Education, Universities and Research	This work was supported by a Postdoctoral fellowship from the Basque Governments Department of Education, Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyavoo A, 2013, J CLIN ENDOCR METAB, V98, P1248, DOI 10.1210/jc.2012-3531; Celi F, 2003, EUR J CLIN NUTR, V57, P1045, DOI 10.1038/sj.ejcn.1601640; Dahly DL, 2010, INT J OBESITY, V34, P751, DOI 10.1038/ijo.2009.275; De Mars G, 2007, TWIN RES HUM GENET, V10, P180; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Ghosh JR, 2006, HUM BIOL, V78, P733, DOI 10.1353/hub.2007.0012; Grijalva-Eternod CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056078; Haugaard LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056357; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Mancia G, 2007, AM J CARDIOL, V100, p3J, DOI 10.1016/j.amjcard.2007.05.008; McMahon T.A., 1984, MUSCLES REFLEXES LOC; Melanson K J, 2001, Cardiol Rev, V9, P202, DOI 10.1097/00045415-200107000-00005; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Mota J, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-42; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Power C, 2003, J EPIDEMIOL COMMUN H, V57, P969, DOI 10.1136/jech.57.12.969; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Silventoinen K, 2007, EUR J CARDIOV PREV R, V14, P555, DOI 10.1097/HJR.0b013e328014672e; Stettler N, 2000, AM J CLIN NUTR, V72, P378; Sundstrom J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d643; Thomis MA, 1997, J APPL PHYSIOL, V82, P959, DOI 10.1152/jappl.1997.82.3.959; Tiainen K, 2005, MED SCI SPORT EXER, V37, P72, DOI 10.1249/01.MSS.0000150081.04037.BB; VIITASALO JT, 1985, ERGONOMICS, V28, P1563, DOI 10.1080/00140138508963288; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; WHINCUP PH, 1989, BMJ-BRIT MED J, V299, P587, DOI 10.1136/bmj.299.6699.587; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; World Health Organization, CARD DIS CVDS; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	47	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63361	10.1371/journal.pone.0063361	http://dx.doi.org/10.1371/journal.pone.0063361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146HW	23696817	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900030
J	van den Brink, DM; Banerji, O; Tear, G				van den Brink, Daan M.; Banerji, Oishik; Tear, Guy			Commissureless Regulation of Axon Outgrowth across the Midline Is Independent of Rab Function	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; CNS MIDLINE; NEUROMUSCULAR SYNAPTOGENESIS; DROSOPHILA-MELANOGASTER; UBIQUITIN LIGASE; CELL-ADHESION; PROTEIN; NEURONS; RECEPTORS; SLIT	Nervous system function requires that neurons within neural circuits are connected together precisely. These connections form during the process of axon guidance whereby each neuron extends an axon that migrates, often large distances, through a complex environment to reach its synaptic target. This task can be simplified by utilising intermediate targets to divide the route into smaller sections. This requires that axons adapt their behaviour as they migrate towards and away from intermediate targets. In the central nervous system the midline acts as an intermediate target for commissural axons. In Drosophila commissural axons switch from attraction towards to extension away from the midline by regulating the levels of the Roundabout receptor on their cell surface. This is achieved by Commissureless which directs Roundabout to an intracellular compartment in the soma prior to reaching the midline. Once across the midline Roundabout is allowed to reach the surface and acts as a receptor for the repellent ligand Slit that is secreted by cells at the midline. Here we investigated candidate intracellular mechanisms that may facilitate the intracellular targeting of Commissureless and Roundabout within the soma of commissural neurons. Using modified forms of Commissureless or Rabs we show that neither ubiquitination nor Rab activity are necessary for the intracellular targeting of Commissureless. In addition we reveal that axon outgrowth of many populations of neurons within the Drosophila central nervous system is also independent of Rab activity.	[van den Brink, Daan M.; Banerji, Oishik; Tear, Guy] Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London	Tear, G (corresponding author), Kings Coll London, Med Res Council Ctr Dev Neurobiol, London WC2R 2LS, England.	guy.tear@kcl.ac.uk	van den Brink, Daan/S-7529-2017	van den Brink, Daan/0000-0002-3048-5382; Banerji, Oishik/0000-0003-4614-8441; Tear, Guy/0000-0002-3114-7537	BBSRC (Biotechnology and Biological Sciences Research Council) [BB/G022399/1]; NIH [OD010949-10]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014287/1, BB/K002031/1, BB/G022399/1, C19246] Funding Source: researchfish; Medical Research Council [G0901899, G0401440] Funding Source: researchfish; BBSRC [BB/K002031/1, BB/F014287/1, BB/G022399/1] Funding Source: UKRI; MRC [G0901899, G0401440] Funding Source: UKRI	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the BBSRC (Biotechnology and Biological Sciences Research Council), Ref BB/G022399/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Bloomington Drosophila Stock Center, Matthias Landgraf, Hugo Bellen, Marcus Gonzalez-Gaitan, Sean Sweeney and Daniela Rotin for providing strains of Drosophila used in this study. We also thank the Drosophila Genomics Resource Center, supported by NIH grant OD010949-10 for the supply of S2 cells.	Allen J, 2009, DEV BIOL, V327, P4, DOI 10.1016/j.ydbio.2008.12.013; Bhuin T, 2011, INT J DEV BIOL, V55, P269, DOI 10.1387/ijdb.103149tb; Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2010, COLD SPRING HARB PER, V2; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; HUBER LA, 1995, MOL CELL BIOL, V15, P918; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Kamata T, 1998, MOL BRAIN RES, V54, P219, DOI 10.1016/S0169-328X(97)00332-X; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Long KE, 2000, J NEUROBIOL, V44, P230, DOI 10.1002/1097-4695(200008)44:2<230::AID-NEU12>3.0.CO;2-W; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Philipp M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-36; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Star EN, 2005, J PHYSIOL-LONDON, V569, P103, DOI 10.1113/jphysiol.2005.092528; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Winckler B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001826; Wolf B, 1998, DEVELOPMENT, V125, P3853; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	55	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64427	10.1371/journal.pone.0064427	http://dx.doi.org/10.1371/journal.pone.0064427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696892	Green Submitted, gold, Green Published			2022-12-25	WOS:000319081900095
J	Xiao, S; White, JF; Betenbaugh, MJ; Grisshammer, R; Shiloach, J				Xiao, Su; White, Jim F.; Betenbaugh, Michael J.; Grisshammer, Reinhard; Shiloach, Joseph			Transient and Stable Expression of the Neurotensin Receptor NTS1: A Comparison of the Baculovirus-Insect Cell and the T-REx-293 Expression Systems	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; HIGH-LEVEL EXPRESSION; INTEGRAL MEMBRANE-PROTEINS; PURIFICATION; OVEREXPRESSION; RHODOPSIN; PEPTIDE	Nowadays, baculovirus-infected insect cells and tetracycline-inducible mammalian cell lines (T-REx-293) are intensively used for G protein-coupled receptor (GPCR) production for crystallography purposes. Here we constructed a suspension T-REx-293 cell line to stably express an engineered neurotensin receptor 1 (NTS1) mutant and we quantitatively compared this cell line with the transient baculovirus-insect cell system throughout a milligram-scale NTS1 expression and purification process. The two systems were comparable with respect to functional NTS1 expression levels and receptor binding affinity for the agonist [H-3] neurotensin. However, NTS1 surface display on T-REx-293 cells determined by radio-ligand binding assays was 2.8 fold higher than that on insect cells. This work demonstrates two approaches for preparing milligram quantities of purified NTS1 suitable for structural studies and provides useful input to users in choosing and optimizing an appropriate expression host for other GPCRs.	[Xiao, Su; Shiloach, Joseph] NIDDKD, Biotechnol Core Lab, Bethesda, MD 20892 USA; [White, Jim F.; Grisshammer, Reinhard] NINDS, Membrane Prot Struct & Funct Unit, NIH, Rockville, MD USA; [Xiao, Su; Betenbaugh, Michael J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University	Grisshammer, R (corresponding author), NINDS, Membrane Prot Struct & Funct Unit, NIH, Rockville, MD USA.	rkgriss@helix.nih.gov; josephs@intra.niddk.nih.gov	Grisshammer, Reinhard/C-3089-2015; Betenbaugh, Michael J./A-3252-2010	Betenbaugh, Michael J./0000-0002-6336-4659	Intramural Research Program of the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases); Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003016] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institutes of Health (SX, JS: National Institute of Diabetes and Digestive and Kidney Diseases; JFW, RG: National Institute of Neurological Disorders and Stroke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrell J, 2013, MOL MEMBR BIOL, V30, P52, DOI 10.3109/09687688.2012.703703; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Chen JS, 2003, CURR CANCER DRUG TAR, V3, P219, DOI 10.2174/1568009033481994; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Corin K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00172; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hedayat A, 1999, ORTHOGONAL ARRAYS TH, Vxxii, P416; Kim JS, 2004, BIOTECHNOL PROGR, V20, P1788, DOI 10.1021/bp025536y; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; O'Malley MA, 2007, J STRUCT BIOL, V159, P166, DOI 10.1016/j.jsb.2007.05.001; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schimpff RM, 2001, J NEUROL NEUROSUR PS, V70, P784, DOI 10.1136/jnnp.70.6.784; Shi CH, 2005, BIOCHEMISTRY-US, V44, P15705, DOI 10.1021/bi051292p; Shibata Y, 2013, BIOCH BIOPH IN PRESS; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; White JF, 2004, FEBS LETT, V564, P289, DOI 10.1016/S0014-5793(04)00195-4; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; White JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012579	35	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63679	10.1371/journal.pone.0063679	http://dx.doi.org/10.1371/journal.pone.0063679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696845	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900051
J	Hoier, B; Prats, C; Qvortrup, K; Pilegaard, H; Bangsbo, J; Hellsten, Y				Hoier, Birgitte; Prats, Clara; Qvortrup, Klaus; Pilegaard, Henriette; Bangsbo, Jens; Hellsten, Ylva			Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscle	FASEB JOURNAL			English	Article						transmission electron microscopy; confocal microscopy; microdialysis; exercise	VEGF EXPRESSION; ANGIOGENIC FACTORS; GENE-EXPRESSION; SINGLE BOUT; EXERCISE; PGC-1-ALPHA; CELLS; CAPILLARIZATION; DYSTROPHIN; PERICYTES	The subcellular distribution and secretion of vascular endothelial growth factor (VEGF) was examined in skeletal muscle of healthy humans. Skeletal muscle biopsies were obtained from m.v. lateralis before and after a 2 h bout of cycling exercise. VEGF localization was conducted on preparations of teased muscle fibers by transmission electron microscopy (TEM) and confocal microscopy (CM). Muscle interstitial fluid was sampled from microdialysis probes placed in the thigh muscle. TEM and CM analysis revealed two primary sites of localization of VEGF: in vesicles located in the subsarcolemmal regions and between the contractile elements within the muscle fibers; and in pericytes situated on the skeletal muscle capillaries. Quantitation of the subsarcolemmal density of VEGF vesicles, calculated on top of myonuclei, in the muscle fibers revealed a approximate to 50% increase (P<0.05) after exercise. The observation of more VEGF vesicles close to sarcolemma after exercise, combined with a 5-fold increase (P<0.05) in VEGF in the interstitial fluid, suggest that VEGF-containing vesicles redistribute to sarcolemma and that VEGF is secreted to the extracellular fluid. This study provides the first evidence in humans for a mechanism by which skeletal muscle fibers can control capillary growth by releasing VEGF from intracellular vesicles during contraction.Hoier, B., Prats, C., Qvortrup, K., Pilegaard, H., Bangsbo, J., Hellsten, Y. Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscle.	[Hoier, Birgitte; Bangsbo, Jens; Hellsten, Ylva] Univ Copenhagen, Dept Nutr Exercise & Sport, DK-2100 Copenhagen, Denmark; [Prats, Clara; Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, Core Facil Integrated Microscopy, DK-2100 Copenhagen, Denmark; [Pilegaard, Henriette] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Hellsten, Y (corresponding author), Univ Copenhagen, Sect Integrat Physiol, Dept Nutr Exercise & Sport, Univ Pk 13, DK-2100 Copenhagen, Denmark.	yhellsten@ifi.ku.dk	Pilegaard, Henriette/M-2315-2014; Prats, Clara/F-5993-2014; Hoier, Birgitte/D-4395-2015; Bangsbo, Jens/A-7192-2015; Hellsten, Ylva/B-3420-2015	Pilegaard, Henriette/0000-0002-1071-0327; Prats, Clara/0000-0001-6465-3068; Hoier, Birgitte/0000-0002-2436-4314; Bangsbo, Jens/0000-0003-1305-9274; Hellsten, Ylva/0000-0002-2435-9558; Qvortrup, Klaus/0000-0001-8811-0260	Lundbeck; Lundbeck Foundation [R34-2009-3844] Funding Source: researchfish	Lundbeck(Lundbeck Corporation); Lundbeck Foundation(Lundbeckfonden)	The authors thank Gemma Kroos, Karina Olsen, Jens Jung Nielsen, Zhila Nikrozi, and Mary-Ann Gleie for their expert technical assistance. The study was funded by Lundbeck.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355; Chang HJ, 2006, INT J ONCOL, V28, P135; Egginton S, 2000, ADV EXP MED BIOL, V476, P81; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Friedrich O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001762; Gavin TP, 2007, ACTA PHYSIOL, V191, P139, DOI 10.1111/j.1748-1716.2007.01723.x; Gavin TP, 2004, J APPL PHYSIOL, V96, P19, DOI 10.1152/japplphysiol.00748.2003; Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Hoffner L, 2003, J PHYSIOL-LONDON, V550, P217, DOI 10.1113/jphysiol.2002.037051; Hoier B, 2010, J PHYSIOL-LONDON, V588, P3833, DOI 10.1113/jphysiol.2010.190439; Hoier B., 2011, J PHYSL, V590, P596; Hoier B, 2010, AM J PHYSIOL-HEART C, V299, pH857, DOI 10.1152/ajpheart.00082.2010; Jensen L., 2004, Angiogenesis, V7, P255, DOI 10.1007/s10456-004-4184-4; Jensen L, 2004, AM J PHYSIOL-REG I, V287, pR397, DOI 10.1152/ajpregu.00071.2004; Jensen L, 2004, J PHYSIOL-LONDON, V557, P571, DOI 10.1113/jphysiol.2003.057711; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5; Martell A.E., 1976, CRITICAL STABILITY C, V4; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nordsborg N, 2003, AM J PHYSIOL-REG I, V285, pR143, DOI 10.1152/ajpregu.00029.2003; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Olfert IM, 2010, AM J PHYSIOL-REG I, V299, pR1059, DOI 10.1152/ajpregu.00347.2010; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Radegran G, 1999, AM J PHYSIOL-HEART C, V276, pH1951, DOI 10.1152/ajpheart.1999.276.6.H1951; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Richardson RS, 1999, AM J PHYSIOL-HEART C, V277, pH2247, DOI 10.1152/ajpheart.1999.277.6.H2247; Rullman E, 2007, J APPL PHYSIOL, V102, P2346, DOI 10.1152/japplphysiol.00822.2006; Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Tang K, 2004, PHYSIOL GENOMICS, V18, P63, DOI 10.1152/physiolgenomics.00023.2004; Wagner PD, 2011, BIOCHEM SOC T, V39, P1556, DOI 10.1042/BST20110646	36	44	45	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3496	3504		10.1096/fj.12-224618	http://dx.doi.org/10.1096/fj.12-224618			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23709615				2022-12-25	WOS:000328840500010
J	Ku, BM; Kim, DS; Kim, KH; Yoo, BC; Kim, SH; Gong, YD; Kim, SY				Ku, Bo Mi; Kim, Dae-Seok; Kim, Kyung-Hee; Yoo, Byong Chul; Kim, Seok-Hyun; Gong, Young-Dae; Kim, Soo-Youl			Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma	FASEB JOURNAL			English	Article						kidney cancer; autophagy; protein cross-linking	CROSS-LINKING ENZYMES; TISSUE TRANSGLUTAMINASE; CANCER-CELLS; SURVIVAL; DISEASE; PROTEIN; PATHWAY; COMPLEX; ALPHA	Renal cell carcinoma (RCC), the predominant form of kidney cancer, is characterized by high resistance to radiation and chemotherapy. This study shows that expression of protein cross-linking enzyme transglutaminase 2 (TGase 2) is markedly increased in 7 renal cell carcinoma (RCC) cell lines in comparison to HEK293 and other cancer cell lines, such as NCI 60. However, the key role of TGase 2 in RCC was not clear. The down-regulation of TGase 2 was found to stabilize p53 expression, thereby inducing a 3- to 10-fold increase in apoptosis for 786-O, A498, CAKI-1, and ACHN cell lines by DAPI staining. MEF cells from TGase 2(-/-) mice showed stabilized p53 under apoptotic stress to compare to MEFs from wild-type mice. TGase 2 directly cross links the DNA binding domain of p53, leading to p53 depletion via autophagy in RCC. TGase 2 and p53 expression showed an inverse relationship in RCC cells. This finding implies that induced expression of TGase 2 promotes tumor cell survival through p53 depletion in RCC.Ku, B.M., Kim, D.-S. Kim, K.-H., Yoo, B.C., Kim, S.-H., Gong, Y.-D., Kim, S.-Y. Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.	[Ku, Bo Mi; Kim, Dae-Seok; Kim, Seok-Hyun; Kim, Soo-Youl] Natl Canc Ctr, Div Canc Biol, Canc Cell & Mol Biol Branch, Goyang 410769, Gyeonggi Do, South Korea; [Kim, Kyung-Hee; Yoo, Byong Chul] Natl Canc Ctr, Colorectal Canc Branch, Div Translat & Clin Res 1, Res Inst, Goyang 410769, Gyeonggi Do, South Korea; [Gong, Young-Dae] Dongguk Univ, Ctr Innovat Drug Lib Res, Seoul, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Dongguk University	Kim, SY (corresponding author), Natl Canc Ctr, Div Canc Biol, Canc Cell & Mol Biol Branch, 323 Ilsan Ro, Goyang 410769, Gyeonggi Do, South Korea.	kimsooyoul@gmail.com	Kim, Hyung-Kwan/R-8375-2019	Kim, Kyung-Hee/0000-0003-0214-0296	National Cancer Center in Korea [NCC1110011-2]; Bio and Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2012053532]	National Cancer Center in Korea; Bio and Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a research grant (NCC1110011-2) from the National Cancer Center in Korea to S.Y.K. and also partially supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF), funded by the Korean government (MEST; 2012053532). The authors declare no conflicts of interest.	Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712; D'Eletto M, 2012, CELL DEATH DIFFER, V19, P1228, DOI 10.1038/cdd.2012.2; D'Eletto M, 2009, AUTOPHAGY, V5, P1145, DOI 10.4161/auto.5.8.10040; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hidaka H, 2012, ONCOTARGET, V3, P44; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Kawasaki T, 1999, ONCOL REP, V6, P329; Kim DS, 2011, ONCOGENE, V30, P4780, DOI 10.1038/onc.2011.183; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kim DS, 2010, BIOCHEM BIOPH RES CO, V403, P479, DOI 10.1016/j.bbrc.2010.11.063; Kim SJ, 2013, AMINO ACIDS, V44, P73, DOI 10.1007/s00726-011-1089-6; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Lipworth L, 2006, J UROLOGY, V176, P2353, DOI 10.1016/j.juro.2006.07.130; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Park SS, 2006, J BIOL CHEM, V281, P34965, DOI 10.1074/jbc.M604150200; RABINOVITCH RA, 1994, J CLIN ONCOL, V12, P206, DOI 10.1200/JCO.1994.12.1.206	26	45	47	2	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3487	3495		10.1096/fj.12-224220	http://dx.doi.org/10.1096/fj.12-224220			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23704086				2022-12-25	WOS:000328840500009
J	Al-Qusairi, L; Prokic, I; Amoasii, L; Kretz, C; Messaddeq, N; Mandel, JL; Laporte, J				Al-Qusairi, Lama; Prokic, Ivana; Amoasii, Leonela; Kretz, Christine; Messaddeq, Nadia; Mandel, Jean-Louis; Laporte, Jocelyn			Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways	FASEB JOURNAL			English	Article						centronuclear myopathy; myotubular myopathy; atrophy; atrogene	HUMAN SKELETAL-MUSCLE; SIGNALING PATHWAYS; PHOSPHATASE; EXPRESSION; LIGASES; FAMILY; GROWTH; MAINTENANCE; ATROGIN-1; ENDOSOME	Mutations in the phosphoinositide phosphatase myotubularin (MTM1) results in X-linked myotubular/centronuclear myopathy (XLMTM), characterized by a severe decrease in muscle mass and strength in patients and murine models. However, the molecular mechanism involved in the muscle hypotrophy is unclear. Here we show that the IGF1R/Akt pathway is affected in Mtm1-deficient murine muscles, characterized by an increase in IGF1 receptor and Akt levels in both the presymptomatic and symptomatic phases. Moreover, up-regulation of atrogenes was observed in the presymptomatic phase of the myopathy, supporting overactivation of the ubiquitin-proteasome pathway. In parallel, the autophagy machinery was affected as indicated by the increase in the number of autophagosomes and of autophagy markers, such as LC3 and P62. However, phosphorylation of FOXO3a and mTOR were abnormal at late but not at early stages of the disease, suggesting that myotubularin acts both upstream in the IGF1R/Akt pathway and downstream on the balance between the autophagy and ubiquitin-proteasome pathways in vivo. Adeno-associated virus-mediated delivery of Mtm1 into Mtm1-null muscles rescued muscle mass and normalized the expression levels of IGF1 receptor, the ubiquitin-proteasome pathway, and autophagy markers. These data support the hypothesis that the unbalanced regulation of the ubiquitin proteasome pathway and the autophagy machinery is a primary cause of the XLMTM pathogenesis.Al-Qusairi, L., Prokic, I., Amoasii, L., Kretz, C., Messaddeq, N., Mandel, J.-L., Laporte, J. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.	[Al-Qusairi, Lama; Prokic, Ivana; Amoasii, Leonela; Kretz, Christine; Messaddeq, Nadia; Mandel, Jean-Louis; Laporte, Jocelyn] IGBMC, Dept Translat Med & Neurogenet, F-67404 Illkirch Graffenstaden, France; [Al-Qusairi, Lama; Prokic, Ivana; Amoasii, Leonela; Kretz, Christine; Messaddeq, Nadia; Mandel, Jean-Louis; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Al-Qusairi, Lama; Prokic, Ivana; Amoasii, Leonela; Kretz, Christine; Messaddeq, Nadia; Mandel, Jean-Louis; Laporte, Jocelyn] CNRS, UMR 7104, Illkirch Graffenstaden, France; [Al-Qusairi, Lama; Prokic, Ivana; Amoasii, Leonela; Kretz, Christine; Messaddeq, Nadia; Mandel, Jean-Louis; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] Coll France, Dept Human Genet, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France	Laporte, J (corresponding author), IGBMC, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	jocelyn@igbmc.fr	laporte, jocelyn/J-7008-2012; Al-Qusairi/AAQ-6912-2021; laporte, jocelyn/O-4888-2019; Laporte, Jocelyn/H-6801-2016; Mandel, Jean Louis/Q-2668-2016	Al-Qusairi, Lama/0000-0002-2956-2811; Mandel, Jean Louis/0000-0002-0535-6589; Amoasii, Leonela/0000-0001-7960-2749	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg (UdS); College de France; Agence Nationale de la Recherche (ANR); ERA-Net E-rare; Fondation pour la Recherche Medicale (FRM); Association Francaise contre les Myopathies (AFM); FRM; Association Paul Mandel	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (UdS)(European Commission); College de France; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ERA-Net E-rare; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); FRM(Fondation pour la Recherche Medicale); Association Paul Mandel	The authors thank Pascale Koebel and Belinda S. Cowling [Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), Illkirch, France] for production of AAV, Jean-Luc Weickert for the electron microscopy imaging, Josiane Hergueux for the semithin section preparation, Marie-France Champy (Institut Clinique de la Souris, Illkirch, France) for plasma IGF1 level and metabolic determinations, Jude Samulski (Gene Therapy Center, University of North Carolina, Chapel Hill, NC, USA) for the pXR1-AAV1 plasmid, and Ricardos Tabet (IGBMC, Illkirch, France) for primers of ribosomal RNA analysis. This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), University of Strasbourg (UdS), College de France, Agence Nationale de la Recherche (ANR), ERA-Net E-rare, Fondation pour la Recherche Medicale (FRM), and Association Francaise contre les Myopathies (AFM). L.A.-Q. was supported by a fellowship from FRM and by Association Paul Mandel.	Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Amoasii L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002965; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Cao C, 2007, TRAFFIC, V8, P1052, DOI 10.1111/j.1600-0854.2007.00586.x; Cebollero E, 2012, AUTOPHAGY, V8, P1868, DOI 10.4161/auto.22162; Cebollero E, 2012, CURR BIOL, V22, P1545, DOI 10.1016/j.cub.2012.06.029; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Dowling JJ, 2010, HUM MOL GENET, V19, P2668, DOI 10.1093/hmg/ddq153; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Fetalvero KM, 2013, MOL CELL BIOL, V33, P98, DOI 10.1128/MCB.01075-12; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gaugler M, 2011, J APPL PHYSIOL, V111, P192, DOI 10.1152/japplphysiol.00175.2011; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Goldspink G, 2004, EXP GERONTOL, V39, P1433, DOI 10.1016/j.exger.2004.08.010; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Hnia Karim, 2012, Adv Biol Regul, V52, P98; Hnia K, 2011, J CLIN INVEST, V121, P70, DOI 10.1172/JCI44021; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pierson CR, 2012, HUM MOL GENET, V21, P811, DOI 10.1093/hmg/ddr512; Pierson CR, 2005, J NEUROPATH EXP NEUR, V64, P555, DOI 10.1097/01.jnen.0000171653.17213.2e; Razidlo GL, 2011, J BIOL CHEM, V286, P20005, DOI 10.1074/jbc.M110.197749; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Romero NB, 2011, SEMIN PEDIATR NEUROL, V18, P250, DOI 10.1016/j.spen.2011.10.006; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Stephens TJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE688, DOI 10.1152/ajpendo.00101.2001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Tosch V, 2010, NEUROMUSCULAR DISORD, V20, P375, DOI 10.1016/j.nmd.2010.03.015; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	59	46	48	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3384	3394		10.1096/fj.12-220947	http://dx.doi.org/10.1096/fj.12-220947			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23695157				2022-12-25	WOS:000329877600043
J	Ahuja, S; Jahr, N; Im, SC; Vivekanandan, S; Popovych, N; Le Clair, SV; Huang, R; Soong, R; Xu, JD; Yamamoto, K; Nanga, RP; Bridges, A; Waskell, L; Ramamoorthy, A				Ahuja, Shivani; Jahr, Nicole; Im, Sang-Choul; Vivekanandan, Subramanian; Popovych, Nataliya; Le Clair, Stephanie V.; Huang, Rui; Soong, Ronald; Xu, Jiadi; Yamamoto, Kazutoshi; Nanga, Ravi P.; Bridges, Angela; Waskell, Lucy; Ramamoorthy, Ayyalusamy			A Model of the Membrane-bound Cytochrome b(5)-Cytochrome P450 Complex from NMR and Mutagenesis Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Enzyme Catalysis; Membrane Proteins; NMR; Structural Biology	PROTEIN-PROTEIN ASSOCIATION; TRANSIENT ENCOUNTER COMPLEXES; NADPH-CYTOCHROME-P450 REDUCTASE; ELECTRON-TRANSPORT; BINDING-SITE; B(5); SPECTROSCOPY; STATE; TOOL; PURIFICATION	Microsomal cytochrome b(5) (cytb(5)) is a membrane-bound protein that modulates the catalytic activity of its redox partner, cytochrome P4502B4 (cytP450). Here, we report the first structure of full-length rabbit ferric microsomal cytb(5) (16 kDa), incorporated in two different membrane mimetics (detergent micelles and lipid bicelles). Differential line broadening of the cytb(5) NMR resonances and site-directed mutagenesis data were used to characterize the cytb(5) interaction epitope recognized by ferric microsomal cytP450 (56 kDa). Subsequently, a data-driven docking algorithm, HADDOCK (high ambiguity driven biomolecular docking), was used to generate the structure of the complex between cytP4502B4 and cytb(5) using experimentally derived restraints from NMR, mutagenesis, and the double mutant cycle data obtained on the full-length proteins. Our docking and experimental results point to the formation of a dynamic electron transfer complex between the acidic convex surface of cytb(5) and the concave basic proximal surface of cytP4502B4. The majority of the binding energy for the complex is provided by interactions between residues on the C-helix and -bulge of cytP450 and residues at the end of helix 4 of cytb(5). The structure of the complex allows us to propose an interprotein electron transfer pathway involving the highly conserved Arg-125 on cytP450 serving as a salt bridge between the heme propionates of cytP450 and cytb(5). We have also shown that the addition of a substrate to cytP450 likely strengthens the cytb(5)-cytP450 interaction. This study paves the way to obtaining valuable structural, functional, and dynamic information on membrane-bound complexes.	[Ahuja, Shivani; Jahr, Nicole; Vivekanandan, Subramanian; Popovych, Nataliya; Le Clair, Stephanie V.; Huang, Rui; Soong, Ronald; Xu, Jiadi; Yamamoto, Kazutoshi; Nanga, Ravi P.; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Im, Sang-Choul; Bridges, Angela; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Im, Sang-Choul; Bridges, Angela; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Huang, Rui/N-4022-2017	Huang, Rui/0000-0002-4064-6397; Xu, Jiadi/0000-0001-9698-5622; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	National Institutes of Health [GM084018, GM095640, GM094209, GM035533]; Veterans Affairs merit grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084018, R01GM094209, R01GM095640, R01GM035533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084018 and GM095640 (to A. R.) and GM094209 and GM035533 (to L.W.). This work was also supported by a Veterans Affairs merit grant (to L.W.).	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Banci L, 2000, EUR J BIOCHEM, V267, P755, DOI 10.1046/j.1432-1327.2000.01054.x; Basaran N, 1999, BIOCHEMISTRY-US, V38, P15245, DOI 10.1021/bi991404a; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CARAVATTI P, 1983, CHEM PHYS LETT, V100, P305, DOI 10.1016/0009-2614(83)80276-0; CHESTER DW, 1992, BIOPHYS J, V61, P1224, DOI 10.1016/S0006-3495(92)81932-X; Chudaev MV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P667, DOI 10.1023/A:1010215516226; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clarke TA, 2004, J BIOL CHEM, V279, P36809, DOI 10.1074/jbc.M406055200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAILEY HA, 1978, J BIOL CHEM, V253, P8203; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deep S, 2005, BIOCHEMISTRY-US, V44, P10654, DOI 10.1021/bi050482x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denny JK, 2001, J MAGN RESON, V152, P217, DOI 10.1006/jmre.2001.2405; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Durr UHN, 2007, J AM CHEM SOC, V129, P6670, DOI 10.1021/ja069028m; Dvinskikh SV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212939; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GREENHUT SF, 1993, BIOCHIM BIOPHYS ACTA, V1149, P1, DOI 10.1016/0005-2736(93)90018-U; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; Harris RK, 2002, SOLID STATE NUCL MAG, V22, P458, DOI 10.1006/snmr.2002.0063; HOLLOWAY PW, 1990, BIOCHEMISTRY-US, V29, P9631, DOI 10.1021/bi00493a018; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; KNELLER DG, 1993, J CELL BIOCHEM, P254; Koberova M, 2013, INT J ELECTROCHEM SC, V8, P125; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurnikov IV., 2000, HARLEM MOL MODELING; LEE KB, 1990, BIOCHEMISTRY-US, V29, P9623, DOI 10.1021/bi00493a017; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; MORGAN ET, 1984, DRUG METAB DISPOS, V12, P358; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; NAKAMURA K, 1994, BBA-PROTEIN STRUCT M, V1207, P40, DOI 10.1016/0167-4838(94)90049-3; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nevzorov AA, 2003, J MAGN RESON, V160, P33, DOI 10.1016/S1090-7807(02)00138-6; Nguyen KT, 2010, J AM CHEM SOC, V132, P15112, DOI 10.1021/ja106508f; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Omura T., 1967, METHOD ENZYMOL, P556, DOI [DOI 10.1016/0076-6879(67)10096-7, 10.1016/0076-6879(67)10096-7.]; Orlando L, 2010, CANCER TREAT REV, V36, pS67, DOI 10.1016/S0305-7372(10)70023-2; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; RODGERS KK, 1988, SCIENCE, V240, P1657, DOI 10.1126/science.2837825; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Shao WP, 2003, BIOCHEMISTRY-US, V42, P14774, DOI 10.1021/bi030145t; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; Soong R, 2010, J AM CHEM SOC, V132, P5779, DOI 10.1021/ja910807e; Suh JY, 2007, J AM CHEM SOC, V129, P12954, DOI 10.1021/ja0760978; Sulc M, 2012, NEUROENDOCRINOL LETT, V33, P41; TAMBURINI PP, 1986, ARCH BIOCHEM BIOPHYS, V245, P512, DOI 10.1016/0003-9861(86)90244-4; TAMBURINI PP, 1983, J BIOL CHEM, V258, P3444; TAMBURINI PP, 1987, P NATL ACAD SCI USA, V84, P11, DOI 10.1073/pnas.84.1.11; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; VERGERES G, 1992, J BIOL CHEM, V267, P12583; Volkov AN, 2010, J BIOMOL NMR, V48, P225, DOI 10.1007/s10858-010-9452-6; Volkov AN, 2005, PROTEIN SCI, V14, P799, DOI 10.1110/ps.041150205; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang Q, 2004, PROTEIN SCI, V13, P2161, DOI 10.1110/ps.04721104; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	83	92	93	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22080	22095		10.1074/jbc.M112.448225	http://dx.doi.org/10.1074/jbc.M112.448225			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23709268	Green Published, hybrid			2022-12-25	WOS:000328841900053
J	Muthiah, AS; Aruni, W; Robles, AG; Dou, Y; Roy, F; Fletcher, HM				Muthiah, Arun S.; Aruni, Wilson; Robles, Antonette G.; Dou, Yuetan; Roy, Francis; Fletcher, Hansel M.			In Porphyromonas gingivalis VimF Is Involved in Gingipain Maturation through the Transfer of Galactose	PLOS ONE			English	Article							PUTATIVE GLYCOSYLTRANSFERASE; ARG-GINGIPAIN; BIOFILM FORMATION; DEPENDENT MODULATION; CYSTEINE PROTEINASES; PERIODONTAL-DISEASE; GENE DOWNSTREAM; VIRULENCE; GLYCOSYLATION; RGPB	Previously, we have reported that gingipain activity in Porphyromonas gingivalis, the major causative agent in adult periodontitis, is post-translationally regulated by the unique Vim proteins including VimF, a putative glycosyltransferase. To further characterize VimF, an isogenic mutant defective in this gene in a different P. gingivalis genetic background was evaluated. In addition, the recombinant VimF protein was used to further confirm its glycosyltransferase function. The vimF-defective mutant (FLL476) in the P. gingivalis ATCC 33277 genetic background showed a phenotype similar to that of the vimF-defective mutant (FLL95) in the P. gingivalis W83 genetic background. While hemagglutination was not detected and autoaggregation was reduced, biofilm formation was increased in FLL476. HeLa cells incubated with P. gingivalis FLL95 and FLL476 showed a 45% decrease in their invasive capacity. Antibodies raised against the recombinant VimF protein in E. coli immunoreacted only with the deglycosylated native VimF protein from P. gingivalis. In vitro glycosyltransferase activity for rVimF was observed using UDP-galactose and N-acetylglucosamine as donor and acceptor substrates, respectively. In the presence of rVimF and UDP-galactose, a 60 kDa protein from the extracellular fraction of FLL95 which was identified by mass spectrometry as Rgp gingipain, immunoreacted with the glycan specific mAb 1B5 antibody. Taken together, these results suggest the VimF glycoprotein is a galactosyltransferase that may be specific for gingipain glycosylation. Moreover, galatose is vital for the growing glycan chain.	[Muthiah, Arun S.; Aruni, Wilson; Robles, Antonette G.; Dou, Yuetan; Roy, Francis; Fletcher, Hansel M.] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Dept Basic Sci, Loma Linda, CA 92350 USA	Loma Linda University	Fletcher, HM (corresponding author), Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Dept Basic Sci, Loma Linda, CA 92350 USA.	hfletcher@llu.edu	WILSON, ARUNI/AAU-1908-2020	Aruni, Wilson/0000-0002-9208-0153	National Institute of Dental and Craniofacial Research (NIDCR) [DE13664, DE019730, DE01973004S1, DE022508, DE022724]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019730, R01DE022508, R21DE022724, R56DE013664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013664] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants DE13664 DE019730, DE01973004S1, DE022508, and DE022724 from National Institute of Dental and Craniofacial Research (NIDCR) (to HMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaibou H, 2001, INFECT IMMUN, V69, P325, DOI 10.1128/IAI.69.1.325-335.2001; Andriankaja OM, 2010, AUST DENT J, V55, P252, DOI 10.1111/j.1834-7819.2010.01231.x; Aruni AW, 2012, INFECT IMMUN, V80, P550, DOI 10.1128/IAI.06062-11; Aruni W, 2011, INFECT IMMUN, V79, P2779, DOI 10.1128/IAI.00106-11; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chen T, 2000, MICROB PATHOGENESIS, V28, P235, DOI 10.1006/mpat.1999.0338; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Davey ME, 2006, J BACTERIOL, V188, P5510, DOI 10.1128/JB.01685-05; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Deng CH, 2004, ANAL BIOCHEM, V330, P219, DOI 10.1016/j.ab.2004.03.014; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Eick S, 2003, ACTA BIOCHIM POL, V50, P725; Fisher MA, 2011, KIDNEY INT, V79, P347, DOI 10.1038/ki.2010.384; Frisbee Stephanie J, 2010, J Dent Hyg, V84, P177; Fu H, 2007, PLANTA, V226, P1511, DOI 10.1007/s00425-007-0587-y; Gallagher A, 2003, CURR PROTEIN PEPT SC, V4, P427, DOI 10.2174/1389203033486974; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Han YW, 2011, J DENT RES, V90, P289, DOI 10.1177/0022034510381905; Harris J Robin, 2007, Methods Mol Biol, V369, P107; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hinsa SM, 2006, MICROBIOL-SGM, V152, P1375, DOI 10.1099/mic.0.28696-0; Kishi M, 2012, MOL ORAL MICROBIOL, V27, P458, DOI 10.1111/j.2041-1014.2012.00659.x; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Nakayama K, 2003, CURR PROTEIN PEPT SC, V4, P389, DOI 10.2174/1389203033486983; Narimatsu M, 2004, INFECT IMMUN, V72, P2698, DOI 10.1128/IAI.72.5.2698-2702.2004; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; Olango GJ, 2003, INFECT IMMUN, V71, P3740, DOI 10.1128/IAI.71.7.3740-3747.2003; Osbourne D, 2012, MOL ORAL MICROBIOL, V27, P420, DOI 10.1111/j.2041-1014.2012.00661.x; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa Jan, 2007, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2120s49; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Sato K, 2009, MICROBIOL-SGM, V155, P1282, DOI 10.1099/mic.0.025163-0; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Tokuda M, 1998, INFECT IMMUN, V66, P1159, DOI 10.1128/IAI.66.3.1159-1166.1998; Vanterpool E, 2006, MICROBIOL-SGM, V152, P3383, DOI 10.1099/mic.0.29146-0; Vanterpool E, 2005, INFECT IMMUN, V73, P3971, DOI 10.1128/IAI.73.7.3971-3982.2005; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; Vanterpool E, 2004, INFECT IMMUN, V72, P5555, DOI 10.1128/IAI.72.10.5555-5564.2004; Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Zhang W, 2011, J PERIODONTOL, V82, P909, DOI 10.1902/jop.2010.100501	57	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63367	10.1371/journal.pone.0063367	http://dx.doi.org/10.1371/journal.pone.0063367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717416	Green Published, gold, Green Submitted			2022-12-25	WOS:000319385300038
J	Chen, Y; Yu, ZZ; Packham, JC; Mattey, DL				Chen, Ying; Yu, Zanzhe; Packham, Jonathan C.; Mattey, Derek L.			Influence of Adult Height on Rheumatoid Arthritis: Association with Disease Activity, Impairment of Joint Function and Overall Disability	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-HORMONE; SHORT STATURE; LOCI; SUSCEPTIBILITY; VARIANTS; GENDER; HEALTH; COHORT; WOMEN	Objectives: To investigate whether normal variation of adult height is associated with clinical characteristics in rheumatoid arthritis (RA), including disease activity (DAS28), impairment of joint function (mechanical joint score, MJS) and overall disability (health assessment questionnaire, HAQ). Methods: A cohort (134 males, 287 females) of consecutively recruited RA patients of Northern European origin was studied. Height, weight and demographic information were obtained. A core set of disease measurements, including DAS28, MJS and HAQ, were recorded at baseline, 12 and 24 months. Other clinical variables (e.g. disease duration, IgM rheumatoid factor, antibodies to cyclic citrullinated peptide, C-reactive protein, erythrocyte sedimentation rate) were recorded at baseline. Socioeconomic status, smoking status, comorbid condition, other autoimmune conditions and drug therapy were also recorded. Associations were analyzed using univariate statistics and multivariate linear regression models. Mediation tests were also carried out for evaluating the relationship between gender, height and disease measures. Results: In males, height was inversely associated with DAS28, MJS and HAQ (at baseline and over 24 months) independent of other factors (e.g. weight, body mass index, age, disease duration, osteoporosis, autoantibodies, erosive disease, joint replacement, steroid use, smoking status, socioeconomic status and comorbid disease). In females, a similar trend was seen but the relationships were non significant. In the whole population, the association of female gender with more active disease and poor function disappeared after adjustment for height. Mediation analysis indicated that height served as a full mediator in the relationship of gender with disease activity and overall disability. Confirmation of these findings was demonstrated in a second RA population (n = 288). Conclusion: Adult height is inversely associated with disease activity, impairment of joint function and overall disability in RA, particularly in males. The association of female sex with more severe disease activity and disability appears to be mediated by smaller stature.	[Chen, Ying; Packham, Jonathan C.; Mattey, Derek L.] Haywood Hosp, Haywood Rheumatol Ctr, Stoke On Trent, Staffs, England; [Chen, Ying; Yu, Zanzhe; Mattey, Derek L.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Keele University	Mattey, DL (corresponding author), Haywood Hosp, Haywood Rheumatol Ctr, High Lane, Stoke On Trent, Staffs, England.	d.l.mattey@keele.ac.uk	Chen, Ying/I-4349-2013	Chen, Ying/0000-0002-5919-743X; Mattey, Derek/0000-0002-4676-5434; Packham, Jon/0000-0001-5531-1680	Medical Research Council; Haywood Rheumatism Research and Development Foundation [507273]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Haywood Rheumatism Research and Development Foundation	Funding was provided by the Medical Research Council and the Haywood Rheumatism Research and Development Foundation (Charity number 507273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlmen M, 2010, ANN RHEUM DIS, V69, P230, DOI 10.1136/ard.2008.102244; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bostrom EA, 2011, ARTHRITIS RHEUM-US, V63, P2894, DOI 10.1002/art.30527; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; Cerhan JR, 2002, J RHEUMATOL, V29, P246; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chen Y, 2011, J RHEUMATOL, V38, P802, DOI 10.3899/jrheum.101095; Chiarelli F, 2004, EUR J ENDOCRINOL, V151, pU109, DOI 10.1530/eje.0.151U109; Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Crimmins EM, 2006, PNAS, V103, P598; De Bellis A, 2008, J ENDOCRINOL INVEST, V31, P1132, DOI 10.1007/BF03345664; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; FRIES JF, 1982, J RHEUMATOL, V9, P789; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Griffiths AM, 2009, DIGEST DIS, V27, P404, DOI 10.1159/000228581; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Jawaheer D, 2010, CLIN EXP RHEUMATOL, V28, P454; Jawaheer D, 2006, ARTHRITIS RHEUM-US, V54, P3087, DOI 10.1002/art.22120; Jawaheer D, 2010, J RHEUMATOL, V37, P2475, DOI 10.3899/jrheum.091432; Johnson AH, 2002, RHEUMATOLOGY, V41, P189, DOI 10.1093/rheumatology/41.2.189; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Kuiper S, 2001, J RHEUMATOL, V28, P1809; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Lawlor DA, 2002, DIABETOLOGIA, V45, P1097, DOI 10.1007/s00125-002-0887-5; Lee YH, 2012, CLIN RHEUMATOL; Lettre G, 2011, HUM GENET, V129, P465, DOI 10.1007/s00439-011-0969-x; Malemud CJ, 2007, CLIN CHIM ACTA, V375, P10, DOI 10.1016/j.cca.2006.06.033; Meisel P, 2007, J CLIN PERIODONTOL, V34, P390, DOI 10.1111/j.1600-051X.2007.01068.x; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nemet D, 2009, J PEDIATR ENDOCR MET, V22, P979; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Pass C, 2009, CELL BIOCHEM FUNCT, V27, P119, DOI 10.1002/cbf.1551; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Tengstrand B, 2004, J RHEUMATOL, V31, P214; Ushiyama T, 1999, ANN RHEUM DIS, V58, P7, DOI 10.1136/ard.58.1.7; VESSEY MP, 1987, CONTRACEPTION, V35, P457, DOI 10.1016/0010-7824(87)90082-5; Ward K, 2011, J EPIDEMIOL COMMUN H, V65, P226, DOI 10.1136/jech.2009.096792; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64862	10.1371/journal.pone.0064862	http://dx.doi.org/10.1371/journal.pone.0064862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705017	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000319330200171
J	Cheng, HY; Wu, RP; Gebre, AK; Hanna, RN; Smith, DJ; Parks, JS; Ley, K; Hedrick, CC				Cheng, Hsin-Yuan; Wu, Runpei; Gebre, Abraham K.; Hanna, Richard N.; Smith, Dan J.; Parks, John S.; Ley, Klaus; Hedrick, Catherine C.			Increased Cholesterol Content in Gammadelta (gamma delta) T Lymphocytes Differentially Regulates Their Activation	PLOS ONE			English	Article							E-DEFICIENT MICE; LIPID RAFTS; INTRAEPITHELIAL LYMPHOCYTES; INTERFERON-GAMMA; CELL-ACTIVATION; NILE-RED; RECEPTOR; ATHEROSCLEROSIS; STIMULATION; EXPRESSION	Gammadelta (gamma delta) T lymphocytes respond quickly upon antigen encounter to produce a cytokine response. In this study, we sought to understand how functions of gamma delta T cells are differentially regulated compared to alpha beta T cells. We found that cholesterol, an integral component of the plasma membrane and a regulator of TCR signaling, is increased in gamma delta T cells compared to alpha beta T cells, and modulates their function. Higher levels of activation markers, and increased lipid raft content in gamma delta cells suggest that gamma delta T cells are more activated. Cholesterol depletion effectively decreased lipid raft formation and activation of gamma T cells, indicating that increased cholesterol content contributes to the hyper-activated phenotype of gamma delta T cells, possibly through enhanced clustering of TCR signals in lipid rafts. TCR stimulation assays and western blotting revealed that instead of a lower TCR threshold, enhanced TCR signaling through ERK1/2 activation is likely the cause for high cholesterol-induced rapid activation and proliferation in gamma delta T cells. Our data indicate that cholesterol metabolism is differentially regulated in gamma delta T cells. The high intracellular cholesterol content leads to enhanced TCR signaling and increases activation and proliferation of gamma delta T cells.	[Cheng, Hsin-Yuan; Wu, Runpei; Hanna, Richard N.; Ley, Klaus; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA; [Gebre, Abraham K.; Parks, John S.] Wake Forest Sch Med, Dept Pathol Lipid Sci, Winston Salem, NC USA; [Smith, Dan J.] Targeson Inc, San Diego, CA USA	La Jolla Institute for Immunology; Wake Forest University	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA USA.	hedrick@liai.org			National Institutes of Health [P01HL055798, R01HL097368, R01HL049373, R01HL094525]; American Diabetes Association Mentor-Based Postdoctoral Fellowship [7-12-MN-31]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115232, R01HL094525, P01HL055798, R01HL097368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Mentor-Based Postdoctoral Fellowship(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health Grants P01HL055798 and R01HL097368 (to C.C.H.), R01HL049373 and R01HL094525 (to J.S.P.), and American Diabetes Association Mentor-Based Postdoctoral Fellowship 7-12-MN-31 (to H.-Y.C. and C.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Born WK, 2010, J IMMUNOL, V184, P4055, DOI 10.4049/jimmunol.0903679; Brandes M, 2009, P NATL ACAD SCI USA, V106, P2307, DOI 10.1073/pnas.0810059106; Champagne E, 2011, ARCH IMMUNOL THER EX, V59, P117, DOI 10.1007/s00005-011-0118-1; Chen Y, 2012, J IMMUNOL, V189, P61, DOI 10.4049/jimmunol.1103272; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Eberl M, 2009, TRENDS IMMUNOL, V30, P562, DOI 10.1016/j.it.2009.09.001; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; Fulop T, 2001, MECH AGEING DEV, V122, P1413, DOI 10.1016/S0047-6374(01)00274-3; Gao YL, 2001, J AUTOIMMUN, V17, P261, DOI 10.1006/jaut.2001.0547; Gombos I, 2006, IMMUNOL LETT, V104, P59, DOI 10.1016/j.imlet.2005.11.021; Graff JC, 2006, INT IMMUNOL, V18, P613, DOI 10.1093/intimm/dxl001; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; INGHIRAMI G, 1990, AM J PATHOL, V136, P357; Jameson JM, 2010, CELL IMMUNOL, V264, P71, DOI 10.1016/j.cellimm.2010.04.013; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jensen KDC, 2009, CURR OPIN IMMUNOL, V21, P140, DOI 10.1016/j.coi.2009.02.008; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Jury EC, 2007, SEMIN CELL DEV BIOL, V18, P608, DOI 10.1016/j.semcdb.2007.08.002; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kapsenberg ML, 2009, IMMUNITY, V31, P181, DOI 10.1016/j.immuni.2009.08.004; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; Laird RM, 2009, MOL IMMUNOL, V46, P2429, DOI 10.1016/j.molimm.2009.03.029; Li D, 2009, J BIOL CHEM, V284, P21001, DOI 10.1074/jbc.M109.002865; Lu HZ, 2011, TOHOKU J EXP MED, V223, P193, DOI 10.1620/tjem.223.193; Major AS, 2004, ARTERIOSCL THROM VAS, V24, P2351, DOI 10.1161/01.ATV.0000147112.84168.87; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Rudel LL, 1998, ARTERIOSCL THROM VAS, V18, P1818, DOI 10.1161/01.ATV.18.11.1818; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Surls J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038733; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Wong GW, 2010, SEMIN IMMUNOL, V22, P228, DOI 10.1016/j.smim.2010.04.005; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	46	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63746	10.1371/journal.pone.0063746	http://dx.doi.org/10.1371/journal.pone.0063746			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704936	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200067
J	Colak, D; Nofal, A; AlBakheet, A; Nirmal, M; Jeprel, H; Eldali, A; AL-Tweigeri, T; Tulbah, A; Ajarim, D; Al Malik, O; Inan, MS; Kaya, N; Park, BH; Bin Amer, SM				Colak, Dilek; Nofal, Asmaa; AlBakheet, AlBandary; Nirmal, Maimoona; Jeprel, Hatim; Eldali, Abdelmoneim; AL-Tweigeri, Taher; Tulbah, Asma; Ajarim, Dahish; Al Malik, Osama; Inan, Mehmet S.; Kaya, Namik; Park, Ben H.; Bin Amer, Suad M.			Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women	PLOS ONE			English	Article							CARCINOMA IN-SITU; GENOMIC ANALYSES; PATHOLOGICAL FEATURES; DUCTAL CARCINOMA; MICROARRAY DATA; MUTATION STATUS; PATIENT AGE; TGF-ALPHA; SURVIVAL; PROGNOSIS	Breast cancer in young women is more aggressive with a poorer prognosis and overall survival compared to older women diagnosed with the disease. Despite recent research, the underlying biology and molecular alterations that drive the aggressive nature of breast tumors associated with breast cancer in young women have yet to be elucidated. In this study, we performed transcriptomic profile and network analyses of breast tumors arising in Middle Eastern women to identify age-specific gene signatures. Moreover, we studied molecular alterations associated with cancer progression in young women using cross-species comparative genomics approach coupled with copy number alterations (CNA) associated with breast cancers from independent studies. We identified 63 genes specific to tumors in young women that showed alterations distinct from two age cohorts of older women. The network analyses revealed potential critical regulatory roles for Myc, PI3K/Akt, NF-kappa B, and IL-1 in disease characteristics of breast tumors arising in young women. Cross-species comparative genomics analysis of progression from pre-invasive ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) revealed 16 genes with concomitant genomic alterations, CCNB2, UBE2C, TOP2A, CEP55, TPX2, BIRC5, KIAA0101, SHCBP1, UBE2T, PTTG1, NUSAP1, DEPDC1, HELLS, CCNB1, KIF4A, and RRM2, that may be involved in tumorigenesis and in the processes of invasion and progression of disease. Array findings were validated using qRT-PCR, immunohistochemistry, and extensive in silico analyses of independently performed microarray datasets. To our knowledge, this study provides the first comprehensive genomic analysis of breast cancer in Middle Eastern women in age-specific cohorts and potential markers for cancer progression in young women. Our data demonstrate that cancer appearing in young women contain distinct biological characteristics and deregulated signaling pathways. Moreover, our integrative genomic and cross-species analysis may provide robust biomarkers for the detection of disease progression in young women, and lead to more effective treatment strategies.	[Colak, Dilek; Eldali, Abdelmoneim] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Nofal, Asmaa; Nirmal, Maimoona; Jeprel, Hatim; Bin Amer, Suad M.] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [AlBakheet, AlBandary; Inan, Mehmet S.; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [AL-Tweigeri, Taher; Ajarim, Dahish] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia; [Tulbah, Asma] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia; [Al Malik, Osama] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia; [Park, Ben H.] Johns Hopkins Univ, Sch Med, Dept Oncol,Breast Canc Res Program, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21205 USA	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Johns Hopkins University; Johns Hopkins Medicine	Colak, D (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia.	dcolakkaya@kfshrc.edu.sa; sbinamer2@gmail.com		Colak, Dilek/0000-0001-6485-8768	King Abdulaziz City for Science and Technology (KACST) [ARP-2432]; King Faisal Specialist Hospital and Research Center; National Plan for Science, Technology and Innovation program/KACST [11-BIO2072-20]	King Abdulaziz City for Science and Technology (KACST); King Faisal Specialist Hospital and Research Center; National Plan for Science, Technology and Innovation program/KACST	This study was funded by a King Abdulaziz City for Science and Technology grant (KACST # ARP-2432 to SMA), King Faisal Specialist Hospital and Research Center, and National Plan for Science, Technology and Innovation program/KACST (grant 11-BIO2072-20 to DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Agrup M, 2000, BREAST CANCER RES TR, V63, P23, DOI 10.1023/A:1006498721508; ALA U, 2008, PLOS COMPUT BIOL, P4; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; *AM CANC SOC INC, 2010, BREAST CANC FACTS FI; Amari M, 2003, JPN J CLIN ONCOL, V33, P556, DOI 10.1093/jjco/hyg109; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373; *AR CROS, 2009, CANC INC REP SAUD AR; Bennett CN, 2010, TOXICOL PATHOL, V38, P88, DOI 10.1177/0192623309357074; Bennett CN, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2125; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bombonati A, 2011, J PATHOL, V223, P307, DOI 10.1002/path.2808; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Cantrell VA, 2010, CANCER LETT, V287, P54, DOI 10.1016/j.canlet.2009.05.041; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.3.CO;2-T; Colak D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-146; Collins LC, 2012, BREAST CANCER RES TR, V131, P1061, DOI 10.1007/s10549-011-1872-9; Connelly L, 2011, ONCOGENE, V30, P1402, DOI 10.1038/onc.2010.521; Corzo C, 2006, CANCER GENET CYTOGEN, V165, P151, DOI 10.1016/j.cancergencyto.2005.08.013; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; D'Errico A, 2000, BRIT J CANCER, V82, P865, DOI 10.1054/bjoc.1999.1013; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Elkum N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-222; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graeber TG, 2005, NAT GENET, V37, P7, DOI 10.1038/ng0105-7; Graziano F, 2005, J CLIN ONCOL, V23, P5272, DOI 10.1200/JCO.2005.01.0819; Grimm C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-78; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hantschmann P, 2005, ANTICANCER RES, V25, P1731; Hartley MC, 2006, AM SURGEON, V72, P1189; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Holli K, 1997, EUR J CANCER, V33, P425; Honma S, 2002, ENDOCR J, V49, P371, DOI 10.1507/endocrj.49.371; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jin L, 1997, CANCER-AM CANCER SOC, V80, P421, DOI 10.1002/(SICI)1097-0142(19970801)80:3<421::AID-CNCR10>3.0.CO;2-Z; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maggard MA, 2003, J SURG RES, V113, P109, DOI 10.1016/S0022-4804(03)00179-3; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Martelli AM, 2007, EUR J HISTOCHEM, V51, P125; McAuliffe PF, 2010, CLIN BREAST CANCER, V10, pS59, DOI 10.3816/CBC.2010.s.013; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Olson JE, 2010, BREAST CANCER RES TR, V119, P423, DOI 10.1007/s10549-009-0386-1; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Peeper D, 2006, CELL, V125, P1230, DOI 10.1016/j.cell.2006.06.018; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rossner P, 2009, J CELL MOL MED, V13, P3847, DOI 10.1111/j.1582-4934.2008.00553.x; Rubinstein R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-12; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stav D, 2007, INT J BIOL MARKER, V22, P108, DOI 10.1177/172460080702200204; Stebel A, 2009, ONCOL REP, V21, P217, DOI 10.3892/or_00000211; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	98	79	87	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63204	10.1371/journal.pone.0063204	http://dx.doi.org/10.1371/journal.pone.0063204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704896	Green Published, gold			2022-12-25	WOS:000319330200025
J	Das, A; Saha, T; Ahmad, F; Roy, KB; Rishi, V				Das, Amrita; Saha, Tapas; Ahmad, Faizan; Roy, Kunal B.; Rishi, Vikas			Dodecamer d-AGATCTAGATCT and a Homologous Hairpin form Triplex in the Presence of Peptide REWER	PLOS ONE			English	Article							RECA PROTEIN; HELIX FORMATION; DNA STRANDS; RECOMBINATION; OLIGONUCLEOTIDES; STABILITY; MECHANISM; EXCHANGE; DUPLEX; MODEL	We have designed a dodecamer d-AGATCTAGATCT (RY12) with alternate oligopurines and oligopyrimidines tracts and its homologous 28 bp hairpin oligomer (RY28) that forms a triple helix only in the presence of a pentapeptide REWER. An intermolecular triplex is formed by the single strand invasion of the RY28 duplex by RY12 in the presence of REWER. 5'-oligopurine end of RY12 binds to oligopurine sequence of RY28 in a parallel orientation and its oligopyrimidine stretch then changes strand and adopts an antiparallel orientation with the other strand of the duplex. Evidence for the formation of the triplex come from our studies of the UV melting curves, UV mixing curves, gel retardation assay, and chemical sequencing of 1: 1 mixture of dodecamer and hairpin oligonucleotides in the presence and absence of the peptide REWER. RY12 exists as a duplex that melts at 35 degrees C. The hairpin (RY28) melts at 68 degrees C. 1:1 mixture of RY12 and RY28 in the absence of REWER gives a biphasic transition curve with thermodynamic properties corresponding to those of the melting of the duplex of RY12 and the hairpin RY28. However, the melting curve of this mixture is triphasic in the presence of the REWER; the thermodynamic parameters associated with the first phase (melting of the duplex of RY12), second phase (melting of the triplex) and the third phase (melting of the hairpin) show dependence on the molar ratio of peptide to oligonucleotides. Under appropriate conditions, gel retardation assay showed a shifted band that corresponds to a possible triplex. Chemical sequencing of KMnO4 and DEPC treated mixture of RY12, RY28 and REWER revealed the footprint of triplex.	[Das, Amrita] Univ Kolkata, Dept Chem, Kolkata, W Bengal, India; [Saha, Tapas] Georgetown Univ, Washington, DC USA; [Saha, Tapas; Ahmad, Faizan] Jamia Milia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Saha, Tapas; Roy, Kunal B.] Jawaharlal Nehru Univ, Ctr Biotechnol, New Delhi 110067, India; [Rishi, Vikas] Natl Agri Food Biotechnol Inst NABI, Mohali, Punjab, India	University of Calcutta; Georgetown University; Jamia Millia Islamia; Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Rishi, V (corresponding author), Natl Agri Food Biotechnol Inst NABI, Mohali, Punjab, India.	vikasrishi@nabi.res.in	Ahmad, Faizan/AGH-4493-2022; Das, Amrita/AAM-1107-2021	Ahmad, Faizan/0000-0001-7021-7502; Das, Amrita/0000-0003-3904-2403	DST, Govt. of India project [SP/SO/D39/93]; CSIR, GOI	DST, Govt. of India project; CSIR, GOI(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the DST, Govt. of India project SP/SO/D39/93. TS is thankful to CSIR, GOI for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson TaS M., 1984, OLIGONUCLEOTIDE SYNT; BANERJEE A, 1991, BIOTECHNIQUES, V11, P650; Bertucat G, 1998, J BIOMOL STRUCT DYN, V16, P535, DOI 10.1080/07391102.1998.10508268; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Casey BP, 2001, PROG NUCLEIC ACID RE, V67, P163, DOI 10.1016/S0079-6603(01)67028-4; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CHIU SK, 1993, BIOCHEMISTRY-US, V32, P13146, DOI 10.1021/bi00211a025; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; FURLONG JC, 1986, NUCLEIC ACIDS RES, V14, P3995, DOI 10.1093/nar/14.10.3995; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; GLOVER JNM, 1990, BIOCHEMISTRY-US, V29, P11110, DOI 10.1021/bi00502a014; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; JOHNSTON BH, 1985, CELL, V42, P713, DOI 10.1016/0092-8674(85)90268-5; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Panyutin IG, 2005, TRENDS BIOTECHNOL, V23, P492, DOI 10.1016/j.tibtech.2005.08.001; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Prevost C, 2003, Q REV BIOPHYS, V36, P429, DOI 10.1017/S0033583504003956; RAO BJ, 1993, P NATL ACAD SCI USA, V90, P6646, DOI 10.1073/pnas.90.14.6646; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; ROY KB, 1992, BIOCHEMISTRY-US, V31, P6241, DOI 10.1021/bi00142a011; Roy KB, 2000, J BIOCH MOL BIOL BIO, V3, P99; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; SHCHYOLKINA AK, 1994, FEBS LETT, V339, P113, DOI 10.1016/0014-5793(94)80396-X; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; WASHBROOK E, 1994, BIOCHEM J, V301, P569, DOI 10.1042/bj3010569; WILLIAMSON JR, 1990, NUCLEIC ACIDS RES, V18, P379, DOI 10.1093/nar/18.2.379; ZHURKIN VB, 1994, J MOL BIOL, V239, P181, DOI 10.1006/jmbi.1994.1362	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65010	10.1371/journal.pone.0065010	http://dx.doi.org/10.1371/journal.pone.0065010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705027	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200181
J	Hu, YS; Long, N; Pigino, G; Brady, ST; Lazarov, O				Hu, Yuan-Shih; Long, Nancy; Pigino, Gustavo; Brady, Scott T.; Lazarov, Orly			Molecular Mechanisms of Environmental Enrichment: Impairments in Akt/GSK3 beta, Neurotrophin-3 and CREB Signaling	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FAMILIAL ALZHEIMERS-DISEASE; ELEMENT-BINDING PROTEIN; AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; MESSENGER-RNA; RECEPTOR SUBUNITS; GENE-EXPRESSION	Experience of mice in a complex environment enhances neurogenesis and synaptic plasticity in the hippocampus of wild type and transgenic mice harboring familial Alzheimer's disease (FAD)-linked APPswe/PS1 Delta E9. In FAD mice, this experience also reduces levels of tau hyperphosphorylation and oligomeric beta-amyloid. Although environmental enrichment has significant effects on brain plasticity and neuropathology, the molecular mechanisms underlying these effects are unknown. Here we show that environmental enrichment upregulates the Akt pathway, leading to the downregulation of glycogen synthase kinase 3 beta (GSK3 beta), in wild type but not FAD mice. Several neurotrophic signaling pathways are activated in the hippocampus of both wild type and FAD mice, including brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF), and this increase is accompanied by the upregulation of the BDNF receptor, tyrosine kinase B (TrkB). Interestingly, neurotrophin-3 (NT-3) is upregulated in the brains of wild type mice but not FAD mice, while insulin growth factor-1 (IGF-1) is upregulated exclusively in the brains of FAD mice. Upregulation of neurotrophins is accompanied by the increase of N-Methyl-D-aspartic acid (NMDA) receptors in the hippocampus following environmental enrichment. Most importantly, we observed a significant increase in levels of cAMP response element-binding (CREB) transcripts in the hippocampus of wild type and FAD mice following environmental enrichment. However, CREB phosphorylation, a critical step for the initiation of learning and memory-required gene transcription, takes place in the hippocampus of wild type but not of FAD mice. These results suggest that experience of wild type mice in a complex environmental upregulates critical signaling that play a major role in learning and memory in the hippocampus. However, in FAD mice, some of these pathways are impaired and cannot be rescued by environmental enrichment.	[Hu, Yuan-Shih; Long, Nancy; Pigino, Gustavo; Brady, Scott T.; Lazarov, Orly] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lazarov, O (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60680 USA.	olazarov@uic.edu	Hu, Jennifer Yuan-Shih/AAL-5876-2020; Pigino, Gustavo/L-7002-2019; Lazarov, Orly/F-9406-2015	Lazarov, Orly/0000-0002-5887-948X	NIA [AG033570, 1 RC1 AG036208-01]; New Investigator Research Grant; The Alzheimer's Association; Alzheimer's Research Fund; IDPH; NATIONAL INSTITUTE ON AGING [R01AG033570, RC1AG036208] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Investigator Research Grant; The Alzheimer's Association; Alzheimer's Research Fund; IDPH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by NIA AG033570 (http://www.nia.nih.gov/), NIA 1 RC1 AG036208-01 (http://www.nia.nih.gov/), New Investigator Research Grant, The Alzheimer's Association (http://www.alz.org/), and the Alzheimer's Research Fund, The IDPH (http://www.idph.state.il.us/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Andin J, 2007, BRAIN RES, V1174, P18, DOI 10.1016/j.brainres.2007.06.101; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Avila J, 2010, EXPERT REV NEUROTHER, V10, P703, DOI 10.1586/ERN.10.40; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Billings LM, 2007, J NEUROSCI, V27, P751, DOI 10.1523/JNEUROSCI.4800-06.2007; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chen MJ, 2005, MOL BRAIN RES, V135, P181, DOI 10.1016/j.molbrainres.2004.12.001; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; DaRocha-Souto B, 2012, NEUROBIOL DIS, V45, P425, DOI 10.1016/j.nbd.2011.09.002; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Durany N, 2000, INT J DEV NEUROSCI, V18, P807, DOI 10.1016/S0736-5748(00)00046-0; Elliott E, 2005, EUR J NEUROSCI, V22, P1081, DOI 10.1111/j.1460-9568.2005.04290.x; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukunaga K, 1996, NEUROCHEM INT, V28, P343, DOI 10.1016/0197-0186(95)00097-6; Gortz N, 2008, BEHAV BRAIN RES, V191, P43, DOI 10.1016/j.bbr.2008.03.006; GREENAMYRE JT, 1987, J NEUROCHEM, V48, P543, DOI 10.1111/j.1471-4159.1987.tb04127.x; Hernandez F, 2012, J ALZHEIMERS DIS; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hock C, 1998, NEUROSCI LETT, V241, P151, DOI 10.1016/S0304-3940(98)00019-6; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Hye A, 2005, NEUROSCI LETT, V373, P1, DOI 10.1016/j.neulet.2004.10.031; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Larson J, 2007, ENV ENRICHMENT MOUSE; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Atalaya JP, 2011, EMBO J, V30, P4287, DOI 10.1038/emboj.2011.299; Lopez-Tobon A, 2011, REV NEUROSCIENCE, V22, P143, DOI 10.1515/RNS.2011.015; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; NarisawaSaito M, 1996, J NEUROCHEM, V67, P1124; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Numakawa T, 2012, NEUROSCIENCE; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; OLSSON T, 1994, MOL BRAIN RES, V23, P349, DOI 10.1016/0169-328X(94)90246-1; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Ryder J, 2004, CELL SIGNAL, V16, P187, DOI 10.1016/j.cellsig.2003.07.004; Sakamoto K, 2004, BIOCHEM BIOPH RES CO, V319, P419, DOI 10.1016/j.bbrc.2004.05.020; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sartori CR, 2011, NEUROSCIENCE, V180, P9, DOI 10.1016/j.neuroscience.2011.02.055; Shieh PB, 1999, J NEUROBIOL, V41, P127, DOI 10.1002/(SICI)1097-4695(199910)41:1<127::AID-NEU16>3.0.CO;2-J; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Torasdotter M, 1996, NEUROSCI LETT, V218, P107, DOI 10.1016/S0304-3940(96)13127-X; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	88	87	88	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64460	10.1371/journal.pone.0064460	http://dx.doi.org/10.1371/journal.pone.0064460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700479	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200138
J	Kostakos, V; Juntunen, T; Goncalves, J; Hosio, S; Ojala, T				Kostakos, Vassilis; Juntunen, Tomi; Goncalves, Jorge; Hosio, Simo; Ojala, Timo			Where Am I? Location Archetype Keyword Extraction from Urban Mobility Patterns	PLOS ONE			English	Article								Can online behaviour be used as a proxy for studying urban mobility? The increasing availability of digital mobility traces has provided new insights into collective human behaviour. Mobility datasets have been shown to be an accurate proxy for daily behaviour and social patterns, and behavioural data from Twitter has been used to predict real world phenomena such as cinema ticket sale volumes, stock prices, and disease outbreaks. In this paper we correlate city-scale urban traffic patterns with online search trends to uncover keywords describing the pedestrian traffic location. By analysing a 3-year mobility dataset we show that our approach, called Location Archetype Keyword Extraction (LAKE), is capable of uncovering semantically relevant keywords for describing a location. Our findings demonstrate an overarching relationship between online and offline collective behaviour, and allow for advancing analysis of community-level behaviour by using online search keywords as a practical behaviour proxy.	[Kostakos, Vassilis; Juntunen, Tomi; Goncalves, Jorge; Hosio, Simo; Ojala, Timo] Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland	University of Oulu	Kostakos, V (corresponding author), Univ Oulu, Dept Comp Sci & Engn, Oulu, Finland.	vassilis@ee.oulu.fi	Kostakos, Vassilis/G-8997-2011	Kostakos, Vassilis/0000-0003-2804-6038; Goncalves, Jorge/0000-0002-0117-0322; Hosio, Simo/0000-0002-9609-0965	Academy of Finland; TEKES - the Finnish Funding Agency for Technology and Innovation; City of Oulu; commercial partners of the UbiOulu program	Academy of Finland(Academy of Finland); TEKES - the Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); City of Oulu; commercial partners of the UbiOulu program	This work was partially funded by the Academy of Finland, TEKES - the Finnish Funding Agency for Technology and Innovation, the City of Oulu, and the commercial partners of the UbiOulu program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eagle N, 2009, BEHAV ECOL SOCIOBIOL, V63, P1057, DOI 10.1007/s00265-009-0739-0; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; HILLIER B, 1993, ENVIRON PLANN B, V20, P29, DOI 10.1068/b200029; Kostakos V, 2009, GEOSPATIAL ANAL MODE, P31, DOI DOI 10.1007/978-90-481-8572-63; Kostakos V, 2010, ACM T COMPUT-HUM INT, V17, DOI 10.1145/1721831.1721833; Kumar S, 2011, GOOGLE CORRELATE WHI; Lima A, 2012, NOK MOB DAT CHALL WO; Official Statistics of Finland (OSF), 2012, US INF COMM TECHN; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Whinston A, 2011, WHOSE WHAT IN PRESS	14	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63980	10.1371/journal.pone.0063980	http://dx.doi.org/10.1371/journal.pone.0063980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704964	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200096
J	Larsen, MJ; Kruse, TA; Tan, QH; Laenkholm, AV; Bak, M; Lykkesfeldt, AE; Sorensen, KP; Hansen, TVO; Ejlertsen, B; Gerdes, AM; Thomassen, M				Larsen, Martin J.; Kruse, Torben A.; Tan, Qihua; Laenkholm, Anne-Vibeke; Bak, Martin; Lykkesfeldt, Anne E.; Sorensen, Kristina P.; Hansen, Thomas V. O.; Ejlertsen, Bent; Gerdes, Anne-Marie; Thomassen, Mads			Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling	PLOS ONE			English	Article							BREAST-CANCER; ESTROGEN-RECEPTOR; BRCA2 MUTATIONS; OVARIAN-CANCER; EXPRESSION; PATHOLOGY; COMPLEX; NORMALIZATION; PREVALENCE; PREDICTION	Pathogenic germline mutations in BRCA1 or BRCA2 are detected in less than one third of families with a strong history of breast cancer. It is therefore expected that mutations still remain undetected by currently used screening methods. In addition, a growing number of BRCA1/2 sequence variants of unclear pathogen significance are found in the families, constituting an increasing clinical challenge. New methods are therefore needed to improve the detection rate and aid the interpretation of the clinically uncertain variants. In this study we analyzed a series of 33 BRCA1, 22 BRCA2, and 128 sporadic tumors by RNA profiling to investigate the classification potential of RNA profiles to predict BRCA1/2 mutation status. We found that breast tumors from BRCA1 and BRCA2 mutation carriers display characteristic RNA expression patterns, allowing them to be distinguished from sporadic tumors. The majority of BRCA1 tumors were basal-like while BRCA2 tumors were mainly luminal B. Using RNA profiles, we were able to distinguish BRCA1 tumors from sporadic tumors among basal-like tumors with 83% accuracy and BRCA2 from sporadic tumors among luminal B tumors with 89% accuracy. Furthermore, subtype-specific BRCA1/2 gene signatures were successfully validated in two independent data sets with high accuracies. Although additional validation studies are required, indication of BRCA1/2 involvement ("BRCAness'') by RNA profiling could potentially be valuable as a tool for distinguishing pathogenic mutations from benign variants, for identification of undetected mutation carriers, and for selecting patients sensitive to new therapeutics such as PARP inhibitors.	[Larsen, Martin J.; Kruse, Torben A.; Tan, Qihua; Sorensen, Kristina P.; Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Larsen, Martin J.; Kruse, Torben A.; Sorensen, Kristina P.; Thomassen, Mads] Univ Southern Denmark, Inst Clin, Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Bak, Martin] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Lykkesfeldt, Anne E.] Danish Canc Soc, Res Ctr, Breast Canc Grp, Unit Cell Death & Metab, Copenhagen, Denmark; [Hansen, Thomas V. O.] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen, Denmark; [Ejlertsen, Bent] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Danish Breast Canc Cooperat Grp,Stat Ctr, Copenhagen, Denmark; [Gerdes, Anne-Marie] Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Danish Cancer Society; Rigshospitalet; University of Copenhagen; Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Larsen, MJ (corresponding author), Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark.	martin.larsen@rsyd.dk	Hansen, Thomas/GWZ-2858-2022; Bak, Martin/D-1392-2012; Tan, Qihua/AAG-2582-2019; Larsen, Martin Jakob/L-5794-2019; Tan, Qihua/F-1349-2015; Hansen, Thomas v. O./J-9361-2014	Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Hansen, Thomas v. O./0000-0003-4635-2653; Laenkholm, Anne-Vibeke/0000-0003-2166-8686; Gerdes, Anne-Marie/0000-0002-0328-3320	Heidi Seide Jacobsen; Ministry of the Interior and Ministry of Health; University of Southern Denmark; Odense University Hospital; Danish Cancer Society; The Danish Council for Strategic Research (DBCG-TIBCAT); Dansk Kraeftforsknings Fond; Breast Friends; Kobenhavns Universitets fond for kraeftforskning; Savvaerksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat; Arvid Nilssons Fond; Agnes og Poul Friis Fond; Raimond og Dagmar Ringgard Bohns Fond; Fonden til Laegevidenskabens Fremme; Kong Christian IX og Dronning Louises Jubilaeumslegat; Ingenior K. A. Rohde og hustrus Legat; Snedkermester Sophus Jacobsens og hustru Astrid Jacobsens Fond; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning; Helen Rudes Fond; Karen A. Tolstrups Fond	Heidi Seide Jacobsen; Ministry of the Interior and Ministry of Health; University of Southern Denmark; Odense University Hospital; Danish Cancer Society(Danish Cancer Society); The Danish Council for Strategic Research (DBCG-TIBCAT); Dansk Kraeftforsknings Fond; Breast Friends; Kobenhavns Universitets fond for kraeftforskning; Savvaerksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat; Arvid Nilssons Fond; Agnes og Poul Friis Fond; Raimond og Dagmar Ringgard Bohns Fond; Fonden til Laegevidenskabens Fremme; Kong Christian IX og Dronning Louises Jubilaeumslegat; Ingenior K. A. Rohde og hustrus Legat; Snedkermester Sophus Jacobsens og hustru Astrid Jacobsens Fond; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning; Helen Rudes Fond; Karen A. Tolstrups Fond	The work was supported by Heidi Seide Jacobsen, Ministry of the Interior and Ministry of Health, University of Southern Denmark, Odense University Hospital, Danish Cancer Society, The Danish Council for Strategic Research (DBCG-TIBCAT), Dansk Kraeftforsknings Fond, Breast Friends, Kobenhavns Universitets fond for kraeftforskning, Savvaerksejer Jeppe Juhls og hustru Ovita Juhls Mindelegat, Arvid Nilssons Fond, Agnes og Poul Friis Fond, Raimond og Dagmar Ringgard Bohns Fond, Fonden til Laegevidenskabens Fremme, Kong Christian IX og Dronning Louises Jubilaeumslegat, Ingenior K. A. Rohde og hustrus Legat, Snedkermester Sophus Jacobsens og hustru Astrid Jacobsens Fond, Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning, Helen Rudes Fond, Karen A. Tolstrups Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Brozek I, 2012, FAM CANCER, V11, P351, DOI 10.1007/s10689-012-9519-5; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Diaz LK, 2007, ADV ANAT PATHOL, V14, P419, DOI 10.1097/PAP.0b013e3181594733; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fostira F, 2012, BREAST CANCER RES TR, V134, P353, DOI 10.1007/s10549-012-2021-9; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Gerdes AM, 2006, CLIN GENET, V69, P171, DOI 10.1111/j.1399-0004.2006.00568.x; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Jonsson G, 2012, CANCER RES, V72, P4028, DOI 10.1158/0008-5472.CAN-12-0097; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lakhani SR, 1997, LANCET, V349, P1505; Lakhani SR, 2001, NAT MED, V7, P408, DOI 10.1038/86464; Lakhani SR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2483; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Lisowska Katarzyna Marta, 2011, Front Biosci (Elite Ed), V3, P125, DOI 10.2741/e227; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Mulligan AM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3052; Nagel JHA, 2012, BREAST CANCER RES TR, V132, P439, DOI 10.1007/s10549-011-1588-x; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; OSHAUGHNESSY J, 2011, RANDOMIZED PHASE 3 S; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Thomassen M, 2006, BIOCHEM BIOPH RES CO, V344, P1111, DOI 10.1016/j.bbrc.2006.03.227; Tung N, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2478; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; van der Groep P, 2011, CELL ONCOL, V34, P71, DOI 10.1007/s13402-011-0010-3; van der Kolk DM, 2010, BREAST CANCER RES TR, V124, P643, DOI 10.1007/s10549-010-0805-3; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaziri SAJ, 2001, CLIN CANCER RES, V7, P1937; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Yang YH, 2003, INST MATH S, V40, P403; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	50	69	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64268	10.1371/journal.pone.0064268	http://dx.doi.org/10.1371/journal.pone.0064268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704984	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200128
J	Paradis, R; Lazar, N; Antinozzi, P; Perbal, B; Buteau, J				Paradis, Renee; Lazar, Noureddine; Antinozzi, Peter; Perbal, Bernard; Buteau, Jean			Nov/Ccn3, a Novel Transcriptional Target of FoxO1, Impairs Pancreatic beta-Cell Function	PLOS ONE			English	Article							FORKHEAD PROTEIN FOXO1; GROWTH-FACTOR CTGF; SUSCEPTIBILITY LOCUS; INSULIN-SECRETION; CCN PROTEINS; HUMAN NOV; DIFFERENTIATION; GENE; PROLIFERATION; REPLICATION	Type 2 diabetes is characterized by both insulin resistance and progressive deterioration of beta-cell function. The forkhead transcription factor FoxO1 is a prominent mediator of insulin signaling in beta-cells. We reasoned that identification of FoxO1 target genes in beta-cells could reveal mechanisms linking beta-cell dysfunction to insulin resistance. In this study, we report the characterization of Nov/Ccn3 as a novel transcriptional target of FoxO1 in pancreatic beta-cells. FoxO1 binds to an evolutionarily conserved response element in the Ccn3 promoter to regulate its expression. Accordingly, CCN3 levels are elevated in pancreatic islets of mice with overexpression of a constitutively active form of FoxO1 or insulin resistance. Our functional studies reveal that CCN3 impairs beta-cell proliferation concomitantly with a reduction in cAMP levels. Moreover, CCN3 decreases glucose oxidation, which translates into inhibition of glucose-stimulated Ca2+ entry and insulin secretion. Our results identify CCN3, a novel transcriptional target of FoxO1 in pancreatic beta-cells, as a potential target for therapeutic intervention in the treatment of diabetes.	[Paradis, Renee; Buteau, Jean] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Lazar, Noureddine; Perbal, Bernard] Univ Paris 07, Unite Format & Rech Biochim, Paris, France; [Antinozzi, Peter] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA	Laval University; UDICE-French Research Universities; Universite Paris Cite; Wake Forest University	Buteau, J (corresponding author), Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada.	jbuteau@ualberta.ca			European PROTHETS (Prognosis and therapeutic targets of Ewing's family of tumours) program; Ministere de l'Education Nationale de la Recherche et de la Technologie; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	European PROTHETS (Prognosis and therapeutic targets of Ewing's family of tumours) program; Ministere de l'Education Nationale de la Recherche et de la Technologie; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JB is a Canadian Diabetes Association scholar and a Fonds de la Recherche en Sante du Quebec junior investigator. NL was supported by the European PROTHETS (Prognosis and therapeutic targets of Ewing's family of tumours) program. This work was supported by the Ministere de l'Education Nationale de la Recherche et de la Technologie (PB), the Natural Sciences and Engineering Research Council of Canada (JB) and the Canadian Institutes of Health Research (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; An P, 2006, DIABETES, V55, P551, DOI 10.2337/diabetes.55.02.06.db05-0714; Antinozzi PA, 2006, P NATL ACAD SCI USA, V103, P3698, DOI 10.1073/pnas.0510521103; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Charrier A, 2013, CYTOKINE GROWTH F R, V24, P59, DOI 10.1016/j.cytogfr.2012.07.001; Crawford LA, 2009, MOL ENDOCRINOL, V23, P324, DOI 10.1210/me.2008-0045; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Frayling TM, 2003, DIABETES, V52, P1857, DOI 10.2337/diabetes.52.7.1857; Guney MA, 2011, P NATL ACAD SCI USA, V108, P15242, DOI 10.1073/pnas.1100072108; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hribal ML, 2002, AM J PHYSIOL-ENDOC M, V282, pE977, DOI 10.1152/ajpendo.00561.2001; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kocialkowski S, 2001, ANAT EMBRYOL, V203, P417, DOI 10.1007/s004290100177; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martinerie C, 1996, ONCOGENE, V12, P1479; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal Bernard, 2006, Cell Commun Signal, V4, P3, DOI 10.1186/1478-811X-4-3; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ritzel RA, 2004, J CLIN ENDOCR METAB, V89, P795, DOI 10.1210/jc.2003-031120; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Sale MM, 2002, DIABETES, V51, pS316, DOI 10.2337/diabetes.51.2007.S316; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; Vaessen N, 2002, DIABETES, V51, P856, DOI 10.2337/diabetes.51.3.856; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249	41	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64957	10.1371/journal.pone.0064957	http://dx.doi.org/10.1371/journal.pone.0064957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705021	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200175
J	Vasconcelos, M; Monteiro, T; Kacelnik, A				Vasconcelos, Marco; Monteiro, Tiago; Kacelnik, Alex			Context-Dependent Preferences in Starlings: Linking Ecology, Foraging and Choice	PLOS ONE			English	Article							SEQUENTIAL CHOICE; SUNK COST; STATE; PIGEONS; JUSTIFICATION; RATIONALITY; DECISIONS; CONTRAST; HUMANS	Foraging animals typically encounter opportunities that they either pursue or skip, but occasionally meet several alternatives simultaneously. Behavioural ecologists predict preferences using absolute properties of each option, while decision theorists focus on relative evaluations at the time of choice. We use European starlings (Sturnus vulgaris) to integrate ecological reasoning with decision models, linking and testing hypotheses for value acquisition and choice mechanism. We hypothesise that options' values depend jointly on absolute attributes, learning context, and subject's state. In simultaneous choices, preference could result either from comparing subjective values using deliberation time, or from processing each alternative independently, without relative comparisons. The combination of the value acquisition hypothesis and independent processing at choice time has been called the Sequential Choice Model. We test this model with options equated in absolute properties to exclude the possibility of preference being built at the time of choice. Starlings learned to obtain food by responding to four stimuli in two contexts. In context [AB], they encountered options A(5) or B-10 in random alternation; in context [CD], they met C-10 or D-20. Delay to food is denoted, in seconds, by the suffixes. Observed latency to respond (L-i) to each option alone (our measure of value) ranked thus: L-A approximate to L-C<<L-B, L-D, consistently with value being sensitive to both delay and learning context. We then introduced simultaneous presentations of A(5) vs. C-10 and B-10 vs. C-10, using latencies in no-choice tests to predict sign and strength of preference in pairings. Starlings preferred A(5) over C-10 and C-10 over B-10. There was no detectable evaluation time, and preference magnitude was predictable from latency differentials. This implies that value reflects learning rather than choice context, that preferences are not constructed by relative judgements at the time of choice, and that mechanisms adapted for sequential decisions are effective to predict choice behaviour.	[Vasconcelos, Marco] Univ Minho, Sch Psychol, Braga, Portugal; [Monteiro, Tiago; Kacelnik, Alex] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Universidade do Minho; University of Oxford	Vasconcelos, M (corresponding author), Univ Minho, Sch Psychol, Braga, Portugal.	mvasconcelos@psi.uminho.pt; alex.kacelnik@zoo.ox.ac.uk	Vasconcelos, Marco/A-3887-2015; Monteiro, Tiago/F-6840-2011	Vasconcelos, Marco/0000-0002-1215-0749; Monteiro, Tiago/0000-0002-2836-8961	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G007144/1]; Portuguese Foundation for Science and Technology (FCT); BBSRC [BB/G007144/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007144/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/G007144/1 to AK www.bbsrc.ac.uk; TM was supported by a Doctoral Grant from the Portuguese Foundation for Science and Technology (FCT) www.fct.pt/index.phtml.en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, LEARNING BEHAV CONT; Arkes HR, 1999, PSYCHOL BULL, V125, P591, DOI 10.1037/0033-2909.125.5.591; Aw JM, 2009, BEHAV PROCESS, V81, P333, DOI 10.1016/j.beproc.2008.09.002; Aw J, 2012, BEHAV PROCESS, V89, P95, DOI 10.1016/j.beproc.2011.09.007; Aw JM, 2011, ANIM BEHAV, V81, P1117, DOI 10.1016/j.anbehav.2011.02.015; Bateson M., 1993, CURRENCIES DECISION; BELKE TW, 1992, ANIM LEARN BEHAV, V20, P401, DOI 10.3758/BF03197963; Blough D. S., 2006, COMP COGNITION EXPT, P89; Cardinal RN, 2010, BEHAV RES METHODS, V42, P1059, DOI 10.3758/BRM.42.4.1059; Catania A.C., 1970, THEORY REINFORCEMENT, P1; DAWKINS R, 1976, NATURE, V262, P131, DOI 10.1038/262131a0; Freidin E, 2009, BEHAV PROCESS, V80, P218, DOI 10.1016/j.beproc.2008.12.001; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grafen A., 2002, MODERN STAT LIFE SCI; GUTMAN A, 1977, J EXP ANAL BEHAV, V27, P219, DOI 10.1901/jeab.1977.27-219; Johnson AW, 2011, P ROY SOC B-BIOL SCI, V278, P1450, DOI 10.1098/rspb.2010.1581; Kacelnik A, 2011, BEHAV ECOL SOCIOBIOL, V65, P547, DOI 10.1007/s00265-010-1101-2; Klein ED, 2005, PSYCHON B REV, V12, P335, DOI 10.3758/BF03196381; Marsh B, 2004, BEHAV ECOL, V15, P396, DOI 10.1093/beheco/arh034; Navarro AD, 2005, J EXP ANAL BEHAV, V83, P1, DOI 10.1901/jeab.2005.21-04; Pompilio L, 2006, SCIENCE, V311, P1613, DOI 10.1126/science.1123924; Pompilio L, 2005, ANIM BEHAV, V70, P571, DOI 10.1016/j.anbehav.2004.12.009; Pompilio L, 2010, P NATL ACAD SCI USA, V107, P508, DOI 10.1073/pnas.0907250107; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; REYNOLDS GS, 1961, J EXP ANAL BEHAV, V4, P57, DOI 10.1901/jeab.1961.4-57; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; Schuck-Paim C, 2004, PLOS BIOL, V2, P2305, DOI 10.1371/journal.pbio.0020402; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shapiro MS, 2008, J EXP PSYCHOL-ANIM B, V34, P75, DOI 10.1037/0097-7403.34.1.75; Staddon JER, 2003, ANNU REV PSYCHOL, V54, P115, DOI 10.1146/annurev.psych.54.101601.145124; Stephens D.W., 1986, pi; Stephens DW, 2009, BEHAV PROCESS, V80, P252, DOI 10.1016/j.beproc.2008.11.014; Stephens DW, 2004, P ROY SOC B-BIOL SCI, V271, P2459, DOI 10.1098/rspb.2004.2871; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Vasconcelos M, 2008, LEARN BEHAV, V36, P12, DOI 10.3758/LB.36.1.12; Vasconcelos M, 2010, BEHAV PROCESS, V84, P435, DOI 10.1016/j.beproc.2009.11.010; Vlaev I, 2011, TRENDS COGN SCI, V15, P546, DOI 10.1016/j.tics.2011.09.008; Zar JH, 1999, BIOSTATISTICAL ANAL; Zentall TR, 2010, CURR DIR PSYCHOL SCI, V19, P296, DOI 10.1177/0963721410383381	41	12	12	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64934	10.1371/journal.pone.0064934	http://dx.doi.org/10.1371/journal.pone.0064934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705019	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200173
J	Lehnhoff, EA; Keith, BK; Dyer, WE; Menalled, FD				Lehnhoff, Erik A.; Keith, Barbara K.; Dyer, William E.; Menalled, Fabian D.			Impact of Biotic and Abiotic Stresses on the Competitive Ability of Multiple Herbicide Resistant Wild Oat (Avena fatua)	PLOS ONE			English	Article							LOLIUM-RIGIDUM POPULATION; LETTUCE LACTUCA-SERRIOLA; SULFONYLUREA-RESISTANT; SEED-GERMINATION; ACETYL-COENZYME; FITNESS; METABOLISM; PLANTS; CARBOXYLASE; EVOLUTION	Ecological theory predicts that fitness costs of herbicide resistance should lead to the reduced relative abundance of resistant populations upon the cessation of herbicide use. This greenhouse research investigated the potential fitness costs of two multiple herbicide resistant (MHR) wild oat (Avena fatua) populations, an economically important weed that affects cereal and pulse crop production in the Northern Great Plains of North America. We compared the competitive ability of two MHR and two herbicide susceptible (HS) A. fatua populations along a gradient of biotic and abiotic stresses The biotic stress was imposed by three levels of wheat (Triticum aestivum) competition (0, 4, and 8 individuals pot(-1)) and an abiotic stress by three nitrogen (N) fertilization rates (0, 50 and 100 kg N ha(-1)). Data were analyzed with linear mixed-effects models and results showed that the biomass of all A. fatua populations decreased with increasing T. aestivum competition at all N rates. Similarly, A. fatua relative growth rate (RGR) decreased with increasing T. aestivum competition at the medium and high N rates but there was no response with 0 N. There were no differences between the levels of biomass or RGR of HS and MHR populations in response to T. aestivum competition. Overall, the results indicate that MHR does not confer growth-related fitness costs in these A. fatua populations, and that their relative abundance will not be diminished with respect to HS populations in the absence of herbicide treatment.	[Lehnhoff, Erik A.; Menalled, Fabian D.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Keith, Barbara K.; Dyer, William E.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Lehnhoff, EA (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	erik.lehnhoff@montana.edu			U.S. Environmental Protection Agency [X8-97873401-0]; Montana Wheat and Barley Committee [408-1655]; Montana Noxious Weed Trust Fund [2011-033]	U.S. Environmental Protection Agency(United States Environmental Protection Agency); Montana Wheat and Barley Committee; Montana Noxious Weed Trust Fund	This research was funded through grants by the U.S. Environmental Protection Agency, http://www.epa.gov, (Grant # X8-97873401-0); the Montana Wheat and Barley Committee, http://wbc.agr.mt.gov, (Grant # 408-1655); and the Montana Noxious Weed Trust Fund, http://agr.mt.gov/agr/Programs/Weeds/TrustFund, (Grant# 2011-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCERRUTHLING M, 1992, WEED TECHNOL, V6, P303, DOI 10.1017/S0890037X00034771; ALCOCERRUTHLING M, 1992, WEED TECHNOL, V6, P437, DOI 10.1017/S0890037X00035016; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Beckie HJ, 2012, CAN J PLANT SCI, V92, P1329, DOI 10.4141/CJPS2012-005; Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Beckie HJ, 2012, WEED SCI, V60, P10, DOI 10.1614/WS-D-11-00110.1; Blackshaw RE, 2008, WEED SCI, V56, P743, DOI 10.1614/WS-08-065.1; Cousens RD, 1997, WEED RES, V37, P1, DOI 10.1111/j.1365-3180.1997.tb01816.x; Delye C, 2011, WEED RES, V51, P433, DOI 10.1111/j.1365-3180.2011.00864.x; Delye C, 2013, ANN BOT, V111, P481; EVANS RM, 1991, WEED TECHNOL, V5, P33, DOI 10.1017/S0890037X00033212; Heap I., 2013, INT SURVEY HERBICIDE; HEAP IM, 1993, WEED SCI, V41, P232, DOI 10.1017/S0043174500076116; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Holt J. S., 1994, P299; Hunt R, 1982, PLANT GROWTH ANAL; JOHNSON RR, 1995, PLANT MOL BIOL, V28, P113, DOI 10.1007/BF00042043; Lehnhoff EA, AGRONOMY J IN PRESS; Maneechote C, 1997, PESTIC SCI, V49, P105, DOI 10.1002/(SICI)1096-9063(199702)49:2&lt;105::AID-PS507&gt;3.0.CO;2-3; Maxwell B. D., 1994, HERBICIDE RESISTANCE, P353; MAXWELL BD, 1990, WEED TECHNOL, V4, P2, DOI 10.1017/S0890037X0002488X; Menchari Y, 2008, J APPL ECOL, V45, P939, DOI 10.1111/j.1365-2664.2008.01462.x; Mortensen DA, 2012, BIOSCIENCE, V62, P75, DOI 10.1525/bio.2012.62.1.12; NAYLOR JM, 1976, CAN J BOT, V54, P306, DOI 10.1139/b76-028; O'Donovan JT, 1999, CAN J PLANT SCI, V79, P303, DOI 10.4141/P98-060; ODONOVAN JT, 1994, WEED SCI, V42, P195, DOI 10.1017/S0043174500080267; Park KW, 2005, WEED SCI, V53, P780, DOI 10.1614/WS-05-006R1.1; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Reade JPH, 2004, WEED SCI, V52, P468, DOI 10.1614/P2002-168D; SOMODY CN, 1984, WEED SCI, V32, P353, DOI 10.1017/S0043174500059129; Tardif FJ, 2006, NEW PHYTOL, V169, P251, DOI 10.1111/j.1469-8137.2005.01596.x; Vila-Aiub MM, 2011, HEREDITY, V107, P386, DOI 10.1038/hdy.2011.29; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2009, J ECOL, V97, P772, DOI 10.1111/j.1365-2745.2009.01511.x; Vila-Aiub MM, 2005, NEW PHYTOL, V167, P787, DOI 10.1111/j.1469-8137.2005.01465.x; Vila-Aiub MM, 2005, J APPL ECOL, V42, P288, DOI 10.1111/j.1365-2664.2005.01017.x	36	16	16	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64478	10.1371/journal.pone.0064478	http://dx.doi.org/10.1371/journal.pone.0064478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696896	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900099
J	Li, AQ; Hardy, R; Stoner, S; Tuckermann, J; Seibel, M; Zhou, H				Li, Aiqing; Hardy, Rowan; Stoner, Shihani; Tuckermann, Jan; Seibel, Markus; Zhou, Hong			Deletion of Mesenchymal Glucocorticoid Receptor Attenuates Embryonic Lung Development and Abdominal Wall Closure	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; DIFFERENTIAL EXPRESSION; ELASTIN PRODUCTION; GENE-EXPRESSION; MESSENGER-RNA; PROTEIN; MICE; IDENTIFICATION; FIBROBLASTS; PROMOTER	As a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors, the glucocorticoid receptor (GR) is essential for normal embryonic development. To date, the role of mesenchymal glucocorticoid signaling during development has not been fully elucidated. In the present study, we investigated the role of the GR during embryogenesis specifically in mesenchymal tissues. To this aim, we crossed GRflox mice with Dermo1-Cre mice to generate GR(Dermo1) mice, where the GR gene was deleted within mesenchymal cells. Compared to their wild type littermates, GR(Dermo1) mice displayed severe pulmonary atelectasis, defects in abdominal wall formation resulting in intestinal herniation, abnormal extracellular matrix synthesis in connective tissues and high postnatal lethality. Lungs of GR(Dermo1) mice failed to progress from the canalicular to saccular stage, as evidenced by the presence of immature air sacs, thickened interstitial mesenchyme and an underdeveloped vascular network between E17.5 and E18.5. Furthermore, myofibroblasts and vascular smooth muscle cells, although present in normal numbers in GR(Dermo1) animals, were characterized by significantly reduced elastin synthesis, whilst epithelial lining cells of the immature saccules were poorly differentiated. A marked reduction in normal elastin and collagen deposits were also observed in connective tissues adjacent to the umbilical hernia. This study demonstrates that eliminating the GR in cells of the mesenchymal lineage results in marked effects on interstitial fibroblast function, including a significant decrease in elastin synthesis. This results in lung atelectasis and postnatal lethality, as well as additional and hitherto unrecognized developmental defects in abdominal wall formation. In addition, altered glucocorticoid signaling in the mesenchyme attenuates normal lung epithelial differentiation.	[Li, Aiqing; Hardy, Rowan; Stoner, Shihani; Seibel, Markus; Zhou, Hong] Univ Sydney, ANZAC Res Inst, Bone Res Program, Sydney, NSW 2006, Australia; [Hardy, Rowan] Univ Birmingham, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Tuckermann, Jan] Univ Ulm, Inst Gen Zool & Endocrinol, D-89069 Ulm, Germany; [Seibel, Markus] Concord Hosp, Dept Endocrinol & Metab, Sydney, NSW, Australia	University of Sydney; ANZAC Research Institute; University of Birmingham; Ulm University; Concord Repatriation General Hospital	Zhou, H (corresponding author), Univ Sydney, ANZAC Res Inst, Bone Res Program, Sydney, NSW 2006, Australia.	h.zhou@sydney.edu.au	Hardy, Rowan S/N-9185-2018; Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016	Hardy, Rowan S/0000-0001-6938-6739; Seibel, Markus J/0000-0002-2701-378X; Zhou, Hong/0000-0001-5899-9660	National Health & Medical Research Council, Australia [632818]; Arthritis Research UK [19552]; National Imaging Facility, Australia; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish	National Health & Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Research UK(Versus Arthritis); National Imaging Facility, Australia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Health & Medical Research Council, Australia, Project Grant 632818 to Hong Zhou and Markus J Seibel. Rowan Hardy received support from Arthritis Research UK (ref no 19552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Colette Fong-Yee and Claudia Hulso for expert technical assistance and thank Mamdouh Khalil and his staff for excellent animal care. The authors thank Dr Timothy Stait-Gardner and Professor William. S. Price, University of Western Sydney, for scientific and technical assistance and for MRI analysis. MRI scan was performed using the 11.7 T MR scanner at the University of Western and was supported by the National Imaging Facility, Australia.	Ahasan MM, 2012, ARTHRITIS RHEUMATISM; ASZTERBAUM M, 1993, J CLIN INVEST, V91, P2703, DOI 10.1172/JCI116509; Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Bolt RJ, 2001, PEDIATR PULM, V32, P76, DOI 10.1002/ppul.1092; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; DelMonaco M, 1997, J INVEST DERMATOL, V108, P938, DOI 10.1111/1523-1747.ep12295241; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; FRIEDMAN DW, 1993, ANN SURG, V218, P754, DOI 10.1097/00000658-199312000-00009; Habermehl D, 2011, MOL ENDOCRINOL, V25, P1280, DOI 10.1210/me.2009-0380; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manwani N, 2010, AM J RESP CELL MOL, V43, P599, DOI 10.1165/rcmb.2009-0263OC; Mariani TJ, 1997, EXP LUNG RES, V23, P131, DOI 10.3109/01902149709074026; MECHAM RP, 1984, J BIOL CHEM, V259, P2414; Oikarinen AI, BIOCH PHARM, V37, P1451; Parker MG, 1993, CURR OPIN CELL BIOL, V5, P499, DOI 10.1016/0955-0674(93)90016-J; PEREZ JR, 1992, J CELL BIOCHEM, V50, P26, DOI 10.1002/jcb.240500107; Pierce RA, 1995, CIBA F SYMP, V192, P199; Schneider JE, 2004, J MAGN RESON IMAGING, V20, P981, DOI 10.1002/jmri.20211; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Starcher BC, 2000, CHEST, V117, p229S, DOI 10.1378/chest.117.5_suppl_1.229S-a; SWEE MH, 1995, J BIOL CHEM, V270, P14899, DOI 10.1074/jbc.270.25.14899; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Vachharajani A, 2009, PEDIATR SURG INT, V25, P139, DOI 10.1007/s00383-008-2301-y; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	35	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63578	10.1371/journal.pone.0063578	http://dx.doi.org/10.1371/journal.pone.0063578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696835	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900043
J	Ma, LL; Tai, XH; Su, LY; Shi, LJ; Wang, EH; Qin, L				Ma, Lanlan; Tai, Xuhui; Su, Liye; Shi, Lijuan; Wang, Enhua; Qin, Ling			The Neuronal Responses to Repetitive Acoustic Pulses in Different Fields of the Auditory Cortex of Awake Rats	PLOS ONE			English	Article							AMPLITUDE-MODULATION; TEMPORAL INFORMATION; CORTICAL FIELDS; GUINEA-PIGS; ALBINO-RAT; STIMULI; SYSTEM; ORGANIZATION; SOUND; CAT	Cortical representation of time-varying features of acoustic signals is a fundamental issue of acoustic processing remaining unresolved. The rat is a widely used animal model for auditory cortical processing. Though some electrophysiological studies have investigated the neural responses to temporal repetitive sounds in the auditory cortex (AC) of rats, most of them were conducted under anesthetized condition. Recently, it has been shown that anesthesia could significantly alter the temporal patterns of neural response. For this reason, we systematically examined the single-unit neural responses to click-trains in the core region of rat AC under awake condition. Consistent with the reports on anesthetized rats, we confirmed the existence of characteristic tonotopic organizations, which were used to divide the AC into anterior auditory field (AAF), primary auditory cortex (A1) and posterior auditory field (PAF). We further found that the neuron's capability to synchronize to the temporal repetitive stimuli progressively decreased along the anterior-to-posterior direction of AC. The median of maximum synchronization rate was 64, 32 and 16 Hz in AAF, A1 and PAF, respectively. On the other hand, the percentage of neurons, which showed non-synchronized responses and could represent the stimulus repetition rate by the mean firing rate, increased from 7% in AAF and A1 to 20% in PAF. These results suggest that the temporal resolution of acoustic processing gradually increases from the anterior to posterior part of AC, and thus there may be a hierarchical stream along this direction of rat AC.	[Ma, Lanlan; Su, Liye; Shi, Lijuan; Qin, Ling] China Med Univ, Dept Physiol, Shenyang, Peoples R China; [Tai, Xuhui] 463rd Hosp PLA, Dept Otolaryngol, Shenyang, Peoples R China; [Wang, Enhua; Qin, Ling] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Peoples R China; [Qin, Ling] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Physiol, Chuo, Yamanashi, Japan	China Medical University; China Medical University; University of Yamanashi	Qin, L (corresponding author), China Med Univ, Dept Physiol, Shenyang, Peoples R China.	qinlingling@yahoo.com			National Nature Science Foundation of China [30970979, 31171057]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China under Grant No. 30970979 and 31171057 (LQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2006, HEARING RES, V213, P107, DOI 10.1016/j.heares.2005.12.011; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; Camalier CR, 2012, P NATL ACAD SCI USA, V109, P18168, DOI 10.1073/pnas.1206387109; Carrasco A, 2011, J NEUROPHYSIOL, V106, P1166, DOI 10.1152/jn.00940.2010; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Gaese BH, 2003, EUR J NEUROSCI, V18, P2638, DOI 10.1046/j.1460-9568.2003.03007.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KALTWASSER MT, 1990, J COMP PSYCHOL, V104, P227, DOI 10.1037/0735-7036.104.3.227; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Mardia K. V., 2000, DIRECTIONAL STAT; Oshurkova E, 2008, NEUROSCIENCE, V153, P1289, DOI 10.1016/j.neuroscience.2008.03.030; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Profant O, 2013, HEARING RES, V296, P51, DOI 10.1016/j.heares.2012.11.021; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Rennaker RL, 2007, NEUROSCIENCE, V145, P357, DOI 10.1016/j.neuroscience.2006.11.043; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010	36	11	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64288	10.1371/journal.pone.0064288	http://dx.doi.org/10.1371/journal.pone.0064288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696877	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900080
J	Mhlongo, S; Dietrich, J; Otwombe, KN; Robertson, G; Coates, TJ; Gray, G				Mhlongo, Sakhile; Dietrich, Janan; Otwombe, Kennedy N.; Robertson, Gavin; Coates, Thomas J.; Gray, Glenda			Factors Associated with Not Testing For HIV and Consistent Condom Use among Men in Soweto, South Africa	PLOS ONE			English	Article							PROJECT ACCEPT; BEHAVIOR; HEALTH; TRANSMISSION; TOWNSHIP; ADULTS	Background: Besides access to medical male circumcision, HIV testing, access to condoms and consistent condom use are additional strategies men can use to prevent HIV acquisition. We examine male behavior toward testing and condom use. Objective: To determine factors associated with never testing for HIV and consistent condom use among men who never test in Soweto. Methods: A cross-sectional survey in Soweto was conducted in 1539 men aged 18-32 years in 2007. Data were collected on socio-demographic and behavioral characteristics to determine factors associated with not testing and consistent condom use. Results: Over two thirds (71%) of men had not had an HIV test and the majority (55%, n = 602) were young (18-23). Of those not testing, condom use was poor (44%, n = 304). Men who were 18-23 years (aOR: 2.261, CI: 1.534-3.331), with primary (aOR: 2.096, CI: 1.058-4.153) or high school (aOR: 1.622, CI: 1.078-2.439) education, had sex in the last 6 months (aOR: 1.703, CI: 1.055-2.751), and had >= 1 sexual partner (aOR: 1.749, CI: 1.196-2.557) were more likely not to test. Of those reporting condom use (n = 1036, 67%), consistent condom use was 43% (n = 451). HIV testing did not correlate with condom use. Conclusion: Low rates of both condom use and HIV testing among men in a high HIV prevalence setting are worrisome and indicate an urgent need to develop innovative behavioral strategies to address this shortfall. Condom use is poor in this population whether tested or not tested for HIV, indicating no association between condom use and HIV testing.	[Mhlongo, Sakhile; Dietrich, Janan; Otwombe, Kennedy N.; Robertson, Gavin; Gray, Glenda] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, Gauteng, South Africa; [Coates, Thomas J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Dietrich, Janan] Ottawa Hosp, Canada Africa Prevent Trials Network, Ottawa, ON, Canada	University of Witwatersrand; University of California System; University of California Los Angeles; University of Ottawa; Ottawa Hospital Research Institute	Mhlongo, S (corresponding author), Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, Gauteng, South Africa.	sak-hile@live.com		Dietrich, Janan/0000-0002-1949-3138	U.S. National Institute of Mental Health [U01MH066687, U01MH066688, U01MH066701, U01MH066702]; HPTN Protocol 043 of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases [U01AI068613, U01AI068617, U01AI068619]; Office of AIDS Research of the U.S. National Institutes of Health; SPARC; Canadian Africa Prevention Trials Network (CAPT); South African AIDS Vaccine Initiative (SAAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068617, U01AI068619, U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066702, U01MH066701, U01MH066687, U01MH066688] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HPTN Protocol 043 of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; Office of AIDS Research of the U.S. National Institutes of Health; SPARC; Canadian Africa Prevention Trials Network (CAPT); South African AIDS Vaccine Initiative (SAAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement through contracts U01MH066687 (Johns Hopkins University - David Celentano, PI), U01MH066688 (Medical University of South Carolina - Michael Sweat, PI), U01MH066701 (University of California, Los Angeles - Thomas J. Coates, PI), and U01MH066702 (University of California, San Francisco - Stephen F. Morin, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01AI068613 (HPTN Network Laboratory - Susan Eshleman, PI), U01AI068617 (SCHARP - Deborah Donnell, PI), and U01AI068619 (HIV Prevention Trials Network - Sten Vermund, PI) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases and by the Office of AIDS Research of the U.S. National Institutes of Health. Views expressed are those of the authors and not necessarily those of sponsoring agencies. The first author attended PHRU's publication's programme that was funded by SPARC and the Canadian Africa Prevention Trials Network (CAPT). The second author is supported through the South African AIDS Vaccine Initiative (SAAVI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FOXNEWS; Arthur G, 2007, SEX TRANSM INFECT, V83, P541, DOI 10.1136/sti.2007.026732; Bogart LM, 2011, AJAR-AFR J AIDS RES, V10, P181, DOI 10.2989/16085906.2011.593384; Bryan A, 2006, AIDS BEHAV, V10, P387, DOI 10.1007/s10461-006-9087-5; BuaNews, 2011, BUANEWS; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Chimbindi Natsayi Z, 2010, Open AIDS J, V4, P88, DOI 10.2174/1874613601004010088; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; De Koker P, 2010, SAMJ S AFR MED J, V100, P364, DOI 10.7196/SAMJ.3941; Department of Health, 2012, 2010 NAT ANT SENT HI; Fagbamigbe AF, 2011, AIDS RES THER, P8; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Genberg BL, 2008, JAIDS-J ACQ IMM DEF, V49, P309, DOI 10.1097/QAI.0b013e3181893ed0; GeoNames, 2012, S AFR LARG CIT; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Khumalo-Sakutukwa G, J ACQUIRED IMMUNE DE, V49, P422; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; National Department of Health, 2010, STRAT PLAN 2010 11 2; National Department of Health RoSA, 2010, COUNTR PROGR REP DEC; National Department of Health RoSA, 2007, HIV AIDS STI STRAT P; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; ProjectAccept, 2011, PROJ ACC HPTN 043 PH; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; SARACCO A, 1993, J ACQ IMMUN DEF SYND, V6, P497; Shisana O., 2009, S AFRICAN NATL HIV P; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; UNAIDS, 2001, 2001 DECL COMM HIV A; UNAIDS, 2010, GLOB REP UNAIDS REP; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; Walensky RP, 2010, CLIN INFECT DIS, V50, P272, DOI 10.1086/649214; Weschberg WM, 2010, S AFRICA J PREVENTIO, V38, P132; World Health Organization (WHO), 2003, RIGHT KNOW NEW APPR	34	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e62637	10.1371/journal.pone.0062637	http://dx.doi.org/10.1371/journal.pone.0062637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	146HW	23696786	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900003
J	Schonbrun, M; Kolesnikov, M; Kupiec, M; Weisman, R				Schonbrun, Miriam; Kolesnikov, Masha; Kupiec, Martin; Weisman, Ronit			TORC2 Is Required to Maintain Genome Stability during S Phase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; NITROGEN STARVATION; DNA-DAMAGE; SEXUAL DEVELOPMENT; CELL-DIVISION; REPLICATION; REPAIR; GENE; PATHWAY; GROWTH	DNA damage can occur due to environmental insults or intrinsic metabolic processes and is a major threat to genome stability. The DNA damage response is composed of a series of well coordinated cellular processes that include activation of the DNA damage checkpoint, transient cell cycle arrest, DNA damage repair, and reentry into the cell cycle. Here we demonstrate that mutant cells defective for TOR complex 2 (TORC2) or the downstream AGC-like kinase, Gad8, are highly sensitive to chronic replication stress but are insensitive to ionizing radiation. We show that in response to replication stress, TORC2 is dispensable for Chk1-mediated cell cycle arrest but is required for the return to cell cycle progression. Rad52 is a DNA repair and recombination protein that forms foci at DNA damage sites and stalled replication forks. TORC2 mutant cells show increased spontaneous nuclear Rad52 foci, particularly during S phase, suggesting that TORC2 protects cells from DNA damage that occurs during normal DNA replication. Consistently, the viability of TORC2-Gad8 mutant cells is dependent on the presence of the homologous recombination pathway and other proteins that are required for replication restart following fork replication stalling. Our findings indicate that TORC2 is required for genome integrity. This may be relevant for the growing amount of evidence implicating TORC2 in cancer development.	[Schonbrun, Miriam; Kolesnikov, Masha; Kupiec, Martin; Weisman, Ronit] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, Raanana, Israel	Tel Aviv University; Open University Israel	Weisman, R (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Green Bldg,Rm 211, IL-69978 Tel Aviv, Israel.	ronitt@post.tau.ac.il	weisman, ronit/D-3741-2016; weisman, ronit/R-6969-2016		Association of International Cancer Research [11-0281]; Open University of Israel Research Fund [37076]	Association of International Cancer Research; Open University of Israel Research Fund	This work was supported by Association of International Cancer Research Grant 11-0281 and Open University of Israel Research Fund Grant 37076 (to R. W.).	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Aspuria PJ, 2007, CELL CYCLE, V6, P1692, DOI 10.4161/cc.6.14.4478; Bass KL, 2012, J CELL SCI, V125, P2753, DOI 10.1242/jcs.103119; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Cavero S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001138; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Dovey CL, 2007, GENETICS, V177, P47, DOI 10.1534/genetics.107.077255; Dovey CL, 2009, DNA REPAIR, V8, P1390, DOI 10.1016/j.dnarep.2009.09.008; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; HSIANG YH, 1989, CANCER RES, V49, P5077; Humphrey T, 2000, MUTAT RES-FUND MOL M, V451, P211, DOI 10.1016/S0027-5107(00)00051-8; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; JIMENEZ G, 1992, P NATL ACAD SCI USA, V89, P4952, DOI 10.1073/pnas.89.11.4952; Kawai M, 2001, CURR GENET, V39, P166; Kominami K, 1998, EMBO J, V17, P5388, DOI 10.1093/emboj/17.18.5388; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moynihan EB, 1999, MOL BIOL CELL, V10, P245, DOI 10.1091/mbc.10.2.245; Muris DFR, 1996, J CELL SCI, V109, P73; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; NIWA O, 1989, EMBO J, V8, P3045, DOI 10.1002/j.1460-2075.1989.tb08455.x; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Raji H, 2006, YEAST, V23, P963, DOI 10.1002/yea.1414; Rhind N, 1998, GENETICS, V149, P1729; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Stolz J, 2004, EUKARYOT CELL, V3, P406, DOI 10.1128/EC.3.2.406-412.2004; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tatebe Hisashi, 2010, Small GTPases, V1, P180, DOI 10.4161/sgtp.1.3.14936; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P24736, DOI 10.1074/jbc.M102090200; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Win TZ, 2005, J CELL SCI, V118, P5777, DOI 10.1242/jcs.02694; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	70	24	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19649	19660		10.1074/jbc.M113.464974	http://dx.doi.org/10.1074/jbc.M113.464974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703609	Green Published, hybrid			2022-12-25	WOS:000321515800036
J	Sweeney, NL; Shadrick, WR; Mukherjee, S; Li, KL; Frankowski, KJ; Schoenen, FJ; Frick, DN				Sweeney, Noreena L.; Shadrick, William R.; Mukherjee, Sourav; Li, Kelin; Frankowski, Kevin J.; Schoenen, Frank J.; Frick, David N.			Primuline Derivatives That Mimic RNA to Stimulate Hepatitis C Virus NS3 Helicase-catalyzed ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; EXPANDED FAT NUCLEOSIDE; NUCLEOTIDE ANALOGS; KINETIC-ANALYSIS; CDNA-CLONE; INHIBITORS; TRANSLOCATION; IDENTIFICATION; TRANSCRIPTS; MECHANISM	ATP hydrolysis fuels the ability of helicases and related proteins to translocate on nucleic acids and separate base pairs. As a consequence, nucleic acid binding stimulates the rate at which a helicase catalyzes ATP hydrolysis. In this study, we searched a library of small molecule helicase inhibitors for compounds that stimulate ATP hydrolysis catalyzed by the hepatitis C virus (HCV) NS3 helicase, which is an important antiviral drug target. Two compounds were found that stimulate HCV helicase-catalyzed ATP hydrolysis, both of which are amide derivatives synthesized from the main component of the yellow dye primuline. Both compounds possess a terminal pyridine moiety, which was critical for stimulation. Analogs lacking a terminal pyridine inhibited HCV helicase catalyzed ATP hydrolysis. Unlike other HCV helicase inhibitors, the stimulatory compounds differentiate between helicases isolated from various HCV genotypes and related viruses. The compounds only stimulated ATP hydrolysis catalyzed by NS3 purified from HCV genotype 1b. They inhibited helicases from other HCV genotypes (e.g. 1a and 2a) or related flaviviruses (e.g. Dengue virus). The stimulatory compounds interacted with HCV helicase in the absence of ATP with dissociation constants of about 2 mu M. Molecular modeling and site-directed mutagenesis studies suggest that the stimulatory compounds bind in the HCV helicase RNA-binding cleft near key residues Arg-393, Glu-493, and Ser-231.	[Sweeney, Noreena L.; Shadrick, William R.; Mukherjee, Sourav; Frick, David N.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53211 USA; [Li, Kelin; Frankowski, Kevin J.; Schoenen, Frank J.] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66047 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Kansas	Frick, DN (corresponding author), Univ Wisconsin, Dept Chem & Biochem, 3210 N Cramer St, Milwaukee, WI 53211 USA.	frickd@uwm.edu		Frick, David/0000-0002-2434-7223; Schoenen, Frank/0000-0003-2711-1117	National Institutes of Health [R01 AI088001, U54 HG005031]; UWM Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWM Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI088001 and U54 HG005031, and a Research Growth Initiative Award from the UWM Research Foundation.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Belon CA, 2010, BIOCHEMISTRY-US, V49, P1822, DOI 10.1021/bi901974a; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Borowski P, 2001, J VIROL, V75, P3220, DOI 10.1128/JVI.75.7.3220-3229.2001; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Chen CS, 2009, J MED CHEM, V52, P2716, DOI 10.1021/jm8011905; Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023; Frick DN, 2010, METHODS MOL BIOL, V587, P223, DOI 10.1007/978-1-60327-355-8_16; Frick DN, 2004, NUCLEIC ACIDS RES, V32, P5519, DOI 10.1093/nar/gkh891; Gemma S, 2011, BIOORG MED CHEM LETT, V21, P2776, DOI 10.1016/j.bmcl.2010.09.002; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hanson AM, 2012, METHOD ENZYMOL, V511, P463, DOI 10.1016/B978-0-12-396546-2.00021-8; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kim JW, 2003, J VIROL, V77, P571, DOI 10.1128/JVI.77.1.571-582.2003; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li KL, 2012, J MED CHEM, V55, P3319, DOI 10.1021/jm300021v; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623; Najda-Bernatowicz A, 2010, BIOORGAN MED CHEM, V18, P5129, DOI 10.1016/j.bmc.2010.05.066; Ndjomou J, 2012, ANTIVIR RES, V96, P245, DOI 10.1016/j.antiviral.2012.08.006; Neumann-Haefelin C, 2008, J VIROL, V82, P3438, DOI 10.1128/JVI.01700-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Thibeault D, 2004, J VIROL, V78, P7352, DOI 10.1128/JVI.78.14.7352-7359.2004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang N, 2003, J MED CHEM, V46, P4149, DOI 10.1021/jm030842j; Zhang N, 2003, J MED CHEM, V46, P4776, DOI 10.1021/jm030277k	42	7	7	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19949	19957		10.1074/jbc.M113.463166	http://dx.doi.org/10.1074/jbc.M113.463166			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703611	hybrid, Green Published			2022-12-25	WOS:000321515800060
J	Ho, YY; Fang, YP; Chou, CH; Cheng, HC; Chang, HW				Ho, Ying-Yi; Fang, Yin-Ping; Chou, Cheng-Han; Cheng, Hsi-Chi; Chang, Hsueh-Wen			High Duty Cycle to Low Duty Cycle: Echolocation Behaviour of the Hipposiderid Bat Coelops frithii	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EVOLUTION; CALLS; DISCRIMINATION; CHIROPTERA; MAMMALIA; SOUNDS; PREY	Laryngeally echolocating bats avoid self-deafening (forward masking) by separating pulse and echo either in time using low duty cycle (LDC) echolocation, or in frequency using high duty cycle (HDC) echolocation. HDC echolocators are specialized to detect fluttering targets in cluttered environments. HDC echolocation is found only in the families Rhinolophidae and Hipposideridae in the Old World and in the New World mormoopid, Pteronotus parnellii. Here we report that the hipposiderid Coelops frithii, ostensibly an HDC bat, consistently uses an LDC echolocation strategy whether roosting, flying, or approaching a fluttering target rotating at 50 to 80 Hz. We recorded the echolocation calls of free-flying C. frithii in the field in various situations, including presenting bats with a mechanical fluttering target. The echolocation calls of C. frithii consisted of an initial narrowband component (0.5 +/- 0.3 ms, 90.6 +/- 2.0 kHz) followed immediately by a frequency modulated (FM) sweep (194 to 113 kHz). This species emitted echolocation calls at duty cycles averaging 7.7 +/- 2.8% (n = 87 sequences). Coelops frithii approached fluttering targets more frequently than did LDC bats (C. frithii, approach frequency = 40.4%, n = 80; Myotis spp., approach frequency = 0%, n = 13), and at the same frequency as sympatrically feeding HDC species (Hipposideros armiger, approach rate = 53.3%, n = 15; Rhinolophus monoceros, approach rate = 56.7%, n = 97). We propose that the LDC echolocation strategy used by C. frithii is derived from HDC ancestors, that this species adjusts the harmonic contents of its echolocation calls, and that it may use both the narrowband component and the FM sweep of echolocations calls to detect fluttering targets.	[Ho, Ying-Yi; Chang, Hsueh-Wen] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Fang, Yin-Ping] Natl Chiayi Univ, Dept Biol Resources, Chiayi, Taiwan; [Chou, Cheng-Han] Aletheia Univ, Dept Leisure & Recreat Studies, Tainan, Taiwan; [Chou, Cheng-Han; Cheng, Hsi-Chi] Endem Species Res Inst, Nantou, Taiwan	National Sun Yat Sen University; National Chiayi University; Aletheia University	Chang, HW (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	hwchang@mail.nsysu.edu.tw			Taiwan National Science Council; Forestry Bureau	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Forestry Bureau	Financial support was provided by the Taiwan National Science Council (for HWC) and the Forestry Bureau (for YPF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates P, 2008, IUCN 2012 IUCN RED L, DOI 10.2305/IUCN.UK.2008.RLTS.T20521A9210732.en; Bogdanowicz Wieslaw, 1998, P27; Fenton MB, 2012, J EXP BIOL, V215, P2935, DOI 10.1242/jeb.073171; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Grossetete A, 1998, J ACOUST SOC AM, V103, P2167, DOI 10.1121/1.421362; Hand Suzanne J., 1998, P72; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kossl M, 1999, J COMP PHYSIOL A, V185, P217, DOI 10.1007/s003590050381; Lazure L, 2011, J EXP BIOL, V214, P1131, DOI 10.1242/jeb.048967; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000900; Li G, 2007, J MAMMAL, V88, P736, DOI 10.1644/06-MAMM-A-273R.1; Liu Sen, 2008, Zoological Research, V29, P95; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Murray SW, 2012, MOL PHYLOGENET EVOL, V62, P597, DOI 10.1016/j.ympev.2011.10.021; Neuweiler G, 2003, J COMP PHYSIOL A, V189, P245, DOI 10.1007/s00359-003-0406-2; Schnitzler H-U., 2004, ECHOLOCATION BATS DO, P331; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Shen B, 2011, J MOL EVOL, V73, P109, DOI 10.1007/s00239-011-9460-5; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Simmons NB, 1998, B AM MUS NAT HIST, P4; Skowronski MD, 2008, J ACOUST SOC AM, V123, P2643, DOI 10.1121/1.2896752; SUM YW, 1988, J COMP PHYSIOL A, V163, P349, DOI 10.1007/BF00604010; Thomas JA, 2004, ECHOLOCATION BATS DO; Zhang LB, 2009, ACTA CHIROPTEROL, V11, P71, DOI 10.3161/150811009X465703	30	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e62938	10.1371/journal.pone.0062938	http://dx.doi.org/10.1371/journal.pone.0062938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717396	gold, Green Published, Green Submitted			2022-12-25	WOS:000319385300040
J	Genard, B; Miner, P; Nicolas, JL; Moraga, D; Boudry, P; Pernet, F; Tremblay, R				Genard, Bertrand; Miner, Philippe; Nicolas, Jean-Louis; Moraga, Dario; Boudry, Pierre; Pernet, Fabrice; Tremblay, Rejean			Integrative Study of Physiological Changes Associated with Bacterial Infection in Pacific Oyster Larvae	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; INTERRUPTED FATTY-ACIDS; INNATE IMMUNE-RESPONSE; CRASSOSTREA-GIGAS; ANTIMICROBIAL PEPTIDES; MARINE-INVERTEBRATES; BIOCHEMICAL-CHANGES; MASSIVE MORTALITY; ARACHIDONIC-ACID; OSTREA-EDULIS	Background: Bacterial infections are common in bivalve larvae and can lead to significant mortality, notably in hatcheries. Numerous studies have identified the pathogenic bacteria involved in such mortalities, but physiological changes associated with pathogen exposure at larval stage are still poorly understood. In the present study, we used an integrative approach including physiological, enzymatic, biochemical, and molecular analyses to investigate changes in energy metabolism, lipid remodelling, cellular stress, and immune status of Crassostrea gigas larvae subjected to experimental infection with the pathogenic bacteria Vibrio coralliilyticus. Findings: Our results showed that V. coralliilyticus exposure induced (1) limited but significant increase of larvae mortality compared with controls, (2) declined feeding activity, which resulted in energy status changes (i.e. reserve consumption, beta-oxidation, decline of metabolic rate), (3) fatty acid remodeling of polar lipids (changes in phosphatidylinositol and lysophosphatidylcholine composition,non-methylene-interrupted fatty acids accumulation, lower content of major C-20 polyunsaturated fatty acids as well as activation of desaturases, phospholipase and lipoxygenase), (4) activation of antioxidant defenses (catalase, superoxide dismutase, peroxiredoxin) and cytoprotective processes (heat shock protein 70, pernin), and (5) activation of the immune response (non-self recognition, NF-(kappa kappa) signaling pathway, haematopoiesis, eiconosoids and lysophosphatidyl acid synthesis, inhibitor of metalloproteinase and antimicrobial peptides). Conclusion: Overall, our results allowed us to propose an integrative view of changes induced by a bacterial infection in Pacific oyster larvae, opening new perspectives on the response of marine bivalve larvae to infections.	[Genard, Bertrand; Tremblay, Rejean] Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada; [Miner, Philippe; Nicolas, Jean-Louis; Boudry, Pierre; Pernet, Fabrice] IFREMER, Lab Sci Environm Marin LEMAR, Unite Rech Physiol Fonct Organismes Marins, F-29280 Plouzane, France; [Moraga, Dario] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin LEMAR, Plouzane, France	University of Quebec; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Genard, B (corresponding author), Univ Quebec, Inst Sci Mer, Rimouski, PQ G5L 3A1, Canada.	bertrand.genard@uqar.qc.ca	Tremblay, Rejean/A-4971-2013; Boudry, Pierre/M-3213-2019; Pernet, Fabrice/B-4051-2008; Boudry, Pierre/G-2406-2010	Tremblay, Rejean/0000-0003-2590-8915; Pernet, Fabrice/0000-0001-8886-0184; Boudry, Pierre/0000-0002-5150-2276	Natural Sciences and Engineering Research Council of Canada [299100]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the discovery grants program (individual, 299100) of the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1973, COMP BIOCHEM PHYSIOL, V46, P153, DOI 10.1016/0305-0491(73)90057-6; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BACHERE E, 1995, AQUACULTURE, V132, P17, DOI 10.1016/0044-8486(94)00389-6; Bailey DM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P335, DOI 10.1086/430042; Barnathan G, 2009, BIOCHIMIE, V91, P671, DOI 10.1016/j.biochi.2009.03.020; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Belzile C, 2008, J MARINE SYST, V74, P946, DOI 10.1016/j.jmarsys.2007.12.010; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown Drew C., 1993, Journal of Shellfish Research, V12, P135; Chaney ML, 2011, MOL ECOL, V20, P2942, DOI 10.1111/j.1365-294X.2011.05152.x; CHILDRESS JJ, 1979, MAR BIOL, V52, P273, DOI 10.1007/BF00398141; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; De Decker S, 2011, FISH SHELLFISH IMMUN, V30, P691, DOI 10.1016/j.fsi.2010.12.017; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; DELAUNAY F, 1992, J EXP MAR BIOL ECOL, V163, P209, DOI 10.1016/0022-0981(92)90050-K; DELAUNAY F, 1993, J EXP MAR BIOL ECOL, V173, P163, DOI 10.1016/0022-0981(93)90051-O; DEREWENDA ZS, 1994, ADV PROTEIN CHEM, V45, P1; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; ELSTON R, 1980, Proceedings National Shellfisheries Association, V70, P65; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Flye-Sainte-Marie J, 2007, J EXP MAR BIOL ECOL, V349, P378, DOI 10.1016/j.jembe.2007.05.029; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; Geay F, 2010, COMP BIOCHEM PHYS B, V156, P237, DOI 10.1016/j.cbpb.2010.03.008; Genard B, 2012, GENE, V499, P70, DOI 10.1016/j.gene.2012.02.021; Genard B, 2011, AQUAT LIVING RESOUR, V24, P247, DOI 10.1051/alr/2011114; Gestal C, 2008, REV FISH SCI, V16, P133, DOI 10.1080/10641260802325518; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Haberkorn H, 2010, HARMFUL ALGAE, V9, P427, DOI 10.1016/j.hal.2010.01.003; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; HOLLAND DL, 1973, J MAR BIOL ASSOC UK, V53, P287, DOI 10.1017/S002531540002227X; Hurtado MA, 2009, AQUACULTURE, V294, P300, DOI 10.1016/j.aquaculture.2009.06.009; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Jing X, 2011, FISH SHELLFISH IMMUN, V30, P851, DOI 10.1016/j.fsi.2011.01.007; Kabarowski JHS, 2002, BIOCHEM PHARMACOL, V64, P161, DOI 10.1016/S0006-2952(02)01179-6; Kerouel R, FEMS MICROBIOL ECOL; Kesarcodi-Watson A, 2012, AQUACULTURE, V344, P29, DOI 10.1016/j.aquaculture.2012.02.029; KLINGENSMITH JS, 1982, LIPIDS, V17, P976, DOI 10.1007/BF02534595; Koutsogiannaki S, 2010, ISJ-INVERT SURVIV J, V7, P11; Kraffe E, 2004, LIPIDS, V39, P59, DOI 10.1007/s11745-004-1202-x; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Lambert C, 2007, AQUACULTURE, V270, P413, DOI 10.1016/j.aquaculture.2007.04.074; LANGDON CJ, 1981, J MAR BIOL ASSOC UK, V61, P431, DOI 10.1017/S0025315400047056; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, DEV ENV MODELLING, V3; Linkous A, 2010, CELL MICROBIOL, V12, P1369, DOI 10.1111/j.1462-5822.2010.01505.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna-Gonzalez A, 2004, FISH SHELLFISH IMMUN, V16, P287, DOI 10.1016/S1050-4648(03)00110-4; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Montagnani C, 2008, DEV COMP IMMUNOL, V32, P182, DOI 10.1016/j.dci.2007.06.001; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Pernet F, 2006, J EXP MAR BIOL ECOL, V329, P265, DOI 10.1016/j.jembe.2005.09.008; Pernet F, 2005, J EXP MAR BIOL ECOL, V327, P115, DOI 10.1016/j.jembe.2005.06.008; Pernet F, 2010, MAR ECOL PROG SER, V401, P129, DOI 10.3354/meps08407; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rico-Villa B, 2006, AQUACULTURE, V256, P377, DOI 10.1016/j.aquaculture.2006.02.015; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Samain JF, 2011, AQUAT LIVING RESOUR, V24, P227, DOI 10.1051/alr/2011144; Schmitt P, 2012, DEV COMP IMMUNOL, V37, P363, DOI 10.1016/j.dci.2012.01.004; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Scotti PD, 2001, COMP BIOCHEM PHYS B, V128, P767, DOI 10.1016/S1096-4959(01)00301-3; Seguineau C, 2011, COMP BIOCHEM PHYS A, V160, P87, DOI 10.1016/j.cbpa.2011.05.011; Sethu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010506; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Shrestha S, 2010, DEV COMP IMMUNOL, V34, P530, DOI 10.1016/j.dci.2009.12.013; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Smith W.L., 2003, BIOCH LIPIDS LIPOPRO, V36, P341; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Stanley D, 2009, J INNATE IMMUN, V1, P282, DOI 10.1159/000210371; STEWART JM, 1994, INVERTEBR REPROD DEV, V25, P73, DOI 10.1080/07924259.1994.9672370; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Thomas-Guyon H, 2009, DEV COMP IMMUNOL, V33, P653, DOI 10.1016/j.dci.2008.11.011; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tunaz H, 2003, ARCH INSECT BIOCHEM, V52, P1, DOI 10.1002/arch.10056; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang SL, 2010, FISH SHELLFISH IMMUN, V29, P921, DOI 10.1016/j.fsi.2010.07.035; Yamaura K, 2008, COMP BIOCHEM PHYS B, V149, P168, DOI 10.1016/j.cbpb.2007.09.004; Zhang DC, 2011, DEV COMP IMMUNOL, V35, P1, DOI 10.1016/j.dci.2010.08.007	97	73	73	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64534	10.1371/journal.pone.0064534	http://dx.doi.org/10.1371/journal.pone.0064534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704993	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200147
J	Kaihatsu, K; Sawada, S; Nakamura, S; Nakaya, T; Yasunaga, T; Kato, N				Kaihatsu, Kunihiro; Sawada, Shinjiro; Nakamura, Shota; Nakaya, Takaaki; Yasunaga, Teruo; Kato, Nobuo			Sequence-Specific and Visual Identification of the Influenza Virus NS Gene by Azobenzene-Tethered Bis-Peptide Nucleic Acid	PLOS ONE			English	Article							DUPLEX DNA; PNA; TRANSCRIPTION; RECOGNITION; INHIBITION; BINDING	To rapidly and specifically identify highly virulent influenza virus strains, we prepared an azobenzene-tethered hairpin-type peptide nucleic acid, bisPNA-AZO, which has a complementary sequence against a highly conserved genomic RNA sequence within the ribonucleoprotein complex of the 2009 pandemic influenza A virus, H1N1 subtype. bisPNA-AZO recognizes the conserved virus genome sequence in a sequence-specific manner. Immobilization of bisPNA-AZO on a plate allowed capture of the target virus gene and the generation of a visual colour signal.	[Kaihatsu, Kunihiro; Sawada, Shinjiro; Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Nakamura, Shota; Yasunaga, Teruo] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Nakaya, Takaaki] Kyoto Prefectural Univ Med, Dept Infect Dis, Kyoto, Japan	Osaka University; Osaka University; Kyoto Prefectural University of Medicine	Kaihatsu, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	Kunihiro@sanken.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942	National Institute of Biomedical Innovation Research Grant [09-23];  [22750155]	National Institute of Biomedical Innovation Research Grant; 	This research was supported by by a National Institute of Biomedical Innovation Research Grant (09-23 to KK) and by a Grant-in-Aid for Scientific Research (B) (22750155 to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daum LT, 2007, INFLUENZA OTHER RESP, V1, P167, DOI 10.1111/j.1750-2659.2007.00024.x; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Hamilton SE, 1996, BIOORG MED CHEM LETT, V6, P2897, DOI 10.1016/S0960-894X(96)00538-0; Kaihatsu K, 2003, BIOCHEMISTRY-US, V42, P13996, DOI 10.1021/bi035194k; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KEMLER I, 1994, VIROLOGY, V202, P1028, DOI 10.1006/viro.1994.1432; Kuhn H, 1999, J MOL BIOL, V286, P1337, DOI 10.1006/jmbi.1998.2578; Kummer S, 2011, ANGEW CHEM INT EDIT, V50, P1931, DOI 10.1002/anie.201005902; LEE BW, 1993, J VIROL METHODS, V45, P121, DOI 10.1016/0166-0934(93)90097-B; Liang XG, 2003, J AM CHEM SOC, V125, P16408, DOI 10.1021/ja037248j; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Palese P., 2007, FIELDS VIROLOGY, P1647; Sawada S, 2012, CURR PHARM BIOTECHNO, V13, P2642, DOI 10.2174/138920101314151120122912; Wang W, 2008, NUCLEIC ACIDS RES, V36, P4913, DOI 10.1093/nar/gkn475	16	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64017	10.1371/journal.pone.0064017	http://dx.doi.org/10.1371/journal.pone.0064017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704970	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200105
J	Morgens, DW; Lindbergh, KM; Adachi, M; Radunskaya, A; Cavalcanti, ARO				Morgens, David W.; Lindbergh, Kristen M.; Adachi, Marie; Radunskaya, Ami; Cavalcanti, Andre R. O.			Model for the Evolution of Extremely Fragmented Macronuclei in Ciliates	PLOS ONE			English	Article							LIFE-CYCLE MORPHOGENESIS; GROWTH-RATE; DNA CONTENT; STERKIELLA-HISTRIOMUSCORUM; SYNCHRONOUS SAMPLES; NUCLEAR VOLUME; CELL-VOLUME; SIZE; SEQUENCE	While all ciliates possess nuclear dimorphism, several ciliates - like those in the classes Phyllopharyngea, Spirotrichea, and Armophorea - have an extreme macronuclear organization. Their extensively fragmented macronuclei contain upwards of 20,000 chromosomes, each with upwards of thousands of copies. These features have evolved independently on multiple occasions throughout ciliate evolutionary history, and currently no models explain these structures in an evolutionary context. In this paper, we propose that competition between two forces - the limitation and avoidance of chromosomal imbalances as a ciliate undergoes successive asexual divisions, and the costs of replicating massive genomes - is sufficient to explain this particular nuclear structure. We present a simulation of ciliate cell evolution under control of these forces, allowing certain features of the population to change over time. Over a wide range of parameters, we observe the repeated emergence of this unusual genomic organization found in nature. Although much remains to be understood about the evolution of macronuclear genome organization, our results show that the proposed model is a plausible explanation for the emergence of these extremely fragmented, highly polyploid genomes.	[Morgens, David W.; Lindbergh, Kristen M.; Adachi, Marie; Cavalcanti, Andre R. O.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Morgens, David W.; Lindbergh, Kristen M.; Adachi, Marie; Radunskaya, Ami] Pomona Coll, Dept Math, Claremont, CA 91711 USA	Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Cavalcanti, ARO (corresponding author), Pomona Coll, Dept Biol, Claremont, CA 91711 USA.	aroc@pomona.edu	Cavalcanti, Andre RO/H-9777-2013	Cavalcanti, Andre RO/0000-0001-8708-6932; Radunskaya, Ami/0000-0002-2353-5046	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by a grant from the Howard Hughes Medical Institute to Pomona College. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 1997, EUR J PROTISTOL, V33, P99, DOI 10.1016/S0932-4739(97)80025-9; Adl SM, 2000, J EUKARYOT MICROBIOL, V47, P443, DOI 10.1111/j.1550-7408.2000.tb00073.x; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bell G, 1988, SEX DEATH PROTOZOA H, P102; BERGER JD, 1979, J PROTOZOOL, V26, P18, DOI 10.1111/j.1550-7408.1979.tb02725.x; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Brito PH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-354; CAVALIERSMITH T, 1978, J CELL SCI, V34, P247; Coyne RS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r100; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Coyne RS, 1996, ANNU REV GENET, V30, P557, DOI 10.1146/annurev.genet.30.1.557; DOERDER FP, 1979, J PROTOZOOL, V26, P28, DOI 10.1111/j.1550-7408.1979.tb02726.x; Duerr HP, 2004, PROTIST, V155, P45, DOI 10.1078/1434461000163; Duret L, 2008, GENOME RES, V18, P585, DOI 10.1101/gr.074534.107; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FINLAY BJ, 1977, OECOLOGIA, V30, P75, DOI 10.1007/BF00344893; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; LARSON DD, 1991, J PROTOZOOL, V38, P258, DOI 10.1111/j.1550-7408.1991.tb04439.x; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; ORIAS E, 1991, J PROTOZOOL, V38, P217, DOI 10.1111/j.1550-7408.1991.tb04431.x; PREER JR, 1979, J PROTOZOOL, V26, P14, DOI 10.1111/j.1550-7408.1979.tb02724.x; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Riley JL, 2001, MOL BIOL EVOL, V18, P1372, DOI 10.1093/oxfordjournals.molbev.a003921; SANTANGELO G, 1987, J EXP ZOOL, V243, P401, DOI 10.1002/jez.1402430306; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TAYLOR WD, 1981, AM NAT, V118, P160, DOI 10.1086/283812; TAYLOR WD, 1978, OECOLOGIA, V36, P263, DOI 10.1007/BF00348052; VANTHOF J, 1965, EXP CELL RES, V39, P48, DOI 10.1016/0014-4827(65)90006-6; VANTHOF J, 1963, P NATL ACAD SCI USA, V49, P897, DOI 10.1073/pnas.49.6.897	30	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64997	10.1371/journal.pone.0064997	http://dx.doi.org/10.1371/journal.pone.0064997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705024	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200178
J	Zhai, ZC; Yao, YC; Wang, YJ				Zhai, Zhichen; Yao, Yongchang; Wang, Yingjun			Importance of Suitable Reference Gene Selection for Quantitative RT-PCR during ATDC5 Cells Chondrocyte Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; REAL-TIME; IN-VITRO; HOUSEKEEPING GENES; CHONDROGENESIS; NORMALIZATION; EXPRESSION; CULTURE; ACTIN	Real-time quantitative reverse transcription-polymerase chain reaction (qPCR) is an efficient and accurate method to detect and compare patterns of gene expression. The reliability of qPCR is highly dependent on the selection of appropriate reference genes used for normalization. By analyzing 16 potential candidates of reference genes (GAPDH, Actb, 18 s, PGK1, Hprt, Tbp, Rpl5, B2M, Gusb, Ppia, UBC, Sdha, Eef1a1, H2afz, Tkt and Ldha) through geNorm, we identified Ppia, Tbp, Hprt and Eef1a1 as the most stable reference genes while UBC, B2M, Gusb as the least stable ones during the chondrocyte differentiation of ATDC5 cells. Considering the low expression of Eef1a1 and Tbp would cause divergent results for they failed to provide accurate normalization for RNA extraction and reverse transcription efficiency, we recommended the use of Ppia and Hprt as the most suitable genes to normalize qPCR. In addition, although GAPDH, Actb and 18 s were usually adopted in most of studies using ATDC5 cells, they were found unstable and then were not ideal reference genes for qPCR assay in ATDC5 cells chondrocyte differentiation. Also, we further confirmed that the Ppia and Hprt worked well during chondrocyte differentiation of mouse mesenchymal cells.	[Zhai, Zhichen; Yao, Yongchang; Wang, Yingjun] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhai, Zhichen; Yao, Yongchang; Wang, Yingjun] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Wang, YJ (corresponding author), S China Univ Technol, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China.	imwangyj@163.com	Yao, Yongchang/L-2916-2015	Yao, Yongchang/0000-0002-4338-2606; zhai, zhichen/0000-0002-4489-7812	National Basic Research Program of China [2012CB619100, 2011CB606204]; National Natural Science Foundation of China [51232002]; Guangdong Natural Science Foundation [S2011040000208]; Fundamental Research Funds for the Central Universities [2011ZM0010]; 111 project [B13039]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 project(Ministry of Education, China - 111 Project)	This work was financially supported by National Basic Research Program of China (Grant No. 2012CB619100 and 2011CB606204), National Natural Science Foundation of China (Grant No. 51232002), Guangdong Natural Science Foundation (Grant No. S2011040000208), the Fundamental Research Funds for the Central Universities (Grant No. 2011ZM0010) and the 111 project (B13039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Buxton AN, 2011, TISSUE ENG PT A, V17, P371, DOI [10.1089/ten.tea.2009.0839, 10.1089/ten.TEA.2009.0839]; Clavijo PE, 2012, J IMMUNOL, V188, P1213, DOI 10.4049/jimmunol.1100793; Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kwon HJ, 2010, ACTA BIOMATER, V6, P494, DOI 10.1016/j.actbio.2009.07.033; Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ren SW, 2010, MOL VIS, V16, P1076; Samadian A, 2012, CELL MOL BIOL NOIS S; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Seriwatanachai D, 2012, BIOCHEM BIOPH RES CO, V420, P108, DOI 10.1016/j.bbrc.2012.02.123; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tare B. S., 2005, EUR CELLS MATER, V10, P22; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200	33	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64786	10.1371/journal.pone.0064786	http://dx.doi.org/10.1371/journal.pone.0064786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705012	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200166
J	Bot, M; Van Veldhoven, PP; de Jager, SCA; Johnson, J; Nijstad, N; Van Santbrink, PJ; Westra, MM; Van Der Hoeven, G; Gijbels, MJ; Muller-Tidow, C; Varga, G; Tietge, UJF; Kuiper, J; Van Berkel, TJC; Nofer, JR; Bot, I; Biessen, EAL				Bot, Martine; Van Veldhoven, Paul P.; de Jager, Saskia C. A.; Johnson, Jason; Nijstad, Niels; Van Santbrink, Peter J.; Westra, Marijke M.; Van Der Hoeven, Gerd; Gijbels, Marion J.; Mueller-Tidow, Carsten; Varga, Georg; Tietge, Uwe J. F.; Kuiper, Johan; Van Berkel, Theo J. C.; Nofer, Jerzy-Roch; Bot, Ilze; Biessen, Erik A. L.			Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; SPHINGOSINE-1-PHOSPHATE ANALOG; FTY720; INHIBITION; MONOCYTES; IMMUNITY; KINASE; EXPORT; ROLES	Aims: Altered sphingosine 1-phosphate (S1P) homeostasis and signaling is implicated in various inflammatory diseases including atherosclerosis. As S1P levels are tightly controlled by S1P lyase, we investigated the impact of hematopoietic S1P lyase (Sgpl1(-/-)) deficiency on leukocyte subsets relevant to atherosclerosis. Methods and Results: LDL receptor deficient mice that were transplanted with Sgpl1(-/-) bone marrow showed disrupted S1P gradients translating into lymphopenia and abrogated lymphocyte mitogenic and cytokine response as compared to controls. Remarkably however, Sgpl1(-/-) chimeras displayed mild monocytosis, due to impeded stromal retention and myelopoiesis, and plasma cytokine and macrophage expression patterns, that were largely compatible with classical macrophage activation. Collectively these two phenotypic features of Sgpl1 deficiency culminated in diminished atherogenic response. Conclusions: Here we not only firmly establish the critical role of hematopoietic S1P lyase in controlling S1P levels and T cell trafficking in blood and lymphoid tissue, but also identify leukocyte Sgpl1 as critical factor in monocyte macrophage differentiation and function. Its, partly counterbalancing, pro-and anti-inflammatory activity spectrum imply that intervention in S1P lyase function in inflammatory disorders such as atherosclerosis should be considered with caution.	[Bot, Martine; de Jager, Saskia C. A.; Van Santbrink, Peter J.; Westra, Marijke M.; Kuiper, Johan; Van Berkel, Theo J. C.; Bot, Ilze; Biessen, Erik A. L.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Van Veldhoven, Paul P.; Van Der Hoeven, Gerd] Katholieke Univ Leuven, Dept Mol Cell Biol, LIPIT, Louvain, Belgium; [Johnson, Jason] Bristol Royal Infirm & Gen Hosp, Bristol Heart Inst, Bristol, Avon, England; [Nijstad, Niels; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands; [Gijbels, Marion J.; Biessen, Erik A. L.] Maastricht Univ, Expt Vasc Pathol Grp, Dept Pathol, Med Ctr, Maastricht, Netherlands; [Mueller-Tidow, Carsten] Univ Hosp Munster, Dept Med Hematol & Oncol, Munster, Germany; [Varga, Georg] Univ Munster, Inst Expt Dermatol, D-48149 Munster, Germany; [Nofer, Jerzy-Roch] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Nofer, Jerzy-Roch] Univ Modena & Reggio Emilia, Dept Internal Med Endocrinol & Geriatr, Modena, Italy	Leiden University; Leiden University - Excl LUMC; KU Leuven; Bristol Royal Infirmary; University of Bristol; University of Groningen; Maastricht University; University of Munster; University of Munster; University of Munster; Universita di Modena e Reggio Emilia	Bot, I (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands.	i.bot@lacdr.leidenuniv.nl	de+Jager, Saskia/AAE-1132-2022; , Van Veldhoven Paul/U-6359-2019; Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; de+Jager, Saskia/ABC-4264-2020; Johnson, Jason/AAC-3124-2019; Van Berkel, Theo/ABD-7677-2021	, Van Veldhoven Paul/0000-0002-4478-2564; Müller-Tidow, Carsten/0000-0002-7166-5232; Johnson, Jason/0000-0003-0630-9183; de Jager, Saskia/0000-0002-5233-0066; Bot, Ilze/0000-0002-1242-1959; Biessen, Erik/0000-0002-6454-8548	FWO-Vlaanderen [G.0405.02]; Netherlands Thrombosis Foundation [TSN2004.001]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0405.02, G.0581.09N]; British Heart Foundation [FS/07/053/24069]; Netherlands Organization for Scientific Research (NWO) [917-56-358, 916.86.046]; Netherlands Heart Foundation [2003T201]	FWO-Vlaanderen(FWO); Netherlands Thrombosis Foundation; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); British Heart Foundation(British Heart Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was funded by grant G.0405.02 from FWO-Vlaanderen to P. P. Van Veldhoven, grant TSN2004.001 from the Netherlands Thrombosis Foundation (M.B.), grants G.0405.02 and G.0581.09N from Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (P.P.V.V), grant FS/07/053/24069 from the British Heart Foundation (J.J.), VIDI grant 917-56-358 from the Netherlands Organization for Scientific Research (NWO) (U.J.F.T.), grant 916.86.046 from the Netherlands Organization for Scientific Research (I.B.) and grant 2003T201 from the Netherlands Heart Foundation (E.A.L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P976, DOI 10.1161/01.ATV.0000162171.30089.f6; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Fujii R, 2006, AM J PHYSIOL-GASTR L, V291, pG267, DOI 10.1152/ajpgi.00496.2005; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Gomez-Munoz A, 2003, FEBS LETT, V539, P56, DOI 10.1016/S0014-5793(03)00197-2; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Keul P, 2007, ARTERIOSCL THROM VAS, V27, P607, DOI 10.1161/01.ATV.0000254679.42583.88; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Miyamoto T, 2001, J AM COLL CARDIOL, V37, P1713, DOI 10.1016/S0735-1097(01)01204-9; Nofer JR, 2007, CIRCULATION, V115, P501, DOI 10.1161/CIRCULATIONAHA.106.641407; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Poti F, 2012, VASC PHARMACOL, V57, P56, DOI 10.1016/j.vph.2012.03.003; Poti F, 2012, THROMB HAEMOSTASIS, V107, P552, DOI 10.1160/TH11-08-0583; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; 't Hoen PAC, 2003, CIRC RES, V93, P262, DOI 10.1161/01.RES.0000082978.92494.B1; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Van Veldhoven PP, 2005, CHEM PHYS LIPIDS, V136, P164; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Yatomi Y, 2000, BLOOD, V96, P3431	41	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63360	10.1371/journal.pone.0063360	http://dx.doi.org/10.1371/journal.pone.0063360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700419	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400017
J	Dwyer, DS; Aamodt, EJ				Dwyer, Donard S.; Aamodt, Eric J.			Insulin/IGF-1 Signaling, including Class II/III PI3Ks, beta-Arrestin and SGK-1, Is Required in C. elegans to Maintain Pharyngeal Muscle Performance during Starvation	PLOS ONE			English	Article							GROWTH-FACTOR-I; POSITIVE INOTROPIC ACTION; CAENORHABDITIS-ELEGANS; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; NEURONAL EXCITABILITY; UP-REGULATION; RECEPTOR; LONGEVITY; CHANNEL	In C. elegans, pharyngeal pumping is regulated by the presence of bacteria. In response to food deprivation, the pumping rate rapidly declines by about 50-60%, but then recovers gradually to baseline levels on food after 24 hr. We used this system to study the role of insulin/IGF-1 signaling (IIS) in the recovery of pharyngeal pumping during starvation. Mutant strains with reduced function in the insulin/IGF-1 receptor, DAF-2, various insulins (INS-1 and INS-18), and molecules that regulate insulin release (UNC-64 and NCA-1; NCA-2) failed to recover normal pumping rates after food deprivation. Similarly, reduction or loss of function in downstream signaling molecules (e.g., ARR-1, AKT-1, and SGK-1) and effectors (e.g., CCA-1 and UNC-68) impaired pumping recovery. Pharmacological studies with kinase and metabolic inhibitors implicated class II/III phosphatidylinositol 3-kinases (PI3Ks) and glucose metabolism in the recovery response. Interestingly, both over-and under-activity in IIS was associated with poorer recovery kinetics. Taken together, the data suggest that optimum levels of IIS are required to maintain high levels of pharyngeal pumping during starvation. This work may ultimately provide insights into the connections between IIS, nutritional status and sarcopenia, a hallmark feature of aging in muscle.	[Dwyer, Donard S.] LSU Hlth Sci Ctr, Dept Pharmacol & Psychiat, Shreveport, LA USA; [Dwyer, Donard S.] LSU Hlth Sci Ctr, Dept Toxicol, Shreveport, LA USA; [Dwyer, Donard S.] LSU Hlth Sci Ctr, Dept Neurosci, Shreveport, LA USA; [Aamodt, Eric J.] LSU Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Dwyer, DS (corresponding author), LSU Hlth Sci Ctr, Dept Pharmacol & Psychiat, Shreveport, LA USA.	ddwyer@lsuhsc.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank the C. Elegans Gene Knockout Consortium for producing the RB1494 strain by our request, and acknowledge their provision of other ok strains for these studies via the CGC. Dr. Mei Zhen (U. Toronto) graciously provided the nca-1; nca-2 strain for this work.	Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Babar P, 1999, NEUROBIOL AGING, V20, P513, DOI 10.1016/S0197-4580(99)00094-9; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bidasse KR, 2001, MOL PHARMACOL, V60, P1356, DOI 10.1124/mol.60.6.1356; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Bouhours M, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-16; BRENNER S, 1974, GENETICS, V77, P71; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Castino R, 2008, J NEUROENDOCRINOL, V20, P1165, DOI 10.1111/j.1365-2826.2008.01769.x; Ceda G P, 2005, J Endocrinol Invest, V28, P96; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Delbono O, 2002, BIOGERONTOLOGY, V3, P265, DOI 10.1023/A:1020189627325; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Donohoe DR, 2009, NEUROSCI RES, V64, P280, DOI 10.1016/j.neures.2009.03.012; Dwyer DS, 2011, MOL PSYCHIATR, V16, P595, DOI 10.1038/mp.2010.95; DWYER DS, 2009, SOC NEUR ABSTR ONL; Espinosa A, 2004, J ENDOCRINOL, V182, P339, DOI 10.1677/joe.0.1820339; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gems D, 1998, GENETICS, V150, P129; Guillet C, 2005, DIABETES METAB, V31, pS20, DOI 10.1016/S1262-3636(05)73648-X; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; Hameed M, 2002, EXERC SPORT SCI REV, V30, P15, DOI 10.1097/00003677-200201000-00004; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holzenberger M, 2004, EUR J ENDOCRINOL, V151, pS23, DOI 10.1530/eje.0.151S023; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Jeyaraj S, 2007, BIOCHEM BIOPH RES CO, V356, P629, DOI 10.1016/j.bbrc.2007.03.029; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim JS, 2010, J NUTR BIOCHEM, V21, P1, DOI 10.1016/j.jnutbio.2009.06.014; Kim SJ, 2008, AM J PHYSIOL-HEART C, V295, pH130, DOI 10.1152/ajpheart.00298.2008; KIMURA KD, 2011, COLD SPRING HARB SYM, V76, P1; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Kostek MC, 2005, J APPL PHYSIOL, V98, P2147, DOI 10.1152/japplphysiol.00817.2004; LARSEN PL, 1995, GENETICS, V139, P1567; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee YR, 2005, LEUKEMIA RES, V29, P401, DOI 10.1016/j.leukres.2004.09.010; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Li Q, 2007, AGING CELL, V6, P799, DOI 10.1111/j.1474-9726.2007.00343.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; LUCCHESI BR, 1972, EUR J PHARMACOL, V18, P107, DOI 10.1016/0014-2999(72)90137-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maryon EB, 1998, J CELL SCI, V111, P2885; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Renganathan M, 1998, J BIOL CHEM, V273, P28845, DOI 10.1074/jbc.273.44.28845; RIEKER RP, 1975, YALE J BIOL MED, V48, P353; RYALL JG, 2008, PHARMACOL THERAPEUT, V120, P218; SAWADA M, 1975, ANN NY ACAD SCI, V243, P337, DOI 10.1111/j.1749-6632.1975.tb25375.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Scicchitano BM, 2009, AGING-US, V1, P451, DOI 10.18632/aging.100050; Soos MA, 2001, ARCH BIOCHEM BIOPHYS, V396, P244, DOI 10.1006/abbi.2001.2587; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; Szewczyk NJ, 2007, EMBO J, V26, P935, DOI 10.1038/sj.emboj.7601540; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; VANOBBERGHEN E, 1979, BIOCHIM BIOPHYS ACTA, V582, P486, DOI 10.1016/0304-4165(79)90139-9; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300; Wang XM, 2010, BIOCHEM BIOPH RES CO, V400, P613, DOI 10.1016/j.bbrc.2010.08.113; Weeks KR, 2011, J NEUROSCI RES, V89, P1658, DOI 10.1002/jnr.22705; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055	91	13	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63851	10.1371/journal.pone.0063851	http://dx.doi.org/10.1371/journal.pone.0063851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700438	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400035
J	Brager, AJ; Ehlen, JC; Castanon-Cervantes, O; Natarajan, D; Delisser, P; Davidson, AJ; Paul, KN				Brager, Allison J.; Ehlen, J. Christopher; Castanon-Cervantes, Oscar; Natarajan, Divya; Delisser, Patrick; Davidson, Alec J.; Paul, Ketema N.			Sleep Loss and the Inflammatory Response in Mice Under Chronic Environmental Circadian Disruption	PLOS ONE			English	Article							C-FOS EXPRESSION; HOMEOSTATIC REGULATION; SHIFT WORK; RAT-BRAIN; DEPRIVATION; RHYTHMS; TEMPERATURE; DESYNCHRONIZATION; MELATONIN; DISORDER	Shift work and trans-time zone travel lead to insufficient sleep and numerous pathologies. Here, we examined sleep/wake dynamics during chronic exposure to environmental circadian disruption (ECD), and if chronic partial sleep loss associated with ECD influences the induction of shift-related inflammatory disorder. Sleep and wakefulness were telemetrically recorded across three months of ECD, in which the dark-phase of a light-dark cycle was advanced weekly by 6 h. A three month regimen of ECD caused a temporary reorganization of sleep (NREM and REM) and wake processes across each week, resulting in an approximately 10% net loss of sleep each week relative to baseline levels. A separate group of mice were subjected to ECD or a regimen of imposed wakefulness (IW) aimed to mimic sleep amounts under ECD for one month. Fosimmunoreactivity (IR) was quantified in sleep-wake regulatory areas: the nucleus accumbens (NAc), basal forebrain (BF), and medial preoptic area (MnPO). To assess the inflammatory response, trunk blood was treated with lipopolysaccharide (LPS) and subsequent release of IL-6 was measured. Fos-IR was greatest in the NAc, BF, and MnPO of mice subjected to IW. The inflammatory response to LPS was elevated in mice subjected to ECD, but not mice subjected to IW. Thus, the net sleep loss that occurs under ECD is not associated with a pathological immune response.	[Brager, Allison J.; Ehlen, J. Christopher; Castanon-Cervantes, Oscar; Natarajan, Divya; Delisser, Patrick; Davidson, Alec J.; Paul, Ketema N.] Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Paul, KN (corresponding author), Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA.	kpaul@msm.edu	Ehlen, Christopher/GXV-9278-2022	Ehlen, J. Christopher/0000-0003-3223-9262	 [NS060659];  [NS078410]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS060659, R01NS078410] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors received funding from NS060659 and NS078410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann K, 2012, SLEEP, V35, P933, DOI 10.5665/sleep.1954; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Casiraghi LP, 2012, J BIOL RHYTHM, V27, P59, DOI 10.1177/0748730411429447; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Chapdelaine S, 2012, J SLEEP RES, V21, P380, DOI 10.1111/j.1365-2869.2012.00998.x; CIRELLI C, 1995, J SLEEP RES, V4, P92, DOI 10.1111/j.1365-2869.1995.tb00157.x; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; Deboer T, 2007, EUR J NEUROSCI, V26, P3518, DOI 10.1111/j.1460-9568.2007.05964.x; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Faraut B, 2012, SLEEP MED REV, V16, P137, DOI 10.1016/j.smrv.2011.05.001; Greco MA, 2000, NEUROREPORT, V11, P437, DOI 10.1097/00001756-200002280-00002; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Gvilia I, 2006, J NEUROSCI, V26, P9426, DOI 10.1523/JNEUROSCI.2012-06.2006; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Logan RW, 2012, J IMMUNOL, V188, P2583, DOI 10.4049/jimmunol.1102715; Majde JA, 2005, J ALLERGY CLIN IMMUN, V116, P1188, DOI 10.1016/j.jaci.2005.08.005; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Postnova S, 2012, J BIOL RHYTHM, V27, P91, DOI 10.1177/0748730411419934; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Sack RL, 2007, SLEEP, V30, P1484, DOI 10.1093/sleep/30.11.1484; Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012; Semba K, 2001, BEHAV BRAIN RES, V120, P75, DOI 10.1016/S0166-4328(00)00362-4; Wisor JP, 2011, SLEEP, V34, P1335, DOI 10.5665/SLEEP.1274; Wisor JP, 2011, SLEEP, V34, P261, DOI 10.1093/sleep/34.3.261; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yan L, 2011, NEUROSCIENCE, V183, P99, DOI 10.1016/j.neuroscience.2011.03.041	28	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63752	10.1371/journal.pone.0063752	http://dx.doi.org/10.1371/journal.pone.0063752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696854	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900057
J	Nishimura, K; Oki, T; Kitaura, J; Kuninaka, S; Saya, H; Sakaue-Sawano, A; Miyawaki, A; Kitamura, T				Nishimura, Koutarou; Oki, Toshihiko; Kitaura, Jiro; Kuninaka, Shinji; Saya, Hideyuki; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Kitamura, Toshio			APC(CDH1) Targets MgcRacGAP for Destruction in the Late M Phase	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; STAT TRANSCRIPTION FACTORS; CELL-CYCLE; MITOTIC SPINDLE; RHO FAMILY; HEMATOPOIETIC-CELLS; GAP ACTIVITY; AURORA-B; CYTOKINESIS	Background: Male germ cell RacGTPase activating protein (MgcRacGAP) is an important regulator of the Rho family GTPases - RhoA, Rac1, and Cdc42 - and is indispensable in cytokinesis and cell cycle progression. Inactivation of RhoA by phosphorylated MgcRacGAP is an essential step in cytokinesis. MgcRacGAP is also involved in G1-S transition and nuclear transport of signal transducer and activator of transcription 3/5 (STAT3/5). Expression of MgcRacGAP is strictly controlled in a cell cycle-dependent manner. However, the underlying mechanisms have not been elucidated. Methodology/Principal Findings: Using MgcRacGAP deletion mutants and the fusion proteins of full-length or partial fragments of MgcRacGAP to mVenus fluorescent protein, we demonstrated that MgcRacGAP is degraded by the ubiquitin-proteasome pathway in the late M to G1 phase via APC(CDH1). We also identified the critical region for destruction located in the C-terminus of MgcRacGAP, AA537-570, which is necessary and sufficient for CDH1-mediated MgcRacGAP destruction. In addition, we identified a PEST domain-like structure with charged residues in MgcRacGAP and implicate it in effective ubiquitination of MgcRacGAP. Conclusions/Significance: Our findings not only reveal a novel mechanism for controlling the expression level of MgcRacGAP but also identify a new target of APC(CDH1). Moreover our results identify a C-terminal region AA537-570 of MgcRacGAP as its degron.	[Nishimura, Koutarou; Oki, Toshihiko; Kitaura, Jiro; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo, Japan; [Oki, Toshihiko; Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Stem Cell Signaling, Minato Ku, Tokyo, Japan; [Kuninaka, Shinji; Saya, Hideyuki] Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res,Shinjuku Ku, Tokyo, Japan; [Kuninaka, Shinji] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Lab Cell Funct & Dynam, Adv Technol Dev Grp, Brain Sci Inst, Wako, Saitama, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] JST, ERATO, Wako, Saitama, Japan	University of Tokyo; University of Tokyo; Keio University; Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST)	Kitamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo, Japan.	kitamura@ims.u-tokyo.ac.jp	Kuninaka, Shinji/J-7158-2013; Saya, Hideyuki/J-4325-2013; Miyawaki, Atsushi/K-3569-2014; Kitamura, Toshio/AAA-2071-2021	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390; Saya, Hideyuki/0000-0001-6610-1902	MEXT, Japan [22118002, 23591370]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (Grant number 22118002) and Grant-in-Aid Scientific Research (C) (Grant number 23591370), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG XL, 2004, SCI STKE, pE31; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; D'Avino PP, 2009, NAT CELL BIOL, V11, P112, DOI 10.1038/ncb0209-112; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Glotzer M, 2009, CURR BIOL, V19, pR162, DOI 10.1016/j.cub.2008.12.028; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kawashima T, 2000, BLOOD, V96, P2116; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; Kitamura T, 2001, CELL STRUCT FUNCT, V26, P645, DOI 10.1247/csf.26.645; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lee JS, 2004, EXP CELL RES, V293, P275, DOI 10.1016/j.yexcr.2003.10.015; Lekomtsev S, 2012, NATURE, V492, P276, DOI 10.1038/nature11773; Liot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023676; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2003, CURR BIOL, V13, pR589, DOI 10.1016/S0960-9822(03)00521-9; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Naoe H, 2010, MOL CELL BIOL, V30, P3994, DOI 10.1128/MCB.01358-09; Oceguera-Yanez F, 2005, J CELL BIOL, V168, P221, DOI 10.1083/jcb.200408085; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Qiao XX, 2010, CELL CYCLE, V9, P3904, DOI 10.4161/cc.9.19.13585; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2008, CHEM BIOL, V15, P1243, DOI 10.1016/j.chembiol.2008.10.015; Seguin L, 2009, MOL CELL BIOL, V29, P570, DOI 10.1128/MCB.01275-08; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Tonozuka Y, 2004, BLOOD, V104, P3550, DOI 10.1182/blood-2004-03-1066; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; Van de Putte T, 2001, MECH DEVELOP, V102, P33, DOI 10.1016/S0925-4773(01)00279-9; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Yamada T, 2008, BIOCHEM BIOPH RES CO, V372, P941, DOI 10.1016/j.bbrc.2008.05.170; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	48	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63001	10.1371/journal.pone.0063001	http://dx.doi.org/10.1371/journal.pone.0063001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696789	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900006
J	Pittet, JF; Koh, H; Fang, XH; Iles, K; Christiaans, S; Anjun, N; Wagener, BM; Park, DW; Zmijewski, JW; Matthay, MA; Roux, J				Pittet, Jean-Francois; Koh, Hidefumi; Fang, Xiaohui; Iles, Karen; Christiaans, Sarah; Anjun, Naseem; Wagener, Brant M.; Park, Dae Won; Zmijewski, Jaroslaw W.; Matthay, Michael A.; Roux, Jeremie			HMGB1 Accelerates Alveolar Epithelial Repair via an IL-1 beta- and alpha v beta 6 Integrin-dependent Activation of TGF-beta 1	PLOS ONE			English	Article							ACUTE LUNG INJURY; MOBILITY GROUP BOX-1; TGF-BETA ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; IN-VITRO; WOUND REPAIR; PULMONARY-FIBROSIS; TYPE-2 CELLS; II CELLS; PROTEIN	High mobility group box 1 (HMGB1) protein is a danger-signaling molecule, known to activate an inflammatory response via TLR4 and RAGE. HMGB1 can be either actively secreted or passively released from damaged alveolar epithelial cells. Previous studies have shown that IL-1 beta, a critical mediator acute lung injury in humans that is activated by HMGB1, enhances alveolar epithelial repair, although the mechanisms are not fully understood. Herein, we tested the hypothesis that HMGB1 released by wounded alveolar epithelial cells would increase primary rat and human alveolar type II cell monolayer wound repair via an IL-1 beta-dependent activation of TGF-beta 1. HMGB1 induced in primary cultures of rat alveolar epithelial cells results in the release of IL-1 beta that caused the activation of TGF-beta 1 via a p38 MAPK-, RhoA- and alpha v beta 6 integrin-dependent mechanism. Furthermore, active TGF-beta 1 accelerated the wound closure of primary rat epithelial cell monolayers via a PI3 kinase alpha-dependent mechanism. In conclusion, this study demonstrates that HMGB1 released by wounded epithelial cell monolayers, accelerates wound closure in the distal lung epithelium via the IL-1 beta-mediated alpha v beta 6-dependent activation of TGF-beta 1, and thus could play an important role in the resolution of acute lung injury by promoting repair of the injured alveolar epithelium.	[Pittet, Jean-Francois; Iles, Karen; Christiaans, Sarah; Anjun, Naseem; Wagener, Brant M.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Koh, Hidefumi] Keio Univ, Sch Med, Div Pulm Med, Tokyo, Japan; [Iles, Karen] Univ Alabama Birmingham, Birmingham, AL USA; [Park, Dae Won; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Park, Dae Won] Korea Univ, Ansan Hosp, Div Infect Dis, Ansan, South Korea; [Fang, Xiaohui; Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Fang, Xiaohui; Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Roux, Jeremie] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; Keio University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School	Roux, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	Jeremie_Roux@hms.harvard.edu	Wagener, Brant/AAI-7480-2020; Ha, C/GZL-9046-2022; Kim, Il/L-6481-2019; Roux, Jeremie/A-9746-2013	Roux, Jeremie/0000-0001-5712-8660; Park, Dae Won/0000-0002-7653-686X	National Institutes of Health (NIH) [P50HL074005, HL-51854, HL-51856, T32 GM008440]; ALA Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107585, R01HL051854, R37HL051856, P50HL074005, R01HL051856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086416, T32GM008440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALA Senior Research Training Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily supported by National Institutes of Health (NIH) grants P50HL074005, Project 4 (JFP), HL-51854 and HL-51856 (MAM), T32 GM008440 and ALA Senior Research Training Fellowship (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Bitto A, 2010, PHARMACOL RES, V61, P116, DOI 10.1016/j.phrs.2009.07.014; Buckley S, 2008, AM J PHYSIOL-LUNG C, V294, pL739, DOI 10.1152/ajplung.00294.2007; Buckley S, 2011, AM J RESP CELL MOL, V45, P1212, DOI 10.1165/rcmb.2010-0325OC; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Geiser T, 2001, AM J RESP CRIT CARE, V163, P1384, DOI 10.1164/ajrccm.163.6.2006131; Geiser T, 2000, AM J PHYSIOL-LUNG C, V279, pL1184, DOI 10.1152/ajplung.2000.279.6.L1184; Howell DCJ, 2005, AM J PATHOL, V166, P1353, DOI 10.1016/S0002-9440(10)62354-1; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Neurohr C, 2006, AM J RESP CELL MOL, V35, P252, DOI 10.1165/rcmb.2006-0013OC; Ogawa EN, 2006, AM J RESP CRIT CARE, V174, P400, DOI 10.1164/rccm.200605-699OC; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Pankow S, 2006, J CELL SCI, V119, P4033, DOI 10.1242/jcs.03175; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pugin J, 1996, AM J RESP CRIT CARE, V153, P1850, DOI 10.1164/ajrccm.153.6.8665045; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Ranzato E, 2009, MOL CELL BIOCHEM, V332, P199, DOI 10.1007/s11010-009-0192-4; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; TIBALLI RN, 1995, J CLIN MICROBIOL, V33, P915, DOI 10.1128/JCM.33.4.915-917.1995; van Zoelen MAD, 2007, CRIT CARE MED, V35, P2799, DOI 10.1097/01.CCM.0000287588.69000.97; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2002, LANCET, V360, P619, DOI 10.1016/S0140-6736(02)09774-X; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Whitsett JA, 2011, J CLIN INVEST, V121, P2543, DOI 10.1172/JCI58704; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902	56	39	40	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63907	10.1371/journal.pone.0063907	http://dx.doi.org/10.1371/journal.pone.0063907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696858	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900062
J	van den Berg, SW; van der A, DL; Spijkerman, AMW; van Woudenbergh, GJ; Tijhuis, MJ; Amiano, P; Ardanaz, E; Beulens, JWJ; Boeing, H; Clavel-Chapelon, F; Crowe, FL; de Lauzon-Guillain, B; Fagherazzi, G; Franks, PW; Freisling, H; Gonzalez, C; Grioni, S; Halkjaer, J; Huerta, JM; Huybrechts, I; Kaaks, R; Khaw, KT; Masala, G; Nilsson, PM; Overvad, K; Panico, S; Quiros, JR; Rolandsson, O; Sacerdote, C; Sanchez, MJ; Schulze, MB; Slimani, N; Struijk, EA; Tjonneland, A; Tumino, R; Sharp, SJ; Langenberg, C; Forouhi, NG; Feskens, EJM; Riboli, E; Wareham, NJ				van den Berg, Saskia W.; van der A, Daphne L.; Spijkerman, Annemieke M. W.; van Woudenbergh, Geertruida J.; Tijhuis, Mariken J.; Amiano, Pilar; Ardanaz, Eva; Beulens, Joline W. J.; Boeing, Heiner; Clavel-Chapelon, Francoise; Crowe, Francesca L.; de Lauzon-Guillain, Blandine; Fagherazzi, Guy; Franks, Paul W.; Freisling, Heinz; Gonzalez, Carlos; Grioni, Sara; Halkjaer, Jytte; Maria Huerta, Jose; Huybrechts, Inge; Kaaks, Rudolf; Khaw, Kay Tee; Masala, Giovanna; Nilsson, Peter M.; Overvad, Kim; Panico, Salvatore; Ramon Quiros, J.; Rolandsson, Olov; Sacerdote, Carlotta; Sanchez, Maria-Jose; Schulze, Matthias B.; Slimani, Nadia; Struijk, Ellen A.; Tjonneland, Anne; Tumino, Rosario; Sharp, Stephen J.; Langenberg, Claudia; Forouhi, Nita G.; Feskens, Edith J. M.; Riboli, Elio; Wareham, Nicholas J.		InterAct Consortium	The Association between Dietary Energy Density and Type 2 Diabetes in Europe: Results from the EPIC-InterAct Study	PLOS ONE			English	Article							LIFE-STYLE; METABOLIC SYNDROME; GLYCEMIC LOAD; WEIGHT CHANGE; RISK; MELLITUS; CANCER; ADULTS; PREDICTS; INDEX	Background: Observational studies implicate higher dietary energy density (DED) as a potential risk factor for weight gain and obesity. It has been hypothesized that DED may also be associated with risk of type 2 diabetes (T2D), but limited evidence exists. Therefore, we investigated the association between DED and risk of T2D in a large prospective study with heterogeneity of dietary intake. Methodology/Principal Findings: A case-cohort study was nested within the European Prospective Investigation into Cancer (EPIC) study of 340,234 participants contributing 3.99 million person years of follow-up, identifying 12,403 incident diabetes cases and a random subcohort of 16,835 individuals from 8 European countries. DED was calculated as energy (kcal) from foods (except beverages) divided by the weight (gram) of foods estimated from dietary questionnaires. Prentice-weighted Cox proportional hazard regression models were fitted by country. Risk estimates were pooled by random effects meta-analysis and heterogeneity was evaluated. Estimated mean (sd) DED was 1.5 (0.3) kcal/g among cases and subcohort members, varying across countries (range 1.4-1.7 kcal/g). After adjustment for age, sex, smoking, physical activity, alcohol intake, energy intake from beverages and misreporting of dietary intake, no association was observed between DED and T2D (HR 1.02 (95% CI: 0.93-1.13), which was consistent across countries (l(2) = 2.9%). Conclusions/Significance: In this large European case-cohort study no association between DED of solid and semi-solid foods and risk of T2D was observed. However, despite the fact that there currently is no conclusive evidence for an association between DED and T2DM risk, choosing low energy dense foods should be promoted as they support current WHO recommendations to prevent chronic diseases.	[van den Berg, Saskia W.; van der A, Daphne L.; Spijkerman, Annemieke M. W.; Tijhuis, Mariken J.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [van Woudenbergh, Geertruida J.; Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Sect Nutr & Epidemiol, NL-6700 AP Wageningen, Netherlands; [Amiano, Pilar] Basque Govt, Inst BIO Donostia, Donostia San Sebastian, Spain; [Amiano, Pilar; Ardanaz, Eva; Maria Huerta, Jose; Sanchez, Maria-Jose] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Amiano, Pilar] Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst ISPN, Pamplona, Spain; [Beulens, Joline W. J.; Struijk, Ellen A.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Clavel-Chapelon, Francoise; de Lauzon-Guillain, Blandine; Fagherazzi, Guy] INSERM, Villejuif, France; [Clavel-Chapelon, Francoise; de Lauzon-Guillain, Blandine; Fagherazzi, Guy] Ctr Res Epidemiol & Populat Hlth CESP, Villejuif, France; [Clavel-Chapelon, Francoise; de Lauzon-Guillain, Blandine; Fagherazzi, Guy] Univ Paris Sud, Villejuif, France; [Crowe, Francesca L.] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Franks, Paul W.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Freisling, Heinz; Huybrechts, Inge] Int Agcy Res Canc, F-69372 Lyon, France; [Gonzalez, Carlos] Catalan Inst Oncol, Dept Epidemiol, Unit Nutr Environm & Canc, Barcelona, Spain; [Grioni, Sara] Nutr Epidemiol Unit, Milan, Italy; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Maria Huerta, Jose] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Khaw, Kay Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Masala, Giovanna] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Nilsson, Peter M.] Lund Univ, Univ Hosp Scania, Dept Clin Sci Med, Malmo, Sweden; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Ramon Quiros, J.] Asturias Hlth & Hlth Care Council, Oviedo, Spain; [Sacerdote, Carlotta] Human Genet Fdn HuGeF, Turin, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent, Turin, Italy; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Schulze, Matthias B.] German Inst Human Nutr, Dept Mol Epidemiol, Potsdam, Germany; [Slimani, Nadia] Int Agcy Res Canc, Dietary Exposure Assessment Grp DEX, F-69372 Lyon, France; [Tumino, Rosario] Canc Registry & Histopathol Unit, Ragusa, Italy; [Tumino, Rosario] Aire Onlus, Ragusa, Spain; [Sharp, Stephen J.; Langenberg, Claudia; Forouhi, Nita G.; Wareham, Nicholas J.] MRC Epidemiol Unit, Cambridge, England; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Basque Government; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Utrecht University; Utrecht University Medical Center; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; Lund University; Skane University Hospital; Umea University; World Health Organization; International Agency for Research on Cancer (IARC); Catalan Institute of Oncology; Danish Cancer Society; Murcia Regional Health Council; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; Lund University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Naples Federico II; Escuela Andaluza de Salud Publica; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London	van den Berg, SW (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	saskia.van.den.berg@rivm.nl	Fagherazzi, Guy/ABB-2555-2020; de Lauzon-Guillain, Blandine/P-4659-2016; Franks, Paul/AAA-3300-2020; Feskens, Edith/ABI-1446-2020; Sánchez, Maria-José/D-1087-2011; Grioni, Sara/K-5320-2016; Schulze, Matthias B/AAH-6906-2021; Masala, Giovanna/AAC-5474-2022; Clavel-Chapelon, Francoise/G-6733-2014; Khaw, Kay-Tee/AAZ-3209-2021; Huerta, José María/N-8654-2015; Langenberg, Claudia/ABG-9067-2021; Fagherazzi, Guy/P-3534-2017	Fagherazzi, Guy/0000-0001-5033-5966; de Lauzon-Guillain, Blandine/0000-0001-5887-8842; Feskens, Edith/0000-0001-5819-2488; Sánchez, Maria-José/0000-0003-4817-0757; Grioni, Sara/0000-0002-5891-8426; Schulze, Matthias B/0000-0002-0830-5277; Masala, Giovanna/0000-0002-5758-9069; Huerta, José María/0000-0002-9637-3869; Langenberg, Claudia/0000-0002-5017-7344; Fagherazzi, Guy/0000-0001-5033-5966; Panico, Salvatore/0000-0002-5498-8312; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921; Beulens, Joline/0000-0002-4181-0937; Franks, Paul/0000-0002-0520-7604; Struijk, Ellen/0000-0002-9302-9616; Crowe, Francesca/0000-0003-4026-1726; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Forouhi, Nita/0000-0002-5041-248X; Freisling, Heinz/0000-0001-8648-4998	European Union [LSHM-CT-2006-037197]; NL Agency [IGE05012]; Board of the UMC Utrecht; Imperial College Biomedical Research Centre; Medical Research Council [G1000143, MC_UP_A100_1003, G0401527, MC_UU_12015/1] Funding Source: researchfish; MRC [MC_UP_A100_1003, MC_UU_12015/1] Funding Source: UKRI	European Union(European Commission); NL Agency; Board of the UMC Utrecht; Imperial College Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The EPIC-InterAct Study received funding from the European Union (Integrated project LSHM-CT-2006-037197 in the Framework Programme 6 of the European Community). DLvdA: Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands; AMWS: Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands; EA: Health Research Fund (FIS) of the Spanish Ministry of Health; Navarre Regional Government and CIBER Epidemiologia y Salud Publica (CIBERESP).; JWJB: Verification of diabetes cases in EPIC-NL was additionally funded by NL Agency grant IGE05012 and an Incentive Grant from the Board of the UMC Utrecht.; FLC: Cancer Research UK; PWF: Swedish Research Council, Novo Nordisk, Swedish Diabetes Association, Swedish Heart-Lung Foundation; JH: Danish Cancer Society; JMH: Health Research Fund of the Spanish Ministry of Health; Murcia Regional Government (Nu 6236); RK: German Cancer Aid, German Ministry of Research (BMBF); KTK: Medical Research Council UK, Cancer Research UK; PN: Swedish Research Council; KO: Danish Cancer Society; SP: Compagnia di San Paolo; JRQ: Asturias Regional Government; OR: The Vasterboten County Council; AT: Danish Cancer Society; RT: AIRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian Regional Government; ER: ER was supported in this work by the Imperial College Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080; Bedard D, 2004, PUBLIC HEALTH NUTR, V7, P675, DOI 10.1079/PHN2003578; Bes-Rastrollo M, 2008, AM J CLIN NUTR, V88, P769, DOI 10.1093/ajcn/88.3.769; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bollen CW, 2006, ARCH DIS CHILD-FETAL, V91, pF233; Du HD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005339; Esmaillzadeh A, 2011, EUR J CLIN NUTR, V65, P598, DOI 10.1038/ejcn.2010.284; Freisling H, 2012, BRIT J NUTR, V107, P910, DOI 10.1017/S0007114511003564; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kien CL, 2004, AM J CLIN NUTR, V80, P876, DOI 10.1093/ajcn/80.4.876; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; Ledikwe JH, 2006, J AM DIET ASSOC, V106, P1172, DOI 10.1016/j.jada.2006.05.013; Ledikwe JH, 2006, AM J CLIN NUTR, V83, P1362, DOI 10.1093/ajcn/83.6.1362; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; Lissner L, 2000, BRIT J NUTR, V83, pS21; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; McCrory MA, 2006, PHYSIOL BEHAV, V87, P451, DOI 10.1016/j.physbeh.2004.10.025; Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; Prentice AM, 1996, INT J OBESITY, V20, pS18; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rolls BJ, 2005, J AM DIET ASSOC, V105, pS98, DOI 10.1016/j.jada.2005.02.033; Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Savage JS, 2008, AM J CLIN NUTR, V88, P677, DOI 10.1093/ajcn/88.3.677; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Wang J, 2008, DIABETES CARE, V31, P2120, DOI 10.2337/dc08-1085; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WHO, 2003, WHO TECHN REP SER, V916, P54; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e59947	10.1371/journal.pone.0059947	http://dx.doi.org/10.1371/journal.pone.0059947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696784	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900001
J	Comstock, CES; Augello, MA; Goodwin, JF; de Leeuw, R; Schiewer, MJ; Ostrander, WF; Burkhart, RA; McClendon, AK; McCue, PA; Trabulsi, EJ; Lallas, CD; Gomella, LG; Centenera, MM; Brody, JR; Butler, LM; Tilley, WD; Knudsen, KE				Comstock, C. E. S.; Augello, M. A.; Goodwin, J. F.; de Leeuw, R.; Schiewer, M. J.; Ostrander, W. F., Jr.; Burkhart, R. A.; McClendon, A. K.; McCue, P. A.; Trabulsi, E. J.; Lallas, C. D.; Gomella, L. G.; Centenera, M. M.; Brody, J. R.; Butler, L. M.; Tilley, W. D.; Knudsen, K. E.			Targeting cell cycle and hormone receptor pathways in cancer	ONCOGENE			English	Article						PD-0332991; cyclin-dependent kinase; retinoblastoma protein; prostate cancer; tumor explants	DEPENDENT KINASE INHIBITOR; ANDROGEN RECEPTOR; CRYSTAL-STRUCTURE; PHASE-I; CDK4/6 INHIBITION; PD 0332991; PHARMACOLOGICAL INHIBITION; ANTITUMOR-ACTIVITY; DNA-REPAIR; FLAVOPIRIDOL	The cyclin/cyclin-dependent kinase (CDK)/retinoblastoma (RB)-axis is a critical modulator of cell cycle entry and is aberrant in many human cancers. New nodes of therapeutic intervention are needed that can delay or combat the onset of malignancies. The antitumor properties and mechanistic functions of PD-0332991 (PD; a potent and selective CDK4/6 inhibitor) were investigated using human prostate cancer (PCa) models and primary tumors. PD significantly impaired the capacity of PCa cells to proliferate by promoting a robust G(1)-arrest. Accordingly, key regulators of the G(1)-S cell cycle transition were modulated including G1 cyclins D, E and A. Subsequent investigation demonstrated the ability of PD to function in the presence of existing hormone-based regimens and to cooperate with ionizing radiation to further suppress cellular growth. Importantly, it was determined that PD is a critical mediator of PD action. The anti-proliferative impact of CDK4/6 inhibition was revealed through reduced proliferation and delayed growth using PCa cell xenografts. Finally, first-in-field effects of PD on proliferation were observed in primary human prostatectomy tumor tissue explants. This study shows that selective CDK4/6 inhibition, using PD either as a single-agent or in combination, hinders key proliferative pathways necessary for disease progression and that RB status is a critical prognostic determinant for therapeutic efficacy. Combined, these pre-clinical findings identify selective targeting of CDK4/6 as a bona fide therapeutic target in both early stage and advanced PCa and underscore the benefit of personalized medicine to enhance treatment response.	[Comstock, C. E. S.; Augello, M. A.; Goodwin, J. F.; de Leeuw, R.; Schiewer, M. J.; Ostrander, W. F., Jr.; McClendon, A. K.; McCue, P. A.; Gomella, L. G.; Knudsen, K. E.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Burkhart, R. A.; Brody, J. R.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [McCue, P. A.] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Trabulsi, E. J.; Lallas, C. D.; Gomella, L. G.; Knudsen, K. E.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Centenera, M. M.; Butler, L. M.] Univ Adelaide, Dame Roma Mitchell Canc Res Lab, Sch Med, Hanson Inst, Adelaide, SA, Australia; [Tilley, W. D.; Knudsen, K. E.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Hanson Institute; University of Adelaide; Jefferson University	Knudsen, KE (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 South 10th St,BLSB 1008A, Philadelphia, PA 19107 USA.	karen.knudsen@jefferson.edu	Butler, Lisa M/C-9843-2010; Butler, Lisa/AAP-9088-2020; Comstock, Clay/B-6122-2008	Butler, Lisa/0000-0003-2698-3220; Schiewer, Matthew/0000-0002-2325-4228; centenera, margaret/0000-0002-2206-0632; Knudsen, Karen/0000-0002-1301-890X; de Leeuw, Renee/0000-0002-5550-7613; Comstock, Clay/0000-0001-5867-1489; Tilley, Wayne/0000-0003-1893-2626	National Institutes of Health [CA099996, CA159945]; Department of Defense New Investigator Award [PC094507]; Department of Defense Predoctoral Fellowships [PC094596, PC094195]; National Health and Medical Research Council (NHMRC) of Australia [627185]; Cancer Council of South Australia Senior research Fellowship; Prostate Cancer Foundation of Australia; Enabling Grant from the NHMRC; NATIONAL CANCER INSTITUTE [R01CA159945, R01CA099996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense New Investigator Award(United States Department of Defense); Department of Defense Predoctoral Fellowships(United States Department of Defense); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of South Australia Senior research Fellowship(Cancer Council South Australia); Prostate Cancer Foundation of Australia; Enabling Grant from the NHMRC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the KEK laboratory for ongoing scientific discussions and Dr Tanmayi Mankame for critical reading of the manuscript. We thank Dr Wen-Shuz Yeow (currently at TheGreenCell; Washington, DC) for assistance with the growth and maintenance of the CRPC cell lines. We especially thank Magdalena Potoczek for assistance regarding RB staining. This work was supported, in whole or in part, by: National Institutes of Health Grants: CA099996 and CA159945 (to KEK); Department of Defense New Investigator Award PC094507 (to CESC); and Department of Defense Predoctoral Fellowships: PC094596 (to MAA) and PC094195 (to MJS); National Health and Medical Research Council (NHMRC) of Australia (627185; to WDT and LMB), a Cancer Council of South Australia Senior research Fellowship (to LMB), and an infrastructure grant from the Prostate Cancer Foundation of Australia and an Enabling Grant from the NHMRC (to WDT).	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Aparicio A, 2011, NAT REV UROL, V8, P562, DOI 10.1038/nrurol.2011.107; Baughn LB, 2006, CANCER RES, V66, P7661, DOI 10.1158/0008-5472.CAN-06-1098; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Centenera MM, 2012, CLIN CANCER RES, V18, P3562, DOI 10.1158/1078-0432.CCR-12-0782; Cole AM, 2010, CANCER RES, V70, P8149, DOI 10.1158/0008-5472.CAN-10-0315; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Comstock CES, 2011, J BIOL CHEM, V286, P8117, DOI 10.1074/jbc.M110.170720; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Diaz-Padilla I, 2009, INVEST NEW DRUG, V27, P586, DOI 10.1007/s10637-009-9236-6; Dickson MA, 2009, CURR ONCOL, V16, P120; Drees M, 1997, CLIN CANCER RES, V3, P273; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Freemantle SJ, 2007, J CELL BIOCHEM, V102, P869, DOI 10.1002/jcb.21519; Fry DW, 2004, MOL CANCER THER, V3, P1427; Halvorsen OJ, 2000, CANCER, V88, P416, DOI 10.1002/(SICI)1097-0142(20000115)88:2<416::AID-CNCR24>3.3.CO;2-R; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Ismail A, 2011, CLIN CANCER RES, V17, P4513, DOI 10.1158/1078-0432.CCR-11-0244; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen KE, 2011, EXPERT REV ENDOCRINO, V6, P483, DOI 10.1586/EEM.11.33; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Korzynska A, 2008, BIOCYBERN BIOMED ENG, V28, P75; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Liu G, 2004, CLIN CANCER RES, V10, P924, DOI 10.1158/1078-0432.CCR-03-0050; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Lu H, 2006, J MED CHEM, V49, P3826, DOI 10.1021/jm0600388; Martin JM, 2011, DRUGS, V71, P1019, DOI 10.2165/11591500-000000000-00000; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Menu E, 2008, CANCER RES, V68, P5519, DOI 10.1158/0008-5472.CAN-07-6404; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Mostaghel EA, 2011, ENDOCRIN METAB CLIN, V40, P625, DOI 10.1016/j.ecl.2011.05.013; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Roberts PJ, 2012, JNCI-J NATL CANCER I, V104, P476, DOI 10.1093/jnci/djs002; Rodriguez-Otero P, 2011, BRIT J HAEMATOL, V155, P73, DOI 10.1111/j.1365-2141.2011.08812.x; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Schiewer MJ, 2012, MOL CELL ENDOCRINOL, V352, P34, DOI 10.1016/j.mce.2011.06.033; Schiewer MJ, 2012, ENDOCR-RELAT CANCER, V19, P1, DOI 10.1530/ERC-11-0072; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Senderowicz AM, 1998, J CLIN ONCOL, V16, P2986, DOI 10.1200/JCO.1998.16.9.2986; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sutherland JJ, 2011, MOL CANCER THER, V10, P242, DOI 10.1158/1535-7163.MCT-10-0720; Thangavel C, 2011, ENDOCR-RELAT CANCER, V18, P333, DOI 10.1530/ERC-10-0262; Thomas JP, 2002, CANCER CHEMOTH PHARM, V50, P465, DOI 10.1007/s00280-002-0527-2; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Tzelepi V, 2012, CLIN CANCER RES, V18, P666, DOI 10.1158/1078-0432.CCR-11-1867; Udayakumar T, 2010, SEMIN RADIAT ONCOL, V20, P258, DOI 10.1016/j.semradonc.2010.05.007; Vaughn DJ, 2009, NEW ENGL J MED, V360, P423, DOI 10.1056/NEJMc0808558; Wang L, 2007, BLOOD, V110, P2075, DOI 10.1182/blood-2007-02-071266; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wesierska-Gadek J, 2011, J CELL PHYSIOL, V226, P341, DOI 10.1002/jcp.22426; Wetherill YB, 2006, MOL CANCER THER, V5, P3181, DOI 10.1158/1535-7163.MCT-06-0272; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Zhang C, 2009, CLIN CANCER RES, V15, P238, DOI 10.1158/1078-0432.CCR-08-0897; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	65	78	79	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2013	32	48					5481	5491		10.1038/onc.2013.83	http://dx.doi.org/10.1038/onc.2013.83			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	263BE	23708653	hybrid, Green Published			2022-12-25	WOS:000327780800005
J	Xie, GX; Zhong, W; Li, HK; Li, Q; Qiu, YP; Zheng, XJ; Chen, HY; Zhao, XQ; Zhang, SC; Zhou, ZX; Zeisel, SH; Jia, W				Xie, Guoxiang; Zhong, Wei; Li, Houkai; Li, Qiong; Qiu, Yunping; Zheng, Xiaojiao; Chen, Huiyuan; Zhao, Xueqing; Zhang, Shucha; Zhou, Zhanxiang; Zeisel, Steven H.; Jia, Wei			Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption	FASEB JOURNAL			English	Article						gastrointestinal tract; liver; blood; ultraperformance liquid chromatography mass spectrometry; metabolomics	GUT MICROBIOTA; LIVER; ALCOHOL; CHOLESTEROL; CONJUGATION; HOMEOSTASIS; RECEPTOR; GROWTH; COA	Our understanding of the bile acid metabolism is limited by the fact that previous analyses have primarily focused on a selected few circulating bile acids; the bile acid profiles of the liver and gastrointestinal tract pools are rarely investigated. Here, we determined how chronic ethanol consumption altered the bile acids in multiple body compartments (liver, gastrointestinal tract, and serum) of rats. Rats were fed a modified Lieber-DeCarli liquid diet with 38% of calories as ethanol (the amount equivalent of 4-5 drinks in humans). While conjugated bile acids predominated in the liver (98.3%), duodenum (97.8%), and ileum (89.7%), unconjugated bile acids comprised the largest proportion of measured bile acids in serum (81.2%), the cecum (97.7%), and the rectum (97.5%). In particular, taurine-conjugated bile acids were significantly decreased in the liver and gastrointestinal tract of ethanol-treated rats, while unconjugated and glycine-conjugated species increased. Ethanol consumption caused increased expression of genes involved in bile acid biosynthesis, efflux transport, and reduced expression of genes regulating bile acid influx transport in the liver. These results provide an improved understanding of the systemic modulations of bile acid metabolism in mammals through the gut-liver axis.Xie, G., Zhong, W., Li, H., Li, Q., Qiu, Y., Zheng, X., Chen, H., Zhao, X., Zhang, S., Zhou, Z., Zeisel, S. H., Jia, W. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption.	[Xie, Guoxiang; Zhong, Wei; Li, Houkai; Li, Qiong; Qiu, Yunping; Zheng, Xiaojiao; Chen, Huiyuan; Zhao, Xueqing; Zhou, Zhanxiang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Xie, Guoxiang; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai 200030, Peoples R China; [Xie, Guoxiang; Jia, Wei] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Zhang, Shucha; Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC USA	University of North Carolina; University of North Carolina Greensboro; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System; University of North Carolina; University of North Carolina Chapel Hill	Jia, W (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA.	z_zhou@uncg.edu; wjia@cc.hawaii.edu	Jia, Wei/AAN-5102-2020; Qiu, Yunping/AAO-5200-2021; li, houkai/S-6785-2019; chen, hui/HDO-2955-2022; Li, Qiong/I-4114-2013; Xie, Guoxiang/F-3022-2016	Jia, Wei/0000-0002-3739-8994; li, houkai/0000-0003-2846-7895; Xie, Guoxiang/0000-0002-0951-4150; Qiu, Yunping/0000-0003-1039-5264	U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism [R01 AA020212]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020212] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was financially supported by U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism grant R01 AA020212.	Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Corrao G, 1997, J STUD ALCOHOL, V58, P486, DOI 10.15288/jsa.1997.58.486; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; DUPONT J, 1974, LIPIDS, V9, P294, DOI 10.1007/BF02532210; FALANY CN, 1994, J BIOL CHEM, V269, P19375; HARDISON WGM, 1977, AM J PHYSIOL, V232, pE75, DOI 10.1152/ajpendo.1977.232.1.E75; HEPNER GW, 1973, J CLIN INVEST, V52, P433, DOI 10.1172/JCI107200; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; IGA T, 1982, BIOCHEM PHARMACOL, V31, P205; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Delgado-Villa MJ, 2009, J STUD ALCOHOL DRUGS, V70, P615, DOI 10.15288/jsad.2009.70.615; KILLENBERG PG, 1978, J BIOL CHEM, V253, P1005; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Miyata M, 2011, J PHARMACOL EXP THER, V336, P188, DOI 10.1124/jpet.110.171736; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Niemela O, 2007, CLIN CHIM ACTA, V377, P39, DOI 10.1016/j.cca.2006.08.035; Oliva L, 1998, ALCOHOL CLIN EXP RES, V22, P1538; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; REDDY BS, 1981, CANCER RES, V41, P3766; Reschly EJ, 2008, J LIPID RES, V49, P1577, DOI 10.1194/jlr.M800138-JLR200; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Robben J., 1987, FRONTIERS MICROBIOLO, P241, DOI [10.1007/978-94-009-3353-8_25, DOI 10.1007/978-94-009-3353-8_25]; Shi XL, 2012, J BIOL CHEM, V287, P6336, DOI 10.1074/jbc.M111.312199; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Vlahcevic ZR, 1996, HEPATOLOGY TXB LIVER, V1, P376; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wei J, 2009, J DIGEST DIS, V10, P85, DOI 10.1111/j.1751-2980.2009.00369.x; WOSTMANN BS, 1973, J NUTR, V103, P982, DOI 10.1093/jn/103.7.982; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017	34	120	123	5	56	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3583	3593		10.1096/fj.13-231860	http://dx.doi.org/10.1096/fj.13-231860			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23709616	Green Submitted, Green Published			2022-12-25	WOS:000328840500018
J	Appolaire, A; Rosenbaum, E; Dura, MA; Colombo, M; Marty, V; Savoye, MN; Godfroy, A; Schoehn, G; Girard, E; Gabel, F; Franzetti, B				Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Godfroy, Anne; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno			Pyrococcus horikoshii TET2 Peptidase Assembling Process and Associated Functional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LEUCINE AMINOPEPTIDASE; SUBSTRATE-SPECIFICITY; BLEOMYCIN HYDROLASE; PROTEIN-DEGRADATION; TRICORN PROTEASE; REVEALS; COMPLEX; MACROMOLECULES; SCATTERING	Tetrahedral (TET) aminopeptidases are large polypeptide destruction machines present in prokaryotes and eukaryotes. Here, the rules governing their assembly into hollow 12-subunit tetrahedrons are addressed by using TET2 from Pyrococcus horikoshii (PhTET2) as a model. Point mutations allowed the capture of a stable, catalytically active precursor. Small angle x- ray scattering revealed that it is a dimer whose architecture in solution is identical to that determined by x- ray crystallography within the fully assembled TET particle. Small angle x- ray scattering also showed that the reconstituted PhTET2 dodecameric particle displayed the same quaternary structure and thermal stability as the wild-type complex. The PhTET2 assembly intermediates were characterized by analytical ultracentrifugation, native gel electrophoresis, and electron microscopy. They revealed that PhTET2 assembling is a highly ordered process in which hexamers represent the main intermediate. Peptide degradation assays demonstrated that oligomerization triggers the activity of the TET enzyme toward large polypeptidic substrates. Fractionation experiments in Pyrococcus and Halobacterium cells revealed that, in vivo, the dimeric precursor co-exists together with assembled TET complexes. Taken together, our observations explain the biological significance of TET oligomerization and suggest the existence of a functional regulation of the dimer-dodecamer equilibrium in vivo.	[Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno] CNRS, Inst Biol Struct, UMR5075, F-38027 Grenoble, France; [Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno] CEA Grenoble, F-38054 Grenoble, France; [Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno] Univ Grenoble 1, F-38027 Grenoble, France; [Godfroy, Anne] IFREMER, UMR6197, Lab Microbiol Environm Extremes, F-29280 Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale	Franzetti, B (corresponding author), Inst Biol Struct, 41 Rue J Horowitz, F-38027 Grenoble 1, France.	franzetti@ibs.fr	Anne, Godfroy/J-9897-2017; Godfroy, Anne/X-1992-2018	Anne, Godfroy/0000-0003-0483-4160; Godfroy, Anne/0000-0003-0483-4160; Schoehn, Guy/0000-0002-1459-3201; Noirclerc-Savoye, Marjolaine/0000-0002-5481-6561; Girard, Eric/0000-0002-5758-6095; Gabel, Frank/0000-0003-3446-2601	Agence Nationale de la Recherche ["MacroTET"-BLAN-07-3204002, "Archelyse" ANR-12-BSV8-0019-01]; GRD Ecchis; French Ministry for Research and Technology; French National Research Agency	Agence Nationale de la Recherche(French National Research Agency (ANR)); GRD Ecchis; French Ministry for Research and Technology; French National Research Agency(French National Research Agency (ANR))	This work was supported in part by the Agence Nationale de la Recherche Grants "MacroTET"-BLAN-07-3204002 and "Archelyse" ANR-12-BSV8-0019-01 and the GRD Ecchis.; Supported by a Ph.D. scholarship from the French Ministry for Research and Technology.; Supported by a French National Research Agency postdoctoral fellowship.	Ando S, 1999, FEBS LETT, V447, P25, DOI 10.1016/S0014-5793(99)00257-4; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; BURLEY SK, 1990, P NATL ACAD SCI USA, V87, P6878, DOI 10.1073/pnas.87.17.6878; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chaikuad A, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-14; Chamieh H, 2008, BIOCHEM J, V411, P387, DOI 10.1042/BJ20071502; Chen YY, 2012, J BIOL CHEM, V287, P13356, DOI 10.1074/jbc.M112.347518; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Delfosse V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004712; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Dura MA, 2009, MOL MICROBIOL, V72, P26, DOI 10.1111/j.1365-2958.2009.06600.x; Dura MA, 2005, BIOCHEMISTRY-US, V44, P3477, DOI 10.1021/bi047736j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187; Glatter O, 2002, N-HOLLAND D, P73; Godfroy A, 2000, FEMS MICROBIOL LETT, V186, P127, DOI 10.1111/j.1574-6968.2000.tb09093.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Gonzalez JM, 1998, EXTREMOPHILES, V2, P123, DOI 10.1007/s007920050051; Guzman-Rojas L, 2012, P NATL ACAD SCI USA, V109, P1637, DOI 10.1073/pnas.1120790109; Holz RC, 2003, CURR OPIN CHEM BIOL, V7, P197, DOI 10.1016/S1367-5931(03)00033-4; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Kim D, 2010, BIOCHEM BIOPH RES CO, V391, P431, DOI 10.1016/j.bbrc.2009.11.075; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; O'Farrell PA, 1999, STRUCT FOLD DES, V7, P619, DOI 10.1016/S0969-2126(99)80083-5; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Remaut H, 2001, NAT STRUCT BIOL, V8, P674, DOI 10.1038/90380; Rosenbaum E, 2011, BBA-PROTEINS PROTEOM, V1814, P1289, DOI 10.1016/j.bbapap.2010.11.008; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schoehn G, 2006, J BIOL CHEM, V281, P36327, DOI 10.1074/jbc.M604417200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Svedberg T, 1940, THE ULTRACENTRIFUGE; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Talon R, 2011, J SYNCHROTRON RADIAT, V18, P74, DOI 10.1107/S0909049510036824; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; Thompson MW, 1998, EUR J BIOCHEM, V258, P923, DOI 10.1046/j.1432-1327.1998.2580923.x; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	55	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22542	22554		10.1074/jbc.M113.450189	http://dx.doi.org/10.1074/jbc.M113.450189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23696647	Green Published, hybrid			2022-12-25	WOS:000330596300034
J	Sogaard, R; Borre, L; Braunstein, TH; Madsen, KL; MacAulay, N				Sogaard, Rikke; Borre, Lars; Braunstein, Thomas H.; Madsen, Kenneth L.; MacAulay, Nanna			Functional Modulation of the Glutamate Transporter Variant GLT1b by the PDZ Domain Protein PICK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; AMINO-ACID TRANSPORTERS; LONG-TERM DEPRESSION; DIFFERENTIAL REGULATION; SPLICE VARIANTS; NERVOUS-SYSTEM; ION FLUXES; RAT-BRAIN; GLT-1; LOCALIZATION	The dominant glutamate transporter isoform in the mammalian brain, GLT1, exists as at least three splice variants, GLT1a, GLT1b, and GLT1c. GLT1b interacts with the scaffold protein PICK1 (protein interacting with kinase C1), which is implicated in glutamatergic neurotransmission via its regulatory effect on trafficking of AMPA-type glutamate receptors. The 11 extreme C-terminal residues specific for the GLT1b variant are essential for its specific interaction with the PICK1 PDZ domain, but a functional consequence of this interaction has remained unresolved. To identify a functional effect of PICK1 on GLT1a or GLT1b separately, we employed the Xenopus laevis expression system. GLT1a and GLT1b displayed similar electrophysiological properties and EC50 for glutamate. Co-expressed PICK1 localized efficiently to the plasma membrane and resulted in a 5-fold enhancement of the leak current in GLT1b-expressing oocytes with only a minor effect on [H-3] glutamate uptake. Three different GLT1 substrates all caused a slow TBOA-sensitive decay in the membrane current upon prolonged application, which provides support for the leak current being mediated by GLT1b itself. Leak and glutamate-evoked currents in GLT1a-expressing oocytes were unaffected by PICK1 co-expression. PKC activation down-regulated GLT1a and GLT1b activity to a similar extent, which was not affected by co-expression of PICK1. In conclusion, PICK1 may not only affect glutamatergic neurotransmission by its regulatory effect on glutamate receptors but may also affect neuronal excitability via an increased GLT1b-mediated leak current. This may be particularly relevant in pathological conditions such as amyotrophic lateral sclerosis and cerebral hypoxia, which are associated with neuronal GLT1b up-regulation.	[Sogaard, Rikke; MacAulay, Nanna] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Borre, Lars; Madsen, Kenneth L.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Braunstein, Thomas H.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	MacAulay, N (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	Madsen, Kenneth/C-7778-2012; MacAulay, Nanna/AER-7709-2022; Braunstein, Thomas Hartig/B-8064-2008	Madsen, Kenneth/0000-0001-9274-6691; MacAulay, Nanna/0000-0002-7800-6600; Braunstein, Thomas Hartig/0000-0001-6632-7960	Lundbeck Foundation; Dagmar Marshall grant	Lundbeck Foundation(Lundbeckfonden); Dagmar Marshall grant	This work was supported by a grant from the Lundbeck Foundation and a Dagmar Marshall grant (to R.S.).	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Baron A, 2002, J BIOL CHEM, V277, P50463, DOI 10.1074/jbc.M208848200; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Bergles DE, 2002, J NEUROSCI, V22, P10153; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; D'Amico A, 2010, TRAFFIC, V11, P1455, DOI 10.1111/j.1600-0854.2010.01110.x; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dev KK, 2000, J NEUROSCI, V20, P7252; Focant MC, 2013, NEUROPATH APPL NEURO, V39, P231, DOI 10.1111/j.1365-2990.2012.01282.x; Gebhardt FM, 2010, J BIOL CHEM, V285, P31313, DOI 10.1074/jbc.M110.153494; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jansen AM, 2009, J COMP NEUROL, V517, P313, DOI 10.1002/cne.22155; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Karatas-Wulf U, 2009, NEUROSCIENCE, V161, P794, DOI 10.1016/j.neuroscience.2009.04.017; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Pow DV, 2004, DEV BRAIN RES, V153, P1, DOI 10.1016/j.devbrainres.2004.06.019; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sogaard R, 2012, AM J PHYSIOL-CELL PH, V302, pC880, DOI 10.1152/ajpcell.00238.2011; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Sullivan R, 2004, GLIA, V45, P155, DOI 10.1002/glia.10317; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	55	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20195	20207		10.1074/jbc.M113.471128	http://dx.doi.org/10.1074/jbc.M113.471128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23697999	hybrid, Green Published			2022-12-25	WOS:000321715100009
J	Hassan, BH; Lindsey-Boltz, LA; Kemp, MG; Sancar, A				Hassan, Bachar H.; Lindsey-Boltz, Laura A.; Kemp, Michael G.; Sancar, Aziz			Direct Role for the Replication Protein Treslin (Ticrr) in the ATR Kinase-mediated Checkpoint Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; C-TERMINAL TAIL; TOPBP1; PHOSPHORYLATION; INITIATION; RECONSTITUTION; ACTIVATION; CLASPIN; COMPLEX; DOMAIN	TopBP1 (topoisomerase II beta-binding protein 1) is a dual replication/checkpoint protein. Treslin/Ticrr, an essential replication protein, was discovered as a binding partner for TopBP1 and also in a genetic screen for checkpoint regulators in zebrafish. Treslin is phosphorylated by CDK2/cyclin E in a cell cycle-dependent manner, and its phosphorylation state dictates its interaction with TopBP1. The role of Treslin in the initiation of DNA replication has been partially elucidated; however, its role in the checkpoint response remained elusive. In this study, we show that Treslin stimulates ATR phosphorylation of Chk1 both in vitro and in vivo in a TopBP1-dependent manner. Moreover, we show that the phosphorylation state of Treslin at Ser-1000 is important for its checkpoint activity. Overall, our results indicate that, like TopBP1, Treslin is a dual replication/checkpoint protein that directly participates in ATR-mediated checkpoint signaling.	[Hassan, Bachar H.; Lindsey-Boltz, Laura A.; Kemp, Michael G.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Lindsey-Boltz, Laura/A-3121-2010	Kemp, Michael G./0000-0001-8203-0745; Lindsey-Boltz, Laura/0000-0001-6493-8194	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833.	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Canman CE, 2001, CURR BIOL, V11, pR121, DOI 10.1016/S0960-9822(01)00057-4; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lin SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002801; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076	31	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18903	18910		10.1074/jbc.M113.475517	http://dx.doi.org/10.1074/jbc.M113.475517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23696651	Green Published, hybrid			2022-12-25	WOS:000321335800028
J	Alout, H; Ndam, NT; Sandeu, MM; Djegbe, I; Chandre, F; Dabire, RK; Djogbenou, LS; Corbel, V; Cohuet, A				Alout, Haoues; Ndam, Nicaise Tuikue; Sandeu, Marcel Maurice; Djegbe, Innocent; Chandre, Fabrice; Dabire, Roch Kounbobr; Djogbenou, Luc Salako; Corbel, Vincent; Cohuet, Anna			Insecticide Resistance Alleles Affect Vector Competence of Anopheles gambiae s.s. for Plasmodium falciparum Field Isolates	PLOS ONE			English	Article							HIGH WOLBACHIA DENSITY; MALARIA TRANSMISSION; CULEX-PIPIENS; LABORATORY MODELS; GENE-EXPRESSION; IMMUNE-RESPONSE; BURKINA-FASO; REAL-TIME; MOSQUITO; INFECTION	The widespread insecticide resistance raises concerns for vector control implementation and sustainability particularly for the control of the main vector of human malaria, Anopheles gambiae sensu stricto. However, the extent to which insecticide resistance mechanisms interfere with the development of the malignant malaria parasite in its vector and their impact on overall malaria transmission remains unknown. We explore the impact of insecticide resistance on the outcome of Plasmodium falciparum infection in its natural vector using three An. gambiae strains sharing a common genetic background, one susceptible to insecticides and two resistant, one homozygous for the ace-1(R) mutation and one for the kdr mutation. Experimental infections of the three strains were conducted in parallel with field isolates of P. falciparum from Burkina Faso (West Africa) by direct membrane feeding assays. Both insecticide resistant mutations influence the outcome of malaria infection by increasing the prevalence of infection. In contrast, the kdr resistant allele is associated with reduced parasite burden in infected individuals at the oocyst stage, when compared to the susceptible strain, while the ace-1(R) resistant allele showing no such association. Thus insecticide resistance, which is particularly problematic for malaria control efforts, impacts vector competence towards P. falciparum and probably parasite transmission through increased sporozoite prevalence in kdr resistant mosquitoes. These results are of great concern for the epidemiology of malaria considering the widespread pyrethroid resistance currently observed in Sub-Saharan Africa and the efforts deployed to control the disease.	[Alout, Haoues; Chandre, Fabrice; Corbel, Vincent; Cohuet, Anna] UM1 UM2 CNRS 5290 IRD 224, Inst Rech Dev, Montpellier, France; [Alout, Haoues; Dabire, Roch Kounbobr; Cohuet, Anna] Inst Rech Sci Sante, Bobo Dioulasso 01, Burkina Faso; [Ndam, Nicaise Tuikue] Inst Sci Biomed & Appl, Cotonou, Benin; [Ndam, Nicaise Tuikue; Sandeu, Marcel Maurice] Univ Paris 05, IRD, UMR 216, Paris, France; [Sandeu, Marcel Maurice; Djegbe, Innocent] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Djogbenou, Luc Salako] Univ Abomey Calavi, Inst Reg Sante Publ, Cotonou, Benin; [Corbel, Vincent] Kasetsart Univ, Fac Agr, Dept Entomol, Bangkok, Thailand	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Entomological Research Center of Cotonou (CREC); University of Abomey Calavi; Kasetsart University	Alout, H (corresponding author), UM1 UM2 CNRS 5290 IRD 224, Inst Rech Dev, Montpellier, France.	haoues.alout@ird.fr	Cohuet, Anna/B-2745-2017; Corbel, VIncent/G-9576-2016; Alout, Haoues/N-9556-2016; Chandre, Fabrice/Q-3429-2019; Dabire, Roch Kounbobr/ABF-3525-2020	Cohuet, Anna/0000-0002-1876-5656; Alout, Haoues/0000-0001-7917-2697; Chandre, Fabrice/0000-0002-1994-9705; corbel, vincent/0000-0003-0995-3257; DJOGBENOU, Salako Luc/0000-0002-7381-6321; Tuikue Ndam, Nicaise/0000-0003-2646-2513	European Community [242095, 223736]; IRD	European Community(European Commission); IRD	This work was financed by the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreements no242095 and no223736. Also, the authors thank IRD for financial support and for fellowship to HA. The authors would also thank the Laboratoire Mixte International de Lutte Integree contre le Paludisme (LLIP), Cotonou, Benin, and the Laboratoire Mixte International "Maladies a vecteurs en Afrique de l'Ouest" (LAMIVECT), Bobo Dioulasso, Burkina Faso for technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2004, EVOLUTION, V58, P579, DOI 10.1111/j.0014-3820.2004.tb01680.x; Aguilar R, 2005, ACTA TROP, V95, P285, DOI 10.1016/j.actatropica.2005.06.005; Ahmed AM, 2002, OIKOS, V97, P371, DOI 10.1034/j.1600-0706.2002.970307.x; [Anonymous], NATURE; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Djegbe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017496; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Ferguson HM, 2002, TRENDS PARASITOL, V18, P256, DOI 10.1016/S1471-4922(02)02281-X; Gouagna LC, 2004, TROP MED INT HEALTH, V9, P937, DOI 10.1111/j.1365-3156.2004.01300.x; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Hurd H, 2004, INT J PARASITOL, V34, P1459, DOI 10.1016/j.ijpara.2004.10.002; Kuznetsova A., 2012, MIXMOD ANAL MIXED MO; Labbe P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P363, DOI 10.1016/B978-0-12-384890-1.00014-5; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2007, AM J TROP MED HYG, V76, P475, DOI 10.4269/ajtmh.2007.76.475; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McCarroll L, 2002, INSECT BIOCHEM MOLEC, V32, P1345, DOI 10.1016/S0965-1748(02)00097-8; Mendes AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11; Morassin B, 2002, AM J TROP MED HYG, V66, P503, DOI 10.4269/ajtmh.2002.66.503; PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Rehman H, 2011, SCAND J IMMUNOL, V73, P459, DOI 10.1111/j.1365-3083.2011.02521.x; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Roxstrom-Lindquist K, 2005, INSECT MOL BIOL, V14, P645, DOI 10.1111/j.1365-2583.2005.00593.x; Sandeu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052719; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; SHUTE G. T., 1956, ANN TROP MED AND PARASITOL, V50, P92; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; SKAUG H., 2012, GEN LINEAR MIXED MOD; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; Suwanchaichinda C, 2005, ENVIRON TOXICOL PHAR, V20, P77, DOI 10.1016/j.etap.2004.10.004; VANHANDEL E, 1989, J AM MOSQUITO CONTR, V5, P180; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Vezilier J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-379; Vizioli J, 2000, INSECT MOL BIOL, V9, P75, DOI 10.1046/j.1365-2583.2000.00164.x; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 1998, TEST PROC MSECT RES; Zuur Alain F., 2009, P1	66	82	83	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63849	10.1371/journal.pone.0063849	http://dx.doi.org/10.1371/journal.pone.0063849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704944	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200075
J	Anomal, R; de Villers-Sidani, E; Merzenich, MM; Panizzutti, R				Anomal, Renata; de Villers-Sidani, Etienne; Merzenich, Michael M.; Panizzutti, Rogerio			Manipulation of BDNF Signaling Modifies the Experience-Dependent Plasticity Induced by Pure Tone Exposure during the Critical Period in the Primary Auditory Cortex	PLOS ONE			English	Article							MOUSE VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; BARREL CORTEX; RAT; EXPRESSION; OVEREXPRESSION; NEUROTROPHINS; MATURATION; COLUMNS; CLOSURE	Sensory experience powerfully shapes cortical sensory representations during an early developmental "critical period" of plasticity. In the rat primary auditory cortex (A1), the experience-dependent plasticity is exemplified by significant, long-lasting distortions in frequency representation after mere exposure to repetitive frequencies during the second week of life. In the visual system, the normal unfolding of critical period plasticity is strongly dependent on the elaboration of brain-derived neurotrophic factor (BDNF), which promotes the establishment of inhibition. Here, we tested the hypothesis that BDNF signaling plays a role in the experience-dependent plasticity induced by pure tone exposure during the critical period in the primary auditory cortex. Elvax resin implants filled with either a blocking antibody against BDNF or the BDNF protein were placed on the A1 of rat pups throughout the critical period window. These pups were then exposed to 7 kHz pure tone for 7 consecutive days and their frequency representations were mapped. BDNF blockade completely prevented the shaping of cortical tuning by experience and resulted in poor overall frequency tuning in A1. By contrast, BDNF infusion on the developing A1 amplified the effect of 7 kHz tone exposure compared to control. These results indicate that BDNF signaling participates in the experience-dependent plasticity induced by pure tone exposure during the critical period in A1.	[Anomal, Renata; de Villers-Sidani, Etienne; Merzenich, Michael M.; Panizzutti, Rogerio] Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Anomal, Renata; Panizzutti, Rogerio] Univ Fed Rio de Janeiro, Inst Biomed Sci, Program Basic Clin Neurosci, Rio De Janeiro, Brazil	University of California System; University of California San Francisco; Universidade Federal do Rio de Janeiro	Panizzutti, R (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	rogerio@icb.ufrj.br		Anomal, Renata/0000-0003-3528-0535	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ; National Institutes of Health; Long-Term Fellowship from the Human Frontier Science Program, HFSP; Clinician-Scientist Award of the Canadian Institutes of Health Research; CAPES	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Long-Term Fellowship from the Human Frontier Science Program, HFSP; Clinician-Scientist Award of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ to R.P. and National Institutes of Health grants to M.M.M. R.P. is a recipient of the Long-Term Fellowship from the Human Frontier Science Program, HFSP. E.V.S. was supported by a Clinician-Scientist Award of the Canadian Institutes of Health Research. R.A. was supported by predoctoral fellowships from CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2003, J NEUROSCI, V23, P10765; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; BERARDI N, 1994, P NATL ACAD SCI USA, V91, P684, DOI 10.1073/pnas.91.2.684; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Cabelli RJ, 1996, J NEUROSCI, V16, P7965; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; de Villers-Sidani E, 2010, P NATL ACAD SCI USA, V107, P13900, DOI 10.1073/pnas.1007885107; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Grossberg S, 2003, CEREB CORTEX, V13, P852, DOI 10.1093/cercor/13.8.852; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hata Y, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-03-j0002.2000; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; Kuczewski N, 2011, J NEUROCHEM, V118, P533, DOI 10.1111/j.1471-4159.2011.07192.x; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Vinogradov S, 2009, BIOL PSYCHIAT, V66, P549, DOI 10.1016/j.biopsych.2009.02.017; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Xu JH, 2010, CEREB CORTEX, V20, P804, DOI 10.1093/cercor/bhp143; Xu JH, 2010, J NEUROSCI RES, V88, P614, DOI 10.1002/jnr.22232; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhou XM, 2011, J NEUROSCI, V31, P5625, DOI 10.1523/JNEUROSCI.6470-10.2011; Zhou XM, 2010, P NATL ACAD SCI USA, V107, P14839, DOI 10.1073/pnas.1009433107; Zhou XM, 2009, NAT NEUROSCI, V12, P26, DOI 10.1038/nn.2239; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	37	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64208	10.1371/journal.pone.0064208	http://dx.doi.org/10.1371/journal.pone.0064208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700463	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200123
J	Bohni, N; Cordero-Maldonado, ML; Maes, J; Siverio-Mota, D; Marcourt, L; Munck, S; Kamuhabwa, AR; Moshi, MJ; Esguerra, CV; de Witte, PAM; Crawford, AD; Wolfender, JL				Bohni, Nadine; Lorena Cordero-Maldonado, Maria; Maes, Jan; Siverio-Mota, Dany; Marcourt, Laurence; Munck, Sebastian; Kamuhabwa, Appolinary R.; Moshi, Mainen J.; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.; Wolfender, Jean-Luc			Integration of Microfractionation, qNMR and Zebrafish Screening for the In Vivo Bioassay-Guided Isolation and Quantitative Bioactivity Analysis of Natural Products	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; STRUCTURE ELUCIDATION; GENISTEIN; DISCOVERY; ISOFLAVONE; IDENTIFICATION; INHIBITION; DRUGS; UHPLC	Natural products (NPs) are an attractive source of chemical diversity for small-molecule drug discovery. Several challenges nevertheless persist with respect to NP discovery, including the time and effort required for bioassay-guided isolation of bioactive NPs, and the limited biomedical relevance to date of in vitro bioassays used in this context. With regard to bioassays, zebrafish have recently emerged as an effective model system for chemical biology, allowing in vivo high-content screens that are compatible with microgram amounts of compound. For the deconvolution of the complex extracts into their individual constituents, recent progress has been achieved on several fronts as analytical techniques now enable the rapid microfractionation of extracts, and microflow NMR methods have developed to the point of allowing the identification of microgram amounts of NPs. Here we combine advanced analytical methods with high-content screening in zebrafish to create an integrated platform for microgram-scale, in vivo NP discovery. We use this platform for the bioassay-guided fractionation of an East African medicinal plant, Rhynchosia viscosa, resulting in the identification of both known and novel isoflavone derivatives with anti-angiogenic and anti-inflammatory activity. Quantitative microflow NMR is used both to determine the structure of bioactive compounds and to quantify them for direct dose-response experiments at the microgram scale. The key advantages of this approach are (1) the microgram scale at which both biological and analytical experiments can be performed, (2) the speed and the rationality of the bioassay-guided fractionation - generic for NP extracts of diverse origin - that requires only limited sample-specific optimization and (3) the use of microflow NMR for quantification, enabling the identification and dose-response experiments with only tens of micrograms of each compound. This study demonstrates that a complete in vivo bioassay-guided fractionation can be performed with only 20 mg of NP extract within a few days.	[Bohni, Nadine; Marcourt, Laurence; Wolfender, Jean-Luc] Univ Lausanne, Univ Geneva, EPGL, Sch Pharmaceut Sci, Geneva, Switzerland; [Lorena Cordero-Maldonado, Maria; Maes, Jan; Siverio-Mota, Dany; Esguerra, Camila V.; de Witte, Peter A. M.; Crawford, Alexander D.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium; [Lorena Cordero-Maldonado, Maria] Univ Cuenca, Sch Biochem & Pharm, Fac Chem Sci, Cuenca, Ecuador; [Munck, Sebastian] Univ Leuven, VIB Ctr Biol Dis, Louvain, Belgium; [Kamuhabwa, Appolinary R.; Moshi, Mainen J.] Muhimbili Univ Hlth & Allied Sci, Fac Pharm, Dar Es Salaam, Tanzania	University of Geneva; University of Lausanne; KU Leuven; Universidad de Cuenca; Flanders Institute for Biotechnology (VIB); KU Leuven; Muhimbili University of Health & Allied Sciences	Crawford, AD (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	alexander.crawford@pharm.kuleuven.be	Jean-Luc, Wolfender JLW/O-2163-2018; Esguerra, Camila/N-6159-2015; Jean-Luc, Wolfender JLW/EWV-1043-2022; Esguerra, Camila/D-7657-2014; Marcourt, Laurence/A-3411-2014	Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Esguerra, Camila/0000-0002-2271-8094; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Esguerra, Camila/0000-0001-7891-1427; Marcourt, Laurence/0000-0002-9614-1099; Moshi, Mainen/0000-0002-8850-3221; Munck, Sebastian/0000-0002-5182-5358; Bohni, Nadine/0000-0001-5188-1256; de Witte, Peter/0000-0002-9989-9567	Swiss National Science Foundation (SNSF) [CRSII3_127187]; Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador; Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador; Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba	MLCM was funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador. DSM was funded by a fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba. This work was funded in part by the Swiss National Science Foundation (SNSF, CRSII3_127187 to JLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Philippe J. Eugster for the acquisition of UHPLC-PDA-TOFMS data and for assistance on dereplication, and the Aquaculture Core Facility of the Biomedical Sciences Group at KU Leuven. MLCM acknowledges the support of the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" at the University of Cuenca, Ecuador. DSM acknowledges the support of the Vlaamse Interuniversitaire Raad (VLIR) linked to a VLIR-UOS cooperation program with the Central University "Martha Abreu" from Las Villas, Santa Clara, Cuba.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Barantin L, 1997, MAGN RESON MED, V38, P179, DOI 10.1002/mrm.1910380203; Buckingham J., 2012, DICT NATURAL PRODUCT; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Caligiani A, 2010, NUTRIENTS, V2, P280, DOI 10.3390/nu2030280; Crawford AD, 2011, PLANTA MED, V77, P1348; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; Dalisay DS, 2009, J NAT PROD, V72, P732, DOI 10.1021/np8007649; Eldridge GR, 2002, ANAL CHEM, V74, P3963, DOI 10.1021/ac025534s; Espina R, 2009, CHEM RES TOXICOL, V22, P299, DOI 10.1021/tx800251p; Eugster PJ, 2012, RSC CHROMATOGR MONOG, P354, DOI 10.1039/9781849735490-00354; Farina HG, 2006, ONCOL REP, V16, P885; FOTSIS T, 1993, P NATL ACAD SCI USA, V90, P2690, DOI 10.1073/pnas.90.7.2690; Fotsis T, 1998, BAILLIERE CLIN ENDOC, V12, P649, DOI 10.1016/S0950-351X(98)80009-8; Funari CS, 2012, J CHROMATOGR A, V1259, P167, DOI 10.1016/j.chroma.2012.03.069; Gassner NC, 2007, J NAT PROD, V70, P383, DOI 10.1021/np060555t; Giera M, 2009, ANAL CHEM, V81, P5460, DOI 10.1021/ac900622b; Glauser G, 2010, PHYTOCHEM ANALYSIS, V21, P95, DOI 10.1002/pca.1155; Guillarme D, 2008, EUR J PHARM BIOPHARM, V68, P430, DOI 10.1016/j.ejpb.2007.06.018; Guillarme D, 2009, J CHROMATOGR A, V1216, P3232, DOI 10.1016/j.chroma.2009.02.032; HANAWA F, 1991, PHYTOCHEMISTRY, V30, P157, DOI 10.1016/0031-9422(91)84117-B; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hu JF, 2005, PLANTA MED, V71, P176, DOI 10.1055/s-2005-837787; Johansen KT, 2011, J NAT PROD, V74, P2454, DOI 10.1021/np200780m; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; KINOSHITA T, 1978, CHEM PHARM BULL, V26, P141; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Marrero-Ponce Y, 2011, EUR J MED CHEM, V46, P5736, DOI 10.1016/j.ejmech.2011.07.053; Marston A, 2007, PHYTOCHEMISTRY, V68, P2786, DOI 10.1016/j.phytochem.2007.08.004; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Rosen J, 2009, J MED CHEM, V52, P1953, DOI 10.1021/jm801514w; Sadowska-Krowicka H, 1998, P SOC EXP BIOL MED, V217, P351; Si HW, 2007, CURR MED CHEM, V14, P2581, DOI 10.2174/092986707782023325; TAHARA S, 1991, PHYTOCHEMISTRY, V30, P1683, DOI 10.1016/0031-9422(91)84234-J; Vargas S, 2011, J PHARMACEUT BIOMED, V56, P880, DOI 10.1016/j.jpba.2011.06.026; Veitch NC, 2009, NAT PROD REP, V26, P776, DOI 10.1039/b616809b; Wang B, 2005, J OCUL PHARMACOL TH, V21, P107, DOI 10.1089/jop.2005.21.107; Welsch ME, 2010, CURR OPIN CHEM BIOL, V14, P347, DOI 10.1016/j.cbpa.2010.02.018; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Williams RB, 2012, PLANTA MED, V78, P160, DOI 10.1055/s-0031-1280293; Zhou GX, 2007, CHEM PHARM BULL, V55, P1287, DOI 10.1248/cpb.55.1287; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	47	40	41	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64006	10.1371/journal.pone.0064006	http://dx.doi.org/10.1371/journal.pone.0064006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700445	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200103
J	Naveca, FG; Sabido, M; de Almeida, TAP; Veras, EA; Mejia, MDC; Galban, E; Benzaken, AS				Naveca, Felipe Gomes; Sabido, Meritxell; Pires de Almeida, Tatiana Amaral; Veras, Elaine Araujo; Contreras Mejia, Matilde del Carmen; Galban, Enrique; Benzaken, Adele Schwartz			Etiology of Genital Ulcer Disease in a Sexually Transmitted Infection Reference Center in Manaus, Brazilian Amazon	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SIMPLEX-VIRUS TYPE-2; PRIMARY-HEALTH-CARE; TREPONEMA-PALLIDUM; SYNDROMIC MANAGEMENT; CLINICAL-DIAGNOSIS; MOLECULAR METHODS; HSV-2 INFECTION; HIV-INFECTION	Objectives: To determine the etiology and factors associated with genital ulcer disease (GUD) among patients presenting to a sexually transmitted infections clinic in Manaus, Brazil; and to compare a multiplex polymerase chain reaction (M-PCR) assay for the diagnosis of GUD with standard methods. Methods: Ulcer swabs were collected and used for Tzanck test and processed in an M-PCR to detect herpes simplex virus (HSV-1/2), Treponema pallidum (T. pallidum), and Haemophilus ducreyi (H. ducreyi). Sera were tested for HIV and syphilis antibodies. Multivariable analysis was used to measure the association between clinical aspects and GUD. M-PCR results were compared with syphilis serology and Tzanck tests. Results: Overall, 434 GUD samples were evaluated, 84.8% from men. DNA from HSV-2 was detected in 55.3% of GUD samples, T. pallidum in 8.3%, HSV-1 in 3.2%, and 32.5% of GUD specimens were negative for the DNA of all three pathogens. No cases of H. ducreyi were identified. HIV serology among GUD patients was 3.2%. Treponemal antibodies and Tzanck test positivity for genital herpes was detected in 25 (5.8%) and in 125 (30.3%) of GUD patients, respectively. In multivariable analysis genital herpes etiology by M-PCR was associated with the vesicular, multiple and recurrent lesions whereas T. pallidum with non-vesicular, non-recurrent lesions. Compared to M-PCR, syphilis serology was 27.8% sensitive and 96.2% specific whereas Tzanck test was 43.8% sensitive and 88.9% specific. Conclusions: The predominance of genital herpes etiology suggests a revision of existing national syndromic treatment guidelines in Brazil to include antiherpetic treatment for all GUD patients. The use of M-PCR can significantly improve the diagnosis of GUD and provide a greater sensitivity than standard diagnostics.	[Naveca, Felipe Gomes; Veras, Elaine Araujo; Contreras Mejia, Matilde del Carmen; Galban, Enrique; Benzaken, Adele Schwartz] Fundacao Alfredo Matta, Manaus, Amazonas, Brazil; [Naveca, Felipe Gomes; Pires de Almeida, Tatiana Amaral] Inst Leonidas & Maria Deane Fiocruz Amazonia, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil; [Sabido, Meritxell] Fundacio Sida & Soc, Barcelona, Spain; [Pires de Almeida, Tatiana Amaral] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Galban, Enrique] Fac Med Calixto Garcia, Havana, Cuba; [Benzaken, Adele Schwartz] UNAIDS, Brasilia, DF, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Amazonas	Sabido, M (corresponding author), Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.	xellsabido@gmail.com	Almeida, Tatiana/B-3404-2013; Naveca, Felipe/H-1130-2012	Almeida, Tatiana/0000-0001-7395-3062; Naveca, Felipe/0000-0002-2888-1060; Schwartz Benzaken, Adele/0000-0002-5789-0695	Regional Scientific Development Program (DCR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM; CNPq/FAPEAM; FAPEAM	Regional Scientific Development Program (DCR); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); CNPq/FAPEAM; FAPEAM	The study was funded by the Regional Scientific Development Program (DCR) Call 005/2007 of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM (www.fapeam.am.gov.br). FGN received CNPq/FAPEAM fellowship. TAPA, EAV and MCCM received FAPEAM fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HJ, 2003, SEX TRANSM DIS, V30, P114, DOI 10.1097/00007435-200302000-00004; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Beyrer C, 1998, J INFECT DIS, V178, P243, DOI 10.1086/515603; Brankin AE, 2009, INT J STD AIDS, V20, P650, DOI 10.1258/ijsa.2009.009067; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2006, PROGR NAC DST AIDS M; Bruisten SM, 2001, J CLIN MICROBIOL, V39, P601, DOI 10.1128/JCM.39.2.601-605.2001; Burris H, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S5; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cheluget B, 2004, SEX TRANSM DIS, V31, P522, DOI 10.1097/01.olq.0000137896.40790.7d; Chen CY, 2012, METHODS MOL BIOL, V903, P103, DOI 10.1007/978-1-61779-937-2_6; Clark JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007201; CONE RW, 1994, JAMA-J AM MED ASSOC, V272, P792, DOI 10.1001/jama.272.10.792; DANGOR Y, 1990, SEX TRANSM DIS, V17, P184, DOI 10.1097/00007435-199010000-00007; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Cavalcante EGF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-595; FOLKERS E, 1988, GENITOURIN MED, V64, P249; Gayet-Ageron A, 2013, SEX TRANSM INFECT, V89, P251, DOI 10.1136/sextrans-2012-050622; Heymans R, 2010, J CLIN MICROBIOL, V48, P497, DOI 10.1128/JCM.00720-09; Hope-Rapp E, 2010, SEX TRANSM DIS, V37, P153, DOI 10.1097/OLQ.0b013e3181bf5a98; Hoyo C, 2005, SEX TRANSM DIS, V32, P231, DOI 10.1097/01.olq.0000149669.98128.ce; JANIER M, 1990, GENITOURIN MED, V66, P43; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; Lai W, 2003, SEX TRANSM INFECT, V79, P202, DOI 10.1136/sti.79.3.202; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Leslie DE, 2007, J CLIN MICROBIOL, V45, P93, DOI 10.1128/JCM.01578-06; Lewis DA, 2003, SEX TRANSM INFECT, V79, P68, DOI 10.1136/sti.79.1.68; Lewis DA, 2012, SEX TRANSM DIS, V39, P880, DOI 10.1097/OLQ.0b013e318269cf90; Lin HC, 1999, CANCER RES, V59, P807; Makasa M, 2012, SEX TRANSM DIS, V39, P787, DOI 10.1097/OLQ.0b013e31826ae97d; Ministerio da Saude do Brasil, 2008, PROGR NAC DST AIDS P; Ministerio da Saude do Brasil, 2006, MIN SAUD BRAS SER MA, V68; Moodley P, 2003, SEX TRANSM DIS, V30, P241, DOI 10.1097/00007435-200303000-00013; Gomes CMM, 2007, BRAZ J INFECT DIS, V11, P254, DOI 10.1590/S1413-86702007000200018; Morrow RA, 2003, J CLIN MICROBIOL, V41, P5212, DOI 10.1128/JCM.41.11.5212-5214.2003; Morse SA, 1997, J INFECT DIS, V175, P583, DOI 10.1093/infdis/175.3.583; Nilsen A, 2007, ACTA DERM-VENEREOL, V87, P355, DOI 10.2340/00015555-0241; Orle KA, 1996, J CLIN MICROBIOL, V34, P49, DOI 10.1128/JCM.34.1.49-54.1996; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Paz-Bailey G, 2010, CLIN INFECT DIS, V50, P1060, DOI 10.1086/651115; Pedrosa VL, 2011, J BRAS DOENCAS SEX T, V23, P57; Prabhakar P, 2012, SEX TRANSM DIS, V39, P906, DOI 10.1097/OLQ.0b013e3182663e22; Risbud A, 1999, SEX TRANSM DIS, V26, P55, DOI 10.1097/00007435-199901000-00009; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Sambrook J., 2001, MOL CLONING LAB MANU; Suntoke TR, 2009, SEX TRANSM INFECT, V85, P97, DOI 10.1136/sti.2008.034207; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Totten PA, 2000, J CLIN MICROBIOL, V38, P268; Vickerman P, 2008, SEX TRANSM INFECT, V84, P243, DOI 10.1136/sti.2007.027136; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; WHO, 2007, TRAIN MAN WHO PACK E, P1	51	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63953	10.1371/journal.pone.0063953	http://dx.doi.org/10.1371/journal.pone.0063953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704961	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200092
J	Zhang, HR; Wei, XM; Tao, HJ; Mwansisya, TE; Pu, WD; He, Z; Hu, AM; Xu, L; Liu, ZN; Shan, BC; Xue, ZM				Zhang, Huiran; Wei, Xiaomei; Tao, Haojuan; Mwansisya, Tumbwene E.; Pu, Weidan; He, Zhong; Hu, Aimin; Xu, Lin; Liu, Zhening; Shan, Baoci; Xue, Zhimin			Opposite Effective Connectivity in the Posterior Cingulate and Medial Prefrontal Cortex between First-Episode Schizophrenic Patients with Suicide Risk and Healthy Controls	PLOS ONE			English	Article							WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; DEFAULT NETWORK; BRAIN; DOPAMINE; MODE; FMRI; INVOLVEMENT; DYSFUNCTION; CIRCUITS	Objective: The schizophrenic patients with high suicide risk are characterized by depression, better cognitive function, and prominent positive symptoms. However, the neurobiological basis of suicide attempts in schizophrenia is not clear. The suicide in schizophrenia is implicated in the defects in emotional process and decision-making, which are associated with prefrontal-cingulate circuit. In order to explore the possible neurobiological basis of suicide in schizophrenia, we investigated the correlation of prefrontal-cingulate circuit with suicide risk in schizophrenia via dynamic casual modelling. Method: Participants were 33 first-episode schizophrenic patients comprising of a high suicide risk group (N = 14) and a low suicide risk group (N = 19). A comparison group of healthy controls (N = 15) were matched for age, gender and education. N-back tasking functional magnetic resonance imaging data was collected. Results: Compared with healthy controls group, the two patients groups showed decreased task-related suppression during 2-back task state versus baseline state in the left posterior cingulate and medial prefrontal cortex; the hyper-connectivity from the left posterior cingulate cortex to the left medial prefrontal cortex existed in both schizophrenic patients groups, but hypo-connectivity in the opposite direction only existed in the schizophrenic patients group with high suicide risk. Conclusions: The hyper-connectivity from the left posterior cingulate cortex to the left medial prefrontal cortex may suggest that the abnormal effective connectivity was associated with risk for schizophrenia. The hypo-connectivity in the opposite direction may represent a possible correlate of increased vulnerability to suicide attempt.	[Zhang, Huiran; Tao, Haojuan; Mwansisya, Tumbwene E.; Pu, Weidan; Hu, Aimin; Liu, Zhening; Xue, Zhimin] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Wei, Xiaomei; Shan, Baoci] Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China; [Zhang, Huiran] Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou, Peoples R China; [Mwansisya, Tumbwene E.] Univ Dodoma, Dept Clin Nursing & Community Hlth, Dodoma, Tanzania; [He, Zhong] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China	Central South University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Zhengzhou University; Central South University; Chinese Academy of Sciences; Kunming Institute of Zoology	Wei, XM (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Nucl Anal Tech, Beijing, Peoples R China.	zningl@163.com; x.zhimin@163.com		Shan, Baoci/0000-0001-7417-5063; Xu, Lin/0000-0002-2710-3507; Liu, Zhening/0000-0001-6893-2427	National Natural Science Foundation of China [81171287, 30971053, 81271485, 81071092]; National 973 Program of China [2011CB707800]; Specialized Research Fund for the Doctoral Program of Higher Education [20110162110017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (81171287, 30971053 to Dr. Zhimin Xue, and 81271485, 81071092 to Dr. Z. Liu), the National 973 Program of China (2011CB707800 to Dr. Zhening Liu), and Specialized Research Fund for the Doctoral Program of Higher Education (20110162110017 to Dr. Zhening Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar EJ, 2008, PROG NEURO-PSYCHOPH, V32, P1673, DOI 10.1016/j.pnpbp.2008.06.016; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; D'Argembeau A, 2012, CEREB CORTEX, V22, P659, DOI 10.1093/cercor/bhr144; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Delaney C, 2012, SCHIZOPHR RES, V140, P232, DOI 10.1016/j.schres.2012.06.017; Dutta R, 2010, ARCH GEN PSYCHIAT, V67, P1230, DOI 10.1001/archgenpsychiatry.2010.157; Feenstra MGP, 2000, PROG BRAIN RES, V126, P133; Fenton WS, 1997, AM J PSYCHIAT, V154, P199; First M. B., 2014, SCID 5 105 STRUCTURE; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gupta S, 1998, PSYCHIAT SERV, V49, P1353, DOI 10.1176/ps.49.10.1353; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Holt D. J., 2009, SCHIZOPHRENIA B, V37, P164; Johnson SC, 2005, J COGNITIVE NEUROSCI, V17, P1897, DOI 10.1162/089892905775008607; Laviolette SR, 2006, CELL MOL LIFE SCI, V63, P1597, DOI 10.1007/s00018-006-6027-5; Laviolette SR, 2007, SCHIZOPHRENIA BULL, V33, P971, DOI 10.1093/schbul/sbm048; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Mendrek A, 2005, PSYCHOL MED, V35, P187, DOI 10.1017/S0033291704003228; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Parks J., 2006, MORBIDITY MORTALITY; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Rusch N, 2008, PSYCHIAT RES-NEUROIM, V164, P206, DOI 10.1016/j.pscychresns.2007.12.011; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sripada CS, 2011, HUM BRAIN MAPP, V32, P1637, DOI 10.1002/hbm.21136; Stretton J, 2012, NEUROIMAGE, V60, P1696, DOI 10.1016/j.neuroimage.2012.01.126; Taiminen T, 2001, SCHIZOPHR RES, V47, P199, DOI 10.1016/S0920-9964(00)00126-2; Tan HY, 2005, AM J PSYCHIAT, V162, P1849, DOI 10.1176/appi.ajp.162.10.1849; Thermenos HW, 2010, AM J MED GENET B, V153B, P120, DOI 10.1002/ajmg.b.30964; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106	45	48	49	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63477	10.1371/journal.pone.0063477	http://dx.doi.org/10.1371/journal.pone.0063477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704911	Green Published, gold			2022-12-25	WOS:000319330200043
J	Meng, ZJ; Zhang, XY; Wu, J; Pei, RJ; Xu, Y; Yang, DL; Roggendorf, M; Lu, MJ				Meng, Zhongji; Zhang, Xiaoyong; Wu, Jun; Pei, Rongjuan; Xu, Yang; Yang, Dongliang; Roggendorf, Michael; Lu, Mengji			RNAi Induces Innate Immunity through Multiple Cellular Signaling Pathways	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SMALL-INTERFERING RNAS; DOUBLE-STRANDED RNAS; PROTEIN-KINASE; PRIMARY HEPATOCYTES; GENE-EXPRESSION; REPLICATION; INHIBITION; SIRNA; INDUCTION	Background & Aims: Our previous results showed that the knockdown of woodchuck hepatitis virus (WHV) by RNA interference (RNAi) led to upregulation of interferon stimulated genes (ISGs) in primary hepatocytes. In the present study, we tested the hypothesis that the cellular signaling pathways recognizing RNA molecules may be involved the ISG stimulation by RNAi. Methods: Primary murine hepatocytes (PMHs) from wild type mice and WHV transgenic (Tg) mice were prepared and treated with defined siRNAs. The mRNA levels of target genes and ISGs were detected by real-time RT-PCR. The involvement of the signaling pathways including RIG-I/MDA5, PKR, and TLR3/7/8/9 was examined by specific inhibition and the analysis of their activation by Western blotting. Results: In PMHs from WHV Tg mice, specific siRNAs targeting WHV, mouse beta-actin, and GAPDH reduced the levels of targeted mRNAs and increased the mRNA expression of IFN-beta, MxA, and IP-10. The enhanced ISG expression by siRNA transfection were abolished by siRNA-specific 2'-O-methyl antisense RNA and the inhibitors 2-AP and chloroquine blocking PKR and other TLR-mediated signaling pathways. Furthermore, Western blotting revealed that RNAi results in an increase in PKR phosphorylation and nuclear translocation of IRF3 and NF-eB, indicating the possible role of IRF3 in the RNAi-directed induction of ISGs. In contrast, silencing of RIG-I and MDA5 failed to block RNAi-mediated MxA induction. Conclusions: RNAi is capable of enhancing innate immune responses through the PKR-and TLR-dependent signaling pathways in primary hepatocytes. The immune stimulation by RNAi may contribute to the antiviral activity of siRNAs in vivo.	[Meng, Zhongji; Zhang, Xiaoyong; Pei, Rongjuan; Roggendorf, Michael; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Meng, Zhongji] Hubei Univ Med, Taihe Hosp, Dept Infect Dis, Shiyan, Peoples R China; [Wu, Jun; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Xu, Yang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Peoples R China	University of Duisburg Essen; Hubei University of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	mengji.lu@uni-due.de	Lu, Mengji/ABF-9410-2020	Meng, Zhongji/0000-0003-0401-535X	Deutsche Forschungsgemeinschaft [GK1045/2, TRR60]; Natural Science Foundation of Hubei Province, China [2010CDZ036]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This study was supported by the grants of Deutsche Forschungsgemeinschaft (GK1045/2 and TRR60), and partially supported by the Natural Science Foundation of Hubei Province, China (2010CDZ036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.200636617; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert G, 2011, GASTROENTEROLOGY, V141, P696, DOI 10.1053/j.gastro.2011.05.001; Fernandez M, 2003, J GEN VIROL, V84, P2073, DOI 10.1099/vir.0.18966-0; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Fucini RV, 2012, NUCLEIC ACID THER, V22, P205, DOI 10.1089/nat.2011.0334; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kabilova TO, 2012, NUCLEIC ACID THER, V22, P196, DOI 10.1089/nat.2011.0328; Klein C, 2003, GASTROENTEROLOGY, V125, P9, DOI 10.1016/S0016-5085(03)00720-0; Konishi M, 2003, HEPATOLOGY, V38, P842, DOI 10.1053/jhep.2003.50416; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Meng ZJ, 2008, J VIROL METHODS, V150, P27, DOI 10.1016/j.jviromet.2008.02.008; Meng ZJ, 2009, VIROLOGY, V384, P88, DOI 10.1016/j.virol.2008.11.012; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; Moss EG, 2003, NAT CELL BIOL, V5, P771, DOI 10.1038/ncb0903-771; Olejniczak M, 2012, RNA, V18, P930, DOI 10.1261/rna.025627.110; Olejniczak M, 2011, CURR GENE THER, V11, P532, DOI 10.2174/156652311798192770; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shlomai A, 2003, HEPATOLOGY, V37, P764, DOI 10.1053/jhep.2003.50146; Singh SK, 2009, BIODRUGS, V23, P269, DOI 10.2165/11317120-000000000-00000; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Subramanya S, 2010, EXPERT OPIN BIOL TH, V10, P201, DOI 10.1517/14712590903448158; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Wu HL, 2005, GASTROENTEROLOGY, V128, P708, DOI 10.1053/j.gastro.2004.12.007; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Wu M, 2007, J GEN VIROL, V88, P3260, DOI 10.1099/vir.0.82959-0; Yoo JW, 2006, BIOCHEM BIOPH RES CO, V347, P1053, DOI 10.1016/j.bbrc.2006.07.001; Zhang XY, 2009, CELL MICROBIOL, V11, P1624, DOI 10.1111/j.1462-5822.2009.01353.x; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	50	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64708	10.1371/journal.pone.0064708	http://dx.doi.org/10.1371/journal.pone.0064708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700487	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400063
J	Tan, CS; Broge, TA; Seung, E; Vrbanac, V; Viscidi, R; Gordon, J; Tager, AM; Koralnik, IJ				Tan, Chen Sabrina; Broge, Thomas A., Jr.; Seung, Edward; Vrbanac, Vlad; Viscidi, Raphael; Gordon, Jennifer; Tager, Andrew M.; Koralnik, Igor J.			Detection of JC Virus-Specific Immune Responses in a Novel Humanized Mouse Model	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; CYTOTOXIC T-LYMPHOCYTES; DNA; MICE; PML; BK; INDIVIDUALS; REPLICATION; ASSOCIATION; EXPRESSION	Progressive Multifocal Leukoencephalopathy (PML) is an often fatal disease caused by the reactivation of the JC virus (JCV). Better understanding of viral-host interactions has been hampered by the lack of an animal model. Engrafting NOD/SCID/IL-2-Rg (null) mice with human lymphocytes and thymus, we generated a novel animal model for JCV infection. Mice were inoculated with either a PML isolate, JCV Mad-4, or with JCV CY, found in the kidney and urine of healthy individuals. While mice remained asymptomatic following inoculation, JCV DNA was occasionally detected in both the blood and the urine compartments. Mice generated both humoral and cellular immune responses against JCV. Expressions of immune exhaustion marker, PD-1, on lymphocytes were consistent with response to infection. Using this model we present the first in vivo demonstration of virological and immunological differences between JCV Mad-4 and CY. This model may prove valuable for studying JCV host immune responses.	[Tan, Chen Sabrina] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Tan, Chen Sabrina; Broge, Thomas A., Jr.; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Tan, Chen Sabrina; Broge, Thomas A., Jr.; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div NeuroVirol, Boston, MA 02215 USA; [Seung, Edward; Vrbanac, Vlad; Tager, Andrew M.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Viscidi, Raphael] Johns Hopkins Med Ctr, Baltimore, MD USA; [Gordon, Jennifer] Temple Univ, Dept Neurosci, Ctr Neurovirol, Sch Med, Philadelphia, PA 19122 USA; [Gordon, Jennifer] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Harvard Medical School	Tan, CS (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	ctan@bidmc.harvard.edu		Viscidi, Raphael/0000-0002-7906-8002	National Institutes of Health (NIH) [R01 NS 047029, NS 074995, NS R56 041198, K24 NS 060950]; Harvard University Center for AIDS Research (CFAR); NIH [P30 AI60354, K08 NS 064215-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074995, R56NS041198, K08NS064215, K24NS060950, R01NS047029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was conducted with support from National Institutes of Health (NIH) grants R01 NS 047029, NS 074995, NS R56 041198, and K24 NS 060950 to IJK; grants to CST and AMT from Harvard University Center for AIDS Research (CFAR); an NIH-funded program (P30 AI60354), and NIH grant K08 NS 064215-01 to CST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Du Pasquier RA, 2004, BRAIN, V127, P1970, DOI 10.1093/brain/awh215; Du Pasquier RA, 2003, J VIROL, V77, P11918, DOI 10.1128/JVI.77.22.11918-11926.2003; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Gheuens S, 2011, J VIROL, V85, P7256, DOI 10.1128/JVI.02506-10; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Koralnik IJ, 2002, J IMMUNOL, V168, P499, DOI 10.4049/jimmunol.168.1.499; Koralnik IJ, 1999, NEUROLOGY, V52, P253, DOI 10.1212/WNL.52.2.253; Lima MA, 2007, J VIROL, V81, P3361, DOI 10.1128/JVI.01809-06; MARKOWITZ RB, 1993, J INFECT DIS, V167, P13, DOI 10.1093/infdis/167.1.13; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; PADGETT BL, 1976, J INFECT DIS, V133, P686, DOI 10.1093/infdis/133.6.686; Perkins MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003014; Radhakrishnan S, 2003, J VIROL, V77, P10638, DOI 10.1128/JVI.77.19.10638-10644.2003; Reid CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/infdis/jir256; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Smith RWP, 2003, EUR J BIOCHEM, V270, P2030, DOI 10.1046/j.1432-1033.2003.03579.x; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; Tan CS, 2012, JAIDS-J ACQ IMM DEF, V60, P244, DOI 10.1097/QAI.0b013e31825a313c; Tremolada S, 2010, VIROLOGY, V404, P312, DOI 10.1016/j.virol.2010.05.012; Viscidi RP, 2011, CLIN INFECT DIS, V53, P711, DOI 10.1093/cid/cir507; White RE, 2012, J CLIN INVEST, V122, P1487, DOI 10.1172/JCI58092; Wuthrich C, 2009, ANN NEUROL, V65, P742, DOI 10.1002/ana.21619; YOGO Y, 1990, J VIROL, V64, P3139, DOI 10.1128/JVI.64.6.3139-3143.1990	27	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64313	10.1371/journal.pone.0064313	http://dx.doi.org/10.1371/journal.pone.0064313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700470	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400053
J	Ahmed, M; Goldgur, Y; Hu, J; Guo, HF; Cheung, NKV				Ahmed, Mahiuddin; Goldgur, Yehuda; Hu, Jian; Guo, Hong-Fen; Cheung, Nai-Kong V.			In silico Driven Redesign of a Clinically Relevant Antibody for the Treatment of GD2 Positive Tumors	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURES; ANTI-GD2 ANTIBODY; MOLECULAR DOCKING; NEUROBLASTOMA; ANTIGEN; REFINEMENT; EXPRESSION; GROWTH	Ganglioside GD2 is a cell surface glycolipid that is highly expressed on cancer cells of neuroectodermal origin, including neuroblastoma, retinoblastoma, melanoma, sarcomas, brain tumors and small cell lung cancer. Monoclonal antibodies (MoAb) that target GD2 have shown clinical efficacy in the treatment of GD2 expressing tumors, and are expected to be the new standard of care for the treatment of pediatric neuroblastoma. In this study, the crystal structure of anti-GD2 murine MoAb 3F8 was solved to 1.65 angstrom resolution and used as a template for molecular docking simulations of its antigen, the penta-saccharide head group of GD2. Molecular docking revealed a binding motif composed of 12 key interacting amino acid side-chains, involving an extensive network of interactions involving main-chain and side-chain hydrogen bonding, two Pi - CH interactions, and an important charged interaction between Arg95 of the H3 loop with the penultimate sialic acid residue of GD2. Based on in silico scanning mutagenesis of the 12 interacting amino acids from the docked 3F8:GD2 model, a single point mutation (Heavy Chain: Gly54Ile) was engineered into a humanized 3F8 (hu3F8) MoAb and found to have a 6-9 fold enhancement in antibody-dependent cell-mediated cytotoxicity of neuroblastoma and melanoma cell lines. With enhanced tumor-killing properties, the re-engineered hu3F8 has the potential be a more effective antibody for the treatment of GD2-positive tumors.	[Ahmed, Mahiuddin; Hu, Jian; Guo, Hong-Fen; Cheung, Nai-Kong V.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Goldgur, Yehuda] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Cheung, NKV (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	cheungn@mskcc.org			National Institutes of Health [ULI RR024996]; National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000459, UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, UL1RR024996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grant ULI RR024996, TL1 training award to MA. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino M, 2009, J CHEM INF MODEL, V49, P2749, DOI 10.1021/ci900388a; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Brignole C, 2005, CANCER LETT, V228, P181, DOI 10.1016/j.canlet.2004.11.065; CHEE DO, 1976, CANCER RES, V36, P1503; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Cheung N.K., 2012, J CLIN ONCOL; Cheung NKV, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19864; Cheung NKV, 2012, J CLIN ONCOL, V30, P3264, DOI 10.1200/JCO.2011.41.3807; CHEUNG NKV, 1986, J NATL CANCER I, V77, P739, DOI 10.1093/jnci/77.3.739; Cheung NKV, 2004, J NUCL MED, V45, P867; CHEUNG NKV, 1985, CANCER RES, V45, P2642; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GILLIES SD, 1989, J IMMUNOL METHODS, V125, P191, DOI 10.1016/0022-1759(89)90093-8; HAKOMORI S, 1994, PROG BRAIN RES, V101, P241; Heimburg-Molinaro Jamie, 2009, V534, P341, DOI 10.1007/978-1-59745-022-5_24; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Kushner B., 2007, P AN M AM SOC CLIN, V25, p526s; LADISCH S, 1994, P NATL ACAD SCI USA, V91, P1974, DOI 10.1073/pnas.91.5.1974; LAMMIE GA, 1993, INT J ONCOL, V3, P909; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Modak S, 2007, CANCER INVEST, V25, P67, DOI 10.1080/07357900601130763; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; MUJOO K, 1991, CANCER IMMUNOL IMMUN, V34, P198, DOI 10.1007/BF01742313; MUJOO K, 1989, CANCER RES, V49, P2857; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NATALI PG, 1989, CANCER RES, V49, P1269; POKKULURI PR, 1994, J MOL BIOL, V243, P283, DOI 10.1006/jmbi.1994.1654; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; SEEGER RC, 1977, CANCER RES, V37, P1364; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	37	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63359	10.1371/journal.pone.0063359	http://dx.doi.org/10.1371/journal.pone.0063359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696816	gold, Green Submitted, Green Published			2022-12-25	WOS:000319081900029
J	Hundahl, CA; Elfving, B; Muller, HK; Hay-Schmidt, A; Wegener, G				Hundahl, Christian Ansgar; Elfving, Betina; Mueller, Heidi Kaastrup; Hay-Schmidt, Anders; Wegener, Gregers			A Gene-Environment Study of Cytoglobin in the Human and Rat Hippocampus	PLOS ONE			English	Article							CHRONIC RESTRAINT STRESS; NITRIC-OXIDE SYNTHASE; ELECTROCONVULSIVE SEIZURES; DIFFERENTIAL EXPRESSION; PREFRONTAL CORTEX; MESSENGER-RNA; NEUROGLOBIN; PROTEIN; NEURONS; SCHIZOPHRENIA	Background: Cytoglobin (Cygb) was discovered a decade ago as the fourth vertebrate heme-globin. The function of Cygb is still unknown, but accumulating evidence from in vitro studies point to a putative role in scavenging of reactive oxygen species and nitric oxide metabolism and in vivo studies have shown Cygb to be up regulated by hypoxic stress. This study addresses three main questions related to Cygb expression in the hippocampus: 1) Is the rat hippocampus a valid neuroanatomical model for the human hippocampus; 2) What is the degree of co-expression of Cygb and neuronal nitric oxide synthase (nNOS) in the rat hippocampus; 3) The effect of chronic restraint stress (CRS) on Cygb and nNOS expression. Methods: Immunohistochemistry was used to compare Cygb expression in the human and rat hippocampi as well as Cygb and nNOS co-expression in the rat hippocampus. Transcription and translation of Cygb and nNOS were investigated using quantitative real-time polymerase chain reaction (real-time qPCR) and Western blotting on hippocampi from Flinders (FSL/FRL) rats exposed to CRS. Principal Findings: Cygb expression pattern in the human and rat hippocampus was found to be similar. A high degree of Cygb and nNOS co-expression was observed in the rat hippocampus. The protein levels of nNOS and Cygb were significantly up-regulated in FSL animals in the dorsal hippocampus. In the ventral hippocampus Cygb protein levels were significantly up-regulated in the FSL compared to the FRL, following CRS. Significance: The rodent hippocampus can be used to probe questions related to Cygb protein localization in human hippocampus. The high degree of Cygb and nNOS co-expression gives support for Cygb involvement in nitric oxide metabolism. CRS induced Cygb and nNOS expression indicating that Cygb expression is stress responsive. Cygb and nNOS may be important in physiological response to stress.	[Hundahl, Christian Ansgar] Univ Tartu, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Elfving, Betina; Mueller, Heidi Kaastrup; Wegener, Gregers] Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Aarhus, Denmark; [Hundahl, Christian Ansgar; Hay-Schmidt, Anders] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Wegener, Gregers] North West Univ, Unit Drug Res & Dev, Sch Pharm Pharmacol, Potchefstroom, South Africa	University of Tartu; Aarhus University; University of Copenhagen; North West University - South Africa	Wegener, G (corresponding author), Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Aarhus, Denmark.	wegener@dadlnet.dk	Wegener, Gregers/A-1019-2011; Wegener, Gregers/Z-3945-2019; Elfving, Betina/H-2814-2019; Hundahl, Christian Ansgar/H-3938-2015	Wegener, Gregers/0000-0002-0081-0068; Elfving, Betina/0000-0001-6939-5088; Kaastrup Muller, Heidi/0000-0002-9842-8114	Lundbeck Foundation [2011-8923]; Danish Medical Research Council [11-1078/97]; NOVO-Nordisk Foundation; King Christian X Foundation; AU-IDEAS (Aarhus University Research Foundation); Foundation for Providing Medical Research; Estonian Ministry of Science and Education [SF0180125s08]; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NOVO-Nordisk Foundation(Novo Nordisk Foundation); King Christian X Foundation; AU-IDEAS (Aarhus University Research Foundation); Foundation for Providing Medical Research; Estonian Ministry of Science and Education(Ministry of Education and Research, Estonia); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation (2011-8923), the Danish Medical Research Council (11-1078/97), the NOVO-Nordisk Foundation, King Christian X Foundation, AU-IDEAS (Aarhus University Research Foundation), the Foundation for Providing Medical Research, the Estonian Ministry of Science and Education (SF0180125s08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Bernstein HG, 2002, ANN NY ACAD SCI, V973, P91, DOI 10.1111/j.1749-6632.2002.tb04613.x; Bernstein HG, 1998, NEUROSCIENCE, V83, P867, DOI 10.1016/S0306-4522(97)00461-2; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; De Oliveira RMW, 2000, J PSYCHOPHARMACOL, V14, P1; Echeverry MB, 2004, NEUROSCIENCE, V125, P981, DOI 10.1016/j.neuroscience.2003.12.046; Ejchel-Cohen TF, 2006, BRAIN RES, V1090, P156, DOI 10.1016/j.brainres.2006.03.062; Elfving B, 2008, SYNAPSE, V62, P662, DOI 10.1002/syn.20538; Elfving B, 2012, SYNAPSE, V66, P340, DOI 10.1002/syn.21518; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Gardner AM, 2010, J BIOL CHEM; Gardner PR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/683729; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Halligan KE, 2009, J BIOL CHEM; Hamdane D, 2003, J BIOL CHEM; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Harvey BH, 2004, PSYCHOPHARMACOLOGY, V175, P494, DOI 10.1007/s00213-004-1836-4; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P173, DOI 10.1159/000129698; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Joca Sâmia Regiane L, 2003, Rev. Bras. Psiquiatr., V25, P46, DOI 10.1590/S1516-44462003000600011; Karolewicz B, 2004, J NEUROCHEM, V91, P1057, DOI 10.1111/j.1471-4159.2004.02792.x; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kim YK, 2006, PROG NEURO-PSYCHOPH, V30, P1091, DOI 10.1016/j.pnpbp.2006.04.008; Lee BH, 2006, NEUROPSYCHOBIOLOGY, V53, P127, DOI 10.1159/000092542; Leza JC, 1998, J PHARMACOL EXP THER, V286, P1397; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h; Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Mammen PPA, 2006, J HISTOCHEM CYTOCHEM, V54, P1349, DOI 10.1369/jhc.6A7008.2006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Muller HK, 2012, SYNAPSE, V66, P270, DOI 10.1002/syn.20986; Muller HK, 2011, BRAIN RES, V1385, P26, DOI 10.1016/j.brainres.2011.02.048; Oliveira RMW, 2008, BRAZ J MED BIOL RES, V41, P333, DOI 10.1590/S0100-879X2008000400012; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Orlowski D, 2012, STRESS, V15, P514, DOI 10.3109/10253890.2011.643516; Overstreet DH, 2013, PHARMACOL REV, V65, P143, DOI 10.1124/pr.111.005397; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Raida Z, 2012, BIOCHEM BIOPH RES CO, V424, P274, DOI 10.1016/j.bbrc.2012.06.105; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Suzuki E, 2001, J AFFECT DISORDERS, V63, P221, DOI 10.1016/S0165-0327(00)00164-6; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vestergaard-Poulsen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020653; Wegener G, 2010, INT J NEUROPSYCHOPH, V13, P461, DOI 10.1017/S1461145709990241; WYSS JM, 1979, NEUROSCIENCE, V4, P463, DOI 10.1016/0306-4522(79)90124-6; Xing GQ, 2002, SCHIZOPHR RES, V58, P21, DOI 10.1016/S0920-9964(01)00388-7	58	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63288	10.1371/journal.pone.0063288	http://dx.doi.org/10.1371/journal.pone.0063288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696808	Green Submitted, gold, Green Published			2022-12-25	WOS:000319081900022
J	Munshi, SU; Rewari, BB; Bhavesh, NS; Jameel, S				Munshi, Saif Ullah; Rewari, Bharat Bhushan; Bhavesh, Neel Sarovar; Jameel, Shahid			Nuclear Magnetic Resonance Based Profiling of Biofluids Reveals Metabolic Dysregulation in HIV-Infected Persons and Those on Anti-Retroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; METABONOMIC ANALYSIS; NMR-SPECTROSCOPY; AMINO-ACIDS; SERUM; DIAGNOSIS; PLASMA; IDENTIFICATION; PREVALENCE; SUPPORT	Background: Although HIV causes immune deficiency by infection and depletion of immunocytes, metabolic alterations with clinical manifestations are also reported in HIV/AIDS patients. Here we aimed to profile metabolite changes in the plasma, urine, and saliva of HIV/AIDS patients, including those on anti-retroviral therapy (ART). Methods: Metabolic profiling of biofluids collected from treatment naive HIV/AIDS patients and those receiving ART was done with solution-state nuclear magnetic resonance (NMR) spectroscopy followed by statistical analysis and annotation. Results: In Principal Component Analysis (PCA) of the NMR spectra, Principal Component 1 (PC1) alone accounted for 99.3%, 87.2% and 78.8% variations in plasma, urine, and saliva, respectively. Partial least squares discriminant analysis (PLS-DA) was applied to generate three-component models, which showed plasma and urine to be better than saliva in discriminating between patients and healthy controls, and between ART-naive patients and those receiving therapy. Twenty-six metabolites were differentially altered in any or two types of samples. Our results suggest that urinary Neopterin, and plasma Choline and Sarcosine could be used as metabolic biomarkers of HIV/AIDS infection. Pathway analysis revealed significant alternations in 12 metabolic pathways. Conclusions: This study catalogs differentially regulated metabolites in biofluids, which helped classify subjects as healthy controls, HIV/AIDS patients, and those on ART. It also underscores the importance of further studying the consequences of HIV infection on host metabolism and its implications for pathogenesis.	[Munshi, Saif Ullah; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Rewari, Bharat Bhushan] Natl AIDS Control Org, New Delhi, India; [Bhavesh, Neel Sarovar] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Bhavesh, NS (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India.	neelsb@icgeb.res.in; shahid@icgeb.res.in	Bhavesh, Neel Sarovar/F-3127-2015	Bhavesh, Neel Sarovar/0000-0002-7248-4978	Department of Biotechnology (DBT), Government of India; NII, New Delhi; ICGEB	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); NII, New Delhi; ICGEB	The authors thank Department of Biotechnology (DBT), Government of India for providing financial support for the 500 MHz and 700 MHz NMR spectrometers at the ICGEB and NII, New Delhi. SUM received a Pre-Doctoral Fellowship from ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani Akanmu, 2010, Indian J Sex Transm Dis AIDS, V31, P99, DOI 10.4103/0253-7184.74995; Barchiesi F, 2002, J ANTIMICROB CHEMOTH, V50, P999, DOI 10.1093/jac/dkf233; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Carr A, 2003, CLIN INFECT DIS, V36, pS96, DOI 10.1086/367565; Chen HY, 2004, AIDS RES HUM RETROV, V20, P513, DOI 10.1089/088922204323087769; Coen M, 2005, CLIN INFECT DIS, V41, P1582, DOI 10.1086/497836; DEGANS J, 1989, CLIN NEUROL NEUROSUR, V91, P199, DOI 10.1016/0303-8467(89)90114-5; DESIMONE C, 1992, AIDS, V6, P203, DOI 10.1097/00002030-199202000-00011; Di Rocco A, 2002, NEUROLOGY, V58, P730, DOI 10.1212/WNL.58.5.730; Dobs AS, 1996, J CLIN ENDOCR METAB, V81, P4108, DOI 10.1210/jc.81.11.4108; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Flyckt RL, 2009, MENOPAUSE, V16, P680, DOI 10.1097/gme.0b013e318199d5c4; Garcia-Lorda P, 2000, JPEN-PARENTER ENTER, V24, P317, DOI 10.1177/0148607100024006317; Gasparis AP, 2001, NUTRITION, V17, P981, DOI 10.1016/S0899-9007(01)00707-9; Ghannoum M. A., 2012, OMICS, DOI [10.1089/omi.2011.0035, DOI 10.1089/0MI.2011.0035]; GHAURI FYK, 1993, NMR BIOMED, V6, P163, DOI 10.1002/nbm.1940060210; Godoy MMG, 2010, J VIRAL HEPATITIS, V17, P854, DOI 10.1111/j.1365-2893.2009.01252.x; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; GRUNFELD C, 1992, AM J CLIN NUTR, V55, P455, DOI 10.1093/ajcn/55.2.455; Hewer R, 2006, J PHARMACEUT BIOMED, V41, P1442, DOI 10.1016/j.jpba.2006.03.006; HORTIN GL, 1994, CLIN CHEM, V40, P785; Hughes JW, 2004, J PSYCHOSOM RES, V57, P353, DOI 10.1016/j.jpsychores.2004.02.016; Imai K, 2009, J IMMUNOL, V182, P3688, DOI 10.4049/jimmunol.0802906; Ironson G, 2008, INT J BEHAV MED, V15, P221, DOI 10.1080/10705500802219606; Jordao AA, 1998, NUTRITION, V14, P423, DOI 10.1016/S0899-9007(98)00012-4; Kamga HLF, 2011, J AIDS HIV RES, V3, P30; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Laurichesse H, 1998, J NUTR, V128, P1342, DOI 10.1093/jn/128.8.1342; Li P, 2007, BRIT J NUTR, V98, P237, DOI 10.1017/S000711450769936X; Lindon JC, 1999, ANNU REP NMR SPECTRO, V38, P1, DOI 10.1016/S0066-4103(08)60035-6; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Madigan Ann, 1996, Pediatric Dentistry, V18, P129; Mao Y, 2008, J ZHEJIANG UNIV-SC B, V9, P474, DOI 10.1631/jzus.B0820044; Mataftsi M, 2011, ORAL DIS, V17, P13, DOI 10.1111/j.1601-0825.2010.01727.x; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Meyer SA, 1996, HIV RESOURCE REV, V1, P1; Meyerhoff DJ, 1999, NEUROLOGY, V52, P995, DOI 10.1212/WNL.52.5.995; Munshi SU, 2011, J VIRAL HEPATITIS, V18, pE591, DOI 10.1111/j.1365-2893.2011.01488.x; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Philippeos C, 2009, J BIOMOL NMR, V44, P127, DOI 10.1007/s10858-009-9329-8; Rietschel P, 2000, CLIN INFECT DIS, V31, P1240, DOI 10.1086/317457; ROSER W, 1995, MAGNET RESON MED, V33, P811, DOI 10.1002/mrm.1910330611; Salas-Salvado J, 2001, CLIN NUTR, V20, P379, DOI 10.1054/clnu.2001.0429; Sharpstone DR, 1996, AIDS, V10, P1377, DOI 10.1097/00002030-199610000-00010; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sundstrom JB, 2003, EXP BIOL MED, V228, P730, DOI 10.1177/153537020322800613; Tan J, 2008, ENVIRON SCI TECHNOL, V42, P2681, DOI 10.1021/es7021363; Teichmann J, 1998, Eur J Med Res, V3, P533; Teichmann J, 2003, EUR J MED RES, V8, P77; Vorster HH, 2004, PUBLIC HEALTH NUTR, V7, P1055, DOI 10.1079/PHN2004643; Wanchu A, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-15; Weis BC, 2004, MAGN RESON MED, V51, P649, DOI 10.1002/mrm.20057; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xia JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-507; Yarasheski KE, 2005, AM J PHYSIOL-ENDOC M, V288, pE278, DOI 10.1152/ajpendo.00359.2004	61	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64298	10.1371/journal.pone.0064298	http://dx.doi.org/10.1371/journal.pone.0064298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696880	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900083
J	Pelaez-Garcia, A; Barderas, R; Torres, S; Hernandez-Varas, P; Teixido, J; Bonilla, F; de Herreros, AG; Casal, JI				Pelaez-Garcia, Alberto; Barderas, Rodrigo; Torres, Sofia; Hernandez-Varas, Pablo; Teixido, Joaquin; Bonilla, Felix; Garcia de Herreros, Antonio; Ignacio Casal, J.			FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; T(4/14) MULTIPLE-MYELOMA; PROSTATE-CANCER; CELL-LINES; HEPATOCELLULAR-CARCINOMA; RECEPTOR 4; IN-VIVO; GLY388ARG POLYMORPHISM; LUNG ADENOCARCINOMA; SOMATIC MUTATIONS	Fibroblast growth factor receptor 4 (FGFR4) is vital in early development and tissue repair. FGFR4 expression levels are very restricted in adult tissues, except in several solid tumors including colorectal cancer, which showed overexpression of FGFR4. Here, FGFR4 mutation analysis discarded the presence of activating mutations, other than Arg(388), in different colorectal cancer cell lines and tumoral samples. Stable shRNA FGFR4-silencing in SW480 and SW48 cell lines resulted in a significant decrease in cell proliferation, adhesion, cell migration and invasion. This decrease in the tumorigenic and invasive capabilities of colorectal cancer cells was accompanied by a decrease of Snail, Twist and TGF beta gene expression levels and an increase of E-cadherin, causing a reversion to a more epithelial phenotype, in three different cell lines. In addition, FGFR4-signaling activated the oncogenic SRC, ERK1/2 and AKT pathways in colon cancer cells and promoted an increase in cell survival. The relevance of FGFR4 in tumor growth was supported by two different strategies. Kinase inhibitors abrogated FGFR4-related cell growth and signaling pathways at the same extent than FGFR4-silenced cells. Specific FGFR4-targeting using antibodies provoked a similar reduction in cell growth. Moreover, FGFR4 knock-down cells displayed a reduced capacity for in vivo tumor formation and angiogenesis in nude mice. Collectively, our data support a crucial role for FGFR4 in tumorigenesis, invasion and survival in colorectal cancer. In addition, FGFR4 targeting demonstrated its applicability for colorectal cancer therapy.	[Pelaez-Garcia, Alberto; Barderas, Rodrigo; Torres, Sofia; Ignacio Casal, J.] CSIC, CIB, Dept Celular & Mol Med, Madrid, Spain; [Hernandez-Varas, Pablo; Teixido, Joaquin] CSIC, CIB, Chemokines & Cell Migrat Lab, Madrid, Spain; [Bonilla, Felix] Hosp Puerta de Hierro Majadahonda, Madrid, Spain; [Garcia de Herreros, Antonio] Hosp del Mar, IMIM, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Casal, JI (corresponding author), CSIC, CIB, Dept Celular & Mol Med, Madrid, Spain.	icasal@cib.csic.es	de Herreros, A Garcia/H-3104-2014; Casal, Ignacio/M-2312-2014; Barderas, Rodrigo/K-3560-2014; Teixidó, Joaquin/J-8543-2014	de Herreros, A Garcia/0000-0001-5270-0808; Casal, Ignacio/0000-0003-1085-2840; Barderas, Rodrigo/0000-0003-3539-7469; Torres, Sofia/0000-0002-9007-8105; Hernandez-Varas, Pablo/0000-0001-8664-9203	Spanish Ministry of Science and Innovation [BIO2009-08818]; Comunidad de Madrid [S2011/BMD-2344/Colomics2]; FPI fellowship of the Spanish Ministry of Science and Innovation; JAE-DOC/FSE Contract (CSIC)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FPI fellowship of the Spanish Ministry of Science and Innovation; JAE-DOC/FSE Contract (CSIC)	This research was supported by grant BIO2009-08818 from the Spanish Ministry of Science and Innovation, grant to established research groups (AECC) and grant S2011/BMD-2344/Colomics2 from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Francisco X. Real (CNIO) for helpful collaboration and Novartis for the kind gift of inhibitor TKI-258. A. Pelaez-Garcia is a recipient of a FPI fellowship of the Spanish Ministry of Science and Innovation. R. Barderas was a recipient of a JAE-DOC/FSE Contract (CSIC) and is currently a fellow of the Ramon y Cajal programme. S. Torres was a recipient of a ProteoRed contract.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Auguste P, 2001, CANCER RES, V61, P1717; Babel I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001784; Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Bange J, 2002, CANCER RES, V62, P840; Barderas R, 2008, INT J CANCER, V122, P2351, DOI 10.1002/ijc.23395; Barderas R, 2012, J PROTEOMICS, V75, P4647, DOI 10.1016/j.jprot.2012.03.004; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Cronauer MV, 2003, EUR UROL, V43, P309, DOI 10.1016/S0302-2838(03)00005-8; de Frutos CA, 2007, DEV CELL, V13, P872, DOI 10.1016/j.devcel.2007.09.016; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ezzat S, 2002, J CLIN INVEST, V109, P69, DOI 10.1172/JCI200214036; FitzGerald LM, 2009, PROSTATE CANCER P D, V12, P192, DOI 10.1038/pcan.2008.46; French DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036713; GAGOS S, 1995, ANTICANCER RES, V15, P369; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; Heinzle C, 2012, CANCER RES, V72, P5767, DOI 10.1158/0008-5472.CAN-11-3654; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Lee SH, 2005, CLIN CANCER RES, V11, P3633, DOI 10.1158/1078-0432.CCR-04-2129; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; Martinez-Torrecuadrada JL, 2008, MOL CANCER THER, V7, P862, DOI 10.1158/1535-7163.MCT-07-0394; MORIKAWA K, 1988, CANCER RES, V48, P1943; MORIKAWA K, 1988, CANCER RES, V48, P6863; Nan H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-172; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ruhe JE, 2007, CANCER RES, V67, P11368, DOI 10.1158/0008-5472.CAN-07-2703; Sahadevan K, 2007, J PATHOL, V213, P82, DOI 10.1002/path.2205; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Spinola M, 2005, ONCOL REP, V14, P415; Spinola M, 2005, J CLIN ONCOL, V23, P7307, DOI 10.1200/JCO.2005.17.350; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Streit S, 2004, INT J CANCER, V111, P213, DOI 10.1002/ijc.20204; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Timmerman P, 2009, J BIOL CHEM, V284, P34126, DOI 10.1074/jbc.M109.041459; Tomlinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038972; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Trudel S, 2004, BLOOD, V103, P3521, DOI 10.1182/blood-2003-10-3650; Trudel S, 2006, BLOOD, V107, P4039, DOI 10.1182/blood-2005-10-4179; Wang JH, 2004, CLIN CANCER RES, V10, P6169, DOI 10.1158/1078-0432.CCR-04-0408; Wang JH, 2008, NEOPLASIA, V10, P847, DOI 10.1593/neo.08450; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Yang CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033870; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200; Zhu XG, 2010, AM J PATHOL, V177, P2860, DOI 10.2353/ajpath.2010.100509	54	43	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63695	10.1371/journal.pone.0063695	http://dx.doi.org/10.1371/journal.pone.0063695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696849	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900055
J	Utsunomiya, YT; O'Brien, AMP; Sonstegard, TS; Van Tassell, CP; do Carmo, AS; Meszaros, G; Solkner, J; Garcia, JF				Utsunomiya, Yuri Tani; O'Brien, Ana Maria Perez; Sonstegard, Tad Stewart; Van Tassell, Curtis Paul; do Carmo, Adriana Santana; Meszaros, Gabor; Soelkner, Johann; Garcia, Jose Fernando			Detecting Loci under Recent Positive Selection in Dairy and Beef Cattle by Combining Different Genome-Wide Scan Methods	PLOS ONE			English	Article							ARTIFICIAL SELECTION; CELL-DEATH; SIGNATURES; LACTATION; RECEPTOR; REGIONS; PROTEIN; ASSOCIATION; METABOLISM; FOOTPRINTS	As the methodologies available for the detection of positive selection from genomic data vary in terms of assumptions and execution, weak correlations are expected among them. However, if there is any given signal that is consistently supported across different methodologies, it is strong evidence that the locus has been under past selection. In this paper, a straightforward frequentist approach based on the Stouffer Method to combine P-values across different tests for evidence of recent positive selection in common variations, as well as strategies for extracting biological information from the detected signals, were described and applied to high density single nucleotide polymorphism (SNP) data generated from dairy and beef cattle (taurine and indicine). The ancestral Bovinae allele state of over 440,000 SNP is also reported. Using this combination of methods, highly significant (P<3.17 x 10(-7)) population-specific sweeps pointing out to candidate genes and pathways that may be involved in beef and dairy production were identified. The most significant signal was found in the Cornichon homolog 3 gene (CNIH3) in Brown Swiss (P = 3.82 x 10(-12)), and may be involved in the regulation of pre-ovulatory luteinizing hormone surge. Other putative pathways under selection are the glucolysis/gluconeogenesis, transcription machinery and chemokine/cytokine activity in Angus; calpain-calpastatin system and ribosome biogenesis in Brown Swiss; and gangliosides deposition in milk fat globules in Gyr. The composite method, combined with the strategies applied to retrieve functional information, may be a useful tool for surveying genome-wide selective sweeps and providing insights in to the source of selection.	[Utsunomiya, Yuri Tani; do Carmo, Adriana Santana] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil; [O'Brien, Ana Maria Perez; Meszaros, Gabor; Soelkner, Johann] BOKU Univ Nat Resources & Life Sci, Div Livestock Sci, Dept Sustainable Agr Syst, Vienna, Austria; [Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil; [Sonstegard, Tad Stewart; Van Tassell, Curtis Paul] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA	Universidade Estadual Paulista; University of Natural Resources & Life Sciences, Vienna; Universidade Estadual Paulista; United States Department of Agriculture (USDA)	Solkner, J (corresponding author), BOKU Univ Nat Resources & Life Sci, Div Livestock Sci, Dept Sustainable Agr Syst, Vienna, Austria.	johann.soelkner@boku.ac.at; jfgarcia@fmva.unesp.br	Van Tassell, Curtis P./O-4247-2019; Utsunomiya, Yuri Tani T/K-5214-2013; Mészáros, Gábor/I-2658-2019; Carmo, Adriana S/E-4342-2016	Van Tassell, Curtis P./0000-0002-8416-2087; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Mészáros, Gábor/0000-0002-5937-0060; Carmo, Adriana S/0000-0002-2712-4789; Solkner, Johann/0000-0002-1517-5829; Perez O'Brien, Ana Maria/0000-0002-2077-8421	European Science Foundation; Advances in Farm Animal Genomic Resources project [3726]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [560922/2010-8, 483590/2010-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/16643-2, 2010/52030-2]; USDA Agricultural Research Service [1265-31000-098D]	European Science Foundation(European Science Foundation (ESF)European Commission); Advances in Farm Animal Genomic Resources project; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research received support from the European Science Foundation and the Advances in Farm Animal Genomic Resources project (process no 3726), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (processes 560922/2010-8 and 483590/2010-0), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (processes 2011/16643-2 and 2010/52030-2) and USDA Agricultural Research Service (project 1265-31000-098D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the U. S. Department of Agriculture, the University of Natural Resources and Life Sciences Vienna, and The HapMap and The Zebu Genome Consortia for providing the genotypes used in this paper. We want to express our highest gratitude to the European Science Foundation and the Advances in Farm Animal Genomic Resources project for supporting this research. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the authors or their respective institutions.	Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Arnandis T, 2012, CELL DEATH DIFFER, V19, P1536, DOI 10.1038/cdd.2012.46; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bode L, 2004, J NUTR, V134, P3016, DOI 10.1093/jn/134.11.3016; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fay JC, 2000, GENETICS, V155, P1405; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; FU YX, 1993, GENETICS, V133, P693; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Grosz MD, 1999, J HERED, V90, P233, DOI 10.1093/jhered/90.1.233; Hayes BJ, 2008, ANIM GENET, V39, P105, DOI 10.1111/j.1365-2052.2007.01683.x; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kinsella RJ, 2011, ENSEMBL BIOMARTS HUB; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Koohmaraie M, 2006, MEAT SCI, V74, P34, DOI 10.1016/j.meatsci.2006.04.025; Kuhla B, 2011, J PROTEOME RES, V10, P4252, DOI 10.1021/pr200425h; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Momoeda M, 2007, J BIOCHEM, V142, P525, DOI 10.1093/jb/mvm175; Murray C, 2010, PHILOS T R SOC B, V365, P2531, DOI 10.1098/rstb.2010.0103; Nielsen R, 1998, GENETICS, V148, P929; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Oleksyk TK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001712; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schwarzenbacher H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-48; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Sugimoto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013817; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAJIMA F, 1989, GENETICS, V123, P585; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wilde CJ, 1997, EXP PHYSIOL, V82, P943, DOI 10.1113/expphysiol.1997.sp004075; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zhao CP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/756284; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949	56	70	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64280	10.1371/journal.pone.0064280	http://dx.doi.org/10.1371/journal.pone.0064280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696874	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900077
J	Pradhan, P; Reusser, DE; Kropp, JP				Pradhan, Prajal; Reusser, Dominik E.; Kropp, Juergen P.			Embodied Greenhouse Gas Emissions in Diets	PLOS ONE			English	Article							FOOD-CONSUMPTION PATTERNS; CLIMATE; TRANSFORMATION; AGRICULTURE; ENERGY	Changing food consumption patterns and associated greenhouse gas (GHG) emissions have been a matter of scientific debate for decades. The agricultural sector is one of the major GHG emitters and thus holds a large potential for climate change mitigation through optimal management and dietary changes. We assess this potential, project emissions, and investigate dietary patterns and their changes globally on a per country basis between 1961 and 2007. Sixteen representative and spatially differentiated patterns with a per capita calorie intake ranging from 1,870 to >3,400 kcal/day were derived. Detailed analyses show that low calorie diets are decreasing worldwide, while in parallel diet composition is changing as well: a discernable shift towards more balanced diets in developing countries can be observed and steps towards more meat rich diets as a typical characteristics in developed countries. Low calorie diets which are mainly observable in developing countries show a similar emission burden than moderate and high calorie diets. This can be explained by a less efficient calorie production per unit of GHG emissions in developing countries. Very high calorie diets are common in the developed world and exhibit high total per capita emissions of 3.7-6.1 kg CO2eq./day due to high carbon intensity and high intake of animal products. In case of an unbridled demographic growth and changing dietary patterns the projected emissions from agriculture will approach 20 Gt CO2eq./yr by 2050.	[Pradhan, Prajal; Reusser, Dominik E.; Kropp, Juergen P.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kropp, Juergen P.] Univ Potsdam, Dept Geo & Environm Sci, Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Pradhan, P (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	pradhan@pik-potsdam.de	Kropp, Juergen/D-8220-2012; Pradhan, Prajal/ABE-2912-2020	Kropp, Juergen/0000-0001-7791-3420; Pradhan, Prajal/0000-0003-0491-5489	Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany within the framework of the International Climate Protection Initiative	Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany within the framework of the International Climate Protection Initiative	The authors acknowledge the financial support from the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety of Germany who supports this work within the framework of the International Climate Protection Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N, 2006, WORLD AGR 2030 2050; BAUER HU, 1992, IEEE T NEURAL NETWOR, V3, P570, DOI 10.1109/72.143371; Bruinsma J, 2003, WORLD AGR 2015 2030; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Conforti P, 1997, AGR ECOSYST ENVIRON, V65, P231, DOI 10.1016/S0167-8809(97)00048-0; Costa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029262; DFT-UK, 2008, CARB SUST REP REN TR; Eshel G, 2006, EARTH INTERACT, V10, DOI 10.1175/EI167.1; Eshel G, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI321.1; FAO, 2001, FOOD BAL SHEETS HDB; FAOSTAT, 2011, GLOBAL FOOD LOSSES F; Fleurbaey M, 2009, J ECON LIT, V47, P1029, DOI 10.1257/jel.47.4.1029; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gerbens-Leenes PW, 2010, APPETITE, V55, P597, DOI 10.1016/j.appet.2010.09.013; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; Grigg D., 1999, GeoJournal, V48, P259, DOI 10.1023/A:1007047007738; GRIGG D, 1995, GEOFORUM, V26, P1, DOI 10.1016/0016-7185(94)00020-8; GRIGG D, 1995, J HIST GEOGR, V21, P247, DOI 10.1006/jhge.1995.0018; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Jolliffe, 2002, PRINCIPAL COMPONENT; KARIEL HG, 1966, ANN ASSOC AM GEOGR, V56, P68, DOI 10.1111/j.1467-8306.1966.tb00544.x; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kohonen T., 2001, SPRINGER SERIES INFO; Kropp J, 1998, APPL GEOGR, V18, P83, DOI 10.1016/S0143-6228(97)00048-9; Kropp JP, 2008, PROTOTYPING BROAD SC, P155; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Ludeke M. K. B., 1999, Environmental Modeling & Assessment, V4, P315, DOI 10.1023/A:1019032821703; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Metz ORDB, 2007, CLIMATE CHANGE 2007; Molden D, 2007, WATER FOOD WATER LIF, P279; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Schneider U. A., 2008, ENERGY EFFICIENCY, V2, P195, DOI DOI 10.1007/S12053-008-9035-5; Skupin A, 2002, LECT NOTES COMPUT SC, V2539, P161; Skupin A, 2008, INTRO WHAT IS SELF O, P1; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; TW Andreson, 2003, INTRO MULTIVARIATE S; UNDP, 2009, OV BARR HUM MOB DEV; US EPA, 2006, GLOB ANTHR NON CO2 G; WILLETT WC, 1994, SCIENCE, V264, P532, DOI 10.1126/science.8160011; Yan J, 2008, VISUAL EXPLORATION S, P67	48	79	79	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e62228	10.1371/journal.pone.0062228	http://dx.doi.org/10.1371/journal.pone.0062228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23700408	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700007
J	Boothe, DL; Cohen, AH; Troyer, TW				Boothe, David L.; Cohen, Avis H.; Troyer, Todd W.			Phase Locking Asymmetries at Flexor-Extensor Transitions during Fictive Locomotion	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; MAMMALIAN SPINAL-CORD; MOTOR UNITS; CAT; HINDLIMB; CYCLE; MUSCLES; RHYTHM; ORGANIZATION; MECHANISMS	The motor output for walking is produced by a network of neurons termed the spinal central pattern generator (CPG) for locomotion. The basic building block of this CPG is a half-center oscillator composed of two mutually inhibitory sets of interneurons, each controlling one of the two dominant phases of locomotion: flexion and extension. To investigate symmetry between the two components of this oscillator, we analyzed the statistics of natural variation in timing during fictive locomotion induced by stimulation of the midbrain locomotor region in the cat. As a complement to previously published analysis of these data focused on burst and cycle durations, we present a new analysis examining the strength of phase locking at the transitions between flexion and extension. Across our sample of nerve pairs, phase locking at the transition from extension to flexion (E to F) is stronger than at the transition from flexion to extension (F to E). This pattern did not reverse when considering bouts of fictive locomotion that were flexor vs. extensor dominated, demonstrating that asymmetric locking at the transitions between phases is dissociable from which phase dominates cycle duration. We also find that the strength of phase locking is correlated with the mean latency between burst offset and burst onset. These results are interpreted in the context of a hypothesis where network inhibition and intrinsic oscillatory mechanisms make distinct contributions to flexor-extensor alternation in half-center networks.	[Boothe, David L.; Cohen, Avis H.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Cohen, Avis H.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Cohen, Avis H.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Troyer, Todd W.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Texas System; University of Texas at San Antonio (UTSA)	Troyer, TW (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	todd.troyer@utsa.edu	Troyer, Todd W/C-2817-2011	Troyer, Todd W/0000-0002-2037-219X	United States National Science Foundation [IOS-0951310]; Division Of Integrative Organismal Systems [0951310] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work partially supported by United States National Science Foundation Grant IOS-0951310 to TWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAHAM LD, 1985, EXP BRAIN RES, V58, P580, DOI 10.1007/BF00235874; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Burke RE, 2001, J NEUROPHYSIOL, V86, P447, DOI 10.1152/jn.2001.86.1.447; Degtyarenko MA, 1996, J NEUROPHYSIOL, V76, P2972, DOI 10.1152/jn.1996.76.5.2972; DUM RP, 1980, J NEUROPHYSIOL, V43, P1615, DOI 10.1152/jn.1980.43.6.1615; EMONETDENAND F, 1988, J PHYSIOL-LONDON, V400, P135, DOI 10.1113/jphysiol.1988.sp017115; Endo T, 2008, J NEUROPHYSIOL, V100, P3043, DOI 10.1152/jn.90729.2008; ENGBERG I., 1964, PROGR BRAIN RES, V12, P274, DOI 10.1016/S0079-6123(08)60628-7; Frigon A, 2010, J NEUROSCI, V30, P7061, DOI 10.1523/JNEUROSCI.0450-10.2010; Frigon A, 2009, J PHYSIOL-LONDON, V587, P4617, DOI 10.1113/jphysiol.2009.176669; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Gossard JP, 2011, PROG BRAIN RES, V188, P15, DOI 10.1016/B978-0-444-53825-3.00007-3; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; GRILLNER S, 1984, ACTA PHYSIOL SCAND, V120, P393, DOI 10.1111/j.1748-1716.1984.tb07400.x; Jones SR, 2006, J MATH BIOL, V52, P115, DOI 10.1007/s00285-005-0348-0; Juvin L, 2007, J PHYSIOL-LONDON, V583, P115, DOI 10.1113/jphysiol.2007.133413; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; Louage DHG, 2004, J NEUROPHYSIOL, V91, P2051, DOI 10.1152/jn.00816.2003; Lundberg A, 1969, NANSEN MEMORIAL LECT, VV, P5; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MELLEN N, 1995, J NEUROPHYSIOL, V73, P1020, DOI 10.1152/jn.1995.73.3.1020; PERRET C, 1980, BRAIN RES, V187, P333, DOI 10.1016/0006-8993(80)90207-3; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Sherwood WE, 2011, J COMPUT NEUROSCI, V30, P323, DOI 10.1007/s10827-010-0259-y; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Spardy LE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065003; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Zar JH, 1999, BIOSTATISTICAL ANAL	32	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64421	10.1371/journal.pone.0064421	http://dx.doi.org/10.1371/journal.pone.0064421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700475	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200133
J	Christoforou, N; Chellappan, M; Adler, AF; Kirkton, RD; Wu, TY; Addis, RC; Bursac, N; Leong, KW				Christoforou, Nicolas; Chellappan, Malathi; Adler, Andrew F.; Kirkton, Robert D.; Wu, Tianyi; Addis, Russell C.; Bursac, Nenad; Leong, Kam W.			Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 Enhance the Cardio-Inducing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SERUM RESPONSE FACTOR; HUMAN SOMATIC-CELLS; LENTIVIRAL VECTORS; HUMAN FIBROBLASTS; GENE-EXPRESSION; DEFINED FACTORS; IN-VIVO; ELECTROPHYSIOLOGICAL PROPERTIES; FUNCTIONAL CARDIOMYOCYTES	Transient overexpression of defined combinations of master regulator genes can effectively induce cellular reprogramming: the acquisition of an alternative predicted phenotype from a differentiated cell lineage. This can be of particular importance in cardiac regenerative medicine wherein the heart lacks the capacity to heal itself, but simultaneously contains a large pool of fibroblasts. In this study we determined the cardio-inducing capacity of ten transcription factors to actuate cellular reprogramming of mouse embryonic fibroblasts into cardiomyocyte-like cells. Overexpression of transcription factors MYOCD and SRF alone or in conjunction with Mesp1 and SMARCD3 enhanced the basal but necessary cardio-inducing effect of the previously reported GATA4, TBX5, and MEF2C. In particular, combinations of five or seven transcription factors enhanced the activation of cardiac reporter vectors, and induced an upregulation of cardiac-specific genes. Global gene expression analysis also demonstrated a significantly greater cardio-inducing effect when the transcription factors MYOCD and SRF were used. Detection of cross-striated cells was highly dependent on the cell culture conditions and was enhanced by the addition of valproic acid and JAK inhibitor. Although we detected Ca2+ transient oscillations in the reprogrammed cells, we did not detect significant changes in resting membrane potential or spontaneously contracting cells. This study further elucidates the cardio-inducing effect of the transcriptional networks involved in cardiac cellular reprogramming, contributing to the ongoing rational design of a robust protocol required for cardiac regenerative therapies.	[Christoforou, Nicolas; Chellappan, Malathi; Adler, Andrew F.; Kirkton, Robert D.; Bursac, Nenad; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Wu, Tianyi] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Addis, Russell C.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Addis, Russell C.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Leong, KW (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	kam.leong@duke.edu	Leong, Kam W/A-7270-2009; Leong, Kam/O-9302-2019; Bursac, Nenad/AAU-5548-2021	Leong, Kam W/0000-0002-8133-4955; Leong, Kam/0000-0002-8133-4955; Bursac, Nenad/0000-0002-5688-6061; Wu, Tianyi/0000-0002-5386-2355; Kirkton, Robert/0000-0003-2285-1140	Flight Attendant Medical Research Institute - Young Clinical Scientist Award; NIH-NHLBI [R01HL104326, R21HL106203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106203, R01HL104326] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute - Young Clinical Scientist Award; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding from Flight Attendant Medical Research Institute - Young Clinical Scientist Award (www.famri.org) and NIH-NHLBI grants R01HL104326 and R21HL106203 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028719; Barth AS, 2008, MOL THER, V16, P957, DOI 10.1038/mt.2008.30; Bernheim L, 1996, J PHYSIOL-LONDON, V493, P129, DOI 10.1113/jphysiol.1996.sp021369; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; de Groot JR, 2003, CARDIOVASC RES, V60, P288, DOI 10.1016/j.cardiores.2003.07.004; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; IANNACCONE ST, 1987, J CELL PHYSIOL, V133, P409, DOI 10.1002/jcp.1041330230; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Ke QG, 2007, MOL PHARMACOL, V72, P1063, DOI 10.1124/mol.107.035881; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McSpadden LC, 2009, AM J PHYSIOL-CELL PH, V297, pC339, DOI 10.1152/ajpcell.00024.2009; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SUBRAMANIAM A, 1993, J BIOL CHEM, V268, P4331; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Welch P. D., 1967, AUDIO ELECTROACOUSTI, V15, P70, DOI DOI 10.1109/TAU.1967.1161901; Xiao YF, 2006, AM J PHYSIOL-CELL PH, V291, pC407, DOI 10.1152/ajpcell.00020.2006; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	62	99	102	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63577	10.1371/journal.pone.0063577	http://dx.doi.org/10.1371/journal.pone.0063577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704920	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200051
J	Jensen, AV; Jensen, L; Faurholt-Jepsen, D; Aabye, MG; Praygod, G; Kidola, J; Faurholt-Jepsen, M; Changalucha, J; Range, N; Krarup, H; Friis, H; Andersen, AB				Jensen, Andreas V.; Jensen, Lotte; Faurholt-Jepsen, Daniel; Aabye, Martine G.; Praygod, George; Kidola, Jeremiah; Faurholt-Jepsen, Maria; Changalucha, John; Range, Nyagosya; Krarup, Henrik; Friis, Henrik; Andersen, Aase B.			The Prevalence of Latent Mycobacterium tuberculosis Infection Based on an Interferon-gamma Release Assay: A Cross-Sectional Survey among Urban Adults in Mwanza, Tanzania	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HIV; GLYCOPROTEIN; DIAGNOSIS; DISEASE; IMPACT; TOOLS	Introduction: One third of the world's population is estimated to be latently infected with Mycobacterium tuberculosis (LTBI). Surveys of LTBI are rarely performed in resource poor TB high endemic countries like Tanzania although low-income countries harbor the largest burden of the worlds LTBI. The primary objective was to estimate the prevalence of LTBI in household contacts of pulmonary TB cases and a group of apparently healthy neighborhood controls in an urban setting of such a country. Secondly we assessed potential impact of LTBI on inflammation by quantitating circulating levels of an acute phase reactant: alpha-1-acid glycoprotein (AGP) in neighborhood controls. Methods: The study was nested within the framework of two nutrition studies among TB patients in Mwanza, Tanzania. Household contacts-and neighborhood controls were invited to participate. The study involved a questionnaire, BMI determination and blood samples to measure AGP, HIV testing and a Quantiferon Gold In tube (QFN-IT) test to detect signs of LTBI. Results: 245 household contacts and 192 neighborhood controls had available QFN-IT data. Among household contacts, the proportion of QFT-IT positive was 59% compared to 41% in the neighborhood controls (p = 0.001). In a linear regression model adjusted for sex, age, CD4 and HIV, a QFT-IT positive test was associated with a 10% higher level of alpha-1- acid glycoprotein(AGP) (10(B) 1.10, 95% CI 1.01; 1.20, p = 0.03), compared to individuals with a QFT-IT negative test. Conclusion: LTBI is highly prevalent among apparently healthy urban Tanzanians even without known exposure to TB in the household. LTBI was found to be associated with elevated levels of AGP. The implications of this observation merit further studies.	[Jensen, Andreas V.; Jensen, Lotte; Andersen, Aase B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Faurholt-Jepsen, Daniel; Faurholt-Jepsen, Maria; Friis, Henrik] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Aabye, Martine G.] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr, Copenhagen, Denmark; [Praygod, George; Kidola, Jeremiah; Changalucha, John] Natl Inst Med Res, Mwanza Res Ctr, Mwanza, Tanzania; [Range, Nyagosya] Natl Inst Med Res, Muhimbili Res Ctr, Dar Es Salaam, Tanzania; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	University of Southern Denmark; Odense University Hospital; University of Copenhagen; University of Copenhagen; National Institute of Medical Research; National Institute of Medical Research; Aalborg University; Aalborg University Hospital	Jensen, AV (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	Avestj@hotmail.com	Faurholt-Jepsen, Daniel/D-9453-2012; Friis, Henrik/P-2891-2019; Friis, Henrik/N-2047-2014; Faurholt-Jepsen, Daniel/M-6324-2019; PrayGod, George/L-7098-2018	Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Jensen, Andreas Vestergaard/0000-0002-8532-4703; Jeremiah, Kidola/0000-0001-7900-9689; PrayGod, George/0000-0002-0329-4839; Andersen, Aase Bengaard/0000-0003-4779-7603; Krarup, Henrik/0000-0001-5294-2428; Jensen, Lotte/0000-0001-7855-4036	University of Copenhagen	University of Copenhagen	The study was funded by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004220; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Almeida MLD, 2009, T ROY SOC TROP MED H, V103, P575, DOI 10.1016/j.trstmh.2008.11.024; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Faurholt-Jepsen M, 2011, BR J NUTR, P1; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hernandez-Pando R, 1998, EXP MOL PATHOL, V65, P25, DOI 10.1006/exmp.1998.2224; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Idh J, 2010, SCAND J INFECT DIS, V42, P650, DOI 10.3109/00365548.2010.482942; Johnson DA, 2006, BIOMED CHROMATOGR, V20, P551, DOI 10.1002/bmc.641; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Ling D, 2011, LANCET INFECT DIS; Menzies D, 2011, INDIAN J MED RES, V133, P257; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; PrayGod G, 2011, J NUTR, V141, P685, DOI 10.3945/jn.110.131672; Ramanath RG, 1971, INDIAN J TUBERC, VXVIII, P3; Sheriff FG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-52; World Health Organization, 2009, 09 AIDS EP UPD; World Health Organization stop TB Department, 2010, US TUB INT GAMM REL, P1; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	24	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64008	10.1371/journal.pone.0064008	http://dx.doi.org/10.1371/journal.pone.0064008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700446	Green Published, gold			2022-12-25	WOS:000319330200104
J	Saberi, S; Emberly, E				Saberi, Saeed; Emberly, Eldon			Non-Equilibrium Polar Localization of Proteins in Bacterial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI-CELLS; SPATIAL-ORGANIZATION; CHROMOSOME; DIVISION; CHEMORECEPTOR; CAULOBACTER; REVEALS	Many proteins are observed to localize to the poles within bacterial cells. Some bacteria show unipolar localization, yet under different conditions bipolar patterns can emerge. One mechanism for spontaneous polar localization has been shown to involve the combination of protein aggregation and nucleoid occlusion. Whether the different observed patterns represent global energy minima for the cellular system remains to be determined. In this paper we show that for a model consisting only of protein aggregation along with an excluded volume effect due to the DNA polymer, that unipolar patterns are the global energy ground state regardless of protein concentration and DNA density. We extend the model to allow for proteins to be added to the cellular volume at a constant rate and show that bipolar (or multi-foci) patterns emerge as the result of the system being kinetically trapped in a local energy minimum. Lastly we also consider the situation of a growing cell that starts with a pre-existing aggregate at one of the poles and determine conditions under which either unipolar or bipolar patterns can exist at the point when it is ready to divide. This work sheds new interpretations on recently published experimental data and suggests experiments to test whether such a mechanism can drive patterning in bacteria.	[Saberi, Saeed; Emberly, Eldon] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Emberly, E (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	eemberly@sfu.ca			NSERC Operating Grant	NSERC Operating Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a NSERC Operating Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bowman GR, 2010, MOL MICROBIOL, V76, P173, DOI 10.1111/j.1365-2958.2010.07088.x; Buenemann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013806; Charlebois R, 1999, STRUCTURE DNA BACTER, P171; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Junier I, 2012, J MOL BIOL, V419, P369, DOI 10.1016/j.jmb.2012.03.009; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Pelletier J, 2012, P NATL ACAD SCI USA, V109, pE2649, DOI 10.1073/pnas.1208689109; Ping LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038427; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Saberi S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000986; Thiem S, 2008, MOL MICROBIOL, V68, P1228, DOI 10.1111/j.1365-2958.2008.06227.x; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Wang H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218101; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412	29	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64075	10.1371/journal.pone.0064075	http://dx.doi.org/10.1371/journal.pone.0064075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700458	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200111
J	Weisman, S; Kessler, DA				Weisman, Shlomit; Kessler, David A.			Coexistence in an Inhomogeneous Environment	PLOS ONE			English	Article							DISPERSAL	We examine the two-dimensional extension of the model of Kessler and Sander of competition between two species identical except for dispersion rates. In this class of models, the spatial inhomogeneity of reproduction rates gives rise to an implicit cost of dispersal, due to the tendency to leave favorable locations. Then, as in the Hamilton-May model with its explicit dispersal cost, the tradeoff between dispersal case and the beneficial role of dispersal in limiting fluctuations, leads to an advantage of one dispersal rate over another, and the eventual extinction of the disadvantaged species. In two dimensions we find that while the competition leads to the elimination of one species at high and low population density, at intermediate densities the two species can coexist essentially indefinitely. This is a new phenomenon not present in either the one-dimensional form of the Kessler Sander model nor in the totally connected Hamilton-May model, and points to the importance of geometry in the question of dispersal.	[Weisman, Shlomit; Kessler, David A.] Bar Ilan Univ, Dept Phys, Ramat Gan, Israel	Bar Ilan University	Kessler, DA (corresponding author), Bar Ilan Univ, Dept Phys, Ramat Gan, Israel.	kessler@dave.ph.biu.ac.il	Kessler, David/B-1391-2008	Kessler, David/0000-0002-5279-1655				COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; Dockery J, 1998, J MATH BIOL, V37, P61, DOI 10.1007/s002850050120; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HASTINGS A, 1983, THEOR POPUL BIOL, V24, P244, DOI 10.1016/0040-5809(83)90027-8; Kessler DA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041907	5	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62699	10.1371/journal.pone.0062699	http://dx.doi.org/10.1371/journal.pone.0062699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704883	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200012
J	Aldrin, M; Storvik, B; Kristoffersen, AB; Jansen, PA				Aldrin, Magne; Storvik, Bard; Kristoffersen, Anja Brathen; Jansen, Peder Andreas			Space-Time Modelling of the Spread of Salmon Lice between and within Norwegian Marine Salmon Farms	PLOS ONE			English	Article							LEPEOPHTHEIRUS-SALMONIS; ATLANTIC SALMON; SEA LICE; POPULATION-DYNAMICS; WILD SALMON; SALAR L.; TRANSMISSION; INFESTATION; PARASITES; ANEMIA	Parasitic salmon lice are potentially harmful to salmonid hosts and farm produced lice pose a threat to wild salmonids. To control salmon lice infections in Norwegian salmonid farming, numbers of lice are regularly counted and lice abundance is reported from all salmonid farms every month. We have developed a stochastic space-time model where monthly lice abundance is modelled simultaneously for all farms. The set of farms is regarded as a network where the degree of contact between farms depends on their seaway distance. The expected lice abundance at each farm is modelled as a function of i) lice abundance in previous months at the same farm, ii) at neighbourhood farms, and iii) other, unspecified sources. In addition, the model includes explanatory variables such as seawater temperature and farm-numbers of fish. The model gives insight into factors that affect salmon lice abundance and contributing sources of infection. New findings in this study were that 66% of the expected salmon lice abundance was attributed to infection within farms, 28% was attributed to infection from neighbourhood farms and 6% to non-specified sources of infection. Furthermore, we present the relative risk of infection between neighbourhood farms as a function of seaway distance, which can be viewed as a between farm transmission kernel for salmon lice. The present modelling framework lays the foundation for development of future scenario simulation tools for examining the spread and abundance of salmon lice on farmed salmonids under different control regimes.	[Aldrin, Magne; Storvik, Bard] Norwegian Comp Ctr, Oslo, Norway; [Aldrin, Magne] Univ Oslo, Dept Math, Oslo, Norway; [Kristoffersen, Anja Brathen; Jansen, Peder Andreas] Norwegian Vet Inst, Oslo, Norway; [Kristoffersen, Anja Brathen] Univ Oslo, Dept Informat, N-0316 Oslo, Norway	University of Oslo; Norwegian Veterinary Institute; University of Oslo	Aldrin, M (corresponding author), Norwegian Comp Ctr, Oslo, Norway.	magne.aldrin@nr.no	Aldrin, Magne/A-7425-2017	Aldrin, Magne/0000-0003-2718-8528	Research Council of Norway project PREVENT, "Salmon lice-prevention and treatment" [199778/S40]	Research Council of Norway project PREVENT, "Salmon lice-prevention and treatment"	This work was funded by the Research Council of Norway project PREVENT, "Salmon lice-prevention and treatment," project number 199778/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalen OO, 2008, STAT BIOL HEALTH, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldrin M, 2011, J R SOC INTERFACE, V8, P1346, DOI 10.1098/rsif.2010.0737; Aldrin M, 2010, PREV VET MED, V93, P51, DOI 10.1016/j.prevetmed.2009.09.010; Amundrud TL, 2009, J FISH DIS, V32, P27, DOI 10.1111/j.1365-2761.2008.00980.x; [Anonymous], 2008, MODEL SELECTION MODE; [Anonymous], 2009, LAKSE SJOAUREFISKE 2, P423; Bjorn PA, 2002, ICES J MAR SCI, V59, P131, DOI 10.1006/jmsc.2001.1143; Bricknell IR, 2006, DIS AQUAT ORGAN, V71, P201, DOI 10.3354/dao071201; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Diggle PJ, 2006, STAT METHODS MED RES, V15, P325, DOI 10.1191/0962280206sm454oa; Grenfell BT, 1995, PARASITOLOGY, V111, pS135, DOI 10.1017/S0031182000075867; Held L, 2012, BIOMETRICAL J, V54, P824, DOI 10.1002/bimj.201200037; Heuch PA, 2001, DIS AQUAT ORGAN, V45, P145, DOI 10.3354/dao045145; Hohle M, 2009, BIOMETRICAL J, V51, P961, DOI 10.1002/bimj.200900050; Irvine RJ, 2000, PARASITOLOGY, V120, P297, DOI 10.1017/S0031182099005430; Jackson D, 2013, J FISH DIS, V36, P273, DOI 10.1111/jfd.12054; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; Johnson N., 1993, UNIVARIATE DISCRETE, Vsecond; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2012, P ROYAL SOC B, V280, DOI DOI 10.1098/RSPB.2012.2359; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2011, P NATL ACAD SCI USA, V108, P14700, DOI 10.1073/pnas.1101845108; Little R. J. A., 1987, STAT ANAL MISSING DA; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Marty GD, 2010, P NATL ACAD SCI USA, V107, P22599, DOI 10.1073/pnas.1009573108; Scheel I, 2007, J R SOC INTERFACE, V4, P699, DOI 10.1098/rsif.2007.0217; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Skilbrei OT, 2013, J FISH DIS, V36, P249, DOI 10.1111/jfd.12052; Stien A, 2005, MAR ECOL PROG SER, V290, P263, DOI 10.3354/meps290263; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Torrissen O, 2011, REV FISH SCI, V19, P257, DOI 10.1080/10641262.2011.597890; Zuur Alain F., 2009, P1	35	46	47	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64039	10.1371/journal.pone.0064039	http://dx.doi.org/10.1371/journal.pone.0064039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700455	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400046
J	Parikh, RY; Kim, HD				Parikh, Rasesh Y.; Kim, Harold D.			The Effect of an Intervening Promoter Nucleosome on Gene Expression	PLOS ONE			English	Article							PHO5 PROMOTER; TRANSCRIPTIONAL ACTIVATION; DNA-SEQUENCE; IN-VIVO; OCCUPANCY; RECONSTITUTION; ACCESSIBILITY; NUMBERS; BINDING; SWI/SNF	Nucleosomes, which are the basic packaging units of chromatin, are stably positioned in promoters upstream of most stress-inducible genes. These promoter nucleosomes are generally thought to repress gene expression due to exclusion; they prevent transcription factors from accessing their target sites on the DNA. However, the role of promoter nucleosomes that do not directly occlude transcription factor binding sites is not obvious. Here, we varied the stability of a non-occluding nucleosome positioned between a transcription factor binding site and the TATA box region in an inducible yeast promoter and measured downstream gene expression level. We found that gene expression level depends on the occupancy of the non-occluding nucleosome in a non-monotonic manner. We postulated that a non-occluding nucleosome can serve both as a vehicle of and a barrier to chromatin remodeling activity and built a quantitative, nonequilibrium model to explain the observed nontrivial effect of the intervening nucleosome. Our work sheds light on the dual role of nucleosome as a repressor and an activator and expands the standard model of gene expression to include irreversible promoter chromatin transitions.	[Parikh, Rasesh Y.; Kim, Harold D.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Kim, HD (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	harold.kim@physics.gatech.edu			Burroughs Wellcome Fund CASI award	Burroughs Wellcome Fund CASI award(Burroughs Wellcome Fund)	HDK received support from Burroughs Wellcome Fund CASI award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; Dhasarathy A, 2005, MOL CELL BIOL, V25, P2698, DOI 10.1128/MCB.25.7.2698-2707.2005; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Ertel F, 2010, MOL CELL BIOL, V30, P4060, DOI 10.1128/MCB.01399-09; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Mao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017521; Mao CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.83; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Sanso M, 2011, NUCLEIC ACIDS RES, V39, P6369, DOI 10.1093/nar/gkr255; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Terrell AR, 2002, J BIOL CHEM, V277, P31038, DOI 10.1074/jbc.M204662200; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; VOGEL K, 1989, MOL CELL BIOL, V9, P2050, DOI 10.1128/MCB.9.5.2050; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	51	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63072	10.1371/journal.pone.0063072	http://dx.doi.org/10.1371/journal.pone.0063072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700413	Green Submitted, Green Published, gold			2022-12-25	WOS:000319966400011
J	Su, JY; Lai, HQ; Chen, JP; Li, L; Wong, YS; Chen, TF; Li, XL				Su, Jianyu; Lai, Haoqiang; Chen, Jianping; Li, Lin; Wong, Yum-Shing; Chen, Tianfeng; Li, Xiaoling			Natural Borneol, a Monoterpenoid Compound, Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Enhancement of Cellular Uptake and Activation of ROS-Mediated DNA Damage	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; INTESTINAL-ABSORPTION; CANCER-CELLS; DRUG-RESISTANCE; P-GLYCOPROTEIN; BREAST-CANCER; MCF-7 CELLS; PREVENTION; SELENIUM; AKT	Selenocystine (SeC) has been identified as a novel compound with broad-spectrum anticancer activities. Natural borneol (NB) is a monoterpenoid compound that has been used as a promoter of drug absorption. In the present study, we demonstrated that NB significantly enhanced the cellular uptake of SeC and potentiated its antiproliferative activity on HepG2 cells by induction of apoptosis. NB effectively synergized with SeC to reduce cancer cell growth through the triggering apoptotic cell death. Further mechanistic studies by Western blotting showed that treatment of the cells with NB and SeC activated the intrinsic apoptotic pathway by regulation of pro-survival and pro-apoptotic Bcl-2 family proteins. Treatment of the cells with NB and SeC induced the activation of p38MAPK and inactivation of Akt and ERK. NB also potentiated SeC to trigger intracellular ROS generation and DNA strand breaks as examined by Comet assay. Moreover, the thiol-reducing antioxidants effectively blocked the occurrence of cell apoptosis, which confirmed the important role of ROS in cell apoptosis. Taken together, these results reveal that NB strongly potentiates SeC-induced apoptosis in cancer cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage. NB could be further developed as a chemosensitizer of SeC in treatment of human cancers.	[Su, Jianyu; Chen, Jianping; Li, Lin] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Lai, Haoqiang; Chen, Tianfeng; Li, Xiaoling] Jinan Univ, Dept Chem, Guangzhou, Guangdong, Peoples R China; [Wong, Yum-Shing] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China	South China University of Technology; Jinan University; Chinese University of Hong Kong	Su, JY (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China.	jysu@scut.edu.cn; tlxlli@jnu.edu.cn	Chen, Tianfeng/AAG-6123-2019	Su, Jianyu/0000-0002-1662-0461	National Natural Science Foundation of China [31101278, 31130042, 21271002, 21201082]; Guangdong Province, 973-plan [2012CB720800]; national science and technology support program [2012BAD37B01]; Doctoral Foundation of Ministry of Education of China; Research Fund for the Doctoral Program of Higher Education of China [20110172120033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province, 973-plan; national science and technology support program; Doctoral Foundation of Ministry of Education of China(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (31101278, 31130042, 21271002 and 21201082) and Guangdong Province, 973-plan (2012CB720800), the national science and technology support program (2012BAD37B01), the Doctoral Foundation of Ministry of Education of China, and the Research Fund for the Doctoral Program of Higher Education of China (20110172120033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjorkhem-Bergman L, 2005, CARCINOGENESIS, V26, P125, DOI 10.1093/carcin/bgh290; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Breier A, 2013, ANTI-CANCER AGENT ME, V13, P159, DOI 10.2174/187152013804487380; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Cai Z, 2008, J DRUG TARGET, V16, P178, DOI 10.1080/10611860701794395 ; Cao J, 2009, FREE RADICAL BIO MED, V47, P536, DOI 10.1016/j.freeradbiomed.2009.05.024; Chan JYW, 2000, LIFE SCI, V67, P2117, DOI 10.1016/S0024-3205(00)00798-0; Chen J, 2011, MOL CANCER THER, V10, P2340, DOI 10.1158/1535-7163.MCT-11-0415; Chen T, 2008, CELL MOL LIFE SCI, V65, P2763, DOI 10.1007/s00018-008-8329-2; Chen TF, 2009, BIOMED PHARMACOTHER, V63, P105, DOI 10.1016/j.biopha.2008.03.009; Chen TF, 2008, BIOMED PHARMACOTHER, V62, P77, DOI 10.1016/j.biopha.2007.12.002; Chen TF, 2009, INT J BIOCHEM CELL B, V41, P666, DOI 10.1016/j.biocel.2008.07.014; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Donovan M, 2004, BBA-MOL CELL RES, V1644, P133, DOI 10.1016/j.bbamcr.2003.08.011; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Fan JG, 2009, J GASTROEN HEPATOL, V24, P712, DOI 10.1111/j.1440-1746.2009.05776.x; Gao Y, 2008, INT J PHARMACEUT, V354, P126, DOI 10.1016/j.ijpharm.2007.11.061; Guo X R, 2012, MICROWAVE MILLIMETER, P1, DOI DOI 10.1016/J.C0NC0G.2012.12.001; Hait WN, 2005, SEMIN ONCOL, V32, pS16, DOI 10.1053/j.seminoncol.2005.09.011; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Horvathova E, 2009, FOOD CHEM TOXICOL, V47, P1318, DOI 10.1016/j.fct.2009.03.002; Katzenellenbogen M, 2007, MOL CANCER THER, V6, P1283, DOI 10.1158/1535-7163.MCT-06-0420; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Kopper Laszlo, 2008, V11, P103, DOI 10.1007/978-1-4020-6729-7_7; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Lee JS, 2010, CANCER LETT, V297, P144, DOI 10.1016/j.canlet.2010.05.006; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lu Y, 2011, J ZHEJIANG UNIV-SC B, V12, P143, DOI 10.1631/jzus.B1000121; Makin G, 2001, BREAST CANCER RES, V3, P150, DOI 10.1186/bcr289; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Rikiishi H, 2007, J BIOENERG BIOMEMBR, V39, P91, DOI 10.1007/s10863-006-9065-7; Shen Q, 2011, AAPS PHARMSCITECH, V12, P1044, DOI 10.1208/s12249-011-9672-4; Varma MVS, 2004, CURR DRUG METAB, V5, P375, DOI 10.2174/1389200043335423; Wang NS, 2003, TRADIT CHIN DRUG RES, V14, P96; [吴纯洁 WU Chujie], 2005, [中国药学杂志, Chinese Pharmaceutical Journal], V40, P1710; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Yamaguchi K, 2005, ONCOGENE, V24, P5868, DOI 10.1038/sj.onc.1208742; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Zhou YQ, 2010, ENVIRON TOXICOL PHAR, V29, P229, DOI 10.1016/j.etap.2010.01.004	49	80	84	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63502	10.1371/journal.pone.0063502	http://dx.doi.org/10.1371/journal.pone.0063502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700426	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400022
J	Krismer, F; Wenning, GK; Li, YT; Poewe, W; Stefanova, N				Krismer, Florian; Wenning, Gregor K.; Li, Yuntao; Poewe, Werner; Stefanova, Nadia			Intact Olfaction in a Mouse Model of Multiple System Atrophy	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; OLIGODENDROCYTE PROMOTER; DYSFUNCTION; BULB; NEURODEGENERATION; EXPRESSION; DEGENERATION; DISORDERS; STAGE	Background: Increasing evidence suggests that olfaction is largely preserved in multiple system atrophy while most patients with Parkinson's disease are hyposmic. Consistent with these observations, recent experimental studies demonstrated olfactory deficits in transgenic Parkinson's disease mouse models, but corresponding data are lacking for MSA models. Methods: Olfactory function and underlying neuropathological changes were investigated in a transgenic multiple system atrophy mouse model based on targeted oligodendroglial overexpression of alpha-synuclein as well as wild-type controls. The study was divided into (1) a pilot study investigating olfactory preference testing and (2) a long-term study characterizing changes in the olfactory bulb of aging transgenic multiple system atrophy mice. esults: In our pilot behavioral study, we observed no significant differences in investigation time in the olfactory preference test comparing transgenic with wild-type animals. These findings were accompanied by unaffected tyrosine hydroxylase-positive cell numbers in the olfactory bulb. Similarly, although a significant age-related increase in the amount of alpha-synuclein within the olfactory bulb was detected in the long-term study, progressive degeneration of the olfactory bulb could not be verified. Conclusions: Our experimental data show preserved olfaction in a transgenic multiple system atrophy mouse model despite alpha-synucleinopathy in the olfactory bulb. These findings are in line with the human disorder supporting the concept of a primary oligodendrogliopathy with variable neuronal involvement.	[Krismer, Florian; Wenning, Gregor K.; Li, Yuntao; Poewe, Werner; Stefanova, Nadia] Med Univ Innsbruck, Dept Neurol, Div Neurobiol, A-6020 Innsbruck, Austria; [Li, Yuntao] Nanjing Med Univ, Affiliated Hosp 2, Sch Clin Med 2, Nanjing, Jiangsu, Peoples R China	Medical University of Innsbruck; Nanjing Medical University	Stefanova, N (corresponding author), Med Univ Innsbruck, Dept Neurol, Div Neurobiol, A-6020 Innsbruck, Austria.	nadia.stefanova@i-med.ac.at	Stefanova, Nadia/ABF-5664-2020; Krismer, Florian/T-1011-2017	Stefanova, Nadia/0000-0001-8188-639X; Krismer, Florian/0000-0002-4493-5073; Wenning, Gregor/0000-0001-9077-1666	Austrian Science Fund (FWF) [F04404-B19, P25161-B24]; Austrian Science Fund (FWF) [P 25161] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants of the Austrian Science Fund (FWF): F04404-B19 and P25161-B24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Garland EM, 2011, NEUROLOGY, V76, P456, DOI 10.1212/WNL.0b013e31820a0caf; Glass Philip G, 2012, Mov Disord, V27, P327, DOI 10.1002/mds.23972; Goldstein DS, 2009, PARKINSONISM RELAT D, V15, P516, DOI 10.1016/j.parkreldis.2008.12.009; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kikuchi A, 2011, PARKINSONISM RELAT D, V17, P698, DOI 10.1016/j.parkreldis.2011.07.011; Kim YH, 2011, NEUROSCIENCE, V172, P379, DOI 10.1016/j.neuroscience.2010.10.072; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kovacs T, 2003, MOVEMENT DISORD, V18, P938, DOI 10.1002/mds.10466; Muller A, 2002, J CLIN NEUROSCI, V9, P521, DOI 10.1054/jocn.2001.1071; Nee L E, 1993, Clin Auton Res, V3, P281, DOI 10.1007/BF01829019; Nuber S, 2011, NEUROBIOL DIS, V44, P192, DOI 10.1016/j.nbd.2011.06.017; PEARCE RKB, 1995, MOVEMENT DISORD, V10, P283, DOI 10.1002/mds.870100309; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Stefanova N, 2012, ACTA NEUROPATHOL, V124, P51, DOI 10.1007/s00401-012-0977-5; Stefanova N, 2012, NEUROTOX RES, V21, P393, DOI 10.1007/s12640-011-9294-3; Stefanova N, 2009, EXP NEUROL, V219, P368, DOI 10.1016/j.expneurol.2009.05.016; Stemberger S, 2010, EXP NEUROL, V224, P459, DOI 10.1016/j.expneurol.2010.05.008; Suzuki M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-157; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Ubeda-Banon I, 2010, MOVEMENT DISORD, V25, P1701, DOI 10.1002/mds.23197; Ubhi K, 2010, J NEUROSCI, V30, P6236, DOI 10.1523/JNEUROSCI.0567-10.2010; Wenning GK, 2004, LANCET NEUROL, V3, P93, DOI 10.1016/S1474-4422(03)00662-8; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247, DOI 10.1111/j.1600-0404.1995.tb06998.x; Witt Rochelle M, 2009, J Vis Exp, DOI 10.3791/949; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032	34	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64625	10.1371/journal.pone.0064625	http://dx.doi.org/10.1371/journal.pone.0064625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691255	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900112
J	Masala, S; Zedda, MA; Cossu, D; Ripoli, C; Palermo, M; Sechi, LA				Masala, Speranza; Zedda, Maria Antonietta; Cossu, Davide; Ripoli, Carlo; Palermo, Mario; Sechi, Leonardo A.			Zinc Transporter 8 and MAP3865c Homologous Epitopes are Recognized at T1D Onset in Sardinian Children	PLOS ONE			English	Article							TYPE-1; AUTOANTIGEN; ZNT8	Our group has recently demonstrated that Mycobacterium avium subspecies paratuberculosis (MAP) infection significantly associates with T1D in Sardinian adult patients. Due to the potential role played by MAP in T1D pathogenesis, it is relevant to better characterize the prevalence of anti-MAP antibodies (Abs) in the Sardinian population, studying newly diagnosed T1D children. Therefore, we investigated the seroreactivity against epitopes derived from the ZnT8 autoantigen involved in children at T1D onset and their homologous sequences of the MAP3865c protein. Moreover, sera from all individuals were tested for the presence of Abs against: the corresponding ZnT8 C-terminal region, the MAP specific protein MptD, the T1D autoantigen GAD65 and the T1D unrelated Acetylcholine Receptor. The novel MAP3865c(281-287) epitope emerges here as the major C-terminal epitope recognized. Intriguingly ZnT8(186-194) immunodominant peptide was cross-reactive with the homologous sequences MAP3865c(133-141), strengthening the hypothesis that MAP could be an environmental trigger of T1D through a molecular mimicry mechanism. All eight epitopes were recognized by circulating Abs in T1D children in comparison to healthy controls, suggesting that these Abs could be biomarkers of T1D. It would be relevant to investigate larger cohorts of children, followed over time, to elucidate whether Ab titers against these MAP/Znt8 epitopes wane after diagnosis.	[Masala, Speranza; Cossu, Davide; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Sardinia, Italy; [Zedda, Maria Antonietta; Ripoli, Carlo] Clin Pediat Macciotta, Cagliari, Sardinia, Italy; [Palermo, Mario] AOU, Endocrinol Unit, Dept Med, Sassari, Sardinia, Italy	University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Sardinia, Italy.	sechila@uniss.it	Cossu, Davide/AAD-7958-2019; Sechi, Leonardo Antonio/Y-3109-2018; ripoli, carlo/ABF-7927-2021; Cossu, Davide/C-4452-2013	Cossu, Davide/0000-0002-0557-9467; Masala, Speranza/0000-0003-4943-9164; sechi, leonardo antonio/0000-0003-0566-2049; Ripoli, Carlo/0000-0002-2530-0822	Sardinian Region L.R. 7: Progetti di ricerca di base; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale Protocollo: 2009ZYECWZ and Italian Minister of Health; Finalized Research [RF-2009-1545765]; Fondazione Banco di Sardegna	Sardinian Region L.R. 7: Progetti di ricerca di base; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale Protocollo: 2009ZYECWZ and Italian Minister of Health(Ministry of Education, Universities and Research (MIUR)); Finalized Research; Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This research was supported by the Sardinian Region L.R. 7 2009 and 2010: Progetti di ricerca di base; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale < Bando PRIN 2009 > Protocollo: 2009ZYECWZ and Italian Minister of Health, "Finalized Research" Protocollo: RF-2009-1545765, to LAS; and by the Fondazione Banco di Sardegna for Speranza Masala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Bitti MLM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/785262; Cossu D, 2013, FUTURE MICROBIOL, V8, P223, DOI [10.2217/fmb.12.135, 10.2217/FMB.12.135]; Enee E, 2012, DIABETES, V61, P1779, DOI 10.2337/db12-0071; Galli L, 2012, PEDIATR INFECT DIS J, V31, P1295, DOI 10.1097/INF.0b013e3182757c4d; Hummel K, 2012, J PEDIATR-US, V161, P652, DOI 10.1016/j.jpeds.2012.03.061; Knip M, 2010, DIABETES CARE, V33, P1206, DOI 10.2337/dc09-1040; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Regnell SE, 2013, DIABETIC MED, V30, P155, DOI 10.1111/dme.12099; Scotto M, 2012, DIABETOLOGIA, V55, P2026, DOI 10.1007/s00125-012-2543-z; Sechi LA, 2004, MICROBIOLOGICA, V27, P75; Sechi LA, 2008, CLIN VACCINE IMMUNOL, V15, P320, DOI 10.1128/CVI.00381-07; Sechi LA, 2008, CLIN INFECT DIS, V46, P148, DOI 10.1086/524084; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104	15	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63371	10.1371/journal.pone.0063371	http://dx.doi.org/10.1371/journal.pone.0063371			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696819	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900038
J	Lv, YT; Margulies, DS; Villringer, A; Zang, YF				Lv, Yating; Margulies, Daniel S.; Villringer, Arno; Zang, Yu-Feng			Effects of Finger Tapping Frequency on Regional Homogeneity of Sensorimotor Cortex	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; MOTOR CORTEX; COHERENCE; ASYMMETRY; MOVEMENT; DISEASE; BRAIN	Resting-state functional magnetic resonance imaging (RS-fMRI) has been widely used to investigate temporally correlated fluctuations between distributed brain areas, as well as to characterize local synchronization of low frequency (<0.1 Hz) spontaneous fMRI signal. Regional homogeneity (ReHo) was proposed as a voxel-wise measure of the synchronization of the timecourses of neighboring voxels and has been used in many studies of brain disorders. However, the interpretation of ReHo remains challenging because the effect of high frequency task on ReHo is still not clear. In order to investigate the effect of a high-frequency task on the modulation of local synchronization of resting-state activity, we employed three right-finger movement scanning sessions: slow-event related ('Slow'), fast-event related ('Fast'), and continuous finger pressure ('Tonic'), from 21 healthy participants and compared the ReHo of the three task states with that of resting-state ('Rest'). In the contralateral sensorimotor cortex, 'Slow' task state showed greater ReHo than 'Rest' in low frequency band (0-0.08Hz) fMRI signal, but lower ReHo in high frequency band (0.08-1.67 Hz); 'Fast' task state showed lower ReHo than 'Rest' in both the low and high frequency band; 'Tonic' state did not show any significant difference compared to 'Rest'. The results in the contralateral sensorimotor cortex suggest that local synchronization of BOLD signal varies with different finger tapping speed. In the ipsilateral sensorimotor cortex, all the three task states had lower ReHo than the 'Rest' state both in the low and high frequency, suggesting a similar effect of fast and slow finger tapping frequencies on local synchronization of BOLD signal in the ipsilateral motor cortex.	[Lv, Yating; Margulies, Daniel S.; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Lv, Yating; Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Margulies, Daniel S.; Villringer, Arno] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zang, Yu-Feng] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Max Planck Society; Hangzhou Normal University; Humboldt University of Berlin; Beijing Normal University	Zang, YF (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	zangyf@hznu.edu.cn	ZANG, Yu-Feng/J-1558-2012; Margulies, Daniel/L-4719-2016	ZANG, Yu-Feng/0000-0003-1833-8010; Margulies, Daniel/0000-0002-8880-9204; Villringer, Arno/0000-0003-2604-2404; Lv, Yating/0000-0002-5547-3361	National Natural Science Foundation of China (NSFC) [81020108022, 30770594]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC) (81020108022, 30770594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki Y, 2006, NEUROSCIENCE, V141, P2147, DOI 10.1016/j.neuroscience.2006.05.030; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Deshpande G, 2009, HUM BRAIN MAPP, V30, P13, DOI 10.1002/hbm.20482; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He Y, 2004, LECT NOTES COMPUT SC, V3217, P907; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li Y, 2012, CEREB CORTEX, DOI [10.1093/cercor/bhs185, DOI 10.1093/CERC0R/BHS185]; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; NETZ J, 1995, EXP BRAIN RES, V104, P527; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Rao SM, 1996, J CEREBR BLOOD F MET, V16, P1250, DOI 10.1097/00004647-199611000-00020; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	25	23	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64115	10.1371/journal.pone.0064115	http://dx.doi.org/10.1371/journal.pone.0064115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696867	Green Published, gold			2022-12-25	WOS:000319081900070
J	Majhi, MC; Behera, AK; Kulshreshtha, NM; Mahmooduzafar; Kumar, R; Kumar, A				Majhi, Manash Chandra; Behera, Abhisek Kumar; Kulshreshtha, Niha Mohan; Dr Mahmooduzafar; Kumar, Rita; Kumar, Anil			ExtremeDB: A Unified Web Repository of Extremophilic Archaea and Bacteria	PLOS ONE			English	Article								Extremophiles are the microorganisms which can survive under extreme conditions of temperature, pressure, pH, salinity etc. They have gained much attention for their potential role in biotechnological and industrial applications. The large amount of experimental data in the literature is so diverse, that it becomes difficult and time consuming for the researcher to implement it in various areas of research. Therefore, a systematic arrangement of data and redirection in a similar fashion through web interface can assist researchers in analyzing the data as per their requirement. ExtremeDB is a freely available web based relational database which integrates general characteristics, genome-proteome information, industrial applications and recent scientific investigations of the seven major groups of 865 extremophillic microorganisms. The search options are user friendly and analyses tools such as Compare and Extreme BLAST have been incorporated for comparative analysis of two or more extremophiles and determining the sequence similarity of a given protein/nucleotide in relation to other extremophiles respectively. The effort put forth herein in the form of database, would open up new avenues on the potential utility of extremophiles in applied research. ExtremeDB is freely accessible via http://extrem.igib.res.in.	[Majhi, Manash Chandra; Behera, Abhisek Kumar; Kulshreshtha, Niha Mohan; Kumar, Rita] CSIR, Inst Genom & Integrat Biol, Environm Biotechnol Div, Delhi, India; [Majhi, Manash Chandra; Dr Mahmooduzafar] Jamia Hamdard, Dept Bot, Delhi, India; [Kulshreshtha, Niha Mohan] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Kumar, Anil] Natl Inst Immunol, Patent Div, New Delhi 110067, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Jamia Hamdard University; Savitribai Phule Pune University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Kumar, R (corresponding author), CSIR, Inst Genom & Integrat Biol, Environm Biotechnol Div, Delhi, India.	rita@igib.res.in; anilk@nii.ac.in	Kumar, Anil/AAT-4547-2020; Kulshreshtha, Niha Mohan/V-8333-2019; Kumar, Anil/L-3294-2016	Kumar, Anil/0000-0002-8785-6033; Kulshreshtha, Niha Mohan/0000-0003-1880-8174; Kumar, Anil/0000-0002-8785-6033	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by funding from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atomi H, 2005, CURR OPIN CHEM BIOL, V9, P166, DOI 10.1016/j.cbpa.2005.02.013; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; Eichler J, 2001, BIOTECHNOL ADV, V19, P261, DOI 10.1016/S0734-9750(01)00061-1; Gomes J, 2004, FOOD TECHNOL BIOTECH, V42, P223; Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Schafer G, 2004, J BIOENERG BIOMEMBR, V36, P3, DOI 10.1023/B:JOBB.0000019693.71612.4c; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Seckbach J, 2000, PROC SPIE, V4137, P89, DOI 10.1117/12.411613; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000	13	9	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63083	10.1371/journal.pone.0063083	http://dx.doi.org/10.1371/journal.pone.0063083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696792	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900008
J	Pei, HX; Ma, N; Chen, JW; Zheng, Y; Tian, J; Li, J; Zhang, S; Fei, ZJ; Gao, JP				Pei, Haixia; Ma, Nan; Chen, Jiwei; Zheng, Yi; Tian, Ji; Li, Jing; Zhang, Shuai; Fei, Zhangjun; Gao, Junping			Integrative Analysis of miRNA and mRNA Profiles in Response to Ethylene in Rose Petals during Flower Opening	PLOS ONE			English	Article							GENE-EXPRESSION; ANTHOCYANIN BIOSYNTHESIS; PLANT MICRORNAS; ARABIDOPSIS; REVEAL; STRESS; TRANSCRIPTOME; RECEPTOR; IDENTIFICATION; EVOLUTION	MicroRNAs play an important role in plant development and plant responses to various biotic and abiotic stimuli. As one of the most important ornamental crops, rose (Rosa hybrida) possesses several specific morphological and physiological features, including recurrent flowering, highly divergent flower shapes, colors and volatiles. Ethylene plays an important role in regulating petal cell expansion during rose flower opening. Here, we report the population and expression profiles of miRNAs in rose petals during flower opening and in response to ethylene based on high throughput sequencing. We identified a total of 33 conserved miRNAs, as well as 47 putative novel miRNAs were identified from rose petals. The conserved and novel targets to those miRNAs were predicted using the rose floral transcriptome database. Expression profiling revealed that expression of 28 known (84.8% of known miRNAs) and 39 novel (83.0% of novel miRNAs) miRNAs was substantially changed in rose petals during the earlier opening period. We also found that 28 known and 22 novel miRNAs showed expression changes in response to ethylene treatment. Furthermore, we performed integrative analysis of expression profiles of miRNAs and their targets. We found that ethylene-caused expression changes of five miRNAs (miR156, miR164, miR166, miR5139 and rhy-miRC1) were inversely correlated to those of their seven target genes. These results indicate that these miRNA/target modules might be regulated by ethylene and were involved in ethylene-regulated petal growth.	[Pei, Haixia; Ma, Nan; Chen, Jiwei; Zheng, Yi; Tian, Ji; Li, Jing; Zhang, Shuai; Gao, Junping] China Agr Univ, Dept Ornamental Hort, Beijing 100094, Peoples R China; [Zheng, Yi; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	China Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Gao, JP (corresponding author), China Agr Univ, Dept Ornamental Hort, Beijing 100094, Peoples R China.	gaojp@cau.edu.cn	Fei, Zhangjun/H-5152-2012; Zheng, Yi/F-6150-2016	Zheng, Yi/0000-0002-8042-7770	National Natural Science Foundation of China [31071827, 31130359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grants (Grant no. 31071827 and 31130359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Bennett BC, ENCY LIFE SUPPORT SY; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Channeliere S, 2002, FEBS LETT, V515, P35, DOI 10.1016/S0014-5793(02)02413-4; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; De Paepe A, 2004, PLANT J, V39, P537, DOI 10.1111/j.1365-313X.2004.02156.x; Debener T, 2009, CRIT REV PLANT SCI, V28, P267, DOI 10.1080/07352680903035481; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Dubois A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-638; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; El-Kereamy A, 2003, PHYSIOL PLANTARUM, V119, P175, DOI 10.1034/j.1399-3054.2003.00165.x; Gantulga D, 2009, PHYTOCHEMISTRY, V70, P1999, DOI 10.1016/j.phytochem.2009.08.008; Gao ZH, 2012, MOL CELLS, V34, P239, DOI 10.1007/s10059-012-0004-7; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; HEINRICHS F, 2008, AIPH UNION FLEURS, V56, P16; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jay F, 2010, METHODS MOL BIOL, V592, P183, DOI 10.1007/978-1-60327-005-2_13; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kim J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-657; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma N, 2005, SCI CHINA SER C, V48, P434, DOI 10.1360/062004-37; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; Ma N, 2006, J EXP BOT, V57, P2763, DOI 10.1093/jxb/erl033; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Muller R, 2000, J HORTIC SCI BIOTECH, V75, P12; Muller R, 2003, J FOOD AGRIC ENVIRON, V1, P87; Peaucelle A, 2007, DEVELOPMENT, V134, P1045, DOI 10.1242/dev.02774; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Reid M. S., 1989, Acta Horticulturae, P215; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Tan H, 2006, POSTHARVEST BIOL TEC, V40, P97, DOI 10.1016/j.postharvbio.2006.01.007; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Van Zhong G, 2003, PLANT MOL BIOL, V53, P117, DOI 10.1023/B:PLAN.0000009270.81977.ef; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang D, 2004, PLANT CELL REP, V22, P422, DOI 10.1007/s00299-003-0721-7; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xue JQ, 2008, J EXP BOT, V59, P2161, DOI 10.1093/jxb/ern078; Yasumura Y, 2012, PLANT J, V72, P947, DOI 10.1111/tpj.12005; Zhang TC, 2012, COMPUT BIOL CHEM, V38, P10, DOI 10.1016/j.compbiolchem.2012.04.001; Zhang Y., 2011, MOL BIOL REP, V39, P1975; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zuo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-7	68	63	67	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64290	10.1371/journal.pone.0064290	http://dx.doi.org/10.1371/journal.pone.0064290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696879	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900082
J	Rhodehouse, BC; Mayo, JN; Beard, RS; Chen, CH; Bearden, SE				Rhodehouse, Bryce C.; Mayo, Jamie N.; Beard, Richard S., Jr.; Chen, Cheng-Hung; Bearden, Shawn E.			Opening of the Blood-Brain Barrier before Cerebral Pathology in Mild Hyperhomocysteinemia	PLOS ONE			English	Article							TOTAL HOMOCYSTEINE LEVELS; PLASMA HOMOCYSTEINE; COGNITIVE IMPAIRMENT; RISK-FACTOR; ALZHEIMERS-DISEASE; HYPERTENSIVE-RATS; BECLIN 1; PERMEABILITY; DEMENTIA; STROKE	Hyperhomocysteinemia (HHcy) is a risk factor for cognitive impairment. The purpose of this study was to determine the temporal pattern of cerebral pathology in a mouse model of mild HHcy, because understanding this time course provides the basis for understanding the mechanisms involved. C57Bl/6 mice with heterozygous deletion cystathionine beta-synthase (cbs(+/-); Het) were used as a model of mild HHcy along with their wild-type littermates (cbs(+/+); WT). Mice were 'young' (5.3 +/- 0.2 months of age) and 'old' (16.6 +/- 0.9 months of age). Blood-brain barrier (BBB) permeability was quantified from Evans blue and sodium fluorescein extravasation. Microvascular architecture was assessed by z-stack confocal microscopy. Leukoaraiosis was measured from Luxol fast blue stained slides of paraffin brain sections. Inflammation was quantified using standard antibody-based immunohistochemical techniques. Cognitive function was assessed using the Morris water maze. BBB permeability was significantly greater in Het vs. WT mice at all ages (p<0.05). There were no differences in microvascular architecture among the groups. Compared with all other groups, old Het mice had significantly greater leukoaraiosis, inflammation in the fornix, and cognitive impairment (p<0.05). In mild HHcy, increased permeability of the BBB precedes the onset of cerebral pathology. This new paradigm may play a role in the progression of disease in HHcy.	[Rhodehouse, Bryce C.; Mayo, Jamie N.; Beard, Richard S., Jr.; Chen, Cheng-Hung; Bearden, Shawn E.] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [Bearden, Shawn E.] Idaho State Univ, ISU Biomed Res Inst, Pocatello, ID 83209 USA	Idaho; Idaho State University; Idaho; Idaho State University	Bearden, SE (corresponding author), Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA.	bearshaw@isu.edu	Beard Jr., Richard/E-2051-2013; Beard, Richard Scott/I-3695-2019	Beard Jr., Richard/0000-0001-8545-3014; Beard, Richard Scott/0000-0001-8545-3014	National Institutes of Health (NIH) [HL106548, P20 RR-016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL106548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) HL106548, P20 RR-016454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Beard RS, 2012, VASC PHARMACOL, V56, P159, DOI 10.1016/j.vph.2012.01.004; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Carmel R, 2001, HOMOCYSTEINE HLTH DI, Vxvi; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Dayal S, 2008, ARTERIOSCL THROM VAS, V28, P1596, DOI 10.1161/ATVBAHA.108.166421; Dayali S, 2007, ANTIOXID REDOX SIGN, V9, P1899, DOI 10.1089/ars.2007.1806; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Graban A, 2009, J NEUROL SCI, V283, P116, DOI 10.1016/j.jns.2009.02.344; Huber JD, 2008, CURR PHARM DESIGN, V14, P1594, DOI 10.2174/138161208784705441; Jalal FY, 2012, STROKE, V43, P1115, DOI 10.1161/STROKEAHA.111.643080; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim J, 2007, J NUTR, V137, P2093, DOI 10.1093/jn/137.9.2093; Lee JM, 2007, STROKE, V38, P3289, DOI 10.1161/STROKEAHA.107.491621; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Lominadze D, 2006, AM J PHYSIOL-HEART C, V290, pH1206, DOI 10.1152/ajpheart.00376.2005; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moustapha A, 1999, KIDNEY INT, V55, P1470, DOI 10.1046/j.1523-1755.1999.00378.x; Naka H, 2006, EUR J NEUROL, V13, P261, DOI 10.1111/j.1468-1331.2006.01205.x; Rhodehouse BC, 2013, J ALZHEIMERS DIS; Rohn TT, 2011, NEUROBIOL DIS, V43, P68, DOI 10.1016/j.nbd.2010.11.003; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sachdev P, 2004, J NEUROL SCI, V226, P25, DOI 10.1016/j.jns.2004.09.006; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Seshadri S, 2006, J ALZHEIMERS DIS, V9, P393; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Tyagi N, 2010, J RECEPT SIG TRANSD, V30, P78, DOI 10.3109/10799891003614808; UELAND PM, 1989, J LAB CLIN MED, V114, P473; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; van Gijn J, 2000, LANCET, V356, P612, DOI 10.1016/S0140-6736(00)02599-X; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Wong A, 2006, J NEUROL, V253, P441, DOI 10.1007/s00415-005-0022-x; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22; Zylberstein DE, 2008, J AM GERIATR SOC, V56, P1087, DOI 10.1111/j.1532-5415.2008.01724.x	42	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63951	10.1371/journal.pone.0063951	http://dx.doi.org/10.1371/journal.pone.0063951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696861	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900065
J	Shimasaki, T; Masaki, T; Mitsutomi, K; Ueno, D; Gotoh, K; Chiba, S; Kakuma, T; Yoshimatsu, H				Shimasaki, Takanobu; Masaki, Takayuki; Mitsutomi, Kimihiko; Ueno, Daisuke; Gotoh, Koro; Chiba, Seiichi; Kakuma, Tetsuya; Yoshimatsu, Hironobu			The Dipeptidyl Peptidase-4 Inhibitor Des-Fluoro-Sitagliptin Regulates Brown Adipose Tissue Uncoupling Protein Levels in Mice with Diet-Induced Obesity	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLP-1 RECEPTOR; IV INHIBITOR; DOUBLE-BLIND; EFFICACY; SAFETY; METFORMIN; THERMOGENESIS; PIOGLITAZONE; EXPRESSION	Objective: Dipeptidyl peptidase (DPP)-4 is responsible for the degradation of several peptides that contain an alanine or proline at the penultimate position or position P1. DPP-4 inhibitors (DPP-4is) have protective effects against type-2 diabetes and several metabolic disorders. Methods: In the present study, we examined the effects of des-fluoro-sitagliptin (DFS), a DDP-4i, on body adiposity and levels of peroxisome proliferator-activated receptor (PPAR)-alpha, PPAR-gamma coactivator-1 (PGC-1), and uncoupling proteins (UCPs) in mice with diet-induced obesity. Results: Treatment with DFS dose-dependently decreased the weight of white adipose tissue and serum levels of glucose, compared with controls, without influencing food intake (P<0.05). Additionally, DFS treatment increased the levels of PPAR-alpha, PGC-1, and UCPs in brown adipose tissue (BAT), and of PPAR-alpha and UCP3 in skeletal muscle (P<0.05). Furthermore, the effects on BAT PGC-1 and muscle PPAR-alpha levels were attenuated by treatment with the glucagon-like peptide 1 (GLP-1) antagonist exendin (9-39). Interestingly, hypothalamic levels of proopiomelanocortin (POMC) were increased by DFS treatment and the effects of DFS on PPAR-alpha, PGC-1, and UCP levels were attenuated in melanocortin (MC)-4 receptor-deficient mice. Conclusions: In conclusion, high-dose DFS appeared to regulate body adiposity and UCPs in mice with diet-induced obesity, at least partly through a GLP-1 and/or MC-4 pathway.	[Shimasaki, Takanobu; Masaki, Takayuki; Mitsutomi, Kimihiko; Ueno, Daisuke; Gotoh, Koro; Chiba, Seiichi; Kakuma, Tetsuya; Yoshimatsu, Hironobu] Oita Univ, Fac Med, Dept Internal Med 1, Yufu, Japan	Oita University	Masaki, T (corresponding author), Oita Univ, Fac Med, Dept Internal Med 1, Yufu, Japan.	masaki@oita-u.ac.jp		Masaki, Takayuki/0000-0002-2378-849X				Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cardoso AR, 2010, BBA-BIOENERGETICS, V1797, P832, DOI 10.1016/j.bbabio.2009.12.017; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; Derosa G, 2010, METABOLISM, V59, P887, DOI 10.1016/j.metabol.2009.10.007; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Lehrke Michael, 2011, Rev Diabet Stud, V8, P382, DOI 10.1900/RDS.2011.8.382; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Masaki T, 2003, ENDOCRINOLOGY, V144, P3547, DOI 10.1210/en.2003-0301; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Mostyn Alison, 2008, Organogenesis, V4, P182; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Polakof S, 2011, J NEUROENDOCRINOL, V23, P508, DOI 10.1111/j.1365-2826.2011.02137.x; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Sangle GV, 2012, ENDOCRINOLOGY, V153, P564, DOI 10.1210/en.2011-1732; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; Vendrell J, 2011, ENDOCRINOLOGY, V152, P4072, DOI 10.1210/en.2011-1070; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Yasuda T, 2004, NEUROSCIENCE, V125, P535, DOI 10.1016/j.neuroscience.2003.11.039; Zaninovich AA, 2001, MEDICINA-BUENOS AIRE, V61, P597	36	42	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63626	10.1371/journal.pone.0063626	http://dx.doi.org/10.1371/journal.pone.0063626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696840	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900047
J	Turovsky, EA; Turovskaya, MV; Dolgacheva, LP; Zinchenko, VP; Dynnik, VV				Turovsky, Egor A.; Turovskaya, Mariya V.; Dolgacheva, Ludmila P.; Zinchenko, Valery P.; Dynnik, Vladimir V.			Acetylcholine Promotes Ca(2+)and NO-Oscillations in Adipocytes Implicating Ca2+-> NO -> cGMP -> cADP-ribose -> Ca2+ Positive Feedback Loop - Modulatory Effects of Norepinephrine and Atrial Natriuretic Peptide	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; WHITE ADIPOSE-TISSUE; CYCLIC ADP-RIBOSE; SOLUBLE GUANYLATE-CYCLASE; NITRIC-OXIDE SYNTHASE; CA2+-INDUCED CA2+ RELEASE; VASCULAR SMOOTH-MUSCLE; HEPATIC GLUCOSE-UPTAKE; CALCIUM OSCILLATIONS; RYANODINE RECEPTOR	Purpose: This study investigated possible mechanisms of autoregulation of Ca2+ signalling pathways in adipocytes responsible for Ca2+ and NO oscillations and switching phenomena promoted by acetylcholine (ACh), norepinephrine (NE) and atrial natriuretic peptide (ANP). Methods: Fluorescent microscopy was used to detect changes in Ca2+ and NO in cultures of rodent white adipocytes. Agonists and inhibitors were applied to characterize the involvement of various enzymes and Ca2+-channels in Ca2+ signalling pathways. Results: ACh activating M-3-muscarinic receptors and Gbc protein dependent phosphatidylinositol 3 kinase induces Ca2+ and NO oscillations in adipocytes. At low concentrations of ACh which are insufficient to induce oscillations, NE or alpha 1, alpha 2-adrenergic agonists act by amplifying the effect of ACh to promote Ca2+ oscillations or switching phenomena. SNAP, 8-BrcAMP, NAD and ANP may also produce similar set of dynamic regimes. These regimes arise from activation of the ryanodine receptor (RyR) with the implication of a long positive feedback loop (PFL): Ca2+-> NO -> cGMP -> cADPR -> Ca2+, which determines periodic or steady operation of a short PFL based on Ca2+-induced Ca2+ release via RyR by generating cADPR, a coagonist of Ca2+ at the RyR. Interplay between these two loops may be responsible for the observed effects. Several other PFLs, based on activation of endothelial nitric oxide synthase or of protein kinase B by Ca2+-dependent kinases, may reinforce functioning of main PFL and enhance reliability. All observed regimes are independent of operation of the phospholipase C/Ca2+-signalling axis, which may be switched off due to negative feedback arising from phosphorylation of the inositol-3-phosphate receptor by protein kinase G. Conclusions: This study presents a kinetic model of Ca2+-signalling system operating in adipocytes and integrating signals from various agonists, which describes it as multivariable multi feedback network with a family of nested positive feedback.	[Turovsky, Egor A.; Turovskaya, Mariya V.; Dolgacheva, Ludmila P.; Zinchenko, Valery P.; Dynnik, Vladimir V.] Russian Acad Sci, Inst Cell Biophys, Dept Intracellular Signalling, Pushchino 142292, Russia; [Dynnik, Vladimir V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Dept Syst Biochem, Pushchino 142292, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Dynnik, VV (corresponding author), Russian Acad Sci, Inst Cell Biophys, Dept Intracellular Signalling, Pushchino 142292, Russia.	dynnik@rambler.ru		Turovskaya, Maria/0000-0003-1995-8633; Zinchenko, Valery/0000-0002-1990-3803	Ministry of Science and Education of Russian Federation [16.512.11.2092]; Russian Academy of Sciences Presidium [01201256033, 01201258223]; Russian Foundation for Basic Research [10-04-01306-a]	Ministry of Science and Education of Russian Federation(Ministry of Education and Science, Russian Federation); Russian Academy of Sciences Presidium(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The study was conducted with the support of the Ministry of Science and Education of Russian Federation, State Contract No16.512.11.2092, Program No7 of Russian Academy of Sciences Presidium (project 01201256033), Program No7 of Russian Academy of Sciences Presidium (project 01201258223), Russian Foundation for Basic Research (project 10-04-01306-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; AKPAN JO, 1974, BIOCHEM BIOPH RES CO, V61, P222, DOI 10.1016/0006-291X(74)90556-7; An ZB, 2010, DIABETES, V59, P2999, DOI 10.2337/db10-0138; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Bai Y, 2009, AM J PHYSIOL-LUNG C, V297, pL347, DOI 10.1152/ajplung.90559.2008; Bartness TJ, 2002, J CLIN INVEST, V110, P1235, DOI 10.1172/JCI200217047; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Berthoud HR, 2006, AM J PHYSIOL-REG I, V291, pR1240, DOI 10.1152/ajpregu.00428.2006; Bhardwaj G, 2011, IET SYST BIOL, V5, P174, DOI 10.1049/iet-syb.2010.0019; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Borghans JAM, 1997, BIOPHYS CHEM, V66, P25, DOI 10.1016/S0301-4622(97)00010-0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Cinquin O, 2002, CR BIOL, V325, P1085, DOI 10.1016/S1631-0691(02)01533-0; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cobbold P H, 1990, Semin Cell Biol, V1, P311; Colyer J, 1998, ANN NY ACAD SCI, V853, P79, DOI 10.1111/j.1749-6632.1998.tb08258.x; Dai JM, 2007, AM J RESP CELL MOL, V36, P600, DOI 10.1165/rcmb.2006-0096OC; de la Fuente IM, 1998, ACTA BIOTHEOR, V46, P37, DOI 10.1023/A:1000899820111; De Pitta M, 2009, J BIOL PHYS, V35, P383, DOI 10.1007/s10867-009-9155-y; DECROLY O, 1982, P NATL ACAD SCI-BIOL, V79, P6917, DOI 10.1073/pnas.79.22.6917; Deshmukh AS, 2010, DIABETOLOGIA, V53, P1142, DOI 10.1007/s00125-010-1716-x; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; DYNNIK V V, 1986, P185; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fliers E, 2003, J NEUROENDOCRINOL, V15, P1005, DOI 10.1046/j.1365-2826.2003.01096.x; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fridlyand LE, 2010, AM J PHYSIOL-ENDOC M, V299, pE517, DOI 10.1152/ajpendo.00177.2010; Fritz N, 2005, J CELL SCI, V118, P2261, DOI 10.1242/jcs.02344; Fritz N, 2008, PFLUG ARCH EUR J PHY, V456, P277, DOI 10.1007/s00424-007-0379-z; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Giordano A, 2006, AM J PHYSIOL-REG I, V291, pR1243, DOI 10.1152/ajpregu.00679.2005; Golebiewska U, 2010, CRIT REV BIOCHEM MOL, V45, P97, DOI 10.3109/10409231003598812; Grassiolli S, 2007, EUR J PHARMACOL, V556, P223, DOI 10.1016/j.ejphar.2006.11.022; Hampson LJ, 2007, FEBS LETT, V581, P3955, DOI 10.1016/j.febslet.2007.07.026; HARDY RW, 1992, ENDOCRINOLOGY, V130, P3694, DOI 10.1210/en.130.6.3694; HAROOTUNIAN AT, 1991, CELL CALCIUM, V12, P153, DOI 10.1016/0143-4160(91)90017-9; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; KANETO A, 1974, ENDOCRINOLOGY, V95, P1005, DOI 10.1210/endo-95-4-1005; Kannan MS, 1997, AM J PHYSIOL-LUNG C, V272, pL659, DOI 10.1152/ajplung.1997.272.4.L659; Kasseckert SA, 2009, CARDIOVASC RES, V83, P381, DOI 10.1093/cvr/cvp065; Keizer J, 1996, BIOPHYS J, V71, P3477, DOI 10.1016/S0006-3495(96)79543-7; Kerchner KR, 2004, J BIOL CHEM, V279, P44554, DOI 10.1074/jbc.M406071200; Kimura C, 2004, J PHYSIOL-LONDON, V554, P721, DOI 10.1113/jphysiol.2003.057059; Kitano H, 2007, E SCHERING RES FDN W, V61, P69; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; Konopacka A, 2008, NEUROCHEM INT, V52, P1160, DOI 10.1016/j.neuint.2007.12.005; Kreier F, 2007, AM J PHYSIOL-REG I, V293, pR548, DOI 10.1152/ajpregu.00890.2006; Kruger WA, 2009, J BIOL CHEM, V284, P1820, DOI 10.1074/jbc.M804590200; Kummer U, 2000, BIOPHYS J, V79, P1188, DOI 10.1016/S0006-3495(00)76373-9; Kunerth S, 2004, J CELL SCI, V117, P2141, DOI 10.1242/jcs.01063; LAUTT WW, 1983, PROG NEUROBIOL, V21, P323, DOI 10.1016/0301-0082(83)90016-3; Lavrentovich M, 2008, J THEOR BIOL, V251, P553, DOI 10.1016/j.jtbi.2007.12.011; LEE KC, 1985, ENDOCRINOLOGY, V117, P307, DOI 10.1210/endo-117-1-307; Lee SW, 2010, J KOREA TRADE, V14, P37; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Li JH, 2009, DIABETES, V58, P2776, DOI 10.2337/db09-0522; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; Liu TP, 2002, AUTON NEUROSCI-BASIC, V96, P113, DOI 10.1016/S1566-0702(01)00396-4; Looms DK, 2001, BIOCHEM J, V355, P87, DOI 10.1042/bj3550087; Louvet L, 2005, NEUROSCI LETT, V381, P149, DOI 10.1016/j.neulet.2005.02.024; Masuda W, 2010, J BIOL CHEM, V285, P37927, DOI 10.1074/jbc.M110.168989; Matsuhisa M, 2000, METABOLISM, V49, P11, DOI 10.1016/S0026-0495(00)90538-9; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Mishra J, 2002, BIOPHYS J, V83, P1298, DOI 10.1016/S0006-3495(02)73901-5; Mitrani P, 2007, AM J PHYSIOL-ENDOC M, V292, pE1069, DOI 10.1152/ajpendo.00477.2006; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Moustafa A, 2011, NITRIC OXIDE-BIOL CH, V24, P139, DOI 10.1016/j.niox.2011.02.001; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; Nguyen LK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002317; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Ozawa T, 2010, MOL MED REP, V3, P199, DOI [10.3892/mmr_000000240, 10.3892/mmr_00000240]; PILO B, 1987, Indian Journal of Physiology and Pharmacology, V31, P159; Prakash YS, 1998, AM J PHYSIOL, V274, pC1653; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; PUBLICOVER NG, 1993, P NATL ACAD SCI USA, V90, P2087, DOI 10.1073/pnas.90.5.2087; RASHATWAR SS, 1987, P NATL ACAD SCI USA, V84, P5685, DOI 10.1073/pnas.84.16.5685; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RIDGWAY EB, 1976, J CELL BIOL, V69, P223, DOI 10.1083/jcb.69.1.223; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; Rooney TA, 1996, J BIOL CHEM, V271, P19817, DOI 10.1074/jbc.271.33.19817; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Safonov M.G., 1980, STABILITY ROBUSTNESS; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schlossmann J, 2011, AM J PHYSIOL-HEART C, V301, pH672, DOI 10.1152/ajpheart.00198.2011; Schroder F, 2003, CARDIOVASC RES, V60, P268, DOI 10.1016/S0008-6363(03)00546-7; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Secondo A, 2006, AM J PHYSIOL-CELL PH, V290, pC233; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shiota M, 2000, AM J PHYSIOL-ENDOC M, V278, pE544, DOI 10.1152/ajpendo.2000.278.3.E544; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; SUMII K, 1995, CIRC RES, V77, P803, DOI 10.1161/01.RES.77.4.803; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Thul R, 2008, ADV EXP MED BIOL, V641, P1; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; TRUXAL J. G., 1955, AUTOMATIC FEEDBACK C; Turovsky EA, 2012, BIOCHEM MOSC SUPPL S, V6, P35, DOI 10.1134/S1990747811060158; Turovsky EA, 2012, BIOCHEM MOSC SUPPL S, V6, P26, DOI 10.1134/S199074781106016X; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Whitacre James M., 2012, Frontiers in Genetics, V3, P5, DOI [10.3389/fgene.2012.00005, 10.3389/fgene.2012.00067]; White RA, 2003, FASEB J, V17, P482, DOI 10.1096/fj.02-0622fje; Willmott N, 1996, J BIOL CHEM, V271, P3699; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Yang TT, 2009, NEUROSCI LETT, V451, P57, DOI 10.1016/j.neulet.2008.12.029; YOSHIDA Y, 1991, J BIOL CHEM, V266, P19819; Young SH, 2002, J BIOL CHEM, V277, P46871, DOI 10.1074/jbc.M207083200; Zemel MB, 2008, J NUTR, V138, P1047, DOI 10.1093/jn/138.6.1047; Zhang SB, 2011, NEUROCHEM RES, V36, P1175, DOI 10.1007/s11064-011-0457-7; Zolle O, 2000, J BIOL CHEM, V275, P25892, DOI 10.1074/jbc.M000786200	131	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63483	10.1371/journal.pone.0063483	http://dx.doi.org/10.1371/journal.pone.0063483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696827	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900036
J	Tian, TV; Tomavo, N; Huot, L; Flourens, A; Bonnelye, E; Flajollet, S; Hot, D; Leroy, X; de Launoit, Y; Duterque-Coquillaud, M				Tian, T. V.; Tomavo, N.; Huot, L.; Flourens, A.; Bonnelye, E.; Flajollet, S.; Hot, D.; Leroy, X.; de Launoit, Y.; Duterque-Coquillaud, M.			Identification of novel TMPRSS2: ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2	ONCOGENE			English	Article						prostate cancer; TMPRSS2: ERG fusion; migration; invasion; MMP9; PLXNA2	GENE FUSION; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; CELL INVASION; TUMOR-CELLS; EXPRESSION; RESISTANT; FAMILY; MATRIX-METALLOPROTEINASE-9; HETEROGENEITY	Prostate cancer (PCa) is one of the major public health problems in Western countries. Recently, the TMPRSS2: ERG gene fusion, which results in the aberrant expression of the transcription factor ERG, has been shown to be the most common gene rearrangement in PCa. Previous studies have determined the contributions of this fusion in PCa disease initiation and/or progression in vitro and in vivo. In this study on TMPRSS2: ERG regulation in PCa, we used an androgen receptor and TMPRSS2: ERG fusion double-negative PCa cell model: PC3c. In three cell clones with different TMPRSS2: ERG expression levels, ectopic expression of the fusion resulted in significant induction of cell migration and invasion in a dose-dependent manner. In agreement with this phenotype, high-throughput microarray analysis revealed that a set of genes, functionally associated with cell motility and invasiveness, were deregulated in a dose-dependent manner in TMPRSS2: ERG-expressing cells. Importantly, we identified increased MMP9 (Metalloproteinase 9) and PLXNA2 (Plexin A2) expression in TMPRSS2: ERG-positive PCa samples, and their expression levels were significantly correlated with ERG expression in a PCa cohort. In line with these findings, there was evidence that TMPRSS2: ERG directly and positively regulates MMP9 and PLXNA2 expression in PC3c cells. Moreover, PLXNA2 upregulation contributed to TMPRSS2: ERG-mediated enhancements of PC3c cell migration and invasion. Furthermore, and importantly, PLXNA2 expression was upregulated in metastatic PCa tumors compared with localized primary PCa tumors. This study provides novel insights into the role of the TMPRSS2: ERG fusion in PCa metastasis.	[Tian, T. V.; Tomavo, N.; Flourens, A.; Flajollet, S.; de Launoit, Y.; Duterque-Coquillaud, M.] CNRS, UMR8161, Inst Biol Lille, F-59021 Lille, France; [Tian, T. V.; Tomavo, N.; Huot, L.; Flourens, A.; Flajollet, S.; Hot, D.; de Launoit, Y.; Duterque-Coquillaud, M.] Inst Pasteur, IFR142, F-59019 Lille, France; [Tian, T. V.; Tomavo, N.; Huot, L.; Flourens, A.; Flajollet, S.; Hot, D.; Leroy, X.; de Launoit, Y.; Duterque-Coquillaud, M.] Univ Lille Nord France, Lille, France; [Tian, T. V.; Leroy, X.] Univ Droit & Sante Lille II, Fac Med Henri Warembourg, Lille, France; [Huot, L.; Hot, D.] CNRS, UMR8204, INSERM U1019, Ctr Infect & Immunite Lille, Lille, France; [Bonnelye, E.] INSERM, U1033, F-69008 Lyon, France; [Leroy, X.] CHRU Lille, Inst Pathol, F-59037 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Duterque-Coquillaud, M (corresponding author), CNRS, UMR8161, Inst Biol Lille, 1 Rue Prof Calmette,BP447, F-59021 Lille, France.	martine.duterque@ibl.fr	Bonnelye, Edith/AAT-9134-2021; Hot, David/M-6775-2016; TIAN, TIAN/O-1726-2015	Duterque-Coquillaud, Martine/0000-0003-3943-5629; Hot, David/0000-0002-2361-0616; de Launoit, Yvan/0000-0003-1837-9808; TIAN, TIAN/0000-0002-9906-0980	Centre national de la recherche scientifique (CNRS); La Ligue contre le Cancer (Comite ' du Pas-de- Calais); Institut national du cancer [INCa_4419]; Institut Pasteur of Lille/ Nord-Pas-de-Calais Regional Council (Region Nord- Pas-de-Calais); Association pour la recherche sur le cancer (ARC)	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); La Ligue contre le Cancer (Comite ' du Pas-de- Calais); Institut national du cancer(Institut National du Cancer (INCA) France); Institut Pasteur of Lille/ Nord-Pas-de-Calais Regional Council (Region Nord- Pas-de-Calais)(Region Hauts-de-France); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	We would like to thank A Fradet, M Le Jeune, M Holder, C Delliaux, G Boulay, M Dubuissez, I Loison, Z Kherrouche and N Malaquin for their excellent technical advices; D Lacorre and E Werkmeister from the BioImaging Center Lille Nord de France for their technical assistance; E Lelievre and D Leprince for their stimulating discussions; and C Engel- Gautier for her critical reading of the manuscript. We also like to thank the local Tumor Tissue Bank (Tumorothe` que), Regional Reference Oncology Center (CRRC) ( Head, Pr. MC Copin) in Lille, France. This work was supported by grants from the Centre national de la recherche scientifique (CNRS), La Ligue contre le Cancer (Comite ' du Pas-de- Calais) and the Institut national du cancer (INCa_4419). TV Tian is a recipient of PhD fellowships from the Institut Pasteur of Lille/ Nord-Pas-de-Calais Regional Council (Region Nord- Pas-de-Calais) and the Association pour la recherche sur le cancer (ARC).	Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Barry M, 2007, UROLOGY, V70, P630, DOI 10.1016/j.urology.2007.08.032; Becker-Santos DD, 2012, CARCINOGENESIS, V33, P2558, DOI 10.1093/carcin/bgs285; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Blanc V, 2011, PROSTATE, V71, P649, DOI 10.1002/pros.21281; Brown CB, 2001, DEVELOPMENT, V128, P3071; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; dos Reis ST, 2009, J UROLOGY, V181, P2320, DOI 10.1016/j.juro.2009.01.012; FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230; Flajollet S, 2009, J IMMUNOL, V183, P6948, DOI 10.4049/jimmunol.0902053; Fradet A, 2010, BONE, V47, pS289, DOI 10.1016/j.bone.2010.01.224; Franco M, 2008, EMBO REP, V9, P865, DOI 10.1038/embor.2008.139; Furusato B, 2010, PROSTATE CANCER P D, V13, P228, DOI 10.1038/pcan.2010.23; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guo CC, 2012, HUM PATHOL, V43, P644, DOI 10.1016/j.humpath.2011.06.018; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hance MW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.389015; Hanzawa M, 2000, CARCINOGENESIS, V21, P1079, DOI 10.1093/carcin/21.6.1079; Hermans KG, 2009, CLIN CANCER RES, V15, P6398, DOI 10.1158/1078-0432.CCR-09-1176; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hoogland AM, 2012, MODERN PATHOL, V25, P471, DOI 10.1038/modpathol.2011.176; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kato T, 2012, BIOCHEM BIOPH RES CO, V417, P966, DOI 10.1016/j.bbrc.2011.12.047; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Le Jeune M, 2010, EXP CELL RES, V316, P203, DOI 10.1016/j.yexcr.2009.10.002; Leshem O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021650; Macintosh CA, 1998, CANCER RES, V58, P23; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Mehra R, 2007, CANCER RES, V67, P7991, DOI 10.1158/0008-5472.CAN-07-2043; Minner S, 2013, MODERN PATHOL, V26, P106, DOI 10.1038/modpathol.2012.130; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Nakamura Y, 2004, J IMMUNOL, V172, P1945, DOI 10.4049/jimmunol.172.3.1945; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Nam RK, 2007, CANCER BIOL THER, V6, P40, DOI 10.4161/cbt.6.1.3489; Nese N, 2010, ANAL QUANT CYTOL, V32, P90; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Perner S, 2010, UROLOGY, V75, P762, DOI 10.1016/j.urology.2009.10.010; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Scher HI, 2011, J CLIN ONCOL, V29, P3695, DOI 10.1200/JCO.2011.35.8648; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Squire JA, 2011, ADV CANCER RES, V112, P183, DOI 10.1016/B978-0-12-387688-1.00007-7; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vlaeminck-Guillem V, 2000, MECH DEVELOP, V91, P331, DOI 10.1016/S0925-4773(99)00272-5; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhou C, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-11; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	80	48	51	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2204	2214		10.1038/onc.2013.176	http://dx.doi.org/10.1038/onc.2013.176			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23708657	Green Submitted, Green Published			2022-12-25	WOS:000334996000006
J	Kamranvar, SA; Chen, X; Masucci, MG				Kamranvar, S. A.; Chen, X.; Masucci, M. G.			Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus	ONCOGENE			English	Article						EBV; telomere; telomerase; ALT; shelterin; TRF2	LYMPHOBLASTOID CELL-LINES; PROMOTES GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; CHROMOSOME ENDS; MAMMALIAN TELOMERES; PROTECTS TELOMERES; PML BODY; MAINTENANCE; TRF2; DAMAGE	Malignant cells achieve replicative immortality by two alternative mechanisms, a common one dependent on de novo synthesis of telomeric DNA by telomerase, and a rare one based on telomere recombination known as alternative lengthening of telomeres (ALT). Epstein-Barr virus (EBV) transforms human B-lymphocytes into lymphoblastoid cell lines with unlimited growth potential in vitro and in vivo. Here we show that newly EBV-infected cells exhibit multiple signs of telomere dysfunction, including the occurrence of extra-chromosomal telomeres, telomere fusion and telomere length heterogeneity, and undergo progressive increase in telomere length without a parallel increase in telomerase activity. This phenotype is accompanied by the accumulation of telomere-associated promyelocytic leukemia nuclear bodies and telomeric-sister chromatid exchange, suggesting that EBV infection promotes the activation of ALT. Newly infected cells also display a significant reduction of telomere-associated TRF2 and express low levels of TRF1, TRF2, POT1 and ATRX, pointing to telomere de-protection as an important correlate of ALT activation. Collectively, these findings highlight the involvement of recombination-dependent mechanisms for maintenance of telomere homeostasis in EBV-induced B-cell immortalization.	[Kamranvar, S. A.; Chen, X.; Masucci, M. G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809; Chen, Xinsong/0000-0002-3214-9075	Swedish Cancer Society; Swedish Medical Research Council; Karolinska Institutet, Stockholm, Sweden; China Scholarship Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Stockholm, Sweden; China Scholarship Council(China Scholarship Council)	This study was supported by grants awarded by the Swedish Cancer Society, the Swedish Medical Research Council and the Karolinska Institutet, Stockholm, Sweden. XC was supported by a fellowship awarded by the China Scholarship Council.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bechter OE, 2003, EMBO REP, V4, P1138, DOI 10.1038/sj.embor.7400027; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chen F, 2005, INT J CANCER, V113, P284, DOI 10.1002/ijc.20594; Chung I, 2012, NUCLEUS-PHILA, V3, P263, DOI 10.4161/nucl.20326; De La Fuente R, 2011, REPRODUCTION, V142, P221, DOI 10.1530/REP-10-0380; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Henson JD, 2010, FEBS LETT, V584, P3800, DOI 10.1016/j.febslet.2010.06.009; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Kamranvar SA, 2007, ONCOGENE, V26, P5115, DOI 10.1038/sj.onc.1210324; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kataoka H, 1997, DIFFERENTIATION, V62, P203; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Lacoste S, 2010, ONCOGENE, V29, P503, DOI 10.1038/onc.2009.359; Lenoir GM, 1985, IARC SCI PUBL, V60, P308; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Mei YP, 2006, CANCER LETT, V232, P189, DOI 10.1016/j.canlet.2005.02.010; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Parish CR, 2009, CURRENT PROT IMMUNOL, V84; PURTILO DT, 1992, LAB INVEST, V67, P5; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Royle NJ, 2008, CYTOGENET GENOME RES, V122, P281, DOI 10.1159/000167814; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sugimoto M, 1999, MECH AGEING DEV, V107, P51, DOI 10.1016/S0047-6374(98)00131-6; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Terrin L, 2008, J VIROL, V82, P10175, DOI 10.1128/JVI.00321-08; TORSTEINSDOTTIR S, 1991, CELL IMMUNOL, V137, P501, DOI 10.1016/0008-8749(91)90097-U; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Walker JR, 2012, MECH AGEING DEV, V133, P421, DOI 10.1016/j.mad.2012.05.002; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yang J, 2004, J EXP CLIN CANC RES, V23, P495; Yeager TR, 1999, CANCER RES, V59, P4175; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	63	36	38	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2013	32	49					5522	5530		10.1038/onc.2013.189	http://dx.doi.org/10.1038/onc.2013.189			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	269XF	23708666	hybrid, Green Published			2022-12-25	WOS:000328276400003
J	Lapointe, CP; Wickens, M				Lapointe, Christopher P.; Wickens, Marvin			The Nucleic Acid-binding Domain and Translational Repression Activity of a Xenopus Terminal Uridylyl Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL POLY(A) POLYMERASES; HISTONE MESSENGER-RNAS; NUCLEOTIDYL TRANSFERASES; CAENORHABDITIS-ELEGANS; 3' URIDYLATION; PRE-MICRORNA; ALPHA-HELIX; REV PROTEIN; STEM-LOOP; I-TASSER	Terminal uridylyl transferases (TUTs) catalyze the addition of uridines to the 3' ends of RNAs and are implicated in the regulation of both messenger RNAs and microRNAs. To better understand how TUTs add uridines to RNAs, we focused on a putative TUT from Xenopus laevis, XTUT7. We determined that XTUT7 catalyzed the addition of uridines to RNAs. Mutational analysis revealed that a truncated XTUT7 enzyme, which contained solely the nucleotidyl transferase and poly(A) polymerase-associated domains, was sufficient for catalytic activity. XTUT7 activity decreased upon removal of the CCHC zinc finger domains and a short segment of basic amino acids (the basic region). This basic region bound nucleic acids in vitro. We also demonstrated that XTUT7 repressed translation of a polyadenylated RNA, to which it added a distinct number of uridines. We generated a predicted structure of the XTUT7 catalytic core that indicated histidine 1269 was likely important for uridine specificity. Indeed, mutation of histidine 1269 broadened the nucleotide specificity of XTUT7 and abolished XTUT7-dependent translational repression. Our data reveal key aspects of how XTUT7 adds uridines to RNAs, highlight the role of the basic region, illustrate that XTUT7 can repress translation, and identify an amino acid important for uridine specificity.	[Lapointe, Christopher P.; Wickens, Marvin] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu		Lapointe, Christopher/0000-0002-0406-105X	National Institutes of Health [GM31892, GM50942]; Wisconsin Alumni Research Foundation; Genentech; Wharton Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031892, R37GM031892, R01GM050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Alumni Research Foundation; Genentech(Roche HoldingGenentech); Wharton Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31892 and GM50942 (to M. W.).; Supported by Wisconsin Alumni Research Foundation, Genentech, and Wharton Predoctoral Fellowships.	Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Blahna MT, 2011, J BIOL CHEM, V286, P42381, DOI 10.1074/jbc.M111.259689; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Cooke A, 2011, P NATL ACAD SCI USA, V108, P15870, DOI 10.1073/pnas.1105151108; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Jones M, 2012, DANCING TIMES, V102, P11; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lunde BM, 2012, NUCLEIC ACIDS RES, V40, P9815, DOI 10.1093/nar/gks740; Martin G, 2008, BBA-GENE REGUL MECH, V1779, P206, DOI 10.1016/j.bbagrm.2007.12.003; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Munoz-Tello P, 2012, STRUCTURE, V20, P977, DOI 10.1016/j.str.2012.04.006; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Norbury CJ, 2010, BIOCHEM SOC T, V38, P1150, DOI 10.1042/BST0381150; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidt MJ, 2010, WIRES RNA, V1, P142, DOI 10.1002/wrna.16; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Su W, 2013, RNA, V19, P1, DOI 10.1261/rna.034470.112; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yates LA, 2012, NAT STRUCT MOL BIOL, V19, P782, DOI 10.1038/nsmb.2329; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051	69	19	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20723	20733		10.1074/jbc.M113.455451	http://dx.doi.org/10.1074/jbc.M113.455451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709223	hybrid, Green Published			2022-12-25	WOS:000321715100057
J	Ali, EM; Kobayashi, K; Yamaoka, N; Ishikawa, M; Nishiguchi, M				Ali, Emran Md.; Kobayashi, Kappei; Yamaoka, Naoto; Ishikawa, Masayuki; Nishiguchi, Masamichi			Graft Transmission of RNA Silencing to Non-Transgenic Scions for Conferring Virus Resistance in Tobacco	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; MOSAIC-VIRUS; GENE; PLANTS; TOBAMOVIRUS; STRAIN; MULTIPLICATION; INTERFERENCE; MOBILE; DEFENSE	RNA silencing is a mechanism of gene regulation by sequence specific RNA degradation and is involved in controlling endogenous gene expression and defense against invasive nucleic acids such as viruses. RNA silencing has been proven to be transmitted between scions and rootstocks through grafting, mostly using transgenic plants. It has been reported that RNA silencing of tobacco endogenous genes, NtTOM1 and NtTOM3, that are required for tobamovirus multiplication, resulted in high resistance against several tobamoviruses. In the present study, we examined the graft transmission of RNA silencing for conferring virus resistance to non-transgenic scions of the same and different Nicotiana species grafted onto rootstocks in which both NtTOM1 and NtTOM3 were silenced. Non-transgenic Nicotiana tabacum (cvs. Samsun and Xanthi nc) and N. benthamiana were used as scions for grafting onto the rootstocks silenced with both genes. Short interfering RNA (siRNA) of NtTOM1 and NtTOM3 was detected in both the scions and the rootstocks eight weeks after grafting. The leaves were detached from the scions and inoculated with several tobamoviruses. The virus accumulation was tested by ELISA and northern blot analysis. The viruses were detected in grafted scions at extremely low levels, showing that virus resistance was conferred. These results suggest that RNA silencing was induced in and virus resistance was conferred to the non-transgenic scions by grafting onto silenced rootstocks. The effect of low temperature on siRNA accumulation and virus resistance was not significantly observed in the scions.	[Ali, Emran Md.; Kobayashi, Kappei; Yamaoka, Naoto; Nishiguchi, Masamichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Ishikawa, Masayuki] Natl Inst Agrobiol Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan	Ehime University; National Institute of Agrobiological Sciences - Japan	Nishiguchi, M (corresponding author), Ehime Univ, Fac Agr, 3-5-7 Tarumi, Matsuyama, Ehime 790, Japan.	mnishigu@agr.ehime-u.ac.jp			Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan [24580065]; Japan Science and Technology Agency for the A-step (Adaptable & Seamless Technology Transfer Program through Target-driven R D); Grants-in-Aid for Scientific Research [24580065] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency for the A-step (Adaptable & Seamless Technology Transfer Program through Target-driven R D); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Program for Promotion of Basic and Applied Researches in Bio-oriented Industry (BRAIN), the Ministry of Education, Culture, Sports and Technology of Japan [Grant-in-Aid for Scientific Research for Scientific Research (C), No. 24580065] to MN and Japan Science and Technology Agency for the A-step (Adaptable & Seamless Technology Transfer Program through Target-driven R & D) to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2005, FEBS LETT, V579, P4479, DOI 10.1016/j.febslet.2005.07.021; Bai SL, 2011, J EXP BOT, V62, P4561, DOI 10.1093/jxb/err163; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen Bing, 2007, Journal of Zhejiang University-Science B, V8, P256, DOI 10.1631/jzus.2007.B0256; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Crete P, 2001, PLANT J, V28, P493, DOI 10.1046/j.1365-313X.2001.01171.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fagard M, 2000, PLANT MOL BIOL, V43, P285, DOI 10.1023/A:1006404016494; Flachowsky H, 2012, INT J MOL SCI, V13, P9992, DOI 10.3390/ijms13089992; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Haque AKMN, 2007, PLANT MOL BIOL, V63, P35, DOI 10.1007/s11103-006-9070-6; Hewezi T, 2005, PLANT BIOTECHNOL J, V3, P81, DOI 10.1111/j.1467-7652.2004.00103.x; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hu QO, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-41; Ishikawa M, 2004, P JPN ACAD B-PHYS, V80, P215, DOI 10.2183/pjab.80.215; Kameda T, 2004, BIOCHEM BIOPH RES CO, V315, P599, DOI 10.1016/j.bbrc.2004.01.097; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Li M, 2006, CHINESE SCI BULL, V51, P313, DOI 10.1007/s11434-006-0313-3; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; NISHIGUCHI M, 1985, NUCLEIC ACIDS RES, V13, P5585, DOI 10.1093/nar/13.15.5585; NOZU Y, 1968, J MOL BIOL, V35, P643, DOI 10.1016/S0022-2836(68)80021-X; OHNO T, 1984, J BIOCHEM-TOKYO, V96, P1915, DOI 10.1093/oxfordjournals.jbchem.a135026; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shimamoto I, 1998, ARCH VIROL, V143, P1801, DOI 10.1007/s007050050418; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Sonoda S, 2000, PLANT J, V21, P1, DOI 10.1046/j.1365-313x.2000.00645.x; Szittya G, 2003, EMBO J, V22, P633, DOI 10.1093/emboj/cdg74; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yamanaka T, 2000, P NATL ACAD SCI USA, V97, P10107, DOI 10.1073/pnas.170295097; Yamanaka T, 2002, J VIROL, V76, P2491, DOI 10.1128/JVI.76.5.2491-2497.2002	39	31	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63257	10.1371/journal.pone.0063257	http://dx.doi.org/10.1371/journal.pone.0063257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717405	gold, Green Submitted, Green Published			2022-12-25	WOS:000320362700012
J	Asai, Y; Tateyama, S; Nomura, T				Asai, Yoshiyuki; Tateyama, Shota; Nomura, Taishin			Learning an Intermittent Control Strategy for Postural Balancing Using an EMG-Based Human-Computer Interface	PLOS ONE			English	Article							VISUAL FEEDBACK DELAYS; INVERTED PENDULUM; MANUAL TRACKING; INTERNAL-MODELS; VISUOMOTOR TRACKING; STIFFNESS; SYSTEMS; ANKLE; MOVEMENT; INSTABILITY	It has been considered that the brain stabilizes unstable body dynamics by regulating co-activation levels of antagonist muscles. Here we critically reexamined this established theory of impedance control in a postural balancing task using a novel EMG-based human-computer interface, in which subjects were asked to balance a virtual inverted pendulum using visual feedback information on the pendulum's position. The pendulum was actuated by a pair of antagonist joint torques determined in real-time by activations of the corresponding pair of antagonist ankle muscles of subjects standing upright. This motor-task raises a frustrated environment; a large feedback time delay in the sensorimotor loop, as a source of instability, might favor adopting the non-reactive, preprogrammed impedance control, but the ankle muscles are relatively hard to co-activate, which hinders subjects from adopting the impedance control. This study aimed at discovering how experimental subjects resolved this frustrated environment through motor learning. One third of subjects adapted to the balancing task in a way of the impedance-like control. It was remarkable, however, that the majority of subjects did not adopt the impedance control. Instead, they acquired a smart and energetically efficient strategy, in which two muscles were inactivated simultaneously at a sequence of optimal timings, leading to intermittent appearance of periods of time during which the pendulum was not actively actuated. Characterizations of muscle inactivations and the pendulumics sway showed that the strategy adopted by those subjects was a type of intermittent control that utilizes a stable manifold of saddle-type unstable upright equilibrium that appeared in the state space of the pendulum when the active actuation was turned off.	[Asai, Yoshiyuki] Grad Univ, Okinawa Inst Sci & Technol, Okinawa, Japan; [Tateyama, Shota; Nomura, Taishin] Osaka Univ, Grad Sch Engn Sci, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; Osaka University	Nomura, T (corresponding author), Osaka Univ, Grad Sch Engn Sci, Osaka, Japan.	taishin@bpe.es.osaka-u.ac.jp	Nomura, Taishin/J-8408-2012	Nomura, Taishin/0000-0002-6545-2097	JSPS [23300166, 23650156]; MEXT Global COE Program "in silico medicine'' at Osaka University; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [22136002] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Global COE Program "in silico medicine'' at Osaka University; Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS grants-in-aid 23300166 and 23650156, MEXT Global COE Program "in silico medicine'' at Osaka University, and the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Bormann R, 2004, NEUROCOMPUTING, V58, P517, DOI 10.1016/j.neucom.2004.01.089; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Cluff T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005998; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Conforto S, 2001, GAIT POSTURE, V14, P28, DOI 10.1016/S0966-6362(01)00112-6; Doeringer JA, 1998, J NEUROPHYSIOL, V80, P1787, DOI 10.1152/jn.1998.80.4.1787; Engbert R, 2011, P NATL ACAD SCI USA, V108, pE765, DOI 10.1073/pnas.1102730108; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Foulkes AJM, 2000, EXP BRAIN RES, V131, P101, DOI 10.1007/s002219900286; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GOMI H, 1993, NEURAL NETWORKS, V6, P933, DOI 10.1016/S0893-6080(09)80004-X; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Honda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037900; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Insperger T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0763; Insperger T, 2010, IMA J MATH CONTROL I, V27, P457, DOI 10.1093/imamci/dnq020; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kobravi HR, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046007; Kowalczyk P, 2012, J R SOC INTERFACE, V9, P234, DOI 10.1098/rsif.2011.0212; Lakie M, 2003, J PHYSIOL-LONDON, V551, P357, DOI 10.1113/jphysiol.2002.036939; Loram ID, 2012, J R SOC INTERFACE, V9, P2070, DOI 10.1098/rsif.2012.0142; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2004, J PHYSIOL-LONDON, V556, P683, DOI 10.1113/jphysiol.2004.062398; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; Milton J, 2009, PHIL T R SOC A, V367, P1181; Milton JG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065005; Morasso PG, 2002, J NEUROPHYSIOL, V88, P2157, DOI 10.1152/jn.2002.88.4.2157; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Morasso P, 2011, J PHYSIOL-LONDON, V589, P459, DOI 10.1113/jphysiol.2010.203604; Nigg B.M., 1994, BIOMECHANICS MUSCULO; Nomura T, 2013, MATH BIOSCI, V245, P86, DOI 10.1016/j.mbs.2013.02.002; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; Saha DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030301; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Squeri V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011189; Stepan G, 2000, MATH COMPUT MODEL, V31, P199, DOI 10.1016/S0895-7177(00)00039-X; Stepan G, 2006, ANNU REV CONTROL, V30, P159, DOI 10.1016/j.arcontrol.2006.08.002; Stephen DG, 2010, COGNITION, V115, P154, DOI 10.1016/j.cognition.2009.12.010; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; UTKIN VI, 1977, IEEE T AUTOMAT CONTR, V22, P212, DOI 10.1109/TAC.1977.1101446; van de Kamp C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002843; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; Weyand PG, 2009, IEEE ENG MED BIO, P6878, DOI 10.1109/IEMBS.2009.5333126; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	67	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62956	10.1371/journal.pone.0062956	http://dx.doi.org/10.1371/journal.pone.0062956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UP	23717398	Green Submitted, Green Published, gold			2022-12-25	WOS:000320362700007
J	Sapkota, Y; Yasui, Y; Lai, R; Sridharan, M; Robson, PJ; Cass, CE; Mackey, JR; Damaraju, S				Sapkota, Yadav; Yasui, Yutaka; Lai, Raymond; Sridharan, Malinee; Robson, Paula J.; Cass, Carol E.; Mackey, John R.; Damaraju, Sambasivarao			Identification of a Breast Cancer Susceptibility Locus at 4q31.22 Using a Genome-Wide Association Study Paradigm	PLOS ONE			English	Article							RISK-FACTORS; GENE; MUTATIONS; EXPRESSION; VARIANT; EPIDEMIOLOGY; ALLELES; DISEASE; LINKAGE; PROTEIN	More than 40 single nucleotide polymorphisms (SNPs) for breast cancer susceptibility were identified by genome-wide association studies (GWASs). However, additional SNPs likely contribute to breast cancer susceptibility and overall genetic risk, prompting this investigation for additional variants. Six putative breast cancer susceptibility SNPs identified in a two-stage GWAS that we reported earlier were replicated in a follow-up stage 3 study using an independent set of breast cancer cases and controls from Canada, with an overall cumulative sample size of 7,219 subjects across all three stages. The study design also encompassed the 11 variants from GWASs previously reported by various consortia between the years 20072009 to (i) enable comparisons of effect sizes, and (ii) identify putative prognostic variants across studies. All SNP associations reported with breast cancer were also adjusted for body mass index (BMI). We report a strong association with 4q31.22-rs1429142 (combined per allele odds ratio and 95% confidence interval = 1.28 [1.17-1.41] and P-combined = 1.5x10(-7)), when adjusted for BMI. Ten of the 11 breast cancer susceptibility loci reported by consortia also showed associations in our predominantly Caucasian study population, and the associations were independent of BMI; four FGFR2 SNPs and TNRC9-rs3803662 were among the most notable associations. Since the original report by Garcia-Closas et al. 2008, this is the second study to confirm the association of 8q24.21-rs13281615 with breast cancer outcomes.	[Sapkota, Yadav; Cass, Carol E.; Mackey, John R.; Damaraju, Sambasivarao] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Sapkota, Yadav; Lai, Raymond; Sridharan, Malinee; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Robson, Paula J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Cass, Carol E.; Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Robson, Paula J.] Alberta Hlth Serv Canc Care, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Alberta Health Services (AHS)	Damaraju, S (corresponding author), Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada.	Sambasivarao.Damaraju@albertahealthservices.ca	Sapkota, Yadav/O-2142-2015; Yasui, Yutaka/E-2564-2015; Robson, Paula J/Q-3351-2017	Sapkota, Yadav/0000-0001-5943-9454; Yasui, Yutaka/0000-0002-7717-8638; Robson, Paula J/0000-0003-4640-1371	Alberta Cancer Research Institute (ACRI); CBCF (Canadian Breast Cancer Foundation); Alberta Cancer Board (ACB); CBCF-Prairies/North West Territories Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund; Alberta Innovates-Health Solutions; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy; Canadian Partnership Against Cancer	Alberta Cancer Research Institute (ACRI); CBCF (Canadian Breast Cancer Foundation); Alberta Cancer Board (ACB); CBCF-Prairies/North West Territories Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund; Alberta Innovates-Health Solutions; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy; Canadian Partnership Against Cancer	This work was supported by Alberta Cancer Research Institute (ACRI), CBCF (Canadian Breast Cancer Foundation) operating grants and Alberta Cancer Board (ACB) operating grants to SD. Funding for the CBCF Tumor Bank was provided by the CBCF-Prairies/North West Territories Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund, managed by the Alberta Innovates-Health Solutions. The Tomorrow Project was funded by the Alberta Cancer Foundation and the Alberta Cancer Prevention Legacy (managed by Alberta Innovates -Health Solutions) and the Canadian Partnership Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bryant Heather, 2006, Chronic Dis Can, V27, P51; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2012, CAN CANC STAT 2012; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; *GOLD HEL INC, HEL SNP VAR SUIT VER; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Krishnan AV, 2004, PROSTATE, V59, P243, DOI 10.1002/pros.20006; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Miao JY, 2012, J NEUROL SCI, V323, P232, DOI 10.1016/j.jns.2012.09.027; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sapkota Y, 2012, EUR J HUM GENET, V20, P682, DOI 10.1038/ejhg.2011.273; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Short SM, 2007, BREAST J, V13, P130, DOI 10.1111/j.1524-4741.2007.00389.x; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Theriault BL, 2012, INT J CANCER, V130, P1844, DOI 10.1002/ijc.26189; THERNEAU T, 2012, PACKAGE SURVIVAL ANA, P36; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Wang KS, 2012, GENE, V500, P80, DOI 10.1016/j.gene.2012.03.046; Wang XK, 2010, CANCER GENET CYTOGEN, V196, P64, DOI 10.1016/j.cancergencyto.2009.09.003; Wiesmann F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2319; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	47	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e62550	10.1371/journal.pone.0062550	http://dx.doi.org/10.1371/journal.pone.0062550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717390	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700004
J	Chakraborty, P; Goswami, SK; Rajani, S; Sharma, S; Kabir, SN; Chakravarty, B; Jana, K				Chakraborty, Pratip; Goswami, S. K.; Rajani, Shweta; Sharma, Sunita; Kabir, Syed N.; Chakravarty, Baidyanath; Jana, Kuladip			Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; SPONTANEOUS-ABORTION; PLASMA HOMOCYSTEINE; FETAL LOSS; WOMEN; VITAMIN-B-12; REPRODUCTION; MISCARRIAGE; OBESITY; RISK	Recurrent pregnancy loss (RPL) in polycystic ovary syndrome (PCOS), which occurs in similar to 50% of total pregnancies is a frequent obstetric complication. Among the several hypotheses, insulin resistance (IR), obesity and hyperhomocysteinemia (HHcy) play significant role/s in RPL. This study was conducted to assess the link between elevated levels of homocysteine and IR in PCOS-associated women with RPL in Kolkata, India. A retrospective study was conducted of one hundred and twenty six PCOS women (<30 years) who experienced two or more spontaneous abortions during the first trimester presenting to Institute of Reproductive Medicine (IRM) in Kolkata during the period of March 2008 through February 2011. One hundred and seventeen non-PCOS subjects with matching age range were randomly chosen as controls. Incidence of HHcy and IR was 70.63% (n = 89) and 56.34% (n = 71), respectively, in RPL-affected PCOS population which was significantly higher (p<0.04; p<0.0001) when compared to the non-PCOS set (HHcy: 57.26%; IR: 6.83%). Rates of miscarriage were significantly higher (p<0.008; p<0.03) in hyperhomocysteinemia-induced miscarriage when compared to the normohomocysteinemic segment (PCOS: 70.63% vs. 29.36% & non-PCOS: 57.26% vs. 42.73%) along with the insulin resistant (p<0.04; p<0.0001) population (PCOS: 70.63% vs. 56.34% & non-PCOS: 57.26% vs. 6.83%) in both groups. A probabilistic causal model evaluated HHcy as the strongest plausible factor for diagnosis of RPL. A probability percentage of 43.32% in the cases of HHcy-mediated RPL suggests its increased tendency when compared to IR mediated miscarriage (37.29%), further supported by ROC-AUC (HHcy: 0.778vs. IR: 0.601) values. Greater susceptibility towards HHcy may increase the incidence for miscarriage in women in India and highlights the need to combat the condition in RPL control programs in the subcontinent.	[Chakraborty, Pratip] Inst Reprod Med, Dept Infertil, Kolkata, India; [Goswami, S. K.; Rajani, Shweta; Sharma, Sunita; Chakravarty, Baidyanath] Inst Reprod Med, Dept Assisted Reprod, Kolkata, India; [Kabir, Syed N.] CSIR Indian Inst Chem Biol, Kolkata, India; [Jana, Kuladip] Calcutta Improvement Trust Scheme VIIM, Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Bose Institute	Jana, K (corresponding author), Calcutta Improvement Trust Scheme VIIM, Bose Inst, Div Mol Med, Kolkata, W Bengal, India.	kuladip@bic.boseinst.ernet.in	Jana, Kuladip/GXG-3481-2022	Jana, Kuladip/0000-0003-4748-253X				Amer SAK, 2002, HUM REPROD, V17, P2035, DOI 10.1093/humrep/17.8.2035; Atiomo WU, 1998, FERTIL STERIL, V69, P236, DOI 10.1016/S0015-0282(97)00486-X; Azem F, 2004, HUM REPROD, V19, P368, DOI 10.1093/humrep/deh069; Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.3.CO;2-7; Bennett M, 2001, J REPROD MED, V46, P209; Boxmeer JC, 2008, HUM REPROD, V23, P2570, DOI 10.1093/humrep/den292; Bussen S, 1999, HUM REPROD, V14, P18, DOI 10.1093/humrep/14.1.18; Chakraborty P, 2013, BIOL TRACE ELEM RES, V152, P9, DOI 10.1007/s12011-012-9592-5; Ebisch IMW, 2006, HUM REPROD, V21, P1725, DOI 10.1093/humrep/del081; Essah Paulina A, 2004, Hormones (Athens), V3, P221; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Giudice LC, 2006, BEST PRACT RES CL EN, V20, P235, DOI 10.1016/j.beem.2006.03.005; Gosman GG, 2006, HUM REPROD UPDATE, V12, P585, DOI 10.1093/humupd/dml024; Hogge WA, 2003, AM J OBSTET GYNECOL, V189, P397, DOI 10.1067/S0002-9378(03)00700-2; Kaya C, 2009, REPROD BIOMED ONLINE, V19, P721, DOI 10.1016/j.rbmo.2009.06.005; Lee RM, 2000, SEMIN REPROD MED, V18, P433, DOI 10.1055/s-2000-13733; Lindblad B, 2005, ACTA OBSTET GYN SCAN, V84, P1055, DOI 10.1111/j.0001-6349.2005.00876.x; Makino A, 2004, AM J REPROD IMMUNOL, V52, P60, DOI 10.1111/j.1600-0897.2004.00187.x; Maryam Kotanaie, 2012, BMC Res Notes, V5, P133, DOI 10.1186/1756-0500-5-133; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Nadir Y, 2007, ANN HEMATOL, V86, P35, DOI 10.1007/s00277-006-0194-1; Nafiye Y, 2010, FERTIL STERIL, V93, P1864, DOI 10.1016/j.fertnstert.2008.12.024; Pacchiarotti A, 2007, J ASSIST REPROD GEN, V24, P459, DOI 10.1007/s10815-007-9165-2; Palomba S, 2005, FERTIL STERIL, V84, P761, DOI 10.1016/j.fertnstert.2005.04.021; Pritchand D., 2006, UPDATE RELATION COMM; Qublan HS, 2006, HUM REPROD, V21, P2694, DOI 10.1093/humrep/del203; Rai R, 2000, HUM REPROD, V15, P612, DOI 10.1093/humrep/15.3.612; Rai R, 1996, BRIT J OBSTET GYNAEC, V103, P106, DOI 10.1111/j.1471-0528.1996.tb09658.x; Raziel A, 2001, AM J REPROD IMMUNOL, V45, P65, DOI 10.1111/j.8755-8920.2001.450201.x; Schachter M, 2003, HUM REPROD, V18, P721, DOI 10.1093/humrep/deg190; Sun L, 2010, J ENDOCRINOL INVEST, V33, P77, DOI [10.1007/BF03346557, 10.3275/6470]; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Tian L, 2007, J CLIN ENDOCR METAB, V92, P1430, DOI 10.1210/jc.2006-1123; Wang JX, 2002, OBES RES, V10, P551, DOI 10.1038/oby.2002.74; Wijeyaratne CN, 2004, CLIN ENDOCRINOL, V60, P560, DOI 10.1111/j.1365-2265.2004.02019.x; World Health Organization, 2000, WHO TECHNICAL REPORT, V894, P3	37	47	55	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64446	10.1371/journal.pone.0064446	http://dx.doi.org/10.1371/journal.pone.0064446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700477	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200136
J	Pal, R; Thakur, PB; Li, SM; Minard, C; Rodney, GG				Pal, Rituraj; Thakur, Poulami Basu; Li, Shumin; Minard, Charles; Rodney, George G.			Real-Time Imaging of NADPH Oxidase Activity in Living Cells Using a Novel Fluorescent Protein Reporter	PLOS ONE			English	Article							SKELETAL-MUSCLE; REACTIVE OXYGEN; DYE 2'-7'-DICHLOROFLUORESCEIN; RELEASE; INHIBITOR	Production of reactive oxygen species (ROS) has been implicated in the pathology of many conditions, including cardiovascular, inflammatory and degenerative diseases, aging, muscular dystrophy, and muscle fatigue. NADPH oxidases (Nox) have recently gained attention as an important source of ROS involved in redox signaling. However, our knowledge of the source of ROS has been limited by the relatively impoverished array of tools available to study them and the limitations of all imaging probes to provide meaningful spatial resolution. By linking redox-sensitive GFP (roGFP) to the Nox organizer protein, p47(phox), we have developed a redox sensitive protein to specifically assess Nox activity (p47-roGFP). Stimulation of murine macrophages with endotoxin resulted in rapid, reversible oxidation of p47-roGFP. In murine skeletal muscle, both passive stretch and repetitive electrical stimulation resulted in oxidation of p47-roGFP. The oxidation of p47-roGFP in both macrophages and skeletal muscle was blocked by a Nox specific peptide inhibitor. Furthermore, expression of p47-roGFP in p47(phox) deficient cells restored Nox activity. As Nox has been linked to pathological redox signaling, our newly developed Nox biosensor will allow for the direct assessment of Nox activity and the development of therapeutic Nox inhibitors.	[Pal, Rituraj; Thakur, Poulami Basu; Li, Shumin; Rodney, George G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Minard, Charles] Baylor Coll Med, Dan L Duncan Inst Clin & Translat Res, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Rodney, GG (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	Rodney@bcm.edu		Rodney, George G/0000-0002-6968-1516	National Institutes of Health [R01 AR061370]; Baylor College of Medicine Seed Funds; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Seed Funds; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The construction of p47-roGFP was made possible from Baylor College of Medicine Seed Funds. All other aspects were supported by a grant from the National Institutes of Health (R01 AR061370) and Baylor College of Medicine Seed Funds to GGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Dworakowski R, 2006, BIOCHEM SOC T, V34, P960, DOI 10.1042/BST0340960; Geiszt M, 2012, ANTIOXID RE IN PRESS; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Janiszewski M, 2002, FREE RADICAL BIO MED, V32, P446, DOI 10.1016/S0891-5849(01)00828-0; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Lavigne MC, 2001, FASEB J, V15, P285; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; LOLAIT SJ, 1984, J CLIN INVEST, V73, P277, DOI 10.1172/JCI111203; Marchesi E, 1999, FREE RADICAL BIO MED, V26, P148, DOI 10.1016/S0891-5849(98)00174-9; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Michaelson LP, 2010, MUSCLE NERVE, V42, P522, DOI 10.1002/mus.21724; Paletta-Silva R, 2013, INT J MOL SCI, V14, P3683, DOI 10.3390/ijms14023683; Patwell DM, 2004, FREE RADICAL BIO MED, V37, P1064, DOI 10.1016/j.freeradbiomed.2004.06.026; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; REID MB, 1992, J APPL PHYSIOL, V73, P1805, DOI 10.1152/jappl.1992.73.5.1805; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Rodney GG, 2008, AM J PHYSIOL-CELL PH, V294, pC1288, DOI 10.1152/ajpcell.00033.2008; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026	31	51	51	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63989	10.1371/journal.pone.0063989	http://dx.doi.org/10.1371/journal.pone.0063989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704967	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200099
J	Takebe, Y; Saucedo, CJ; Lund, G; Uenishi, R; Hase, S; Tsuchiura, T; Kneteman, N; Ramessar, K; Tyrrell, DLJ; Shirakura, M; Wakita, T; McMahon, JB; O'Keefe, BR				Takebe, Yutaka; Saucedo, Carrie J.; Lund, Garry; Uenishi, Rie; Hase, Saiki; Tsuchiura, Takayo; Kneteman, Norman; Ramessar, Koreen; Tyrrell, D. Lorne J.; Shirakura, Masayuki; Wakita, Takaji; McMahon, James B.; O'Keefe, Barry R.			Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus	PLOS ONE			English	Article							ANTI-HIV PROTEIN; RECOMBINANT PRODUCTION; INACTIVATING PROTEIN; GLYCOSYLATION SITES; HCV INFECTION; CYANOVIRIN-N; GRIFFITHSIN; RIBAVIRIN; ENTRY; RESISTANCE	Hepatitis C virus (HCV) infection is a significant public health problem with over 170,000,000 chronic carriers and infection rates increasing worldwide. Chronic HCV infection is one of the leading causes of hepatocellular carcinoma which was estimated to result in,10,000 deaths in the United States in the year 2011. Current treatment options for HCV infection are limited to PEG-ylated interferon alpha (IFN-alpha), the nucleoside ribavirin and the recently approved HCV protease inhibitors telaprevir and boceprevir. Although showing significantly improved efficacy over the previous therapies, treatment with protease inhibitors has been shown to result in the rapid emergence of drug-resistant virus. Here we report the activity of two proteins, originally isolated from natural product extracts, which demonstrate low or sub-nanomolar in vitro activity against both genotype I and genotype II HCV. These proteins inhibit viral infectivity, binding to the HCV envelope glycoproteins E1 and E2 and block viral entry into human hepatocytes. In addition, we demonstrate that the most potent of these agents, the protein griffithsin, is readily bioavailable after subcutaneous injection and shows significant in vivo efficacy in reducing HCV viral titers in a mouse model system with engrafted human hepatocytes. These results indicate that HCV viral entry inhibitors can be an effective component of anti-HCV therapy and that these proteins should be studied further for their therapeutic potential.	[Takebe, Yutaka; Uenishi, Rie; Hase, Saiki; Tsuchiura, Takayo] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Saucedo, Carrie J.] SAIC Frederick, Mol Targets Lab, Frederick, MD USA; [Lund, Garry; Kneteman, Norman; Tyrrell, D. Lorne J.] KMT Hepatech, Edmonton, AB, Canada; [Ramessar, Koreen; McMahon, James B.; O'Keefe, Barry R.] NCI, Ctr Canc Res, Mol Targets Lab, Frederick, MD 21701 USA; [Shirakura, Masayuki; Wakita, Takaji] Natl Inst Infect Dis, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institute of Infectious Diseases (NIID)	O'Keefe, BR (corresponding author), NCI, Ctr Canc Res, Mol Targets Lab, Frederick, MD 21701 USA.	okeefeba@mail.nih.gov			Ministry of Health, Labor and Welfare (JAPAN); Human Sciences Foundation; Intramural research Program of the NIH; National Cancer Institute; Center for Cancer Research; National Cancer Institute, National Institutes of Health [N01-CO-12400, HHSN261200800001E]; NIAID; NATIONAL CANCER INSTITUTE [ZICBC010469] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare (JAPAN)(Ministry of Health, Labour and Welfare, Japan); Human Sciences Foundation; Intramural research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Y.T. is supported by grants of the hepatitis study group from the Ministry of Health, Labor and Welfare (JAPAN) and the Human Sciences Foundation. This research was supported by the Intramural research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400 and HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The patents for both Griffithsin and Scytovirin are wholly owned by the U.S. Government. Drs. O'Keefe and McMahon are named inventors on patents for both proteins. Norman Kneteman, Garry Lund and Lorne Tyrrell are affiliated to KMT Hepatech which is a contract research organization funded by NIAID for hepatitis C studies with no competing interests. KMT Hepatech has no rights or interests in further developing the antiviral proteins griffithsin and scytovirin for commercial use. Their involvement in this manuscript does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barth H, 2008, J HEPATOL, V49, P134, DOI 10.1016/j.jhep.2008.03.012; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Davis GL, 2005, LIVER TRANSPLANT, V11, P941, DOI 10.1002/lt.20405; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giomarelli B, 2006, PROTEIN EXPRES PURIF, V47, P194, DOI 10.1016/j.pep.2005.10.014; Goffard A, 2005, J VIROL, V79, P8400, DOI 10.1128/JVI.79.13.8400-8409.2005; Goffard A, 2003, BIOCHIMIE, V85, P295, DOI 10.1016/S0300-9084(03)00004-X; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; McFeeters RL, 2007, J MOL BIOL, V369, P451, DOI 10.1016/j.jmb.2007.03.030; Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11; Meunier JC, 1999, J GEN VIROL, V80, P887, DOI 10.1099/0022-1317-80-4-887; Michaels AJ, CURR OPINION GASTROE, V26, P196; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mori T, 1998, PROTEIN EXPRES PURIF, V12, P151, DOI 10.1006/prep.1997.0838; Moulaei T, 2007, PROTEIN SCI, V16, P2756, DOI 10.1110/ps.073157507; Naggie S, 2010, J ANTIMICROB CHEMOTH, V65, P2063, DOI 10.1093/jac/dkq284; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Pol S, 2010, J HEPATOL, V52, pS462, DOI 10.1016/S0168-8278(10)61190-7; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schiano TD, 2006, LIVER TRANSPLANT, V12, P1381, DOI 10.1002/lt.20876; Slater-Handshy T, 2004, VIROLOGY, V319, P36, DOI 10.1016/j.virol.2003.10.008; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Xiong CY, 2006, PROTEIN EXPRES PURIF, V46, P233, DOI 10.1016/j.pep.2005.09.019; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang HJ, 2009, J NAT PROD, V72, P2158, DOI 10.1021/np900549e; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	43	93	99	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64449	10.1371/journal.pone.0064449	http://dx.doi.org/10.1371/journal.pone.0064449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700478	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200137
J	Hamaji, T; Ferris, PJ; Nishii, I; Nishimura, Y; Nozaki, H				Hamaji, Takashi; Ferris, Patrick J.; Nishii, Ichiro; Nishimura, Yoshiki; Nozaki, Hisayoshi			Distribution of the Sex-Determining Gene MID and Molecular Correspondence of Mating Types within the Isogamous Genus Gonium (Volvocales, Chlorophyta)	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; MULTICOCCUM VOLVOCALES; EVOLUTION; REPRODUCTION; LOCUS; MORPHOLOGY; PROTEIN; IDENTIFICATION; PHYLOGENIES; FUSION	Background: Isogamous organisms lack obvious cytological differences in the gametes of the two complementary mating types. Consequently, it is difficult to ascertain which of the two mating types are homologous when comparing related but sexual isolated strains or species. The colonial volvocalean algal genus Gonium consists of such isogamous organisms with heterothallic mating types designated arbitrarily as plus or minus in addition to homothallic strains. Homologous molecular markers among lineages may provide an "objective" framework to assign heterothallic mating types. Methodology/Principal Findings: Using degenerate primers designed based on previously reported MID orthologs, the "master regulator" of mating types/sexes in the colonial Volvocales, MID homologs were identified and their presence/absence was examined in nine strains of four species of Gonium. Only one of the two complementary mating types in each of the four heterothallic species has a MID homolog. In addition to heterothallic strains, a homothallic strain of G. multicoccum has MID. Molecular evolutionary analysis suggests that MID of this homothallic strain retains functional constraint comparable to that of the heterothallic strains. Conclusion/Significance: We coordinated mating genotypes based on presence or absence of a MID homolog, respectively, in heterothallic species. This scheme should be applicable to heterothallic species of other isogamous colonial Volvocales including Pandorina and Yamagishiella. Homothallism emerged polyphyletically in the colonial Volvocales, although its mechanism remains unknown. Our identification of a MID homolog for a homothallic strain of G. multicoccum suggests a MID-dependent mechanism is involved in the sexual developmental program of this homothallic species.	[Hamaji, Takashi; Nishimura, Yoshiki] Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kyoto, Japan; [Ferris, Patrick J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Nishii, Ichiro] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	Kyoto University; University of Arizona; National University of Singapore; University of Tokyo	Hamaji, T (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	hamaji@pmg.bot.kyoto-u.ac.jp	NOZAKI, HISAYOSHI/G-4926-2014	Nishimura, Yoshiki/0000-0001-8686-9206; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498	Japan Society for the Promotion of Science [19-7661, 23-5499, 24112707, 24247042]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Society for the Promotion of Science (Research fellowship numbers 19-7661 and 23-5499, for TH; Grants-in-Aid for Scientific Research numbers 24112707 and 24247042, for HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; BOYNTON JE, 1987, P NATL ACAD SCI USA, V84, P2391, DOI 10.1073/pnas.84.8.2391; CAMPBELL AM, 1995, MOL BIOL CELL, V6, P87, DOI 10.1091/mbc.6.1.87; Coleman AW, 2012, J PHYCOL, V48, P491, DOI 10.1111/j.1529-8817.2012.01168.x; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; COLEMAN AW, 1959, J PROTOZOOL, V6, P249, DOI 10.1111/j.1550-7408.1959.tb04366.x; COLEMAN AW, 1975, J PHYCOL, V11, P282, DOI 10.1111/j.0022-3646.1975.00282.x; DETMERS PA, 1983, J CELL BIOL, V97, P522, DOI 10.1083/jcb.97.2.522; DETMERS PA, 1985, CELL MOTIL CYTOSKEL, V5, P415, DOI 10.1002/cm.970050505; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Ferris PJ, 1997, GENETICS, V146, P859; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Ferris PJ, 2002, GENETICS, V160, P181; Ferris PJ, 1996, MOL BIOL CELL, V7, P1235, DOI 10.1091/mbc.7.8.1235; GOLDSTEIN M, 1964, J PROTOZOOL, V11, P317, DOI 10.1111/j.1550-7408.1964.tb01762.x; GOODENOUGH UW, 1982, J CELL BIOL, V92, P378, DOI 10.1083/jcb.92.2.378; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2009, J PHYCOL, V45, P1310, DOI 10.1111/j.1529-8817.2009.00744.x; Harris EH, 2008, CLAMYDOMONAS SOURCEB; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin H, 2007, GENETICS, V176, P913, DOI 10.1534/genetics.106.066167; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Misamore MJ, 2003, MOL BIOL CELL, V14, P2530, DOI 10.1091/mbc.E02-12-0790; Mogi Y, 2012, J PHYCOL, V48, P670, DOI 10.1111/j.1529-8817.2012.01149.x; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; NOZAKI H, 1991, PHYCOLOGIA, V30, P381, DOI 10.2216/i0031-8884-30-5-381.1; Nozaki H, 1996, J PLANT RES, V109, P353, DOI 10.1007/BF02344484; NOZAKI H, 1986, PHYCOLOGIA, V25, P29, DOI 10.2216/i0031-8884-25-1-29.1; NOZAKI H, 1989, PHYCOLOGIA, V28, P77, DOI 10.2216/i0031-8884-28-1-77.1; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki H, 2008, BIOLOGIA, V63, P772, DOI 10.2478/s11756-008-0097-9; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Setohigashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019545; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANWINKLESWIFT KP, 1986, GENETICS, V113, P601; Werner R, 1998, PLANT MOL BIOL REP, V16, P295, DOI 10.1023/A:1007583508766; Werner R, 2001, J PHYCOL, V37, P427, DOI 10.1046/j.1529-8817.2001.037003427.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamada Toshihiro K., 2006, Journal of Japanese Botany, V81, P139; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zamora I, 2004, BIOTECHNIQUES, V37, P534, DOI 10.2144/04374BM01	52	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64385	10.1371/journal.pone.0064385	http://dx.doi.org/10.1371/journal.pone.0064385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696888	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900091
J	Lahiri, I; Mukherjee, P; Pata, JD				Lahiri, Indrajit; Mukherjee, Purba; Pata, Janice D.			Kinetic Characterization of Exonuclease-Deficient Staphylococcus aureus PolC, a C-family Replicative DNA Polymerase	PLOS ONE			English	Article							ESCHERICHIA-COLI; III HOLOENZYME; ALPHA-SUBUNIT; STEADY-STATE; NUCLEOTIDE INCORPORATION; THERMUS-AQUATICUS; CRYSTAL-STRUCTURE; I KLENOW; FIDELITY; REPLISOME	PolC is the C-family replicative polymerase in low G+C content Gram-positive bacteria. To date several structures of C-family polymerases have been reported, including a high resolution crystal structure of a ternary complex of PolC with DNA and incoming deoxynucleoside triphosphate (dNTP). However, kinetic information needed to understand the enzymatic mechanism of C-family polymerases is limited. For this study we have performed a detailed steady-state and pre-steady-state kinetic characterization of correct dNTP incorporation by PolC from the Gram-positive pathogen Staphylococcus aureus, using a construct lacking both the non-conserved N-terminal domain and the 3'-5' exonuclease domain (Sau-PolC-Delta N Delta Exo). We find that Sau-PolC-Delta N Delta Exo has a very fast catalytic rate (k(pol) 330 s(-1)) but also dissociates from DNA rapidly (k(off) -, 150 s(-1)), which explains the low processivity of PolC in the absence of sliding clamp processivity factor. Although Sau-PolC-Delta N Delta Exo follows the overall enzymatic pathway defined for other polymerases, some significant differences exist. The most striking feature is that the nucleotidyl transfer reaction for Sau-PolC-Delta N Delta Exo is reversible and is in equilibrium with dNTP binding. Simulation of the reaction pathway suggests that rate of pyrophosphate release, or a conformational change required for pyrophosphate release, is much slower than rate of bond formation. The significance of these findings is discussed in the context of previous data showing that binding of the beta-clamp processivity factor stimulates the intrinsic nucleotide incorporation rate of the C-family polymerases, in addition to increasing processivity.	[Lahiri, Indrajit; Mukherjee, Purba; Pata, Janice D.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Lahiri, Indrajit; Mukherjee, Purba; Pata, Janice D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Pata, JD (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	jpata@wadsworth.org	Mukherjee, Purba/Q-6811-2019	Mukherjee, Purba/0000-0001-9869-6509; Pata, Janice/0000-0001-5999-5442; Lahiri, Indrajit/0000-0002-5633-7978	NIH [R01-GM080573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080573] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01-GM080573 to J.D.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Bertram JG, 2004, J BIOL CHEM, V279, P33047, DOI 10.1074/jbc.C400265200; BONNER CA, 1992, J BIOL CHEM, V267, P11431; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Bruck I, 2000, J BIOL CHEM, V275, P28971, DOI 10.1074/jbc.M003565200; Bruck I, 2005, J BIOL CHEM, V280, P18152, DOI 10.1074/jbc.M413595200; Bruck I, 2002, J BIOL CHEM, V277, P17334, DOI 10.1074/jbc.M110198200; Bullard JM, 2002, J BIOL CHEM, V277, P13246, DOI 10.1074/jbc.M108708200; BURROWS JA, 1992, BIOCHEM J, V287, P971, DOI 10.1042/bj2870971; Dieckman LM, 2010, BIOCHEMISTRY-US, V49, P7344, DOI 10.1021/bi100556m; Dohrmann PR, 2011, J MOL BIOL, V414, P15, DOI 10.1016/j.jmb.2011.09.039; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Einolf HJ, 2001, J BIOL CHEM, V276, P3764, DOI 10.1074/jbc.M006696200; Evans RJ, 2008, P NATL ACAD SCI USA, V105, P20695, DOI 10.1073/pnas.0809989106; FAY PJ, 1981, J BIOL CHEM, V256, P976; Filee J, 2002, J MOL EVOL, V54, P763, DOI 10.1007/s00239-001-0078-x; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Huang YP, 1999, J MOL EVOL, V48, P756, DOI 10.1007/PL00006520; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Johnson K. A, 1992, TRANSIENT STATE KINE, P1; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Kim DR, 1997, J BACTERIOL, V179, P6721, DOI 10.1128/jb.179.21.6721-6728.1997; Klemperer N, 2000, J BIOL CHEM, V275, P26136, DOI 10.1074/jbc.M002566200; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lowe LG, 1996, BIOCHEMISTRY-US, V35, P9840, DOI 10.1021/bi960485x; MAKI H, 1985, J BIOL CHEM, V260, P2987; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; Shapiro A, 2005, ANAL BIOCHEM, V347, P254, DOI 10.1016/j.ab.2005.09.023; Standish AJ, 2013, BIOCHEM BIOPH RES CO, V430, P167, DOI 10.1016/j.bbrc.2012.11.049; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Werneburg BG, 1996, BIOCHEMISTRY-US, V35, P7041, DOI 10.1021/bi9527202; Wing RA, 2008, J MOL BIOL, V382, P859, DOI 10.1016/j.jmb.2008.07.058; Yanagihara F, 2007, GENES GENET SYST, V82, P273, DOI 10.1266/ggs.82.273; Yang F, 2002, ANAL BIOCHEM, V304, P110, DOI 10.1006/abio.2001.5591; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63489	10.1371/journal.pone.0063489	http://dx.doi.org/10.1371/journal.pone.0063489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696828	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900037
J	Wang, MF; Chen, JQ; Ying, J; Yu, J; Huang, BF; Ren, ZX; Wang, XY; Guo, QQ; Wang, YL; Qiu, LY; Yu, HS; Wan, RG				Wang, Maofeng; Chen, Junqing; Ying, Jun; Yu, Jiong; Huang, Bifei; Ren, Zhaoxiang; Wang, Xianyu; Guo, Qiaoqiao; Wang, Yunlai; Qiu, Liuyi; Yu, Hongsheng; Wan, Rugen			Serum Angiopoietin-2 and beta-hCG as Predictors of Prolonged Uterine Bleeding after Medical Abortion in the First Trimester	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BUCCAL MISOPROSTOL; RECEPTORS TIE-1; EARLY-PREGNANCY; EXPRESSION; MIFEPRISTONE; WOMEN; CONTRACEPTION; ENDOMETRIUM; PROGESTIN	Objective: The combination of mifepristone and misoprostol is an established method for induction of early first trimester abortion, but there is no consensus about the best evaluation of treatment outcome. We evaluate serum Angiopoietin-2(Ang-2) and beta human chorionic gonadotropin (beta-hCG) in women who had undergone a medical abortion as markers of prolonged uterine bleeding (PUB). Methods: Prospective trial involving 2843 women attending an gynecology outpatient clinic who following a medical abortion with mifepristone and misoprostol, the study cohort was divided into women with duration of uterine bleeding >14 days (PUB) and women with duration of uterine bleeding <= 14 days (normal uterine bleeding, NUB). Serum determinations of Ang-2 levels by ELISA and beta-hCG levels by electrochemiluminiscence immunoassay. Receiver Operating Characteristics (ROC) analyses were calculated and plotted for the diagnostic accuracy of serum beta-hCG and Ang-2 concentration to discriminate PUB and NUB. Results: Baseline characteristics for both groups were similar, Only duration of bleeding showed a significant difference between the PUB group and NUB group. Ang-2 serum levels moderately correlated with serum beta-hCG levels with statistically significant correlation coefficients of 0.536. Serum beta-hCG and Ang-2 levels on day 7 and on day 14 after medical abortion were signifcantly higher in PUB group than in NUB group. Plotted as ROC curves, beta-hCG area under curve (AUC) was 0.65 (95% CI, 0.53-0.76) on day 7, rising to AUC = 0.83 (95% CI, 0.75-0.92) on day 14. Using Ang-2 on day 7 and day 14 as predictive parameter resulted in an analogous AUC (AUC = 0.61 on day 7, AUC = 0.78 on day 14). Conclusions: Both parameters are clinically useful as a diagnostic test in predicting PUB after medical abortion, and can be helpful in uncertain clinical situations, but should be considered as supplementary to a general clinical evaluation.	[Wang, Maofeng; Ren, Zhaoxiang; Yu, Hongsheng; Wan, Rugen] Wenzhou Med Coll, Affiliated Dongyang Hosp, Dept Clin Lab Med, Dongyang, Zhejiang, Peoples R China; [Chen, Junqing; Wang, Xianyu] Wenzhou Med Coll, Affiliated Dongyang Hosp, Dept Gynecol, Dongyang, Zhejiang, Peoples R China; [Ying, Jun] Wenzhou Med Coll, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Yu, Jiong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Bifei; Qiu, Liuyi] Wenzhou Med Coll, Affiliated Dongyang Hosp, Pathol Ctr, Dongyang, Zhejiang, Peoples R China; [Guo, Qiaoqiao; Wang, Yunlai] Wenzhou Med Coll, Dept Ultrasonog, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University	Wan, RG (corresponding author), Wenzhou Med Coll, Affiliated Dongyang Hosp, Dept Clin Lab Med, Dongyang, Zhejiang, Peoples R China.	13967995216@163.com		Yu, Jiong/0000-0002-1821-1178	Science and Technology Project of Jinhua city [2012-3-083]	Science and Technology Project of Jinhua city	This study was supported by Science and Technology Project of Jinhua city (2012-3-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2009, PRENATAL DIAG, V29, P847, DOI 10.1002/pd.2307; Baschat A, 2010, AM J PERINAT, V27, P9, DOI 10.1055/s-0029-1224865; Cheng LN, 2006, CONTRACEPTION, V74, P61, DOI 10.1016/j.contraception.2006.03.004; Chong E, 2012, CONTRACEPTION, V86, P251, DOI 10.1016/j.contraception.2011.12.012; Chou Szu-Yuan, 2006, Taiwan J Obstet Gynecol, V45, P48; Daponte A, 2013, CLIN CHIM ACTA, V415, P145, DOI 10.1016/j.cca.2012.10.031; Demir R, 2009, FOLIA HISTOCHEM CYTO, V47, P435, DOI 10.2478/v10042-009-0100-5; El-Baradie SMY, 2008, J OBSTET GYNAECOL CA, V30, P877, DOI 10.1016/S1701-2163(16)32966-8; Fjerstad M, 2009, CONTRACEPTION, V80, P282, DOI 10.1016/j.contraception.2009.03.010; Goldstone P, 2012, MED J AUSTRALIA, V197, P282, DOI 10.5694/mja12.10297; Haimov-Kochman R, 2007, ACTA OBSTET GYN SCAN, V86, P462, DOI 10.1080/00016340701203632; Hurliman AK, 2010, FERTIL STERIL, V93, P1493, DOI 10.1016/j.fertnstert.2009.04.036; Krikun G, 2002, AM J PATHOL, V161, P979, DOI 10.1016/S0002-9440(10)64258-7; Kulier R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002855.pub4; Lockwood CJ, 2004, HISTOL HISTOPATHOL, V19, P167, DOI 10.14670/HH-19.167; Miyabayashi K, 2005, J EXP ZOOL PART A, V303A, P590, DOI 10.1002/jez.a.188; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Norris W, 2011, PLACENTA, V32, pS182, DOI 10.1016/j.placenta.2011.01.009; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pietrowski D, 2003, FERTIL STERIL, V80, P1026, DOI 10.1016/S0015-0282(03)01011-2; Pietrowski D, 2010, HORM METAB RES, V42, P328, DOI 10.1055/s-0030-1249021; Plaisier M, 2007, FERTIL STERIL, V88, P176, DOI 10.1016/j.fertnstert.2006.11.102; Qian HL, 2010, J INT MED RES, V38, P100, DOI 10.1177/147323001003800112; Rorbye C, 2004, HUM REPROD, V19, P85, DOI 10.1093/humrep/deh041; Rudolfsson SH, 2003, BIOL REPROD, V69, P1231, DOI 10.1095/biolreprod.102.013375; Seval Y, 2008, PLACENTA, V29, P809, DOI 10.1016/j.placenta.2008.06.009; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Stepan H, 2009, AM J HYPERTENS, V22, P314, DOI 10.1038/ajh.2008.340; Woolnough C, 2012, MICROVASC RES, V84, P367, DOI 10.1016/j.mvr.2012.08.003; World Health Organization, 2012, FACTS IND AB WORLDW; Wu Shang-chun, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P479, DOI 10.3881/j.issn.1000-503X.2010.05.001; Wulff C, 2000, J CLIN ENDOCR METAB, V85, P4302, DOI 10.1210/jc.85.11.4302	32	1	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63755	10.1371/journal.pone.0063755	http://dx.doi.org/10.1371/journal.pone.0063755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696855	Green Submitted, Green Published			2022-12-25	WOS:000319081900059
J	Galaleldeen, A; Taylor, AB; Chen, D; Schuermann, JP; Holloway, SP; Hou, SP; Gong, SQ; Zhong, GM; Hart, PJ				Galaleldeen, Ahmad; Taylor, Alexander B.; Chen, Ding; Schuermann, Jonathan P.; Holloway, Stephen P.; Hou, Shuping; Gong, Siqi; Zhong, Guangming; Hart, P. John			Structure of the Chlamydia trachomatis Immunodominant Antigen Pgp3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Chlamydia; Immunology; Tumor Necrosis Factor (TNF); X-ray Crystallography; Beta-Helix; Beta-Propeller; Helical Coiled-coil; Pgp3; Sexually Transmitted Disease	SEGMENTED COILED-COIL; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REGULATOR; BACTERIOPHAGE-T4 FIBRITIN; TERMINAL DOMAIN; PROTEIN; PLASMID; RESOLUTION; REVEALS; ALPHA	Chlamydia trachomatis infection is the most common sexually transmitted bacterial disease. Left untreated, it can lead to ectopic pregnancy, pelvic inflammatory disease, and infertility. Here we present the structure of the secreted C. trachomatis protein Pgp3, an immunodominant antigen and putative virulence factor. The approximate to 84-kDa Pgp3 homotrimer, encoded on a cryptic plasmid, consists of globular N- and C-terminal assemblies connected by a triple-helical coiled-coil. The C-terminal domains possess folds similar to members of the TNF family of cytokines. The closest Pgp3 C-terminal domain structural homologs include a lectin from Burkholderia cenocepacia, the C1q component of complement, and a portion of the Bacillus anthracis spore surface protein BclA, all of which play roles in bioadhesion. The N-terminal domain consists of a concatenation of structural motifs typically found in trimeric viral proteins. The central parallel triple-helical coiled-coil contains an unusual alternating pattern of apolar and polar residue pairs that generate a rare right-handed superhelical twist. The unique architecture of Pgp3 provides the basis for understanding its role in chlamydial pathogenesis and serves as the platform for its optimization as a potential vaccine antigen candidate.	[Galaleldeen, Ahmad; Taylor, Alexander B.; Holloway, Stephen P.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Chen, Ding; Hou, Shuping; Gong, Siqi; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Galaleldeen, Ahmad] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Schuermann, Jonathan P.] Cornell Univ, Dept Chem & Chem Biol, Northeastern Collaborat Access Team, Ithaca, NY 14853 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cornell University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78229 USA.	zhongg@uthscsa.edu; pjhart@biochem.uthscsa.edu	Gong, Siqi/ABD-9207-2020; Gong, Siqi/AAM-1568-2021	Gong, Siqi/0000-0002-1111-6039; Taylor, Alexander/0000-0003-3517-6033; Galaleldeen, Ahmad/0000-0003-1160-6908	National Institutes of Health [AI47997, AI64537]; Robert A. Welch Foundation [AQ-1399]; National Center for Research Resources at the National Institute of Health [RR-15301]; U.S. Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; Cancer Therapy & Research Center Cancer Center [NCI P30CA054174]; United States Department of Defense to the UTSA/UTHSCSA Center for Excellence in Genomics Research [W911NF-11-1-0136]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); National Center for Research Resources at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Cancer Therapy & Research Center Cancer Center; United States Department of Defense to the UTSA/UTHSCSA Center for Excellence in Genomics Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI47997 and AI64537 (to G.Z.). This work was also supported by Robert A. Welch Foundation Grant AQ-1399 (to P.J.H.). This work is partially the result of research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by Award RR-15301 from the National Center for Research Resources at the National Institute of Health. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences under Contract W-31-109-ENG-38. This work was also supported in part by Cancer Therapy & Research Center Cancer Center Support Grant NCI P30CA054174 and Contract Number W911NF-11-1-0136 from the United States Department of Defense to the UTSA/UTHSCSA Center for Excellence in Genomics Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; CASPAR DLD, 1988, NATURE, V332, P659, DOI 10.1038/332659a0; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chen DJ, 2010, WIRELESSHART: REAL-TIME MESH NETWORK FOR INDUSTRIAL AUTOMATION, P3, DOI 10.1007/978-1-4419-6047-4_1; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; COMANDUCCI M, 1993, J GEN MICROBIOL, V139, P1083, DOI 10.1099/00221287-139-5-1083; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; den Hartog JE, 2006, HUM REPROD UPDATE, V12, P719, DOI 10.1093/humupd/dml030; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donati M, 2003, VACCINE, V21, P1089, DOI 10.1016/S0264-410X(02)00631-X; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel J, 2004, P NATL ACAD SCI USA, V101, P9947, DOI 10.1073/pnas.0403633101; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Ghebrehiwet B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00052; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Liu CQ, 2008, BIOTECHNOL BIOENG, V99, P774, DOI 10.1002/bit.21637; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Lu CX, 2012, INVEST OPHTH VIS SCI, V53, P2551, DOI 10.1167/iovs.11-9212; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1999, CRYSTALLIZATION BIOL; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Mitraki A, 1999, EUR J BIOCHEM, V264, P599, DOI 10.1046/j.1432-1327.1999.00683.x; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221; Reiter DM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002166; Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200; Seetharaman SV, 2010, ARCH BIOCHEM BIOPHYS, V503, P183, DOI 10.1016/j.abb.2010.08.014; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	76	27	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22068	22079		10.1074/jbc.M113.475012	http://dx.doi.org/10.1074/jbc.M113.475012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23703617	Green Published, hybrid			2022-12-25	WOS:000328841900052
J	Lietzan, AD; St Maurice, M				Lietzan, Adam D.; St Maurice, Martin			A Substrate-induced Biotin Binding Pocket in the Carboxyltransferase Domain of Pyruvate Carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE DOMAIN; CRYSTAL-STRUCTURE; MECHANISM; ROLES; C-13; TLS; DECARBOXYLATION; IDENTIFICATION; ACETOACETATE; OXALACETATE	Biotin-dependent enzymes catalyze carboxyl transfer reactions by efficiently coordinating multiple reactions between spatially distinct active sites. Pyruvate carboxylase (PC), a multifunctional biotin-dependent enzyme, catalyzes the bicarbonate- and MgATP-dependent carboxylation of pyruvate to oxaloacetate, an important anaplerotic reaction in mammalian tissues. To complete the overall reaction, the tethered biotin prosthetic group must first gain access to the biotin carboxylase domain and become carboxylated and then translocate to the carboxyltransferase domain, where the carboxyl group is transferred from biotin to pyruvate. Here, we report structural and kinetic evidence for the formation of a substrate-induced biotin binding pocket in the carboxyltransferase domain of PC from Rhizobium etli. Structures of the carboxyltransferase domain reveal that R. etli PC occupies a symmetrical conformation in the absence of the biotin carboxylase domain and that the carboxyltransferase domain active site is conformationally rearranged upon pyruvate binding. This conformational change is stabilized by the interaction of the conserved residues Asp(590) and Tyr(628) and results in the formation of the biotin binding pocket. Site-directed mutations at these residues reduce the rate of biotin-dependent reactions but have no effect on the rate of biotin-independent oxaloacetate decarboxylation. Given the conservation with carboxyltransferase domains in oxaloacetate decarboxylase and transcarboxylase, the structure-based mechanism described for PC may be applicable to the larger family of biotin-dependent enzymes.	[Lietzan, Adam D.; St Maurice, Martin] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	St Maurice, M (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	martin.stmaurice@marquette.edu	St. Maurice, Martin/AGJ-6319-2022; Lietzan, Adam/AAT-4163-2021; St.Maurice, Martin/AAL-5054-2021	St. Maurice, Martin/0000-0002-6507-9528; Lietzan, Adam/0000-0001-6388-2491; 	National Institutes of Health [GM070455]; National Science Foundation [DBI-959442]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070455] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0959442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070455 (to W. W. Cleland, J. C. Wallace, P. V. Attwood, and M. St. Maurice). This work was also supported in part through instrumentation funded by the National Science Foundation through grant DBI-959442. Use of the Advanced Photon Source was supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817).	Adina-Zada A, 2012, BIOCHEMISTRY-US, V51, P8208, DOI 10.1021/bi301060d; ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8191, DOI 10.1021/bi00373a011; ATTWOOD PV, 1991, BIOCHEM J, V273, P443, DOI 10.1042/bj2730443; ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8197, DOI 10.1021/bi00373a012; ATTWOOD PV, 1995, INT J BIOCHEM CELL B, V27, P231, DOI 10.1016/1357-2725(94)00087-R; Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Duangpan S, 2010, BIOCHEMISTRY-US, V49, P3296, DOI 10.1021/bi901894t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Gamberino WC, 1997, J NEUROCHEM, V69, P2312; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOODALL GJ, 1981, BIOCHEM J, V199, P603, DOI 10.1042/bj1990603; Granjon T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010935; Han J, 2010, J ENDOCRINOL, V204, P143, DOI 10.1677/JOE-09-0391; Hazen SA, 1997, DEV NEUROSCI-BASEL, V19, P162, DOI 10.1159/000111202; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; Lasso G, 2010, STRUCTURE, V18, P1300, DOI 10.1016/j.str.2010.07.008; Lietzan AD, 2011, BIOCHEMISTRY-US, V50, P9708, DOI 10.1021/bi201277j; LIU KJM, 1991, BIOCHEM BIOPH RES CO, V179, P366, DOI 10.1016/0006-291X(91)91379-Q; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; Marlier JF, 2013, BIOCHEMISTRY-US, V52, P2888, DOI 10.1021/bi400075t; Maveyraud L, 1996, J AM CHEM SOC, V118, P7435, DOI 10.1021/ja9609718; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolfenden R, 2011, J AM CHEM SOC, V133, P5683, DOI 10.1021/ja111457h; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yongbiao J, 2004, BIOCHEMISTRY-US, V43, P5912, DOI 10.1021/bi035783q; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; Zeczycki Tonya N, 2010, Open Enzym Inhib J, V3, P8; Zeczycki TN, 2011, BIOCHEMISTRY-US, V50, P9724, DOI 10.1021/bi2012788; Zeczycki TN, 2011, BIOCHEMISTRY-US, V50, P9694, DOI 10.1021/bi201276r; Zeczycki TN, 2009, BIOCHEMISTRY-US, V48, P4305, DOI 10.1021/bi9003759; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	46	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19915	19925		10.1074/jbc.M113.477828	http://dx.doi.org/10.1074/jbc.M113.477828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23698000	hybrid, Green Published			2022-12-25	WOS:000321515800057
J	Yu, Y; Qi, LH; Wu, JZ; Wang, YL; Fang, WG; Zhang, HQ				Yu, Yu; Qi, Lihua; Wu, Junzhou; Wang, Yunling; Fang, Weigang; Zhang, Hongquan			Kindlin 2 Regulates Myogenic Related Factor Myogenin via a Canonical Wnt Signaling in Myogenic Differentiation	PLOS ONE			English	Article							BETA-CATENIN; LOCALIZATION; EXPRESSION; MYOD	Kindlin 2, as an integrin-associated protein, is required for myocyte elongation and fusion. However, the association of Kindlin 2 with muscle differentiation-related signaling pathways is unknown. Here, we identified a mechanism that Kindlin 2 regulates myogenic regulatory factors myogenin via a canonical Wnt/beta-catenin signaling. We found that knockdown of Kindlin 2 leads to the abolishment of beta-catenin/TCF4-mediated transcription in C2C12 cells, followed by the impairment of myogenic differentiation. Mechanistically, nuclear translocation of both Kindlin 2 and beta-catenin is induced during myogenic differentiation. In particular, Kindlin 2 forms a tripartite complex with active beta-catenin and TCF4, and hence co-occupied on the promoter of myogenin to enhance its expression. Functionally, depletion of Kindlin 2 impairs myogenic differentiation via downregulation of myogenin. Taken together, our data reveal that Kindlin 2 is required for Wnt signaling-regulated myogenic differentiation, providing a mechanistic insight into the role of Kindlin-2 in muscle development.	[Yu, Yu; Qi, Lihua; Wu, Junzhou; Wang, Yunling; Fang, Weigang; Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Minist Educ China, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China; [Yu, Yu; Qi, Lihua; Wu, Junzhou; Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Lab Mol Cell Biol & Tumor Biol, Beijing 100871, Peoples R China; [Fang, Weigang] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China	Ministry of Education, China; Peking University; Peking University; Peking University	Zhang, HQ (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ China, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	Hongquan.Zhang@bjmu.edu.cn	Qi, LI/AAF-3389-2019		National Natural Science Foundation of China [30830048, 81230051, 31170711, 81101495]; Ministry of Science and Technology of China [2010CB912203, 2010CB529402]; 111 Project of the Ministry of Education; Beijing Natural Science Foundation [7120002]; Peking University [BMU20120314]; Leading Academic Discipline Project of Beijing Education Bureau	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111 Project of the Ministry of Education(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University(Peking University); Leading Academic Discipline Project of Beijing Education Bureau	This work was supported by grants from National Natural Science Foundation of China 30830048, 81230051, 31170711 and 81101495, the Ministry of Science and Technology of China 2010CB912203 and 2010CB529402, the 111 Project of the Ministry of Education, Beijing Natural Science Foundation 7120002 and a Peking University grant BMU20120314 and Leading Academic Discipline Project of Beijing Education Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Huh Michael S., 2005, Birth Defects Research, V75, P180, DOI 10.1002/bdrc.20045; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Qi L, 2013, INT J CANC; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	19	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63490	10.1371/journal.pone.0063490	http://dx.doi.org/10.1371/journal.pone.0063490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717433	Green Published, Green Submitted, gold			2022-12-25	WOS:000320362700026
J	Gao, L; Zhang, WW; Sun, YP; Yang, Q; Ren, J; Liu, JH; Wang, HX; Feng, WH				Gao, Li; Zhang, Weiwei; Sun, Yipeng; Yang, Qian; Ren, Jie; Liu, Jinhua; Wang, Hexiang; Feng, Wen-hai			Cryptoporus volvatus Extract Inhibits Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) In Vitro and In Vivo	PLOS ONE			English	Article							RNA-SYNTHESIS; CORDYCEPIN TRIPHOSPHATE; ANTIVIRAL ACTIVITY; REPLICATION; CHINA; POLYSACCHARIDE; INFECTION; EMERGENCE; CELLS; POLYMERASE	Porcine reproductive and respiratory syndrome virus (PRRSV) is an important arterivirus that can cause significant losses in swine industry. At present, there are no adequate control strategies against PRRSV. Thus, there is an urgent need for new treatment regimens that have efficacious antiviral activity to compensate for vaccines. Cryptoporus volvatus commonly serves as an anti-infective agent in Tradational Chinese Medicines. In this report, we exploited whether the aqueous extract from the fruiting body of Cryptoporus volvatus had the potential to inhibit PRRSV infection. Our results showed that the extract significantly inhibited PRRSV infection by repressing virus entry, viral RNA expression, and possibly viral protein synthesis, cell-to-cell spread, and releasing of virus particles. However, it did not block PRRSV binding to cells. Further studies confirmed that the extract directly inhibited PRRSV RNA-dependent RNA polymerase (RdRp) activity, thus interfering with PRRSV RNA and protein synthesis. More importantly, the extract efficiently inhibited highly pathologic PRRSV (HPPRRSV) infection in vivo, reduced virus load in serum, and increased the survival rate of pigs inoculated with HP-PRRSV strain. Collectively, our findings imply that the aqueous extract from the fruiting body of Cryptoporus volvatus has the potential to be used for anti-PRRSV therapies.	[Gao, Li; Zhang, Weiwei; Sun, Yipeng; Yang, Qian; Ren, Jie; Liu, Jinhua; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Gao, Li; Zhang, Weiwei; Yang, Qian; Ren, Jie; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, Minist Agr, Key Lab Soil Microbiol, Beijing 100094, Peoples R China; [Gao, Li; Zhang, Weiwei; Sun, Yipeng; Yang, Qian; Wang, Hexiang; Feng, Wen-hai] China Agr Univ, Coll Biol Sci, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Sun, Yipeng; Liu, Jinhua] China Agr Univ, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Wang, HX (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hxwang@cau.edu.cn; whfeng@cau.edu.cn			National Natural Science Foundation of China [30770101]; Faculty Starting Grant and State Key Laboratory of Agrobiotechnology [2010SKLAB06-1, 2012SKLAB01-6]; China Agricultural University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Faculty Starting Grant and State Key Laboratory of Agrobiotechnology; China Agricultural University, China	This work was supported by the National Natural Science Foundation of China (#30770101), and the Faculty Starting Grant and State Key Laboratory of Agrobiotechnology (Grant 2010SKLAB06-1 and 2012SKLAB01-6), China Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 1996, P NATL ACAD SCI USA, V93, P13152, DOI 10.1073/pnas.93.23.13152; Beerens N, 2007, J VIROL, V81, P8384, DOI 10.1128/JVI.00564-07; Cafruny WA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-90; Faccin LC, 2007, LETT APPL MICROBIOL, V45, P24, DOI 10.1111/j.1472-765X.2007.02153.x; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gao L, 2012, J VIROL, DOI [10.1128/JVI.02386-02312, DOI 10.1128/JVI.02386-02312]; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Horrigan BJ, 2006, EXPLORE-NY, V2, P153, DOI 10.1016/j.explore.2005.12.011; Jin Sai-hong, 2003, Zhongguo Zhongyao Zazhi, V28, P650; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Karuppannan AK, 2012, ANTIVIR RES, V94, P188, DOI 10.1016/j.antiviral.2012.03.008; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kreutz LC, 1996, VIRUS RES, V42, P137, DOI 10.1016/0168-1702(96)01313-5; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mothana RAA, 2003, FITOTERAPIA, V74, P177, DOI 10.1016/S0367-326X(02)00305-2; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ni JQ, 2012, J VET DIAGN INVEST, V24, P349, DOI 10.1177/1040638711434111; PANICALI DL, 1978, J VIROL, V25, P124, DOI 10.1128/JVI.25.1.124-128.1978; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Quinting B, 2007, J VET DIAGN INVEST, V19, P238, DOI 10.1177/104063870701900302; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sattentau QJ, 2011, CURR OPIN VIROL, V1, P396, DOI 10.1016/j.coviro.2011.09.004; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tomei L, 2004, J VIROL, V78, P938, DOI 10.1128/JVI.78.2.938-946.2004; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; WHITE JL, 1979, J VIROL, V29, P811, DOI 10.1128/JVI.29.2.811-814.1979; Wootton S, 2000, ARCH VIROL, V145, P2297, DOI 10.1007/s007050070022; Wu JZ, 1999, J FUJIAN COLL TCM, V9, P33; Wu ZY, 1990, XIA HUA COMPENDIUM M; Xie QM, 2006, J ETHNOPHARMACOL, V107, P424, DOI 10.1016/j.jep.2006.03.040; Xu J.T., 1997, CHINESE MED MYCOLOGY; Yamamoto KA, 2013, INT J BIOL MACROMOL, V52, P9, DOI 10.1016/j.ijbiomac.2012.09.029; Yao HY, 2011, J ETHNOPHARMACOL, V137, P1267, DOI 10.1016/j.jep.2011.07.058; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	46	26	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63767	10.1371/journal.pone.0063767	http://dx.doi.org/10.1371/journal.pone.0063767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704937	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200068
J	Horton, RE; Grant, GD; Matthews, B; Batzloff, M; Owen, SJ; Kyan, S; Flegg, CP; Clark, AM; Ulett, GC; Morrison, N; Peak, IR; Beacham, IR				Horton, Rachel E.; Grant, Gary D.; Matthews, Ben; Batzloff, Michael; Owen, Suzzanne J.; Kyan, Stephanie; Flegg, Cameron P.; Clark, Amanda M.; Ulett, Glen C.; Morrison, Nigel; Peak, Ian R.; Beacham, Ifor R.			Quorum Sensing Negatively Regulates Multinucleate Cell Formation during Intracellular Growth of Burkholderia pseudomallei in Macrophage-Like Cells	PLOS ONE			English	Article							MELIOIDOSIS; VIRULENCE; PATHOGENICITY; EPIDEMIOLOGY; PLASTICITY; EVOLUTION; BACTERIA; SYSTEM; MODEL	Burkholderia pseudomallei is a Gram-negative environmental bacterium and the causative agent of melioidosis, a potentially fatal, acute or chronic disease endemic in the tropics. Acyl homoserine lactone (AHL)-mediated quorum sensing and signalling have been associated with virulence and biofilm formation in numerous bacterial pathogens. In the canonical acyl-homoserine lactone signalling paradigm, AHLs are detected by a response regulator. B. pseudomallei encodes three AHL synthases, encoded by bpsl1, bpsl2 and bpsl3, and five regulator genes. In this study, we mutated the B. pseudomallei AHL synthases individually and in double and triple combination. Five AHLs were detected and quantified by tandem liquid chromatography-mass spectroscopy. The major AHLs produced were N-octanoylhomoserine lactone and N-(3-hydroxy-decanoyl)homoserine lactone, the expression of which depended on bpsl1 and bpsl2, respectively. B. pseudomallei infection of macrophage cells causes cell fusion, leading to multinucleated cells (3 or more nuclei per cell). A triple mutant defective in production of all three AHL synthases was associated with a striking phenotype of massively enhanced host cellular fusion in macrophages. However, neither abrogation of host cell fusion, achieved by mutation of bimA or hcp1, nor enhancement of fusion altered intracellular replication of B. pseudomallei. Furthermore, when tested in murine models of acute melioidosis the AHL synthase mutants were not attenuated for virulence. Collectively, this study identifies important new aspects of the genetic basis of AHL synthesis in B. pseudomallei and the roles of these AHLs in systemic infection and in cell fusion in macrophages for this important human pathogen.	[Horton, Rachel E.; Batzloff, Michael; Owen, Suzzanne J.; Kyan, Stephanie; Flegg, Cameron P.; Ulett, Glen C.; Peak, Ian R.; Beacham, Ifor R.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Grant, Gary D.] Griffith Univ, Sch Pharm, Gold Coast, Qld, Australia; [Matthews, Ben] Griffith Univ, Smart Water Res Ctr, Gold Coast, Qld, Australia; [Clark, Amanda M.; Ulett, Glen C.; Morrison, Nigel; Peak, Ian R.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia	Griffith University; Griffith University; Griffith University; Griffith University	Beacham, IR (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	i.beacham@griffith.edu.au	Morrison, Nigel A/F-4082-2012; Peak, Ian R/C-5677-2009; Clark, Amanda/X-2325-2019	Morrison, Nigel A/0000-0003-4774-3808; Clark, Amanda/0000-0003-1590-2560; Grant, Gary/0000-0002-2574-5442; Ulett, Glen/0000-0002-9638-8091; Beacham, Ifor/0000-0002-3473-1579	National Health and Medical Research Council; Griffith University; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Griffith University(Griffith University); Australian Research Council(Australian Research Council)	This work has been supported by the National Health and Medical Research Council and by Griffith University. GCU is supported by a Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boddey JA, 2007, CELL MICROBIOL, V9, P514, DOI 10.1111/j.1462-5822.2006.00807.x; Brown NF, 2000, J MED MICROBIOL, V49, P993, DOI 10.1099/0022-1317-49-11-993; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Cheng Allen C, 2003, Commun Dis Intell Q Rep, V27, P272; Chugh TD, 2008, J BIOSCIENCES, V33, P549, DOI 10.1007/s12038-008-0073-0; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; Coulthurst SJ, 2007, EMBO REP, V8, P698, DOI 10.1038/sj.embor.7400984; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gamage AM, 2011, MICROBIOL-SGM, V157, P1176, DOI 10.1099/mic.0.046540-0; Gould TA, 2006, J BACTERIOL, V188, P773, DOI 10.1128/JB.188.2.773-783.2006; HASSAN MR, 2012, MELIOIDOSIS CENTURY, P87; Hassan MRA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-302; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Inglis TJJ, 2006, APPL ENVIRON MICROB, V72, P6865, DOI 10.1128/AEM.01036-06; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Logue CA, 2009, J MICROBIOL METH, V76, P320, DOI 10.1016/j.mimet.2008.12.007; Lumjiaktase P, 2006, MICROBIOL-SGM, V152, P3651, DOI 10.1099/mic.0.29226-0; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Moxon ER, 2005, TRENDS MICROBIOL, V13, P563, DOI 10.1016/j.tim.2005.10.004; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Rolim DB, 2005, EMERG INFECT DIS, V11, P1458, DOI 10.3201/eid1109.050493; Saravu K, 2010, SE ASIAN J TROP MED, V41, P401; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x	42	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63394	10.1371/journal.pone.0063394	http://dx.doi.org/10.1371/journal.pone.0063394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704903	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200032
J	Barboni, B; Mangano, C; Valbonetti, L; Marruchella, G; Berardinelli, P; Martelli, A; Muttini, A; Mauro, A; Bedini, R; Turriani, M; Pecci, R; Nardinocchi, D; Zizzari, VL; Tete, S; Piattelli, A; Mattioli, M				Barboni, Barbara; Mangano, Carlo; Valbonetti, Luca; Marruchella, Giuseppe; Berardinelli, Paolo; Martelli, Alessandra; Muttini, Aurelio; Mauro, Annunziata; Bedini, Rossella; Turriani, Maura; Pecci, Raffaella; Nardinocchi, Delia; Zizzari, Vincenzo Luca; Tete, Stefano; Piattelli, Adriano; Mattioli, Mauro			Synthetic Bone Substitute Engineered with Amniotic Epithelial Cells Enhances Bone Regeneration after Maxillary Sinus Augmentation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; MEMBRANE; HYDROXYAPATITE; DIFFERENTIATION; SCAFFOLDS; FABRICATION; PLACENTA; SURFACE; REPAIR	Background: Evidence has been provided that a cell-based therapy combined with the use of bioactive materials may significantly improve bone regeneration prior to dental implant, although the identification of an ideal source of progenitor/stem cells remains to be determined. Aim: In the present research, the bone regenerative property of an emerging source of progenitor cells, the amniotic epithelial cells (AEC), loaded on a calcium-phosphate synthetic bone substitute, made by direct rapid prototyping (rPT) technique, was evaluated in an animal study. Material And Methods: Two blocks of synthetic bone substitute (similar to 0.14 cm(3)), alone or engineered with 1x10(6) ovine AEC (oAEC), were grafted bilaterally into maxillary sinuses of six adult sheep, an animal model chosen for its high translational value in dentistry. The sheep were then randomly divided into two groups and sacrificed at 45 and 90 days post implantation (p.i.). Tissue regeneration was evaluated in the sinus explants by micro-computer tomography (micro-CT), morphological, morphometric and biochemical analyses. Results And Conclusions: The obtained data suggest that scaffold integration and bone deposition are positively influenced by allotransplantated oAEC. Sinus explants derived from sheep grafted with oAEC engineered scaffolds displayed a reduced fibrotic reaction, a limited inflammatory response and an accelerated process of angiogenesis. In addition, the presence of oAEC significantly stimulated osteogenesis either by enhancing bone deposition or making more extent the foci of bone nucleation. Besides the modulatory role played by oAEC in the crucial events successfully guiding tissue regeneration (angiogenesis, vascular endothelial growth factor expression and inflammation), data provided herein show that oAEC were also able to directly participate in the process of bone deposition, as suggested by the presence of oAEC entrapped within the newly deposited osteoid matrix and by their ability to switch-on the expression of a specific bonerelated protein (osteocalcin, OCN) when transplanted into host tissues.	[Barboni, Barbara; Valbonetti, Luca; Marruchella, Giuseppe; Berardinelli, Paolo; Martelli, Alessandra; Muttini, Aurelio; Mauro, Annunziata; Turriani, Maura; Nardinocchi, Delia; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Bedini, Rossella; Pecci, Raffaella] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Mangano, Carlo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Zizzari, Vincenzo Luca; Tete, Stefano; Piattelli, Adriano] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Barboni, Barbara; Valbonetti, Luca; Muttini, Aurelio; Tete, Stefano] Stem TeCh Grp, Chieti, Italy	University of Teramo; Istituto Superiore di Sanita (ISS); University of Insubria; G d'Annunzio University of Chieti-Pescara	Tete, S (corresponding author), Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.	tete@unich.it	Valbonetti, Luca/AAX-9885-2020; Valbonetti, Luca/F-4078-2012; Bedini, Rossella/B-2465-2013	Valbonetti, Luca/0000-0001-5914-615X; Valbonetti, Luca/0000-0001-5914-615X; Pecci, Raffaella/0000-0002-6500-9124; MAURO, ANNUNZIATA/0000-0003-3907-0244; Bedini, Rossella/0000-0002-0830-6632	Tercas Foundation; PRIN [PRIN 20102ZLNJ5]; Ministry of Education, University and Research (M.I.U.R.), Rome, Italy	Tercas Foundation; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministry of Education, University and Research (M.I.U.R.), Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by Tercas Foundation and by PRIN 2010-2011 (PRIN 20102ZLNJ5) financed by the Ministry of Education, University and Research (M.I.U.R.), Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039; Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49; Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Banas RA, 2008, HUM IMMUNOL, V69, P321, DOI 10.1016/j.humimm.2008.04.007; Barbara B, 2004, THERIOGENOLOGY, V62, P943, DOI 10.1016/j.theriogenology.2003.12.010; Barboni B, 2012, CELL TRANSPLANT, V21, P2377, DOI 10.3727/096368912X638892; Barboni B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030974; Berardinelli P, 2013, CLIN ORAL INVEST, V17, P1661, DOI 10.1007/s00784-012-0857-3; Beyth S, 2011, BRIT MED BULL, V99, P199, DOI 10.1093/bmb/ldr035; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Cargnoni A, 2009, CELL TRANSPLANT, V18, P1147, DOI 10.3727/096368909X12483162196764; Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5; Colosimo A, 2013, CELL TRANSPLANT, V22, P99, DOI 10.3727/096368912X638883; Crespi R, 2009, J PERIODONTOL, V80, P586, DOI 10.1902/jop.2009.080466; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Davis J.W., 1910, J HOPKINS MED J, V15, P307; Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127; Elwan MA, 1998, J NEUROSCI RES, V53, P107, DOI 10.1002/(SICI)1097-4547(19980701)53:1<107::AID-JNR11>3.0.CO;2-6; Evangelista M, 2008, CYTOTECHNOLOGY, V58, P33, DOI 10.1007/s10616-008-9162-z; Fierz FC, 2008, BIOMATERIALS, V29, P3799, DOI 10.1016/j.biomaterials.2008.06.012; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Froum SJ, 1998, INT J PERIODONT REST, V18, P529; Graziano A, 2008, J CELL PHYSIOL, V214, P166, DOI 10.1002/jcp.21175; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hori J, 2006, CORNEA, V25, pS53, DOI 10.1097/01.ico.0000247214.31757.5c; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Kim JS, 2000, EXP EYE RES, V70, P329, DOI 10.1006/exer.1999.0794; Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539; Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K; KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448; Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040; Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Marcus AJ, 2008, DIFFERENTIATION, V76, P130, DOI 10.1111/j.1432-0436.2007.00194.x; Marongiu F., 2010, CURR PROTOC STEM CEL, VChapter 1; Martelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-72; Mattioli M, 2012, CELL BIOL INT, V36, P7, DOI 10.1042/CBI20100720; Mendonca JJ, 2010, PLAST RECONSTR SURG, V126, P1700, DOI 10.1097/PRS.0b013e3181f24164; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki T., 2010, CURR PROTOC STEM CEL; Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0; Miki T, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt66; Miscia S, 2009, NEUROBIOL AGING, V30, P394, DOI 10.1016/j.neurobiolaging.2007.07.011; Muttini A, 2010, VET RES COMMUN, V34, pS117, DOI 10.1007/s11259-010-9396-z; Parolini O, 2011, PLACENTA, V32, pS186, DOI 10.1016/j.placenta.2010.12.016; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8; Razzouk S, 2012, J PERIODONTOL, V83, P547, DOI 10.1902/jop.2011.110384; RIPAMONTI PW, 2008, J CELL MOL MED, V3, P1; Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3; Runyan CM, 2010, FACIAL PLAST SURG, V26, P385, DOI 10.1055/s-0030-1265017; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Sant'Anna LB, 2011, CELL TRANSPLANT, V20, P441, DOI 10.3727/096368910X522252; Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6; Schumacher M, 2010, J MATER SCI-MATER M, V21, P3039, DOI 10.1007/s10856-010-4153-y; Solomon A, 2001, BRIT J OPHTHALMOL, V85, P444, DOI 10.1136/bjo.85.4.444; Sorni Marco, 2005, Med Oral Patol Oral Cir Bucal, V10 Suppl 1, pE45; Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804; Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Takahashi S, 2001, TOHOKU J EXP MED, V193, P279, DOI 10.1620/tjem.193.279; TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D; Tamagawa Tomoharu, 2004, Hum Cell, V17, P125; Tete S, 2007, INT J IMMUNOPATH PH, V20, P819, DOI 10.1177/039463200702000418; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X; Ward BB, 2010, ORAL DIS, V16, P709, DOI 10.1111/j.1601-0825.2010.01682.x; Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	86	48	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63256	10.1371/journal.pone.0063256	http://dx.doi.org/10.1371/journal.pone.0063256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696804	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900031
J	Araujo, AR; Reis, M; Rocha, H; Aguiar, B; Morales-Hojas, R; Macedo-Ribeiro, S; Fonseca, NA; Reboiro-Jato, D; Reboiro-Jato, M; Fdez-Riverola, F; Vieira, CP; Vieira, J				Araujo, Ana Rita; Reis, Micael; Rocha, Helder; Aguiar, Bruno; Morales-Hojas, Ramiro; Macedo-Ribeiro, Sandra; Fonseca, Nuno A.; Reboiro-Jato, David; Reboiro-Jato, Miguel; Fdez-Riverola, Florentino; Vieira, Cristina P.; Vieira, Jorge			The Drosophila melanogaster methuselah Gene: A Novel Gene with Ancient Functions	PLOS ONE			English	Article							DEVELOPMENTAL EXPRESSION; ADAPTIVE EVOLUTION; STRESS RESISTANCE; LIFE-SPAN; PROTEIN; FAMILY; RECEPTOR; MUTANT; ORIGIN	The Drosophila melanogaster G protein-coupled receptor gene, methuselah (mth), has been described as a novel gene that is less than 10 million years old. Nevertheless, it shows a highly specific expression pattern in embryos, larvae, and adults, and has been implicated in larval development, stress resistance, and in the setting of adult lifespan, among others. Although mth belongs to a gene subfamily with 16 members in D. melanogaster, there is no evidence for functional redundancy in this subfamily. Therefore, it is surprising that a novel gene influences so many traits. Here, we explore the alternative hypothesis that mth is an old gene. Under this hypothesis, in species distantly related to D. melanogaster, there should be a gene with features similar to those of mth. By performing detailed phylogenetic, synteny, protein structure, and gene expression analyses we show that the D. virilis GJ12490 gene is the orthologous of mth in species distantly related to D. melanogaster. We also show that, in D. americana (a species of the virilis group of Drosophila), a common amino acid polymorphism at the GJ12490 orthologous gene is significantly associated with developmental time, size, and lifespan differences. Our results imply that GJ12490 orthologous genes are candidates for developmental time and lifespan differences in Drosophila in general.	[Araujo, Ana Rita; Reis, Micael; Rocha, Helder; Aguiar, Bruno; Morales-Hojas, Ramiro; Macedo-Ribeiro, Sandra; Vieira, Cristina P.; Vieira, Jorge] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Fonseca, Nuno A.] Univ Porto, Ctr Res Adv Comp Syst CRACS INESC Porto, P-4100 Oporto, Portugal; [Fonseca, Nuno A.] EMBL European Bioinformat Inst, Cambridge, England; [Reboiro-Jato, David; Reboiro-Jato, Miguel; Fdez-Riverola, Florentino] Univ Vigo, Dept Informat, Orense, Spain	Universidade do Porto; INESC TEC; Universidade do Porto; European Molecular Biology Laboratory (EMBL); Universidade de Vigo	Vieira, CP (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Fonseca, Nuno A./B-7801-2009; Macedo-Ribeiro, Sandra/D-9258-2011; INESC-TEC, CRACS/F-7527-2012; Reboiro-Jato, Miguel/G-1102-2011; Reboiro-Jato, Miguel/AAB-8453-2022; Fdez-Riverola, Florentino/G-1411-2011; Vieira, Cristina P./K-1775-2013; Vieira, Jorge/J-7477-2013	Fonseca, Nuno A./0000-0003-4832-578X; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Reboiro-Jato, Miguel/0000-0001-8749-2703; Reboiro-Jato, Miguel/0000-0001-8749-2703; Fdez-Riverola, Florentino/0000-0002-3943-8013; Vieira, Cristina P./0000-0002-7139-2107; Vieira, Jorge/0000-0001-7032-5220; Rocha, Helder/0000-0003-1062-2498; Araujo, Ana Rita/0000-0003-3567-4155; Reis, Micael/0000-0002-2601-0886	FEDER Funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008) FCOMP-01-0124-FEDER-008916 (PTDC/EIA-EIA/100897/2008), FCOMP-01-0124-FEDER-022718 (PEST-C/SAU/LA0002/2011)]; FCT [SFRH/BD/61142/2009]	FEDER Funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER Funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008), FCOMP-01-0124-FEDER-008916 (PTDC/EIA-EIA/100897/2008), and the project FCOMP-01-0124-FEDER-022718 (PEST-C/SAU/LA0002/2011). Micael Reis is funded by a PhD grant attributed by FCT with the reference SFRH/BD/61142/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldal EA, 2006, EVOLUTION, V60, P1435, DOI 10.1111/j.0014-3820.2006.tb01222.x; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Cardoso JCR, 2005, J MOL ENDOCRINOL, V34, P753, DOI 10.1677/jme.1.01730; Cardoso JCR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-135; Cook-Wiens E, 2002, EXP GERONTOL, V37, P1347, DOI 10.1016/S0531-5565(02)00096-7; Duvernell DD, 2003, MOL ECOL, V12, P1277, DOI 10.1046/j.1365-294X.2003.01841.x; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gimenez LED, 2013, AGING CELL, V12, P121, DOI 10.1111/acel.12027; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Kim H, 2006, MOL CELLS, V21, P261; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388; Mertens I, 2007, PEPTIDES, V28, P1775, DOI 10.1016/j.peptides.2007.05.005; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; Nordstrom KJV, 2009, MOL BIOL EVOL, V26, P71, DOI 10.1093/molbev/msn228; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Patel MV, 2012, J EXP ZOOL PART B, V318B, P368, DOI 10.1002/jez.b.22453; Petrosyan A, 2007, BEHAV GENET, V37, P585, DOI 10.1007/s10519-007-9159-y; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; REAGAN JD, 1994, J BIOL CHEM, V269, P9; Reboiro-Jato D, 2012, J INTEGR BIOINFORMAT, V9, DOI 10.2390/biecoll-jib-2012-200; Reis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025520; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santos JS, 2010, DEV DYNAM, V239, P1010, DOI 10.1002/dvdy.22228; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vieira J, 2009, J MOL EVOL, V69, P32, DOI 10.1007/s00239-009-9249-y; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zhang YE, 2012, BIOESSAYS, V34, P982, DOI 10.1002/bies.201200008	40	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63747	10.1371/journal.pone.0063747	http://dx.doi.org/10.1371/journal.pone.0063747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696853	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900058
J	Bol, GM; Raman, V; van der Groep, P; Vermeulen, JF; Patel, AH; van der Wall, E; van Diest, PJ				Bol, Guus M.; Raman, Venu; van der Groep, Petra; Vermeulen, Jeroen F.; Patel, Arvind H.; van der Wall, Elsken; van Diest, Paul J.			Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; DEAD-BOX PROTEINS; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; DOWN-REGULATION; FACTOR-1-ALPHA; HIF-1-ALPHA; HIF-1; RESISTANCE; INCREASES	Aims: DDX3 is an RNA helicase that has antiapoptotic properties, and promotes proliferation and transformation. In addition, DDX3 was shown to be a direct downstream target of HIF-1 alpha (the master regulatory of the hypoxia response) in breast cancer cell lines. However, the relation between DDX3 and hypoxia has not been addressed in human tumors. In this paper, we studied the relation between DDX3 and the hypoxic responsive proteins in human breast cancer. Methods and Results: DDX3 expression was investigated by immunohistochemistry in breast cancer in comparison with hypoxia related proteins HIF-1 alpha, GLUT1, CAIX, EGFR, HER2, Akt1, FOXO4, p53, ER alpha, COMMD1, FER kinase, PIN1, E-cadherin, p21, p27, Transferrin receptor, FOXO3A, c-Met and Notch1. DDX3 was overexpressed in 127 of 366 breast cancer patients, and was correlated with overexpression of HIF-1 alpha and its downstream genes CAIX and GLUT1. Moreover, DDX3 expression correlated with hypoxia-related proteins EGFR, HER2, FOXO4, ER alpha and c-Met in a HIF-1 alpha dependent fashion, and with COMMD1, FER kinase, Akt1, E-cadherin, TfR and FOXO3A independent of HIF-1 alpha. Conclusions: In invasive breast cancer, expression of DDX3 was correlated with overexpression of HIF-1 alpha and many other hypoxia related proteins, pointing to a distinct role for DDX3 under hypoxic conditions and supporting the oncogenic role of DDX3 which could have clinical implication for current development of DDX3 inhibitors.	[Bol, Guus M.; Raman, Venu; van der Groep, Petra; Vermeulen, Jeroen F.; van Diest, Paul J.] Univ Med Ctr Utrecht, Ctr Canc, Dept Pathol, Utrecht, Netherlands; [van der Groep, Petra; van der Wall, Elsken] Univ Med Ctr Utrecht, Ctr Canc, Div Internal Med & Dermatol, Utrecht, Netherlands; [Bol, Guus M.; Raman, Venu] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Raman, Venu; van Diest, Paul J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Patel, Arvind H.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins University; University of Glasgow	van Diest, PJ (corresponding author), Univ Med Ctr Utrecht, Ctr Canc, Dept Pathol, Utrecht, Netherlands.	P.J.vandiest@umcutrecht.nl		Bol, Guus/0000-0002-4021-3823	Dr. Saal van Swanenberg foundation; Dutch Cancer Society [UU 2010-4856]; FAMRI; MRC [MC_U130184144, MC_UU_12014/2] Funding Source: UKRI; Medical Research Council [MC_UU_12014/2, MC_U130184144] Funding Source: researchfish	Dr. Saal van Swanenberg foundation; Dutch Cancer Society(KWF Kankerbestrijding); FAMRI; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Dr. Saal van Swanenberg foundation [GMB], the Dutch Cancer Society (UU 2010-4856)[GMB] and FAMRI [VR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2010, SEER CANC STAT REV 1; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Belon CA, 2010, BIOCHEMISTRY-US, V49, P1822, DOI 10.1021/bi901974a; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Bos R, 2004, BREAST CANCER RES, V6, pR450, DOI 10.1186/bcr813; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Botlagunta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017563; Brenkman AB, 2008, CANCER RES, V68, P7597, DOI 10.1158/0008-5472.CAN-08-1059; Brugarolas J, 2004, CANCER CELL, V6, P7, DOI 10.1016/j.ccr.2004.06.020; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Cho JY, 2005, MOL ENDOCRINOL, V19, P1191, DOI 10.1210/me.2004-0162; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gort EH, 2006, ONCOGENE, V25, P6123, DOI 10.1038/sj.onc.1209643; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Greijer AE, 2005, CELL ONCOL, V27, P43; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hayashi M, 2005, ENDOCRINOLOGY, V146, P4682, DOI 10.1210/en.2005-0416; Horree N, 2008, J PATHOL, V214, P38, DOI 10.1002/path.2244; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Kondaskar A, 2011, ACS MED CHEM LETT, V2, P252, DOI 10.1021/ml100281b; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kumar R, 2008, ORG LETT, V10, P4681, DOI 10.1021/ol8020176; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Li Y, 2006, CANCER RES, V66, P8520, DOI 10.1158/0008-5472.CAN-05-4364; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Maga G, 2008, J MED CHEM, V51, P6635, DOI 10.1021/jm8008844; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Moelans CB, 2009, CELL ONCOL, V31, P1, DOI 10.3233/CLO-2009-0461; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Radi M, 2012, BIOORG MED CHEM LETT, V22, P2094, DOI 10.1016/j.bmcl.2011.12.135; Ravi R, 2000, GENE DEV, V14, P34; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Salem Y, 2005, CELL SIGNAL, V17, P341, DOI 10.1016/j.cellsig.2004.08.001; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Stoner M, 2002, MOL ENDOCRINOL, V16, P2231, DOI 10.1210/me.2001-0347; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; van de Sluis B, 2010, J CLIN INVEST, P2119; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; van der Groep P, 2004, JNCI-J NATL CANCER I, V96, P712, DOI 10.1093/jnci/djh114; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yedavalli VSRK, 2008, J MED CHEM, V51, P5043, DOI 10.1021/jm800332m; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008	66	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63548	10.1371/journal.pone.0063548	http://dx.doi.org/10.1371/journal.pone.0063548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696831	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000319081900039
J	Nagpal, L; Haque, MM; Saha, A; Mukherjee, N; Ghosh, A; Ranu, BC; Stuehr, DJ; Panda, K				Nagpal, Latika; Haque, Mohammad M.; Saha, Amit; Mukherjee, Nirmalya; Ghosh, Arnab; Ranu, Brindaban C.; Stuehr, Dennis J.; Panda, Koustubh			Mechanism of Inducible Nitric-oxide Synthase Dimerization Inhibition by Novel Pyrimidine Imidazoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHYDROBIOPTERIN INTERACTION; SUBUNIT DIMERIZATION; ESCHERICHIA-COLI; OXYGENASE DOMAIN; NO SYNTHASE; DIMER; HEME; CALMODULIN; EXPRESSION; SUBSTRATE	Overproduction of nitric oxide (NO) by inducible nitric-oxide synthase (iNOS) has been etiologically linked to several inflammatory, immunological, and neurodegenerative diseases. As dimerization of NOS is required for its activity, several dimerization inhibitors, including pyrimidine imidazoles, are being evaluated for therapeutic inhibition of iNOS. However, the precise mechanism of their action is still unclear. Here, we examined the mechanism of iNOS inhibition by a pyrimidine imidazole core compound and its derivative (PID), having low cellular toxicity and high affinity for iNOS, using rapid stopped-flow kinetic, gel filtration, and spectrophotometric analysis. PID bound to iNOS heme to generate an irreversible PID-iNOS monomer complex that could not be converted to active dimers by tetrahydrobiopterin (H4B) and L-arginine (Arg). We utilized the iNOS oxygenase domain (iNOSoxy) and two monomeric mutants whose dimerization could be induced (K82AiNOSoxy) or not induced (D92AiNOSoxy) with H4B to elucidate the kinetics of PID binding to the iNOS monomer and dimer. We observed that the apparent PID affinity for the monomer was 11 times higher than the dimer. PID binding rate was also sensitive to H4B and Arg site occupancy. PID could also interact with nascent iNOS monomers in iNOS-synthesizing RAW cells, to prevent their post-translational dimerization, and it also caused irreversible monomerization of active iNOS dimers thereby accomplishing complete physiological inhibition of iNOS. Thus, our study establishes PID as a versatile iNOS inhibitor and therefore a potential in vivo tool for examining the causal role of iNOS in diseases associated with its overexpression as well as therapeutic control of such diseases.	[Nagpal, Latika; Panda, Koustubh] Univ Calcutta, Dept Biotechnol, Kolkata 700019, India; [Nagpal, Latika; Panda, Koustubh] Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata 700019, India; [Haque, Mohammad M.; Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Saha, Amit; Mukherjee, Nirmalya; Ranu, Brindaban C.] Indian Assoc Cultivat Sci, Dept Organ Chem, Kolkata 700032, India	University of Calcutta; University of Calcutta; Cleveland Clinic Foundation; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA.	stuehrd@ccf.org; kpbcg@caluniv.ac.in	Saha, Amit/Z-5717-2019; Panda, Koustubh/E-5273-2017	Nagpal, Latika/0000-0003-0510-7299; GHOSH, ARNAB/0000-0002-7498-1994; Panda, Koustubh/0000-0002-4783-2221; MUKHERJEE, NIRMALYA/0000-0002-6755-2235; HAQUE, MOHAMMAD/0000-0003-0852-6368	UGC UPE; National Institute of Health [GM51491, CA53914, HL58883]; INSPIRE-DST Fellowship, Government of India; Fulbright-Nehru Doctoral and Professional Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	UGC UPE(University Grants Commission, India); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSPIRE-DST Fellowship, Government of India; Fulbright-Nehru Doctoral and Professional Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by UGC UPE (Modern Biology) research grant (to K. P.) and by National Institute of Health Grants GM51491, CA53914, and HL58883 (to D. J. S.) and INSPIRE-DST Fellowship, Government of India, and Fulbright-Nehru Doctoral and Professional Research Fellowship (to L. N.).	Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bienkowska-Haba M, 2006, ARCH IMMUNOL THER EX, V54, P201, DOI 10.1007/s00005-006-0025-z; Blasko E, 2002, J BIOL CHEM, V277, P295, DOI 10.1074/jbc.M105691200; BOULLERNE AI, 1995, J NEUROIMMUNOL, V60, P117, DOI 10.1016/0165-5728(95)00061-6; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Burnstock G., 1997, NITRIC OXIDE HLTH DI, P1; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Davey DD, 2007, J MED CHEM, V50, P1146, DOI 10.1021/jm061319i; Enkhbaatar P, 2003, AM J PHYSIOL-HEART C, V285, pH2430, DOI 10.1152/ajpheart.00055.2003; Fedorov R, 2004, P NATL ACAD SCI USA, V101, P5892, DOI 10.1073/pnas.0306588101; Gahman TC, 2011, BIOORG MED CHEM LETT, V21, P6888, DOI 10.1016/j.bmcl.2011.08.112; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Ichinose F, 2003, AM J PHYSIOL-HEART C, V285, pH2524, DOI 10.1152/ajpheart.00530.2003; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; KRONCKE KD, 1995, BIOL CHEM H-S, V376, P327; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; MARTIN W, 1986, J PHARMACOL EXP THER, V237, P529; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MILSTIEN S, 1994, J NEUROCHEM, V63, P1178; NAKANE M, 1993, FEBS LETT, V316, P175, DOI 10.1016/0014-5793(93)81210-Q; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; Panda K, 2005, P NATL ACAD SCI USA, V102, P10117, DOI 10.1073/pnas.0408972102; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043; RodriguezCrespo I, 1997, BIOCHEMISTRY-US, V36, P8530, DOI 10.1021/bi970192j; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Sennequier N, 1999, J BIOL CHEM, V274, P930, DOI 10.1074/jbc.274.2.930; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1987, CANCER RES, V47, P5590; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	45	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19685	19697		10.1074/jbc.M112.446542	http://dx.doi.org/10.1074/jbc.M112.446542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696643	hybrid, Green Published			2022-12-25	WOS:000321515800039
J	Ariga, T; Kubota, M; Nakane, M; Oguro, K; Yu, RK; Ando, S				Ariga, Toshio; Kubota, Masaru; Nakane, Makoto; Oguro, Kenji; Yu, Robert K.; Ando, Susumu			Anti-Chol-1 Antigen, GQ1b alpha, Antibodies Are Associated with Alzheimer's Disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PROGRESSIVE MULTIPLE-SCLEROSIS; CHOLINERGIC-SPECIFIC ANTIGEN; ANTIGANGLIOSIDE ANTIBODIES; PARKINSONS-DISEASE; GANGLIOSIDE METABOLISM; GLYCOLIPIDS; NEURONS; SERUM; MODEL	The interaction of amyloid beta-proteins (A beta) with membrane gangliosides has been reported to be an early event in A beta fibril formation in Alzheimer's disease (AD). Neuronal degeneration in AD has been postulated to be associated with the presence of anti-ganglioside antibodies in patient sera. Using an enzyme-linked immunosorbent assay (ELISA) and high-performance thin-layer chromatography (HPTLC) immunostaining, sera from 27 individuals (10 with AD, 6 with vascular dementia (VD), and 11 non-demented age-matched pathological controls) were examined in order to detect anti-glycosphingolipid (GSL) antibodies, including anti-cholinergic-specific antigen (Chol-1 alpha; GQ1b alpha) antibodies. All sera had natural antibodies against ganglio-N-tetraosyl gangliosides (brain-type gangliosides). However, sera of demented patients with AD and VD had significantly higher titers of anti-GSL antibodies than those in age-matched pathological controls. Although most serum antibodies, including anti-GM1, -GT1b, -GQ1b, -GQ1b alpha, were of the IgM type, the presence of the IgG type antibodies was also significantly elevated in the sera of demented patients with AD. Anti-GT1b antibodies of the IgG type were elevated in AD (90%, 9 of 10 cases) and VD (100%), respectively. Most surprisingly, anti-GQ1b alpha antibodies (IgM) were found in 90% (9/10) and 100% (6/6) in the sera of patients with AD and VD, respectively. Since GQ1ba is present in the cerebral cortex and hippocampus, the presence of anti-GQ1b alpha antibodies may play an important role in disrupting cholinergic synaptic transmission and may participate in the pathogenesis of dementia. We conclude that elevated anti-GSL antibody titers may be useful as an aid for clinical diagnosis of those dementias.	[Ariga, Toshio; Yu, Robert K.] Georgia Regents Univ, Inst Mol Med & Genet, Med Coll Georgia, Augusta, GA USA; [Ariga, Toshio; Yu, Robert K.] VA Med Ctr, Augusta, GA USA; [Kubota, Masaru; Oguro, Kenji] Oyama Orthoped & Internal Med Hosp, Oyama, Tochigi, Japan; [Nakane, Makoto] Teikyo Univ, Sch Med, Dept Neurosurg, Univ Hosp Mizonokuchi, Kawasaki, Kanagawa, Japan; [Ando, Susumu] Tokyo Metropolitan Geriatr Hosp, Itabashi Ku, Tokyo 173, Japan; [Ando, Susumu] Inst Gerontol, Itabashi Ku, Tokyo, Japan	University System of Georgia; Augusta University; Teikyo University	Nakane, M (corresponding author), Teikyo Univ, Sch Med, Dept Neurosurg, Univ Hosp Mizonokuchi, Kawasaki, Kanagawa, Japan.	nsnakane@med.teikyo-u.ac.jp			National Institutes of Health; Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	TA and RKY were supported by grants from National Institutes of Health and Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin N, 1996, ACTA NEUROL SCAND, V93, P99; ANDO S, 1992, J BIOCHEM, V111, P287, DOI 10.1093/oxfordjournals.jbchem.a123751; ANDO S, 1977, J BIOL CHEM, V252, P6247; ARIGA T, 1987, J LIPID RES, V28, P285; ARIGA T, 1984, ARCH BIOCHEM BIOPHYS, V232, P305, DOI 10.1016/0003-9861(84)90546-0; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Ariga T, 2010, ASN NEURO, V2, DOI 10.1042/AN20100021; Ariga T, 2010, J NEUROSCI RES, V88, P2303, DOI 10.1002/jnr.22393; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; CHAPMAN J, 1988, J NEUROCHEM, V51, P479, DOI 10.1111/j.1471-4159.1988.tb01063.x; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; Chen XS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-12; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; DERRINGTON EA, 1990, DEV BRAIN RES, V52, P131, DOI 10.1016/0165-3806(90)90228-Q; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; FOLEY P, 1988, J NEUROL, V235, P466, DOI 10.1007/BF00314249; FREDDO L, 1985, NEUROLOGY, V35, P1420, DOI 10.1212/WNL.35.10.1420; Haghighi S, 2012, ACTA NEUROL SCAND, V125, P64, DOI 10.1111/j.1600-0404.2011.01554.x; Hatzifilippou E, 2008, AM J ALZHEIMERS DIS, V23, P274, DOI 10.1177/1533317508317816; HIRABAYASHI Y, 1992, J BIOL CHEM, V267, P12973; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Ilyas AA, 2003, J NEUROIMMUNOL, V139, P76, DOI 10.1016/S0165-5728(03)00131-0; Kanda T, 2000, NEUROLOGY, V55, P585, DOI 10.1212/WNL.55.4.585; KASAI N, 1986, J NEUROL SCI, V75, P33, DOI 10.1016/0022-510X(86)90048-1; KOHRIYAMA T, 1987, J NEUROCHEM, V48, P1516, DOI 10.1111/j.1471-4159.1987.tb05694.x; Kuwabara S, 2000, J NEUROL NEUROSUR PS, V68, P191, DOI 10.1136/jnnp.68.2.191; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Marconi S, 2006, MULT SCLER J, V12, P302, DOI 10.1191/135248506ms1279oa; Mata S, 1999, MULT SCLER, V5, P379, DOI 10.1191/135245899678846483; Mizutamari RK, 1998, J NEUROSCI RES, V51, P237, DOI 10.1002/(SICI)1097-4547(19980115)51:2<237::AID-JNR12>3.0.CO;2-5; MIZUTAMARI RK, 1994, J NEUROIMMUNOL, V50, P215, DOI 10.1016/0165-5728(94)90048-5; Mosek A, 2000, DEMENT GERIATR COGN, V11, P36, DOI 10.1159/000017211; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; OKADA N, 1983, IMMUNOLOGY, V50, P75; Pender MP, 2003, J CLIN NEUROSCI, V10, P63, DOI 10.1016/S0967-5868(02)00270-9; Plumb J, 2002, BRAIN PATHOL, V12, P154; Ravindranath MH, 2005, ANN NY ACAD SCI, V1050, P229, DOI 10.1196/annals.1313.024; REN SL, 1992, J BIOL CHEM, V267, P12632; Sadatipour BT, 1998, ANN NEUROL, V44, P980, DOI 10.1002/ana.410440621; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Schott K, 1996, PSYCHIAT RES, V59, P251, DOI 10.1016/0165-1781(95)02703-3; Vyshkina T, 2008, LAB INVEST, V88, P796, DOI 10.1038/labinvest.2008.53; Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381; YU RK, 1994, PROG BRAIN RES, V101, P31; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06; Yuki N, 1997, J NEUROL SCI, V150, P81, DOI 10.1016/S0022-510X(97)05392-6; Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x; Zaprianova Emilia, 2004, Ideggyogy Sz, V57, P94	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63326	10.1371/journal.pone.0063326	http://dx.doi.org/10.1371/journal.pone.0063326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717411	Green Published, gold, Green Submitted			2022-12-25	WOS:000319435600010
J	Aslami, H; Pulskens, WP; Kuipers, MT; Bos, AP; van Kuilenburg, ABP; Wanders, RJA; Roelofsen, J; Roelofs, JJTH; Kerindongo, RP; Beurskens, CJP; Schultz, MJ; Kulik, W; Weber, NC; Juffermans, NP				Aslami, Hamid; Pulskens, Wilco P.; Kuipers, Maria T.; Bos, Aafkeline P.; van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Roelofsen, Jeroen; Roelofs, Joris J. T. H.; Kerindongo, Raphaela P.; Beurskens, Charlotte J. P.; Schultz, Marcus J.; Kulik, Wim; Weber, Nina C.; Juffermans, Nicole P.			Hydrogen Sulfide Donor NaHS Reduces Organ Injury in a Rat Model of Pneumococcal Pneumosepsis, Associated with Improved Bio-Energetic Status	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; ACUTE LUNG INJURY; MITOCHONDRIAL DYSFUNCTION; KAPPA-B; HYPOTHERMIA; SEPSIS; METABOLISM; ACTIVATION; MECHANISMS; INTERACTS	Sepsis is characterized by a generalized inflammatory response and organ failure, associated with mitochondrial dysfunction. Hydrogen sulfide donor NaHS has anti-inflammatory properties, is able to reduce metabolism and can preserve mitochondrial morphology and function. Rats were challenged with live Streptococcus pneumonia or saline and infused with NaHS (36 mmol/kg/h) or vehicle. Lung and kidney injury markers were measured as well as mitochondrial function, viability and biogenesis. Infusion of NaHS reduced heart rate and body temperature, indicative of a hypo-metabolic state. NaHS infusion reduced sepsis-related lung and kidney injury, while host defense remained intact, as reflected by unchanged bacterial outgrowth. The reduction in organ injury was associated with a reversal of a fall in active oxidative phosphorylation with a concomitant decrease in ATP levels and ATP/ADP ratio. Preservation of mitochondrial respiration was associated with increased mitochondrial expression of alpha-tubulin and protein kinase C-epsilon, which acts as regulators of respiration. Mitochondrial damage was decreased by NaHS, as suggested by a reduction in mitochondrial DNA leakage in the lung. Also, NaHS treatment was associated with upregulation of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha, with a subsequent increase in transcription of mitochondrial respiratory subunits. These findings indicate that NaHS reduces organ injury in pneumosepsis, possibly via preservation of oxidative phosphorylation and thereby ATP synthesis as well as by promoting mitochondrial biogenesis. Further studies on the involvement of mitochondria in sepsis are required.	[Aslami, Hamid; Kuipers, Maria T.; Bos, Aafkeline P.; Kerindongo, Raphaela P.; Beurskens, Charlotte J. P.; Schultz, Marcus J.; Weber, Nina C.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Wanders, Ronald J. A.; Roelofsen, Jeroen; Kulik, Wim] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Pulskens, Wilco P.; Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Aslami, H (corresponding author), Univ Amsterdam, Acad Med Ctr, LEICA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.aslami@amc.uva.nl	Weber, Nina/CAH-0231-2022; Pulskens, Wilco/P-6023-2015; Schultz, Marcus/AAB-6379-2021	Weber, Nina/0000-0003-1111-9042; Pulskens, Wilco/0000-0001-9697-3189; Schultz, Marcus/0000-0003-3969-7792; Roelofs, Joris/0000-0001-9595-6571; van Kuilenburg, Andre/0000-0002-7989-4910				Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Agudo-Lopez A, 2011, FEBS LETT, V585, P99, DOI 10.1016/j.febslet.2010.11.015; Akram AR, 2010, CHEST, V138, P825, DOI 10.1378/chest.09-3071; Aslami H, 2010, INTENS CARE MED, V36, P1946, DOI 10.1007/s00134-010-2022-2; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Baumgart K, 2010, CRIT CARE MED, V38, P588, DOI 10.1097/CCM.0b013e3181b9ed2e; Bierau J, 2001, BIOCHEM PHARMACOL, V62, P1099, DOI 10.1016/S0006-2952(01)00756-0; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bracht H, 2012, CRIT CARE MED, V40, P2157, DOI 10.1097/CCM.0b013e31824e6b30; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Chu SJ, 2005, CHEST, V128, P327, DOI 10.1378/chest.128.1.327; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Esechie A, 2008, CLIN SCI, V115, P91, DOI 10.1042/CS20080021; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Gellerich FN, 1999, SHOCK, V11, P336, DOI 10.1097/00024382-199905000-00006; Goeters C, 2002, CRIT CARE MED, V30, P2032, DOI 10.1097/00003246-200209000-00013; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lim CM, 2004, INTENS CARE MED, V30, P1638, DOI 10.1007/s00134-004-2336-z; Lim CM, 2003, INTENS CARE MED, V29, P453, DOI 10.1007/s00134-002-1529-6; Mongardon N, 2011, CRIT CARE MED, V39, P1359, DOI 10.1097/CCM.0b013e3182120b56; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tappy L, 2007, CRIT CARE MED, V35, pS531, DOI 10.1097/01.CCM.0000278062.28122.A4; Torres A, 2010, AM J RESP CRIT CARE, V181, P782, DOI 10.1164/rccm.201001-0030UP; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4; Wagner F, 2011, SHOCK, V35, P396, DOI 10.1097/SHK.0b013e3181ffff0e; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yang KY, 2011, CRIT CARE, V15, DOI 10.1186/cc9412; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	36	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63497	10.1371/journal.pone.0063497	http://dx.doi.org/10.1371/journal.pone.0063497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717435	gold, Green Published, Green Submitted			2022-12-25	WOS:000319435600019
J	Shchelkunova, TA; Morozov, IA; Rubtsov, PM; Bobryshev, YV; Sobenin, IA; Orekhov, AN; Andrianova, IV; Smirnov, AN				Shchelkunova, Tatyana A.; Morozov, Ivan A.; Rubtsov, Petr M.; Bobryshev, Yuri V.; Sobenin, Igor A.; Orekhov, Alexander N.; Andrianova, Irina V.; Smirnov, Alexander N.			Lipid Regulators during Atherogenesis: Expression of LXR, PPAR, and SREBP mRNA in the Human Aorta	PLOS ONE			English	Article							SCAVENGER RECEPTORS; VASCULAR-LESIONS; ATHEROSCLEROSIS; MACROPHAGES; ARTERIOSCLEROSIS; TRANSREPRESSION; INFLAMMATION; DEFINITION; COMMITTEE; PATHWAYS	Transcription factors LXRs, PPARs, and SREBPs have been implicated in a multitude of physiological and pathological processes including atherogenesis. However, little is known about the regulation of these transcription factors at different stages of atherosclerosis progression. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to compare the contents of mRNAs in pairs intact-injured aorta fragments taken from the same donors. Only minor changes in LXR alpha, LXR beta, PPAR alpha, PPAR gamma, SREBP1, and SREBP2 mRNA levels were found in initial lesions as compared with intact non-diseased tissue. The contents of all mRNAs but SREBP2 mRNA were found to be progressively up-regulated in fatty streaks and fibrous lipoid plaques. These changes were only partially reproduced in cultured macrophages upon lipid loading. Wave-shaped changes in abundance of correlations between given group of mRNAs and 28 atherosclerosis-related mRNA species in the course of atherogenesis were observed. The impact of specific mRNA correlations on the total correlations also significantly varied between different lesion types. The study suggests that the extent and forms of LXR/PPAR/SREBP participation in intima functions vary nonlinear in individual fashion in atherogenesis. We speculate that the observed changes in mRNAs expression and coupling reflect shifts in lipid ligands availability and cellular composition in the course of atherosclerosis progression.	[Shchelkunova, Tatyana A.; Smirnov, Alexander N.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Morozov, Ivan A.; Rubtsov, Petr M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Bobryshev, Yuri V.; Sobenin, Igor A.; Orekhov, Alexander N.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Bobryshev, Yuri V.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Bobryshev, Yuri V.] St Vincents Hosp Sydney, Kensington, NSW, Australia; [Bobryshev, Yuri V.] Univ Western Sydney Macarthur, Sch Med, Campbelltown, NSW 2560, Australia; [Sobenin, Igor A.] Russian Cardiol Res & Prod Complex, Moscow, Russia; [Orekhov, Alexander N.; Andrianova, Irina V.] Skolkovo Innovat Ctr, Atherosclerosis Res Inst, Moscow, Russia; [Andrianova, Irina V.] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; University of New South Wales Sydney; Western Sydney University; National Medical Research Center of Cardiology; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Bobryshev, YV (corresponding author), Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Moscow, Russia.	y.bobryshev@unsw.edu.au	Orekhov, Alexander N/J-4838-2013; Bobryshev, Yuri/J-2838-2013; Rubtsov, Petr/A-8459-2016; Sobenin, Igor A/J-4282-2013; Morozov, Ivan/CAJ-5409-2022; Shchelkunova, Tatiana/ABD-8130-2021	Orekhov, Alexander N/0000-0002-6495-1628; Rubtsov, Petr/0000-0002-9867-2344; Sobenin, Igor A/0000-0003-0978-6444; 	Russian Foundation for Basic Research; Russian Ministry of Education and Science	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	The authors thank the Russian Foundation for Basic Research and the Russian Ministry of Education and Science for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Butcher MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00044; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Ishii T, 2006, EUR RESPIR J, V27, P300, DOI 10.1183/09031936.06.00090405; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Li MD, 2011, PPAR RES, V2011, DOI 10.1155/2011/742785; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manduteanu I, 2012, J CELL MOL MED, V16, P1978, DOI 10.1111/j.1582-4934.2012.01552.x; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Nagy ZS, 2013, MOL CELL ENDOCRINOL, V368, P85, DOI 10.1016/j.mce.2012.04.003; Razzhevaikin VN, 2010, ZH OBSHCH BIOL, V71, P75; SEDOV KR, 1988, VESTN AKAD MED NAUK+, P69; Shchelkunova TA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P920, DOI 10.1134/S0006297908080105; Shchelkunova TA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1178, DOI 10.1134/S0006297911100129; Smirnov AN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P793, DOI 10.1134/S0006297910070011; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Treuter E, 2011, CELL RES, V21, P711, DOI 10.1038/cr.2011.52; Villablanca AC, 2010, CLIN SCI, V119, P493, DOI 10.1042/CS20100248; Wadosky KM, 2012, AM J PHYSIOL-HEART C, V302, pH515, DOI 10.1152/ajpheart.00703.2011	26	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63374	10.1371/journal.pone.0063374	http://dx.doi.org/10.1371/journal.pone.0063374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717417	Green Submitted, Green Published, gold			2022-12-25	WOS:000319435600013
J	Geslin, B; Gauzens, B; Thebault, E; Dajoz, I				Geslin, Benoit; Gauzens, Benoit; Thebault, Elisa; Dajoz, Isabelle			Plant Pollinator Networks along a Gradient of Urbanisation	PLOS ONE			English	Article							FLOWER CONSTANCY; BUMBLE BEES; HABITAT FRAGMENTATION; TEMPORAL STABILITY; LANDSCAPE CONTEXT; FORAGING RANGES; DIVERSITY; SPECIALIZATION; COMMUNITIES; COMPETITION	Background: Habitat loss is one of the principal causes of the current pollinator decline. With agricultural intensification, increasing urbanisation is among the main drivers of habitat loss. Consequently studies focusing on pollinator community structure along urbanisation gradients have increased in recent years. However, few studies have investigated how urbanisation affects plant-pollinator interaction networks. Here we assessed modifications of plant-pollinator interactions along an urbanisation gradient based on the study of their morphological relationships. Methodology/Principal Findings: Along an urbanisation gradient comprising four types of landscape contexts (semi-natural, agricultural, suburban, urban), we set up experimental plant communities containing two plant functional groups differing in their morphological traits ("open flowers'' and "tubular flowers''). Insect visitations on these communities were recorded to build plant-pollinator networks. A total of 17 857 interactions were recorded between experimental plant communities and flower-visitors. The number of interactions performed by flower-visitors was significantly lower in urban landscape context than in semi-natural and agricultural ones. In particular, insects such as Syrphidae and solitary bees that mostly visited the open flower functional group were significantly impacted by urbanisation, which was not the case for bumblebees. Urbanisation also impacted the generalism of flower-visitors and we detected higher interaction evenness in urban landscape context than in agricultural and suburban ones. Finally, in urban context, these modifications lowered the potential reproductive success of the open flowers functional group. Conclusions/Significance: Our findings show that open flower plant species and their specific flower-visitors are especially sensitive to increasing urbanisation. These results provide new clues to improve conservation measures within urbanised areas in favour of specialist flower-visitors. To complete this functional approach, studies using networks resolved to the species level along urbanised gradients would be required.	[Geslin, Benoit; Gauzens, Benoit; Thebault, Elisa; Dajoz, Isabelle] CNRS, Lab Biogeochim & Ecol Milieux Continentaux UMR 76, Paris, Ile De France, France; [Dajoz, Isabelle] Univ Paris Diderot, Paris, Ile De France, France; [Geslin, Benoit] Univ Paris 06, Paris, Ile De France, France; [Geslin, Benoit] Ecole Normale Super, F-75231 Paris, Ile De France, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Geslin, B (corresponding author), CNRS, Lab Biogeochim & Ecol Milieux Continentaux UMR 76, Paris, Ile De France, France.	bgeslin@biologie.ens.fr	Geslin, Benoit/GWV-5377-2022; Geslin, Benoît/AAP-7068-2020	Geslin, Benoît/0000-0002-2464-7998; Thebault, Elisa/0000-0002-9669-5227	Region Ile-de-France through DIM Astrea [ASTREA 2009-01-22]; R2DS	Region Ile-de-France through DIM Astrea(Region Ile-de-France); R2DS	This work was supported by a grant from Region Ile-de-France through DIM Astrea (Grant number : ASTREA 2009-01-22; URL: http://www.dim-astrea.fr/dim_astrea/) and R2DS (URL: http://www.r2ds-ile-de-france.com/) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebil A, 2012, TRENDS ECOL EVOL, V27, P142, DOI 10.1016/j.tree.2011.11.017; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; [Anonymous], 2010, R LANG ENV STAT COMP; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Bellmann H., 1999, GUIDE ABEILLES BOURD; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.1890/0012-9658(2002)083[2394:QDOFWM]2.0.CO;2; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Bretz F., 2010, MULTIPLE COMP USING; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Devoto M, 2012, ECOL LETT, V15, P319, DOI 10.1111/j.1461-0248.2012.01740.x; Dormann C. F., 2009, OPEN ECOL J, V2, P7, DOI DOI 10.2174/1874213000902010007; Dormann CF, 2012, VISUALISING BIPARTIT; Ebeling A, 2008, OIKOS, V117, P1808, DOI 10.1111/j.1600-0706.2008.16819.x; Ebeling A, 2012, OECOLOGIA, V169, P453, DOI 10.1007/s00442-011-2205-8; Ebeling A, 2011, BASIC APPL ECOL, V12, P300, DOI 10.1016/j.baae.2011.04.005; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; FORD MA, 1985, HEREDITY, V54, P99, DOI 10.1038/hdy.1985.12; Frund J, 2011, ECOL LETT, V14, P896, DOI 10.1111/j.1461-0248.2011.01654.x; Gallet R, 2009, EVOLUTION, V63, P641, DOI 10.1111/j.1558-5646.2008.00559.x; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gegear RJ, 2004, ETHOLOGY, V110, P793, DOI 10.1111/j.1439-0310.2004.01010.x; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hennig EI, 2012, URBAN ECOSYST, V15, P149, DOI 10.1007/s11252-011-0202-7; Hennig EI, 2011, PERSPECT PLANT ECOL, V13, P137, DOI 10.1016/j.ppees.2011.03.003; Ibanez S, 2012, OECOLOGIA, V170, P233, DOI 10.1007/s00442-012-2290-3; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; INOUYE DW, 1978, ECOLOGY, V59, P672, DOI 10.2307/1938769; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kaiser-Bunbury CN, 2009, PERSPECT PLANT ECOL, V11, P241, DOI 10.1016/j.ppees.2009.04.001; Kay Q. O. N, 1969, WATSONIA, V7, P130; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Magura T, 2008, LANDSCAPE URBAN PLAN, V86, P134, DOI 10.1016/j.landurbplan.2008.01.005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Michener C.D., 2007, BEES WORLD, Vsecond; Ollerton J, 2012, TRENDS ECOL EVOL, V27, P141, DOI 10.1016/j.tree.2011.12.001; Perfectti F, 2009, OIKOS, V118, P1430, DOI 10.1111/j.1600-0706.2009.17491.x; Pesson P, 1984, POLLINISATION PRODUC; Pinheiro J, 2001, MIXED EFFECTS MODELS; PLEASANTS JM, 1979, OECOLOGIA, V41, P283, DOI 10.1007/BF00377432; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; SEANEY R. R., 1970, Advanc. Agron., V22, P119, DOI 10.1016/S0065-2113(08)60267-9; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; SVENSSON R, 1986, Svensk Botanisk Tidskrift, V80, P31; THOMSON JD, 1987, OECOLOGIA, V71, P295, DOI 10.1007/BF00377298; Thorp RW, 2009, CITIES ENV CATE, V2; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; WASER NM, 1978, OECOLOGIA, V36, P223, DOI 10.1007/BF00349811; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	76	125	126	8	337	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63421	10.1371/journal.pone.0063421	http://dx.doi.org/10.1371/journal.pone.0063421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717421	Green Published, gold			2022-12-25	WOS:000320362700019
J	Alves, CF; Alves, CF; Figueiredo, MM; Souza, CC; Machado-Coelho, GLL; Melo, MN; Tafuri, WL; Raso, P; Soares, RP; Tafuri, WL				Alves, Cibele Fontes; Alves, Cintia Fontes; Figueiredo, Maria Marta; Souza, Carolina Carvalho; Lins Machado-Coelho, George Luiz; Melo, Maria Norma; Tafuri, Washington Luiz; Raso, Pedro; Soares, Rodrigo Pedro; Tafuri, Wagner Luiz			American Tegumentary Leishmaniasis: Effectiveness of an Immunohistochemical Protocol for the Detection of Leishmania in Skin	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; MUCOCUTANEOUS LEISHMANIASIS; IMMUNOPEROXIDASE METHOD; MINAS-GERAIS; DIAGNOSIS; CHAGASI; BRAZIL; AMASTIGOTES; CLASSIFICATION; IDENTIFICATION	Background: American tegumentary leishmaniasis (ATL) is endemic in Latin America, where Brazil has over 27 thousand cases per year. The aim of the present study was to develop an immunohistochemical method (IHC) for ATL diagnosis. For this purpose, we used serum from a dog naturally infected with Leishmania (L) infantum (canine hyperimmune serum) as the primary antibody, followed by a detection system with a secondary biotinylated antibody. Methodology: Skin samples were obtained from 73 patients in an endemic area of Caratinga, Minas Gerais (MG) State, Brazil all testing positive for ATL with the Montenegro skin test, microscopy, and PCR. Canine hyperimmune serum of a dog naturally infected with Leishmania (L.) infantum was employed as a primary antibody in an immunohistochemical diagnostic method using streptavidin-biotin peroxidase. To assess the specificity of this reaction, IHC assays employing two monoclonal antibodies were carried out. As the polymer-based technology is less time-consuming and labor intensive than the IHC labeled streptavidin-biotin peroxidase method, we compared the two methods for all samples. Results: The IHC method detected ATL in 67 of the 73 cases (91.8%). Immunolabeled parasites were primarily detected inside macrophages either in the superficial or the deep dermis. Detection was facilitated by the high contrast staining of amastigotes (dark brown) against the light blue background. A lower detection rate (71.2%) was observed with the both of the monoclonal Leishmania antibodies compared to the canine hyperimmune serum. This may have been due to a non-specific background staining observed in all histological samples rendering positive detection more difficult. The higher efficacy of the canine hyperimmune serum in the IHC method was confirmed by the method using streptavidin-biotin peroxidase as well as that with the polymer-based technology (biotin-avidin-free system). Conclusions: The data are encouraging with regard to validating IHC as a standard alternative method for ATL diagnosis.	[Alves, Cibele Fontes; Figueiredo, Maria Marta; Souza, Carolina Carvalho; Tafuri, Wagner Luiz] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Alves, Cintia Fontes; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Lins Machado-Coelho, George Luiz] Univ Fed Ouro Preto, Escola Farm, Dept Ciencias Med, Ouro Preto, MG, Brazil; [Tafuri, Washington Luiz; Raso, Pedro] Univ Fed Minas Gerais, Fac Med, Dept Anat Patol, Belo Horizonte, MG, Brazil; [Soares, Rodrigo Pedro] Ctr Pesquisas Rene Rachou FIOCRUZ, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Tafuri, WL (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil.	wagnertafuri@gmail.com	Coelho, George Luiz Lins Machado/S-3411-2019; Soares, Rodrigo/S-5191-2019; Machado-Coelho, George Luiz Lins/ABA-4312-2021; Machado-Coelho, George L L/K-5972-2012	Coelho, George Luiz Lins Machado/0000-0002-9806-9721; Soares, Rodrigo/0000-0002-7966-3629; Machado-Coelho, George L L/0000-0002-9806-9721; Fontes Alves, Cibele/0000-0003-2390-3686; Tafuri, Wagner Luiz/0000-0002-7556-0737	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG) [CDS-AQP 00068-08]; Pro-reitoria de Pesquisa [PRPq-Edital 07/2010]; Control Zoonosis Center of the Municipality of Ribeirao das Neves, Belo Horizonte Metropolitan area; Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-reitoria de Pesquisa; Control Zoonosis Center of the Municipality of Ribeirao das Neves, Belo Horizonte Metropolitan area; Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil	The authors thank the Control Zoonosis Center of the Municipality of Ribeirao das Neves, Belo Horizonte Metropolitan area; Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG CDS-AQP 00068-08); and Pro-reitoria de Pesquisa (PRPq-Edital 07/2010), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Andrade-Narvaez Fernando J., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P191, DOI 10.1590/S0036-46652005000400003; Barbosa AJ, 1988, REV SOC BRAS MED TRO, V21, P1; BARRAL A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P579, DOI 10.1590/S0074-02761987000400018; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; Coelho-Finamore JM, 2011, INT J PARASITOL, V41, P333, DOI 10.1016/j.ijpara.2010.10.004; Costa J M, 1990, Rev Soc Bras Med Trop, V23, P205, DOI 10.1590/S0037-86821990000400004; da Silva SM, 2012, ANTIMICROB AGENTS CH, V56, P2858, DOI 10.1128/AAC.00208-12; de Magalhaes A V, 1982, Rev Inst Med Trop Sao Paulo, V24, P268; Curti MCD, 2011, BRAZ J INFECT DIS, V15, P12, DOI 10.1590/S1413-86702011000100003; DEBRUJIN MHL, 1993, TROP MED PARASITOL, V44, P201; DEMAGALHAES AV, 1986, REV I MED TROP, V28, P421, DOI 10.1590/S0036-46651986000600008; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DOSTROVSKY A, 1946, ANN TROP MED PARASIT, V40, P265, DOI 10.1080/00034983.1946.11685285; Figueiredo MM, 2010, HISTOL HISTOPATHOL, V25, P877, DOI 10.14670/HH-25.877; Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011; HERMETO MV, 1993, MEM I OSWALDO CRUZ, V88, P635, DOI 10.1590/S0074-02761993000400025; LIVNI N, 1983, VIRCHOWS ARCH A, V401, P147, DOI 10.1007/BF00692639; Lunedo SN, 2012, ACTA HISTOCHEM, V114, P252, DOI 10.1016/j.acthis.2011.06.002; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Melo M N, 1977, Rev Inst Med Trop Sao Paulo, V19, P161; (MS/SVS) MdS-SdVS, 2011, LEISHM TEG AM DISTR; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; Piani A, 1999, MICROBES INFECT, V1, P589, DOI 10.1016/S1286-4579(99)80058-6; Quintella LP, 2009, REV I MED TROP, V51, P83, DOI 10.1590/S0036-46652009000200005; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; RIDLEY DS, 1980, T ROY SOC TROP MED H, V74, P515, DOI 10.1016/0035-9203(80)90069-3; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; SALINAS G, 1989, MEM I OSWALDO CRUZ, V84, P53, DOI 10.1590/S0074-02761989000100010; Schubach A, 2001, MEM I OSWALDO CRUZ, V96, P987, DOI 10.1590/S0074-02762001000700018; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Singh S, 2003, J Postgrad Med, V49, P55; STERNBERGER LA, 1986, J HISTOCHEM CYTOCHEM, V34, P599, DOI 10.1177/34.5.3517144; Tafuri WL, 2004, J IMMUNOL METHODS, V292, P17, DOI 10.1016/j.jim.2004.05.009; TOLSON DL, 1989, MOL BIOCHEM PARASIT, V35, P109, DOI 10.1016/0166-6851(89)90113-8; Vega-Lopez F, 2003, CURR OPIN INFECT DIS, V16, P97, DOI 10.1097/00001432-200304000-00006; Volpini AC, 2006, CLIN MICROBIOL INFEC, V12, P815, DOI 10.1111/j.1469-0691.2006.01422.x; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176	42	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63343	10.1371/journal.pone.0063343	http://dx.doi.org/10.1371/journal.pone.0063343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704900	Green Published, gold			2022-12-25	WOS:000319330200029
J	Faguer, S; Mayeur, N; Casemayou, A; Pageaud, AL; Courtellemont, C; Cartery, C; Fournie, GJ; Schanstra, JP; Tack, I; Bascands, JL; Chauveau, D				Faguer, Stanislas; Mayeur, Nicolas; Casemayou, Audrey; Pageaud, Anne-Laure; Courtellemont, Claire; Cartery, Claire; Fournie, Gilbert J.; Schanstra, Joost P.; Tack, Ivan; Bascands, Jean-Loup; Chauveau, Dominique			Hnf-1 beta Transcription Factor Is an Early Hif-1 alpha-Independent Marker of Epithelial Hypoxia and Controls Renal Repair	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EXPRESSION; FAILURE; DISEASE; GENE; RATS; REGENERATION; SUPPRESSORS; HOMEOSTASIS; MUTATIONS	Epithelial repair following acute kidney injury (AKI) requires epithelial-mesenchyme-epithelial cycling associated with transient re-expression of genes normally expressed during kidney development as well as activation of growth factors and cytokine-induced signaling. In normal kidney, the Hnf-1 beta transcription factor drives nephrogenesis, tubulogenesis and epithelial homeostasis through the regulation of epithelial planar cell polarity and expression of developmental or tubular segment-specific genes. In a mouse model of ischemic AKI induced by a 2-hours hemorrhagic shock, we show that expression of this factor is tightly regulated in the early phase of renal repair with a biphasic expression profile (early down-regulation followed by transient over-expression). These changes are associated to tubular epithelial differentiation as assessed by KSP-cadherin and megalin-cubilin endocytic complex expression analysis. In addition, early decrease in Hnf1b expression is associated with the transient over-expression of one of its main target genes, the suppressor of cytokine signaling Socs3, which has been shown essential for renal repair. In vitro, hypoxia induced early up-regulation of Hnf-1 beta from 1 to 24 hours, independently of the hypoxia-inducible factor Hif-1 alpha. When prolonged, hypoxia induced Hnf-1 beta down-regulation while normoxia led to Hnf-1 beta normalization. Last, Hnf-1 beta down-regulation using RNA interference in HK-2 cells led to phenotype switch from an epithelial to a mesenchyme state. Taken together, we showed that Hnf-1 beta may drive recovery from ischemic AKI by regulating both the expression of genes important for homeostasis control during organ repair and the state of epithelial cell differentiation.	[Faguer, Stanislas; Courtellemont, Claire; Cartery, Claire; Fournie, Gilbert J.; Chauveau, Dominique] CHU Rangueil, Dept Nephrol & Transplantat Organes, F-31054 Toulouse, France; [Faguer, Stanislas; Mayeur, Nicolas; Casemayou, Audrey; Pageaud, Anne-Laure; Schanstra, Joost P.; Tack, Ivan; Bascands, Jean-Loup; Chauveau, Dominique] Fac Med Toulouse, INSERM, U1048, Inst Malad Metab & Cardiovasc,Equipe 12, F-31073 Toulouse, France; [Faguer, Stanislas; Chauveau, Dominique] CHU Rangueil, Ctr Reference Malad Renales Rares, F-31054 Toulouse, France; [Tack, Ivan] CHU Rangueil, Serv Explorat Physiol, F-31054 Toulouse, France; [Mayeur, Nicolas] CHU Purpan, Equipe Accueil Inserm 4564, Dept Anesthesie Reanimat, Toulouse, France; [Faguer, Stanislas; Mayeur, Nicolas; Courtellemont, Claire; Schanstra, Joost P.; Tack, Ivan; Bascands, Jean-Loup; Chauveau, Dominique] Univ Toulouse 3, F-31062 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Faguer, S (corresponding author), CHU Rangueil, Dept Nephrol & Transplantat Organes, F-31054 Toulouse, France.	faguer.s@chu-toulouse.fr	Schanstra, Joost P/X-7724-2018	Schanstra, Joost P/0000-0002-7471-372X; Bascands, Jean-loup/0000-0002-1667-5913	Fondation pour la Recherche Medicale; Societe de Nephrologie	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe de Nephrologie	SF received a grant from the Fondation pour la Recherche Medicale, CC received a grant from the Societe de Nephrologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalat S, 2009, J AM SOC NEPHROL, V20, P1123, DOI 10.1681/ASN.2008060633; Allard J, 2011, CRIT CARE MED; Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dey BR, 2000, BIOCHEM BIOPH RES CO, V278, P38, DOI 10.1006/bbrc.2000.3762; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Franquesa M, 2005, GENE THER, V12, P1551, DOI 10.1038/sj.gt.3302569; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Grigoryev DN, 2008, J AM SOC NEPHROL, V19, P547, DOI 10.1681/ASN.2007040469; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Homsi E, 2002, NEPHRON, V92, P192, DOI 10.1159/000064478; Homsi E, 2009, AM J NEPHROL, V29, P283, DOI 10.1159/000159275; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Lindoso RS, 2009, NEPHROL DIAL TRANSPL, V24, P2628, DOI 10.1093/ndt/gfp307; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Mayeur N, 2011, CRIT CARE MED, V39, P2131, DOI 10.1097/CCM.0b013e31821f04f0; Mitazaki S, 2009, TOXICOLOGY, V265, P115, DOI 10.1016/j.tox.2009.10.005; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Racusen L, 2001, MORPHOLOGIC BASIS AC; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Tan JC, 2005, PEDIATR NEPHROL, V20, P567, DOI 10.1007/s00467-004-1766-8; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Terada Y, 2003, J AM SOC NEPHROL, V14, P1223, DOI 10.1097/01.ASN.0000060577.94532.06; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; Xu EY, 2008, CHEM RES TOXICOL, V21, P1548, DOI 10.1021/tx800061w; Yoshioka K, 2011, J RECEPT SIG TRANSD, V31, P132, DOI 10.3109/10799893.2010.538852	37	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63585	10.1371/journal.pone.0063585	http://dx.doi.org/10.1371/journal.pone.0063585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704921	Green Published, gold			2022-12-25	WOS:000319330200052
J	Gilg, O; Moe, B; Hanssen, SA; Schmidt, NM; Sittler, B; Hansen, J; Reneerkens, J; Sabard, B; Chastel, O; Moreau, J; Phillips, RA; Oudman, T; Biersma, EM; Fenstad, AA; Lang, J; Bollache, L				Gilg, Olivier; Moe, Borge; Hanssen, Sveinn Are; Schmidt, Niels Martin; Sittler, Benoit; Hansen, Jannik; Reneerkens, Jeroen; Sabard, Brigitte; Chastel, Olivier; Moreau, Jerome; Phillips, Richard A.; Oudman, Thomas; Biersma, Elisabeth M.; Fenstad, Anette A.; Lang, Johannes; Bollache, Loic			Trans-Equatorial Migration Routes, Staging Sites and Wintering Areas of a High-Arctic Avian Predator: The Long-tailed Skua (Stercorarius longicaudus)	PLOS ONE			English	Article							PELAGIC SEABIRD; CLIMATE-CHANGE; TRACKING; ATLANTIC; DYNAMICS; GEOLOCATION; REVEALS; HABITAT; WATERS; MURRES	The Long-tailed Skua, a small (<300 g) Arctic-breeding predator and seabird, is a functionally very important component of the Arctic vertebrate communities in summer, but little is known about its migration and winter distribution. We used light-level geolocators to track the annual movements of eight adult birds breeding in north-east Greenland (n = 3) and Svalbard (n = 5). All birds wintered in the Southern Hemisphere (mean arrival-departure dates on wintering grounds: 24 October-21 March): five along the south-west coast of Africa (0-40 degrees S, 0-15 degrees E), in the productive Benguela upwelling, and three further south (30-40 degrees S, 0-50 degrees E), in an area extending into the south-west Indian Ocean. Different migratory routes and rates of travel were documented during post-breeding (345 km d(-1) in late August-early September) and spring migrations (235 km d(-1) in late April) when most birds used a more westerly flyway. Among the different staging areas, a large region off the Grand Banks of Newfoundland appears to be the most important. It was used in autumn by all but one of the tracked birds (from a few days to three weeks) and in spring by five out of eight birds (from one to more than six weeks). Two other staging sites, off the Iberian coast and near the Azores, were used by two birds in spring for five to six weeks. Over one year, individuals travelled between 43,900 and 54,200 km (36,600-45,700 when excluding staging periods) and went as far as 10,500-13,700 km (mean 12,800 km) from their breeding sites. This study has revealed important marine areas in both the south and north Atlantic Ocean. Sustainable management of these ocean basins will benefit Long-tailed Skuas as well as other trans-equatorial migrants from the Arctic.	[Gilg, Olivier; Moreau, Jerome; Bollache, Loic] Univ Bourgogne, Lab Biogeosci, UMR CNRS 5561, Dijon, France; [Gilg, Olivier; Sittler, Benoit; Sabard, Brigitte; Moreau, Jerome; Lang, Johannes; Bollache, Loic] Grp Rech Ecol Arct Francheville, Francheville, France; [Moe, Borge; Hanssen, Sveinn Are] Norwegian Inst Nat Res NINA, Tromso, Norway; [Schmidt, Niels Martin; Hansen, Jannik] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Schmidt, Niels Martin] Aarhus Univ, Arct Res Ctr, Aarhus C, Denmark; [Sittler, Benoit] Univ Freiburg, Inst Landespflege, D-79106 Freiburg, Germany; [Reneerkens, Jeroen] Univ Groningen, Anim Ecol Grp, Groningen, Netherlands; [Chastel, Olivier] CNRS, Ctr Etud Biol Chize, Chize, France; [Phillips, Richard A.; Biersma, Elisabeth M.] NERC, British Antarct Survey, Cambridge, England; [Oudman, Thomas; Biersma, Elisabeth M.] Univ Groningen, Arct Ctr, Groningen, Netherlands; [Oudman, Thomas] Royal Netherlands Inst Sea Res, Den Burg, Texel, Netherlands; [Fenstad, Anette A.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Lang, Johannes] Inst Anim Ecol & Nat Educ, Gonterskirchen, Germany	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Norwegian Institute Nature Research; Aarhus University; Aarhus University; University of Freiburg; University of Groningen; Centre National de la Recherche Scientifique (CNRS); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Norwegian University of Science & Technology (NTNU)	Gilg, O (corresponding author), Univ Bourgogne, Lab Biogeosci, UMR CNRS 5561, Dijon, France.	olivier.gilg@gmail.com	GILG, Olivier/C-2588-2008; Hanssen, Sveinn Are/C-9989-2009; moreau, jerome/A-3496-2013; Biersma, Elisabeth Machteld/AAL-9818-2020; Schmidt, Niels Martin/G-3843-2011; Moe, Børge/P-2946-2015; Reneerkens, Jeroen/J-3880-2015; Hansen, Jannik/J-5679-2013	GILG, Olivier/0000-0002-9083-4492; Hanssen, Sveinn Are/0000-0003-1792-435X; Biersma, Elisabeth Machteld/0000-0002-9877-2177; Schmidt, Niels Martin/0000-0002-4166-6218; Moe, Børge/0000-0002-2306-1899; Reneerkens, Jeroen/0000-0003-0674-8143; Hansen, Jannik/0000-0003-1181-6905; Hansen, Jannik/0000-0002-2716-9928; BOLLACHE, Loic/0000-0003-0316-6746; Lang, Johannes/0000-0002-7387-795X	Conseil Regional de Bourgogne; French Polar Institut (IPEV; project "1036-Interactions"); Danish Environmental Protection Agency; Groupe de Recherche en Ecologie Arctique (GREA); Fram Centre, Arctic Field Grant; Norwegian Institute for Nature Research (NINA); Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); French Polar Institut (IPEV; project "1036-Interactions"); Danish Environmental Protection Agency; Groupe de Recherche en Ecologie Arctique (GREA); Fram Centre, Arctic Field Grant; Norwegian Institute for Nature Research (NINA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the Conseil Regional de Bourgogne, the French Polar Institut (IPEV; project "1036-Interactions"), the Danish Environmental Protection Agency and the Groupe de Recherche en Ecologie Arctique (GREA) for their support to this study in Greenland. Research in Svalbard was funded by the Fram Centre, Arctic Field Grant, and by the Norwegian Institute for Nature Research (NINA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLON F, 1991, BIRDING WORLD, V4, P440; Boertmann David, 2011, Marine Ornithology, V39, P183; Boertmann David, 1994, Meddelelser om Gronland Bioscience, V38, P1; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; de Korte J, 1985, BEAUFORT, V35, P93; DEKORTE J, 1988, ARDEA, V76, P27; Distiller G, 2012, MAR ECOL PROG SER, V461, P245, DOI 10.3354/meps09807; Dubois Phillipe J., 2009, Ornithos, V16, P220; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Furness RW, 1987, SKUAS, P336; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hansen J, 2011, BIRD STUDY, V58, P522, DOI 10.1080/00063657.2011.601411; Harrison P, 1989, SEABIRDS, P448; Hedd A, 2011, ANIM CONSERV, V14, P630, DOI 10.1111/j.1469-1795.2011.00479.x; Howell Steve N. G., 1995, Bulletin of the British Ornithologists' Club, V115, P57; Imboden C., 1972, Vogelwarte, V26, P336; IUCN, 2022, IUCN RED LIST THREAT; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Johnson AW, 1965, BIRDS CHILE ADJACENT, V1, P398; Kampp K., 1982, Dansk Ornitologisk Forenings Tidsskrift, V76, P129; Kovacs KM, 2006, BIRDS MAMMALS SVALBA, P203; LAMBERT K, 1980, Beitraege zur Vogelkunde, V26, P199; LAMBERT K, 1988, Beitraege zur Vogelkunde, V34, P29; LAMBERT K, 1973, Canadian Field-Naturalist, V87, P57; Lambert Kurt, 2005, Durban Museum Novitates, V30, P45; Lambert Kurt, 2006, Marine Ornithology, V34, P77; Langrand O., 1995, GUIDE OISEAUX MADAGA; Lovenskiold H. L., 1964, Skrifter om Norsk Polarinstitutt, VNo. 129, P1; Magnusdottir E, 2012, BIRD STUDY, V59, P1; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; Mosbech A, 2012, POLAR BIOL, V35, P305, DOI 10.1007/s00300-011-1064-4; Nilsson K, 2008, VAR FAGELVARLD, V5, P18; North American Banding Council, 2001, N AM BAND STUD GUID; Okes NC, 2009, BIOL CONSERV, V142, P2361, DOI 10.1016/j.biocon.2009.05.031; Olsen KM, 1997, SKUAS JAEGERS, P192; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Ramos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040822; RYAN PG, 1989, OSTRICH, V60, P89; Schmidt NM, 2008, ADV ECOL RES, V40, P345, DOI 10.1016/S0065-2504(07)00015-3; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Sittler B, 2011, J ORNITHOL, V152, P375, DOI 10.1007/s10336-010-0597-6; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Tuck G, 1985, GUIDE SEABIRDS OCEAN, P144; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Wiley R. H., 1998, BIRDS N AM ONLINE; Zmudczynska K, 2012, POLAR BIOL, V35, P1233, DOI 10.1007/s00300-012-1169-4	62	42	47	0	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64614	10.1371/journal.pone.0064614	http://dx.doi.org/10.1371/journal.pone.0064614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705000	Green Accepted, Green Published, gold			2022-12-25	WOS:000319330200154
J	Konieczna, P; Ferstl, R; Ziegler, M; Frei, R; Nehrbass, D; Lauener, RP; Akdis, CA; O'Mahony, L				Konieczna, Patrycja; Ferstl, Ruth; Ziegler, Mario; Frei, Remo; Nehrbass, Dirk; Lauener, Roger P.; Akdis, Cezmi A.; O'Mahony, Liam			Immunomodulation by Bifidobacterium infantis 35624 in the Murine Lamina Propria Requires Retinoic Acid-Dependent and Independent Mechanisms	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; IRRITABLE-BOWEL-SYNDROME; REGULATORY T-CELLS; IMMUNE-RESPONSES; TGF-BETA; INFLAMMATION; MICROBIOTA; MICE; MACROPHAGES; EFFICACY	Appropriate dendritic cell processing of the microbiota promotes intestinal homeostasis and protects against aberrant inflammatory responses. Mucosal CD103(+) dendritic cells are able to produce retinoic acid from retinal, however their role in vivo and how they are influenced by specific microbial species has been poorly described. Bifidobacterium infantis 35624 (B. infantis) feeding to mice resulted in increased numbers of CD103+ retinaldehyde dehydrogenase (RALDH)(+) dendritic cells within the lamina propria (LP). Foxp3(+) lymphocytes were also increased in the LP, while T(H)1 and T(H)17 subsets were decreased. 3,7-dimethyl-2,6-octadienal (citral) treatment of mice blocked the increase in CD103(+)RALDH(+) dendritic cells and the decrease in T(H)1 and T(H)17 lymphocytes, but not the increase in Foxp3(+) lymphocytes. B. infantis reduced the severity of DSS-induced colitis, associated with decreased T(H)1 and T(H)17 cells within the LP. Citral treatment confirmed that these effects were RALDH mediated. RALDH(+) dendritic cells decreased within the LP of control inflamed animals, while RALDH(+) dendritic cells numbers were maintained in the LP of B. infantis-fed mice. Thus, CD103(+)RALDH(+) LP dendritic cells are important cellular targets for microbiota-associated effects on mucosal immunoregulation.	[Konieczna, Patrycja; Ferstl, Ruth; Ziegler, Mario; Frei, Remo; Akdis, Cezmi A.; O'Mahony, Liam] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Frei, Remo; Lauener, Roger P.; Akdis, Cezmi A.] Christine Kuhne Ctr Allergy Res & Educ CK CARE, Davos, Switzerland; [Nehrbass, Dirk] AO Res Inst Davos ARI, Davos, Switzerland; [Lauener, Roger P.] Hochgebirgsklin Davos Wolfgang, Davos, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	O'Mahony, L (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	liam.omahony@siaf.uzh.ch	Ferstl, Ruth/ABB-9679-2021; Lauener, Roger P/O-8612-2016; Frei, Remo/AAI-9180-2020; O'Mahony, Liam/AAG-5838-2019; Akdis, Cezmi/AAV-4844-2020	Lauener, Roger P/0000-0002-8412-606X; O'Mahony, Liam/0000-0003-4705-3583; Akdis, Cezmi/0000-0001-8020-019X	Swiss National Foundation [32030-132899, 310030-127356]; Christine Kuhne Center for Allergy Research and Education (CK-CARE); European Union (EU) Marie Curie; Novartis; Stallergenes	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Christine Kuhne Center for Allergy Research and Education (CK-CARE); European Union (EU) Marie Curie; Novartis(Novartis); Stallergenes	The authors are supported by Swiss National Foundation grants (project numbers 32030-132899 and 310030-127356), Christine Kuhne Center for Allergy Research and Education (CK-CARE) and European Union (EU) Marie Curie grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following conflicts. Liam O'Mahony is a consultant to Alimentary Health Ltd. Cezmi A. Akdis has received research support from Novartis and Stallergenes and consulted for Actellion, Aventis and Allergopharma. Patrycja Konieczna, Mario Ziegler, Dirk Nehrbass, Remo Frei, Ruth Ferstl and Roger P. Lauener have no conflict of interest. The authors do not have any additional financial or non-financial disclosures, which have not already been described online. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jeon SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002714; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Konieczna P, 2012, GUT MICROBES, V3, P261, DOI 10.4161/gmic.20358; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Leavy O, 2012, NAT REV IMMUNOL, V12, P319, DOI 10.1038/nri3213; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Murphy CT, 2010, J LEUKOCYTE BIOL, V88, P1271, DOI 10.1189/jlb.0909627; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Shanahan F, 2010, AM J GASTROENTEROL, V105, P275, DOI 10.1038/ajg.2009.729; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017	33	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62617	10.1371/journal.pone.0062617	http://dx.doi.org/10.1371/journal.pone.0062617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704880	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200009
J	Ma, KF; Song, YP; Yang, XH; Zhang, ZY; Zhang, DQ				Ma, Kaifeng; Song, Yuepeng; Yang, Xiaohui; Zhang, Zhiyi; Zhang, Deqiang			Variation in Genomic Methylation in Natural Populations of Chinese White Poplar	PLOS ONE			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; GENETIC DIVERSITY; AFLP; POLYMORPHISM; AMPLIFICATION; INHERITANCE; DIFFERENTIATION; REPLICATION; VARIABILITY	Background: It is thought that methylcytosine can be inherited through meiosis and mitosis, and that epigenetic variation may be under genetic control or correlation may be caused by neutral drift. However, DNA methylation also varies with tissue, developmental stage, and environmental factors. Eliminating these factors, we analyzed the levels and patterns, diversity and structure of genomic methylcytosine in the xylem of nine natural populations of Chinese white poplar. Principal Findings: On average, the relative total methylation and non-methylation levels were approximately 26.567% and 42.708% (P < 0.001), respectively. Also, the relative CNG methylation level was higher than the relative CG methylation level. The relative methylation/non-methylation levels were significantly different among the nine natural populations. Epigenetic diversity ranged from 0.811 (Gansu) to 1.211 (Shaanxi), and the coefficients of epigenetic differentiation (G(ST) = 0.159) were assessed by Shannon's diversity index. Co-inertia analysis indicated that methylation-sensitive polymorphism (MSP) and genomic methylation pattern (CG-CNG) profiles gave similar distributions. Using a between-group eigen analysis, we found that the Hebei and Shanxi populations were independent of each other, but the Henan population intersected with the other populations, to some degree. Conclusions: Genome methylation in Populus tomentosa presented tissue-specific characteristics and the relative 5' CCGG methylation level was higher in xylem than in leaves. Meanwhile, the genome methylation in the xylem shows great epigenetic variation and could be fixed and inherited though mitosis. Compared to genetic structure, data suggest that epigenetic and genetic variation do not completely match.	[Ma, Kaifeng; Song, Yuepeng; Yang, Xiaohui; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Ma, Kaifeng; Song, Yuepeng; Yang, Xiaohui; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Coll Biol Sci & Technol, Minist Educ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn	Song, Yuepeng/T-8731-2019		Fundamental Research Funds for Central Universities [TD2012-01]; State Key Basic Research Program of China [2012CB114506]; National Natural Science Foundation of China [31170622, 30872042]	Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); State Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for Central Universities (No. TD2012-01), the State Key Basic Research Program of China (No. 2012CB114506) and the Project of the National Natural Science Foundation of China (No. 31170622, 30872042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Bussell JD, 1999, MOL ECOL, V8, P775, DOI 10.1046/j.1365-294X.1999.00627.x; Campbell RB, 1976, CAN J FOREST RES, V6, P251; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gong L, 2007, CAN J BOT, V85, P813, DOI 10.1139/B07-072; Groves M, 2008, ENDANG SPECIES RES, V9, P255; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Hasbun R, 2005, ACTA HORTIC, P333, DOI 10.17660/ActaHortic.2005.693.42; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; HOLLIDAY R, 1994, DEV GENET, V15, P453, DOI 10.1002/dvg.1020150602; Kakutani T, 1999, GENETICS, V151, P831; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kovarik A, 1997, GENE, V204, P25, DOI 10.1016/S0378-1119(97)00503-9; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu S, 2012, MOL GENET GENOMICS, V287, P643, DOI 10.1007/s00438-012-0704-x; Ma KF, 2012, TREE GENET GENOMES, V8, P1407, DOI 10.1007/s11295-012-0527-2; Massicotte R, 2011, EPIGENETICS-US, V6, P422, DOI 10.4161/epi.6.4.14532; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; MONTERO LM, 1992, NUCLEIC ACIDS RES, V20, P3207, DOI 10.1093/nar/20.12.3207; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Oakeley EJ, 1996, PLANT MOL BIOL, V31, P927, DOI 10.1007/BF00019481; Parisod C, 2005, ANN BOT-LONDON, V95, P277, DOI 10.1093/aob/mci023; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Rachmayanti Y, 2006, PLANT MOL BIOL REP, V24, P45, DOI 10.1007/BF02914045; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang YM, 2004, CELL MOL BIOL LETT, V9, P543; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Winfield MO, 1998, MOL ECOL, V7, P3, DOI 10.1046/j.1365-294x.1998.00299.x; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Zhang D, 2004, THEOR APPL GENET, V108, P657, DOI 10.1007/s00122-003-1478-7; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002; Zhu ZhiTi, 1997, Journal of Beijing Forestry University, English edition, V6, P1	51	16	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63977	10.1371/journal.pone.0063977	http://dx.doi.org/10.1371/journal.pone.0063977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704963	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200095
J	Romano, E; Michetti, C; Caruso, A; Laviola, G; Scattoni, ML				Romano, Emilia; Michetti, Caterina; Caruso, Angela; Laviola, Giovanni; Scattoni, Maria Luisa			Characterization of Neonatal Vocal and Motor Repertoire of Reelin Mutant Mice	PLOS ONE			English	Article							MOUSE MODEL; NEUROBEHAVIORAL DEVELOPMENT; ULTRASONIC VOCALIZATIONS; BEHAVIORAL-PHENOTYPE; VULNERABILITY FACTOR; COGNITIVE FUNCTION; AUTISTIC DISORDER; CEREBRAL-CORTEX; ANIMAL-MODELS; RETT-SYNDROME	Reelin is a large secreted extracellular matrix glycoprotein playing an important role in early neurodevelopment. Several genetic studies found an association between RELN gene and increased risk of autism suggesting that reelin deficiency may be a vulnerability factor in its etiology. Moreover, a reduced reelin expression has been observed in several brain regions of subjects with Autism Spectrum Disorders. Since a number of reports have documented presence of vocal and neuromotor abnormalities in patients with autism and suggested that these dysfunctions predate the onset of the syndrome, we performed a fine-grain characterization of the neonatal vocal and motor repertoire in reelin mutant mice to explore the developmental precursors of the disorder. Our findings evidence a general delay in motor and vocal development in heterozygous (50% reduced reelin) and reeler (lacking reelin gene) mutant mice. As a whole, an increased number of calls characterized heterozygous pup's emission. Furthermore, the typical ontogenetic peak in the number of calls characterizing wild-type pups on postnatal day 4 appeared slightly delayed in heterozygous pups (to day 6) and was quite absent in reeler littermates, which exhibited a flat profile during development. We also detected a preferential use of a specific call category (two-components) by heterozygous and reeler mice at postnatal days 6 and 8 as compared to their wild-type littermates. With regard to the analysis of spontaneous movements, a differential profile emerged early in development among the three genotypes. While only slight coordination difficulties are exhibited by heterozygous pups, all indices of motor development appear delayed in reeler mice. Overall, our results evidence a genotype-dependent deviation in ultrasonic vocal repertoire and a general delay in motor development in reelin mutant pups.	[Romano, Emilia; Laviola, Giovanni] Ist Super Sanita, Behav Neurosci Sect, Dept Cell Biol & Neurosci, Rome, Italy; [Michetti, Caterina; Caruso, Angela; Scattoni, Maria Luisa] Ist Super Sanita, Neurotoxicol & Neuroendocrinol Sect, Dept Cell Biol & Neurosci, Rome, Italy; [Romano, Emilia] Ist Ricovero & Cura Carattere Sci, Bambino Gesu Childrens Hosp, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu	Scattoni, ML (corresponding author), Ist Super Sanita, Neurotoxicol & Neuroendocrinol Sect, Dept Cell Biol & Neurosci, Rome, Italy.	marialuisa.scattoni@iss.it	Laviola, Giovanni/AAA-2391-2022; Laviola, Giovanni/K-4392-2016; Caruso, Angela/K-4262-2018; Michetti, Caterina/K-4441-2018; Scattoni, Maria Luisa/K-4116-2016	Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Caruso, Angela/0000-0002-6364-3922; Michetti, Caterina/0000-0003-4402-6985; Scattoni, Maria Luisa/0000-0002-6659-0280	Italian Ministry of Health Grant, Young Researcher, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders'; ERAnet "PrioMedChild'', Italian Ministry of Health; IRE-IFO [RF2008]	Italian Ministry of Health Grant, Young Researcher, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders'; ERAnet "PrioMedChild'', Italian Ministry of Health; IRE-IFO	This work has been supported by the Italian Ministry of Health Grant, Young Researcher 2008, GR3-"Non-invasive tools for early detection of Autism Spectrum Disorders'' (MLS, CM and AC); by the ERAnet "PrioMedChild'', Italian Ministry of Health (ER) and IRE-IFO (RF2008) "MECP2 phosphorilation and related kinase in Rett syndrom'' (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley-Koch AE, 2007, PSYCHIAT GENET, V17, P221, DOI 10.1097/YPG.0b013e32809c2f75; Bhat AN, 2012, INFANT BEHAV DEV, V35, P838, DOI 10.1016/j.infbeh.2012.07.019; Biamonte F, 2009, NEUROBIOL DIS, V36, P103, DOI 10.1016/j.nbd.2009.07.001; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Branchi I, 2002, GENES BRAIN BEHAV, V1, P135, DOI 10.1034/j.1601-183X.2002.10301.x; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Brigman JL, 2006, BEHAV NEUROSCI, V120, P984, DOI 10.1037/0735-7044.120.4.984; Bryson SE, 2007, J AUTISM DEV DISORD, V37, P12, DOI 10.1007/s10803-006-0328-2; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; CIRULLI F, 1994, DEV PSYCHOBIOL, V27, P301, DOI 10.1002/dev.420270505; COHENSALMON C, 1985, PHYSIOL BEHAV, V35, P167, DOI 10.1016/0031-9384(85)90331-2; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; Costa E, 2001, NEUROBIOL DIS, V8, P723, DOI 10.1006/nbdi.2001.0436; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; Dutta S, 2011, CELL MOL NEUROBIOL, V31, P45, DOI 10.1007/s10571-010-9551-7; Esposito G, 2011, BRAIN DEV-JPN, V33, P367, DOI 10.1016/j.braindev.2010.07.006; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P139, DOI 10.1023/A:1019857620251; Fatemi SH, 2001, J AUTISM DEV DISORD, V31, P529, DOI 10.1023/A:1013234708757; Fatemi SH, 2001, MOL PSYCHIATR, V6, P129, DOI 10.1038/sj.mp.4000129; Flanagan J, 2007, AM J OCCUPATIONAL TH; Folsom TD, 2012, NEUROPHARMACOLOGY; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; GOFFINET AM, 1979, ANAT EMBRYOL, V157, P205, DOI 10.1007/BF00305160; GOFFINET AM, 1984, DEV BRAIN RES, V16, P263, DOI 10.1016/0165-3806(84)90031-2; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; HadjSahraoui N, 1996, J NEUROGENET, V11, P45, DOI 10.3109/01677069609107062; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; Johnson CP, 2008, PEDIATR REV, V29, P86, DOI 10.1542/pir.29-3-86; KANNER L, 1971, J AUTISM CHILD SCHIZ, V1, P119, DOI 10.1007/BF01537953; Kelemenova S, 2010, PSYCHIAT GENET, V20, P137, DOI 10.1097/YPG.0b013e32833a1eb3; Keller F, 2003, MOL NEUROBIOL, V28, P1, DOI 10.1385/MN:28:1:1; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Krueger DD, 2006, PSYCHOPHARMACOLOGY, V189, P95, DOI 10.1007/s00213-006-0530-0; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Laviola G, 2006, PSYCHOPHARMACOLOGY, V187, P331, DOI 10.1007/s00213-006-0426-z; Laviola G, 2009, NEUROSCI BIOBEHAV R, V33, P560, DOI 10.1016/j.neubiorev.2008.09.006; Macri S, 2010, PSYCHONEUROENDOCRINO, V35, P1374, DOI 10.1016/j.psyneuen.2010.03.012; Maestro S, 2006, ACTA PSYCHIAT SCAND, V113, P68, DOI 10.1111/j.1600-0447.2005.00695.x; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Ognibene E, 2007, BRAIN RES, V1131, P173, DOI 10.1016/j.brainres.2006.11.007; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Phagava H, 2008, Georgian Med News, P100; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Podhorna J, 2004, BEHAV BRAIN RES, V153, P43, DOI 10.1016/j.bbr.2003.10.033; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Ricceri L, 2007, BEHAV BRAIN RES, V183, P111, DOI 10.1016/j.bbr.2007.05.035; Romano E, 2013, NEUROTOX RES; Santos M, 2007, GENES BRAIN BEHAV, V6, P277, DOI 10.1111/j.1601-183X.2006.00258.x; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Shair HN, 2003, DEV PSYCHOBIOL, V42, P206, DOI 10.1002/dev.10087; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Smith A, 2009, PSYCHOL REC, V59, P489, DOI 10.1007/BF03395675; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; SPEAR LP, 1986, PSYCHOPHARMACOLOGY, V90, P106; Teitelbaum O, 2004, P NATL ACAD SCI USA, V101, P11909, DOI 10.1073/pnas.0403919101; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tordjman S, 2007, BEHAV GENET, V37, P61, DOI 10.1007/s10519-006-9120-5; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tueting P, 1999, NEUROREPORT, V10, P1329, DOI 10.1097/00001756-199904260-00032; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Zhang H, 2002, MOL PSYCHIATR, V7, P1012, DOI 10.1038/sj.mp.4001124; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	81	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64407	10.1371/journal.pone.0064407	http://dx.doi.org/10.1371/journal.pone.0064407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700474	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200132
J	Serkebaeva, YM; Kim, Y; Liesack, W; Dedysh, SN				Serkebaeva, Yulia M.; Kim, Yongkyu; Liesack, Werner; Dedysh, Svetlana N.			Pyrosequencing-Based Assessment of the Bacteria Diversity in Surface and Subsurface Peat Layers of a Northern Wetland, with Focus on Poorly Studied Phyla and Candidate Divisions	PLOS ONE			English	Article							PALUDICOLA GEN. NOV.; ACIDIC SPHAGNUM PEAT; COMMUNITY STRUCTURE; PEATLANDS; RNA; METHANOGENESIS; ACIDOBACTERIA; SEARCH; BOG	Northern peatlands play a key role in the global carbon and water budget, but the bacterial diversity in these ecosystems remains poorly described. Here, we compared the bacterial community composition in the surface (0-5 cm depth) and subsurface (45-50 cm) peat layers of an acidic (pH 4.0) Sphagnum-dominated wetland, using pyrosequencing of 16 S rRNA genes. The denoised sequences (37,229 reads, average length similar to 430 bp) were affiliated with 27 bacterial phyla and corresponded to 1,269 operational taxonomic units (OTUs) determined at 97% sequence identity. Abundant OTUs were affiliated with the Acidobacteria (35.5 +/- 2.4% and 39.2 +/- 1.2% of all classified sequences in surface and subsurface peat, respectively), Alphaproteobacteria (15.9 +/- 1.7% and 25.8 +/- 1.4%), Actinobacteria (9.5 +/- 2.0% and 10.7 +/- 0.5%), Verrucomicrobia (8.5 +/- 1.4% and 0.6 +/- 0.2%), Planctomycetes (5.8 +/- 0.4% and 9.7 +/- 0.6%), Deltaproteobacteria (7.1 +/- 0.4% and 4.4%+/- 0.3%), and Gammaproteobacteria (6.6 +/- 0.4% and 2.1 +/- 0.1%). The taxonomic patterns of the abundant OTUs were uniform across all the subsamples taken from each peat layer. In contrast, the taxonomic patterns of rare OTUs were different from those of the abundant OTUs and varied greatly among subsamples, in both surface and subsurface peat. In addition to the bacterial taxa listed above, rare OTUs represented the following groups: Armatimonadetes, Bacteroidetes, Chlamydia, Chloroflexi, Cyanobacteria, Elusimicrobia, Fibrobacteres, Firmicutes, Gemmatimonadetes, Spirochaetes, AD3, WS1, WS4, WS5, WYO, OD1, OP3, BRC1, TM6, TM7, WPS-2, and FCPU426. OTU richness was notably higher in the surface layer (882 OTUs) than in the anoxic subsurface peat (483 OTUs), with only 96 OTUs common to both data sets. Most members of poorly studied phyla, such as the Acidobacteria, Verrucomicrobia, Planctomycetes and the candidate division TM6, showed a clear preference for growth in either oxic or anoxic conditions. Apparently, the bacterial communities in surface and subsurface layers of northern peatlands are highly diverse and taxonomically distinct, reflecting the different abiotic conditions in microhabitats within the peat profile.	[Serkebaeva, Yulia M.; Kim, Yongkyu; Liesack, Werner] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia; [Serkebaeva, Yulia M.; Dedysh, Svetlana N.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Research Center of Biotechnology RAS; Russian Academy of Sciences; Max Planck Society	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de	Dedysh, Svetlana/S-1655-2016; Serkebaeva, Yulia M./H-3425-2012	Dedysh, Svetlana/0000-0001-8903-8053; Kim, Yongkyu/0000-0002-6781-7168; Liesack, Werner/0000-0002-9533-1552	Program "Molecular and Cell Biology'' of Russian Academy of Sciences; Deutsche Forschungsgemeinschaft [LI 455/5-1]; DAAD [A/11/86114]; Max Planck Society	Program "Molecular and Cell Biology'' of Russian Academy of Sciences; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was supported in parts by the Program "Molecular and Cell Biology'' of Russian Academy of Sciences and by the Deutsche Forschungsgemeinschaft (LI 455/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; YMS was supported by a DAAD fellowship for doctoral students (reference no. A/11/86114). YK was supported by a postdoctoral fellowship of the Max Planck Society.	Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Ausec L, 2009, SOIL BIOL BIOCHEM, V41, P1874, DOI 10.1016/j.soilbio.2009.06.010; Bragina Anastasia, 2011, Front Microbiol, V2, P275, DOI 10.3389/fmicb.2011.00275; Bragina A, 2012, ISME J, V6, P802, DOI 10.1038/ismej.2011.151; Cadillo-Quiroz H, 2006, ENVIRON MICROBIOL, V8, P1428, DOI 10.1111/j.1462-2920.2006.01036.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen Y, 2008, ENVIRON MICROBIOL, V10, P446, DOI 10.1111/j.1462-2920.2007.01466.x; Chin KJ, 2001, INT J SYST EVOL MICR, V51, P1965, DOI 10.1099/00207713-51-6-1965; Dedysh SN, 2009, MICROBIOLOGY+, V78, P655, DOI 10.1134/S0026261709060010; Dedysh SN, 2006, APPL ENVIRON MICROB, V72, P2110, DOI 10.1128/AEM.72.3.2110-2117.2006; Dedysh SN, 2001, APPL ENVIRON MICROB, V67, P4850, DOI 10.1128/AEM.67.10.4850-4857.2001; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11; Hu BL, 2011, APPL ENVIRON MICROB, V77, P966, DOI 10.1128/AEM.02402-10; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Ivanova AO, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00005; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; Juottonen H, 2005, ENVIRON MICROBIOL, V7, P1547, DOI 10.1111/j.1462-2920.2005.00838.x; Kip N, 2010, NAT GEOSCI, V3, P617, DOI 10.1038/NGEO939; Kivinen E., 1981, ANN ACAD SCI FENNICA, P1; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Kulichevskaya IS, 2007, INT J SYST EVOL MICR, V57, P2680, DOI 10.1099/ijs.0.65157-0; Kulichevskaya IS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00146; Kulichevskaya IS, 2010, INT J SYST EVOL MICR, V60, P301, DOI 10.1099/ijs.0.013250-0; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lin X, 2012, APPL ENVIRON MICROB, V78, P7023, DOI 10.1128/AEM.01750-12; Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mannisto MK, 2012, INT J SYST EVOL MICR, V62, P2097, DOI 10.1099/ijs.0.031864-0; Matthews E, 1987, GLOBAL BIOGEOCHEM CY, V1, P61, DOI 10.1029/GB001i001p00061; Morales SE, 2006, MICROB ECOL, V52, P34, DOI 10.1007/s00248-005-0264-2; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Panikov NS, 1999, POLAR RES, V18, P237, DOI 10.1111/j.1751-8369.1999.tb00299.x; Pankratov TA, 2012, INT J SYST EVOL MICR, V62, P430, DOI 10.1099/ijs.0.029629-0; Pankratov TA, 2011, ENVIRON MICROBIOL, V13, P1800, DOI 10.1111/j.1462-2920.2011.02491.x; Pankratov TA, 2010, INT J SYST EVOL MICR, V60, P2951, DOI 10.1099/ijs.0.021824-0; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rheims H, 1996, J IND MICROBIOL, V17, P159, DOI 10.1007/BF01574689; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Sun CL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00081; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Utsumi M, 2003, J GEN APPL MICROBIOL, V49, P75, DOI 10.2323/jgam.49.75; Vecherskaya M, 2009, ENV MICROBIOL REP, V1, P442, DOI 10.1111/j.1758-2229.2009.00069.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Winderl C, 2008, APPL ENVIRON MICROB, V74, P792, DOI 10.1128/AEM.01951-07; Zadorina EV, 2009, MICROBIOLOGY+, V78, P218, DOI 10.1134/S0026261709020131	55	115	123	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63994	10.1371/journal.pone.0063994	http://dx.doi.org/10.1371/journal.pone.0063994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700443	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200100
J	Yang, CS; Yuk, JM; Kim, JJ; Hwang, JH; Lee, CH; Kim, JM; Oh, GT; Choi, HS; Jo, EK				Yang, Chul-Su; Yuk, Jae-Min; Kim, Jwa-Jin; Hwang, Jung Hwan; Lee, Chul-Ho; Kim, Jin-Man; Oh, Goo Taeg; Choi, Hueng-Sik; Jo, Eun-Kyeong			Small Heterodimer Partner-Targeting Therapy Inhibits Systemic Inflammatory Responses through Mitochondrial Uncoupling Protein 2	PLOS ONE			English	Article							NUCLEAR RECEPTOR SHP; GENE-EXPRESSION; NITRIC-OXIDE; FENOFIBRATE; KINASE; ALPHA; AMPK; METABOLISM; ACTIVATION; MECHANISMS	The orphan nuclear receptor, small heterodimer partner (SHP), appears to play a negative regulatory role in innate immune signaling. Emerging evidence warrants further study on the therapeutic targeting of SHP to suppress excessive and deleterious inflammation. Here we show that fenofibrate, which targets SHP, is required for inhibiting systemic inflammation via mitochondrial uncoupling protein 2 (UCP2). In vivo administration of fenofibrate ameliorated systemic inflammatory responses and increased survival upon experimental sepsis through SHP. An abundance of SHP was observed in mice fed fenofibrate and in cultured macrophages through LKB1-dependent activation of the AMP-activated protein kinase pathway. Fenofibrate significantly blocked endotoxin-triggered inflammatory signaling responses via SHP, but not via peroxisome proliferator-activated receptor (PPAR)-alpha. In addition to the known mechanism by which SHP modulates innate signaling, we identify a new role of fenofibrate-induced SHP on UCP2 induction, which is required for the suppression of inflammatory responses through modulation of mitochondrial ROS production. These data strongly suggest that the SHP-inducing drug fenofibrate paves the way for novel therapies for systemic inflammation by targeting SHP.	[Yang, Chul-Su; Yuk, Jae-Min; Kim, Jwa-Jin; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon, South Korea; [Kim, Jin-Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Yang, Chul-Su; Yuk, Jae-Min; Kim, Jwa-Jin; Kim, Jin-Man; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon, South Korea; [Hwang, Jung Hwan; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Lab Anim Ctr, Taejon, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Chonnam National University	Jo, EK (corresponding author), Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon, South Korea.	hayoungj@cnu.ac.kr	Oh, Goo Taeg/AAQ-9995-2021; Yang, Chul-Su/J-3833-2013	KIM, JIN MAN/0000-0003-0905-9730; Eun-Kyeong, Jo/0000-0001-7191-0587; Yuk, Jae-Min/0000-0002-0630-9194	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A100588]; National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2007-0054932]; National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A100588), by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2007-0054932), by National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology, and by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Garruti G, 2012, J LIPIDS, V2012, DOI 10.1155/2012/304292; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Goto M, 2010, MOD RHEUMATOL, V20, P238, DOI 10.1007/s10165-009-0261-2; Gouni-Berthold I., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P513, DOI 10.2174/156800605774962022; Hiukka A, 2010, NAT REV ENDOCRINOL, V6, P454, DOI 10.1038/nrendo.2010.89; Kato Y, 2010, HORM METAB RES, V42, P632, DOI 10.1055/s-0030-1255033; Keating GM, 2007, DRUGS, V67, P121, DOI 10.2165/00003495-200767010-00013; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kladna A, 2006, BIOPOLYMERS, V82, P99, DOI 10.1002/bip.20402; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lalloyer F, 2011, ARTERIOSCL THROM VAS, V31, P1573, DOI 10.1161/ATVBAHA.110.220525; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Leloup C, 2011, ANTIOXID REDOX SIGN, V14, P519, DOI 10.1089/ars.2010.3424; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mansouri RM, 2008, ENDOCRINOLOGY, V149, P3215, DOI 10.1210/en.2007-1339; Marshall JC, 2001, CRIT CARE MED, V29, pS99, DOI 10.1097/00003246-200107001-00032; McKeage K, 2011, DRUGS, V71, P1917, DOI 10.2165/11208090-000000000-00000; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Patel NSA, 2009, J PHARMACOL EXP THER, V328, P635, DOI 10.1124/jpet.108.146191; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sehgal N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035427; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tomizawa A, 2011, METABOLISM, V60, P513, DOI 10.1016/j.metabol.2010.04.020; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wong TY, 2012, AM J OPHTHALMOL, V154, P6, DOI 10.1016/j.ajo.2012.03.013; Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	58	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63435	10.1371/journal.pone.0063435	http://dx.doi.org/10.1371/journal.pone.0063435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704907	gold, Green Submitted, Green Published			2022-12-25	WOS:000319330200037
J	Grottke, O; Rossaint, R; Henskens, Y; van Oerle, R; ten Cate, H; Spronk, HH				Grottke, Oliver; Rossaint, Rolf; Henskens, Yvonne; van Oerle, Rene; ten Cate, Hugo; Spronk, HenriM. H.			Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; PIG MODEL; COAGULOPATHY; TRANSFUSION; COAGULATION; INJURY	Background: The use of PCC for the treatment of trauma-induced coagulopathy potentially increase the risk of thromboembolism and disseminated intravascular coagulation, which is addressed to an imbalance of both pro-and anticoagulants. As PCCs differ in composition, we used an in vitro dilutional approach to assess the overall thrombin generation of five different PCCs through various laboratory assays. Methods: The vitamin K-dependent coagulation factors, heparin, and antithrombin were assessed in five commercially available PCCs. The procoagulant potential of the PCCs was assessed in plasma and whole blood from 4 healthy donors by means of classical coagulation assays, thrombin generation assay and thromboelastometry. In order to reflect coagulopathy, whole blood was diluted to 80, 60, 40, and 20% with Ringer's lactate solution. Results: The five different PCCs were characterised by comparable levels of factors II, VII, IX and X (all around 20-30 IU/mL), whereas the heparin (0 to 17.6 IU/mL) and antithrombin (0.06 to 1.29 IU/mL) levels were remarkably different between manufactures. In vitro dilution of blood induced a prolongation of the PT and aPTT, and attenuation of thrombin generation and ExTem induced thromboelastometry. Overall, non-or low-heparin containing PCCs restored the in vitro dilutional coagulopathy, whereas PCCs containing heparin have an anticoagulant effect. The thrombin generation assay showed to be the most sensitive method for assessment of PCC effects. Conclusions: This study shows that most available PCCs are not balanced regarding their pro-and anticoagulants. The effect of measured differences in thrombin generation among different PCCs requires further investigations to elaborate the clinical meaning of this finding in the treatment of trauma induced coagulopathy.	[Grottke, Oliver; Rossaint, Rolf] RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Henskens, Yvonne] Maastricht Univ Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands; [van Oerle, Rene; ten Cate, Hugo; Spronk, HenriM. H.] Maastricht Univ Med Ctr, Lab Clin Thrombosis & Haemostasis, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Spronk, HH (corresponding author), Maastricht Univ Med Ctr, Lab Clin Thrombosis & Haemostasis, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands.	henri.spronk@maastrichtuniversity.nl	Grottke, Oliver/F-1508-2018; Cate, Hugo ten/AAM-4000-2021; Henskens, Yvonne/AAD-8596-2020	ten Cate, Hugo/0000-0001-7796-4463; Spronk, Henri/0000-0002-3858-334X; Grottke, Oliver/0000-0002-0722-3122	Maastricht University Medical Center; RWTH Aachen; Novo Nordisk; Biotest; CSL Behring; Nycomed; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Leo Pharma	Maastricht University Medical Center; RWTH Aachen; Novo Nordisk(Novo Nordisk); Biotest; CSL Behring; Nycomed; Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Leo Pharma(LEO Pharma)	This study was financed by the Maastricht University Medical Center and the RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Oliver Grottke has received research funding from Novo Nordisk, Biotest, CSL Behring, Nycomed and honoraria for consultancy from Bayer Healthcare and Boehringer Ingelheim. Rolf Rossaint has received honoraria for lectures and consultancy from CSL Behring and Novo Nordisk. Hugo ten Cate has received speaker fees from Bayer, Boehringer Ingelheim, GlaxoSmithKline and Leo Pharma. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baglin TP, 2007, BRIT J HAEMATOL, V136, P26, DOI 10.1111/j.1365-2141.2006.06379.x; Bruce D, 2008, CRIT CARE, V12, DOI 10.1186/cc6987; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2008, ANESTH ANALG, V106, P1070, DOI 10.1213/ane.0b013e318165dfbb; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Dusel CH, 2004, BLOOD COAGUL FIBRIN, V15, P405, DOI 10.1097/01.mbc.0000114437.81125.2b; Fries D, 2006, BRIT J ANAESTH, V97, P460, DOI 10.1093/bja/ael191; Grottke O, 2011, BLOOD, V118, P1943, DOI 10.1182/blood-2011-03-343046; Honickel M, 2011, THROMB HAEMOSTASIS, V106, P724, DOI 10.1160/TH11-02-0101; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Levi M, 2011, VOX SANG, V101, P154, DOI 10.1111/j.1423-0410.2011.01472.x; Levy JH, 2008, ANESTHESIOLOGY, V109, P918, DOI 10.1097/ALN.0b013e3181895bd8; Romisch J, 1998, SEMIN THROMB HEMOST, V24, P175, DOI 10.1055/s-2007-995838; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scharbert G, 2012, WIEN KLIN WOCHENSCHR, V124, P320, DOI 10.1007/s00508-012-0171-8; Schick KS, 2009, CRIT CARE, V13, DOI 10.1186/cc8186; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Sorensen B, 2011, CRIT CARE, V15, DOI 10.1186/cc9311; Takeyama M, 2007, BLOOD COAGUL FIBRIN, V18, P1, DOI 10.1097/01.mbc.0000256021.16453.de	22	34	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64100	10.1371/journal.pone.0064100	http://dx.doi.org/10.1371/journal.pone.0064100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696866	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900079
J	Matjila, M; Millar, R; van der Spuy, Z; Katz, A				Matjila, Mushi; Millar, Robert; van der Spuy, Zephne; Katz, Arieh			The Differential Expression of Kiss1, MMP9 and Angiogenic Regulators across the Feto-Maternal Interface of Healthy Human Pregnancies: Implications for Trophoblast Invasion and Vessel Development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; HUMAN PLACENTA; IN-VITRO; HYPERTENSIVE DISORDERS; SOLUBLE RECEPTOR; VEGF EXPRESSION; HYPOXIA; KISSPEPTIN-10	Genes involved in invasion of trophoblast cells and angiogenesis are crucial in determining pregnancy outcome. We therefore studied expression profiles of these genes in both fetal and maternal tissues to enhance our understanding of feto-maternal dialogue. We investigated the expression of genes involved in trophoblast invasion, namely Kiss1, Kiss1 Receptor (Kiss1R) and MMP9 as well as the expression of angiogenic ligands Vascular Endothelial Growth Factor-A (VEGF-A) and Prokineticin-1 (PROK1) and their respective receptors (VEGFR1, VEGFR2 and PROK1R) across the feto-maternal interface of healthy human pregnancies. The placenta, placental bed and decidua parietalis were sampled at elective caesarean delivery. Real-time RT-PCR was used to investigate transcription, while immunohistochemistry and western blot analyses were utilized to study protein expression. We found that the expression of Kiss1 (p<0.001), Kiss1R (p<0.05) and MMP9 (p<0.01) were higher in the placenta compared to the placental bed and decidua parietalis. In contrast, the expression of VEGF-A was highest in the placental bed (p<0.001). While VEGFR1 expression was highest in the placenta (p<0.01), the expression of VEGFR2 was highest in the placental bed (p<0.001). Lastly, both PROK1 (p<0.001) and its receptor PROK1R (p<0.001) had highest expression in the placenta. Genes associated with trophoblast invasion were highly expressed in the placenta which could suggest that the influence on invasion capacity may largely be exercised at the fetal level. Furthermore, our findings on angiogenic gene expression profiles suggest that angiogenesis may be regulated by two distinct pathways with the PROK1/PROK1R system specifically mediating angiogenesis in the fetus and VEGFA/VEGFR2 ligand-receptor pair predominantly mediating maternal angiogenesis.	[Matjila, Mushi; Millar, Robert; Katz, Arieh] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Biochem, MRC UCT Receptor Biol Unit, ZA-7700 Rondebosch, South Africa; [Matjila, Mushi; van der Spuy, Zephne] Groote Schuur Hosp, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa; [Millar, Robert] Univ Pretoria, Mammalian Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Cape Town; University of Cape Town; University of Pretoria; University of Edinburgh	Matjila, M (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Biochem, MRC UCT Receptor Biol Unit, ZA-7700 Rondebosch, South Africa.	mushi.matjila@uct.ac.za; arieh.katz@uct.ac.za	van der Spuy, Zephne./ABD-5006-2021	van der Spuy, Zephne./0000-0001-7548-7819; Millar, Robert P/0000-0003-3606-2708	Tshukululu Trust (Discovery Foundation Academic Fellowship Award); Netcare's Physician Trust (Hamilton Naki Scholarship); MRC (SA); Harry Crossley Clinical Research Scholarship; Nina Lipshitz Fund; UCT's Emerging Researcher Project; MRC (UK)	Tshukululu Trust (Discovery Foundation Academic Fellowship Award); Netcare's Physician Trust (Hamilton Naki Scholarship); MRC (SA)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harry Crossley Clinical Research Scholarship; Nina Lipshitz Fund; UCT's Emerging Researcher Project; MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Tshukululu Trust (Discovery Foundation Academic Fellowship Award) and Netcare's Physician Trust (Hamilton Naki Scholarship) who funded the time required for benchwork training of MM. The MRC (SA), Harry Crossley Clinical Research Scholarship, the Nina Lipshitz Fund and UCT's Emerging Researcher Project who funded various aspects of the study. The MRC (SA) in particular supported the work done at UCT (University of Cape Town) while the MRC (UK) supported the studies at the MRC Human Reproductive Sciences Unit (HRSU) in Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akercan F, 2008, ARCH GYNECOL OBSTET, V277, P109, DOI 10.1007/s00404-007-0430-5; Aplin JD, 2000, J CLIN INVEST, V105, P559, DOI 10.1172/JCI9512; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; Chung JY, 2004, J CLIN ENDOCR METAB, V89, P2484, DOI 10.1210/jc.2003-031580; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Gurel D, 2003, PATHOL RES PRACT, V199, P803, DOI 10.1078/0344-0338-00499; Hoffmann P, 2006, ENDOCRINOLOGY, V147, P1675, DOI 10.1210/en.2005-0912; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lee KH, 2009, ONCOL RES, V18, P107, DOI 10.3727/096504009789954591; Li Na, 2009, Chinese Journal of Pathology, V38, P263, DOI 10.3760/cma.j.issn.0529-5807.2009.04.010; Liang Shan, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P109; Lu JY, 2011, J REPROD DEVELOP, V57, P84, DOI 10.1262/jrd.10-008K; Moodley J, 2011, CARDIOVASC J AFR, V22, P31, DOI CVJ-21.026; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nelson DM, 1999, AM J OBSTET GYNECOL, V180, P896, DOI 10.1016/S0002-9378(99)70661-7; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Padavala S, 2006, J SOC GYNECOL INVEST, V13, P40, DOI 10.1016/j.jsgi.2005.09.010; PARK JE, 1994, J BIOL CHEM, V269, P25646; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; Qiao Chong, 2005, Zhonghua Yi Xue Za Zhi, V85, P839; Ramaesh T, 2010, ENDOCRINOLOGY, V151, P5927, DOI 10.1210/en.2010-0565; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; Sgambati E, 2004, BJOG-INT J OBSTET GY, V111, P564, DOI 10.1111/j.1471-0528.2004.00143.x; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Shiraishi S, 1996, PLACENTA, V17, P111, DOI 10.1016/S0143-4004(96)80004-X; Vuorela P, 2000, MOL HUM REPROD, V6, P276, DOI 10.1093/molehr/6.3.276; World Medical Association Declaration of Helsinki, B WHO, V79, P373; Xu P, 2000, BIOL REPROD, V62, P988, DOI 10.1095/biolreprod62.4.988; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang H, 2011, REPROD BIOL, V11, P99, DOI 10.1016/S1642-431X(12)60048-5; Zhang Hong, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P509; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387	46	20	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63574	10.1371/journal.pone.0063574	http://dx.doi.org/10.1371/journal.pone.0063574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696833	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900041
J	Sato, T; Tran, TH; Peck, AR; Girondo, MA; Liu, C; Goodman, CR; Neilson, LM; Freydin, B; Chervoneva, I; Hyslop, T; Kovatich, AJ; Hooke, JA; Shriver, CD; Fuchs, SY; Rui, H				Sato, T.; Tran, T. H.; Peck, A. R.; Girondo, M. A.; Liu, C.; Goodman, C. R.; Neilson, L. M.; Freydin, B.; Chervoneva, I.; Hyslop, T.; Kovatich, A. J.; Hooke, J. A.; Shriver, C. D.; Fuchs, S. Y.; Rui, H.			Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression	ONCOGENE			English	Article						breast cancer; CK5; BCL6; prolactin; progesterone; Stat5	SIGNAL TRANSDUCER; STEM-CELLS; TRANSCRIPTION FACTOR; GENE-REGULATION; IN-VITRO; STAT5; ACTIVATOR; HORMONE; RECEPTORS; PHOSPHORYLATION	Prolactin controls the development and function of milk-producing breast epithelia but also supports growth and differentiation of breast cancer, especially luminal subtypes. A principal signaling mediator of prolactin, Stat5, promotes cellular differentiation of breast cancer cells in vitro, and loss of active Stat5 in tumors is associated with antiestrogen therapy failure in patients. In luminal breast cancer, progesterone induces a cytokeratin-5 (CK5)-positive basal cell-like population. This population possesses characteristics of tumor stem cells including quiescence, therapy resistance and tumor-initiating capacity. Here we report that prolactin counteracts induction of the CK5-positive population by the synthetic progestin (Pg) R5020 in luminal breast cancer cells both in vitro and in vivo. CK5-positive cells were chemoresistant as determined by fourfold reduced rate of apoptosis following docetaxel exposure. Pg-induction of CK5 was preceded by marked upregulation of BCL6, an oncogene and transcriptional repressor critical for the maintenance of leukemia-initiating cells. Knockdown of BCL6 prevented induction of CK5-positive cell population by Pg. Prolactin suppressed Pg-induced BCL6 through Jak2-Stat5 but not Erk-or Akt-dependent pathways. In premenopausal but not postmenopausal patients with hormone receptor-positive breast cancer, tumor protein levels of CK5 correlated positively with BCL6, and high BCL6 or CK5-protein levels were associated with unfavorable clinical outcome. Suppression of Pg-induction of CK5positive cells represents a novel prodifferentiation effect of prolactin in breast cancer. The present progress may have direct implications for breast cancer progression and therapy as loss of prolactin receptor-Stat5 signaling occurs frequently and BCL6 inhibitors currently being evaluated for lymphomas may have value for breast cancer.	[Sato, T.; Tran, T. H.; Peck, A. R.; Girondo, M. A.; Liu, C.; Goodman, C. R.; Neilson, L. M.; Rui, H.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Freydin, B.; Chervoneva, I.; Hyslop, T.] Thomas Jefferson Univ, Div Biostat, Philadelphia, PA 19107 USA; [Kovatich, A. J.] MDR Global Syst LLC, Windber, PA USA; [Hooke, J. A.; Shriver, C. D.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Fuchs, S. Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Fuchs, S. Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; Walter Reed National Military Medical Center; University of Pennsylvania; University of Pennsylvania	Rui, H (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, 233S 10th St,BLSB 330, Philadelphia, PA 19107 USA.	hallgeir.rui@jefferson.edu		Goodman, Chelain/0000-0001-9083-3652; Kovatich, Albert/0000-0002-5169-4087	Komen for the Cure Promise Grant [KG091116]; NIH [CA101841, CA118740, CA092900]; NCI [1P30CA56036]; Commonwealth University Research Enhancement Program; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA101841, R01CA092900, R01CA142425, P30CA056036, R01CA118740] Funding Source: NIH RePORTER	Komen for the Cure Promise Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth University Research Enhancement Program; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Komen for the Cure Promise Grant KG091116 (HR, TH, JAH, AJK, CDS, TS, ARP, MAG, CL, BF, and IC), NIH grants CA101841 (HR), CA118740 (HR), CA092900 (SYF) and NCI Support Grant 1P30CA56036 to the Kimmel Cancer Center. The Project is funded, in part, under a Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health (HR). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The views expressed in this article are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense or US Government.	Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Dagvadorj A, 2008, CLIN CANCER RES, V14, P1317, DOI 10.1158/1078-0432.CCR-07-2024; Daniel AR, 2009, P NATL ACAD SCI USA, V106, P14287, DOI 10.1073/pnas.0905118106; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Johnson KJ, 2010, AM J PATHOL, V177, P2971, DOI 10.2353/ajpath.2010.090399; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kabos P, 2011, BREAST CANCER RES TR, V128, P45, DOI 10.1007/s10549-010-1078-6; Keen JC, 2003, CANCER-AM CANCER SOC, V97, P825, DOI 10.1002/cncr.11126; Knutson TP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3211; Lee HJ, 2012, MOL CELL ENDOCRINOL, V357, P101, DOI 10.1016/j.mce.2011.09.020; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2012, ONCOLOGY-NY, V26, P688; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Logarajah S, 2003, ONCOGENE, V22, P5572, DOI 10.1038/sj.onc.1206689; Neilson LM, 2007, MOL ENDOCRINOL, V21, P2218, DOI 10.1210/me.2007-0173; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Peck AR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3328; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sartorius CA, 2005, CANCER RES, V65, P9779, DOI 10.1158/0008-5472.CAN-05-0505; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Sultan AS, 2008, CANCER SCI, V99, P272, DOI 10.1111/j.1349-7006.2007.00685.x; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Tran TH, 2010, CANCER RES, V70, P1711, DOI 10.1158/0008-5472.CAN-09-2314; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095	47	34	36	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2215	2224		10.1038/onc.2013.172	http://dx.doi.org/10.1038/onc.2013.172			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23708665	Green Accepted			2022-12-25	WOS:000334996000007
J	Argemi, X; Hansmann, Y; Christmann, D; Lefebvre, S; Jaulhac, B; Jehl, F				Argemi, Xavier; Hansmann, Yves; Christmann, Daniel; Lefebvre, Sophie; Jaulhac, Benoit; Jehl, Francois			In Vitro Activity of Daptomycin against Enterococcus faecalis under Various Conditions of Growth-Phases, Inoculum and pH	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTIVE ENDOCARDITIS; PSEUDOMONAS-AERUGINOSA; PHARMACODYNAMIC MODEL; COMBINATION; VANCOMYCIN; RIFAMPIN; AMINOGLYCOSIDES; EFFICACY; THERAPY	Enterococcus faecalis (E. faecalis) has become a major leading cause of nosocomial endocarditis. Treatment of such infections remains problematic and new therapeutic options are needed. Nine E. faecalis strains were tested: six obtained from patients presenting endocarditis, one with isolated bacteremia, and two reference strains. Antibiotics included daptomycin, alone or in combination, linezolid, tigecycline, rifampicin, gentamicin, teicoplanin, ceftriaxone and amoxicillin. Time-kill studies included colony counts at 1, 4 and 24 h of incubation. Significant bactericidal activity was defined as a decrease of >= 3log(10)CFU/ml after 24 h of incubation. Antibiotics were tested at a low (10(6) CFU/ml) and high (10(9) CFU/ml) inoculum, against exponential- and stationary-phase bacteria. We also performed time kill studies of chemically growth arrested E. faecalis. Various pH conditions were used during the tests. In exponential growth phase and with a low inoculum, daptomycin alone at 60 mu g/ml and the combination amoxicillin-gentamicin both achieved a 4-log(10) reduction in one hour on all strains. In exponential growth phase with a high inoculum, daptomycin alone was bactericidal at a concentration of 120 mu g/ml. All the combinations tested with this drug were indifferent. In stationary phase with a high inoculum daptomycin remained bactericidal but exhibited a pH dependent activity and slower kill rates. All combinations that did not include daptomycin were not bactericidal in conditions of high inoculum, whatever the growth phase. The results indicate that daptomycin is the only antibiotic that may be able of overcoming the effects of growth phase and high inoculum.	[Argemi, Xavier; Hansmann, Yves; Christmann, Daniel] Strasbourg Univ Hosp, Dept Infect Dis, Strasbourg, France; [Lefebvre, Sophie; Jaulhac, Benoit; Jehl, Francois] Univ Strasbourg, Inst Bacteriol, Fac Med, Strasbourg, France; [Lefebvre, Sophie; Jaulhac, Benoit; Jehl, Francois] Strasbourg Univ Hosp, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Argemi, X (corresponding author), Strasbourg Univ Hosp, Dept Infect Dis, Strasbourg, France.	xavier_argemi@hotmail.com						Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Benvenuto M, 2006, ANTIMICROB AGENTS CH, V50, P3245, DOI 10.1128/AAC.00247-06; BLASER J, 1988, J ANTIMICROB CHEMOTH, V22, P15, DOI 10.1093/jac/22.1.15; Cafini E, 2007, J ANTIMICROB CHEMOTH, V59, P1185, DOI 10.1093/jac/dkm078; Canton R, 2010, J ANTIMICROB CHEMOTH, V65, P1126, DOI 10.1093/jac/dkq087; Cha R, 2004, J ANTIMICROB CHEMOTH, V54, P259, DOI 10.1093/jac/dkh259; Chakraborty A, 2009, J ANTIMICROB CHEMOTH, V64, P151, DOI 10.1093/jac/dkp155; CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V28, P331, DOI 10.1128/AAC.28.2.331; Euba G, 2009, ANTIMICROB AGENTS CH, V53, P4305, DOI 10.1128/AAC.00444-09; EUCAST, 2011, CLIN BREAKP; Falagas ME, 2006, J ANTIMICROB CHEMOTH, V57, P639, DOI 10.1093/jac/dkl044; FDA, 2010, FDA APPR DRUG PROD; Figueroa DA, 2009, CLIN INFECT DIS, V49, P177, DOI 10.1086/600039; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Gavalda J, 1999, ANTIMICROB AGENTS CH, V43, P639, DOI 10.1128/AAC.43.3.639; Gavalda Joan, 2007, Ann Intern Med, V146, P574; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hall AD, 2012, ANTIMICROB AGENTS CH, V56, P3174, DOI 10.1128/AAC.06439-11; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jevitt LA, 2003, MICROB DRUG RESIST, V9, P389, DOI 10.1089/107662903322762833; John AK, 2009, ANTIMICROB AGENTS CH, V53, P2719, DOI 10.1128/AAC.00047-09; Kelesidis T, 2011, CLIN INFECT DIS, V52, P228, DOI 10.1093/cid/ciq113; LAMP KC, 1992, ANTIMICROB AGENTS CH, V36, P2709, DOI 10.1128/AAC.36.12.2709; LaPlante KL, 2009, ANTIMICROB AGENTS CH, V53, P3880, DOI 10.1128/AAC.00134-09; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; MAINARDI JL, 1995, ANTIMICROB AGENTS CH, V39, P1984, DOI 10.1128/AAC.39.9.1984; Marty FM, 2006, J CLIN MICROBIOL, V44, P595, DOI 10.1128/JCM.44.2.595-597.2006; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Maurin M, 2001, ANTIMICROB AGENTS CH, V45, P2977, DOI 10.1128/AAC.45.11.2977-2986.2001; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Quinn B, 2007, J ANTIMICROB CHEMOTH, V60, P1380, DOI 10.1093/jac/dkm375; Rice DAK, 2009, ARCH ORTHOP TRAUM SU, V129, P1495, DOI 10.1007/s00402-008-0772-x; Richter SS, 2003, J ANTIMICROB CHEMOTH, V52, P123, DOI 10.1093/jac/dkg288; Sabol K, 2005, ANTIMICROB AGENTS CH, V49, P1664, DOI 10.1128/AAC.49.4.1664-1665.2005; Saleh-Mghir A, 2011, ANTIMICROB AGENTS CH, V55, P4589, DOI 10.1128/AAC.00675-11; Steenbergen JN, 2009, J ANTIMICROB CHEMOTH, V64, P1130, DOI 10.1093/jac/dkp346; Vouillamoz J, 2006, J ANTIMICROB CHEMOTH, V58, P1208, DOI 10.1093/jac/dkl406; Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64218	10.1371/journal.pone.0064218	http://dx.doi.org/10.1371/journal.pone.0064218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700464	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200124
J	Peintner, U; Schwarz, S; Mesic, A; Moreau, PA; Moreno, G; Saviuc, P				Peintner, Ursula; Schwarz, Stefanie; Mesic, Armin; Moreau, Pierre-Arthur; Moreno, Gabriel; Saviuc, Philippe			Mycophilic or Mycophobic? Legislation and Guidelines on Wild Mushroom Commerce Reveal Different Consumption Behaviour in European Countries	PLOS ONE			English	Article							FUNGI	Mycophiles forage for and pick vast quantities of a wide variety of wild mushroom species. As a result, mushroom intoxications are comparatively frequent in such countries with mycophiles. Thus, national governments are forced to release guidelines or enact legislation in order to ensure the safe commerce of wild mushrooms due to food safety concerns. It is in these guidelines and laws that one can observe whether a country is indeed mycophobic or mycophilic. Furthermore, these laws and guidelines provide valuable information on mushroom preferences and on the consumption habits of each country. As such we were interested in the questions as to whether mushroom consumption behaviour was different within Europe, and if it was possible to discover the typical or distinctive culinary preferences of Slavic or Romanic speaking people, people from special geographical regions or from different zones. This work is based on the analysis of edible mushroom lists available in specific guidelines or legislation related to the consumption and commerce of mushrooms in 27 European countries. The overall diversity of edible mushrooms authorised to be commercialised in Europe is very high. However, only 60 out of a total 268 fungal species can be cultivated. This highlights the importance of guidelines or legislation for the safe commerce of wild mushrooms. The species richness and composition of the mushrooms listed for commerce is very heterogeneous within Europe. The consumption behaviour is not only language-family-related, but is strongly influenced by geographical location and neighbouring countries. Indicator species were detected for different European regions; most of them are widespread fungi, and thus prove culture-specific preferences for these mushrooms. Our results highlight tradition and external input such as trade and cultural exchange as strong factors shaping mushroom consumption behaviour.	[Peintner, Ursula; Schwarz, Stefanie] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria; [Mesic, Armin] Rudjer Boskovic Inst, Zagreb, Croatia; [Moreau, Pierre-Arthur] Commiss Environm Soc Mycol France, Paris, France; [Moreau, Pierre-Arthur] Univ Lille Nord France, UFR Pharm, Lab Sci Vgetales & Fongiques, Lille, France; [Moreno, Gabriel] Univ Alcala, Dept Ciencias Vida Bot, Madrid, Spain; [Saviuc, Philippe] Michallon Hosp, Toxicovigilance Ctr, Grenoble, France	University of Innsbruck; Rudjer Boskovic Institute; Universite de Lille - ISITE; Universite de Lille; Universidad de Alcala; CHU Grenoble Alpes	Peintner, U (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	Ursula.Peintner@uibk.ac.at	Mešić, Armin/AAJ-1858-2020; MOREAU, PIERRE-ARTHUR/AAP-8248-2020; Moreno, Gabriel/K-8537-2017; Peintner, Ursula/AAY-9138-2020	Mešić, Armin/0000-0002-4479-600X; Peintner, Ursula/0000-0001-5388-4266; Moreau, Pierre-Arthur/0000-0003-4783-3643	University Innsbruck	University Innsbruck	The work was supported by University Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista-Ferreira JL, 2012, COMMUNICATION; Benjamin DR, 1995, MUSHROOMS POISONS PA; Cetto B, 1966, PARLAMO FUNGHI; De Roman M, 2006, ECON BOT, V60, P284, DOI 10.1663/0013-0001(2006)60[284:TMOLDI]2.0.CO;2; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ferri G, 1934, VIE ITALIA RIV MENSI, P757; Garibay-Orijel R, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-4; Hawksworth DL, 1996, NATURE, V379, P503, DOI 10.1038/379503a0; Jensvoll L, 2012, MUSHROOMS TRADED FOO, V2012; Jensvoll L, 2012, MUSHROOMS TRADED FOO, V2012; Koz'yakov SM, 1984, MUSHROOMS EDIBLE CON, P204; McCune B., 2011, PC ORD MULTIVARIATE; Mitchell D., 2010, BC Journal of Ecosystems and Management, V11, P27; Moreno G, 2002, MONDO FUNGHI, V59-60, P575; PEREZMORENO J, 1995, FOOD ADDIT CONTAM, V12, P355, DOI 10.1080/02652039509374315; Pilz D, 2002, FOREST ECOL MANAG, V155, P3, DOI 10.1016/S0378-1127(01)00543-6; Saviuc P, 2009, VENTE CHAMPIGNONS SA; Saviuc Philippe, 2006, Toxicol Rev, V25, P199, DOI 10.2165/00139709-200625030-00004; SCHEURLEN C, 1994, Z GASTROENTEROL, V32, P399; Schwabe, 2003, GIFTPILZE PILZGIFTE; Sitta N, 1997, FUNGHI EPIGEI SPONTA; Sitta N, 2008, ECON BOT, V62, P307, DOI 10.1007/s12231-008-9037-4; SONNENBICHLER J, 1994, BIOL CHEM H-S, V375, P71, DOI 10.1515/bchm3.1994.375.1.71; Steidle H, 1930, N-S ARCH EX PATH PH, V151, P232, DOI 10.1007/BF01862466; Vetelainen M, 2008, STATE PLANT GENETIC, P14; Wang X, 2012, SPECTROCHIM ACTA A, V91, P285, DOI 10.1016/j.saa.2012.02.004; Watling Roy, 1997, Mycologist, V11, P101; Zent EL, 2004, ECON BOT, V58, P214, DOI 10.1663/0013-0001(2004)058[0214:KAUOFB]2.0.CO;2; Zivanovic S, 2006, IDENTIFICATION OPPOR	29	56	59	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63926	10.1371/journal.pone.0063926	http://dx.doi.org/10.1371/journal.pone.0063926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704957	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200088
J	Smith, JAM				Smith, Joseph A. M.			The Role of Phragmites australis in Mediating Inland Salt Marsh Migration in a Mid-Atlantic Estuary	PLOS ONE			English	Article							SEA-LEVEL RISE; DELAWARE BAY; SEDIMENT ACCRETION; TIDAL MARSH; COMMON REED; WEST-COAST; INVASION; FOREST; CONNECTICUT; VEGETATION	Many sea level rise adaptation plans emphasize the protection of adjacent uplands to allow for inland salt marsh migration, but little empirical information exists on this process. Using aerial photos from 1930 and 2006 of Delaware Estuary coastal habitats in New Jersey, I documented the rate of coastal forest retreat and the rate of inland salt marsh migration across 101.1 km of undeveloped salt marsh and forest ecotone. Over this time, the amount of forest edge at this ecotone nearly doubled. In addition, the average amount of forest retreat was 141.2 m while the amount of salt marsh inland migration was 41.9 m. Variation in forest retreat within the study area was influenced by variation in slope. The lag between the amount of forest retreat and salt marsh migration is accounted for by the presence of Phragmites australis which occupies the forest and salt marsh ecotone. Phragmites expands from this edge into forest dieback areas, and the ability of salt marsh to move inland and displace Phragmites is likely influenced by salinity at both an estuary-wide scale and at the scale of local subwatersheds. Inland movement of salt marsh is lowest at lower salinity areas further away from the mouth of the estuary and closer to local heads of tide. These results allow for better prediction of salt marsh migration in estuarine landscapes and provide guidance for adaptation planners seeking to prioritize those places with the highest likelihood of inland salt marsh migration in the near-term.	Nature Conservancy, Delmont, NJ USA	Nature Conservancy	Smith, JAM (corresponding author), Nature Conservancy, Delmont, NJ USA.	smithjam@gmail.com						Able KW, 2003, ESTUARIES, V26, P40, DOI 10.1007/BF02691692; Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; ADAMS DA, 1963, ECOLOGY, V44, P445, DOI 10.2307/1932523; Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Barlow PM, 2010, HYDROGEOL J, V18, P247, DOI 10.1007/s10040-009-0514-3; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Bird E., 2008, COASTAL GEOMORPHOLOG; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Boorman Laurence A., 1999, Mangroves and Salt Marshes, V3, P227; BRINSON MM, 1995, ESTUARIES, V18, P648, DOI 10.2307/1352383; Chambers RM, 1998, AQUAT BOT, V62, P161, DOI 10.1016/S0304-3770(98)00095-3; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; CIVCO DL, 1986, ENVIRON MANAGE, V10, P229, DOI 10.1007/BF01867361; Dahl TE, 2011, STATUS TRENDS WETLAN; Dahl TE, 2006, FISH WILDLIFE SERVIC, V112, P112; Desantis LRG, 2007, GLOBAL CHANGE BIOL, V13, P2349, DOI 10.1111/j.1365-2486.2007.01440.x; Doody J. Pat, 2004, Journal of Coastal Conservation, V10, P129, DOI 10.1007/BF02818949; Engelhart SE, 2009, GEOLOGY, V37, P1115, DOI 10.1130/G30360A.1; FLETCHER CH, 1993, GEOLOGY, V21, P121, DOI 10.1130/0091-7613(1993)021<0121:SLRAAT>2.3.CO;2; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Goodman JE, 2007, MAR GEOL, V242, P109, DOI 10.1016/j.margeo.2006.09.017; Hussein AH, 2009, SOIL SCI SOC AM J, V73, P185, DOI 10.2136/sssaj2006.0436; KEARNEY MS, 1994, J COASTAL RES, V10, P1010; Kitchell W., 1857, GEOLOGY COUNTY CAPE; Lissner J, 1997, AQUAT BOT, V55, P247, DOI 10.1016/S0304-3770(96)01085-6; Lopez JA, 2009, J COASTAL RES, P186, DOI 10.2112/SI54-020.1; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; MEYERSON AL, 1972, MAR GEOL, V12, P335, DOI 10.1016/0025-3227(72)90033-3; Middleton BA, 2013, ECOL ENG, V54, P183, DOI 10.1016/j.ecoleng.2013.01.025; Minchinton TE, 2003, ECOL APPL, V13, P1400, DOI 10.1890/02-5136; Nagler P, 2005, ENVIRON MONIT ASSESS, V109, P255, DOI 10.1007/s10661-005-6285-y; Niering W., 1977, CONNECTICULT ARBORET, V22; Nikitina DL, 2000, MAR GEOL, V171, P7, DOI 10.1016/S0025-3227(00)00104-3; NYDICK KR, 1995, MAR GEOL, V124, P137, DOI 10.1016/0025-3227(95)00037-Y; Orson R. A., 1999, Biological Invasions, V1, P149, DOI 10.1023/A:1010047731369; Padeletti A, 2008, DELAWARE ESTURARY BE; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Philipp KR, 2005, ECOL ENG, V25, P275, DOI 10.1016/j.ecoleng.2005.04.008; PHILLIPS JD, 1986, ANN ASSOC AM GEOGR, V76, P50, DOI 10.1111/j.1467-8306.1986.tb00103.x; RAUZON MJ, 2002, TURNING TIDE ERADICA, P240; Rooth J. E., 2003, Estuaries, V26, P475, DOI 10.1007/BF02823724; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Snyder D., 2004, OVERVIEW NONINDIGENO; St Amand Lisa A, 1991, BC ENV AFF L REV, V19, P1; Stephenson W, 2008, COAST COAST 2008 AUS, P90; Stone W, 1910, PLANTS SO NEW JERSEY; The Nature Conservancy NOAA National Ocean Service Center, 2011, MARSH MOV MAN GUID U; Thieler ER, 2005, US GEOLOGICAL SURVEY; Tong CF, 2013, ECOL ENG, V51, P151, DOI 10.1016/j.ecoleng.2012.12.010; Townend I, 2002, PHILOS T R SOC A, V360, P1477, DOI 10.1098/rsta.2002.1011; van de Plassche O., 1991, J COASTAL RES, V11, P159; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; WESTERVELT K, 2006, GUIDE NATURAL COMMUN; Whitney MM, 2006, J PHYS OCEANOGR, V36, P3, DOI 10.1175/JPO2805.1; Williams K, 1998, AM J BOT, V85, P1745, DOI 10.2307/2446509; Williams K, 1999, ECOLOGY, V80, P2045, DOI 10.1890/0012-9658(1999)080[2045:SLRACF]2.0.CO;2; Wilson CA, 2008, ESTUAR COAST SHELF S, V80, P483, DOI 10.1016/j.ecss.2008.09.004	64	67	67	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65091	10.1371/journal.pone.0065091	http://dx.doi.org/10.1371/journal.pone.0065091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705031	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200186
J	Suo, LN; Sun, XY; Jiang, WJ				Suo, Linna; Sun, Xiangyang; Jiang, Weijie			Effect of Pretreatment on Biomass Residue Structure and the Application of Pyrolysed and Composted Biomass Residues in Soilless Culture	PLOS ONE			English	Article							ANTHURIUM-ANDREANUM LIND.; MUNICIPAL SOLID-WASTE; GROWING MEDIA; GROWTH; PEAT; SUBSTITUTE; PLANTS; COIR	The changes in the structural characteristics of biomass residues during pyrolysis and composting were investigated. The biomass residues particles were prepared by pyrolysing at temperatures ranging from 350 to 400. For soilless production of the ornamental plant Anthurium andraeanum, pure sphagnum peat moss (P) has traditionally been used as the growing medium. This use of P must be reduced, however, because P is an expensive and nonrenewable resource. The current study investigated the use of biomass residues as substitutes for P in A. andraeanum production. Plants were grown for 15 months in 10 soilless media that contained different proportions of pyrolysed corn cobs (PC), composted corn cobs (C), pyrolysed garden wastes (PG), and P. Although the media altered the plant nutrient content, A. andraeanum growth, development, and yield were similar with media consisting of 50% P+50% PC, 50% P+35% PC+15% PG, and 100% P. This finding indicates that, when pyrolysed, organic wastes, which are otherwise an environmental problem, can be used to reduce the requirement for peat in the soilless culture of A. andraeanum.	[Suo, Linna; Sun, Xiangyang] Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China; [Suo, Linna; Jiang, Weijie] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Beijing Forestry University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China.	sunxy1965@126.com; jiangweijie@caas.cn			Key Projects of the Beijing Municipal Science and Technology Committee of China [D09040903780801]	Key Projects of the Beijing Municipal Science and Technology Committee of China	This study was supported by the Key Projects of the Beijing Municipal Science and Technology Committee of China (Grant No. D09040903780801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2002, BIORESOURCE TECHNOL, V82, P241, DOI 10.1016/S0960-8524(01)00189-4; Abad M, 2001, BIORESOURCE TECHNOL, V77, P197, DOI 10.1016/S0960-8524(00)00152-8; [Anonymous], 2002, CULTIVATION GUIDE AN, P140; Aydogan A, 2011, ATMOS ENVIRON, V45, P2675, DOI 10.1016/j.atmosenv.2011.02.062; Benito M, 2005, BIORESOURCE TECHNOL, V96, P597, DOI 10.1016/j.biortech.2004.06.006; BRADY NC, 1996, NATURE PROPERTIES SO, P495; Caballero R, 2009, SCI HORTIC-AMSTERDAM, V122, P244, DOI 10.1016/j.scienta.2009.05.010; Chang KH, 2010, SCI HORTIC-AMSTERDAM, V125, P434, DOI 10.1016/j.scienta.2010.04.011; Chen G, 2011, USE ORGANIC AGR WAST, P13; Du GuoDong, 2007, Journal of Shenyang Agricultural University, V38, P40; Dufour L, 2005, SCI HORTIC-AMSTERDAM, V105, P269, DOI 10.1016/j.scienta.2005.01.022; Dufour L, 2003, SCI HORTIC-AMSTERDAM, V98, P25, DOI 10.1016/S0304-4238(02)00196-6; Garcia-Gomez A, 2002, BIORESOURCE TECHNOL, V83, P81, DOI 10.1016/S0960-8524(01)00211-5; Granberry DM, 2001, BIOCYCLE, V42, P60; Guo S. R, 2003, SOILLESS CULTURE; Hargreaves JC, 2008, AGR ECOSYST ENVIRON, V123, P1, DOI 10.1016/j.agee.2007.07.004; HIGAKI T, 1992, HORTSCIENCE, V27, P909, DOI 10.21273/HORTSCI.27.8.909; Ingelmo F, 1998, BIORESOURCE TECHNOL, V63, P123, DOI 10.1016/S0960-8524(97)00105-3; Ioannidou OA, 2010, CHEMOSPHERE, V80, P1328, DOI 10.1016/j.chemosphere.2010.06.044; JIMENEZ EI, 1993, PLANT SOIL, V148, P115, DOI 10.1007/BF02185391; Kahn BA, 2005, COMPOST SCI UTIL, V13, P175; Laws N, 1996, RAP MARKET INFORM B, P11; Leboda R, 2005, J COLLOID INTERF SCI, V284, P39, DOI 10.1016/j.jcis.2004.09.052; Mamo M, 1999, J ENVIRON QUAL, V28, P1074, DOI 10.2134/jeq1999.00472425002800040003x; Marianthi T, 2006, BIORESOURCE TECHNOL, V97, P1631, DOI 10.1016/j.biortech.2005.07.027; Mills HA, 1998, J PLANT NUTR, V21, P199, DOI 10.1080/01904169809365394; Offord CA, 1998, AUST J EXP AGR, V38, P879, DOI 10.1071/EA98059; PRYCE S, 1991, Professional Horticulture, V5, P101; Sharon M, 2007, INT J HYDROGEN ENERG, V32, P4238, DOI 10.1016/j.ijhydene.2007.05.038; SIMINIS HI, 1990, BIOCYCLE, V31, P60; Sonneveld C., 1993, Acta Horticulturae, P61; Suo LN, 2011, J HORTIC SCI BIOTECH, V86, P366, DOI 10.1080/14620316.2011.11512775; Wilson SB, 2001, HORTTECHNOLOGY, V11, P31, DOI 10.21273/HORTTECH.11.1.31; [谢耀坚 XIE Yao-jian], 2008, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V28, P62; [No title captured]	35	2	2	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64550	10.1371/journal.pone.0064550	http://dx.doi.org/10.1371/journal.pone.0064550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704995	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200149
J	Yuan, J; Yu, M; Cao, AL; Chen, X; Zhang, LH; Song, Y; Cheng, X; Zhou, ZH; Wang, M; Guo, HP; Du, R; Liao, YH				Yuan, Jing; Yu, Miao; Cao, Ai-Lin; Chen, Xiao; Zhang, Li-Hua; Song, You; Cheng, Xiang; Zhou, Zi-Hua; Wang, Min; Guo, He-Ping; Du, Rong; Liao, Yu-Hua			A Novel Epitope from CD22 Regulates Th1 and Th17 Cell Function in Systemic Lupus Erythematosus	PLOS ONE			English	Article							T-CELLS; B-CELLS; IN-VIVO; RECEPTOR CD22; ANTIBODY; EPRATUZUMAB; ENGAGEMENT; DISEASE; MICE	The published antibodies (Abs) against CD22 on B cells including Epratuzumab could inhibit B cell activation mainly through binding to C2-set Ig domain of CD22, but they are rarely reported to modulate the pathogenic CD4(+) T cell function in systemic lupus erythematosus (SLE). Recently, it was proved that the extracellular amino-terminal V-set Ig domain of CD22 might mediate the interaction of B and T cells, but for now the exact effect of this domain on CD4(+) T cell biology have not been identified. Thus, in this study, we screened out a peptide termed B2285 from this V-set Ig domain, developed the novel specific anti-B2285 Abs in rabbits, and investigated their effects in MRL/lpr mice with spontaneous SLE. The results showed that anti-B2285 Abs could ameliorate the disease severity obviously in spontaneous SLE mice with the decreased differentiations of Th1 and Th17 cells and no changes of Th2 and Treg cells. In co-cultured B cells and CD4(+) T cells, this specific anti-CD22 Abs was observed to inhibit the anti-dsDNA Abs production, CD4(+) T cells proliferation, the protein levels of T-bet and ROR gamma t, and the mRNA levels of TNF-alpha, IFN-gamma, IL-6 and IL-17 in CD4(+) T cells. Moreover, the expression of CD45RO on CD4(+) T cells could be also apparently diminished by this novel Abs. The data suggested that anti-B2285 Abs could slow SLE progression significantly by regulating Th1 and Th17 cells function via B-T cell interaction and the cytokine network regulation. The treatment against V-set Ig domain of CD22 would be a valuable therapeutic method for SLE and other autoimmune diseases.	[Yuan, Jing; Yu, Miao; Cao, Ai-Lin; Chen, Xiao; Zhang, Li-Hua; Cheng, Xiang; Zhou, Zi-Hua; Wang, Min; Guo, He-Ping; Liao, Yu-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Lab Cardiovasc Immunol,Inst Cardiol, Wuhan 430074, Peoples R China; [Song, You; Du, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Rheumatol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Du, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Rheumatol, Wuhan 430074, Peoples R China.	dudurong2003@yahoo.com.cn; liaoyh27@126.com	饭, 蔡/AAI-5850-2020; Song, You/GRS-3401-2022		National Natural Science Foundation of China [81100158]; National Basic Research Program of China (973 Program) [2007CB512000, 2007CB512005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (81100158) and National Basic Research Program of China (973 Program, 2007CB512000, 2007CB512005) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1992, P NATL ACAD SCI USA, V89, P10242, DOI 10.1073/pnas.89.21.10242; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Carnahan J, 2003, CLIN CANCER RES, V9, p3982S; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; Haas KM, 2006, J IMMUNOL, V177, P3063, DOI 10.4049/jimmunol.177.5.3063; Heimberger AB, 2003, CLIN CANCER RES, V9, P4247; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; LAW CL, 1995, J IMMUNOL, V155, P3368; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Robak E, 2009, CURR DRUG TARGETS, V10, P26, DOI 10.2174/138945009787122833; SCHULTE RJ, 1992, SCIENCE, V258, P1001, DOI 10.1126/science.1279802; SGROI D, 1995, P NATL ACAD SCI USA, V92, P4026, DOI 10.1073/pnas.92.9.4026; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; Tuscano J, 1996, BLOOD, V87, P4723, DOI 10.1182/blood.V87.11.4723.bloodjournal87114723; Yuan J, 2010, INT IMMUNOPHARMACOL, V10, P272, DOI 10.1016/j.intimp.2009.11.010; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	22	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64572	10.1371/journal.pone.0064572	http://dx.doi.org/10.1371/journal.pone.0064572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704998	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200152
J	Garrido-Sanchez, L; Escote, X; Coin-Araguez, L; Fernandez-Garcia, JC; El Bekay, R; Vendrell, J; Garcia-Fuentes, E; Tinahones, FJ				Garrido-Sanchez, Lourdes; Escote, Xavier; Coin-Aragueez, Leticia; Carlos Fernandez-Garcia, Jose; El Bekay, Rajaa; Vendrell, Joan; Garcia-Fuentes, Eduardo; Tinahones, Francisco J.			Munc18c in Adipose Tissue Is Downregulated in Obesity and Is Associated with Insulin	PLOS ONE			English	Article							STIMULATED GLUT4 TRANSLOCATION; LIVER-X RECEPTORS; TYROSINE PHOSPHORYLATION; 3T3-L1 ADIPOCYTES; MEMBRANE-FUSION; FATTY-ACID; BINDING; GLUCOSE; SYNTAXIN-4; RESISTANCE	Objective: Munc18c is associated with glucose metabolism and could play a relevant role in obesity. However, little is known about the regulation of Munc18c expression. We analyzed Munc18c gene expression in human visceral (VAT) and subcutaneous (SAT) adipose tissue and its relationship with obesity and insulin. Materials and Methods: We evaluated 70 subjects distributed in 12 non-obese lean subjects, 23 overweight subjects, 12 obese subjects and 23 nondiabetic morbidly obese patients (11 with low insulin resistance and 12 with high insulin resistance). Results: The lean, overweight and obese persons had a greater Munc18c gene expression in adipose tissue than the morbidly obese patients (p<0.001). VAT Munc18c gene expression was predicted by the body mass index (B = -0.001, p = 0.009). In SAT, no associations were found by different multiple regression analysis models. SAT Munc18c gene expression was the main determinant of the improvement in the HOMA-IR index 15 days after bariatric surgery (B = -2148.4, p = 0.038). SAT explant cultures showed that insulin produced a significant down-regulation of Munc18c gene expression (p = 0.048). This decrease was also obtained when explants were incubated with liver X receptor alpha (LXR alpha) agonist, either without (p = 0.038) or with insulin (p = 0.050). However, Munc18c gene expression was not affected when explants were incubated with insulin plus a sterol regulatory element-binding protein-1c (SREBP-1c) inhibitor (p = 0.504). Conclusions: Munc18c gene expression in human adipose tissue is down-regulated in morbid obesity. Insulin may have an effect on the Munc18c expression, probably through LXR alpha and SREBP-1c.	[Garrido-Sanchez, Lourdes; Escote, Xavier; Vendrell, Joan] Univ Rovira & Virgili, Endocrinol & Diabet Unit, Joan Univ Hosp 23, IISPV, Tarragona, Spain; [Garrido-Sanchez, Lourdes; Escote, Xavier; Vendrell, Joan] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Tarragona, Spain; [Coin-Aragueez, Leticia; Carlos Fernandez-Garcia, Jose; El Bekay, Rajaa; Tinahones, Francisco J.] Hosp Clin Virgen de la Victoria, Serv Endocrinol & Nutr, Malaga, Spain; [Coin-Aragueez, Leticia; El Bekay, Rajaa; Garcia-Fuentes, Eduardo; Tinahones, Francisco J.] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Malaga, Spain; [El Bekay, Rajaa; Garcia-Fuentes, Eduardo] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [Garcia-Fuentes, Eduardo] Hosp Reg Univ Carlos Haya, Serv Endocrinol & Nutr, Malaga, Spain	Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Hospital Virgen de la Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; Hospital Carlos Haya	Garcia-Fuentes, E (corresponding author), Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBEROBN, Malaga, Spain.	edugf1@gmail.com; fjtinahones@hotmail.com	Vendrell, Joan j/V-4034-2018; Bekay, Rajaa El/AAZ-3959-2020; Escoté, Xavier/AAH-2973-2020; Escote, Xavier/AAC-6335-2019; El Bekay, RAJAA/AGN-6069-2022; Tinahones, Francisco José/AAB-2882-2020; Garcia-Fuentes, Eduardo/AAB-1607-2020; Escote, Xavier/G-3440-2015; Fernandez-Garcia, Jose Carlos/B-5312-2013	Vendrell, Joan j/0000-0002-6994-6115; Escote, Xavier/0000-0003-1172-3995; El Bekay, RAJAA/0000-0003-3332-3431; Escote, Xavier/0000-0003-1172-3995; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; Tinahones, Francisco J/0000-0001-6871-4403; GARCIA-FUENTES, EDUARDO/0000-0002-3491-2724	Instituto de Salud Carlos III [CP04/00133, PS09/01060, PS09/00997]; Servicio Andaluz de Salud [PI0255/2007]; Programa Juan de la Cierva [JCI-2009-04086]; Research Stabilization Program of the Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria (FIS) "Miguel Servet" [CP07/00288]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Servicio Andaluz de Salud; Programa Juan de la Cierva; Research Stabilization Program of the Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria (FIS) "Miguel Servet"	This work was supported in part by grants from Instituto de Salud Carlos III [CP04/00133, PS09/01060, PS09/00997], Servicio Andaluz de Salud [PI0255/2007]. L. Garrido-Sanchez is supported by a fellowship from the Programa Juan de la Cierva [JCI-2009-04086]. E. Garcia-Fuentes is supported by the Research Stabilization Program of the Instituto de Salud Carlos III (ISCIII). R. El Bekay is supported by fellowships from the Fondo de Investigacion Sanitaria (FIS) "Miguel Servet" [CP07/00288]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-19; Bergman BC, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-21; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; CZECH MP, 1995, ANNU REV NUTR, V15, P441, DOI 10.1146/annurev.nu.15.070195.002301; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Garcia-Fuentes E, 2010, OBESITY, V18, P952, DOI 10.1038/oby.2009.314; Garcia-Serrano S, 2011, MOL MED, V17, P273, DOI 10.2119/molmed.2010.00078; Garrido-Sanchez L, 2012, SURG OBES RELAT DIS, V8, P145, DOI 10.1016/j.soard.2011.03.010; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; Harte AL, 2003, DIABETES OBES METAB, V5, P462, DOI 10.1046/j.1463-1326.2003.00274.x; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; Hugo ER, 2008, J CLIN ENDOCR METAB, V93, P4006, DOI 10.1210/jc.2008-1172; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; James David E., 1994, Trends in Cell Biology, V4, P120, DOI 10.1016/0962-8924(94)90066-3; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; Kuipers I, 2010, EUR J HEART FAIL, V12, P1042, DOI 10.1093/eurjhf/hfq109; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Macaulay SL, 2002, FEBS LETT, V528, P154, DOI 10.1016/S0014-5793(02)03279-9; Moutier E, 2012, J BIOL CHEM, V287, P26328, DOI 10.1074/jbc.M112.361790; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Pehkonen P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-50; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Phan TQ, 2010, MOL CELL ENDOCRINOL, V319, P88, DOI 10.1016/j.mce.2009.11.010; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schmelzle K, 2006, DIABETES, V55, P2171, DOI 10.2337/db06-0148; Spurlin BA, 2004, DIABETES, V53, P2223, DOI 10.2337/diabetes.53.9.2223; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Tinahones FJ, 2009, OBESITY, V17, P240, DOI 10.1038/oby.2008.536; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Yu X, 2011, EMBO J, V30, P3754, DOI 10.1038/emboj.2011.277	49	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63937	10.1371/journal.pone.0063937	http://dx.doi.org/10.1371/journal.pone.0063937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700440	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400037
J	Prata, N; Bell, S; Weidert, K; Gessessew, A				Prata, Ndola; Bell, Suzanne; Weidert, Karen; Gessessew, Amanuel			Potential for Cost Recovery: Women's Willingness to Pay for Injectable Contraceptives in Tigray, Ethiopia	PLOS ONE			English	Article							REPRODUCTIVE HEALTH-SERVICES; QUALITY; DEMAND; PRICE; CARE	Objective: To investigate factors associated with a woman's willingness to pay (WTP) for injectable contraceptives in Tigray, Ethiopia. Methods: We used a multistage random sampling design to generate a representative sample of reproductive age women from the Central Zone of Tigray, Ethiopia to participate in a survey (N = 1490). Respondents who had ever used injectable contraceptives or who were interested in using them were asked whether they would be willing to pay, and if so, how much. Logistic regression odds ratios (ORs) with 95% confidence intervals (CIs) and p-values were used to assess which factors were associated with WTP in our final model. Findings: On average, respondents were willing to pay 11 birr ($0.65 USD) per injection. Being married, completing any amount of education, having given birth, and having visited a health facility in the last 12 months (whether received family planning information or not) were associated with statistically significantly increased odds of WTP. Having initiated sexual activity and having 1-2 children (compared to 0 children) were associated with statistically significantly decreased odds of WTP. We also detected two significant interactions. Among women who prefer injectable contraceptives, their odds of WTP for injectable contraceptives vary across length of time they have used them. And among women who work for pay, their odds of WTP for injectable contraceptives vary by whether they agree with their husband/partner about the ideal number of children. Conclusion: In a sector that continually struggles with funding, cost recovery for contraceptive services may offer a means of improved financial sustainability while increasing rural access to injectable contraceptives. Results indicate there are opportunities for cost recovery in rural Tigray, Ethiopia and highlight factors that could be leveraged to increase WTP for injectable contraceptives.	[Prata, Ndola; Bell, Suzanne; Weidert, Karen] Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA; [Gessessew, Amanuel] Mekele Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Mekele, Ethiopia	University of California System; University of California Berkeley; Mekelle University	Prata, N (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Bixby Ctr Populat Hlth & Sustainabil, Berkeley, CA 94720 USA.	ndola@berkeley.edu			Joffe Charitable Trust	Joffe Charitable Trust	Funding was received from the Joffe Charitable Trust for a project to increase access to injectable contraceptives at community level in Ethiopia. Data from this study comes from the baseline survey for the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; AKIN JS, 1995, SOC SCI MED, V40, P1527, DOI 10.1016/0277-9536(94)00274-W; Alderman H, 1996, WORLD BANK RES OBSER, V11, P3, DOI 10.1093/wbro/11.1.3; Babalola S, 2008, STUD FAMILY PLANN, V39, P211, DOI 10.1111/j.1728-4465.2008.168.x; Beekle AT, 2006, INT NURS REV, V53, P269, DOI 10.1111/j.1466-7657.2006.00492.x; Bratt JH, 2002, HEALTH POLICY PLANN, V17, P281, DOI 10.1093/heapol/17.3.281; Bratt JH, 2010, HEALTH POLICY, V95, P159, DOI 10.1016/j.healthpol.2009.11.015; Central Statistical Agency (CSA) ORC Macro, 2000, ETH DEM HLTH SURV; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV DH; Central Statistical Agency Ethiopia ORC Macro, 2006, 2005 ETH DEM HLTH SU; Central Statistical Agency ICF International, 2012, ETH DEMPGR HLTH SURV; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Daniel EE, 2008, INT FAM PLAN PERSPEC, V34, P189, DOI [10.1363/3418908, 10.1363/ifpp.34.189.08]; Foreit JR, 2003, HEALTH POLICY, V63, P37, DOI 10.1016/S0168-8510(02)00039-8; Gebresilassie FE, 2011, J HEALTH POPUL NUTR, V29, P200, DOI 10.3329/jhpn.v29i3.7867; Gertler P., 1990, WILLINGNESS PAY MED; HASSAN EO, 1994, CONTRACEPTION, V49, P469, DOI 10.1016/0010-7824(94)90005-1; Hennink M., 2005, African Population Studies, V20, P125; Janowitz B, 1999, ISSUES FINANCING FAM; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; Korra A., 1997, Ethiopian Journal of Health Development, V11, P17; Lande R, 2006, POPULATION REPORTS K; LEWIS MA, 1986, STUD FAMILY PLANN, V17, P126, DOI 10.2307/1967030; Matheny G, 2004, INT FAM PLAN PERSPEC, V30, P134, DOI 10.1363/3013404; Routh S, 2000, J HEALTH POPUL NUTR, V18, P69; Schuler SR, 2002, HEALTH POLICY PLANN, V17, P273, DOI 10.1093/heapol/17.3.273; SCHWARTZ JB, 1988, WORLD BANK ECON REV, V2, P49, DOI 10.1093/wber/2.1.49; Smith WA, 2010, SOCIAL MARKETING DEV, V319; StataCorp, 2009, STAT SURV DAT REF MA; UC Berkeley Bixby Center for Population Health and Sustainability Mekelle University, 2011, COMM BAS DISTR DMPA; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64032	10.1371/journal.pone.0064032	http://dx.doi.org/10.1371/journal.pone.0064032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158JQ	23700451	gold, Green Published, Green Submitted			2022-12-25	WOS:000319966400043
J	Trauer, U; Hilker, M				Trauer, Ute; Hilker, Monika			Parental Legacy in Insects: Variation of Transgenerational Immune Priming during Offspring Development	PLOS ONE			English	Article							MANDUCA-SEXTA; TENEBRIO-MOLITOR; MEALWORM BEETLE; INNATE IMMUNITY; EVOLUTIONARY ECOLOGY; INFECTION; RESPONSES; PARASITE; DEFENSE; PROPHENOLOXIDASE	In insects, a parental immune challenge can prepare and enhance offspring immune activity. Previous studies of such transgenerational immune priming (TGIP) mainly focused on a single offspring life stage. However, different developmental stages may be exposed to different risks and show different susceptibility to parental immune priming. Here we addressed the question (i) whether TGIP effects on the immunity of Manduca sexta offspring vary among the different developmental offspring stages. We differentiated between unchallenged and immunochallenged offspring; for the latter type of offspring, we further investigated (ii) whether TGIP has an impact on the time that enhanced immune levels persist after offspring immune challenge. Finally, we determined (iii) whether TGIP effects on offspring performance depend on the offspring stage. Our results show that TGIP effects on phenoloxidase (PO) activity, but not on antibacterial activity, vary among unchallenged offspring stages. In contrast, TGIP effects on PO and antibacterial activity did not vary among immunochallenged offspring stages. The persistence of enhanced immune levels in immunochallenged offspring was dependent on the parental immune state. Antibacterial (but not PO) activity in offspring of immunochallenged parents decreased over five days after pupal immune challenge, whereas no significant change over time was detectable in offspring of control parents. Finally, TGIP effects on the developmental time of unchallenged offspring varied among stages; young larvae of immunochallenged parents developed faster and gained more weight than larvae of control parents. However, offspring females of immunochallenged parents laid fewer eggs than females derived from control parents. These findings suggest that the benefits which the offspring gains from TGIP during juvenile development are paid by the adults with reduced reproductive power. Our study shows that TGIP effects vary among offspring stages and depend on the type of immunity (PO or antibacterial activity) as well as the time past offspring immune challenge.	[Trauer, Ute; Hilker, Monika] Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, Berlin, Germany	Free University of Berlin	Hilker, M (corresponding author), Free Univ Berlin, Inst Biol Appl Zool Anim Ecol, Berlin, Germany.	hilker@zedat.fu-berlin.de			German Research Foundation [Hi 416/18-1]	German Research Foundation(German Research Foundation (DFG))	The German Research Foundation (www.dfg.de, Hi 416/18-1) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Cisarovsky G, 2012, J EVOLUTION BIOL, V25, P1053, DOI 10.1111/j.1420-9101.2012.02507.x; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; Daukste J, 2012, J EVOLUTION BIOL, V25, P1298, DOI 10.1111/j.1420-9101.2012.02516.x; Diamond SE, 2010, OIKOS, V119, P542, DOI 10.1111/j.1600-0706.2009.17242.x; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Freitak D, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-7; Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; Jiang HB, 2008, INSECT SCI, V15, P53, DOI 10.1111/j.1744-7917.2008.00187.x; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KANOST MR, 1988, ARCH INSECT BIOCHEM, V8, P147, DOI 10.1002/arch.940080302; Kingsolver JG, 2012, FUNCT ECOL, V26, P598, DOI 10.1111/j.1365-2435.2012.01972.x; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; LAWSON FRANCIS R., 1959, ANN ENT SOC AMER, V52, P741, DOI 10.1093/aesa/52.6.741; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Little TJ, 2004, TRENDS ECOL EVOL, V19, P58, DOI 10.1016/j.tree.2003.11.011; Mira A, 2002, OIKOS, V97, P387, DOI 10.1034/j.1600-0706.2002.970309.x; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; NIJHOUT MM, 1974, BIOL BULL-US, V146, P377, DOI 10.2307/1540412; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Pham LN, 2008, INSECT IMMUNOLOGY, P97, DOI 10.1016/B978-012373976-6.50007-0; Ragan Emily J., 2009, P34; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Rao XJ, 2010, DEV COMP IMMUNOL, V34, P1119, DOI 10.1016/j.dci.2010.06.007; REINECKE JP, 1980, BIOL BULL-US, V158, P129, DOI 10.2307/1540764; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2009, BIOL LETTERS, V5, P798, DOI 10.1098/rsbl.2009.0458; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Shi ZH, 2010, J INSECT PHYSIOL, V56, P1696, DOI 10.1016/j.jinsphys.2010.06.013; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Sorrentino RP, 2002, BIOTECHNIQUES, V32, P815, DOI 10.2144/02324st08; Srygley RB, 2012, J INSECT PHYSIOL, V58, P342, DOI 10.1016/j.jinsphys.2011.12.005; Thomas AM, 2010, ECOL ENTOMOL, V35, P200, DOI 10.1111/j.1365-2311.2009.01169.x; Tidbury HJ, 2012, P ROY SOC B-BIOL SCI, V279, P4505, DOI 10.1098/rspb.2012.1841; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; Vogelweith F, 2011, FUNCT ECOL, V25, P1241, DOI 10.1111/j.1365-2435.2011.01911.x; Wang ZX, 2011, EXP PARASITOL, V127, P135, DOI 10.1016/j.exppara.2010.07.005; Zanchi C, 2011, J ANIM ECOL, V80, P1174, DOI 10.1111/j.1365-2656.2011.01872.x; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	57	52	54	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63392	10.1371/journal.pone.0063392	http://dx.doi.org/10.1371/journal.pone.0063392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700423	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400021
J	Szade, K; Bukowska-Strakova, K; Nowak, WN; Szade, A; Kachamakova-Trojanowska, N; Zukowska, M; Jozkowicz, A; Dulak, J				Szade, Krzysztof; Bukowska-Strakova, Karolina; Nowak, Witold Norbert; Szade, Agata; Kachamakova-Trojanowska, Neli; Zukowska, Monika; Jozkowicz, Alicja; Dulak, Jozef			Murine Bone Marrow Lin(-)Sca-1(+)CD45(-) Very Small Embryonic-Like (VSEL) Cells Are Heterogeneous Population Lacking Oct-4A Expression	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ADULT TISSUES; COMPETITIVE REPOPULATION; OCT4 EXPRESSION; PLURIPOTENCY; ASSAY; DEFINES; PHOSPHATIDYLSERINE; RECONSTITUTION; IDENTIFICATION	Murine very small embryonic-like (VSEL) cells, defined by the Lin(-)Sca-1(+)CD45(-) phenotype and small size, were described as pluripotent cells and proposed to be the most primitive hematopoietic precursors in adult bone marrow. Although their isolation and potential application rely entirely on flow cytometry, the immunophenotype of VSELs has not been extensively characterized. Our aim was to analyze the possible heterogeneity of Lin(-)Sca(+)CD45(-) population and investigate the extent to which VSELs characteristics may overlap with that of hematopoietic stem cells (HSCs) or endothelial progenitor cells (EPCs). The study evidenced that murine Lin(-)Sca-1(+)CD45(-) population was heterogeneous in terms of c-Kit and KDR expression. Accordingly, the c-Kit(+)KDR(-), c-Kit(-)KDR(+), and c-Kit(-)KDR(-) subpopulations could be distinguished, while cKit(+)KDR(+) events were very rare. The c-Kit(+)KDR(-) subset contained almost solely small cells, meeting the size criterion of VSELs, in contrast to relatively bigger c-Kit(-)KDR(+) cells. The c-Kit(-)KDR(-)FSC(low) subset was highly enriched in Annexin V-positive, apoptotic cells, hence omitted from further analysis. Importantly, using qRT-PCR, we evidenced lack of Oct-4A and Oct-4B mRNA expression either in whole adult murine bone marrow or in the sorted of Lin(-)Sca-1(+)CD45(-)FSC(low) population, even by single-cell qRT-PCR. We also found that the Lin(-)Sca-1(+)CD45(-) c-Kit(+) subset did not exhibit hematopoietic potential in a single cell-derived colony in vitro assay, although it comprised the Sca-1(+)c-Kit(+)Lin(-) (SKL) CD34(-)CD45(-)CD105(+) cells, expressing particular HSC markers. Co-culture of Lin(-)Sca-1(+)CD45(-)FSC(low) with OP9 cells did not induce hematopoietic potential. Further investigation revealed that SKL CD45(-)CD105(+) subset consisted of early apoptotic cells with fragmented chromatin, and could be contaminated with nuclei expelled from erythroblasts. Concluding, murine bone marrow Lin(-)Sca1(+)CD45(-)FSC(low) cells are heterogeneous population, which do not express the pluripotency marker Oct-4A. Despite expression of some hematopoietic markers by a Lin(-)Sca-1(+)CD45(-)c-Kit(+)KDR(-) subset of VSELs, they do not display hematopoietic potential in a clonogenic assay and are enriched in early apoptotic cells.	[Szade, Krzysztof; Bukowska-Strakova, Karolina; Nowak, Witold Norbert; Szade, Agata; Kachamakova-Trojanowska, Neli; Zukowska, Monika; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland; [Szade, Krzysztof; Bukowska-Strakova, Karolina; Nowak, Witold Norbert; Szade, Agata; Kachamakova-Trojanowska, Neli] Jagiellonian Univ, Jagiellonian Ctr Expt Therapeut, Krakow, Poland	Jagiellonian University; Jagiellonian University	Jozkowicz, A (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland.	alicja.jozkowicz@uj.edu.pl; jozef.dulak@uj.edu.pl	Szade, Krzysztof/AIF-3657-2022; Bukowska-Strakova, Karolina/HGF-0752-2022; Szade, Agata/E-7328-2018; Kachamakova-Trojanowska, Neli/K-3776-2019; Szade, Krzysztof/AAW-5483-2020	Bukowska-Strakova, Karolina/0000-0001-9181-439X; Szade, Agata/0000-0002-0575-4659; Nowak, Witold/0000-0002-1526-3511; Szade, Krzysztof/0000-0002-7227-4276; Kachamakova-Trojanowska, Neli/0000-0002-3226-0726; Zukowska, Monika/0000-0002-2832-2146	European Union [POIG 01.01.02-00-109/09, 01.01.02.069/09, POIG.02.01.00-12-064/08, POIG.02.02.00-014/08]; Foundation for Polish Science; Wellcome Trust Senior Research Fellowship in Biomedical Science	European Union(European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Wellcome Trust Senior Research Fellowship in Biomedical Science(Wellcome Trust)	This work was supported by grants POIG 01.01.02-00-109/09 and 01.01.02.069/09 from the European Union structural funds. K. Szade is the recipient of the Ventures grant from the Foundation for Polish Science. A. Jozkowicz was a recipient of the Wellcome Trust Senior Research Fellowship in Biomedical Science. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is also beneficiary of the structural funds from the European Union (grants POIG.02.01.00-12-064/08; POIG.02.02.00-014/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Chen CZ, 2003, IMMUNITY, V19, P525, DOI 10.1016/S1074-7613(03)00265-6; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; Cui YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030389; Danova-Alt R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034899; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guo CL, 2012, STEM CELL RES, V9, P69, DOI 10.1016/j.scr.2012.04.004; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Heider A, 2012, CYTOM PART A, DOI [10.1002/cyto.a.22229, DOI 10.1002/CYT0.A.22229]; Ivanovic Z, 2012, STEM CELLS DEV, V21, P2561, DOI 10.1089/scd.2012.0058; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2013, DOI 10.3324/haematol.2010.029827; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kotoula V, 2008, STEM CELLS, V26, P290, DOI 10.1634/stemcells.2007-0726; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia M, 2011, LEUKEMIA, V25, P1370, DOI 10.1038/leu.2011.98; Lee JCM, 2004, BLOOD, V103, P1912, DOI 10.1182/blood-2003-03-0928; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; LESLEY J, 1984, CELL IMMUNOL, V83, P14, DOI 10.1016/0008-8749(84)90220-X; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Liu R, 2009, EUR J HAEMATOL, V83, P220, DOI 10.1111/j.1600-0609.2009.01271.x; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; Mizuno N, 2008, J BIOL CHEM, V283, P30997, DOI 10.1074/jbc.M802992200; Moody JL, 2007, STEM CELLS, V25, P2809, DOI 10.1634/stemcells.2006-0602; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ratajczak J, 2011, EXP HEMATOL, V39, P225, DOI 10.1016/j.exphem.2010.10.007; Ratajczak MZ, 2008, STEM CELL REV, V4, P89, DOI 10.1007/s12015-008-9018-0; Ratajczak MZ, 2008, EXP HEMATOL, V36, P742, DOI 10.1016/j.exphem.2008.03.010; Ratajczak MZ, 2011, DIFFERENTIATION, V81, P153, DOI 10.1016/j.diff.2011.01.006; Ratajczak MZ, 2010, AGING-US, V2, P875, DOI 10.18632/aging.100231; Ratajczak MZ, 2009, MICRON, V40, P386, DOI 10.1016/j.micron.2008.09.009; Ryan JM, 2013, STEM CELL REV REP, V9, P408, DOI 10.1007/s12015-011-9336-5; Salomao M, 2010, BLOOD, V116, P267, DOI 10.1182/blood-2010-02-264127; Schmid I, 2007, NAT PROTOC, V2, P187, DOI 10.1038/nprot.2006.458; Shapiro H., 2003, PRACTICAL FLOW CYTOM, P275; Shin DM, 2009, LEUKEMIA, V23, P2042, DOI 10.1038/leu.2009.153; Shin DM, 2012, STEM CELLS DEV, V21, P1639, DOI 10.1089/scd.2011.0389; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Voura EB, 1997, EXP HEMATOL, V25, P1172; Wang X, 2010, STEM CELLS, V28, P885, DOI 10.1002/stem.419; Warthemann R, 2012, MOL HUM REPROD, V18, P605, DOI 10.1093/molehr/gas032; White MG, 2011, J ENDOCRINOL, V211, P169, DOI 10.1530/JOE-11-0123; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zuba-Surma EK, 2009, MECH AGEING DEV, V130, P58, DOI 10.1016/j.mad.2008.02.003; Zuba-Surma EK, 2008, J CELL MOL MED, V12, P292, DOI 10.1111/j.1582-4934.2007.00154.x; Zuba-Surma EK, 2009, ANN NY ACAD SCI, V1176, P205, DOI 10.1111/j.1749-6632.2009.04562.x; Zuba-Surma EK, 2009, CYTOM PART A, V75A, P4, DOI 10.1002/cyto.a.20665; Zuba-Surma EK, 2008, CYTOM PART A, V73A, P1116, DOI 10.1002/cyto.a.20667	62	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63329	10.1371/journal.pone.0063329	http://dx.doi.org/10.1371/journal.pone.0063329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696815	Green Published, gold			2022-12-25	WOS:000319107900035
J	Gholizadeh, S; Sun, NL; De Jaeger, X; Bechard, M; Coolen, L; Laviolette, SR				Gholizadeh, Shervin; Sun, Ninglei; De Jaeger, Xavier; Bechard, Melanie; Coolen, Lique; Laviolette, Steven R.			Early versus Late-Phase Consolidation of Opiate Reward Memories Requires Distinct Molecular and Temporal Mechanisms in the Amygdala-Prefrontal Cortical Pathway	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; NEURONAL PLASTICITY; DOPAMINE TERMINALS; HEROIN-SEEKING; CORTEX; ACTIVATION; RECONSOLIDATION	The consolidation of newly acquired memories involves the temporal transition from a recent, less stable trace to a more permanent consolidated form. Opiates possess potent rewarding effects and produce powerful associative memories. The activation of these memories is associated with opiate abuse relapse phenomena and the persistence of compulsive opiate dependence. However, the neuronal, molecular and temporal mechanisms by which associative opiate reward memories are consolidated are not currently understood. We report that the consolidation of associative opiate reward memories involves a temporal and molecular switch between the basolateral nucleus of the amygdala (BLA) (early consolidation phase) to the medial prefrontal cortex (mPFC) (late consolidation phase). We demonstrate at the molecular, behavioral and neuronal levels that the consolidation of a recently acquired opiate reward memory involves an extracellular signal-related kinase (ERK)-dependent phosphorylation process within the BLA. In contrast, later-stage consolidation of a newly acquired memory is dependent upon a calcium-calmodulin-dependent (CaMKII), ERK-independent, mechanism in the mPFC, over a 12 hr temporal gradient. In addition, using in vivo multi-unit neuronal recordings in the mPFC, we report that protein synthesis within the BLA modulates the consolidation of opiate-reward memory in neuronal mPFC sub-populations, via the same temporal dynamic.	[Gholizadeh, Shervin; Sun, Ninglei; De Jaeger, Xavier; Bechard, Melanie; Coolen, Lique; Laviolette, Steven R.] Univ Western Ontario, Dept Psychiat, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada	Western University (University of Western Ontario)	Laviolette, SR (corresponding author), Univ Western Ontario, Dept Psychiat, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 3K7, Canada.	steven.laviolette@schulich.uwo.ca	Sun, Ninglei/F-5243-2014	Sun, Ninglei/0000-0002-5803-8613; De Jaeger, Xavier/0000-0003-2511-5659; Coolen, Lique/0000-0003-2920-1116	Canadian Institute of Health Research Grant [MOP82797]; Natural Sciences and Engineering Research Council U.S.R.A. Award	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council U.S.R.A. Award	This was supported by the Canadian Institute of Health Research Grant # MOP82797 and an Natural Sciences and Engineering Research Council U.S.R.A. Award to M.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RC, 2006, NEUROSCI LETT, V395, P93, DOI 10.1016/j.neulet.2005.10.057; Alvarez-Jaimes L, 2005, J PHARMACOL EXP THER, V314, P1144, DOI 10.1124/jpet.105.086140; Berhow MT, 1996, J NEUROSCI, V16, P4707; Bishop SF, 2011, CEREB CORTEX, V21, P68, DOI 10.1093/cercor/bhq060; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Carr DB, 2000, J COMP NEUROL, V425, P275, DOI 10.1002/1096-9861(20000918)425:2<275::AID-CNE9>3.0.CO;2-Z; Carr DB, 1999, J NEUROSCI, V19, P11049, DOI 10.1523/JNEUROSCI.19-24-11049.1999; Daglish MRC, 2001, AM J PSYCHIAT, V158, P1680, DOI 10.1176/appi.ajp.158.10.1680; De Jaeger X, 2013, PSYCHOPHARMACOLOGY, V225, P687, DOI 10.1007/s00213-012-2852-4; Floresco SB, 2007, J NEUROSCI, V27, P2045, DOI 10.1523/JNEUROSCI.5474-06.2007; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frenois F, 2005, J NEUROSCI, V25, P1366, DOI 10.1523/JNEUROSCI.3090-04.2005; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Igaz LM, 2006, CELL MOL NEUROBIOL, V26, P989, DOI 10.1007/s10571-006-9116-y; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Lai YT, 2008, NEUROBIOL LEARN MEM, V90, P164, DOI 10.1016/j.nlm.2008.03.006; Langleben DD, 2008, AM J PSYCHIAT, V165, P390, DOI 10.1176/appi.ajp.2007.07010070; Languille S, 2009, EUR J NEUROSCI, V30, P1923, DOI 10.1111/j.1460-9568.2009.06971.x; Laviolette SR, 2005, J NEUROSCI, V25, P6066, DOI 10.1523/JNEUROSCI.1168-05.2005; Laviolette SR, 2004, NAT NEUROSCI, V7, P160, DOI 10.1038/nn1182; Laviolette SR, 2006, J NEUROSCI, V26, P6458, DOI 10.1523/JNEUROSCI.0707-06.2006; Lintas A, 2011, J NEUROSCI, V31, P11172, DOI 10.1523/JNEUROSCI.1781-11.2011; Luo F, 2004, NEUROIMAGE, V22, P1328, DOI 10.1016/j.neuroimage.2004.03.017; Maroun M, 2003, J NEUROSCI, V23, P4406; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Olmstead MC, 1997, BEHAV NEUROSCI, V111, P1324, DOI 10.1037/0735-7044.111.6.1324; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Schafe GE, 2000, J NEUROSCI, V20, P8177; Shalev U, 2003, BEHAV BRAIN RES, V145, P79, DOI 10.1016/S0166-4328(03)00103-7; Sun NL, 2012, PSYCHOPHARMACOLOGY, V222, P645, DOI 10.1007/s00213-012-2665-5; Sun NL, 2011, CEREB CORTEX, V21, P2665, DOI 10.1093/cercor/bhr031; Tan HB, 2010, CEREB CORTEX, V20, P1486, DOI 10.1093/cercor/bhp210; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; Valjent E, 1999, J NEUROSCI, V19, P8685; Wu J, 2006, J NEUROPHYSIOL, V95, P3519, DOI 10.1152/jn.01235.2005; Yim AJ, 2006, BEHAV BRAIN RES, V171, P162, DOI 10.1016/j.bbr.2006.03.031	46	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63612	10.1371/journal.pone.0063612	http://dx.doi.org/10.1371/journal.pone.0063612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696837	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900045
J	Jiao, SH; Chu, Q; Wang, YC; Xie, ZQ; Hou, SY; Liu, AR; Wu, HJ; Liu, L; Geng, FJ; Wang, CY; Qin, CH; Tan, R; Huang, XX; Tan, SX; Wu, M; Xu, XZ; Liu, X; Yu, Y; Zhang, Y				Jiao, Shihui; Chu, Qin; Wang, Yachun; Xie, Zhenquan; Hou, Shiyu; Liu, Airong; Wu, Hongjun; Liu, Lin; Geng, Fanjun; Wang, Congyong; Qin, Chunhua; Tan, Rui; Huang, Xixia; Tan, Shixin; Wu, Meng; Xu, Xianzhou; Liu, Xuan; Yu, Ying; Zhang, Yuan			Identification of the Causative Gene for Simmental Arachnomelia Syndrome Using a Network-Based Disease Gene Prioritization Approach	PLOS ONE			English	Article							CATTLE; ASSOCIATION	Arachnomelia syndrome (AS), mainly found in Brown Swiss and Simmental cattle, is a congenital lethal genetic malformation of the skeletal system. In this study, a network-based disease gene prioritization approach was implemented to rank genes in the previously reported similar to 7 Mb region on chromosome 23 associated with AS in Simmental cattle. The top 6 ranked candidate genes were sequenced in four German Simmental bulls, one known AS-carrier ROMEL and a pooled sample of three known non-carriers (BOSSAG, RIFURT and HIRMER). Two suspicious mutations located in coding regions, a mis-sense mutation c.1303G>A in the bystin-like (BYSL) gene and a 2-bp deletion mutation c.1224_1225delCA in the molybdenum cofactor synthesis step 1 (MOCS1) gene were detected. Bioinformatic analysis revealed that the mutation in MOCS1 was more likely to be the causative mutation. Screening the c.1224_1225delCA site in 383 individuals from 12 cattle breeds/lines, we found that only the bull ROMEL and his 12 confirmed progeny carried the mutation. Thus, our results confirm the conclusion of Buitkamp et al. that the 2-bp deletion mutation c.1224_1225delCA in exon 11 of the MOCS1 gene is causative for AS in Simmental cattle. Furthermore, a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was developed to detect the causative mutation.	[Jiao, Shihui; Wang, Yachun; Liu, Xuan; Yu, Ying; Zhang, Yuan] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim & Breeding, Beijing 100094, Peoples R China; [Chu, Qin] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Xie, Zhenquan; Hou, Shiyu] Anshan Hengli Dairy Farm, Anshan, Liaoning, Peoples R China; [Wu, Hongjun] Hailaer Farm Buro, Xiertala Breeding Farm, Hailaer, Inner Mongolia, Peoples R China; [Liu, Airong] Hailaer Farm Buro, Hailaer, Inner Mongolia, Peoples R China; [Liu, Lin] Beijing Dairy Cattle Ctr, Beijing, Peoples R China; [Geng, Fanjun; Wang, Congyong] Dingyuan Seedstock Bulls Breeding Ltd Co, Zhengzhou, Henan, Peoples R China; [Qin, Chunhua] Ningxia Sygen BioEngn Res Ctr, Ningxia, Peoples R China; [Tan, Rui] Xinjiang Gen Livestock Serv, Urumqi, Xinjiang, Peoples R China; [Huang, Xixia] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Tan, Shixin] Xinjiang Tianshan Anim Husb Bioengn Co Ltd, Urumqi, Xinjiang, Peoples R China; [Wu, Meng; Xu, Xianzhou] Dalian Xuelong Ind Ltd Grp, Dalian, Liaoning, Peoples R China	China Agricultural University; Beijing Academy of Agriculture & Forestry; Xinjiang Agricultural University	Wang, YC (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Agr Anim & Breeding, Beijing 100094, Peoples R China.	wangyachun@cau.edu.cn			National Key Technologies R D Program [2011BAD28B02]; China Agriculture Research System [CARS-37]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Key Technologies R D Program(National Key Technology R&D Program); China Agriculture Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work is supported by the National Key Technologies R & D Program (2011BAD28B02), China Agriculture Research System (CARS-37), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetturo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012742; Bloch-Zupan A, 2011, AM J HUM GENET, V89, P773, DOI 10.1016/j.ajhg.2011.11.002; Buitkamp J, 2009, ANIM GENET, V40, P894, DOI 10.1111/j.1365-2052.2009.01933.x; Buitkamp J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-11; Buitkamp J, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-39; Diribarne M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019281; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Drogemuller C, 2009, MAMM GENOME, V20, P53, DOI 10.1007/s00335-008-9157-2; Hettema JM, 2011, BIOL PSYCHIAT, V70, P888, DOI 10.1016/j.biopsych.2011.07.012; Jiang L, 2012, PHYSIOL GENOMICS, V44, P305, DOI 10.1152/physiolgenomics.00047.2011; Liu X, 2008, POULTRY SCI, V87, P1314, DOI 10.3382/ps.2007-00512; Masoudi-Nejad A, 2012, MOL GENET GENOMICS, V287, P679, DOI 10.1007/s00438-012-0710-z; Mccarthy C, 1998, CHROMAS 1 45; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Rieck G W, 1975, Dtsch Tierarztl Wochenschr, V82, P342; Salunkhe AS, 2011, MOL BIOTECHNOL, V49, P90, DOI 10.1007/s12033-011-9382-x; Seichter D, 2011, ANIM GENET, V42, P544, DOI 10.1111/j.1365-2052.2010.02167.x; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506	19	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64468	10.1371/journal.pone.0064468	http://dx.doi.org/10.1371/journal.pone.0064468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696895	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900098
J	Lin, CH; Soong, K; Fan, TY				Lin, Che-Hung; Soong, Keryea; Fan, Tung-Yung			Hourglass Mechanism with Temperature Compensation in the Diel Periodicity of Planulation of the Coral, Seriatopora hystrix	PLOS ONE			English	Article							LARVAL RELEASE; INTERTIDAL SPONGE; LIGHT; TWILIGHTS; ENTRAINMENT; PATTERNS; CLOCK; MODEL	Brooding corals often exhibit daily planulation peaks in certain phases of lunar months during their reproductive season. The mechanism controlling this diurnal phenomenon, however, remains uncertain. Seriatopora hystrix populations of Southern Taiwan exhibit a highly synchronized planulation rhythm characterized by pre-dawn peak release episodes over a period of 4-6 days per month throughout the year. In this study, controlled light-dark cycles and temperatures were used to study the mechanism of the diel planulation rhythm in the laboratory. Seriatopora hystrix did not release planulae under continuous light or continuous darkness. Thus, the lack of free-run did not support a regulatory mechanism involving an endogenous oscillator. Under some lighting conditions, planula release occurred in two peaks per day. Both peaks always occur under dark phases of various light-dark cycles in the laboratory. The first peak occurred when the dark period just started, which might be stimulated by an abrupt transition between light and darkness. The second, pre-dawn peak consistently occurred 23 hrs after application of light. We concluded that this peak of planula release of S. hystrix was cued by sunrise of the previous day. Temperature treatments at 1uC intervals from 23.5-28.5 degrees C did not change the diel time of planula release. We suggest that the temperature compensation exhibited in the hourglass model of this species may have a common origin as that of the oscillator model of circadian clocks, due to the similar duration (23 h) and period (similar to 24 h) between the two. The timing mechanism of planulation discovered here represents an intermediate stage between the hourglass and the oscillator models.	[Lin, Che-Hung; Soong, Keryea] Natl Sun Yat Sen Univ, Inst Marine Biol, Kaohsiung 80424, Taiwan; [Fan, Tung-Yung] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Fan, Tung-Yung] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolut, Pingtung, Taiwan	National Sun Yat Sen University; National Museum of Marine Biology & Aquarium; National Dong Hwa University	Fan, TY (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.	tyfan@nmmba.gov.tw			National Science Council of the Republic of China [NSC94-2621-B-291-001]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This research was supported by National Science Council of the Republic of China (NSC94-2621-B-291-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO S, 1988, BIOL BULL, V175, P181, DOI 10.2307/1541557; AMANO S, 1986, BIOL BULL, V171, P371, DOI 10.2307/1541679; ASCHOFF J, 1989, ANIM BEHAV, V37, P881, DOI 10.1016/0003-3472(89)90132-2; ASCHOFF J, 1966, ECOLOGY, V47, P657, DOI 10.2307/1933949; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Boulos Z, 1996, J COMP PHYSIOL A, V179, P687, DOI 10.1007/BF00216132; Boulos Z, 2005, J BIOL RHYTHM, V20, P132, DOI 10.1177/0748730404272907; Boulos Z, 2002, J BIOL RHYTHM, V17, P353, DOI 10.1177/074873002129002654; Brady AK, 2009, CORAL REEFS, V28, P677, DOI 10.1007/s00338-009-0498-4; BUNNING E, 1969, PHOTOCHEM PHOTOBIOL, V9, P219, DOI 10.1111/j.1751-1097.1969.tb07286.x; ENGELMANN W, 1978, J COMP PHYSIOL, V127, P229, DOI 10.1007/BF01350113; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Goodbody-Gringley G, 2010, J EXP MAR BIOL ECOL, V389, P70, DOI 10.1016/j.jembe.2010.03.016; Harrigan JF, 1972, PLANULA LARVAE POCIL; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HOBSON ES, 1978, FISH B-NOAA, V76, P133; Holloran M.K., 1986, Hawaii Institute of Marine Biology Technical Report, P161; HUG DH, 1977, BIOCHEMISTRY-US, V16, P3995, DOI 10.1021/bi00637a009; Hurlbut CJ, 1988, HAWAII AM ZOOL, V28, P189; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; JOHNSON KG, 1992, MAR ECOL PROG SER, V87, P265, DOI 10.3354/meps087265; Kao CC, 2010, MAR FRESHW BEHAV PHY, V43, P1, DOI 10.1080/10236240903495320; KOJIS BL, 1981, B MAR SCI, V31, P558; Lee HJ, 1999, CONT SHELF RES, V19, P871, DOI 10.1016/S0278-4343(99)00006-0; Nozais C, 2003, J MAR BIOL ASSOC UK, V83, P1227, DOI 10.1017/S0025315403008555; OLSON RR, 1983, BIOL BULL, V165, P221, DOI 10.2307/1541366; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; RAO KP, 1954, AM NAT, V88, P33, DOI 10.1086/281806; Rensing L, 2001, CHRONOBIOL INT, V18, P329, DOI 10.1081/CBI-100103961; SAUNDERS DS, 1987, J THEOR BIOL, V128, P73, DOI 10.1016/S0022-5193(87)80032-2; Saunders DS, 2002, INSECT CLOCKS; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Villanueva RD, 2008, MAR ECOL PROG SER, V370, P111, DOI 10.3354/meps07659; WATANABE H, 1973, BIOL BULL, V144, P556, DOI 10.2307/1540308	36	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64584	10.1371/journal.pone.0064584	http://dx.doi.org/10.1371/journal.pone.0064584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691251	Green Submitted, Green Published, gold			2022-12-25	WOS:000319052700110
J	Konrad, FM; Neudeck, G; Vollmer, I; Ngamsri, KC; Thiel, M; Reutershan, J				Konrad, Franziska M.; Neudeck, Gianna; Vollmer, Irene; Ngamsri, Kristian C.; Thiel, Manfred; Reutershan, Joerg			Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A(2A) dependent	FASEB JOURNAL			English	Article						neutrophils; migration; oxidative burst; phosphodiesterase inhibitor; PTX	ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; NECROSIS-FACTOR-ALPHA; PHOSPHODIESTERASE INHIBITION; NEUTROPHIL ACTIVATION; DOUBLE-BLIND; SEQUESTRATION; PERMEABILITY; LISOFYLLINE; MIGRATION	Pentoxifylline (PTX) has been shown to exert anti-inflammatory effects in experimental acute lung injury. However, results in humans were controversial. Recent in vitro studies suggested that the adenosine receptor A(2A) may be required for PTX to be effective. Therefore, we studied the association between A(2A) and PTX in a murine model of LPS-induced pulmonary inflammation. PTX treatment (10 mg/kg) reduced cellular influx (by 40%), microvascular permeability (30%), and the release of chemotactic cytokines into the alveolar space (TNF- 60%, IL-6 60%, and CXCL2/3 53%, respectively). These protective effects were abolished completely in A(2A)(-/-) mice and in wild-type mice that had been treated with the selective A(2A) antagonist (1 mg/kg), but effects were not different in mice with altered adenosine levels. In vitro transmigration assays revealed a pivotal role of the endothelium in PTX-mediated PMN migration, with a reduction of 50% (2 mM PTX). This effect was also A(2A) dependent. Further, oxidative burst of human PMNs was A(2A)-dependently reduced by 53% after PTX treatment. In summary, PTX exhibits its anti-inflammatory effects in LPS-induced lung injury through an A(2A)-dependent pathway. These results will help to better understand previous conflicting data on PTX in inflammation and will direct further studies to consider the predominant role of A(2A).Konrad, F. M., Neudeck, G., Vollmer, I., Ngamsri, K. C., Thiel, M., Reutershan, J. Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A(2A) dependent.	[Konrad, Franziska M.; Neudeck, Gianna; Vollmer, Irene; Ngamsri, Kristian C.; Reutershan, Joerg] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Thiel, Manfred] Univ Med Ctr, Dept Anesthesiol, Mannheim, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg	Reutershan, J (corresponding author), Univ Tubingen, Dept Anesthesiol & Intens Care Med, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	joerg.reutershan@uni-tuebingen.de			German Research Foundation [RE 1683/3-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation grant RE 1683/3-1 (to J.R.).	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bursten SL, 1996, CRIT CARE MED, V24, P1129, DOI 10.1097/00003246-199607000-00011; Bursten SL, 1998, J PHARMACOL EXP THER, V284, P337; Cepkova Magda, 2006, J Intensive Care Med, V21, P119, DOI 10.1177/0885066606287045; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Coimbra R, 2004, J TRAUMA, V57, P1157, DOI 10.1097/01.TA.0000151261.28640.F7; Costantini TW, 2010, IMMUNOPHARM IMMUNOT, V32, P82, DOI 10.3109/08923970903183557; de Campos T, 2008, PANCREAS, V37, P42, DOI 10.1097/MPA.0b013e3181612d19; de Oliveira IS, 2008, CLINICS, V63, P77, DOI 10.1590/S1807-59322008000100014; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Ege T, 2004, THORAC CARDIOV SURG, V52, P10, DOI 10.1055/s-2004-815798; El-Lakkany N, 2011, EXP PARASITOL, V129, P152, DOI 10.1016/j.exppara.2011.06.015; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; George CLS, 1999, AM J PHYSIOL-LUNG C, V276, pL776, DOI 10.1152/ajplung.1999.276.5.L776; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Haddad JJ, 2002, J PHARMACOL EXP THER, V300, P559, DOI 10.1124/jpet.300.2.559; HIRSCH S, 1983, IMMUNOGENETICS, V18, P229, DOI 10.1007/BF00952962; Konrad FM, 2012, AM J PHYSIOL-LUNG C, V303, pL425, DOI 10.1152/ajplung.00387.2011; Korhonen K, 2004, PEDIATR RES, V56, P901, DOI 10.1203/01.PDR.0000145256.19073.E4; Kreth S, 2010, SHOCK, V34, P10, DOI 10.1097/SHK.0b013e3181cdc3e2; KUDOH I, 1995, ANESTHESIOLOGY, V82, P531, DOI 10.1097/00000542-199502000-00023; Kudoh I, 2001, CRIT CARE MED, V29, P1621, DOI 10.1097/00003246-200108000-00020; Lall RN, 2006, J AM COLL SURGEONS, V202, P10, DOI 10.1016/j.jamcollsurg.2005.07.018; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mazar J, 2005, ANESTHESIOLOGY, V102, P1174, DOI 10.1097/00000542-200506000-00017; Michetti C, 2003, J SURG RES, V115, P92, DOI 10.1016/S0022-4804(03)00219-1; Miyazaki H, 1999, ANESTHESIOLOGY, V90, P1650, DOI 10.1097/00000542-199906000-00022; MORIUCHI H, 1995, CRIT CARE MED, V23, P357, DOI 10.1097/00003246-199502000-00023; Ngamsri KC, 2010, J IMMUNOL, V185, P4374, DOI 10.4049/jimmunol.1000433; Olson TS, 2002, AM J PHYSIOL-REG I, V282, pR1245, DOI 10.1152/ajpregu.00540.2001; PORTER JM, 1982, AM HEART J, V104, P66, DOI 10.1016/0002-8703(82)90642-1; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2007, J IMMUNOL, V179, P1254, DOI 10.4049/jimmunol.179.2.1254; Reutershan J, 2007, AM J RESP CRIT CARE, V175, P1027, DOI 10.1164/rccm.200612-1822OC; Reyes G, 2011, MOL MEMBR BIOL, V28, P412, DOI 10.3109/09687688.2011.604861; Rhee CK, 2009, CRIT CARE, V13, DOI 10.1186/cc8149; RICE GC, 1994, P NATL ACAD SCI USA, V91, P3857, DOI 10.1073/pnas.91.9.3857; Schick MA, 2012, J PHYSIOL-LONDON, V590, P2693, DOI 10.1113/jphysiol.2012.232116; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Schulte G, 2004, ACTA PHYSIOL SCAND, V182, P133, DOI 10.1111/j.1365-201X.2004.01350.x; Spindler V, 2011, AM J PATHOL, V178, P2424, DOI 10.1016/j.ajpath.2011.01.014; STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364; Wagner R, 2010, AM J PHYSIOL-LUNG C, V299, pL502, DOI 10.1152/ajplung.00083.2010; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WELSH CH, 1988, AM REV RESPIR DIS, V138, P1106, DOI 10.1164/ajrccm/138.5.1106; Wiedemann HP, 2002, CRIT CARE MED, V30, P1; Zeni F, 1996, CRIT CARE MED, V24, P207, DOI 10.1097/00003246-199602000-00005; Zhang J-Y, 2011, PLOS ONE, V6	53	28	28	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3524	3535		10.1096/fj.13-228122	http://dx.doi.org/10.1096/fj.13-228122			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23699177				2022-12-25	WOS:000328840500013
J	Pruss-Ustun, A; Wolf, J; Driscoll, T; Degenhardt, L; Neira, M; Calleja, JMG				Pruess-Ustuen, Annette; Wolf, Jennyfer; Driscoll, Tim; Degenhardt, Louisa; Neira, Maria; Calleja, Jesus Maria Garcia			HIV Due to Female Sex Work: Regional and Global Estimates	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; INJECTION-DRUG USE; YUNNAN-PROVINCE; BRIDGING GROUPS; RISK BEHAVIORS; PREVALENCE; INTERVENTIONS; PREVENTION; TRANSMISSION; DYNAMICS	Introduction: Female sex workers (FSWs) are at high risk of HIV infection. Our objective was to determine the proportion of HIV prevalence in the general female adult population that is attributable to the occupational exposure of female sex work, due to unprotected sexual intercourse. Methods: Population attributable fractions of HIV prevalence due to female sex work were estimated for 2011. A systematic search was conducted to retrieve required input data from available sources. Data gaps of HIV prevalence in FSWs for 2011 were filled using multilevel modeling and multivariate linear regression. The fraction of HIV attributable to female sex work was estimated as the excess HIV burden in FSWs deducting the HIV burden in FSWs due to injecting drug use. Results: An estimated fifteen percent of HIV in the general female adult population is attributable to (unsafe) female sex work. The region with the highest attributable fraction is Sub Saharan Africa, but the burden is also substantial for the Caribbean, Latin America and South and Southeast Asia. We estimate 106,000 deaths from HIV are a result of female sex work globally, 98,000 of which occur in Sub-Saharan Africa. If HIV prevalence in other population groups originating from sexual contact with FSWs had been considered, the overall attributable burden would probably be much larger. Discussion: Female sex work is an important contributor to HIV transmission and the global HIV burden. Effective HIV prevention measures exist and have been successfully targeted at key populations in many settings. These must be scaled up. Conclusion: FSWs suffer from high HIV burden and are a crucial core population for HIV transmission. Surveillance, prevention and treatment of HIV in FSWs should benefit both this often neglected vulnerable group and the general population.	[Pruess-Ustuen, Annette; Wolf, Jennyfer; Neira, Maria] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland; [Driscoll, Tim] Univ Sydney, Sydney Med Sch, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Sch Populat Hlth, Melbourne, Vic, Australia; [Calleja, Jesus Maria Garcia] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	World Health Organization; University of Sydney; University of New South Wales Sydney; University of Melbourne; World Health Organization	Pruss-Ustun, A (corresponding author), WHO, Dept Publ Hlth & Environm, CH-1211 Geneva, Switzerland.	pruessa@who.int	Degenhardt, Louisa J/D-4515-2012	Degenhardt, Louisa J/0000-0002-8513-2218				Aceijas C, 2006, SEX TRANSM INFECT, V82, P344, DOI 10.1136/sti.2005.019471.corr.1; Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Breen C, 2005, DRUG ALCOHOL REV, V24, P353, DOI 10.1080/09595230500263871; Bruckova M, 2006, AM J TROP MED HYG, V75, P1017, DOI 10.4269/ajtmh.2006.75.1017; Burgos JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011413; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Chew L, 1998, PROSTITUTION MIGRATI; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Farias MSD, 2011, INT J INFECT DIS, V15, pE635, DOI 10.1016/j.ijid.2011.05.007; EuroHIV, 2006, HIV AIDS SURV EUR; Fazito E, 2012, SEX TRANSM INFECT, V88, pI24, DOI 10.1136/sextrans-2012-050647; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Gaffey MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022704; Ghys PD, 2001, AIDS, V15, pS33, DOI 10.1097/00002030-200104003-00005; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; Government of Canada Public Health Agency of Canada, INF DIS HIV AIDS REP; Groneberg DA, 2006, LANCET, V368, P840, DOI 10.1016/S0140-6736(06)69324-0; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Hesketh T, 2005, AIDS CARE, V17, P958, DOI 10.1080/09540120500100676; ICF International, 2012, PERC MEN RESP REP SE; International Harm Reduction Program (IHRD) Open Society Institute, 2008, HARM RED DEV 2008 CO; IOM, 2011, INT BIOL BEH SURV SU; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Laga M, 2012, AIDS, V26, P1223, DOI 10.1097/QAD.0b013e32835462b8; Lau JTF, 2008, DRUG ALCOHOL DEPEN, V97, P54, DOI 10.1016/j.drugalcdep.2008.03.024; Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Magnani R, 2010, SEX TRANSM INFECT, V86, P393, DOI 10.1136/sti.2009.038059; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McInnes CW, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-5; Medhi GK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-273; Miller CL, 2011, CAN MED ASSOC J, V183, P1147, DOI 10.1503/cmaj.101257; Monitoring the AIDS epidemic (MAP), 2005, SEX WORK HIV AIDS AS; Monitoring the AIDS pandemic (MAP), 2005, DRUG INJ HIV AIDS AS; National Epidemiology Center Department of Health, 2005, INT HIV BEH SER SURV; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; Ota E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006045.pub3; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Pyett PM, 1997, AIDS CARE, V9, P539, DOI 10.1080/713613193; Ray S, 2001, J URBAN HEALTH, V78, P581, DOI 10.1093/jurban/78.4.581; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Rodriguez CM, 2002, AIDS, V16, pS34, DOI 10.1097/00002030-200212003-00006; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Ross MW, 2012, SCAND J WORK ENV HEA, V38, P105, DOI 10.5271/sjweh.3184; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; TAMPEP International Foundation, 2009, SEX WORK EUR MAPP PR; Toledo CA, 2010, AIDS EDUC PREV, V22, P299, DOI 10.1521/aeap.2010.22.4.299; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2008, UNAIDS FAQS WHO IS B; UNAIDS, 2012, GLOBAL REPORT UNAIDS; UNAIDS, 2011, WORLD AIDS DAY REP 2; UNAIDS, 2012, UNGASS COUNTR REP; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS, 2012, UNAIDS GUID NOT HIV; UNAIDS, 2006, REP GLOB AIDS EP; UNAIDS, 2022, HIV AIDS DAT HUB AS; UNAIDS World Bank, 2010, NEW HIV INF MOD TRAN; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wariki WMV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005272.pub3; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; WHO, 2012, WHO DEF REG GROUP; WHO, 2011, DIS INJ REG EST CAUS; WHO, 2012, METR POP ATTR FRACT; World Health Organization, 2011, PREV HIV SEX WORK SU; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Zhao J, 2011, AIDS BEHAV, V15, P635, DOI 10.1007/s10461-010-9786-9	77	104	105	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63476	10.1371/journal.pone.0063476	http://dx.doi.org/10.1371/journal.pone.0063476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151BM	23717432	Green Published, gold			2022-12-25	WOS:000319435600018
J	Power, ML; Emery, S; Gillings, MR				Power, Michelle L.; Emery, Samantha; Gillings, Michael R.			Into the Wild: Dissemination of Antibiotic Resistance Determinants via a Species Recovery Program	PLOS ONE			English	Article							ESCHERICHIA-COLI; INTEGRONS; GENES; POPULATIONS; SALMONELLA; ELEMENTS; STRAINS; HUMANS; WATER	Management strategies associated with captive breeding of endangered species can establish opportunities for transfer of pathogens and genetic elements between human and animal microbiomes. The class 1 integron is a mobile genetic element associated with clinical antibiotic resistance in gram-negative bacteria. We examined the gut microbiota of endangered brush-tail rock wallabies Petrogale penicillata to determine if they carried class 1 integrons. No integrons were detected in 65 animals from five wild populations. In contrast, class 1 integrons were detected in 48% of fecal samples from captive wallabies. The integrons contained diverse cassette arrays that encoded resistance to streptomycin, spectinomycin, and trimethoprim. Evidence suggested that captive wallabies had acquired typical class 1 integrons on a number of independent occasions, and had done so in the absence of strong selection afforded by antibiotic therapy. Sufficient numbers of bacteria containing diverse class 1 integrons must have been present in the general environment occupied by the wallabies to account for this acquisition. The captive wallabies have now been released, in an attempt to bolster wild populations of the species. Consequently, they can potentially spread resistance integrons into wild wallabies and into new environments. This finding highlights the potential for genes and pathogens from human sources to be acquired during captive breeding and to be unwittingly spread to other populations.	[Power, Michelle L.; Emery, Samantha; Gillings, Michael R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Power, ML (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	michelle.power@mq.edu.au	Gillings, Michael/AAF-5772-2020; Gillings, Michael R/C-6553-2008	Gillings, Michael/0000-0002-4043-4351; Gillings, Michael R/0000-0002-4043-4351; Power, Michelle/0000-0003-3160-4301	Ian Potter foundation; Australian Research Council [LP110200569]	Ian Potter foundation; Australian Research Council(Australian Research Council)	The funding for this work was provided by the Ian Potter foundation and the Australian Research Council LP110200569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow RS, 2008, J APPL MICROBIOL, V104, P651, DOI 10.1111/j.1365-2672.2007.03572.x; Barlow RS, 2009, J APPL MICROBIOL, V107, P540, DOI 10.1111/j.1365-2672.2009.04240.x; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies M, 2008, AUSTR VET J, V54, P507; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; DECC, 2008, REC PLAN BRUSH TAIL; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Frankham R, 2005, ANNU REV GENET, V29, P305; Ghosh S, 2009, APPL MICROBIOL BIOT, V84, P791, DOI 10.1007/s00253-009-2125-2; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; Goncalves A, 2012, LETT APPL MICROBIOL, V54, P73, DOI 10.1111/j.1472-765X.2011.03173.x; Hardwick SA, 2008, FEMS MICROBIOL LETT, V278, P207, DOI 10.1111/j.1574-6968.2007.00992.x; Holmes AJ, 2003, J BACTERIOL, V185, P918, DOI 10.1128/JB.185.3.918-928.2003; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Laroche E, 2009, FEMS MICROBIOL ECOL, V68, P118, DOI 10.1111/j.1574-6941.2009.00655.x; Lunney Daniel, 1997, Australian Mammalogy, V19, P281; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Nawaz M, 2009, FOODBORNE PATHOG DIS, V6, P553, DOI 10.1089/fpd.2008.0204; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Pellegrini C, 2009, J ANTIMICROB CHEMOTH, V63, P901, DOI 10.1093/jac/dkp061; Sato M, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-46; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Sherley M, 2000, ENVIRON MICROBIOL, V2, P620, DOI 10.1046/j.1462-2920.2000.00145.x; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Soderquist Todd, 2011, Australian Mammalogy, V33, P202, DOI 10.1071/AM10053; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Taggart DA, 2008, PETROGALE PENICILLAT; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Zhang XY, 2009, MICROB DRUG RESIST, V15, P223, DOI 10.1089/mdr.2009.0905	38	31	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63017	10.1371/journal.pone.0063017	http://dx.doi.org/10.1371/journal.pone.0063017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717399	Green Published, gold			2022-12-25	WOS:000320362700008
J	Ho, MC; Lee, YH; Jeng, YM; Chen, CN; Chang, KJ; Tsui, H				Ho, Ming-Chih; Lee, Yu-Hsin; Jeng, Yung-Ming; Chen, Chiung-Nien; Chang, King-Jen; Tsui, Po-Hsiang			Relationship between Ultrasound Backscattered Statistics and the Concentration of Fatty Droplets in Livers: An Animal Study	PLOS ONE			English	Article							MACROVESICULAR HEPATIC STEATOSIS; PERFORMANCE EVALUATION; CT; DISEASE; FEASIBILITY; ATTENUATION; DONORS; TISSUE; ADULT; VIVO	Ultrasound grayscale B-mode imaging is the most frequently used modality for examining fatty liver. Different concentrations and arrangements of fatty droplets in the liver may produce different statistical distributions of ultrasound backscatter signals, which may be treated as a useful clue for assessing the stage of fatty liver. To verify this point, we investigate the relationship between changes in backscattered statistics and the concentration of fatty droplets in the liver. Fatty liver was induced in rats fed a methionine-choline-deficient diet. Livers were excised from rats for in vitro ultrasound scanning using a single-element transducer. The envelopes of the acquired raw ultrasound signals were used for the analysis of the backscattered statistics by ultrasound Nakagami parametric imaging, which has been shown as a reliable tool to model the statistical distribution of ultrasound backscatter signals. Histological analyses and the measurements of triglyceride and cholesterol in the rat liver were conducted for comparison with the Nakagami parameter. Results show that the ultrasound Nakagami parameter has an excellent correlation with the concentration of fatty droplets, demonstrating that ultrasound backscatter statistics depend on the degree of fatty liver in rats.	[Ho, Ming-Chih; Lee, Yu-Hsin; Chen, Chiung-Nien; Chang, King-Jen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan; [Ho, Ming-Chih; Lee, Yu-Hsin; Jeng, Yung-Ming; Chen, Chiung-Nien; Chang, King-Jen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Ho, Ming-Chih; Chen, Chiung-Nien; Chang, King-Jen] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 10764, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pathol, Taipei 10764, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung University	Tsui, H (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan.	tsuiph@mail.cgu.edu.tw	Ho, Ming-Chih/AAR-9783-2021; Tsui, Po-Hsiang/AHE-7426-2022	Ho, Ming-Chih/0000-0003-3660-1062; Chang, King jen/0000-0001-9811-3422; JENG, YUNG-MING/0000-0002-3878-4491; CHEN, CHIUNG-NIEN/0000-0003-1192-5220; Tsui, Po-Hsiang/0000-0002-5604-1800	National Science Council (Taiwan) [NSC100-3114-B-002-004]; National Taiwan University Hospital [NTUH. 99-S1377]	National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the National Science Council (Taiwan) under Grant No. NSC100-3114-B-002-004, and National Taiwan University Hospital under Grant No. NTUH. 99-S1377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chen CH, 2008, DIGEST DIS SCI, V53, P1699, DOI 10.1007/s10620-007-0048-2; de Andrade AR, 2008, ANN HEPATOL, V7, P364; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Gaitini D, 2004, ULTRASOUND MED BIOL, V30, P1321, DOI 10.1016/j.ultrasmedbio.2004.08.001; Ghoshal G, 2012, ULTRASOUND MED BIOL, V38, P2238, DOI 10.1016/j.ultrasmedbio.2012.08.010; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Kamel IR, 2001, AM J ROENTGENOL, V176, P193, DOI 10.2214/ajr.176.1.1760193; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kim SH, 2006, RADIOLOGY, V240, P116, DOI 10.1148/radiol.2393042218; Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176; Lu ZF, 1999, ULTRASOUND MED BIOL, V25, P1047, DOI 10.1016/S0301-5629(99)00055-1; Mehta SR, 2008, WORLD J GASTROENTERO, V14, P3476, DOI 10.3748/wjg.14.3476; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; PIEKARSKI J, 1980, RADIOLOGY, V137, P727, DOI 10.1148/radiology.137.3.6934563; Pilleul F, 2005, GASTROEN CLIN BIOL, V29, P1143, DOI 10.1016/S0399-8320(05)82179-7; Po-Hsiang Tsui, 2005, Journal of Medical and Biological Engineering, V25, P45; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Ricci C, 1997, J HEPATOL, V27, P108, DOI 10.1016/S0168-8278(97)80288-7; Shankar PM, 2000, IEEE T ULTRASON FERR, V47, P727, DOI 10.1109/58.842062; Shiga T, 2009, J GASTROENTEROL, V44, P757, DOI 10.1007/s00535-009-0059-1; Tsui PH, 2004, ULTRASOUND MED BIOL, V30, P1345, DOI 10.1016/j.ultrasmedbio.2004.08.009; Tsui PH, 2008, ULTRASONIC IMAGING, V30, P78, DOI 10.1177/016173460803000202; Tsui PH, 2007, PHYS MED BIOL, V52, P6413, DOI 10.1088/0031-9155/52/21/005; Tsui PH, 2007, ULTRASOUND MED BIOL, V33, P608, DOI 10.1016/j.ultrasmedbio.2006.10.005; Tsui PH, 2012, ULTRASONIC IMAGING, V34, P110, DOI 10.1177/016173461203400204; Tsui PH, 2012, MED PHYS, V39, P2369, DOI 10.1118/1.3700235; Tsui PH, 2011, MED PHYS, V38, P2019, DOI 10.1118/1.3562899; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wang B, 2003, ACTA RADIOL, V44, P92; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662	31	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63543	10.1371/journal.pone.0063543	http://dx.doi.org/10.1371/journal.pone.0063543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704917	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200048
J	Sassoli, C; Chellini, F; Pini, A; Tani, A; Nistri, S; Nosi, D; Zecchi-Orlandini, S; Bani, D; Formigli, L				Sassoli, Chiara; Chellini, Flaminia; Pini, Alessandro; Tani, Alessia; Nistri, Silvia; Nosi, Daniele; Zecchi-Orlandini, Sandra; Bani, Daniele; Formigli, Lucia			Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-beta/Smad3 Signaling	PLOS ONE			English	Article							TISSUE INHIBITOR; FIBROSIS; NOTCH; DIFFERENTIATION; EXPRESSION; ACTIVATION; MICE; METALLOPROTEINASES; REGENERATION; INDUCTION	The hormone relaxin (RLX) is produced by the heart and has beneficial actions on the cardiovascular system. We previously demonstrated that RLX stimulates mouse neonatal cardiomyocyte growth, suggesting its involvement in endogenous mechanisms of myocardial histogenesis and regeneration. In the present study, we extended the experimentation by evaluating the effects of RLX on primary cultures of neonatal cardiac stromal cells. RLX inhibited TGF-beta 1-induced fibroblast-myofibroblast transition, as judged by its ability to down-regulate a-smooth muscle actin and type I collagen expression. We also found that the hormone up-regulated metalloprotease (MMP)-2 and MMP-9 expression and downregulated the tissue inhibitor of metalloproteinases (TIMP)-2 in TGF-beta 1-stimulated cells. Interestingly, the effects of RLX on cardiac fibroblasts involved the activation of Notch-1 pathway. Indeed, Notch-1 expression was significantly decreased in TGF-beta 1-stimulatedfibroblasts as compared to the unstimulated controls; this reduction was prevented by the addition of RLX to TGF-b1-stimulated cells. Moreover, pharmacological inhibition of endogenous Notch-1 signaling by N-3,5-difluorophenyl acetyl-L-alanyl-2-phenylglycine-1,1-dimethylethyl ester (DAPT), a c-secretase specific inhibitor, as well as the silencing of Notch-1 ligand, Jagged-1, potentiated TGF-beta 1-induced myofibroblast differentiation and abrogated the inhibitory effects of RLX. Interestingly, RLX and Notch-1 exerted their inhibitory effects by interfering with TGF-beta 1 signaling, since the addition of RLX to TGF-beta 1-stimulated cells caused a significant decrease in Smad3 phosphorylation, a typical downstream event of TGF-beta 1 receptor activation, while the treatment with a prevented this effect. These data suggest that Notch signaling can down-regulate TGF-beta 1/Smad3-induced fibroblast-myofibroblast transition and that RLX could exert its well known anti-fibrotic action through the up-regulation of this pathway. In conclusion, the results of the present study beside supporting the role of RLX in the field of cardiac fibrosis, provide novel experimental evidence on the molecular mechanisms underlying its effects.	[Sassoli, Chiara; Chellini, Flaminia; Pini, Alessandro; Tani, Alessia; Nistri, Silvia; Nosi, Daniele; Zecchi-Orlandini, Sandra; Bani, Daniele; Formigli, Lucia] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy	University of Florence	Formigli, L (corresponding author), Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy.	formigli@unifi.it	SASSOLI, CHIARA/AAC-4023-2019	SASSOLI, CHIARA/0000-0002-1337-0938; Pini, Alessandro/0000-0001-9828-2082	University of Florence; Italian Ministry of University; Research-MIUR-PRIN	University of Florence; Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research-MIUR-PRIN	This work was financially supported by research grants from the University of Florence to C.S., S.Z.O., D.B and L.F. and the Italian Ministry of University and Research-MIUR-PRIN 2008 to S.Z.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bani D, 2011, CURR DRUG SAF, V6, P324, DOI 10.2174/157488611798918719; Bani D, 2009, CURR DRUG SAF, V4, P238, DOI 10.2174/157488609789006967; Barnes BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1501, DOI 10.1152/ajpcell.00217.2009; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Dschietzig T, 2006, PHARMACOL THERAPEUT, V112, P38, DOI 10.1016/j.pharmthera.2006.03.004; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fan YH, 2011, PHYSIOL RES, V60, P739, DOI 10.33549/physiolres.932149; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Formigli L, 2009, J MOL CELL CARDIOL, V47, P335, DOI 10.1016/j.yjmcc.2009.05.008; Groot AJ, 2012, ADV EXP MED BIOL, V727, P15, DOI 10.1007/978-1-4614-0899-4_2; Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kolonin MG, 2012, STEM CELL RES, V8, P312, DOI 10.1016/j.scr.2011.11.005; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Nistri S, 2012, J CELL MOL MED, V16, P507, DOI 10.1111/j.1582-4934.2011.01328.x; Pini A, 2012, AORM ANN RESP MED, V3, P65; Pini A, 2010, J PHARMACOL EXP THER, V335, P589, DOI 10.1124/jpet.110.170977; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Samuel CS, 2007, BIOCHEMISTRY-US, V46, P5374, DOI 10.1021/bi700238h; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2009, ANN NY ACAD SCI, V1160, P294, DOI 10.1111/j.1749-6632.2008.03823.x; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2004, KIDNEY INT, V65, P2054, DOI 10.1111/j.1523-1755.2004.00628.x; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Sassoli C, 2011, J MOL CELL CARDIOL, V51, P399, DOI 10.1016/j.yjmcc.2011.06.004; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Su Y, 2006, J GASTROINTEST SURG, V10, P1230, DOI 10.1016/j.gassur.2006.08.017; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	55	103	106	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63896	10.1371/journal.pone.0063896	http://dx.doi.org/10.1371/journal.pone.0063896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704950	Green Published, gold			2022-12-25	WOS:000319330200081
J	Song, RF; Preston, G; Ichihara, A; Yosypiv, IV				Song, Renfang; Preston, Graeme; Ichihara, Atsuhiro; Yosypiv, Ihor V.			Deletion of the Prorenin Receptor from the Ureteric Bud Causes Renal Hypodysplasia	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; TRANSCRIPTION FACTOR FOXI1; BRANCHING MORPHOGENESIS; TUBULAR-ACIDOSIS; KIDNEY DEVELOPMENT; MAMMALIAN KIDNEY; RENIN; RET; NEPHROGENESIS; ACIDIFICATION	The role of the prorenin receptor (PRR) in the regulation of ureteric bud (UB) branching morphogenesis is unknown. Here, we investigated whether PRR acts specifically in the UB to regulate UB branching, kidney development and function. We demonstrate that embryonic (E) day E13.5 mouse metanephroi, isolated intact E11.5 UBs and cultured UB cells express PRR mRNA. To study its role in UB development, we conditionally ablated PRR in the developing UB (PRRUB-/-) using Hoxb7(Cre) mice. On E12.5, PRRUB-/- mice had decreased UB branching and increased UB cell apoptosis. These defects were associated with decreased expression of Ret, Wnt11, Etv4/Etv5, and reduced phosphorylation of Erk1/2 in the UB. On E18.5, mutants had marked kidney hypoplasia, widespread apoptosis of medullary collecting duct cells and decreased expression of Foxi1, AE1 and H(+-)ATPase alpha 4 mRNA. Ultimately, they developed occasional small cysts in medullary collecting ducts and had decreased nephron number. To test the functional consequences of these alterations, we determined the ability of PRRUB-/- mice to acidify and concentrate the urine on postnatal (P) day P30. PRR UB2/2 mice were polyuric, had lower urine osmolality and a higher urine pH following 48 hours of acidic loading with NH4Cl. Taken together, these data show that PRR present in the UB epithelia performs essential functions during UB branching morphogenesis and collecting duct development via control of Ret/Wnt11 pathway gene expression, UB cell survival, activation of Erk1/2, terminal differentiation and function of collecting duct cells needed for maintaining adequate water and acid-base homeostasis. We propose that mutations in PRR could possibly cause renal hypodysplasia and renal tubular acidosis in humans.	[Song, Renfang; Preston, Graeme; Yosypiv, Ihor V.] Tulane Univ, Sch Med, Dept Pediat, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Ichihara, Atsuhiro] Inst Endocrinol & Hypertent, Dept Med, Tokyo, Japan	Tulane University	Yosypiv, IV (corresponding author), Tulane Univ, Sch Med, Dept Pediat, Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA.	iiosipi@tulane.edu			National Institutes of Health [DK-71699]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from National Institutes of Health Grant DK-71699 (I.V.Y.) www.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Al-Awqati Q, 2011, PHYSIOLOGY, V26, P266, DOI 10.1152/physiol.00008.2011; [Anonymous], 2010, NAPRTCS ANN REP; Barasch J, 1996, AM J PHYSIOL-RENAL, V271, pF50, DOI 10.1152/ajprenal.1996.271.1.F50; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; Buechling T, 2010, CURR BIOL, V20, P1263, DOI 10.1016/j.cub.2010.05.028; Cain JE, 2010, PEDIATR RES, V68, P91, DOI 10.1203/00006450-201011001-00175; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Jain S, 2010, J CLIN INVEST, V120, P778, DOI 10.1172/JCI41619; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Jouret F, 2005, J AM SOC NEPHROL, V16, P3235, DOI 10.1681/ASN.2004110935; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Lin SH, 2002, J CLIN ENDOCR METAB, V87, P2694, DOI 10.1210/jc.87.6.2694; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Miura GI, 2003, TRANSGENIC RES, V12, P131, DOI 10.1023/A:1022118627058; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Riediger F, 2011, J AM SOC NEPHROL, V22, P2193, DOI 10.1681/ASN.2011020200; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Song RF, 2011, MECH DEVELOP, V128, P359, DOI 10.1016/j.mod.2011.07.002; Song RF, 2011, PEDIATR NEPHROL, V26, P353, DOI 10.1007/s00467-010-1629-4; Song RF, 2010, AM J PHYSIOL-RENAL, V298, pF807, DOI 10.1152/ajprenal.00147.2009; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Vidarsson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004471; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Yosypiv IV, 2006, J AM SOC NEPHROL, V17, P1005, DOI 10.1681/ASN.2005080803; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	41	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63835					12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704941				2022-12-25	WOS:000319330200072
J	Tan, DZ; Crabb, WM; Whitman, WB; Tong, L				Tan, Dazhi; Crabb, Warren M.; Whitman, William B.; Tong, Liang			Crystal Structure of DmdD, a Crotonase Superfamily Enzyme That Catalyzes the Hydration and Hydrolysis of Methylthioacryloyl-CoA	PLOS ONE			English	Article							ANGSTROM RESOLUTION; COENZYME-A; ENOYL-COENZYME; THIOL ESTERS; HYDROLASE; ISOMERASE; SOFTWARE	Dimethyl-sulphoniopropionate (DMSP) is produced in abundance by marine phytoplankton, and the catabolism of this compound is an important source of carbon and reduced sulfur for marine bacteria and other organisms. The enzyme DmdD catalyzes the last step in the methanethiol (MeSH) pathway of DMSP catabolism. DmdD is a member of the crotonase superfamily of enzymes, and it catalyzes both the hydration and the hydrolysis of methylthioacryloyl-CoA (MTA-CoA), converting it to acetaldehyde, CO2, MeSH, and CoA. We report here the crystal structure of Ruegeria pomeroyi DmdD free enzyme at 1.5 angstrom resolution and the structures of the E121A mutant in complex with MTA-CoA and 3-methylmercaptopropionate-CoA (MMPA-CoA) at 1.8 angstrom resolution. DmdD is a hexamer, composed of a dimer of trimers where the three monomers of each trimer are related by a crystallographic 3-fold axis. The overall structure of this hexamer is similar to those of canonical crotonases. However, the C-terminal loops of DmdD in one of the trimers assume a different conformation and contribute to CoA binding in the active site of a neighboring monomer of the trimer, while these loops in the second trimer are disordered. MTA-CoA is bound deep in the active site in the first trimer, but shows a 1.5 angstrom shift in its position in the second trimer. MMPA-CoA has a similar binding mode to MTA-CoA in the first trimer. MMPA-CoA cannot be hydrated and is only hydrolyzed slowly by DmdD. Replacement of the sulfur atom in MMPA-CoA with a methylene group abolishes hydrolysis, suggesting that the unique property of the substrate is a major determinant of the hydrolysis activity of DmdD.	[Tan, Dazhi; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Crabb, Warren M.; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Columbia University; University System of Georgia; University of Georgia	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Whitman, William/AAC-5896-2020	Tong, Liang/0000-0002-0563-6468; Whitman, William/0000-0003-1229-0423; Tan, Dazhi/0000-0002-1862-8125	National Institutes of Health [DK067238]; National Science Foundation [MCB-1158037]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1158037] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by a grant from the National Institutes of Health (DK067238) to LT and National Science Foundation (MCB-1158037) to WBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Batchelar ET, 2008, ANGEW CHEM INT EDIT, V47, P9322, DOI 10.1002/anie.200803906; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; DOUGLAS KT, 1986, ACCOUNTS CHEM RES, V19, P186, DOI 10.1021/ar00126a005; Eberhard ED, 2004, J AM CHEM SOC, V126, P7188, DOI 10.1021/ja0482381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Feng YG, 2002, BIOCHEMISTRY-US, V41, P12883, DOI 10.1021/bi020382g; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; Hamed RB, 2009, CHEMBIOCHEM, V10, P246, DOI 10.1002/cbic.200800652; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; KUCHTA RD, 1985, J BIOL CHEM, V260, P3181; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Staudinger J, 2001, CHEMOSPHERE, V44, P561, DOI 10.1016/S0045-6535(00)00505-1; WATERSON RM, 1972, J BIOL CHEM, V247, P5258; Wong BJ, 2003, J AM CHEM SOC, V125, P12076, DOI 10.1021/ja037652i	27	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63870	10.1371/journal.pone.0063870	http://dx.doi.org/10.1371/journal.pone.0063870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704947	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200078
J	Wade, ASI; Barov, B; Burfield, IJ; Gregory, RD; Norris, K; Butler, SJ				Wade, Amy S. I.; Barov, Boris; Burfield, Ian J.; Gregory, Richard D.; Norris, Ken; Butler, Simon J.			Quantifying the Detrimental Impacts of Land-Use and Management Change on European Forest Bird Populations	PLOS ONE			English	Article							FARMLAND BIODIVERSITY; COMMUNITIES; WOODLAND; ECOLOGY; CONSERVATION	The ecological impacts of changing forest management practices in Europe are poorly understood despite European forests being highly managed. Furthermore, the effects of potential drivers of forest biodiversity decline are rarely considered in concert, thus limiting effective conservation or sustainable forest management. We present a trait-based framework that we use to assess the detrimental impact of multiple land-use and management changes in forests on bird populations across Europe. Major changes to forest habitats occurring in recent decades, and their impact on resource availability for birds were identified. Risk associated with these changes for 52 species of forest birds, defined as the proportion of each species' key resources detrimentally affected through changes in abundance and/or availability, was quantified and compared to their pan-European population growth rates between 1980 and 2009. Relationships between risk and population growth were found to be significantly negative, indicating that resource loss in European forests is an important driver of decline for both resident and migrant birds. Our results demonstrate that coarse quantification of resource use and ecological change can be valuable in understanding causes of biodiversity decline, and thus in informing conservation strategy and policy. Such an approach has good potential to be extended for predictive use in assessing the impact of possible future changes to forest management and to develop more precise indicators of forest health.	[Wade, Amy S. I.; Norris, Ken] Univ Reading, Ctr Agri Environm Res, Sch Agr Policy & Dev, Reading, Berks, England; [Barov, Boris] BirdLife Europe, Brussels, Belgium; [Burfield, Ian J.] BirdLife Int, Cambridge, England; [Gregory, Richard D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Butler, Simon J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Reading; BirdLife International; Royal Society for Protection of Birds; University of East Anglia	Butler, SJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	simon.j.butler@uea.ac.uk	Wade, Amy/GSN-9485-2022; Barov, Boris/GQZ-8085-2022; Wade, Amy/GSO-1924-2022; Butler, Simon/H-1703-2011	Gregory, Richard/0000-0002-7419-5053; Butler, Simon/0000-0002-5111-5639	Stichting BirdLife Europe; NERC (National Environment Research Council) [NE/I020350/1]; European Commission; Royal Society for Protection of Birds; Biotechnology and Biological Sciences Research Council [BB/F011911/1] Funding Source: researchfish; Natural Environment Research Council [NE/I020350/1] Funding Source: researchfish; BBSRC [BB/F011911/1] Funding Source: UKRI; NERC [NE/I020350/1] Funding Source: UKRI	Stichting BirdLife Europe; NERC (National Environment Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Royal Society for Protection of Birds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project described in the manuscript was funded by Stichting BirdLife Europe. SJB was supported by a NERC (National Environment Research Council) Postdoctoral Fellowship (NE/I020350/1). The funders had no role in study design, data collection or analysis but contributed to preparation of the manuscript.; The Pan European Common Bird Monitoring Scheme (PECBMS) is supported financially by the European Commission and The Royal Society for Protection of Birds. Special thanks go to the many individuals and organisations responsible for national data collation across Europe, from the many thousands of skilled volunteer ornithologists, to the smaller numbers of dedicated professional staff responsible for data collation and analysis. Thanks to Mario Abreu, Birdlife Finland, Uno Brinnen, Llui's Brotons, Lena Dahl, Margus Ellermaa, Rob Fuller, Teemu Lehtiniemi, Asko Lohmus, Jiri Reif, Albane Siramy, Maris Strazds, Raimo Virkkala, Christian Verschueren, Petr Vorisek and Marcus Walsh for advice and comments.	Andersson FO, 2000, FOREST ECOL MANAG, V132, P111, DOI 10.1016/S0378-1127(00)00384-4; Angelstam Per, 2004, Ecological Bulletins, V51, P11; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Birdlife International I., 2004, BIRDS EUR POP EST TR; Burbaite Lina, 2009, Estonian Journal of Ecology, V58, P169, DOI 10.3176/eco.2009.3.02; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Butler SJ, 2009, J APPL ECOL, V46, P1154, DOI 10.1111/j.1365-2664.2009.01709.x; Camprodon J, 2006, FOREST ECOL MANAG, V221, P72, DOI 10.1016/j.foreco.2005.10.044; De la Montana E, 2006, J APPL ECOL, V43, P651, DOI 10.1111/j.1365-2664.2006.01171.x; de Warnaffe GDB, 2004, BIOL CONSERV, V118, P219, DOI 10.1016/j.biocon.2003.08.015; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Forest Europe UNECE and FAO, 2011, STAT TRENDS SUST FOR; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Imbeau L, 2001, CONSERV BIOL, V15, P1151, DOI 10.1046/j.1523-1739.2001.0150041151.x; Laiolo P, 2003, FOREST ECOL MANAG, V179, P441, DOI 10.1016/S0378-1127(02)00542-X; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; Leech DI, 2007, IBIS, V149, P128, DOI 10.1111/j.1474-919X.2007.00729.x; Lohmus A, 2010, FOREST ECOL MANAG, V260, P155, DOI 10.1016/j.foreco.2010.04.018; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Niemela J, 1997, CONSERV BIOL, V11, P601, DOI 10.1046/j.1523-1739.1997.06008.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; PETTERSSON RB, 1995, BIOL CONSERV, V74, P57, DOI 10.1016/0006-3207(95)00015-V; Pullin AS, 2009, CONSERV BIOL, V23, P818, DOI 10.1111/j.1523-1739.2009.01283.x; Quine CP, 2007, IBIS, V149, P161, DOI 10.1111/j.1474-919X.2007.00742.x; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Shorohova E, 2004, ECOLOGICAL B, P137; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Snow D.W., 1998, BIRDS W PALEARCTIC; Spiecker H, 2003, J ENVIRON MANAGE, V67, P55, DOI 10.1016/S0301-4797(02)00188-3; Thaxter CB, 2010, BIOL CONSERV, V143, P2006, DOI 10.1016/j.biocon.2010.05.004; Tomialojc Ludwik, 2005, British Birds, V98, P174; Tucker G.M., 1997, HABITATS BIRDS EUROP; VIRKKALA R, 1987, ANN ZOOL FENN, V24, P281	41	16	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64552	10.1371/journal.pone.0064552	http://dx.doi.org/10.1371/journal.pone.0064552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704997	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000319330200151
J	Hahn, GH; Hyttel-Sorensen, S; Petersen, SM; Pryds, O; Greisen, G				Hahn, Gitte H.; Hyttel-Sorensen, Simon; Petersen, Sandra M.; Pryds, Ole; Greisen, Gorm			Cerebral Effects of Commonly Used Vasopressor-Inotropes: A Study in Newborn Piglets	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; DOPAMINE INFUSIONS; BLOOD-PRESSURE; CIRCULATION; HEMODYNAMICS; SPECTROSCOPY; STIMULATION; HYPOTENSION; REACTIVITY; ARTERIAL	Background: Despite widespread use in sick infants, it is still debated whether vasopressor-inotropes have direct cerebral effects that might affect neurological outcome. We aimed to test direct cerebrovascular effects of three commonly used vasopressor-inotropes (adrenaline, dopamine and noradrenaline) by comparing the responses to those of nonpharmacologically induced increases in blood pressure. We also searched for reasons for a mismatch between the response in perfusion and oxygenation. Methods: Twenty-four piglets had long and short infusions of the three vasopressor-inotropes titrated to raise mean arterial blood pressure (MAP) 10 mmHg in random order. Nonpharmacological increases in MAP were induced by inflation of a balloon in the descending aorta. We measured cerebral oxygenation (near-infrared spectroscopy), perfusion (laser-Doppler), oxygen consumption (co-oximetry of arterial and superior sagittal sinus blood), and microvascular heterogeneity (side stream dark field video microscopy). Results: Vasopressor-inotropes increased cerebral oxygenation significantly less (p <= 0.01) compared to non-pharmacological MAP increases, whereas perfusion was similar. Furthermore, cerebral total hemoglobin concentration increased significantly less during vasopressor-inotrope infusions (p = 0.001). These physiologic responses were identical between the three vasopressor-inotropes (p > 0.05). Furthermore, they induced a mild, although insignificant increase in cerebral metabolism and microvascular heterogeneity (p > 0.05). Removal of the scalp tissue did not influence the mismatch (p > 0.05). Conclusion: We demonstrated a moderate vasopressor-inotrope induced mismatch between cerebral perfusion and oxygenation. Scalp removal did not affect this mismatch, why vasopressor-inotropes appear to have direct cerebral actions. The statistically nonsignificant increases in cerebral metabolism and/or microvascular heterogeneity may explain the mismatch. Alternatively, it may simply reflect a vasopressor-inotrope-induced decrease in the arterial-to-venous volume ratio as detected by near-infrared spectroscopy.	[Hahn, Gitte H.; Hyttel-Sorensen, Simon; Petersen, Sandra M.; Greisen, Gorm] Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark; [Pryds, Ole] Copenhagen Univ Hosp, Hvidovre Hosp, Dept Pediat, Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Hahn, GH (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Copenhagen, Denmark.	gitte.holst.hahn@gmail.com	Greisen, Gorm/AAA-6463-2022; Hahn, Gitte/AAN-4967-2020	Greisen, Gorm/0000-0001-8042-3262; Meinich Juhl, Sandra/0000-0003-1404-8251	Lundbeck Foundation; Aase and Einar Danielsens Foundation; Augustinus Foundation; Lundbeck Foundation [R77-2010-7200] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Aase and Einar Danielsens Foundation; Augustinus Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Lundbeck Foundation, Aase and Einar Danielsens Foundation and The Augustinus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1038/sj.mn.7300110; Bevan R, 1998, PEDIATR RES, V44, P730, DOI 10.1203/00006450-199811000-00016; Borch K, 2010, ACTA PAEDIATR, V99, P1489, DOI 10.1111/j.1651-2227.2010.01856.x; Chapados I, 2008, NEONATOLOGY, V94, P300, DOI 10.1159/000151650; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; De Backer D, 2010, INTENS CARE MED, V36, P1813, DOI 10.1007/s00134-010-2005-3; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; EDVINSSON L, 2002, CEREBRAL BLOOD FLOW, P191; EKSTROMJODAL B, 1982, CRIT CARE MED, V10, P375, DOI 10.1097/00003246-198206000-00008; Fanaroff JM, 2006, PEDIATRICS, V117, P1131, DOI 10.1542/peds.2005-1230; GRONLUND JU, 1995, EARLY HUM DEV, V41, P129, DOI 10.1016/0378-3782(95)01615-A; Hahn GH, 2012, ACTA PAEDIATR, V101, P736, DOI 10.1111/j.1651-2227.2012.02666.x; Hahn GH, 2012, PEDIATR RES, V71, P253, DOI 10.1038/pr.2011.46; Jayasinghe D, 2003, PEDIATR RES, V54, P848, DOI 10.1203/01.PDR.0000088071.30873.DA; Kumar A, 2008, PEDIATRICS, V122, pE722, DOI 10.1542/peds.2008-0269; Lundstrom K, 2000, EARLY HUM DEV, V57, P157, DOI 10.1016/S0378-3782(00)00048-7; MCCULLOCH J, 1977, AM J PHYSIOL, V233, pH222, DOI 10.1152/ajpheart.1977.233.2.H222; Munro MJ, 2004, PEDIATRICS, V114, P1591, DOI 10.1542/peds.2004-1073; Myburgh JA, 2002, ANAESTH INTENS CARE, V30, P725, DOI 10.1177/0310057X0203000602; Pellicer A, 2005, PEDIATRICS, V115, P1501, DOI 10.1542/peds.2004-1396; Sassano-Higgins S, 2011, J PERINATOL, V31, P647, DOI 10.1038/jp.2011.2; Seri I, 1998, J PEDIATR-US, V133, P728, DOI 10.1016/S0022-3476(98)70141-6; SERI I, 1984, J PEDIATR-US, V105, P489, DOI 10.1016/S0022-3476(84)80035-9; SORENSEN H, 2012, ANESTHESIOLOGY; Synnes AR, 2001, J PEDIATR-US, V138, P525, DOI 10.1067/mpd.2001.111822; Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; WAGERLE LC, 1990, AM J PHYSIOL, V258, pH1432, DOI 10.1152/ajpheart.1990.258.5.H1432; Wong FY, 2010, ANESTHESIOLOGY, V113, P1385, DOI 10.1097/ALN.0b013e3181fc5567; Wong FY, 2009, INTENS CARE MED, V35, P1777, DOI 10.1007/s00134-009-1602-5; Zhang J, 1999, ARCH DIS CHILD-FETAL, V81, pF99, DOI 10.1136/fn.81.2.F99	32	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63069	10.1371/journal.pone.0063069	http://dx.doi.org/10.1371/journal.pone.0063069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700412	Green Submitted, Green Published, gold			2022-12-25	WOS:000319966400010
J	Xie, XZ; Wang, YY; Zhu, HM; Zhou, H; Zhou, JM				Xie, Xinzhou; Wang, Yuanyuan; Zhu, Hongmin; Zhou, Hu; Zhou, Jingmin			Impact of Coronary Tortuosity on Coronary Blood Supply: A Patient-Specific Study	PLOS ONE			English	Article							MYOCARDIAL-PERFUSION DEFECTS; FLOW; ARTERIES; PRESSURE; MODEL	Background: Tortuous coronary arteries are commonly observed in clinical screenings and it may cause a reduction of the coronary pressure. However, whether this reduction leads to significant decreasing in the coronary blood supply is still unknown. The purpose of this study was to investigate the effect of the coronary tortuosity (CT) on the coronary blood supply. Method: A computational fluid dynamics (CFD) study was conducted to evaluate the impact of tortuosity on the coronary blood supply. Two patient-specific left anterior descending coronary artery (LAD) models and the corresponding non-tortuous models were reconstructed to perform three-dimensional CFD analysis. The lumped parameter model was coupled to the outlet of the simulated branches to represent the absent downstream vasculatures. The rest and exercise conditions were modeled by specifying proper boundary conditions. Result: Under resting condition, the mean flow rate could be maintained by decreasing less than 8% of the downstream vascular bed's resistance for tortuous models. While during exercise (maximal dilatation condition), the maximal coronary blood supply would reduce up to 14.9% due to tortuosity. Assuming that the flow rate can be maintained by the autoregulation effect under the maximal dilatation condition, the distal resistances for CT models still have to reduce more than 23% to maintain blood perfusion. Conclusions: Coronary tortuosity has minor influence on coronary blood supply at rest; while during exercise, patients with CT may lack the ability to adjust distal resistance sufficiently to compensate for the extra resistances generated by tortuosity and this may further lead to an ineffective regulation of the blood supply.	[Xie, Xinzhou; Wang, Yuanyuan; Zhou, Hu] Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China; [Zhu, Hongmin; Zhou, Jingmin] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, YY (corresponding author), Fudan Univ, Dept Elect Engn, Shanghai 200433, Peoples R China.	yywang@fudan.edu.cn	Lv, Yuanjie/AER-0767-2022		National Natural Science Foundation of China [61271071, 11228411]; National Key Technology R&D Program of China [2012BAI13B02]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110071110017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 61271071 and No. 11228411), the National Key Technology R&D Program of China (No. 2012BAI13B02) and Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20110071110017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER SA, 1983, ANNU REV FLUID MECH, V15, P461, DOI 10.1146/annurev.fl.15.010183.002333; Blanco PJ, 2007, COMPUT METHOD APPL M, V196, P4391, DOI 10.1016/j.cma.2007.05.008; BURATTINI R, 1985, ANN BIOMED ENG, V13, P385, DOI 10.1007/BF02407768; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Gaibazzi N, 2011, AM J CARDIOL, V108, P973, DOI 10.1016/j.amjcard.2011.05.030; Han HC, 2012, J VASC RES, V49, P185, DOI 10.1159/000335123; Heller LJ., 2018, CARDIOVASCULAR PHYSL, VNinth; Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6; Kim HJ, 2010, FINITE ELEM ANAL DES, V46, P514, DOI 10.1016/j.finel.2010.01.007; Larrabide I, 2012, COMPUT BIOL MED, V42, P993, DOI 10.1016/j.compbiomed.2012.07.011; Lee J, 2012, ANN BIOMED ENG, V40, P2399, DOI 10.1007/s10439-012-0583-7; Li Y, 2012, CHINESE MED J-PEKING, V125, P3581, DOI 10.3760/cma.j.issn.0366-6999.2012.19.041; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042558, 10.1371/journal.pone.0043023]; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024232; Perktold K, 1998, J BIOMECH, V31, P217, DOI 10.1016/S0021-9290(97)00118-8; Prosi M, 2004, J BIOMECH, V37, P1767, DOI 10.1016/j.jbiomech.2004.01.021; Qiao AK, 2004, MED ENG PHYS, V26, P545, DOI 10.1016/j.medengphy.2004.04.008; Torii R, 2010, ANN BIOMED ENG, V38, P2606, DOI 10.1007/s10439-010-0008-4; Torii R, 2009, COMMUN NUMER METH EN, V25, P565, DOI 10.1002/cnm.1231; Turgut O, 2007, INT J CARDIOVAS IMAG, V23, P671, DOI 10.1007/s10554-006-9186-4; Vignon-Clementel IE, 2010, COMPUT METHOD BIOMEC, V13, P625, DOI 10.1080/10255840903413565; Zegers ES, 2007, NETH HEART J, V15, P191, DOI 10.1007/BF03085979; Zeng DH, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2937744	23	29	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e64564	10.1371/journal.pone.0064564	http://dx.doi.org/10.1371/journal.pone.0064564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23691249	Green Submitted, Green Published, gold			2022-12-25	WOS:000319107900110
J	Hinrichs, S; Patten, NL; Waite, AM				Hinrichs, Saskia; Patten, Nicole L.; Waite, Anya M.			Temporal Variations in Metabolic and Autotrophic Indices for Acropora digitifera and Acropora spicifera - Implications for Monitoring Projects	PLOS ONE			English	Article							CORAL STYLOPHORA-PISTILLATA; REEF CORALS; SKELETAL GROWTH; CHLOROPHYLL FLUORESCENCE; MARINE PROCHLOROCOCCUS; ELEMENTAL COMPOSITION; PHOTO-ACCLIMATION; RNA/DNA RATIOS; IN-SITU; ZOOXANTHELLAE	Coral health indices are important components of the management assessments of coral reefs, providing insight into local variation in reef condition, as well as tools for comparisons between reefs and across various time scales. Understanding how such health indices vary in space and time is critical to their successful implementation as management tools. Here we compare autotrophic and heterotrophic coral health indices, examining specifically the temporal variation driven by the local environmental variation, at three scales (diel, daily and seasonal). We compared metabolic indices (RNA/DNA ratio, protein concentration) and autotrophic indices (Chlorophyll a (Chl a), zooxanthellae density, effective quantum yield (yield) and relative electron transport rate (rETR)) for two dominant Acropora species, A. digitifera and A. spicifera at Ningaloo Reef (north-western Australia) in August 2010 (austral winter) and February 2011 (austral summer). Clear seasonal patterns were documented for metabolic indices, zooxanthellae density and rETR, while cyclic diel patterns only occurred for yield and rETR, and RNA/DNA ratio. Significant daily variation was observed for RNA/DNA ratio, Chl a concentration, yield and rETR. Results suggest that zooxanthellae density and protein concentrations are good long-term indicators of coral health whose variance is largely seasonal, while RNA/DNA ratio and rETR can be used for both long-term (seasonal) and short-term (diel) coral monitoring. Chl a can be used to describe changes between days and yield for both diel and daily variations. Correlations between health indices and light history showed that short-term changes in irradiance had the strongest impact on all health indices except zooxanthellae density for A. digitifera; for A. spicifera no correlation was observed at all. However, cumulative irradiance over the several days before sampling showed significant correlations with most health indices suggesting that a time-lag effect has to be taken into account when interpreting diel variations in coral condition.	[Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; Univ Western Australia, Oceans Inst M470, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Waite, AM (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia.	anya.waite@uwa.edu.au	Waite, Anya M/A-5492-2015	Waite, Anya M/0000-0003-2965-0296	Australian Research Council; Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government; Western Australian Marine Science Institute (Node 2)	Australian Research Council(Australian Research Council); Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government; Western Australian Marine Science Institute (Node 2)	Funding was provided by a Discovery Grant to A. M. Waite from the Australian Research Council, the Endeavour International Postgraduate Research (IPRS) Scholarship from the Australian Government and a top-up scholarship from the Western Australian Marine Science Institute (Node 2) to S. Hinrichs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; Brown BE, 1999, CORAL REEFS, V18, P99; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Buckley L, 1999, HYDROBIOLOGIA, V401, P265, DOI 10.1023/A:1003798613241; CARON DA, 1995, DEEP-SEA RES PT I, V42, P943, DOI 10.1016/0967-0637(95)00027-4; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Chicharo LMZ, 2001, J EXP MAR BIOL ECOL, V259, P121, DOI 10.1016/S0022-0981(01)00229-5; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; DOYLE RW, 1973, J EXP MAR BIOL ECOL, V14, P201; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; Dubinsky Z., 1994, Pacific Science, V48, P313; Esteves E, 2009, ECOL FRESHW FISH, V18, P132, DOI 10.1111/j.1600-0633.2008.00332.x; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; Fitt WK, 2000, BIOL BULL, V198, P110, DOI 10.2307/1542809; FITT WK, 1995, LIMNOL OCEANOGR, V40, P976, DOI 10.4319/lo.1995.40.5.0976; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Harris R.P., 2000, ZOOPLANKTON METHODOL; Heidelberg KB, 2004, CORAL REEFS, V23, P263, DOI 10.1007/s00338-004-0375-0; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Hinrichs S, CORAL REEFS IN PRESS; Hinrichs S, PLOS ONE IN PRESS; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hoegh-Guldberg O, 1994, PAC SCI, V48, P263; HOEGHGULDBERG O, 1989, MAR ECOL PROG SER, V57, P173, DOI 10.3354/meps057173; Hoogenboom MO, 2008, ECOLOGY, V89, P1144, DOI 10.1890/07-1272.1; Hoogenboom MO, 2006, MAR ECOL PROG SER, V313, P1, DOI 10.3354/meps313001; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Humphrey C, 2009, CHANGES RNA DNA RATI; Instruments L, 2000, QUIKCHEM FIA AUTOMAT; Jeffrey SW, 1975, BIOCH PHYSL PFLANZ, V167, P1; Johannes R.E., 1974, Proceedings int Coral Reef Symp, V2, P127; Lesser MP, 2001, MAR ECOL PROG SER, V212, P69, DOI 10.3354/meps212069; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; Lowe RJ, 2008, PECS LIVERPOOL; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCAULEY PJ, 1995, MAR BIOL, V123, P145, DOI 10.1007/BF00350333; Muller-Parker Gisele, 1997, P96; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Patten N, 2011, CORAL REEFS, P1; Pearce AF, 2012, J MARINE SY IN PRESS; Piniak GA, 2008, ESTUAR COAST SHELF S, V77, P56, DOI 10.1016/j.ecss.2007.08.023; Piniak GA, 2009, BIOL BULL-US, V216, P55, DOI 10.1086/BBLv216n1p55; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Schneider K, 2009, LIMNOL OCEANOGR, V54, P1995, DOI 10.4319/lo.2009.54.6.1995; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Sheppard CRC, 2009, BIOL COR REEFS; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; Strickland D, 2010, THESIS U W AUSTR; Titlyanov E, 2000, MAR BIOL, V137, P463, DOI 10.1007/s002270000370; Titlyanov E.A., 2002, RUSS J MAR BIOL, V28, P16; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Titlyanov EA, 2004, SYMBIOSIS, V36, P211; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V263, P211, DOI 10.1016/S0022-0981(01)00309-4; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; Ulstrup KE, 2008, MAR ECOL PROG SER, V361, P139, DOI 10.3354/meps07360; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; VERITY PG, 1992, LIMNOL OCEANOGR, V37, P1434, DOI 10.4319/lo.1992.37.7.1434; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8; Watson RJ, 2004, J ENVIRON MONITOR, V7, P37; Winters G, 2003, LIMNOL OCEANOGR, V48, P1388, DOI 10.4319/lo.2003.48.4.1388; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	85	3	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63693	10.1371/journal.pone.0063693	http://dx.doi.org/10.1371/journal.pone.0063693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696848	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900054
J	Jiang, SY; Gonzalez, JM; Ramachandran, S				Jiang, Shu-Ye; Gonzalez, Jose M.; Ramachandran, Srinivasan			Comparative Genomic and Transcriptomic Analysis of Tandemly and Segmentally Duplicated Genes in Rice	PLOS ONE			English	Article							LINEAGE-SPECIFIC EXPANSION; WIDE ANALYSIS; EXPRESSION DIVERGENCE; FUNCTIONAL DIVERGENCE; WHOLE-GENOME; ARABIDOPSIS; FAMILY; CONSERVATION; METHYLATION; INSTABILITY	Tandem and segmental duplications significantly contribute to gene family expansion and genome evolution. Genome-wide identification of tandem and segmental genes has been analyzed before in several plant genomes. However, comparative studies in functional bias, expression divergence and their roles in species domestication are still lacking. We have carried out a genome-wide identification and comparative analysis of tandem and segmental genes in the rice genome. A total of 3,646 and 3,633 pairs of tandem and segmental genes, respectively, were identified in the genome. They made up around 30% of total annotated rice genes (excluding transposon-coding genes). Both tandem and segmental duplicates showed different physical locations and exhibited a biased subset of functions. These two types of duplicated genes were also under different functional constrains as shown by nonsynonymous substitutions per site (Ka) and synonymous substitutions per site (Ks) analysis. They are also differently regulated depending on the tissues and abiotic and biotic stresses based on transcriptomics data. The expression divergence might be related to promoter differentiation and DNA methylation status after tandem or segmental duplications. Both tandem and segmental duplications differ in their contribution to genetic novelty but evidence suggests that they play their role in species domestication and genome evolution.	[Jiang, Shu-Ye; Ramachandran, Srinivasan] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Gonzalez, Jose M.] Univ La Laguna, Dept Microbiol, Tenerife, Spain	National University of Singapore; Universidad de la Laguna	Ramachandran, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	sri@tll.org.sg	Gonzalez, Jose M./C-3333-2013	Gonzalez, Jose M./0000-0002-9926-3323; Jiang, Shu-Ye/0000-0003-4867-2335	Temasek Life Sciences Laboratory (Singapore); Singapore National Research Foundation under the Competitive Research Programme Funding Scheme (CRP) [NRF-CRP7-2010-02]	Temasek Life Sciences Laboratory (Singapore)(National University of Singapore); Singapore National Research Foundation under the Competitive Research Programme Funding Scheme (CRP)	This research was supported by Temasek Life Sciences Laboratory (Singapore) and by the Singapore National Research Foundation under the Competitive Research Programme Funding Scheme (CRP Award No. NRF-CRP7-2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chi YH, 2011, DNA RES, V18, P1, DOI 10.1093/dnares/dsq031; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Force A, 1999, GENETICS, V151, P1531; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Giannuzzi G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-436; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; Han YP, 2011, J EXP BOT, V62, P5117, DOI 10.1093/jxb/err215; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiang SY, 2008, DEV BIOL, V314, P418, DOI 10.1016/j.ydbio.2007.11.031; Jiang SY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-79; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ohno S., 1970, P1; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Seoighe C, 2003, MOL BIOL EVOL, V20, P484, DOI 10.1093/molbev/msg059; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thornton K, 2002, MOL BIOL EVOL, V19, P918, DOI 10.1093/oxfordjournals.molbev.a004149; Wang XY, 2011, GENES-BASEL, V2, P1, DOI 10.3390/genes2010001; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zhang LQ, 2003, GENOME RES, V13, P2533, DOI 10.1101/gr.1318503; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; Zou C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000581	52	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63551	10.1371/journal.pone.0063551	http://dx.doi.org/10.1371/journal.pone.0063551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696832	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900040
J	Lenzi, J; Lombardi, R; Gori, D; Zanini, N; Tedesco, D; Masetti, M; Jovine, E; Fantini, MP				Lenzi, Jacopo; Lombardi, Raffaele; Gori, Davide; Zanini, Nicola; Tedesco, Dario; Masetti, Michele; Jovine, Elio; Fantini, Maria Pia			Impact of Procedure Volumes and Focused Practice on Short-Term Outcomes of Elective and Urgent Colon Cancer Resection in Italy	PLOS ONE			English	Article							IN-HOSPITAL-MORTALITY; COLORECTAL SURGERY; POSTOPERATIVE MORTALITY; OPERATIVE MORTALITY; RISK-FACTORS; MORBIDITY; QUALITY; READMISSION; COMPLICATIONS; REOPERATION	Background: The relationship between hospital volumes and short-term patients' outcomes of colon cancer (CC) surgery is not well established in the literature. Moreover, evidence about short-term outcomes of urgent compared with elective CC procedures is scanty. The aims of this study are 1) to determine whether caseloads and other hospital characteristics are associated with short-term outcomes of CC surgery; 2) to compare the outcomes of urgent and elective CC surgery. Methods: A total of 14,200 patients undergoing CC surgery between 2005 and 2010 in the General Surgery Units (GSUs) of the hospitals of Emilia-Romagna region, Northern Italy, were identified from the hospital discharge records database. The outcomes of interest were 30-day in-hospital mortality, re-intervention and 30-day re-admission. Using multilevel analysis, we analyzed the relationship of GSU volumes and focused practice, defined as the percentage of CC operations over total operations, with the three outcomes. Results: High procedure volumes were associated with a lower risk of 30-day in-hospital mortality, after adjusting for patients' characteristics [aOR (95% CI) = 0.51 (0.33-0.81)]. Stratified analyses for elective and urgent surgery showed that high volumes were associated with a lower 30-day mortality for elective patients [aOR (95% CI) = 0.35 (0.17-0.71)], but not for urgent patients [aOR (95% CI) = 0.72 (0.42-1.24)]. Focused practice was an independent predictor of re-intervention [aOR (95% CI) = 0.67 (0.47-0.97)] and re-admission [aRR (95% CI) = 0.88 (0.78-0.98)]. Conclusions: The present study adds evidence in support of the notion that patients with CC undergoing surgery at high-volume and focused surgical units experience better short-term outcomes.	[Lenzi, Jacopo; Gori, Davide; Tedesco, Dario; Fantini, Maria Pia] Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, Bologna, Italy; [Lombardi, Raffaele; Zanini, Nicola; Masetti, Michele; Jovine, Elio] Maggiore Hosp, Dept Surg, Gen Surg Unit, Bologna, Italy	University of Bologna; AUSL di Bologna	Fantini, MP (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, Bologna, Italy.	mariapia.fantini@unibo.it	Masetti, Michele/AAT-4638-2020; Lombardi, Raffaele/AAD-2517-2022; Gori, Davide/AAC-3486-2022; Tedesco, Dario/AAC-1848-2019; Tedesco, Dario/AAD-8342-2022; Lenzi, Jacopo/W-4835-2017	Masetti, Michele/0000-0003-2259-8675; Lombardi, Raffaele/0000-0002-2219-4972; Gori, Davide/0000-0003-4954-9419; Tedesco, Dario/0000-0002-5027-5446; Lenzi, Jacopo/0000-0003-2882-4223; Zanini, Nicola/0000-0002-4877-5759				Alves A, 2005, ARCH SURG-CHICAGO, V140, P278, DOI 10.1001/archsurg.140.3.278; Ansari MZ, 2000, AUST NZ J SURG, V70, P6, DOI 10.1046/j.1440-1622.2000.01733.x; Archampong D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005391.pub3; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4; Bilimoria KY, 2008, J CLIN ONCOL, V26, P4626, DOI 10.1200/JCO.2007.15.6356; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Biondo S, 2010, ARCH SURG-CHICAGO, V145, P79, DOI 10.1001/archsurg.2009.208; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Davoli Marina, 2005, Epidemiol Prev, V29, P3; Drolet S, 2011, J GASTROINTEST SURG, V15, P541, DOI 10.1007/s11605-011-1433-x; Engel AF, 2005, BRIT J SURG, V92, P1526, DOI 10.1002/bjs.5153; Finlayson EVA, 2003, ARCH SURG-CHICAGO, V138, P721, DOI 10.1001/archsurg.138.7.721; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Goodney PP, 2003, ANN SURG, V238, P161, DOI 10.1097/01.SLA.0000081094.66659.c3; Gooiker GA, 2011, BRIT J SURG, V98, P485, DOI 10.1002/bjs.7413; Greenblatt DY, 2010, ANN SURG, V251, P659, DOI 10.1097/SLA.0b013e3181d3d27c; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Guinier D, 2007, DIS COLON RECTUM, V50, P1316, DOI 10.1007/s10350-007-0310-x; Hendren S, 2010, DIS COLON RECTUM, V53, P1587, DOI 10.1007/DCR.0b013e3181f2f202; Ingraham AM, 2010, J AM COLL SURGEONS, V210, P155, DOI 10.1016/j.jamcollsurg.2009.10.016; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jencks SF, N ENGL J MED, V360, P1418; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Karanicolas PJ, 2009, ANN SURG, V249, P954, DOI 10.1097/SLA.0b013e3181a77bcd; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Longo WE, 2000, DIS COLON RECTUM, V43, P83, DOI 10.1007/BF02237249; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Marusch F, 2001, BRIT J SURG, V88, P1397, DOI 10.1046/j.0007-1323.2001.01873.x; Morris AM, 2007, ANN SURG, V245, P73, DOI 10.1097/01.sla.0000231797.37743.9f; Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181; Osler M, 2011, ANN SURG, V253, P733, DOI 10.1097/SLA.0b013e318207556f; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Ragg JL, 2009, DIS COLON RECTUM, V52, P1296, DOI 10.1007/DCR.0b013e3181a0e639; Richards CH, 2010, J GASTROINTEST SURG, V14, P1511, DOI 10.1007/s11605-010-1333-5; Rogers SO, 2006, ANN SURG, V244, P1003, DOI 10.1097/01.sla.0000231759.10432.a7; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Spruce LR, 2012, J AM ACAD NURSE PRAC, V24, P167, DOI 10.1111/j.1745-7599.2012.00714.x; Statistica Emilia-Romagna, 2011, POP RES PROV COM CLA; Stitzenberg KB, 2009, J CLIN ONCOL, V27, P4671, DOI 10.1200/JCO.2008.20.1715; van Westreenen HL, 2011, DIS COLON RECTUM, V54, P1438, DOI 10.1097/DCR.0b013e31822c64f1; Yuen E, 2011, TUMORI, V97, P428, DOI 10.1700/950.10393; Zorzi M, 2009, EPIDEMIOL PREV, V33, P57	46	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64245	10.1371/journal.pone.0064245	http://dx.doi.org/10.1371/journal.pone.0064245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696873	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900076
J	Puranik, S; Sahu, PP; Mandal, SN; Suresh, BV; Parida, SK; Prasad, M				Puranik, Swati; Sahu, Pranav Pankaj; Mandal, Sambhu Nath; Suresh, Venkata B.; Parida, Swarup Kumar; Prasad, Manoj			Comprehensive Genome-Wide Survey, Genomic Constitution and Expression Profiling of the NAC Transcription Factor Family in Foxtail Millet (Setaria italica L.)	PLOS ONE			English	Article							FACTOR GENE FAMILY; SALT TOLERANCE; FUNCTIONAL-ANALYSIS; CONSERVED DOMAIN; RESPONSIVE GENES; CELL-DIVISION; STRESS; ARABIDOPSIS; PROTEIN; RICE	The NAC proteins represent a major plant-specific transcription factor family that has established enormously diverse roles in various plant processes. Aided by the availability of complete genomes, several members of this family have been identified in Arabidopsis, rice, soybean and poplar. However, no comprehensive investigation has been presented for the recently sequenced, naturally stress tolerant crop, Setaria italica (foxtail millet) that is famed as a model crop for bioenergy research. In this study, we identified 147 putative NAC domain-encoding genes from foxtail millet by systematic sequence analysis and physically mapped them onto nine chromosomes. Genomic organization suggested that inter-chromosomal duplications may have been responsible for expansion of this gene family in foxtail millet. Phylogenetically, they were arranged into 11 distinct sub-families (I-XI), with duplicated genes fitting into one cluster and possessing conserved motif compositions. Comparative mapping with other grass species revealed some orthologous relationships and chromosomal rearrangements including duplication, inversion and deletion of genes. The evolutionary significance as duplication and divergence of NAC genes based on their amino acid substitution rates was understood. Expression profiling against various stresses and phytohormones provides novel insights into specific and/or overlapping expression patterns of SiNAC genes, which may be responsible for functional divergence among individual members in this crop. Further, we performed structure modeling and molecular simulation of a stress-responsive protein, SiNAC128, proffering an initial framework for understanding its molecular function. Taken together, this genome-wide identification and expression profiling unlocks new avenues for systematic functional analysis of novel NAC gene family candidates which may be applied for improvising stress adaption in plants.	[Puranik, Swati; Sahu, Pranav Pankaj; Mandal, Sambhu Nath; Suresh, Venkata B.; Parida, Swarup Kumar; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	manoj_prasad@nipgr.ac.in	Bonthala, Venkata Suresh/G-9852-2013; Puranik, Swati/AGE-3515-2022; PURANIK, SWATI/AAT-9159-2021; Prasad, Manoj/AAE-8540-2019; Sahu, Pranav Pankaj/H-3855-2018; Sahu, Pranav Pankaj/S-6642-2019	Bonthala, Venkata Suresh/0000-0001-6550-1648; Puranik, Swati/0000-0003-1787-1550; Prasad, Manoj/0000-0003-0691-0163; Sahu, Pranav Pankaj/0000-0003-4801-6602; Sahu, Pranav Pankaj/0000-0003-4801-6602	National Institute of Plant Genome Research (NIPGR), New Delhi, India; NIPGR	National Institute of Plant Genome Research (NIPGR), New Delhi, India; NIPGR	The authors work in this area was supported by the core grant from National Institute of Plant Genome Research (NIPGR), New Delhi, India. SP acknowledges the award of Research Associateship from NIPGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen QF, 2011, PROTEIN CELL, V2, P55, DOI 10.1007/s13238-011-1010-9; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Christianson JA, 2010, PLANT SIGNAL BEHAV, V5, P428, DOI 10.4161/psb.5.4.10847; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Ehrlich J, 1997, GENETICS, V147, P289; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jayaraman A, 2008, MOL BIOTECHNOL, V40, P241, DOI 10.1007/s12033-008-9081-4; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kato H, 2010, J PLANT PHYSIOL, V167, P571, DOI 10.1016/j.jplph.2009.11.004; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Ko JH, 2007, PLANT J, V50, P1035, DOI 10.1111/j.1365-313X.2007.03109.x; Lecharny Alain, 2003, Journal of Structural and Functional Genomics, V3, P111, DOI 10.1023/A:1022614001371; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, PLANT SIGNAL BEHAV, V6, P1588, DOI 10.4161/psb.6.10.17130; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Puranik S, 2011, J PLANT PHYSIOL, V168, P280, DOI 10.1016/j.jplph.2010.07.005; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Srinivasan N, 1995, PRACTICAL APPROACH S, P111; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang X, 2009, J VIROL, V83, P9720, DOI 10.1128/JVI.00941-09; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062	92	104	111	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64594	10.1371/journal.pone.0064594	http://dx.doi.org/10.1371/journal.pone.0064594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145XK	23691254	Green Published, gold, Green Submitted			2022-12-25	WOS:000319052700112
J	Godbout, C; Castella, LF; Smith, EA; Talele, N; Chow, ML; Garonna, A; Hinz, B				Godbout, Charles; Castella, Lysianne Follonier; Smith, Eric A.; Talele, Nilesh; Chow, Melissa L.; Garonna, Adriano; Hinz, Boris			The Mechanical Environment Modulates Intracellular Calcium Oscillation Activities of Myofibroblasts	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; GROWTH-FACTOR-BETA; SUBSTRATE STIFFNESS; GRANULATION-TISSUE; FOCAL ADHESIONS; MECHANOSENSITIVE CHANNELS; CONTRACTILE ACTIVITY; SCAR FORMATION; CELL-MOVEMENT; STRESS FIBERS	Myofibroblast contraction is fundamental in the excessive tissue remodeling that is characteristic of fibrotic tissue contractures. Tissue remodeling during development of fibrosis leads to gradually increasing stiffness of the extracellular matrix. We propose that this increased stiffness positively feeds back on the contractile activities of myofibroblasts. We have previously shown that cycles of contraction directly correlate with periodic intracellular calcium oscillations in cultured myofibroblasts. We analyze cytosolic calcium dynamics using fluorescent calcium indicators to evaluate the possible impact of mechanical stress on myofibroblast contractile activity. To modulate extracellular mechanics, we seeded primary rat subcutaneous myofibroblasts on silicone substrates and into collagen gels of different elastic modulus. We modulated cell stress by cell growth on differently adhesive culture substrates, by restricting cell spreading area on micro-printed adhesive islands, and depolymerizing actin with Cytochalasin D. In general, calcium oscillation frequencies in myofibroblasts increased with increasing mechanical challenge. These results provide new insight on how changing mechanical conditions for myofibroblasts are encoded in calcium oscillations and possibly explain how reparative cells adapt their contractile behavior to the stresses occurring in normal and pathological tissue repair.	[Godbout, Charles; Castella, Lysianne Follonier; Smith, Eric A.; Talele, Nilesh; Chow, Melissa L.; Hinz, Boris] Univ Toronto, Fac Dent, Matrix Dynam Grp, Lab Tissue Repair & Regenerat, Toronto, ON, Canada; [Godbout, Charles; Castella, Lysianne Follonier; Garonna, Adriano] Ecole Polytech Fed Lausanne, Lab Cell Biophys, Lausanne, Switzerland	University of Toronto; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hinz, B (corresponding author), Univ Toronto, Fac Dent, Matrix Dynam Grp, Lab Tissue Repair & Regenerat, Toronto, ON, Canada.	boris.hinz@utoronto.ca	Talele, Nilesh Prakash/GRE-5860-2022	Talele, Nilesh Prakash/0000-0003-2758-8599; Godbout, Charles/0000-0003-4805-3454; Hinz, Boris/0000-0002-0526-393X	Canadian Institutes of Health Research (CIHR) [101130, 210820, 286720]; Collaborative Health Research Programme (CIHR/NSERC) [1004005, 413783]; Canada Foundation for Innovation and Ontario Research Fund (CFI/ORF) [26653]; Heart and Stroke Foundation Ontario [NA7086]; European Union's Seventh Framework Program [237946]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Collaborative Health Research Programme (CIHR/NSERC)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation and Ontario Research Fund (CFI/ORF); Heart and Stroke Foundation Ontario(Heart & Stroke Foundation of CanadaHeart & Stroke Foundation of Ontario); European Union's Seventh Framework Program	CG is supported by a post-doctoral fellowship from the Canadian Institutes of Health Research (CIHR) (grant 101130). The research of BH is supported by the CIHR (grants 210820 and 286720), the Collaborative Health Research Programme (CIHR/NSERC grants 1004005 and 413783), the Canada Foundation for Innovation and Ontario Research Fund (CFI/ORF grant 26653), and the Heart and Stroke Foundation Ontario (grant NA7086). Some of the data presented herein were funded from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement 237946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033; Alizadeh N, 2007, WOUND REPAIR REGEN, V15, P809, DOI 10.1111/j.1524-475X.2007.00312.x; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; ARORA PD, 1994, J CELL PHYSIOL, V161, P187, DOI 10.1002/jcp.1041610202; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Bogatkevich GS, 2009, ARTHRITIS RHEUM-US, V60, P3455, DOI 10.1002/art.24935; Bond JE, 2011, PLAST RECONSTR SURG, V128, p438E, DOI 10.1097/PRS.0b013e31822b7352; Castella LF, 2010, EXP CELL RES, V316, P2390, DOI 10.1016/j.yexcr.2010.04.033; Castella LF, 2010, J CELL SCI, V123, P1751, DOI 10.1242/jcs.066795; Chan MWC, 2010, METHOD CELL BIOL, V98, P179, DOI 10.1016/S0091-679X(10)98008-4; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Crow A, 2012, BIOPHYS J, V102, P443, DOI 10.1016/j.bpj.2011.11.4020; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; Follonier L, 2008, J CELL SCI, V121, P3305, DOI 10.1242/jcs.024521; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gurtner GC, 2011, ANN SURG, V254, P217, DOI 10.1097/SLA.0b013e318220b159; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Huang X, 2012, AM J RESP CELL MOL B; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Junker JP, 2008, BURNS; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Kuipers AJ, 2012, EUR J CELL BIOL, V91, P834, DOI 10.1016/j.ejcb.2012.05.006; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Marinkovic A, 2012, AM J PHYSL LUNG CELL; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Orgill DP, 2011, PLAST RECONSTR SURG, V127, p105S, DOI 10.1097/PRS.0b013e318200a427; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pietramaggiori G, 2007, ANN SURG, V246, P896, DOI 10.1097/SLA.0b013e3180caa47f; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Raab M, 2012, J CELL BIOL; Rodriguez AG, 2011, BIOPHYS J, V101, P2455, DOI 10.1016/j.bpj.2011.09.057; Scherer SS, 2008, PLAST RECONSTR SURG, V122, P786, DOI 10.1097/PRS.0b013e31818237ac; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Sirghi L, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/36/365702; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Sun YY, 2012, J ELECTRON MATER, V41, P519, DOI 10.1007/s11664-011-1800-0; Takeda Y, 2010, HYPERTENS RES, V33, P965, DOI 10.1038/hr.2010.112; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Tsai FC, 2012, CURR BIOL, V22, P837, DOI 10.1016/j.cub.2012.03.037; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212; Wrobel LK, 2002, CELL MOTIL CYTOSKEL, V52, P82, DOI 10.1002/cm.10034; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	81	52	52	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64560	10.1371/journal.pone.0064560	http://dx.doi.org/10.1371/journal.pone.0064560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	23691248	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107400134
J	Cai, Y; Geutjes, EJ; de Lint, K; Roepman, P; Bruurs, L; Yu, LR; Wang, W; van Blijswijk, J; Mohammad, H; de Rink, I; Bernards, R; Baylin, SB				Cai, Y.; Geutjes, E-J; de Lint, K.; Roepman, P.; Bruurs, L.; Yu, L-R; Wang, W.; van Blijswijk, J.; Mohammad, H.; de Rink, I.; Bernards, R.; Baylin, S. B.			The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes	ONCOGENE			English	Article						NuRD; DNMTs; tumor suppressor genes; silencing; colon cancer; WNT signaling	HISTONE DEACETYLASE INHIBITION; CHROMATIN-REMODELING COMPLEX; DNA METHYLATION; FACTOR CHD4; CANCER; METHYLTRANSFERASE; HYPERMETHYLATION; DEMETHYLATION; EXPRESSION; DAMAGE	Many tumor suppressor genes (TSGs) are silenced through synergistic layers of epigenetic regulation including abnormal DNA hypermethylation of promoter CpG islands, repressive chromatin modifications and enhanced nucleosome deposition over transcription start sites. The protein complexes responsible for silencing of many of such TSGs remain to be identified. Our previous work demonstrated that multiple silenced TSGs in colorectal cancer cells can be partially reactivated by DNA demethylation in cells disrupted for the DNA methyltransferases 1 and 3B (DNMT1 and 3B) or by DNMTi inhibitors (DNMTi). Herein, we used proteomic and functional genetic approaches to identify additional proteins that cooperate with DNMTs in silencing these key silenced TSGs in colon cancer cells. We discovered that DNMTs and the core components of the NuRD (Mi-2/nucleosome remodeling and deacetylase) nucleosome remodeling complex, chromo domain helicase DNA-binding protein 4 (CHD4) and histone deacetylase 1 (HDAC1) occupy the promoters of several of these hypermethylated TSGs and physically and functionally interact to maintain their silencing. Consistent with this, we find an inverse relationship between expression of HDAC1 and 2 and these TSGs in a large panel of primary colorectal tumors. We demonstrate that DNMTs and NuRD cooperate to maintain the silencing of several negative regulators of the WNT and other signaling pathways. We find that depletion of CHD4 is synergistic with DNMT inhibition in reducing the viability of colon cancer cells in correlation with reactivation of TSGs, suggesting that their combined inhibition may be beneficial for the treatment of colon cancer. Since CHD4 has ATPase activity, our data identify CHD4 as a potentially novel drug target in cancer.	[Cai, Y.; Wang, W.; Mohammad, H.; Baylin, S. B.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21287 USA; [Cai, Y.; Wang, W.; Mohammad, H.; Baylin, S. B.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Geutjes, E-J; de Lint, K.; Bruurs, L.; van Blijswijk, J.; Bernards, R.] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, North Holland, Netherlands; [Geutjes, E-J; de Lint, K.; Bruurs, L.; van Blijswijk, J.; Bernards, R.] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, North Holland, Netherlands; [Roepman, P.] Agendia NV, Dept Res & Dev, Amsterdam, Netherlands; [Yu, L-R] US FDA, Div Syst Biol, Ctr Excellence Prote, Natl Ctr Toxicol Res, Jefferson, AR USA; [de Rink, I.] Netherlands Canc Inst, Cent Microarray & Deep Sequencing Core Facil, NL-1066 CX Amsterdam, North Holland, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Netherlands Cancer Institute; Netherlands Cancer Institute; Agendia; US Food & Drug Administration (FDA); Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, 121 Plesmanlaan, NL-1066 CX Amsterdam, North Holland, Netherlands.	r.bernards@nki.nl; sbaylin@jhmi.edu		Yu, Li-Rong/0000-0001-6084-991X; Wang, Wei/0000-0003-1339-4080; de Lint, Klaas/0000-0001-7134-444X; Bernards, Rene/0000-0001-8677-3423	Netherlands Organization for Scientific Research (NWO); National Institute of Environmental Health Sciences (NIEHS) [ES011858]; National Cancer Institute (NCI) [CA043318]; NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011858] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank JH Dannenberg for the gift of Hdac1 plasmids. We thank JH Dannenberg, P Kumar and members of the Bernards, Baylin laboratory for discussions and Kathy Bender and H. Liu for manuscript preparation. This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO) to RB, and by grants ES011858 National Institute of Environmental Health Sciences (NIEHS) CA043318 National Cancer Institute (NCI) to SB. The views presented in this article do not necessarily reflect those of the US Food and Drug Administration.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Phesse TJ, 2008, MOL CELL BIOL, V28, P6094, DOI 10.1128/MCB.00539-08; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Sansom OJ, 2003, NAT GENET, V34, P145, DOI 10.1038/ng1155; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	51	80	82	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 24	2014	33	17					2157	2168		10.1038/onc.2013.178	http://dx.doi.org/10.1038/onc.2013.178			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF8WJ	23708667	Green Accepted			2022-12-25	WOS:000334996000002
J	Hankins, JL; Ward, KE; Linton, SS; Barth, BM; Stahelin, RV; Fox, TE; Kester, M				Hankins, Jody L.; Ward, Katherine E.; Linton, Sam S.; Barth, Brian M.; Stahelin, Robert V.; Fox, Todd E.; Kester, Mark			Ceramide 1-Phosphate Mediates Endothelial Cell Invasion via the Annexin a2-p11 Heterotetrameric Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); TISSUE-PLASMINOGEN ACTIVATOR; TNF-ALPHA; A2 HETEROTETRAMER; BIOACTIVE LIPIDS; II TETRAMER; RECEPTOR; CERAMIDE-1-PHOSPHATE; PROLIFERATION; MOBILIZATION	The bioactive sphingolipid, ceramide 1-phosphate (C-1-P), has been implicated as an extracellular chemotactic agent directing cellular migration in hematopoietic stem/progenitor cells and macrophages. However, interacting proteins that could mediate these actions of C-1-P have, thus far, eluded identification. We have now identified and characterized interactions between ceramide 1-phosphate and the annexin a2-p11 heterotetramer constituents. This C-1-P-receptor complex is capable of facilitating cellular invasion. Herein, we demonstrate in both coronary artery macrovascular endothelial cells and retinal microvascular endothelial cells that C-1-P induces invasion through an extracellular matrix barrier. By employing surface plasmon resonance, lipid-binding ELISA, and mass spectrometry technologies, we have demonstrated that the heterotetramer constituents bind to C-1-P. Although the annexin a2-p11 heterotetramer constituents do not bind the lipid C-1-P exclusively, other structurally similar lipids, such as phosphatidylserine, sphingosine 1-phosphate, and phosphatidic acid, could not elicit the potent chemotactic stimulation observed with C-1-P. Further, we show that siRNA-mediated knockdown of either annexin a2 or p11 protein significantly inhibits C-1-P-directed invasion, indicating that the heterotetrameric complex is required for C-1-P-mediated chemotaxis. These results imply that extracellular C-1-P, acting through the extracellular annexin a2-p11 heterotetrameric protein, can mediate vascular endothelial cell invasion.	[Hankins, Jody L.; Linton, Sam S.; Fox, Todd E.; Kester, Mark] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA 17033 USA; [Barth, Brian M.] Penn State Univ, Dept Med, Coll Med, Hershey, PA 17033 USA; [Ward, Katherine E.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Notre Dame; Indiana University System; Indiana University South Bend	Kester, M (corresponding author), Penn State Coll Med, Dept Pharmacol, R130, Hershey, PA 17033 USA.	mkester@psu.edu	Stahelin, Robert/L-3567-2019; Kester, Mark/ABG-4615-2020	Linton, Samuel/0000-0003-2419-0673; Barth, Brian/0000-0002-3542-1804; Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [R01HL076789, EY018336]; American Diabetes Association Research Award; Pennsylvania Department of Health using Tobacco Settlement Funds; American Heart Association [GRNT12080254, 11PRE7640028]; National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship [T32GM075762]; NATIONAL EYE INSTITUTE [R01EY018336] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research Award(American Diabetes Association); Pennsylvania Department of Health using Tobacco Settlement Funds; American Heart Association(American Heart Association); National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL076789 and EY018336 (to M. K.). This work has also been supported by an American Diabetes Association Research Award (to M. K.). Core Facility services and instruments (ABI 4000 QTrap, 5600 TripleTOF) used in this project were funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds. Additional support for these studies came from American Heart Association Grant GRNT12080254 (to R. V. S.). Penn State Research Foundation has previously licensed ceramide-based delivery systems and nanotechnologies to Keystone Nano Inc. (State College, PA). M. Kester is Chief Medical Officer of Keystone Nano Inc.; Supported by American Heart Association Predoctoral Fellowship 11PRE7640028 and National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship T32GM075762.	BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V131, P554, DOI 10.1111/j.1365-2141.2005.05806.x; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Eichner A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002617; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Gangoiti P, 2012, BIOCHIMIE, V94, P597, DOI 10.1016/j.biochi.2011.09.009; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; GomezMunoz A, 1997, BIOCHEM J, V325, P435, DOI 10.1042/bj3250435; GOMEZMUNOZ A, 1995, MOL PHARMACOL, V47, P883; Granado MH, 2009, CELL SIGNAL, V21, P405, DOI 10.1016/j.cellsig.2008.11.003; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hankins JL, 2011, J BIOL CHEM, V286, P44357, DOI 10.1074/jbc.M111.264010; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Hou YC, 2008, CANCER INVEST, V26, P809, DOI 10.1080/07357900801898664; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Juarez JG, 2012, BLOOD, V119, P707, DOI 10.1182/blood-2011-04-348904; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Kim CH, 2012, LEUKEMIA, V26, P106, DOI 10.1038/leu.2011.185; Kim TJ, 2011, EXP CELL RES, V317, P2041, DOI 10.1016/j.yexcr.2011.05.011; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kooijman EE, 2009, BIOPHYS J, V96, P2204, DOI 10.1016/j.bpj.2008.11.062; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; KRISTOFFERSEN EK, 1994, SCAND J IMMUNOL, V40, P237, DOI 10.1111/j.1365-3083.1994.tb03456.x; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Lamour NF, 2011, J BIOL CHEM, V286, P42808, DOI 10.1074/jbc.M111.310169; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Lijnen HR, 1998, THROMB HAEMOSTASIS, V79, P1171; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; McElwain MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026993; Menke M, 2004, CHEMBIOCHEM, V5, P1003, DOI 10.1002/cbic.200400004; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Mitra P, 2007, FEBS LETT, V581, P735, DOI 10.1016/j.febslet.2007.01.041; O'Neill Sean M, 2008, Vasc Dis Prev, V5, P200, DOI 10.2174/156727008785133809; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; Ratajczak MZ, 2012, LEUKEMIA, V26, P63, DOI 10.1038/leu.2011.242; Ratajczak MZ, 2012, ADV EXP MED BIOL, V946, P37, DOI 10.1007/978-1-4614-0106-3_3; Ross M, 2003, BIOCHEMISTRY-US, V42, P3131, DOI 10.1021/bi027069z; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; SATO Y, 1993, EXP CELL RES, V204, P223, DOI 10.1006/excr.1993.1028; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Surette AP, 2011, BLOOD, V118, P3172, DOI 10.1182/blood-2011-05-353482; Waisman DM, 2005, BRIT J HAEMATOL, V131, P553, DOI 10.1111/j.1365-2141.2005.05805.x; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Ward KE, 2013, J LIPID RES, V54, P636, DOI 10.1194/jlr.M031088; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	65	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19726	19738		10.1074/jbc.M113.481622	http://dx.doi.org/10.1074/jbc.M113.481622			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696646	hybrid, Green Published			2022-12-25	WOS:000321515800042
J	Scaglione, KM; Basrur, V; Ashraf, NS; Konen, JR; Elenitoba-Johnson, KSJ; Todi, SV; Paulson, HL				Scaglione, Kenneth Matthew; Basrur, Venkatesha; Ashraf, Naila S.; Konen, John R.; Elenitoba-Johnson, Kojo S. J.; Todi, Sokol V.; Paulson, Henry L.			The Ubiquitin-conjugating Enzyme (E2) Ube2w Ubiquitinates the N Terminus of Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE; MHC-I; DEGRADATION; LYSINE; RESIDUES; UBIQUITYLATION; MECHANISM; ATAXIN-3; CYSTEINE; REVEALS	Attachment of ubiquitin to substrate is typically thought to occur via formation of an isopeptide bond between the C-terminal glycine residue of ubiquitin and a lysine residue in the substrate. In vitro, Ube2w is nonreactive with free lysine yet readily ubiquitinates substrate. Ube2w also contains novel residues within its active site that are important for its ability to ubiquitinate substrate. To identify the site of modification, we analyzed ubiquitinated substrates by mass spectrometry and found the N-terminal -NH2 group as the site of conjugation. To confirm N-terminal ubiquitination, we generated lysine-less and N-terminally blocked versions of one substrate, the polyglutamine disease protein ataxin-3, and showed that Ube2w can ubiquitinate a lysine-less, but not N-terminally blocked, ataxin-3. This was confirmed with a second substrate, the neurodegenerative disease protein Tau. Finally, we directly sequenced the N terminus of unmodified and ubiquitinated ataxin-3, demonstrating that Ube2w attaches ubiquitin to the N terminus of its substrates. Together these data demonstrate that Ube2w has novel enzymatic properties that direct ubiquitination of the N terminus of substrates.	[Scaglione, Kenneth Matthew; Ashraf, Naila S.; Konen, John R.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Todi, Sokol V.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Scaglione, KM (corresponding author), Univ Michigan, Sch Med, Dept Neurol, 109 Zina Pitcher Pl,4001 BSRB, Ann Arbor, MI 48109 USA.	kscaglio@umich.edu; henryp@umich.edu		Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health [K99 NS073936, R00 NS064097, R01 AG034228, R01 NS038712]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS073936, R01NS038712, R00NS064097, R00NS073936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K99 NS073936 (to K. M. S.), R00 NS064097 (to S. V. T.), and R01 AG034228 and R01 NS038712 (to H. L. P.).	Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Barghorn Stefan, 2004, V299, P35; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Ikeda M, 2002, VIROLOGY, V300, P153, DOI 10.1006/viro.2002.1562; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Tokunaga F, 2012, ENDOCR J, V59, P641, DOI 10.1507/endocrj.EJ12-0148; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	36	66	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18784	18788		10.1074/jbc.C113.477596	http://dx.doi.org/10.1074/jbc.C113.477596			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23696636	hybrid, Green Published			2022-12-25	WOS:000321335800016
J	Piana, A; Sotgiu, G; Cocuzza, C; Musumeci, R; Marras, V; Pischedda, S; Deidda, S; Muresu, E; Castiglia, P				Piana, Andrea; Sotgiu, Giovanni; Cocuzza, Clementina; Musumeci, Rosario; Marras, Vincenzo; Pischedda, Stefania; Deidda, Silvia; Muresu, Elena; Castiglia, Paolo			High HPV-51 Prevalence in Invasive Cervical Cancers: Results of a Pre-Immunization Survey in North Sardinia, Italy	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS GENOTYPE; CROSS-PROTECTIVE EFFICACY; HIV-INFECTED WOMEN; RISK; EPIDEMIOLOGY; VACCINATION; PERSISTENCE; DISEASE; LESIONS; IMPACT	Background: Human Papilloma virus (HPV) is recognized as the etiological agent of benign and malignant ano-genital lesions. The most prevalent genotypes associated with cervical carcinoma are HPV-16 and -18 worldwide. However, recent studies have emphasized the role of other genotypes, such as HPV-51, in the pathogenesis of cervical dysplasia. The aim of the study was to estimate the burden of HPV-51 infection in invasive cervical malignant lesions in Northern Sardinia, Italy. Methods/Principal Findings: An observational, retrospective, prevalence, mono-center study was carried out to evaluate the presence of HPV genotypes in tissues biopsies of cervical lesions (CIN-1, CIN-2, CIN-3 and invasive carcinoma) gathered from 1996 to 2009. Biological samples were collected from women admitted consecutively to a tertiary university hospital situated in Sassari, Italy. Molecular methods were used to identify 28 oncogenic HPV types. A total of 155 formalin-fixed and paraffin-embedded cervical tissue samples were analyzed. Approximately half of the cervical lesions were classified as invasive carcinoma. HPV-DNA was detected in 71% of the samples, with a higher frequency (100%) in those categorized as invasive neoplasia. Mono-or co-infections were demonstrated in 45.8% and 25.8% of the cervical samples, respectively. Overall, the most prevalent HPV types were -16 (49%) and -51 (19.4%), with an increased frequency of detection associated with the severity of the cervical lesions. Conclusions/Significance: This survey highlights for the first time the relevant role of HPV-51 infection in the pathogenesis of invasive cervical cancer prior to the introduction of a vaccination program. Although a selection bias could have influenced the results, other recent studies have described the impact of HPV-51. This remarkable epidemiological element should be carefully evaluated, particularly in the view of opting for preventive vaccines, whose cross-protection patterns determine their efficacy in protecting against infection from HPV types that are not included in the vaccine itself.	[Piana, Andrea; Sotgiu, Giovanni; Pischedda, Stefania; Deidda, Silvia; Muresu, Elena; Castiglia, Paolo] Univ Sassari, Dept Biomed Sci, Hyg & Prevent Med Unit, AOU Sassari, I-07100 Sassari, Italy; [Cocuzza, Clementina; Musumeci, Rosario] Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, Milan, Italy; [Marras, Vincenzo] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy	University of Sassari; University of Milano-Bicocca; University of Sassari	Castiglia, P (corresponding author), Univ Sassari, Dept Biomed Sci, Hyg & Prevent Med Unit, AOU Sassari, I-07100 Sassari, Italy.	paolo.castiglia@uniss.it	Musumeci, Rosario/B-8306-2008; Cocuzza, Clementina Elvezia/AAE-2064-2019; Sotgiu, Giovanni/N-1032-2017	Musumeci, Rosario/0000-0003-0143-3601; Cocuzza, Clementina Elvezia/0000-0001-6166-1134; Sotgiu, Giovanni/0000-0002-1600-4474; PIANA, Andrea Fausto/0000-0002-6609-8886; Castiglia, Paolo/0000-0002-0972-4828	Sardinian Region from Ricerca sanitaria finalizzata -2006; Ministry of University	Sardinian Region from Ricerca sanitaria finalizzata -2006; Ministry of University	This work was supported by the Sardinian Region (grant for EM from Ricerca sanitaria finalizzata -2006) and by the Ministry of University (fellowship for SP and SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarossi A, 2009, J MED VIROL, V81, P529, DOI 10.1002/jmv.21347; Balbi G, 2012, EUR J GYNAECOL ONCOL, V33, P467; Broccolo F, 2009, J MED VIROL, V81, P278, DOI 10.1002/jmv.21395; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Faridi R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-269; Gargiulo F, 2007, VIRUS RES, V125, P176, DOI 10.1016/j.virusres.2006.12.017; Garnett GP, 2000, J CLIN VIROL, V19, P101, DOI 10.1016/S1386-6532(00)00129-3; GOLDMAN B, 2013, VACCINE; Guido M, 2013, CURR PHARM DESIGN, V19, P1498; IARC, 2011, IARC MON EV CARC R B, V100; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mane A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038731; Masia G, 2009, VACCINE, V27, pA11, DOI 10.1016/j.vaccine.2008.10.095; Merikukka M, 2011, INT J CANCER, V128, P1114, DOI 10.1002/ijc.25675; Mollers M, 2013, VACCINE, V31, P394, DOI 10.1016/j.vaccine.2012.10.087; Mollers M, 2012, CANCER EPIDEMIOL, V36, P519, DOI 10.1016/j.canep.2012.07.006; Panatto D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-623; Piana A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-785; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sandri MT, 2009, J MED VIROL, V81, P271, DOI 10.1002/jmv.21382; Schiffman M, 2012, LANCET ONCOL, V13, P10, DOI 10.1016/S1470-2045(11)70324-2; SCHMEINK C, 2012, INT J CANC; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Venturoli S, 2008, J MED VIROL, V80, P1434, DOI 10.1002/jmv.21198; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC WOR; Xi LF, 2003, INT J CANCER, V103, P803, DOI 10.1002/ijc.10876; Zhang HY, 2012, ASIAN PAC J CANCER P, V13, P91, DOI 10.7314/APJCP.2012.13.1.091	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63395	10.1371/journal.pone.0063395	http://dx.doi.org/10.1371/journal.pone.0063395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717420	gold, Green Published, Green Submitted			2022-12-25	WOS:000320362700018
J	Campanella, F; Fabbro, F; Urgesi, C				Campanella, Fabio; Fabbro, Franco; Urgesi, Cosimo			Cognitive and Anatomical Underpinnings of the Conceptual Knowledge for Common Objects and Familiar People: A Repetitive Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							FUSIFORM FACE AREA; SEMANTIC DEMENTIA; FAMOUS FACES; PROPER-NAMES; RECOGNITION; APHASIA; ORGANIZATION; ACCESS; REPRESENTATION; MEMORY	Several studies have addressed the issue of how knowledge of common objects is organized in the brain, whereas the cognitive and anatomical underpinnings of familiar people knowledge have been less explored. Here we applied repetitive transcranial magnetic stimulation (rTMS) over the left and right temporal poles before asking healthy individuals to perform a speeded word-to-picture matching task using familiar people and common objects as stimuli. We manipulated two widely used semantic variables, namely the semantic distance and the familiarity of stimuli, to assess whether the semantic organization of familiar people knowledge is similar to that of common objects. For both objects and faces we reliably found semantic distance and familiarity effects, with less accurate and slower responses for stimulus pairs that were more closely related and less familiar. However, the effects of semantic variables differed across categories, with semantic distance effects larger for objects and familiarity effects larger for faces, suggesting that objects and faces might share a partially comparable organization of their semantic representations. The application of rTMS to the left temporal pole modulated, for both categories, semantic distance, but not familiarity effects, revealing that accessing object and face concepts might rely on overlapping processes within left anterior temporal regions. Crucially, rTMS of the left temporal pole affected only the recognition of pairs of stimuli that could be discriminated at specific levels of categorization (e.g., two kitchen tools or two famous persons), with no effect for discriminations at either superordinate or individual levels. Conversely, rTMS of the right temporal pole induced an overall slowing of reaction times that positively correlated with the visual similarity of the stimuli, suggesting a more perceptual rather than semantic role of the right anterior temporal regions. Results are discussed in the light of current models of face and object semantic representations in the brain.	[Campanella, Fabio] Azienda Osped Univ Santa Maria Misericord, Neurosurg Unit, Udine, Italy; [Campanella, Fabio; Fabbro, Franco; Urgesi, Cosimo] Univ Udine, Dept Human Sci, I-33100 Udine, Italy; [Fabbro, Franco; Urgesi, Cosimo] Ist Ricovero & Cura Carattere Sci E Medea, San Vito Al Tagliamento, Pordenone, Italy	Hospital Santa Maria della Misericordia; University of Udine; IRCCS Eugenio Medea	Campanella, F (corresponding author), Azienda Osped Univ Santa Maria Misericord, Neurosurg Unit, Udine, Italy.	fabio.campanella@uniud.it	Urgesi, Cosimo/K-4688-2016	Urgesi, Cosimo/0000-0003-0572-1328; FABBRO, Franco/0000-0003-3476-6867	Fondazione Cassa di Risparmio di Udine e Pordenone (CRUP); Scientific Institute (IRCCS) 'E. Medea' (Ricerca Corrente, Italian Ministry of Health); Consorzio Universitario Italia Argentina (CUIA)	Fondazione Cassa di Risparmio di Udine e Pordenone (CRUP); Scientific Institute (IRCCS) 'E. Medea' (Ricerca Corrente, Italian Ministry of Health); Consorzio Universitario Italia Argentina (CUIA)	This work was supported by grants from Fondazione Cassa di Risparmio di Udine e Pordenone (CRUP) (http://www.fondazionecrup.it/)to FF, and from Scientific Institute (IRCCS) 'E. Medea' (Ricerca Corrente 2011, Italian Ministry of Health) and Consorzio Universitario Italia Argentina (CUIA) (http://www.cuia.net/) to CU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertinetto PM, CORPUS LESSICO FREQU; Brambati SM, 2006, J COGNITIVE NEUROSCI, V18, P1644, DOI 10.1162/jocn.2006.18.10.1644; BRIGGS G G, 1975, Cortex, V11, P230; Campanella F, 2010, NEUROPSYCHOLOGIA, V48, P1583, DOI 10.1016/j.neuropsychologia.2010.02.002; Campanella F, 2009, BRAIN, V132, P87, DOI 10.1093/brain/awn302; Capitani E, 2003, COGN NEUROPSYCHOL, V20, P213, DOI 10.1080/02643290244000266; Crutch SJ, 2005, COGN NEUROPSYCHOL, V22, P851, DOI 10.1080/02643290442000374; Crutch SJ, 2005, BRAIN, V128, P615, DOI 10.1093/brain/awh349; Crutch SJ, 2004, NEUROPSYCHOLOGIA, V42, P584, DOI 10.1016/j.neuropsychologia.2003.10.009; Crutch SJ, 2003, BRAIN, V126, P1821, DOI 10.1093/brain/awg187; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Douville K, 2005, NEUROPSYCHOLOGIA, V43, P693, DOI 10.1016/j.neuropsychologia.2004.09.005; EVANS JJ, 1995, BRAIN, V118, P1, DOI 10.1093/brain/118.1.1; FORDE E, 1995, MEMORY, V3, P265, DOI 10.1080/09658219508253154; Gainotti G, 2000, CORTEX, V36, P539, DOI 10.1016/S0010-9452(08)70537-9; Gainotti G, 2007, NEUROPSYCHOLOGIA, V45, P1591, DOI 10.1016/j.neuropsychologia.2006.12.013; Gainotti G, 2012, CORTEX, V48, P521, DOI 10.1016/j.cortex.2011.06.019; Gauthier I, 2003, COGN NEUROPSYCHOL, V20, P507, DOI 10.1080/02643290244000275; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Gorno-Tempini ML, 2001, BRAIN, V124, P2087, DOI 10.1093/brain/124.10.2087; Gross CG, 2002, NEUROSCIENTIST, V8, P512, DOI 10.1177/107385802237175; HINTON GE, 1991, PSYCHOL REV, V98, P74, DOI 10.1037/0033-295X.98.1.74; Hodges JR, 1998, NEUROPSYCHOLOGIA, V36, P803, DOI 10.1016/S0028-3932(97)00126-7; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Jefferies E, 2007, NEUROPSYCHOLOGIA, V45, P1065, DOI 10.1016/j.neuropsychologia.2006.09.009; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KERR NH, 1982, MEM COGNITION, V10, P603, DOI 10.3758/BF03202443; Kitchener EG, 1999, COGNITIVE NEUROPSYCH, V16, P589, DOI 10.1080/026432999380744; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lubrano V, 2014, HUM BRAIN MAPP, V35, P429, DOI 10.1002/hbm.22189; MCNEIL JE, 1994, NEUROPSYCHOLOGIA, V32, P193, DOI 10.1016/0028-3932(94)90005-1; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; NOBLE CE, 1954, J EXP PSYCHOL, V47, P13, DOI 10.1037/h0060025; Papagno C, 2001, NEUROPSYCHOLOGIA, V39, P678, DOI 10.1016/S0028-3932(01)00007-0; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; PLAUT DC, 1993, COGNITIVE NEUROPSYCH, V10, P377, DOI 10.1080/02643299308253469; Pobric G, 2007, P NATL ACAD SCI USA, V104, P20137, DOI 10.1073/pnas.0707383104; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ralph MAL, 2009, CEREB CORTEX, V19, P832, DOI 10.1093/cercor/bhn131; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Seidenberg M, 2002, NEUROPSYCHOLOGIA, V40, P446, DOI 10.1016/S0028-3932(01)00096-3; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; SEMENZA C, 1988, COGNITIVE NEUROPSYCH, V5, P711, DOI 10.1080/02643298808253279; SMITH RC, 1971, J EXP PSYCHOL, V88, P279, DOI 10.1037/h0031002; Snowden J., 1989, BEHAV NEUROL, V2, P167, DOI [DOI 10.1093/NEUCAS/1.1.39-Y, https://doi.org/10.1155/1989/124043, DOI 10.1155/1989/124043]; Snowden JS, 2004, BRAIN, V127, P860, DOI 10.1093/brain/awh099; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thompson SA, 2004, NEUROPSYCHOLOGIA, V42, P359, DOI 10.1016/j.neuropsychologia.2003.08.004; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; TYRRELL PJ, 1990, J NEUROL NEUROSUR PS, V53, P1046, DOI 10.1136/jnnp.53.12.1046; WARRINGTON EK, 1979, BRAIN, V102, P43, DOI 10.1093/brain/102.1.43; Warrington EK, 2004, COGN NEUROPSYCHOL, V21, P299, DOI 10.1080/02643290342000546; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Warrington EK, 1996, BRAIN, V119, P611, DOI 10.1093/brain/119.2.611; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	63	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64596	10.1371/journal.pone.0064596	http://dx.doi.org/10.1371/journal.pone.0064596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704999	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200153
J	Drozak, J; Chrobok, L; Poleszak, O; Jagielski, AK; Derlacz, R				Drozak, Jakub; Chrobok, Lukasz; Poleszak, Olga; Jagielski, Adam K.; Derlacz, Rafal			Molecular Identification of Carnosine N-Methyltransferase as Chicken Histamine N-Methyltransferase-Like Protein (HNMT-Like)	PLOS ONE			English	Article							AUTONOMIC NERVES; SKELETAL-MUSCLE; ANSERINE; HUMANS	Anserine (beta-alanyl-N(Pi)-methyl-L-histidine), a naturally occurring derivative of carnosine (beta-alanyl-L-histidine), is an abundant constituent of skeletal muscles and brain of many vertebrates. Although it has long been proposed to serve as a proton buffer, radicals scavenger and transglycating agent, its physiological function remains obscure. The formation of anserine is catalyzed by carnosine N-methyltransferase which exhibits unknown molecular identity. In the present investigation, we have purified carnosine N-methyltransferase from chicken pectoral muscle about 640-fold until three major polypeptides of about 23, 26 and 37 kDa coeluting with the enzyme were identified in the preparation. Mass spectrometry analysis of these polypeptides resulted in an identification of histamine N-methyltransferase-like (HNMT-like) protein as the only meaningful candidate. Analysis of GenBank database records indicated that the hnmt-like gene might be a paralogue of histamine N-methyltransferase gene, while comparison of their protein sequences suggested that HNMT-like protein might have acquired a new activity. Chicken HNMT-like protein was expressed in COS-7 cells, purified to homogeneity, and shown to catalyze the formation of anserine as confirmed by both chromatographic and mass spectrometry analysis. Both specificity and kinetic studies carried out on the native and recombinant enzyme were in agreement with published data. Particularly, several compounds structurally related to carnosine, including histamine and L-histidine, were tested as potential substrates for the enzyme, and carnosine was the only methyl group acceptor. The identification of the gene encoding carnosine N-methyltransferase might be beneficial for estimation of the biological functions of anserine.	[Drozak, Jakub; Chrobok, Lukasz; Poleszak, Olga; Jagielski, Adam K.; Derlacz, Rafal] Univ Warsaw, Inst Biochem, Dept Metab Regulat, Fac Biol, Warsaw, Poland	University of Warsaw	Drozak, J (corresponding author), Univ Warsaw, Inst Biochem, Dept Metab Regulat, Fac Biol, Warsaw, Poland.	jdrozak@biol.uw.edu.pl		Drozak, Jakub/0000-0002-3601-3845; Krupska, Olga/0000-0003-3218-7108	Polish Ministry of Science and Higher Education [Decision 0081/P01/2010/70]; European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"; Ministry of Science and Higher Education from Funds of Science and Polish Technology [Decision 372/FNiTP/115/2009]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union - the European Regional Development Fund within the Operational Programme "Innovative economy"; Ministry of Science and Higher Education from Funds of Science and Polish Technology	This work was supported by the Iuventus Plus grant (Decision 0081/P01/2010/70) from the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/home/). It was carried out with the use of CePT infrastructure financed by the European Union - the European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013 (https://cept.wum.edu.pl/). Dionex ICS-3000 chromatograph used for dipeptide measurements was financed by Ministry of Science and Higher Education from Funds of Science and Polish Technology (Decision 372/FNiTP/115/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boldyrev AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P313, DOI 10.1134/S0006297912040013; Boldyrev A.A., 2007, CARNOSINE OXIDATIVE; BOWSHER RR, 1983, J BIOL CHEM, V258, P2215; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; FRANCIS DM, 1980, BIOCHEM J, V187, P819, DOI 10.1042/bj1870819; GE Healthcare, 2010, GEL FILTR PRINC METH, P31; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubomura D, 2010, NUTR NEUROSCI, V13, P183, DOI 10.1179/147683010X12611460764363; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; MCMANUS IR, 1962, J BIOL CHEM, V237, P1207; Mora L, 2007, J AGR FOOD CHEM, V55, P4664, DOI 10.1021/jf0703809; Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007; Pegova A, 2000, COMP BIOCHEM PHYS B, V127, P443, DOI 10.1016/S0305-0491(00)00279-0; RAGHAVAN M, 1992, EUR J BIOCHEM, V210, P311, DOI 10.1111/j.1432-1033.1992.tb17423.x; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Szwergold BS, 2005, BIOCHEM BIOPH RES CO, V336, P36, DOI 10.1016/j.bbrc.2005.08.033; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; WHITAKER JR, 1963, ANAL CHEM, V35, P1950, DOI 10.1021/ac60205a048; Wong Alvin, 2006, Natl Cathol Bioeth Q, V6, P473	27	28	30	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64805	10.1371/journal.pone.0064805	http://dx.doi.org/10.1371/journal.pone.0064805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705015	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200169
J	Fattash, I; Bhardwaj, P; Hui, C; Yang, GY				Fattash, Isam; Bhardwaj, Priyanka; Hui, Caleb; Yang, Guojun			A Rice Stowaway MITE for Gene Transfer in Yeast	PLOS ONE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; CHROMOSOMAL TRANSPOSITION; TC1/MARINER-LIKE ELEMENT; HIGH-COPY; FAMILY; DROSOPHILA; DNA; MOBILIZATION; PLASMID; AMPLIFICATION	Miniature inverted repeat transposable elements (MITEs) lack protein coding capacity and often share very limited sequence similarity with potential autonomous elements. Their capability of efficient transposition and dramatic amplification led to the proposition that MITEs are an untapped rich source of materials for transposable element (TE) based genetic tools. To test the concept of using MITE sequence in gene transfer, a rice Stowaway MITE previously shown to excise efficiently in yeast was engineered to carry cargo genes (neo and gfp) for delivery into the budding yeast genome. Efficient excision of the cargo gene cassettes was observed even though the excision frequency generally decreases with the increase of the cargo sizes. Excised elements insert into new genomic loci efficiently, with about 65% of the obtained insertion sites located in genes. Elements at the primary insertion sites can be remobilized, frequently resulting in copy number increase of the element. Surprisingly, the orientation of a cargo gene (neo) on a construct bearing dual reporter genes (gfp and neo) was found to have a dramatic effect on transposition frequency. These results demonstrated the concept that MITE sequences can be useful in engineering genetic tools to deliver cargo genes into eukaryotic genomes.	[Fattash, Isam; Bhardwaj, Priyanka; Hui, Caleb; Yang, Guojun] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Yang, GY (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	gage.yang@utoronto.ca	Fattash, Isam/J-3078-2013	Fattash, Isam/0000-0001-6227-8487	National Sciences and Engineering Research Council (NSERC) Discovery Grant (Canada) [RGPIN 371565]; Canadian Foundation for Innovation [CFI24456, IOF-12]; Ontario Research Foundation [ORF24456]; University of Toronto	National Sciences and Engineering Research Council (NSERC) Discovery Grant (Canada); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Foundation; University of Toronto(University of Toronto)	Supported by the National Sciences and Engineering Research Council (NSERC) Discovery Grant (Canada) (RGPIN 371565 to GY), Canadian Foundation for Innovation (CFI24456 and IOF-12 to GY) and Ontario Research Foundation (ORF24456 to GY) and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Casa AM, 2002, THEOR APPL GENET, V104, P104, DOI 10.1007/s001220200012; CHANDLER M, 1982, J MOL BIOL, V154, P229, DOI 10.1016/0022-2836(82)90062-6; Chang RY, 2001, THEOR APPL GENET, V102, P773, DOI 10.1007/s001220051709; Charrier B, 1999, PLANT J, V18, P431, DOI 10.1046/j.1365-313X.1999.00469.x; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dufresne M, 2008, FUNGAL GENET BIOL, V45, P1552, DOI 10.1016/j.fgb.2008.09.004; Evertts AG, 2007, GENETICS, V177, P2519, DOI 10.1534/genetics.107.081075; Fadool JM, 1998, P NATL ACAD SCI USA, V95, P5182, DOI 10.1073/pnas.95.9.5182; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; GARFINKEL DJ, 1988, GENETICS, V120, P95; GORYSHIN IY, 1994, P NATL ACAD SCI USA, V91, P10834, DOI 10.1073/pnas.91.23.10834; Gueiros FJ, 1997, SCIENCE, V277, P753; Hancock CN, 2011, PLANT PHYSIOL, V157, P552, DOI 10.1104/pp.111.181206; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; HSIAO CL, 1981, GENE, V15, P157, DOI 10.1016/0378-1119(81)90125-6; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kwon SJ, 2006, MOL CELLS, V21, P360; Langdon T, 2003, GENETICS, V163, P1097; Li J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1358; LI X, 2012, P NATL ACAD SCI US; Lin XY, 2006, J EXP BOT, V57, P2313, DOI 10.1093/jxb/erj203; Lozovsky ER, 2002, GENETICS, V160, P527; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; MEAD DJ, 1986, MOL GEN GENET, V205, P417, DOI 10.1007/BF00338076; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Momose M, 2010, GENETICS, V186, P59, DOI 10.1534/genetics.110.117606; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Parekh RN, 1996, BIOTECHNOL PROGR, V12, P16, DOI 10.1021/bp9500627; Patel M, 2004, THEOR APPL GENET, V108, P1492, DOI 10.1007/s00122-004-1590-3; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Takahashi H, 2006, GENOME, V49, P1616, DOI 10.1139/G06-115; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; WAY JC, 1985, GENETICS, V111, P705; Weil CF, 2000, NAT GENET, V26, P187, DOI 10.1038/82827; YAAKOV B, 2012, PLANT PHYSL; Yaakov B, 2012, THEOR APPL GENET, V124, P1365, DOI 10.1007/s00122-012-1793-y; Yang G, 2001, MOL GENET GENOMICS, V266, P417, DOI 10.1007/s004380100530; Yang GJ, 2003, J MOL EVOL, V56, P255, DOI 10.1007/s00239-002-2397-y; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Yang GJ, 2006, PLANT CELL, V18, P2469, DOI 10.1105/tpc.106.045906; Yang GJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-283; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688; ZAKIAN VA, 1979, CELL, V17, P923, DOI 10.1016/0092-8674(79)90332-5; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	56	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64135	10.1371/journal.pone.0064135	http://dx.doi.org/10.1371/journal.pone.0064135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704977	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200119
J	Gonzalez, A; Casado, C; Arino, J; Casamayor, A				Gonzalez, Asier; Casado, Carlos; Arino, Joaquin; Casamayor, Antonio			Ptc6 Is Required for Proper Rapamycin-Induced Down-Regulation of the Genes Coding for Ribosomal and rRNA Processing Proteins in S-cerevisiae	PLOS ONE			English	Article							YEAST; PHOSPHATASE; TOR; EXPRESSION; 2C; COMPLEX; GENOME; TARGET; STRESS; ROLES	Ptc6 is one of the seven components (Ptc1-Ptc7) of the protein phosphatase 2C family in the yeast Saccharomyces cerevisiae. In contrast to other type 2C phosphatases, the cellular role of this isoform is poorly understood. We present here a comprehensive characterization of this gene product. Cells lacking Ptc6 are sensitive to zinc ions, and somewhat tolerant to cell-wall damaging agents and to Li+. Ptc6 mutants are sensitive to rapamycin, albeit to lesser extent than ptc1 cells. This phenotype is not rescued by overexpression of PTC1 and mutation of ptc6 does not reproduce the characteristic genetic interactions of the ptc1 mutation with components of the TOR pathway, thus suggesting different cellular roles for both isoforms. We show here that the rapamycin-sensitive phenotype of ptc6 cells is unrelated to the reported role of Pt6 in controlling pyruvate dehydrogenase activity. Lack of Ptc6 results in substantial attenuation of the transcriptional response to rapamycin, particularly in the subset of repressed genes encoding ribosomal proteins or involved in rRNA processing. In contrast, repressed genes involved in translation are Ptc6-independent. These effects cannot be attributed to the regulation of the Sch9 kinase, but they could involve modulation of the binding of the Ifh1 co-activator to specific gene promoters.	[Casamayor, Antonio] Univ Autonoma Barcelona, Fac Vet, IBB, Cerdanyola De Valles, Spain; Univ Autonoma Barcelona, Fac Vet, Dept Bioquim & Biol Mol, Cerdanyola De Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Casamayor, A (corresponding author), Univ Autonoma Barcelona, Fac Vet, IBB, Cerdanyola De Valles, Spain.	Antonio.Casamayor@uab.es	Casamayor, Antonio/A-3190-2012; Casamayor, Antonio/C-2509-2017; González, Asier/A-7064-2012; Arino, Joaquin/D-3756-2011	Casamayor, Antonio/0000-0003-2788-7329; Arino, Joaquin/0000-0002-6774-2987; Arino Carmona, Joaquin/0000-0002-0390-4270	SysMo2 [EUI2009-04147]; Ministry of Science and Innovation, Spain; FEDER; Ajut de Suport a les Activitats dels Grups de Recerca [2009SGR-1091]; ICREA Academia Award (Generalitat de Catalunya);  [BFU2009-11593];  [BFU2011-30197-C3-01]	SysMo2; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Ajut de Suport a les Activitats dels Grups de Recerca; ICREA Academia Award (Generalitat de Catalunya)(ICREA); ; 	Supported by grants BFU2009-11593 to A.C. and EUI2009-04147 (SysMo2) and BFU2011-30197-C3-01 to J.A., and Ministry of Science and Innovation, Spain, and FEDER. J.A. is the recipient of "Ajut de Suport a les Activitats dels Grups de Recerca'' (Grant 2009SGR-1091) and an ICREA Academia Award (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Abeliovich H, 2011, ANTIOXID REDOX SIGN, V14, P2003, DOI 10.1089/ars.2010.3807; Adams A, 1997, METHODS YEAST GENETI; Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Alberola TM, 2004, INT MICROBIOL, V7, P199; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Calero F, 2000, J BACTERIOL, V182, P394, DOI 10.1128/JB.182.2.394-399.2000; Casamayor A, 2012, BIOCHEM J, V444, P39, DOI 10.1042/BJ20112099; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferrer-Dalmau J, 2010, BIOCHEM J, V426, P355, DOI 10.1042/BJ20091909; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gonzalez A, 2009, MOL CELL BIOL, V29, P2876, DOI 10.1128/MCB.01740-08; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karra K, 2012, DATABASE; Kim EM, 2011, J PEPT SCI, V17, P392, DOI 10.1002/psc.1312; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruiz A, 2008, J BIOL CHEM, V283, P13923, DOI 10.1074/jbc.M708683200; Ruiz A, 2006, MOL MICROBIOL, V62, P263, DOI 10.1111/j.1365-2958.2006.05370.x; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Sakumoto N, 2002, YEAST, V19, P587, DOI 10.1002/yea.860; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	55	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64470	10.1371/journal.pone.0064470	http://dx.doi.org/10.1371/journal.pone.0064470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704987	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200140
J	Hirano, T; Kobayashi, N; Matsuhashi, T; Watanabe, D; Watanabe, T; Takasuga, A; Sugimoto, M; Sugimoto, Y				Hirano, Takashi; Kobayashi, Naohiko; Matsuhashi, Tamako; Watanabe, Daisaku; Watanabe, Toshio; Takasuga, Akiko; Sugimoto, Mayumi; Sugimoto, Yoshikazu			Mapping and Exome Sequencing Identifies a Mutation in the IARS Gene as the Cause of Hereditary Perinatal Weak Calf Syndrome	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; QUANTITATIVE TRAIT LOCI; CATTLE; DEFICIENCY; GENOME; MAP	We identified an IARS (isoleucyl-tRNA synthetase) c.235G>C (p.Val79Leu) substitution as the causative mutation for neonatal weakness with intrauterine growth retardation (perinatal weak calf syndrome). In Japanese Black cattle, the syndrome was frequently found in calves sired by Bull A. Hence, we employed homozygosity mapping and linkage analysis. In order to identify the perinatal weak calf syndrome locus in a 4.04-Mb region of BTA 8, we analysed a paternal half-sibling family with a BovineSNP50 BeadChip and microsatellites. In this critical region, we performed exome sequencing to identify a causative mutation. Three variants were detected as possible candidates for causative mutations that were predicted to disrupt the protein function, including a G>C (p.Val79Leu) mutation in IARS c.235. The IARS c.235G>C mutation was not a homozygous risk allele in the 36 healthy offspring of Bull A. Moreover, the IARS Val79 residue and its flanking regions were evolutionarily and highly conserved. The IARS mutant (Leu79) had decreased aminoacylation activity. Additionally, the homozygous mutation was not found in any of 1526 healthy cattle. Therefore, we concluded that the IARS c.235G>C mutation was the cause of hereditary perinatal weak calf syndrome.	[Hirano, Takashi; Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Fukushima, Japan; [Hirano, Takashi] Tokyo Univ Agr, Kanagawa, Japan; [Kobayashi, Naohiko; Matsuhashi, Tamako] Gifu Prefectural Livestock Res Inst, Hida Beef Cattle Res Dept, Gifu, Japan; [Watanabe, Daisaku] Kitasato Univ, Sch Vet Med & Anim Sci, Aomori, Japan; [Watanabe, Toshio; Takasuga, Akiko; Sugimoto, Mayumi] Natl Livestock Breeding Ctr, Fukushima, Japan	Tokyo University of Agriculture; Kitasato University	Hirano, T (corresponding author), Shirakawa Inst Anim Genet, Fukushima, Japan.	t3hirano@nodai.ac.jp			Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This work was supported by grants from the Japan Racing and Livestock Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; CHURCHILL GA, 1994, GENETICS, V138, P963; Doi H, 2011, AM J HUM GENET, V89, P320, DOI 10.1016/j.ajhg.2011.07.012; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; HALEY CS, 1994, GENETICS, V136, P1195; Hirano T, 1996, ANIM GENET, V27, P365, DOI 10.1111/j.1365-2052.1996.tb00980.x; Hirano T, 2000, GENOME RES, V10, P659, DOI 10.1101/gr.10.5.659; Hirano T, 2012, ANIM GENET, V43, P11, DOI 10.1111/j.1365-2052.2011.02209.x; Ihara N, 2004, GENOME RES, V14, P1987, DOI 10.1101/gr.2741704; Inaba M, 1996, J CLIN INVEST, V97, P1804, DOI 10.1172/JCI118610; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kappes SM, 1997, GENOME RES, V7, P235, DOI 10.1101/gr.7.3.235; Kunieda M, 2005, MAMM GENOME, V16, P383, DOI 10.1007/s00335-004-2462-5; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Miyamoto Y, 2002, J BIOL CHEM, V277, P28810, DOI 10.1074/jbc.M203827200; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ogata Y, 1999, J VET MED A, V46, P327, DOI 10.1046/j.1439-0442.1999.00221.x; Ogawa H., 1996, Journal of Veterinary Medicine, Japan, V49, P411; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Takasu M, 2008, J VET MED SCI, V70, P1173, DOI 10.1292/jvms.70.1173; Visscher PM, 1996, GENETICS, V143, P1013; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xu SZ, 1996, GENETICS, V143, P1417; Yamakuchi H, 2000, ANIM GENET, V31, P13, DOI 10.1046/j.1365-2052.2000.00586.x	38	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64036	10.1371/journal.pone.0064036	http://dx.doi.org/10.1371/journal.pone.0064036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23700453	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200107
J	Kim, H; Choi, SH; Kim, JH; Ryoo, I; Kim, SC; Yeom, JA; Shin, H; Jung, SC; Lee, AL; Yun, TJ; Park, CK; Sohn, CH; Park, SH				Kim, Hyungjin; Choi, Seung Hong; Kim, Ji-Hoon; Ryoo, Inseon; Kim, Soo Chin; Yeom, Jeong A.; Shin, Hwaseon; Jung, Seung Chai; Lee, A. Leum; Yun, Tae Jin; Park, Chul-Kee; Sohn, Chul-Ho; Park, Sung-Hye			Gliomas: Application of Cumulative Histogram Analysis of Normalized Cerebral Blood Volume on 3 T MRI to Tumor Grading	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; PREDICTIVE VALUES; PERFUSION; MAPS; DIFFERENTIATION; SPECTROSCOPY; SPECIFICITY; SENSITIVITY; REGION; FLOW	Background: Glioma grading assumes significant importance in that low- and high-grade gliomas display different prognoses and are treated with dissimilar therapeutic strategies. The objective of our study was to retrospectively assess the usefulness of a cumulative normalized cerebral blood volume (nCBV) histogram for glioma grading based on 3 T MRI. Methods: From February 2010 to April 2012, 63 patients with astrocytic tumors underwent 3 T MRI with dynamic susceptibility contrast perfusion-weighted imaging. Regions of interest containing the entire tumor volume were drawn on every section of the co-registered relative CBV (rCBV) maps and T2-weighted images. The percentile values from the cumulative nCBV histograms and the other histogram parameters were correlated with tumor grades. Cochran's Q test and the McNemar test were used to compare the diagnostic accuracies of the histogram parameters after the receiver operating characteristic curve analysis. Using the parameter offering the highest diagnostic accuracy, a validation process was performed with an independent test set of nine patients. Results: The 99th percentile of the cumulative nCBV histogram (nCBV C99), mean and peak height differed significantly between low- and high-grade gliomas (P = <0.001, 0.014 and <0.001, respectively) and between grade III and IV gliomas (P = <0.001, 0.001 and <0.001, respectively). The diagnostic accuracy of nCBV C99 was significantly higher than that of the mean nCBV (P = 0.016) in distinguishing high- from low-grade gliomas and was comparable to that of the peak height (P = 1.000). Validation using the two cutoff values of nCBV C99 achieved a diagnostic accuracy of 66.7% (6/9) for the separation of all three glioma grades. Conclusion: Cumulative histogram analysis of nCBV using 3 T MRI can be a useful method for preoperative glioma grading. The nCBV C99 value is helpful in distinguishing high- from low-grade gliomas and grade IV from III gliomas.	[Kim, Hyungjin; Choi, Seung Hong; Kim, Ji-Hoon; Ryoo, Inseon; Kim, Soo Chin; Yeom, Jeong A.; Shin, Hwaseon; Jung, Seung Chai; Lee, A. Leum; Yun, Tae Jin; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chul-Kee] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Sohn, ChulHo/AAV-4565-2021; Park, Chul-Kee/J-5499-2012; Park, Chul-Kee/O-7842-2019	Park, Chul-Kee/0000-0002-2350-9876; Yun, Tae Jin/0000-0001-8441-4574; Choi, Seung Hong/0000-0002-0412-2270	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1120300]; Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs [A112028]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare technology R&D Projects, Ministry for Health, Welfare Family Affairs	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1120300) and the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (A112028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras J, 2011, NEURORADIOLOGY, V53, P483, DOI 10.1007/s00234-010-0769-3; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252; Bjornerud A, 2003, P HUM BRAIN MAPPING, P19; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2005, AM J NEURORADIOL, V26, P266; Choi SH, 2007, CLIN RADIOL, V62, P453, DOI 10.1016/j.crad.2006.12.001; Emblem KE, 2008, AM J NEURORADIOL, V29, P1664, DOI 10.3174/ajnr.A1182; Emblem KE, 2008, RADIOLOGY, V247, P808, DOI 10.1148/radiol.2473070571; Fink JR, 2012, J MAGN RESON IMAGING, V35, P56, DOI 10.1002/jmri.22801; Garzon B, 2011, ACTA RADIOL, V52, P1052, DOI 10.1258/ar.2011.100510; Hilario A, 2012, AM J NEURORADIOL, V33, P701, DOI 10.3174/ajnr.A2846; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Kim HS, 2010, RADIOLOGY, V256, P906, DOI 10.1148/radiol.10091461; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Law M, 2007, AM J NEURORADIOL, V28, P761; Law M, 2006, RADIOLOGY, V238, P658, DOI 10.1148/radiol.2382042180; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lev MH, 1999, NEUROIMAG CLIN N AM, V9, P309; Liu X, 2011, NEURO-ONCOLOGY, V13, P447, DOI 10.1093/neuonc/noq197; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Pedersen CL, 2013, CLIN NEUROL NEUROSUR, V115, P1, DOI 10.1016/j.clineuro.2012.07.002; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Schmainda KM, 2004, AM J NEURORADIOL, V25, P1524; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; Thomsen H, 2012, ACTA RADIOL, V53, P95, DOI 10.1258/ar.2011.110242; Tozer DJ, 2007, NMR BIOMED, V20, P49, DOI 10.1002/nbm.1091; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014; Yeh SA, 2005, BRIT J RADIOL, V78, P230, DOI 10.1259/bjr/28534346; Young R, 2007, J MAGN RESON IMAGING, V26, P1053, DOI 10.1002/jmri.21064; Zonari P, 2007, NEURORADIOLOGY, V49, P795, DOI 10.1007/s00234-007-0253-x	34	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63462	10.1371/journal.pone.0063462	http://dx.doi.org/10.1371/journal.pone.0063462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704910	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200042
J	Mitchell, G; Fugere, A; Gaudreau, KP; Brouillette, E; Frost, EH; Cantin, AM; Malouin, F				Mitchell, Gabriel; Fugere, Alexandre; Gaudreau, Karine Pepin; Brouillette, Eric; Frost, Eric H.; Cantin, Andre M.; Malouin, Francois			SigB Is a Dominant Regulator of Virulence in Staphylococcus aureus Small-Colony Variants	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; BIOFILM; EXPRESSION; AGR; PERSISTENT; OPERON; COLONIZATION; EVOLUTION; MUTANTS; STRAINS	Staphylococcus aureus small-colony variants (SCVs) are persistent pathogenic bacteria characterized by slow growth and, for many of these strains, an increased ability to form biofilms and to persist within host cells. The virulence-associated gene expression profile of SCVs clearly differs from that of prototypical strains and is often influenced by SigB rather than by the agr system. One objective of this work was to confirm the role of SigB in the control of the expression of virulence factors involved in biofilm formation and intracellular persistence of SCVs. This study shows that extracellular proteins are involved in the formation of biofilm by three SCV strains, which, additionally, have a low biofilm-dispersing activity. It was determined that SigB activity modulates biofilm formation by strain SCV CF07-S and is dominant over that of the agr system without being solely responsible for the repression of proteolytic activity. On the other hand, the expression of fnbA and the control of nuclease activity contributed to the SigB-dependent formation of biofilm of this SCV strain. SigB was also required for the replication of CF07-S within epithelial cells and may be involved in the colonization of lungs by SCVs in a mouse infection model. This study methodically investigated SigB activity and associated mechanisms in the various aspects of SCV pathogenesis. Results confirm that SigB activity importantly influences the production of virulence factors, biofilm formation and intracellular persistence for some clinical SCV strains.	[Mitchell, Gabriel; Fugere, Alexandre; Gaudreau, Karine Pepin; Brouillette, Eric; Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, Ctr Etude & Valorisat Div Microbienne, Sherbrooke, PQ J1K 2R1, Canada; [Cantin, Andre M.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada; [Cantin, Andre M.] Univ Sherbrooke, Fac Med & Sci Sante, Unite Rech Pulm, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Malouin, F (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, Ctr Etude & Valorisat Div Microbienne, Sherbrooke, PQ J1K 2R1, Canada.	Francois.Malouin@USherbrooke.ca		Malouin, Francois/0000-0001-5031-345X; Frost, Eric/0000-0001-8958-4388	Cystic Fibrosis Canada; Alexander-Graham-Bell Graduate Scholarship from the Natural Science and Engineering Research Council of Canada; Fonds quebecois de la recherche sur la nature et les technologies	Cystic Fibrosis Canada; Alexander-Graham-Bell Graduate Scholarship from the Natural Science and Engineering Research Council of Canada; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	This study was supported by a grant from Cystic Fibrosis Canada (http://www.cysticfibrosis.ca/en/index.php). GM was the recipient of an Alexander-Graham-Bell Graduate Scholarship from the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) and received a doctoral research scholarship from the Fonds quebecois de la recherche sur la nature et les technologies (http://www.fqrnt.gouv.qc.ca) during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Bates DM, 2003, J INFECT DIS, V187, P1654, DOI 10.1086/374642; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Brouillette E, 2004, FEMS IMMUNOL MED MIC, V41, P35, DOI 10.1016/j.femsim.2003.12.007; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cui LZ, 2012, P NATL ACAD SCI USA, V109, pE1647, DOI 10.1073/pnas.1204307109; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marti M, 2010, MICROBES INFECT, V12, P55, DOI 10.1016/j.micinf.2009.10.005; Mitchell G, 2011, INFECT IMMUN, V79, P3541, DOI 10.1128/IAI.00078-11; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Mitchell G, 2010, MICROB PATHOGENESIS, V48, P18, DOI 10.1016/j.micpath.2009.10.003; Mitchell G, 2008, MOL MICROBIOL, V70, P1540, DOI 10.1111/j.1365-2958.2008.06511.x; Moisan FN, 2006, J BACTERIOL, V188, P64, DOI 10.1128/JB.188.1.64-76.2006; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Palmer ME, 2011, MBIO, V2, DOI 10.1128/mBio.00241-11; Palmer ML, 2006, J CELL PHYSIOL, V206, P759, DOI 10.1002/jcp.20519; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Resch A, 2005, FEMS MICROBIOL LETT, V252, P89, DOI 10.1016/j.femsle.2005.08.048; Rice KC, 2004, J BACTERIOL, V186, P3029, DOI 10.1128/JB.186.10.3029-3037.2004; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Senn MM, 2005, J BACTERIOL, V187, P7397, DOI 10.1128/JB.187.21.7397-7406.2005; Singh R, 2010, J MED MICROBIOL, V59, P521, DOI 10.1099/jmm.0.017046-0; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005	54	52	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65018	10.1371/journal.pone.0065018	http://dx.doi.org/10.1371/journal.pone.0065018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705029	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200183
J	Shen, HR; Qiu, LH; Zhang, ZQ; Qin, YY; Cao, C; Di, W				Shen, Hao-ran; Qiu, Li-hua; Zhang, Zhi-qing; Qin, Yuan-yuan; Cao, Cong; Di, Wen			Genome-Wide Methylated DNA Immunoprecipitation Analysis of Patients with Polycystic Ovary Syndrome	PLOS ONE			English	Article							INSULIN-RESISTANCE; WOMEN; EXPRESSION; PROTEIN; ENVIRONMENT; METFORMIN; BETA	Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder of uncertain etiology. Recent studies suggested that insulin resistance (IR) plays an important role in the development of PCOS. In the current study, we aimed to investigate the molecular mechanism of IR in PCOS. We employed genome-wide methylated DNA immunoprecipitation (MeDIP) analysis to characterize genes that are differentially methylated in PCOS patients vs. healthy controls. Besides, we also identified the differentially methylated genes between patients with PCOS-non-insulin resistance (PCOS-NIR) and PCOS-insulin resistance (PCOS-IR). A total of 79 genes were differentially methylated between PCOS-NIR vs. PCOS-IR patients, and 40 genes were differentially methylated in PCOS patients vs. healthy controls. We analyzed these differentially methylated genes by constructing regulatory networks and protein-protein interaction (PPI) networks. Further, Gene Ontology (GO) and pathway enrichment analysis were also performed to investigate the biological functions of networks. We identified multiple categories of genes that were differentially methylated between PCOS-NIR and PCOS-IR patients, or between PCOS patients and healthy controls. Significantly, GO categories of immune response were differentially methylated in PCOS-IR vs. PCOS-NIR. Further, genes in cancer pathways were also differentially methylated in PCOS-NIR vs. PCOS-IR patients or in PCOS patients vs. healthy controls. The results of this current study will help to further understand the mechanism of PCOS.	[Shen, Hao-ran; Qiu, Li-hua; Qin, Yuan-yuan; Di, Wen] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; diwen163@163.com	Shen, Haoran/Q-6397-2017	Shen, Haoran/0000-0002-5679-6998	Ministry of Science and Technology of China [2006DFA32780]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the International Collaborative Items of Ministry of Science and Technology of China (No. 2006DFA32780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angioni S, 2011, GYNECOL ENDOCRINOL, V27, P468, DOI 10.3109/09513590.2010.492886; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Baillargeon JP, 2003, CLIN OBSTET GYNECOL, V46, P325, DOI 10.1097/00003081-200306000-00011; Bianco RB, 2006, EUR J CANCER, V42, P290, DOI 10.1016/j.ejca.2005.07.034; Cho LW, 2009, CLIN ENDOCRINOL, V70, P233, DOI 10.1111/j.1365-2265.2008.03309.x; Cupisti S, 2010, FERTIL STERIL, V94, P2647, DOI 10.1016/j.fertnstert.2010.03.048; Diamanti-Kandarakis E, 2006, ENDOCRINE, V30, P19, DOI 10.1385/ENDO:30:1:19; Evian Annual Reprod EVAR Workshop, 2011, HUM REPROD UPDATE, V17, P829, DOI 10.1093/humupd/dmr033; Goldenberg N, 2008, Minerva Ginecol, V60, P63; Halperin IJ, 2011, HUM REPROD, V26, P191, DOI 10.1093/humrep/deq301; Harries LW, 2012, AGING CELL, V11, P262, DOI 10.1111/j.1474-9726.2011.00782.x; Hickey TE, 2006, J CLIN ENDOCR METAB, V91, P2789, DOI 10.1210/jc.2006-0069; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Huang AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001334; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchison SK, 2011, J CLIN ENDOCR METAB, V96, pE48, DOI 10.1210/jc.2010-0828; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kaboord Barbara, 2008, V424, P349, DOI 10.1007/978-1-60327-064-9_27; KAI A, 1994, CARBOHYD POLYM, V23, P235, DOI 10.1016/0144-8617(94)90184-8; Karels B, 2011, DEV MOUSE MODEL POLY, pP94; Kim JJ, 2010, FERTIL STERIL, V93, P1942, DOI 10.1016/j.fertnstert.2008.12.040; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Legro RS, 2002, FERTIL STERIL, V78, P569, DOI 10.1016/S0015-0282(02)03275-2; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Ly LP, 2005, EUR J ENDOCRINOL, V152, P471, DOI 10.1530/eje.1.01844; Nardo LG, 2009, HUM REPROD, V24, P2917, DOI 10.1093/humrep/dep225; NATSUKA S, 1992, BLOOD, V79, P460; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qu F, 2012, J MOL MED, V90, P911, DOI 10.1007/s00109-012-0881-4; SANDSTROM LP, 1993, ALCOHOL, V10, P303, DOI 10.1016/0741-8329(93)90010-L; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Swedenborg E, 2009, CELL MOL LIFE SCI, V66, P3873, DOI 10.1007/s00018-009-0118-z; Tasali E, 2011, J CLIN ENDOCR METAB, V96, P365, DOI 10.1210/jc.2010-1187; Tosi F, 2009, EUR J ENDOCRINOL, V161, P737, DOI 10.1530/EJE-09-0379; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Yamamoto H, 2002, J CELL SCI, V115, P3601, DOI 10.1242/jcs.00044	41	35	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64801	10.1371/journal.pone.0064801	http://dx.doi.org/10.1371/journal.pone.0064801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705014	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200168
J	Vinci, MC; Tessitore, G; Castiglioni, L; Prandi, F; Soncini, M; Santoro, R; Consolo, F; Colazzo, F; Micheli, B; Sironi, L; Polvani, G; Pesce, M				Vinci, Maria Cristina; Tessitore, Giulio; Castiglioni, Laura; Prandi, Francesca; Soncini, Monica; Santoro, Rosaria; Consolo, Filippo; Colazzo, Francesca; Micheli, Barbara; Sironi, Luigi; Polvani, Gianluca; Pesce, Maurizio			Mechanical Compliance and Immunological Compatibility of Fixative-Free Decellularized/Cryopreserved Human Pericardium	PLOS ONE			English	Article							FIXED BOVINE PERICARDIUM; AORTIC-VALVE-REPLACEMENT; IMMUNE-RESPONSE; HEART-VALVES; ALPHA-GAL; GLUTARALDEHYDE; CALCIFICATION; BIOCOMPATIBILITY; HOMOGRAFT; PORCINE	Background: The pericardial tissue is commonly used to produce bio-prosthetic cardiac valves and patches in cardiac surgery. The procedures adopted to prepare this tissue consist in treatment with aldehydes, which do not prevent post-graft tissue calcification due to incomplete xeno-antigens removal. The adoption of fixative-free decellularization protocols has been therefore suggested to overcome this limitation. Although promising, the decellularized pericardium has not yet used in clinics, due to the absence of proofs indicating that the decellularization and cryopreservation procedures can effectively preserve the mechanical properties and the immunologic compatibility of the tissue. Principal Findings: The aim of the present work was to validate a procedure to prepare decellularized/cryopreserved human pericardium which may be implemented into cardiovascular homograft tissue Banks. The method employed to decellularize the tissue completely removed the cells without affecting ECM structure; furthermore, uniaxial tensile loading tests revealed an equivalent resistance of the decellularized tissue to strain, before and after the cryopreservation, in comparison with the fresh tissue. Finally, immunological compatibility, showed a minimized host immune cells invasion and low levels of systemic inflammation, as assessed by tissue transplantation into immune-competent mice. Conclusions: Our results indicate, for the first time, that fixative-free decellularized pericardium from cadaveric tissue donors can be banked according to Tissue Repository-approved procedures without compromising its mechanical properties and immunological tolerance. This tissue can be therefore treated as a safe homograft for cardiac surgery.	[Vinci, Maria Cristina; Prandi, Francesca; Santoro, Rosaria; Pesce, Maurizio] Ctr Cardiol Monzino IRCCS, Lab Ingn Tissutale Cardiovasc, Milan, Italy; [Tessitore, Giulio; Polvani, Gianluca] Univ Milan, Dipartimento Sci Cardiovasc, Milan, Italy; [Castiglioni, Laura; Colazzo, Francesca; Sironi, Luigi] Univ Milan, Dipartimento Farmacol, Milan, Italy; [Soncini, Monica; Consolo, Filippo] Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy; [Micheli, Barbara] Banca Tessuti Cardiovasc Reg Lombardia, Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; Polytechnic University of Milan	Pesce, M (corresponding author), Ctr Cardiol Monzino IRCCS, Lab Ingn Tissutale Cardiovasc, Milan, Italy.	maurizio.pesce@ccfm.it	Consolo, Filippo/A-7607-2018; Pesce, Maurizio/B-4260-2010; santoro, rosaria/AAI-3983-2020; Pesce, Maurizio/AAA-4207-2019; Vinci, Maria Cristina/E-7401-2016; Santoro, Rosaria/F-3704-2018; Santoro, Rosaria/AAY-3921-2021; POLVANI, GIANLUCA/I-4656-2018; Sironi, Luigi/S-8174-2016; Soncini, Monica/E-9609-2018	Consolo, Filippo/0000-0002-7948-3847; Pesce, Maurizio/0000-0002-3097-8961; santoro, rosaria/0000-0003-3980-1959; Pesce, Maurizio/0000-0002-3097-8961; Vinci, Maria Cristina/0000-0001-6323-147X; Santoro, Rosaria/0000-0003-3980-1959; POLVANI, GIANLUCA/0000-0003-1055-0965; COLAZZO, FRANCESCA/0000-0002-5782-1606; Soncini, Monica/0000-0001-8607-7196; SIRONI, LUIGI/0000-0002-4738-3454; castiglioni, laura/0000-0002-0772-3231	Ricerca Corrente, Centro Cardiologico Monzino	Ricerca Corrente, Centro Cardiologico Monzino	The present work has been financed by Ricerca Corrente, Centro Cardiologico Monzino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barili F, 2007, ARTIF ORGANS, V31, P152, DOI 10.1111/j.1525-1594.2007.00355.x; Bloch O, 2011, TISSUE ENG PT A, V17, P2399, DOI [10.1089/ten.tea.2011.0046, 10.1089/ten.TEA.2011.0046]; CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467, DOI 10.1016/S0022-5223(19)42561-0; Chen CH, 2010, REPRODUCTION, V140, P105, DOI 10.1530/REP-09-0448; Creemers P, 2002, TRANSPL IMMUNOL, V10, P285, DOI 10.1016/S0966-3274(02)00072-2; Dahms SE, 1998, BRIT J UROL, V82, P411; Dainese L, 2006, ARTIF ORGANS, V30, P259, DOI 10.1111/j.1525-1594.2006.00213.x; Dainese L, 2012, J HEART VALVE DIS, V21, P125; DONG X, 2009, J MAT SCI MAT MED; Gaipa G, 2010, J CELL MOL MED, V14, P1619, DOI 10.1111/j.1582-4934.2009.00854.x; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Grabenwoger M, 1996, ANN THORAC SURG, V62, P772; Guldner NW, 2012, J THORAC CARDIOV SUR, V143, P1152, DOI 10.1016/j.jtcvs.2011.10.076; Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948; Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x; Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17; Koolbergen DR, 2002, J THORAC CARDIOV SUR, V124, P689, DOI 10.1067/mtc.2002.124514; Korossis SA, 2002, J HEART VALVE DIS, V11, P463; LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475; LEVY RJ, 1986, AM J PATHOL, V122, P71; Maizato MJS, 2008, ARTIF ORGANS, V32, P268, DOI 10.1111/j.1525-1594.2008.00541.x; Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311; McClure RS, 2010, ANN THORAC SURG, V89, P1410, DOI 10.1016/j.athoracsur.2010.01.046; Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017; Mirsadraee S, 2007, J SURG RES, V143, P407, DOI 10.1016/j.jss.2007.01.026; Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763; Oei FBS, 2000, EUR J CARDIO-THORAC, V18, P466, DOI 10.1016/S1010-7940(00)00540-6; Pompilio G, 2004, ANN THORAC SURG, V78, P557, DOI 10.1016/j.athoracsur.2004.02.037; Puvimanasinghe JPA, 2005, ANN THORAC SURG, V80, P825, DOI 10.1016/j.athoracsur.2005.03.064; Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629; Rodas ACD, 2011, ARTIF ORGANS, V35, P502, DOI 10.1111/j.1525-1594.2011.01255.x; Sinha P, 2012, J THORAC CARDIOV SUR, V143, P224, DOI 10.1016/j.jtcvs.2011.09.043; Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263; Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f; Vincentelli A, 1998, ANN THORAC SURG, V66, pS255, DOI 10.1016/S0003-4975(98)01098-4; Welters MJP, 2001, CLIN EXP IMMUNOL, V124, P353, DOI 10.1046/j.1365-2249.2001.01557.x; Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030	37	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64769	10.1371/journal.pone.0064769	http://dx.doi.org/10.1371/journal.pone.0064769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705010	Green Published, gold			2022-12-25	WOS:000319330200164
J	Jia, HM; Feng, YF; Liu, YT; Chang, X; Chen, L; Zhang, HW; Ding, G; Zou, ZM				Jia, Hong-mei; Feng, Yu-fei; Liu, Yue-tao; Chang, Xing; Chen, Lin; Zhang, Hong-wu; Ding, Gang; Zou, Zhong-mei			Integration of H-1 NMR and UPLC-Q-TOF/MS for a Comprehensive Urinary Metabonomics Study on a Rat Model of Depression Induced by Chronic Unpredictable Mild Stress	PLOS ONE			English	Article							BETA-HYDROXYBUTYRATE; MASS-SPECTROMETRY; PLASMA; XIAOYAOSAN; BIOMARKERS; BRAIN; METABOLISM; GLUTAMATE; TOXICITY; STRATEGY	Depression is a type of complex psychiatric disorder with long-term, recurrent bouts, and its etiology remains largely unknown. Here, an integrated approach utilizing H-1 NMR and UPLC-Q-TOF/MS together was firstly used for a comprehensive urinary metabonomics study on chronic unpredictable mild stress (CUMS) treated rats. More than twenty-nine metabolic pathways were disturbed after CUMS treatment and thirty-six potential biomarkers were identified by using two complementary analytical technologies. Among the identified biomarkers, nineteen (10, 11, 16, 17, 21-25, and 27-36) were firstly reported as potential biomarkers of CUMS-induced depression. Obviously, this paper presented a comprehensive map of the metabolic pathways perturbed by CUMS and expanded on the multitude of potential biomarkers that have been previously reported in the CUMS model. Four metabolic pathways, including valine, leucine and isoleucine biosynthesis; phenylalanine, tyrosine and tryptophan biosynthesis; tryptophan metabolism; synthesis and degradation of ketone bodies had the deepest influence in the pathophysiologic process of depression. Fifteen potential biomarkers (1-2, 4-6, 15, 18, 20-23, 27, 32, 35-36) involved in the above four metabolic pathways might become the screening criteria in clinical diagnosis and predict the development of depression. Moreover, the results of Western blot analysis of aromatic L-amino acid decarboxylase (DDC) and indoleamine 2, 3-dioxygenase (IDO) in the hippocampus of CUMS-treated rats indicated that depletion of 5-HT and tryptophan, production of 5-MT and altered expression of DDC and IDO together played a key role in the initiation and progression of depression. In addition, none of the potential biomarkers were detected by NMR and LC-MS simultaneously which indicated the complementary of the two kinds of detection technologies. Therefore, the integration of 1 H NMR and UPLC-Q-TOF/MS in metabonomics study provided an approach to identify the comprehensive potential depression-related biomarkers and helpful in further understanding the underlying molecular mechanisms of depression through the disturbance of metabolic pathways.	[Jia, Hong-mei; Liu, Yue-tao; Chang, Xing; Chen, Lin; Zhang, Hong-wu; Ding, Gang; Zou, Zhong-mei] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Jia, Hong-mei; Liu, Yue-tao; Chang, Xing; Chen, Lin; Zhang, Hong-wu; Ding, Gang; Zou, Zhong-mei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Feng, Yu-fei] Beijing Hosp, Minist Publ Hlth, Dept Pharm, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Zou, ZM (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	zmzou@implad.ac.cn			National Natural Science Foundation of China [81173512]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09301002-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on Major New Drug Innovation	The authors gratefully acknowledge financial support from the National Natural Science Foundation of China (Grant No. 81173512). This study was also supported by National S&T Major Special Project on Major New Drug Innovation (2012ZX09301002-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranibar N, 2011, ANAL BIOCHEM, V410, P84, DOI 10.1016/j.ab.2010.11.023; Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; Beltran A, 2012, ANAL CHEM, V84, P5838, DOI 10.1021/ac3005567; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Dai YT, 2010, J ETHNOPHARMACOL, V128, P482, DOI 10.1016/j.jep.2010.01.016; Dardzinski BJ, 2000, PEDIATR RES, V48, P248, DOI 10.1203/00006450-200008000-00021; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Gao XX, 2013, PHYTOTHER RES, V27, P1074, DOI 10.1002/ptr.4805; Gao XX, 2011, J ETHNOPHARMACOL, V137, P690, DOI 10.1016/j.jep.2011.06.024; Goodpaster AM, 2011, ANAL CHEM, V83, P896, DOI 10.1021/ac102572b; Gosetti F, 2013, ANAL BIOANAL CHEM, V405, P907, DOI 10.1007/s00216-012-6269-z; Guo K, 2009, ANAL CHEM, V81, P3919, DOI 10.1021/ac900166a; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; ITO T, 1995, J CHROMATOGR B, V670, P317, DOI 10.1016/0378-4347(95)00174-3; Jung J, 2011, TOXICOL LETT, V200, P1, DOI 10.1016/j.toxlet.2010.09.020; KASCKOW JW, 2013, J PSYCHIATR RES, P40; Li ZY, 2010, RAPID COMMUN MASS SP, V24, P3539, DOI 10.1002/rcm.4809; Liu XJ, 2012, MAGN RESON CHEM, V50, P187, DOI 10.1002/mrc.2865; Liu XJ, 2012, J PHARM PHARMACOL, V64, P578, DOI 10.1111/j.2042-7158.2011.01412.x; Maes M, 2012, PSYCHIAT RES, V196, P243, DOI 10.1016/j.psychres.2011.09.029; Martin JC, 2009, ATHEROSCLEROSIS, V206, P127, DOI 10.1016/j.atherosclerosis.2009.01.040; Ni Y, 2008, FEBS LETT, V582, P2627, DOI 10.1016/j.febslet.2008.06.040; Noh HS, 2006, J NEUROSCI RES, V83, P702, DOI 10.1002/jnr.20736; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Reo NV, 2002, DRUG CHEM TOXICOL, V25, P375, DOI 10.1081/DCT-120014789; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Shi BY, 2013, BEHAV BRAIN RES, V241, P86, DOI 10.1016/j.bbr.2012.11.036; Su ZH, 2011, J PHARMACEUT BIOMED, V55, P533, DOI 10.1016/j.jpba.2011.02.013; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; TAKIKAWA O., 2007, INT C SER, V1304, p290 ; TROMBETTA LD, 1988, TOXICOL APPL PHARM, V93, P154, DOI 10.1016/0041-008X(88)90035-X; Wang XY, 2009, J PROTEOME RES, V8, P2511, DOI 10.1021/pr801086k; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xu F, 2011, PHYTOMEDICINE, V18, P1130, DOI 10.1016/j.phymed.2011.05.002; Zandio M, 2002, An Sist Sanit Navar, V25 Suppl 3, P43; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1; Zheng SN, 2010, CLIN CHIM ACTA, V411, P204, DOI 10.1016/j.cca.2009.11.003; ZHENG SN, 2010, UPLC MS BASED PLASMA, DOI DOI 10.1007/S11306-010-0261-4; Zhou YZ, 2011, J ETHNOPHARMACOL, V137, P236, DOI 10.1016/j.jep.2011.05.016	42	32	37	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63624	10.1371/journal.pone.0063624	http://dx.doi.org/10.1371/journal.pone.0063624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696839	gold, Green Submitted, Green Published			2022-12-25	WOS:000319107900051
J	Egawa, T; Yeh, SR; Rousseau, DL				Egawa, Tsuyoshi; Yeh, Syun-Ru; Rousseau, Denis L.			Redox-Controlled Proton Gating in Bovine Cytochrome c Oxidase	PLOS ONE			English	Article							OXYGEN-REDUCTION; CARBON-MONOXIDE; HEME; MECHANISM; PUMP; TRANSLOCATION; RAMAN; PATHWAY; PHASES; MUTANT	Cytochrome c oxidase is the terminal enzyme in the electron transfer chain of essentially all organisms that utilize oxygen to generate energy. It reduces oxygen to water and harnesses the energy to pump protons across the mitochondrial membrane in eukaryotes and the plasma membrane in prokaryotes. The mechanism by which proton pumping is coupled to the oxygen reduction reaction remains unresolved, owing to the difficulty of visualizing proton movement within the massive membrane-associated protein matrix. Here, with a novel hydrogen/deuterium exchange resonance Raman spectroscopy method, we have identified two critical elements of the proton pump: a proton loading site near the propionate groups of heme a, which is capable of transiently storing protons uploaded from the negative-side of the membrane prior to their release into the positive side of the membrane and a conformational gate that controls proton translocation in response to the change in the redox state of heme a. These findings form the basis for a postulated molecular model describing a detailed mechanism by which unidirectional proton translocation is coupled to electron transfer from heme a to heme a(3), associated with the oxygen chemistry occurring in the heme a(3) site, during enzymatic turnover.	[Egawa, Tsuyoshi; Yeh, Syun-Ru; Rousseau, Denis L.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Rousseau, DL (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA.	denis.rousseau@einstein.yu.edu		Yeh, Syun-Ru/0000-0002-9858-386X	National Institutes of Health grant [GM098799]; National Science Foundation Grant [NSF0956358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098799, R01GM086482] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported the National Institutes of Health grant GM098799 to D.L.R and National Science Foundation Grant NSF0956358 to S.-R.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGADE PV, 1986, J BIOL CHEM, V261, P5969; ARTZATBANOV VY, 1978, FEBS LETT, V87, P180, DOI 10.1016/0014-5793(78)80327-5; BABCOCK GT, 1983, BIOCHEMISTRY-US, V22, P2314, DOI 10.1021/bi00279a002; Belevich I, 2008, ANTIOXID REDOX SIGN, V10, P1, DOI 10.1089/ars.2007.1705; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; BICKAR D, 1984, J BIOL CHEM, V259, P777; Branden G, 2006, BBA-BIOENERGETICS, V1757, P1052, DOI 10.1016/j.bbabio.2006.05.020; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; CALLAHAN PM, 1983, BIOCHEMISTRY-US, V22, P452, DOI 10.1021/bi00271a031; Capitanio G, 2006, BIOCHEMISTRY-US, V45, P1930, DOI 10.1021/bi052080v; Capitanio G, 2011, BBA-BIOENERGETICS, V1807, P1287, DOI 10.1016/j.bbabio.2011.02.004; Capitanio N, 1817, BIOCHIM BIOPHYS ACTA, P558; Egawa T, 2009, ANAL BIOCHEM, V394, P141, DOI 10.1016/j.ab.2009.06.035; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; Gorbikova EA, 2008, P NATL ACAD SCI USA, V105, P10733, DOI 10.1073/pnas.0802512105; Han HZ, 2011, P NATL ACAD SCI USA, V108, P14109, DOI 10.1073/pnas.1018958108; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; Kim Y, 2001, J AM CHEM SOC, V123, P757, DOI 10.1021/ja0027867; LI XY, 1990, J PHYS CHEM-US, V94, P47, DOI 10.1021/j100364a008; MALATESTA F, 1995, BIOPHYS CHEM, V54, P1, DOI 10.1016/0301-4622(94)00117-3; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Musser SM, 1998, J MOL EVOL, V46, P508, DOI 10.1007/PL00006332; Papa S, 1998, J BIOENERG BIOMEMBR, V30, P109, DOI 10.1023/A:1020519914011; Pereira MM, 2008, BBA-BIOENERGETICS, V1777, P929, DOI 10.1016/j.bbabio.2008.05.441; Rousseau DL, 1999, NATURE, V400, P412, DOI 10.1038/22664; Sharpe MA, 2008, J BIOENERG BIOMEMBR, V40, P541, DOI 10.1007/s10863-008-9182-6; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Siegbahn PEM, 2003, J PHYS CHEM B, V107, P10946, DOI 10.1021/jp035486v; Siletsky SA, 1817, BIOCHIM BIOPHYS ACTA, P476; Song YF, 2006, BIOCHEMISTRY-US, V45, P7959, DOI 10.1021/bi052183d; Sugitani R, 2009, BBA-BIOENERGETICS, V1787, P1140, DOI 10.1016/j.bbabio.2009.04.004; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tiefenbrunn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022348; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 1807, BIOCHIM BIOPHYS ACTA, P1279; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P395, DOI 10.1016/j.bbabio.2006.04.028	47	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63669	10.1371/journal.pone.0063669	http://dx.doi.org/10.1371/journal.pone.0063669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696843	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900050
J	Slattery, ML; John, E; Torres-Mejia, G; Stern, M; Lundgreen, A; Hines, L; Giuliano, A; Baumgartner, K; Herrick, J; Wolff, RK				Slattery, Martha L.; John, Esther; Torres-Mejia, Gabriela; Stern, Mariana; Lundgreen, Abbie; Hines, Lisa; Giuliano, Anna; Baumgartner, Kathy; Herrick, Jennifer; Wolff, Roger K.			Matrix Metalloproteinase Genes Are Associated with Breast Cancer Risk and Survival: The Breast Cancer Health Disparities Study	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POLYMORPHISMS; POPULATION; SUSCEPTIBILITY; MATRIX-METALLOPROTEINASE-2; INFERENCE; MMP-9; WOMEN	Matrix metalloproteinases (MMPs) contribute to cancer through their involvement in cancer invasion and metastasis. We evaluated genetic variation in MMP1 (9 SNPs), MMP2 (8 SNPs), MMP3 (4 SNPs), and MMP9 (3 SNPs) and breast cancer risk among Hispanic (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1586 controls) women in the Breast Cancer Health Disparities Study. Ancestral informative markers (n = 104) were assessed to determine Native American (NA) ancestry. MMP1 [4 single nucleotide polymorphisms (SNPs)] and MMP2 (2 SNPs) were associated with breast cancer overall. MMP1 rs996999 had strongest associations among women with the most NA ancestry (OR 1.61,95% CI 1.09,2.40) as did MMP3 rs650108 (OR 1.36, 95% CI 1.05,1.75) and MMP9 rs3787268 (OR 1.52, 95% CI 1.09,2.13). The adaptive rank truncated product (ARTP) showed a significant pathway p(artp) value of 0.04, with a stronger association among women with the most NA ancestry (p(artp) = 0.02). Significant pathway genes using the ARTP were MMP1 for all women (p(artp) = 0.02) and MMP9 for women with the most NA ancestry (p(artp) = 0.024); MMP2 was borderline significant overall (p(artp) = 0.06) and MMP1 and MMP3 were borderline significant for women with the most NA ancestry (p(artp) = 0.07 and 0.06 respectively). MMP1 and MMP2 were associated with ER+/PR+ and ER+/PR-tumors; MMP3 and MMP9 were associated with ER-/PR- tumors. The pathway was highly significant with survival (p(artp) = 0.0041) with MMP2 having the strongest gene association (p(artp) = 0.0007). Our findings suggest that genetic variation in MMP genes influence breast cancer development and survival in this genetically admixed population.	[Slattery, Martha L.; Lundgreen, Abbie; Herrick, Jennifer; Wolff, Roger K.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [John, Esther] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [John, Esther] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Torres-Mejia, Gabriela] Ctr Invest Salud Poblac, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Stern, Mariana] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hines, Lisa] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA; [Giuliano, Anna] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Baumgartner, Kathy] Univ Louisville, Dept Epidemiol & Populat Hlth, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA	Utah System of Higher Education; University of Utah; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Stanford University; Instituto Nacional de Salud Publica; University of Southern California; University of Colorado System; University of Colorado at Colorado Springs; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Louisville	Slattery, ML (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	marty.slattery@hsc.utah.edu		Herrick, Jennifer/0000-0001-9257-8843	National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA140002, R01CA078682] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1770, DOI 10.1158/1055-9965.EPI-09-0125; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1324, DOI 10.1158/1055-9965.EPI-09-0046; Delgado-Enciso I, 2008, GYNECOL OBSTET INVES, V65, P68, DOI 10.1159/000108282; Falush D, 2003, GENETICS, V164, P1567; Grieu F, 2004, BREAST CANCER RES TR, V88, P197, DOI 10.1007/s10549-004-0595-6; John EM, 2005, CANCER EPIDEM BIOMAR, V14, P2905, DOI 10.1158/1055-9965.EPI-05-0483; John EM, 2003, CANCER EPIDEM BIOMAR, V12, P1143; Kai Yu OL, 2011, ARTP GENE PATHWAY P; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; McColgan P, 2009, INT J CANCER, V125, P1473, DOI 10.1002/ijc.24441; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pritchard JK, 2000, GENETICS, V155, P945; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Roehe AV, BREAST CANC RES TREA, V102, P123; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Slattery ML, 2007, BREAST CANCER RES TR, V102, P85, DOI 10.1007/s10549-006-9292-y; Slattery ML, 2012, CARCINOGENESIS, V33, P1512, DOI 10.1093/carcin/bgs163; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhou YF, 2004, CARCINOGENESIS, V25, P399, DOI 10.1093/carcin/bgh020	22	66	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63165	10.1371/journal.pone.0063165	http://dx.doi.org/10.1371/journal.pone.0063165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696797	Green Submitted, Green Published, gold			2022-12-25	WOS:000319081900013
J	Calero-Nieto, FJ; Joshi, A; Bonadies, N; Kinston, S; Chan, WI; Gudgin, E; Pridans, C; Landry, JR; Kikuchi, J; Huntly, BJ; Gottgens, B				Calero-Nieto, F. J.; Joshi, A.; Bonadies, N.; Kinston, S.; Chan, W-I; Gudgin, E.; Pridans, C.; Landry, J-R; Kikuchi, J.; Huntly, B. J.; Gottgens, B.			HOX-mediated LMO2 expression in embryonic mesoderm is recapitulated in acute leukaemias	ONCOGENE			English	Article						gene regulation; haematopoiesis; HOX; leukaemia; LMO2	ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; T-CELL LEUKEMIA; TRANSCRIPTION FACTOR; STEM-CELL; ONCOGENIC PATHWAYS; CALM/AF10 FUSION; GENE; CANCER; PROMOTER	The Lim Domain Only 2 (LMO2) leukaemia oncogene encodes an LIM domain transcriptional cofactor required for early haematopoiesis. During embryogenesis, LMO2 is also expressed in developing tail and limb buds, an expression pattern we now show to be recapitulated in transgenic mice by an enhancer in LMO2 intron 4. Limb bud expression depended on a cluster of HOX binding sites, while posterior tail expression required the HOX sites and two E-boxes. Given the importance of both LMO2 and HOX genes in acute leukaemias, we further demonstrated that the regulatory hierarchy of HOX control of LMO2 is activated in leukaemia mouse models as well as in patient samples. Moreover, Lmo2 knock-down impaired the growth of leukaemic cells, and high LMO2 expression at diagnosis correlated with poor survival in cytogenetically normal AML patients. Taken together, these results establish a regulatory hierarchy of HOX control of LMO2 in normal development, which can be resurrected during leukaemia development. Redeployment of embryonic regulatory hierarchies in an aberrant context is likely to be relevant in human pathologies beyond the specific example of ectopic activation of LMO2.	[Calero-Nieto, F. J.; Joshi, A.; Bonadies, N.; Kinston, S.; Chan, W-I; Gudgin, E.; Pridans, C.; Landry, J-R; Huntly, B. J.; Gottgens, B.] Univ Cambridge, Dept Haematol, Wellcome Trust, Cambridge CB2 0XY, England; [Calero-Nieto, F. J.; Joshi, A.; Bonadies, N.; Kinston, S.; Chan, W-I; Gudgin, E.; Pridans, C.; Landry, J-R; Huntly, B. J.; Gottgens, B.] Univ Cambridge, MRC Cambridge Stem Cell Inst, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Kikuchi, J.] Jichi Med Sch, Div Stem Cell Regulat, Ctr Mol Med, Shimotsuke, Tochigi, Japan	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Jichi Medical University	Calero-Nieto, FJ (corresponding author), Univ Cambridge, Dept Haematol, Wellcome Trust, Hills Rd, Cambridge CB2 0XY, England.	fjc28@cam.ac.uk; bg200@cam.ac.uk	Bonadies, Nicolas/F-2388-2017; huntly, brian JP/E-6725-2014; Pridans, Clare/AAF-9953-2020	Bonadies, Nicolas/0000-0001-8761-2066; huntly, brian JP/0000-0003-0312-161X; Pridans, Clare/0000-0001-9423-557X; Calero-Nieto, Fernando/0000-0003-3358-8253; Gottgens, Berthold/0000-0001-6302-5705; Joshi, Anagha/0000-0003-1184-3305	Leukaemia and Lymphoma Research; MRC; BBSRC; CRUK; Leukaemia and Lymphoma Society; Swiss National Science Foundation; EMBO long term fellowship; EG holds a Kay Kendall Clinical Research Training Fellowship; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI	Leukaemia and Lymphoma Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK(Cancer Research UK); Leukaemia and Lymphoma Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO long term fellowship(European Molecular Biology Organization (EMBO)); EG holds a Kay Kendall Clinical Research Training Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Terry Rabbitts for providing the Lmo2 LacZ knock-in mice, Dr Shubha Anand for discussion of results and technical help; Ms Frances Stedham for technical support; and Dr Val Wilson for advice on early embryonic expression patterns. Work in the authors' laboratories is supported by grants from Leukaemia and Lymphoma Research, the MRC, BBSRC, CRUK and Leukaemia and Lymphoma Society. NB was supported by the Swiss National Science Foundation, AJ is the recipient of an EMBO long term fellowship and EG holds a Kay Kendall Clinical Research Training Fellowship.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; Bonadies N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016330; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Carlson KM, 2000, LEUKEMIA, V14, P100, DOI 10.1038/sj.leu.2401629; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Crable SC, 2003, BLOOD, V101, P4757, DOI 10.1182/blood-2002-09-2702; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dik WA, 2005, LEUKEMIA, V19, P1948, DOI 10.1038/sj.leu.2403891; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; FISCH P, 1992, ONCOGENE, V7, P2389; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gottgens B, 1997, ONCOGENE, V15, P2419, DOI 10.1038/sj.onc.1201426; Hammond SM, 2005, LEUKEMIA RES, V29, P89, DOI 10.1016/j.leukres.2004.05.013; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; Kvinlaug BT, 2011, CANCER RES, V71, P4117, DOI 10.1158/0008-5472.CAN-11-0176; La Celle PT, 2001, J BIOL CHEM, V276, P32844, DOI 10.1074/jbc.M104598200; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Landry JR, 2005, BLOOD, V106, P2680, DOI 10.1182/blood-2004-12-4755; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Mead PE, 2001, DEVELOPMENT, V128, P2301; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; Raimondi SC, 2007, ATLAS GENET CYTOGENE, V11, P639; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Treanor LM, 2011, BLOOD, V118, P24, DOI 10.1182/blood.V118.21.47.47; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Zeng CY, 1998, P NATL ACAD SCI USA, V95, P10637, DOI 10.1073/pnas.95.18.10637; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	46	10	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 28	2013	32	48					5471	5480		10.1038/onc.2013.175	http://dx.doi.org/10.1038/onc.2013.175			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	263BE	23708655	hybrid, Green Published			2022-12-25	WOS:000327780800004
J	de la Roche, J; Eberhardt, MJ; Klinger, AB; Stanslowsky, N; Wegner, F; Koppert, W; Reeh, PW; Lampert, A; Fischer, MJM; Leffler, A				de la Roche, Jeanne; Eberhardt, Mirjam J.; Klinger, Alexandra B.; Stanslowsky, Nancy; Wegner, Florian; Koppert, Wolfgang; Reeh, Peter W.; Lampert, Angelika; Fischer, Michael J. M.; Leffler, Andreas			The Molecular Basis for Species-specific Activation of Human TRPA1 Protein by Protons Involves Poorly Conserved Residues within Transmembrane Domains 5 and 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; VANILLOID RECEPTOR TRPV1; ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; COVALENT MODIFICATION; SENSORY NEURONS; PAIN SENSATION; NITRIC-OXIDE; ACID; NOCICEPTORS	The surveillance of acid-base homeostasis is concerted by diverse mechanisms, including an activation of sensory afferents. Proton-evoked activation of rodent sensory neurons is mainly mediated by the capsaicin receptor TRPV1 and acid-sensing ion channels. In this study, we demonstrate that extracellular acidosis activates and sensitizes the human irritant receptor TRPA1 (hTRPA1). Proton-evoked membrane currents and calcium influx through hTRPA1 occurred at physiological acidic pH values, were concentration-dependent, and were blocked by the selective TRPA1 antagonist HC030031. Both rodent and rhesus monkey TRPA1 failed to respond to extracellular acidosis, and protons even inhibited rodent TRPA1. Accordingly, mouse dorsal root ganglion neurons lacking TRPV1 only responded to protons when hTRPA1 was expressed heterologously. This species-specific activation of hTRPA1 by protons was reversed in both mouse and rhesus monkey TRPA1 by exchange of distinct residues within transmembrane domains 5 and 6. Furthermore, protons seem to interact with an extracellular interaction site to gate TRPA1 and not via a modification of intracellular N-terminal cysteines known as important interaction sites for electrophilic TRPA1 agonists. Our data suggest that hTRPA1 acts as a sensor for extracellular acidosis in human sensory neurons and should thus be taken into account as a yet unrecognized transduction molecule for proton-evoked pain and inflammation. The species specificity of this property is unique among known endogenous TRPA1 agonists, possibly indicating that evolutionary pressure enforced TRPA1 to inherit the role as an acid sensor in human sensory neurons.	[de la Roche, Jeanne; Eberhardt, Mirjam J.; Koppert, Wolfgang; Leffler, Andreas] Hannover Med Sch, Dept Anesthesia & Crit Care Med, D-30625 Hannover, Germany; [Stanslowsky, Nancy; Wegner, Florian] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany; [Eberhardt, Mirjam J.; Klinger, Alexandra B.; Reeh, Peter W.; Lampert, Angelika; Fischer, Michael J. M.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Hannover Medical School; Hannover Medical School; University of Erlangen Nuremberg	de la Roche, J (corresponding author), Hannover Med Sch, Clin Anesthesia & Crit Care Med, Carl Neuberg Str 1, D-30625 Hannover, Germany.	delaroche.jeanne@mh-hannover.de; leffler.andreas@mh-hannover.de	Reeh, Peter W./J-8981-2012; Lampert, Angelika/F-7198-2010; Fischer, Michael J.M./P-8715-2014	Reeh, Peter W./0000-0002-4367-094X; Lampert, Angelika/0000-0001-6319-6272; Fischer, Michael J.M./0000-0002-3811-7066	Hannover Medical School; German Research Association [LA2740/2-1]	Hannover Medical School; German Research Association(German Research Foundation (DFG))	This study was supported by an internal grant of the Hannover Medical School (to J.d.I.R.) and by German Research Association Grant LA2740/2-1 (to A.L.).	Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumann TK, 1996, PAIN, V65, P31, DOI 10.1016/0304-3959(95)00145-X; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bianchi BR, 2012, J PHARMACOL EXP THER, V341, P360, DOI 10.1124/jpet.111.189902; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Cadiou H, 2007, J NEUROSCI, V27, P13251, DOI 10.1523/JNEUROSCI.2135-07.2007; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; Chen J, 2009, J GEN PHYSIOL, V133, P623, DOI 10.1085/jgp.200910246; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Delaunay A, 2012, P NATL ACAD SCI USA, V109, P13124, DOI 10.1073/pnas.1120350109; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; KRISHTAL OA, 1981, BRAIN RES, V214, P150, DOI 10.1016/0006-8993(81)90446-7; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Leffler A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-62; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; STEEN KH, 1992, J NEUROSCI, V12, P86; Steen KH, 1999, EUR J NEUROSCI, V11, P2783, DOI 10.1046/j.1460-9568.1999.00695.x; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Wang S, 2010, J BIOL CHEM, V285, P11547, DOI 10.1074/jbc.M109.058727; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c	52	73	74	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20280	20292		10.1074/jbc.M113.479337	http://dx.doi.org/10.1074/jbc.M113.479337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709225	Green Published, hybrid			2022-12-25	WOS:000321715100017
J	Mantelin, S; Bhattarai, KK; Jhaveri, TZ; Kaloshian, I				Mantelin, Sophie; Bhattarai, Kishor K.; Jhaveri, Teraneh Z.; Kaloshian, Isgouhi			Mi-1-Mediated Resistance to Meloidogyne incognita in Tomato May Not Rely on Ethylene but Hormone Perception through ETR3 Participates in Limiting Nematode Infection in a Susceptible Host	PLOS ONE			English	Article							CAMPESTRIS PV. VESICATORIA; ROOT-KNOT NEMATODES; SIGNALING PATHWAY; GENE-EXPRESSION; POTATO APHID; NEVER-RIPE; PSEUDOMONAS-SYRINGAE; SALICYLIC-ACID; CELL-DEATH; BIOSYNTHESIS	Root-knot nematodes, Meloidogyne spp., are important pests of tomato (Solanum lycopersicum) and resistance to the three most prevalent species of this genus, including Meloidogyne incognita, is mediated by the Mi-1 gene. Mi-1 encodes a nucleotide binding (NB) leucine-rich repeat (LRR) resistance (R) protein. Ethylene (ET) is required for the resistance mediated by a subset of NB-LRR proteins and its role in Mi-1-mediated nematode resistance has not been characterized. Infection of tomato roots with M. incognita differentially induces ET biosynthetic genes in both compatible and incompatible interactions. Analyzing the expression of members of the ET biosynthetic gene families ACC synthase (ACS) and ACC oxidase (ACO), in both compatible and incompatible interactions, shows differences in amplitude and temporal expression of both ACS and ACO genes in these two interactions. Since ET can promote both resistance and susceptibility against microbial pathogens in tomato, we investigated the role of ET in Mi-1-mediated resistance to M. incognita using both genetic and pharmacological approaches. Impairing ET biosynthesis or perception using virus-induced gene silencing (VIGS), the ET-insensitive Never ripe (Nr) mutant, or 1-methylcyclopropene (MCP) treatment, did not attenuate Mi-1-mediated resistance to M. incognita. However, Nr plants compromised in ET perception showed enhanced susceptibility to M. incognita indicating a role for ETR3 in basal resistance to root-knot nematodes.	[Mantelin, Sophie; Bhattarai, Kishor K.; Jhaveri, Teraneh Z.; Kaloshian, Isgouhi] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Kaloshian, Isgouhi] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Kaloshian, I (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.	isgouhi.kaloshian@ucr.edu			National Science Foundation [IOB-0543937]; University of California Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of California Agricultural Experiment Station(University of California System)	This research was supported in part by grants from the National Science Foundation (grant no. IOB-0543937) and the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso CT, 2007, J PLANT GROWTH REGUL, V26, P92, DOI 10.1007/s00344-007-0013-5; Balaji V, 2008, PLANT PHYSIOL, V146, P1797, DOI 10.1104/pp.107.115188; Bent AF, 2006, CROP SCI, V46, P893, DOI 10.2135/cropsci2005.08-0235; Bhattarai KK, 2007, PLANT PHYSIOL, V144, P312, DOI 10.1104/pp.107.097246; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; Ciardi JA, 2000, PLANT PHYSIOL, V123, P81, DOI 10.1104/pp.123.1.81; Ciardi JA, 2001, MOL PLANT MICROBE IN, V14, P487, DOI 10.1094/MPMI.2001.14.4.487; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; de Ilarduya OM, 2004, MOL PLANT MICROBE IN, V17, P55, DOI 10.1094/MPMI.2004.17.1.55; de Wild HPJ, 2003, J EXP BOT, V54, P1537, DOI 10.1093/jxb/erg159; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; DROPKIN VH, 1969, ANNU REV PHYTOPATHOL, V7, P101, DOI 10.1146/annurev.py.07.090169.000533; Eulgem T, 2004, PLANT PHYSIOL, V135, P1129, DOI 10.1104/pp.104.040444; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fudali SL, 2013, MOL PLANT MICROBE IN, V26, P75, DOI 10.1094/MPMI-05-12-0107-R; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GLAZER I, 1984, J AM SOC HORTIC SCI, V109, P886; GLAZER I, 1985, J NEMATOL, V17, P145; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Klee H, 2002, PHYSIOL PLANTARUM, V115, P336, DOI 10.1034/j.1399-3054.2002.1150302.x; Lambert KN, 1999, PHYSIOL MOL PLANT P, V55, P341, DOI 10.1006/pmpp.1999.0239; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Li Q, 2006, MOL PLANT MICROBE IN, V19, P655, DOI 10.1094/MPMI-19-0655; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lund ST, 1998, PLANT CELL, V10, P371, DOI 10.1105/tpc.10.3.371; Mantelin S, 2009, NEW PHYTOL, V183, P444, DOI 10.1111/j.1469-8137.2009.02870.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; O'Donnell PJ, 2001, PLANT J, V25, P315, DOI 10.1046/j.1365-313x.2001.00968.x; RICK CM, 1956, ADV GENET, V8, P267, DOI 10.1016/S0065-2660(08)60504-0; ROBERTS PA, 1986, PLANT DIS, V70, P547, DOI 10.1094/PD-70-547; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Sisler EC, 2006, BIOTECHNOL ADV, V24, P357, DOI 10.1016/j.biotechadv.2006.01.002; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tieman DV, 2000, P NATL ACAD SCI USA, V97, P5663, DOI 10.1073/pnas.090550597; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Wubben MJE, 2001, MOL PLANT MICROBE IN, V14, P1206, DOI 10.1094/MPMI.2001.14.10.1206; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YEN HC, 1995, PLANT PHYSIOL, V107, P1343, DOI 10.1104/pp.107.4.1343; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042	49	19	23	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63281	10.1371/journal.pone.0063281	http://dx.doi.org/10.1371/journal.pone.0063281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	23717408	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600008
J	Hwang, J; Kim, M; Kim, S; Lee, J				Hwang, Jeongeun; Kim, Miju; Kim, Seunghwan; Lee, Jinwon			Quantifying Morphological Parameters of the Terminal Branching Units in a Mouse Lung by Phase Contrast Synchrotron Radiation Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MICRO-CT; MODEL; GAS; DIAMETER; GEOMETRY; ACINUS; LENGTH; BIFURCATION; PROGRESSION	An effective technique of phase contrast synchrotron radiation computed tomography was established for the quantitative analysis of the microstructures in the respiratory zone of a mouse lung. Heitzman's method was adopted for the whole-lung sample preparation, and Canny's edge detector was used for locating the air-tissue boundaries. This technique revealed detailed morphology of the respiratory zone components, including terminal bronchioles and alveolar sacs, with sufficiently high resolution of 1.74 mu m isotropic voxel size. The technique enabled visual inspection of the respiratory zone components and comprehension of their relative positions in three dimensions. To check the method's feasibility for quantitative imaging, morphological parameters such as diameter, surface area and volume were measured and analyzed for sixteen randomly selected terminal branching units, each consisting of a terminal bronchiole and a pair of succeeding alveolar sacs. The four types of asymmetry ratios concerning alveolar sac mouth diameter, alveolar sac surface area, and alveolar sac volume are measured. This is the first ever finding of the asymmetry ratio for the terminal bronchioles and alveolar sacs, and it is noteworthy that an appreciable degree of branching asymmetry was observed among the alveolar sacs at the terminal end of the airway tree, despite the number of samples was small yet. The series of efficient techniques developed and confirmed in this study, from sample preparation to quantification, is expected to contribute to a wider and exacter application of phase contrast synchrotron radiation computed tomography to a variety of studies.	[Hwang, Jeongeun; Kim, Miju] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Kim, Seunghwan] POSTECH, Dept Phys, Pohang, South Korea; [Kim, Seunghwan] POSTECH, Inst Edge Theoret Sci, Pohang, South Korea; [Lee, Jinwon] POSTECH, Dept Mech Engn, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, J (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.	jwlee@postech.ac.kr	; Hwang, Jeongeun/F-7550-2012	KIM, Seunghwan/0000-0002-0563-3902; Hwang, Jeongeun/0000-0002-5821-5405	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0000326]; National Core Research Center (NCRC);  [20100028450]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Core Research Center (NCRC); 	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0000326) and National Core Research Center (NCRC) funded by (No. 20100028450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, TRACHEOBRONCHIAL GEO; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; BOWES C, 1982, J APPL PHYSIOL, V52, P624, DOI 10.1152/jappl.1982.52.3.624; Bronnikov AV, 2002, J OPT SOC AM A, V19, P472, DOI 10.1364/JOSAA.19.000472; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Carrozzi L, 2011, RADIOLOGY, V261, P688, DOI 10.1148/radiol.11111950; Churg AM, 2005, THURLBECKS PATHOLOGY; ENGEL LA, 1983, J APPL PHYSIOL, V54, P609, DOI 10.1152/jappl.1983.54.3.609; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Heitzman ER, 1984, LUNG RADIOLOGIC PATH, P4; Hogg James C, 2009, Proc Am Thorac Soc, V6, P546, DOI 10.1513/pats.200905-029DS; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; HORSFIELD K, 1976, RESP PHYSIOL, V26, P351, DOI 10.1016/0034-5687(76)90005-0; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Kang MY, 2012, TRANS KOREAN SOC MEC, V36, P301, DOI 10.3795/KSME-B.2012.36.3.301; Kang MY, 2011, J BIOMECH, V44, P1196, DOI 10.1016/j.jbiomech.2011.02.011; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Lee DY, 2008, ANAT REC, V291, P379, DOI 10.1002/ar.20643; Lee D, 2011, COMPUT BIOL MED, V41, P707, DOI 10.1016/j.compbiomed.2011.06.006; Lee D, 2011, ANN BIOMED ENG, V39, P1805, DOI 10.1007/s10439-011-0279-4; Lee E, 2008, ANN BIOMED ENG, V36, P1004, DOI 10.1007/s10439-008-9474-3; Lee JW, 2007, MED BIOL ENG COMPUT, V45, P1071, DOI 10.1007/s11517-007-0232-8; Litzlbauer HD, 2010, ANAT REC, V293, P1607, DOI 10.1002/ar.21161; Liu XX, 2010, PHYS MED BIOL, V55, P2399, DOI 10.1088/0031-9155/55/8/017; Majumdar A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168101; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; PAIVA M, 1984, J APPL PHYSIOL, V56, P418, DOI 10.1152/jappl.1984.56.2.418; Parameswaran H, 2009, J APPL PHYSIOL, V107, P583, DOI 10.1152/japplphysiol.91227.2008; Parsons DW, 2008, J ANAT, V213, P217, DOI 10.1111/j.1469-7580.2008.00950.x; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P371, DOI 10.1016/0034-5687(70)90093-9; Phillips CG, 1995, RESP PHYSIOL, V102, P303, DOI 10.1016/0034-5687(95)00056-9; Pogany A, 1997, REV SCI INSTRUM, V68, P2774, DOI 10.1063/1.1148194; Quirk JD, 2011, RADIOLOGY, V260, P866, DOI 10.1148/radiol.11102226; Rausch SMK, 2011, ANN BIOMED ENG, V39, P2835, DOI 10.1007/s10439-011-0328-z; Renne R, 2001, TOXICOL PATHOL, V29, P587, DOI 10.1080/019262301317226401; Suki B, 2012, PULM PHARMACOL THER, V25, P268, DOI 10.1016/j.pupt.2011.04.027; Sznitman J, 2010, J VISUAL-JAPAN, V13, P337, DOI 10.1007/s12650-010-0043-0; Tawhai MH, 2001, RESP PHYSIOL, V127, P241, DOI 10.1016/S0034-5687(01)00238-9; Tsuda A, 2008, J APPL PHYSIOL, V105, P964, DOI 10.1152/japplphysiol.90546.2008; Tsuda A, 2008, RESP PHYSIOL NEUROBI, V163, P139, DOI 10.1016/j.resp.2008.02.010; Vasilescu DM, 2011, J APPL PHYSL; Watz H, 2005, RADIOLOGY, V236, P1053, DOI 10.1148/radiol.2363041142; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006; West JB, 1977, BIOENGINEERING ASPEC, P1; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0017400	49	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63552	10.1371/journal.pone.0063552	http://dx.doi.org/10.1371/journal.pone.0063552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704918	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200049
J	Juel, HB; Faber, C; Svendsen, SG; Vallejo, AN; Nissen, MH				Juel, Helene B.; Faber, Carsten; Svendsen, Signe G.; Vallejo, Abbe N.; Nissen, Mogens H.			Inflammatory Cytokines Protect Retinal Pigment Epithelial Cells from Oxidative Stress-Induced Death	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COMPLEMENT FACTOR-H; MACULAR DEGENERATION; MOLECULAR-MECHANISMS; POSSIBLE INVOLVEMENT; INDUCED APOPTOSIS; DRUSEN FORMATION; POTENTIAL ROLE; ARPE-19 CELLS; GROWTH-FACTOR	Purpose: To investigate the effects of inflammatory factors and oxidative stress on cell survival of the human retinal pigment epithelial (RPE) cell line, ARPE-19. Methods: Confluent RPE cells were treated with peripheral blood mononuclear cells-conditioned medium (PCM), H2O2, NaIO3, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, or combinations of these. Cell viability was determined by viability assays and by light microscopy. Effector molecules of cell death were investigated by immunofluorescence microscopy and flow cytometry. Microarrays were performed to screen for differential expression of anti-oxidative enzymes, and protein expression was validated by immunoblotting. Results: Viability of RPE cells was reduced by exposure to inflammatory agents (PCM, IFN gamma+/-TNF alpha) or to oxidative agents (H2O2 or NaIO3). Unexpectedly, cells treated with either H2O2 or NaIO3 were partially protected from cell death by the addition of PCM. This protection was conferred, at least in part, by IFN gamma and TNF alpha. Cell death induced by H2O2 or NaIO3 was preceded by mitochondrial dysfunction and by p62 upregulation, both of which were attenuated by PCM and/or by IFN gamma+TNF alpha. RPE cells co-cultured with activated T cells, or treated with cytokines showed increased expression of antio-xidative genes, with upregulation of superoxide dismutase 2 protein following PCM treatment. Conclusion: Oxidative stress-induced cell death was reduced by concomitant inflammatory stress. This is likely due to the cytokine-mediated induction of the anti-oxidative stress response, upregulating protective anti-oxidant pathway(s). These findings suggest caution for the clinical use of anti-inflammatory agents in the management of immune-associated eye diseases such as age-related macular degeneration.	[Juel, Helene B.; Faber, Carsten; Svendsen, Signe G.; Nissen, Mogens H.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark; [Vallejo, Abbe N.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Dept Immunol,Pittsburgh Canc Inst, Pittsburgh, PA 15261 USA; [Vallejo, Abbe N.] Univ Pittsburgh, Sch Med, McGowan Inst Regenerat Med, Pittsburgh, PA USA	University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Juel, HB (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Eye Res Unit, Copenhagen, Denmark.	hjuel@sund.ku.dk	Nissen, Mogens/B-4825-2008; Faber, Carsten/N-3210-2019; Juel, Helene/AAD-2843-2020; Faber, Carsten/I-4150-2013	Nissen, Mogens/0000-0001-7729-8667; Faber, Carsten/0000-0002-2517-7270; Faber, Carsten/0000-0002-2517-7270; Svendsen, Signe Goul/0000-0003-1618-5604; Juel, Helene B/0000-0002-5763-8545	Velux Fonden; Vaern om Synet; Synoptikfonden; Candy Foundation; NATIONAL INSTITUTE ON AGING [R01AG030734] Funding Source: NIH RePORTER	Velux Fonden(Velux Fonden); Vaern om Synet; Synoptikfonden; Candy Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by research grants from Velux Fonden (veluxfonden.dk); Vaern om Synet (www.vos.dk); Synoptikfonden (www.synoptik-fonden.dk); and the Candy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Boekhoorn SS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1396, DOI 10.1001/archopht.125.10.1396; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; BURKE JM, 1989, CURR EYE RES, V8, P1279, DOI 10.3109/02713688909013907; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Cao GF, 2011, BIOCHEM BIOPH RES CO, V414, P499, DOI 10.1016/j.bbrc.2011.09.094; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Choi SH, 2011, ACTA OPHTHALMOL, V89, pE350, DOI 10.1111/j.1755-3768.2011.02113.x; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Ehrlich R, 2008, CLIN INTERV AGING, V3, P473; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fong WG, 2012, ADV EXP MED BIOL, V723, P207, DOI 10.1007/978-1-4614-0631-0_28; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Harris MS, 1996, CURR EYE RES, V15, P255, DOI 10.3109/02713689609007619; Hyttinen JMT, 2011, REJUV RES, V14, P651, DOI 10.1089/rej.2011.1220; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Juel HB, 2011, EXP EYE RES, V92, P180, DOI 10.1016/j.exer.2011.01.003; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kaarniranta K, 2010, ACTA OPHTHALMOL, V88, P387, DOI 10.1111/j.1755-3768.2009.01840.x; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kasahara E, 2005, INVEST OPHTH VIS SCI, V46, P3426, DOI 10.1167/iovs.05-0344; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khandhadia S, 2012, IMMUNOBIOLOGY, V217, P127, DOI 10.1016/j.imbio.2011.07.019; Khandhadia S, 2012, ADV EXP MED BIOL, V724, P15, DOI 10.1007/978-1-4614-0653-2_2; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P561, DOI 10.1167/iovs.09-3774; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Klein R, 2008, OPHTHALMOLOGY, V115, P1742, DOI 10.1016/j.ophtha.2008.03.021; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kurz T, 2009, AUTOPHAGY, V5, P494, DOI 10.4161/auto.5.4.7961; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Liu JH, 2010, J OCUL PHARMACOL TH, V26, P249, DOI 10.1089/jop.2009.0127; Malek G, 2012, ADV EXP MED BIOL, V723, P51, DOI 10.1007/978-1-4614-0631-0_8; Markomichelakis NN, 2005, AM J OPHTHALMOL, V139, P537, DOI 10.1016/j.ajo.2004.09.058; Mitter SK, 2012, ADV EXP MED BIOL, V723, P83, DOI 10.1007/978-1-4614-0631-0_12; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rosello A, 2012, CLIN EXP IMMUNOL, V168, P52, DOI 10.1111/j.1365-2249.2011.04544.x; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P300, DOI 10.1001/archopht.125.3.300; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Shankar A, 2007, AM J EPIDEMIOL, V165, P375, DOI 10.1093/aje/kwk022; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Thampi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034468; Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Viiri J, 2010, MOL VIS, V16, P1399; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Wang Y, 2011, EYE, V25, P127, DOI 10.1038/eye.2010.196; Yang DL, 2009, INVEST OPHTH VIS SCI, V50, P4998, DOI 10.1167/iovs.09-3620; Yin JG, 2011, J CELL PHYSIOL, V226, P2025, DOI 10.1002/jcp.22532; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	72	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64619	10.1371/journal.pone.0064619	http://dx.doi.org/10.1371/journal.pone.0064619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705001	Green Submitted, gold, Green Published			2022-12-25	WOS:000319330200155
J	Zhang, YQ; Zhao, JL; Lau, WB; Jiao, LY; Liu, BJ; Yuan, YX; Wang, XL; Gao, EH; Koch, WJ; Ma, XL; Wang, YJ				Zhang, Yanqing; Zhao, Jianli; Lau, Wayne Bond; Jiao, Li-Yuan; Liu, Baojiang; Yuan, Yuexing; Wang, Xiaoliang; Gao, Erhe; Koch, Walter J.; Ma, Xin-Liang; Wang, Yajing			Tumor Necrosis Factor-alpha and Lymphotoxin-alpha Mediate Myocardial Ischemic Injury via TNF Receptor 1, but Are Cardioprotective When Activating TNF Receptor 2	PLOS ONE			English	Article							HEART-FAILURE; INDUCED CARDIOMYOPATHY; TRANSGENIC MICE; INFARCTION; ATHEROSCLEROSIS; ISCHEMIA/REPERFUSION; ADIPONECTIN; THERAPY; DISEASE; MODEL	Objective: This study determines the roles of tumor necrosis factor-alpha (TNF alpha) and lymphotoxin-alpha (LT alpha) in post-myocardial infarction (post-MI) cardiac injury, and identifies the TNF receptor type responsible for TNF alpha- and LT alpha-mediated cardiac injury. Methods and Results: Adult male wild type (WT), TNF alpha(-/-), LT alpha(-/-), TNFR1(-/-), and TNFR2(-/-) mice were subjected to MI via coronary artery occlusion. Functional, histological, and biochemical analyses were performed 1 to 7 days post-MI. In WT mice, MI significantly increased both TNF alpha and LT alpha levels in plasma, but in distinct temporal manner. Plasma TNF alpha peaked 1 day after MI, and decreased toward baseline 3 days after MI. In contrast, plasma LTa became significantly increased 3 days post-MI, and remained elevated thereafter. TNF alpha deletion significantly improved cardiac function 3 days, but not 7 days, after MI. In contrast, LT alpha deletion had no effect upon cardiac dysfunction 3 days after MI, but improved cardiac function 7 days after MI. More importantly, knockout of TNFR1 and TNFR2 had opposite effects upon post-MI cardiac dysfunction, which was markedly attenuated by TNFR1 deletion (P<0.01 vs. WT), but exacerbated by TNFR2 deletion (P<0.05 vs. WT). Conclusion: Our study demonstrates that TNF alpha and LT alpha overproduction contribute to early and late cardiac dysfunction after MI, respectively. We provide clear evidence that both TNF alpha and LT alpha mediate post-MI cardiac dysfunction via TNFR1 stimulation, whereas TNFR2 activation is cardioprotective against ischemic injury. Simultaneous inhibition of TNF alpha and LT alpha or specific TNFR1 function blockade may represent superior cardioprotective approaches over general TNF activity suppression.	[Zhang, Yanqing; Zhao, Jianli; Jiao, Li-Yuan; Liu, Baojiang] Shanxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Taiyuan, Peoples R China; [Lau, Wayne Bond; Yuan, Yuexing; Wang, Xiaoliang; Ma, Xin-Liang; Wang, Yajing] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Wang, Xiaoliang; Wang, Yajing] Shanxi Med Univ, Dept Physiol, Taiyuan, Peoples R China; [Gao, Erhe; Koch, Walter J.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA	Shanxi Medical University; Jefferson University; Shanxi Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ma, XL (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.	Xin.Ma@Jefferson.edu; Yajing.Wang@jefferson.edu		Lau, Wayne Bond/0000-0002-8064-8290	Natural Science Foundation of China [30900592, 81170199]; American Diabetes Association [1-11-JF56, 7-11-BS-93]; National Institutes of Health (NIH) [HL-63828, HL-096686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096686, R01HL063828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Natural Science Foundation of China (30900592 and 81170199 to YJW), American Diabetes Association (1-11-JF56 to YJW, 7-11-BS-93 to XLM), and the National Institutes of Health (NIH) (HL-63828, HL-096686 to XLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; Jang Y, 2007, CLIN CHIM ACTA, V384, P124, DOI 10.1016/j.cca.2007.06.017; Jang Y, 2007, CLIN CHIM ACTA, V377, P221, DOI 10.1016/j.cca.2006.10.002; Kishore R, 2011, ADV EXP MED BIOL, V691, P433, DOI 10.1007/978-1-4419-6612-4_45; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Kubota T, 2000, CIRCULATION, V101, P2518, DOI 10.1161/01.CIR.101.21.2518; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Li SH, 2007, AM J PHYSIOL-HEART C, V293, pH1847, DOI 10.1152/ajpheart.00578.2007; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Monden Y, 2007, AM J PHYSIOL-HEART C, V293, pH743, DOI 10.1152/ajpheart.00166.2007; Naoum JJ, 2006, MED SCI MONITOR, V12, pRA121; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Schulz R, 2009, CIRCULATION, V119, P1355, DOI 10.1161/CIRCULATIONAHA.108.846105; Schulz S, 2006, EUR CYTOKINE NETW, V17, P148, DOI 10.1684/ecn.2006.0031; Suna S, 2008, J ATHEROSCLER THROMB, V15, P160, DOI 10.5551/jat.E553; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Wang YJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE384, DOI 10.1152/ajpendo.90975.2008; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; YOKOYAMA T, 1993, J CLIN INVEST, V92, P2303, DOI 10.1172/JCI116834	28	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e60227	10.1371/journal.pone.0060227	http://dx.doi.org/10.1371/journal.pone.0060227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704873	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200002
J	Hiscox, A; Khammanithong, P; Kaul, S; Sananikhom, P; Luthi, R; Hill, N; Brey, PT; Lindsay, SW				Hiscox, Alexandra; Khammanithong, Phasouk; Kaul, Surinder; Sananikhom, Pany; Luthi, Ruedi; Hill, Nigel; Brey, Paul T.; Lindsay, Steve W.			Risk Factors for Mosquito House Entry in the Lao PDR	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS; SATELLITE VILLAGES; MALARIA VECTORS; REDUCE EXPOSURE; BREEDING SITES; RURAL TOWN; SRI-LANKA; GAMBIA; INTERVENTIONS; PATTERNS	Background: Construction of the Nam Theun 2 hydroelectric project and flooding of a 450 km(2) area of mountain plateau in south-central Lao PDR resulted in the resettlement of 6,300 people to newly built homes. We examined whether new houses would have altered risk of house entry by mosquitoes compared with traditional homes built from poorer construction materials. Methodology/Principal Findings: Surveys were carried out in the Nam Theun 2 resettlement area and a nearby traditional rice farming area in 2010. Mosquitoes were sampled in bedrooms using CDC light traps in 96 resettlement houses and 96 traditional houses and potential risk factors for mosquito house entry were recorded. Risk of mosquito house entry was more than twice as high in traditional bamboo houses compared with those newly constructed from wood (Putative Japanese Encephalitis (JE) vector incidence rate ratio (IRR) = 2.26, 95% CI 1.38-3.70, P = 0.001; Anopheline IRR = 2.35, 95% CI: 1.30-4.23, P = 0.005). Anophelines were more common in homes with cattle compared against those without (IRR = 2.32, 95% CI: 1.29-4.17, P = 0.005). Wood smoke from cooking fires located under the house or indoors was found to be protective against house entry by both groups of mosquito, compared with cooking in a separate room beside the house (Putative JE vector IRR = 0.43, 95% CI: 0.26-0.73, P = 0.002; Anopheline IRR = 0.22, 95% CI: 0.10-0.51, P, 0.001). Conclusions/Significance: Construction of modern wooden homes should help reduce human-mosquito contact in the Lao PDR. Reduced mosquito contact rates could lead to reduced transmission of diseases such as JE and malaria. Cattle ownership was associated with increased anopheline house entry, so zooprophylaxis for malaria control is not recommended in this area. Whilst wood smoke was protective against putative JE vector and anopheline house entry we do not recommend indoor cooking since smoke inhalation can enhance respiratory disease.	[Hiscox, Alexandra; Brey, Paul T.] Inst Pasteur Laos, Viangchan, Laos; [Hiscox, Alexandra; Hill, Nigel] London Sch Hyg & Trop Med, London WC1, England; [Khammanithong, Phasouk] Khammouane Prov Hlth Off, Thakhek, Laos; [Kaul, Surinder; Sananikhom, Pany; Luthi, Ruedi] Nam Theun 2 Power Co, Viangchan, Laos; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; Durham University	Hiscox, A (corresponding author), Inst Pasteur Laos, Viangchan, Laos.	alexandra.hiscox@wur.nl		Lindsay, Steve/0000-0002-3461-9050	Fondation EDF Diversiterre; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Fondation EDF Diversiterre; Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Fondation EDF Diversiterre. SWL was supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) Program of the Science and Technology Directory, Department of Homeland Security, and Fogarty International Center, National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hassan A, 2010, TROP BIOMED, V27, P404; Biran A, 2007, T ROY SOC TROP MED H, V101, P1065, DOI 10.1016/j.trstmh.2007.07.010; BOCKARIE MJ, 1994, ACTA TROP, V57, P337, DOI 10.1016/0001-706X(94)90080-9; Cao MQ, 2010, TROP MED INT HEALTH, V15, P918, DOI 10.1111/j.1365-3156.2010.02563.x; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; CHARLWOOD JD, 1984, T ROY SOC TROP MED H, V78, P141, DOI 10.1016/0035-9203(84)90204-9; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gunawardena DM, 1998, AM J TROP MED HYG, V58, P533, DOI 10.4269/ajtmh.1998.58.533; Hackett L., 1937, MALARIA EUROPE ECOLO; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hiscox A, 2011, THESIS U LONDON LOND; Kirby MJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-41; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kulkarni MA, 2006, J MED ENTOMOL, V43, P580, DOI 10.1603/0022-2585(2006)43[580:EEOMVA]2.0.CO;2; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; LINDSAY SW, 1989, MED VET ENTOMOL, V3, P97, DOI 10.1111/j.1365-2915.1989.tb00481.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Liu W, 2010, EPIDEMIOL INFECT, V138, P1292, DOI 10.1017/S0950268810000063; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Rattanarithikul Rampa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1; Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1; REUBEN R, 1992, AM J TROP MED HYG, V46, P654, DOI 10.4269/ajtmh.1992.46.654; Richards EE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-32; SCHULTZ G W, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P49; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; SNOW WF, 1987, MED VET ENTOMOL, V1, P9, DOI 10.1111/j.1365-2915.1987.tb00318.x; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; van der Hoek W, 2003, INT J EPIDEMIOL, V32, P280, DOI 10.1093/ije/dyg055; Van Miert E, 2012, PEDIATR PULM, V47, P358, DOI 10.1002/ppul.21554; WHO, 1982, WHO OFFS PUBL, V66	34	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e62769	10.1371/journal.pone.0062769	http://dx.doi.org/10.1371/journal.pone.0062769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700411	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000319966400009
J	Kinaston, RL; Walter, RK; Jacomb, C; Brooks, E; Tayles, N; Halcrow, SE; Stirling, C; Reid, M; Gray, AR; Spinks, J; Shaw, B; Fyfe, R; Buckley, HR				Kinaston, Rebecca L.; Walter, Richard K.; Jacomb, Chris; Brooks, Emma; Tayles, Nancy; Halcrow, Sian E.; Stirling, Claudine; Reid, Malcolm; Gray, Andrew R.; Spinks, Jean; Shaw, Ben; Fyfe, Roger; Buckley, Hallie R.			The First New Zealanders: Patterns of Diet and Mobility Revealed through Isotope Analysis	PLOS ONE			English	Article							RB-SR AGE; CARBON; COLLAGEN; MIGRATION; NITROGEN; RATIOS; ISLAND; COLONIZATION; EXTRACTION; CHRONOLOGY	Direct evidence of the environmental impact of human colonization and subsequent human adaptational responses to new environments is extremely rare anywhere in the world. New Zealand was the last Polynesian island group to be settled by humans, who arrived around the end of the 13th century AD. Little is known about the nature of human adaptation and mobility during the initial phase of colonization. We report the results of the isotopic analysis (carbon, nitrogen and strontium) of the oldest prehistoric skeletons discovered in New Zealand to assess diet and migration patterns. The isotope data show that the culturally distinctive burials, Group 1, had similar diets and childhood origins, supporting the assertion that this group was distinct from Group 2/3 and may have been part of the initial colonizing population at the site. The Group 2/3 individuals displayed highly variable diets and likely lived in different regions of the country before their burial at Wairau Bar, supporting the archaeological evidence that people were highly mobile in New Zealand since the initial phase of human settlement.	[Kinaston, Rebecca L.; Tayles, Nancy; Halcrow, Sian E.; Buckley, Hallie R.] Univ Otago, Dept Anat, Otago Sch Med Sci, Dunedin, New Zealand; [Walter, Richard K.; Jacomb, Chris; Brooks, Emma; Spinks, Jean] Univ Otago, Dept Anthropol & Archaeol, Dunedin, New Zealand; [Stirling, Claudine] Univ Otago, Dept Chem, Community Trust Otago Ctr Trace Element Anal, Dunedin, New Zealand; [Reid, Malcolm] Univ Otago, Dept Chem, Dunedin, New Zealand; [Gray, Andrew R.] Univ Otago, Dept Preventat & Social Med, Dunedin, New Zealand; [Shaw, Ben] Australian Natl Univ, Coll Arts & Social Sci, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Fyfe, Roger] Canterbury Museum, Christchurch, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Otago; Australian National University	Kinaston, RL (corresponding author), Univ Otago, Dept Anat, Otago Sch Med Sci, Dunedin, New Zealand.	rebecca.kinaston@otago.ac.nz	Gray, Andrew Robert/L-9161-2015; Buckley, Hallie/Q-5458-2019; Shaw, Ben/H-3235-2016	Gray, Andrew Robert/0000-0003-4299-2194; Halcrow, Sian/0000-0001-6038-7997; Shaw, Ben/0000-0002-8107-3425; Reid, Malcolm/0000-0002-4129-0214	School of Medical Sciences, University of Otago; Mason Foundation; Marsden Fund	School of Medical Sciences, University of Otago; Mason Foundation; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	University of Otago Research Grant (http://www.otago.ac.nz/research/otago004140.html);A grant-in-aid by the School of Medical Sciences, University of Otago (http://osms.otago.ac.nz/); The Mason Foundation (http://research-hub.griffith.edu.au/display/fosc_MASONG); Royal Society of New Zealand Marsden Fund (http://www.royalsociety.org.nz/programmes/funds/marsden/)grant number UOO0711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 1999, NEW ZEAL J GEOL GEOP, V42, P33, DOI 10.1080/00288306.1999.9514830; Adams CJ, 1997, NEW ZEAL J GEOL GEOP, V40, P275, DOI 10.1080/00288306.1997.9514760; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P201, DOI 10.1080/00288306.2004.9515048; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P189, DOI 10.1080/00288306.2004.9515047; Adams CJ, 2004, NEW ZEAL J GEOL GEOP, V47, P173, DOI 10.1080/00288306.2004.9515046; Ambrose S.H., 1993, PREHISTORIC HUMAN BO, P1, DOI 10.1007/978-3-662-02894-0_1; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; ANDERSON A, 1991, ANTIQUITY, V65, P767, DOI 10.1017/S0003598X00080510; Anderson A, 1996, WORLD ARCHAEOL, V27, P359, DOI 10.1080/00438243.1996.9980314; Anderson A., 1982, NZ J ARCHAEOLOGY, V4, P45; Anderson A.J., 1989, PRODIGIOUS BIRDS MOA; ANDERSON AJ, 1983, ARCHAEOL OCEAN, V18, P1; Bentley R.A., 2009, ASIAN PERSPECT, V48, P79, DOI [10.1353/asi.0.0017, DOI 10.1353/ASI.0.0017]; Bentley RA, 2007, AM ANTIQUITY, V72, P645, DOI 10.2307/25470438; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2005, ANTIQUITY, V79, P865, DOI 10.1017/S0003598X00115005; Bentley RA, 2004, J ARCHAEOL SCI, V31, P365, DOI 10.1016/j.jas.2003.09.003; Brooks E., 2009, ARCHAEOLOGY NZ, V52, P259; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Buckley HR, 2010, J PAC ARCHAEOL, V1, P1; Budd P, 2004, ANTIQUITY, V78, P127, DOI 10.1017/S0003598X0009298X; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Davidson J.M., 1984, PREHISTORY NZ; Davidson J, 2011, J PAC ARCHAEOL, V2, P93; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Duff R, 1950, MOA HUNTER PERIOD MA; Duff R.S., 1977, MOA HUNTER PERIOD MA; Duff RS., 1956, MOA HUNTER PERIOD MA; Evans JA, 2009, J GEOL SOC LONDON, V166, P617, DOI 10.1144/0016-76492008-043; Evans J, 2010, J HIST ASTRON, V41, P1; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; GEORGE AD, 1991, CHEM GEOL, V87, P11, DOI 10.1016/0168-9622(91)90030-Z; Golson J., 1959, ANTHR S SEAS, P29; GRAHAM IJ, 1985, CHEM GEOL, V52, P317, DOI 10.1016/0168-9622(85)90042-9; HARRISON TM, 1980, GEOCHIM COSMOCHIM AC, V44, P1985, DOI 10.1016/0016-7037(80)90198-2; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Higgins R, 2003, KI TE WHAIAO INTRO M, P85; Higham T, 1999, ANTIQUITY, V73, P420, DOI 10.1017/S0003598X00088360; HIGHAM TFG, 2004, NZ ARCHAEOLOGICAL AS, V26, P215; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Horton TW, 2003, NEW ZEAL J GEOL GEOP, V46, P457, DOI 10.1080/00288306.2003.9515021; HOUGHTON P, 1975, Records of the Canterbury Museum, V9, P231; HOUGHTON P, 1978, J POLYNESIAN SOC, V87, P257; Houghton P., 1996, PEOPLE GREAT OCEAN A; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Katzenberg MA., 2008, BIOL ANTHR HUMAN SKE, P413, DOI 10.1002/9780470245842; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Knapp M, 2012, P NATL ACAD IN PRESS; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Leach B, 2003, NZ J ARCHAEOL, V23, P31; Leach B. Foss, 1977, NZ ARCHAEOLOGICAL AS, V20, P107; Marshall Y, 1987, NZ J ARCHAEOLOGY, V9, P55; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Nagaoka L, 2002, J ANTHROPOL ARCHAEOL, V21, P419, DOI 10.1016/S0278-4165(02)00008-9; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Oskam CL, 2012, QUATERNARY SCI REV, V52, P41, DOI 10.1016/j.quascirev.2012.07.007; PIN C, 1992, ANAL CHIM ACTA, V269, P249, DOI 10.1016/0003-2670(92)85409-Y; Pollard AM, 2011, ANTIQUITY, V85, P631, DOI 10.1017/S0003598X00068034; Pollock N., 1992, THESE ROOTS REMAIN F; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Price TD, 1998, ANTIQUITY, V72, P405, DOI 10.1017/S0003598X00086683; Richards MP, 2009, ARCHAEOL OCEAN, V44, P29, DOI 10.1002/j.1834-4453.2009.tb00042.x; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Salmond A., 1976, HUI STUDY MAORI CERE; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SCHWARCZ HP, 1991, YEARB PHYS ANTHROPOL, V34, P283; Scofield Paul, 2003, Records of the Canterbury Museum, V17, P17; Sealy J., 2005, HDB ARCHAEOLOGICAL S, P269; Shaw B, 2011, J ANTHROPOL ARCHAEOL, V30, P344, DOI 10.1016/j.jaa.2011.05.004; Shaw B, 2010, J ARCHAEOL SCI, V37, P605, DOI 10.1016/j.jas.2009.10.025; Shaw BJ, 2009, J ARCHAEOL SCI, V36, P1079, DOI 10.1016/j.jas.2008.12.010; Smith I, 2005, EXPLOITATION AND CULTURAL IMPORTANCE OF SEA MAMMALS, P6; Smith I.W., 1989, SAYING SO DOESNT MAK, P76; Thornton J., 2009, FIELD GUIDE NZ GEOLO; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Walter R, 2006, WORLD ARCHAEOL, V38, P274, DOI 10.1080/00438240600693992; Walter R, 2010, ANTIQUITY, V84, P497, DOI 10.1017/S0003598X00066734; Wilkes O, 1964, FURTHER WORK WAIRAU	83	44	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2013	8	5							e64580	10.1371/journal.pone.0064580	http://dx.doi.org/10.1371/journal.pone.0064580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	145XK	23691250	Green Published, Green Submitted, gold			2022-12-25	WOS:000319052700109
J	Martin, D; Nguyen, Q; Molinolo, A; Gutkind, JS				Martin, D.; Nguyen, Q.; Molinolo, A.; Gutkind, J. S.			Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene	ONCOGENE			English	Article						Kaposi's sarcoma; mTOR; PI3K; 4EBP; rapamycin; cancer	KAPOSIS-SARCOMA; MAMMALIAN TARGET; PROTEIN; CELL; INFECTION; GROWTH; PATHOGENESIS; EXPRESSION; SIROLIMUS; CYTOKINES	Dysregulation of the PI3K/Akt/mTOR pathway is one of the most frequent events in human cancer. However, the clinical benefits of PI3K/Akt/mTOR inhibitors have not yet achieved their predicted potential in many of the most prevalent human cancers. Of interest, treatment of Kaposi's sarcoma (KS) patients with rapamycin provided the first evidence of the antineoplastic activity of mTOR inhibitors in humans, becoming the standard of care for KS arising in renal transplant patients. Thus, the study of KS may provide a unique opportunity to dissect the contribution of specific mTOR downstream targets to cancer development. The KS associated herpesvirus (KSHV) is the etiological agent for KS, and the KSHV-encoded oncogene viral-G protein-coupled receptor (vGPCR) promotes the potent activation of the PI3K-Akt-mTOR pathway by both direct and paracrine mechanisms. We focused on a direct target of mTOR, EIF4EBP1/2/3 (4EBP), which inhibits the translation of eukaryotic initiation factor 4E (eiF4E)-bound mRNAs. 4EBP phosphorylation by mTOR relieves its inhibitory activity, hence resulting in increased eiF4E-dependent mRNA translation. We developed a paracrine transformation model, recapitulating the cellular composition of KS lesions, in which vGPCR-expressing cells promote the rapid proliferation of endothelial cells, thus expressing KSHV-latent genes by the release of growth factors. Using this model, we show here that the accumulation of dephosphorylated 4EBP in response to rapamycin or by the expression of an mTOR-insensitive mutant of 4EBP1 is sufficient to disrupt the eiF4E function downstream of mTOR to a similar extent than the mTOR catalytic inhibitor Torin2 and to halt KS development. We also provide evidence that eiF4E contributes to paracrine neoplastic, signaling through the release of pro-angiogenic factors that are acting on endothelial cells, expressing KSHV-latent genes. These findings may provide a preclinical platform and the rationale for the development of novel mTOR, inhibiting agents that may selectively disrupt the mTOR-4EBP interaction for the treatment of KS and other tumor lesions, exhibiting hyperactive mTOR pathway function.	[Martin, D.; Nguyen, Q.; Molinolo, A.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bldg 30 Room 320,30 Convent Dr MSC 4340, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Martin Izquierdo, Daniel/0000-0002-8880-9087	National Institutes of Health Intramural AIDS-Targeted Antiviral Program; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health Intramural AIDS-Targeted Antiviral Program; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the National Institutes of Health Intramural AIDS-Targeted Antiviral Program and the National Institute of Dental and Craniofacial Research. We apologize to colleagues whose primary research papers may not have been cited due to space constraints.	Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bieleski L, 2001, J VIROL, V75, P1864, DOI 10.1128/JVI.75.4.1864-1869.2001; Cesarman E, 2000, J EXP MED, V191, P417, DOI 10.1084/jem.191.3.417; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Gasperini P, 2009, LEUKEMIA, V23, P1867, DOI 10.1038/leu.2009.117; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994, DOI 10.1189/jlb.1107777; Hosseini-Moghaddam SM, 2012, TRANSPL INFECT DIS, V14, P338, DOI 10.1111/j.1399-3062.2011.00714.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu QS, 2012, METHODS MOL BIOL, V821, P447, DOI 10.1007/978-1-61779-430-8_29; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Sodhi A, 2004, P NATL ACAD SCI USA, V101, P4821, DOI 10.1073/pnas.0400835101; Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Stallone G, 2008, TRANSPL INT, V21, P825, DOI 10.1111/j.1432-2277.2008.00697.x; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502; Vuiblet V, 2012, NEPHROL DIAL TRANSPL, V27, P411, DOI 10.1093/ndt/gfr261; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	28	14	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2405	2412		10.1038/onc.2013.193	http://dx.doi.org/10.1038/onc.2013.193			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23708663	Bronze			2022-12-25	WOS:000335451800013
J	Eckhard, U; Schonauer, E; Brandstetter, H				Eckhard, Ulrich; Schoenauer, Esther; Brandstetter, Hans			Structural Basis for Activity Regulation and Substrate Preference of Clostridial Collagenases G, H, and T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; PROTEIN-STRUCTURE; HISTOLYTICUM; PROTEASES; DOMAINS; ASTACIN; ENZYMES	Clostridial collagenases are among the most efficient enzymes to degrade by far the most predominant protein in the biosphere. Here we present crystal structures of the peptidases of three clostridial collagenase isoforms (ColG, ColH, and ColT). The comparison of unliganded and liganded structures reveals a quaternary subdomain dynamics. In the unliganded ColH structure, this globular dynamics is modulated by an aspartate switch motion that binds to the catalytic zinc. We further identified a calcium binding site in proximity to the catalytic zinc. Both ions are required for full activity, explaining why calcium critically affects the enzymatic activity of clostridial collagenases. Our studies further reveal that loops close to the active site thus serve as characteristic substrate selectivity filter. These elements explain the distinct peptidolytic and collagenolytic activities of these enzymes and provide a rational framework to engineer collagenases with customized substrate specificity as well as for inhibitor design.	[Eckhard, Ulrich; Schoenauer, Esther; Brandstetter, Hans] Salzburg Univ, Dept Mol Biol, Div Struct Biol, A-5020 Salzburg, Austria	Salzburg University	Brandstetter, H (corresponding author), Salzburg Univ, Dept Mol Biol, Div Struct Biol, Billrothstr 11, A-5020 Salzburg, Austria.	hans.brandstetter@sbg.ac.at	Eckhard, Ulrich/L-3733-2016; Brandstetter, Hans/E-6754-2011	Eckhard, Ulrich/0000-0001-5863-4514; Brandstetter, Hans/0000-0002-6089-3045; Schonauer, Esther/0000-0002-2625-9446	Priority Program Biosciences and Health of the University of Salzburg; Land Salzburg; Austrian Science Fund (FWF) [P20582-B03]; Austrian Science Fund (FWF) [P 20582] Funding Source: researchfish	Priority Program Biosciences and Health of the University of Salzburg; Land Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Priority Program Biosciences and Health of the University of Salzburg, the Land Salzburg, and the Austrian Science Fund (FWF Project P20582-B03).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; BOND MD, 1984, BIOCHEMISTRY-US, V23, P3085, DOI 10.1021/bi00308a036; Brandhorst H, 2010, TRANSPLANTATION, V90, P334, DOI 10.1097/TP.0b013e3181e49bd7; Breite AG, 2011, TRANSPL P, V43, P3171, DOI 10.1016/j.transproceed.2011.09.059; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Bruggemann H, 2004, ANAEROBE, V10, P53, DOI 10.1016/j.anaerobe.2003.08.001; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Desai SS, 2011, J HAND SURG-AM, V36A, P936, DOI 10.1016/j.jhsa.2011.03.002; Ducka P, 2009, APPL MICROBIOL BIOT, V83, P1055, DOI 10.1007/s00253-009-1953-4; Eckhard U, 2008, ACTA CRYSTALLOGR F, V64, P419, DOI 10.1107/S1744309108010476; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; Eckhard U, 2011, BIOL CHEM, V392, P1039, DOI 10.1515/BC.2011.099; Eckhard U, 2009, BIOL CHEM, V390, P11, DOI 10.1515/BC.2009.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FRENCH MF, 1992, J PROTEIN CHEM, V11, P83, DOI 10.1007/BF01025095; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, TOXICON, V39, P1769, DOI 10.1016/S0041-0101(01)00163-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOOKHTIAR KA, 1985, BIOCHEMISTRY-US, V24, P6527, DOI 10.1021/bi00344a033; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 2011, BIOL EXTRACELL MATR, P95, DOI 10.1007/978-3-642-16861-1_5; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ravanti L, 2000, INT J MOL MED, V6, P391; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Shi L, 2009, J WOUND OSTOMY CONT, V36, pS12, DOI 10.1097/WON.0b013e3181bfdd1a; STOCKER W, 1993, EUR J BIOCHEM, V214, P215, DOI 10.1111/j.1432-1033.1993.tb17915.x; Tallant C, 2010, J BIOL CHEM, V285, P13951, DOI 10.1074/jbc.M109.083378; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; VANWART HE, 1985, BIOCHEMISTRY-US, V24, P6520, DOI 10.1021/bi00344a032; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zhang P, 2009, NEW ENGL J MED, V361, P2578, DOI 10.1056/NEJMc0909497	47	48	56	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20184	20194		10.1074/jbc.M112.448548	http://dx.doi.org/10.1074/jbc.M112.448548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703618	hybrid, Green Published			2022-12-25	WOS:000321715100008
J	Kim, H; Kim, K; Yu, SJ; Jang, ES; Yu, J; Cho, G; Yoon, JH; Kim, Y				Kim, Hyunsoo; Kim, Kyunggon; Yu, Su Jong; Jang, Eun Sun; Yu, Jiyoung; Cho, Geunhee; Yoon, Jung-Hwan; Kim, Youngsoo			Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction Monitoring	PLOS ONE			English	Article							LC-MS/MS ANALYSIS; ALPHA-FETOPROTEIN; GENE-EXPRESSION; ABSOLUTE QUANTIFICATION; PROTEOMIC ANALYSIS; PROTEIN PROFILE; IMMUNE-RESPONSE; LIVER-CANCER; SIGNATURE; CELLS	Hepatocellular carcinoma (HCC) is one of the most common and aggressive cancers and is associated with a poor survival rate. Clinically, the level of alpha-fetoprotein (AFP) has been used as a biomarker for the diagnosis of HCC. The discovery of useful biomarkers for HCC, focused solely on the proteome, has been difficult; thus, wide-ranging global data mining of genomic and proteomic databases from previous reports would be valuable in screening biomarker candidates. Further, multiple reaction monitoring (MRM), based on triple quadrupole mass spectrometry, has been effective with regard to high-throughput verification, complementing antibody-based verification pipelines. In this study, global data mining was performed using 5 types of HCC data to screen for candidate biomarker proteins: cDNA microarray, copy number variation, somatic mutation, epigenetic, and quantitative proteomics data. Next, we applied MRM to verify HCC candidate biomarkers in individual serum samples from 3 groups: a healthy control group, patients who have been diagnosed with HCC (Before HCC treatment group), and HCC patients who underwent locoregional therapy (After HCC treatment group). After determining the relative quantities of the candidate proteins by MRM, we compared their expression levels between the 3 groups, identifying 4 potential biomarkers: the actin-binding protein anillin (ANLN), filamin-B (FLNB), complementary C4-A (C4A), and AFP. The combination of 2 markers (ANLN, FLNB) improved the discrimination of the before HCC treatment group from the healthy control group compared with AFP. We conclude that the combination of global data mining and MRM verification enhances the screening and verification of potential HCC biomarkers. This efficacious integrative strategy is applicable to the development of markers for cancer and other diseases.	[Kim, Hyunsoo; Kim, Kyunggon; Yu, Jiyoung; Kim, Youngsoo] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul 151, South Korea; [Yu, Su Jong; Jang, Eun Sun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Cho, Geunhee] Yonsei Univ, Dept Life Sci, Seoul 120749, South Korea; [Cho, Geunhee] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University	Yoon, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yoonjh@snu.ac.kr; biolab@snu.ac.kr	Kim, Youngsoo/D-6046-2012	Yoon, Jung-Hwan/0000-0002-9128-3610; Yu, Su Jong/0000-0001-8888-7977; Kim, Hyunsoo/0000-0002-8441-3376	National Research Foundation of Korea National Research Foundation of Korea [2011-0030740]; Proteogenomic Research Program; Korea government [MEST]	National Research Foundation of Korea National Research Foundation of Korea(National Research Foundation of Korea); Proteogenomic Research Program; Korea government [MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea National Research Foundation of Korea grant (No. 2011-0030740) and the Proteogenomic Research Program, funded by the Korea government [MEST]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2008, CANCER RES, V68, P2641, DOI 10.1158/0008-5472.CAN-07-5590; Alkofer B, 2011, J VISC SURG, V148, P3, DOI 10.1016/j.jviscsurg.2010.12.012; Bei R, 2011, CURR MOL MED, V11, P564, DOI 10.2174/156652411800615162; Bertino G, 2011, MINERVA MED, V102, P363; Bertino G, 2012, SEMIN ONCOL, V39, P410, DOI 10.1053/j.seminoncol.2012.05.001; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; Chen N, 2008, PROTEOMICS, V8, P5108, DOI 10.1002/pmic.200800280; Chochi Y, 2009, J PATHOL, V217, P677, DOI 10.1002/path.2491; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Cottingham Katie, 2009, J Proteome Res, V8, P428; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; De Zhu J, 2005, CELL RES, V15, P272; Donati Marcello, 2010, Front Biosci (Schol Ed), V2, P571; Duffy MJ, 2001, CRIT REV CL LAB SCI, V38, P225, DOI 10.1080/20014091084218; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kakehashi A, 2011, TOXICOL SCI, V119, P61, DOI 10.1093/toxsci/kfq307; Kim K, 2010, J PROTEOME RES, V9, P689, DOI 10.1021/pr901013d; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Lee HJ, 2010, J PROTEOME RES, V9, P308, DOI 10.1021/pr900649b; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Li C, 2004, MOL CELL PROTEOMICS, V3, P399, DOI 10.1074/mcp.M300133-MCP200; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Mannova P, 2006, MOL CELL PROTEOMICS, V5, P2319, DOI 10.1074/mcp.M600121-MCP200; Masuzaki R, 2012, SEMIN ONCOL, V39, P434, DOI 10.1053/j.seminoncol.2012.05.009; Nakagawa Kan, 2012, Gan To Kagaku Ryoho, V39, P671; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Niu DD, 2009, PROTEOMICS, V9, P3856, DOI 10.1002/pmic.200900071; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Park Joong Won, 2004, Korean J Hepatol, V10, P88; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Robinson Philip, 2008, Cancer Imaging, V8 Spec No A, pS128, DOI 10.1102/1470-7330.2008.9019; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Stefaniuk P, 2010, WORLD J GASTROENTERO, V16, P418, DOI 10.3748/wjg.v16.i4.418; Stergachis AB, 2011, NAT METHODS, V8, P1041, DOI [10.1038/NMETH.1770, 10.1038/nmeth.1770]; Sun YL, 2008, J PROTEOME RES, V7, P3847, DOI 10.1021/pr800153s; Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Yan W, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r54; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhang JH, 2009, PROTEOMICS, V9, P2836, DOI 10.1002/pmic.200800911	48	25	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2013	8	5							e63468	10.1371/journal.pone.0063468	http://dx.doi.org/10.1371/journal.pone.0063468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UP	23717429	Green Published, gold, Green Submitted			2022-12-25	WOS:000320362700024
J	Chiu, CC; Haung, JW; Chang, FR; Huang, KJ; Huang, HM; Huang, HW; Chou, CK; Wu, YC; Chang, HW				Chiu, Chien-Chih; Haung, Jo-Wen; Chang, Fang-Rong; Huang, Kuang-Jing; Huang, Hsuan-Min; Huang, Hurng-Wern; Chou, Chon-Kit; Wu, Yang-Chang; Chang, Hsueh-Wei			Golden Berry-Derived 4 beta-hydroxywithanolide E for Selectively Killing Oral Cancer Cells by Generating ROS, DNA Damage, and Apoptotic Pathways	PLOS ONE			English	Article							COMPOUND WITHAFERIN-A; EXTRACT; H2AX; PROLIFERATION; CYTOTOXICITY; ACTIVATION; INDUCTION; DEATH; ATR	Background: Most chemotherapeutic drugs for killing cancer cells are highly cytotoxic in normal cells, which limits their clinical applications. Therefore, a continuing challenge is identifying a drug that is hypersensitive to cancer cells but has minimal deleterious effects on healthy cells. The aims of this study were to evaluate the potential of 4 beta-hydroxywithanolide (4 beta HWE) for selectively killing cancer cells and to elucidate its related mechanisms. Methodology and Principal Findings: Changes in survival, oxidative stress, DNA damage, and apoptosis signaling were compared between 4 beta HWE-treated oral cancer (Ca9-22) and normal fibroblast (HGF-1) cells. At 24 h and 48 h, the numbers of Ca9-22 cells were substantially decreased, but the numbers of HGF-1 cells were only slightly decreased. Additionally, the IC50 values for 4 beta HWE in the Ca9-22 cells were 3.6 and 1.9 mu g/ml at 24 and 48 h, respectively. Time-dependent abnormal increases in ROS and dose-responsive mitochondrial depolarization can be exploited by using 4 beta HWE in chemotherapies for selectively killing cancer cells. Dose-dependent DNA damage measured by comet-nuclear extract assay and flow cytometry-based gamma-H2AX/propidium iodide (PI) analysis showed relatively severer damage in the Ca9-22 cells. At both low and high concentrations, 4 beta HWE preferably perturbed the cell cycle in Ca9-22 cells by increasing the subG1 population and arrest of G1 or G2/M. Selective induction of apoptosis in Ca9-22 cells was further confirmed by Annexin V/PI assay, by preferential expression of phosphorylated ataxia-telangiectasia- and Rad3-related protein (p-ATR), and by cleavage of caspase 9, caspase 3, and poly ADP-ribose polymerase (PARP). Conclusions/Significance: Together, the findings of this study, particularly the improved understanding of the selective killing mechanisms of 4 beta HWE, can be used to improve efficiency in killing oral cancer cells during chemoprevention and therapy.	[Chiu, Chien-Chih; Chou, Chon-Kit] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Haung, Jo-Wen; Huang, Kuang-Jing; Huang, Hsuan-Min; Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Fang-Rong; Wu, Yang-Chang; Chang, Hsueh-Wei] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Huang, Hurng-Wern] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Wu, Yang-Chang] China Med Univ, Dept Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Wu, Yang-Chang] China Med Univ Hosp, Ctr Mol Canc, Taichung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wu, YC (corresponding author), Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan.	yachwu@mail.cmu.edu.tw; changhw@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Wu, Yang-Chang/C-5682-2009; Chiu, Chien-Chih/AAW-9861-2020	Chang, Hsueh-Wei/0000-0003-0068-2366; Wu, Yang-Chang/0000-0001-7815-2686; Chiu, Chien-Chih/0000-0001-7307-2468; Chang, Fang-Rong/0000-0003-2549-4193	National Science Council [NSC101-2320-B-037-049]; Department of Health, Executive Yuan, Republic of China [DOH102-TD-C-111-002]; National Sun Yat-Sen University-KMU Joint Research Project [NSYSU-KMU 102-034]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Republic of China; National Sun Yat-Sen University-KMU Joint Research Project	This study was supported by grants from the National Science Council (NSC101-2320-B-037-049), the Department of Health, Executive Yuan, Republic of China (DOH102-TD-C-111-002), and the National Sun Yat-Sen University-KMU Joint Research Project (#NSYSU-KMU 102-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004470; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Amritpal Singh, 2010, International Journal of Green Pharmacy, V4, P229, DOI 10.4103/0973-8258.74130; Chang HC, 2007, MOL CANCER THER, V6, P1572, DOI 10.1158/1535-7163.MCT-06-0812; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chiang SL, 2007, TOXICOL SCI, V100, P66, DOI 10.1093/toxsci/kfm201; Chiu CC, 2011, J AGR FOOD CHEM, V59, P4288, DOI 10.1021/jf200566a; Chiu CC, 2010, CANCER LETT, V295, P92, DOI 10.1016/j.canlet.2010.02.017; Chiu CC, 2009, DNA CELL BIOL, V28, P501, DOI 10.1089/dna.2009.0852; Choi MJ, 2011, TOXICOL IN VITRO, V25, P692, DOI 10.1016/j.tiv.2011.01.010; Choudhary MI, 2010, PHYTOCHEMISTRY, V71, P2205, DOI 10.1016/j.phytochem.2010.08.019; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Daniel D, 2003, INT IMMUNOPHARMACOL, V3, P1791, DOI 10.1016/j.intimp.2003.08.004; Fricker M, 2013, J BIOL CHEM, V288, P9145, DOI 10.1074/jbc.M112.427880; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lubin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005735; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Myoung H, 2003, CANCER SCI, V94, P215, DOI 10.1111/j.1349-7006.2003.tb01422.x; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Noori, 2012, ADV LIFE SCI, V2, P6, DOI [10.5923/j.als.20120201.02, DOI 10.5923/J.ALS.20120201.02]; Ovadje P, 2011, J ETHNOPHARMACOL, V133, P86, DOI 10.1016/j.jep.2010.09.005; PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205; Priyandoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019552; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Sun YL, 2010, CANCER RES, V70, P2880, DOI 10.1158/0008-5472.CAN-09-4572; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Wang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037764; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Wu SJ, 2004, LIFE SCI, V74, P2061, DOI 10.1016/j.lfs.2003.09.058; Yeh CC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-142; Yeh CC, 2012, MOLECULES, V17, P10916, DOI 10.3390/molecules170910916; Yen CY, 2012, MUTAT RES-GEN TOX EN, V747, P253, DOI 10.1016/j.mrgentox.2012.06.003; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	42	79	79	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64739	10.1371/journal.pone.0064739	http://dx.doi.org/10.1371/journal.pone.0064739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705007	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200161
J	Fofana, I; Xiao, F; Thumann, C; Turek, M; Zona, L; Tawar, RG; Grunert, F; Thompson, J; Zeisel, MB; Baumert, TF				Fofana, Isabel; Xiao, Fei; Thumann, Christine; Turek, Marine; Zona, Laetitia; Tawar, Rajiv G.; Grunert, Fritz; Thompson, John; Zeisel, Mirjam B.; Baumert, Thomas F.			A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission	PLOS ONE			English	Article							B TYPE-I; SCAVENGER RECEPTOR; LIVER-TRANSPLANTATION; NEUTRALIZING ANTIBODIES; HEPATOMA-CELLS; ENTRY FACTOR; VIRAL ENTRY; INFECTION; CD81; CLAUDIN-1	Background and Aims: Hepatitis C virus (HCV) infection is a challenge to prevent and treat because of the rapid development of drug resistance and escape. Viral entry is required for initiation, spread, and maintenance of infection, making it an attractive target for antiviral strategies. Methods: Using genetic immunization, we produced four monoclonal antibodies (mAbs) against the HCV host entry factor CD81. The effects of antibodies on inhibition of HCV infection and dissemination were analyzed in HCV permissive human liver cell lines. Results: The anti-CD81 mAbs efficiently inhibited infection by HCV of different genotypes as well as a HCV escape variant selected during liver transplantation and re-infecting the liver graft. Kinetic studies indicated that anti-CD81 mAbs target a post-binding step during HCV entry. In addition to inhibiting cell-free HCV infection, one antibody was also able to block neutralizing antibody-resistant HCV cell-cell transmission and viral dissemination without displaying any detectable toxicity. Conclusion: A novel anti-CD81 mAb generated by genetic immunization efficiently blocks HCV spread and dissemination. This antibody will be useful to further unravel the role of virus-host interactions during HCV entry and cell-cell transmission. Furthermore, this antibody may be of interest for the development of antivirals for prevention and treatment of HCV infection.	[Fofana, Isabel; Xiao, Fei; Thumann, Christine; Turek, Marine; Zona, Laetitia; Tawar, Rajiv G.; Zeisel, Mirjam B.; Baumert, Thomas F.] INSERM, Inst Virol, U1110, Strasbourg, France; [Fofana, Isabel; Xiao, Fei; Thumann, Christine; Turek, Marine; Zona, Laetitia; Tawar, Rajiv G.; Zeisel, Mirjam B.; Baumert, Thomas F.] Univ Strasbourg, Strasbourg, France; [Grunert, Fritz; Thompson, John] Aldevron GmbH, Freiburg, Germany; [Baumert, Thomas F.] Hop Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Baumert, TF (corresponding author), INSERM, Inst Virol, U1110, Strasbourg, France.	Thomas.Baumert@unistra.fr	Baumert, Thomas/ABF-4718-2020; Zeisel, Mirjam B/E-9205-2016; Xiao, Fei/E-7133-2013	Baumert, Thomas/0000-0002-8864-2168; Zeisel, Mirjam B/0000-0003-1606-0131; Xiao, Fei/0000-0001-7353-2700	Inserm, University of Strasbourg; European Union [ERC-2008-AdG-233130-HEPCENT]; chair of excellence program of the Agence Nationale de la Recherche France [ANR-05-CEXC-008]; ANRS [2009/183, 2011/132, 2012/239]; Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir) [ANR-10-LAB-28]; Direction Generale de l'Offre de Soins [A12027MS]; Aldevron (Pro Inno II) [KA0690901UL8]	Inserm, University of Strasbourg; European Union(European Commission); chair of excellence program of the Agence Nationale de la Recherche France(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir)(French National Research Agency (ANR)); Direction Generale de l'Offre de Soins; Aldevron (Pro Inno II)	This work was supported by Inserm, University of Strasbourg, the European Union (ERC-2008-AdG-233130-HEPCENT, INTERREG-IV-Rhin Superieur-FEDER-Hepato-Regio-Net 2009 and 2012), the chair of excellence program of the Agence Nationale de la Recherche France (ANR-05-CEXC-008), ANRS (2009/183, 2011/132, 2012/239), Laboratoire d'excellence LabEx HEPSYS (Investissement d'Avenir; ANR-10-LAB-28), the Direction Generale de l'Offre de Soins (A12027MS) and Aldevron (Pro Inno II (KA0690901UL8)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Boyle JS, 1997, P NATL ACAD SCI USA, V94, P14626, DOI 10.1073/pnas.94.26.14626; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Charlton M, 2011, HEPATOLOGY, V54, P3, DOI 10.1002/hep.24470; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Farquhar MJ, 2012, J VIROL, V86, P4305, DOI 10.1128/JVI.06996-11; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lacek K, 2012, J HEPATOL, V57, P17, DOI 10.1016/j.jhep.2012.02.018; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schwarz AK, 2009, J VIROL, V83, P12407, DOI 10.1128/JVI.01552-09; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watt K, 2009, AM J TRANSPLANT, V9, P1707, DOI 10.1111/j.1600-6143.2009.02702.x; Witteveldt J, 2009, J GEN VIROL, V90, P48, DOI 10.1099/vir.0.006700-0; Zahid MN, 2013, HEPATOLOGY, V57, P492, DOI 10.1002/hep.26097; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802	53	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64221	10.1371/journal.pone.0064221	http://dx.doi.org/10.1371/journal.pone.0064221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704981	Green Published, gold			2022-12-25	WOS:000319330200125
J	Hajjarian, Z; Nadkarni, SK				Hajjarian, Zeinab; Nadkarni, Seemantini K.			Evaluation and Correction for Optical Scattering Variations in Laser Speckle Rheology of Biological Fluids	PLOS ONE			English	Article							DIFFUSING-WAVE-SPECTROSCOPY; DYNAMIC LIGHT-SCATTERING; POLARIZED-LIGHT; TRACKING MICRORHEOMETRY; ATHEROSCLEROTIC PLAQUES; REFLECTION MEASUREMENTS; MULTIPLE-SCATTERING; VISCOELASTIC MODULI; GLUCOSE-LEVELS; TURBID MEDIA	Biological fluids fulfill key functionalities such as hydrating, protecting, and nourishing cells and tissues in various organ systems. They are capable of these versatile tasks owing to their distinct structural and viscoelastic properties. Characterizing the viscoelastic properties of bio-fluids is of pivotal importance for monitoring the development of certain pathologies as well as engineering synthetic replacements. Laser Speckle Rheology (LSR) is a novel optical technology that enables mechanical evaluation of tissue. In LSR, a coherent laser beam illuminates the tissue and temporal speckle intensity fluctuations are analyzed to evaluate mechanical properties. The rate of temporal speckle fluctuations is, however, influenced by both optical and mechanical properties of tissue. Therefore, in this paper, we develop and validate an approach to estimate and compensate for the contributions of light scattering to speckle dynamics and demonstrate the capability of LSR for the accurate extraction of viscoelastic moduli in phantom samples and biological fluids of varying optical and mechanical properties.	[Hajjarian, Zeinab; Nadkarni, Seemantini K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Nadkarni, SK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	snadkarni@partners.org			NIH grant [R21 HL 088306, U54 EB015408-01]; ARRA grant [R21 HL 088306-02S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119867, R21HL088306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015408] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the NIH grant No. R21 HL 088306 (SN), NIH grant No. U54 EB015408-01 (SN), and the ARRA grant No. R21 HL 088306-02S1 (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALUCANI U, 1990, BER BUNSEN PHYS CHEM, V94, P261, DOI 10.1002/bbpc.19900940313; Bartel S, 2000, APPL OPTICS, V39, P1580, DOI 10.1364/AO.39.001580; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bizheva KK, 1998, PHYS REV E, V58, P7664, DOI 10.1103/PhysRevE.58.7664; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Brown W., 1993, DYNAMIC LIGHT SCATTE; Cardinaux F, 2002, EUROPHYS LETT, V57, P738, DOI 10.1209/epl/i2002-00525-0; Chen DT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.108301; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Cipelletti L, 1999, REV SCI INSTRUM, V70, P3214, DOI 10.1063/1.1149894; Cohen-Addad S, 2001, PHYS REV LETT, V86, P4700, DOI 10.1103/PhysRevLett.86.4700; Cote D, 2005, OPT EXPRESS, V13, P148, DOI 10.1364/OPEX.13.000148; Dasgupta BR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021504; Dasgupta BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051505; Datta SS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041404; Diebold U, 2003, CATAL TODAY, V85, P93, DOI 10.1016/S0920-5861(03)00378-X; Divine JG, 2007, CLIN ORTHOP RELAT R, P113, DOI 10.1097/BLO.0b013e31802f5421; DURIAN DJ, 1995, PHYS REV E, V51, P3350, DOI 10.1103/PhysRevE.51.3350; Fam H, 2007, BIORHEOLOGY, V44, P59; FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777; FREUND I, 1992, PHYS REV B, V45, P8162, DOI 10.1103/PhysRevB.45.8162; GANG H, 1995, PHYS REV E, V52, P6289, DOI 10.1103/PhysRevE.52.6289; Giacomelli M, 2010, OPT EXPRESS, V18, P14616, DOI 10.1364/OE.18.014616; Giacomelli MG, 2008, OPT LETT, V33, P2452, DOI 10.1364/OL.33.002452; Goodman J. W., 2007, SPECKLE PHENOMENA OP; GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2463, DOI 10.1364/AO.22.002463; GROENHUIS RAJ, 1983, APPL OPTICS, V22, P2456, DOI 10.1364/AO.22.002456; Hajjarian Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00316; Hajjarian Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533322; Harden JL, 2001, CURR OPIN COLLOID IN, V6, P438, DOI 10.1016/S1359-0294(01)00115-7; Hielscher AH, 1997, APPL OPTICS, V36, P125, DOI 10.1364/AO.36.000125; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jonas M, 2008, BIOPHYS J, V95, P895, DOI 10.1529/biophysj.107.120303; Jonas M, 2008, BIOPHYS J, V94, P1459, DOI 10.1529/biophysj.106.098111; Klose AD, 1998, P SOC PHOTO-OPT INS, V3566, P151, DOI 10.1117/12.334363; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LEE B, 1992, BIORHEOLOGY, V29, P521; Lemieux PA, 1998, PHYS REV E, V57, P4498, DOI 10.1103/PhysRevE.57.4498; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; Luigi N, 2003, RHEOLOGY BIOL FLUIDS; MACKINTOSH FC, 1992, PHYS REV B, V45, P8165, DOI 10.1103/PhysRevB.45.8165; MACKINTOSH FC, 1989, PHYS REV B, V40, P9342, DOI 10.1103/PhysRevB.40.9342; MARET G, 1987, Z PHYS B CON MAT, V65, P409, DOI 10.1007/BF01303762; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; Mason TG, 1999, CURR OPIN COLLOID IN, V4, P231, DOI 10.1016/S1359-0294(99)00035-7; Mason TG, 1997, J OPT SOC AM A, V14, P139, DOI 10.1364/JOSAA.14.000139; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; McNeil LE, 2001, APPL OPTICS, V40, P3726, DOI 10.1364/AO.40.003726; McNeil LE, 2000, ACTA MATER, V48, P4571, DOI 10.1016/S1359-6454(00)00243-3; Meyers M.A., 1999, MECH BEHAV MAT; MIDDLETON AA, 1991, PHYS REV B, V43, P5934, DOI 10.1103/PhysRevB.43.5934; Miller CC, 1924, P R SOC LOND A-CONTA, V106, P724, DOI 10.1098/rspa.1924.0100; Moschakis T, 2010, J COLLOID INTERF SCI, V345, P278, DOI 10.1016/j.jcis.2010.02.005; MUGNAI A, 1980, J ATMOS SCI, V37, P1291, DOI 10.1175/1520-0469(1980)037<1291:SORBMN>2.0.CO;2; Nadkarni SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982529; Nadkarni SK, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186046; Nadkarni SK, 2005, CIRCULATION, V112, P885, DOI 10.1161/CIRCULATIONAHA.104.520098; Nickerson CS, 2008, J BIOMECH, V41, P1840, DOI 10.1016/j.jbiomech.2008.04.015; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; PINE DJ, 1988, PHYS REV LETT, V60, P1134, DOI 10.1103/PhysRevLett.60.1134; PINE DJ, 1990, J PHYS-PARIS, V51, P2101, DOI 10.1051/jphys:0199000510180210100; PINNICK RG, 1976, APPL OPTICS, V15, P384, DOI 10.1364/AO.15.000384; Ramella-Roman JC, 2005, OPT EXPRESS, V13, P4420, DOI 10.1364/OPEX.13.004420; Sakadzic S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163902; Schmitt JM, 1998, APPL OPTICS, V37, P2788, DOI 10.1364/AO.37.002788; SCHMITT JM, 1990, J OPT SOC AM A, V7, P2141, DOI 10.1364/JOSAA.7.002141; SCHURZ J, 1987, BIORHEOLOGY, V24, P385; Sharif-Kashani P, 2011, J BIOMECH, V44, P419, DOI 10.1016/j.jbiomech.2010.10.002; TUCHIN V.V., 2002, HDB OPTICAL BIOMEDIC, VPM107; Ullah H, 2012, LASER PHYS, V22, P797, DOI 10.1134/S1054660X12040251; Ullah H, 2011, LASER PHYS, V21, P1962, DOI 10.1134/S1054660X11190285; Viasnoff V, 2002, REV SCI INSTRUM, V73, P2336, DOI 10.1063/1.1476699; Wang L.V., 2012, BIOMEDICAL OPTICS PR; Wax A, 2001, APPL OPTICS, V40, P4222, DOI 10.1364/AO.40.004222; Weitz D. A., 1993, DYNAMIC LIGHT SCATTE; Wu J, 2007, LANGMUIR, V23, P4324, DOI 10.1021/la0625190; Yodh AG, 1999, SPIE, V2979, P468	77	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e65014	10.1371/journal.pone.0065014	http://dx.doi.org/10.1371/journal.pone.0065014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23705028	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200182
J	Schaafsma, SM; Geuze, RH; Lust, JM; Schiefenhovel, W; Groothuis, TGG				Schaafsma, Sara M.; Geuze, Reint H.; Lust, Jessica M.; Schiefenhoevel, Wulf; Groothuis, Ton G. G.			The Relation between Handedness Indices and Reproductive Success in a Non-Industrial Society	PLOS ONE			English	Article							2 LARGE COHORTS; HAND PREFERENCE; FRENCH ADULTS; HUMANS; LATERALIZATION; PERFORMANCE; CREATIVITY; ARTISTS; ABILITY; SKILL	The evolution of handedness in human populations has intrigued scientists for decades. However, whether handedness really affects Darwinian fitness is unclear and not yet studied in a non-industrial society where selection pressures on health and handedness are likely to be similar to the situation in which handedness has evolved. We measured both hand preference and asymmetry of hand skill (speed of fine motor control, measured by a pegboard task, and accuracy of throwing), as they measure different aspects of handedness. We investigated the associations between both the direction (left versus right) and strength (the degree to which a certain preference or asymmetry in skill is manifested, independent of the direction) of handedness. We analyzed to what extent these measures predict the number of offspring and self-reported illness in a non-industrial society in Papua, Indonesia. As it is known that body height and fitness are correlated, data on body height was also collected. Due to low numbers of left-handers we could not investigate the associations between direction of hand preference and measures of Darwinian fitness. We found a positive association between strength of asymmetry of hand skill (pegboard) and the number of children men sired. We also found a positive association for men between strength of hand preference and number of children who died within the first three years of life. For women we found no such effects. Our results may indicate that strength of handedness, independent of direction, has fitness implications and that the persistence of the polymorphism in handedness may be ascribed to either balancing selection on strength of asymmetry of hand skill versus strength of hand preference, or sexual antagonistic selection. No relationships between health and handedness were found, perhaps due to disease related selective disappearance of subjects with a specific handedness.	[Schaafsma, Sara M.; Groothuis, Ton G. G.] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [Geuze, Reint H.; Lust, Jessica M.] Univ Groningen, Groningen, Netherlands; [Schiefenhoevel, Wulf] Max Planck Inst Ornithol, Human Ethol Grp, Andechs, Germany	University of Groningen; University of Groningen; Max Planck Society	Schaafsma, SM (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.	Sschaafsma@rockefeller.edu	Schaafsma, Sara/J-8192-2014	Schaafsma, Sara/0000-0003-0476-7877	European Commission through the Sixth Framework Programme; Netherlands Organisation for Scientific Research (NWO) through the Evolution and Behaviour - Interdisciplinary Research Projects; Gratema Stichting; Department of Psychology	European Commission through the Sixth Framework Programme(European Commission); Netherlands Organisation for Scientific Research (NWO) through the Evolution and Behaviour - Interdisciplinary Research Projects(Netherlands Organization for Scientific Research (NWO)); Gratema Stichting; Department of Psychology	This study was supported by the European Commission through the Sixth Framework Programme, by the Netherlands Organisation for Scientific Research (NWO) through the Evolution and Behaviour - Interdisciplinary Research Projects and by the Gratema Stichting to TGGG and by the Department of Psychology to RHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1974, NEUROPSYCHOLOGIA, V12, P527, DOI 10.1016/0028-3932(74)90083-9; Annett M, 2004, BRIT J PSYCHOL, V95, P339, DOI 10.1348/0007126041528130; Annett M, 2002, HANDEDNESS BRAIN ASY; BOROD JC, 1984, BRIT J PSYCHOL, V75, P177, DOI 10.1111/j.2044-8295.1984.tb01889.x; BYRNE B, 1974, BRIT J PSYCHOL, V65, P279, DOI 10.1111/j.2044-8295.1974.tb01402.x; CONNOLLY KJ, 1992, NEUROPSYCHOLOGIA, V30, P13, DOI 10.1016/0028-3932(92)90010-J; Doyen AL, 2008, LATERALITY, V13, P179, DOI 10.1080/13576500701764124; Eaton WO, 1996, J CHILD PSYCHOL PSYC, V37, P613, DOI 10.1111/j.1469-7610.1996.tb01448.x; Faurie C, 2005, P ROY SOC B-BIOL SCI, V272, P25, DOI 10.1098/rspb.2004.2926; Faurie C, 2008, BRIT J PSYCHOL, V99, P533, DOI 10.1348/000712608X291563; Faurie C, 2006, EVOL HUM BEHAV, V27, P457, DOI 10.1016/j.evolhumbehav.2006.04.001; Geuze RH, 2012, NEUROPSYCHOLOGIA, V50, P612, DOI 10.1016/j.neuropsychologia.2011.12.017; Good JMM., 1994, PSYCHOL MUSIC, V22, P148, DOI DOI 10.1177/0305735694222004; GOTESTAM KO, 1990, PERCEPT MOTOR SKILL, V70, P1323, DOI 10.2466/PMS.70.4.1323-1327; HASSLER M, 1993, NEUROPSYCHOLOGIA, V31, P655, DOI 10.1016/0028-3932(93)90137-O; Healy M, 2009, MLWIN VERSION 2 21; Llaurens V, 2009, PHILOS T R SOC B, V364, P881, DOI 10.1098/rstb.2008.0235; McCullagh P, 1989, MONOGRAPHS STAT APPL, V2nd; McManus IC, 2010, LATERALITY, V15, P186, DOI 10.1080/13576500802565313; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; Miller, 2000, MATING MIND SEXUAL C; Morfit NS, 2001, BRAIN COGNITION, V46, P209, DOI 10.1016/S0278-2626(01)80068-3; Nettle D, 2006, P ROY SOC B-BIOL SCI, V273, P611, DOI 10.1098/rspb.2005.3349; Nettle D, 2003, BRAIN COGNITION, V52, P390, DOI 10.1016/S0278-2626(03)00187-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; PETERSON JM, 1979, PERCEPT MOTOR SKILL, V48, P961, DOI 10.2466/pms.1979.48.3.961; Preti A, 2007, J NERV MENT DIS, V195, P837, DOI 10.1097/NMD.0b013e3181568180; Raymond M, 1996, P ROY SOC B-BIOL SCI, V263, P1627, DOI 10.1098/rspb.1996.0238; Saulnier T, 1960, PAPOUS COUPEURS TETE; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Schaafsma SM, 2012, EVOL HUM BEHAV, V33, P94, DOI 10.1016/j.evolhumbehav.2011.06.001; SCHIEFENHOVEL W, 1975, HOMO, V26, P263; Schiefenhovel W., 1991, ENCY WORLD CULTURES, VII, P55; SEARLEMAN A, 1989, PSYCHOL BULL, V105, P397, DOI 10.1037/0033-2909.105.3.397; SEARLEMAN A, 1987, NEUROPSYCHOLOGIA, V25, P367, DOI 10.1016/0028-3932(87)90025-X; Steenhuis R E, 1999, Laterality, V4, P3, DOI 10.1080/135765099397079; Van Strien J, 2002, DUTCH HANDEDNESS QUE; Vuoksimaa E, 2009, NEUROPSYCHOLOGIA, V47, P1294, DOI 10.1016/j.neuropsychologia.2009.01.007	40	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63114	10.1371/journal.pone.0063114	http://dx.doi.org/10.1371/journal.pone.0063114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149OK	23704893	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200022
J	Spring, FA; Griffiths, RE; Mankelow, TJ; Agnew, C; Parsons, SF; Chasis, JA; Anstee, DJ				Spring, Frances A.; Griffiths, Rebecca E.; Mankelow, Tosti J.; Agnew, Christopher; Parsons, Stephen F.; Chasis, Joel A.; Anstee, David J.			Tetraspanins CD81 and CD82 Facilitate alpha 4 beta 1-Mediated Adhesion of Human Erythroblasts to Vascular Cell Adhesion Molecule-1	PLOS ONE			English	Article							LATE ACTIVATION ANTIGEN-4; HEMATOPOIETIC PROGENITORS; INTEGRIN ALPHA(4)BETA(1); STROMAL MACROPHAGES; ALPHA-4 INTEGRINS; FIBRONECTIN; EXPRESSION; ERYTHROPOIESIS; IDENTIFICATION; PROTEINS	The proliferation and terminal differentiation of erythroid progenitors occurs in human bone marrow within erythroblastic islands, specialised structures consisting of a central macrophage surrounded by developing erythroid cells. Many cell-cell and cell-matrix adhesive interactions maintain and regulate the co-ordinated daily production of reticulocytes. Erythroid cells express only one integrin, alpha 4 beta 1, throughout differentiation, and its interactions with both macrophage Vascular Cell Adhesion Molecule-1 and with extracellular matrix fibronectin are critical for erythropoiesis. We observed that proerythroblasts expressed a broad tetraspanin phenotype, and investigated whether any tetraspanin could modulate integrin function. A specific association between alpha 4 beta 1 and CD81, CD82 and CD151 was demonstrated by confocal microscopy and co-immune precipitation. We observed that antibodies to CD81 and CD82 augmented adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 but not to the fibronectin spliceoforms FnIII(12-IIICS-15) and FnIII(12-15). In contrast, different anti-CD151 antibodies augmented or inhibited adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 and the fibronectin spliceoform FnIII(12-IIICS-15) but not to FnIII12-15. These results strongly suggest that tetraspanins have a functional role in terminal erythropoiesis by modulating interactions of erythroblast a4b1 with both macrophages and extracellular matrix.	[Spring, Frances A.; Griffiths, Rebecca E.; Mankelow, Tosti J.; Parsons, Stephen F.; Anstee, David J.] Bristol Inst Transfus Sci, Bristol, Avon, England; [Agnew, Christopher] Univ Bristol, Dept Biochem, Bristol, Avon, England; [Chasis, Joel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of Bristol; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Spring, FA (corresponding author), Bristol Inst Transfus Sci, Bristol, Avon, England.	frances.spring@nhsbt.nhs.uk	Anstee, David/AAE-9231-2020; Griffiths, Rebecca E/C-6127-2017	Griffiths, Rebecca E/0000-0001-7461-0635; Mankelow, Tosti/0000-0003-3434-1973	National Institute for Health Research; Department of Health (England); Biological and Biotechnology Research Council [BB/7007256]; National Institutes of Health grant [DK32094]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health (England); Biological and Biotechnology Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by grants from three United Kingdom (UK) grant funding bodies, the National Institute for Health Research (http://www.ccf.nihr.ac.uk/PGfAR/Pages/Home.aspx; FAS, DJA), the Department of Health (England) (http://www.dh.gov.uk/health/category/research; REG, TJM, SFP) and the Biological and Biotechnology Research Council (http://www.bbsrc.ac.uk/home/home.aspx; grant BB/7007256, CA). National Institutes of Health grant DK32094 (http://grants.nih.gov/grants/oer.htm) funded JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew C, 2011, P NATL ACAD SCI USA, V108, P15174, DOI 10.1073/pnas.1106341108; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; ASHMAN LK, 1998, LEUCOCYTE TYPING, P681; BEHR S, 1995, J EXP MED, V182, P1191, DOI 10.1084/jem.182.5.1191; Berditchevski F, 2001, J CELL SCI, V114, P4143; BESSIS M, 1958, Rev Hematol, V13, P8; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Coulombel L, 1997, ACTA HAEMATOL-BASEL, V97, P13, DOI 10.1159/000203655; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; CROCKER PR, 1985, J EXP MED, V162, P993, DOI 10.1084/jem.162.3.993; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; GREEN CA, 2005, TRANSFUSION MED, V15, pP53; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Hamamura K, 1996, BLOOD, V87, P2513, DOI 10.1182/blood.V87.6.2513.bloodjournal8762513; Han P, 2004, CYTOTHERAPY, V6, P465, DOI 10.1080/14653240410004998; HANSPAL M, 1994, BLOOD, V84, P3494; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Longhurst CM, 1999, EUR J BIOCHEM, V263, P104, DOI 10.1046/j.1432-1327.1999.00467.x; Mankelow TJ, 2004, BLOOD, V103, P1503, DOI 10.1182/blood-2003-08-2792; Mannion BA, 1996, J IMMUNOL, V157, P2039; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MOHANDAS N, 1978, BLOOD, V51, P633; MORRIS L, 1991, J CELL SCI, V99, P141; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Newham P, 1998, J IMMUNOL, V160, P4508; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PAPAYANNOPOULOU T, 1992, BLOOD, V79, P1686; Pellinen T, 2012, J CELL SCI, V125, P649, DOI 10.1242/jcs.090704; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Ripich T, 2011, HAEMATOL-HEMATOL J, V96, P1743, DOI 10.3324/haematol.2011.050468; ROSEMBLATT M, 1991, J CLIN INVEST, V87, P6, DOI 10.1172/JCI115002; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Schofield KP, 1999, BLOOD, V93, P410, DOI 10.1182/blood.V93.1.410; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; SHAW S, 1995, LEUCOCYTE DIFFERENTI, P16; Smythe JS, 1996, BLOOD, V87, P2968, DOI 10.1182/blood.V87.7.2968.bloodjournal8772968; SOLIGO D, 1990, BRIT J HAEMATOL, V76, P323, DOI 10.1111/j.1365-2141.1990.tb06363.x; Southcott MJG, 1999, BLOOD, V93, P4425, DOI 10.1182/blood.V93.12.4425.412k22_4425_4435; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Ulyanova T, 2011, BLOOD, V117, P975, DOI 10.1182/blood-2010-05-283218; VERFAILLIE CM, 1991, J EXP MED, V174, P693, DOI 10.1084/jem.174.3.693; Vidal M, 2010, TRANSFUS CLIN BIOL, V17, P131, DOI 10.1016/j.tracli.2010.05.004; VUILLETGAUGLER MH, 1990, BLOOD, V75, P865; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; YANAI N, 1994, BLOOD, V83, P2844, DOI 10.1182/blood.V83.10.2844.2844; Yanez-Mo M, 2001, MICROCIRCULATION, V8, P153; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740	66	22	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62654	10.1371/journal.pone.0062654	http://dx.doi.org/10.1371/journal.pone.0062654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704882	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200011
J	Zhou, JL; Cheng, M; Liao, YH; Hu, Y; Wu, M; Wang, Q; Qin, B; Wang, H; Zhu, Y; Gao, XM; Goukassian, D; Zhao, TC; Tang, YL; Kishore, R; Qin, GJ				Zhou, Junlan; Cheng, Min; Liao, Yu-Hua; Hu, Yu; Wu, Min; Wang, Qing; Qin, Bo; Wang, Hong; Zhu, Yan; Gao, Xiu-Mei; Goukassian, David; Zhao, Ting C.; Tang, Yao-Liang; Kishore, Raj; Qin, Gangjian			Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COA REDUCTASE INHIBITOR; CORONARY-HEART-DISEASE; STATIN THERAPY; HEMATOPOIETIC PROGENITOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; MESSENGER-RNA; STEM-CELLS; AKT	Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.	[Zhou, Junlan; Kishore, Raj; Qin, Gangjian] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Cheng, Min; Liao, Yu-Hua] Northwestern Univ, Feinberg Sch Med, Dept Cardiol, Chicago, IL 60611 USA; [Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hematol, Wuhan 430074, Hubei, Peoples R China; [Wu, Min] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Plast Surg, Wuhan 430074, Hubei, Peoples R China; [Wang, Qing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Cardio X Inst,Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Hubei, Peoples R China; [Qin, Bo] Weinberg Coll Arts & Sci, Chicago, IL USA; [Wang, Hong; Zhu, Yan; Gao, Xiu-Mei] Tianjin Univ Tradit Chinese Med, Minist Educ, Key Lab Pharmacol Tradit Chinese Med Formulae, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Goukassian, David] Tufts Univ, Sch Med, Steward St Elizabeths Med Ctr, Boston, MA 02111 USA; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA; [Tang, Yao-Liang] Univ Cincinnati, Cardiovasc Res Ctr, Div Cardiovasc Dis, Cincinnati, OH USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Tianjin University of Traditional Chinese Medicine; St. Elizabeth's Medical Center; Tufts University; Boston University; Roger Williams Medical Center; University System of Ohio; University of Cincinnati	Qin, GJ (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA.	g-qin@northwestern.edu	Zhu, Yan/A-1548-2017	Zhu, Yan/0000-0002-3197-7936; Goukassian, David/0000-0001-5270-5270; Tang, Yaoliang/0000-0002-8372-1545	National Institutes of Health [HL093439, HL113541]; American Heart Association [0430135N, 10POST4360009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093439, R01HL113541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL093439 and HL113541 to G.Q.) and American Heart Association grants (0430135N to G.Q. and 10POST4360009 to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Balakumar P, 2012, J MOL CELL CARDIOL, V52, P83, DOI 10.1016/j.yjmcc.2011.09.014; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Cheng M, 2012, PROG MOL BIOL TRANSL, V111, P243, DOI 10.1016/B978-0-12-398459-3.00011-3; Cheng M, 2010, CIRC RES, V107, P1083, DOI 10.1161/CIRCRESAHA.110.220970; Clearfield MB, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-35; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gill M, 2001, CIRC RES, V88, P167; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Heart Protection Study Collaborati, 2007, J VASC SURG, V45, P645, DOI 10.1016/j.jvs.2006.12.054; Heart Protection Study Collaborative G, 2007, J VASC SURG, V45, P653; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Katsumoto M, 2005, CIRC J, V69, P1547, DOI 10.1253/circj.69.1547; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Kosmidou I, 2007, ARTERIOSCL THROM VAS, V27, P2642, DOI 10.1161/ATVBAHA.107.154492; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lemarie CA, 2011, AM J PHYSIOL-HEART C, V300, pH745, DOI 10.1152/ajpheart.00321.2010; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807; Liu S, 2000, TRENDS CARDIOVAS MED, V10, P253, DOI 10.1016/S1050-1738(00)00073-6; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Merla R, 2007, AM J PHYSIOL-HEART C, V293, pH1918, DOI 10.1152/ajpheart.00416.2007; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Pedersen TR, 2004, ATHEROSCLEROSIS SUPP, V5, P81, DOI 10.1016/j.atherosclerosissup.2004.08.027; Preiss D, 2012, NAT REV CARDIOL, V9, P190, DOI 10.1038/nrcardio.2012.15; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Qin GJ, 2006, J EXP MED, V203, P153, DOI 10.1084/jem.20050459; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Skaletz-Rorowski A, 2003, CURR OPIN LIPIDOL, V14, P599, DOI 10.1097/00041433-200312000-00008; Suzuki G, 2009, CIRC RES, V104, P255, DOI 10.1161/CIRCRESAHA.108.188730; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter Dirk H, 2004, Semin Vasc Med, V4, P385, DOI 10.1055/s-2004-869595; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Yemisci M, 2008, CEREBROVASC DIS, V26, P190, DOI 10.1159/000145327; Zhou JL, 2009, CIRCULATION, V120, P1213, DOI 10.1161/CIRCULATIONAHA.109.859207; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	61	34	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63126	10.1371/journal.pone.0063126	http://dx.doi.org/10.1371/journal.pone.0063126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704894	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200023
J	Ng, GHB; Gong, ZY				Ng, Grace Hwee Boon; Gong, Zhiyuan			GFP Transgenic Medaka (Oryzias latipes) under the Inducible cyp1a Promoter Provide a Sensitive and Convenient Biological Indicator for the Presence of TCDD and Other Persistent Organic Chemicals	PLOS ONE			English	Article							IN-VIVO; AROMATIC-HYDROCARBONS; ZEBRAFISH EMBRYOS; RECEPTOR; DIOXIN; FISH; EXPOSURE; CELLS; TOXICITY; SYSTEM	Persistent organic pollutants (POPs) are resistant to environmental degradation and can cause multitude of health problems. Cytochrome P450 1A (Cyp1a) is often up-regulated by POPs through the activation of aryl hydrocarbon receptor (AhR) pathway and is thus usually used as a biomarker for xenobiotics exposure. To develop a convenient in vivo tool to monitor xenobiotic contamination in the water, we have established GFP transgenic medaka using the inducible cyp1a promoter, Tg(cyp1a: gfp). Here we tested Tg(cyp1a: gfp) medaka at three different stages, prehatching embryos, newly hatched fry and adult with 2,3,7,8-tetrachlorodiebnzo-p-dioxin (TCDD), a dioxin. While GFP induction was observed in all three stages, newly hatched fry were the most sensitive with the lowest observed effective concentration of 0.005 nM or 16.1 ng/L. The highly sensitive organs included the kidney, liver and intestine. With high concentrations of TCDD, several other organs such as the olfactory pit, tail fin, gills, lateral line neuromast cells and blood vessels also showed GFP expression. In addition, Tg(cyp1a: gfp) medaka fry also responded to two other AhR agonists, 3-methylcholanthrene and benzo[a] pyrene, for GFP induction, but no significant GFP induction was observed towards several other chemicals tested, indicating the specificity of this transgenic line. The GFP inducibility of Tg(cyp1a: gfp) medaka at both fry and adult stages may be useful for development of high-throughput assays as well as online water monitoring system to detect xenobiotic toxicity.	[Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; Singapore MIT Alliance, Computat & Syst Biol, Singapore, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260; Ng, Grace/0000-0002-4516-7299	Singapore National Research Foundation under its Environmental and Water Technologies Strategic Research Programme; Environment and Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]; NGS graduate scholarship	Singapore National Research Foundation under its Environmental and Water Technologies Strategic Research Programme(National Research Foundation, Singapore); Environment and Water Industry Programme Office (EWI) of the PUB; NGS graduate scholarship	This work was supported by the Singapore National Research Foundation under its Environmental and Water Technologies Strategic Research Programme and administered by the Environment and Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. GHBN acknowledges the support from an NGS graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS JMMJG, 1995, EUR J PHARM-ENVIRON, V293, P463; Andreasen EA, 2002, TOXICOL SCI, V68, P403, DOI 10.1093/toxsci/68.2.403; Blechinger SR, 2002, ENVIRON HEALTH PERSP, V110, P1041, DOI 10.1289/ehp.021101041; Bugiak B, 2009, AQUAT TOXICOL, V95, P299, DOI 10.1016/j.aquatox.2009.03.009; Bussmann UA, 2013, COMP BIOCHEM PHYS C, V157, P111, DOI 10.1016/j.cbpc.2012.10.006; Carvan Michael J. III, 2000, Annals of the New York Academy of Sciences, V919, P133; Elskens M, 2011, TALANTA, V85, P1966, DOI 10.1016/j.talanta.2011.07.014; Hahn ME, 2002, SCI TOTAL ENVIRON, V289, P49, DOI 10.1016/S0048-9697(01)01016-6; Hahn ME, 1996, ENVIRON TOXICOL CHEM, V15, P582, DOI 10.1002/etc.5620150425; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kurauchi K, 2005, ENVIRON SCI TECHNOL, V39, P2762, DOI 10.1021/es0486465; Legler J, 2000, ENVIRON SCI TECHNOL, V34, P4439, DOI 10.1021/es0000605; Lele Z, 1996, BIOTECHNOL ADV, V14, P57, DOI 10.1016/0734-9750(96)00004-3; Ma Q, 2007, DRUG METAB DISPOS, V35, P1009, DOI 10.1124/dmd.107.015826; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Ng GHB, 2011, BIOCHIMIE, V93, P1858, DOI 10.1016/j.biochi.2011.07.006; Noury P, 2006, ENVIRON TOXICOL, V21, P324, DOI 10.1002/tox.20184; Sanderson JT, 1996, TOXICOL APPL PHARM, V137, P316, DOI 10.1006/taap.1996.0086; Sarasquete C, 2000, SCI TOTAL ENVIRON, V247, P313, DOI 10.1016/S0048-9697(99)00500-8; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wu YL, 2008, GENE, V408, P85, DOI 10.1016/j.gene.2007.10.027; Yan ZH, 2012, COMP BIOCHEM PHYS C, V156, P17, DOI 10.1016/j.cbpc.2012.03.001; Zeng ZQ, 2005, ENVIRON SCI TECHNOL, V39, P9001, DOI 10.1021/es050728l; Zhou BS, 2006, AQUAT TOXICOL, V80, P109, DOI 10.1016/j.aquatox.2006.07.021; Zhou HL, 2010, TOXICOL MECH METHOD, V20, P279, DOI 10.3109/15376516.2010.485227; Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002	39	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64334	10.1371/journal.pone.0064334	http://dx.doi.org/10.1371/journal.pone.0064334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700472	Green Submitted, Green Published, gold			2022-12-25	WOS:000319966400055
J	Qiu, T; Zhang, ZK; Chen, G				Qiu, Tian; Zhang, Zi-Ke; Chen, Guang			Information Filtering via a Scaling-Based Function	PLOS ONE			English	Article							OF-THE-ART; RECOMMENDER SYSTEMS; PREDICTION	Finding a universal description of the algorithm optimization is one of the key challenges in personalized recommendation. In this article, for the first time, we introduce a scaling-based algorithm (SCL) independent of recommendation list length based on a hybrid algorithm of heat conduction and mass diffusion, by finding out the scaling function for the tunable parameter and object average degree. The optimal value of the tunable parameter can be abstracted from the scaling function, which is heterogeneous for the individual object. Experimental results obtained from three real datasets, Netflix, MovieLens and RYM, show that the SCL is highly accurate in recommendation. More importantly, compared with a number of excellent algorithms, including the mass diffusion method, the original hybrid method, and even an improved version of the hybrid method, the SCL algorithm remarkably promotes the personalized recommendation in three other aspects: solving the accuracy-diversity dilemma, presenting a high novelty, and solving the key challenge of cold start problem.	[Qiu, Tian; Chen, Guang] Nanchang Hangkong Univ, Sch Informat Engn, Nanchang, Peoples R China; [Zhang, Zi-Ke] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zi-Ke] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zhang, Zi-Ke] Beijing Computat Sci Res Ctr, Beijing, Peoples R China	Nanchang Hangkong University; Hangzhou Normal University; University of Electronic Science & Technology of China; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC)	Qiu, T (corresponding author), Nanchang Hangkong Univ, Sch Informat Engn, Nanchang, Peoples R China.	tianqiu.edu@gmail.com	qiu, tian/G-6080-2014		National Natural Science Foundation of China [11175079, 11105024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (grant nos. 11175079 and 11105024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Ahn HJ, 2008, INFORM SCIENCES, V178, P37, DOI 10.1016/j.ins.2007.07.024; Balabanovic M, 1997, COMMUN ACM, V40, P66, DOI 10.1145/245108.245124; Billsus D, 2000, USER MODEL USER-ADAP, V10, P147, DOI 10.1023/A:1026501525781; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Breese J. S., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P43; Cantador I, 2009, P ECML PKDD DISC CHA, P17; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chu W., 2009, P 18 INT C WORLD WID, P691, DOI [DOI 10.1145/1526709.1526802, 10.1145/1526709.1526802]; Delgado J., 1999, SIGIR WORKSH REC SYS, P85; Getoor L, 1999, WORKSH WEB US AN US; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Goldberg K, 2001, INFORM RETRIEVAL, V4, P133, DOI 10.1023/A:1011419012209; Groh G, 2007, GROUP'07: PROCEEDINGS OF THE 2007 INTERNATIONAL ACM CONFERENCE ON SUPPORTING GROUP WORK, P127; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Hofmann T, 2004, ACM T INFORM SYST, V22, P89, DOI 10.1145/963770.963774; Hofmann T., 2003, P 26 ANN INT ACM SIG, P259, DOI [10.1145/860435.860483, DOI 10.1145/860435.860483]; Jamali M, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P397; Ju S, 2009, P ECML PKDD DISC CHA, V497, P109; Kim HN, 2010, ELECTRON COMMER R A, V9, P73, DOI 10.1016/j.elerap.2009.08.004; Lam X.N., 2008, P 2 INT C UB INF MAN, DOI [10.1145/1352793.1352837, DOI 10.1145/1352793.1352837]; Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8; Liang H, 2010, P 21 ACM C HYP HYP, P51, DOI DOI 10.1145/1810617.1810628; Lipczak Marek, 2009, P ECML PKDD DISC CHA, P157; Liu C, 2012, PHYSICA A, V391, P5704, DOI 10.1016/j.physa.2012.06.034; Liu J, 2009, PHYSICA A, V388, P3643, DOI 10.1016/j.physa.2009.05.021; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu JG, 2010, PHYSICA A, V389, P881, DOI 10.1016/j.physa.2009.10.027; Liu JG, 2009, INT J MOD PHYS C, V20, P1925, DOI 10.1142/S0129183109014825; Liu RR, 2009, PHYSICA A, V388, P462, DOI 10.1016/j.physa.2008.10.010; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Marlin B, 2003, ADV NEURAL INF PROCE, P16; Nakamura A., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P395; Papagelis M, 2005, ENG APPL ARTIF INTEL, V18, P781, DOI 10.1016/j.engappai.2005.06.010; Park YJ, 2008, RECSYS'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P11; Pazzani M. J., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P325; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Ren J, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/58007; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Shang MS, 2010, PHYSICA A, V389, P1259, DOI 10.1016/j.physa.2009.11.041; Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005; Zhang ZK, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501660; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhang ZK, 2010, PHYSICA A, V389, P179, DOI 10.1016/j.physa.2009.08.036; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2010, P NATL ACAD SCI USA, V107, P4511, DOI 10.1073/pnas.1000488107; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008	51	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63531	10.1371/journal.pone.0063531	http://dx.doi.org/10.1371/journal.pone.0063531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23696829	Green Published, gold, Green Submitted			2022-12-25	WOS:000319107900047
J	Brautigam, CA; Padrick, SB; Schuck, P				Brautigam, Chad A.; Padrick, Shae B.; Schuck, Peter			Multi-Signal Sedimentation Velocity Analysis with Mass Conservation for Determining the Stoichiometry of Protein Complexes	PLOS ONE			English	Article							EQUILIBRIUM-ANALYSIS; AFFINITY; BINDING; MACROMOLECULES; DISTRIBUTIONS; CONSTRAINTS; COEFFICIENT; LIPOPROTEIN; BOUNDARY	Multi-signal sedimentation velocity analytical ultracentrifugation (MSSV) is a powerful tool for the determination of the number, stoichiometry, and hydrodynamic shape of reversible protein complexes in two- and three-component systems. In this method, the evolution of sedimentation profiles of macromolecular mixtures is recorded simultaneously using multiple absorbance and refractive index signals and globally transformed into both spectrally and diffusion-deconvoluted component sedimentation coefficient distributions. For reactions with complex lifetimes comparable to the time-scale of sedimentation, MSSV reveals the number and stoichiometry of co-existing complexes. For systems with short complex lifetimes, MSSV reveals the composition of the reaction boundary of the coupled reaction/migration process, which we show here may be used to directly determine an association constant. A prerequisite for MSSV is that the interacting components are spectrally distinguishable, which may be a result, for example, of extrinsic chromophores or of different abundances of aromatic amino acids contributing to the UV absorbance. For interacting components that are spectrally poorly resolved, here we introduce a method for additional regularization of the spectral deconvolution by exploiting approximate knowledge of the total loading concentrations. While this novel mass conservation principle does not discriminate contributions to different species, it can be effectively combined with constraints in the sedimentation coefficient range of uncomplexed species. We show in theory, computer simulations, and experiment, how mass conservation MSSV as implemented in SEDPHAT can enhance or even substitute for the spectral discrimination of components. This should broaden the applicability of MSSV to the analysis of the composition of reversible macromolecular complexes.	[Brautigam, Chad A.; Padrick, Shae B.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Schuck, P (corresponding author), Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA.	peter.schuck@nih.gov	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Brautigam, Chad/0000-0001-6563-1338; Padrick, Shae/0000-0002-6916-6194	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, DHHS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, DHHS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the intramural research program of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Bevington PR., 2002, DATA REDUCTION ERROR; Brautigam CA, 2011, METHODS, V54, P4, DOI 10.1016/j.ymeth.2010.12.029; Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; Brown PH, 2008, AAPS J, V10, P481, DOI 10.1208/s12248-008-9058-z; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Correia JJ, 2009, METHOD ENZYMOL, V455, P419, DOI 10.1016/S0076-6879(08)04215-8; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Doan N, 2008, J BIOL CHEM, V283, P28747, DOI 10.1074/jbc.M803127200; Gabrielson JP, 2011, METHODS, V54, P83, DOI 10.1016/j.ymeth.2010.12.030; Ghirlando R, 2011, METHODS, V54, P145, DOI 10.1016/j.ymeth.2010.12.005; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Johnson M.L., 1994, MODERN ANAL ULTRACEN, P37; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2011, METHODS, V54, P39, DOI 10.1016/j.ymeth.2011.01.002; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; PHILLIPS DL, 1962, J ACM, V9, P84, DOI 10.1145/321105.321114; Philo JS, 2000, METHOD ENZYMOL, V321, P100; Ridgeway WK, 2012, P NAT ACAD SCI US; Salvay AG, 2006, PROG COLL POL SCI S, V131, P74, DOI 10.1007/2882_006; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2007, PROTEIN INTERACTIONS, P469; Schuck P, 2010, EUR BIOPHYS J BIOPHY, V39, P1261, DOI 10.1007/s00249-009-0545-7; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; Schuck P, 2010, ANAL BIOCHEM, V401, P280, DOI 10.1016/j.ab.2010.02.037; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Zhao H., 2013, CURR PROTOC PROTEIN, V7; Zhao H, 2012, ANAL CHEM IN PRESS; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010	44	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e62694	10.1371/journal.pone.0062694	http://dx.doi.org/10.1371/journal.pone.0062694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696787	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900004
J	Hu, ZR; Song, N; Xing, JW; Chen, YH; Han, ZF; Yao, YY; Peng, HR; Ni, ZF; Sun, QX				Hu, Zhaorong; Song, Na; Xing, Jiewen; Chen, Yanhong; Han, Zongfu; Yao, Yingyin; Peng, Huiru; Ni, Zhongfu; Sun, Qixin			Overexpression of Three TaEXPA1 Homoeologous Genes with Distinct Expression Divergence in Hexaploid Wheat Exhibit Functional Retention in Arabidopsis	PLOS ONE			English	Article							CELL-WALL EXTENSION; BETA-EXPANSIN GENES; MULTIGENE FAMILY; ALPHA-EXPANSIN; LEAF; EVOLUTION; POLYPLOIDY; ELONGATION; PROTEINS; GROWTH	Common wheat is a hexaploid species with most of the genes present as triplicate homoeologs. Expression divergences of homoeologs are frequently observed in wheat as well as in other polyploid plants. However, little is known about functional variances among homologous genes arising from polyploidy. Expansins play diverse roles in plant developmental processes related to the action of cell wall loosening. Expression of the three TaEXPA1 homoeologs varied dynamically at different stages and organs, and epigenetic modifications contribute to the expression divergence of three TaEXPA1 homoeologs during wheat development. Nevertheless, their functions remain to be clarified. We found that over expression of TaEXPA1-A, -B and -D produced similar morphological changes in transgenic Arabidopsis plants, including increased germination and growth rate during seedling and adult stages, indicating that the proteins encoded by these three wheat TaEXPA1 homoeologs have similar (or conserved) functions in Arabidopsis. Collectively, our present study provided an example of a set of homoeologous genes expression divergence in different developmental stages and organs in hexaploid wheat but functional retention in transgenic Arabidopsis plants.	[Hu, Zhaorong; Song, Na; Xing, Jiewen; Chen, Yanhong; Han, Zongfu; Yao, Yingyin; Peng, Huiru; Ni, Zhongfu; Sun, Qixin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Utilizat MOE, State Key Lab Agrobiotechnol,Key Lab Crop Heteros, Beijing 100094, Peoples R China; [Hu, Zhaorong; Song, Na; Xing, Jiewen; Chen, Yanhong; Han, Zongfu; Yao, Yingyin; Peng, Huiru; Ni, Zhongfu; Sun, Qixin] Natl Plant Gene Res Ctr, Beijing, Peoples R China	China Agricultural University	Sun, QX (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Utilizat MOE, State Key Lab Agrobiotechnol,Key Lab Crop Heteros, Beijing 100094, Peoples R China.	qxsun@cau.edu.cn			Major Program of the National Natural Science Foundation of China [31290210, 31290212]; National Science Foundation for Distinguished Young Scholars [30925023]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Major Program of the National Natural Science Foundation of China (31290210, 31290212) and National Science Foundation for Distinguished Young Scholars (30925023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi P, 2012, PLANT BIOTECHNOL-NAR, V29, P245, DOI 10.5511/plantbiotechnology.12.0224a; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Bottley A, 2006, PLANT J, V47, P897, DOI 10.1111/j.1365-313X.2006.02841.x; Brummell DA, 1999, PLANT CELL, V11, P2203, DOI 10.1105/tpc.11.11.2203; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chen F, 2000, PLANT PHYSIOL, V124, P1265, DOI 10.1104/pp.124.3.1265; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Cho HT, 1997, PLANT PHYSIOL, V113, P1145, DOI 10.1104/pp.113.4.1145; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 1998, PLANT PHYSIOL, V118, P333, DOI 10.1104/pp.118.2.333; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Gookin TE, 2003, PLANT SCI, V164, P769, DOI 10.1016/S0168-9452(03)00063-3; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Hu ZR, 2011, GENE, V471, P13, DOI 10.1016/j.gene.2010.10.001; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jin Y, 2006, PROTOPLASMA, V228, P13, DOI 10.1007/s00709-006-0176-0; Kashkush K, 2002, GENETICS, V160, P1651; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lin Z, 2005, MOL GENET GENOMICS, V274, P548, DOI 10.1007/s00438-005-0029-0; Liu ZL, 2007, CURR BIOL, V17, P1669, DOI 10.1016/j.cub.2007.08.030; Lynch M, 2000, GENETICS, V154, P459; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Reidy B, 2001, PLANT MOL BIOL, V46, P491, DOI 10.1023/A:1010621417854; SHCHERBAN TY, 1995, P NATL ACAD SCI USA, V92, P9245, DOI 10.1073/pnas.92.20.9245; Shitsukawa N, 2007, PLANT CELL, V19, P1723, DOI 10.1105/tpc.107.051813; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udall JA, 2006, CROP SCI, V46, pS3, DOI 10.2135/cropsci2006.07.0489tpg; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Zhang NG, 2000, PLANT CELL PHYSIOL, V41, P1305, DOI 10.1093/pcp/pcd064; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108	51	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63667	10.1371/journal.pone.0063667	http://dx.doi.org/10.1371/journal.pone.0063667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696842	Green Published, gold, Green Submitted			2022-12-25	WOS:000319081900049
J	Kreutzfeldt, KM; McAdam, PR; Claxton, P; Holmes, A; Seagar, AL; Laurenson, IF; Fitzgerald, JR				Kreutzfeldt, Kaj M.; McAdam, Paul R.; Claxton, Pauline; Holmes, Anne; Seagar, A. Louise; Laurenson, Ian F.; Fitzgerald, J. Ross			Molecular Longitudinal Tracking of Mycobacterium abscessus spp. during Chronic Infection of the Human Lung	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; BOLLETII; MASSILIENSE; CHELONAE; STRAINS; EPIDEMIOLOGY; TUBERCULOSIS; SEQUENCE; RESISTANCE	The Mycobacterium abscessus complex is an emerging cause of chronic pulmonary infection in patients with underlying lung disease. The M. abscessus complex is regarded as an environmental pathogen but its molecular adaptation to the human lung during long-term infection is poorly understood. Here we carried out a longitudinal molecular epidemiological analysis of 178 M. abscessus spp. isolates obtained from 10 cystic fibrosis (CF) and 2 non CF patients over a 13 year period. Multi-locus sequence and molecular typing analysis revealed that 11 of 12 patients were persistently colonized with the same genotype during the course of the infection while replacement of a M. abscessus sensu stricto strain with a Mycobacterium massiliense strain was observed for a single patient. Of note, several patients including a pair of siblings were colonized with closely-related strains consistent with intra-familial transmission or a common infection reservoir. In general, a switch from smooth to rough colony morphology was observed during the course of long-term infection, which in some cases correlated with an increasing severity of clinical symptoms. To examine evolution during long-term infection of the CF lung we compared the genome sequences of 6 sequential isolates of Mycobacterium bolletii obtained from a single patient over an 11 year period, revealing a heterogeneous clonal infecting population with mutations in regulators controlling the expression of virulence factors and complex lipids. Taken together, these data provide new insights into the epidemiology of M. abscessus spp. during long-term infection of the CF lung, and the molecular transition from saprophytic organism to human pathogen.	[Kreutzfeldt, Kaj M.; McAdam, Paul R.; Holmes, Anne; Fitzgerald, J. Ross] Univ Edinburgh, Roslin Inst & Edinburgh Infect Dis, Edinburgh, Midlothian, Scotland; [Claxton, Pauline; Seagar, A. Louise; Laurenson, Ian F.] Royal Infirm Edinburgh NHS Trust, SMRL, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Fitzgerald, JR (corresponding author), Univ Edinburgh, Roslin Inst & Edinburgh Infect Dis, Easter Bush Campus, Edinburgh, Midlothian, Scotland.	Ross.Fitzgerald@ed.ac.uk	GenePool, The/D-8812-2012		Biotechnology and Biological Sciences Research Council; Medical Research Council, UK; Tenovus Scotland; Health Protection Scotland; National Services Scotland; BBSRC [BBS/E/D/20231761, BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; Health Protection Scotland; National Services Scotland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Biotechnology and Biological Sciences Research Council, the Medical Research Council, UK, and Tenovus Scotland. This research is part of the remit of the Scottish Mycobacteria Reference Laboratory and was partly funded through its contract with Health Protection Scotland and National Services Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, EMERG INFECT DIS, V15, P302, DOI 10.3201/eid1502.080837; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Bange FC, 2001, CLIN INFECT DIS, V32, P1648, DOI 10.1086/320525; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Choi GE, 2012, J BACTERIOL, V194, P2756, DOI 10.1128/JB.00354-12; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Cullen AR, 2000, AM J RESP CRIT CARE, V161, P641, DOI 10.1164/ajrccm.161.2.9903062; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Falkinham JO, 2001, APPL ENVIRON MICROB, V67, P1225, DOI 10.1128/AEM.67.3.1225-1231.2001; FRASER VJ, 1992, AM REV RESPIR DIS, V145, P853, DOI 10.1164/ajrccm/145.4_Pt_1.853; Galil K, 1999, EMERG INFECT DIS, V5, P681, DOI 10.3201/eid0505.990509; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Gordon A.H., 2010, FASTX TOOLKIT; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Huang WC, 2010, J MED MICROBIOL, V59, P1203, DOI 10.1099/jmm.0.020586-0; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kuo YM, 2011, EMERG INFECT DIS, V17, P2077, DOI 10.3201/eid1711.110050; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Macheras E, 2009, J CLIN MICROBIOL, V47, P2596, DOI 10.1128/JCM.00037-09; MALONEY SA, 1994, J INFECT DIS, V169, P1166, DOI 10.1093/infdis/169.5.1166; Maurer FP, 2012, J ANTIMICROB CHEMOTH, V67, P2606, DOI 10.1093/jac/dks279; McAdam PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024301; Medjahed H, 2009, APPL ENVIRON MICROB, V75, P1331, DOI 10.1128/AEM.01914-08; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Sampaio JLM, 2006, DIAGN MICR INFEC DIS, V55, P107, DOI 10.1016/j.diagmicrobio.2006.01.006; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Sechi LA, 1998, J CLIN MICROBIOL, V36, P128, DOI 10.1128/JCM.36.1.128-132.1998; Silbert S, 2001, J CLIN MICROBIOL, V39, P3976, DOI 10.1128/JCM.39.11.3976-3981.2001; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	42	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63237	10.1371/journal.pone.0063237	http://dx.doi.org/10.1371/journal.pone.0063237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696800	Green Published, Green Submitted, gold			2022-12-25	WOS:000319081900016
J	Wei, XC; Zhang, XH; Shen, D; Wang, HP; Wu, QJ; Lu, P; Qiu, Y; Song, JP; Zhang, YJ; Li, XX				Wei, Xiaochun; Zhang, Xiaohui; Shen, Di; Wang, Haiping; Wu, Qingjun; Lu, Peng; Qiu, Yang; Song, Jiangping; Zhang, Youjun; Li, Xixiang			Transcriptome Analysis of Barbarea vulgaris Infested with Diamondback Moth (Plutella xylostella) Larvae	PLOS ONE			English	Article							BETA-AMYRIN SYNTHASE; TRITERPENE SAPONIN BIOSYNTHESIS; RESPONSIVE GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; CYTOCHROME-P450 FAMILY; GIBBERELLIN RECEPTORS; SECONDARY METABOLISM; ABSCISIC-ACID; PLANT-GROWTH; ARABIDOPSIS	Background: The diamondback moth (DBM, Plutella xylostella) is a crucifer-specific pest that causes significant crop losses worldwide. Barbarea vulgaris (Brassicaceae) can resist DBM and other herbivorous insects by producing feeding-deterrent triterpenoid saponins. Plant breeders have long aimed to transfer this insect resistance to other crops. However, a lack of knowledge on the biosynthetic pathways and regulatory networks of these insecticidal saponins has hindered their practical application. A pyrosequencing-based transcriptome analysis of B. vulgaris during DBM larval feeding was performed to identify genes and gene networks responsible for saponin biosynthesis and its regulation at the genome level. Principal Findings: Approximately 1.22, 1.19, 1.16, 1.23, 1.16, 1.20, and 2.39 giga base pairs of clean nucleotides were generated from B. vulgaris transcriptomes sampled 1, 4, 8, 12, 24, and 48 h after onset of P. xylostella feeding and from non-inoculated controls, respectively. De novo assembly using all data of the seven transcriptomes generated 39,531 unigenes. A total of 37,780 (95.57%) unigenes were annotated, 14,399 of which were assigned to one or more gene ontology terms and 19,620 of which were assigned to 126 known pathways. Expression profiles revealed 2,016-4,685 up-regulated and 557-5188 down-regulated transcripts. Secondary metabolic pathways, such as those of terpenoids, glucosinolates, and phenylpropanoids, and its related regulators were elevated. Candidate genes for the triterpene saponin pathway were found in the transcriptome. Orthological analysis of the transcriptome with four other crucifer transcriptomes identified 592 B. vulgaris-specific gene families with a P-value cutoff of 1e(-5). Conclusion: This study presents the first comprehensive transcriptome analysis of B. vulgaris subjected to a series of DBM feedings. The biosynthetic and regulatory pathways of triterpenoid saponins and other DBM deterrent metabolites in this plant were classified. The results of this study will provide useful data for future investigations on pest-resistance phytochemistry and plant breeding.	[Wei, Xiaochun; Zhang, Xiaohui; Shen, Di; Wang, Haiping; Wu, Qingjun; Lu, Peng; Qiu, Yang; Song, Jiangping; Zhang, Youjun; Li, Xixiang] China Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Li, XX (corresponding author), China Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China.	lixx0612@163.com	Zhang, Xiaohui/AAH-8653-2020; Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Key Technology R & D Program of the Ministry of Science and Technology of China [2013BAD01B04]; Core Research Budget of the Non-profit Governmental Research Institution (CAAS) [2012ZL026]	National Key Technology R & D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Core Research Budget of the Non-profit Governmental Research Institution (CAAS)	The work was supported by grants from the National Key Technology R & D Program of the Ministry of Science and Technology of China (2013BAD01B04) and Core Research Budget of the Non-profit Governmental Research Institution (CAAS,2012ZL026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Agerbirk N, 2003, J CHEM ECOL, V29, P1417, DOI 10.1023/A:1024217504445; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bachran C, 2010, BRIT J PHARMACOL, V159, P345, DOI 10.1111/j.1476-5381.2009.00543.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bedon F, 2010, J EXP BOT, V61, P3847, DOI 10.1093/jxb/erq196; Bohlmann J, 2012, TREE PHYSIOL, V32, P943, DOI 10.1093/treephys/tps065; Bones AM, 2006, PHYTOCHEMISTRY, V67, P1053, DOI 10.1016/j.phytochem.2006.02.024; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; CAELLES C, 1989, PLANT MOL BIOL, V13, P627, DOI 10.1007/BF00016018; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; Confalonieri M, 2009, PLANT BIOTECHNOL J, V7, P172, DOI 10.1111/j.1467-7652.2008.00385.x; Dal Cin V, 2011, PLANT CELL, V23, P2738, DOI 10.1105/tpc.111.086975; Diet A, 2006, PLANT CELL, V18, P1630, DOI 10.1105/tpc.105.038653; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; Fuchs H, 2009, CURR DRUG TARGETS, V10, P140, DOI 10.2174/138945009787354584; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Harmatha Juraj, 2003, Phytochemistry Reviews, V2, P321, DOI 10.1023/B:PHYT.0000045494.98645.a3; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Herrera JBR, 1998, PHYTOCHEMISTRY, V49, P1905, DOI 10.1016/S0031-9422(98)00366-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu Ke, 2009, Acta Horticulturae Sinica, V36, P1013; Hu YL, 2010, PLANT CELL, V22, P3093, DOI 10.1105/tpc.109.072652; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Huang MD, 2007, PLANT MOL BIOL, V63, P557, DOI 10.1007/s11103-006-9109-8; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030364; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Joshi RK, 2011, GENET MOL RES, V10, P2637, DOI 10.4238/2011.October.25.10; Just MJ, 1998, PLANTA MED, V64, P404, DOI 10.1055/s-2006-957469; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kejnovsky E, 2012, PLANT GENOME DIVERSI, V1, P17; Kieffer M, 2011, PLANT J, V68, P147, DOI 10.1111/j.1365-313X.2011.04674.x; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Kuzina V, 2011, PHYTOCHEMISTRY, V72, P188, DOI 10.1016/j.phytochem.2010.11.007; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Miclaus M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002131; Mizoi J, 1819, BIOCHIM BIOPHYS ACTA, P86; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nielsen NJ, 2010, J AGR FOOD CHEM, V58, P5509, DOI 10.1021/jf903988f; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Pandey SP, 2008, P NATL ACAD SCI USA, V105, P4559, DOI 10.1073/pnas.0711363105; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Plett JM, 2010, PLANT J, V64, P419, DOI 10.1111/j.1365-313X.2010.04343.x; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; RAY A, 1994, P NATL ACAD SCI USA, V91, P5761, DOI 10.1073/pnas.91.13.5761; Renwick JAA, 2006, J CHEM ECOL, V32, P755, DOI 10.1007/s10886-006-9036-9; Ringli C, 2008, PLANT CELL, V20, P1470, DOI 10.1105/tpc.107.053249; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sarfraz M, 2006, CROP PROT, V25, P625, DOI 10.1016/j.cropro.2005.09.011; Villada ES, 2009, J EXP BOT, V60, P3269, DOI 10.1093/jxb/erp163; Schilmiller AL, 2009, PLANT J, V60, P771, DOI 10.1111/j.1365-313X.2009.03996.x; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Seki H, 2008, P NATL ACAD SCI USA, V105, P14204, DOI 10.1073/pnas.0803876105; Shibuya M, 2006, FEBS J, V273, P948, DOI 10.1111/j.1742-4658.2006.05120.x; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Shinoda T, 2002, J CHEM ECOL, V28, P587, DOI 10.1023/A:1014500330510; Skibbe M, 2008, PLANT CELL, V20, P1984, DOI 10.1105/tpc.108.058594; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091; Suzuki H, 2009, PLANT J, V60, P48, DOI 10.1111/j.1365-313X.2009.03936.x; Tian L, 2004, P NATL ACAD SCI USA, V101, P402, DOI 10.1073/pnas.2237237100; Tu Y, 2010, PLANT CELL, V22, P3357, DOI 10.1105/tpc.109.072827; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; van Leur H, 2008, J CHEM ECOL, V34, P121, DOI 10.1007/s10886-007-9424-9; Vickers RA, 2004, ENTOMOL EXP APPL, V111, P7, DOI 10.1111/j.0013-8703.2004.00140.x; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Waliwitiya R, 2012, J ECON ENTOMOL, V105, P72, DOI 10.1603/EC10381; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zhang HC, 2009, PLANT CELL REP, V28, P1205, DOI 10.1007/s00299-009-0721-3; Zhao CL, 2010, NAT PROD COMMUN, V5, P1147; Zhao ZC, 2012, MOL BIOL REP, V39, P6409, DOI 10.1007/s11033-011-1303-3; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399	109	27	32	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64481	10.1371/journal.pone.0064481	http://dx.doi.org/10.1371/journal.pone.0064481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696897	gold, Green Submitted, Green Published			2022-12-25	WOS:000319081900100
J	Shahnazari, M; Chu, V; Wronski, TJ; Nissenson, RA; Halloran, BP				Shahnazari, Mohammad; Chu, Vivian; Wronski, Thomas J.; Nissenson, Robert A.; Halloran, Bernard P.			CXCL12/CXCR4 signaling in the osteoblast regulates the mesenchymal stem cell and osteoclast lineage populations	FASEB JOURNAL			English	Article						bone; chemokine; skeletal homeostasis	CHEMOKINE RECEPTOR CXCR4; BONE-FORMATION; MICE LACKING; EXPRESSION; DIFFERENTIATION; MAINTENANCE; PROMOTES; SURVIVAL; RANKL; SDF-1	The chemokine CXCL12 and its receptor CXCR4 play a key role in regulation of hematopoietic stem cells and cell migratory function during morphogenesis. Osteoblasts express both the ligand and the receptor, but little is known about the role of CXCL12-CXCR4 signaling in maintaining skeletal homeostasis. Using Cre-Lox technology to delete CXCR4 in mature osteoblasts in mice, we show here a significant decrease in bone mass and alterations in cancellous bone structure. CXCR4 gene ablation increased the number of colony-forming units (CFU), CFU-positive for alkaline phosphatase (CFU-AP(+)), and mineralizing nodules in bone marrow stromal cell (BMSC) cultures. The adipocyte precursor population decreased in BMSCs harvested from the KO animals. The nonadherent population of BMSCs harvested from the long bone diaphysis of KO animals formed more osteoclasts, a finding that was associated with increased circulatory levels of pyridinoline, a marker of bone resorption. Our data show that osteoblast-specific CXCR4 deletion has profound effects on the mesenchymal stem cell pool and allocation to the osteoblastic and adipocytic cell lineages. They also show that CXCL12/CXCR4 signaling in the mature osteoblast can feedback to regulate the osteoclast precursor pool size and play a multifunctional role in regulating bone formation and resorption.Shahnazari, M., Chu, V., Wronski, T. J., Nissenson, R. A., Halloran, B. P. CXCL12/CXCR4 signaling in the osteoblast regulates the mesenchymal stem cell and osteoclast lineage populations.	[Shahnazari, Mohammad; Chu, Vivian; Nissenson, Robert A.; Halloran, Bernard P.] Vet Affairs Med Ctr, Div Endocrinol, San Francisco, CA 94123 USA; [Shahnazari, Mohammad; Nissenson, Robert A.; Halloran, Bernard P.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Wronski, Thomas J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; State University System of Florida; University of Florida	Halloran, BP (corresponding author), Vet Affairs Med Ctr, Div Endocrinol, 4150 Clement St, San Francisco, CA 94123 USA.	bernard.halloran@ucsf.edu	Shahnazari, Mohammad Reza/AAU-8573-2020	Shahnazari, Mohammad Reza/0000-0001-8647-5426	U.S. Department of Veterans Affairs Merit Review program; Northern California Institute for Research and Education; Veterans Affairs [I01BX001496] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Merit Review program(US Department of Veterans Affairs); Northern California Institute for Research and Education; Veterans Affairs(US Department of Veterans Affairs)	The CXCR4<SUP>wt/f</SUP> mice were kindly provided by Dr. Yong-Rui Zou (Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, NY, USA). The authors are grateful to Alicia Leeper and Alyssa Williams (University of Florida, Gainesville, FL, USA) for technical assistance with bone histomorphometry. Funds for these studies were provided by the U.S. Department of Veterans Affairs Merit Review program and the Northern California Institute for Research and Education.	Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Cao JJ, 2005, J BONE MINER RES, V20, P1659, DOI 10.1359/JBMR.050503; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Diamond P, 2009, J BONE MINER RES, V24, P1150, DOI [10.1359/jbmr.090210, 10.1359/JBMR.090210]; Hoggatt J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt54; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Ono N, 2012, J CELL PHYSIOL, V227, P408, DOI 10.1002/jcp.22986; PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360; Parikka V, 2001, ENDOCRINOLOGY, V142, P5371, DOI 10.1210/en.142.12.5371; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Shinohara K, 2011, J ORTHOP RES, V29, P1064, DOI 10.1002/jor.21374; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zhu W, 2011, J BIOL CHEM, V286, P26794, DOI 10.1074/jbc.M111.250985	27	49	50	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3505	3513		10.1096/fj.12-225763	http://dx.doi.org/10.1096/fj.12-225763			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23704087				2022-12-25	WOS:000328840500011
J	Armstrong, C; Wilkinson, H; Meade, J; Biro, D; Freeman, R; Guilford, T				Armstrong, Chris; Wilkinson, Helen; Meade, Jessica; Biro, Dora; Freeman, Robin; Guilford, Tim			Homing Pigeons Respond to Time-Compensated Solar Cues Even in Sight of the Loft	PLOS ONE			English	Article							SUN COMPASS ORIENTATION; CLOCK-SHIFT EXPERIMENTS; RELEASE SITE REDUCE; DEFLECTION; NAVIGATION; LANDMARKS; FAMILIARITY; TRACKING; BIRDS; GPS	The sun has long been thought to guide bird navigation as the second step in a two-stage process, in which determining position using a map is followed by course setting using a compass, both over unfamiliar and familiar terrain. The animal's endogenous clock time-compensates the solar compass for the sun's apparent movement throughout the day, and this allows predictable deflections in orientation to test for the compass' influence using clock-shift manipulations. To examine the influence of the solar compass during a highly familiar navigational task, 24 clock-shifted homing pigeons were precision-tracked from a release site close to and in sight of their final goal, the colony loft. The resulting trajectories displayed significant partial deflection from the loft direction as predicted by either fast or slow clock-shift treatments. The partial deflection was also found to be stable along the entire trajectory indicating regular updating of orientation via input from the solar compass throughout the final approach flight to the loft. Our results demonstrate that time-compensated solar cues are deeply embedded in the way birds orient during homing flight, are accessed throughout the journey and on a remarkably fine-grained scale, and may be combined effectively simultaneously with direct guidance from familiar landmarks, even when birds are flying towards a directly visible goal.	[Armstrong, Chris; Wilkinson, Helen; Meade, Jessica; Biro, Dora; Freeman, Robin; Guilford, Tim] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Wilkinson, Helen] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Meade, Jessica] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Freeman, Robin] CoMPLEX, London, England	University of Oxford; Durham University; University of New South Wales Sydney; University of London; University College London	Guilford, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tim.guilford@zoo.ox.ac.uk	Meade, Jessica/A-6411-2013; Meade, Jessica/O-7771-2019	Biro, Dora/0000-0002-3408-6274	Biotechnology and Biological Sciences Research Council studentship	Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded with the help of a Biotechnology and Biological Sciences Research Council studentship (Chris Armstrong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Able K.P., 1985, Contributions in Marine Science, V27, P516; ABLE KP, 1977, CONDOR, V79, P393, DOI 10.2307/1368027; BAKER RR, 1984, BIRD NAVIGATION SOLU; Biro D, 2002, J EXP BIOL, V205, P3833; Biro D, 2007, P NATL ACAD SCI USA, V104, P7471, DOI 10.1073/pnas.0701575104; Chappell J, 1997, J EXP BIOL, V200, P2269; FULLER E, 1983, J COMP PHYSIOL, V153, P55; Gagliardo A, 2005, J EXP BIOL, V208, P4002, DOI 10.1242/jeb.01851; Gagliardo A, 2005, J EXP BIOL, V208, P469, DOI 10.1242/jeb.01383; Gagliardo A, 1999, J NEUROSCI, V19, P311, DOI 10.1523/JNEUROSCI.19-01-00311.1999; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; GRAUE LOUIS C., 1963, THE OHIO JOUR SCI, V63, P214; Holland R, 2000, IBIS, V142, P111, DOI 10.1111/j.1474-919X.2000.tb07690.x; Holland RA, 2003, J EXP BIOL, V206, P1773, DOI 10.1242/jeb.00365; Keeton W.T., 1974, Advances Study Behav, V5, P47, DOI 10.1016/S0065-3454(08)60020-0; Kramer G., 1953, Journal fuer Ornithologie, V94, P201, DOI 10.1007/BF01922508; MOORE FR, 1987, BIOL REV, V62, P65, DOI 10.1111/j.1469-185X.1987.tb00626.x; MURPHY PA, 1981, COPEIA, P638; Papi F., 1992, ANIMAL HOMING, DOI [DOI 10.1007/978-94-011-1588-9_1, 10.1007/978-94-011-1588-9_1]; Schmidt-Koenig K., 1961, Zeitschrift fuer Tierpsychologie, V18, P221; Thorup K, 2009, J EXP BIOL, V212, P3597, DOI 10.1242/jeb.021238; Wallraff HG, 1999, J EXP BIOL, V202, P2121; Wiltschko R, 2005, J EXP BIOL, V208, P4001, DOI 10.1242/jeb.01850; Wiltschko R, 2001, BEHAV ECOL SOCIOBIOL, V49, P393, DOI 10.1007/s002650000313; WILTSCHKO R, 1994, BEHAV ECOL SOCIOBIOL, V35, P63, DOI 10.1007/s002650050071; WILTSCHKO R, 1981, BEHAV ECOL SOCIOBIOL, V9, P135, DOI 10.1007/BF00293584; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054; WILTSCHKO W, 1976, BEHAV ECOL SOCIOBIOL, V1, P229, DOI 10.1007/BF00300066; WILTSCHKO W, 1983, COMP BIOCHEM PHYS A, V76, P709, DOI 10.1016/0300-9629(83)90132-9; Zimmerman PH, 2003, APPL ANIM BEHAV SCI, V80, P327, DOI 10.1016/S0168-1591(02)00233-2	30	9	9	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2013	8	5							e63130	10.1371/journal.pone.0063130	http://dx.doi.org/10.1371/journal.pone.0063130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150JB	23717401	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319385300039
J	Chen, X; Du, YP; Nan, J; Zhang, XX; Qin, XD; Wang, YX; Hou, JW; Wang, Q; Yang, JB				Chen, Xing; Du, Yuping; Nan, Jing; Zhang, Xinxin; Qin, Xiaodong; Wang, Yuxin; Hou, Jianwen; Wang, Qin; Yang, Jinbo			Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; TYROSINE KINASE; SUPPRESSES GROWTH; HUMAN BREAST; LUNG-CANCER; APOPTOSIS; MUTATION; JAK2; SRC; PATHWAY	Signal abnormalities in human cells usually cause unexpected consequences for individual health. We focus on these kinds of events involved in JAK-STAT signal pathways, especially the ones triggered by aberrant activated STAT3, an oncoprotein which participates in essential processes of cell survival, growth and proliferation in many types of tumors, as well as immune diseases. By establishing a STAT3 signal based high-throughput drug screening system in human lung cancer A549 cells, we have screened a library from natural products which contained purified compounds from medicinal herbs. One compound, named Brevilin A, exhibited both strong STAT3 signal inhibition and STAT3 signal dependent cell growth inhibition. Further investigations revealed that Brevilin A not only inhibits STAT3 signaling but also STAT1 signaling for cytokines induced phosphorylation of STAT3 and STAT1 as well as the expression of their target genes. In addition, we found Brevilin A could attenuate the JAKs activity by blocking the JAKs tyrosine kinase domain JH1. The levels of cytokine induced phosphorylation of STATs and other substrates were dramatically reduced by treatment of Brevilin A. The roles of Brevilin A targeting on JAKs activity indicate that Brevilin A may not only be used as a STAT3 inhibitor but also a compound blocking other JAK-STAT hyperactivation. Thus, these findings provided a strong impetus for the development of selective JAK-STAT inhibitors and therapeutic drugs in order to improve survival of patients with hyperactivated JAKs and STATs.	[Chen, Xing; Du, Yuping; Nan, Jing; Zhang, Xinxin; Qin, Xiaodong; Wang, Yuxin; Hou, Jianwen; Wang, Qin; Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Yang, Jinbo] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44106 USA	Lanzhou University; Cleveland Clinic Foundation	Yang, JB (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China.	yangjb@lzu.edu.cn	Yang, Jinbo/AAM-9580-2020		The Science and Technology Support Project of Gansu Providence [1104FK CA123]; Ministry of Science and Technology of the People's Republic of China [2009DFA30990]; Gansu Provincial Science and Technology [0708WCGA149]; National Natural Science Foundation of China [2009AA01A130]	The Science and Technology Support Project of Gansu Providence; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Gansu Provincial Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 1104FK CA123 from The Science and Technology Support Project of Gansu Providence to Q.W.; 2009DFA30990 from the Ministry of Science and Technology of the People's Republic of China, 0708WCGA149 from the Gansu Provincial Science and Technology and 2009AA01A130 from National Natural Science Foundation of China to J.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Chau MN, 2008, BIOCHEM BIOPH RES CO, V377, P627, DOI 10.1016/j.bbrc.2008.10.025; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; FALLON RJ, 1990, BIOCHEM BIOPH RES CO, V170, P1191, DOI 10.1016/0006-291X(90)90519-S; Foster NI, 1982, AM J CLIN ONCOL-CANC, V5, P331; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; He JX, 2012, J BIOSCIENCES, V37, P243, DOI 10.1007/s12038-012-9202-x; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kusaba T, 2006, ONCOL REP, V15, P1445; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee SO, 2004, PROSTATE, V60, P303, DOI 10.1002/pros.20072; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li C, 2008, WANFANG MED ONLINE; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Liu BH, 2010, INT IMMUNOPHARMACOL, V10, P1608, DOI 10.1016/j.intimp.2010.09.017; Mora LB, 2002, CANCER RES, V62, P6659; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murakami Y, 1998, J CELL PHYSIOL, V175, P220, DOI 10.1002/(SICI)1097-4652(199805)175:2<220::AID-JCP12>3.0.CO;2-C; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Ni Z, 2000, CANCER RES, V60, P1225; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 1999, CANCER RES, V59, P5059; Okamoto M, 1997, CANCER RES, V57, P141; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Porcu M, 2009, HAEMATOL-HEMATOL J, V94, P435, DOI 10.3324/haematol.13587; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Weerasinghe P, 2007, INT J ONCOL, V31, P129; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020965	52	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63697	10.1371/journal.pone.0063697	http://dx.doi.org/10.1371/journal.pone.0063697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704931	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200062
J	Lopes, AL; Botelho, LM				Lopes, Antonio Luis; Botelho, Luis Miguel			Distributed Coordination of Heterogeneous Agents Using a Semantic Overlay Network and a Goal-Directed Graphplan Planner	PLOS ONE			English	Article							SERVICE	In this paper, we describe a distributed coordination system that allows agents to seamlessly cooperate in problem solving by partially contributing to a problem solution and delegating the subproblems for which they do not have the required skills or knowledge to appropriate agents. The coordination mechanism relies on a dynamically built semantic overlay network that allows the agents to efficiently locate, even in very large unstructured networks, the necessary skills for a specific problem. Each agent performs partial contributions to the problem solution using a new distributed goal-directed version of the Graphplan algorithm. This new goal-directed version of the original Graphplan algorithm provides an efficient solution to the problem of "distraction", which most forward-chaining algorithms suffer from. We also discuss a set of heuristics to be used in the backward-search process of the planning algorithm in order to distribute this process amongst idle agents in an attempt to find a solution in less time. The evaluation results show that our approach is effective in building a scalable and efficient agent society capable of solving complex distributable problems.	[Lopes, Antonio Luis; Botelho, Luis Miguel] Inst Univ Lisboa ISCTE IUL, Inst Telecomunicacoes, Lisbon, Portugal	Instituto de Telecomunicacoes; Instituto Universitario de Lisboa	Lopes, AL (corresponding author), Inst Univ Lisboa ISCTE IUL, Inst Telecomunicacoes, Lisbon, Portugal.	alsl@iscte.pt	Lopes, António/B-2934-2012	Lopes, António/0000-0003-3045-0304; Botelho, Luis Miguel/0000-0001-7154-8362	Portuguese Foundation for Science and Technology [SFRH/BD/27533/2006, PTDC/EEACRO/104658/2008, PEst-OE/EEI/LA0008/2011]; ISCTE-Instituto Universitario de Lisboa; Instituto de Telecomunicacoes	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ISCTE-Instituto Universitario de Lisboa; Instituto de Telecomunicacoes	This work described in the paper has been supported by the Portuguese Foundation for Science and Technology (http://alfa.fct.mctes.pt/index.phtml.en) under the scholarship grant SFRH/BD/27533/2006 and the grants PTDC/EEACRO/104658/2008 and PEst-OE/EEI/LA0008/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the support of ISCTE-Instituto Universitario de Lisboa and Instituto de Telecomunicacoes.	Abdallah S, 2004, IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY, PROCEEDINGS, P162, DOI 10.1109/IAT.2004.1342939; Anderson C, 1998, P 4 INT C AI PLANN S; Ben-Ami D., 2005, P 4 INT JOINT C AUT, P339; Blum AL, 1997, ARTIF INTELL, V90, P281, DOI 10.1016/S0004-3702(96)00047-1; Botelho LM, 2008, WHITESTEIN SER SOFTW, P263, DOI 10.1007/978-3-7643-8575-0_12; Chatalic P, 2006, J ARTIFICIAL INTELLI, V25, P5; Costa P, 2008, WHITESTEIN SER SOFTW, P289, DOI 10.1007/978-3-7643-8575-0_13; Cox J, 2005, P AAMAS05, P821, DOI [10.1145/1082473.1082598, DOI 10.1145/1082473.1082598.URL]; Crespo A, 2005, LECT NOTES ARTIF INT, V3601, P1, DOI 10.1007/11574781_1; Crespo A, 2002, INT CON DISTR COMP S, P23, DOI 10.1109/ICDCS.2002.1022239; de Weerdt M., 2007, P 6 INT JOINT C AUT; DURFEE EH, 1991, IEEE T SYST MAN CYB, V21, P1167, DOI 10.1109/21.120067; Elahi M, 2003, MAICS, P18; FIKES RE, 1971, ARTIF INTELL, V2, P189, DOI 10.1016/0004-3702(71)90010-5; Fung RYK, 2005, INT J ADV MANUF TECH, V25, P811, DOI 10.1007/s00170-003-1900-y; Gaston M. E., 2005, P 4 INT JOINT C AUTO, P230; Iwen M, 2002, PROC INT C TOOLS ART, P138, DOI 10.1109/TAI.2002.1180798; Jamali N, 2005, LECT NOTES ARTIF INT, V3446, P40; Kalogeraki V., 2002, Proceedings of the Eleventh International Conference on Information and Knowledge Management. CIKM 2002, P300, DOI 10.1145/584792.584842; Kambhampati S., 1997, Recent Advances in AI Planning. 4th European Conference on Planning, ECP'97 Proceedings, P260, DOI 10.1007/3-540-63912-8_91; Lopes A, 2008, AAMAS WORKSH AG PEER; Lopes Antonio L., 2008, Journal of Networks, V3, P38, DOI 10.4304/jnw.3.2.38-47; Lopes AL, 2007, LECT NOTES COMPUT SC, V4504, P1; Lv Q., 2002, Performance Evaluation Review, V30, P258, DOI 10.1145/511399.511369; Ogston E., 2002, Proceedings of the First International Joint Conference on Autonomous Agents and Multiagent Systems, P151; Pellier D, 2010, ICAART 2010: PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON AGENTS AND ARTIFICIAL INTELLIGENCE, VOL 2: AGENTS, P128; Peot M, 1996, P 3 INT C ART INT PL; Risson J, 2006, COMPUT NETW, V50, P3485, DOI 10.1016/j.comnet.2006.02.001; ROWSTRON A., IFIP ACM INT C DISTR, P329, DOI DOI 10.1007/3-540-45518-3_18; Sacerdoti E, 1975, P 4 INT JOINT C ART, P206; Shoham Y., 1992, P AAAI 92, P276; Stoica I, 2001, ACM SIGCOMM COMP COM, V31, P149, DOI 10.1145/964723.383071; ter Mors A, 2004, IC-AI '04 & MLMTA'04 , VOL 1 AND 2, PROCEEDINGS, P795; Tsoumakos D, 2003, THIRD INTERNATIONAL CONFERENCE ON PEER-TO-PEER COMPUTING (P2P2003), PROCEEDINGS, P102, DOI 10.1109/PTP.2003.1231509; Walsh W. E., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P260, DOI 10.1145/352871.352900; Walsh W.E., 1999, P 3 INT C MULT AG SY, P325; Weld D. S., 1999, AI Magazine, V20, P93; Weld DS, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P897; Wellman MP, 1993, J ARTIF INTELL RES, V1, P1; Wellman MP, 2001, GAME ECON BEHAV, V35, P271, DOI 10.1006/game.2000.0822; Yang B., 2002, P INT C DISTR COMP S; Zhao B. Y., 2001, TECHNICAL REPORT	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e62931	10.1371/journal.pone.0062931	http://dx.doi.org/10.1371/journal.pone.0062931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704885	gold, Green Published			2022-12-25	WOS:000319330200014
J	Metting, Z; Cerliani, L; Rodiger, LA; van der Naalt, J				Metting, Zwany; Cerliani, Leonardo; Rodiger, Lars A.; van der Naalt, Joukje			Pathophysiological Concepts in Mild Traumatic Brain Injury: Diffusion Tensor Imaging Related to Acute Perfusion CT Imaging	PLOS ONE			English	Article							HEAD-INJURY; DAMAGE; DYSFUNCTION; IMPAIRMENT	Background: A subgroup of patients with mild traumatic brain injury (TBI) experiences residual symptoms interfering with their return to work. The pathophysiological substrate of the suboptimal outcome in these patients is a source of debate. Objective: To provide greater insight into the pathophysiological mechanisms of mild TBI. Methods: Diffusion tensor imaging (DTI) was performed during follow-up of 18 patients with mild TBI and compared with healthy control subjects. DTI data of the patient group were also compared with perfusion CT imaging in the acute phase of injury. Results: In patients with mild TBI, a trend was observed for a decreased fractional anisotropy (FA) in widespread bilateral frontal white matter areas with increased mean diffusivity (MD) in the parieto-temporal regions, compared to healthy control subjects. Cerebral blood volume (CBV) correlated significantly with FA in several white matter tracts including the corpus callosum, the internal capsule, the inferior fronto-occipital fascicle, the corticospinal tract, the superior and the inferior longitudinal fascicle. Conclusion: In mild TBI with normal conventional imaging significant associations between cerebral perfusion in the acute phase of injury and DTI analyses in the chronic phase of injury were discerned. The pathophysiological concept of these findings is being outlined.	[Metting, Zwany; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Cerliani, Leonardo] Univ Groningen, NeuroImaging Ctr, Groningen, Netherlands; [Cerliani, Leonardo] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Rodiger, Lars A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Groningen	Metting, Z (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands.	z.metting@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; cerliani, leonardo/0000-0002-2655-6133	ZonMw, Den Haag, The Netherlands [39200002]; NWO MaGW Open competition grant [400-08-089]; NIHC grant [056-13-017]	ZonMw, Den Haag, The Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); NWO MaGW Open competition grant; NIHC grant	This study was funded by ZonMw, Den Haag, The Netherlands (grant number 39200002). In addition, L. Cerliani is supported by an NWO MaGW Open competition grant (grant number 400-08-089) and by an NIHC grant (grant number 056-13-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	20	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64461	10.1371/journal.pone.0064461	http://dx.doi.org/10.1371/journal.pone.0064461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704986	Green Published, Green Submitted, gold			2022-12-25	WOS:000319330200139
J	Ou, LJ; Zhang, ZQ; Dai, XZ; Zou, XX				Ou, Li-jun; Zhang, Zhu-qing; Dai, Xiong-ze; Zou, Xue-xiao			Photooxidation Tolerance Characters of a New Purple Pepper	PLOS ONE			English	Article							PHOTOINHIBITION; STRESS; PHOTOSYNTHESIS; INACTIVATION; ACCLIMATION; SYSTEM; FIELD	Huai Zi (HZ) is a new purple mutant of green pepper (PI 631133) that is obtained from the United States Department of Agriculture. The net photosynthetic rate (P-N), chlorophyll fluorescence parameters, antioxidant substances, antioxidant enzymes, photosystem 1 (PS1) and PS2 activities were studied through methyl viologen (MV) treatment. The results showed that the P-N, actual photochemical efficiency of PS2 (Phi PS2), photochemical quenching coefficient (q(P)), PS1 and PS2 activities in HZ were lower than those in green pepper. HZ had a stronger ability to eliminate reactive oxygen species(O-2(center dot-)) and accumulated less malondialdehyde (MDA) (a membrane lipid peroxidation product) than did green pepper, and had a higher content of antioxidants and antioxidant enzyme activity. This suggests that the lower light energy absorption and higher thermal dissipation and antioxidant activity of HZ contributed to a more stable PS2 photosynthetic capacity, which resulted in photooxidation tolerance. Hence, our study strongly suggests that pepper hybrids can achieve a modest ratio of chlorophyll and anthocyanin content, high P-N and resistance to photooxidation, improving yield and resistance to adverse environments.	[Ou, Li-jun; Zhang, Zhu-qing; Dai, Xiong-ze; Zou, Xue-xiao] Hunan Acad Agr Sci, Vegetable Inst, Changsha, Hunan, Peoples R China; [Ou, Li-jun] Huaihua Univ, Key Lab Hunan Prov Study & Utilizat Ethn Med Plan, Huaihua, Hunan, Peoples R China; [Ou, Li-jun] Huaihua Univ, Dept Life Sci, Huaihua, Hunan, Peoples R China	Hunan Academy of Agricultural Sciences; Huaihua University; Huaihua University	Zou, XX (corresponding author), Hunan Acad Agr Sci, Vegetable Inst, Changsha, Hunan, Peoples R China.	zou_xuexiao@163.com			China Agriculture Research System [CARS-25-A-8]; construct program of the key discipline in Hunan province	China Agriculture Research System; construct program of the key discipline in Hunan province	This work was supported by China Agriculture Research System (CARS-25-A-8) and the construct program of the key discipline in Hunan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1997, PHYSIOL PLANTARUM, V100, P214, DOI 10.1034/j.1399-3054.1997.1000202.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Azevedo GFC, 2012, PHOTOSYNTHETICA, V50, P86, DOI 10.1007/s11099-012-0001-2; Bahler D., 1991, HORTSCIENCE, V26, P736; Baltscheffsky M., 1990, CURRENT RES PHOTOSYN, VII, P447; Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2; Domingues N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038162; Dong YanXiang, 2007, Acta Horticulturae Sinica, V34, P1595; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; [高玉 GAO Yu], 2009, [生态学报, Acta Ecologica Sinica], V29, P3335; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Hendrickson L, 2004, PHOTOSYNTH RES, V82, P73, DOI 10.1023/B:PRES.0000040446.87305.f4; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Jiang WeiBing, 2006, Acta Horticulturae Sinica, V33, P577; Jiao DM, 2001, PHOTOSYNTHETICA, V39, P167, DOI 10.1023/A:1013758504857; Kruger GHJ, 1997, PHYSIOL PLANTARUM, V101, P265, DOI 10.1034/j.1399-3054.1997.1010203.x; Li HongWei, 2010, Acta Agronomica Sinica, V36, P449, DOI 10.3724/SP.J.1006.2010.00449; Li M, 2007, PHOTOSYNTHETICA, V45, P222, DOI 10.1007/s11099-007-0036-y; Li XG, 2004, PHOTOSYNTHETICA, V42, P257, DOI 10.1023/B:PHOT.0000040598.48732.af; Lin ZF, 2009, PHOTOSYNTHETICA, V47, P46, DOI 10.1007/s11099-009-0009-4; Lin ZhiFang, 1999, Acta Agronomica Sinica, V25, P284; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Millaleo R, 2013, J EXP BOT, V64, P343, DOI 10.1093/jxb/ers339; Murchie EH, 1999, PLANT PHYSIOL, V119, P553, DOI 10.1104/pp.119.2.553; NAKANO Y, 1987, PLANT CELL PHYSIOL, V28, P131; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OGREN E, 1992, PHOTOSYNTH RES, V33, P63, DOI 10.1007/BF00032983; Rao DM, 2003, PHOTOSYNTHETICA, V41, P33, DOI 10.1023/A:1025848110029; Solecka D, 1997, ACTA PHYSIOL PLANT, V19, P257, DOI 10.1007/s11738-997-0001-1; Sui XiaoLei, 2005, Acta Horticulturae Sinica, V32, P222; [隋益虎 Sui Yihu], 2009, [食品与发酵工业, Food and Fermentation Industries], V35, P162; [隋益虎 Sui Yihu], 2005, [种子, Seed], V24, P19; [隋益虎 Sui Yihu], 2004, [植物生理学通讯, Plant Physiology Communications], V40, P693; TANAKA K, 1985, PLANT CELL PHYSIOL, V26, P1425; Teng Y.D., 1997, CHINA VEG, V17, P29; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang MeiLing, 2008, Acta Horticulturae Sinica, V35, P547; Wu HanYing, 2001, Acta Horticulturae Sinica, V28, P517; Xue YiXia, 2010, Acta Horticulturae Sinica, V37, P397; Yong ZH, 2007, PHOTOSYNTHETICA, V45, P85, DOI 10.1007/s11099-007-0013-5; Zhang Qi'an, 2005, China Vegetables, P36; Zhou HK, 2005, J CHIN CAPS, V5, P28	43	7	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63593	10.1371/journal.pone.0063593	http://dx.doi.org/10.1371/journal.pone.0063593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704924	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200055
J	Endo, H; Niioka, M; Kobayashi, N; Tanaka, M; Watanabe, T				Endo, Hitoshi; Niioka, Maki; Kobayashi, Noriko; Tanaka, Mamoru; Watanabe, Tetsu			Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INCREASED INTESTINAL PERMEABILITY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; INSULIN SENSITIVITY; HEPATIC STEATOSIS; MESSENGER-RNA; SIRT1; NRF2; PHOSPHORYLATION	Nonalcoholic fatty liver disease (NAFLD) includes simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The gut-derived endotoxin plays an essential role in the pathophysiological development and progression of NAFLD. By using rat models of choline-deficient/L-amino acid-defined (CDAA)-diet-induced NAFLD, we examined whether MIYAIRI 588-a butyrate-producing probiotic - prevents the progression of pathophysiological changes from steatosis to hepatocarcinogenesis. In vivo experiments showed that treatment with MIYAIRI 588 reduced CDAA-diet-induced hepatic lipid deposition and significantly improved the triglyceride content, insulin resistance, serum endotoxin levels, and hepatic inflammatory indexes. We also found that MIYAIRI 588 substantially increased the activation of hepatic adenosine 5'-monophosphate-activated protein kinase (AMPK) and AKT and the expression of lipogenesis-or lipolysisrelated proteins. MIYAIRI 588 also improved CDAA-diet-induced delocalization and substantially decreased the expression of the tight-junction proteins intestinal zonula occluden-1 and occludin in CDAA-diet-fed rats. Further, the MIYAIRI 588-treated rats also showed remarkable induction of nuclear factor erythoid 2-related factor 2 (Nrf2) and its targeted antioxidative enzymes, which suppressed hepatic oxidative stress. In vitro studies revealed that treatment with sodium butyrate (NaB) also activated AMPK and AKT and enhanced Nrf2 expression by precluding ubiquitination, thereby increasing the half-life of the Nrf2 protein. Pharmacological studies and siRNA knockdown experiments showed that NaB-mediated AMPK activation induced the phosphorylation and nuclear translocation of Sirtuin 1, leading to the increased assembly of mammalian TOR complex 2 and phosphorylation of AKT at Ser473 and subsequent induction of Nrf2 expression and activation. These favorable changes caused an obvious decrease in hepatic fibrous deposition, GST-P-positive foci development, and hepatocarcinogenesis. Our data clearly established that the probiotic MIYAIRI 588 has beneficial effects in the prevention of NAFLD progression.	[Endo, Hitoshi; Watanabe, Tetsu] Tokai Univ, Sch Med, Dept Community Hlth, Ctr Mol Prevent & Environm Med, Isehara, Kanagawa 25911, Japan; Tokai Univ, Sch Med, Dept Cell Biol & Histol, Teaching & Res Support Ctr, Isehara, Kanagawa 25911, Japan; [Kobayashi, Noriko; Tanaka, Mamoru] Miyarisan Pharmaceut Co Res Lab, Nagano, Japan	Tokai University; Tokai University	Endo, H (corresponding author), Tokai Univ, Sch Med, Dept Community Hlth, Ctr Mol Prevent & Environm Med, Isehara, Kanagawa 25911, Japan.	h-endo@tokai-u.jp; tewatana@is.icc.u-tokai.ac.jp		Endo, Hitoshi/0000-0001-6113-9338	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23590755, 23701113]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (23590755 to TW) and Grant-in-Aid for Young Scientists (23701113 to HE) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Endo H, 2008, ENVIRON HEALTH PERSP, V116, P873, DOI 10.1289/ehp.10696; Endo H, 2011, PATHOBIOLOGY, V78, P239, DOI 10.1159/000328841; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Garcia-Trevijano ER, 1999, HEPATOLOGY, V29, P960, DOI 10.1002/hep.510290346; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kodama Y, 2009, GASTROENTEROLOGY, V137, P1467, DOI 10.1053/j.gastro.2009.06.045; Koketsu Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE719, DOI 10.1152/ajpendo.00253.2007; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Lavina B, 2009, GUT, V58, P118, DOI 10.1136/gut.2008.149880; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Miyoshi M, 2011, CLIN NUTR, V30, P252, DOI 10.1016/j.clnu.2010.09.012; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Okada K, 2012, J GASTROENTEROL, V47, P924, DOI 10.1007/s00535-012-0552-9; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Sakai M, 2007, BIOCHEM BIOPH RES CO, V357, P575, DOI 10.1016/j.bbrc.2007.03.174; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Sugimoto H, 2010, AM J PHYSIOL-GASTR L, V298, pG283, DOI 10.1152/ajpgi.00296.2009; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Vernia P, 2003, EUR J CLIN INVEST, V33, P244, DOI 10.1046/j.1365-2362.2003.01130.x; Wachtershauser A, 2000, EUR J NUTR, V39, P164, DOI 10.1007/s003940070020; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Watanabe T, 2000, J HEPATOL, V33, P224, DOI 10.1016/S0168-8278(00)80363-3; Watanabe T, 2001, J HEPATOL, V35, P465, DOI 10.1016/S0168-8278(01)00177-5; Weerachayaphorn J, 2009, HEPATOLOGY, V50, P1588, DOI 10.1002/hep.23151; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	64	212	238	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e63388	10.1371/journal.pone.0063388	http://dx.doi.org/10.1371/journal.pone.0063388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23696823	gold, Green Published, Green Submitted			2022-12-25	WOS:000319081900034
J	Cheng, LM; Sage, EH; Yan, Q				Cheng, Lamei; Sage, E. Helene; Yan, Qi			SPARC Fusion Protein Induces Cellular Adhesive Signaling	PLOS ONE			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; FOCAL ADHESIONS; MELANOMA-CELLS; DNA-SYNTHESIS; LENS CAPSULE; IN-VITRO; BINDING; ATTACHMENT	Secreted protein, acidic and rich in cysteine (SPARC) has been described as a counteradhesive matricellular protein with a diversity of biological functions associated with morphogenesis, remodeling, cellular migration, and proliferation. We have produced mouse SPARC with a FLAG-tag at the N-terminus of SPARC (Flag-SPARC, FSP) in a Bac-to-Bac baculoviral expression system. After affinity purification, this procedure yields SPARC of high purity, with an electrophoretic mobility of similar to 44 kDa under reducing conditions, and similar to 38-39 kDa under non-reducing conditions. Unexpectedly, FSP adsorbed to plastic supported cell attachment and spreading, in a calcium-dependent manner. The adhesive activity of native FSP was inhibited by prior incubation with anti-SPARC IgG. Cell adhesion to FSP induced the formation of filopodia and lamellipodia but not focal adhesions that were prominent on cells that were attached to fibronectin. In addition, FSP induced the tyrosine phosphorylation of FAK and paxillin in attached epithelial cells. Erk1/2 and Rac were also activated in cells attached to FSP, but at a lower level in comparison to cells on fibronectin. This study provides new insight into the biological functions of SPARC, a matricellular protein with important roles in cell-extracellualr matrix interactions.	[Cheng, Lamei; Sage, E. Helene; Yan, Qi] Benaroya Res Inst, Seattle, WA USA; [Sage, E. Helene; Yan, Qi] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; [Cheng, Lamei] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China	Benaroya Research Institute; University of Washington; University of Washington Seattle; Central South University	Yan, Q (corresponding author), Benaroya Res Inst, Seattle, WA USA.	qyanresearch@gmail.com	; Brestic, Marian/A-8263-2012	Brestic, Marian/0000-0002-6597-7838; Brestic, Marian/0000-0003-3470-6100	National Institutes of Health [EY014150, GM40711]; NATIONAL EYE INSTITUTE [R01EY014150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant EY014150 and GM40711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk JA, 1996, INT J BIOCHEM CELL B, V28, P1031, DOI 10.1016/1357-2725(96)00036-2; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Girard JP, 1996, J BIOL CHEM, V271, P4511; Haber CL, 2008, INT J CANCER, V122, P1465, DOI 10.1002/ijc.23216; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HARLAN JM, 1983, LAB INVEST, V48, P269; Huynh MH, 2011, DEV GENES EVOL, V220, P315, DOI 10.1007/s00427-010-0349-x; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; McClung HM, 2012, CARCINOGENESIS, V33, P275, DOI 10.1093/carcin/bgr276; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nagaraju GPC, 2011, CANCER TREAT REV, V37, P559, DOI 10.1016/j.ctrv.2010.12.001; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Schaller MD, 1996, J ENDOCRINOL, V150, P1, DOI 10.1677/joe.0.1500001; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; TUSZYNSKI GP, 1987, SCIENCE, V236, P1570, DOI 10.1126/science.2438772; VARANI J, 1986, EXP CELL RES, V167, P376, DOI 10.1016/0014-4827(86)90178-3; Yan Q, 2005, INVEST OPHTH VIS SCI, V46, P4652, DOI 10.1167/iovs.05-0460; Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2; Yan Q, 2002, J CELL SCI, V115, P2747	35	68	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2013	8	1							e53202	10.1371/journal.pone.0053202	http://dx.doi.org/10.1371/journal.pone.0053202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076FX	23349702	gold, Green Published, Green Submitted			2022-12-25	WOS:000313943000011
J	Yang, HX; Zhou, Y; Gu, JL; Xie, SY; Xu, Y; Zhu, GF; Wang, L; Huang, JY; Ma, H; Yao, JH				Yang, Hongxing; Zhou, Yan; Gu, Jianlei; Xie, Shuying; Xu, Yao; Zhu, Genfeng; Wang, Lei; Huang, Jiyue; Ma, Hong; Yao, Jihua			Deep mRNA Sequencing Analysis to Capture the Transcriptome Landscape of Zebrafish Embryos and Larvae	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; GENE-EXPRESSION; CYCLIN G1; PROTEIN; DOWNSTREAM; KNOCKDOWN; FAMILY; SEQ; DIFFERENTIATION; CONVERGENCE	Transcriptome analysis is a powerful tool to obtain large amount genome-scale gene expression profiles. Despite its extensive usage to diverse biological problems in the last decade, transcriptomic researches approaching the zebrafish embryonic development have been very limited. Several recent studies have made great progress in this direction, yet the large gap still exists, especially regarding to the transcriptome dynamics of embryonic stages from early gastrulation onwards. Here, we present a comprehensive analysis about the transcriptomes of 9 different stages covering 7 major periods (cleavage, blastula, gastrula, segmentation, pharyngula, hatching and early larval stage) in zebrafish development, by recruiting the RNA-sequencing technology. We detected the expression for at least 24,065 genes in at least one of the 9 stages. We identified 16,130 genes that were significantly differentially expressed between stages and were subsequently classified into six clusters. Each revealed gene cluster had distinct expression patterns and characteristic functional pathways, providing a framework for the understanding of the developmental transcriptome dynamics. Over 4000 genes were identified as preferentially expressed in one of the stages, which could be of high relevance to stage-specific developmental and molecular events. Among the 68 transcription factor families active during development, most had enhanced average expression levels and thus might be crucial for embryogenesis, whereas the inactivation of the other families was likely required by the activation of the zygotic genome. We discussed our RNA-seq data together with previous findings about the Wnt signaling pathway and some other genes with known functions, to show how our data could be used to advance our understanding about these developmental functional elements. Our study provides ample information for further study about the molecular and cellular mechanisms underlying vertebrate development.	[Yang, Hongxing; Xie, Shuying; Zhu, Genfeng; Wang, Lei; Huang, Jiyue; Ma, Hong] Fudan Univ, State Key Lab Genet Engn, Inst Plant Biol, Ctr Evolutionary Biol,Sch Life Sci, Shanghai 200433, Peoples R China; [Zhou, Yan; Gu, Jianlei] Fudan Univ, State Key Lab Genet Engn, Dept Microbiol, Sch Life Sci, Shanghai 200433, Peoples R China; [Xu, Yao; Yao, Jihua] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Ma, Hong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ma, H (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Plant Biol, Ctr Evolutionary Biol,Sch Life Sci, Shanghai 200433, Peoples R China.	hongma@fudan.edu.cn; yaojh@fudan.edu.cn	Ma, Hong/W-5251-2018; Gu, Jianlei/ABD-5512-2020; Huang, Jiyue/AAL-8416-2021	Ma, Hong/0000-0001-8717-4422; Huang, Jiyue/0000-0002-7185-4201; Gu, Jian-lei/0000-0002-9337-5017	National Basic Research Program of China [2011CB943804, 2012CB944603]; Fudan University	National Basic Research Program of China(National Basic Research Program of China); Fudan University	This work was supported by grants from the National Basic Research Program of China (2011CB943804 and 2012CB944603) and funds from Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Angotzi AR, 2011, GEN COMP ENDOCR, V171, P332, DOI 10.1016/j.ygcen.2011.02.026; Argenton F, 2004, MECH DEVELOP, V121, P131, DOI 10.1016/j.mod.2004.01.001; Assou S, 2011, HUM REPROD UPDATE, V17, P272, DOI 10.1093/humupd/dmq036; Becknell B, 2005, ADV IMMUNOL, V86, P209, DOI 10.1016/S0065-2776(04)86006-1; Bei JX, 2006, MOL IMMUNOL, V43, P860, DOI 10.1016/j.molimm.2005.06.040; Bellipanni G, 2010, J CELL PHYSIOL, V222, P286, DOI 10.1002/jcp.21944; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Cheesman SE, 2004, GENE EXPR PATTERNS, V5, P107, DOI 10.1016/j.modgep.2004.05.006; Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Duffy KT, 2005, NUCLEIC ACIDS RES, V33, P4914, DOI 10.1093/nar/gki799; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; FOURNIER A, 2011, BRIEF FUNCT GENOMICS; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Gardiner MR, 2005, DEV DYNAM, V234, P992, DOI 10.1002/dvdy.20571; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Gregory R.W., 2011, GPLOTS VARIOUS R PRO; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Harrison MRM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-24; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Itoh M, 2002, DEVELOPMENT, V129, P2317; Jin J, 2010, DEV DYNAM, V239, P2426, DOI 10.1002/dvdy.22369; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim HS, 2007, NEUROSCI LETT, V414, P26, DOI 10.1016/j.neulet.2006.12.027; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkel MD, 2008, DEVELOPMENT, V135, P919, DOI 10.1242/dev.010660; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Ko MSH, 2006, DEV DYNAM, V235, P2437, DOI 10.1002/dvdy.20859; Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu GZ, 2007, MOL IMMUNOL, V44, P1190, DOI 10.1016/j.molimm.2006.06.024; Lo J, 2003, GENOME RES, V13, P455, DOI 10.1101/gr.885403; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Moleri S, 2011, GENE EXPR PATTERNS, V11, P3, DOI 10.1016/j.gep.2010.08.006; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; Norton WH, 2005, DEVELOPMENT, V132, P645, DOI 10.1242/dev.01611; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pezeron G, 2006, GENE EXPR PATTERNS, V6, P835, DOI 10.1016/j.modgep.2006.02.002; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Pollard KM, 2011, J IMMUNOTOXICOL, V8, P228, DOI 10.3109/1547691X.2011.583614; Prykhozhij SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013549; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Renninger SL, 2011, EUR J NEUROSCI, V33, P658, DOI 10.1111/j.1460-9568.2010.07574.x; Rinner O, 2005, NEURON, V47, P231, DOI 10.1016/j.neuron.2005.06.010; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scholpp S, 2007, DEVELOPMENT, V134, P3167, DOI 10.1242/dev.001461; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Shen YC, 2004, DEV BIOL, V269, P237, DOI 10.1016/j.ydbio.2004.01.037; Sisson BE, 2009, GENE EXPR PATTERNS, V9, P520, DOI 10.1016/j.gep.2009.07.003; Smith L, 2003, HUM MOL GENET, V12, pR1, DOI 10.1093/hmg/ddg053; Stearns G, 2007, J NEUROSCI, V27, P13866, DOI 10.1523/JNEUROSCI.3136-07.2007; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Team RDC, 2019, R LANG ENV STAT COMP; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022555; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X; Yarden A, 1996, DEV DYNAM, V206, P1; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Y, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-7; Zhao L, 2003, MOL CANCER RES, V1, P195; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	105	123	124	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e64058	10.1371/journal.pone.0064058	http://dx.doi.org/10.1371/journal.pone.0064058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700457	Green Published, gold, Green Submitted			2022-12-25	WOS:000319966400047
J	Debieu, M; Tang, C; Stich, B; Sikosek, T; Effgen, S; Josephs, E; Schmitt, J; Nordborg, M; Koornneef, M; de Meaux, J				Debieu, Marilyne; Tang, Chunlao; Stich, Benjamin; Sikosek, Tobias; Effgen, Sigi; Josephs, Emily; Schmitt, Johanna; Nordborg, Magnus; Koornneef, Maarten; de Meaux, Juliette			Co-Variation between Seed Dormancy, Growth Rate and Flowering Time Changes with Latitude in Arabidopsis thaliana	PLOS ONE			English	Article							NATURAL ALLELIC VARIATION; GENOME-WIDE ASSOCIATION; LIFE-HISTORY; GENETIC-VARIATION; CLINAL VARIATION; PLANT-GROWTH; LOCUS-C; GERMINATION; ADAPTATION; SELECTION	Life-history traits controlling the duration and timing of developmental phases in the life cycle jointly determine fitness. Therefore, life-history traits studied in isolation provide an incomplete view on the relevance of life-cycle variation for adaptation. In this study, we examine genetic variation in traits covering the major life history events of the annual species Arabidopsis thaliana: seed dormancy, vegetative growth rate and flowering time. In a sample of 112 genotypes collected throughout the European range of the species, both seed dormancy and flowering time follow a latitudinal gradient independent of the major population structure gradient. This finding confirms previous studies reporting the adaptive evolution of these two traits. Here, however, we further analyze patterns of co-variation among traits. We observe that co-variation between primary dormancy, vegetative growth rate and flowering time also follows a latitudinal cline. At higher latitudes, vegetative growth rate is positively correlated with primary dormancy and negatively with flowering time. In the South, this trend disappears. Patterns of trait co-variation change, presumably because major environmental gradients shift with latitude. This pattern appears unrelated to population structure, suggesting that changes in the coordinated evolution of major life history traits is adaptive. Our data suggest that A. thaliana provides a good model for the evolution of trade-offs and their genetic basis.	[Debieu, Marilyne] CNRS UMR2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France; [Debieu, Marilyne; Effgen, Sigi; Koornneef, Maarten; de Meaux, Juliette] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Tang, Chunlao] Univ So Calif, Los Angeles, CA USA; [Stich, Benjamin] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Sikosek, Tobias; de Meaux, Juliette] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Josephs, Emily] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Schmitt, Johanna] Univ Calif Davis, Davis, CA USA; [Nordborg, Magnus] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Koornneef, Maarten] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Max Planck Society; University of Southern California; Max Planck Society; University of Munster; Brown University; University of California System; University of California Davis; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Wageningen University & Research	Debieu, M (corresponding author), CNRS UMR2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France.	marilyne.debieu@gmail.com	Sikosek, Tobias/E-4939-2014	Sikosek, Tobias/0000-0001-9929-3525; de Meaux, Juliette/0000-0002-2942-4750; Nordborg, Magnus/0000-0001-7178-9748; Koornneef, Maarten/0000-0002-7759-4869	Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft [SFB680]	Max Planck Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max Planck Gesellschaft and the Deutsche Forschungsgemeinschaft (SFB680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1992, J ECOL, V80, P109, DOI 10.2307/2261067; Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baskin CC, 1998, SEEDS, P1, DOI 10.1016/B978-012080260-9/50001-4; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; BASKIN JM, 1983, BOT GAZ, V144, P540, DOI 10.1086/337408; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Burke S, 2005, ECOL ENTOMOL, V30, P613, DOI 10.1111/j.0307-6946.2005.00741.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; GEBER MA, 1990, EVOLUTION, V44, P799, DOI 10.1111/j.1558-5646.1990.tb03806.x; Griffith C, 2004, AM J BOT, V91, P837, DOI 10.3732/ajb.91.6.837; GROSS KL, 1991, OECOLOGIA, V87, P270, DOI 10.1007/BF00325266; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Hoffmann MH, 2005, EVOLUTION, V59, P1425; Hopkins R, 2008, NEW PHYTOL, V179, P155, DOI 10.1111/j.1469-8137.2008.02447.x; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KALISZ S, 1989, EVOLUTION, V43, P1263, DOI 10.1111/j.1558-5646.1989.tb02573.x; KING D, 1982, THEOR POPUL BIOL, V22, P1, DOI 10.1016/0040-5809(82)90032-6; Kivela SM, 2009, AM NAT, V174, P526, DOI 10.1086/605371; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; MASUDA M, 1992, OECOLOGIA, V89, P42, DOI 10.1007/BF00319013; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; MCGRAW JB, 1990, TRENDS ECOL EVOL, V5, P251, DOI 10.1016/0169-5347(90)90065-L; Mendez-Vigo B, 2011, PLANT PHYSIOL, V157, P1942, DOI 10.1104/pp.111.183426; Meng PH, 2008, MOL PLANT, V1, P145, DOI 10.1093/mp/ssm014; Metcalf CJE, 2009, ECOL LETT, V12, P593, DOI 10.1111/j.1461-0248.2009.01320.x; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; Montesinos A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007213; Montesinos-Navarro A, 2012, EVOLUTION, V66, P3417, DOI 10.1111/j.1558-5646.2012.01689.x; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Perez-Perez JM, 2002, GENETICS, V162, P893; Pritchard JK, 2000, GENETICS, V155, P945; Rees M, 2006, AM NAT, V168, pE53, DOI 10.1086/505762; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rutter MT, 2007, ANN BOT-LONDON, V99, P529, DOI 10.1093/aob/mcl282; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Samis KE, 2012, ECOL EVOL, V2, P1162, DOI 10.1002/ece3.262; Schmuths H, 2006, ANN BOT-LONDON, V97, P623, DOI 10.1093/aob/mcl012; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stearns S.C., 1992, pi; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stratton DA, 1998, HEREDITY, V81, P144, DOI 10.1046/j.1365-2540.1998.00369.x; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Wagmann K, 2012, ANN BOT, P1; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weinig C, 2002, GENETICS, V162, P1875; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	80	171	182	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e61075	10.1371/journal.pone.0061075	http://dx.doi.org/10.1371/journal.pone.0061075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24349402	Green Published, Green Submitted, gold			2022-12-25	WOS:000319435600002
J	Liu, YX; Wang, XJ; Liu, YX; Sun, DP; Ding, SJ; Zhang, BB; Du, ZH; Xue, FZ				Liu, Yunxia; Wang, Xianjun; Liu, Yanxun; Sun, Dapeng; Ding, Shujun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong			Detecting Spatial-Temporal Clusters of HFMD from 2007 to 2011 in Shandong Province, China	PLOS ONE			English	Article							MOUTH-DISEASE; FOOT; HAND; OUTBREAK; ONYCHOMADESIS; EPIDEMIOLOGY; INFECTIONS; CITY	Background: Hand, foot, and mouth disease (HFMD) has caused major public health concerns worldwide, and has become one of the leading causes of children death. China is the most serious epidemic area with a total of 3,419,149 reported cases just from 2008 to 2010, and its different geographic areas might have different spatial epidemiology characteristics at different spatial-temporal scale levels. We conducted spatial and spatial-temporal epidemiology analysis to HFMD at county level in Shandong Province, China. Methods: Based on the China National Disease Surveillance Reporting and Management System, the spatial-temporal database of HFMD from 2007 to 2011 was built. The global autocorrelation statistic (Moran's I) was first used to detect the spatial autocorrelation of HFMD cases in each year. Purely Spatial scan statistics combined with Space-time scan statistic were used to detect epidemic clusters. Results: The annual average incidence rate was 93.70 per 100,000 in Shandong Province. Most HFMD cases (93.94%) were aged within 0-5 years old with an average male-to-female sex ratio 1.71, and the incidence seasonal peak was between April and July. The dominant pathogen was EV71 (47.35%), and CoxA16 (26.59%). HFMD had positive spatial autocorrelation at medium spatial scale level (county level) with higher Moran's I from 0.31 to 0.62 (P<0.001). Seven spatial-temporal clusters were detected from 2007 to 2011 in the landscape of the whole Shandong, with EV71 or CoxA16 as the dominant pathogen for most hotspots areas. Conclusions: The spatial-temporal clusters of HFMD wandered around the whole Shandong Province during 2007 to 2011, with EV71 or CoxA16 as the dominant pathogen. These findings suggested that a real-time spatial-temporal surveillance system should be established for identifying high incidence region and conducting prevention to HFMD timely.	[Liu, Yunxia; Liu, Yanxun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Wang, Xianjun; Sun, Dapeng; Ding, Shujun] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Shandong University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81001292]; Shandong Province science and technology development plan [2009GG10002055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province science and technology development plan	This work was supported by No.81001292 of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm), 2009GG10002055 of Shandong Province science and technology development plan in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Anselin L, 2004, GEODA0 95I RELEASE N; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Cao Li-Hua, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P227; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Ministry of Health, 2008, HAND FOOT MOUTH DIS; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu Wen-dong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P813; Ma E, 2010, JPN J INFECT DIS, V63, P422; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Tang Xian-yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P274; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	36	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63447	10.1371/journal.pone.0063447	http://dx.doi.org/10.1371/journal.pone.0063447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	24098769	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200039
J	Yang, HA; Tao, Y; Zheng, ZQ; Zhang, QS; Zhou, GF; Sweetingham, MW; Howieson, JG; Li, CD				Yang, Huaan; Tao, Ye; Zheng, Zequn; Zhang, Qisen; Zhou, Gaofeng; Sweetingham, Mark W.; Howieson, John G.; Li, Chengdao			Draft Genome Sequence, and a Sequence-Defined Genetic Linkage Map of the Legume Crop Species Lupinus angustifolius L.	PLOS ONE			English	Article							ANTHRACNOSE DISEASE RESISTANCE; MARKER-ASSISTED SELECTION; MOLECULAR MARKERS; PCR MARKERS; CONFERRING RESISTANCE; DOMESTICATION GENES; DIAPORTHE-TOXICA; KERNEL FIBER; DE-NOVO; CONSTRUCTION	Lupin (Lupinus angustifolius L.) is the most recently domesticated crop in major agricultural cultivation. Its seeds are high in protein and dietary fibre, but low in oil and starch. Medical and dietetic studies have shown that consuming lupin-enriched food has significant health benefits. Were port the draft assembly from a whole genome shotgun sequencing dataset for this legume species with 26.9x coverage of the genome, which is predicted to contain 57,807 genes. Analysis of the annotated genes with metabolic pathways provided a partial understanding of some key features of lupin, such as the amino acid profile of storage proteins in seeds. Furthermore, we applied the NGS-based RAD-sequencing technology to obtain 8,244 sequence-defined markers for anchoring the genomic sequences. A total of 4,214 scaffolds from the genome sequence assembly were aligned into the genetic map. The combination of the draft assembly and a sequence-defined genetic map made it possible to locate and study functional genes of agronomic interest. The identification of co-segregating SNP markers, scaffold sequences and gene annotation facilitated the identification of a candidate R gene associated with resistance to the major lupin disease anthracnose. We demonstrated that the combination of medium-depth genome sequencing and a high-density genetic linkage map by application of NGS technology is a cost-effective approach to generating genome sequence data and a large number of molecular markers to study the genomics, genetics and functional genes of lupin, and to apply them to molecular plant breeding. This strategy does not require prior genome knowledge, which potentiates its application to a wide range of non-model species.	[Yang, Huaan; Zhang, Qisen; Zhou, Gaofeng; Sweetingham, Mark W.; Li, Chengdao] Dept Agr & Food Western Australia, S Perth, WA, Australia; [Tao, Ye; Zheng, Zequn] Beijing Genome Inst, Shenzhen, Peoples R China; [Howieson, John G.] Murdoch Univ, Ctr Rhizobium Studies, Murdoch, WA 6150, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; Beijing Genomics Institute (BGI); Murdoch University	Li, CD (corresponding author), Dept Agr & Food Western Australia, S Perth, WA, Australia.	chengdao.li@agric.wa.gov.au	Ma, Hong/W-5251-2018; Gu, Jianlei/ABD-5512-2020; Huang, Jiyue/AAL-8416-2021	Ma, Hong/0000-0001-8717-4422; Huang, Jiyue/0000-0002-7185-4201; Gu, Jian-lei/0000-0002-9337-5017	Department of Agriculture and Food Western Australia (DAFWA) through the Consolidated Fund; Murdoch University through the Research Capacity Fund; Grains Research and Development Corporation (GRDC) of Australia [DAW00170]	Department of Agriculture and Food Western Australia (DAFWA) through the Consolidated Fund; Murdoch University through the Research Capacity Fund; Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp)	This work was jointly funded by Department of Agriculture and Food Western Australia (DAFWA) through the Consolidated Fund to HY, QZ, MWS and CL, Beijing Genome Institute (BGI) for providing the facility and reagents on genome sequencing and RAD sequencing, Murdoch University through the Research Capacity Fund to JGW, and the Grains Research and Development Corporation (GRDC) of Australia through the funding of research project DAW00170 to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer BJ, 2004, BRIT J NUTR, V91, P591, DOI 10.1079/BJN20031088; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bhat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039181; Boersma JG, 2007, PLANT BREEDING, V126, P612, DOI 10.1111/j.1439-0523.2007.01417.x; Boersma JG, 2007, PLANT BREEDING, V126, P306, DOI 10.1111/j.1439-0523.2007.01347.x; Boersma JG, 2007, GENET MOL BIOL, V30, P623, DOI 10.1590/S1415-47572007000400020; Boersma J, 2009, MOL BREEDING, V23, P259, DOI 10.1007/s11032-008-9230-2; Boersma JG, 2005, CELL MOL BIOL LETT, V10, P331; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Collins NC, 1998, MOL PLANT MICROBE IN, V11, P968, DOI 10.1094/MPMI.1998.11.10.968; Eagles HA, 2001, AUST J AGR RES, V52, P1349, DOI 10.1071/AR01067; Foley RC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-59; Gao LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-521; GLADSTONES J. S., 1970, Field Crop Abstracts, V23, P123; Haiminen N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-194; Hall RS, 2005, ASIA PAC J CLIN NUTR, V14, P91; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Howieson John G., 1998, P149; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Ilgoutz SC, 1997, PLANT MOL BIOL, V34, P613, DOI 10.1023/A:1005868105651; Islam S, 2011, CROP PASTURE SCI, V62, P765, DOI 10.1071/CP11046; Johnson SK, 2006, BRIT J NUTR, V95, P372, DOI 10.1079/BJN20051648; Lee YP, 2006, AM J CLIN NUTR, V84, P975, DOI 10.1093/ajcn/84.5.975; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2011, CROP PASTURE SCI, V62, P218, DOI 10.1071/CP10352; Li X, 2012, PLANT BREEDING, V131, P540, DOI 10.1111/j.1439-0523.2012.01978.x; Li X, 2012, MOL BREEDING, V29, P361, DOI 10.1007/s11032-011-9552-3; Li X, 2010, EUPHYTICA, V176, P49, DOI 10.1007/s10681-010-0212-1; Lin RM, 2009, MOL BREEDING, V23, P153, DOI 10.1007/s11032-008-9222-2; Lovati MR, 2012, BRIT J NUTR, V107, P67, DOI 10.1017/S0007114511002601; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Molnar SJ, 2000, GENOME, V43, P224, DOI 10.1139/gen-43-2-224; Naganowska B, 2003, ANN BOT-LONDON, V92, P349, DOI 10.1093/aob/mcg145; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Nelson MN, 2010, DNA RES, V17, P73, DOI 10.1093/dnares/dsq001; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2008, CURR OPIN PL BIOL, V1, P123; SENGBUSCH R. von., 1942, Landwirtschaftliche Jahrbucher, V91, P719; Shankar M, 1996, PHYTOPATHOLOGY, V86, P692, DOI 10.1094/Phyto-86-692; Sharp PJ, 2001, AUST J AGR RES, V52, P1357, DOI 10.1071/AR01052; Swiecicki Wiktor, 1995, Journal of Applied Genetics, V36, P155; van Barneveld RJ, 1999, NUTR RES REV, V12, P203, DOI 10.1079/095442299108728938; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Wasche A, 2001, NAHRUNG, V45, P393, DOI 10.1002/1521-3803(20011001)45:6<393::AID-FOOD393>3.0.CO;2-O; Yang H, 2004, MOL BREEDING, V14, P145, DOI 10.1023/B:MOLB.0000038003.49638.97; Yang H, 2002, THEOR APPL GENET, V105, P265, DOI 10.1007/s00122-002-0925-1; Yang H, 2001, MOL BREEDING, V7, P203, DOI 10.1023/A:1011363205557; Yang HA, 1998, AUST J AGR RES, V49, P1213, DOI 10.1071/A98074; Yang H, 2008, MOL BREEDING, V21, P473, DOI 10.1007/s11032-007-9146-2; Yang HA, 2013, THEOR APPL GENET, V126, P511, DOI 10.1007/s00122-012-1997-1; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; You M, 2005, CELL MOL BIOL LETT, V10, P123	62	123	124	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e64799	10.1371/journal.pone.0064799	http://dx.doi.org/10.1371/journal.pone.0064799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23700457	gold, Green Published, Green Submitted			2022-12-25	WOS:000319725500047
J	Liang, HY; Hussey, SE; Sanchez-Avila, A; Tantiwong, P; Musi, N				Liang, Hanyu; Hussey, Sophie E.; Sanchez-Avila, Alicia; Tantiwong, Puntip; Musi, Nicolas			Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle	PLOS ONE			English	Article							LPS-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETIC SUBJECTS; HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; RESISTANCE; GLUCOSE; SENSITIVITY; ENDOTOXEMIA; OBESITY	Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR) 4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.	[Liang, Hanyu; Hussey, Sophie E.; Sanchez-Avila, Alicia; Tantiwong, Puntip; Musi, Nicolas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Liang, Hanyu; Hussey, Sophie E.; Tantiwong, Puntip; Musi, Nicolas] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Audie L Murphy Div, San Antonio, TX USA; [Liang, Hanyu; Hussey, Sophie E.; Tantiwong, Puntip; Musi, Nicolas] Texas Diabet Inst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Musi, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	musi@uthscsa.edu		Liang, Huiying/0000-0002-9987-8002	National Institutes of Health [RO1-DK80157, RO1- DK089229, TR000149, 1F32DK095565-01A1]; American Diabetes Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095565, R01DK089229, R01DK080157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RO1-DK80157 and RO1- DK089229 to N.M., TR000149 to UTHSCSA, and 1F32DK095565-01A1 to S.H.) and the American Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Alhusaini S, 2010, BIOCHEM BIOPH RES CO, V397, P472, DOI 10.1016/j.bbrc.2010.05.138; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Bouzakri K, 2008, DIABETES, V57, P1508, DOI 10.2337/db07-0583; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Frisard MI, 2010, AM J PHYSIOL-ENDOC M, V298, pE988, DOI 10.1152/ajpendo.00307.2009; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gubern C, 2006, DIABETES, V55, P216, DOI 10.2337/diabetes.55.1.216; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Laugerette F, 2011, BIOCHIMIE, V93, P39, DOI 10.1016/j.biochi.2010.04.016; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nieto-Vazquez I, 2008, DIABETES, V57, P3211, DOI 10.2337/db07-1062; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Sun LA, 2010, DIABETES CARE, V33, P1925, DOI 10.2337/dc10-0340; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van der Crabben SN, 2009, J CLIN ENDOCR METAB, V94, P463, DOI 10.1210/jc.2008-0761; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	39	113	119	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63983	10.1371/journal.pone.0063983	http://dx.doi.org/10.1371/journal.pone.0063983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23704966	gold, Green Published, Green Submitted			2022-12-25	WOS:000319330200098
J	Zhang, XP; Wang, H; Duvernay, MT; Zhu, S; Wu, GY				Zhang, Xiaoping; Wang, Hong; Duvernay, Matthew T.; Zhu, Shu; Wu, Guangyu			The Angiotensin II Type 1 Receptor C-Terminal Lys Residues Interact with Tubulin and Modulate Receptor Export Trafficking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; CARDIAC MYOCYTES; ALPHA(2)-ADRENERGIC RECEPTORS; ANTEROGRADE TRAFFICKING; ADRENERGIC-RECEPTORS; INTRACELLULAR LOOP; ADENYLYL-CYCLASE	The physiological and pathological functions of angiotensin II are largely mediated through activating the cell surface angiotensin II type 1 receptor (AT1R). However, the molecular mechanisms underlying the transport of newly synthesized AT1R from the endoplasmic reticulum (ER) to the cell surface remain poorly defined. Here we demonstrated that the C-terminus (CT) of AT1R directly and strongly bound to tubulin and the binding domains were mapped to two consecutive Lys residues at positions 310 and 311 in the CT membrane-proximal region of AT1R and the acidic CT of tubulin, suggestive of essentially ionic interactions between AT1R and tubulin. Furthermore, mutation to disrupt tubulin binding dramatically inhibited the cell surface expression of AT1R, arrested AT1R in the ER, and attenuated AT1R-mediated signaling measured as ERK1/2 activation. These data demonstrate for the first time that specific Lys residues in the CT juxtamembrane region regulate the processing of AT1R through interacting with tubulin. These data also suggest an important role of the microtubule network in the cell surface transport of AT1R.	[Zhang, Xiaoping; Wang, Hong; Duvernay, Matthew T.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Wang, Hong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhu, Shu; Wu, Guangyu] Georgia Regents Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; University System of Georgia; Augusta University	Wu, GY (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA.	guwu@gru.edu	zhang, xiaoping/G-9688-2013; Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	National Institutes of Health grant [R01GM076167]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant R01GM076167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Ciruela F, 2001, J NEUROCHEM, V76, P750, DOI 10.1046/j.1471-4159.2001.00099.x; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Duvernay MT, 2011, J BIOL CHEM, V286, P14080, DOI 10.1074/jbc.M111.222323; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050416; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MIZUNO M, 1994, J CELL SCI, V107, P1321; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; POPOVA JS, 1994, J BIOL CHEM, V269, P21748; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SADOSHIMA J, 1995, CIRC RES, V76, P1; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; SARASTE J, 1991, J CELL SCI, V100, P415; Sarma T, 2003, FASEB J, V17, P848, DOI 10.1096/fj.02-0730com; Saugstad JA, 2002, J NEUROCHEM, V80, P980, DOI 10.1046/j.0022-3042.2002.00778.x; Saunders C, 2000, MOL PHARMACOL, V57, P44; Saunders C, 1997, J BIOL CHEM, V272, P19035, DOI 10.1074/jbc.272.30.19035; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Touyz RM, 2000, PHARMACOL REV, V52, P639; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Yin HJ, 2011, INT J BIOCHEM CELL B, V43, P401, DOI 10.1016/j.biocel.2010.11.010; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014	51	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57805	10.1371/journal.pone.0057805	http://dx.doi.org/10.1371/journal.pone.0057805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451270	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500135
J	Liu, Y; Miao, W; Wang, JQ; Gao, PY; Yin, GH; Zhang, LP; Lv, CK; Ji, ZY; Yu, T; Sabel, BA; He, HG; Peng, Y				Liu, Yue; Miao, Wen; Wang, Jieqiong; Gao, Peiyi; Yin, Guangheng; Zhang, Liping; Lv, Chuankai; Ji, Zhiying; Yu, Tong; Sabel, B. A.; He, Huiguang; Peng, Yun			Structural Abnormalities in Early Tourette Syndrome Children: A Combined Voxel-Based Morphometry and Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							TIC SEVERITY; FRONTAL-LOBE; BRAIN; VOLUMES; CONNECTIVITY; LOCALIZATION; INHIBITION; PREVALENCE; ATTENTION; SYSTEM	Tourette Syndrome (TS) is characterized with chronic motor and vocal tics beginning in childhood. Abnormality of both gray (GM) and white matter (WM) has been observed in cortico-striato-thalamo-cortical circuits and sensory-motor cortex of adult TS patient. It is not clear if these morphological changes are also present in TS children and if there are any microstructural changes of WM. To understand the developmental cause of such changes, we investigated volumetric changes of GM and WM using VBM and microstructural changes of WM using DTI, and correlated these changes with tic severity and duration. T1 images and Diffusion Tensor Images (DTI) from 21 TS children were compared with 20 age and gender matched health control children using a 1.5T Philips scanner. All of the 21 TS children met the DSM-IV-TR criteria. T1 images were analyzed using DARTEL-VBM in conjunction with statistical parametric mapping (SPM). Diffusion tensor imaging (DTI) analysis was performed using Tract-Based Spatial Statistics (TBSS). Brain volume changes were found in left superior temporal gyrus, left and right paracentral gyrus, right precuneous cortex, right pre- and post-central gyrus, left temporal occipital fusiform cortex, right frontal pole, and left lingual gyrus. Significant axial diffusivity (AD) and mean diffusivity (MD) increases were found in anterior thalamic radiation, right cingulum bundle projecting to the cingulate gurus and forceps minor. Decreases in white matter volume (WMV) in the right frontal pole were inversely related with tic severity (YGTSS), and increases in AD and MD were positively correlated with tic severity and duration, respectively. These changes in TS children can be interpreted as signs of neural plasticity in response to the experiential demand. Our findings may suggest that the morphological and microstructural measurements from structural MRI and DTI can potentially be used as a biomarker of the pathophysiologic pattern of early TS children.	[Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Miao, Wen; Wang, Jieqiong; Sabel, B. A.; He, Huiguang] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Key Lab Magnet Imaging Device & Tech, Beijing Childrens Hosp, Beijing, Peoples R China; [Gao, Peiyi] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Zhang, Liping; Ji, Zhiying] Capital Med Univ, Dept Med, Beijing Childrens Hosp, Beijing, Peoples R China; [Sabel, B. A.] Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany	Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University; Capital Medical University; Otto von Guericke University	He, HG (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	huiguang.he@ia.ac.cn; ppengyun@yahoo.com	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [61271151, 61228103, 31271161]; capital health research and development of special [2011-2009-03]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); capital health research and development of special; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China (61271151, 61228103, and 31271161) and the capital health research and development of special (2011-2009-03). SB was partly supported by Chinese Academy of Sciences Senior Visiting Professorships Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bloch MH, 2005, NEUROLOGY, V65, P1253, DOI 10.1212/01.wnl.0000180957.98702.69; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Boroojerdi B, 1999, BRIT J PSYCHIAT, V175, P375, DOI 10.1192/bjp.175.4.375; CDE MR, 2011, MULT SCLER INT, V2011, P4875; COMINGS DE, 1984, AM J HUM GENET, V36, P586; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Draganski B, 2010, BRAIN, V133, P3661, DOI 10.1093/brain/awq300; Fahim C, 2009, BRAIN TOPOGR, V22, P176, DOI 10.1007/s10548-009-0105-6; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Fredericksen KA, 2002, NEUROLOGY, V58, P85, DOI 10.1212/WNL.58.1.85; Gerard E, 2003, J PSYCHOSOM RES, V55, P13, DOI 10.1016/S0022-3999(02)00581-0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hugdahl K, 1998, BEHAV BRAIN SCI, V21, P335, DOI 10.1017/S0140525X98301211; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lucas A R, 1982, Adv Neurol, V35, P267; Makki MI, 2008, MOVEMENT DISORD, V23, P2349, DOI 10.1002/mds.22264; Marsh R, 2007, AM J PSYCHIAT, V164, P955, DOI 10.1176/appi.ajp.164.6.955; Mason A, 1998, DEV MED CHILD NEUROL, V40, P292; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Neuner I, 2010, NEUROIMAGE, V51, P1184, DOI 10.1016/j.neuroimage.2010.02.049; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Plessen KJ, 2004, AM J PSYCHIAT, V161, P2028, DOI 10.1176/appi.ajp.161.11.2028; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Rueda MR, 2005, DEV NEUROPSYCHOL, V28, P573, DOI 10.1207/s15326942dn2802_2; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schiffer B, 2007, J PSYCHIATR RES, V41, P753, DOI 10.1016/j.jpsychires.2006.06.003; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Singer HS, 2005, LANCET NEUROL, V4, P149, DOI 10.1016/S1474-4422(05)01012-4; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Stern JS, 2005, POSTGRAD MED J, V81, P12, DOI 10.1136/pgmj.2004.023614; STOKES A, 1991, PEDIATRICS, V87, P936; Thomalla G, 2009, BRAIN, V132, P765, DOI 10.1093/brain/awn339; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011	50	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76105	10.1371/journal.pone.0076105	http://dx.doi.org/10.1371/journal.pone.0076105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098769	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500139
J	Szema, AM; Hamidi, SA; Smith, SD; Benveniste, H				Szema, Anthony M.; Hamidi, Sayyed A.; Smith, S. David; Benveniste, Helene			VIP Gene Deletion in Mice Causes Cardiomyopathy Associated with Upregulation of Heart Failure Genes	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SMOOTH-MUSCLE-CELLS; CARDIAC TROPONIN-T; ALPHA-TROPOMYOSIN; PROLIFERATION; MUTATION; LACKING; TRANSITION	Rationale: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular smooth muscle proliferation, is absent in pulmonary arteries of patients with idiopathic pulmonary arterial hypertension (PAH). We previously determined that targeted deletion of the VIP gene in mice leads to PAH with pulmonary vascular remodeling and right ventricular (RV) dilatation. Whether the left ventricle is also affected by VIP gene deletion is unknown. In the current study, we examined if VIP knockout mice (VIP-/-) develop both right (RV) and left ventricular (LV) cardiomyopathy, manifested by LV dilatation and systolic dysfunction, as well as overexpression of genes conducive to heart failure. Methods: We examined VIP-/- and wild type (WT) mice using Magnetic Resonance Imaging (MRI) for evidence of cardiomyopathy associated with biventricular dilation and wall thickness changes. Lung tissue from VIP-/- and WT mice was subjected to whole-genome gene microarray analysis. Results: Lungs from VIP-/- mice showed overexpression of cardiomyopathy genes: Myh1 was upregulated 224 times over WT, and Mylpf was increased 72 fold. Tnnt3 was increased 105 times and tnnc2 181 fold. Hearts were dilated in VIP-/- mice, with thinning of LV wall and increase in RV and LV chamber size, though RV enlargement varied. Weights of VIP-/- mice were consistently lower. Conclusions: Critically-important heart failure-related genes are upregulated in VIP-/- mice associated with the spontaneous cardiomyopathy phenotype, involving both left and right ventricles, suggesting that loss of the VIP gene orchestrates a panoply of pathogenic genes which are detrimental to both left and right cardiac homeostasis.	[Szema, Anthony M.; Hamidi, Sayyed A.] Vet Affairs Med Ctr, Northport, NY USA; [Szema, Anthony M.; Hamidi, Sayyed A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Smith, S. David] Brookhaven Natl Lab, Upton, NY 11973 USA; [Benveniste, Helene] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Benveniste, Helene] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Szema, AM (corresponding author), Vet Affairs Med Ctr, Northport, NY USA.	anthony.szema@stonybrookmedicine.edu		Curtis, Laura/0000-0003-2380-2201; Smith, Samuel/0000-0003-1983-4470; Von Wagner, Christian/0000-0002-7971-0691	National Institutes of Health (NIH) [K08 HL 071263]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL071263] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) K08 HL 071263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan B, 2010, ANATOL J CARDIOL, V10, P9, DOI 10.5152/akd.2010.114; ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Arad M, 2002, HUM MOL GENET, V11, P2499, DOI 10.1093/hmg/11.20.2499; Bronicki RA, 2010, PEDIATR CRIT CARE ME, V11, pS15, DOI 10.1097/PCC.0b013e3181c7671c; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Fujino N, 2002, AM J CARDIOL, V89, P29, DOI 10.1016/S0002-9149(01)02158-0; Haberl I, 2007, EUR J HUM GENET, V15, P18, DOI 10.1038/sj.ejhg.5201711; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim J, 1998, REGUL PEPTIDES, V75-6, P201, DOI 10.1016/S0167-0115(98)00069-X; Kokado H, 2000, CIRCULATION, V102, P663, DOI 10.1161/01.CIR.102.6.663; MARUNO K, 1995, AM J PHYSIOL-LUNG C, V268, pL1047, DOI 10.1152/ajplung.1995.268.6.L1047; McCann C, 2012, POSTGRAD MED J, V88, P271, DOI 10.1136/postgradmedj-2011-130292; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Miyata A, 1998, ANN NY ACAD SCI, V865, P73, DOI 10.1111/j.1749-6632.1998.tb11165.x; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; *NAT LIB MED, 2013, GEN HOM REF PULM ART; OISO Y, 1993, BIOCHEM CELL BIOL, V71, P156, DOI 10.1139/o93-025; Raiesdana A, 2006, ANN MED, V38, P95, DOI 10.1080/07853890600622143; Regitz-Zagrosek V, 2000, CIRCULATION, V102, pE112; Said SI, 2007, CIRCULATION, V115, P1260, DOI 10.1161/CIRCULATIONAHA.106.681718; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shedeed SA, 2010, PEDIATR CARDIOL, V31, P1008, DOI 10.1007/s00246-010-9753-2; St Hilaire RC, 2010, PEPTIDES, V31, P1517, DOI 10.1016/j.peptides.2010.04.024; Swetz KM, 2012, J HEART LUNG TRANSPL, V31, P1102, DOI 10.1016/j.healun.2012.08.010; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301	31	194	194	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e61449	10.1371/journal.pone.0061449	http://dx.doi.org/10.1371/journal.pone.0061449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	23700405	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400004
J	Zhang, XD; Qi, L; Wu, JC; Qin, ZH				Zhang, Xing-Ding; Qi, Lin; Wu, Jun-Chao; Qin, Zheng-Hong			DRAM1 Regulates Autophagy Flux through Lysosomes	PLOS ONE			English	Article							3-NITROPROPIONIC ACID; MITOCHONDRIAL TOXIN; CELL-DEATH; PROTEIN-DEGRADATION; INTRALYSOSOMAL PH; CORTICAL-NEURONS; RAT STRIATUM; H+-ATPASE; APOPTOSIS; ACTIVATION	We have previously reported that the mitochondria inhibitor 3-nitropropionic acid (3-NP), induces the expression of DNA damage-regulated autophagy modulator1 (DRAM1) and activation of autophagy in rat striatum. Although the role of DRAM1 in autophagy has been previously characterized, the detailed mechanism by which DRAM1 regulates autophagy activity has not been fully understood. The present study investigated the role of DRAM1 in regulating autophagy flux. In A549 cells expressing wilt-type TP53, 3-NP increased the protein levels of DRAM1 and LC3-II, whereas decreased the levels of SQSTM1 (sequestosome 1). The increase in LC3-II and decrease in SQSTM1 were blocked by the autophagy inhibitor 3-methyl-adenine. Lack of TP53 or knock-down of TP53 in cells impaired the induction of DRAM1. Knock-down of DRAM1 with siRNA significantly reduced 3-NP-induced upregulation of LC3-II and downregulation of SQSTM1, indicating DRAM1 contributes to autophagy activation. Knock-down of DRAM1 robustly decreased rate of disappearance of induced autophagosomes, increased RFP-LC3 fluorescence dots and decreased the decline of LC3-II after withdraw of rapamycin, indicating DRAM1 promotes autophagy flux. DRAM1 siRNA inhibited lysosomal V-ATPase and acidification of lysosomes. As a result, DRAM1 siRNA reduced activation of lysosomal cathepsin D. Similar to DRAM1 siRNA, lysosomal inhibitors E64d and chloroquine also inhibited clearance of autophagosomes and activation of lysosomal cathapsin D after 3-NP treatment. These data suggest that DRAM1 plays important roles in autophagy activation induced by mitochondria dysfunction. DRAM1 affects autophagy through argument of lysosomal acidification, fusion of lysosomes with autophagosomes and clearance of autophagosomes.	[Qin, Zheng-Hong] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Qin, ZH (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China.	zhqin5@hotmail.com	zhang, xiaoping/G-9688-2013; Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	National Natural Science Foundation of China [30930035]; National Basic Science Key Project (973 project) [CB510003]; Priority Academic Program development of Jiangsu Higher Education Institutes; Graduate Training Innovation Project of Jiangsu Province [CX09B_042Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Key Project (973 project)(National Basic Research Program of China); Priority Academic Program development of Jiangsu Higher Education Institutes; Graduate Training Innovation Project of Jiangsu Province	This work was partially supported by the National Natural Science Foundation of China (No 30930035), by the National Basic Science Key Project (973 project, CB510003), by the Priority Academic Program development of Jiangsu Higher Education Institutes, and by Graduate Training Innovation Project of Jiangsu Province (CX09B_042Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; BEAL MF, 1993, J NEUROSCI, V13, P4181; BEHRENS MI, 1995, NEUROREPORT, V6, P545, DOI 10.1097/00001756-199502000-00034; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; EZAKI J, 1992, J BIOCHEM, V112, P33, DOI 10.1093/oxfordjournals.jbchem.a123861; Galavotti S, 2013, ONCOGENE, V32, P699, DOI 10.1038/onc.2012.111; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; HOLTZMAN E, 1969, J CELL BIOL, V40, P863, DOI 10.1083/jcb.40.3.863; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim GW, 2002, J CEREBR BLOOD F MET, V22, P798, DOI 10.1097/00004647-200207000-00005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Layton GT, 2001, INFLAMM RES, V50, P400, DOI 10.1007/PL00000262; Leventhal L, 2000, J COMP NEUROL, V425, P471, DOI 10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Qin ZH, 1999, J NEUROSCI, V19, P4023; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SMITH ML, 1987, J BIOL CHEM, V262, P1244; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	7	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2013	8	5							e63245	10.1371/journal.pone.0063245	http://dx.doi.org/10.1371/journal.pone.0063245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RJ	23451270	Green Published, Green Submitted, gold			2022-12-25	WOS:000319107900030
J	Maire, V; Baldeyron, C; Richardson, M; Tesson, B; Vincent-Salomon, A; Gravier, E; Marty-Prouvost, B; De Koning, L; Rigaill, G; Dumont, A; Gentien, D; Barillot, E; Roman-Roman, S; Depil, S; Cruzalegui, F; Pierre, A; Tucker, GC; Dubois, T				Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.; Dubois, Thierry			TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer	PLOS ONE			English	Article							P53-DEPENDENT POSTMITOTIC CHECKPOINT; SPINDLE-ASSEMBLY CHECKPOINT; GENE-EXPRESSION PATTERNS; BASAL-LIKE CARCINOMAS; MOLECULAR PORTRAITS; MITOTIC CHECKPOINT; KINASE INHIBITORS; DNA-DAMAGE; MPS1; CELLS	Triple-negative breast cancer (TNBC) represents a subgroup of breast cancers (BC) associated with the most aggressive clinical behavior. No targeted therapy is currently available for the treatment of patients with TNBC. In order to discover potential therapeutic targets, we searched for protein kinases that are overexpressed in human TNBC biopsies and whose silencing in TNBC cell lines causes cell death. A cohort including human BC biopsies obtained at Institut Curie as well as normal tissues has been analyzed at a gene-expression level. The data revealed that the human protein kinase monopolar spindle 1 (hMPS1), also known as TTK and involved in mitotic checkpoint, is specifically overexpressed in TNBC, compared to the other BC subgroups and healthy tissues. We confirmed by immunohistochemistry and reverse phase protein array that TNBC expressed higher levels of TTK protein compared to the other BC subgroups. We then determined the biological effects of TTK depletion by RNA interference, through analyses of tumorigenic capacity and cell viability in different human TNBC cell lines. We found that RNAi-mediated depletion of TTK in various TNBC cell lines severely compromised their viability and their ability to form colonies in an anchorage-independent manner. Moreover, we observed that TTK silencing led to an increase in H2AX phosphorylation, activation of caspases 3/7, sub-G1 cell population accumulation and high annexin V staining, as well as to a decrease in G1 phase cell population and an increased aneuploidy. Altogether, these data indicate that TTK depletion in TNBC cells induces apoptosis. These results point out TTK as a protein kinase overexpressed in TNBC that may represent an attractive therapeutic target specifically for this poor prognosis associated subgroup of breast cancer.	[Maire, Virginie; Baldeyron, Celine; Richardson, Marion; Tesson, Bruno; Vincent-Salomon, Anne; Gravier, Eleonore; Marty-Prouvost, Berengere; De Koning, Leanne; Rigaill, Guillem; Dumont, Aurelie; Gentien, David; Barillot, Emmanuel; Roman-Roman, Sergio; Dubois, Thierry] Inst Curie, Res Ctr, Paris, France; [Maire, Virginie; Baldeyron, Celine; Tesson, Bruno; Marty-Prouvost, Berengere; Rigaill, Guillem; Dumont, Aurelie; Roman-Roman, Sergio; Dubois, Thierry] Dept Translat Res, Breast Canc Biol Grp, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] INSERM, U900, Paris, France; [Tesson, Bruno; Gravier, Eleonore; Rigaill, Guillem; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [De Koning, Leanne] RPPA Platform, Dept Translat Res, Paris, France; [Rigaill, Guillem] AgroParisTech, INRA, UMR 518, MIA, Paris, France; [Gentien, David] Dept Translat Res, Platform Mol Biol Facil, Paris, France; [Depil, Stephane; Cruzalegui, Francisco; Pierre, Alain; Tucker, Gordon C.] Inst Rech SERVIER, Oncol Res & Dev Unit, Croissy Sur Seine, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Servier; Institut de Recherches Internationales Servier	Dubois, T (corresponding author), Inst Curie, Res Ctr, Paris, France.	thierry.dubois@curie.fr	Gentien, David/O-9356-2019; Roman-Roman, Sergio/K-9993-2014; Baldeyron, Céline/F-6990-2019; Gentien, David/L-7757-2017; Soussana, Jean-Francois/P-2094-2016; Gross, Nicolas/I-2368-2016; Dubois, Thierry/D-2852-2017; Wright, Ian/G-4979-2012	Roman-Roman, Sergio/0000-0001-6459-2613; Baldeyron, Céline/0000-0003-2311-1523; Gentien, David/0000-0001-8317-5188; Soussana, Jean-Francois/0000-0002-1932-6583; Gross, Nicolas/0000-0001-9730-3240; Dubois, Thierry/0000-0003-4739-6164; Wright, Ian/0000-0001-8338-9143; Rigaill, Guillem/0000-0002-7176-7511; Maire, Vincent/0000-0002-3245-2568; BARILLOT, Emmanuel/0000-0003-2724-2002; Martin, Raphael/0000-0001-8778-7915	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa); Canceropole Ile de France	Institut de Recherches Servier; Institut Curie; grant of Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile de France(Region Ile-de-France)	This work was supported by Institut de Recherches Servier and Institut Curie. GR is supported by a grant of Institut National du Cancer (INCa) and LDK by a grant from Canceropole Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Azoulay S, 2005, MODERN PATHOL, V18, P1623, DOI 10.1038/modpathol.3800483; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Fadare O, 2008, NAT CLIN PRACT ONCOL, V5, P149, DOI 10.1038/ncponc1038; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kilpinen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015068; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; RIGAILL G, 2010, ARXIV10040887V1, P40887; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Thomson TA, 2001, MODERN PATHOL, V14, P1079, DOI 10.1038/modpathol.3880440; Thykjaer T, 2001, CANCER RES, V61, P2492; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; VALENTIN MD, 2012, BREAST CANC RES TREA; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zafrani B, 2000, HISTOPATHOLOGY, V37, P536, DOI 10.1046/j.1365-2559.2000.01006.x	71	118	120	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2013	8	6							e63712	10.1371/journal.pone.0063712	http://dx.doi.org/10.1371/journal.pone.0063712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158JQ	24130879	Green Published, Green Submitted, gold			2022-12-25	WOS:000319966400027
J	Ai, HS; Huang, LS; Ren, J				Ai, Huashui; Huang, Lusheng; Ren, Jun			Genetic Diversity, Linkage Disequilibrium and Selection Signatures in Chinese and Western Pigs Revealed by Genome-Wide SNP Markers	PLOS ONE			English	Article							B RECEPTOR GENE; DOMESTIC PIG; ADAPTATION; DELETION; TRAITS; ORIGIN; BREEDS; EXTENT	To investigate population structure, linkage disequilibrium (LD) pattern and selection signature at the genome level in Chinese and Western pigs, we genotyped 304 unrelated animals from 18 diverse populations using porcine 60 K SNP chips. We confirmed the divergent evolution between Chinese and Western pigs and showed distinct topological structures of the tested populations. We acquired the evidence for the introgression of Western pigs into two Chinese pig breeds. Analysis of runs of homozygosity revealed that historical inbreeding reduced genetic variability in several Chinese breeds. We found that intrapopulation LD extents are roughly comparable between Chinese and Western pigs. However, interpopulation LD is much longer in Western pigs compared with Chinese pigs with average r(0.3)(2) values of 125 kb for Western pigs and only 10.5 kb for Chinese pigs. The finding indicates that higher-density markers are required to capture LD with causal variants in genome-wide association studies and genomic selection on Chinese pigs. Further, we looked across the genome to identify candidate loci under selection using F-ST outlier tests on two contrast samples: Tibetan pigs versus lowland pigs and belted pigs against non-belted pigs. Interestingly, we highlighted several genes including ADAMTS12, SIM1 and NOS1 that show signatures of natural selection in Tibetan pigs and are likely important for genetic adaptation to high altitude. Comparison of our findings with previous reports indicates that the underlying genetic basis for high-altitude adaptation in Tibetan pigs, Tibetan peoples and yaks is likely distinct from one another. Moreover, we identified the strongest signal of directional selection at the EDNRB loci in Chinese belted pigs, supporting EDNRB as a promising candidate gene for the white belt coat color in Chinese pigs. Altogether, our findings advance the understanding of the genome biology of Chinese and Western pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019; Cheng, Alfred/C-3327-2014; Wu, William K.K./A-3277-2009; Chan, Franky/M-1043-2018; Chan, Francis K.L./F-4851-2010; SUNG, Joseph J Y/R-3203-2018	Yu, Fei-Hai/0000-0001-5007-1745; Cheng, Alfred/0000-0003-2345-6951; Dong, Bi-Cheng/0000-0002-9658-9969; Wu, William K.K./0000-0002-5662-5240; Chan, Franky/0000-0003-0567-2052; Zhang, Lin/0000-0003-1634-3780; Chan, Francis K.L./0000-0001-7388-2436; SUNG, Joseph J Y/0000-0003-3125-5199	Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31160450]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136) and National Natural Science Foundation of China (31160450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Giuffra E, 2000, GENETICS, V154, P1785; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kline DD, 1998, J PHYSIOL-LONDON, V511, P273, DOI 10.1111/j.1469-7793.1998.273bi.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; McLaren D. G., 1990, Animal Breeding Abstracts, V58, P347; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren Jun, 2002, Acta Genetica Sinica, V29, P774; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; SVED J A, 1971, Theoretical Population Biology, V2, P125; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045	42	212	229	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56001	10.1371/journal.pone.0056001	http://dx.doi.org/10.1371/journal.pone.0056001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409110	Green Submitted, gold, Green Published			2022-12-25	WOS:000315157200102
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
